PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cheng, NM; Fang, YHD; Tsan, DL; Hsu, CH; Yen, TC				Cheng, Nai-Ming; Fang, Yu-Hua Dean; Tsan, Din-Li; Hsu, Ching-Han; Yen, Tzu-Chen			Respiration-Averaged CT for Attenuation Correction of PET Images - Impact on PET Texture Features in Non-Small Cell Lung Cancer Patients	PLOS ONE			English	Article							TOTAL LESION GLYCOLYSIS; LEARNING HEALTH-CARE; F-18-FDG PET; HETEROGENEITY; RADIOTHERAPY; CARCINOMA; SURVIVAL; MOTION; VOLUME; QUANTITATION	Purpose We compared attenuation correction of PET images with helical CT (PET/HCT) and respiration-averaged CT (PET/ACT) in patients with non-small-cell lung cancer (NSCLC) with the goal of investigating the impact of respiration-averaged CT on F-18 FDG PET texture parameters. Materials and Methods A total of 56 patients were enrolled. Tumors were segmented on pretreatment PET images using the adaptive threshold. Twelve different texture parameters were computed: standard uptake value (SUV) entropy, uniformity, entropy, dissimilarity, homogeneity, coarseness, busyness, contrast, complexity, grey-level nonuniformity, zone-size nonuniformity, and high grey-level large zone emphasis. Comparisons of PET/HCT and PET/ACT were performed using Wilcoxon signed-rank tests, intraclass correlation coefficients, and Bland-Altman analysis. Receiver operating characteristic (ROC) curves as well as univariate and multivariate Cox regression analyses were used to identify the parameters significantly associated with disease-specific survival (DSS). A fixed threshold at 45% of the maximum SUV (T45) was used for validation. Results SUV maximum and total lesion glycolysis (TLG) were significantly higher in PET/ACT. However, texture parameters obtained with PET/ACT and PET/HCT showed a high degree of agreement. The lowest levels of variation between the two modalities were observed for SUV entropy (9.7%) and entropy (9.8%). SUV entropy, entropy, and coarseness from both PET/ACT and PET/HCT were significantly associated with DSS. Validation analyses using T45 confirmed the usefulness of SUV entropy and entropy in both PET/HCT and PET/ACT for the prediction of DSS, but only coarseness from PET/ACT achieved the statistical significance threshold. Conclusions Our results indicate that 1) texture parameters from PET/ACT are clinically useful in the prediction of survival in NSCLC patients and 2) SUV entropy and entropy are robust to attenuation correction methods.	[Cheng, Nai-Ming; Yen, Tzu-Chen] Chang Gung Mem Hospita, Dept Nucl Med, Linkou, Taiwan; [Cheng, Nai-Ming; Yen, Tzu-Chen] Chang Gung Univ, Coll Med, Dept Nucl Med, Taoyuan 33305, Taiwan; [Cheng, Nai-Ming; Hsu, Ching-Han] Natl Tsing Hua Univ, Dept Biomed Engn & Environm Sci, Hsinchu 30071, Taiwan; [Fang, Yu-Hua Dean] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Tsan, Din-Li] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Radiat Oncol, Taoyuan 33305, Taiwan	Chang Gung University; National Tsing Hua University; National Cheng Kung University; Chang Gung Memorial Hospital; Chang Gung University	Yen, TC (corresponding author), Chang Gung Mem Hospita, Dept Nucl Med, Linkou, Taiwan.; Yen, TC (corresponding author), Chang Gung Univ, Coll Med, Dept Nucl Med, Taoyuan 33305, Taiwan.	yentc1110@gmail.com	Hsu, Ching-Han/G-6029-2010	Hsu, Ching-Han/0000-0003-2351-2052				Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Alessio AM, 2007, J NUCL MED, V48, P794, DOI 10.2967/jnumed.106.035717; AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Borst GR, 2005, EUR J CANCER, V41, P1533, DOI 10.1016/j.ejca.2005.03.026; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Cheng NM, 2009, EUR J NUCL MED MOL I, V36, P607, DOI 10.1007/s00259-008-0995-7; Chi PCM, 2007, MED PHYS, V34, P2039, DOI 10.1118/1.2733810; Chicklore S, 2013, EUR J NUCL MED MOL I, V40, P133, DOI 10.1007/s00259-012-2247-0; Clausi DA, 2002, CAN J REMOTE SENS, V28, P45, DOI 10.5589/m02-004; Cohade C, 2003, EUR J NUCL MED MOL I, V30, P721, DOI 10.1007/s00259-002-1055-3; Cook GJR, 2014, CLIN TRANSL IMAGING, V2, P269, DOI 10.1007/s40336-014-0064-0; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; El Naqa I, 2014, CLIN TRANSL IMAGING, V2, P305, DOI 10.1007/s40336-014-0063-1; Erdi YE, 2004, J NUCL MED, V45, P1287; Fang YHD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/248505; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Goerres GW, 2003, RADIOLOGY, V226, P906, DOI 10.1148/radiol.2263011732; Goerres GW, 2002, EUR J NUCL MED MOL I, V29, P351, DOI 10.1007/s00259-001-0710-4; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Kuo WH, 2012, ACAD RADIOL, V19, P685, DOI 10.1016/j.acra.2012.02.013; Lambin P, 2015, ACTA ONCOL, V54, P1289, DOI 10.3109/0284186X.2015.1062136; Lambin P, 2013, RADIOTHER ONCOL, V109, P159, DOI 10.1016/j.radonc.2013.07.007; Lambin P, 2012, EUR J CANCER, V48, P441, DOI 10.1016/j.ejca.2011.11.036; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Lee CK, 2013, JNCI-J NATL CANCER I, V105, P595, DOI 10.1093/jnci/djt072; Lee KH, 2006, CLIN CANCER RES, V12, P4232, DOI 10.1158/1078-0432.CCR-05-2710; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Nehmeh SA, 2004, MED PHYS, V31, P1333, DOI 10.1118/1.1739671; Nestle U, 2005, J NUCL MED, V46, P1342; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Osman MM, 2003, J NUCL MED, V44, P240; Pan T, 2004, MED PHYS, V31, P333, DOI 10.1118/1.1639993; Pan TS, 2006, MED PHYS, V33, P3931, DOI 10.1118/1.2349843; Pan TS, 2005, J NUCL MED, V46, P1481; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Parmar C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102107; Pyka T, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0407-7; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Tixier F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099567; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Trani D, 2015, CLIN CANCER RES, V21, P5511, DOI 10.1158/1078-0432.CCR-15-0290; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; van Elmpt W., 2015, EUR J NUCL MED MOL I; Wang HM, 2016, INT J CANCER, V138, P731, DOI 10.1002/ijc.29811; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4; Yip S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115510	58	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150509	10.1371/journal.pone.0150509	http://dx.doi.org/10.1371/journal.pone.0150509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930211	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500162
J	Cho, H; Berger, B; Peng, J				Cho, Hyunghoon; Berger, Bonnie; Peng, Jian			Reconstructing Causal Biological Networks through Active Learning	PLOS ONE			English	Article							MODELS	Reverse-engineering of biological networks is a central problem in systems biology. The use of intervention data, such as gene knockouts or knockdowns, is typically used for teasing apart causal relationships among genes. Under time or resource constraints, one needs to carefully choose which intervention experiments to carry out. Previous approaches for selecting most informative interventions have largely been focused on discrete Bayesian networks. However, continuous Bayesian networks are of great practical interest, especially in the study of complex biological systems and their quantitative properties. In this work, we present an efficient, information-theoretic active learning algorithm for Gaussian Bayesian networks (GBNs), which serve as important models for gene regulatory networks. In addition to providing linear-algebraic insights unique to GBNs, leading to significant runtime improvements, we demonstrate the effectiveness of our method on data simulated with GBNs and the DREAM4 network inference challenge data sets. Our method generally leads to faster recovery of underlying network structure and faster convergence to final distribution of confidence scores over candidate graph structures using the full data, in comparison to random selection of intervention experiments.	[Cho, Hyunghoon; Berger, Bonnie; Peng, Jian] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Berger, Bonnie; Peng, Jian] MIT, Dept Math, Cambridge, MA 02139 USA; [Peng, Jian] Univ Illinois, Dept Comp Sci, Champaign, IL USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Illinois System; University of Illinois Urbana-Champaign	Berger, B; Peng, J (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Berger, B; Peng, J (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.; Peng, J (corresponding author), Univ Illinois, Dept Comp Sci, Champaign, IL USA.	bab@mit.edu; jianpeng@illinois.edu		Peng, Jian/0000-0002-1736-2978; Cho, Hyunghoon/0000-0002-2713-0150				Eberhardt F, 2012, UAI 08 P 24 C UNC AR, P161; Friedman N., 1999, P 15 C UNC ART INT; Geiger D., 1994, P 10 INT C UNC ART I; Giudici P, 2003, MACH LEARN, V50, P127, DOI 10.1023/A:1020202028934; Greenfield A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013397; Grzegorczyk M, 2010, METHODS MOL BIOL, V662, P121, DOI 10.1007/978-1-60761-800-3_6; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hauser A, 2015, J R STAT SOC B, V77, P291, DOI 10.1111/rssb.12071; Hauser A, 2014, INT J APPROX REASON, V55, P926, DOI 10.1016/j.ijar.2013.11.007; He YB, 2008, J MACHINE LEARNING R, V9; Maathuis MH, 2010, NAT METHODS, V7, P247, DOI 10.1038/nmeth0410-247; Maathuis MH, 2009, ANN STAT, V37, P3133, DOI 10.1214/09-AOS685; Markowetz F, 2003, P 3 INT WORKSH DISTR, P2; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mooij JM, 2013, P 29 C UNC ART INT; Murphy K. P., 2001, TECHNICAL REPORT; Neuberg LG, 2003, ECONOMET THEOR, V19, P675, DOI 10.1017/S026646603004109; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rau A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-111; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Spirtes P., 2000, CAUSATION PREDICTION, V81; Tong S., 2001, INT JOINT C ARTIFICI, P863; Werhli AV, 2006, BIOINFORMATICS, V22, P2523, DOI 10.1093/bioinformatics/btl391	23	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150611	10.1371/journal.pone.0150611	http://dx.doi.org/10.1371/journal.pone.0150611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930205	Green Submitted, gold, Green Published			2022-12-27	WOS:000371434500176
J	Eack, SM; Wojtalik, JA; Barb, SM; Newhill, CE; Keshavan, MS; Phillips, ML				Eack, Shaun M.; Wojtalik, Jessica A.; Barb, Scott M.; Newhill, Christina E.; Keshavan, Matcheri S.; Phillips, Mary L.			Fronto-Limbic Brain Dysfunction during the Regulation of Emotion in Schizophrenia	PLOS ONE			English	Article							WORKING-MEMORY; METAANALYSIS; INTERFERENCE; PERFORMANCE; DEPRESSION; STRATEGIES; EXPERIENCE; SELECTION; BIPOLAR; MODEL	Schizophrenia is characterized by significant and widespread impairments in the regulation of emotion. Evidence is only recently emerging regarding the neural basis of these emotion regulation impairments, and few studies have focused on the regulation of emotion during effortful cognitive processing. To examine the neural correlates of deficits in effortful emotion regulation, schizophrenia outpatients (N = 20) and age- and gender-matched healthy volunteers (N = 20) completed an emotional faces n-back task to assess the voluntary attentional control subprocess of emotion regulation during functional magnetic resonance imaging. Behavioral measures of emotional intelligence and emotion perception were administered to examine brain-behavior relationships with emotion processing outcomes. Results indicated that patients with schizophrenia demonstrated significantly greater activation in the bilateral striatum, ventromedial prefrontal, and right orbitofrontal cortices during the effortful regulation of positive emotional stimuli, and reduced activity in these same regions when regulating negative emotional information. The opposite pattern of results was observed in healthy individuals. Greater fronto-striatal response to positive emotional distractors was significantly associated with deficits in facial emotion recognition. These findings indicate that abnormalities in striatal and prefrontal cortical systems may be related to deficits in the effortful emotion regulatory process of attentional control in schizophrenia, and may significantly contribute to emotion processing deficits in the disorder.	[Eack, Shaun M.; Wojtalik, Jessica A.; Barb, Scott M.; Newhill, Christina E.] Univ Pittsburgh, Sch Social Work, Pittsburgh, PA 15260 USA; [Eack, Shaun M.; Phillips, Mary L.] Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA USA; [Keshavan, Matcheri S.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Massachusetts Mental Hlth Ctr,Publ Psychiat Div, Boston, MA 02215 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Eack, SM (corresponding author), Univ Pittsburgh, Sch Social Work, Pittsburgh, PA 15260 USA.; Eack, SM (corresponding author), Univ Pittsburgh, Sch Med, Western Psychiat Inst & Clin, Pittsburgh, PA USA.	sme12@pitt.edu		Wojtalik, Jessica/0000-0001-6079-4496	National Institutes of Health [MH 95783, RR 24154]; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the National Institutes of Health, grants MH 95783 (SME) and RR 24154 (SME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMONS RB, 1962, PSYCHOL REP, V11, P111, DOI 10.1177/003329416201100106; Anticevic A, 2012, SCHIZOPHR RES, V141, P8, DOI 10.1016/j.schres.2012.07.007; Anticevic A, 2011, BIOL PSYCHIAT, V70, P1159, DOI 10.1016/j.biopsych.2011.07.010; Anticevic A, 2012, SCHIZOPHRENIA BULL, V38, P967, DOI 10.1093/schbul/sbq168; Becerril K, 2011, SCHIZOPHRENIA BULL, V37, P1027, DOI 10.1093/schbul/sbq009; BERENBAUM H, 1992, J ABNORM PSYCHOL, V101, P37, DOI 10.1037/0021-843X.101.1.37; Bertocci MA, 2012, PSYCHOL MED, V42, P1417, DOI 10.1017/S003329171100242X; Carter CS, 2009, SCHIZOPHRENIA BULL, V35, P153, DOI 10.1093/schbul/sbn157; Eack SM, 2010, SCHIZOPHRENIA BULL, V36, P370, DOI 10.1093/schbul/sbn091; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; First MB, 2002, STRUCTURED CLIN INTE; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Gumora G, 2002, J SCHOOL PSYCHOL, V40, P395, DOI 10.1016/S0022-4405(02)00108-5; Gyurak A, 2011, COGNITION EMOTION, V25, P400, DOI 10.1080/02699931.2010.544160; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Kohler CG, 2003, AM J PSYCHIAT, V160, P1768, DOI 10.1176/appi.ajp.160.10.1768; Kohler CG, 2010, SCHIZOPHRENIA BULL, V36, P1009, DOI 10.1093/schbul/sbn192; Kring AM, 2013, ANNU REV CLIN PSYCHO, V9, P409, DOI 10.1146/annurev-clinpsy-050212-185538; Ladouceur CD, 2005, J ABNORM CHILD PSYCH, V33, P165, DOI 10.1007/s10802-005-1825-z; Ladouceur CD, 2009, EMOTION, V9, P855, DOI 10.1037/a0017747; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Marwaha S, 2014, SCHIZOPHRENIA BULL, V40, P269, DOI 10.1093/schbul/sbt149; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Nuechterlein KH, 2008, AM J PSYCHIAT, V165, P203, DOI 10.1176/appi.ajp.2007.07010042; O'Driscoll C, 2014, CLIN PSYCHOL REV, V34, P482, DOI 10.1016/j.cpr.2014.07.002; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Taylor SF, 2012, BIOL PSYCHIAT, V71, P136, DOI 10.1016/j.biopsych.2011.09.007; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van der Meer L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099667; Ward D.B., 2000, SIMULTANEOUS INFEREN; Webb TL, 2012, PSYCHOL BULL, V138, P775, DOI 10.1037/a0027600; Whitfield-Gabrieli, 2011, ARTIFACT DETECTION T; ZUBIN J, 1977, J ABNORM PSYCHOL, V86, P103, DOI 10.1037/0021-843X.86.2.103	37	14	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149297	10.1371/journal.pone.0149297	http://dx.doi.org/10.1371/journal.pone.0149297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930284	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000371434500023
J	Shu, Y; Ming, J; Zhang, P; Wang, QZ; Jiao, FJ; Tian, B				Shu, Yang; Ming, Jie; Zhang, Pei; Wang, Qingzhi; Jiao, Fengjuan; Tian, Bo			Parkinson-Related LRRK2 Mutation R1628P Enables Cdk5 Phosphorylation of LRRK2 and Upregulates Its Kinase Activity	PLOS ONE			English	Article							HAN-CHINESE POPULATION; SIGNALING PATHWAYS; DISEASE; PATHOGENESIS; G2385R; DOMAIN; NEURODEGENERATION; POLYMORPHISM; ASSOCIATION; VARIANTS	Background Recent studies have linked certain single nucleotide polymorphisms in the leucine-rich repeat kinase 2 (LRRK2) gene with Parkinson's disease (PD). Among the mutations, LRRK2 c.4883G>C (R1628P) variant was identified to have a significant association with the risk of PD in ethnic Han-Chinese populations. But the molecular pathological mechanisms of R1628P mutation in PD is still unknown. Principle Findings Unlike other LRRK2 mutants in the Roc-COR-Kinase domain, the R1628P mutation didn't alter the LRRK2 kinase activity and promote neuronal death directly. LRRK2 R1628P mutation increased the binding affinity of LRRK2 with Cyclin-dependent kinase 5 (Cdk5). Interestingly, R1628P mutation turned its adjacent amino acid residue S1627 on LRRK2 protein to a novel phosphorylation site of Cdk5, which could be defined as a typical type II (+) phosphorylation-related single nucleotide polymorphism. Importantly, we showed that the phosphorylation of S1627 by Cdk5 could activate the LRRK2 kinase, and neurons ectopically expressing R1628P displayed a higher sensitivity to 1-methyl-4-phenylpyridinium, a bioactive metabolite of environmental toxin MPTP, in a Cdk5-dependent manner. Conclusion Our data indicate that Parkinson-related LRRK2 mutation R1628P leads to Cdk5 phosphorylation of LRRK2 at S1627, which would upregulate the kinase activity of LRRK2 and consequently cause neuronal death.	[Shu, Yang; Zhang, Pei; Wang, Qingzhi; Jiao, Fengjuan; Tian, Bo] Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Neurobiol, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China; [Shu, Yang] Jiangsu Univ, Cent Lab, Affiliated Hosp, 438 Jiefang Rd, Zhenjiang 212000, Jiangsu, Peoples R China; [Ming, Jie] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Tongji Med Sch, 1277 Jiefang Ave, Wuhan 430022, Hubei Province, Peoples R China; [Zhang, Pei; Tian, Bo] Huazhong Univ Sci & Technol, Inst Brain Res, Collaborat Innovat Ctr Brain Sci, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China; [Zhang, Pei; Tian, Bo] Minist Educ, Key Lab Neurol Dis, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Jiangsu University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tian, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Neurobiol, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China.; Tian, B (corresponding author), Huazhong Univ Sci & Technol, Inst Brain Res, Collaborat Innovat Ctr Brain Sci, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China.; Tian, B (corresponding author), Minist Educ, Key Lab Neurol Dis, 13 Hangkong Rd, Wuhan 430030, Hubei Province, Peoples R China.	tianbo@mails.tjmu.edu.cn	TIAN, BO/G-2354-2011	TIAN, BO/0000-0002-8318-3046	National Natural Science Foundation of China [31071208, 31371384]; Program for New Century Excellent Talents in University [NCET-10-0415]; Doctor Startup Fund Program [JDFYRC-2015005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Doctor Startup Fund Program	This work was supported by the National Natural Science Foundation of China (No. 31071208, 31371384), Program for New Century Excellent Talents in University (No. NCET-10-0415), Doctor Startup Fund Program (JDFYRC-2015005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly JO, 2005, ANN NEUROL, V57, P762, DOI 10.1002/ana.20456; Ambroso MR, 2014, P NATL ACAD SCI USA, V111, P6982, DOI 10.1073/pnas.1402233111; Cai JP, 2013, NEUROL SCI, V34, P2001, DOI 10.1007/s10072-013-1436-3; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dhillon Amanpreet S, 2008, J Agromedicine, V13, P37, DOI 10.1080/10599240801986215; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Esteves AR, 2014, EXP NEUROL, V261, P206, DOI 10.1016/j.expneurol.2014.05.025; Fu XL, 2013, PARKINSONISM RELAT D, V19, P397, DOI 10.1016/j.parkreldis.2012.08.007; Gaki GS, 2014, NEUROMOL MED, V16, P217, DOI 10.1007/s12017-014-8294-x; Gentile S, 2008, P NATL ACAD SCI USA, V105, P14704, DOI 10.1073/pnas.0802250105; Gotthardt K, 2008, EMBO J, V27, P2239, DOI 10.1038/emboj.2008.150; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hirsch EC, 2013, MOVEMENT DISORD, V28, P24, DOI 10.1002/mds.25032; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Lewis PA, 2012, JOVE-J VIS EXP, DOI 10.3791/3495; Li XT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017153; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Lin MK, 2014, GENOME MED, V6, DOI 10.1186/gm566; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pulkes T, 2011, J NEUROL NEUROSUR PS, V82, P1179, DOI 10.1136/jnnp.2009.194597; Qing H, 2009, BIOCHEM BIOPH RES CO, V387, P149, DOI 10.1016/j.bbrc.2009.06.142; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Ren J, 2010, MOL CELL PROTEOMICS, V9, P623, DOI 10.1074/mcp.M900273-MCP200; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Ryu GM, 2009, NUCLEIC ACIDS RES, V37, P1297, DOI 10.1093/nar/gkn1008; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Sulzer D, 2013, MOVEMENT DISORD, V28, P715, DOI 10.1002/mds.25187; Tufi R, 2014, NAT CELL BIOL, V16, P157, DOI 10.1038/ncb2901; Wang CD, 2012, PARKINSONISM RELAT D, V18, P958, DOI 10.1016/j.parkreldis.2012.05.003; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102	32	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149739	10.1371/journal.pone.0149739	http://dx.doi.org/10.1371/journal.pone.0149739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930193	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500050
J	Rojo-Bartolome, I; de Cerio, OD; Diez, G; Cancio, I				Rojo-Bartolome, Iratxe; de Cerio, Oihane Diaz; Diez, Guzman; Cancio, Ibon			Identification of Sex and Female's Reproductive Stage in Commercial Fish Species through the Quantification of Ribosomal Transcripts in Gonads	PLOS ONE			English	Article							FACTOR-IIIA; REVERSE TRANSCRIPTION; ENDOCRINE DISRUPTION; BIOCHEMICAL RESEARCH; GENE-EXPRESSION; RNA; XENOPUS; TFIIIA; OOGENESIS; OOCYTES	The estimation of maturity and sex of fish stocks in European waters is a requirement of the EU Data Collection Framework as part of the policy to improve fisheries management. On the other hand, research on fish biology is increasingly focused in molecular approaches, researchers needing correct identification of fish sex and reproductive stage without necessarily having in house the histological know-how necessary for the task. Taking advantage of the differential gene transcription occurring during fish sex differentiation and gametogenesis, the utility of 5S ribosomal RNA (5S rRNA) and General transcription factor IIIA (gtf3a) in the molecular identification of sex and gametogenic stage was tested in different economically-relevant fish species from the Bay of Biscay. Gonads of 9 fish species (, Atlantic, Atlantic-chub and horse mackerel, blue whiting, bogue, European anchovy, hake and pilchard and megrim), collected from local commercial fishing vessels were histologically sexed and 5S and 18S rRNA concentrations were quantified by capillary electrophoresis to calculate a 5S/18S rRNA index. Degenerate primers permitted cloning and sequencing of gtf3a fragments in 7 of the studied species. 5S rRNA and gtf3a transcript levels, together with 5S/18S rRNA index, distinguished clearly ovaries from testis in all of the studied species. The values were always higher in females than in males. 5S/18S rRNA index values in females were always highest when fish were captured in early phases of ovary development whilst, in later vitellogenic stages, the values decreased significantly. In megrim and European anchovy, where gonads in different oogenesis stages were obtained, the 5S/18S rRNA index identified clearly gametogenic stage. This approach, to the sexing and the quantitative non-subjective identification of the maturity stage of female fish, could have multiple applications in the study of fish stock dynamics, fish reproduction and fecundity and fish biology in general.	[Rojo-Bartolome, Iratxe; de Cerio, Oihane Diaz; Cancio, Ibon] Univ Basque Country UPV EHU, Res Ctr Expt Marine Biol & Biotechnol Plentzia PI, Dept Zool & Anim Cell Biol, CBET Res Grp, Areatza Z-G, E-48620 Plentzia, Basque Country, Spain; [Diez, Guzman] AZTI, Div Marine Res, Txatxarramendi S-N, E-48395 Bizkaia, Basque Country, Spain	University of Basque Country; AZTI	Cancio, I (corresponding author), Univ Basque Country UPV EHU, Res Ctr Expt Marine Biol & Biotechnol Plentzia PI, Dept Zool & Anim Cell Biol, CBET Res Grp, Areatza Z-G, E-48620 Plentzia, Basque Country, Spain.	ibon.cancio@ehu.es	Cancio, Ibon/M-4594-2019; de cerio, Oihane Diaz/H-3336-2015; Cancio, Ibon/I-2821-2015	Cancio, Ibon/0000-0003-4841-0079; de cerio, Oihane Diaz/0000-0002-5605-8434; Cancio, Ibon/0000-0003-4841-0079	University of the Basque Country, Basque Government; Spanish MINECO [UFI 11/3, S-PE11UN007, S-PE12UN086, S-PE13UN101, IT810-13, AGL2012-33477]; Basque Government	University of the Basque Country, Basque Government(Basque Government); Spanish MINECO(Spanish Government); Basque Government(Basque Government)	This work was funded by the University of the Basque Country, Basque Government and the Spanish MINECO through projects: UFI 11/3, S-PE11UN007, S-PE12UN086, S-PE13UN101, IT810-13 and AGL2012-33477. IR is recipient of a grant for predoctoral studies of the Basque Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LA, 1995, DEV BIOL, V168, P284, DOI 10.1006/dbio.1995.1080; Armstrong MJ, 2012, FISH RES, V117, P35, DOI 10.1016/j.fishres.2010.12.028; Campo D, 2009, J MOL EVOL, V68, P208, DOI 10.1007/s00239-009-9207-8; Damstra T, 2002, WHOIPCSEDC022; De Santis C, 2011, MAR BIOTECHNOL, V13, P170, DOI 10.1007/s10126-010-9277-z; DENIS H, 1977, DEV BIOL, V59, P228, DOI 10.1016/0012-1606(77)90256-1; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; de Cerio OD, 2012, ENVIRON SCI TECHNOL, V46, P7763, DOI 10.1021/es301132b; Espigares F, 2015, GEN COMP ENDOCR, V224, P176, DOI 10.1016/j.ygcen.2015.08.013; Fan ZF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/291067; Filby AL, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-10; Gornung E, 2007, GENOME, V50, P787, DOI 10.1139/G07-058; Kroupova H, 2011, COMP BIOCHEM PHYS A, V159, P141, DOI 10.1016/j.cbpa.2011.02.007; Layat E, 2013, BBA-GENE REGUL MECH, V1829, P274, DOI 10.1016/j.bbagrm.2012.10.013; Libus J, 2006, BIOTECHNIQUES, V41, P156, DOI 10.2144/000112232; Lubzens E, 2010, GEN COMP ENDOCR, V165, P367, DOI 10.1016/j.ygcen.2009.05.022; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Manousaki T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-655; MAZABRAUD A, 1975, DEV BIOL, V44, P326, DOI 10.1016/0012-1606(75)90403-0; McDonough CJ, 2005, FISH B-NOAA, V103, P601; Mittelholzer C, 2007, J MOL ENDOCRINOL, V39, P319, DOI 10.1677/JME-07-0070; Morgan M. Joanne, 2009, Journal of Northwest Atlantic Fishery Science, V41, P37; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P33, DOI 10.2960/J.v33.a3; Murua H., 2003, Journal of Northwest Atlantic Fishery Science, V33, P23, DOI 10.2960/J.v33.a2; Ogilvie MK, 1997, GENE, V203, P103, DOI 10.1016/S0378-1119(97)00499-X; Ortiz-Zarragoitia M, 2014, MAR DRUGS, V12, P4756, DOI 10.3390/md12094756; Penberthy WT, 2003, GENE, V305, P205, DOI 10.1016/S0378-1119(03)00384-6; PFAFF SL, 1991, DEV BIOL, V145, P241, DOI 10.1016/0012-1606(91)90123-K; Prager MH, 2003, N AM J FISH MANAGE, V23, P349, DOI 10.1577/1548-8675(2003)023<0349:TALFMO>2.0.CO;2; Puy-Azurmendi E, 2013, SCI TOTAL ENVIRON, V443, P233, DOI 10.1016/j.scitotenv.2012.10.078; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Roger B, 2002, BIOCHEM BIOPH RES CO, V290, P1151, DOI 10.1006/bbrc.2001.6304; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Szymanski M, 2003, BIOCHEM J, V371, P641, DOI 10.1042/BJ20020872; Wischnewski J, 2004, EUR J CELL BIOL, V83, P55, DOI 10.1078/0171-9335-00358; Witthames PR, 2009, FISH B-NOAA, V107, P148	38	16	16	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149711	10.1371/journal.pone.0149711	http://dx.doi.org/10.1371/journal.pone.0149711			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918444	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400038
J	Fernandez-Marcelo, T; Sanchez-Pernaute, A; Pascua, I; De Juan, C; Head, J; Torres-Garcia, AJ; Iniesta, P				Fernandez-Marcelo, Tamara; Sanchez-Pernaute, Andres; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Torres-Garcia, Antonio-Jose; Iniesta, Pilar			Clinical Relevance of Telomere Status and Telomerase Activity in Colorectal Cancer	PLOS ONE			English	Article							NONSMALL CELL LUNG; COLON-CANCER; LENGTH; EXPRESSION; PROGNOSIS; CARCINOMA; SURVIVAL; TUMORS; INSTABILITY; PROGRESSION	The role of telomeres and telomerase in colorectal cancer (CRC) is well established as the major driving force in generating chromosomal instability. However, their potential as prognostic markers remains unclear. We investigated the outcome implications of telomeres and telomerase in this tumour type. We considered telomere length (TL), ratio of telomere length in cancer to non-cancer tissue (T/N ratio), telomerase activity and TERT levels; their relation with clinical variables and their role as prognostic markers. We analyzed 132 CRCs and paired non-cancer tissues. Kaplan-Meier curves for disease-free survival were calculated for TL, T/N ratio, telomerase activity and TERT levels. Overall, tumours had shorter telomeres than non-tumour tissues (P < 0.001) and more than 80% of CRCs displayed telomerase activity. Telomere lengths of non-tumour tissues and CRCs were positively correlated (P < 0.001). Considering telomere status and clinical variables, the lowest degree of telomere shortening was shown by tumours located in the rectum (P = 0.021). Regarding prognosis studies, patients with tumours showing a mean TL < 6.35 Kb experienced a significantly better clinical evolution (P < 0.001) and none of them with the highest degree of tumour telomere shortening relapsed during the follow-up period (P = 0.043). The mean TL in CRCs emerged as an independent prognostic factor in the Cox analysis (P = 0.017). Telomerase-positive activity was identified as a marker that confers a trend toward a poor prognosis. In CRC, our results support the use of telomere status as an independent prognostic factor. Telomere status may contribute to explaining the different molecular identities of this tumour type.	[Fernandez-Marcelo, Tamara; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Iniesta, Pilar] Univ Complutense, Fac Pharm 2, Dept Biochem & Mol Biol 2, E-28040 Madrid, Spain; [Sanchez-Pernaute, Andres; Torres-Garcia, Antonio-Jose] San Carlos Hosp, Serv Gen Surg & Digest Tract, Madrid 28040, Spain; [Fernandez-Marcelo, Tamara; Sanchez-Pernaute, Andres; Pascua, Irene; De Juan, Carmen; Head, Jacqueline; Torres-Garcia, Antonio-Jose; Iniesta, Pilar] Sanitary Res Inst San Carlos Hosp IdISSC, Madrid 28040, Spain	Complutense University of Madrid; San Paolo-Polo Universitaria Hospital	Iniesta, P (corresponding author), Univ Complutense, Fac Pharm 2, Dept Biochem & Mol Biol 2, E-28040 Madrid, Spain.; Iniesta, P (corresponding author), Sanitary Res Inst San Carlos Hosp IdISSC, Madrid 28040, Spain.	insepi@ucm.es	Sánchez-Pernaute, Andrés/J-9588-2016; Fernández-Marcelo, Tamara/Y-9067-2019; Fernández-Marcelo, Tamara/N-9196-2018; Torres, Antonio/AAH-9479-2020	Fernández-Marcelo, Tamara/0000-0001-6550-3838; Fernández-Marcelo, Tamara/0000-0001-6550-3838; Torres, Antonio/0000-0002-9472-854X	Fundacion de Investigacion Medica Mutua Madrilena; Santander-UCM	Fundacion de Investigacion Medica Mutua Madrilena; Santander-UCM	This work was supported by grants from Fundacion de Investigacion Medica Mutua Madrilena and Santander-UCM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine TA, 2015, BRIT J CANCER, V112, P313, DOI 10.1038/bjc.2014.561; Ayiomamitis GD, 2014, CAN J SURG, V57, P199, DOI 10.1503/cjs.031312; Baichoo E, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00158; Bertorelle R, 2013, BRIT J CANCER, V108, P278, DOI 10.1038/bjc.2012.602; Bertorelle R, 2014, WORLD J GASTROENTERO, V20, P1940, DOI 10.3748/wjg.v20.i8.1940; Bisoffi M, 2006, INT J CANCER, V119, P2255, DOI 10.1002/ijc.22120; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boardman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080015; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; Ferlay J, 2012, IARC CANC BASE; Fernandez-Marcelo T, 2012, ONCOLOGY-BASEL, V82, P153, DOI 10.1159/000335678; Frias C, 2008, LUNG CANCER, V60, P416, DOI 10.1016/j.lungcan.2007.11.001; Garcia-Aranda C, 2006, CANCER-AM CANCER SOC, V106, P541, DOI 10.1002/cncr.21625; Gertler R, 2004, J CLIN ONCOL, V22, P1807, DOI 10.1200/JCO.2004.09.160; Giunco S, 2015, CURR PATHOBIOL REP, DOI [10.1007/s40139-015-0097-x, DOI 10.1007/S40139-015-0097-X]; Gonzalez-Quevedo R, 2002, J CLIN ONCOL, V20, P254, DOI 10.1200/JCO.20.1.254; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hao XD, 2013, ONCOL REP, V29, P226, DOI 10.3892/or.2012.2098; Kalia M, 2015, METABOLISM, V64, pS16, DOI 10.1016/j.metabol.2014.10.027; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Lu YM, 2013, FRONT MED-PRC, V7, P411, DOI 10.1007/s11684-013-0293-z; Malaska J, 2004, NEOPLASMA, V51, P90; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Mzahma R, 2015, TUMOR BIOL, V36, P8703, DOI 10.1007/s13277-015-3545-5; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pancione Massimo, 2012, Patholog Res Int, V2012, P509348, DOI 10.1155/2012/509348; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Rampazzo E, 2010, BRIT J CANCER, V102, P1300, DOI 10.1038/sj.bjc.6605644; Samassekou O, 2010, ANN ANAT, V192, P284, DOI 10.1016/j.aanat.2010.07.005; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Tanaka H, 2014, NEOPLASIA, V16, P814, DOI 10.1016/j.neo.2014.08.009; TURNBULL RB, 1967, ANN SURG, V166, P420; Valls C, 2011, COLORECTAL DIS, V13, P1265, DOI 10.1111/j.1463-1318.2010.02433.x; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X; World Cancer Research Fund / American Institute for Cancer Research, 2011, CONT UPD PROJ REP FO; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Worthley Daniel L, 2010, Clin Biochem Rev, V31, P31	42	30	30	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149626	10.1371/journal.pone.0149626	http://dx.doi.org/10.1371/journal.pone.0149626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913901	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700023
J	Redouane, B; Cohen, E; Stephens, D; Keilty, K; Mouzaki, M; Narayanan, U; Moraes, T; Amin, R				Redouane, Brahim; Cohen, Eyal; Stephens, Derek; Keilty, Krista; Mouzaki, Marialena; Narayanan, Unni; Moraes, Theo; Amin, Reshma			Parental Perceptions of Quality of Life in Children on Long-Term Ventilation at Home as Compared to Enterostomy Tubes	PLOS ONE			English	Article							HEALTH-CARE NEEDS; CHRONIC RESPIRATORY-FAILURE; MECHANICAL VENTILATION; UNITED-KINGDOM; PEDIATRIC POPULATION; IDENTIFYING CHILDREN; UTILITY SCORES; CHILDHOOD; INDEX; PEDSQL(TM)-4.0	Objective Health related quality of life (HRQL) of children using medical technology at home is largely unknown. Our aim was to examine the HRQL in children on long-term ventilation at home (LTHV) in comparison to a cohort using an enterostomy tube. Study Design Participants were divided into three groups: 1) LTHV without an enterostomy tube (LTHV cohort); 2) Enterostomy tube (GT cohort); 3) LTHV with an enterostomy tube (LTHV+ GT cohort). Caregivers of children >= 5 years and followed at SickKids, Toronto, Canada, completed three questionnaires: Health Utilities Index 2/3 (HUI2/3), Caregiver Priorities Caregiver Health Index (CPCHILD), and the Paediatric Quality of Life Inventory (PedsQL). The primary outcome was the difference in utility (HUI2/3) scores between the cohorts. Results One hundred and nineteen children were enrolled; 47 in the LTHV cohort, 44 in the GT cohort, and 28 in the LTHV+ GT cohort. In univariate analysis, HUI2 mean (SE) scores were lowest for the GT cohort, 0.4 (0.04) followed by the LTHV+ GT, 0.42 (0.05) and then the LTHV cohort, 0.7 (0.04), p = 0.001. A similar trend was seen for the HUI3 mean (SE) scores: GT cohort, 0.1 (0.06), followed by the LTHV +GT cohort, 0.2 (0.08) and then the LTHV cohort, 0.5 (0.06), p = 0.0001. Technology cohort, nursing hours and the severity of health care needs predicted HRQL as measured by the HUI2/3. Conclusion The HRQL of these children is low. Children on LTHV had higher HRQL than children using enterostomy tubes. Further work is needed to identify modifiable factors that can improve HRQL.	[Redouane, Brahim; Moraes, Theo; Amin, Reshma] Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Redouane, Brahim; Cohen, Eyal; Keilty, Krista; Mouzaki, Marialena; Narayanan, Unni; Moraes, Theo; Amin, Reshma] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Cohen, Eyal] Hosp Sick Children, Div Pediat Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Cohen, Eyal; Narayanan, Unni; Amin, Reshma] Hosp Sick Children, Dept Child Hlth & Evaluat Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Stephens, Derek] Hosp Sick Children, Dept Biostat Design & Anal, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Keilty, Krista] Hosp Sick Children, Ctr Innovat & Excellence Child & Family Ctr Care, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Mouzaki, Marialena] Hosp Sick Children, Div Gastroenterol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Narayanan, Unni] Hosp Sick Children, Dept Orthoped Surg, 555 Univ Ave, Toronto, ON M5G 1X8, Canada; [Keilty, Krista] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Amin, R (corresponding author), Hosp Sick Children, Div Resp Med, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.; Amin, R (corresponding author), Univ Toronto, Dept Pediat, Toronto, ON, Canada.; Amin, R (corresponding author), Hosp Sick Children, Dept Child Hlth & Evaluat Sci, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	reshma.amin@sickkids.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Narayanan, Unni G./0000-0003-0051-9622	Health Utilities Index New Investigator Grant [HUI2/3]	Health Utilities Index New Investigator Grant	This work was supported by a Health Utilities Index New Investigator Grant (The licensing fees to use the HUI2/3 were waived for this study), http://www.healthutilities.com/fees.htm. The Health Utilities Index New Investigator Grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin R, 2013, PEDIAT PULMONOL; Barr RD, 2000, J CLIN ONCOL, V18, P3280, DOI 10.1200/JCO.2000.18.18.3280; Bertrand P, 2006, ARCH BRONCONEUMOL, V42, P165, DOI 10.1016/S1579-2129(06)60437-0; Bethell CD, 2002, AMBUL PEDIATR, V2, P49, DOI 10.1367/1539-4409(2002)002<0049:COTCWS>2.0.CO;2; Bethell CD, 2002, AMBUL PEDIATR, V2, P38, DOI 10.1367/1539-4409(2002)002<0038:ICWSHC>2.0.CO;2; Bramlett MD, 2009, MATERN CHILD HLTH J, V13, P151, DOI 10.1007/s10995-008-0339-z; Ebrahim S, 2013, J CHILD HLTH CARE; Edwards EA, 2005, J PAEDIATR CHILD H, V41, P652, DOI 10.1111/j.1440-1754.2005.00753.x; Eiser C, 2001, Health Technol Assess, V5, P1; Evans S, 2006, J HUM NUTR DIET, V19, P27, DOI 10.1111/j.1365-277X.2006.00662.x; Fauroux B, 1995, EUR RESPIR J, V8, P2062, DOI 10.1183/09031936.95.08122062; Fauroux B, 2003, PEDIATR PULM, V35, P119, DOI 10.1002/ppul.10237; Feeny D, 2004, SOC SCI MED, V58, P799, DOI 10.1016/S0277-9536(03)00254-5; Feudtner Chris, 2005, BMC Pediatr, V5, P8, DOI 10.1186/1471-2431-5-8; Fox D, 2014, J PEDIAT GASTROENTER; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Gowans M, 2007, PEDIATR PULM, V42, P231, DOI 10.1002/ppul.20558; Graham RJ, 2007, PEDIATRICS, V119, pE1280, DOI 10.1542/peds.2006-2471; Gritti A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-55; GUYATT GH, 1993, ANN INTERN MED, V118, P622, DOI 10.7326/0003-4819-118-8-199304150-00009; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Jardine E, 1999, BMJ-BRIT MED J, V318, P295, DOI 10.1136/bmj.318.7179.295; Jardine E, 1998, THORAX, V53, P762, DOI 10.1136/thx.53.9.762; Kamm M, 2001, SWISS MED WKLY, V131, P261; Kuo DZ, 2011, ARCH PEDIAT ADOL MED, V165, P1020, DOI 10.1001/archpediatrics.2011.172; Mahant S, 2009, ARCH DIS CHILD, V94, P668, DOI 10.1136/adc.2008.149542; McDougall CM, 2013, ARCH DIS CHILD, V98, P660, DOI 10.1136/archdischild-2012-303062; Narayanan UG, 2006, DEV MED CHILD NEUROL, V48, P804, DOI 10.1017/S0012162206001745; Oktem S, 2008, RESPIRATION, V76, P76, DOI 10.1159/000110801; Ottonello G, 2007, PEDIATR INT, V49, P801, DOI 10.1111/j.1442-200X.2007.02463.x; Paulides FM, 2012, INTENS CARE MED, V38, P847, DOI 10.1007/s00134-012-2545-9; Petrou S, 2009, MED DECIS MAKING, V29, P291, DOI 10.1177/0272989X08327398; Pogany L, 2006, QUAL LIFE RES, V15, P143, DOI 10.1007/s11136-005-0198-7; Racca F, 2011, MINERVA ANESTESIOL, V77, P892; ROBINSON RO, 1990, ARCH DIS CHILD, V65, P1235, DOI 10.1136/adc.65.11.1235; Saigal S, 1996, JAMA-J AM MED ASSOC, V276, P453, DOI 10.1001/jama.276.6.453; Tibballs J, 2010, J PAEDIATR CHILD H, V46, P57, DOI 10.1111/j.1440-1754.2009.01618.x; Tilford JM, 2005, QUAL LIFE RES, V14, P1087, DOI 10.1007/s11136-004-3305-2; van der Lee JH, 2007, JAMA-J AM MED ASSOC, V297, P2741, DOI 10.1001/jama.297.24.2741; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Verrips E, 2008, PEDIATRICS, V122, P556, DOI 10.1542/peds.2007-1043; Wallis C, 2011, ARCH DIS CHILD, V96, P998, DOI 10.1136/adc.2010.192864; Yi MS, 2003, J PEDIATR-US, V142, P133, DOI 10.1067/mpd.2003.51	44	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149999	10.1371/journal.pone.0149999	http://dx.doi.org/10.1371/journal.pone.0149999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26914939	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700044
J	Xue, Y; Wilkes, JG; Moskal, TJ; Williams, AJ; Cooper, WM; Nayak, R; Rafii, F; Buzatu, DA				Xue, Yong; Wilkes, Jon G.; Moskal, Ted J.; Williams, Anna J.; Cooper, Willie M.; Nayak, Rajesh; Rafii, Fatemeh; Buzatu, Dan A.			Development of a Flow Cytometry-Based Method for Rapid Detection of Escherichia coli and Shigella Spp. Using an Oligonucleotide Probe	PLOS ONE			English	Article							FOOD MATRIX INTERFERENCE; COMBINATION; PROTEIN	Standard methods to detect Escherichia coli contamination in food use the polymerase chain reaction (PCR) and agar culture plates. These methods require multiple incubation steps and take a long time to results. An improved rapid flow-cytometry based detection method was developed, using a fluorescence-labeled oligonucleotide probe specifically binding a16S rRNA sequence. The method positively detected 51 E. coli isolates as well as 4 Shigella species. All 27 non-E. coli strains tested gave negative results. Comparison of the new genetic assay with a total plate count (TPC) assay and agar plate counting indicated similar sensitivity, agreement between cytometry cell and colony counts. This method can detect a small number of E. coli cells in the presence of large numbers of other bacteria. This method can be used for rapid, economical, and stable detection of E. coli and Shigella contamination in the food industry and other contexts.	[Xue, Yong; Wilkes, Jon G.; Williams, Anna J.; Cooper, Willie M.; Buzatu, Dan A.] US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Nayak, Rajesh; Rafii, Fatemeh] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Xue, Y (corresponding author), US FDA, Div Syst Biol, Natl Ctr Toxicol Res, Jefferson, AR USA.	Yong.Xue@fda.hhs.gov		Xue, Yong/0000-0002-9091-3772	US federal government	US federal government	This work was supported by the US federal government.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Besser RE, 1999, ANNU REV MED, V50, P355, DOI 10.1146/annurev.med.50.1.355; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Buzatu DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094254; Buzatu DA, 2013, FOOD MICROBIOL, V36, P416, DOI 10.1016/j.fm.2013.07.007; CDC, 2011, E COL OUTBR INV; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P975; Davey HM, 1996, MICROBIOL REV, V60, P641, DOI 10.1128/MMBR.60.4.641-696.1996; Doherty SB, 2010, J MICROBIOL METH, V82, P301, DOI 10.1016/j.mimet.2010.07.003; EWING WH, 1949, J BACTERIOL, V57, P633, DOI 10.1128/JB.57.6.633-638.1949; Feng P.D., BAM DIARRHEAGENIC ES; FSIS, 2010, PROC US ESCH COL O15; Joachimsthal EL, 2003, WORLD J MICROB BIOT, V19, P527, DOI 10.1023/A:1025122032762; Kenzaka T, 2001, J HEALTH SCI, V47, P353, DOI 10.1248/jhs.47.353; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721, DOI 10.4315/0362-028X-73.9.1721; Neil KP, 2012, CLIN INFECT DIS, V54, P511, DOI 10.1093/cid/cir831; Newell DG, 2010, INT J FOOD MICROBIOL, V139, pS3, DOI 10.1016/j.ijfoodmicro.2010.01.021; Rangel JM, 2005, EMERGING INFECT DIS, V11; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Vogt RL, 2005, PUBLIC HEALTH REP, V120, P174, DOI 10.1177/003335490512000211; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wilkes JG, 2012, FOOD MICROBIOL, V30, P281, DOI 10.1016/j.fm.2011.11.002	23	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150038	10.1371/journal.pone.0150038	http://dx.doi.org/10.1371/journal.pone.0150038			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913737	gold, Green Published			2022-12-27	WOS:000371175700048
J	Chu, YH; Hsu, YC; Keil, B; Kuo, WJ; Lin, FH				Chu, Ying-Hua; Hsu, Yi-Cheng; Keil, Boris; Kuo, Wen-Jui; Lin, Fa-Hsuan			A 32-Channel Head Coil Array with Circularly Symmetric Geometry for Accelerated Human Brain Imaging	PLOS ONE			English	Article							TO-NOISE RATIO; 3 TESLA; PHASED-ARRAY; PARALLEL MRI; DESIGN; ACQUISITION; RECONSTRUCTION; GRADIENTS; FIELDS; SENSE	The goal of this study is to optimize a 32-channel head coil array for accelerated 3T human brain proton MRI using either a Cartesian or a radial k-space trajectory. Coils had curved trapezoidal shapes and were arranged in a circular symmetry (CS) geometry. Coils were optimally overlapped to reduce mutual inductance. Low-noise pre-amplifiers were used to further decouple between coils. The SNR and noise amplification in accelerated imaging were compared to results from a head coil array with a soccer-ball (SB) geometry. The maximal SNR in the CS array was about 120% (1070 vs. 892) and 62% (303 vs. 488) of the SB array at the periphery and the center of the FOV on a transverse plane, respectively. In onedimensional 4-fold acceleration, the CS array has higher averaged SNR than the SB array across the whole FOV. Compared to the SB array, the CS array has a smaller g-factor at head periphery in all accelerated acquisitions. Reconstructed images using a radial k-space trajectory show that the CS array has a smaller error than the SB array in 2- to 5-fold accelerations.	[Chu, Ying-Hua; Hsu, Yi-Cheng; Lin, Fa-Hsuan] Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan; [Keil, Boris] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Keil, Boris] Mittelhessen Univ Appl Sci, Dept Life Sci Engn, Inst Med Phys & Radiat Safety, Giessen, Germany; [Kuo, Wen-Jui] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan	National Taiwan University; Harvard University; Massachusetts General Hospital; National Yang Ming Chiao Tung University	Lin, FH (corresponding author), Natl Taiwan Univ, Inst Biomed Engn, Taipei 10764, Taiwan.	fhlin@ntu.edu.tw	Keil, Boris/AAX-9557-2020; Keil, Boris/P-1411-2014; Lin, Fa-Hsuan/G-6988-2012	Lin, Fa-Hsuan/0000-0002-9539-1731; Keil, Boris/0000-0003-0805-8330	National Science Council, Taiwan [NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046]; Academy of Finland (the FiDiPro program); Ministry of Science and Technology, Taiwan [MOST 103-2628-B-002-002-MY3, MOST 104-2314-B-002 -238, MOST 102-2410-H-010-004 -MY2]; Ministry of Economic Affairs, Taiwan [100-EC-17-A-19-S1-175]; National Health Research Institute, Taiwan [NHRI-EX103-10247EI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academy of Finland (the FiDiPro program)(Academy of Finland); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Economic Affairs, Taiwan(Ministry of Economic Affairs, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by NSC 101-2628-B-002-005-MY3, NSC 100-2325-B-002-046 (National Science Council, Taiwan), and Academy of Finland (the FiDiPro program). This work was also partially supported by MOST 103-2628-B-002-002-MY3, MOST 104-2314-B-002 -238, MOST 102-2410-H-010-004 -MY2 (Ministry of Science and Technology, Taiwan), 100-EC-17-A-19-S1-175 (Ministry of Economic Affairs, Taiwan), and NHRI-EX103-10247EI (National Health Research Institute, Taiwan). The funders had no role in study design,	AHN CB, 1986, IEEE T MED IMAGING, V5, P2, DOI 10.1109/TMI.1986.4307732; Bodurka J, 2004, MAGNET RESON MED, V51, P165, DOI 10.1002/mrm.10693; Cohen-Adad J, 2011, MAGN RESON MED, V66, P1198, DOI 10.1002/mrm.22906; De Zanche N, 2008, NMR BIOMED, V21, P644, DOI 10.1002/nbm.1237; de Zwart JA, 2004, MAGNET RESON MED, V51, P22, DOI 10.1002/mrm.10678; de Zwart JA, 2002, MAGNET RESON MED, V47, P1218, DOI 10.1002/mrm.10169; Deppe MH, 2011, MAGN RESON MED, V66, P1788, DOI 10.1002/mrm.22962; Duan Q, 2009, SPIE MED IMAGING; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Hergt M, 2007, P 15 ANN M ISMRM BER; Keil B, 2013, MAGN RESON MED, V70, P248, DOI 10.1002/mrm.24427; Keil B, 2011, MAGN RESON MED, V66, P1777, DOI 10.1002/mrm.22961; Kellman P, 2005, MAGNET RESON MED, V54, P1439, DOI 10.1002/mrm.20713; Lin FH, 2006, MAGN RESON MED, V56, P787, DOI 10.1002/mrm.20997; Lin FH, 2012, MAGN RESON MED, V68, P1145, DOI 10.1002/mrm.24115; McDougall MP, 2005, MAGN RESON MED, V54, P386, DOI 10.1002/mrm.20568; Mispelter J, 2006, NMR PROBEHEADS BIOPH; NOLL DC, 1991, IEEE T MED IMAGING, V10, P629, DOI 10.1109/42.108599; Nordmeyer-Massner JA, 2009, MAGN RESON MED, V61, P429, DOI 10.1002/mrm.21868; Ohliger MA, 2003, MAGNET RESON MED, V50, P1018, DOI 10.1002/mrm.10597; Ohliger MA, 2006, NMR BIOMED, V19, P300, DOI 10.1002/nbm.1046; Pipe JG, 1999, MAGNET RESON MED, V42, P963, DOI 10.1002/(SICI)1522-2594(199911)42:5<963::AID-MRM17>3.0.CO;2-L; Possanzini C, 2008, P 16 ANN M ISMRM TOR; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schmitt M, 2008, MAGN RESON MED, V59, P1431, DOI 10.1002/mrm.21598; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Sodickson DK, 2001, MED PHYS, V28, P1629, DOI 10.1118/1.1386778; Stockmann JP, 2010, MAGN RESON MED, V64, P447, DOI 10.1002/mrm.22425; Stollberger R, 1996, MAGNET RESON MED, V35, P246, DOI 10.1002/mrm.1910350217; Wiesinger F, 2004, MAGNET RESON MED, V52, P376, DOI 10.1002/mrm.20183; Wiggins GC, 2006, MAGN RESON MED, V56, P216, DOI 10.1002/mrm.20925; Wiggins GC, 2009, MAGN RESON MED, V62, P754, DOI 10.1002/mrm.22028	33	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149446	10.1371/journal.pone.0149446	http://dx.doi.org/10.1371/journal.pone.0149446			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909652	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700034
J	Davies, AB; Tambling, CJ; Kerley, GIH; Asner, GP				Davies, Andrew B.; Tambling, Craig J.; Kerley, Graham I. H.; Asner, Gregory P.			Effects of Vegetation Structure on the Location of Lion Kill Sites in African Thicket	PLOS ONE			English	Article							NATIONAL-PARK; HUNTING SUCCESS; PREDATION RISK; SOUTH-AFRICA; SEMIARID ENVIRONMENT; FORAGING BEHAVIOR; PREY PREFERENCES; EASTERN-CAPE; PANTHERA-LEO; VIGILANCE	Predator-prey relationships are integral to ecosystem stability and functioning. These relationships are, however, difficult to maintain in protected areas where large predators are increasingly being reintroduced and confined. Where predators make kills has a profound influence on their role in ecosystems, but the relative importance of environmental variables in determining kill sites, and how these might vary across ecosystems is poorly known. We investigated kill sites for lions in South Africa's thicket biome, testing the importance of vegetation structure for kill site locations compared to other environmental variables. Kill sites were located over four years using GPS telemetry and compared to non-kill sites that had been occupied by lions, as well as to random sites within lion ranges. Measurements of 3D vegetation structure obtained from Light Detection and Ranging (LiDAR) were used to calculate the visible area (viewshed) around each site and, along with wind and moonlight data, used to compare kill sites between lion sexes, prey species and prey sexes. Viewshed area was the most important predictor of kill sites (sites in dense vegetation were twice as likely to be kill sites compared to open areas), followed by wind speed and, less so, moonlight. Kill sites for different prey species varied with vegetation structure, and male prey were killed when wind speeds were higher compared to female prey of the same species. Our results demonstrate that vegetation structure is an important component of predator-prey interactions, with varying effects across ecosystems. Such differences require consideration in terms of the ecological roles performed by predators, and in predator and prey conservation.	[Davies, Andrew B.; Asner, Gregory P.] Carnegie Inst Sci, Dept Global Ecol, 260 Panama St, Stanford, CA 94305 USA; [Tambling, Craig J.; Kerley, Graham I. H.] Nelson Mandela Metropolitan Univ, Dept Zool, Ctr African Conservat Ecol, ZA-6031 Port Elizabeth, South Africa	Carnegie Institution for Science; Nelson Mandela University	Davies, AB (corresponding author), Carnegie Inst Sci, Dept Global Ecol, 260 Panama St, Stanford, CA 94305 USA.	adavies@carnegiescience.edu	Tambling, Craig/H-3554-2019; Asner, Gregory/G-9268-2013	Tambling, Craig/0000-0001-9830-5985; Asner, Gregory/0000-0001-7893-6421; Davies, Andrew/0000-0002-0003-1435	Andrew Mellon Foundation; International Foundation for Science; Avatar Alliance Foundation; Gordon and Betty Moore Foundation; John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation; Margaret A. Cargill Foundation; Bidvest Car Rental; Eveready; National Research Foundation; Claude Leon Foundation; Nelson Mandela Metropolitan University	Andrew Mellon Foundation; International Foundation for Science(International Foundation for Science); Avatar Alliance Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine R. MacArthur Foundation; Grantham Foundation for the Protection of the Environment; W. M. Keck Foundation(W.M. Keck Foundation); Margaret A. Cargill Foundation; Bidvest Car Rental; Eveready; National Research Foundation; Claude Leon Foundation; Nelson Mandela Metropolitan University	This study has been supported by the Andrew Mellon Foundation, The International Foundation for Science, Avatar Alliance Foundation, Gordon and Betty Moore Foundation, John D. and Catherine R. MacArthur Foundation, Grantham Foundation for the Protection of the Environment, W. M. Keck Foundation, Margaret A. Cargill Foundation, Mary Anne Nyburg Baker and G. Leonard Baker Jr., William R. Hearst III, Bidvest Car Rental and Eveready. C.J. Tambling was funded by Post-Doctoral Fellowships from the National Research Foundation, the Claude Leon Foundation and the Nelson Mandela Metropolitan University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Asner GP, 2016, ECOGRAPHY, V39, P240, DOI 10.1111/ecog.01640; Asner GP, 2012, REMOTE SENS ENVIRON, V124, P454, DOI 10.1016/j.rse.2012.06.012; Asner GP, 2009, P NATL ACAD SCI USA, V106, P4947, DOI 10.1073/pnas.0810637106; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beale CM, 2013, BIOL CONSERV, V167, P224, DOI 10.1016/j.biocon.2013.08.025; Britten GL, 2014, ECOL LETT, V17, P1518, DOI 10.1111/ele.12354; BURGER J, 1994, BEHAVIOUR, V131, P153, DOI 10.1163/156853994X00415; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Ceballos G, 2005, SCIENCE, V309, P603, DOI 10.1126/science.1114015; Creel S, 2014, BEHAV ECOL, V25, P773, DOI 10.1093/beheco/aru050; Davidson Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055182; Davidson Z, 2012, J MAMMAL, V93, P677, DOI 10.1644/10-MAMM-A-424.1; Davies AB, 2014, TRENDS ECOL EVOL, V29, P681, DOI 10.1016/j.tree.2014.10.005; de Boer WF, 2010, J MAMMAL, V91, P1280, DOI 10.1644/09-MAMM-A-392.1; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Funston PJ, 1998, ANIM BEHAV, V56, P1333, DOI 10.1006/anbe.1998.0884; Funston PJ, 2001, J ZOOL, V253, P419, DOI 10.1017/S0952836901000395; Fynn RWS, 2011, AFR J ECOL, V49, P175, DOI 10.1111/j.1365-2028.2010.01245.x; Hall LK, 2013, BEHAV PROCESS, V94, P76, DOI 10.1016/j.beproc.2012.12.007; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hayward M. W., 2009, REINTRODUCTION TOP O; Hayward MW, 2007, J WILDLIFE MANAGE, V71, P1567, DOI 10.2193/2006-264; Hayward MW, 2007, AFR J ECOL, V45, P135, DOI 10.1111/j.1365-2028.2006.00686.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Hopcraft JGC, 2005, J ANIM ECOL, V74, P559, DOI 10.1111/j.1365-2656.2005.00955.x; Kerley GIH, 2006, S AFR J SCI, V102, P395; Landman M, 2014, BIOTROPICA, V46, P42, DOI 10.1111/btp.12066; Landman M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045334; Leuthold W, 1977, AFRICAN UNGULATES A; Levick SR, 2009, BIOL CONSERV, V142, P1693, DOI 10.1016/j.biocon.2009.03.004; Loarie SR, 2013, ANIM BEHAV, V85, P899, DOI 10.1016/j.anbehav.2013.01.018; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; Miller SM, 2013, S AFR J WILDL RES, V43, P138, DOI 10.3957/056.043.0202; Moncrieff GR, 2014, NEW PHYTOL, V201, P908, DOI 10.1111/nph.12551; Owen-Smith N, 2008, J ANIM ECOL, V77, P173, DOI 10.1111/j.1365-2656.2007.01314.x; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Parr CL, 2012, DIVERS DISTRIB, V18, P493, DOI 10.1111/j.1472-4642.2012.00882.x; R Development Core Team, 2014, R LANG ENV STAT COMP; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ripple WJ, 2012, BIOL CONSERV, V145, P205, DOI 10.1016/j.biocon.2011.11.005; Schaller G. B., 1972, SERENGETI LION STUDY; Scheel D, 1991, ANIM BEHAV, V41, P467; SMUTS G L, 1977, East African Wildlife Journal, V15, P81; STANDER PE, 1992, CAN J ZOOL, V70, P8, DOI 10.1139/z92-002; STANDER PE, 1993, SYM ZOOL S, P127; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Tambling CJ, 2005, J APPL ECOL, V42, P431, DOI 10.1111/j.1365-2664.2005.01039.x; Tambling CJ, 2013, BASIC APPL ECOL, V14, P694, DOI 10.1016/j.baae.2013.09.010; Tambling CJ, 2012, ECOLOGY, V93, P1297; Tambling CJ, 2010, J WILDLIFE MANAGE, V74, P549, DOI 10.2193/2009-010; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; VANORSDOL KG, 1984, AFR J ECOL, V22, P79; Vierling KT, 2008, FRONT ECOL ENVIRON, V6, P90, DOI 10.1890/070001; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	59	59	61	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149098	10.1371/journal.pone.0149098	http://dx.doi.org/10.1371/journal.pone.0149098			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910832	Green Submitted, gold, Green Published			2022-12-27	WOS:000371164700022
J	Obersteiner, A; Gilles, S; Frank, U; Beck, I; Haring, F; Ernst, D; Rothballer, M; Hartmann, A; Traidl-Hoffmann, C; Schmid, M				Obersteiner, Andrea; Gilles, Stefanie; Frank, Ulrike; Beck, Isabelle; Haering, Franziska; Ernst, Dietrich; Rothballer, Michael; Hartmann, Anton; Traidl-Hoffmann, Claudia; Schmid, Michael			Pollen-Associated Microbiome Correlates with Pollution Parameters and the Allergenicity of Pollen	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; AIRBORNE POLLEN; BACTERIA; DIVERSITY; ALLERGY; BIODIVERSITY; POLLUTANTS; PRIMERS; DEFENSE; ADULTS	Pollen allergies have been rapidly increasing over the last decades. Many allergenic proteins and non-allergenic adjuvant compounds of pollen are involved in the plant defense against environmental or microbial stress. The first aim of this study was to analyze and compare the colonizing microbes on allergenic pollen. The second aim was to investigate detectable correlations between pollen microbiota and parameters of air pollution or pollen allergenicity. To reach these aims, bacterial and fungal DNA was isolated from pollen samples of timothy grass (Phleum pratense, n = 20) and birch trees (Betula pendula, n = 55). With this isolated DNA, a terminal restriction fragment length polymorphism analysis was performed. One result was that the microbial diversity on birch tree and timothy grass pollen samples (Shannon/Simpson diversity indices) was partly significantly correlated to allergenicity parameters (Bet v 1/Phl p 5, pollen-associated lipid mediators). Furthermore, the microbial diversity on birch pollen samples was correlated to on-site air pollution (nitrogen dioxide (NO2), ammonia (NH3), and ozone (O-3)). What is more, a significant negative correlation was observed between the microbial diversity on birch pollen and the measured NO2 concentrations on the corresponding trees. Our results showed that the microbial composition of pollen was correlated to environmental exposure parameters alongside with a differential expression of allergen and pollen-associated lipid mediators. This might translate into altered allergenicity of pollen due to environmental and microbial stress.	[Obersteiner, Andrea; Rothballer, Michael; Hartmann, Anton; Schmid, Michael] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Microbe Plant Interact, Neuherberg, Germany; [Gilles, Stefanie; Beck, Isabelle; Haering, Franziska; Traidl-Hoffmann, Claudia] Tech Univ Munich, UNIKA T, Inst Environm Med, Augsburg, Germany; [Gilles, Stefanie; Traidl-Hoffmann, Claudia] CK Care, Christine Kuhne Ctr Allergy Res & Educ, Davos, Switzerland; [Frank, Ulrike; Ernst, Dietrich] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Inst Biochem Plant Pathol, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schmid, M (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth GmbH, Res Unit Microbe Plant Interact, Neuherberg, Germany.	michael.schmid@helmholtz-muenchen.de	Rothballer, Michael/B-5219-2015; Schmid, Michael/D-7105-2013; Gilles-Stein, Stefanie/AAA-3741-2021; Hartmann, Anton/AAN-8922-2020; Ernst, Dieter/M-7336-2014	Rothballer, Michael/0000-0003-4881-2705; Gilles-Stein, Stefanie/0000-0002-5159-2558; Traidl-Hoffmann, Claudia/0000-0001-5085-5179; Ernst, Dieter/0000-0003-0503-0228; Kolek, Franziska/0000-0001-8703-1894				Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; [Anonymous], 2007, BIOSTATISTIK EINFUHR; Avnery S, 2013, GLOBAL CHANGE BIOL, V19, P1285, DOI 10.1111/gcb.12118; Barberan A, 2015, P NATL ACAD SCI USA, V112, P5756, DOI 10.1073/pnas.1420815112; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Beck I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080147; Blackmore S, 2007, NEW PHYTOL, V174, P483, DOI 10.1111/j.1469-8137.2007.02060.x; Boehme MWJ, 2013, DEUT MED WOCHENSCHR, V138, P1651, DOI 10.1055/s-0033-1343330; Bostock RM, 2014, ANNU REV PHYTOPATHOL, V52, P517, DOI 10.1146/annurev-phyto-081211-172902; Bowers RM, 2011, ISME J, V5, P601, DOI 10.1038/ismej.2010.167; Buters J, 2015, J ALLERGY CLIN IMMUN, V136, P87, DOI 10.1016/j.jaci.2015.01.049; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Chen Z, 2009, WATER AIR SOIL POLL, V198, P189, DOI 10.1007/s11270-008-9838-1; Chowdhury SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068818; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; COLLDAHL H, 1968, ACTA ALLERGOL, V23, P387, DOI 10.1111/j.1398-9995.1968.tb04071.x; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Diaz-Sanchez D, 2005, AM J PHYSIOL-LUNG C, V289, pL722, DOI 10.1152/ajplung.00217.2005; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; El Kelish A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-176; Finkel OM, 2012, APPL ENVIRON MICROB, V78, P6187, DOI 10.1128/AEM.00888-12; Gilles S, 2015, WORLD ALLERGY ORGAN, V8, DOI 10.1186/s40413-014-0054-8; Gilles S, 2011, J ALLERGY CLIN IMMUN, V127, P454, DOI 10.1016/j.jaci.2010.12.1082; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Heinrich J, 2004, CURR OPIN ALLERGY CL, V4, P341, DOI 10.1097/00130832-200410000-00003; Heydenreich B, 2012, CLIN EXP ALLERGY, V42, P76, DOI 10.1111/j.1365-2222.2011.03888.x; Hu Y, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1831-x; Jacquard C, 2009, PLANTA, V229, P393, DOI 10.1007/s00425-008-0838-6; Khodai-Kalaki M, 2015, MBIO, V6, DOI 10.1128/mBio.00679-15; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Loeffler C, 2005, PLANT PHYSIOL, V137, P328, DOI 10.1104/pp.104.051714; Lord NS, 2002, FEMS MICROBIOL ECOL, V42, P327, DOI 10.1111/j.1574-6941.2002.tb01022.x; Madmony A, 2005, FOLIA MICROBIOL, V50, P209, DOI 10.1007/BF02931568; Mattina MI, 2003, ENVIRON POLLUT, V124, P375, DOI 10.1016/S0269-7491(03)00060-5; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Nowak D, 1996, EUR RESPIR J, V9, P2541, DOI 10.1183/09031936.96.09122541; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Oeder S, 2015, ALLERGY; Rastogi G, 2012, ISME J, V6, P1812, DOI 10.1038/ismej.2012.32; Reisberg EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078613; Ring J, 2014, ALLERGY, V69, P978, DOI 10.1111/all.12406; Scagel CF, 1997, NEW PHYTOL, V136, P627, DOI 10.1046/j.1469-8137.1997.00779.x; Strunk O, 1997, ARB SOFTWARE PROGRAM; SWOBODA I, 1994, BBA-GENE STRUCT EXPR, V1219, P457, DOI 10.1016/0167-4781(94)90072-8; SWOBODA I, 1995, PROTOPLASMA, V187, P103, DOI 10.1007/BF01280237; Takahashi M, 2005, NEW PHYTOL, V168, P149, DOI 10.1111/j.1469-8137.2005.01493.x; Team RDC, 2014, R LANG ENV STAT COMP; Thoma I, 2003, PLANT J, V34, P363, DOI 10.1046/j.1365-313X.2003.01730.x; Thoma I, 2004, CHEM PHYS LIPIDS, V128, P135, DOI 10.1016/j.chemphyslip.2003.10.002; Tiwari S, 2006, ENVIRON MONIT ASSESS, V119, P15, DOI 10.1007/s10661-005-9001-z; Traidl-Hoffmann C, 2009, J ALLERGY CLIN IMMUN, V123, P558, DOI 10.1016/j.jaci.2008.12.003; Trda L, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00219; Wang XL, 2009, BIOCHEM BIOPH RES CO, V387, P430, DOI 10.1016/j.bbrc.2009.07.020; Wimmer M, 2015, ALLERGY; Zhao F, 2015, PLANT CELL ENV, DOI 10.1111/pce.12601.; Zinkl GM, 1999, DEVELOPMENT, V126, P5431; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	62	45	48	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149545	10.1371/journal.pone.0149545	http://dx.doi.org/10.1371/journal.pone.0149545			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910418	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700040
J	Senter, P; Juengst, SL				Senter, Phil; Juengst, Sara L.			Record-Breaking Pain: The Largest Number and Variety of Forelimb Bone Maladies in a Theropod Dinosaur	PLOS ONE			English	Article							NUTRITIONAL SECONDARY HYPERPARATHYROIDISM; NATURALLY-OCCURRING NEOPLASMS; MUSTELA-PUTORIUS-FURO; BIRDS; INFECTION; STATE; PALEOPATHOLOGY; OSTEOARTHRITIS; AUSTRALIA; PATHOLOGY	Bone abnormalities are common in theropod dinosaur skeletons, but before now no specimen was known with more than four afflicted bones of the pectoral girdle and/or forelimb. Here we describe the pathology of a specimen of the theropod dinosaur Dilophosaurus wetherilli with eight afflicted bones of the pectoral girdle and forelimb. On its left side the animal has a fractured scapula and radius and large fibriscesses in the ulna and the proximal thumb phalanx. On its right side the animal has abnormal torsion of the humeral shaft, bony tumors on the radius, a truncated distal articular surface of metacarpal III, and angular deformities of the first phalanx of the third finger. Healing and remodeling indicates that the animal survived for months and possibly years after its ailments began, but its right third finger was permanently deformed and lacked the capability of flexion. The deformities of the humerus and the right third finger may be due to developmental osteodysplasia, a condition known in extant birds but unreported in non-avian dinosaurs before now.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA; [Juengst, Sara L.] Appalachian State Univ, Dept Anthropol, Boone, NC 28608 USA	University of North Carolina; Fayetteville State University; University of North Carolina; Appalachian State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC USA.	psenter@uncfsu.edu		Juengst, Sara/0000-0002-2207-6095				Allen ME, 2003, BIOLOGY, HUSBANDRY, AND MEDICINE OF THE GREEN IGUANA, P47; Angel C. Roselina, 1996, P11; [Anonymous], 2012, COMPLETE DINOSAUR; Bennett R. Avery, 1996, P281; Blondiaux J, 2012, INT J PALEOPATHOL, V2, P223, DOI 10.1016/j.ijpp.2012.10.002; Boyer Thomas H., 1996, P385; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brownstein D.G., 1984, P1; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Chitty J, 2013, ESSENTIALS OF TORTOISE MEDICINE AND SURGERY, P1, DOI 10.1002/9781118656372; Crabill Mark R., 1996, P95; Crespo R, 2002, AVIAN DIS, V46, P245, DOI 10.1637/0005-2086(2002)046[0245:AOTCRI]2.0.CO;2; Crespo R., 2013, DIS POULTRY, V13th, P1233; Farrow C.S, 2003, VET DIAGNOSTIC IMAGI, P481; Frye F.L., 1984, P633; Frye FL., 1991, REPTILE CARE ATLAS D; FRYE FL, 1973, HUSBANDRY MED SURG C; Gilsleider Ed, 1994, Seminars in Avian and Exotic Pet Medicine, V3, P81; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Hanna RR, 2002, J VERTEBR PALEONTOL, V22, P76, DOI 10.1671/0272-4634(2002)022[0076:MIAIIA]2.0.CO;2; Harcourt-Brown Nigel H, 2002, Vet Clin North Am Exot Anim Pract, V5, P49, DOI 10.1016/S1094-9194(03)00046-X; Huchzermeyer F.W., 2003, CROCODILES BIOL HUSB; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Huchzermeyer FW, 2002, REV SCI TECH OIE, V21, P265, DOI 10.20506/rst.21.2.1334; Ippen R, 1966, Zentralbl Allg Pathol, V108, P424; Isaza R, 2000, J ZOO WILDLIFE MED, V31, P20, DOI 10.1638/1042-7260(2000)031[0020:POAOIS]2.0.CO;2; Johnson JG, 2014, J EXOT PET MED, V23, P266, DOI 10.1053/j.jepm.2014.06.007; KALIN J. A., 1937, ZEITSCHR MORPH U OKOL TIERE, V32, P327, DOI 10.1007/BF00403078; Kirkwood J, 2000, AVIAN MED, P173; Kirkwood J, 2000, AVIAN MED, P170; Klaphake Eric, 2010, Veterinary Clinics of North America Exotic Animal Practice, V13, P375, DOI 10.1016/j.cvex.2010.05.007; Krautwald-Junghanns M. E., 2011, Diagnostic imaging of exotic pets: birds, small mammals, reptiles, P70; KREEGER T J, 1984, Journal of Wildlife Diseases, V20, P245; Lipkin C., 2008, TYRANNOSAURUS REX TY, P166; Lovell NC, 1997, YEARB PHYS ANTHROPOL, V40, P139; Mader D.R, 2006, REPTILE MED SURG; Mader Douglas R., 1996, P374; Mills DL, 2003, TXB SMALL ANIMAL SUR, V1, P1849; Mitchell Mark A., 2002, Veterinary Clinics of North America Exotic Animal Practice, V5, P97, DOI 10.1016/S1094-9194(03)00048-3; Molnar R.E., 2001, P337; Moodie RL., 1923, PALEOPATHOLOGY INTRO; Nair V., 2013, DIS POULTRY, P553; Nesbitt SJ, 2015, ACTA PALAEONTOL POL, V60, P513, DOI 10.4202/app.00143.2014; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Osmolska H, 1972, PALAEONTOL POL, V27, P5; Perpinan D, 2008, J EXOT PET MED, V17, P144, DOI 10.1053/j.jepm.2008.03.013; PETERSEN K, 1972, Proceedings of the Utah Academy of Sciences Arts and Letters, V49, P44; REECE RL, 1992, AVIAN PATHOL, V21, P3, DOI 10.1080/03079459208418815; Reece RL, 1996, AVIAN PATHOL, V25, P407, DOI 10.1080/03079459608419153; Reese S, 2011, DIAGNOSTIC IMAGING E, P244; Reptiles Pees M., 2011, DIAGNOSTIC IMAGING E, P378; RIDDELL C, 1981, ADV VET SCI COMP MED, V25, P277; Roberts C., 2007, ARCHAEOLOGY DIS; Rothschild B, 2005, LIFE O PAST, P351; Rothschild BM, 2007, J VET MED A, V54, P265, DOI 10.1111/j.1439-0442.2007.00937.x; Rothschild BM, 1997, NATURE, V387, P357, DOI 10.1038/387357a0; Rothschild BM, 1993, PALEOPATHOLOGY DIS F; Rothschild Bruce, 2001, P331; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144036; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; SILLER WG, 1959, BRIT J CANCER, V13, P642, DOI 10.1038/bjc.1959.70; Silverman Sam, 1996, P258; SOKOLOFF L, 1959, LAB INVEST, V8, P1209; Speer Brian L., 1996, P147; Trully Jr TN, 2002, VET CLIN N AM EXOT A, V5, P23; Walker P., 1997, TROUBLED TIMES VIOLE, P145; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Wallach J. D., 1982, Noninfectious diseases of wildlife, P113; WALLACH JD, 1969, J AM VET MED ASSOC, V155, P1046; WALLACH JD, 1967, J AM VET MED ASSOC, V151, P880; Welles DP, 1984, PALAEONTOGR ABT A, V185, P85; Williams Jamie, 2002, Veterinary Clinics of North America Exotic Animal Practice, V5, P1, DOI 10.1016/S1094-9194(03)00043-4; Wolff EDS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007288	75	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149140	10.1371/journal.pone.0149140	http://dx.doi.org/10.1371/journal.pone.0149140			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909701	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700024
J	Steenweg, R; Hebblewhite, M; Gummer, D; Low, B; Hunt, B				Steenweg, Robin; Hebblewhite, Mark; Gummer, David; Low, Brian; Hunt, Bill			Assessing Potential Habitat and Carrying Capacity for Reintroduction of Plains Bison (Bison bison bison) in Banff National Park	PLOS ONE			English	Article							FREE-RANGING BISON; FORAGE AVAILABILITY; WOOD BISON; ELK; HETEROGENEITY; COMPETITION; SELECTION; PATTERNS; SCALE	Interest in bison (Bison bison, B. bonasus) conservation and restoration continues to grow globally. In Canada, plains bison (B. b. bison) are threatened, occupying less than 0.5% of their former range. The largest threat to their recovery is the lack of habitat in which they are considered compatible with current land uses. Fences and direct management make range expansion by most bison impossible. Reintroduction of bison into previously occupied areas that remain suitable, therefore, is critical for bison recovery in North America. Banff National Park is recognized as historical range of plains bison and has been identified as a potential site for reintroduction of a wild population. To evaluate habitat quality and assess if there is sufficient habitat for a breeding population, we developed a Habitat Suitability Index (HSI) model for the proposed reintroduction and surrounding areas in Banff National Park (Banff). We then synthesize previous studies on habitat relationships, forage availability, bison energetics and snowfall scenarios to estimate nutritional carrying capacity. Considering constraints on nutritional carrying capacity, the most realistic scenario that we evaluated resulted in an estimated maximum bison density of 0.48 bison/km2. This corresponds to sufficient habitat to support at least 600 to 1000 plains bison, which could be one of the largest 10 plains bison populations in North America. Within Banff, there is spatial variation in predicted bison habitat suitability and population size that suggests one potential reintroduction site as the most likely to be successful from a habitat perspective. The successful reintroduction of bison into Banff would represent a significant global step towards conserving this iconic species, and our approach provides a useful template for evaluating potential habitat for other endangered species reintroductions into their former range.	[Steenweg, Robin; Hebblewhite, Mark] Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA; [Gummer, David; Low, Brian; Hunt, Bill] Pk Canada, Banff Natl Pk, Resource Conservat, Banff, AB, Canada	University of Montana System; University of Montana	Hebblewhite, M (corresponding author), Univ Montana, Wildlife Biol Program, Coll Forestry & Conservat, Missoula, MT 59812 USA.	mark.hebblewhite@umontana.edu	Hebblewhite, Mark/AAI-8101-2020; hebblewhite, mark/G-6164-2013	Hebblewhite, Mark/0000-0001-5382-1361; 	University of Montana; Parks Canada	University of Montana; Parks Canada	Funding was provided by the University of Montana and Parks Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, IUCN RED LIST THREAT, DOI 10. 2305/iucn. uk. 2008. rlts. t40637a10346312. en; Babin JS, 2011, ECOLOGY, V92, P240, DOI 10.1890/10-0252.1; Beck JL, 2006, J WILDLIFE MANAGE, V70, P283, DOI 10.2193/0022-541X(2006)70[283:EOESRN]2.0.CO;2; Bjornlie DD, 2001, J WILDLIFE MANAGE, V65, P560, DOI 10.2307/3803109; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2003, WILDLIFE SOC B, V31, P670; Bruggeman JE, 2009, TERR ECOL SER, V3, P623, DOI 10.1016/S1936-7961(08)00228-5; Campbell B.H., 1983, Wildlife Society Bulletin, V11, P16; CARBYN LN, 1988, ARCTIC, V41, P297; Caughley G., 1979, P2; COSEWIC, 2004, COSEWIC ASS STAT REP; Coughenour MB, 2005, BISON ELK YELLOWSTON; Dancose K, 2011, ECOL APPL, V21, P1871, DOI 10.1890/10-0779.1; Fischer LA, 2005, CAN J ZOOL, V83, P1162, DOI 10.1139/Z05-117; Fortin D, 2003, WILDLIFE SOC B, V31, P804; Fortin D, 2009, ANIM BEHAV, V78, P887, DOI 10.1016/j.anbehav.2009.06.026; Fortin ME, 2007, GROUP SIZE EFFECTS M; Franklin S.E., 2001, REMOTE SENSING SUSTA, DOI 10.1201/9781420032857; Fuller JA, 2007, J WILDLIFE MANAGE, V71, P1924, DOI 10.2193/2006-200; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gardner CL, 2007, ARCTIC, V43, P231; Gates C., 2008, IUCN RED LIST THREAT; Gates CC, 2010, AM BISON STATUS SURV; Geremia C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016848; Gross J. E., 2005, EFFECTS POPULATION C; Hamilton SG, 2005, ESTIMATING WINTER CA; Hebblewhite M, 2010, CONSERV BIOL, V24, P341, DOI 10.1111/j.1523-1739.2009.01343.x; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hebblewhite M, 2006, WILDLIFE SOC B, V34, P1280, DOI 10.2193/0091-7648(2006)34[1280:ITMBOM]2.0.CO;2; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x; HOBBS NT, 1985, J WILDLIFE MANAGE, V49, P814, DOI 10.2307/3801716; Holechek J.L., 2010, RANGE MANAGEMENT PRI; Holland W, 1983, ECOLOGICAL LAND CLAS; Hurd TE, 2011, BISON RESTORAT UNPUB; Hutto R.L., 1985, P455; IUCN, INT UN CONS NAT GUID; Kay CE, 2001, CROSSING BOUNDARIES IN PARK MANAGEMENT: PROCEEDINGS OF THE 11TH CONFERENCE ON RESEARCH AND RESOURCE MANAGEMENT IN PARKS AND ON PUBLIC LANDS, P143; Keller BJ, 2011, FACTORS AFFECTING SP; Kerley GIH, 2012, ECOGRAPHY, V35, P519, DOI 10.1111/j.1600-0587.2011.07146.x; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Kuzyk Gerald W., 2009, Open Conservation Biology Journal, V3, P24, DOI 10.2174/1874839200903010024; Langemann E. Gwyn, 2004, P79; Larter NC, 1988, DIET HABITAT SELECTI; Leverkus SER, 2012, SEASONAL RANGE USE W; McDermid G. J., 2005, REMOTE SENSING LARGE; Ministry of Environment, 2005, SI200572 MIN ENV; Mitchell JA, 2002, 38 ALB CONS ASS ALB; National Operational Hydrologic Remote Sensing Center, 2004, SNOW DATA ASSIMILATI, DOI [10.7265/N5TB14TC, DOI 10.7265/N5TB14TC]; Owen-Smith RN., 2002, CAMB ST ECO, DOI 10.1017/CBO9780511525605; Parks Canada, 2013, PLAN REINTR PLAINS B; Parks Canada, 2010, BANFF NAT PARK MAN P; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Plumb GE, 2009, BIOL CONSERV, V142, P2377, DOI 10.1016/j.biocon.2009.05.019; Ranglack DH, 2015, RANGELAND ECOL MANAG, V68, P349, DOI 10.1016/j.rama.2015.05.008; Ranglack DH, 2015, J APPL ECOL, V52, P467, DOI 10.1111/1365-2664.12386; Roe FG., 1970, N AM BUFFALO CRITICA; Roloff GJ, 1999, WILDLIFE SOC B, V27, P973; Sachro LL, 2005, J ENVIRON MANAGE, V77, P183, DOI 10.1016/j.jenvman.2005.04.003; Sanderson EW, 2008, CONSERV BIOL, V22, P252, DOI 10.1111/j.1523-1739.2008.00899.x; SHAW JH, 1989, J WILDLIFE MANAGE, V53, P896, DOI 10.2307/3809584; SINCLAIR A. R. E., 2005, WILDLIFE ECOLOGY MAN; Strong WL, 2009, J ENVIRON MANAGE, V90, P434, DOI 10.1016/j.jenvman.2007.11.002; TURNER MG, 1994, ECOL APPL, V4, P472, DOI 10.2307/1941951; US Fish and WIdllife Service, 1981, STAND DEV HAB SUIT I; Van Vuren D. H., 2001, Animal Biodiversity and Conservation, V24, P117; WALLACE LL, 1995, LANDSCAPE ECOL, V10, P75, DOI 10.1007/BF00153825; White CA, 2001, PLAINS BISON RESTORA, P143; WYDEVEN AP, 1985, J WILDLIFE MANAGE, V49, P805, DOI 10.2307/3801715; Zeigenfuss LC, 2003, ECOLOGY NATIVE UNGUL	71	36	36	7	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150065	10.1371/journal.pone.0150065	http://dx.doi.org/10.1371/journal.pone.0150065			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910226	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700060
J	Zhu, W; Mai, ZL; Qin, J; Duan, XL; Liu, Y; Zhao, ZJ; Yuan, J; Wan, SP; Zeng, GH				Zhu, Wei; Mai, Zanlin; Qin, Jing; Duan, Xiaolu; Liu, Yang; Zhao, Zhijian; Yuan, Jian; Wan, Shaw P.; Zeng, Guohua			Difference in 24-Hour Urine Composition between Diabetic and Non-Diabetic Adults without Nephrolithiasis	PLOS ONE			English	Article							KIDNEY-STONES; GLYCEMIC CONTROL; INSULIN-RESISTANCE; CITRATE EXCRETION; RISK; MELLITUS; CALCIUM	Background Diabetic patients are more likely to develop kidney stones than the general population. The underlying mechanisms for this disparity remain to be elucidated. Little is known about the relationship between urine composition and diabetes mellitus in non-stone-forming individuals. We sought to examine the differences in the 24-hour (24-h) urine composition between diabetic and non-diabetic adults who were not stone formers. Methods A convenience sample of 538 individuals without a history of nephrolithiasis, gout, hyperparathyroidism, or gastroenteric diseases participated in this study. The 24-h urine profiles of 115 diabetic adults were compared with those of 423 non-diabetic adults. Diabetes was defined by self-reported physician diagnosis or medication use. All participants were non-stone formers confirmed by urinary tract ultrasonography. Participants provided a fasting blood sample and a single 24-h urine collection for stone risk analysis. Student's t-test was used to compare mean urinary values. Linear regression models were adjusted for age, gender, body mass index, hypertension, fasting serum glucose, serum total cholesterol, estimated creatinine clearance rate and urinary factors. Results Univariable analysis showed that the diabetic participants had significantly higher 24-h urine volumes and lower urine calcium and magnesium excretions than non-diabetic participants (all P < 0.05). After multivariate adjustment, no significant differences in 24-h urine composition were observed between diabetic and non-diabetic participants except for a slightly increased 24-h urine volume in diabetic participants (all P > 0.05). The main limitation of this study is that the convenience samples and self-reported data may have been sources of bias. Conclusion Our data showed that there were no differences in 24-h urine composition between diabetic and non-diabetic adults who are not stone formers. The reason for it might be the improved glycemic control in diabetic individuals in our study. Therefore, a tighter glycemic control might reduce stone formation in diabetic adults.	[Zhu, Wei; Mai, Zanlin; Qin, Jing; Duan, Xiaolu; Liu, Yang; Zhao, Zhijian; Yuan, Jian; Wan, Shaw P.; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China; [Zhu, Wei; Mai, Zanlin; Qin, Jing; Duan, Xiaolu; Liu, Yang; Zhao, Zhijian; Yuan, Jian; Wan, Shaw P.; Zeng, Guohua] Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China; [Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Kangda Rd 1, Guangzhou 510230, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Dept Urol, Guangzhou, Guangdong, Peoples R China.; Zeng, GH (corresponding author), Guangdong Key Lab Urol, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.sina.com			National Natural Science Foundation, China [81370804, 81170652]; Colleges and universities in Guangzhou Yangcheng scholars research project [12A017S]; Science and technology project in Guangzhou (the people's livelihood special major science and Technology) [201300000096]	National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC)); Colleges and universities in Guangzhou Yangcheng scholars research project; Science and technology project in Guangzhou (the people's livelihood special major science and Technology)	This work was financed by a grant from National Natural Science Foundation, China (No. 81370804 and No. 81170652), Colleges and universities in Guangzhou Yangcheng scholars research project (No. 12A017S), and Science and technology project in Guangzhou (the people's livelihood special major science and Technology) (No. 201300000096). Guohua Zeng received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Professor William G. Robertson for improving the use of English in the manuscript. This work was financed by a grant from National Natural Science Foundation, China (No. 81370804 and No. 81170652), Colleges and universities in Guangzhou Yangcheng scholars research project (No. 12A017S), and Science and technology project in Guangzhou (the people's livelihood special major science and Technology) (No. 201300000096).	Cameron MA, 2006, J AM SOC NEPHROL, V17, P1422, DOI 10.1681/ASN.2005121246; Cupisti A, 2007, BIOMED PHARMACOTHER, V61, P86, DOI 10.1016/j.biopha.2006.09.012; Curhan GC, 2001, KIDNEY INT, V59, P2290, DOI 10.1046/j.1523-1755.2001.0590062290.x; Daudon M, 2006, J AM SOC NEPHROL, V17, P2026, DOI 10.1681/ASN.2006030262; Domingos F, 2014, SCAND J UROL, V48, P414, DOI 10.3109/21681805.2014.903513; Eisner BH, 2010, J UROLOGY, V183, P2244, DOI 10.1016/j.juro.2010.02.007; Fram EB, 2015, UROLOGY; Hartman C, 2015, BJU INT, V115, P619, DOI 10.1111/bju.12807; Ibernon M, 2005, NEPHROL DIAL TRANSPL, V20, P467, DOI 10.1093/ndt/gfh596; Kabeya Y, 2012, INTERNAL MED, V51, P699, DOI 10.2169/internalmedicine.51.6426; Laube N, 2003, CLIN CHEM, V49, P281, DOI 10.1373/49.2.281; Mandel EI, 2013, CLIN J AM SOC NEPHRO, V8, P901, DOI 10.2215/CJN.07190712; McGuire BB, 2015, J ENDOUROL, V29, P730, DOI 10.1089/end.2014.0544; NAGASAKA S, 1995, ENDOCR J, V42, P377, DOI 10.1507/endocrj.42.377; Shavit L, 2015, NEPHROL DIAL TRANSPL, V30, P607, DOI 10.1093/ndt/gfu350; Taylor EN, 2005, KIDNEY INT, V68, P1230, DOI 10.1111/j.1523-1755.2005.00516.x; Tiselius HG, 2002, ENDOCRIN METAB CLIN, V31, P1031, DOI 10.1016/S0889-8529(02)00027-0; Torricelli FCM, 2014, UROLOGY, V84, P544, DOI 10.1016/j.urology.2014.02.074; Weinberg AE, 2014, EUR UROL, V65, P242, DOI 10.1016/j.eururo.2013.03.026	19	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150006	10.1371/journal.pone.0150006	http://dx.doi.org/10.1371/journal.pone.0150006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906900	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000028
J	Cordara, G; van Eerde, A; Grahn, EM; Winter, HC; Goldstein, IJ; Krengel, U				Cordara, Gabriele; van Eerde, Andre; Grahn, Elin M.; Winter, Harry C.; Goldstein, Irwin J.; Krengel, Ute			An Unusual Member of the Papain Superfamily: Mapping the Catalytic Cleft of the Marasmius oreades agglutinin (MOA) with a Caspase Inhibitor	PLOS ONE			English	Article							CYSTEINE PROTEASES; CRYSTAL-STRUCTURE; OXYANION HOLE; ACTIVE-SITE; COMPLEX; PROTEIN; LECTIN; SPECIFICITY; SUBSTRATE; MECHANISM	Papain-like cysteine proteases (PLCPs) constitute the largest group of thiol-based protein degrading enzymes and are characterized by a highly conserved fold. They are found in bacteria, viruses, plants and animals and involved in a number of physiological and pathological processes, parasitic infections and host defense, making them interesting targets for drug design. The Marasmius oreades agglutinin (MOA) is a blood group B-specific fungal chimerolectin with calcium-dependent proteolytic activity. The proteolytic domain of MOA presents a unique structural arrangement, yet mimicking the main structural elements in known PLCPs. Here we present the X-ray crystal structure of MOA in complex with Z-VAD-fmk, an irreversible caspase inhibitor known to cross-react with PLCPs. The structural data allow modeling of the substrate binding geometry and mapping of the fundamental enzyme-substrate interactions. The new information consolidates MOA as a new, yet strongly atypical member of the papain superfamily. The reported complex is the first published structure of a PLCP in complex with the well characterized caspase inhibitor Z-VAD-fmk.	[Cordara, Gabriele; van Eerde, Andre; Grahn, Elin M.; Krengel, Ute] Univ Oslo, Dept Chem, Oslo, Norway; [Cordara, Gabriele] Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway; [Winter, Harry C.; Goldstein, Irwin J.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Oslo; University of Oslo; University of Michigan System; University of Michigan	Cordara, G; Krengel, U (corresponding author), Univ Oslo, Dept Chem, Oslo, Norway.; Cordara, G (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Biochem, Oslo, Norway.	gabriele.cordara@kjemi.uio.no; ute.krengel@kjemi.uio.no		Krengel, Ute/0000-0001-6688-8151	University of Oslo; Norwegian Research Council [216625]; BioStruct-X	University of Oslo; Norwegian Research Council(Research Council of NorwayEuropean Commission); BioStruct-X	The work was funded by the University of Oslo and carried out as part of the GlycoNor consortium. This work was supported in part by the Norwegian Research Council (grant number: 216625; www.forskningsradet.no no) and BioStruct-X (www.biostruct-x.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BROMME D, 1994, J BIOL CHEM, V269, P30238; Bromme D, 2001, Curr Protoc Protein Sci, VChapter 21, DOI 10.1002/0471140864.ps2102s21; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Cordara G, 2014, BIOCHEM BIOPH RES CO, V447, P586, DOI 10.1016/j.bbrc.2014.04.043; Cordara G, 2011, BIOCHEM BIOPH RES CO, V408, P405, DOI 10.1016/j.bbrc.2011.04.031; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dubey VK, 2007, AFR J BIOTECHNOL, V6, P1077; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FEARNHEAD HO, 1995, FEBS LETT, V375, P283, DOI 10.1016/0014-5793(95)01228-7; Futai E, 1999, MOL GEN GENET, V260, P559, DOI 10.1007/s004380050929; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; GAUTHIER F, 1993, ARCH BIOCHEM BIOPHYS, V306, P304, DOI 10.1006/abbi.1993.1516; Gomes MTR, 2012, AMINO ACIDS, V43, P2381, DOI 10.1007/s00726-012-1318-7; Grahn E, 2007, J MOL BIOL, V369, P710, DOI 10.1016/j.jmb.2007.03.016; Grahn EM, 2009, J MOL BIOL, V390, P457, DOI 10.1016/j.jmb.2009.04.074; Gul S, 2008, BIOCHEMISTRY-US, V47, P2025, DOI 10.1021/bi702126p; HEINEMANN U, 1982, J MOL BIOL, V161, P591, DOI 10.1016/0022-2836(82)90410-7; Hofmann B, 1993, ACTA CRYSTALLOGR A S, V2, pc102; HOWARD AD, 1991, J IMMUNOL, V147, P2964; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kerr LD, 2009, J MED CHEM, V52, P852, DOI 10.1021/jm8013663; KHOURI HE, 1991, BIOCHEMISTRY-US, V30, P8929, DOI 10.1021/bi00101a003; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kruger RP, 2002, J BIOL CHEM, V277, P15002, DOI 10.1074/jbc.M200165200; Lecaille F, 2002, CHEM REV, V102, P4459, DOI 10.1021/cr0101656; Lee JH, 2005, P NATL ACAD SCI USA, V102, P9144, DOI 10.1073/pnas.0502082102; Madala PK, 2010, CHEM REV, V110, pPR1, DOI 10.1021/cr900368a; Matsumoto K, 1999, BIOPOLYMERS, V51, P99, DOI 10.1002/(SICI)1097-0282(1999)51:1<99::AID-BIP11>3.0.CO;2-R; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MENARD R, 1991, BIOCHEMISTRY-US, V30, P8924, DOI 10.1021/bi00101a002; MENARD R, 1993, FEBS LETT, V328, P107, DOI 10.1016/0014-5793(93)80975-Z; MENARD R, 1995, BIOCHEMISTRY-US, V34, P464, DOI 10.1021/bi00002a010; Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nagler DK, 1999, BIOCHEMISTRY-US, V38, P4868, DOI 10.1021/bi982632s; O'Farrell PA, 2007, BIOCHEM J, V401, P421, DOI 10.1042/BJ20060641; PICKERSGILL RW, 1992, ACTA CRYSTALLOGR B, V48, P59, DOI 10.1107/S0108768191006572; POLGAR L, 1982, BIOCHEM J, V207, P1; Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v; RAWLINGS ND, 1993, BIOCHEM J, V290, P205, DOI 10.1042/bj2900205; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rozman-Pungercar J, 2003, CELL DEATH DIFFER, V10, P881, DOI 10.1038/sj.cdd.4401247; Rzychon M, 2004, ACTA BIOCHIM POL, V51, P861; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmitz C, 2005, MOL BIOL CELL, V16, P1319, DOI 10.1091/mbc.E04-05-0425; Shindo T, 2008, MOL PLANT PATHOL, V9, P119, DOI [10.1111/j.1364-3703.2007.00439.x, 10.1111/J.1364-3703.2007.00439.X]; Smith R.F., 1976, INTEGRATED PEST MANA, P1, DOI DOI 10.1007/978-1-4615-7269-5_1; STORER AC, 1994, METHOD ENZYMOL, V244, P486; TAYLOR MAJ, 1994, PROTEIN ENG, V7, P1267, DOI 10.1093/protein/7.10.1267; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tsuge H, 1999, BIOCHEM BIOPH RES CO, V266, P411, DOI 10.1006/bbrc.1999.1830; Turk B, 1997, BIOL CHEM, V378, P141; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; VARUGHESE KI, 1989, BIOCHEMISTRY-US, V28, P1330, DOI 10.1021/bi00429a058; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; Wolfenden R, 2001, ACCOUNTS CHEM RES, V34, P938, DOI 10.1021/ar000058i; Zhao G, 2006, J BIOL CHEM, V281, P13751, DOI 10.1074/jbc.M600137200	64	4	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149407	10.1371/journal.pone.0149407	http://dx.doi.org/10.1371/journal.pone.0149407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901797	Green Published, gold			2022-12-27	WOS:000371276100071
J	Zarmi, Y				Zarmi, Yair			Spatially Extended Relativistic Particles Out of Traveling Front Solutions of Sine-Gordon Equation in (1+2) Dimensions	PLOS ONE			English	Article							DOUBLE PENDULUMS CHAIN; EVOLUTION-EQUATIONS; DIFFERENTIAL-EQUATIONS; SOLITON EXCITATIONS; PERTURBATION-THEORY; DNA PROMOTERS; FIELD-THEORY; MODEL; DYNAMICS; SCHRODINGER	Slower-than-light multi-front solutions of the Sine-Gordon in (1+2) dimensions, constructed through the Hirota algorithm, are mapped onto spatially localized structures, which emulate free, spatially extended, massive relativistic particles. A localized structure is an image of the junctions at which the fronts intersect. It propagates together with the multi-front solution at the velocity of the latter. The profile of the localized structure obeys the linear wave equation in (1+2) dimensions, to which a term that represents interaction with a slower-than-light, Sine-Gordon-multi-front solution has been added. This result can be also formulated in terms of a (1+2)-dimensional Lagrangian system, in which the Sine-Gordon and wave equations are coupled. Expanding the Euler-Lagrange equations in powers of the coupling constant, the zero-order part of the solution reproduces the (1+2)-dimensional Sine-Gordon fronts. The first-order part is the spatially localized structure. PACS: 02.30.Ik, 03.65.Pm, 05.45.Yv, 02.30.Ik.	[Zarmi, Yair] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-8499000 Midreshet Ben Gurion, Israel	Ben Gurion University	Zarmi, Y (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-8499000 Midreshet Ben Gurion, Israel.	zarmi@bgu.ac.il						Ablowitz MJ, 2000, PHYS LETT A, V267, P132, DOI 10.1016/S0375-9601(00)00020-7; Ablowitz MJ, 1991, NONLINEAR EVOLUTION; Alagesan T, 2004, CHAOS SOLITON FRACT, V21, P879, DOI 10.1016/j.chaos.2003.12.052; Barone A, 1971, RIV NUOVO CIMENTO, V1, P227, DOI DOI 10.1007/BF02820622; Boiti M, 1995, CHAOS SOLITON FRACT, V5, P2377, DOI 10.1016/0960-0779(94)E0106-Y; Burde GI, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026615; Cadoni M, 2007, J NONLINEAR MATH PHY, V14, P128, DOI 10.2991/jnmp.2007.14.1.10; Cadoni M, 2007, J PHYS A-MATH THEOR, V40, P12917, DOI 10.1088/1751-8113/40/43/006; CALLAN CG, 1975, NUCL PHYS B, V93, P29, DOI 10.1016/0550-3213(75)90150-9; CAMASSA R, 1993, PHYS REV LETT, V71, P1661, DOI 10.1103/PhysRevLett.71.1661; CLARKSON PA, 1985, LETT MATH PHYS, V10, P297, DOI 10.1007/BF00420570; COLEMAN S, 1975, PHYS REV D, V11, P2088, DOI 10.1103/PhysRevD.11.2088; Daniel M, 2007, PHYSICA D, V231, P10, DOI 10.1016/j.physd.2007.04.005; DASHEN RF, 1974, PHYS REV D, V10, P4114, DOI 10.1103/PhysRevD.10.4114; DAUXOIS T, 1992, PHYSICA D, V57, P267, DOI 10.1016/0167-2789(92)90003-6; DAUXOIS T, 1991, PHYS LETT A, V159, P390, DOI 10.1016/0375-9601(91)90367-H; DAVEY A, 1974, PROC R SOC LON SER-A, V338, P101, DOI 10.1098/rspa.1974.0076; Derks G, 2011, PHYSICA D, V240, P1805, DOI 10.1016/j.physd.2011.08.005; EBOLI OJP, 1983, PHYS REV B, V28, P689, DOI 10.1103/PhysRevB.28.689; ENGLANDER SW, 1980, P NATL ACAD SCI-BIOL, V77, P7222, DOI 10.1073/pnas.77.12.7222; FADDEEV LD, 1978, PHYS REP, V42, P1, DOI 10.1016/0370-1573(78)90058-3; Frenkel Y, 1939, J PHYS USSR, V1, P137; Golobin E, 2000, PHYS LETT A, V266, P67; Griffiths SD, 2003, THEOR MATH PHYS+, V137, P1448, DOI 10.1023/A:1026008907682; HIROTA R, 1972, J PHYS SOC JPN, V33, P1459, DOI 10.1143/JPSJ.33.1459; HIROTA R, 1973, J PHYS SOC JPN, V35, P1566, DOI 10.1143/JPSJ.35.1566; JOSEPHSO.BD, 1965, ADV PHYS, V14, P419, DOI 10.1080/00018736500101091; Kadomtsev B. B., 1970, Soviet Physics - Doklady, V15, P539; KAUP DJ, 1978, PROC R SOC LON SER-A, V361, P413, DOI 10.1098/rspa.1978.0110; Khusnutdinova KR, 2003, WAVE MOTION, V38, P1, DOI 10.1016/S0165-2125(03)00022-2; KOBAYASHI KK, 1976, J PHYS SOC JPN, V41, P1091, DOI 10.1143/JPSJ.41.1091; KONOPELCHENKO BG, 1984, PHYS LETT A, V102, P15, DOI 10.1016/0375-9601(84)90442-0; KONOPELCHENKO BG, 1991, INVERSE PROBL, V7, P739, DOI 10.1088/0266-5611/7/5/007; Krasnobaeva LA, 2008, RUSS PHYS J+, V51, P89, DOI 10.1007/s11182-008-9020-7; Kundu A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.154101; LAMB GL, 1971, REV MOD PHYS, V43, P99, DOI 10.1103/RevModPhys.43.99; Lennholm E, 2003, PHYSICA D, V177, P233, DOI 10.1016/S0167-2789(02)00769-8; Maldacena J, 2001, J HIGH ENERGY PHYS, V27, P062; MANDELSTAM S, 1975, PHYS REV D, V11, P3026, DOI 10.1103/PhysRevD.11.3026; Manton N, 2007, TOPOLOGICAL FRONTS; Nakagiri S, 2001, TAIWAN J MATH, V5, P297, DOI 10.11650/twjm/1500407338; NIZHNIK LP, 1980, DOKL AKAD NAUK SSSR+, V254, P332; PERRING JK, 1962, NUCL PHYS, V31, P550, DOI 10.1016/0029-5582(62)90774-5; POLYAKOV AM, 1974, JETP LETT+, V20, P194; ROSENAU P, 1993, PHYS REV LETT, V70, P564, DOI 10.1103/PhysRevLett.70.564; RUBINSTE.J, 1970, J MATH PHYS, V11, P258, DOI 10.1063/1.1665057; Ruijsenaars SNM, 2001, NATO SCI SER II-MATH, V35, P273; Salas AH, 2010, NONLINEAR ANAL-REAL, V11, P3930, DOI 10.1016/j.nonrwa.2010.02.020; SALERNO M, 1991, PHYS REV A, V44, P5292, DOI 10.1103/PhysRevA.44.5292; SALERNO M, 1994, PHYS LETT A, V193, P263, DOI 10.1016/0375-9601(94)90594-0; SALERNO M, 1992, PHYS LETT A, V167, P49, DOI 10.1016/0375-9601(92)90624-U; SCOTT AC, 1969, AM J PHYS, V37, P52, DOI 10.1119/1.1975404; SCOTT AC, 1973, P IEEE, V61, P1443, DOI 10.1109/PROC.1973.9296; SEEGER A, 1953, Z PHYS, V134, P173, DOI 10.1007/BF01329410; Shang DS, 2010, APPL MATH COMPUT, V217, P1577, DOI 10.1016/j.amc.2009.06.072; TAKENO S, 1987, PROG THEOR PHYS, V77, P548, DOI 10.1143/PTP.77.548; Tang XY, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.046601; THOOFT G, 1974, NUCL PHYS B, VB 79, P276; Vanitha M, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041911; Vasumathi V, 2008, PHYS LETT A, V373, P76, DOI 10.1016/j.physleta.2008.10.058; VESELOV AP, 1984, DOKL AKAD NAUK SSSR+, V279, P20; WEISS J, 1984, J MATH PHYS, V25, P2226, DOI 10.1063/1.526415; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; WITTEN E, 1979, NUCL PHYS B, V160, P57, DOI 10.1016/0550-3213(79)90232-3; Yakushevich L. V., 2013, Biophysics, V58, P439, DOI 10.1134/S0006350913040209; Yakushevich L. V., 2008, Biophysics, V53, P21, DOI 10.1134/S0006350908010041; Yakushevich L. V., 2007, Biophysics, V52, P179, DOI 10.1134/S0006350907020066; YAKUSHEVICH LV, 1994, PHYSICA D, V79, P77, DOI 10.1016/0167-2789(94)90038-8; YOMOSA S, 1995, J PHYS SOC JPN, V64, P1917, DOI 10.1143/JPSJ.64.1917; Zarmi Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124306; Zarmi Y, 2014, NONLINEARITY, V27, P1499, DOI 10.1088/0951-7715/27/6/1499; Zhang J, 2003, MATH METHOD APPL SCI, V26, P11, DOI 10.1002/mma.340; Zhao YM, 2011, J APPL MATH SCI, V5, P1621; Zhao YM, 2014, J APPL MATH, DOI 10.1155/2014/534346	75	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0148993	10.1371/journal.pone.0148993	http://dx.doi.org/10.1371/journal.pone.0148993			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930077	gold, Green Published			2022-12-27	WOS:000371434500014
J	Park, S; Lee, J; Son, Y				Park, Saerom; Lee, Jaewook; Son, Youngdoo			Predicting Market Impact Costs Using Nonparametric Machine Learning Models	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LARGE TRADES; FLUCTUATIONS; PRICES	Market impact cost is the most significant portion of implicit transaction costs that can reduce the overall transaction cost, although it cannot be measured directly. In this paper, we employed the state-of-the-art nonparametric machine learning models: neural networks, Bayesian neural network, Gaussian process, and support vector regression, to predict market impact cost accurately and to provide the predictive model that is versatile in the number of variables. We collected a large amount of real single transaction data of US stock market from Bloomberg Terminal and generated three independent input variables. As a result, most nonparametric machine learning models outperformed a-state-of-the-art benchmark parametric model such as I-star model in four error measures. Although these models encounter certain difficulties in separating the permanent and temporary cost directly, nonparametric machine learning models can be good alternatives in reducing transaction costs by considerably improving in prediction performance.	[Park, Saerom; Lee, Jaewook] Seoul Natl Univ, Dept Ind Engn, Seoul 151742, South Korea; [Son, Youngdoo] Seoul Natl Univ, Res Inst Engn & Entrepreneurship, Seoul 151742, South Korea; [Son, Youngdoo] Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA; [Park, Saerom; Lee, Jaewook] Seoul Natl Univ, 39-311,1 Gwanak Ro, Seoul 151742, South Korea; [Son, Youngdoo] Rutgers State Univ, A203,Engn Bldg A Wing, Piscataway, NJ 08854 USA	Seoul National University (SNU); Seoul National University (SNU); Rutgers State University New Brunswick; Seoul National University (SNU); Rutgers State University New Brunswick	Son, Y (corresponding author), Seoul Natl Univ, Res Inst Engn & Entrepreneurship, Seoul 151742, South Korea.; Son, Y (corresponding author), Rutgers State Univ, Dept Ind & Syst Engn, Piscataway, NJ 08854 USA.; Son, Y (corresponding author), Rutgers State Univ, A203,Engn Bldg A Wing, Piscataway, NJ 08854 USA.	hand02@snu.ac.kr		Son, Youngdoo/0000-0002-1912-5853	National Research Foundation of Korea (NRF) - Korean government (MEST) [2011-0017657]; National Science Foundation [CCF-1144502]	National Research Foundation of Korea (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/nrf_eng_cms/) grant funded the Korean government (MEST) (No. 2011-0017657). This work was also conducted during a visit of the second author to DIMACS, partially enabled through support from the National Science Foundation under grant number CCF-1144502. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren R., 2005, RISK, V18, P58; [Anonymous], 2013, SCI ALGORITHMIC TRAD; [Anonymous], [No title captured]; Bershova N, 2013, QUANT FINANC, V13, P1759, DOI 10.1080/14697688.2013.861076; Bhattacharyya S, 2002, IEEE T EVOLUT COMPUT, V6, P169, DOI 10.1109/4235.996016; Bikker JA, 2008, J FORECASTING, V27, P21, DOI 10.1002/for.1052; Bikker JA, 2007, J INT MONEY FINANC, V26, P974, DOI 10.1016/j.jimonfin.2007.01.007; Bouchaud JP, 2004, QUANT FINANC, V4, P176, DOI 10.1088/1469-7688/4/2/007; Cao LJ, 2003, IEEE T NEURAL NETWOR, V14, P1506, DOI 10.1109/TNN.2003.820556; Chen W.H., 2006, INT J ELECT FINANCE, V1, P49, DOI DOI 10.1504/IJEF.2006.008837; Cressie N., 2011, STAT SPATIO TEMPORAL; Drucker H, 1997, ADV NEUR IN, V9, P155; Foresee FD, 1997, 1997 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-4, P1930, DOI 10.1109/ICNN.1997.614194; Frino A, 2008, J FUTURES MARKETS, V28, P1147, DOI 10.1002/fut.20366; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Gunduz Y, 2011, QUANT FINANC, V11, P1709, DOI 10.1080/14697688.2010.531041; Han GS, 2008, EXPERT SYST APPL, V35, P515, DOI 10.1016/j.eswa.2007.07.041; Huberman G., 2005, Review of Finance, V9, P165, DOI 10.1007/s10679-005-7591-5; HUTCHINSON JM, 1994, J FINANC, V49, P851, DOI 10.2307/2329209; Kato T, 2014, FINANC STOCH, V18, P695, DOI 10.1007/s00780-014-0232-0; Kim KJ, 2012, COMPUT OPER RES, V39, P1800, DOI 10.1016/j.cor.2011.06.023; Kim SH, 1997, EXPERT SYST APPL, V13, P85, DOI 10.1016/S0957-4174(97)00010-9; Lee YC, 2007, EXPERT SYST APPL, V33, P67, DOI 10.1016/j.eswa.2006.04.018; Liao SH, 2013, EXPERT SYST APPL, V40, P1542, DOI 10.1016/j.eswa.2012.08.075; Lillo F, 2003, NATURE, V421, P129, DOI 10.1038/421129a; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Osuna E, 1997, P 1997 IEEE WORKSH N; Park H, 2014, EXPERT SYST APPL, V41, P5227, DOI 10.1016/j.eswa.2014.01.032; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; Rasmussen C.E., 1996, THESIS U TORONTO; Rasmussen CE, 2006, GAUSSAIN PROCESSES M; Rosenblatt F., 1962, PRINCIPLES NEURODYNA, DOI 10.21236/AD0256582; Rumelhart D.E., 1985, LEARNING INTERNAL RE; Son Y, 2012, EXPERT SYST APPL, V39, P11607, DOI 10.1016/j.eswa.2012.04.015; Ticknor JL, 2013, EXPERT SYST APPL, V40, P5501, DOI 10.1016/j.eswa.2013.04.013	35	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150243	10.1371/journal.pone.0150243	http://dx.doi.org/10.1371/journal.pone.0150243			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5WU	26926235	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200031
J	Sutoyo, E; Mungad, M; Hamid, S; Herawan, T				Sutoyo, Edi; Mungad, Mungad; Hamid, Suraya; Herawan, Tutut			An Efficient Soft Set-Based Approach for Conflict Analysis	PLOS ONE			English	Article							DECISION-MAKING; FUZZY-SETS; REDUCTION; LOGICS; SYSTEM	Conflict analysis has been used as an important tool in economic, business, governmental and political dispute, games, management negotiations, military operations and etc. There are many mathematical formal models have been proposed to handle conflict situations and one of the most popular is rough set theory. With the ability to handle vagueness from the conflict data set, rough set theory has been successfully used. However, computational time is still an issue when determining the certainty, coverage, and strength of conflict situations. In this paper, we present an alternative approach to handle conflict situations, based on some ideas using soft set theory. The novelty of the proposed approach is that, unlike in rough set theory that uses decision rules, it is based on the concept of co-occurrence of parameters in soft set theory. We illustrate the proposed approach by means of a tutorial example of voting analysis in conflict situations. Furthermore, we elaborate the proposed approach on real world dataset of political conflict in Indonesian Parliament. We show that, the proposed approach achieves lower computational time as compared to rough set theory of up to 3.9%.	[Sutoyo, Edi; Mungad, Mungad; Hamid, Suraya; Herawan, Tutut] Univ Malaya, Dept Informat Syst, Kuala Lumpur, Malaysia	Universiti Malaya	Sutoyo, E (corresponding author), Univ Malaya, Dept Informat Syst, Kuala Lumpur, Malaysia.	edisutoyo@um.edu.my	Sutoyo, Edi/U-5355-2019; Hamid, Suraya/B-9864-2010; Herawan, Tutut/AAB-6534-2021; Sutoyo, Edi/B-7340-2018	Hamid, Suraya/0000-0001-9075-7338; Herawan, Tutut/0000-0001-9262-9137; Sutoyo, Edi/0000-0002-8413-5070	University of Malaya High Impact Research Grant from Ministry of Education Malaysia [UM.C/625/HIR/MOHE/SC/13/2]	University of Malaya High Impact Research Grant from Ministry of Education Malaysia	This work is supported by University of Malaya High Impact Research Grant no vote UM.C/625/HIR/MOHE/SC/13/2 from Ministry of Education Malaysia.	Agarwal M, 2013, APPL SOFT COMPUT, V13, P3552, DOI 10.1016/j.asoc.2013.03.015; Aktas H, 2007, INFORM SCIENCES, V177, P2726, DOI 10.1016/j.ins.2006.12.008; Alcantud JCR, 2016, INFORM FUSION, V29, P142, DOI 10.1016/j.inffus.2015.08.007; Alcantud JCR, 2016, INT J APPROX REASON, V68, P45, DOI 10.1016/j.ijar.2015.10.004; [安利平 An Liping], 2002, [天津大学学报. 自然科学与工程技术版, Journal of Tianjin University], V35, P15; [安利平 An Liping], 2002, [北京科技大学学报, Journal of University Science and Technology Beijing], V24, P91; Babitha KV, 2011, COMPUT MATH APPL, V62, P2235, DOI 10.1016/j.camwa.2011.07.010; Babitha KV, 2010, COMPUT MATH APPL, V60, P1840, DOI 10.1016/j.camwa.2010.07.014; Broumi S, J INTELLIGENT FUZZY; Cagman N., 2012, HACETTEPE J MATH STA, V41; Casti JL, 1989, MATH MODELS NATURE M; Crossingham Bodie, 2008, 2008 IEEE International Conference on Systems, Man and Cybernetics (SMC 2008), P1198, DOI 10.1109/ICSMC.2008.4811445; Das S, 2014, APPL SOFT COMPUT, V24, P196, DOI 10.1016/j.asoc.2014.06.050; Deja R, 2000, STUD FUZZ SOFT COMP, V56, P491; Deja R, 2001, NEW FRONT ARTIF INTE, P349; Deli I., 2015, J NEW THEORY, V6, P88; Deli I., 2015, INT J MACHINE LEARNI, P1; Deli I., 2014, NEUTROSOPHIC SETS SY, V5, P65, DOI 10.5281/zenodo.22601; Deli I, 2015, FILOMAT, V29, P1901, DOI 10.2298/FIL1509901D; Deli I, 2015, APPL SOFT COMPUT, V28, P109, DOI 10.1016/j.asoc.2014.11.053; Deng TQ, 2013, APPL MATH MODEL, V37, P4139, DOI 10.1016/j.apm.2012.09.010; Feng F, 2010, COMPUT MATH APPL, V60, P1756, DOI 10.1016/j.camwa.2010.07.006; Feng F, 2010, J COMPUT APPL MATH, V234, P10, DOI 10.1016/j.cam.2009.11.055; Feng QR, 2014, APPL SOFT COMPUT, V24, P749, DOI 10.1016/j.asoc.2014.08.042; GAU WL, 1993, IEEE T SYST MAN CYB, V23, P610, DOI 10.1109/21.229476; Gong K, 2013, APPL MATH MODEL, V37, P4474, DOI 10.1016/j.apm.2012.09.067; Herawan T, 2011, KNOWL-BASED SYST, V24, P186, DOI 10.1016/j.knosys.2010.08.005; Inuiguchi M, 2007, EUR J OPER RES, V181, P1540, DOI 10.1016/j.ejor.2005.11.054; Jiang YC, 2011, APPL MATH MODEL, V35, P824, DOI 10.1016/j.apm.2010.07.038; Jiang YC, 2010, COMPUT MATH APPL, V59, P2087, DOI 10.1016/j.camwa.2009.12.014; Li XJ, 2005, 2005 IEEE INTERNATIONAL CONFERENCE ON GRANULAR COMPUTING, VOLS 1 AND 2, P180; Liau CJ, 2000, INT J UNCERTAIN FUZZ, V8, P93, DOI 10.1142/S0218488500000071; Ma J, 2008, INT C COMP SUPP COOP, P64; Ma XQ, 2014, IEEE T FUZZY SYST, V22, P57, DOI 10.1109/TFUZZ.2013.2246571; Maeda Y, 1999, LECT NOTES ARTIF INT, V1711, P382; Maji P.K., 2001, J FUZZY MATH, V9, P589, DOI DOI 10.1109/IWISA.2010.5473444; Majumdar P, 2010, COMPUT MATH APPL, V59, P1425, DOI 10.1016/j.camwa.2009.12.006; Mamat R, 2013, KNOWL-BASED SYST, V52, P11, DOI 10.1016/j.knosys.2013.05.009; Molodtsov D, 1999, COMPUT MATH APPL, V37, P19, DOI 10.1016/S0898-1221(99)00056-5; Pawlak Z, 2005, EUR J OPER RES, V166, P649, DOI 10.1016/j.ejor.2003.09.038; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; PAWLAK Z, 1984, INT J MAN MACH STUD, V21, P127, DOI 10.1016/S0020-7373(84)80062-0; Pawlak Z, 1998, INFORM SCIENCES, V109, P65, DOI 10.1016/S0020-0255(97)10072-X; Pawlak Z, 2007, E SERVICE INTELLIGEN, V37, P35; Ramanna S, 2006, LECT NOTES ARTIF INT, V4259, P274; Rodriguez RM, 2014, INT J INTELL SYST, V29, P495, DOI 10.1002/int.21654; Roy AR, 2007, J COMPUT APPL MATH, V203, P412, DOI 10.1016/j.cam.2006.04.008; Sezgin A, 2011, COMPUT MATH APPL, V61, P1457, DOI 10.1016/j.camwa.2011.01.018; Skowron A, 2006, LECT NOTES ARTIF INT, V4062, P233; Wang C, 2013, INFORM SCIENCES, V244, P92, DOI 10.1016/j.ins.2013.05.013; Xiao Z, 2012, APPL MATH MODEL, V36, P4592, DOI 10.1016/j.apm.2011.11.049; Xu W, 2010, COMPUT MATH APPL, V59, P787, DOI 10.1016/j.camwa.2009.10.015; Xu Z., 2014, HESITANT FUZZY SETS; Yao YY, 2007, 2007 IEEE SYMPOSIUM ON FOUNDATIONS OF COMPUTATIONAL INTELLIGENCE, VOLS 1 AND 2, P302, DOI 10.1109/FOCI.2007.372184; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	55	9	9	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0148837	10.1371/journal.pone.0148837	http://dx.doi.org/10.1371/journal.pone.0148837			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928627	gold, Green Submitted, Green Published			2022-12-27	WOS:000371424200004
J	Attia, EF; Jolley, SE; Crothers, K; Schnapp, LM; Liles, WC				Attia, Engi F.; Jolley, Sarah E.; Crothers, Kristina; Schnapp, Lynn M.; Liles, W. Conrad			Soluble Vascular Cell Adhesion Molecule-1 (sVCAM-1) Is Elevated in Bronchoalveolar Lavage Fluid of Patients with Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; ACUTE LUNG INJURY; ENDOTHELIAL ACTIVATION BIOMARKERS; CRITICALLY-ILL; EXPRESSION; PLASMA; ARDS; ANGIOPOIETIN-2; ASSOCIATION; MORTALITY	Introduction Pulmonary vascular endothelial activation has been implicated in acute respiratory distress syndrome (ARDS), yet little is known about the presence and role of endothelial activation markers in the alveolar space in ARDS. We hypothesized that endothelial activation biomarkers would be differentially expressed in bronchoalveolar lavage fluid from patients with ARDS compared with healthy volunteers, and that biomarker concentrations would be associated with ARDS severity. Methods We performed a cross-sectional analysis of data from 26 intubated patients with ARDS undergoing evaluation for clinically suspected ventilator-associated pneumonia and five healthy volunteers. Patients underwent bronchoalveolar lavage a median of five days after intubation. Healthy volunteers also underwent bronchoalveolar lavage. Endothelial activation biomarkers (soluble vascular cell adhesion molecule-1 [sVCAM-1], soluble endothelial selectin [sESEL], angiopoietin-1 [Ang-1] and angiopoietin-2 [Ang-2]) were measured in bronchoalveolar lavage fluid. Clinically suspected ventilator-associated pneumonia was confirmed with microbiologic culture data. Results Patients with ARDS had significantly higher median sVCAM-1 concentrations in the bronchoalveolar lavage fluid compared with healthy volunteers (985 vs 119 pg/mL, p = 0.03). Additionally, there was a trend toward greater bronchoalveolar lavage fluid sVCAM-1 concentrations among patients with moderate/severe compared to mild ARDS (1395 vs 209 pg/mL, p = 0.06). We did not detect significant differences in bronchoalveolar lavage fluid levels of sESEL, Ang-1 or Ang-2 between patients with ARDS and healthy volunteers. Median bronchoalveolar lavage fluid biomarker levels did not differ between patients with and without microbiologically-confirmed ventilator-associated pneumonia. Conclusions sVCAM-1 concentrations were significantly higher in the bronchoalveolar lavage fluid of patients with ARDS compared to healthy controls, and tended to be higher in moderate/severe ARDS compared to mild ARDS. Our findings add to the growing evidence supporting the concept that endothelial activation plays an important mechanistic role in the pathogenesis of ARDS. Further studies are necessary to characterize the role and/or clinical significance of sVCAM-1 and other endothelial activation markers present in the alveolar space in ARDS.	[Attia, Engi F.; Crothers, Kristina] Univ Washington, Dept Med, Div Pulm & Crit Care Med, Seattle, WA USA; [Jolley, Sarah E.] Louisiana State Univ, Hlth Sci Ctr, Dept Med, Sect Pulm Crit Care & Allergy Immunol, New Orleans, LA USA; [Schnapp, Lynn M.] Med Univ S Carolina, Dept Med, Div Pulm Crit Care Allergy & Sleep Med, Charleston, SC 29425 USA; [Liles, W. Conrad] Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA; [Liles, W. Conrad] Univ Washington, Dept Pathol, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, W. Conrad] Univ Washington, Dept Pharmacol, Ctr Lung Biol, Seattle, WA 98195 USA; [Liles, W. Conrad] Univ Washington, Dept Global Hlth, Ctr Lung Biol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Medical University of South Carolina; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Liles, WC (corresponding author), Univ Washington, Dept Med, Ctr Lung Biol, Seattle, WA USA.; Liles, WC (corresponding author), Univ Washington, Dept Pathol, Ctr Lung Biol, Seattle, WA 98195 USA.; Liles, WC (corresponding author), Univ Washington, Dept Pharmacol, Ctr Lung Biol, Seattle, WA 98195 USA.; Liles, WC (corresponding author), Univ Washington, Dept Global Hlth, Ctr Lung Biol, Seattle, WA 98195 USA.	wcliles@uw.edu	Attia, Engi Farouk/J-7793-2019	Attia, Engi Farouk/0000-0002-5044-9602; Crothers, Kristina/0000-0001-9702-0371	University of Washington Department of Medicine; National Institutes of Health [F32 HL125031]; National Institute of General Medical Sciences of the National Institutes of Health [1 U54 GM104940];  [K24 HL068796]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104940] Funding Source: NIH RePORTER	University of Washington Department of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided in part by research funds from the University of Washington Department of Medicine. Dr. Schnapp is supported by K24 HL068796. Dr. Attia received a grant (F32 HL125031) from the National Institutes of Health. Dr. Jolley is supported in part by 1 U54 GM104940 from the National Institute of General Medical Sciences of the National Institutes of Health, which funds the Louisiana Clinical and Translational Science Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouridakis P, 2002, RESPIR RES, V3, DOI 10.1186/rr193; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Bhargava M, 2012, TRANSL RES, V159, P205, DOI 10.1016/j.trsl.2012.01.007; Binnie A, 2014, CURR OPIN CRIT CARE, V20, P47, DOI 10.1097/MCC.0000000000000048; BOCHNER BS, 1995, J IMMUNOL, V154, P799; Burnham EL, 2004, CRIT CARE MED, V32, P675, DOI 10.1097/01.CCM.0000114824.65158.4E; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chen JZ, 2008, PROTEOM CLIN APPL, V2, P585, DOI 10.1002/prca.200780006; Etter H, 1998, CYTOKINE, V10, P395, DOI 10.1006/cyto.1997.0308; Forel JM, 2012, CRIT CARE, V16, DOI 10.1186/cc11312; Graham SM, 2013, AIDS, V27, P1803, DOI 10.1097/QAD.0b013e328360e9fb; Graham SM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-263; Hellyer TP, 2015, THORAX, V70, P41, DOI 10.1136/thoraxjnl-2014-205766; Lee KS, 2007, EXP MOL MED, V39, P733, DOI 10.1038/emm.2007.80; Markowicz P, 2000, AM J RESP CRIT CARE, V161, P1942, DOI 10.1164/ajrccm.161.6.9909122; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; MEDURI GU, 1995, CHEST, V108, P1303, DOI 10.1378/chest.108.5.1303; Muller AM, 2002, J PATHOL, V198, P270, DOI 10.1002/path.1186; Muller AM, 2002, EXP MOL PATHOL, V73, P171, DOI 10.1006/exmp.2002.2446; Nguyen EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058782; Orfanos SE, 2004, INTENS CARE MED, V30, P1702, DOI 10.1007/s00134-004-2370-x; Palazzo SJ, 2012, RESP CARE, V57, P2052, DOI 10.4187/respcare.01703; Papazian L, 1996, AM J RESP CRIT CARE, V154, P91, DOI 10.1164/ajrccm.154.1.8680705; Park WY, 2001, AM J RESP CRIT CARE, V164, P1896, DOI 10.1164/ajrccm.164.10.2104013; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; SCHLEIMER RP, 1992, J IMMUNOL, V148, P1086; Shapiro NI, 2010, CRIT CARE, V14, DOI 10.1186/cc9290; STEINBERG KP, 1994, AM J RESP CRIT CARE, V150, P113, DOI 10.1164/ajrccm.150.1.8025736; van der Heijden M, 2008, THORAX, V63, P903, DOI 10.1136/thx.2007.087387; Zonneveld R, 2014, CRIT CARE, V18, DOI 10.1186/cc13733	32	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149687	10.1371/journal.pone.0149687	http://dx.doi.org/10.1371/journal.pone.0149687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919714	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400034
J	Beraldo, RA; Meliscki, GC; Silva, BR; Navarro, AM; Bollela, VR; Schmidt, A; Foss-Freitas, MC				Beraldo, Rebeca Antunes; Meliscki, Gabriela Cristina; Silva, Bruna Ramos; Navarro, Anderson Marliere; Bollela, Valdes Roberto; Schmidt, Andre; Foss-Freitas, Maria Cristina			Comparing the Ability of Anthropometric Indicators in Identifying Metabolic Syndrome in HIV Patients	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK-FACTORS; WAIST CIRCUMFERENCE; ANTIRETROVIRAL THERAPY; ABDOMINAL OBESITY; CUTOFF POINTS; DISEASE RISK; RATIO; ADIPOSITY; WEIGHT	Background Highly active antiretroviral therapy (HAART) can cause side effects in HIV patients, as the metabolic syndrome. Early identification of risk for development of cardiovascular diseases using available reliable and practical methods is fundamental. On this basis, the aim of this study was to compare the effectiveness of anthropometric indicators to identify metabolic syndrome in HIV patients on HAART. Methods It is a cross-sectional study. A number of 280 stable HIV patients were studied. It measured weight, height, waist circumference (WC), hip circumference (HP), thigh circumference (TC) and calculated body mass index (BMI), body adiposity index (BAI), waist to hip ratio (WHR) and waist to thigh ratio (WTR). There was also a performance of biochemical tests of lipid profile and fasting glucose. Systemic blood pressure was measured. The criteria proposed by the National Cholesterol Education Program III (NCEP-ATP III) to metabolic syndrome classification was used. Individuals were divided in groups with or without metabolic alterations and their anthropometric indicators were compared. Receiver operating characteristic (ROC) curves were designed for each anthropometric indicator using the metabolic syndrome classification to identify sensitivity and specificity. Results WC was a good tool to identify each metabolic disorder separately: total cholesterol (only females, p<0.05), triglycerides (only males, p<0.001), HDL cholesterol (p<0.05), LDL cholesterol (p<005) and fasting glycemic (p<005). WC also showed the best performance to identify metabolic syndrome in both genders (areas under the curve (AUCs): 0.79 and 0.76 for male and female, respectively), while BAI proved to be an inadequate indicator (AUCs: 0.63 and 0.67 for males and females), respectively, in this population. Conclusions The central adiposity measure (WC) had the best performance to identify metabolic syndrome, and it is a convenient, cheap and reliable tool that can be used in clinical practice routinely to prevent cardiovascular complications in HIV patients.	[Beraldo, Rebeca Antunes; Meliscki, Gabriela Cristina; Silva, Bruna Ramos; Navarro, Anderson Marliere; Bollela, Valdes Roberto; Schmidt, Andre; Foss-Freitas, Maria Cristina] Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, Sao Paulo, Brazil	Universidade de Sao Paulo	Beraldo, RA (corresponding author), Univ Sao Paulo, Dept Internal Med, Ribeirao Preto Med Sch, Sao Paulo, Brazil.	rebecaberaldo@yahoo.com.br	Beraldo, Rebeca/J-7380-2016; , Anderson/D-8601-2016; Schmidt, André/G-1569-2011; Foss-Freitas, Maria/AAV-5971-2021; Foss-Freitas, Maria C/F-1197-2013	Beraldo, Rebeca/0000-0003-3027-7409; , Anderson/0000-0001-9127-3001; Schmidt, André/0000-0002-1090-8165; Foss-Freitas, Maria/0000-0002-1350-1125; Foss-Freitas, Maria C/0000-0002-1350-1125	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/23287-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), to RAB (process number: 2013/23287-3).; We would like to thank the Infectious Disease Ambulatory division of the Ribeirao Preto Medical School, University of Sao Paulo, Brazil. We would like to acknowledge Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for partially supporting this research.	Al-Lawati JA, 2008, PUBLIC HEALTH NUTR, V11, P102, DOI 10.1017/S1368980007000183; Al-Lawati JA, 2008, DIABETES VASC DIS RE, V5, P304, DOI 10.3132/dvdr.2008.044; Bener A, 2010, BOSNIAN J BASIC MED, V10, P210, DOI 10.17305/bjbms.2010.2687; Beraldo RA, 2015, EUR J CLIN NUTR, V69, P274, DOI 10.1038/ejcn.2014.149; Beraldo RA, 2011, REV CHIL NUTR, V38, P404, DOI 10.4067/S0717-75182011000400002; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Boskurt B., 2004, CARDIOVASC TOXICOL, V4, P243; Bouguerra R, 2007, DIABETES OBES METAB, V9, P859, DOI 10.1111/j.1463-1326.2006.00667.x; Bray GA, 2003, POSTGRAD MED, V114, P19, DOI 10.3810/pgm.2003.12.1544; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; DESPRES JP, 1993, NUTRITION, V9, P452; Dong XL, 2011, POSTGRAD MED J, V87, P251, DOI 10.1136/pgmj.2010.100453; Dourado I, 2006, REV SAUDE PUBL, V40, P9, DOI 10.1590/S0034-89102006000800003; Engelson ES, 2006, METABOLISM, V55, P1327, DOI 10.1016/j.metabol.2006.05.018; Foucan L, 2002, J CLIN EPIDEMIOL, V55, P990, DOI 10.1016/S0895-4356(02)00430-4; Giorgino F, 2005, ACTA PHYSIOL SCAND, V183, P13, DOI 10.1111/j.1365-201X.2004.01385.x; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guimaraes MM, 2007, ARQ BRAS ENDOCRINOL, V51, P369, DOI [10.1590/S0004-27302007000300002, 10.1590/S0004-27302007000100008]; Gus M, 1998, Arq Bras Cardiol, V70, P111, DOI 10.1590/S0066-782X1998000200008; Heymsfield SB, 2002, AM J PHYSIOL-ENDOC M, V282, pE132, DOI 10.1152/ajpendo.2002.282.1.E132; Katulanda P, 2011, BRIT J NUTR, V105, P1084, DOI 10.1017/S0007114510004563; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Lakka TA, 2001, ATHEROSCLEROSIS, V154, P497, DOI 10.1016/S0021-9150(00)00514-1; Lam BCC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122985; Lam BCC, 2013, OBESITY, V21, pE634, DOI 10.1002/oby.20504; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lear SA, 2003, METABOLISM, V52, P1295, DOI 10.1016/S0026-0495(03)00196-3; Mallon PWG, 2003, AIDS, V17, P971, DOI 10.1097/00002030-200305020-00005; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; NORGAN NG, 1990, EUR J CLIN NUTR, V44, P79; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; OPPLIGER RA, 1991, MED SCI SPORT EXER, V23, P247; Organization WH, 1998, WELLB MEAS PRIM HLTH; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161; Scott CL, 2003, AM J CARDIOL, V92, p35I, DOI 10.1016/S0002-9149(03)00507-1; Segatto Aline Francielle Mota, 2012, BMC Res Notes, V5, P543, DOI 10.1186/1756-0500-5-543; Soares LR, 2015, REV INST MED TROP SP, V57, P105, DOI 10.1590/S0036-46652015000200002; Sutinen J, 2007, AM J PHYSIOL-ENDOC M, V292, pE687, DOI 10.1152/ajpendo.00219.2006; Van Harmelen V, 1998, DIABETES, V47, P913, DOI 10.2337/diabetes.47.6.913; von Eyben FE, 2003, INT J OBESITY, V27, P941, DOI 10.1038/sj.ijo.0802309; World Health Organization (WHO), 1995, WHO TECHN REP SER, V854, P378; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	45	12	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149905	10.1371/journal.pone.0149905	http://dx.doi.org/10.1371/journal.pone.0149905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919174	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400056
J	Farasat, H; Akmali, V; Sharifi, M				Farasat, Hossein; Akmali, Vahid; Sharifi, Mozafar			Population Genetic Structure of the Endangered Kaiser's Mountain Newt, Neurergus kaiseri (Amphibia: Salamandridae)	PLOS ONE			English	Article							ECOLOGICAL SPECIATION; ENVIRONMENTAL-FACTORS; WESTERN IRAN; CONSERVATION; DIFFERENTIATION; ABUNDANCE; GEOGRAPHY; PATTERNS; INSIGHTS; DISTANCE	Species often exhibit different levels of genetic structuring correlated to their environment. However, understanding how environmental heterogeneity influences genetic variation is difficult because the effects of gene flow, drift and selection are confounded. We investigated the genetic variation and its ecological correlates in an endemic and critically endangered stream breeding mountain newt, Neurergus kaiseri, within its entire range in southwestern Iran. We identified two geographic regions based on phylogenetic relationships using Bayesian inference and maximum likelihood of 779 bp mtDNA (D-loop) in 111 individuals from ten of twelve known breeding populations. This analysis revealed a clear divergence between northern populations, located in more humid habitats at higher elevation, and southern populations, from drier habitats at lower elevations regions. From seven haplotypes found in these populations none was shared between the two regions. Analysis of molecular variance (AMOVA) of N. kaiseri indicates that 94.03% of sequence variation is distributed among newt populations and 5.97% within them. Moreover, a high degree of genetic subdivision, mainly attributable to the existence of significant variance among the two regions is shown (theta(CT) = 0.94, P = 0.002). The positive and significant correlation between geographic and genetic distances (r = 0.61, P = 0.002) following controlling for environmental distance suggests an important influence of geographic divergence of the sites in shaping the genetic variation and may provide tools for a possible conservation based prioritization policy for the endangered species.	[Farasat, Hossein; Akmali, Vahid; Sharifi, Mozafar] Razi Univ, Dept Biol, Fac Sci, Ctr Environm Studies, Bagheabrisham 6714967346, Kermanshah, Iran	Razi University	Sharifi, M (corresponding author), Razi Univ, Dept Biol, Fac Sci, Ctr Environm Studies, Bagheabrisham 6714967346, Kermanshah, Iran.	sharifimozafar2012@gmail.com	Farasat, Hussein/AAG-2534-2019	Farasat, Hussein/0000-0001-7457-9965; Akmali, Vahid/0000-0001-8946-3527; /0000-0003-0826-3000	Razi University; Iran National Science Foundation [91057377]	Razi University; Iran National Science Foundation(Iran National Science Foundation (INSF))	This study was financially supported by Razi University and the Iran National Science Foundation (Project No: 91057377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkenhol N, 2009, ECOGRAPHY, V32, P818, DOI 10.1111/j.1600-0587.2009.05807.x; Bekkevold D, 2005, EVOLUTION, V59, P2656; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Crispo E, 2006, MOL ECOL, V15, P49, DOI 10.1111/j.1365-294X.2005.02764.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Excoffier, 2007, HDB STAT GENETICS, P980; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farasat H, 2015, J HERPETOL; Foll M, 2006, GENETICS, V174, P875, DOI 10.1534/genetics.106.059451; Gebremedhin B, 2009, ANIM CONSERV, V12, P89, DOI 10.1111/j.1469-1795.2009.00238.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Habel JC, 2015, BIOL J LINN SOC, V115, P1, DOI 10.1111/bij.12481; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Helfer V, 2012, MOL ECOL, V21, P4706, DOI 10.1111/j.1365-294X.2012.05742.x; Hendrix R, 2014, AMPHIBIA-REPTILIA, V35, P173, DOI 10.1163/15685381-00002939; Hendrix R, 2010, MOL ECOL RESOUR, V10, P1038, DOI 10.1111/j.1755-0998.2010.02861.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; James PMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025359; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Khafagi O., 2012, Universal Journal of Environmental Research and Technology, V2, P515; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kittlein MJ, 2008, P ROY SOC B-BIOL SCI, V275, P2633, DOI 10.1098/rspb.2008.0816; Martinez-Meyer E, 2006, ORYX, V40, P411, DOI 10.1017/S0030605306001360; Mota-Vargas C, 2012, J NAT CONSERV, V20, P10, DOI 10.1016/j.jnc.2011.07.002; Panchal M, 2007, BIOINFORMATICS, V23, P509, DOI 10.1093/bioinformatics/btl614; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rambaut A., 2018, FIGTREE; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rousset F, 1997, GENETICS, V145, P1219; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt BR, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-19; Schmitt T, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-11; Schulte U, 2007, AMPHIBIA-REPTILIA, V28, P531, DOI 10.1163/156853807782152543; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; Sharifi M, IUCN 2009 IUCN RED L; Sharifi M, 2014, HERPETOZOA, V27, P77; Sharifi M, 2013, HERPETOL CONSERV BIO, V8, P724; Shepard DB, 2008, MOL ECOL, V17, P5315, DOI 10.1111/j.1365-294X.2008.03998.x; Steinfartz S, 2000, MOL ECOL, V9, P397, DOI 10.1046/j.1365-294x.2000.00870.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEMPLETON AR, 1992, GENETICS, V132, P619; Temunovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042764; Wang BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067345; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Watanabe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093055; Welch JR, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081226, 10.1371/journal.pone.0083443, 10.1371/journal.pone.0059853]; Wellenreuther M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020440; Wielstra B, 2015, BIOL J LINN SOC, V114, P574, DOI 10.1111/bij.12446; WRIGHT HE, 1967, J ECOL, V55, P415, DOI 10.2307/2257886; Wright S, 1943, GENETICS, V28, P114; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30	56	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149596	10.1371/journal.pone.0149596	http://dx.doi.org/10.1371/journal.pone.0149596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918642	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400026
J	Bayarri-Lara, C; Ortega, FG; de Guevara, ACL; Puche, JL; Zafra, JR; de Miguel-Perez, D; Ramos, ASP; Giraldo-Ospina, CF; Gomez, JAN; Delgado-Rodriguez, M; Lorente, JA; Serrano, MJ				Bayarri-Lara, Clara; Ortega, Francisco G.; Ladron de Guevara, Antonio Cueto; Puche, Jose L.; Ruiz Zafra, Javier; de Miguel-Perez, Diego; Sanchez-Palencia Ramos, Abel; Fernando Giraldo-Ospina, Carlos; Navajas Gomez, Juan A.; Delgado-Rodriguez, Miguel; Lorente, Jose A.; Jose Serrano, Maria			Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection	PLOS ONE			English	Article							PERIPHERAL-BLOOD; EGFR; EXPRESSION; SURVIVAL	Background Surgery is the treatment of choice for patients with non-small cell lung cancer (NSCLC) stages I-IIIA. However, more than 20% of these patients develop recurrence and die due to their disease. The release of tumor cells into peripheral blood (CTCs) is one of the main causes of recurrence of cancer. The objectives of this study are to identify the prognostic value of the presence and characterization of CTCs in peripheral blood in patients undergoing radical resection for NSCLC. Patients and Methods 56 patients who underwent radical surgery for previously untreated NSCLC were enrolled in this prospective study. Peripheral blood samples for CTC analysis were obtained before and one month after surgery. In addition CTCs were phenotypically characterized by epidermal growth factor receptor (EGFR) expression. Results 51.8% of the patients evaluated were positive with the presence of CTCs at baseline. A decrease in the detection rate of CTCs was observed in these patients one month after surgery (32.1%) (p = 0.035). The mean number of CTCs was 3.16 per 10 ml (range 0-84) preoperatively and 0.66 (range 0-3) in postoperative determination. EGFR expression was found in 89.7% of the patients at baseline and in 38.9% patients one month after surgery. The presence of CTCs after surgery was significantly associated with early recurrence (p = 0.018) and a shorter disease free survival (DFS) (p =.008). In multivariate analysis CTC presence after surgery (HR = 5.750, 95% CI: 1.50-21.946, p = 0.010) and N status (HR = 0.296, 95% CI: 0.091-0.961, p = 0.043) were independent prognostic factors for DFS. Conclusion CTCs can be detected and characterized in patients undergoing radical resection for non-small cell lung cancer. Their presence might be used to identify patients with increased risk of early recurrence.	[Bayarri-Lara, Clara; Ladron de Guevara, Antonio Cueto; Ruiz Zafra, Javier; Sanchez-Palencia Ramos, Abel; Fernando Giraldo-Ospina, Carlos; Navajas Gomez, Juan A.] Virgen de las Nieves Univ Hosp, Dept Thorac Surg, Ave Fuerzas Armadas 2, Granada 18014, Spain; [Ortega, Francisco G.; Puche, Jose L.; de Miguel-Perez, Diego; Lorente, Jose A.; Jose Serrano, Maria] Univ Granada, GENYO, Ctr Genom & Oncol Res, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain; [Puche, Jose L.; Jose Serrano, Maria] San Cecilio Clin Univ Hosp, Integral Oncol Div, Ave Dr Oloriz 16, Granada 18012, Spain; [Delgado-Rodriguez, Miguel] Univ Jaen, CIBERESP, Div Prevent Med & Publ Hlth, Campus Lagunillas, Jaen 23071, Spain; [Lorente, Jose A.] Univ Granada, Dept Legal Med, Lab Genet Identificat, Avda Madrid 11, Granada 18012, Spain	Hospital Universitario Virgen de las Nieves; Pfizer; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universidad de Jaen; University of Granada	Serrano, MJ (corresponding author), Univ Granada, GENYO, Ctr Genom & Oncol Res, Pfizer,Andalusian Reg Govt, PTS Granada Ave Ilustrac 114, Granada 18016, Spain.; Serrano, MJ (corresponding author), San Cecilio Clin Univ Hosp, Integral Oncol Div, Ave Dr Oloriz 16, Granada 18012, Spain.	mjose.serrano@genyo.es	De Miguel Pérez, Diego/AAW-3113-2020; LORENTE, JOSE A./B-8372-2008	De Miguel Pérez, Diego/0000-0002-2822-4466; LORENTE, JOSE A./0000-0002-9892-7386; Ortega Sanchez, Francisco Gabriel/0000-0003-0563-2237	Fundacion de Investigacion Basica Alenjando Otero	Fundacion de Investigacion Basica Alenjando Otero	This work was supported by Fundacion de Investigacion Basica Alenjando Otero (www.Fibao.es) (MJS). The funders had no role in study design, data collection and analyses, decision to publish or preparation of the manuscript.	Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Hofman V, 2014, CURR MOL MED, V14, P440, DOI 10.2174/1566524014666140414205455; Hofman V, 2011, CLIN CANCER RES, V17, P827, DOI 10.1158/1078-0432.CCR-10-0445; Iinuma H, 2011, J CLIN ONCOL, V29, P1547, DOI 10.1200/JCO.2010.30.5151; Serrano MJ, 2009, CANCER BIOL THER, V8, P671, DOI 10.4161/cbt.8.8.7834; Kelsey CR, 2009, CANCER-AM CANCER SOC, V115, P5218, DOI 10.1002/cncr.24625; Krebs MG, 2011, J CLIN ONCOL, V29, P1556, DOI 10.1200/JCO.2010.28.7045; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Nadal R, 2013, INT J CANCER, V133, P2398, DOI 10.1002/ijc.28263; Nadal R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3180; O'Flaherty JD, 2012, LUNG CANCER, V76, P19, DOI 10.1016/j.lungcan.2011.10.018; Okumura Y, 2009, ANN THORAC SURG, V87, P1669, DOI 10.1016/j.athoracsur.2009.03.073; Rolle Axel, 2005, World J Surg Oncol, V3, P18, DOI 10.1186/1477-7819-3-18; Sawabata N, 2007, GEN THORAC CARDIOVAS, V55, P189, DOI 10.1007/s11748-007-0101-2; Serrano MJ, 2011, ANN ONCOL, V22, P2150, DOI 10.1093/annonc/mdr322; Serrano MJ, 2014, ONCOTARGET, V5, P7486, DOI 10.18632/oncotarget.2217; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Song IH, 2014, EUR J CARDIO-THORAC, V45, P262, DOI 10.1093/ejcts/ezt333; Sundaresan TK, 2015, CLIN CANCER RES IN P; Traynor AM, 2013, LUNG CANCER, V81, P138, DOI 10.1016/j.lungcan.2013.03.020	21	84	90	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148659	10.1371/journal.pone.0148659	http://dx.doi.org/10.1371/journal.pone.0148659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913536	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700008
J	D'Abramo, A; Zingaropoli, MA; Oliva, A; D'Agostino, C; Al Moghazi, S; De Luca, G; Iannetta, M; d'Ettorre, G; Ciardi, MR; Mastroianni, CM; Vullo, V				D'Abramo, Alessandra; Zingaropoli, Maria Antonella; Oliva, Alessandra; D'Agostino, Claudia; Al Moghazi, Samir; De Luca, Giulia; Iannetta, Marco; d'Ettorre, Gabriella; Ciardi, Maria Rosa; Mastroianni, Claudio Maria; Vullo, Vincenzo			Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients	PLOS ONE			English	Article							VASCULAR CALCIFICATION; CARDIOVASCULAR-DISEASE; INFECTED PATIENTS; T-LYMPHOCYTES; ACTIVATION; OSTEOPOROSIS; INFLAMMATION; IMMUNOSENESCENCE; ATHEROSCLEROSIS; BIOMARKERS	HIV-infected patients appear to have a significantly greater risk of non-AIDS comorbidities such as osteoporosis and atherosclerosis. Subjects with osteoporosis are at a higher risk of developing cardiovascular disease than those with normal bone mass, therefore a possible relation between these two conditions can be hypothesized. In the setting of HIV infection, several factors might contribute to bone disease and endothelial dysfunction. The aim of our study was to evaluate the relationship between bone and cardiovascular disease and to investigate the role of traditional factors, T-cell phenotype and osteoprotegerin in HIV positive subjects on effective antiretroviral therapy. We included 94 HIV positive subjects on antiretroviral therapy with virological suppression and 41 healthy subjects matched for age and gender as a control group. Carotid-Intima Media Thickness (c-IMT) and bone mineral density (BMD) were performed by ultrasound and DEXA, respectively. CD4(+)/CD8(+) T-cell activation, senescence and osteoprotegerin plasma levels were measured by flow-cytometry and ELISA, respectively. Among HIV positive patients, 56.4% had osteopenia/osteoporosis and 45.7% had pathological c-IMT (>0.9mm). Subjects with pathological c-IMT and BMD exhibited higher CD4(+) and CD8(+) activated, CD8(+) senescent and osteoprotegerin than subjects with normal c-IMT and BMD. HIV positive subjects with osteopenia/osteoporosis had higher c-IMT than subjects with normal BMD, and linear regression analysis showed a negative correlation between BMD and c-IMT. Several factors are implicated in the pathogenesis of non-AIDS comorbidities in HIV positive patients. Osteoprotegerin together with inflammation and immunosenescence in HIV positive patients could affect bone and vascular system and could be considered as a possible common link between these two diseases.	[D'Abramo, Alessandra; Zingaropoli, Maria Antonella; Oliva, Alessandra; D'Agostino, Claudia; Al Moghazi, Samir; De Luca, Giulia; Iannetta, Marco; d'Ettorre, Gabriella; Ciardi, Maria Rosa; Mastroianni, Claudio Maria; Vullo, Vincenzo] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy	Fondazione Cenci Bolognetti; Sapienza University Rome	D'Abramo, A (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alessandra.dabramo@uniroma1.it	MASTROIANNI, Claudio Maria/O-9741-2019; Iannetta, Marco/M-4619-2019; Iannetta, Marco/B-5596-2017; d'Ettorre, Gabriella/K-4511-2016; D'Abramo, Alessandra/AAA-3054-2019; Oliva, Alessandra/C-1708-2019	MASTROIANNI, Claudio Maria/0000-0002-1286-467X; Iannetta, Marco/0000-0002-6938-8627; Iannetta, Marco/0000-0002-6938-8627; D'Abramo, Alessandra/0000-0002-5160-9743; Oliva, Alessandra/0000-0003-0832-7975; ciardi, maria rosa/0000-0002-0894-6496; D'Agostino, Caudia/0000-0002-4399-8785; d'Ettorre, Gabriella/0000-0002-3571-5677; Zingaropoli, Maria Antonella/0000-0001-9479-8559	Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome	Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome	The present project was supported by the Department of Public Health and Infectious Disease Istituto Pasteur-Fondazione Cenci Bolognetti, "Sapienza" University of Rome.	Aberg Judith A, 2012, Top Antivir Med, V20, P101; Anagnostis P, 2009, OSTEOPOROSIS INT, V20, P197, DOI 10.1007/s00198-008-0648-5; [Anonymous], 1994, ASS FRACT RISK ITS A, V843, P1; Biasillo G, 2010, INTERN EMERG MED, V5, P225, DOI 10.1007/s11739-010-0361-1; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brown TT, 2013, JAIDS-J ACQ IMM DEF, V63, P323, DOI 10.1097/QAI.0b013e318295eb1d; Chakravarti A, 2008, LAB INVEST, V88, P171, DOI 10.1038/labinvest.3700701; Coll B, 2007, STROKE, V38, P2477, DOI 10.1161/STROKEAHA.106.479030; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Compston J, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.3; D'Abramo A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/192594; D'Amelio P, 2008, BONE, V43, P92, DOI 10.1016/j.bone.2008.02.017; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Divers J, 2011, J BONE MINER RES, V26, P1554, DOI 10.1002/jbmr.389; Effros RB, 1997, DEV COMP IMMUNOL, V21, P471, DOI 10.1016/S0145-305X(97)00027-X; Erlandson KM, 2014, JAIDS-J ACQ IMM DEF, V65, P290, DOI 10.1097/QAI.0000000000000005; Freedman BI, 2009, J BONE MINER RES, V24, P1719, DOI [10.1359/JBMR.090501, 10.1359/jbmr.090501]; Guzman-Fulgencio M, 2011, J INFECTION, V63, P382, DOI 10.1016/j.jinf.2011.08.006; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hunt PW, 2014, CURR OPIN HIV AIDS, V9, P302, DOI 10.1097/COH.0000000000000072; Hwang JJ, 2012, JAIDS-J ACQ IMM DEF, V61, P359, DOI 10.1097/QAI.0b013e31826a6c16; Jeong SJ, 2013, YONSEI MED J, V54, P990, DOI 10.3349/ymj.2013.54.4.990; Kelesidis T, 2014, AIDS REV, V16, P123; KESTENS L, 1992, AIDS, V6, P793, DOI 10.1097/00002030-199208000-00004; Kiechl Stefan, 2006, Expert Rev Cardiovasc Ther, V4, P801, DOI 10.1586/14779072.4.6.801; Klatt NR, 2013, IMMUNOL REV, V254, P326, DOI 10.1111/imr.12065; Le Saux S, 2012, ANN NY ACAD SCI, V1247, P69, DOI 10.1111/j.1749-6632.2011.06297.x; Lorenz MW, 2008, ATHEROSCLEROSIS, V196, P720, DOI 10.1016/j.atherosclerosis.2006.12.022; Mancia G, 2013, J HYPERTENS, V31, P1925, DOI 10.1097/HJH.0b013e328364ca4c; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Merlini E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046073; Reid P, 2009, EUR J CELL BIOL, V88, P1, DOI 10.1016/j.ejcb.2008.06.004; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Rubin MR, 2004, J CLIN ENDOCR METAB, V89, P4243, DOI 10.1210/jc.2004-1324; Sprini D, 2014, CLIN CASES MINER BON, V11, P117, DOI 10.11138/ccmbm/2014.11.2.117; Stejskal David, 2001, Biomedical Papers (Olomouc), V145, P61; Tanko LB, 2005, J BONE MINER RES, V20, P1912, DOI 10.1359/JBMR.050711; Tincati C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110287; Van Campenhout A, 2009, ATHEROSCLEROSIS, V204, P321, DOI 10.1016/j.atherosclerosis.2008.09.033; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Worm SW, 2010, CURR OPIN HIV AIDS, V5, P467, DOI 10.1097/COH.0b013e32833f2ea6; Wright HL, 2009, CURR REV MUSCULOSKE, V2, P56, DOI 10.1007/s12178-009-9046-7	45	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149601	10.1371/journal.pone.0149601	http://dx.doi.org/10.1371/journal.pone.0149601			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913505	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700021
J	Nithyamathi, K; Chandramathi, S; Kumar, S				Nithyamathi, Kalimuthu; Chandramathi, Samudi; Kumar, Suresh			Predominance of Blastocystis sp Infection among School Children in Peninsular Malaysia	PLOS ONE			English	Article							ORANG-ASLI; PARASITIC INFECTIONS; INTESTINAL PARASITES; MOLECULAR EPIDEMIOLOGY; DRINKING-WATER; SUBTYPE 3; HOMINIS; ASSOCIATION; PREVALENCE; COMMUNITIES	Background One of the largest cross-sectional study in recent years was carried out to investigate the prevalence of intestinal parasitic infections among urban and rural school children from five states namely Selangor, Perak, Pahang, Kedah and Johor in Peninsula Malaysia. This information would be vital for school authorities to influence strategies for providing better health especially in terms of reducing intestinal parasitism. Methods and Principal Findings A total of 3776 stool cups was distributed to 26 schools throughout the country. 1760 (46.61%) responded. The overall prevalence of intestinal parasitic infection in both rural and urban areas was 13.3%, with Blastocystis sp (10.6%) being the most predominant, followed by Trichuris trichiura (3.4%), Ascaris lumbricoides (1.5%) and hook worm infection (0.9%). Only rural school children had helminthic infection. In general Perak had the highest infection (37.2%, total, n = 317), followed by Selangor (10.4%, total, n = 729), Pahang (8.6%, total, n = 221), Kedah (6.2%, total, n = 195) and Johor (3.4%, total, n = 298). School children from rural schools had higher infection (13.7%, total, n = 922) than urban school children (7.2%, total, n = 838). Subtype (ST) 3 (54.3%) is the most predominant ST with persons infected with only ST1 and ST3 showing symptoms. Blastocystis sp infection significantly associated with low household income, low parent's education and presence of symptoms (p< 0.05). Conclusion It is critical that we institute deworming and treatment to eradicate the parasite especially in rural school children.	[Nithyamathi, Kalimuthu; Kumar, Suresh] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Chandramathi, Samudi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	Samudi, Chandramathi/G-5937-2012; samudi@raju, Chandramathi/AAR-1595-2021		High Impact Research (HIR) Grant - Ministry of High Education (MOHE) [UM.C/625/1/HIR/044]; Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya [PV133-2012A]	High Impact Research (HIR) Grant - Ministry of High Education (MOHE); Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya	This research was supported by High Impact Research (HIR) Grant - Ministry of High Education (MOHE) - (Project UM.C/625/1/HIR/044) and Postgraduate Research Grant (PPP), Institute Graduate Studies, University Malaya - (PV133-2012A).	Abdulsalam AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084372; Abdulsalam AM, 2012, PARASITOLOGY, V139, P1014, DOI 10.1017/S0031182012000340; Aini UN, 2007, ASIA PAC J CLIN NUTR, V16, P724; Al-Mekhlafi HM, 2011, ANN TROP MED PARASIT, V105, P135, DOI 10.1179/136485911X12899838683368; Amin OM, 2002, AM J TROP MED HYG, V66, P799, DOI 10.4269/ajtmh.2002.66.799; Anuar TS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-40; Anuar TS, 2012, INT J PARASITOL, V42, P871, DOI 10.1016/j.ijpara.2012.07.003; Asma L, 2011, TROP BIOMED, V28, P400; Azian MYN, 2007, TROP BIOMED, V24, P55; Balint A, 2014, PARASITOL RES, V113, P1585, DOI 10.1007/s00436-014-3805-0; Bundy D, 1990, REPORT TO THE; Dogruman-Al F, 2008, PARASITOL RES, V103, P685, DOI 10.1007/s00436-008-1031-3; El Safadi D, 2013, AM J TROP MED HYG, V88, P1203, DOI 10.4269/ajtmh.12-0777; Elshazly Atef M., 2006, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V36, P655; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Hakim S. Lokman, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P415; Hartini Y, 2013, TROP BIOMED, V30, P596; Ithoi Init, 2011, Journal of Parasitology Research, V2011; Jamaiah I., 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P68; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; KAN SP, 1987, PUBLIC HEALTH, V101, P243, DOI 10.1016/S0033-3506(87)80075-6; Kaya Selcuk, 2007, Turkiye Parazitoloji Dergisi, V31, P184; Kumarasamy V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-162; Lee IL, 2012, PARASITOL RES, V110, P1553, DOI 10.1007/s00436-011-2665-0; Lee LI, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-130; Leelayoova S, 2008, AM J TROP MED HYG, V79, P401, DOI 10.4269/ajtmh.2008.79.401; Li LH, 2007, PARASITOL RES, V102, P83, DOI 10.1007/s00436-007-0727-0; Lim Y A L, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P30; Lono A, 2011, T ROY SOC TROP MED H, V105, P409, DOI 10.1016/j.trstmh.2011.03.006; Mahdy AKM, 2008, T ROY SOC TROP MED H, V102, P465, DOI 10.1016/j.trstmh.2008.02.004; Menon BS, 1999, J TROP PEDIATRICS, V45, P241, DOI 10.1093/tropej/45.4.241; Motazedian H, 2008, ANN TROP MED PARASIT, V102, P85, DOI 10.1179/136485908X252197; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001550; Norhayati M., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P735; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Poirier P, 2011, J CLIN MICROBIOL, V49, P975, DOI 10.1128/JCM.01392-10; Rahmah N, 1997, Med J Malaysia, V52, P412; Rajamanikam A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-295; Rajeswari B, 1994, Asia Pac J Public Health, V7, P21; Rivera WL, 2008, VET PARASITOL, V156, P178, DOI 10.1016/j.vetpar.2008.06.001; Sagin D. D., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P18; Salim HR, 1999, PARASITOL RES, V85, P1032, DOI 10.1007/s004360050677; SHEEHAN DJ, 1986, J CLIN MICROBIOL, V24, P548, DOI 10.1128/JCM.24.4.548-550.1986; Shekhar K C, 1996, Med J Malaysia, V51, P475; Sinniah B, 2012, TROP BIOMED, V29, P200; Slifko TR, 2000, INT J PARASITOL, V30, P1379, DOI 10.1016/S0020-7519(00)00128-4; Souppart L, 2009, PARASITOL RES, V105, P413, DOI 10.1007/s00436-009-1398-9; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2007, TRENDS PARASITOL, V23, P93, DOI 10.1016/j.pt.2007.01.004; SUN T, 1989, AM J GASTROENTEROL, V84, P1543; Suresh K, 2005, APPL ENVIRON MICROB, V71, P5619, DOI 10.1128/AEM.71.9.5619-5620.2005; Suresh K, 2004, EUR J CLIN MICROBIOL, V23, P509, DOI 10.1007/s10096-004-1123-7; Suresh K, 2001, T ROY SOC TROP MED H, V95, P377, DOI 10.1016/S0035-9203(01)90186-5; Tan Kevin S W, 2010, Curr Infect Dis Rep, V12, P28, DOI 10.1007/s11908-009-0073-8; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2009, PARASITOL RES, V105, P1283, DOI 10.1007/s00436-009-1551-5; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Thathaisong U, 2003, J CLIN MICROBIOL, V41, P967, DOI 10.1128/JCM.41.3.967-975.2003; Vennila GD, 1999, PARASITOL RES, V85, P162, DOI 10.1007/s004360050528; Wang WQ, 2014, VET PARASITOL, V203, P264, DOI 10.1016/j.vetpar.2014.04.006; Wong KHS, 2008, PARASITOL RES, V102, P663, DOI 10.1007/s00436-007-0808-0; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yoshikawa H, 2004, PARASITOL RES, V92, P22, DOI 10.1007/s00436-003-0995-2	63	36	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0136709	10.1371/journal.pone.0136709	http://dx.doi.org/10.1371/journal.pone.0136709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914483	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700001
J	Jia, YF; Sun, HJ; Wu, HQ; Zhang, HL; Zhang, XP; Xiao, DJ; Ma, XL; Wang, YS				Jia, Yanfei; Sun, Haiji; Wu, Hongqiao; Zhang, Huilin; Zhang, Xiuping; Xiao, Dongjie; Ma, Xiaoli; Wang, Yunshan			Nicotine Inhibits Cisplatin-Induced Apoptosis via Regulating alpha 5-nAChR/AKT Signaling in Human Gastric Cancer Cells	PLOS ONE			English	Article							LUNG-CANCER; CIGARETTE-SMOKING; TOBACCO SMOKING; IN-VITRO; PROLIFERATION; RECEPTOR; ACTIVATION; EXPRESSION; CYCLOOXYGENASE-2; INVASION	Gastric cancer incidence demonstrates a strong etiologic association with smoking. Nicotine, the major component in tobacco, is a survival agonist that inhibits apoptosis induced by certain chemotherapeutic agents, but the precise mechanisms involved remain largely unknown. Recently studies have indicated that alpha 5-nicotinic acetylcholine receptor (alpha 5-nAChR) is highly associated with lung cancer risk and nicotine dependence. Nevertheless, no information has been available about whether nicotine also affects proliferation of human gastric cancer cells through regulation of alpha 5-nAChR. To evaluate the hypothesis that alpha 5-nAChR may play a role in gastric cancer, we investigated its expression in gastric cancer tissues and cell lines. The expression of alpha 5-nAChR increased in gastric cancer tissue compared with para-carcinoma tissues. In view of the results, we proceeded to investigate whether nicotine inhibits cisplatin-induced apoptosis via regulating alpha 5-nAChR in gastric cancer cell. The results showed that nicotine significantly promoted cell proliferation in a dose and time-dependent manner through alpha 5-nAChR activation in human gastric cells. Furthermore, nicotine inhibited apoptosis induced by cisplatin. Silence of alpha 5-nAChR ablated the protective effects of nicotine. However, when co-administrating LY294002, an inhibitor of PI3K/AKT pathway, an increased apoptosis was observed. This effect correlated with the induction of Bcl-2, Bax, Survivin and Caspase-3 by nicotine in gastric cell lines. These results suggest that exposure to nicotine might negatively impact the apoptotic potential of chemotherapeutic drugs and that alpha 5-nAChR/AKT signaling plays a key role in the anti-apoptotic activity of nicotine induced by cisplatin.	[Jia, Yanfei; Wu, Hongqiao; Zhang, Huilin; Zhang, Xiuping; Xiao, Dongjie; Ma, Xiaoli; Wang, Yunshan] Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China; [Sun, Haiji] Shandong Normal Univ, Coll Life Sci, Jinan, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong Normal University	Ma, XL; Wang, YS (corresponding author), Shandong Univ, Jinan Cent Hosp, Cent Lab, Jinan 250100, Peoples R China.	mxl7125@126.com; w_yunshan@126.com			National Natural Science Foundation of China [81272588]; Shandong Provincial Natural Science Foundation of China [ZR2012HM061, ZR2013CM010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This work is supported by the National Natural Science Foundation of China (No. 81272588) and Shandong Provincial Natural Science Foundation of China (No. ZR2012HM061 and ZR2013CM010).	Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; Boezen H Marike, 2009, Proc Am Thorac Soc, V6, P701, DOI 10.1513/pats.200907-058DP; Checinska A, 2007, EXP CELL RES, V313, P1215, DOI 10.1016/j.yexcr.2006.12.011; Cheng YA, 1999, ARCH ORAL BIOL, V44, P843, DOI 10.1016/S0003-9969(99)00073-4; Cucina A, 2012, J SURG RES, V178, P233, DOI 10.1016/j.jss.2011.12.029; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; De Dosso S, 2013, CANCER CHEMOTH PHARM, V72, P159, DOI 10.1007/s00280-013-2181-2; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Falasca M, 2010, CURR PHARM DESIGN, V16, P1410, DOI 10.2174/138161210791033950; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gourlay SG, 1997, EUR J CLIN PHARMACOL, V51, P407, DOI 10.1007/s002280050222; Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jin Q, 2008, CARCINOGENESIS, V29, P1614, DOI 10.1093/carcin/bgm234; Kanetaka K, 2012, ANTICANCER RES, V32, P3495; Ladeiras-Lopes R, 2008, CANCER CAUSE CONTROL, V19, P689, DOI 10.1007/s10552-008-9132-y; Lawson GM, 1998, J CLIN PHARMACOL, V38, P510, DOI 10.1002/j.1552-4604.1998.tb05788.x; Lien YC, 2011, ANN SURG ONCOL, V18, P2671, DOI 10.1245/s10434-011-1598-2; Liu Y, 2011, WORLD J GASTROENTERO, V17, P2674, DOI 10.3748/wjg.v17.i21.2674; Ma XL, 2014, TOXICOL APPL PHARM, V278, P172, DOI 10.1016/j.taap.2014.04.023; MacQueen DA, 2014, PHARMACOGENOMICS J, V14, P70, DOI 10.1038/tpj.2012.50; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Mayer B, 2014, ARCH TOXICOL, V88, P5, DOI 10.1007/s00204-013-1127-0; Nakada T, 2012, J TOXICOL SCI, V37, P555; Nishino Y, 2006, JPN J CLIN ONCOL, V36, P800, DOI 10.1093/jjco/hyl112; Nishioka T, 2010, J CELL BIOCHEM, V109, P152, DOI 10.1002/jcb.22392; Pasini F, 2011, ANTICANCER RES, V31, P3543; Schaal C, 2014, MOL CANCER RES, V12, P14, DOI 10.1158/1541-7786.MCR-13-0541; Shin VY, 2008, TOXICOL APPL PHARM, V233, P254, DOI 10.1016/j.taap.2008.08.012; Shin VY, 2005, MOL CANCER RES, V3, P607, DOI 10.1158/1541-7786.MCR-05-0106; Shin VY, 2005, ALCOHOL, V35, P259, DOI 10.1016/j.alcohol.2005.04.007; Shin VY, 2004, TOXICOL APPL PHARM, V195, P103, DOI 10.1016/j.taap.2003.10.009; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Sun HJ, 2015, EXP TOXICOL PATHOL, V67, P477, DOI 10.1016/j.etp.2015.07.001; Sun XP, 2014, FEBS J, V281, P115, DOI 10.1111/febs.12577; Takahari D, 2011, CANCER CHEMOTH PHARM, V67, P1423, DOI 10.1007/s00280-010-1432-8; Tanida S., 2012, INT J SURG ONCOL, V2012, DOI [10.1155/2012/862879, DOI 10.1155/2012/862879]; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; Wang W, 2012, ANN SURG ONCOL, V19, pS580, DOI 10.1245/s10434-011-2064-x; Wang YY, 2014, ONCOL REP, V31, P1480, DOI 10.3892/or.2013.2962; Wojas-Krawczyk K, 2012, EUR J CANCER PREV, V21, P111, DOI 10.1097/CEJ.0b013e32834c9b40; Xu J, 2007, INT J ORAL MAX SURG, V36, P739, DOI 10.1016/j.ijom.2007.05.016; Yu LL, 2010, ONCOL REP, V24, P113, DOI 10.3892/or_00000835; Zeng F, 2012, MED ONCOL, V29, P364, DOI 10.1007/s12032-010-9792-9; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC; Zhang LL, 2013, MOL MED REP, V7, P1387, DOI 10.3892/mmr.2013.1400; Zheng Y, 2007, AM J RESP CELL MOL, V37, P681, DOI 10.1165/rcmb.2007-0051OC; Zhou W, 2012, REGUL PEPTIDES, V176, P13, DOI 10.1016/j.regpep.2012.02.003; Zovko A, 2013, MAR DRUGS, V11, P2574, DOI 10.3390/md11072574	50	28	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149120	10.1371/journal.pone.0149120	http://dx.doi.org/10.1371/journal.pone.0149120			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909550	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700023
J	Leuthardt, EC; Duan, C; Kim, MJ; Campian, JL; Kim, AH; Miller-Thomas, MM; Shimony, JS; Tran, DD				Leuthardt, Eric C.; Duan, Chong; Kim, Michael J.; Campian, Jian L.; Kim, Albert H.; Miller-Thomas, Michelle M.; Shimony, Joshua S.; Tran, David D.			Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier	PLOS ONE			English	Article							NEURON-SPECIFIC ENOLASE; HIGH-GRADE GLIOMAS; INTERSTITIAL THERMAL THERAPY; ADJUVANT TEMOZOLOMIDE; MALIGNANT GLIOMA; CONTROLLED-TRIAL; CEREBRAL-TUMORS; CONTRAST; RADIOTHERAPY; CANCER	Background Poor central nervous system penetration of cytotoxic drugs due to the blood brain barrier (BBB) is a major limiting factor in the treatment of brain tumors. Most recurrent glioblastomas (GBM) occur within the peritumoral region. In this study, we describe a hyperthemic method to induce temporary disruption of the peritumoral BBB that can potentially be used to enhance drug delivery. Methods Twenty patients with probable recurrent GBM were enrolled in this study. Fourteen patients were evaluable. MRI-guided laser interstitial thermal therapy was applied to achieve both tumor cytoreduction and disruption of the peritumoral BBB. To determine the degree and timing of peritumoral BBB disruption, dynamic contrast-enhancement brain MRI was used to calculate the vascular transfer constant (K-trans) in the peritumoral region as direct measures of BBB permeability before and after laser ablation. Serum levels of brain-specific enolase, also known as neuron-specific enolase, were also measured and used as an independent quantification of BBB disruption. Results In all 14 evaluable patients, K-trans levels peaked immediately post laser ablation, followed by a gradual decline over the following 4 weeks. Serum BSE concentrations increased shortly after laser ablation and peaked in 1-3 weeks before decreasing to baseline by 6 weeks. Conclusions The data from our pilot research support that disruption of the peritumoral BBB was induced by hyperthemia with the peak of high permeability occurring within 1-2 weeks after laser ablation and resolving by 4-6 weeks. This provides a therapeutic window of opportunity during which delivery of BBB-impermeant therapeutic agents may be enhanced.	[Leuthardt, Eric C.; Campian, Jian L.; Kim, Albert H.] Washington Univ, Sch Med, Dept Neurol Surg, Brain Laser Ctr, St Louis, MO 63110 USA; [Leuthardt, Eric C.; Kim, Albert H.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO 63110 USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA; [Leuthardt, Eric C.] Washington Univ, Sch Med, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA; [Duan, Chong] Washington Univ, Sch Med, Dept Chem, St Louis, MO 63110 USA; [Kim, Michael J.; Campian, Jian L.] Washington Univ, Sch Med, Dept Med, Neurooncol Program,Div Oncol, St Louis, MO 63110 USA; [Miller-Thomas, Michelle M.; Shimony, Joshua S.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 63110 USA; [Tran, David D.] Univ Florida, Coll Med, McKnight Brain Inst, Lillian S Wells Dept Neurol Surg,Div Neurooncol, Gainesville, FL 32610 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); State University System of Florida; University of Florida	Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, Brain Laser Ctr, St Louis, MO 63110 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Ctr Innovat Neurosci & Technol, St Louis, MO 63110 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Dept Biomed Engn, St Louis, MO 63110 USA.; Leuthardt, EC (corresponding author), Washington Univ, Sch Med, Dept Mech Engn & Mat Sci, St Louis, MO 63110 USA.; Shimony, JS (corresponding author), Washington Univ, Sch Med, Mallinckrodt Inst Radiol, Div Neuroradiol, St Louis, MO 63110 USA.; Tran, DD (corresponding author), Univ Florida, Coll Med, McKnight Brain Inst, Lillian S Wells Dept Neurol Surg,Div Neurooncol, Gainesville, FL 32610 USA.	leuthardte@wudosis.wustl.edu; shimonyj@mir.wustl.edu; david.tran@neurosurgery.ufl.edu	Kim, Albert H./HGF-0057-2022; Duan, Chong/H-7588-2019	Duan, Chong/0000-0001-9817-5340	Barnes Jewish Hospital Foundation; Siteman Cancer Center, Washington University; National Cancer Institute [1K08CA160824]; Pedal the Cause; NATIONAL CANCER INSTITUTE [K08CA160824] Funding Source: NIH RePORTER	Barnes Jewish Hospital Foundation; Siteman Cancer Center, Washington University; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pedal the Cause; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Cancer Frontier Team Science Award from the Barnes Jewish Hospital Foundation and Siteman Cancer Center, Washington University and Pedal the Cause to D. D. T., E. C. L., J. S. S. and J. L. C., and the National Cancer Institute grant 1K08CA160824 to D. D. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; BREM H, 1995, LANCET, V345, P1008, DOI 10.1016/S0140-6736(95)90755-6; Correale J, 1998, NEUROLOGY, V50, P1388, DOI 10.1212/WNL.50.5.1388; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Donaldson SB, 2010, MAGN RESON MED, V63, P691, DOI 10.1002/mrm.22217; Fleming AB, 2002, CLIN PHARMACOKINET, V41, P403, DOI 10.2165/00003088-200241060-00002; Gong W, 2011, BIOL PHARM BULL, V34, P1058, DOI 10.1248/bpb.34.1058; Hawasli AH, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14471; Hawasli AH, 2013, NEUROSURGERY, V73, P1007, DOI 10.1227/NEU.0000000000000144; Hawasli AH, 2012, NEUROSURGERY, V70, DOI 10.1227/NEU.0b013e318232fc90; HOCHBERG FH, 1980, NEUROLOGY, V30, P907, DOI 10.1212/WNL.30.9.907; Holodny AI, 1999, NEURORADIOLOGY, V41, P820, DOI 10.1007/s002340050848; Kallehauge J, 2013, ACTA ONCOL, V52, P1360, DOI 10.3109/0284186X.2013.813637; Kangasniemi M, 2004, LASER SURG MED, V35, P41, DOI 10.1002/lsm.20069; Kangasniemi M, 2003, INVEST RADIOL, V38, P102, DOI 10.1097/00004424-200302000-00005; Kassner A, 2011, METHODS MOL BIOL, V686, P229, DOI 10.1007/978-1-60761-938-3_10; Leach MO, 2012, EUR RADIOL, V22, P1451, DOI 10.1007/s00330-012-2446-x; Lee JJ, 2010, CLIN TRIALS, V7, P584, DOI 10.1177/1740774510373120; Lemee JM, 2015, NEURO-ONCOLOGY, V17, P1322, DOI 10.1093/neuonc/nov119; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Mohammadi AM, 2014, CANCER MED-US, V3, P971, DOI 10.1002/cam4.266; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI [10.1586/erm.10.104, 10.1586/ERM.10.104]; Oztas B, 1998, INT J HYPERTHER, V14, P395, DOI 10.3109/02656739809018241; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Reimer P, 1998, JMRI-J MAGN RESON IM, V8, P240, DOI 10.1002/jmri.1880080140; Sabel M, 2003, LASER SURG MED, V33, P75, DOI 10.1002/lsm.10181; SCHAARSCHMIDT H, 1994, STROKE, V25, P558, DOI 10.1161/01.STR.25.3.558; Schulze CP, 1998, JMRI-J MAGN RESON IM, V8, P115, DOI 10.1002/jmri.1880080123; Schwabe B, 1997, J COMPUT ASSIST TOMO, V21, P818, DOI 10.1097/00004728-199709000-00031; Sommer JC, 2014, J R STAT SOC C-APPL, V63, P695, DOI 10.1111/rssc.12057; Stalnacke BM, 2004, BRAIN INJURY, V18, P899, DOI 10.1080/02699050410001671865; STEWART DJ, 1984, J NEURO-ONCOL, V2, P133; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Westphal M, 2006, ACTA NEUROCHIR, V148, P269, DOI 10.1007/s00701-005-0707-z; Westphal M, 2003, NEURO-ONCOLOGY, V5, P79, DOI 10.1215/15228517-5-2-79; Zhou JY, 2001, J CEREBR BLOOD F MET, V21, P440, DOI 10.1097/00004647-200104000-00013	38	97	99	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148613	10.1371/journal.pone.0148613	http://dx.doi.org/10.1371/journal.pone.0148613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910903	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700011
J	Tschopp, E				Tschopp, Emanuel			Nomenclature of Vertebral Laminae in Lizards, with Comments on Ontogenetic and Serial Variation in Lacertini (Squamata, Lacertidae)	PLOS ONE			English	Article							OSTEOLOGY; DINOSAURIA; NUMBER	Vertebral laminae are bony ridges or sheets that connect important morphological landmarks on the vertebrae, like diapophyses or zygapophyses. They usually exhibit some serial variation throughout the column. A consistent terminology facilitates the morphological description of this variation, and the recognition of patterns that could be taxonomically significant and could serve as phylogenetic characters. Such a terminology was designed for saurischian dinosaurs, and has also been applied to other members of Archosauriformes. Herein, this terminology is applied for the first time to lizards (Squamata). Probably due to their generally smaller size compared to saurischian dinosaurs, lizards have less developed vertebral laminae. Some laminae could not be recognized in this group and others require new names to account for differences in basic vertebral morphology. For instance, the fusion of diapophysis and parapophysis in lacertids into a structure called synapophysis necessitates the creation of the new term synapophyseal laminae for both diapophyseal and parapophyseal laminae. An assessment of occurrence and serial variation in a number of lacertid species shows that some laminae develop throughout ontogeny or only occur in large-sized species, whereas the distribution of other laminae might prove to be taxonomically significant in future.	[Tschopp, Emanuel] Univ Turin, Dipartimento Sci Terra, Turin, Italy; [Tschopp, Emanuel] Univ Nova Lisboa, FCT, GeoBioTec, Caparica, Portugal; [Tschopp, Emanuel] Museu Lourinha, Lourinha, Portugal	University of Turin; Universidade Nova de Lisboa	Tschopp, E (corresponding author), Univ Turin, Dipartimento Sci Terra, Turin, Italy.; Tschopp, E (corresponding author), Univ Nova Lisboa, FCT, GeoBioTec, Caparica, Portugal.; Tschopp, E (corresponding author), Museu Lourinha, Lourinha, Portugal.	etschopp@unito.it	Tschopp, Emanuel/H-2723-2019	Tschopp, Emanuel/0000-0002-5245-6910	European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant [609402-2020]	European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant	This project has received funding from the European Union's FP7 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 609402-2020 researchers: Train to Move (T2M). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold EN, 2007, ZOOTAXA, P1, DOI 10.11646/zootaxa.1430.1.1; Barbadillo L.J., 1984, Amphibia-Reptilia, V4, P215; BARBADILLO LJ, 1994, HERPETOL J, V4, P166; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Blain HA, 2008, GEOL ACTA, V6, P345; Bohmer C, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0077; Burnell A, 2012, B SOC GEOL FR, V183, P151, DOI 10.2113/gssgfbull.183.2.151; CAPUTO V, 1995, TROP ZOOL, V8, P95, DOI 10.1080/03946975.1995.10539275; Carballido JL, 2014, J SYST PALAEONTOL, V12, P335, DOI 10.1080/14772019.2013.764935; Chamero B, 2014, ANAT REC, V297, P1278, DOI 10.1002/ar.22926; Cope E. D., 1892, Proceedings of the American Philosophical Society, Vxxx, P185; de Queiroz K., 1987, University of California Publications in Zoology, V118, P1; ETHERIDGE R, 1967, COPEIA, P699, DOI 10.2307/1441880; Ezcurra MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089165; Gauthier JA, 2012, B PEABODY MUS NAT HI, V53, P3, DOI 10.3374/014.053.0101; Greer AE, 2000, AMPHIBIA-REPTILIA, V21, P121; Hoffstetter R., 1969, P201; Kuhne K, 1913, GEGENBAURS MORPHOLOG, V46, P563; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mannion PD, 2013, ZOOL J LINN SOC-LOND, V168, P98, DOI 10.1111/zoj.12029; Nesbitt SJ, 2009, ZOOL J LINN SOC-LOND, V157, P814, DOI 10.1111/j.1096-3642.2009.00530.x; Parmley D., 1988, Journal of Vertebrate Paleontology, V8, P334; Polly PD, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P197; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; RIEPPEL O, 1980, Amphibia-Reptilia, V1, P95, DOI 10.1163/156853880X00105; Salgado L, 2012, J VERTEBR PALEONTOL, V32, P603, DOI 10.1080/02724634.2012.661004; Sarris I, 2012, INT J MORPHOL, V30, P1363, DOI 10.4067/S0717-95022012000400018; Schwarz Daniela, 2007, Historical Biology, V19, P225, DOI 10.1080/08912960601118651; Sookias RB, 2014, PEERJ, V2, DOI 10.7717/peerj.658; Tschopp E, 2015, PEERJ, V3, DOI 10.7717/peerj.857; Tschopp E, 2013, J SYST PALAEONTOL, V11, P853, DOI 10.1080/14772019.2012.746589; Venczel Marton, 2006, Nymphaea, V33, P25; Wedel MJ, 2003, J VERTEBR PALEONTOL, V23, P344, DOI 10.1671/0272-4634(2003)023[0344:TEOVPI]2.0.CO;2; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA., 2012, CONTRIB MUS PALEONTO, V32, P91	36	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149445	10.1371/journal.pone.0149445	http://dx.doi.org/10.1371/journal.pone.0149445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907769	Green Submitted, Green Published, gold			2022-12-27	WOS:000371163000011
J	Garcia-Martinez, O; De Luna-Bertos, E; Ramos-Torrecillas, J; Ruiz, C; Milia, E; Lorenzo, ML; Jimenez, B; Sanchez-Ortiz, A; Rivas, A				Garcia-Martinez, Olga; De Luna-Bertos, Elvira; Ramos-Torrecillas, Javier; Ruiz, Concepcion; Milia, Egle; Luisa Lorenzo, Maria; Jimenez, Brigida; Sanchez-Ortiz, Araceli; Rivas, Ana			Phenolic Compounds in Extra Virgin Olive Oil Stimulate Human Osteoblastic Cell Proliferation	PLOS ONE			English	Article							BONE LOSS; ALKALINE-PHOSPHATASE; MEDITERRANEAN DIET; DIFFERENTIATION; OVARIECTOMY; POLYPHENOLS; EXPRESSION; OLEUROPEIN; LUTEOLIN; ACIDS	In this study, we aimed to clarify the effects of phenolic compounds and extracts from different extra virgin olive oil (EVOO) varieties obtained from fruits of different ripening stages on osteoblast cells (MG-63) proliferation. Cell proliferation was increased by hydroxytyrosol, luteolin, apigenin, p-coumaric, caffeic, and ferulic acids by approximately 11-16%, as compared with controls that were treated with one vehicle alone, while (+)-pinoresinol, oleuropein, sinapic, vanillic acid and derivative (vanillin) did not affect cell proliferation. All phenolic extracts stimulated MG-63 cell growth, and they induced higher cell proliferation rates than individual compounds. The most effective EVOO phenolic extracts were those obtained from the Picual variety, as they significantly increased cell proliferation by 1822%. Conversely, Arbequina phenolic extracts increased cell proliferation by 9-13%. A decline in osteoblast proliferation was observed in oils obtained from olive fruits collected at the end of the harvest period, as their total phenolic content decreases at this late stage. Further research on the signaling pathways of olive oil phenolic compounds involved in the processes and their metabolism should be carried out to develop new interventions and adjuvant therapies using EVOO for bone health (i. e. osteoporosis) in adulthood and the elderly.	[Garcia-Martinez, Olga; De Luna-Bertos, Elvira; Ramos-Torrecillas, Javier; Ruiz, Concepcion] Univ Granada, Fac Hlth Sci, Avda Ilustrac S-N, E-18071 Granada, Spain; [Milia, Egle] Univ Sassari, Fac Med & Surg, Piazza Univ 21, I-07100 Sassari, Italy; [Luisa Lorenzo, Maria; Rivas, Ana] Univ Granada, Fac Pharm, Dept Nutr & Food Sci, Campus Cartuja S-N, E-18071 Granada, Spain; [Jimenez, Brigida] Minist Agr & Fisheries, Agr Res Training Ctr, Km 2-5, Cordoba, Spain; [Sanchez-Ortiz, Araceli] Minist Agr & Fisheries, Agr Res Training Ctr, Km 18,5, Jaen 23620, Spain	University of Granada; University of Sassari; University of Granada	Rivas, A (corresponding author), Univ Granada, Fac Pharm, Dept Nutr & Food Sci, Campus Cartuja S-N, E-18071 Granada, Spain.	amrivas@ugr.es	Ruiz, Concepcion/L-2808-2014; Ramos-Torrecillas, Javier/F-3746-2012; Milia, Egle/J-1470-2012; García-Martínez, Olga/L-2782-2014; Rivas, Ana/D-7841-2018; Ramos-Torrecillas, Javier/U-5789-2019; SANCHEZ, ARACELI/M-1413-2014; De Luna-Bertos, Elvira/F-8544-2016	Ruiz, Concepcion/0000-0003-4332-6812; Ramos-Torrecillas, Javier/0000-0002-6631-7866; Milia, Egle/0000-0002-4272-0538; García-Martínez, Olga/0000-0003-1912-4639; Rivas, Ana/0000-0002-2143-0750; Ramos-Torrecillas, Javier/0000-0002-6631-7866; SANCHEZ, ARACELI/0000-0003-1648-2924; De Luna-Bertos, Elvira/0000-0002-4381-5942				Artajo LS, 2006, J SCI FOOD AGR, V86, P518, DOI 10.1002/jsfa.2384; Bendini A, 2007, MOLECULES, V12, P1679, DOI 10.3390/12081679; Cashman KD, 2007, J NUTR, V137, p2507S, DOI 10.1093/jn/137.11.2507S; Cerretani L, 2006, EUR FOOD RES TECHNOL, V222, P354, DOI 10.1007/s00217-005-0088-9; Chang CJ, 2006, EUR J CLIN INVEST, V36, P588, DOI 10.1111/j.1365-2362.2006.01676.x; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Choi EM, 2007, CELL BIOL INT, V31, P870, DOI 10.1016/j.cellbi.2007.01.038; Dai Z, 2007, PHYTOMEDICINE, V14, P806, DOI 10.1016/j.phymed.2007.04.003; De Luna-Bertos E, 2013, SCI WORLD J, DOI 10.1155/2013/809891; De Luna-Bertos E, 2012, ScientificWorldJournal, V2012, P834246, DOI 10.1100/2012/834246; Diaz-Rodriguez L, 2012, J BONE MINER METAB, V30, P554, DOI 10.1007/s00774-012-0356-2; ERIKSEN EF, 1988, SCIENCE, V241, P84, DOI 10.1126/science.3388021; Folwarczna J, 2009, PLANTA MED, V75, P1567, DOI 10.1055/s-0029-1185904; Garcia-Martinez O, 2014, GRASAS ACEITES, V65, DOI 10.3989/gya.0111141; Habauzit Veronique, 2008, Phytochemistry Reviews, V7, P313, DOI 10.1007/s11101-007-9078-9; Hagiwara K, 2011, EUR J PHARMACOL, V662, P78, DOI 10.1016/j.ejphar.2011.04.023; Hosoya S, 1998, MOL GENET METAB, V65, P31, DOI 10.1006/mgme.1998.2734; International Olive Oil Council (IOOC), 2009, COIT20DOC29 IOOC; *IOOC, 1984, 6 IOOC; Jimenez B, 2013, FOOD RES INT, V54, P1860, DOI 10.1016/j.foodres.2013.08.016; Kim TH, 2011, J NUTR BIOCHEM, V22, P8, DOI 10.1016/j.jnutbio.2009.11.002; Lai YL, 2007, INT J MOL MED, V19, P123; Lee JW, 2009, CYTOTECHNOLOGY, V61, P125, DOI 10.1007/s10616-010-9253-5; Fernandez-Real JM, 2012, J CLIN ENDOCR METAB, V97, P3792, DOI 10.1210/jc.2012-2221; Martines Suarez J. M., 1975, Grasas y Aceites, V26, P379; Nieto LM, 2010, J SCI FOOD AGR, V90, P2393, DOI 10.1002/jsfa.4097; Notoya M, 2006, EUR J PHARMACOL, V534, P55, DOI 10.1016/j.ejphar.2006.01.028; Puel C, 2004, BRIT J NUTR, V92, P119, DOI 10.1079/BJN20041181; Puel C, 2008, J AGR FOOD CHEM, V56, P9417, DOI 10.1021/jf801794q; Puel C, 2007, BRIT J NUTR, V97, P1012, DOI 10.1017/S0007114507659030; Puel C, 2006, CLIN NUTR, V25, P859, DOI 10.1016/j.clnu.2006.03.009; Rivas A, 2013, INT J FOOD SCI NUTR, V64, P155, DOI 10.3109/09637486.2012.718743; Perez AR, 2014, NUTR HOSP, V29, P989, DOI 10.3305/nh.2014.29.5.7332; Stalikas CD, 2007, J SEP SCI, V30, P3268, DOI 10.1002/jssc.200700261; Stromeier S, 2005, PLANTA MED, V71, P495, DOI 10.1055/s-2005-864148; Sugimoto E, 2000, BIOCHEM PHARMACOL, V59, P471, DOI 10.1016/S0006-2952(99)00351-2; Trzeciakiewicz A, 2009, NUTR RES REV, V22, P68, DOI 10.1017/S095442240926402X; Tsai SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076545; Visioli F, 2011, CURR PHARM DESIGN, V17, P786, DOI 10.2174/138161211795428885; Vissers MN, 2002, J NUTR, V132, P409, DOI 10.1093/jn/132.3.409; Yamaguchi M, 2001, BIOL PHARM BULL, V24, P1437, DOI 10.1248/bpb.24.1437; Yang XJ, 2007, J ASIAN NAT PROD RES, V9, P583, DOI 10.1080/10286020500530433; Zych M, 2009, ACTA BIOCHIM POL, V56, P503	43	54	55	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150045	10.1371/journal.pone.0150045	http://dx.doi.org/10.1371/journal.pone.0150045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930190	gold, Green Submitted, Green Published			2022-12-27	WOS:000371434500092
J	Heino, A; Gissler, M; Hindori-Mohangoo, AD; Blondel, B; Klungsoyr, K; Verdenik, I; Mierzejewska, E; Velebil, P; Olafsdottir, HS; Macfarlane, A; Zeitlin, J				Heino, Anna; Gissler, Mika; Hindori-Mohangoo, Ashna D.; Blondel, Beatrice; Klungsoyr, Kari; Verdenik, Ivan; Mierzejewska, Ewa; Velebil, Petr; Olafsdottir, Helga Sol; Macfarlane, Alison; Zeitlin, Jennifer		Euro-Peristat Sci Comm	Variations in Multiple Birth Rates and Impact on Perinatal Outcomes in Europe	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGY; PRETERM BIRTH; MATERNAL AGE; MORTALITY; EPIDEMIOLOGY; HEALTH; TRENDS; TWINS; RISK	Objective Infants from multiple pregnancies have higher rates of preterm birth, stillbirth and neonatal death and differences in multiple birth rates (MBR) exist between countries. We aimed to describe differences in MBR in Europe and to investigate the impact of these differences on adverse perinatal outcomes at a population level. Methods We used national aggregate birth data on multiple pregnancies, maternal age, gestational age (GA), stillbirth and neonatal death collected in the Euro-Peristat project (29 countries in 2010, N = 5 074 643 births). We also used European Society of Human Reproduction and Embryology (ESHRE) data on assisted conception and single embryo transfer (SET). The impact of MBR on outcomes was studied using meta-analysis techniques with random effects models to derive pooled risk ratios (pRR) overall and for four groups of country defined by their MBR. We computed population attributable risks (PAR) for these groups. Results In 2010, the average MBR was 16.8 per 1000 women giving birth, ranging from 9.1 (Romania) to 26.5 (Cyprus). Compared to singletons, multiples had a nine-fold increased risk (pRR 9.4, 95% CI 9.1-9.8) of preterm birth (<37 weeks GA), an almost 12-fold increased risk (pRR 11.7, 95% CI 11.0-12.4) of very preterm birth (<32 weeks GA). Pooled RR were 2.4 (95% CI 1.5-3.6) for fetal mortality at or after 28 weeks GA and 7.0 (95% CI 6.1-8.0) for neonatal mortality. PAR of neonatal death and very preterm birth were higher in countries with high MBR compared to low MBR (17.1% (95% CI 13.8-20.2) versus 9.8% (95% CI 9.6-11.0) for neonatal death and 29.6% (96% CI 28.5-30.6) versus 17.5% (95% CI 15.7-18.3) for very preterm births, respectively). Conclusions Wide variations in MBR and their impact on population outcomes imply that efforts by countries to reduce MBR could improve perinatal outcomes, enabling better long-term child health.	[Heino, Anna; Gissler, Mika] THL Natl Inst Hlth & Welf, Helsinki, Finland; [Hindori-Mohangoo, Ashna D.] TNO, Netherlands Org Appl Sci Res, Dept Child Hlth, Leiden, Netherlands; [Hindori-Mohangoo, Ashna D.] Anton de Kom Univ Suriname, Fac Med Sci, Dept Publ Hlth, Paramaribo, Suriname; [Blondel, Beatrice; Zeitlin, Jennifer] Paris Descartes Univ, Ctr Epidemiol & Biostat U1153, Obstetr Perinatal & Paediat Epidemiol Res Team, INSERM, Paris, France; [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5018 Bergen, Norway; [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Med Birth Registry Norway, N-5018 Bergen, Norway; [Verdenik, Ivan] Univ Ljubljana, Med Ctr, Ljubljana 61000, Slovenia; [Mierzejewska, Ewa] Natl Res Inst Mother & Child, Dept Epidemiol, Warsaw, Poland; [Velebil, Petr] Inst Care Mother & Child, Prague, Czech Republic; [Olafsdottir, Helga Sol] Landspitali Univ Hosp, Dept Obstet & Gynaecol, Reykjavik, Iceland; [Macfarlane, Alison] City Univ London, Sch Hlth Sci, Ctr Maternal & Child Hlth Res, London EC1V 0HB, England	Finland National Institute for Health & Welfare; Netherlands Organization Applied Science Research; Anton de Kom Universiteit van Suriname; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Ljubljana; Landspitali National University Hospital; City University London	Heino, A (corresponding author), THL Natl Inst Hlth & Welf, Helsinki, Finland.	anna.heino@thl.fi	Zeitlin, Jennifer/G-4973-2017; Sakkeus, Luule/E-9558-2010; Barros, Henrique/Q-8609-2019; Sol Olafsdottir, Helga/GPK-2682-2022; Verdenik, Ivan/G-9618-2012; Klungsøyr, Kari/ABC-6147-2020; Correia, Sofia/AAD-6210-2020; Blondel, Beatrice/G-5011-2017; Cuttini, Marina/AAI-1987-2019	Zeitlin, Jennifer/0000-0002-9568-2969; Sakkeus, Luule/0000-0003-3785-183X; Barros, Henrique/0000-0003-4699-6571; Klungsøyr, Kari/0000-0003-2482-1690; Correia, Sofia/0000-0002-9361-1999; Hukkelhoven, Chantal/0000-0002-0015-1883; Zhang, Wei-Hong/0000-0003-0380-770X; Mierzejewska, Ewa/0000-0003-0822-4781; Hindori-Mohangoo, Ashna/0000-0003-2364-2893; Cuttini, Marina/0000-0002-3284-6874; Zile, Irisa/0000-0003-1553-1130; Francisco, Bolumar Montrull/0000-0001-8007-3231; Szamotulska, Katarzyna/0000-0003-1045-7584; Haidinger, Gerald/0000-0002-1199-6216; Alexandra, Cucu/0000-0001-5646-5999	European Union [20101301, 664691]	European Union(European Commission)	The results from this study are based on data from the Euro-Peristat project, a European project for monitoring and evaluating perinatal outcomes on the European level. The Euro-Peristat project received funding from the European Union in the framework of the Health Programme (grant numbers: 20101301 and 664691). The funding agency was not involved in the study. This study used aggregated national indicators, so ethics approval was not required.	Ananth CV, 2012, SEMIN PERINATOL, V36, P156, DOI 10.1053/j.semperi.2012.02.001; Anthony S, 2009, PAEDIATR PERINAT EP, V23, P292, DOI 10.1111/j.1365-3016.2009.01044.x; Black M, 2010, SEMIN FETAL NEONAT M, V15, P306, DOI 10.1016/j.siny.2010.06.004; Blondel B, 2006, BJOG-INT J OBSTET GY, V113, P528, DOI 10.1111/j.1471-0528.2006.00923.x; Blondel B, 2002, SEMIN PERINATOL, V26, P239, DOI 10.1053/sper.2002.34775; Bodeau-Livinec F, 2013, ARCH DIS CHILD-FETAL, V98, pF480, DOI 10.1136/archdischild-2013-303737; Boyle EM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e896; Chambers GM, 2013, HUM REPROD, V28, P1679, DOI 10.1093/humrep/det080; Christensen K, 2011, SCAND J PUBLIC HEALT, V39, P185, DOI 10.1177/1403494811399170; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Crump C, 2011, AM J EPIDEMIOL, V173, P797, DOI 10.1093/aje/kwq440; Delnord M, 2015, CURRENT OPINION OBST; Euro-Peristat project with SCPE and EUROCAT, HLTH CAR PREGN WOM B; EURO-PERISTAT project with SCPE EUROCAT EURONEOSTAT, 2008, BETT STAT BETT HLTH; EUROCAT E-PpwSa, HLTH CAR PREGN WOM B; Gissler M, 2010, INFORM HEALTH SOC CA, V35, P64, DOI 10.3109/17538157.2010.492923; Giuffre M, 2012, J MATERN-FETAL NEO M, V25, P6, DOI 10.3109/14767058.2012.712350; Gleicher N, 2014, NEW ENGL J MED, V370, P1069, DOI 10.1056/NEJMc1400242; Gouyon JB, 2010, INT J EPIDEMIOL, V39, P769, DOI 10.1093/ije/dyq037; Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Mohangoo AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064869; Mohangoo AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024727; Pharoah POD, 2005, OBSTET GYN CLIN N AM, V32, P55, DOI 10.1016/j.ogc.2004.10.002; Refuerzo JS, 2012, SEMIN FETAL NEONAT M, V17, P143, DOI 10.1016/j.siny.2012.01.012; Russell RB, 2003, OBSTET GYNECOL, V101, P129, DOI 10.1016/S0029-7844(02)02316-5; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Scholten I, 2015, FERTIL STERIL, V103, P179, DOI 10.1016/j.fertnstert.2014.09.033; Sheay W, 2004, OBSTET GYNECOL, V103, P63, DOI 10.1097/01.AOG.0000101291.14773.F0; Tandberg A, 2007, ACTA OBSTET GYN SCAN, V86, P833, DOI 10.1080/00016340701417323; Zeitlin J, 2013, J EPIDEMIOL COMMUN H, V67, P983, DOI 10.1136/jech-2013-203291; Zeitlin J, 2013, BJOG-INT J OBSTET GY, V120, P1356, DOI 10.1111/1471-0528.12281	32	58	59	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149252	10.1371/journal.pone.0149252	http://dx.doi.org/10.1371/journal.pone.0149252			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930069	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500021
J	Liu, SL; Chan, TC; Chu, YT; Wu, JTS; Geng, XY; Zhao, N; Cheng, W; Chen, EF; King, CC				Liu, Shelan; Chan, Ta-Chien; Chu, Yu-Tseng; Wu, Joseph Tsung-Shu; Geng, Xingyi; Zhao, Na; Cheng, Wei; Chen, Enfu; King, Chwan-Chuen			Comparative Epidemiology of Human Infections with Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome Coronaviruses among Healthcare Personnel	PLOS ONE			English	Article							MERS-COV; SARS; WORKERS; TRANSMISSION; SEROPREVALENCE; ANTIBODIES	The largest nosocomial outbreak of Middle East respiratory syndrome (MERS) occurred in South Korea in 2015. Health Care Personnel (HCP) are at high risk of acquiring MERS-Coronavirus (MERS-CoV) infections, similar to the severe acute respiratory syndrome (SARS)-Coronavirus (SARS-CoV) infections first identified in 2003. This study described the similarities and differences in epidemiological and clinical characteristics of 183 confirmed global MERS cases and 98 SARS cases in Taiwan associated with HCP. The epidemiological findings showed that the mean age of MERS-HCP and total MERS cases were 40 (24 similar to 74) and 49 (2 similar to 90) years, respectively, much older than those in SARS [SARS-HCP: 35 (21 similar to 68) years, p = 0.006; total SARS: 42 (0 similar to 94) years, p = 0.0002]. The case fatality rates (CFR) was much lower in MERS-HCP [7.03% (9/128)] or SARS-HCP [12.24% (12/98)] than the MERS-non-HCP [36.96% (34/92), p<0.001] or SARS-non-HCP [24.50% (61/249), p<0.001], however, no difference was found between MERS-HCP and SARS-HCP [p = 0.181]. In terms of clinical period, the days from onset to death [13 (4 similar to 17) vs 14.5 (0 similar to 52), p = 0.045] and to discharge [11 (5 similar to 24) vs 24 (0 similar to 74), p = 0.010] and be hospitalized days [9.5 (3 similar to 22) vs 22 (0 similar to 69), p = 0.040] were much shorter in MERS-HCP than SARS-HCP. Similarly, days from onset to confirmation were shorter in MERS-HCP than MERS-nonHCP [6 (1 similar to 14) vs 10 (1 similar to 21), p = 0.044]. In conclusion, the severity of MERS-HCP and SARS-HCP was lower than that of MERS-non-HCP and SARS-non-HCP due to younger age and early confirmation in HCP groups. However, no statistical difference was found in MERS-HCP and SARS-HCP. Thus, prevention of nosocomial infections involving both novel Coronavirus is crucially important to protect HCP.	[Liu, Shelan; Cheng, Wei; Chen, Enfu] Zhejiang Prov Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Chan, Ta-Chien] Acad Sinica, Ctr Geog Informat Sci, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Chu, Yu-Tseng; Wu, Joseph Tsung-Shu; King, Chwan-Chuen] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chu, Yu-Tseng] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Wu, Joseph Tsung-Shu] Malawi Off, Luke Int, Mzuzu City, Malawi; [Wu, Joseph Tsung-Shu] Mzuzu Univ, Mzuzu City, Malawi; [Geng, Xingyi] Jinan Ctr Dis Control & Prevent, Emergency Off, Jinan, Shandong, Peoples R China; [Zhao, Na] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Natl Res Ctr Wildlife Born Dis, Beijing, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Academia Sinica - Taiwan; National Taiwan University; Academia Sinica - Taiwan; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, SL (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China.; King, CC (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	liushelan@126.com; chwanchuen@gmail.com	Wu, Tsung Shu Joseph/K-6138-2018	Wu, Tsung Shu Joseph/0000-0001-6155-9340	Taiwan Science Foundation (NSF) [92-2751-B-002-020-Y]	Taiwan Science Foundation (NSF)	This study was supported by the Taiwan Science Foundation (NSF Grant #92-2751-B-002-020-Y).	Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Braden CR, 2013, EMERG INFECT DIS, V19, P864, DOI 10.3201/eid1906.130192; Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0; Cowling BJ, 2015, EUROSURVEILLANCE, V20, P7, DOI 10.2807/1560-7917.ES2015.20.25.21163; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Drosten C, 2014, NEW ENGL J MED, V371, P1359, DOI 10.1056/NEJMc1409847; Drosten C, 2014, NEW ENGL J MED, V371, P828, DOI 10.1056/NEJMoa1405858; Gomersall C, 2006, INTENS CARE MED, V32, P564, DOI 10.1007/s00134-006-0081-1; Gossner C, 2016, ZOONOSES PUBLIC HLTH, V63, P1, DOI 10.1111/zph.12171; Hall AJ, 2014, EMERG INFECT DIS, V20, P2148, DOI 10.3201/eid2012.141211; Hui DS, 2014, CURR OPIN PULM MED, V20, P233, DOI 10.1097/MCP.0000000000000046; Ip M, 2004, CLIN INFECT DIS, V38, pE116, DOI 10.1086/421019; Leung GM, 2006, EPIDEMIOL INFECT, V134, P211, DOI 10.1017/S0950268805004826; Memish ZA, 2014, CLIN MICROBIOL INFEC, V20, P469, DOI 10.1111/1469-0691.12562; Memish ZA, 2014, J INFECT DIS, V210, P1590, DOI 10.1093/infdis/jiu292; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Memish ZA, 2013, NEW ENGL J MED, V369, P884, DOI 10.1056/NEJMc1308698; Mizumoto K, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0468-3; Park BJ, 2004, EMERG INFECT DIS, V10, P244; Parry J, 2003, BRIT MED J, V326, P999; Raj VS, 2014, EMERG INFECT DIS, V20, P1339, DOI 10.3201/eid2008.140663; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; Suwantarat N, 2015, CURR OPIN INFECT DIS, V28, P349, DOI 10.1097/QCO.0000000000000183; World Health Organization, INF PREV CONTR HLTH; World Health Organization, 2015, LAB TEST MIDDL E RES; Wu HS, 2004, J BIOMED SCI, V11, P117, DOI 10.1007/BF02256554; Wu TSJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-18; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8; Zumla A, 2015, LANCET RESP MED, V3, P100, DOI 10.1016/S2213-2600(14)70316-9; Zumla A, 2014, LANCET, V383, P1869, DOI 10.1016/S0140-6736(14)60852-7	30	24	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149988	10.1371/journal.pone.0149988	http://dx.doi.org/10.1371/journal.pone.0149988			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930074	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500084
J	Martino-Echarri, E; Brocardo, MG; Mills, KM; Henderson, BR				Martino-Echarri, Estefania; Brocardo, Mariana G.; Mills, Kate M.; Henderson, Beric R.			Tankyrase Inhibitors Stimulate the Ability of Tankyrases to Bind Axin and Drive Assembly of beta-Catenin Degradation-Competent Axin Puncta	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; COLORECTAL-CANCER; TUMOR-GROWTH; COMPLEX; CELLS; POLYMERIZATION; LOCALIZATION; RECRUITMENT; INTERACTS; DOMAINS	Activation of the wnt signaling pathway is a major cause of colon cancer development. Tankyrase inhibitors (TNKSi) have recently been developed to block the wnt pathway by increasing axin levels to promote degradation of the wnt-regulator beta-catenin. TNKSi bind to the PARP (poly(ADP) ribose polymerase) catalytic region of tankyrases (TNKS), preventing the PARylation of TNKS and axin that normally control axin levels through ubiquitination and degradation. TNKSi treatment of APC-mutant SW480 colorectal cancer cells can induce axin puncta which act as sites for assembly of beta-catenin degradation complexes, however this process is poorly understood. Using this model system, we found that siRNA knockdown of TNKSs 1 and 2 actually blocked the ability of TNKSi drugs to induce axin puncta, revealing that puncta formation requires both the expression and the inactivation of TNKS. Immunoprecipitation assays showed that treatment of cells with TNKSi caused a strong increase in the formation of axin-TNKS complexes, correlating with an increase in insoluble or aggregated forms of TNKS/axin. The efficacy of TNKSi was antagonized by proteasome inhibitors, which stabilized the PARylated form of TNKS1 and reduced TNKSi-mediated assembly of axin-TNKS complexes and puncta. We hypothesise that TNKSi act to stimulate TNKS oligomerization and assembly of the TNKS-axin scaffold that form puncta. These new insights may help in optimising the future application of TNKSi in anticancer drug design.	[Martino-Echarri, Estefania; Brocardo, Mariana G.; Mills, Kate M.; Henderson, Beric R.] Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Westmead, NSW 2145, Australia	University of Sydney; Westmead Institute for Medical Research	Henderson, BR (corresponding author), Univ Sydney, Westmead Inst Med Res, Ctr Canc Res, Westmead, NSW 2145, Australia.	beric.henderson@sydney.edu.au		Brocardo, Mariana/0000-0002-3962-7308	Cancer Institute New South Wales, Australia [12/CDF/2-12]; Westmead Institute for Medical Research	Cancer Institute New South Wales, Australia; Westmead Institute for Medical Research(University of Sydney)	This work was supported by a Career Development Fellowship grant (12/CDF/2-12) to BRH from the Cancer Institute New South Wales, Australia (https://www.cancerinstitute.org.au). BRH and MGB were also supported by bridging grants from The Westmead Institute for Medical Research (www.westmeadinstitute.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienz M, 2014, TRENDS BIOCHEM SCI, V39, P487, DOI 10.1016/j.tibs.2014.08.006; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Cong F, 2004, P NATL ACAD SCI USA, V101, P2882, DOI 10.1073/pnas.0307344101; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; De Rycker M, 2004, MOL CELL BIOL, V24, P9802, DOI 10.1128/MCB.24.22.9802-9812.2004; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Faux MC, 2008, ONCOGENE, V27, P5808, DOI 10.1038/onc.2008.205; Faux MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014127; Fiedler M, 2011, P NATL ACAD SCI USA, V108, P1937, DOI 10.1073/pnas.1017063108; Gerlach JP, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140120; Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Lau T, 2013, CANCER RES, V73, P3132, DOI 10.1158/0008-5472.CAN-12-4562; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2010, J MOL CELL BIOL, V2, P70, DOI 10.1093/jmcb/mjp040; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Mendoza-Topaz C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110013; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morrone S, 2012, P NATL ACAD SCI USA, V109, P1500, DOI 10.1073/pnas.1116618109; Pronobis MI, 2015, ELIFE, V4, DOI 10.7554/eLife.08022; Sbodio JI, 2002, BIOCHEM J, V361, P451, DOI 10.1042/0264-6021:3610451; Sharma M, 2007, J BIOL CHEM, V282, P8545, DOI 10.1074/jbc.M610272200; Smith S, 1999, J CELL SCI, V112, P3649; Thorvaldsen TE, 2015, MOL CANCER RES, V13, P1487, DOI 10.1158/1541-7786.MCR-15-0125; Voutsadakis IA, 2008, BBA-MOL BASIS DIS, V1782, P800, DOI 10.1016/j.bbadis.2008.06.007; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Zaarur N, 2014, MOL CELL BIOL, V34, P1336, DOI 10.1128/MCB.00103-14	34	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150484	10.1371/journal.pone.0150484	http://dx.doi.org/10.1371/journal.pone.0150484			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930278	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500156
J	Matejko, AA; Ansari, D				Matejko, Anna A.; Ansari, Daniel			Trajectories of Symbolic and Nonsymbolic Magnitude Processing in the First Year of Formal Schooling	PLOS ONE			English	Article							APPROXIMATE NUMBER SYSTEM; INDIVIDUAL-DIFFERENCES; SENSE; ACUITY; REPRESENTATIONS; ASSOCIATION; ABILITIES; SKILLS	Sensitivity to numerical magnitudes is thought to provide a foundation for higher-level mathematical skills such as calculation. It is still unclear how symbolic (e.g. Arabic digits) and nonsymbolic (e.g. Dots) magnitude systems develop and how the two formats relate to one another. Some theories propose that children learn the meaning of symbolic numbers by scaffolding them onto a pre-existing nonsymbolic system (Approximate Number System). Others suggest that symbolic and nonsymbolic magnitudes have distinct and non-overlapping representations. In the present study, we examine the developmental trajectories of symbolic and nonsymbolic magnitude processing skills and how they relate to each other in the first year of formal schooling when children are becoming more fluent with symbolic numbers. Thirty Grade 1 children completed symbolic and nonsymbolic magnitude processing tasks at three time points in Grade 1. We found that symbolic and nonsymbolic magnitude processing skills had distinct developmental trajectories, where symbolic magnitude processing was characterized by greater gains than nonsymbolic skills over the one-year period in Grade 1. We further found that the development of the two formats only related to one another in the first half of the school year where symbolic magnitude processing skills influenced later nonsymbolic skills. These findings indicate that symbolic and nonsymbolic abilities have different developmental trajectories and that the development of symbolic abilities is not strongly linked to nonsymbolic representations by Grade 1. These findings also suggest that the relationship between symbolic and nonsymbolic processing is not as unidirectional as previously thought.	[Ansari, Daniel] Univ Western Ontario, Dept Psychol, Numer Cognit Lab, Westminster Hall, London, ON, Canada; Univ Western Ontario, Brain & Mind Inst, Westminster Hall, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario)	Ansari, D (corresponding author), Univ Western Ontario, Dept Psychol, Numer Cognit Lab, Westminster Hall, London, ON, Canada.	daniel.ansari@uwo.ca	Ansari, Daniel/B-2832-2009	Ansari, Daniel/0000-0002-7625-618X; Matejko, Anna/0000-0002-4108-5034	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a NSERC Discovery grant.	Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Brankaer C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093565; Bugden S, 2011, COGNITION, V118, P32, DOI 10.1016/j.cognition.2010.09.005; Bulthe J, 2014, NEUROIMAGE, V87, P311, DOI 10.1016/j.neuroimage.2013.10.049; Butterworth B, 2005, J CHILD PSYCHOL PSYC, V46, P3, DOI 10.1111/j.1469-7610.2004.00374.x; Cantlon JF, 2012, P NATL ACAD SCI USA, V109, P10725, DOI 10.1073/pnas.1201893109; Cantlon JF, 2009, J COGNITIVE NEUROSCI, V21, P2217, DOI 10.1162/jocn.2008.21159; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P469, DOI 10.1016/j.jecp.2009.01.010; Dehaene S., 2007, ATTENTION PERFORM, P527, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0024; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Geary DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054651; Gebuis T, 2012, J EXP PSYCHOL GEN, V141, P642, DOI 10.1037/a0026218; Gilmore C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067374; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Kolkman ME, 2013, LEARN INSTR, V25, P95, DOI 10.1016/j.learninstruc.2012.12.001; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Lee I. A., 2013, CALCULATION TEST DIF; Leibovich T, 2013, FRONT PSYCHOL, V4, P1; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Libertus ME, 2009, CURR DIR PSYCHOL SCI, V18, P346, DOI 10.1111/j.1467-8721.2009.01665.x; Lyons IM, 2015, J EXP PSYCHOL GEN, V144, P1021, DOI 10.1037/xge0000094; Lyons IM, 2015, ADV CHILD DEV BEHAV, V48, P93, DOI 10.1016/bs.acdb.2014.11.003; Lyons IM, 2015, HUM BRAIN MAPP, V36, P475, DOI 10.1002/hbm.22641; Lyons IM, 2014, DEVELOPMENTAL SCI, V17, P714, DOI 10.1111/desc.12152; Lyons IM, 2012, J EXP PSYCHOL GEN, V141, P635, DOI 10.1037/a0027248; Merkley R, 2015, FRONT PSYCHOL, V1903; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2015, DEV REV; Mussolin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091839; Nosworthy N, 2013, THESIS U W ONTARIO; Nosworthy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067918; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Purpura DJ, 2013, J EDUC PSYCHOL, V105, P453, DOI 10.1037/a0031753; Sasanguie D, 2014, Q J EXP PSYCHOL, V67, P271, DOI 10.1080/17470218.2013.803581; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; SEKULER R, 1977, CHILD DEV, V48, P630, DOI 10.1111/j.1467-8624.1977.tb01208.x; Starr A, 2013, P NATL ACAD SCI USA, V110, P18116, DOI 10.1073/pnas.1302751110; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; Stoianov IP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01326; Toll SWM, 2015, LEARN INDIVID DIFFER, V38, P10, DOI 10.1016/j.lindif.2014.12.006; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Xenidou-Dervou I, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00487; Xu F, 2005, DEVELOPMENTAL SCI, V8, P88, DOI 10.1111/j.1467-7687.2005.00395.x; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	49	34	40	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149863	10.1371/journal.pone.0149863	http://dx.doi.org/10.1371/journal.pone.0149863			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930195	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500064
J	McCaig, WD; Loving, CL; Hughes, HR; Brockmeier, SL				McCaig, William D.; Loving, Crystal L.; Hughes, Holly R.; Brockmeier, Susan L.			Characterization and Vaccine Potential of Outer Membrane Vesicles Produced by Haemophilus parasuis	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; SERUM-RESISTANCE; SEROVAR 5; PSEUDOMONAS-AERUGINOSA; PROTECTIVE EFFICACY; PROTEOMIC ANALYSIS; SC096 STRAIN; PIGS; PROTEINS; INFLUENZAE	Haemophilus parasuis is a Gram-negative bacterium that colonizes the upper respiratory tract of swine and is capable of causing a systemic infection, resulting in high morbidity and mortality. H. parasuis isolates display a wide range of virulence and virulence factors are largely unknown. Commercial bacterins are often used to vaccinate swine against H. parasuis, though strain variability and lack of cross-reactivity can make this an ineffective means of protection. Outer membrane vesicles (OMV) are spherical structures naturally released from the membrane of bacteria and OMV are often enriched in toxins, signaling molecules and other bacterial components. Examination of OMV structures has led to identification of virulence factors in a number of bacteria and they have been successfully used as subunit vaccines. We have isolated OMV from both virulent and avirulent strains of H. parasuis, have examined their protein content and assessed their ability to induce an immune response in the host. Vaccination with purified OMV derived from the virulent H. parasuis Nagasaki strain provided protection against challenge with a lethal dose of the bacteria.	[McCaig, William D.; Loving, Crystal L.; Hughes, Holly R.; Brockmeier, Susan L.] ARS, Virus & Prion Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA	United States Department of Agriculture (USDA)	Brockmeier, SL (corresponding author), ARS, Virus & Prion Dis Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA.	susan.brockmeier@ars.usda.gov			U.S. Department of Energy; U.S. Department of Agriculture; DOE [DE-AC05-06OR23100]	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); DOE(United States Department of Energy (DOE))	This research was supported in part by an appointment to the U.S. DEDA Agricultural Research Service Postdoctoral Research Program administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement between the U.S. Department of Energy and the U.S. Department of Agriculture. ORISE is managed by ORAU under DOE contract number DE-AC05-06OR23100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindis E, 2014, P NATL ACAD SCI USA, V111, pE1548, DOI 10.1073/pnas.1403683111; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bak H, 2002, VET REC, V151, P502, DOI 10.1136/vr.151.17.502; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Bielaszewska M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003797; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Bonnington KE, 2014, BBA-MOL CELL RES, V1843, P1612, DOI 10.1016/j.bbamcr.2013.12.011; Brockmeier SL, 2008, VET MICROBIOL, V128, P36, DOI 10.1016/j.vetmic.2007.09.025; Brockmeier SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103787; Brockmeier SL, 2013, CLIN VACCINE IMMUNOL, V20, P1466, DOI 10.1128/CVI.00168-13; Chart H, 1995, Methods Mol Biol, V46, P49; Costa-Hurtado M, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-57; Deknuydt F, 2014, J LEUKOCYTE BIOL, V95, P983, DOI 10.1189/jlb.1013527; Delahunty CM, 2007, BIOTECHNIQUES, V43, P563; Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015; Ellis TN, 2010, INFECT IMMUN, V78, P3822, DOI 10.1128/IAI.00433-10; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; Elluri S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106731; Fu SL, 2013, CLIN VACCINE IMMUNOL, V20, P134, DOI 10.1128/CVI.00458-12; Fu SL, 2013, VACCINE, V31, P347, DOI 10.1016/j.vaccine.2012.11.003; Fu SL, 2012, VACCINE, V30, P6839, DOI 10.1016/j.vaccine.2012.09.014; Fulsundar S, 2014, APPL ENVIRON MICROB, V80, P3469, DOI 10.1128/AEM.04248-13; Garcia R., 2007, SWINE NEWS, P85; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Hu MM, 2013, CLIN VACCINE IMMUNOL, V20, P795, DOI 10.1128/CVI.00676-12; Ismail S, 2003, INFECT IMMUN, V71, P5670, DOI 10.1128/IAI.71.10.5670-5675.2003; Jager J, 2015, CELL MICROBIOL, V17, P607, DOI 10.1111/cmi.12392; Jones HE, 2014, CELL MICROBIOL, V16, P519, DOI 10.1111/cmi.12231; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; KIELSTEIN P, 1992, J CLIN MICROBIOL, V30, P862, DOI 10.1128/JCM.30.4.862-865.1992; Kulkarni HM, 2014, MICROBIOL-SGM, V160, P2109, DOI 10.1099/mic.0.079400-0; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lee EY, 2007, PROTEOMICS, V7, P3143, DOI [10.1002/pmic.200700196, 10.1002/pmic.200790083]; Lee JC, 2012, FEMS MICROBIOL LETT, V331, P17, DOI 10.1111/j.1574-6968.2012.02549.x; Li M, 2015, VACCINE, V33, P1695, DOI 10.1016/j.vaccine.2015.02.023; Lichtensteiger CA, 2003, VET MICROBIOL, V93, P79, DOI 10.1016/S0378-1135(02)00443-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loving CL, 2006, J IMMUNOL, V177, P8432, DOI 10.4049/jimmunol.177.12.8432; de la Fuente AJM, 2009, RES VET SCI, V87, P47, DOI 10.1016/j.rvsc.2008.12.012; de la Fuente AJM, 2009, J COMP PATHOL, V140, P169, DOI 10.1016/j.jcpa.2008.10.007; McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12; MINIATS OP, 1991, CAN J VET RES, V55, P33; MORTON RE, 1992, ANAL BIOCHEM, V204, P332, DOI 10.1016/0003-2697(92)90248-6; Mullins MA, 2011, VET MICROBIOL, V153, P407, DOI 10.1016/j.vetmic.2011.06.004; Mullins MA, 2009, J BACTERIOL, V191, P5988, DOI 10.1128/JB.00469-09; Nho JS, 2015, MICROB PATHOGENESIS, V81, P39, DOI 10.1016/j.micpath.2015.03.012; NIELSEN R, 1993, ACTA VET SCAND, V34, P193; Oliveira S, 2004, VET MICROBIOL, V99, P1, DOI 10.1016/j.vetmic.2003.12.001; Olvera A, 2007, VET J, V174, P522, DOI 10.1016/j.tvjl.2006.10.017; Olvera A, 2009, VET RES, V40, DOI 10.1051/vetres/2009007; Ormazabal M, 2014, VACCINE, V32, P6084, DOI 10.1016/j.vaccine.2014.08.084; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Perez-Cruz C, 2013, APPL ENVIRON MICROB, V79, P1874, DOI 10.1128/AEM.03657-12; Pina S, 2009, J BACTERIOL, V191, P576, DOI 10.1128/JB.00703-08; Pirbadian S, 2014, P NATL ACAD SCI USA, V111, P12883, DOI 10.1073/pnas.1410551111; RAPPGABRIELSON VJ, 1992, AM J VET RES, V53, P987; Roier S, 2015, INT J MED MICROBIOL, V305, P298, DOI 10.1016/j.ijmm.2014.12.005; Roier S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042664; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharpe SW, 2011, INFECT IMMUN, V79, P4361, DOI 10.1128/IAI.05332-11; Sinha R, 2015, MICROBES INFECT, V17, P215, DOI 10.1016/j.micinf.2014.10.011; SMART NL, 1989, CAN J VET RES, V53, P390; Soult MC, 2014, J SURG RES, V192, P134, DOI 10.1016/j.jss.2014.05.007; Takahashi K, 2001, J VET MED SCI, V63, P487, DOI 10.1292/jvms.63.487; Wang XR, 2013, VET MICROBIOL, V164, P184, DOI 10.1016/j.vetmic.2013.01.037; Wei XL, 2014, BIOCHEM BIOPH RES CO, V446, P997, DOI 10.1016/j.bbrc.2014.03.049; Xu CG, 2013, VET J, V195, P200, DOI 10.1016/j.tvjl.2012.06.017; Yu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099368; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang B, 2012, VET MICROBIOL, V157, P237, DOI 10.1016/j.vetmic.2011.12.002; Zhou MG, 2009, VACCINE, V27, P5271, DOI 10.1016/j.vaccine.2009.06.051; Zhou MG, 2009, PROTEOMICS, V9, P2722, DOI 10.1002/pmic.200800717	72	36	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149132	10.1371/journal.pone.0149132	http://dx.doi.org/10.1371/journal.pone.0149132			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930282	Green Submitted, gold, Green Published			2022-12-27	WOS:000371434500016
J	Rots, V; Hayes, E; Cnuts, D; Lepers, C; Fullagar, R				Rots, Veerle; Hayes, Elspeth; Cnuts, Dries; Lepers, Christian; Fullagar, Richard			Making Sense of Residues on Flaked Stone Artefacts: Learning from Blind Tests	PLOS ONE			English	Article							SOUTH-AFRICA; SIBUDU CAVE; ARCHAEOLOGICAL RESIDUES; HOWIESONS POORT; TOOL FUNCTION; NEW-GUINEA; ORGANIC RESIDUES; BLOOD RESIDUES; STARCH GRAINS; MICRO-RESIDUE	Residue analysis has become a frequently applied method for identifying prehistoric stone tool use. Residues adhering to the stone tool with varying frequencies are interpreted as being the result of an intentional contact with the worked material during use. Yet, other processes during the life cycle of a stone tool or after deposition may leave residues and these residues may potentially lead to misinterpretations. We present a blind test that was designed to examine this issue. Results confirm that production, retouch, prehension, hafting, various incidental contacts during use and deposition may lead to residue depositions that significantly affect the accurateness of identifications of tool-use. All currently applied residue approaches are concerned. We therefore argue for a closer interaction with independent wear studies and a step-wise procedure in which a low magnification of wear traces is used as a first step for selecting potentially used flakes in archaeological contexts. In addition, residue concentrations on a tool's edge should be sufficiently dense before linking them with use.	[Rots, Veerle; Cnuts, Dries; Lepers, Christian] Univ Liege, TraceoLab Prehist, Liege, Belgium; [Hayes, Elspeth; Fullagar, Richard] Univ Wollongong, Ctr Archaeol Sci, Wollongong, NSW, Australia	University of Liege; University of Wollongong	Rots, V (corresponding author), Univ Liege, TraceoLab Prehist, Liege, Belgium.	veerle.rots@ulg.ac.be	Rots, Veerle/D-2296-2018; Rots, Veerle/AAI-4933-2020; Fullagar, Richard/AAT-1155-2020	Rots, Veerle/0000-0002-6404-3160; Rots, Veerle/0000-0002-6404-3160; Hayes, Elspeth/0000-0001-6897-8142; Fullagar, Richard/0000-0003-1047-1466; Cnuts, Dries/0000-0003-1169-5568	European Research Council under the European Union / ERC [312283]; University of Liege	European Research Council under the European Union / ERC(European Research Council (ERC)); University of Liege(University of Liege)	This research was funded by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement Nr. 312283 (V. Rots) [https://erc.europa.eu/]. Veerle Rots is also indebted to the Fund for Scientific Research (FNRS-FRS); [http://www1.frs-fnrs.be/]. Elspeth Hayes received a travel grant from the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerman K., 2002, AUST ABORIG STUD, V1, P13; ALEXANDER MP, 1969, STAIN TECHNOL, V44, P117, DOI 10.3109/10520296909063335; Atchison J., 1998, CLOSER LOOK RECENT A, P109; Barton H, 1998, J ARCHAEOL SCI, V25, P1231, DOI 10.1006/jasc.1998.0300; BRIUER FL, 1976, AM ANTIQUITY, V41, P478, DOI 10.2307/279013; Broderick M, 1979, LITHIC USE WEAR ANAL, P375; Byrne L, 2006, ARCHAEOMETRY, V48, P549, DOI 10.1111/j.1475-4754.2006.00272.x; Charrie-Duhaut A, 2013, J ARCHAEOL SCI, V40, P3506, DOI 10.1016/j.jas.2012.12.026; Cnuts D, EXTRACTING RES UNPUB; Crowther A, 2007, J ARCHAEOL SCI, V34, P997, DOI 10.1016/j.jas.2006.06.003; Cutler DF, 2008, PLANT ANATOMY APPL A; Denham TP, 2003, SCIENCE, V301, P189, DOI 10.1126/science.1085255; Fullagar R, 2006, J ARCHAEOL SCI, V33, P595, DOI 10.1016/j.jas.2005.07.020; Fullagar R, 1996, ANTIQUITY, V70, P740, DOI 10.1017/S0003598X00084027; Fullagar R, 1997, ANTIQUITY, V71, P300, DOI 10.1017/S0003598X00084921; Fullagar R, 1998, SYDNEY U ARCHAEOLOGI, P13; Fullagar R., 2009, ARCHAEOLOGICAL SCI M, V30, P248; Fullagar R., 2014, ARCHAEOLOGY PRACTICE, P232; Fullagar R., 2006, ANCIENT STARCH RES, P177; Fullagar R., 1988, BRIT ARCHAEOLOGICAL, V411, P133; Fullagar R, 2015, ARCHAEOL OCEAN, V50, P3, DOI 10.1002/arco.5053; Gibson N. E., 2004, SOUTH AFR HUMANIT, V16, P1; Hall J, 2006, AUST ARCHAEOL, P76; Hardy BL, 2004, ANTIQUITY, V78, P547, DOI 10.1017/S0003598X00113213; Hardy BL, 1998, J ARCHAEOL SCI, V25, P177, DOI 10.1006/jasc.1997.0234; Hardy BL, 2013, QUATERNARY SCI REV, V82, P23, DOI 10.1016/j.quascirev.2013.09.028; Hardy BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023768; Haslam M, 2004, J ARCHAEOL SCI, V31, P1715, DOI 10.1016/j.jas.2004.05.006; Haslam M., 2009, ARCHAEOLOGICAL SCI M; Haslam M, 2011, MOUNTAINS MOLEHILLS, P47; Hogberg A, 2009, J ARCHAEOL SCI, V36, P1725, DOI 10.1016/j.jas.2009.03.030; Jones PJ, 2009, TERRA AUSTRALIS, V30, P29; Kealhofer L, 1999, J ARCHAEOL SCI, V26, P527, DOI 10.1006/jasc.1998.0332; Kononenko N., 2011, TECH REP AUSTR MUS O, V21, P1, DOI [10.3853/j.1835-4211.21.2011.1559, DOI 10.3853/J.1835-4211.21.2011.1559]; Lamb J, 2005, J ARCHAEOL SCI, V32, P1433, DOI 10.1016/j.jas.2005.03.020; Langejans GHJ, 2015, MAN ARCHAEOL METH, P199, DOI 10.1007/978-3-319-08257-8_11; Langejans GHJ, 2012, J ARCHAEOL SCI, V39, P1694, DOI 10.1016/j.jas.2011.12.036; Langejans GHJ, 2011, J ARCHAEOL SCI, V38, P985, DOI 10.1016/j.jas.2010.11.013; Lillie R, 1976, CONNS BIOL STAINS; Lombard M, 2004, S AFR ARCHAEOL BULL, V59, P37, DOI 10.2307/3889241; Lombard M, 2004, S AFR J SCI, V100, P159; Lombard M, 2005, J HUM EVOL, V48, P279, DOI 10.1016/j.jhevol.2004.11.006; Lombard M, 2010, ANTIQUITY; Lombard M, 2008, J ARCHAEOL SCI, V35, P26, DOI 10.1016/j.jas.2007.02.021; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Lombard M, 2011, J ARCHAEOL SCI, V38, P1918, DOI 10.1016/j.jas.2011.04.001; Lombard M, 2010, ANTIQUITY, V84, P635, DOI 10.1017/S0003598X00100134; Lombard M, 2007, J ARCHAEOL SCI, V34, P155, DOI 10.1016/j.jas.2006.04.008; Louderback LA, 2015, J ARCHAEOL SCI-REP, V4, P535, DOI 10.1016/j.jasrep.2015.10.011; LOY TH, 1993, WORLD ARCHAEOL, V25, P44, DOI 10.1080/00438243.1993.9980227; LOY TH, 1983, SCIENCE, V220, P1269, DOI 10.1126/science.220.4603.1269; LOY TH, 1992, ANTIQUITY, V66, P898, DOI 10.1017/S0003598X00044811; Matheson CD, 2014, J ARCHAEOL SCI, V41, P230, DOI 10.1016/j.jas.2013.08.018; Monnier GF, 2012, J ARCHAEOL SCI, V39, P3284, DOI 10.1016/j.jas.2012.05.010; NELSON DE, 1986, RADIOCARBON, V28, P170, DOI 10.1017/S0033822200060082; OWEN LR, 1989, ANTHROPOLOGIE, V93, P673; Prinsloo LC, 2014, J ARCHAEOL SCI, V41, P732, DOI 10.1016/j.jas.2013.10.011; Robertson G, 2008, LITHIC TECHNOL; Robertson G, 2009, ANTIQUITY, V83, P296, DOI 10.1017/S0003598X00098446; Rots V, 2003, ANTIQUITY, V77, P805, DOI 10.1017/S0003598X00061743; Rots V, 2004, J ARCHAEOL SCI, V31, P1287, DOI 10.1016/j.jas.2004.02.009; Rots V, 2006, J ARCHAEOL SCI, V33, P935, DOI 10.1016/j.jas.2005.10.018; Rots V., 2004, LITHIC TECHNOLOGY, V29, P7; Rots V., 2010, B CHERCHEURS WALLONI, V2, P51; Rots V., 2010, PREHENSION HAFTING T, DOI 10.2307/j.ctt9qf05s; Rots V, 2015, J HUM EVOL, V89, P298, DOI 10.1016/j.jhevol.2015.07.005; Shafer H., 1979, LITHIC USE WEAR ANAL, P385; Stadelmann E, 1972, METHODS CELL PHYSL, V5; Stephenson B, 2015, J ARCHAEOL SCI, V61, P235, DOI 10.1016/j.jas.2015.06.007; Summerhayes GR, 2010, SCIENCE, V330, P78, DOI 10.1126/science.1193130; Torrence R., 2006, ANCIENT STARCH RES; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Veth P., 1997, AUST ARCHAEOL, V44, P23, DOI DOI 10.1080/03122417.1997.11681590; Wadley L, 2004, J ARCHAEOL SCI, V31, P1491, DOI 10.1016/j.jas.2004.03.010	74	60	60	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150437	10.1371/journal.pone.0150437	http://dx.doi.org/10.1371/journal.pone.0150437			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF5ZW	26930210	Green Published, gold			2022-12-27	WOS:000371434500148
J	Clark, AE; Altwegg, R; Ormerod, JT				Clark, Allan E.; Altwegg, Res; Ormerod, John T.			A Variational Bayes Approach to the Analysis of Occupancy Models	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; PENALIZED LIKELIHOOD; APPROXIMATIONS	Detection-nondetection data are often used to investigate species range dynamics using Bayesian occupancy models which rely on the use of Markov chain Monte Carlo (MCMC) methods to sample from the posterior distribution of the parameters of the model. In this article we develop two Variational Bayes (VB) approximations to the posterior distribution of the parameters of a single-season site occupancy model which uses logistic link functions to model the probability of species occurrence at sites and of species detection probabilities. This task is accomplished through the development of iterative algorithms that do not use MCMC methods. Simulations and small practical examples demonstrate the effectiveness of the proposed technique. We specifically show that (under certain circumstances) the variational distributions can provide accurate approximations to the true posterior distributions of the parameters of the model when the number of visits per site (K) are as low as three and that the accuracy of the approximations improves as K increases. We also show that the methodology can be used to obtain the posterior distribution of the predictive distribution of the proportion of sites occupied (PAO).	[Clark, Allan E.; Altwegg, Res] Univ Cape Town, Dept Stat Sci, Private Bag X3, ZA-7701 Cape Town, South Africa; [Clark, Allan E.; Altwegg, Res] Univ Cape Town, Ctr Stat Ecol Environm & Conservat SEEC, ZA-7701 Cape Town, South Africa; [Ormerod, John T.] Univ Sydney, Sch Math & Stat, Sydney, NSW 2006, Australia; [Ormerod, John T.] ARC Ctr Excellence Math & Stat Frontiers, Melbourne, Vic, Australia	University of Cape Town; University of Cape Town; University of Sydney	Clark, AE (corresponding author), Univ Cape Town, Dept Stat Sci, Private Bag X3, ZA-7701 Cape Town, South Africa.; Clark, AE (corresponding author), Univ Cape Town, Ctr Stat Ecol Environm & Conservat SEEC, ZA-7701 Cape Town, South Africa.	allan.clark@uct.ac.za	Clark, Allan Ernest/S-1063-2019		Australian Research Council [DE130101670]; National Research Foundation [81685, 85802]; South African National Research Foundation	Australian Research Council(Australian Research Council); National Research Foundation; South African National Research Foundation(National Research Foundation - South Africa)	J.T. Ormerod received funding from the Australian Research Council Early Career Award DE130101670. R. Altwegg received funding from a National Research Foundation grant "Dynamic macroecology in conservation" ( Grant No: 81685 and 85802). A.E. Clark received a South African National Research Foundation scholarship to complete this work.	[Anonymous], 2014, R LANG ENV STAT COMP; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Bishop CM, 2008, LECT NOTES COMPUT SC, V5050, P1; Bled F, 2013, ECOL EVOL, V3, P4896, DOI 10.1002/ece3.858; Broms KM, 2014, ECOL APPL, V24, P363, DOI 10.1890/12-2151.1; Choy SL, 2009, ECOLOGY, V90, P265, DOI 10.1890/07-1886.1; Clark JS, 2005, ECOL LETT, V8, P2, DOI 10.1111/j.1461-0248.2004.00702.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Grimmer J, 2010, POLIT ANAL, V18, P1, DOI [10.1093/pan/mpp034, 10.1093/pan/mpq027]; Guillera-Arroita G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099571; Harebottle D. M., 2007, SO AFRICAN BIRD ATLA; Hensman J., 2012, ADV NEURAL INFORM PR, P2888; Hutchinson RA, 2015, METHODS ECOL EVOL, V6, P949, DOI 10.1111/2041-210X.12368; Jaakkola TS, 2000, STAT COMPUT, V10, P25, DOI 10.1023/A:1008932416310; Johnson DS, 2013, ECOLOGY, V94, P801, DOI 10.1890/12-0564.1; Kelly K. M., 2014, JAGSUI RUN JAGS SPEC, P1; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Kuhnert PM, 2010, ECOL LETT, V13, P900, DOI 10.1111/j.1461-0248.2010.01477.x; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McGrory CA, 2007, COMPUT STAT DATA AN, V51, P5352, DOI 10.1016/j.csda.2006.07.020; Moreno M, 2010, ECOLOGY, V91, P341, DOI 10.1890/09-1073.1; Nathoo FS, 2014, BIOMETRICS, V70, P132, DOI 10.1111/biom.12126; Ormerod JT, 2010, AM STAT, V64, P140, DOI 10.1198/tast.2010.09058; Ormerod JT, 2011, CRGTR931 U SYDN SCH; Peron G, 2015, GLOBAL ECOL BIOGEOGR, V24, P215, DOI 10.1111/geb.12251; Plummer M., 2003, P 3 INT WORKSH DISTR, P125, DOI DOI 10.1038/S41598-018-29599-W; Robert C., 2013, MONTE CARLO STAT MET; Royle J. A., 2008, HIERARCHICAL MODELIN; Royle JA, 2007, ECOLOGY, V88, P1813, DOI 10.1890/06-0669.1; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Wang B., 2005, P 10 INT WORKSH ART; Welsh AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052015; You C, 2014, AUST NZ J STAT, V56, P73, DOI 10.1111/anzs.12063	36	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0148966	10.1371/journal.pone.0148966	http://dx.doi.org/10.1371/journal.pone.0148966			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928878	Green Submitted, gold, Green Published			2022-12-27	WOS:000371424200006
J	St-Pierre, S; Jiang, W; Roy, P; Champigny, C; LeBlanc, E; Morley, BJ; Hao, JW; Simard, AR				St-Pierre, Stephanie; Jiang, Wei; Roy, Patrick; Champigny, Camille; LeBlanc, Eric; Morley, Barbara J.; Hao, Junwei; Simard, Alain R.			Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival	PLOS ONE			English	Article							MACROPHAGE ACTIVATION; HEMATOPOIETIC SYSTEM; ATTENUATION; SUBSETS; ALPHA-7; CELLS; HETEROGENEITY; EXPRESSION; TISSUES; CCR2	It is increasingly clear that nicotinic acetylcholine receptors (nAChRs) are involved in immune regulation, and that their activation can protect against inflammatory diseases. Previous data have shown that nicotine diminishes the numbers of peripheral monocytes and macrophages, especially those of the pro-inflammatory phenotype. The goal of the present study was to determine if nicotine modulates the production of bone marrow-derived monocytes/macrophages. In this study, we first found that murine bone marrow cells express multiple nAChR subunits, and that the alpha 7 and alpha 9 nAChRs most predominant subtypes found in immune cells and their precursors. Using primary cultures of murine bone marrow cells, we then determined the effect of nicotine on monocyte colony-stimulating factor and interferon gamma (IFN gamma)-induced monocyte production. We found that nicotine lowered the overall number of monocytes, and more specifically, inhibited the IFN gamma-induced increase in proinflammatory monocytes by reducing cell proliferation and viability. These data suggested that nicotine diminishes the ratio of pro-inflammatory versus anti-inflammatory monocyte produced in the bone marrow. We thus confirmed this hypothesis by measuring cytokine expression, where we found that nicotine inhibited the production of the pro-inflammatory cytokines TNF alpha, IL-1 beta and IL-12, while stimulating the secretion of IL-10, an anti-inflammatory cytokine. Finally, nicotine also reduced the number of pro-inflammatory monocytes in the bone marrow of LPS-challenged mice. Overall, our data demonstrate that both alpha 7 and alpha 9 nAChRs are involved in the regulation of pro-inflammatory M1 monocyte numbers.	[St-Pierre, Stephanie; Roy, Patrick; LeBlanc, Eric; Simard, Alain R.] Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada; [Jiang, Wei; Hao, Junwei] Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin, Peoples R China; [Jiang, Wei; Hao, Junwei] Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, Tianjin, Peoples R China; [Champigny, Camille; Simard, Alain R.] Ctr Format Med Nouveau Brunswick, Moncton, NB, Canada; [Morley, Barbara J.] Boys Town Natl Res Hosp, Omaha, NE 68131 USA	University of Moncton; Tianjin Medical University; Tianjin Medical University; National Research Council Canada; Boys Town National Research Hospital	Simard, AR (corresponding author), Univ Moncton, Dept Chim & Biochim, Moncton, NB E1A 3E9, Canada.; Simard, AR (corresponding author), Ctr Format Med Nouveau Brunswick, Moncton, NB, Canada.	alain.simard@umoncton.ca	Morley, Barbara/AAB-7980-2019; Simard, Alain/E-1493-2013	Simard, Alain/0000-0002-3499-6235; Hao, Junwei/0000-0002-3075-5434	Multiple Sclerosis Society of Canada [EGID1639]; New Brunswick Health Research Foundation [2013-MSOP-500]; New Brunswick Innovation Foundation [RIF2014-006]	Multiple Sclerosis Society of Canada; New Brunswick Health Research Foundation; New Brunswick Innovation Foundation	This work was funded by the Multiple Sclerosis Society of Canada (EGID1639; www.mssociety.ca), the New Brunswick Health Research Foundation (2013-MSOP-500; www.nbhrf.com) and the New Brunswick Innovation Foundation RIF2014-006; www.nbif.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afan AM, 1997, BRIT J HAEMATOL, V98, P569, DOI 10.1046/j.1365-2141.1997.2733092.x; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Bruchfeld A, 2010, J INTERN MED, V268, P94, DOI 10.1111/j.1365-2796.2010.02226.x; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Gahring LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057481; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Kawashima K, 2007, LIFE SCI, V80, P2314, DOI 10.1016/j.lfs.2007.02.036; Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Koval LA, 2008, INT J BIOCHEM CELL B, V40, P980, DOI 10.1016/j.biocel.2007.11.006; Lee RH, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.189; Mabley J, 2011, INFLAMMATION, V34, P231, DOI 10.1007/s10753-010-9228-x; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nizri E, 2009, J IMMUNOL, V183, P6681, DOI 10.4049/jimmunol.0902212; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Serobyan N, 2007, LIFE SCI, V80, P2352, DOI 10.1016/j.lfs.2007.04.017; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Simard AR, 2013, IMMUNOL CELL BIOL, V91, P195, DOI 10.1038/icb.2013.1; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Terrando N, 2014, MOL MED, V20, P667, DOI 10.2119/molmed.2014.00143; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; van Maanen MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116227; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x	36	48	48	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150230	10.1371/journal.pone.0150230	http://dx.doi.org/10.1371/journal.pone.0150230			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925951	Green Submitted, gold, Green Published			2022-12-27	WOS:000371424200029
J	Knol, MH; Dolan, CV; Mellenbergh, GJ; van der Maas, HLJ				Knol, Mariska H.; Dolan, Conor V.; Mellenbergh, Gideon J.; van der Maas, Han L. J.			Measuring the Quality of University Lectures: Development and Validation of the Instructional Skills Questionnaire (ISQ)	PLOS ONE			English	Article							STUDENTS EVALUATIONS; TEACHING EFFECTIVENESS; COLLEGE-TEACHERS; RATINGS; CONSULTATION; VALIDITY; FEEDBACK	In higher education, student ratings are often used to evaluate and improve the quality of courses and professors' instructional skills. Unfortunately, student-rating questionnaires rarely generate specific feedback for professors to improve their instructional skills. The impact of student ratings on professors' instructional skills has proven to be low. This study concerns the psychometric properties of the Instructional Skills Questionnaire (ISQ), a new theory-based student-rating-of-teaching questionnaire with specific questions concerning lecturing skills. The ISQ is administered after a single lecture. This way, it serves as a formative feedback instrument for university professors during courses to assist them to improve and (re-) evaluate their skills if necessary. The ISQ contains seven dimensions of professors' instructional skills and three student (self perceived) learning outcomes. In this study, Dutch students in 75 courses rated three 90-minute lectures (T1, T2 and T3) of their respective professors using the ISQ. In total, 14,298 ISQ-forms were used to rate 225 lectures. The teacher level reliabilities of the seven dimensions were found to be good at each measurement occasion. In addition, confirmatory multilevel factor analysis confirmed a seven dimensional factor structure at the teacher level at each measurement occasion. Furthermore, specific teacher level factors significantly predicted students' (self-assessed) learning outcomes. These results partly supported the proposed theoretical framework on the relationship between the ISQ teaching dimensions and the student learning process, and provided evidence for the construct validity of the instrument. In sum, the ISQ is found to be a reliable and valid instrument, which can be used by professors and faculty development centers to assess and improve university teaching.	[Knol, Mariska H.; Dolan, Conor V.; Mellenbergh, Gideon J.; van der Maas, Han L. J.] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands	University of Amsterdam	Knol, MH (corresponding author), Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands.	contact@mariskaknol.nl		van der Maas, Han L. J./0000-0001-8278-319X	University of Amsterdam	University of Amsterdam	The study was funded by the University of Amsterdam. The authors had full control in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	COHEN PA, 1980, RES HIGH EDUC, V13, P321, DOI 10.1007/BF00976252; CRANTON P, 1990, J EDUC PSYCHOL, V82, P207, DOI 10.1037/0022-0663.82.2.207; DENEVE HMF, 1982, HIGH EDUC, V11, P543, DOI 10.1007/BF00194419; FELDMAN KA, 1984, RES HIGH EDUC, V21, P45, DOI 10.1007/BF00975035; FELDMAN KA, 1989, RES HIGH EDUC, V30, P137, DOI 10.1007/BF00992716; FELDMAN KA, 1989, RES HIGH EDUC, V30, P583, DOI 10.1007/BF00992392; FELDMAN KA, 1983, RES HIGH EDUC, V18, P3, DOI 10.1007/BF00992080; Feldman KA, 1976, RES HIGH EDUC, V5, P243, DOI [10.1007/BF00991967, DOI 10.1007/BF00991967]; Feldman KA, 2007, SCHOLARSHIP OF TEACHING AND LEARNING IN HIGHER EDUCATION: AN EVIDENCE-BASED PERSPECTIVE, P93, DOI 10.1007/1-4020-5742-3_5; Geldhof GJ, PSYCHOL METHODS, V19; GILLMORE GM, 1978, J EDUC MEAS, V15, P1, DOI 10.1111/j.1745-3984.1978.tb00051.x; Hampton SE, 2004, RES HIGH EDUC, V45, P497, DOI 10.1023/B:RIHE.0000032326.00426.d5; Hattie J, 2007, REV EDUC RES, V77, P81, DOI 10.3102/003465430298487; HOWARD GS, 1980, J EDUC PSYCHOL, V72, P810; Hox JJ, 2010, MULTILEVEL ANAL TECH, V2nd; Kember D., 2002, ASSESS EVAL HIGH EDU, V27, P411, DOI [DOI 10.1080/0260293022000009294, 10.1080/0260293022000009294]; Knol MH, 2013, RES HIGH EDUC, V54, P825, DOI 10.1007/s11162-013-9298-3; Marsh H.W., 1997, EFFECTIVE TEACHING H, P241; Marsh H.W., 1992, HIGHER ED HDB THEORY, V8, P143; Marsh Herbert, 1987, INT J EDUC RES, V11, P253, DOI [10.1016/0883-0355(87)90001-2, DOI 10.1016/0883-0355(87)90001-2]; Marsh HW, 2007, SCHOLARSHIP OF TEACHING AND LEARNING IN HIGHER EDUCATION: AN EVIDENCE-BASED PERSPECTIVE, P319, DOI 10.1007/1-4020-5742-3_9; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; MARSH HW, 1984, J EDUC PSYCHOL, V76, P707, DOI 10.1037/0022-0663.76.5.707; Marsh HW, 1997, AM PSYCHOL, V52, P1187, DOI 10.1037/0003-066X.52.11.1187; MARSH HW, 1991, TEACH TEACH EDUC, V7, P303, DOI 10.1016/0742-051X(91)90001-6; MARSH HW, 1993, AM EDUC RES J, V30, P217, DOI 10.3102/00028312030001217; McLaughlin MW, 1988, TEACHER EVALUATION I; Muthen B., 2010, MPLUS USERS GUIDE; Muthen L. K., 2010, MPLUS SOFTWARE VERSI; Oudkerk Pool T, 1979, DIDACTISCHE ANAL; Penny AR, 2004, REV EDUC RES, V74, P215, DOI 10.3102/00346543074002215; Richardson J.T.E, 2005, ASSESS EVAL HIGH EDU, V30, P387, DOI [10.1080/02602930500099193, DOI 10.1080/02602930500099193]; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Toland MD, 2005, EDUC PSYCHOL MEAS, V65, P272, DOI 10.1177/0013164404268667; Verbeek F, 2002, RAPPORTAGE UVALON; Verbeek F, 2005, JAARVERSLAG UVALON 2; Vermunt J., 2000, NEW LEARNING, P209; Vermunt JD, 1996, HIGH EDUC, V31, P25, DOI 10.1007/BF00129106; Vorst HCM, 1992, UVALON UVA PAKKET ON; Wright SL, 2012, ASSESS EVAL HIGH EDU, V37, P683, DOI 10.1080/02602938.2011.563279	40	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149163	10.1371/journal.pone.0149163	http://dx.doi.org/10.1371/journal.pone.0149163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918646	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400014
J	Koefoed, M; Kromann, CB; Juliussen, SR; Hvidtfeldt, D; Ekelund, B; Frandsen, NE; Marckmann, P				Koefoed, Mette; Kromann, Charles Boy; Juliussen, Sophie Ryberg; Hvidtfeldt, Danni; Ekelund, Bo; Frandsen, Niels Erik; Marckmann, Peter			Nutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; CHRONIC KIDNEY-DISEASE; FAT MASS; HEMODIALYSIS; MORTALITY; ESRD	Background and Aims Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. Methods In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean body mass index and obesity in these patients. Results Seventy-nine eligible maintenance dialysis patients participated. The prevalence of protein-energy wasted patients was 4% (95% CI: 2-12) as assessed by the coexistence of low lean body mass index and low fat mass index. Low lean body mass index was seen in 32% (95% CI: 22-44). Obesity prevalence as assessed from fat mass index was 43% (95% CI: 32-55). Coexistence of low lean body mass index and obesity was seen in 10% (95% CI: 5-19). The prevalence of protein-energy wasting and obesity varied considerably, depending on nutritional assessment methodology. Conclusions Our data indicate that protein-energy wasting is uncommon, whereas low lean body mass index and obesity are frequent conditions among patients in maintenance dialysis. A focus on how to increase and preserve lean body mass in dialysis patients is suggested in the future. In order to clearly distinguish between shortage, sufficiency and abundance of protein and/or fat deposits in maintenance dialysis patients, we suggest the simple measurements of lean body mass index and fat mass index.	[Koefoed, Mette] Univ Copenhagen, Dept Internal Med, Nephrol Sect, Holbaek Hosp,Hlth Sci Fac, Holbaek, Denmark; [Kromann, Charles Boy] Univ Copenhagen, Dept Dermatol, Roskilde Hosp, Fac Hlth Sci, Roskilde, Denmark; [Juliussen, Sophie Ryberg; Hvidtfeldt, Danni] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen N, Denmark; [Ekelund, Bo; Frandsen, Niels Erik; Marckmann, Peter] Univ Copenhagen, Dept Internal Med, Nephrol Sect, Roskilde Hosp,Hlth Sci Fac, Roskilde, Denmark	Holbaek Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Koefoed, M (corresponding author), Univ Copenhagen, Dept Internal Med, Nephrol Sect, Holbaek Hosp,Hlth Sci Fac, Holbaek, Denmark.	mkof@regionsjaelland.dk						Agarwal R, 2010, HYPERTENSION, V56, P893, DOI 10.1161/HYPERTENSIONAHA.110.160747; Bergstrom J, 1998, PERITON DIALYSIS INT, V18, P467; Carrero JJ, 2011, KIDNEY INT, V79, P749, DOI 10.1038/ki.2010.487; Carrero JJ, 2015, SEMIN DIALYSIS, V28, P48, DOI 10.1111/sdi.12287; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; Corish CA, 2003, BRIT J NUTR, V89, P137, DOI 10.1079/BJN2002748; Cuppari L, 2013, NEPHROL DIAL TRANSPL, V28, P119, DOI 10.1093/ndt/gft266; Danish Society of Nephrology, 2014, DAN NEFROL SELSK; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Fouque D, 2008, KIDNEY INT, V73, P391, DOI 10.1038/sj.ki.5002585; Frisancho AR, 1990, APPENDIX B TABLE 12, P175; Gotch FA, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_6.10; Gracia-Iguacel C, 2013, NEPHROL DIAL TRANSPL, V28, P175, DOI 10.1093/ndt/gft024; Gracia-Iguacel C, 2013, NEFROLOGIA, V33, P495, DOI 10.3265/Nefrologia.pre2013.Apr.11979; Honda H, 2007, AM J CLIN NUTR, V86, P633, DOI 10.1093/ajcn/86.3.633; Ikizler TA, 2013, KIDNEY INT, V84, P1096, DOI 10.1038/ki.2013.147; Isoyama N, 2014, CLIN J AM SOC NEPHRO, V9, P1720, DOI 10.2215/CJN.10261013; Jindal KK, 1988, SEMIN DIALYSIS, V1, P82, DOI DOI 10.1111/J.1525-139X.1988.TB00710.X; Jones CH, 2004, J RENAL NUTR, V14, P26, DOI 10.1053/j.jrn.2003.09.006; Kamimura MA, 2003, NEPHROL DIAL TRANSPL, V18, P101, DOI 10.1093/ndt/18.1.101; Kramer HJ, 2006, J AM SOC NEPHROL, V17, P1453, DOI 10.1681/ASN.2005111241; Kyle UG, 2003, NUTRITION, V19, P597, DOI 10.1016/S0899-9007(03)00061-3; Laegreid IK, 2014, RENAL FAILURE, V36, P9, DOI 10.3109/0886022X.2013.830206; Rodrigues NCL, 2012, J RENAL NUTR, V22, P409, DOI 10.1053/j.jrn.2012.01.024; MARCKMANN P, 1988, CLIN NEPHROL, V29, P75; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.1.30; Mehrotra R, 2001, ANNU REV NUTR, V21, P343, DOI 10.1146/annurev.nutr.21.1.343; NFK-K/DOQI, 2001, CLIN PRACT GUID NUTR, P82; OSTERKAMP LK, 1995, J AM DIET ASSOC, V95, P215, DOI 10.1016/S0002-8223(95)00050-X; Parikh C, 2003, RENAL FAILURE, V25, P787, DOI 10.1081/JDI-120024294; Portney L, 2009, FDN CLIN RES APPL PR, V1; Rhee CM, 2014, J CACHEXIA SARCOPENI, V5, P177, DOI 10.1007/s13539-014-0160-z; Schutz Y, 2002, INT J OBESITY, V26, P953, DOI 10.1038/sj.ijo.0802037; Sousa AS, 2014, J HUM NUTR DIET, V27, P80, DOI 10.1111/jhn.12093; van Biesen W, 2013, NEPHROL DIAL TRANSPL, V28, P2620, DOI 10.1093/ndt/gft296; World Health Organization, 2008, WAIST CIRCUMFERENCE; Zoccali C, 2009, NEPHROL DIAL TRANSPL, V24, P376, DOI 10.1093/ndt/gfn589	37	15	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150012	10.1371/journal.pone.0150012	http://dx.doi.org/10.1371/journal.pone.0150012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919440	Green Published, gold			2022-12-27	WOS:000371274400069
J	Lai, ESY; Kwok, CL; Wong, PWC; Fu, KW; Law, YW; Yip, PSF				Lai, Eliza S. Y.; Kwok, Chi-Leung; Wong, Paul W. C.; Fu, King-Wa; Law, Yik-Wa; Yip, Paul S. F.			The Effectiveness and Sustainability of a Universal School-Based Programme for Preventing Depression in Chinese Adolescents: A Follow-Up Study Using Quasi-Experimental Design	PLOS ONE			English	Article							MENTAL-HEALTH LITERACY; SOCIAL SUPPORT; MULTIDIMENSIONAL SCALE; CLINICAL-SIGNIFICANCE; YOUNG-PEOPLE; INTERVENTION; CHILDREN; STRESS; HELP; DISORDERS	Background A pilot study about the effectiveness of a universal school-based programme, "The Little Prince is Depressed", for preventing depression in Chinese adolescents in Hong Kong was conducted and reported previously. This study used a larger sample to examine the effectiveness and sustainability of the programme. Methods This study used quasi-experimental design. Twelve schools enrolled in "The Little Prince is Depressed" programme either as an intervention or a control condition. The intervention schools carried out the 12-session programme in two phases: the professional-led first phase and the teacher-led second phase. All participants were required to complete a questionnaire at three time points measuring their (1) depressive, anxiety, and stress levels; (2) knowledge of mental health; (3) attitudes towards mental illness; (4) perceived social support; and (5) help-seeking behaviours. Results A total of 3,391 students participated in the study. The level of depressive symptoms did not reduce significantly at post-intervention; however, a delayed effect was observed at follow-up assessment for the participants of the teacher-led group in reducing anxiety and stress levels. Also, the knowledge of mental health and attitudes towards mental illness of the intervention-group participants significantly improved at post-test, and the outcomes were maintained at 4 to 5 months after the intervention in both the professional-led and the teacher-led conditions (p<.05). A preference among schoolchildren for whom to seek help from was identified. Conclusions The universal depression prevention programme was effective in enhancing knowledge of mental health and promoting a more positive attitude towards mental illness among adolescents in Hong Kong. In particular, the teacher-led group showed better outcomes than the professional-led group in reducing students' anxiety and stress at follow-up period. The programme can achieve sustainability in schools if teachers are provided with adequate support.	[Lai, Eliza S. Y.; Kwok, Chi-Leung; Wong, Paul W. C.; Fu, King-Wa; Law, Yik-Wa; Yip, Paul S. F.] Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China; [Wong, Paul W. C.; Law, Yik-Wa; Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Fac Social Sci, Hong Kong, Hong Kong, Peoples R China; [Fu, King-Wa] Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Yip, PSF (corresponding author), Univ Hong Kong, Hong Kong Jockey Club Ctr Suicide Res & Prevent, Hong Kong, Hong Kong, Peoples R China.	sfpyip@hku.hk	Fu, King-wa/A-2385-2010	Fu, King-wa/0000-0001-8157-5276	Quality Education Fund [2007/0340]; Hong Kong Jockey Club Centre for Suicide Research and Prevention at The University of Hong Kong	Quality Education Fund; Hong Kong Jockey Club Centre for Suicide Research and Prevention at The University of Hong Kong	The Quality Education Fund (www.qef.org.hk) supported the development, implementation and evaluation of the "Little Prince is Depressed" programme (Project no. 2007/0340). The funding institution is The Hong Kong Jockey Club Centre for Suicide Research and Prevention at The University of Hong Kong. Author PSFY received the funding on behalf of the Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns JR, 2006, J ADOLESCENCE, V29, P225, DOI 10.1016/j.adolescence.2005.05.004; Calear AL, 2010, J ADOLESCENCE, V33, P429, DOI 10.1016/j.adolescence.2009.07.004; Carnevale TD, 2013, J SCH NURS, V29, P181, DOI 10.1177/1059840512469231; Cheng C, 1997, J APPL SOC PSYCHOL, V27, P800, DOI 10.1111/j.1559-1816.1997.tb00660.x; Chou KL, 2000, PERS INDIV DIFFER, V28, P299, DOI 10.1016/S0191-8869(99)00098-7; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; Corrigan P, 2004, AM PSYCHOL, V59, P614, DOI 10.1037/0003-066X.59.7.614; Cox SJ, 2010, DEV PSYCHOL, V46, P842, DOI 10.1037/a0019813; Gillham JE, 2012, J CLIN CHILD ADOLESC, V41, P621, DOI 10.1080/15374416.2012.706517; Gladstone TRG, 2009, CAN J PSYCHIAT, V54, P212, DOI 10.1177/070674370905400402; Goldstein H., 1987, MULTILEVEL MODELS ED; Grav S, 2012, J CLIN NURS, V21, P111, DOI 10.1111/j.1365-2702.2011.03868.x; Gulliver A, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-113; Han SS, 2005, J ABNORM CHILD PSYCH, V33, P665, DOI 10.1007/s10802-005-7646-2; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Kelly CM, 2007, MED J AUSTRALIA, V187, pS26; Leung PWL, 2008, EUR CHILD ADOLES PSY, V17, P452, DOI 10.1007/s00787-008-0687-7; LEWINSOHN PM, 1993, J ABNORM PSYCHOL, V102, P110, DOI 10.1037/0021-843X.102.1.110; Maughan B, 2013, J CAN ACAD CHILD ADO, V22, P35; Mehta N, 2009, BRIT J PSYCHIAT, V194, P278, DOI 10.1192/bjp.bp.108.052654; Merikangas Kathleen Ries, 2009, Dialogues Clin Neurosci, V11, P7; Merry SN, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003380.pub3; Moussa MT., 2001, PSYCHOMETRIC PROPERT; Mychailyszyn MP, 2012, CLIN PSYCHOL-SCI PR, V19, P129, DOI 10.1111/j.1468-2850.2012.01279.x; Naylor PB, 2009, BRIT J PSYCHIAT, V194, P365, DOI 10.1192/bjp.bp.108.053058; NOLENHOEKSEMA S, 1994, PSYCHOL BULL, V115, P424, DOI 10.1037/0033-2909.115.3.424; PETERSEN AC, 1991, J YOUTH ADOLESCENCE, V20, P247, DOI 10.1007/BF01537611; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rickwood DJ, 2007, MED J AUSTRALIA, V187, pS35, DOI 10.5694/j.1326-5377.2007.tb01334.x; Ronk FR, 2013, PSYCHOL ASSESSMENT, V25, P1103, DOI 10.1037/a0033100; Sanchez-Villegas A, 2013, J EPIDEMIOL COMMUN H, V67, P81, DOI 10.1136/jech-2012-201435; SAS Institute, 2011, SAS STAT 9 3 US GUID; Sawyer MG, 2010, J CHILD PSYCHOL PSYC, V51, P199, DOI 10.1111/j.1469-7610.2009.02136.x; Sayal K, 2010, ARCH PEDIAT ADOL MED, V164, P462, DOI 10.1001/archpediatrics.2010.40; Sheffield JK, 2006, J CONSULT CLIN PSYCH, V74, P66, DOI 10.1037/0022-006X.74.1.66; Shochet IM, 2001, J CLIN CHILD PSYCHOL, V30, P303, DOI 10.1207/S15374424JCCP3003_3; Spence SH, 2005, J CONSULT CLIN PSYCH, V73, P160, DOI 10.1037/0022-006X.73.1.160; Spence SH, 2007, J CHILD PSYCHOL PSYC, V48, P526, DOI 10.1111/j.1469-7610.2007.01738.x; Stallard P, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6058; Stallard Paul, 2013, Br J Psychiatry Suppl, V54, ps18, DOI 10.1192/bjp.bp.112.119172; Stice E, 2009, J CONSULT CLIN PSYCH, V77, P486, DOI 10.1037/a0015168; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Wahl MS, 2014, INT J ENV RES PUB HE, V11, P5294, DOI 10.3390/ijerph110505294; Wong PWC, 2012, J AFFECT DISORDERS, V142, P106, DOI 10.1016/j.jad.2012.03.050; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	47	26	26	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149854	10.1371/journal.pone.0149854	http://dx.doi.org/10.1371/journal.pone.0149854			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26921275	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400049
J	Liang, DC; Zuo, AJ; Zhao, RL; Shao, H; Born, WK; O'Brien, RL; Kaplan, HJ; Sun, DM				Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Shao, Hui; Born, Willi K.; O'Brien, Rebecca L.; Kaplan, Henry J.; Sun, Deming			CD73 Expressed on gamma delta T Cells Shapes Their Regulatory Effect in Experimental Autoimmune Uveitis	PLOS ONE			English	Article							DENDRITIC CELLS; ISOPENTENYL PYROPHOSPHATE; CANCER-IMMUNOTHERAPY; ADENOSINE RECEPTORS; PURINE METABOLISM; EXTRACELLULAR ATP; TUMOR-GROWTH; ACTIVATION; GENERATION; LYMPHOCYTES	gamma delta T cells can either enhance or inhibit an adaptive immune response, but the mechanisms involved are not fully understood. Given that CD73 is the main enzyme responsible for conversion of AMP into the immunosuppressive molecule adenosine, we investigated its role in the regulatory function of gamma delta T cells in experimental autoimmune uveitis ( EAU). We found that gamma delta T cells expressed different amounts of CD73 during the different stages of EAU and that low CD73 expression on gamma delta T cells correlated with enhanced Th17 response-promoting activity. Functional comparison of CD73-deficient and wild-type B6 (CD73(+/+)) mice showed that failure to express CD73 decreased both the enhancing and suppressive effects of gamma delta T cells on EAU. We also demonstrated that gamma delta T cells expressed different amounts of CD73 when activated by different pathways, which enabled them to either enhance or inhibit an adaptive immune response. Our results demonstrate that targeting CD73 expression on gamma delta T cells may allow us to manipulate their pro- or anti-inflammatory effect on Th17 responses.	[Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Sun, Deming] UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA; [Liang, Dongchun; Zuo, Aijun; Zhao, Ronglan; Sun, Deming] UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Shao, Hui; Kaplan, Henry J.] Univ Louisville, Dept Ophthalmol & Visual Sci, Kentucky Lions Eye Ctr, Louisville, KY 40202 USA; [Born, Willi K.; O'Brien, Rebecca L.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Zhao, Ronglan] Weifang Med Univ, Key Lab Clin Lab Diagnost Univ Shandong, Dept Lab Med, Shandong 261053, Peoples R China	Doheny Eye Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Louisville; National Jewish Health; Weifang Medical University	Sun, DM (corresponding author), UCLA, David Geffen Sch Med, Doheny Eye Inst, Los Angeles, CA 90033 USA.; Sun, DM (corresponding author), UCLA, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA.	dsun@doheny.org			NIH [EY0022403, EY018827]; NATIONAL EYE INSTITUTE [R01EY018827, R01EY022403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by NIH grants EY0022403 and EY018827.	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Beavis PA, 2012, TRENDS IMMUNOL, V33, P231, DOI 10.1016/j.it.2012.02.009; Bhardwaj R, 2009, TRENDS PARASITOL, V25, P256, DOI 10.1016/j.pt.2009.03.004; Bonner F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034730; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen MJZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132348; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Chiplunkar S, 2009, IMMUNOTHERAPY-UK, V1, P663, DOI [10.2217/IMT.09.27, 10.2217/imt.09.27]; Conter LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092009; Cui Y, 2009, J IMMUNOL, V183, P560, DOI 10.4049/jimmunol.0900241; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Ehrentraut H, 2013, FASEB J, V27, P2207, DOI 10.1096/fj.12-225201; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; FILIPPINI A, 1990, P NATL ACAD SCI USA, V87, P8267, DOI 10.1073/pnas.87.21.8267; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Gomes AQ, 2010, CANCER RES, V70, P10024, DOI 10.1158/0008-5472.CAN-10-3236; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Huber SA, 2000, J IMMUNOL, V165, P4174, DOI 10.4049/jimmunol.165.8.4174; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jin DC, 2010, CANCER RES, V70, P2245, DOI 10.1158/0008-5472.CAN-09-3109; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kabelitz D, 2007, CANCER RES, V67, P5, DOI 10.1158/0008-5472.CAN-06-3069; Kobayashi H, 2007, CANCER IMMUNOL IMMUN, V56, P469, DOI 10.1007/s00262-006-0199-6; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Lafont V, 2001, J BIOL CHEM, V276, P15961, DOI 10.1074/jbc.M008684200; Liang DC, 2014, J IMMUNOL, V193, P5498, DOI 10.4049/jimmunol.1401959; Liang DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108932; Liang DC, 2013, J IMMUNOL, V191, P1118, DOI 10.4049/jimmunol.1300626; Liang DC, 2013, INVEST OPHTH VIS SCI, V54, P3493, DOI 10.1167/iovs.12-11432; Liang DC, 2012, J IMMUNOL, V188, P5785, DOI 10.4049/jimmunol.1200109; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mills JH, 2008, P NATL ACAD SCI USA, V105, P9325, DOI 10.1073/pnas.0711175105; Naganuma M, 2006, J IMMUNOL, V177, P2765, DOI 10.4049/jimmunol.177.5.2765; Nian H, 2012, INVEST OPHTH VIS SCI, V53, P897, DOI 10.1167/iovs.11-8297; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; Nian H, 2010, INVEST OPHTH VIS SCI, V51, P4661, DOI 10.1167/iovs.09-5045; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Paul S, 2014, J LEUKOCYTE BIOL, V97, P295; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Perregaux DG, 2000, J IMMUNOL, V165, P4615, DOI 10.4049/jimmunol.165.8.4615; Petermann F, 2010, IMMUNITY, V33, P351, DOI 10.1016/j.immuni.2010.08.013; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poccia F, 2005, IMMUNOL LETT, V100, P14, DOI 10.1016/j.imlet.2005.06.025; Rabinovich GA, 2007, ANNU REV IMMUNOL, V25, P267, DOI 10.1146/annurev.immunol.25.022106.141609; Rincon-Orozco B, 2005, J IMMUNOL, V175, P2144, DOI 10.4049/jimmunol.175.4.2144; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; Schenk U, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001270; Shao H, 2006, EXP EYE RES, V82, P323, DOI 10.1016/j.exer.2005.07.008; Shao H, 2005, J IMMUNOL, V175, P1851, DOI 10.4049/jimmunol.175.3.1851; Smyth LA, 2013, EUR J IMMUNOL, V43, P2430, DOI 10.1002/eji.201242909; Spencer CT, 2008, J IMMUNOL, V181, P4471, DOI 10.4049/jimmunol.181.7.4471; Stagg J, 2011, CANCER RES, V71, P2892, DOI 10.1158/0008-5472.CAN-10-4246; Stagg J, 2010, P NATL ACAD SCI USA, V107, P1547, DOI 10.1073/pnas.0908801107; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Wang H, 2003, J IMMUNOL, V170, P3696, DOI 10.4049/jimmunol.170.7.3696; Wang L, 2011, J CLIN INVEST, V121, P2371, DOI 10.1172/JCI45559; Wang LS, 2001, J IMMUNOL, V167, P6195, DOI 10.4049/jimmunol.167.11.6195; Wesch D, 2006, J IMMUNOL, V176, P1348, DOI 10.4049/jimmunol.176.3.1348; Wesch D, 1997, EUR J IMMUNOL, V27, P952, DOI 10.1002/eji.1830270422; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Yegutkin GG, 2015, EUR J IMMUNOL, V45, P562, DOI 10.1002/eji.201444856; Yoshida Y, 2011, SURG TODAY, V41, P606, DOI 10.1007/s00595-010-4478-7; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108156; Zuo AJ, 2012, MOL IMMUNOL, V50, P125, DOI 10.1016/j.molimm.2011.12.013	73	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150078	10.1371/journal.pone.0150078	http://dx.doi.org/10.1371/journal.pone.0150078			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919582	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400083
J	Machado, D; Pires, D; Perdigao, J; Couto, I; Portugal, I; Martins, M; Amaral, L; Anes, E; Viveiros, M				Machado, Diana; Pires, David; Perdigao, Joao; Couto, Isabel; Portugal, Isabel; Martins, Marta; Amaral, Leonard; Anes, Elsa; Viveiros, Miguel			Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; IN-VITRO; SUSCEPTIBILITY; THIORIDAZINE; VERAPAMIL; MECHANISM; OFLOXACIN; GENE; TB	Given the ability of M. tuberculosis to survive as an intracellular pathogen and its propensity to develop resistance to the existing antituberculosis drugs, its treatment requires new approaches. Here the antimycobacterial properties of verapamil, thioridazine, chlorpromazine, flupenthixol and haloperidol were investigated against a panel of drug resistant M. tuberculosis strains, both in vitro and on human-infected macrophages. These compounds are efflux inhibitors that share among them the characteristic of being ion channel blockers. In vitro, all compounds exhibited synergistic inhibitory activities when combined with isoniazid and rifampicin, and were able to inhibit active efflux, demonstrating their role as efflux inhibitors. Gene expression analysis showed that M. tuberculosis efflux genes were overexpressed in response to antibiotic exposure, in vitro and within macrophages, irrespective of their resistance pattern. These compounds displayed a rapid and high killing activity against M. tuberculosis, associated with a decrease in intracellular ATP levels demonstrating that the bactericidal action of the ion channel blockers against M. tuberculosis clinical strains is associated with their interference with energy metabolism. The compounds led to a decrease in the intracellular mycobacterial load by increasing phagosome acidification and activating lysosomal hydrolases. The results presented in this study enable us to propose the following mechanism of action for these compounds: a) in the bacteria, the compounds generate a cascade of events involving the inhibition of the respiratory chain complexes and energy production for efflux activity. Indirectly, this reduce the resistance level to antituberculosis drugs potentiating their activity; b) on the host cell, the treatment with the ion channel blockers increases phagosome acidification and induces the expression of phagosomal hydrolases, leading to bacterial growth restriction irrespective of their resistance pattern. This work highlights the potential value ion channel blockers as adjuvants of tuberculosis chemotherapy, in particular for the development of new therapeutic strategies, with strong potential for treatment shortening against drug susceptible and resistant forms of tuberculosis. Medicinal chemistry studies are now needed to improve the properties of these compounds, increasing their M. tuberculosis efflux-inhibition and killing-enhancement activity and reduce their toxicity for humans, therefore optimizing their potential for clinical usage.	[Machado, Diana; Couto, Isabel; Viveiros, Miguel] Univ Nova Lisboa, IHMT, Unidade Microbiol Med, P-1200 Lisbon, Portugal; [Machado, Diana; Couto, Isabel; Amaral, Leonard; Viveiros, Miguel] Univ Nova Lisboa, IHMT, GHTM, P-1200 Lisbon, Portugal; [Pires, David; Perdigao, Joao; Portugal, Isabel; Anes, Elsa] Univ Lisbon, Fac Farm, IMed ULisboa Inst Invest Medicamento, P-1699 Lisbon, Portugal; [Pires, David; Anes, Elsa] Univ Lisbon, Fac Med, Inst Med Mol, P-1699 Lisbon, Portugal; [Martins, Marta] Natl Univ Ireland Univ Coll Dublin, UCD Ctr Mol Innovat & Drug Discovery, Sch Publ Hlth Physiotherapy & Sports Sci, UCD Ctr Food Safety, Dublin 4, Ireland	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Lisboa; Universidade de Lisboa; University College Dublin	Viveiros, M (corresponding author), Univ Nova Lisboa, IHMT, Unidade Microbiol Med, P-1200 Lisbon, Portugal.; Viveiros, M (corresponding author), Univ Nova Lisboa, IHMT, GHTM, P-1200 Lisbon, Portugal.	mviveiros@ihmt.unl.pt	Portugal, Isabel/B-1491-2008; Machado, Diana/L-7027-2013; iMed.ULisboa, M2B/B-5277-2014; iMed.ULisboa, HPI/B-4239-2014; Viveiros, Miguel/A-7326-2008; Couto, Isabel/I-2640-2012; Anes, Elsa/K-3124-2013; Pires, David/D-8245-2012; Perdigão, João/L-6893-2013	Portugal, Isabel/0000-0002-7843-0006; Machado, Diana/0000-0003-2375-2726; iMed.ULisboa, M2B/0000-0002-1245-3715; iMed.ULisboa, HPI/0000-0001-5934-0198; Viveiros, Miguel/0000-0001-9676-6251; Couto, Isabel/0000-0003-3536-2733; Anes, Elsa/0000-0001-5934-0198; Pires, David/0000-0001-9602-1516; Perdigão, João/0000-0002-0339-1305; Martins, Marta/0000-0002-0323-2857	Fundacao para a Ciencia e a Tecnologia (Portugal) [PTDC/SAU-FCF/102807/2008, PTDC/BIA-MIC/121859/2010, PTDC/SAU-MII/098024/2008, PTDC/BIA-BCM/102123/2008]; Fundacao Calouste Gulbenkian (Portugal) [SDH49]; Fundacao para a Ciencia e a Tecnologia [PTDC/BIA-MIC/121859/2010, GHTM UID/Multi/04413/2013, SFRH/BD/65060/2009, SFRH/BD/63747/2009, SFRH/BD/45388/2008]	Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacao Calouste Gulbenkian (Portugal); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants PTDC/SAU-FCF/102807/2008 (MV) and PTDC/BIA-MIC/121859/2010 (IC), partially supported by grants PTDC/SAU-MII/098024/2008 (EA) and PTDC/BIA-BCM/102123/2008 (EA) from Fundacao para a Ciencia e a Tecnologia (Portugal; http://www.fct.pt/index.phtml.en), Project Ref<SUP>a</SUP> SDH49 (IC) from Fundacao Calouste Gulbenkian (Portugal; http://www.gulbenkian.pt/Institucional/en/Homepage) and GHTM UID/Multi/04413/2013 (DM IC MV) from Fundacao para a Ciencia e a Tecnologia. DM was supported by grants SFRH/BD/65060/2009 and PTDC/BIA-MIC/121859/2010, from Fundacao para a Ciencia e a Tecnologia. DP and JP were supported by grants SFRH/BD/63747/2009 and SFRH/BD/45388/2008, respectively, from Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KN, 2014, J INFECT DIS, V210, P456, DOI 10.1093/infdis/jiu095; Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; da Silva PEA, 2011, FEMS IMMUNOL MED MIC, V63, P1, DOI 10.1111/j.1574-695X.2011.00831.x; Amaral L, 2007, J ANTIMICROB CHEMOTH, V59, P1237, DOI 10.1093/jac/dkl500; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Black PA, 2014, ANTIMICROB AGENTS CH, V58, P2491, DOI 10.1128/AAC.02293-13; Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; Cambau E, 2015, J ANTIMICROB CHEMOTH, V70, P686, DOI 10.1093/jac/dku438; Daniel WA, 1999, TOXICOL APPL PHARM, V158, P115, DOI 10.1006/taap.1999.8688; de Knegt GJ, 2014, TUBERCULOSIS, V94, P701, DOI 10.1016/j.tube.2014.09.002; Elliott WJ, 2011, J CLIN HYPERTENS, V13, P687, DOI 10.1111/j.1751-7176.2011.00513.x; Filippini P, 2010, ANTIMICROB AGENTS CH, V54, P2712, DOI 10.1128/AAC.01736-09; Glassman AH, 2001, AM J PSYCHIAT, V158, P1774, DOI 10.1176/appi.ajp.158.11.1774; Gumbo T, 2013, NAT GENET, V45, P720, DOI 10.1038/ng.2675; Gupta AK, 2010, MICROB DRUG RESIST, V16, P21, DOI 10.1089/mdr.2009.0054; Gupta S, 2013, AM J RESP CRIT CARE, V188, P600, DOI 10.1164/rccm.201304-0650OC; Gupta S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005305; Hurst JK, 2012, FREE RADICAL BIO MED, V53, P508, DOI 10.1016/j.freeradbiomed.2012.05.008; Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Leung ETY, 2006, ANTIMICROB AGENTS CH, V50, P1075, DOI 10.1128/AAC.50.3.1075-1078.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louw GE, 2009, ANTIMICROB AGENTS CH, V53, P3181, DOI 10.1128/AAC.01577-08; Louw GE, 2011, AM J RESP CRIT CARE, V184, P269, DOI 10.1164/rccm.201011-1924OC; Lu P, 2014, J ANTIBIOT, V67, P835, DOI 10.1038/ja.2014.74; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Machado L, 2011, IN VIVO, V25, P769; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Martins M, 2009, INT J TUBERC LUNG D, V13, P569; Mitchison D, 2012, INT J TUBERC LUNG D, V16, P724, DOI 10.5588/ijtld.12.0083; Modica-Napolitano JS, 2003, ARCH PHARM RES, V26, P951, DOI 10.1007/BF02980205; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Ordway D, 2003, ANTIMICROB AGENTS CH, V47, P917, DOI 10.1128/AAC.47.3.917-922.2003; Pasca MR, 2005, ANTIMICROB AGENTS CH, V49, P4775, DOI 10.1128/AAC.49.11.4775-4777.2005; Perdigao J, 2013, J ANTIMICROB CHEMOTH, V68, P27, DOI 10.1093/jac/dks371; Pieroni M, 2015, J MED CHEM, V58, P5842, DOI 10.1021/acs.jmedchem.5b00428; PROKESCH RC, 1982, ANTIMICROB AGENTS CH, V21, P373, DOI 10.1128/AAC.21.3.373; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Rodrigues Liliana, 2015, Methods Mol Biol, V1285, P227, DOI 10.1007/978-1-4939-2450-9_13; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; Schmalstieg AM, 2012, ANTIMICROB AGENTS CH, V56, P4806, DOI 10.1128/AAC.05546-11; Silva PEA, 2001, ANTIMICROB AGENTS CH, V45, P800, DOI 10.1128/AAC.45.3.800-804.2001; SINGH BN, 1978, DRUGS, V15, P169, DOI 10.2165/00003495-197815030-00001; Singh M, 2011, INDIAN J MED RES, V133, P535; Springer B, 2009, J CLIN MICROBIOL, V47, P1773, DOI 10.1128/JCM.02501-08; Vandal OH, 2008, NAT MED, V14, P849, DOI 10.1038/nm.1795; Viveiros M, 2012, EXPERT REV ANTI-INFE, V10, P983, DOI [10.1586/eri.12.89, 10.1586/ERI.12.89]; Warman AJ, 2013, J ANTIMICROB CHEMOTH, V68, P869, DOI 10.1093/jac/dks483; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102	51	50	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149326	10.1371/journal.pone.0149326	http://dx.doi.org/10.1371/journal.pone.0149326			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919135	Green Submitted, gold, Green Published			2022-12-27	WOS:000371274400017
J	Nair, SA; Raizada, N; Sachdeva, KS; Denkinger, C; Schumacher, S; Dewan, P; Kulsange, S; Boehme, C; Paramsivan, CN; Arinaminpathy, N				Nair, Sreenivas Achuthan; Raizada, Neeraj; Sachdeva, Kuldeep Singh; Denkinger, Claudia; Schumacher, Samuel; Dewan, Puneet; Kulsange, Shubhangi; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan; Arinaminpathy, Nimalan			Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis	PLOS ONE			English	Article							ASSAY	Background Tuberculosis remains a major public health challenge for India. Various studies have documented different levels of TB and multi-drug resistant (MDR) TB among diverse groups of the population. In view of renewed targets set under the End TB strategy by 2035, there is an urgent need for TB diagnosis to be strengthened. Drawing on data from a recent, multi-site study, we address key questions for TB diagnosis amongst symptomatics presenting for care: are there subgroups of patients that are more likely than others, to be positive for TB? In turn, amongst these positive cases, are there factors-apart from treatment history -that may be predictive for multi-drug resistance? Methods We used data from a multi-centric prospective demonstration study, conducted from March 2012 to December 2013 in 18 sub-district level TB programme units (TUs) in India and covering a population of 8.8 million. In place of standard diagnostic tests, upfront Xpert MTB/RIF testing was offered to all presumptive TB symptomatics. Here, using data from this study, we used logistic regression to identify association between risk factors and TB and Rifampicin-Resistant TB among symptomatics enrolled in the study. Results We find that male gender; history of TB treatment; and adult age compared with either children or the elderly are risk factors associated with high TB detection amongst symptomatics, across the TUs. While treatment history is found be a significant risk factor for rifampicin-resistant TB, elderly (65+ yrs) people have significantly lower risk than other age groups. However, pediatric TB cases have no less risk of rifampicin resistance as compared with adults (OR 1.23 (95% C. I. 0.85-1.76)). Similarly, risk of rifampicin resistance among both the genders was the same. These patterns applied across the study sites involved. Notably in Mumbai, amongst those patients with microbiological confirmation of TB, female patients showed a higher risk of having MDR-TB than male patients. Conclusion Our results cast fresh light on the characteristics of symptomatics presenting for care who are most likely to be microbiologically positive for TB, and for rifampicin resistance. The challenges posed by TB control are complex and multifactorial: evidence from diverse sources, including retrospective studies such as that addressed here, can be invaluable in informing future strategies to accelerate declines in TB burden.	[Nair, Sreenivas Achuthan] World Hlth Org, Country Off India, New Delhi, India; [Raizada, Neeraj; Denkinger, Claudia; Schumacher, Samuel; Kulsange, Shubhangi; Boehme, Catharina; Paramsivan, Chinnambedu Nainarappan] Fdn Innovat New Diagnost, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Cent TB Div, New Delhi, India; [Dewan, Puneet] Bill & Melinda Gates Fdn, New Delhi, India; [Arinaminpathy, Nimalan] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England	World Health Organization; Foundation For Innovative New Diagnostics; Imperial College London	Raizada, N (corresponding author), Fdn Innovat New Diagnost, New Delhi, India.	neeraj.raizada@finddx.org		Schumacher, Samuel G/0000-0002-6136-206X; Raizada, Neeraj/0000-0003-2116-332X; Nair, Sreenivas/0000-0002-2586-6797; Arinaminpathy, Nimalan/0000-0001-9502-6876	United States Agency for International Development; Medical Research Council [MR/K010174/1, MR/K010174/1B] Funding Source: researchfish; MRC [MR/K010174/1] Funding Source: UKRI	United States Agency for International Development(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the United States Agency for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida D, 2003, CLIN INFECT DIS, V36, pE152, DOI 10.1086/374931; [Anonymous], INT UNION TUBERCULOS; [Anonymous], 2015, RNTCP ANN STAT REP R; [Anonymous], 2012, FAC REAL DRUG RES TU; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; COMSTOCK GW, 1959, PUBLIC HEALTH REP, V74, P621, DOI 10.2307/4590524; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Das J, 2015, USE STANDARDISED PAT; Enarson RM, 2005, INT J TUBERC LUNG D, V9, P1299; Institute of Medicine (US), 2012, JOINT WORKSH I MED I; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116721; Sachdeva KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126065; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Tolani MP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-9; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, REP PROP POST 2015 T	18	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150054	10.1371/journal.pone.0150054	http://dx.doi.org/10.1371/journal.pone.0150054			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918818	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400077
J	Oliveira, WS; Teixeira, JV; Ren, TI; Cavalcanti, GDC; Sijbers, J				Oliveira, Wendeson S.; Teixeira, Joyce Vitor; Ren, Tsang Ing; Cavalcanti, George D. C.; Sijbers, Jan			Unsupervised Retinal Vessel Segmentation Using Combined Filters	PLOS ONE			English	Article							BLOOD-VESSELS; MATCHED-FILTER; GRAY-LEVEL; IMAGES; CLASSIFICATION; EXTRACTION	Image segmentation of retinal blood vessels is a process that can help to predict and diagnose cardiovascular related diseases, such as hypertension and diabetes, which are known to affect the retinal blood vessels' appearance. This work proposes an unsupervised method for the segmentation of retinal vessels images using a combined matched filter, Frangi's filter and Gabor Wavelet filter to enhance the images. The combination of these three filters in order to improve the segmentation is the main motivation of this work. We investigate two approaches to perform the filter combination: weighted mean and median ranking. Segmentation methods are tested after the vessel enhancement. Enhanced images with median ranking are segmented using a simple threshold criterion. Two segmentation procedures are applied when considering enhanced retinal images using the weighted mean approach. The first method is based on deformable models and the second uses fuzzy C-means for the image segmentation. The procedure is evaluated using two public image databases, Drive and Stare. The experimental results demonstrate that the proposed methods perform well for vessel segmentation in comparison with state-of-the-art methods.	[Oliveira, Wendeson S.; Teixeira, Joyce Vitor; Ren, Tsang Ing; Cavalcanti, George D. C.] Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil; [Sijbers, Jan] Univ Antwerp, Dept Phys, IMinds Vis Lab, Antwerp, Belgium	Universidade Federal de Pernambuco; IMEC; University of Antwerp	Oliveira, WS (corresponding author), Univ Fed Pernambuco, Ctr Informat, Recife, PE, Brazil.	wso@cin.ufpe.br	Sijbers, Jan/C-4214-2011; Cavalcanti, George DC/C-2364-2017; Ren, Tsang Ing/AAD-3221-2022; Sijbers, Jan/H-4324-2015	Sijbers, Jan/0000-0003-4225-2487; Cavalcanti, George DC/0000-0001-7714-2283; Sijbers, Jan/0000-0003-4225-2487	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco [IBPG-0152-1.03/12]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project; CNPq; Capes; Facepe	Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Capes(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Facepe(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	The sources of funding that have supported this work are: Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (http://www.facepe.br/), grant number IBPG-0152-1.03/12, author WSO; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/), authors TIR, GDCC, JVT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br/), authors TIR, GDCC; and Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project (http://www.iwt.be/), author JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partially supported by Brazilian agencies CNPq (Ciencias Sem Fronteiras), Capes, Facepe and by the Flemish Government Agency for Innovation by Science and Technology, Belgium through the SBO TOMFOOD project.	Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Azzopardi G, 2015, MED IMAGE ANAL, V19, P46, DOI 10.1016/j.media.2014.08.002; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; BELKIN NJ, 1995, INFORM PROCESS MANAG, V31, P431, DOI 10.1016/0306-4573(94)00057-A; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; bons ID, 2003, STAT SERIES TXB MONO; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; CHAUDHURI S, 1989, IEEE T MED IMAGING, V8, P263, DOI 10.1109/42.34715; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Gegundez-Arias ME, 2012, IEEE T MED IMAGING, V31, P231, DOI 10.1109/TMI.2011.2167982; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P407, DOI 10.1016/j.cmpb.2012.03.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Jiang XY, 2003, IEEE T PATTERN ANAL, V25, P131, DOI 10.1109/TPAMI.2003.1159954; Li CM, 2008, IEEE T IMAGE PROCESS, V17, P1940, DOI 10.1109/TIP.2008.2002304; Li Q, 2012, EXPERT SYST APPL, V39, P7600, DOI 10.1016/j.eswa.2011.12.046; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez M. E., 1999, Proceedings 1999 International Conference on Image Processing (Cat. 99CH36348), P173, DOI 10.1109/ICIP.1999.822878; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Oliveira WS, 2012, PROC INT C TOOLS ART, P750, DOI 10.1109/ICTAI.2012.106; Oliveira WS, 2012, IEEE IMAGE PROC, P2017, DOI 10.1109/ICIP.2012.6467285; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Sofka M, 2006, IEEE T MED IMAGING, V25, P1531, DOI 10.1109/TMI.2006.884190; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Yin XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095943; Zana F, 2001, IEEE T IMAGE PROCESS, V10, P1010, DOI 10.1109/83.931095; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhao YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122332; Zheng YL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0109765, 10.1371/journal.pone.0093624]	38	52	53	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149943	10.1371/journal.pone.0149943	http://dx.doi.org/10.1371/journal.pone.0149943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919587	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400059
J	Peters, T; Hermans-Beijnsberger, S; Beqqali, A; Bitsch, N; Nakagawa, S; Prasanth, KV; de Windt, LJ; van Oort, RJ; Heymans, S; Schroen, B				Peters, Tim; Hermans-Beijnsberger, Steffie; Beqqali, Abdelaziz; Bitsch, Nicole; Nakagawa, Shinichi; Prasanth, Kannanganattu V.; de Windt, Leon J.; van Oort, Ralph J.; Heymans, Stephane; Schroen, Blanche			Long Non-Coding RNA Malat-1 Is Dispensable during Pressure Overload-Induced Cardiac Remodeling and Failure in Mice	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; XIST GENE; CARDIOMYOPATHY; METASTASIS; INHIBITION; EXPRESSION; MICRORNAS; LNCRNA	Background Long non-coding RNAs (lncRNAs) are a class of RNA molecules with diverse regulatory functions during embryonic development, normal life, and disease in higher organisms. However, research on the role of lncRNAs in cardiovascular diseases and in particular heart failure is still in its infancy. The exceptionally well conserved nuclear lncRNA Metastasis associated in lung adenocarcinoma transcript 1 (Malat-1) is a regulator of mRNA splicing and highly expressed in the heart. Malat-1 modulates hypoxia-induced vessel growth, activates ERK/MAPK signaling, and scavenges the anti-hypertrophic microRNA-133. We therefore hypothesized that Malat-1 may act as regulator of cardiac hypertrophy and failure during cardiac pressure overload induced by thoracic aortic constriction (TAC) in mice. Results Absence of Malat-1 did not affect cardiac hypertrophy upon pressure overload: Heart weight to tibia length ratio significantly increased in WT mice (sham: 5.78 +/- 0.55, TAC 9.79 +/- 1.82 g/mm; p<0.001) but to a similar extend also in Malat-1 knockout (KO) mice (sham: 6.21 +/- 1.12, TAC 8.91 +/- 1.74 g/mm; p<0.01) with no significant difference between genotypes. As expected, TAC significantly reduced left ventricular fractional shortening in WT (sham: 38.81 +/- 6.53%, TAC: 23.14 +/- 11.99%; p<0.01) but to a comparable degree also in KO mice (sham: 37.01 +/- 4.19%, TAC: 25.98 +/- 9.75%; p<0.05). Histological hallmarks of myocardial remodeling, such as cardiomyocyte hypertrophy, increased interstitial fibrosis, reduced capillary density, and immune cell infiltration, did not differ significantly between WT and KO mice after TAC. In line, the absence of Malat-1 did not significantly affect angiotensin II-induced cardiac hypertrophy, dysfunction, and overall remodeling. Above that, pressure overload by TAC significantly induced mRNA levels of the hypertrophy marker genes Nppa, Nppb and Acta1, to a similar extend in both genotypes. Alternative splicing of Ndrg2 after TAC was apparent in WT (isoform ratio; sham: 2.97 +/- 0.26, TAC 1.57 +/- 0.40; p<0.0001) and KO mice (sham: 3.64 +/- 0.37; TAC: 2.24 +/- 0.76; p<0.0001) and interestingly differed between genotypes both at baseline and after pressure overload (p<0.05 each). Conclusion These findings confirm a role for the lncRNA Malat-1 in mRNA splicing. However, no critical role for Malat-1 was found in pressure overload-induced heart failure in mice, despite its reported role in vascularization, ERK/MAPK signaling, and regulation of miR-133.	[Peters, Tim; Hermans-Beijnsberger, Steffie; Heymans, Stephane; Schroen, Blanche] Maastricht Univ, Ctr Heart Failure Res, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands; [Beqqali, Abdelaziz; van Oort, Ralph J.] Univ Amsterdam, Acad Med Ctr, Dept Expt Cardiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bitsch, Nicole; de Windt, Leon J.] Maastricht Univ, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands; [Nakagawa, Shinichi] RIKEN, RNA Biol Lab, Wako, Saitama, Japan; [Prasanth, Kannanganattu V.] Univ Illinois, Dept Cell & Dev Biol, Urbana, IL USA; [Heymans, Stephane] Netherlands Heart Inst ICIN, Utrecht, Netherlands; [Heymans, Stephane] Katholieke Univ Leuven, Dept Cardiovasc Sci, CMVB, Leuven, Belgium	Maastricht University; University of Amsterdam; Maastricht University; RIKEN; University of Illinois System; University of Illinois Urbana-Champaign; KU Leuven	Schroen, B (corresponding author), Maastricht Univ, Ctr Heart Failure Res, Dept Cardiol, CARIM Sch Cardiovasc Dis, NL-6200 MD Maastricht, Netherlands.	B.Schroen@maastrichtuniversity.nl	van Oort, Ralph/C-5713-2011; Beqqali, Abdelaziz/F-8568-2013; Nakagawa, Shinichi/I-4192-2014; de Windt, Leon/AAO-6395-2020	Beqqali, Abdelaziz/0000-0003-1390-5821; Nakagawa, Shinichi/0000-0002-6806-7493; de Windt, Leon/0000-0002-7793-2856; Heymans, Stephane/0000-0001-9477-7803	Dutch Heart Foundation [2009B025, 2012T094]; Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development (ZonMW); Royal Netherlands Academy of Sciences (CVON-ARENA); Netherlands Organization for Scientific Research (NWO) [Vidi 91714363]; European Union Commission [261409]; European Research Council [311549]; Ministry of Education, Science, Sports, and Culture of Japan (MEXT) [26113005]; National Institutes of Health [GM088252]; American Cancer Society [RSG-11-174-01-RMC]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088252] Funding Source: NIH RePORTER	Dutch Heart Foundation(Netherlands Heart Foundation); Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation; Dutch Federation of University Medical Centers; Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Royal Netherlands Academy of Sciences (CVON-ARENA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Union Commission(European Commission); European Research Council(European Research Council (ERC)European Commission); Ministry of Education, Science, Sports, and Culture of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research leading to these results has received funding from the Dutch Heart Foundation (2009B025 to BS and 2012T094 to RJVO, www.hartstichting.nl); the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development (ZonMW) and the Royal Netherlands Academy of Sciences (CVON-ARENA to SH and LJDW and CVON-ARENA young talent grant to AB, www.cvonarena.nl); from the Netherlands Organization for Scientific Research (NWO Vidi 91714363 to BS, www.nwo.nl); from the European Union Commission's Seventh Framework program (261409, ec.europa.eu/research/fp7/index_en.cfm); from the European Research Council (311549 to LJDW, erc.europa.eu); from the Ministry of Education, Science, Sports, and Culture of Japan (MEXT, Grant-in-Aid for Scientific Research on Innovative Areas 26113005 to SN, www.mext.go.jp/english); from the National Institutes of Health (GM088252 to KVP, www.nih.gov); and from the American Cancer Society (RSG-11-174-01-RMC to KVP, www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett AR, 2014, ELIFE, V3, DOI 10.7554/eLife.03058; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castaldi A, 2014, CIRC RES, V115, P273, DOI 10.1161/CIRCRESAHA.115.303252; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Grote P, 2015, TRENDS GENET, V31, P329, DOI 10.1016/j.tig.2015.02.002; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Han XR, 2015, FASEB J, V29, P3054, DOI 10.1096/fj.14-259952; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kong SW, 2010, CIRC-CARDIOVASC GENE, V3, P138, DOI 10.1161/CIRCGENETICS.109.904698; Kurdi M, 2011, HYPERTENSION, V57, P1034, DOI 10.1161/HYPERTENSIONAHA.111.172700; Lee JH, 2011, CIRC RES, V109, P1332, DOI 10.1161/CIRCRESAHA.111.249433; Mattick JS, 2011, FEBS LETT, V585, P1600, DOI 10.1016/j.febslet.2011.05.001; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakagawa S, 2016, BBA-GENE REGUL MECH, V1859, P177, DOI 10.1016/j.bbagrm.2015.06.011; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nelson TJ, 2005, J MOL CELL CARDIOL, V39, P479, DOI 10.1016/j.yjmcc.2005.05.004; Peters T, 2014, PFLUG ARCH EUR J PHY, V466, P1177, DOI 10.1007/s00424-014-1479-1; Puthanveetil P, 2015, J CELL MOL MED, V19, P1418, DOI 10.1111/jcmm.12576; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Watts R, 2013, AM J PHYSIOL-CELL PH, V304, pC995, DOI 10.1152/ajpcell.00392.2012; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; Wu XS, 2014, CANCER BIOL THER, V15, P806, DOI 10.4161/cbt.28584; Wu YH, 2016, TUMOR BIOL, V37, P897, DOI 10.1007/s13277-015-3870-8; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yoon YS, 2005, CIRCULATION, V111, P2073, DOI 10.1161/01.CIR.0000162472.52990.36; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhang MY, 2016, INT J CARDIOL, V203, P214, DOI 10.1016/j.ijcard.2015.10.136; Zhang MY, 2016, INT J CARDIOL, V202, P753, DOI 10.1016/j.ijcard.2015.10.019; Zhang XM, 2001, AM J PHYSIOL-HEART C, V280, pH1782, DOI 10.1152/ajpheart.2001.280.4.H1782	42	36	39	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150236	10.1371/journal.pone.0150236	http://dx.doi.org/10.1371/journal.pone.0150236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919721	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400108
J	Treffel, L; Dmitrieva, L; Gauquelin-Koch, G; Custaud, MA; Blanc, S; Gharib, C; Millet, C				Treffel, Loic; Dmitrieva, Liubov; Gauquelin-Koch, Guillemette; Custaud, Marc-Antoine; Blanc, Stephane; Gharib, Claude; Millet, Catherine			Craniomandibular System and Postural Balance after 3-Day Dry Immersion	PLOS ONE			English	Article							BITE FORCE; MUSCLE TONE; BED REST; MASTICATORY MUSCLES; FOOD CONSISTENCY; MASSETER MUSCLE; LIMB MUSCLE; JAW; COUNTERMEASURE; PRESSURE	The objective of the study was to determine the influence of simulated microgravity by exposure to dry immersion on the craniomandibular system. Twelve healthy male volunteers participated in a 3-day dry immersion study. Before and immediately after exposure we measured maximal bite force using piezoresistive sensors. The mechanical properties of the jaw and cervical muscles were evaluated before, during, and after dry immersion using MyotonPRO. Because recent studies reported the effects of jaw motor activity on the postural stability of humans, stabilometric measurements of center of pressure were performed before and after dry immersion in two mandibular positions: rest position without jaw clenching, and intercuspidal position during voluntary teeth clenching. Results revealed no significant changes of maximal bite force after dry immersion. All postural parameters were significantly altered by dry immersion. There were however no significant differences in stabilometric data according to mandibular position. Moreover the masseter tonicity increased immediately after the end of dry immersion period. Dry immersion could be used as a valid model for studying the effects of microgravity on human subjects. However, 3 days appear insufficient in duration to evaluate the effects of weightlessness on maximal bite force. Our research suggests a link between postural disturbance after dry immersion and masseter tonicity.	[Treffel, Loic; Gharib, Claude; Millet, Catherine] Univ Lyon 1, F-69365 Lyon, France; [Treffel, Loic; Blanc, Stephane] Univ Strasbourg, Ctr Natl Rech Sci, Unite Mixte Rech 7178, Strasbourg, France; [Dmitrieva, Liubov] Moscow Biomed Problems Inst, Moscow, Russia; [Dmitrieva, Liubov; Custaud, Marc-Antoine] Univ Angers, Ctr Natl Rech Sci, Unite Mixte Rech 6214, Inst Natl Sante & Rech Med 1083, Angers, France; [Gauquelin-Koch, Guillemette] Ctr Natl Etud Spatiales, Paris, France; [Custaud, Marc-Antoine] CHU Angers, Ctr Rech Clin, Angers, France; [Gharib, Claude] Ctr Int Osteopathie, St Etienne, France; [Millet, Catherine] Hosp Civils Lyon, Serv Odontol, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Russian Academy of Sciences; Institute of Biomedical Problems of the Russian Academy of Sciences; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Lyon	Millet, C (corresponding author), Univ Lyon 1, F-69365 Lyon, France.; Millet, C (corresponding author), Hosp Civils Lyon, Serv Odontol, Lyon, France.	catherine.millet@univ-lyon1.fr	Amirova, Liubov/V-7924-2017	Amirova, Liubov/0000-0002-9464-6413; Treffel, Loic/0000-0001-7962-1026	Centre National d'Etudes Spatiales [2015 48 0000079]	Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales)	This work was supported by Contract CNES Number 2015 48 0000079, Centre National d'Etudes Spatiales, https://cnes.fr/fr (LT, LD, GGK, MAC, SB, CG and CM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aare S, 2011, PHYSIOL GENOMICS, V43, P1334, DOI 10.1152/physiolgenomics.00116.2011; Aird L, 2012, ARCH GERONTOL GERIAT, V55, pE31, DOI 10.1016/j.archger.2012.03.005; Al-Omiri MK, 2014, J ORAL REHABIL, V41, P624, DOI 10.1111/joor.12174; Alfrey CP, 1996, J APPL PHYSIOL, V81, P98, DOI 10.1152/jappl.1996.81.1.98; Arima T, 2013, J ORAL REHABIL, V40, P900, DOI 10.1111/joor.12097; BAKKE M, 1989, SCAND J DENT RES, V97, P539; Baldini A, 2013, AVIAT SPACE ENVIR MD, V84, P823, DOI 10.3357/ASEM.3541.2013; Bloomberg JJ, 1997, J VESTIBUL RES-EQUIL, V7, P161, DOI 10.1016/S0957-4271(96)00169-3; Boroojerdi B, 2000, CLIN NEUROPHYSIOL, V111, P988, DOI 10.1016/S1388-2457(00)00279-0; Bracco P, 2004, NEUROSCI LETT, V356, P228, DOI 10.1016/j.neulet.2003.11.055; Buisseret-Delmas C, 1999, J COMP NEUROL, V409, P153, DOI 10.1002/(SICI)1096-9861(19990621)409:1<153::AID-CNE11>3.0.CO;2-#; Caiani EG, 2014, J APPL PHYSIOL, V117, P624, DOI 10.1152/japplphysiol.00122.2014; Caron O, 2000, J APPL BIOMECH, V16, P234, DOI 10.1123/jab.16.3.234; Chuang LL, 2012, ARCH PHYS MED REHAB, V93, P532, DOI 10.1016/j.apmr.2011.09.014; Clement G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111107; Cuccia AM, 2011, J BODYW MOV THER, V15, P242, DOI 10.1016/j.jbmt.2010.10.007; Custodio W, 2011, J APPL ORAL SCI, V19, P343, DOI 10.1590/S1678-77572011005000008; Dahlberg G, 1940, STAT METHODS MED BIO; Deriu F, 2010, CLIN NEUROPHYSIOL, V121, P1690, DOI 10.1016/j.clinph.2009.11.093; Diagne M, 2006, J COMP NEUROL, V496, P759, DOI 10.1002/cne.20964; Dietsch AM, 2014, J REHABIL RES DEV, V51, P1127, DOI 10.1682/JRRD.2013.07.0167; Fernandes CP, 2003, DENT MATER, V19, P118, DOI 10.1016/S0109-5641(02)00020-9; Ferrario VF, 2004, J ORAL REHABIL, V31, P18, DOI 10.1046/j.0305-182X.2003.01179.x; Gangloff P, 2002, NEUROSCI LETT, V330, P179, DOI 10.1016/S0304-3940(02)00779-6; Gavronski G, 2007, PHYSIOL MEAS, V28, P625, DOI 10.1088/0967-3334/28/6/002; Giannakopoulos NN, 2013, ARCH ORAL BIOL, V58, P1751, DOI 10.1016/j.archoralbio.2013.09.002; Goto TK, 2001, ANAT RECORD, V262, P293, DOI 10.1002/1097-0185(20010301)262:3<293::AID-AR1043>3.0.CO;2-B; Hellmann D, 2015, HUM MOVEMENT SCI, V43, P125, DOI 10.1016/j.humov.2015.08.009; Hichijo N, 2014, J ORAL REHABIL, V41, P581, DOI 10.1111/joor.12171; HICKENBOTTOM RS, 1985, EXP NEUROL, V89, P442, DOI 10.1016/0014-4886(85)90103-7; Iwase S, 2000, J AUTONOM NERV SYST, V79, P156, DOI 10.1016/S0165-1838(99)00076-4; Kawai N, 2010, J ANAT, V216, P717, DOI 10.1111/j.1469-7580.2010.01235.x; Kozlovskaia I B, 2008, Aviakosm Ekolog Med, V42, P3; Layne CS, 2001, J APPL PHYSIOL, V90, P997, DOI 10.1152/jappl.2001.90.3.997; Lee HM, 2004, J ELECTROMYOGR KINES, V14, P577, DOI 10.1016/j.jelekin.2004.02.002; Linnarsson D, 2015, J APPL PHYSIOL, V118, P29, DOI 10.1152/japplphysiol.00061.2014; Lion A, 2014, INT J NEUROSCI, V124, P558, DOI 10.3109/00207454.2013.864288; MARFURT CF, 1991, J COMP NEUROL, V303, P489, DOI 10.1002/cne.903030313; Marini I, 2015, J ELECTROMYOGR KINES, V25, P531, DOI 10.1016/j.jelekin.2015.02.001; Miura H, 1997, J ORAL REHABIL, V24, P457, DOI 10.1046/j.1365-2842.1997.00530.x; Monemi M, 1999, ACTA PHYSIOL SCAND, V167, P339; Muir J, 2011, GAIT POSTURE, V33, P429, DOI 10.1016/j.gaitpost.2010.12.019; Mulder E, 2014, J MUSCULOSKEL NEURON, V14, P359; Navasiolava NM, 2011, AUTON NEUROSCI-BASIC, V160, P64, DOI 10.1016/j.autneu.2010.10.003; Onambele GL, 2006, J APPL PHYSIOL, V100, P2048, DOI 10.1152/japplphysiol.01442.2005; Pereira LJ, 2006, ACTA ODONTOL SCAND, V64, P193, DOI 10.1080/00016350600703459; Perinetti Giuseppe, 2012, Prog Orthod, V13, P273, DOI 10.1016/j.pio.2011.12.003; Perinetti G, 2011, J ELECTROMYOGR KINES, V21, P877, DOI 10.1016/j.jelekin.2011.05.014; Philippou A, 2015, FASEB J, V29, P2769, DOI 10.1096/fj.14-267336; Ringhof S, 2015, J ORAL REHABIL, V42, P173, DOI 10.1111/joor.12247; Ringhof S, 2015, GAIT POSTURE, V42, P598, DOI 10.1016/j.gaitpost.2015.09.002; SCHNEIDER SM, 2006, ACSMS ADV EXERCISE P; Schneider S, 2015, MED BIOL ENG COMPUT, V53, P57, DOI 10.1007/s11517-014-1211-5; Sforza C, 2006, CRANIO, V24, P43, DOI 10.1179/crn.2006.008; SHULZHENKO EB, 1976, KOSM BIOL AVIAK MED+, V10, P82; Souvestre PA, 2008, HIPPOKRATIA, V12, P41; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Taniguchi H, 2008, J APPL PHYSIOL, V105, P791, DOI 10.1152/japplphysiol.90485.2008; Tolu E, 1993, J Vestib Res, V3, P163; Varga S, 2011, EUR J ORTHODONT, V33, P427, DOI 10.1093/ejo/cjq097; Viguier M, 2009, GAIT POSTURE, V29, P188, DOI 10.1016/j.gaitpost.2008.08.001; Wood SJ, 2015, AEROSP MED HUM PERF, V86, pA45, DOI 10.3357/AMHP.EC07.2015	62	19	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150052	10.1371/journal.pone.0150052	http://dx.doi.org/10.1371/journal.pone.0150052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913867	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700049
J	Agarwal, A; Zhang, W; Kuo, YF; Sharma, G				Agarwal, Amitesh; Zhang, Wei; Kuo, YongFang; Sharma, Gulshan			Process and Outcome Measures among COPD Patients with a Hospitalization Cared for by an Advance Practice Provider or Primary Care Physician	PLOS ONE			English	Article							NURSE-PRACTITIONERS; GENERAL-PRACTITIONERS; ASSISTANTS; READMISSION; COST	Objectives To examine the process and outcomes of care of COPD patients by Advanced Practice Providers (APPs) and primary care physicians. Methods We conducted a cross sectional retrospective cohort study of Medicare beneficiaries with COPD who had at least one hospitalization in 2010. We examined the process measures of receipt of spirometry evaluation, influenza and pneumococcal vaccine, use of COPD medications, and referral to a pulmonary specialist visit. Outcome measures were emergency department (ER) visit, number of hospitalizations and 30-day readmission in 2010. Results A total of 7,257 Medicare beneficiaries with COPD were included. Of these, 1,999 and 5,258 received primary care from APPs and primary care physicians, respectively. Patients in the APP group were more likely to be white, younger, male, residing in non-metropolitan areas and have fewer comorbidities. In terms of process of care measures, APPs were more likely to prescribe short acting bronchodilators (adjusted odds ratio [aOR] = 1.18, 95% Confidence Interval [CI] 1.05-1.32), oxygen therapy (aOR = 1.25, 95% CI 1.12-1.40) and consult a pulmonary specialist (aOR = 1.39, 95% CI 1.23-1.56), but less likely to give influenza and pneumococcal vaccinations. Patients receiving care from APPs had lower rates of ER visits for COPD (aOR = 0.84, 95% CI 0.71-0.98) and had a higher follow-up rate with pulmonary specialist within 30 days of hospitalization for COPD (aOR = 1.25, 95% CI 1.07-1.48) than those cared for by physicians. Conclusions Compared to patients cared for by physicians, patients cared for by APPs were more likely to receive short acting bronchodilator, oxygen therapy and been referred to pulmonologist, however they had lower rates of vaccination probably due to lower age group. Patients cared for by APPs were less like to visit an ER for COPD compared to patients care for by physicians, conversely there was no differences in hospitalization or readmission for COPD between MDs and APPs.	[Agarwal, Amitesh; Zhang, Wei; Sharma, Gulshan] Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA; [Kuo, YongFang] Univ Texas Med Branch, Off Biostat, Galveston, TX 77555 USA; [Kuo, YongFang; Sharma, Gulshan] Univ Texas Med Branch, Sealy Ctr Aging, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Agarwal, A (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Galveston, TX 77555 USA.	anagarwa@utmb.edu	Sharma, Gulshan/AAC-5804-2019		Agency for Healthcare Research and Quality [R01-HS020642, R24-HS022134]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS020642, R24HS022134] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This work was supported by the Agency for Healthcare Research and Quality R01-HS020642 and R24-HS022134.	Chen PGC, 2014, MED CARE, V52, P95, DOI 10.1097/MLR.0000000000000046; Costa DK, 2014, CHEST, V146, P1566, DOI 10.1378/chest.14-0566; DesRoches CM, 2013, NURS OUTLOOK, V61, P400, DOI 10.1016/j.outlook.2013.05.005; Dierick-van Daele ATM, 2009, J ADV NURS, V65, P391, DOI 10.1111/j.1365-2648.2008.04888.x; Everett C, 2013, HEALTH AFFAIR, V32, P1942, DOI 10.1377/hlthaff.2013.0506; Fairman JA, 2011, NEW ENGL J MED, V364, P193, DOI 10.1056/NEJMp1012121; Fordyce MA., 2007, 2005 PHYS SUPPLY DIS; Gavish R, 2015, CHEST, V148, P375, DOI 10.1378/chest.14-1453; Hollinghurst S, 2006, BRIT J GEN PRACT, V56, P530; Hooker RS, 2012, HEALTH SOC CARE COMM, V20, P20, DOI 10.1111/j.1365-2524.2011.01021.x; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Huang ES, 2013, HEALTH AFFAIR, V32, P614, DOI 10.1377/hlthaff.2012.0913; Hughes DR, 2015, JAMA INTERN MED, V175, P101, DOI 10.1001/jamainternmed.2014.6349; Iglehart JK, 2013, NEW ENGL J MED, V368, P1935, DOI 10.1056/NEJMhpr1301084; Jennings JH, 2014, CHEST J; Kuo YF, 2013, HEALTH AFFAIR, V32, P1236, DOI 10.1377/hlthaff.2013.0072; Laurant M, 1996, COCHRANE DATABASE OF; Lenz ER, 2002, DIABETES EDUCATOR, V28, P590, DOI 10.1177/014572170202800413; Litaker David, 2003, J Interprof Care, V17, P223, DOI 10.1080/1356182031000122852; Martinez-Gonzalez NA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-214; Mittman DE, 2002, BMJ-BRIT MED J, V325, P485, DOI 10.1136/bmj.325.7362.485; Mundinger MO, 2000, JAMA-J AM MED ASSOC, V283, P59, DOI 10.1001/jama.283.1.59; Newhouse R. P., 2011, NURSING EC, V29, P230; Petterson SM, 2012, ANN FAM MED, V10, P503, DOI 10.1370/afm.1431; Phillips RL, 2014, MED CARE, V52, P97, DOI 10.1097/MLR.0000000000000047; Prieto-Centurion Valentin, 2014, Ann Am Thorac Soc, V11, P417, DOI 10.1513/AnnalsATS.201308-254OC; Sharma G, 2010, ARCH INTERN MED, V170, P1664, DOI 10.1001/archinternmed.2010.345; Venning P, 2000, BMJ-BRIT MED J, V320, P1048, DOI 10.1136/bmj.320.7241.1048	28	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148522	10.1371/journal.pone.0148522	http://dx.doi.org/10.1371/journal.pone.0148522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910566	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700008
J	Brown, TG; Ouimet, MC; Eldeb, M; Tremblay, J; Vingilis, E; Nadeau, L; Pruessner, J; Bechara, A				Brown, Thomas G.; Ouimet, Marie Claude; Eldeb, Manal; Tremblay, Jacques; Vingilis, Evelyn; Nadeau, Louise; Pruessner, Jens; Bechara, Antoine			Personality, Executive Control, and Neurobiological Characteristics Associated with Different Forms of Risky Driving	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; DECISION-MAKING; ALCOHOL-CONSUMPTION; EMOTIONAL MATERIAL; SALIVARY CORTISOL; DWI INTERVENTION; BEHAVIOR; DUI; DRIVERS; INVOLVEMENT	Background Road crashes represent a huge burden on global health. Some drivers are prone to repeated episodes of risky driving (RD) and are over-represented in crashes and related morbidity. However, their characteristics are heterogeneous, hampering development of targeted intervention strategies. This study hypothesized that distinct personality, cognitive, and neurobiological processes are associated with the type of RD behaviours these drivers predominantly engage in. Methods Four age-matched groups of adult (19-39 years) males were recruited: 1) driving while impaired recidivists (DWI, n = 36); 2) non-alcohol reckless drivers (SPEED, n = 28); 3) drivers with a mixed RD profile (MIXED, n = 27); and 4) low-risk control drivers (CTL, n = 47). Their sociodemographic, criminal history, driving behaviour (by questionnaire and simulation performance), personality (Big Five traits, impulsivity, reward sensitivity), cognitive (disinhibition, decision making, behavioural risk taking), and neurobiological (cortisol stress response) characteristics were gathered and contrasted. Results Compared to controls, group SPEED showed greater sensation seeking, disinhibition, disadvantageous decision making, and risk taking. Group MIXED exhibited more substance misuse, and antisocial, sensation seeking and reward sensitive personality features. Group DWI showed greater disinhibition and more severe alcohol misuse, and compared to the other RD groups, the lowest level of risk taking when sober. All RD groups exhibited less cortisol increase in response to stress compared to controls. Discussion Each RD group exhibited a distinct personality and cognitive profile, which was consistent with stimulation seeking in group SPEED, fearlessness in group MIXED, and poor behavioural regulation associated with alcohol in group DWI. As these group differences were uniformly accompanied by blunted cortisol stress responses, they may reflect the disparate behavioural consequences of dysregulation of the stress system. In sum, RD preference appears to be a useful marker for clarifying explanatory pathways to risky driving, and for research into developing more personalized prevention efforts.	[Brown, Thomas G.; Eldeb, Manal; Tremblay, Jacques; Pruessner, Jens] Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada; [Brown, Thomas G.; Eldeb, Manal; Tremblay, Jacques; Pruessner, Jens] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Brown, Thomas G.] Foster Addict Rehabil Ctr, St Philippe De Laprairie, PQ, Canada; [Ouimet, Marie Claude] Univ Sherbrooke, Fac Med & Hlth Sci, Longueuil, PQ, Canada; [Vingilis, Evelyn] Univ Western Ontario, Dept Family Med, London, ON, Canada; [Vingilis, Evelyn] Univ Western Ontario, Epidemiol & Biostat, London, ON, Canada; [Nadeau, Louise] Univ Montreal, Dept Psychol, CP 6128, Montreal, PQ H3C 3J7, Canada; [Bechara, Antoine] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA	McGill University; University of Sherbrooke; Western University (University of Western Ontario); Western University (University of Western Ontario); Universite de Montreal; University of Southern California	Brown, TG (corresponding author), Douglas Mental Hlth Univ Inst, Res Ctr, Montreal, PQ, Canada.; Brown, TG (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Brown, TG (corresponding author), Foster Addict Rehabil Ctr, St Philippe De Laprairie, PQ, Canada.	thomas.brown@mcgill.ca		Bechara, Antoine/0000-0001-5127-2549; Pruessner, Jens/0000-0002-8582-2980	Programme de recherche en securite routiere-Fonds de recherche du Quebec, Societe de l'assurance automobile du Quebec [2012-OU-144855]; Canadian Institutes of Health Research [SAF 94813]; Fonds de recherche du QuebecSante (Bourse de carriere)	Programme de recherche en securite routiere-Fonds de recherche du Quebec, Societe de l'assurance automobile du Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du QuebecSante (Bourse de carriere)	Support was provided by Programme de recherche en securite routiere (2012-OU-144855)-Fonds de recherche du Quebec, Societe de l'assurance automobile du Quebec (to TGB); Canadian Institutes of Health Research (SAF 94813) (to TGB, MCO, LN); Fonds de recherche du QuebecSante (Bourse de carriere; Career Award) (to MCO).	Aharoni E, 2013, P NATL ACAD SCI USA, V110, P6223, DOI 10.1073/pnas.1219302110; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; Bechara Antoine, 2003, J Gambl Stud, V19, P23, DOI 10.1023/A:1021223113233; Beirness DJ, 2002, RISKY DRIVING ROAD S; Beitel G A, 2000, Inj Prev, V6, P158, DOI 10.1136/ip.6.2.158; Blows S, 2005, ACCIDENT ANAL PREV, V37, P619, DOI 10.1016/j.aap.2005.03.003; Bouchard SM, 2012, ACCIDENT ANAL PREV, V45, P580, DOI 10.1016/j.aap.2011.09.012; Brown T. G., 2012, ALCOHOL RELATED VIOL, P303, DOI [10.1002/9781118411094.ch15, DOI 10.1002/9781118411094.CH15]; Brown TG, 2005, ALCOHOL ALCOHOLISM, V40, P474, DOI 10.1093/alcalc/agh165; Brown TG, 1999, J PSYCHOACTIVE DRUGS, V31, P445, DOI 10.1080/02791072.1999.10471775; Brown TG, 2010, ALCOHOL CLIN EXP RES, V34, P292, DOI 10.1111/j.1530-0277.2009.01092.x; Buchanan TW, 2001, PSYCHONEUROENDOCRINO, V26, P307, DOI 10.1016/S0306-4530(00)00058-5; Burian SE, 2002, HUM PSYCHOPHARM CLIN, V17, P141, DOI 10.1002/hup.384; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P158, DOI 10.1002/hbm.10032; Chein J, 2011, DEVELOPMENTAL SCI, V14, pF1, DOI 10.1111/j.1467-7687.2010.01035.x; Christophersen AS, 2002, DRUG ALCOHOL DEPEN, V66, P85, DOI 10.1016/S0376-8716(01)00187-9; Cima M, 2008, BIOL PSYCHOL, V78, P75, DOI 10.1016/j.biopsycho.2007.12.011; Conley TB, 2001, J SUBST ABUSE TREAT, V20, P287, DOI 10.1016/S0740-5472(01)00159-3; Costa JPT, 2001, ASSESSMENT THERAPY, P235; Couture S, 2008, ACCIDENT ANAL PREV, V40, P246, DOI 10.1016/j.aap.2007.06.003; Couture S, 2015, SUBST ABUS-RES TREAT, V9, P25, DOI 10.4137/SART.S21353; Daeppen JB, 1996, J STUD ALCOHOL, V57, P585, DOI 10.15288/jsa.1996.57.585; Dugosh KL, 2013, CRIMINOL PUBLIC POL, V12, P181, DOI 10.1111/1745-9133.12020; Elonheimo H, 2014, J ADOLESCENCE, V37, P1269, DOI 10.1016/j.adolescence.2014.09.005; Farah H, 2008, TRANSPORT RES F-TRAF, V11, P313, DOI 10.1016/j.trf.2008.01.005; Fernandes R, 2007, J SAFETY RES, V38, P59, DOI 10.1016/j.jsr.2006.09.003; Fernandes R, 2010, TRANSPORT RES F-TRAF, V13, P179, DOI 10.1016/j.trf.2010.04.007; Flowers NT, 2008, ALCOHOL CLIN EXP RES, V32, P639, DOI 10.1111/j.1530-0277.2008.00622.x; Gansler DA, 2011, J CLIN EXP NEUROPSYC, V33, P1040, DOI 10.1080/13803395.2011.596820; Gianoulakis C, 2003, ALCOHOL CLIN EXP RES, V27, P410, DOI 10.1097/01.ALC.0000056614.96137.B8; Glenn AL, 2009, HDB NEUROPSYCHIATRIC, VIII; Golias I., 2001, TRANSP RES F, V4, P243, DOI [10.1016/S1369-8478(01)00026-2, DOI 10.1016/S1369-8478(01)00026-2]; Goodman A, 2008, BIOCHEM PHARMACOL, V75, P266, DOI 10.1016/j.bcp.2007.07.030; GRAY JA, 1987, J RES PERS, V21, P493, DOI 10.1016/0092-6566(87)90036-5; Hawes DJ, 2009, CURR OPIN PSYCHIATR, V22, P357, DOI 10.1097/YCO.0b013e32832bfa6d; Health Canada, 2004, BEST PRACT TREATM RE; Helland A, 2013, ACCIDENT ANAL PREV, V53, P9, DOI 10.1016/j.aap.2012.12.042; Hoeppner BB, 2010, ADDICT BEHAV, V35, P1138, DOI 10.1016/j.addbeh.2010.08.013; Homack Susan, 2006, J Atten Disord, V9, P556, DOI 10.1177/1087054705283578; Horikawa E, 2005, BRAIN COGNITION, V58, P166, DOI 10.1016/j.bandc.2004.10.002; Hutchison KE, 2008, ALCOHOL CLIN EXP RES, V32, P1111, DOI 10.1111/j.1530-0277.2008.00691.x; Iversen H, 2002, PERS INDIV DIFFER, V33, P1251, DOI 10.1016/S0191-8869(02)00010-7; Jessor R., 1987, ALCOHOL DRUGS DRIVIN, V3, P1, DOI DOI 10.1111/J.1360-0443.1987.TB01490.X; Jongen EMM, 2011, PROCD SOC BEHV, V20, DOI 10.1016/j.sbspro.2011.08.067; Junghanns K, 2005, ALCOHOL ALCOHOLISM, V40, P80, DOI 10.1093/alcalc/agh107; Kandasamy N, 2014, P NATL ACAD SCI USA, V111, P3608, DOI 10.1073/pnas.1317908111; Kasar M, 2010, ALCOHOL CLIN EXP RES, V34, P2162, DOI 10.1111/j.1530-0277.2010.01313.x; LaBrie RA, 2007, BEHAV SCI LAW, V25, P603, DOI 10.1002/bsl.769; Lajunen T, 2004, ACCIDENT ANAL PREV, V36, P231, DOI 10.1016/S0001-4575(02)00152-5; Langton L., 2011, POLICE BEHAV TRAFFIC; Lev D, 2008, ACCIDENT ANAL PREV, V40, P223, DOI 10.1016/j.aap.2007.05.009; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lovallo WR, 2013, INT J PSYCHOPHYSIOL, V90, P8, DOI 10.1016/j.ijpsycho.2012.10.006; Lovallo William R., 2007, P227, DOI 10.1016/B978-012370632-4/50014-0; Lovallo WR, 2000, ALCOHOL CLIN EXP RES, V24, P651, DOI 10.1097/00000374-200005000-00009; Marengo D, 2012, TRANSPORT RES F-TRAF, V15, P480, DOI 10.1016/j.trf.2012.04.001; Maxwell JC, 2012, DRUG ALCOHOL DEPEN, V121, P68, DOI 10.1016/j.drugalcdep.2011.08.009; McCrae RR, 2004, PERS INDIV DIFFER, V36, P587, DOI 10.1016/S0191-8869(03)00118-1; Miller MA, 2014, J STUD ALCOHOL DRUGS, V75, P1018, DOI 10.15288/jsad.2014.75.1018; Moan IS, 2013, J STUD ALCOHOL DRUGS, V74, P114, DOI 10.15288/jsad.2013.74.114; [NHTSA USDOT], 2013, TRAFF SAF FACTS 2011; Nochajski TH, 2006, CLIN PSYCHOL REV, V26, P179, DOI 10.1016/j.cpr.2005.11.006; O'Brien F, 2013, ACCIDENT ANAL PREV, V51, P238, DOI 10.1016/j.aap.2012.11.024; O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703; Ouimet MC, 2007, ACCIDENT ANAL PREV, V39, P743, DOI 10.1016/j.aap.2006.11.005; Ouimet MC, 2014, JAMA PEDIATR, V168, P517, DOI 10.1001/jamapediatrics.2013.5387; Ouimet MC, 2013, ALCOHOL CLIN EXP RES, V37, P1979, DOI 10.1111/acer.12180; Ouimet MC, 2010, HDB DRIVING SIMULATI; Palk G, 2011, TRANSPORT RES F-TRAF, V14, P147, DOI 10.1016/j.trf.2010.11.004; Panayiotou G, 2015, ACCIDENT ANAL PREV, V79, P117, DOI 10.1016/j.aap.2015.03.007; Paris JJ, 2010, HORM BEHAV, V57, P35, DOI 10.1016/j.yhbeh.2009.06.003; Peden M., 2004, WORLD REPORT ROAD TR; Petridou E, 2000, EUR J EPIDEMIOL, V16, P819, DOI 10.1023/A:1007649804201; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Pruessner JC, 2003, PSYCHONEUROENDOCRINO, V28, P916, DOI 10.1016/S0306-4530(02)00108-7; RAJALIN S, 1994, ACCIDENT ANAL PREV, V26, P555, DOI 10.1016/0001-4575(94)90017-5; REASON J, 1990, ERGONOMICS, V33, P1315, DOI 10.1080/00140139008925335; Rider Raamses, 2007, Traffic Inj Prev, V8, P147, DOI 10.1080/15389580601111586; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Rosal MC, 2000, PREV MED, V31, P140, DOI 10.1006/pmed.2000.0678; Schumacher JE, 2007, J CONSULT CLIN PSYCH, V75, P823, DOI 10.1037/0022-006X.75.5.823; Schwebel DC, 2007, J SAFETY RES, V38, P501, DOI 10.1016/j.jsr.2007.04.005; Schwebel DC, 2006, ACCIDENT ANAL PREV, V38, P801, DOI 10.1016/j.aap.2006.02.004; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Spiers HJ, 2007, NEUROIMAGE, V36, P245, DOI 10.1016/j.neuroimage.2007.02.032; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Torres P, 2014, J SAFETY RES, V48, P95, DOI 10.1016/j.jsr.2013.12.005; Turner C, 2004, ACCIDENT ANAL PREV, V36, P383, DOI 10.1016/S0001-4575(03)00031-9; Uchiyama Y, 2003, NEUROSCI LETT, V352, P199, DOI 10.1016/j.neulet.2003.08.072; Ulleberg P, 2003, SAFETY SCI, V41, P427, DOI 10.1016/S0925-7535(01)00077-7; Ulleberg P., 2001, TRANSP RES F, V4, P279, DOI [10.1016/S1369-8478(01)00029-8, DOI 10.1016/S1369-8478(01)00029-8]; van der Gronde T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110672; Verschuur WLG, 2008, ACCIDENT ANAL PREV, V40, P644, DOI 10.1016/j.aap.2007.09.001; Vezina L., 2001, CONDUCTEURS HAUT RIS; Weafer J, 2016, J STUD ALCOHOL DRUGS, V77, P86; Whiteside SP, 2001, PERS INDIV DIFFER, V30, P669, DOI 10.1016/S0191-8869(00)00064-7; Wilson LC, 2012, J CONTEMP CRIM JUST, V28, P366, DOI 10.1177/1043986212450232; Woodall WG, 2007, ALCOHOL CLIN EXP RES, V31, P974, DOI 10.1111/j.1530-0277.2007.00380.x; World Health Organization, 2013, GLOB STAT REP ROAD S; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Zuckerman M., 1994, BEHAV EXPRESSIONS BI	103	50	51	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150227	10.1371/journal.pone.0150227	http://dx.doi.org/10.1371/journal.pone.0150227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910345	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700073
J	Yang, N; Friedl, A				Yang, Ning; Friedl, Andreas			Syndecan-1-Induced ECM Fiber Alignment Requires Integrin alpha v beta 3 and Syndecan-1 Ectodomain and Heparan Sulfate Chains	PLOS ONE			English	Article							CELL-SURFACE PROTEOGLYCAN; EXTRACELLULAR-MATRIX; BREAST-CARCINOMA; FIBRONECTIN RECEPTOR; ACTIN-FILAMENTS; BINDING-SITE; SYNERGY SITE; EXPRESSION; COLLAGEN; DOMAIN	Expression of the cell surface proteoglycan syndecan-1 (Sdc1) is frequently induced in stromal fibroblasts of invasive breast carcinomas. We have recently identified a correlation between stromal Sdc1 expression and extracellular matrix (ECM) fiber alignment, both in vitro and in vivo. ECMs derived from Sdc1-positive human mammary fibroblasts (HMF) showed an aligned fiber architecture, which contrasted markedly with the more random fiber arrangement in the ECM produced by Sdc1-negative HMFs. We further demonstrated that aligned fiber architecture promotes the directional migration and invasion of breast carcinoma cells. To decipher the molecular mechanisms governing the formation of an aligned, invasion-permissive ECM, a series of Sdc1 mutants was introduced into HMF. We found that both the ectodomain and heparan sulfate chains of Sdc1 were required for full activity of Sdc1 in regulating ECM alignment, while transmembrane and cytoplasmic domains were dispensable. Sdc1 regulates the activities of several integrins via its ectodomain. Integrins are key players in the assembly of fibronectin-rich ECM. In addition, integrins are capable of regulating cell morphology and cell shape and orientation may affect ECM architecture. Therefore, we investigated the role of integrins in Sdc1-mediated ECM fiber alignment. Sdc1-overexpressing HMF gained an enhanced spindle-shaped morphology when cultured in an overconfluent state under conditions permissive for ECM production, which was partially reversed by siRNA-mediated silencing of beta 3 integrin expression. Moreover, suppression of alpha v beta 3 integrin activity by a function-blocking antibody or beta 3 knockdown largely abolished the aligned ECM fiber architecture and consequently the invasion-permissive properties of the ECM induced by Sdc1. The results suggest that Sdc1 may modulate fibronectin fibrillogenesis and/or alter cell morphology during ECM production through alpha v beta 3 integrin, thereby mediating ECM fiber alignment. Understanding the mechanisms governing ECM organization may lead to the development of novel stroma-targeted therapy for breast cancer, aiming at converting an invasion-permissive to an invasion-restrictive microenvironment.	[Yang, Ning; Friedl, Andreas] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Friedl, Andreas] William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA; [Friedl, Andreas] UW Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System	Friedl, A (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA.; Friedl, A (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Pathol & Lab Med Serv, Dept Vet Affairs Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.; Friedl, A (corresponding author), UW Carbone Canc Ctr, Madison, WI USA.	afriedl@wisc.edu			National Cancer Institute [R01 CA107012-06]; NIH/NCI [R01 CA107012]; NATIONAL CANCER INSTITUTE [R01CA107012, P30CA014520] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute, R01 CA107012-06 (http://www.cancer.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH/NCI grant R01 CA107012. The authors are grateful to other members of the Friedl lab, especially Kristy Key Meyer, for help with experiments. The authors also thank the University of Wisconsin Carbone Cancer Center (P30 CA014520 40) for use of its facilities and Flow Cytometry Laboratory. The contents do not represent the views of the Dept. of Veterans Affairs or the United States Government.	Altemeier WA, 2012, J BIOL CHEM, V287, P34927, DOI 10.1074/jbc.M112.376814; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Anttonen A, 1999, BRIT J CANCER, V79, P558, DOI 10.1038/sj.bjc.6690088; AOTA S, 1994, J BIOL CHEM, V269, P24756; Baba F, 2006, BREAST CANCER RES TR, V98, P91, DOI 10.1007/s10549-005-9135-2; Barbareschi M, 2003, CANCER-AM CANCER SOC, V98, P474, DOI 10.1002/cncr.11515; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Beacham DA, 2005, SEMIN CANCER BIOL, V15, P329, DOI 10.1016/j.semcancer.2005.05.003; Beauvais DM, 2010, J CELL SCI, V123, P3796, DOI 10.1242/jcs.067645; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Beauvais DM, 2003, EXP CELL RES, V286, P219, DOI 10.1016/S0014-4827(03)00126-5; BERNFIELD M, 1990, PHILOS T R SOC B, V327, P171, DOI 10.1098/rstb.1990.0052; Bloom L, 1999, MOL BIOL CELL, V10, P1521, DOI 10.1091/mbc.10.5.1521; BOWDITCH RD, 1994, J BIOL CHEM, V269, P10856; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Choi Y, 2011, MATRIX BIOL, V30, P93, DOI 10.1016/j.matbio.2010.10.006; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Cukierman E, 2002, CURR OPIN CELL BIOL, V14, P633, DOI 10.1016/S0955-0674(02)00364-2; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612; Dumont N, 2013, NEOPLASIA, V15, P249, DOI 10.1593/neo.121950; FOGERTY FJ, 1990, CELL DIFFER DEV, V32, P439, DOI 10.1016/0922-3371(90)90061-Z; Friman T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034082; Gotte M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1641; Goetz JG, 2011, CELL, V146, P148, DOI 10.1016/j.cell.2011.05.040; Hashimoto Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-185; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kauppila S, 1998, J PATHOL, V186, P262, DOI 10.1002/(SICI)1096-9896(1998110)186:3<262::AID-PATH191>3.0.CO;2-3; Khatau SB, 2009, P NATL ACAD SCI USA, V106, P19017, DOI 10.1073/pnas.0908686106; Klass CM, 2000, J CELL SCI, V113, P493; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kusano Y, 2004, J BIOCHEM, V135, P129, DOI 10.1093/jb/mvh015; Langford JK, 1998, J BIOL CHEM, V273, P29965, DOI 10.1074/jbc.273.45.29965; Lebakken CS, 1996, J CELL BIOL, V132, P1209, DOI 10.1083/jcb.132.6.1209; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; LEPPA S, 1992, P NATL ACAD SCI USA, V89, P932, DOI 10.1073/pnas.89.3.932; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lim HC, 2014, BBA-GEN SUBJECTS, V1840, P2482, DOI 10.1016/j.bbagen.2014.01.018; Locker J, 2011, AM J PATHOL, V178, P966, DOI 10.1016/j.ajpath.2010.12.013; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Maeda T, 2004, CANCER RES, V64, P612, DOI 10.1158/0008-5472.CAN-03-2439; Maller O, 2013, J CELL SCI, V126, P4108, DOI 10.1242/jcs.121590; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Mao Y, 2006, CELL COMMUN ADHES, V13, P267, DOI 10.1080/15419060601072215; McQuade KJ, 2003, J BIOL CHEM, V278, P46607, DOI 10.1074/jbc.M304775200; McQuade KJ, 2006, J CELL SCI, V119, P2445, DOI 10.1242/jcs.02970; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Parekh A, 2009, CELL ADHES MIGR, V3, P288, DOI 10.4161/cam.3.3.8888; Paszek MJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000604; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Rapraeger AC, 2013, FEBS J, V280, P2207, DOI 10.1111/febs.12160; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Stanley MJ, 1999, AM J CLIN PATHOL, V112, P377; Stepp MA, 2010, MOL CARCINOGEN, V49, P363, DOI 10.1002/mc.20609; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; VAINIO S, 1989, DEV BIOL, V134, P382, DOI 10.1016/0012-1606(89)90110-3; VAINIO S, 1992, DEV BIOL, V152, P221, DOI 10.1016/0012-1606(92)90130-9; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Vomund AN, 2008, BIOCHEMISTRY-US, V47, P11616, DOI 10.1021/bi8015108; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; WU CY, 1993, J BIOL CHEM, V268, P21883; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yang JT, 1996, MOL BIOL CELL, V7, P1737, DOI 10.1091/mbc.7.11.1737; Yang N, 2011, AM J PATHOL, V178, P325, DOI 10.1016/j.ajpath.2010.11.039	81	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150132	10.1371/journal.pone.0150132	http://dx.doi.org/10.1371/journal.pone.0150132			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909794	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700069
J	Bejugam, PR; Singh, S				Bejugam, Pruthvi Raj; Singh, Shailza			Computing Molecular Devices in L.major through Transcriptome Analysis: Structured Simulation Approach	PLOS ONE			English	Article							NUCLEIC-ACIDS; FORCE-FIELD; RNA	In the modern era of post genomics and transcriptomics, non-coding RNAs and non-coding regions of many RNAs are a big puzzle when we try deciphering their role in specific gene function. Gene function assessment is a main task wherein high throughput technologies provide an impressive body of data that enables the design of hypotheses linking genes to phenotypes. Gene knockdown technologies and RNA-dependent gene silencing are the most frequent approaches to assess the role of key effectors in a particular scenario. Ribozymes are effective modulators of gene expression because of their simple structure, site-specific cleavage activity, and catalytic potential. In our study, after an extensive transcriptomic search of Leishmania major transcriptome we found a Putative ATP dependent DNA helicase (Lmjf_09_0590) 3' UTR which has a structural signature similar to well-known HDV hammerhead ribozyme, even though they have variable sequence motifs. Henceforth, to determine their structural stability and sustainability we analyzed our predicted structural model of this 3' UTR with a 30ns MD simulation, further confirmed with 100ns MD simulation in presence of 5mM MgCl2 ionic environment. In this environment, structural stability was significantly improved by bonded interactions between a RNA backbone and Mg2+ ions. These predictions were further validated in silico using RNA normal mode analysis and anisotropic network modelling (ANM) studies. The study may be significantly imparted to know the functional importance of many such 3'UTRs to predict their role in a mechanistic manner.	[Bejugam, Pruthvi Raj; Singh, Shailza] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Singh, S (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	shailza_iitd@yahoo.com	Bejugam, Pruthvi raj/AAU-1244-2020	Bejugam, Pruthvi raj/0000-0002-0802-9153	University Grants Commission (UGC); Department of Biotechnology, Ministry of Science and Technology, Government of India; University Grants Commission (UGC), Government of India	University Grants Commission (UGC)(University Grants Commission, India); Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India); University Grants Commission (UGC), Government of India(University Grants Commission, India)	Pruthvi Raj Bejugam has acknowledged University Grants Commission (UGC) for the fellowship. The funders have no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Department of Biotechnology, Ministry of Science and Technology, Government of India for support. Pruthvi Raj Bejugam acknowledges University Grants Commission (UGC), Government of India, for the fellowship. The authors would also like to thank the Director, National Centre for Cell Science (NCCS) for supporting the Bioinformatics and High Performance Computing Facility (BHPCF) at NCCS, Pune, India.	Arumugam K, 2010, EMBO J, V29, P387, DOI 10.1038/emboj.2009.337; Atsushi Narita, 2005, NUCELIC ACIDS SYM, P271; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Charlesworth A, 2002, EMBO J, V21, P2798, DOI 10.1093/emboj/21.11.2798; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Dumas C, 2006, EUKARYOT CELL, V5, P2033, DOI 10.1128/EC.00147-06; Echols N, 2012, J APPL CRYSTALLOGR, V45, P581, DOI 10.1107/S0021889812017293; Farrow AL, 2011, MOL CELL BIOCHEM, V350, P47, DOI 10.1007/s11010-010-0681-5; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta SK, 2013, J BIOL CHEM, V288, P4991, DOI 10.1074/jbc.M112.416578; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Klauser B, 2013, NUCLEIC ACIDS RES, V41, P5542, DOI 10.1093/nar/gkt253; Krasovska MV, 2006, BIOPHYS J, V91, P626, DOI 10.1529/biophysj.105.079368; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Matsumoto A, 1999, DYNAMICAL STRUCTURE, P369; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Padilla-Mejia NE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-232; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Rana T, 2011, J BIOL CHEM, V286, P6614, DOI 10.1074/jbc.M110.181735; Veeraraghavan N, 2011, J PHYS CHEM B, V115, P8346, DOI 10.1021/jp203202e; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Westrop GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136891; Zacharias M, 2000, BIOPHYS J, V78, P2528, DOI 10.1016/S0006-3495(00)76798-1; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148909	10.1371/journal.pone.0148909	http://dx.doi.org/10.1371/journal.pone.0148909			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901858	Green Submitted, gold, Green Published			2022-12-27	WOS:000371276100029
J	Harris, DP; Chandrasekharan, UM; Bandyopadhyay, S; Willard, B; DiCorleto, PE				Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.			PRMT5-Mediated Methylation of NF-kappa B p65 at Arg(174) Is Required for Endothelial CXCL11 Gene Induction in Response to TNF-alpha and IFN-gamma Costimulation	PLOS ONE			English	Article							ARGININE METHYLTRANSFERASE 5; INDUCIBLE T-CELL; POSTTRANSLATIONAL MODIFICATION CODES; SMOOTH-MUSCLE-CELLS; I-TAC; CRYSTAL-STRUCTURE; SM PROTEINS; PRMT5; CXCR3; ATHEROSCLEROSIS	Inflammatory agonists differentially activate gene expression of the chemokine family of proteins in endothelial cells (EC). TNF is a weak inducer of the chemokine CXCL11, while TNF and IFN-gamma costimulation results in potent CXCL11 induction. The molecular mechanisms underlying TNF plus IFN-gamma-mediated CXCL11 induction are not fully understood. We have previously reported that the protein arginine methyltransferase PRMT5 catalyzes symmetrical dimethylation of the NF-kappa B subunit p65 in EC at multiple arginine residues. Methylation of Arg(30) and ArWg(35) on p65 is critical for TNF induction of CXCL10 in EC. Here we show that PRMT5-mediated methylation of p65 at Arg(174) is required for induction of CXCL11 when EC are costimulated with TNF and IFN-gamma. Knockdown of PRMT5 by RNAi reduced CXCL11 mRNA and protein levels in costimulated cells. Reconstitution of p65 Arg(174)Ala or Arg(174)Lys mutants into EC that were depleted of endogenous p65 blunted TNF plus IFN-gamma mediated CXCL11 induction. Mass spectrometric analyses showed that p65 Arg(174) arginine methylation is enhanced by TNF plus IFN-gamma costimulation, and is catalyzed by PRMT5. Chromatin immunoprecipitation assays (ChIP) demonstrated that PRMT5 is necessary for p65 association with the CXCL11 promoter in response to TNF plus IFN-gamma. Further, reconstitution of p65 Arg(174)Lys mutant in EC abrogated this p65 association with the CXCL11 promoter. Finally, ChIP and Re-ChIP assays revealed that symmetrical dimethylarginine-containing proteins complexed with the CXCL11 promoter were diminished in p65 Arg(174)Lys-reconstituted EC stimulated with TNF and IFN-gamma. In total, these results indicate that PRMT5-mediated p65 methylation at Arg(174) is essential for TNF plus IFN-gamma-mediated CXCL11 gene induction. We therefore suggest that the use of recently developed small molecule inhibitors of PRMT5 may present a therapeutic approach to moderating chronic inflammatory pathologies.	[Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [Harris, Daniel P.; Chandrasekharan, Unnikrishnan M.; Bandyopadhyay, Smarajit; Willard, Belinda; DiCorleto, Paul E.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Harris, Daniel P.; DiCorleto, Paul E.] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University	DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA.; DiCorleto, PE (corresponding author), Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA.; DiCorleto, PE (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	dicorlp@ccf.org			National Heart, Lung, and Blood Institute (NHLBI) [P01-HL29582]; Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Advancing Translational Sciences (NCATS) [UL1TR000439]; National Center for Research Resources (NCRR) [1S10RR031537-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031537] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL029582] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Case Western Reserve University/Cleveland Clinic CTSA Grant from the National Center for Advancing Translational Sciences (NCATS); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Heart, Lung, and Blood Institute (NHLBI, http://www.nhlbi.nih.gov/) grant P01-HL29582 (to P.E.D.). Support for the collection of HUVEC was made possible by the Case Western Reserve University/Cleveland Clinic CTSA Grant UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS, https://ncats.nih.gov/). The Orbitrap Elite instrument was purchased with a National Center for Research Resources (NCRR, http://www.nih.gov/about/almanac/organization/NCRR.htm) shared instrument grant (1S10RR031537-01). NHLBI, NCATS, and NCRR are components of the United States National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alinari L, 2015, BLOOD, V125, P2530, DOI 10.1182/blood-2014-12-619783; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Azzouz TN, 2005, J BIOL CHEM, V280, P34435, DOI 10.1074/jbc.M505077200; BALDWIN GS, 1971, BIOCHEM J, V123, P69, DOI 10.1042/bj1230069; Bandyopadhyay S, 2012, MOL CELL BIOL, V32, P1202, DOI 10.1128/MCB.05977-11; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; BROSTOFF S, 1971, P NATL ACAD SCI USA, V68, P765, DOI 10.1073/pnas.68.4.765; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Cho EC, 2012, EMBO J, V31, P1785, DOI 10.1038/emboj.2012.17; Chuang TW, 2011, J BIOL CHEM, V286, P8722, DOI 10.1074/jbc.M110.190587; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gerszten RE, 2000, J LAB CLIN MED, V136, P87, DOI 10.1067/mlc.2000.108154; Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Harris DP, 2014, J BIOL CHEM, V289, P15328, DOI 10.1074/jbc.M114.547349; Helbig KJ, 2004, HEPATOLOGY, V39, P1220, DOI 10.1002/hep.20167; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; JONASSON L, 1986, ARTERIOSCLEROSIS, V6, P131, DOI 10.1161/01.ATV.6.2.131; KAKIMOTO Y, 1970, J BIOL CHEM, V245, P5751; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Kraft M, 2001, CLIN EXP IMMUNOL, V126, P474, DOI 10.1046/j.1365-2249.2001.01634.x; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Lacotte S, 2009, ANN NY ACAD SCI, V1173, P310, DOI 10.1111/j.1749-6632.2009.04813.x; Lazzeri E., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P109, DOI 10.2174/1568008053174723; Li Y, 2015, CANCER DISCOV, V5, P288, DOI 10.1158/2159-8290.CD-14-0625; Liu F, 2011, CANCER CELL, V19, P283, DOI 10.1016/j.ccr.2010.12.020; Loetscher P, 2001, J BIOL CHEM, V276, P2986, DOI 10.1074/jbc.M005652200; Lombardi A, 2009, EUR J CELL BIOL, V88, P731, DOI 10.1016/j.ejcb.2009.07.004; Lothrop AP, 2013, FEBS LETT, V587, P1247, DOI 10.1016/j.febslet.2013.01.047; Mach F, 1999, J CLIN INVEST, V104, P1041, DOI 10.1172/JCI6993; Majumder S, 1998, J IMMUNOL, V161, P4736; Mazanet MM, 2000, J IMMUNOL, V164, P5383, DOI 10.4049/jimmunol.164.10.5383; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Miranda TB, 2004, BIOCHEM BIOPH RES CO, V323, P382, DOI 10.1016/j.bbrc.2004.08.107; Mohan K, 2002, J IMMUNOL, V168, P6420, DOI 10.4049/jimmunol.168.12.6420; Nussinov R, 2012, TRENDS BIOCHEM SCI, V37, P447, DOI 10.1016/j.tibs.2012.07.001; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ovchinnikova O, 2009, AM J PATHOL, V174, P693, DOI 10.2353/ajpath.2009.080561; Pollack BP, 1999, J BIOL CHEM, V274, P31531, DOI 10.1074/jbc.274.44.31531; Prabakaran S, 2012, WIRES SYST BIOL MED, V4, P565, DOI 10.1002/wsbm.1185; Scarpati EM, 1996, J BIOL CHEM, V271, P3025, DOI 10.1074/jbc.271.6.3025; Scoumanne A, 2009, NUCLEIC ACIDS RES, V37, P4965, DOI 10.1093/nar/gkp516; Sims RJ, 2008, NAT REV MOL CELL BIO, V9, P815, DOI 10.1038/nrm2502; Smil D, 2015, ACS MED CHEM LETT, V6, P408, DOI 10.1021/ml500467h; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tripsianes K, 2011, NAT STRUCT MOL BIOL, V18, P1414, DOI 10.1038/nsmb.2185; Van Raemdonck K, 2015, CYTOKINE GROWTH F R, V26, P311, DOI 10.1016/j.cytogfr.2014.11.009; Venne AS, 2014, PROTEOMICS, V14, P513, DOI 10.1002/pmic.201300344; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wei H, 2013, P NATL ACAD SCI USA, V110, P13516, DOI 10.1073/pnas.1311784110; Wilczek C, 2011, J BIOL CHEM, V286, P42221, DOI 10.1074/jbc.M111.303677; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zernecke A, 2008, ARTERIOSCL THROM VAS, V28, P1897, DOI 10.1161/ATVBAHA.107.161174; Zheng SS, 2013, MOL CELL, V52, P37, DOI 10.1016/j.molcel.2013.08.039	62	19	19	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148905	10.1371/journal.pone.0148905	http://dx.doi.org/10.1371/journal.pone.0148905			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901772	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100028
J	Lin, PI; Hsieh, CD; Juan, CH; Hossein, MM; Erickson, CA; Lee, YH; Su, MC				Lin, Ping-I; Hsieh, Cheng-Da; Juan, Chi-Hung; Hossein, Md Monir; Erickson, Craig A.; Lee, Yang-Han; Su, Mu-Chun			Predicting Aggressive Tendencies by Visual Attention Bias Associated with Hostile Emotions	PLOS ONE			English	Article							GAZE AVERSION; EYE CONTACT; FACES; QUESTIONNAIRE; INDIVIDUALS; INFORMATION; BEHAVIOR; CHILDREN; BRAIN; ANGER	The goal of the current study is to clarify the relationship between social information processing (e.g., visual attention to cues of hostility, hostility attribution bias, and facial expression emotion labeling) and aggressive tendencies. Thirty adults were recruited in the eye-tracking study that measured various components in social information processing. Baseline aggressive tendencies were measured using the Buss-Perry Aggression Questionnaire (AQ). Visual attention towards hostile objects was measured as the proportion of eye gaze fixation duration on cues of hostility. Hostility attribution bias was measured with the rating results for emotions of characters in the images. The results show that the eye gaze duration on hostile characters was significantly inversely correlated with the AQ score and less eye contact with an angry face. The eye gaze duration on hostile object was not significantly associated with hostility attribution bias, although hostility attribution bias was significantly positively associated with the AQ score. Our findings suggest that eye gaze fixation time towards non-hostile cues may predict aggressive tendencies.	[Lin, Ping-I; Hossein, Md Monir] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Lin, Ping-I] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA; [Hsieh, Cheng-Da; Su, Mu-Chun] Natl Cent Univ, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Juan, Chi-Hung] Natl Cent Univ, Inst Cognit Neurosci, Taoyuan, Taiwan; [Erickson, Craig A.] Cincinnati Childrens Hosp Med Ctr, Div Child & Adolescent Psychiat, Cincinnati, OH 45229 USA; [Lee, Yang-Han] Tamkang Univ, Dept Elect Engn, New Taipei 25137, Taiwan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Central University; National Central University; Cincinnati Children's Hospital Medical Center; Tamkang University	Lin, PI (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA.; Lin, PI (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA.	pingi.lin@gmail.com	Erickson, Craig/M-8933-2017	Lin, Ping-I/0000-0002-9739-7184	Cincinnati Children's Research Foundation; Cincinnati Children's Hospital Research Foundation	Cincinnati Children's Research Foundation; Cincinnati Children's Hospital Research Foundation	This work was supported by the Cincinnati Children's Research Foundation.; Cincinnati Children's Hospital Research Foundation has supported this study (PL, MH, CE). We also appreciate the volunteers for participating in this study.	BLUMBERG SH, 1985, J PERS SOC PSYCHOL, V49, P194, DOI 10.1037/0022-3514.49.1.194; Brotman MA, 2007, BIOL PSYCHIAT, V61, P819, DOI 10.1016/j.biopsych.2006.08.021; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Coss RG, 2002, PRIMATES, V43, P217, DOI 10.1007/BF02629649; d'Acremont M, 2007, J ABNORM CHILD PSYCH, V35, P313, DOI 10.1007/s10802-006-9092-1; Dadds MR, 2012, BRIT J PSYCHIAT, V200, P191, DOI 10.1192/bjp.bp.110.085720; DODGE KA, 1982, CHILD DEV, V53, P620, DOI 10.2307/1129373; ELLSWORTH P, 1973, J PERS SOC PSYCHOL, V28, P280, DOI 10.1037/h0035779; Hall CW, 2006, J PSYCHOL, V140, P255, DOI 10.3200/JRLP.140.3.255-267; Harris JA, 1997, BEHAV RES THER, V35, P1047, DOI 10.1016/S0005-7967(97)00064-8; Hernandez N, 2009, NEUROPSYCHOLOGIA, V47, P1004, DOI 10.1016/j.neuropsychologia.2008.10.023; Horsley TA, 2010, J ABNORM CHILD PSYCH, V38, P587, DOI 10.1007/s10802-009-9361-x; Hortensius R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116232; Hudley C, 1996, AM J PREV MED, V12, P75, DOI 10.1016/S0749-3797(18)30239-3; Lahera G, 2012, DEPRESS RES TREAT, V2012, DOI DOI 10.1155/2012/670549; Matheson E, 2005, AM J MENT RETARD, V110, P57, DOI 10.1352/0895-8017(2005)110<57:EUIAAN>2.0.CO;2; Pantic MV, 2005, WEB BASED DATABASE F; Schonenberg M, 2014, EUR ARCH PSY CLIN N, V264, P61, DOI 10.1007/s00406-013-0440-1; Tang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078149; Tone EB, 2012, DEV PSYCHOPATHOL, V24, P1031, DOI 10.1017/S0954579412000521; Van den Stock J, 2015, SCI REP-UK, V5, DOI 10.1038/srep13779; Van den Stock J, 2014, SOC COGN AFFECT NEUR, V9, P1481, DOI 10.1093/scan/nst138; Wilkowski BM, 2012, PERS SOC PSYCHOL B, V38, P540, DOI 10.1177/0146167211430233; Zhang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031044	25	8	8	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149487	10.1371/journal.pone.0149487	http://dx.doi.org/10.1371/journal.pone.0149487			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901770	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100083
J	Tang, FC; Li, RH; Huang, SL				Tang, Feng-Cheng; Li, Ren-Hau; Huang, Shu-Ling			The Association between Job-Related Psychosocial Factors and Prolonged Fatigue among Industrial Employees in Taiwan	PLOS ONE			English	Article							WORK CHARACTERISTICS; HONG-KONG; POPULATION; HEALTH; PREVALENCE; QUESTIONNAIRE; EPIDEMIOLOGY; SICK	Background and Objectives Prolonged fatigue is common among employees, but the relationship between prolonged fatigue and job-related psychosocial factors is seldom studied. This study aimed (1) to assess the individual relations of physical condition, psychological condition, and job-related psychosocial factors to prolonged fatigue among employees, and (2) to clarify the associations between job-related psychosocial factors and prolonged fatigue using hierarchical regression when demographic characteristics, physical condition, and psychological condition were controlled. Methods A cross-sectional study was employed. A questionnaire was used to obtain information pertaining to demographic characteristics, physical condition (perceived physical health and exercise routine), psychological condition (perceived mental health and psychological distress), job-related psychosocial factors (job demand, job control, and workplace social support), and prolonged fatigue. Results A total of 3,109 employees were recruited. Using multiple regression with controlled demographic characteristics, psychological condition explained 52.0% of the variance in prolonged fatigue. Physical condition and job-related psychosocial factors had an adjusted R-2 of 0.370 and 0.251, respectively. Hierarchical multiple regression revealed that, among job-related psychosocial factors, job demand and job control showed significant associations with fatigue. Conclusion Our findings highlight the role of job demand and job control, in addition to the role of perceived physical health, perceived mental health, and psychological distress, in workers' prolonged fatigue. However, more research is required to verify the causation among all the variables.	[Tang, Feng-Cheng] Changhua Christian Hosp, Dept Occupat Med, Changhua, Taiwan; [Tang, Feng-Cheng] Chaoyang Univ Technol, Dept Leisure Serv Management, Taichung, Taiwan; [Li, Ren-Hau; Huang, Shu-Ling] Chung Shan Med Univ, Dept Psychol, Taichung, Taiwan; [Huang, Shu-Ling] Chung Shan Med Univ Hosp, Room Clin Psychol, Taichung, Taiwan	Changhua Christian Hospital; Chaoyang University of Technology; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Huang, SL (corresponding author), Chung Shan Med Univ, Dept Psychol, Taichung, Taiwan.; Huang, SL (corresponding author), Chung Shan Med Univ Hosp, Room Clin Psychol, Taichung, Taiwan.	shuling@csmu.edu.tw	Li, Ren-Hau/HGU-8191-2022		Health Promotion Administration, Ministry of Health and Welfare, Taiwan [HPA 100-Soc-4]	Health Promotion Administration, Ministry of Health and Welfare, Taiwan	This study was funded by the Health Promotion Administration, Ministry of Health and Welfare, Taiwan (HPA 100-Soc-4) (http://www.hpa.gov.tw/BHPNet/Web/Index/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrea H, 2003, OCCUP ENVIRON MED, V60, P99; Aronsson G, 2000, J EPIDEMIOL COMMUN H, V54, P502, DOI 10.1136/jech.54.7.502; Bultmann U, 2002, J PSYCHOSOM RES, V52, P445, DOI 10.1016/S0022-3999(01)00228-8; Bultmann U, 2000, J Occup Health Psychol, V5, P411, DOI 10.1037/1076-8998.5.4.411; Bultmann U, 2002, INT ARCH OCC ENV HEA, V75, P259, DOI 10.1007/s00420-001-0294-0; Bureau of Labor Insurance, 2015, NUMB INS UN PERS IND; CHENG TA, 1986, PSYCHOL MED, V16, P415, DOI 10.1017/S0033291700009247; Cheng YW, 2003, INT J BEHAV MED, V10, P15, DOI 10.1207/S15327558IJBM1001_02; Chuang H.Y., 2000, TAIWAN FAMILY MED RE, V10, P192, DOI 10.7023/TJFM.200012.0192; DAVID A, 1990, BMJ-BRIT MED J, V301, P1199, DOI 10.1136/bmj.301.6762.1199; De Raeve L, 2009, J PSYCHOSOM RES, V66, P137, DOI 10.1016/j.jpsychores.2008.05.007; Demerouti E, 2009, CAREER DEV INT, V14, P50, DOI 10.1108/13620430910933574; Evengard B, 2005, PSYCHOL MED, V35, P1317, DOI 10.1017/S0033291705005052; Fang J, 2008, NURS HEALTH SCI, V10, P291, DOI 10.1111/j.1442-2018.2008.00407.x; Fries M., 2009, J ACAD BUSINESS ETHI, V2, P1; Goldberg D, 1978, MANUAL GEN HLTH QUES; Hardy GE, 1997, J PSYCHOSOM RES, V43, P83, DOI 10.1016/S0022-3999(97)00019-6; Helfenstein M, 2012, REV ASSOC MED BRAS, V58, P358, DOI 10.1590/S0104-42302012000300018; Kant IJ, 2003, OCCUP ENVIRON MED, V60, P32; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Karasek R., 1985, JOB CONTENT QUESTION; Laberge L, 2011, J ADOLESCENT HEALTH, V48, P289, DOI 10.1016/j.jadohealth.2010.07.003; Lerman SE, 2012, J OCCUP ENVIRON MED, V54, P231, DOI 10.1097/JOM.0b013e318247a3b0; LEWIS G, 1992, J EPIDEMIOL COMMUN H, V46, P92, DOI 10.1136/jech.46.2.92; Loge JH, 1998, J PSYCHOSOM RES, V45, P53, DOI 10.1016/S0022-3999(97)00291-2; Magnan MA, 2015, CLIN J ONCOL NURS, V19, P370, DOI 10.1188/15.CJON.370-372; Magnavita N, 2015, INT ARCH OCC ENV HEA, V88, P185, DOI 10.1007/s00420-014-0952-7; National Statistics Republic of China (Taiwan), 2010, STAND OCC CLASS; Nijs J, 2014, EXERC IMMUNOL REV, V20, P94; PAWLIKOWSKA T, 1994, BRIT MED J, V308, P763, DOI 10.1136/bmj.308.6931.763; Samaha E, 2007, J ADV NURS, V59, P221, DOI 10.1111/j.1365-2648.2007.04338.x; Schmaling KB, 2005, J PSYCHOSOM RES, V58, P375, DOI 10.1016/j.jpsychores.2004.11.001; Sharpe M, 2002, BRIT MED J, V325, P480, DOI 10.1136/bmj.325.7362.480; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Tei-Tominaga M, 2010, IND HEALTH, V48, P305, DOI 10.2486/indhealth.48.305; Vanroelen C, 2010, J EPIDEMIOL COMMUN H, V64, P866, DOI 10.1136/jech.2009.087122; Wang FW, 2009, INT ARCH OCC ENV HEA, V82, P819, DOI 10.1007/s00420-009-0429-2; Wessely S, 2001, ANN INTERN MED, V134, P838, DOI 10.7326/0003-4819-134-9_Part_2-200105011-00007; Williamson A, 2013, FATIGUE, V1, P81, DOI 10.1080/21641846.2012.744581; Wong WS, 2012, J PSYCHOSOM RES, V73, P28, DOI 10.1016/j.jpsychores.2012.04.011; Wong WS, 2010, J AFFECT DISORDERS, V127, P248, DOI 10.1016/j.jad.2010.04.029	42	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150429	10.1371/journal.pone.0150429	http://dx.doi.org/10.1371/journal.pone.0150429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930064	gold, Green Submitted, Green Published			2022-12-27	WOS:000371434500147
J	Devulapalli, S; Shoirah, H; Dhamoon, MS				Devulapalli, Saravana; Shoirah, Hazem; Dhamoon, Mandip S.			Ideal Cardiovascular Health Metrics Are Associated with Disability Independently of Vascular Conditions	PLOS ONE			English	Article							WHITE-MATTER; DISEASE; IMPACT	Background Vascular risk factors may be associated with disability independently of vascular events. We examined whether the American Heart Association's 7 ideal cardiovascular health (CVH) metrics were independently associated with disability in a nationally representative cohort. Methods Adults age >= 20 years from the National Health and Nutrition Examination Survey 20052012 were included. Ideal CVH was calculated as a composite of 7 measures, each scored 0-2. Primary predictors were number of ideal CVH metrics and score of CVH metrics. The outcome was a dichotomous score from 20 activities of daily living (ADL) and instrumental ADLs. Unadjusted and adjusted weighted logistic models estimated associations between ideal CVH and disability. The data were analyzed in 2015. Results Among 22692 participants, mean age was 46.9 years. Cardiac disease and stroke were present in 6.6% and 2.8%; 90.3% had poor physical activity and 89.9% poor diet. Among 3975 individuals with full CVH data, in fully adjusted models, OR for disability was 0.90 (95% CI 0.83-0.98) per point increase in ideal CVH score, and 0.84 (0.73-0.97) per additional number of ideal CVH metrics. Conclusions CVH metrics were strongly and significantly associated with reduced odds of disability independently of vascular and non-vascular conditions. Poorer CVH may cause subclinical vascular disease resulting in disability.	[Devulapalli, Saravana; Shoirah, Hazem; Dhamoon, Mandip S.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dhamoon, MS (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA.	mandip.dhamoon@mssm.edu						Appel LJ, 2012, CIRCULATION, V125, P973, DOI 10.1161/CIRCULATIONAHA.111.088542; Baune BT, 2009, J GERIATR PSYCH NEUR, V22, P266, DOI 10.1177/0891988709342722; BRAULT MW, 2008, AM DISABILITIES 2005; Centers for Disease Control and Prevention, 2015, NHANES SPEC WEIGHT P; Centers for Disease Control and Prevention, 2015, NHANES SURV METH; Crichton GE, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0089317, 10.1371/journal.pone.0099829]; Dhamoon MS, 2015, J AM HEART ASSOC, P4; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Hollar Jr DW, 2015, DISABILITY HLTH J, V8, P51, DOI [10. 1016/ j. dhjo. 2014.07.007, DOI 10.1016/J.DHJ0.2014.07.007]; Kuo HK, 2007, GERONTOLOGY, V53, P102, DOI 10.1159/000096792; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Vermeer SE, 2007, LANCET NEUROL, V6, P611, DOI 10.1016/S1474-4422(07)70170-9; Wolfson L, 2005, J NEUROL SCI, V232, P23, DOI 10.1016/j.jns.2004.12.017; Xanthakis V, 2014, CIRCULATION, V130, P1676, DOI 10.1161/CIRCULATIONAHA.114.009273	17	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150282	10.1371/journal.pone.0150282	http://dx.doi.org/10.1371/journal.pone.0150282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926808	gold, Green Published, Green Submitted			2022-12-27	WOS:000371424200034
J	Treffry-Goatley, A; Lessells, R; Sykes, P; Barnighausen, T; de Oliveira, T; Moletsane, R; Seeley, J				Treffry-Goatley, Astrid; Lessells, Richard; Sykes, Pam; Baernighausen, Till; de Oliveira, Tulio; Moletsane, Relebohile; Seeley, Janet			Understanding Specific Contexts of Antiretroviral Therapy Adherence in Rural South Africa: A Thematic Analysis of Digital Stories from a Community with High HIV Prevalence	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; TREATMENT PROGRAM; IMPROVE ADHERENCE; SCALE-UP; CARE; MEDICATION; INTERVENTIONS; BARRIERS; AIDS	Near-perfect adherence to antiretroviral therapy (ART) is required to achieve the best possible prevention and treatment outcomes. Yet, there have been particular concerns about the challenges of adherence among patients living in resource-limited settings in sub-Saharan Africa. The primary objective of this study was to explore adherence in a low-resourced, rural community of high HIV prevalence in South Africa and to identify specific individual and structural factors that can either challenge or support adherence in this context. We applied digital stories as a qualitative research tool to gain insights into personal contexts of HIV and ART adherence. Through an inductive thematic analysis of twenty story texts, soundtracks and drawings, we explored experiences, understandings, and contexts of the participants and identified potential barriers and facilitators for those on lifelong treatment. We found that many of the stories reflected a growing confidence in the effectiveness of ART, which should be viewed as a key facilitator to successful adherence since this attitude can promote disclosure and boost access to social support. Nevertheless, stories also highlighted the complexity of the issues that individuals and households face as they deal with HIV and ART in this setting and it is clear that an overburdened local healthcare system has often struggled to meet the demands of a rapidly expanding epidemic and to provide the necessary medical and emotional support. Our analysis suggests several opportunities for further research and the design of novel health interventions to support optimal adherence. Firstly, future health promotion campaigns should encourage individuals to test together, or at least accompany each other for testing, to encourage social support from the outset. Additionally, home-based testing and ART club interventions might be recommended to make it easier for individuals to adhere to their treatment regimens and to provide a sense of support and solidarity.	[Treffry-Goatley, Astrid; Lessells, Richard; Baernighausen, Till; de Oliveira, Tulio; Seeley, Janet] Univ KwaZulu Natal, Africa Ctr Populat Hlth, Durban, Kwazulu Natal, South Africa; [Treffry-Goatley, Astrid; Moletsane, Relebohile] Univ KwaZulu Natal, Sch Educ, Durban, Kwazulu Natal, South Africa; [Lessells, Richard] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Sykes, Pam] Digital Storytelling South Africa, Cape Town, South Africa; [Baernighausen, Till] Harvard Univ, Dept Global Hlth & Populat, TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [de Oliveira, Tulio] Univ KwaZulu Natal, Sch Lab Med & Med Sci, Coll Hlth Sci, Durban, Kwazulu Natal, South Africa; [de Oliveira, Tulio] UCL, Res Dept Infect, London, England; [Seeley, Janet] London Sch Hyg & Trop Med, Anthropol & Hlth, London WC1, England	University of Kwazulu Natal; University of Kwazulu Natal; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Treffry-Goatley, A (corresponding author), Univ KwaZulu Natal, Africa Ctr Populat Hlth, Durban, Kwazulu Natal, South Africa.; Treffry-Goatley, A (corresponding author), Univ KwaZulu Natal, Sch Educ, Durban, Kwazulu Natal, South Africa.	astridtg@gmail.com	Bärnighausen, Till/Y-2388-2019	Sykes, Pam/0000-0001-5032-5709; de Oliveira, Tulio/0000-0002-3027-5254; Seeley, Janet/0000-0002-0583-5272; de Oliveira (nee Treffry-Goatley), Astrid/0000-0002-2489-9255; Lessells, Richard/0000-0003-0926-710X	Wellcome Trust International Engagement Award;  [WT099669MA]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD084233] Funding Source: NIH RePORTER	Wellcome Trust International Engagement Award; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	ATG received a Wellcome Trust International Engagement Award. TDO and RM were co-applicant on the grant ( Award number WT099669MA) http://www.wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bam K, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0846-8; Bemelmans M, 2014, TROP MED INT HEALTH, V19, P968, DOI 10.1111/tmi.12332; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Bor J, 2011, TROP MED INT HEALTH, V16, P988, DOI 10.1111/j.1365-3156.2011.02795.x; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Cueva M, 2013, INT J CIRCUMPOL HEAL, V72, DOI 10.3402/ijch.v72i0.21301; Doyal L, 2014, LANCET, V384, P2102, DOI 10.1016/S0140-6736(14)62362-X; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Gubrium A, 2009, HEALTH PROMOT PRACT, V10, P186, DOI 10.1177/1524839909332600; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kagee A, 2011, GLOB PUBLIC HEALTH, V6, P83, DOI 10.1080/17441691003796387; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Krass I, 2015, DIABETIC MED, V32, P725, DOI 10.1111/dme.12651; Lambert J., 2009, DIGITAL STORYTELLING; Lessells RJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-116; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Manasa J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072152; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Michel J, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-20; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Moletsane R, 2009, INT J QUAL STUD EDUC, V22, P315, DOI 10.1080/09518390902835454; Moshabela M, 2011, AIDS BEHAV, V15, P842, DOI 10.1007/s10461-010-9747-3; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V59, P86, DOI 10.1097/QAI.0b013e318236f7d2; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Peltzer K, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-111; Petersen I, 2014, PATIENT EDUC COUNS, V95, P201, DOI 10.1016/j.pec.2014.02.001; Riessman C.K., 2008, NARRATIVE METHODS HU, P21; Riessman CatherineKohler., 2004, SAGE ENCY SOCIAL SCI, P705; Ross AJ, 2011, AFR J PRIM HEALTH CA, V3, DOI 10.4102/phcfm.v3i1.196; Schroeder K, 2004, ARCH INTERN MED, V164, P722, DOI 10.1001/archinte.164.7.722; South African National AIDS Council (SANAC), 2014, PEOPL LIV HIV STIGM; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Wilkinson L, 2013, SO AFRICAN J HIV MED, P14; Zaidi J, 2013, AIDS, V27, P2301, DOI 10.1097/QAD.0b013e328362e832	36	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0148801	10.1371/journal.pone.0148801	http://dx.doi.org/10.1371/journal.pone.0148801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928455	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000371424200003
J	Olier, I; Springate, DA; Ashcroft, DM; Doran, T; Reeves, D; Planner, C; Reilly, S; Kontopantelis, E				Olier, Ivan; Springate, David A.; Ashcroft, Darren M.; Doran, Tim; Reeves, David; Planner, Claire; Reilly, Siobhan; Kontopantelis, Evangelos			Modelling Conditions and Health Care Processes in Electronic Health Records: An Application to Severe Mental Illness with the Clinical Practice Research Datalink	PLOS ONE			English	Article							DATABASES; QUALITY; RISK; PAY	Background The use of Electronic Health Records databases for medical research has become mainstream. In the UK, increasing use of Primary Care Databases is largely driven by almost complete computerisation and uniform standards within the National Health Service. Electronic Health Records research often begins with the development of a list of clinical codes with which to identify cases with a specific condition. We present a methodology and accompanying Stata and R commands (pcdsearch/Rpcdsearch) to help researchers in this task. We present severe mental illness as an example. Methods We used the Clinical Practice Research Datalink, a UK Primary Care Database in which clinical information is largely organised using Read codes, a hierarchical clinical coding system. Pcdsearch is used to identify potentially relevant clinical codes and/or product codes from word-stubs and code-stubs suggested by clinicians. The returned code-lists are reviewed and codes relevant to the condition of interest are selected. The final code-list is then used to identify patients. Results We identified 270 Read codes linked to SMI and used them to identify cases in the database. We observed that our approach identified cases that would have been missed with a simpler approach using SMI registers defined within the UK Quality and Outcomes Framework. Conclusion We described a framework for researchers of Electronic Health Records databases, for identifying patients with a particular condition or matching certain clinical criteria. The method is invariant to coding system or database and can be used with SNOMED CT, ICD or other medical classification code-lists.	[Olier, Ivan] Univ Manchester, Inst Biotechnol, Manchester M13 9GP, Lancs, England; [Olier, Ivan; Springate, David A.; Reeves, David; Planner, Claire; Kontopantelis, Evangelos] Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester M13 9GP, Lancs, England; [Springate, David A.; Reeves, David] Univ Manchester, Inst Populat Hlth, Ctr Biostat, NIHR Sch Primary Care Res, Manchester M13 9GP, Lancs, England; [Ashcroft, Darren M.] Univ Manchester, Manchester Pharm Sch, Ctr Pharmacoepidemiol & Drug Safety, Manchester M13 9GP, Lancs, England; [Doran, Tim] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Reilly, Siobhan] Univ Lancaster, Div Hlth Res, Lancaster, England; [Kontopantelis, Evangelos] Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GP, Lancs, England; [Kontopantelis, Evangelos] Univ Manchester, Ctr Hlth Informat, Vaughan House,Portsmouth St, Manchester M13 9GP, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of York - UK; Lancaster University; University of Manchester; University of Manchester	Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Primary Care, NIHR Sch Primary Care Res, Manchester M13 9GP, Lancs, England.; Kontopantelis, E (corresponding author), Univ Manchester, Inst Populat Hlth, Ctr Hlth Informat, Manchester M13 9GP, Lancs, England.; Kontopantelis, E (corresponding author), Univ Manchester, Ctr Hlth Informat, Vaughan House,Portsmouth St, Manchester M13 9GP, Lancs, England.	e.kontopantelis@manchester.ac.uk	Kontopantelis, Evangelos/H-2966-2019; Reeves, David/H-6203-2014; Ashcroft, Darren/G-3244-2015	Kontopantelis, Evangelos/0000-0001-6450-5815; Reilly, Siobhan Theresa/0000-0003-4372-4415; Reeves, David/0000-0001-6377-6859; Planner, Claire/0000-0003-0938-0444; Ashcroft, Darren/0000-0002-2958-915X; Olier, Ivan/0000-0002-5679-7501	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR) [144]; National Institute for Health Research (NIHR); MRC Health eResearch Centre [MR/K006665/1]; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research (SPCR)(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); MRC Health eResearch Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Institute for Health Research (NIHR) School for Primary Care Research (SPCR), under the title "Exploring the physical health and primary care management of people with serious mental illness (SMI) using the General Practice Research Database" (project no. 144). This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health. The study was carried out in the University of Manchester's Institute of Population Health. MRC Health eResearch Centre Grant MR/K006665/1 supported the time and facilities of one investigator (EK).	Benson T, 2011, COMMUNICATION, V19, P173; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Doran T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2405; Health & Social Care Information Centre, 2014, QOF BUS RUL V28 0 HS; Hsiao Chun-Ju, 2011, NCHS Data Brief, P1; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; KONTOPANTELIS E, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G330; Kontopantelis E, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008650; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Kontopantelis E, 2015, DIABETOLOGIA, V58, P1142, DOI 10.1007/s00125-015-3526-7; Kontopantelis E, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003190; Kontopantelis E, 2013, BMJ QUAL SAF, V22, P53, DOI 10.1136/bmjqs-2012-001033; Kushniruk AW, 2013, INT J MED INFORM, V82, pE149, DOI 10.1016/j.ijmedinf.2012.12.006; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; NHS England, 2014, TERM ROADM NHS REC S; Read J, 1986, BRIT J HEALTHC COMP, V3, P22; Reeves D, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004952; Reilly S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009010; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Royal College of General Practitioners, 1980, J R COLL GEN PRACT O, P1; Shephard E, 2011, FAM PRACT, V28, P352, DOI 10.1093/fampra/cmr039; Silverman SL, 2009, AM J MED, V122, P114, DOI 10.1016/j.amjmed.2008.09.030; Springate DA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007299; Springate DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099825; Webb RT, 2012, J PSYCHOSOM RES, V73, P92, DOI 10.1016/j.jpsychores.2012.05.010; Webb RT, 2012, ARCH GEN PSYCHIAT, V69, P256, DOI 10.1001/archgenpsychiatry.2011.1561	27	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0146715	10.1371/journal.pone.0146715	http://dx.doi.org/10.1371/journal.pone.0146715			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918439	Green Published, gold, Green Accepted			2022-12-27	WOS:000371274400002
J	Salyer, ACD; Caruso, G; Khetani, KK; Fox, LM; Malladi, SS; David, SA				Salyer, Alex C. D.; Caruso, Giuseppe; Khetani, Karishma K.; Fox, Lauren M.; Malladi, Subbalakshmi S.; David, Sunil A.			Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen	PLOS ONE			English	Article							MONOPHOSPHORYL-LIPID-A; STRUCTURE-BASED DESIGN; RECEPTOR 7 AGONISTS; INNATE IMMUNITY; 8-OXOADENINE DERIVATIVES; INFLUENZA VACCINE; RECOGNITION; ACTIVATION; LIGANDS; SAFETY	Small-molecule agonists have been identified for TLR7, TLR8, TLR4 and TLR2 thus far, and chemotypes other than those of canonical ligands are yet to be explored for a number of innate immune receptors. The discovery of novel immunostimulatory molecules would enhance the repertoire of tools available for interrogating innate immune effector mechanisms, and provide additional venues for vaccine adjuvant development. A multiplexed, reporter gene-based high-throughput assay capable of detecting agonists of TLR2, TLR3, TLR4, TLR5, TLR7, TLR8, TLR9, NOD1 and NOD2 was utilized in screening 123,943 compounds, in which amphotericin B (AmpB) and nystatin were identified as prominent hits. The polyene antifungal agents act as TLR2- and TLR4-agonists. The TLR4-stimulatory activity of AmpB was similar to that of monophosphoryl lipid A, suggestive of TRIF-biased signaling. The adjuvantic activity of AmpB, at a dose of 100 micrograms, was comparable to several other candidate adjuvants in rabbit models of immunization. These results point to its potential applicability as a safe and effective adjuvant for human vaccines.	[Salyer, Alex C. D.; Caruso, Giuseppe; Khetani, Karishma K.; Fox, Lauren M.; Malladi, Subbalakshmi S.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Salyer, Alex C. D.; David, Sunil A.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	University of Kansas; University of Minnesota System; University of Minnesota Twin Cities	David, SA (corresponding author), Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.	sdavid@umn.edu	Caruso, Giuseppe/C-1435-2018	Caruso, Giuseppe/0000-0003-1571-5327	National Institutes of Health/National Institute of Allergy and Infectious Diseases [HHSN27220140056C]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases contract HHSN27220140056C (SD).	Adediran SA, 2009, MOL PHARMACEUT, V6, P1582, DOI 10.1021/mp9001602; Agnihotri G, 2011, J MED CHEM, V54, P1490, DOI 10.1021/jm101535e; Agnolon V, 2015, INT J PHARMACEUT, V492, P169, DOI 10.1016/j.ijpharm.2015.06.030; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Andre FE, 2008, B WORLD HEALTH ORGAN, V86, P140, DOI 10.2471/BLT.07.040089; Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Bazin HG, 2015, BIOORG MED CHEM LETT, V25, P1318, DOI 10.1016/j.bmcl.2015.01.037; Beesu M, 2015, J MED CHEM, V58, P7833, DOI 10.1021/acs.jmedchem.5b01087; Beesu M, 2014, J MED CHEM, V57, P7325, DOI 10.1021/jm500701q; Birmingham K, 1999, NAT MED, V5, P469, DOI 10.1038/8332; Bowen WS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001963; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Casella CR, 2008, CELL MOL LIFE SCI, V65, P3231, DOI 10.1007/s00018-008-8228-6; Chan M, 2013, J MED CHEM, V56, P4206, DOI 10.1021/jm301694x; Cheng K, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400139; Clarke TB, 2011, IMMUNOL REV, V243, P9, DOI 10.1111/j.1600-065X.2011.01039.x; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Day TP, 2011, MOL PHARMACEUT, V8, P297, DOI 10.1021/mp100363f; Del Giudice G, 2015, CURR TOP MICROBIOL, V386, P151, DOI 10.1007/82_2014_406; DUTCHER JD, 1968, DIS CHEST, VS 54, P296, DOI 10.1378/chest.54.Supplement_1.296; Eng NF, 2013, HUM VACC IMMUNOTHER, V9, P1661, DOI 10.4161/hv.24715; Esposito S, 2011, PEDIATR INFECT DIS J, V30, pE49, DOI 10.1097/INF.0b013e318206c26e; Farhat K, 2008, J LEUKOCYTE BIOL, V83, P692, DOI 10.1189/jlb.0807586; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Garcon N, 2011, VACCINE, V29, P4453, DOI 10.1016/j.vaccine.2011.04.046; Gerster JF, 2005, J MED CHEM, V48, P3481, DOI 10.1021/jm049211v; Glenny A, 1926, J PATHOL BACTERIOL, V29, P38; Goff PH, 2015, J VIROL, V89, P3221, DOI 10.1128/JVI.03337-14; GRANT JP, 1991, J TROP PEDIATRICS, V37, P272, DOI 10.1093/tropej/37.6.272; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; Hayashi T, 2014, J PHARMACOL EXP THER, V350, P330, DOI 10.1124/jpet.114.214312; Henderson D A, 1980, Henry E Sigerist Suppl Bull Hist Med, P99; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hoffmann J, 2013, CURR OPIN IMMUNOL, V25, P1, DOI 10.1016/j.coi.2013.01.008; Hussein IH, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00269; Irvine KL, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-50; Janeway CA, 1998, J IMMUNOL, V161, P539; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kersse K, 2011, CYTOKINE GROWTH F R, V22, P257, DOI 10.1016/j.cytogfr.2011.09.003; KHOO SH, 1994, J ANTIMICROB CHEMOTH, V33, P203, DOI 10.1093/jac/33.2.203; Knuf M, 2015, HUM VACC IMMUNOTHER, V11, P358, DOI 10.4161/21645515.2014.987014; Knuf M, 2015, VACCINE, V33, P174, DOI 10.1016/j.vaccine.2014.10.085; Kokatla HP, 2014, CHEMMEDCHEM, V9, P719, DOI 10.1002/cmdc.201300573; Kokatla HP, 2013, J MED CHEM, V56, P6871, DOI 10.1021/jm400694d; Kokatla HP, 2013, ORG BIOMOL CHEM, V11, P1179, DOI 10.1039/c2ob26705e; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kumagai Yutaro, 2008, Journal of Infection and Chemotherapy, V14, P86, DOI 10.1007/s10156-008-0596-1; Kumagai Y, 2010, J ALLERGY CLIN IMMUN, V125, P985, DOI 10.1016/j.jaci.2010.01.058; Kumar D, 2015, TRANSPLANTATION; Kurimoto A, 2010, J MED CHEM, V53, P2964, DOI 10.1021/jm100070n; Lan T, 2009, J MED CHEM, V52, P6871, DOI 10.1021/jm901145s; Levine MM, 2009, IMMUNOL CELL BIOL, V87, P274, DOI 10.1038/icb.2009.15; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Malito E, 2012, P NATL ACAD SCI USA, V109, P5229, DOI 10.1073/pnas.1201964109; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Matusiak M, 2015, P NATL ACAD SCI USA, V112, P1541, DOI 10.1073/pnas.1417945112; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Nakamura T, 2013, BIOORG MED CHEM LETT, V23, P669, DOI 10.1016/j.bmcl.2012.11.114; Nour A, 2014, BIOORG MED CHEM LETT, V24, P4931, DOI 10.1016/j.bmcl.2014.09.039; Plotkin SA, 2009, CLIN VACCINE IMMUNOL, V16, P1709, DOI 10.1128/CVI.00290-09; Razonable RR, 2005, ANTIMICROB AGENTS CH, V49, P1617, DOI 10.1128/AAC.49.4.1617-1621.2005; ROBBINS A, 1993, AM J DIS CHILD, V147, P152, DOI 10.1001/archpedi.1993.02160260042019; Rodriguez KR, 2014, J VIROL, V88, P8194, DOI 10.1128/JVI.00640-14; Roethle PA, 2013, J MED CHEM, V56, P7324, DOI 10.1021/jm400815m; Salunke DB, 2013, J MED CHEM, V56, P5885, DOI 10.1021/jm400620g; Salunke DB, 2012, J MED CHEM, V55, P8137, DOI 10.1021/jm301066h; Salunke DB, 2012, J MED CHEM, V55, P3353, DOI 10.1021/jm3000533; Sau K, 2003, J BIOL CHEM, V278, P37561, DOI 10.1074/jbc.M306137200; Schiaffo CE, 2014, J MED CHEM, V57, P339, DOI 10.1021/jm4004957; Shukla NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043612; Shukla NM, 2012, J MED CHEM, V55, P1106, DOI 10.1021/jm2010207; Shukla NM, 2011, BIOORGAN MED CHEM, V19, P3801, DOI 10.1016/j.bmc.2011.04.052; Shukla NM, 2011, BIOORG MED CHEM LETT, V21, P3232, DOI 10.1016/j.bmcl.2011.04.050; Shukla NM, 2010, BIOORG MED CHEM LETT, V20, P6384, DOI 10.1016/j.bmcl.2010.09.093; Shukla NM, 2010, J MED CHEM, V53, P4450, DOI 10.1021/jm100358c; Shukla NM, 2009, BIOORG MED CHEM LETT, V19, P2211, DOI 10.1016/j.bmcl.2009.02.100; SUFFREDINI AF, 1989, NEW ENGL J MED, V321, P280, DOI 10.1056/NEJM198908033210503; Tagliabue A, 2008, HUM VACCINES, V4, P347, DOI 10.4161/hv.4.5.6438; Takeuchi O, 2007, CURR OPIN CELL BIOL, V19, P185, DOI 10.1016/j.ceb.2007.02.006; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Ukani R, 2012, BIOORG MED CHEM LETT, V22, P293, DOI 10.1016/j.bmcl.2011.11.014; Unterholzner L, 2013, IMMUNOBIOLOGY, V218, P1312, DOI 10.1016/j.imbio.2013.07.007; Wu WY, 2010, J MED CHEM, V53, P3198, DOI 10.1021/jm901839g; Yoo E, 2014, J MED CHEM, V57, P7955, DOI 10.1021/jm500744f; Yoo E, 2013, ORG BIOMOL CHEM, V11, P6526, DOI 10.1039/c3ob40816g; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	94	33	33	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149848	10.1371/journal.pone.0149848	http://dx.doi.org/10.1371/journal.pone.0149848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919709	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400048
J	Tao, H; Wang, MM; Zhang, M; Zhang, SP; Wang, CH; Yuan, WJ; Sun, T; He, LJ; Hu, QK				Tao, Hong; Wang, Meng-meng; Zhang, Man; Zhang, Shao-ping; Wang, Chun-hui; Yuan, Wen-jun; Sun, Tao; He, Lan-jie; Hu, Qi-kuan			MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 beta Cells	PLOS ONE			English	Article							DISRUPTION	Background Increasing evidence suggests that miR-126 participates in the glucose homeostasis through its target molecules. Although bioinformatics analysis predicts that miR-126 can bind with the insulin receptor substrate-2(IRS-2) mRNA at the "seed sequence", but there are still no definitely reports to support it. In this study, we provided evidences that IRS-2 was one of the target genes of miR-126. And miR-126 has a proliferation inhibiting effects in INS-1 beta cells, mainly through the suppression of IRS-2. Methods The 3'-UTR of IRS-2 regulated by miR-126 was analyzed by the luciferase assay and western blot. Furthermore, proliferation of INS-1 beta cells stimulated by glucose was tested, and the association between IRS-2 and miR-126 were analyzed. Results We found that mutation of only three of the 6 "seed sequences" can eliminate the inhibition effect of miR-126. In INS-1 beta cells, administration of miR-126 suppresses the proliferation, together with the unbalanced down-regulation of IRS-2 and IRS-1. Over-expression of IRS-2 can reverse the proliferation effect of miR-126, while not of IRS-1. These results suggested that miR-126 inhibited the beta-cell proliferation via the inhibition of IRS-2 instead of IRS-1. Additionally, we also found that high glucose and insulin could stimulate the rapid production of endogenous miR-126 within 6 hours, together with the short term suppression of IRS-1 and IRS-2 expression, and intensify the unbalanced expression of IRS-1 and IRS-2. Conclusions IRS-2 was one of the targets of miR-126. MiR-126 inhibited the beta-cell proliferation through IRS-2 instead of IRS-1. MiR-126 may take part in the glucose homeostasis both through its target IRS-2 and IRS-1. The unbalance between IRS-1 and IRS-2 caused by miR-126 may play an important role in type 2 diabetes.	[Tao, Hong; Wang, Meng-meng; Zhang, Man; Yuan, Wen-jun; Hu, Qi-kuan] Ningxia Med Univ, Dept Physiol, Yinchuan, Peoples R China; [Wang, Meng-meng] Jiamusi Cent Hosp, Dept Epilepsy, Jiamusi, Hei Long Jiang, Peoples R China; [Zhang, Shao-ping; Sun, Tao; Hu, Qi-kuan] Natl Key Lab Incubat Base, Ningxia Key Lab Cerebrocranial Dis, Yinchuan, Peoples R China; [Wang, Chun-hui; He, Lan-jie] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China; [Yuan, Wen-jun] Second Mil Med Univ, Dept Physiol, Shanghai, Peoples R China	Ningxia Medical University; Ningxia Medical University; Naval Medical University	Hu, QK (corresponding author), Ningxia Med Univ, Dept Physiol, Yinchuan, Peoples R China.; Hu, QK (corresponding author), Natl Key Lab Incubat Base, Ningxia Key Lab Cerebrocranial Dis, Yinchuan, Peoples R China.	huqikuan@163.com			National Natural Science Foundation of China [81270880, 30960150, 31260246, 31460300, 81360130]; National Basic Research Program of China (973 program) [2012CB722408]; Ningxia Natural Science Foundation of China [NZ13135]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Ningxia Natural Science Foundation of China	This study was supported by grants of the National Natural Science Foundation of China to Wenjun Yuan (81270880), to Qikuan Hu (30960150, 31260246, 31460300), and to Lanjie He (81360130), http://www.nsfc.gov.cn/; the National Basic Research Program of China (973 program, 2012CB722408), http://www.most.gov.cn/cxfw/; the Ningxia Natural Science Foundation of China to Lanjie He (NZ13135), http://www.nxkjt.gov.cn/.	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Burks DJ, 2001, DIABETES, V50, pS140, DOI 10.2337/diabetes.50.2007.S140; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Hu Yan, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P12, DOI 10.11817/j.issn.1672-7347.2015.01.003; Kubota N, 2008, CELL METAB, V8, P49, DOI 10.1016/j.cmet.2008.05.007; Li HM, 2014, ONCOL REP, V32, P1225, DOI 10.3892/or.2014.3327; Meister J, 2010, THESCIENTIFICWORLDJO, V10, P2090, DOI 10.1100/tsw.2010.198; Mohanty S, 2005, EXP CELL RES, V303, P68, DOI 10.1016/j.yexcr.2004.09.011; Oliveira JM, 2014, CAN J PHYSIOL PHARM, V92, P613, DOI 10.1139/cjpp-2014-0114; Ryu HS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017343; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Zhang T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761617; Zhou J, 2013, CIRC RES, V113, P40, DOI 10.1161/CIRCRESAHA.113.280883; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	14	25	26	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149954	10.1371/journal.pone.0149954	http://dx.doi.org/10.1371/journal.pone.0149954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919700	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400060
J	Tumwesigye, NM; Atuyambe, LM; Kobusingye, OK				Tumwesigye, Nazarius M.; Atuyambe, Lynn M.; Kobusingye, Olive K.			Factors Associated with Injuries among Commercial Motorcyclists: Evidence from a Matched Case Control Study in Kampala City, Uganda	PLOS ONE			English	Article							ROAD TRAFFIC INJURIES; RISK-FACTORS	Introduction Road traffic injuries are the eighth leading cause of death globally and the most affected are young people aged 15-29. By 2030 road traffic deaths will become the fifth leading cause of death unless urgent action is taken. Motorcyclists are among the most vulnerable road users and in Uganda they contribute 41% of all road traffic injuries. This paper establishes factors associated with the injuries of commercial motorcycle riders also known as boda-boda riders in Kampala, Uganda's capital city. Methods The study was matched case-control with a case being a boda-boda rider that was seen at one of the 5 major city hospitals with a road traffic injury while a control was a boda-boda rider that was at the parking stage where the case operated from before the injury. The sample size was 289 riders per arm and data collection took 7 months. A structured questionnaire was used to collect data on background and exposing factors. Being matched case-control data conditional logistic regression was used in the analysis. Results Factors independently associated with injury among motorcyclists were younger age group, being a current alcohol drinker (OR = 2.30, 95% CI: 1.19-4.45), lower engine capacity (< 100cc)(OR = 5.03, 95% CI: 2.91-8.70), riding experience of less than 3 years, not changing a motorcycle in past 1 year (OR = 2.04, 95% CI: 1.19-3.52), riding for a longer time in a day (OR = 6.05, 95% CI: 2.58-14.18) and sharing a motorcycle (OR = 8.25, 95% CI: 2.62-25.9). Other factors associated with injury were low level of knowledge of traffic rules, being stopped by police for checks on condition of motorcycle/license/insurance, working till late. Recommendations More road safety sensitization is required among riders to raise awareness against sharing motorcycles, working for a longer time and alcohol consumption. Police enforcement of drink-driving laws should include riders of commercial motorcycles. Investigate the validity of motorcycle riding licenses and test the riding competency of all who got licenses in last 3 years.	[Tumwesigye, Nazarius M.] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Atuyambe, Lynn M.] Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Kobusingye, Olive K.] Makerere Univ, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Tumwesigye, NM (corresponding author), Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda.	naz@musph.ac.ug		Tumwesigye, Nazarius Mbona/0000-0001-7085-8780; Kobusingye, Olive/0000-0003-2413-599X; Atuyambe, Lynn/0000-0001-5886-5080	World Bank Global Road Safety Facility grant	World Bank Global Road Safety Facility grant	This work was supported by a World Bank Global Road Safety Facility grant to the Road Traffic Injury Research Network (RTIRN). Website: www.rtirn.net.	Adogu P O U, 2009, Niger J Med, V18, P393; Ali S.A., 2015, J STUDIES MANAGEMENT, V1, P532; Babor TF., 2001, AUDIT ALCOHOL USE DI; Berecki-Gisolf J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120617; Chang HL, 2007, TRANSPORT RES F-TRAF, V10, P109, DOI 10.1016/j.trf.2006.08.001; Cheng L.P., 2014, APPL MECH MAT; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Galukande M, E CENTRAL AFRICAN J, V14, P33; Goodman MS, 2012, J BIOM BIOSTAT, V3; Horberry T., ROAD SAFETY RES REPO; HOSMER DW, 1989, APPL LOGISTIC REGRES; Howe J, 2003, TRANSPORT REV, V23, P161, DOI 10.1080/01441640309890; Jacobs G., ESTIMATING GLOBAL RO; Kigera J., 2010, East and Central African Journal of Surgery, V15, P57; Kitara D.L., 2012, E CENTRAL AFRICAN J, V17; KRAUS JF, 1975, AM J EPIDEMIOL, V102, P74, DOI 10.1093/oxfordjournals.aje.a112136; Langley J., 2000, ACCIDENT ANAL PREVEN, V32, P659; Lin MR, 2009, ACCIDENT ANAL PREV, V41, P710, DOI 10.1016/j.aap.2009.03.010; McKnight B., 2009, CONDITIONAL LOGISTIC; Michon K., 2014, MOTORCYCLE ACCIDENTS; Moskal A, 2012, ACCIDENT ANAL PREV, V49, P5, DOI 10.1016/j.aap.2010.08.021; Mullin B, 2000, Inj Prev, V6, P32, DOI 10.1136/ip.6.1.32; Nantulya VM, 2002, BRIT MED J, V324, P1139, DOI 10.1136/bmj.324.7346.1139; Olumidea E.O., 2014, TRAFFIC INJURY PREVE; Oxley J., 2013, ANN ADV AUTOMOT MED, P45; Pang T Y, 2000, Med J Malaysia, V55, P45; Police Information Resource Centre, 2013, PAR CARS UG ROADS DO; Quddus MA, 2002, J SAFETY RES, V33, P445, DOI 10.1016/S0022-4375(02)00051-8; Rivara FP, 1997, NEW ENGL J MED, V337, P543, DOI 10.1056/NEJM199708213370807; Roehler DR, 2013, GLOB HEALTH PROMOT, V20, P37, DOI 10.1177/1757975913509657; Scheiman S, 2010, ACCIDENT ANAL PREV, V42, P758, DOI 10.1016/j.aap.2009.11.005; Schwellnus MP, 2005, S AFR FAM PRACT, V47, P14, DOI 10.1080/20786204.2005.10873255; Slesak G, 2015, TROP MED INT HEALTH, V20, P1578, DOI 10.1111/tmi.12562; Tumwesigye N., 2006, WORLD HEAL ORGAN, V1, P189; Tumwesigye N.M., 2015, COMMUNICATION; Tumwesigye N.M., 2015, BRAIN DEGENERATION D, P33; UN, 2010, GEN ASS ITS 64 SESS; Wells S., 2004, BRIT MED J; Woratanarat P, 2013, ACCIDENT ANAL PREV, V58, P115, DOI 10.1016/j.aap.2013.05.001; World Health Organization, 2008, GLOBAL BURDEN DIS; World Health Organization, 2013, GLOB STAT REP ROAD S; World Health Organization, 2009, GLOB STAT REP ROAD S	42	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148511	10.1371/journal.pone.0148511	http://dx.doi.org/10.1371/journal.pone.0148511			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918871	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400005
J	Navaza, B; Abarca, B; Bisoffi, F; Pool, R; Roura, M				Navaza, Barbara; Abarca, Bruno; Bisoffi, Federico; Pool, Robert; Roura, Maria			Provider-Initiated HIV Testing for Migrants in Spain: A Qualitative Study with Health Care Workers and Foreign-Born Sexual Minorities	PLOS ONE			English	Article							FOR-DISEASE-CONTROL; TRANSGENDER WOMEN; HUMAN-RIGHTS; RECOMMENDATIONS; RISK; PREVALENCE; COMMUNITY; ATTITUDES; AFRICA; EXCEPTIONALISM	Introduction Provider-initiated HIV testing (PITC) is increasingly adopted in Europe. The success of the approach at identifying new HIV cases relies on its effectiveness at testing individuals most at risk. However, its suitability to reach populations facing overlapping vulnerabilities is under researched. This qualitative study examined HIV testing experiences and perceptions amongst Latin-American migrant men who have sex with men and transgender females in Spain, as well as health professionals' experiences offering HIV tests to migrants in Barcelona and Madrid. Methods We conducted 32 in-depth interviews and 8 discussion groups with 38 Latin-American migrants and 21 health professionals. We imported verbatim transcripts and detailed field work notes into the qualitative software package Nvivo-10 and applied to all data a coding framework to examine systematically different HIV testing dimensions and modalities. The dimensions analysed were based on the World Health Organization "5 Cs" principles: Consent, Counselling, Connection to treatment, Correctness of results and Confidentiality. Results Health professionals reported that PITC was conceptually acceptable for them, although their perceived inability to adequately communicate HIV+ results and resulting bottle necks in the flow of care were recurrent concerns. Endorsement and adherence to the principles underpinning the rights-based response to HIV varied widely across health settings. The offer of an HIV test during routine consultations was generally appreciated by users as a way of avoiding the embarrassment of asking for it. Several participants deemed compulsory testing as acceptable on public health grounds. In spite of-and sometimes because of-partial endorsement of rights-based approaches, PITC was acceptable in a population with high levels of internalised stigma. Conclusion PITC is a promising approach to reach sexual minority migrants who hold high levels of internalised stigma but explicit extra efforts are needed to safeguard the rights of the most vulnerable.	[Navaza, Barbara; Abarca, Bruno; Bisoffi, Federico; Roura, Maria] Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; University of Amsterdam	Roura, M (corresponding author), Hosp Clin Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.	maria.roura@isglobal.org	Roura, Maria/K-6668-2014	Roura, Maria/0000-0001-9556-1940	Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship [RYC-2011-08428]; "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR) [2014SGR26]; European Commission [FP7-GA-261495]	Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship; "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study has been funded by the Spanish Ministry of Economy and Competitiveness (MINECO) as part of the "Ramon y Cajal" fellowship awarded to Dr. Maria Roura (RYC-2011-08428, http://www.idi.mineco.gob.es/portal/site/MICINN), who has also received funds from the "Agencia de Gestio d'Ajuts Universitaris i de Recerca", Regional Government of Catalonia (AGAUR Grant 2014SGR26). The group activities with Latin American migrants were conducted as part of the COHEMI project, supported by the European Commission 7th Framework Program, Grant Agreement no FP7-GA-261495 (http://ec.europa.eu/research/health/public-health/public-health-and-health-systems/projects/cohemi_en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African HIV Policy Network, 2008, GUID HIV TEST WEB CO; Alvarez-del Arco D, 2014, EUR J PUBLIC HEALTH, V24, P139, DOI 10.1093/eurpub/ckt108; Alvarez-del Arco D, 2013, EUR J PUBLIC HEALTH, V23, P1039, DOI 10.1093/eurpub/cks130; Andrinopoulos K, 2015, AIDS BEHAV, V19, P60, DOI 10.1007/s10461-014-0813-0; Angotti N, 2011, HEALTH POLICY PLANN, V26, P307, DOI 10.1093/heapol/czq066; [Anonymous], 2015, PAIS; [Anonymous], 2021, HIV TESTING NEW HIV; April MD, 2010, B WORLD HEALTH ORGAN, V88, P703, DOI 10.2471/BLT.09.073049; Arya M, 2012, AIDS PATIENT CARE ST, V26, P256, DOI 10.1089/apc.2011.0402; Bayer R, 2006, NEW ENGL J MED, V355, P647, DOI 10.1056/NEJMp068153; Bayer R, 2009, J HEALTH POLIT POLIC, V34, P301, DOI 10.1215/03616878-2009-002; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Casino G, 2012, LANCET, V379, P1777, DOI 10.1016/S0140-6736(12)60745-4; Celada MT, 2011, AM J BIOETHICS, V11, P31, DOI 10.1080/15265161.2011.560339; Csete J, 2004, LANCET, V363, P493, DOI 10.1016/S0140-6736(04)15509-8; Cunningham CO, 2009, AIDS PATIENT CARE ST, V23, P619, DOI 10.1089/apc.2009.0005; Deblonde J, 2010, EUR J PUBLIC HEALTH, V20, P422, DOI 10.1093/eurpub/ckp231; Deblonde J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2571-y; Deblonde J, 2011, HEALTH POLICY, V103, P101, DOI 10.1016/j.healthpol.2011.06.012; Del Amo J, 2011, EUR J PUBLIC HEALTH, V21, P620, DOI 10.1093/eurpub/ckq150; DeMarco RF, 2012, NURS OUTLOOK, V60, P72, DOI 10.1016/j.outlook.2011.06.002; Diez M, 2014, EUROSURVEILLANCE, V19, P18, DOI 10.2807/1560-7917.ES2014.19.47.20971; ECDC, 2012, MIGR HLTH HIV TEST C; Elmahdi R, 2014, SEX TRANSM INFECT, V90, P119, DOI 10.1136/sextrans-2013-051312; Esteban-Vasallo MD, 2014, INT J INFECT DIS, V19, P39, DOI 10.1016/j.ijid.2013.10.006; European Centre for Disease Prevention and Control (ECDC), 2014, HIV AIDS SURV EUR 20; European Centre for Disease Prevention and Control (ECDC), 2010, HIV TEST INCR UPT EF; Frye V, 2015, AIDS BEHAV, V19, P257, DOI 10.1007/s10461-014-0937-2; Glew S, 2014, BRIT J GEN PRACT, V64, pE60, DOI 10.3399/bjgp14X677103; Glick SN, 2010, JAIDS-J ACQ IMM DEF, V55, P516, DOI 10.1097/QAI.0b013e3181f275e0; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guionnet A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1115; Hardon A, 2011, MED ANTHROPOL, V30, P183, DOI 10.1080/01459740.2011.552455; Haute Autorite de Sante, 2009, DEP INF VIH FRANC ST; Hernando Victoria, 2015, J Acquir Immune Defic Syndr, V70, P204, DOI 10.1097/QAI.0000000000000717; Hoyos J, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18560; Jain CL, 2009, AIDS PATIENT CARE ST, V23, P167, DOI 10.1089/apc.2008.0130; Kaiser Family Foundation, 2011, SURV AM HIV AIDS TOP; Lang N, 2015, ONE GROUP PEOPLE IS; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Leon N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-97; Lifson AR, 2007, LANCET, V369, P539, DOI 10.1016/S0140-6736(07)60249-9; Logie CH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001124; Lorenc T, 2011, HEALTH EDUC RES, V26, P834, DOI 10.1093/her/cyr064; Manirankunda L, 2012, AIDS EDUC PREV, V24, P456, DOI 10.1521/aeap.2012.24.5.456; Ministerio de Sanidad Servicios Sociales e Igualdad, 2014, GUIA REC DIAGN PREC; Mizuno Y, 2012, AIDS BEHAV, V16, P724, DOI 10.1007/s10461-011-9967-1; Moyer E, 2014, MED ANTHROPOL, V33, P263, DOI 10.1080/01459740.2014.890618; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; Navaza B, 2012, AIDS BEHAV, V16, P30, DOI 10.1007/s10461-010-9871-0; Pebody R, 2014, HIV PREVENTION BLACK; Perez-Molina JA, 2012, ENFERM INFEC MICR CL, V30, P472, DOI 10.1016/j.eimc.2012.07.004; Pharris A, 2015, EUROSURVEILLANCE, V20, P2, DOI 10.2807/1560-7917.ES.2015.20.47.30071; Pollard A, 2013, INT J STD AIDS, V24, P307, DOI 10.1177/0956462412472424; Poteat T, 2015, LANCET, V385, P274, DOI 10.1016/S0140-6736(14)60833-3; Prost A, 2009, SEX TRANSM INFECT, V85, P326, DOI 10.1136/sti.2008.033233; Rennie S, 2006, B WORLD HEALTH ORGAN, V84, P52, DOI 10.2471/BLT.05.025536; Roura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136315; Roura M, 2013, AIDS, V27, P617, DOI 10.1097/QAD.0b013e32835b7048; Roura M, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-22; Sibanda Euphemia L, 2012, BMC Health Serv Res, V12, P131, DOI 10.1186/1472-6963-12-131; Societat Catalana de Medicina Familiar i Comunitaria, 2011, GUIA AT PRIM PAC IMM; The International HIV/AIDS Alliance, 2006, TOOLS TOG NOW; Tiittala PJ, 2015, SCAND J PUBLIC HEALT, V43, P393, DOI 10.1177/1403494815573604; Topp Stephanie M, 2012, J Int AIDS Soc, V15, P17352, DOI 10.7448/IAS.15.2.17352; UNAIDS, 2014, UND FAST TRACK ACC A; UNAIDS, 2013, UNAIDS REPORT ON THE; Valenti SE, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.06.005; van Griensven F, 2013, LANCET INFECT DIS, V13, P185, DOI 10.1016/S1473-3099(12)70326-2; Weiser SD, 2006, PLOS MED, V3, P1013, DOI 10.1371/journal.pmed.0030261; WHO/UNAIDS, 2007, GUID PROV IN HIV COU; World Health Organization, 2012, SERV DEL APPR HIV TE; World Health Organization, 2015, WHO CONS GUID HIV TE	73	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150223	10.1371/journal.pone.0150223	http://dx.doi.org/10.1371/journal.pone.0150223			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26914023	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700063
J	Mo, ZW; Huang, JX; Xiao, D; Ashraf, U; Duan, MY; Pan, SG; Tian, H; Xiao, LZ; Zhong, KY; Tang, XR				Mo, Zhaowen; Huang, Jinxia; Xiao, Di; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Xiao, Lizhong; Zhong, Keyou; Tang, Xiangru			Supplementation of 2-Ap, Zn and La Improves 2-Acetyl-1-Pyrroline Concentrations in Detached Aromatic Rice Panicles In Vitro	PLOS ONE			English	Article							ODOR-ACTIVE COMPOUNDS; PROLINE DEHYDROGENASE; FRAGRANCE; GROWTH; GENE; BIOSYNTHESIS; COMPOUND	Aromatic rice is highly prized by consumers worldwide due to its special aromatic character. 2-acetyl-1-pyrroline (2-AP) is considered to be the single most important volatile compound responsible for aroma in aromatic rice. The present study demonstrated the effects of 2-AP, zinc (Zn) and lanthanum (La) on the 2-AP concentration of detached aromatic rice panicles in vitro. Detached panicles from three well-known aromatic cultivars, Guixiangzhan, Pin14, and Pin 15, were cultured separately in basic culture medium supplemented with 2-AP, Zn and La, and 2-AP concentrations were assessed at 7 and 14 days after culture (DAC). The results show that supplementation of 2-AP, Zn and La in the basic culture medium significantly increases the accumulation of proline. 2-AP concentration and the activity of proline dehydrogenase (ProDH) were also increased in rice grains. Zn concentrations were also found to be higher when Zn was added to the basic culture medium, and La concentrations in grains were too low to be measured. Additionally, grain 2-AP concentrations were significantly and positively correlated with proline concentrations, ProDH activities in grains and 2-AP in culture medium. In summary, higher grain 2-AP concentrations might be due to Znand La-induced increases in proline concentrations and ProDH activities, as well as the direct uptake and transportation of 2-AP from the culture medium. Furthermore, application of both Zn and La might be helpful for improving aroma formation in rice. However, interactions of both these elements with the complex process of 2-AP formation remain to be explored.	[Mo, Zhaowen; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Xiao, Lizhong; Zhong, Keyou; Tang, Xiangru] South China Agr Univ, Coll Agr, Dept Crop Sci & Technol, Guangzhou, Guangdong, Peoples R China; [Mo, Zhaowen; Ashraf, Umair; Duan, Meiyang; Pan, Shenggang; Tian, Hua; Zhong, Keyou; Tang, Xiangru] Minist Agr, Sci Observing & Expt Stn Crop Cultivat South Chin, Guangzhou, Guangdong, Peoples R China; [Huang, Jinxia] Wuzhou Municipal Bur Agr, Wuzhou, Guangxi, Peoples R China; [Xiao, Di] Jiaying Univ, Sch Life Sci, Meizhou, Guangdong, Peoples R China	South China Agricultural University; Ministry of Agriculture & Rural Affairs; Jiaying University	Tang, XR (corresponding author), South China Agr Univ, Coll Agr, Dept Crop Sci & Technol, Guangzhou, Guangdong, Peoples R China.; Tang, XR (corresponding author), Minist Agr, Sci Observing & Expt Stn Crop Cultivat South Chin, Guangzhou, Guangdong, Peoples R China.	tangxr@scau.edu.cn	Ashraf, Umair/R-2496-2017; 潘, 圣刚/AAD-2832-2021; Ashraf, Umair/AAJ-1585-2020	Ashraf, Umair/0000-0003-0041-7706; Ashraf, Umair/0000-0003-0041-7706	National Natural Science Foundation of China [31271646]; Natural Science Foundation of Guangdong Province [8151064201000017]; Agricultural Research Projects of Guangdong Province [2011AO20202001]; Agricultural Standardization Project of Guangdong Province [4100 F10003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Agricultural Research Projects of Guangdong Province; Agricultural Standardization Project of Guangdong Province	This study was supported by National Natural Science Foundation of China (31271646), Natural Science Foundation of Guangdong Province (8151064201000017), Agricultural Research Projects of Guangdong Province (2011AO20202001), and Agricultural Standardization Project of Guangdong Province (4100 F10003).	BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhattacharjee P, 2002, INT J FOOD SCI TECH, V37, P1, DOI 10.1046/j.1365-2621.2002.00541.x; Bradbury LMT, 2005, PLANT BIOTECHNOL J, V3, P363, DOI 10.1111/j.1467-7652.2005.00131.x; Bradbury LMT, 2008, PLANT MOL BIOL, V68, P439, DOI 10.1007/s11103-008-9381-x; BUTTERY RG, 1983, J AGR FOOD CHEM, V31, P823, DOI 10.1021/jf00118a036; BUTTERY RG, 1988, J AGR FOOD CHEM, V36, P1006, DOI 10.1021/jf00083a025; Champagne EI, 2008, CEREAL CHEM, V85, P447, DOI 10.1094/CCHEM-85-4-0445; Chen SH, 2008, PLANT CELL, V20, P1850, DOI 10.1105/tpc.108.058917; [段美洋 DUAN Mei-yang], 2009, [华南农业大学学报, Journal of South China Agricultural University], V30, P1; Fang F, 2001, J WENZHOU MED COLL, V31, P398; Fitzgerald MA, 2008, PLANT BIOTECHNOL J, V6, P416, DOI 10.1111/j.1467-7652.2008.00327.x; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Fitzgerald TL, 2010, ENVIRON EXP BOT, V68, P292, DOI 10.1016/j.envexpbot.2010.01.001; Goufo Piebiep, 2010, Frontiers of Agriculture in China, V4, P1, DOI 10.1007/s11703-009-0087-x; Goufo P, 2011, AGRON SUSTAIN DEV, V31, P349, DOI 10.1051/agro/2010011; Hansch R, 2009, CURR OPIN PLANT BIOL, V12, P259, DOI 10.1016/j.pbi.2009.05.006; Hashemi FSG, 2013, CRIT REV PLANT SCI, V32, P445, DOI 10.1080/07352689.2013.807716; Hu S, 2001, CROP RES, V15, P14; HU S, 2002, CROP RES, V16, P14; Huang J, 2010, TILLAGE CULTIVATION, P5; Huang JX, 2008, ACTA AGR BOREALI SIN, V23, P290; Huang TC, 2007, J AGR FOOD CHEM, V55, P5097, DOI 10.1021/jf0700576; Itani T, 2004, PLANT PROD SCI, V7, P178, DOI 10.1626/pps.7.178; Jezussek M, 2002, J AGR FOOD CHEM, V50, P1101, DOI 10.1021/jf0108720; Liang J. S., 1993, Chinese Journal of Rice Science, V7, P77; LING D H, 1983, Plant Cell Reports, V2, P172, DOI 10.1007/BF00270095; Maraval I, 2008, J AGR FOOD CHEM, V56, P5291, DOI 10.1021/jf7037373; Maraval I, 2010, ANAL CHIM ACTA, V675, P148, DOI 10.1016/j.aca.2010.07.024; Mo ZW, 2015, RICE, V8, DOI 10.1186/s12284-015-0040-y; Ncube B, 2013, PLANT PHYSIOL BIOCH, V65, P102, DOI 10.1016/j.plaphy.2013.01.001; Pan XiaoHua, 2000, Acta Agriculturae Universitatis Jiangxiensis, V22, P1; Poonlaphdecha J, 2012, J AGR FOOD CHEM, V60, P3824, DOI 10.1021/jf205130y; Sakthivel K, 2009, BIOTECHNOL ADV, V27, P468, DOI 10.1016/j.biotechadv.2009.04.001; SRINIVAS P, 2004, Patent No. 6723856; Sriseadka T, 2006, J AGR FOOD CHEM, V54, P8183, DOI 10.1021/jf0614490; SUN S, 1991, Acta Agronomica Sinica, V17, P430; Suwanarit A., 1996, Kasetsart Journal, Natural Sciences, V30, P458; [唐湘如 Tang Xiangru], 2006, [杂交水稻, Hybrid Rice], V21, P69; Tateishi Y, 2005, PHYSIOL PLANTARUM, V125, P224, DOI 10.1111/j.1399-3054.2005.00553.x; Wakte Kantilal V., 2011, Physiology and Molecular Biology of Plants, V17, P231, DOI 10.1007/s12298-011-0075-5; [王培 Wang Pei], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P103; Widjaja R, 1996, J SCI FOOD AGR, V70, P151, DOI [10.1002/(SICI)1097-0010(199602)70:2<151::AID-JSFA478>3.0.CO;2-U, 10.1002/(SICI)1097-0010(199602)70:2&lt;151::AID-JSFA478&gt;3.0.CO;2-U]; Wijerathna YMAM, 2014, J EXP BIOL AGRIC SCI, V2, P7; Xiao D, 2009, J AGR SCI, V22, P364; Xiao Di, 2010, Journal of South China Agricultural University, V31, P115; Xie ZB, 2003, J RARE EARTH, V21, P86; Yang DS, 2008, J AGR FOOD CHEM, V56, P2780, DOI 10.1021/jf072685t; Yang SY, 2012, FIELD CROP RES, V125, P151, DOI 10.1016/j.fcr.2011.09.002; [杨晓娟 Yang Xiaojuan], 2014, [华北农学报, Acta Agriculturae Boreali-Sinica], V29, P128; Yoshihashi T, 2002, J AGR FOOD CHEM, V50, P2001, DOI 10.1021/jf011268s; Yoshihashi T., 2005, JAPAN INT RES CTR AG	51	46	50	7	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149523	10.1371/journal.pone.0149523	http://dx.doi.org/10.1371/journal.pone.0149523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910246	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700038
J	Stuntz, M; Perlaky, A; des Vignes, F; Kyriakides, T; Glass, D				Stuntz, Mark; Perlaky, Anna; des Vignes, Franka; Kyriakides, Tassos; Glass, Dan			The Prevalence of Peyronie's Disease in the United States: A Population-Based Study	PLOS ONE			English	Article							MEN; ASSOCIATION	Peyronie's disease (PD) is a connective tissue disorder which can result in penile deformity. The prevalence of diagnosed PD in the United States (US) has been estimated to be 0.5% in adult males, but there is limited additional information comparing definitive and probable PD cases. We conducted a population-based survey to assess PD prevalence using a convenience-sample of adult men participating in the Research Now general population panel. Respondents were categorized according to PD status (definitive, probable, no PD) and segmented by US geographic region, education, and income levels. Of the 7,711 respondents, 57 (0.7%) had definitive PD while 850 (11.0%) had probable PD. Using univariate logistic regression modeling, older age (18-24 vs 24+) (OR = 0.721; 95% CI = 0.570,0.913), Midwest/Northeast/West geographic region (South vs Midwest/Northeast/West) (OR = 0.747; 95% CI = 0.646,0.864), and higher income level (<25K vs 25K+) (OR = 0.820; 95% CI = 0.673,0.997) were each significantly associated with reduced odds of having a definitive/probable PD diagnosis compared with no PD diagnosis. When all three variables were entered in a stepwise multivariable logistic regression, only age (OR = 0.642; 95% CI = 0.497, 0.828) and region (OR = 0.752; 95% CI = 0.647, 0.872) remained significant. This study is the first to report PD prevalence by geographic region and income, and it advocates that the prevalence of PD in the US may be higher than previously cited. Further, given the large discrepancy between definitive PD cases diagnosed by a physician and probable cases not diagnosed by a physician, much more needs to be done to raise awareness of this disease.	[Stuntz, Mark; Perlaky, Anna; des Vignes, Franka; Glass, Dan] Deerfield Inst, New York, NY USA; [Kyriakides, Tassos] Yale Univ, Sch Publ Hlth, Yale Ctr Analyt Serv, New Haven, CT USA	Yale University	Stuntz, M (corresponding author), Deerfield Inst, New York, NY USA.	mstuntz@deerfield.com	Kyriakides, Tassos/E-4980-2013	Kyriakides, Tassos/0000-0001-8913-108X; Stuntz, Mark/0000-0001-9646-1781	Deerfield Management, a healthcare investment firm; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER	Deerfield Management, a healthcare investment firm; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Financial support for this research was funded by the Deerfield Management, a healthcare investment firm dedicated to advancing healthcare through investment, information and philanthropy. The funder provided support in the form of salaries for authors (MS, AP, FDV, DG) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Abernethy J, 1828, CONSEQUENCES GONORRH, V1, P205; Arafa M, 2007, INT J IMPOT RES, V19, P213, DOI 10.1038/sj.ijir.3901518; Deveci S, 2007, J SEX MED, V4, P485, DOI 10.1111/j.1743-6109.2006.00344.x; Devine CJ, 1997, J UROLOGY, V157, P285, DOI 10.1016/S0022-5347(01)65361-8; DiBenedetti DB, 2011, ADV UROL, V2011, P1; El-Sakka AI, 2006, EUR UROL, V49, P564, DOI 10.1016/j.eururo.2005.10.026; El-Sakka AI, 2005, J UROLOGY, V174, P1026, DOI 10.1097/01.ju.0000170231.51306.32; ElSakka AI, 1997, J UROLOGY, V158, P1391, DOI 10.1016/S0022-5347(01)64223-X; Hauck EW, 2001, LANCET, V357, P2049, DOI 10.1016/S0140-6736(00)05119-9; Hellstrom WJG, 2013, J UROLOGY, V190, P627, DOI 10.1016/j.juro.2013.01.090; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Levine LA, 1997, J UROLOGY, V158, P1395, DOI 10.1016/S0022-5347(01)64224-1; LINDSAY MB, 1991, J UROLOGY, V146, P1007, DOI 10.1016/S0022-5347(17)37988-0; LING RSM, 1963, J BONE JOINT SURG BR, V45, P709, DOI 10.1302/0301-620X.45B4.709; Mulhall JP, 2006, J UROLOGY, V175, P2115, DOI 10.1016/S0022-5347(06)00270-9; Musitelli S, 2008, J SEX MED, V5, P1737, DOI 10.1111/j.1743-6109.2007.00692.x; Nugteren HM, 2011, INT J IMPOT RES, V23, P142, DOI 10.1038/ijir.2011.18; NYBERG LM, 1982, J UROLOGY, V128, P48, DOI 10.1016/S0022-5347(17)52751-2; Pawlowska E, 2011, POL J RADIOL, V76, P33; Pryor JP, 2002, INT J IMPOT RES, V14, P414, DOI 10.1038/sj.ijir.3900877; Ralph DJ, 1997, J UROLOGY, V157, P291, DOI 10.1016/S0022-5347(01)65362-X; Rhoden EL, 2001, INT J IMPOT RES, V13, P291, DOI 10.1038/sj.ijir.3900727; Romero FR, 2013, INT BRAZ J UROL, V39, P55, DOI 10.1590/S1677-5538.IBJU.2013.01.08; Schwarzer U, 2001, BJU INT, V88, P727, DOI 10.1046/j.1464-4096.2001.02436.x; Shiraishi K, 2012, J SEX MED, V9, P2716, DOI 10.1111/j.1743-6109.2012.02868.x; Sommer F, 2002, INT J IMPOT RES, V14, P379, DOI 10.1038/sj.ijir.3900863; Tal R, 2012, J SEX MED, V9, P302, DOI 10.1111/j.1743-6109.2011.02502.x; Tefekli A, 2001, INT J IMPOT RES, V13, P18, DOI 10.1038/sj.ijir.3900635; Vi L, 2009, EXP CELL RES, V315, P3574, DOI 10.1016/j.yexcr.2009.07.015	29	58	59	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150157	10.1371/journal.pone.0150157	http://dx.doi.org/10.1371/journal.pone.0150157			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907743	Green Published, Green Submitted, gold			2022-12-27	WOS:000371163000032
J	Sundstrom, KB; Hoang, ATN; Gupta, S; Ahlm, C; Svensson, M; Klingstrom, J				Sundstrom, Karin B.; Hoang, Anh Thu Nguyen; Gupta, Shawon; Ahlm, Clas; Svensson, Mattias; Klingstrom, Jonas			Andes Hantavirus-Infection of a 3D Human Lung Tissue Model Reveals a Late Peak in Progeny Virus Production Followed by Increased Levels of Proinflammatory Cytokines and VEGF-A	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PULMONARY SYNDROME; PATHOGENESIS; SECRETION	Andes virus (ANDV) causes hantavirus pulmonary syndrome (HPS), a severe acute disease with a 40% case fatality rate. Humans are infected via inhalation, and the lungs are severely affected during HPS, but little is known regarding the effects of ANDV-infection of the lung. Using a 3-dimensional air-exposed organotypic human lung tissue model, we analyzed progeny virus production and cytokine-responses after ANDV-infection. After a 7-10 day period of low progeny virus production, a sudden peak in progeny virus levels was observed during approximately one week. This peak in ANDV-production coincided in time with activation of innate immune responses, as shown by induction of type I and III interferons and ISG56. After the peak in ANDV production a low, but stable, level of ANDV progeny was observed until 39 days after infection. Compared to uninfected models, ANDV caused long-term elevated levels of eotaxin-1, IL-6, IL-8, IP-10, and VEGF-A that peaked 20-25 days after infection, i.e., after the observed peak in progeny virus production. Notably, eotaxin-1 was only detected in supernatants from infected models. In conclusion, these findings suggest that ANDV replication in lung tissue elicits a late proinflammatory immune response with possible long-term effects on the local lung cytokine milieu. The change from an innate to a proinflammatory response might be important for the transition from initial asymptomatic infection to severe clinical disease, HPS.	[Sundstrom, Karin B.; Gupta, Shawon] Karolinska Insitutet, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hoang, Anh Thu Nguyen; Gupta, Shawon; Svensson, Mattias; Klingstrom, Jonas] Karolinska Univ Hosp Huddinge, Karolinska Insitutet Stockholm, Dept Med, Ctr Infect Med, Stockholm, Sweden; [Ahlm, Clas] Umea Univ, Dept Clin Microbiol, Div Infect Dis, Umea, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Umea University	Klingstrom, J (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Insitutet Stockholm, Dept Med, Ctr Infect Med, Stockholm, Sweden.	Jonas.Klingstrom@ki.se		Gupta, Shawon/0000-0002-8501-6962; Klingstrom, Jonas/0000-0001-9076-1441	Swedish Research Council [K2014-99X-22624-01-4, K2015-56X-22774-01-3]; Swedish Foundation [SB12-0003]; Karolinska Institutet; Stockholm County Council; Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation; Karolinska Institutet(Karolinska Institutet); Stockholm County Council(Stockholm County Council); Ake Wibergs Stiftelse; Magnus Bergvalls Stiftelse	This work was supported by grants from the Swedish Research Council (Projects K2014-99X-22624-01-4 and K2015-56X-22774-01-3, www.vr.se) and the Swedish Foundation for Strategic Research (Project SB12-0003, www.stratresearch.se), Karolinska Institutet, Stockholm County Council, Ake Wibergs Stiftelse, and Magnus Bergvalls Stiftelse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hoang ATN, 2014, J LEUKOCYTE BIOL, V96, P481, DOI 10.1189/jlb.3TA0513-303R; Borges AA, 2008, MICROBES INFECT, V10, P1150, DOI 10.1016/j.micinf.2008.06.006; Castillo C, 2001, CHEST, V120, P548, DOI 10.1378/chest.120.2.548; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Gavrilovskaya I, 2012, ADV VIROL, V2012, DOI 10.1155/2012/674360; Gupta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003272; Hardestam J, 2009, EMERG INFECT DIS, V15, P1140, DOI 10.3201/eid1507.090097; Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09; KIM SG, 1993, AM J CLIN PATHOL, V100, P398, DOI 10.1093/ajcp/100.4.398; Klingstrom J, 2006, EUR J IMMUNOL, V36, P2649, DOI 10.1002/eji.200535587; Ma Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/812386; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Martinez VP, 2010, EMERG INFECT DIS, V16, P1853, DOI 10.3201/eid1612.091170; Martinez VP, 2005, EMERG INFECT DIS, V11, P1848, DOI 10.3201/eid1112.050501; Martinez-Valdebenito C, 2014, EMERG INFECT DIS, V20, P1629, DOI 10.3201/eid2010.140353; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; Morzunov SP, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00432; Nguyen Hoang A. T., 2012, AM J PHYSIOL-LUNG C, V302, P226; Padula PJ, 1998, VIROLOGY, V241, P323, DOI 10.1006/viro.1997.8976; Papaioannou AI, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-128; Parasa VR, 2014, DIS MODEL MECH, V7, P281, DOI 10.1242/dmm.013854; Rankin SM, 2000, MOL MED TODAY, V6, P20, DOI 10.1016/S1357-4310(99)01635-4; Rasmuson J, 2011, EUR J CLIN MICROBIOL, V30, P685, DOI 10.1007/s10096-010-1141-6; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Rowe RK, 2006, J VIROL, V80, P1087, DOI 10.1128/JVI.80.3.1087-1097.2006; Safronetz D, 2014, P NATL ACAD SCI USA, V111, P7114, DOI 10.1073/pnas.1401998111; Safronetz D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002426; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Shambat SM, 2015, DIS MODEL MECH, V8, P1413, DOI 10.1242/dmm.021923; Shamir ER, 2014, NAT REV MOL CELL BIO, V15, P647, DOI 10.1038/nrm3873; Shrivastava-Ranjan P, 2010, J VIROL, V84, P11227, DOI 10.1128/JVI.01405-10; Spengler JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055310; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Tischler ND, 2008, VIRUS RES, V135, P1, DOI 10.1016/j.virusres.2008.01.013; Tsergouli K, 2013, VIRUSES-BASEL, V5, P3109, DOI 10.3390/v5123109; Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066; Vapalahti O, 2003, LANCET INFECT DIS, V3, P653, DOI 10.1016/S1473-3099(03)00774-6; Yoo PS, 2006, WORLD J GASTROENTERO, V12, P4937, DOI 10.3748/wjg.v12.i31.4937; Young JC, 2000, AM J TROP MED HYG, V62, P714, DOI 10.4269/ajtmh.2000.62.714; ZAKI SR, 1995, AM J PATHOL, V146, P552	40	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149354	10.1371/journal.pone.0149354	http://dx.doi.org/10.1371/journal.pone.0149354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907493	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000009
J	Mesias, MC; Boda-Heggemann, J; Thoelking, J; Lohr, F; Wenz, F; Wertz, H				Mesias, Macarena Cubillos; Boda-Heggemann, Judit; Thoelking, Johannes; Lohr, Frank; Wenz, Frederik; Wertz, Hansjoerg			Quantification and Assessment of Interfraction Setup Errors Based on Cone Beam CT and Determination of Safety Margins for Radiotherapy	PLOS ONE			English	Article							IMAGE-GUIDED RADIOTHERAPY; MODULATED RADIATION-THERAPY; COMPUTED-TOMOGRAPHY; CANCER; TECHNOLOGIES; UNCERTAINTY; GUIDANCE	Introduction To quantify interfraction patient setup-errors for radiotherapy based on cone-beam computed tomography and suggest safety margins accordingly. Material and Methods Positioning vectors of pre-treatment cone-beam computed tomography for different treatment sites were collected (n = 9504). For each patient group the total average and standard deviation were calculated and the overall mean, systematic and random errors as well as safety margins were determined Results The systematic (and random errors) in the superior-inferior, left-right and anterior-posterior directions were: for prostate, 2.5(3.0), 2.6(3.9) and 2.9(3.9) mm; for prostate bed, 1.7(2.0), 2.2(3.6) and 2.6(3.1) mm; for cervix, 2.8(3.4), 2.3(4.6) and 3.2(3.9) mm; for rectum, 1.6(3.1), 2.1(2.9) and 2.5(3.8) mm; for anal, 1.7(3.7), 2.1(5.1) and 2.5(4.8) mm; for head and neck, 1.9(2.3), 1.4(2.0) and 1.7(2.2) mm; for brain, 1.0(1.5), 1.1(1.4) and 1.0(1.1) mm; and for mediastinum, 3.3(4.6), 2.6(3.7) and 3.5(4.0) mm. The CTV-to-PTV margins had the smallest value for brain (3.6, 3.7 and 3.3mm) and the largest for mediastinum (11.5, 9.1 and 11.6mm). For pelvic treatments the means (and standard deviations) were 7.3 (1.6), 8.5 (0.8) and 9.6 (0.8) mm. Conclusions Systematic and random setup-errors were smaller than 5mm. The largest errors were found for organs with higher motion probability. The suggested safety margins were comparable to published values in previous but often smaller studies.	[Mesias, Macarena Cubillos; Boda-Heggemann, Judit; Thoelking, Johannes; Lohr, Frank; Wenz, Frederik; Wertz, Hansjoerg] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Radiat Oncol, Mannheim, Germany	Ruprecht Karls University Heidelberg	Wertz, H (corresponding author), Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Dept Radiat Oncol, Mannheim, Germany.	hansjoerg.wertz@umm.de	Lohr, Frank/AAC-2528-2022	Lohr, Frank/0000-0003-1014-5556	Deutsche Forschungsgemeinschaft; Ruprecht-Karls-Universitat Heidelberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruprecht-Karls-Universitat Heidelberg	We acknowledge the financial support of the Deutsche Forschungsgemeinschaft and Ruprecht-Karls-Universitat Heidelberg within the funding programme Open Access Publishing.	Bissonnette JP, 2012, MED PHYS, V39, P1946, DOI 10.1118/1.3690466; Boda-Heggemann J, 2011, STRAHLENTHER ONKOL, V187, P284, DOI 10.1007/s00066-011-2236-4; Borst GR, 2007, INT J RADIAT ONCOL, V68, P555, DOI 10.1016/j.ijrobp.2007.01.014; Chen YJ, 2012, INT J RADIAT ONCOL, V84, P289, DOI 10.1016/j.ijrobp.2011.10.068; De Los Santos J, 2013, INT J RADIAT ONCOL, V87, P33, DOI 10.1016/j.ijrobp.2013.02.021; Den RB, 2010, INT J RADIAT ONCOL, V76, P1353, DOI 10.1016/j.ijrobp.2009.03.059; Grills IS, 2008, INT J RADIAT ONCOL, V70, P1045, DOI 10.1016/j.ijrobp.2007.07.2352; Huang K, 2012, INT J RADIAT ONCOL, V84, P402, DOI 10.1016/j.ijrobp.2011.12.035; Jaffray DA, 2002, INT J RADIAT ONCOL, V53, P1337, DOI 10.1016/S0360-3016(02)02884-5; Korreman S, 2010, RADIOTHER ONCOL, V94, P129, DOI 10.1016/j.radonc.2010.01.004; Lu HM, 2012, J RADIAT RES, V53, P954, DOI 10.1093/jrr/rrs041; Mayyas E, 2013, MED PHYS, V40, DOI 10.1118/1.4794502; Ost P, 2011, INT J RADIAT ONCOL, V79, P188, DOI 10.1016/j.ijrobp.2009.10.029; Qi XSR, 2013, J RADIOTHER PRACT, V12, P334, DOI 10.1017/S1460396912000337; Qi XS, 2013, INT J RADIAT ONCOL, V86, P432, DOI 10.1016/j.ijrobp.2013.01.022; Santanam L, 2008, INT J RADIAT ONCOL, V71, P1511, DOI 10.1016/j.ijrobp.2008.03.070; Snir JA, 2011, CLIN ONCOL-UK, V23, P625, DOI 10.1016/j.clon.2011.03.007; Tryggestad E, 2011, INT J RADIAT ONCOL, V80, P281, DOI 10.1016/j.ijrobp.2010.06.022; van Herk M, 2004, SEMIN RADIAT ONCOL, V14, P52, DOI 10.1053/j.semradonc.2003.10.003; Velec M, 2010, INT J RADIAT ONCOL, V76, P949, DOI 10.1016/j.ijrobp.2009.07.004; Verellen D, 2007, NAT REV CANCER, V7, P949, DOI 10.1038/nrc2288; Wong JR, 2008, INT J RADIAT ONCOL, V72, P1396, DOI 10.1016/j.ijrobp.2008.03.045; Yeung AR, 2009, INT J RADIAT ONCOL, V74, P1100, DOI 10.1016/j.ijrobp.2008.09.048	23	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150326	10.1371/journal.pone.0150326	http://dx.doi.org/10.1371/journal.pone.0150326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930196	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500127
J	Rovira, V; Geijo-Barrientos, E				Rovira, Victor; Geijo-Barrientos, Emilio			Intra- and Interhemispheric Propagation of Electrophysiological Synchronous Activity and Its Modulation by Serotonin in the Cingulate Cortex of Juvenile Mice	PLOS ONE			English	Article							EPILEPTIFORM ACTIVITY; ANTERIOR CINGULATE; CORTICAL PROJECTIONS; SYNAPTIC ACTIVITY; RAT-BRAIN; RETROSPLENIAL CORTEX; ENTORHINAL CORTEX; PREFRONTAL CORTEX; 5-HT1A RECEPTOR; CEREBRAL-CORTEX	Disinhibition of the cortex (e.g., by GABA -receptor blockade) generates synchronous and oscillatory electrophysiological activity that propagates along the cortex. We have studied, in brain slices of the cingulate cortex of mice (postnatal age 14-20 days), the propagation along layer 2/3 as well as the interhemispheric propagation through the corpus callosum of synchronous discharges recorded extracellularly and evoked in the presence of 10 mu M bicuculline by electrical stimulation of layer 1. The latency of the responses obtained at the same distance from the stimulus electrode was longer in anterior cingulate cortex (ACC: 39.53 +/- 2.83 ms, n = 7) than in retrosplenial cortex slices (RSC: 21.99 +/- 2.75 ms, n = 5; p<0.05), which is equivalent to a lower propagation velocity in the dorso-ventral direction in ACC than in RSC slices (43.0 mm/s vs 72.9 mm/s). We studied the modulation of this propagation by serotonin. Serotonin significantly increased the latency of the intracortical synchronous discharges (18.9% in the ipsilateral hemisphere and 40.2% in the contralateral hemisphere), and also increased the interhemispheric propagation time by 86.4%. These actions of serotonin were mimicked by the activation of either 5-HT1B or 5-HT2A receptors, but not by the activation of the 5-HT1A subtype. These findings provide further knowledge about the propagation of synchronic electrical activity in the cerebral cortex, including its modulation by serotonin, and suggest the presence of deep differences between the ACC and RSC in the structure of the local cortical microcircuits underlying the propagation of synchronous discharges.	[Rovira, Victor; Geijo-Barrientos, Emilio] Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante, Spain; [Rovira, Victor] Drexel Univ, Coll Med, 2900 W Queen Ln, Philadelphia, PA 19129 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Drexel University	Geijo-Barrientos, E (corresponding author), Univ Miguel Hernandez, CSIC, Inst Neurociencias, Alicante, Spain.	emilio.geijo@umh.es	Geijo-Barrientos, Emilio/ABE-5013-2020	Geijo-Barrientos, Emilio/0000-0001-8655-0967	Generalitat Valenciana (Spain) PROMETEO II program [2014/014]; Fundacion Navarro-Tripodi (Alicante, Spain)	Generalitat Valenciana (Spain) PROMETEO II program; Fundacion Navarro-Tripodi (Alicante, Spain)	This work was supported by Generalitat Valenciana (Spain) PROMETEO II program grant 2014/014 and Fundacion Navarro-Tripodi (Alicante, Spain) grant 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alefeld M, 1998, EXP NEUROL, V153, P113, DOI 10.1006/exnr.1998.6837; Amargos-Bosch M, 2004, CEREB CORTEX, V14, P281, DOI 10.1093/cercor/bhg128; Andrade R, 2011, NEUROPHARMACOLOGY, V61, P382, DOI 10.1016/j.neuropharm.2011.01.015; ARANEDA R, 1991, NEUROSCIENCE, V40, P399, DOI 10.1016/0306-4522(91)90128-B; Bagdy G, 2007, J NEUROCHEM, V100, P857, DOI 10.1111/j.1471-4159.2006.04277.x; Beique JC, 2004, J PHYSIOL-LONDON, V556, P739, DOI 10.1113/jphysiol.2003.051284; Beique JC, 2007, P NATL ACAD SCI USA, V104, P9870, DOI 10.1073/pnas.0700436104; Boakes RJ, 1988, J PHYSL; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V542, P567, DOI 10.1113/jphysiol.2002.019059; Castro-Alamancos MA, 2000, J NEUROSCI, V20, P9195; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; DAVIES MF, 1987, BRAIN RES, V423, P347, DOI 10.1016/0006-8993(87)90861-4; de Curtis M, 2001, PROG NEUROBIOL, V63, P541, DOI 10.1016/S0301-0082(00)00026-5; Ferezou I, 2002, J NEUROSCI, V22, P7389; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; GUTNICK MJ, 1982, J NEUROPHYSIOL, V48, P1321, DOI 10.1152/jn.1982.48.6.1321; HABLITZ JJ, 1987, J NEUROPHYSIOL, V58, P1052, DOI 10.1152/jn.1987.58.5.1052; Hoover WB, 2007, BRAIN STRUCT FUNCT, V212, P149, DOI 10.1007/s00429-007-0150-4; Ichinohe N., 2012, FRONT NEUROANAT, V5, P1; KOSOFSKY BE, 1987, SYNAPSE, V1, P153, DOI 10.1002/syn.890010204; Kurotani T, 2013, BRAIN STRUCT FUNCT, V218, P239, DOI 10.1007/s00429-012-0398-1; Laurent A, 2002, J NEUROSCI, V22, P886, DOI 10.1523/JNEUROSCI.22-03-00886.2002; LIDOV HGW, 1980, NEUROSCIENCE, V5, P207, DOI 10.1016/0306-4522(80)90099-8; MCNAMARA JO, 1994, J NEUROSCI, V14, P3413; Meltzer HY, 2011, CURR OPIN PHARMACOL, V11, P59, DOI 10.1016/j.coph.2011.02.007; Murakoshi T, 2001, NEUROSCI LETT, V309, P117, DOI 10.1016/S0304-3940(01)02051-1; OHEARN E, 1984, BRAIN RES BULL, V13, P709, DOI 10.1016/0361-9230(84)90232-6; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; Pinto DJ, 2005, J NEUROSCI, V25, P8131, DOI 10.1523/JNEUROSCI.2278-05.2005; POMPEIANO M, 1992, J NEUROSCI, V12, P440; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; Puig MV, 2010, J NEUROSCI, V30, P2211, DOI 10.1523/JNEUROSCI.3335-09.2010; SALGADO D, 1995, BRAIN RES, V669, P176, DOI 10.1016/0006-8993(94)01235-A; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Santana N, 2004, CEREB CORTEX, V14, P1100, DOI 10.1093/cercor/bhh070; Sari Y, 2004, NEUROSCI BIOBEHAV R, V28, P565, DOI 10.1016/j.neubiorev.2004.08.008; SCHMITZ D, 1995, NEUROSCI LETT, V190, P37, DOI 10.1016/0304-3940(95)11494-H; Schmitz D, 1997, NEUROSCIENCE, V76, P449, DOI 10.1016/S0306-4522(96)00302-8; Schmitz D, 1998, J NEUROPHYSIOL, V80, P1116, DOI 10.1152/jn.1998.80.3.1116; Shibata H, 2004, NEUROSCI RES, V49, P1, DOI 10.1016/j.neures.2004.01.005; Shibata H, 2008, J COMP NEUROL, V506, P30, DOI 10.1002/cne.21523; SIMMONS PA, 1983, J NEUROPHYSIOL, V50, P838, DOI 10.1152/jn.1983.50.4.838; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; TANAKA E, 1993, J NEUROPHYSIOL, V69, P1749, DOI 10.1152/jn.1993.69.5.1749; Trevelyan AJ, 2007, J NEUROSCI, V27, P3383, DOI 10.1523/JNEUROSCI.0145-07.2007; Trevelyan AJ, 2006, J NEUROSCI, V26, P12447, DOI 10.1523/JNEUROSCI.2787-06.2006; Troca-Marin JA, 2010, PFLUG ARCH EUR J PHY, V460, P1073, DOI 10.1007/s00424-010-0875-4; Van De Werd HJJM, 2010, BRAIN STRUCT FUNCT, V214, P339, DOI 10.1007/s00429-010-0247-z; van Groen T, 2003, J COMP NEUROL, V463, P249, DOI 10.1002/cne.10757; VANGROEN T, 1992, J COMP NEUROL, V315, P200, DOI 10.1002/cne.903150207; VANGROEN T, 1990, J COMP NEUROL, V300, P593, DOI 10.1002/cne.903000412; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; VOGT BA, 1981, J COMP NEUROL, V195, P603, DOI 10.1002/cne.901950406; Vogt BA, 2014, BRAIN STRUCT FUNCT, V219, P185, DOI 10.1007/s00429-012-0493-3; Walker J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031415; Wartman BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108711; Weber ET, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00036; WYSS JM, 1990, J COMP NEUROL, V295, P33; Zhuo M, 2007, MOL CELLS, V23, P259	63	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150092	10.1371/journal.pone.0150092	http://dx.doi.org/10.1371/journal.pone.0150092			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930051	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500098
J	Barisione, C; Garibaldi, S; Furfaro, AL; Nitti, M; Palmieri, D; Passalacqua, M; Garuti, A; Verzola, D; Parodi, A; Ameri, P; Altieri, P; Fabbi, P; Ferrar, PF; Brunelli, C; Arsenescu, V; Balbi, M; Palombo, D; Ghigliotti, G				Barisione, Chiara; Garibaldi, Silvano; Furfaro, Anna Lisa; Nitti, Mariapaola; Palmieri, Daniela; Passalacqua, Mario; Garuti, Anna; Verzola, Daniela; Parodi, Alessia; Ameri, Pietro; Altieri, Paola; Fabbi, Patrizia; Ferrar, Pier Francesco; Brunelli, Claudio; Arsenescu, Violeta; Balbi, Manrico; Palombo, Domenico; Ghigliotti, Giorgio			Moderate Increase of Indoxyl Sulfate Promotes Monocyte Transition into Profibrotic Macrophages	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; UREMIC TOXIN; CARDIOVASCULAR-DISEASE; AORTIC-ANEURYSMS; ARTERY-DISEASE; ACTIVATION; EXPRESSION; DIFFERENTIATION; INFLAMMATION; SUBSETS	Objective The uremic toxin Indoxyl-3-sulphate (IS), a ligand of Aryl hydrocarbon Receptor (AhR), raises in blood during early renal dysfunction as a consequence of tubular damage, which may be present even when eGFR is normal or only moderately reduced, and promotes cardiovascular damage and monocyte-macrophage activation. We previously found that patients with abdominal aortic aneurysms (AAAs) have higher CD14(+) CD16(+) monocyte frequency and prevalence of moderate chronic kidney disease (CKD) than age-matched control subjects. Here we aimed to evaluate the IS levels in plasma from AAA patients and to investigate in vitro the effects of IS concentrations corresponding to mild-to-moderate CKD on monocyte polarization and macrophage differentiation. Methods Free IS plasma levels, monocyte subsets and laboratory parameters were evaluated on blood from AAA patients and eGFR-matched controls. THP-1 monocytes, treated with IS 1, 10, 20 mu M were evaluated for CD163 expression, AhR signaling and then induced to differentiate intomacrophages by PMA. Their phenotype was evaluated both at the stage of semi-differentiated and fully differentiatedmacrophages. AAA and control sera were similarly used to treat THP-1 monocytes and the resulting macrophage phenotype was analyzed. Results IS plasma concentration correlated positively with CD14(+) CD16(+) monocytes and was increased in AAA patients. In THP-1 cells, IS promoted CD163 expression and transition to macrophages with hallmarks of classical (IL-6, CCL2, COX2) and alternative phenotype (IL10, PPAR gamma, TGF-beta, TIMP-1), via AhR/Nrf2 activation. Analogously, AAA sera induced differentiation of macrophages with enhanced IL-6, MCP1, TGF-beta, PPAR gamma and TIMP-1 expression. Conclusion IS skews monocyte differentiation toward low-inflammatory, profibrotic macrophages and may contribute to sustain chronic inflammation and maladaptive vascular remodeling.	[Barisione, Chiara; Garibaldi, Silvano; Ameri, Pietro; Altieri, Paola; Fabbi, Patrizia; Brunelli, Claudio; Balbi, Manrico; Ghigliotti, Giorgio] Univ Genoa, IRCCS Univ Hosp San Martino, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy; [Furfaro, Anna Lisa] Giannina Gaslini Inst, Genoa, Italy; [Nitti, Mariapaola; Passalacqua, Mario] Univ Genoa, Dept Expt Med, Genoa, Italy; [Palmieri, Daniela; Palombo, Domenico] Univ Genoa, Unit Vasc & Endovasc Surg, Genoa, Italy; [Garuti, Anna] Univ Genoa, IRCCS Univ Hosp San Martino, Dept Internal Med, Genoa, Italy; [Verzola, Daniela] Univ Genoa, IRCCS Univ Hosp San Martino, Div Nephrol, Dept Internal Med, Genoa, Italy; [Parodi, Alessia] Univ Genoa, CEBR, Genoa, Italy; [Ferrar, Pier Francesco] Univ Genoa, Dept Civil Chem & Environm Engn, Genoa, Italy; [Arsenescu, Violeta] Ohio State Univ, Div Gastroenterol Hepatol & Nutr, Columbus, OH 43210 USA	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; University of Genoa; University of Genoa; University System of Ohio; Ohio State University	Barisione, C (corresponding author), Univ Genoa, IRCCS Univ Hosp San Martino, Div Cardiol, Res Ctr Cardiovasc Biol, Genoa, Italy.	chiara.barisione@unige.it	balbi, manrico/AAC-9676-2019; Nitti, Mariapaola/ABB-1067-2020; Passalacqua, Mario/W-1973-2019; Ameri, Pietro/K-8556-2016; Verzola, Daniela/U-2761-2019	Passalacqua, Mario/0000-0003-2779-6259; Ameri, Pietro/0000-0001-7167-7287; Ghigliotti, Giorgio/0000-0001-8484-542X; VERZOLA, Daniela/0000-0002-2790-5876				Adesso S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076778; Amoruso A, 2007, LIFE SCI, V81, P906, DOI 10.1016/j.lfs.2007.07.017; Arsenescu R, 2011, INFLAMM BOWEL DIS, V17, P1149, DOI 10.1002/ibd.21463; Arsenescu V, 2008, ENVIRON HEALTH PERSP, V116, P761, DOI 10.1289/ehp.10554; Azizzadeh A, 2006, J VASC SURG, V43, P14, DOI 10.1016/j.jvs.2005.08.037; Bahr IN, 2011, HYPERTENSION, V58, P725, DOI 10.1161/HYPERTENSIONAHA.111.173542; Barisione C, 2015, CURR DRUG TARGETS, V16, P366, DOI 10.2174/1389450116666141230114500; Barisione C, 2010, DIS MARKERS, V28, P115, DOI [10.1155/2010/236405, 10.3233/DMA-2010-0691]; Bolati D, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-56; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Boyle JJ, 2011, ARTERIOSCL THROM VAS, V31, P2685, DOI 10.1161/ATVBAHA.111.225813; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Bystrom J, 2008, BLOOD, V112, P4117, DOI 10.1182/blood-2007-12-129767; Damman K, 2011, EUR HEART J, V32, P2705, DOI 10.1093/eurheartj/ehr190; Dawson J, 2006, ANN NY ACAD SCI, V1085, P320, DOI 10.1196/annals.1383.009; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; DiNatale BC, 2010, J BIOL CHEM, V285, P24388, DOI 10.1074/jbc.M110.118570; Evans BR, 2008, MOL PHARMACOL, V73, P387, DOI 10.1124/mol.107.040204; Figarola JL, 2012, INVEST NEW DRUG, V30, P1413, DOI 10.1007/s10637-011-9711-8; Gasiewicz TA, 2010, CHEM-BIOL INTERACT, V184, P246, DOI 10.1016/j.cbi.2009.10.019; Ghigliotti G, 2013, DIS MARKERS, V34, P131, DOI 10.1155/2013/836849; Gondouin B, 2013, KIDNEY INT, V84, P733, DOI 10.1038/ki.2013.133; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Kaneko H, 2011, CARDIOVASC RES, V91, P358, DOI 10.1093/cvr/cvr080; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Lin CJ, 2012, ATHEROSCLEROSIS, V225, P173, DOI 10.1016/j.atherosclerosis.2012.07.012; Lin CJ, 2011, J CLIN LAB ANAL, V25, P191, DOI 10.1002/jcla.20456; Majkova Z, 2009, TOXICOL APPL PHARM, V237, P1, DOI 10.1016/j.taap.2009.02.016; Medjakovic S, 2010, NUTRIENTS, V2, P241, DOI 10.3390/nu2030241; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Phillips RJ, 2005, J INFLAMM-LOND, V31, P2; Platzer B, 2009, J IMMUNOL, V183, P66, DOI 10.4049/jimmunol.0802997; Polfliet MMJ, 2006, IMMUNOBIOLOGY, V211, P419, DOI 10.1016/j.imbio.2006.05.015; Polvani S, 2012, PPAR RES, V2012, DOI 10.1155/2012/641087; Rateri DL, 2011, AM J PATHOL, V179, P1542, DOI 10.1016/j.ajpath.2011.05.049; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Schroeder JC, 2010, BIOCHEMISTRY-US, V49, P393, DOI 10.1021/bi901786x; Shantsila E, 2011, J THROMB HAEMOST, V9, P1056, DOI 10.1111/j.1538-7836.2011.04244.x; Shantsila E, 2014, ATHEROSCLEROSIS, V234, P4, DOI 10.1016/j.atherosclerosis.2014.02.009; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Takada Y, 2010, J IMMUNOL, V184, P2671, DOI 10.4049/jimmunol.0804012; Tang WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119545; Ugocsai P, 2006, CYTOM PART A, V69A, P203, DOI 10.1002/cyto.a.20235; Ullevig S, 2012, ARTERIOSCL THROM VAS, V32, P415, DOI 10.1161/ATVBAHA.111.238899; Urbani S, 2006, CYTOTHERAPY, V8, P243, DOI 10.1080/14653240600735834; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Viaene L, 2013, BIOPHARM DRUG DISPOS, V34, P165, DOI 10.1002/bdd.1834; Virzi GM, 2015, AM J NEPHROL, V41, P474, DOI 10.1159/000438459; Wang MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016653; Watanabe I, 2013, CIRC J, V77, P224, DOI 10.1253/circj.CJ-12-0647; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	54	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149276	10.1371/journal.pone.0149276	http://dx.doi.org/10.1371/journal.pone.0149276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925780	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200008
J	Miyata, S; Kurachi, M; Okano, Y; Sakurai, N; Kobayashi, A; Harada, K; Yamagata, H; Matsuo, K; Takahashi, K; Narita, K; Fukuda, M; Ishizaki, Y; Mikuni, M				Miyata, Shigeo; Kurachi, Masashi; Okano, Yoshiko; Sakurai, Noriko; Kobayashi, Ayumi; Harada, Kenichiro; Yamagata, Hirotaka; Matsuo, Koji; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Ishizaki, Yasuki; Mikuni, Masahiko			Blood Transcriptomic Markers in Patients with Late-Onset Major Depressive Disorder	PLOS ONE			English	Article							TREATMENT-RESISTANT DEPRESSION; LATE-LIFE DEPRESSION; GENE-EXPRESSION; ANIMAL-MODELS; RIBONUCLEASES; BIOMARKERS; PURIFICATION; DISABILITY; SIGNATURES; PATHWAYS	We investigated transcriptomic markers of late-onset major depressive disorder (LOD; onset age of first depressive episode >= 50 years) from the genes expressed in blood cells and identified state-dependent transcriptomic markers in these patients. We assessed the genes expressed in blood cells by microarray and found that the expression levels of 3,066 probes were state-dependently changed in the blood cells of patients with LOD. To select potential candidates from those probes, we assessed the genes expressed in the blood of an animal model of depression, ovariectomized female mice exposed to chronic ultra-mild stress, by microarray and cross-matched the differentially expressed genes between the patients and the model mice. We identified 14 differentially expressed genes that were similarly changed in both patients and the model mice. By assessing statistical significance using real-time quantitative PCR (RT-qPCR), the following 4 genes were selected as candidates: cell death-inducing DFFA-like effector c (CIDEC), ribonuclease 1 (RNASE1), solute carrier family 36 member-1 (SLC36A1), and serine/threonine/tyrosine interacting-like 1 (STYXL1). The discriminating ability of these 4 candidate genes was evaluated in an independent cohort that was validated. Among them, CIDEC showed the greatest discriminant validity (sensitivity 91.3% and specificity 87.5%). Thus, these 4 biomarkers should be helpful for properly diagnosing LOD.	[Miyata, Shigeo; Okano, Yoshiko; Sakurai, Noriko; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Psychiat, Maebashi, Gunma 371, Japan; [Miyata, Shigeo; Okano, Yoshiko; Sakurai, Noriko; Takahashi, Keisuke; Narita, Kosuke; Fukuda, Masato; Mikuni, Masahiko] Gunma Univ, Grad Sch Med, Dept Neurosci, Maebashi, Gunma 371, Japan; [Kurachi, Masashi; Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma 371, Japan; [Kobayashi, Ayumi; Harada, Kenichiro; Yamagata, Hirotaka; Matsuo, Koji] Yamaguchi Univ, Grad Sch Med, Dept Neurosci, Div Neuropsychiat, Ube, Yamaguchi 755, Japan	Gunma University; Gunma University; Gunma University; Yamaguchi University	Miyata, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Psychiat, Maebashi, Gunma 371, Japan.; Miyata, S (corresponding author), Gunma Univ, Grad Sch Med, Dept Neurosci, Maebashi, Gunma 371, Japan.	s_miyata@gunma-u.ac.jp	Miyata, Shigeo/AAQ-6584-2021; Ishizaki, Yasuki/AAB-1209-2020	Miyata, Shigeo/0000-0003-1713-805X; 	Grants-in-Aid for Scientific Research [25670509] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Belzeaux R, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.112; Chan MK, 2014, PROG NEUROBIOL, V122, P45, DOI 10.1016/j.pneurobio.2014.08.002; Cho Peter, 2004, Implant Dent, V13, P79, DOI 10.1097/01.ID.0000116456.76235.BC; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; Diniz BS, 2013, BRIT J PSYCHIAT, V202, P329, DOI 10.1192/bjp.bp.112.118307; Fekadu A, 2009, J AFFECT DISORDERS, V116, P4, DOI 10.1016/j.jad.2008.10.014; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Gansler J, 2014, FASEB J, V28, P752, DOI 10.1096/fj.13-238600; Ghaemi SN, 2000, J CLIN PSYCHIAT, V61, P804, DOI 10.4088/JCP.v61n1013; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; Guilloux JP, 2015, NEUROPSYCHOPHARMACOL, V40, P701, DOI 10.1038/npp.2014.226; Hepgul N, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-28; Hu C, 2015, J AFFECT DISORDERS, V170, P266, DOI 10.1016/j.jad.2014.09.008; Inohara N, 1998, EMBO J, V17, P2526, DOI 10.1093/emboj/17.9.2526; Isrie M, 2015, EUR J MED GENET, V58, P205, DOI 10.1016/j.ejmg.2015.02.006; Ito M, 2011, J LIPID RES, V52, P1450, DOI 10.1194/jlr.M012427; Janssen J, 2006, INT J GERIATR PSYCH, V21, P86, DOI 10.1002/gps.1428; Kendler KS, 2009, BIOL PSYCHIAT, V65, P808, DOI 10.1016/j.biopsych.2008.11.015; Keri S, 2014, J AFFECT DISORDERS, V164, P118, DOI 10.1016/j.jad.2014.04.030; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; Kupfer DJ, 2012, LANCET, V379, P1045, DOI 10.1016/S0140-6736(11)60602-8; Le-Niculescu H, 2009, MOL PSYCHIATR, V14, P156, DOI 10.1038/mp.2008.11; Liang L, 2003, BIOCHEM J, V370, P195, DOI 10.1042/BJ20020656; Liu ML, 2004, INT J CARDIOL, V97, P485, DOI 10.1016/j.ijcard.2003.11.046; Maciejak A, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0149-z; MIZUTA K, 1990, ARCH BIOCHEM BIOPHYS, V281, P144, DOI 10.1016/0003-9861(90)90424-W; Muhonen LH, 2009, PSYCHIAT RES, V167, P115, DOI 10.1016/j.psychres.2008.05.001; Naismith SL, 2012, PROG NEUROBIOL, V98, P99, DOI 10.1016/j.pneurobio.2012.05.009; Nakagawasai O, 2009, LIFE SCI, V84, P512, DOI 10.1016/j.lfs.2009.01.009; Nielsen CU, 2013, BRIT J PHARMACOL, V170, P1041, DOI 10.1111/bph.12341; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Pajer K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.26; Park SC, 2014, YONSEI MED J, V55, P1712, DOI 10.3349/ymj.2014.55.6.1712; Pereira PA, 2014, INT J GERIATR PSYCH, V29, P399, DOI 10.1002/gps.4018; Redei EE, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.66; Redei EE, 2015, ANN NY ACAD SCI, V1344, P37, DOI 10.1111/nyas.12748; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; SATO S, 2013, CNS DRUGS S1, V27, pS; Sharma V, 2005, J AFFECT DISORDERS, V84, P251, DOI 10.1016/j.jad.2004.01.015; Sorrentino S, 1998, CELL MOL LIFE SCI, V54, P785, DOI 10.1007/s000180050207; Sung SC, 2013, PSYCHOL MED, V43, P945, DOI 10.1017/S0033291712001742; Do TTH, 2014, AM J PHYSIOL-ENDOC M, V306, pE668, DOI 10.1152/ajpendo.00437.2013; Uchida S, 2011, NEURON, V69, P359, DOI 10.1016/j.neuron.2010.12.023; Walker DK, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.238; YASUDA T, 1993, BIOCHEM J, V296, P617, DOI 10.1042/bj2960617; Yi ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031283; Yonezawa T, 2011, MOL BIOSYST, V7, P91, DOI 10.1039/c0mb00099j; Zhang Y, 2014, BIOMED ENVIRON SCI, V27, P462, DOI 10.3967/bes2014.074; Zisook S, 2004, PSYCHIAT RES, V129, P127, DOI 10.1016/j.psychres.2004.07.004	50	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150262	10.1371/journal.pone.0150262	http://dx.doi.org/10.1371/journal.pone.0150262			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926397	Green Submitted, gold, Green Published			2022-12-27	WOS:000371424200032
J	Black, CM; Yu, E; McCann, E; Kachroo, S				Black, Christopher M.; Yu, Eric; McCann, Eilish; Kachroo, Sumesh			Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data	PLOS ONE			English	Article							MAINTAINS CLINICAL REMISSION; EFFICACY; SAFETY; ALPHA	Objective To describe the real-world use of adalimumab for maintenance treatment of ulcerative colitis (UC) and associated healthcare costs in English hospitals. Design Retrospective cohort study. Setting Analysis of NHS Hospital Episode Statistics linked with pharmacy dispensing data in English hospitals. Patients Adult UC patients receiving >= 240mg during adalimumab treatment induction, subsequently maintained on adalimumab. Outcomes Frequency and pattern of adalimumab use and dose escalation during maintenance treatment and associated healthcare costs (prescriptions and hospital visits). Results 191 UC patients completed adalimumab treatment induction. 83 (43.46%) dose escalated during maintenance treatment by >= 100% (equivalent to weekly dosing) (median time to dose escalation: 139 days). 56 patients (67.47%) subsequently de-escalated by >= 50% (median time to dose de-escalation: 21 days). Mean all-cause healthcare costs for all patients <= 12 months of index were 13,892 pound. Dose escalators incurred greater mean healthcare costs than non-escalators <= 12 months of index (14,596 pound vs. 13,351) pound. Prescriptions accounted for 96.49% of UC-related healthcare costs (11,090 pound of 11,494 pound in all patients). Conclusions Within the cohort, 43.46% of UC patients escalated their adalimumab dose by >= 100% and incurred greater costs than non-escalators. The apparent underestimation of adalimumab dose escalation in previous studies may have resulted in underestimated costs in healthcare systems.	[Black, Christopher M.; Kachroo, Sumesh] Merck & Co Inc, Kenilworth, NJ USA; [Yu, Eric] IMS Hlth Ltd, London, England; [McCann, Eilish] Merck Sharp & Dohme Ltd, Hoddesdon, England	Merck & Company; Merck & Company	Kachroo, S (corresponding author), Merck & Co Inc, Kenilworth, NJ USA.	sumesh.kachroo@merck.com		Black, Christopher/0000-0003-2934-108X	Merck & Co., Inc., Kenilworth, NJ, USA	Merck & Co., Inc., Kenilworth, NJ, USA	This study was funded by Merck & Co., Inc., Kenilworth, NJ, USA. EY is a consultant to Merck & Co., Inc. through his employment at IMS Health Ltd. All authors, including the sponsor, played a role in study design, data analysis, interpretation of data, decision to publish and preparation of the manuscript.	Baert F, 2013, J CROHNS COLITIS, V7, P154, DOI 10.1016/j.crohns.2012.03.018; Baki E, 2015, WORLD J GASTROENTERO, V21, P3282, DOI 10.3748/wjg.v21.i11.3282; Colombel JF, 2014, AM J GASTROENTEROLOG; Fausel R, 2015, THER CLIN RISK MANAG, V11, P63, DOI 10.2147/TCRM.S55506; National Institute for Health Care and Excellence (NICE), 2015, INFL AD GOL TREAT MO; NICE, 2015, COST STAT ULC COL IM; Reinisch W, 2011, GUT, V60, P780, DOI 10.1136/gut.2010.221127; Royal College of Physicians, 2014, NAT CLIN AUD BIOL TH; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; SPC, 2015, SIMP 100MG SOL INJ; SPC, 2015, HUM PREF PEN PREF SY; SPC, 2015, REM 100MG POWD CONC; Suzuki Y, 2014, J GASTROENTEROL, V49, P283, DOI 10.1007/s00535-013-0922-y; UK Government Department of Health, 2015, PAYM RES NHS TAR 201; Warner B, 2012, GASTROENTEROLOGY, V143, pE42, DOI 10.1053/j.gastro.2012.03.055; Wolf D, 2014, ALIMENT PHARM THER, V40, P486, DOI 10.1111/apt.12863	16	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149692	10.1371/journal.pone.0149692	http://dx.doi.org/10.1371/journal.pone.0149692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919745	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400036
J	Brunton, SL; Brunton, BW; Proctor, JL; Kutz, JN				Brunton, Steven L.; Brunton, Bingni W.; Proctor, Joshua L.; Kutz, J. Nathan			Koopman Invariant Subspaces and Finite Linear Representations of Nonlinear Dynamical Systems for Control	PLOS ONE			English	Article							CARLEMAN LINEARIZATION; SPECTRAL PROPERTIES; MODE DECOMPOSITION; VARIABLES; EQUATIONS; PATTERNS; BEHAVIOR; SERIES; SETS	In this work, we explore finite-dimensional linear representations of nonlinear dynamical systems by restricting the Koopman operator to an invariant subspace spanned by specially chosen observable functions. The Koopman operator is an infinite-dimensional linear operator that evolves functions of the state of a dynamical system. Dominant terms in the Koopman expansion are typically computed using dynamic mode decomposition (DMD). DMD uses linear measurements of the state variables, and it has recently been shown that this may be too restrictive for nonlinear systems. Choosing the right nonlinear observable functions to form an invariant subspace where it is possible to obtain linear reduced-order models, especially those that are useful for control, is an open challenge. Here, we investigate the choice of observable functions for Koopman analysis that enable the use of optimal linear control techniques on nonlinear problems. First, to include a cost on the state of the system, as in linear quadratic regulator (LQR) control, it is helpful to include these states in the observable subspace, as in DMD. However, we find that this is only possible when there is a single isolated fixed point, as systems with multiple fixed points or more complicated attractors are not globally topologically conjugate to a finite-dimensional linear system, and cannot be represented by a finite-dimensional linear Koopman subspace that includes the state. We then present a data-driven strategy to identify relevant observable functions for Koopman analysis by leveraging a new algorithm to determine relevant terms in a dynamical system by l(1)-regularized regression of the data in a nonlinear function space; we also show how this algorithm is related to DMD. Finally, we demonstrate the usefulness of nonlinear observable subspaces in the design of Koopman operator optimal control laws for fully nonlinear systems using techniques from linear optimal control.	[Brunton, Steven L.] Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA; [Brunton, Bingni W.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Proctor, Joshua L.] Inst Dis Modeling, Bellevue, WA 98004 USA; [Kutz, J. Nathan] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brunton, SL (corresponding author), Univ Washington, Dept Mech Engn, Seattle, WA 98195 USA.	sbrunton@uw.edu	Brunton, Steven/AAG-3871-2019	Brunton, Steven/0000-0002-6565-5118	University of Washington; Institute of Disease Modeling; Global Good Fund; US Air Force Office of Scientific Research [FA9550-09-0174]; AFOSR Center of Excellence in Nature Inspired Flight Technologies and Ideas [FA9550-14-1-0398]; Washington Research Foundation; U.S. Air Force Research Labs [FA8651-16-1-0003]	University of Washington(University of Washington); Institute of Disease Modeling; Global Good Fund; US Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); AFOSR Center of Excellence in Nature Inspired Flight Technologies and Ideas; Washington Research Foundation; U.S. Air Force Research Labs	SLB and BWB received funding from University of Washington Start-Up Grants. JLP received support through the Institute of Disease Modeling, which is supported by Bill and Melinda Gates, along with the Global Good Fund. JNK received support from the US Air Force Office of Scientific Research (FA9550-09-0174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Clancy Rowley for insightful and constructive comments on an early draft of this paper, especially his observation that the state can often be recovered from the intrinsic eigenfunction coordinates. We also thank Igor Mezic for making us aware of Carleman linearization and the extremely interesting literature on operator theoretic control of nonlinear systems. SLB acknowledges support from the AFOSR Center of Excellence in Nature Inspired Flight Technologies and Ideas (FA9550-14-1-0398). BWB acknowledges support from the Washington Research Foundation. BWB and SLB acknowledge support from the U.S. Air Force Research Labs (FA8651-16-1-0003). JLP thanks Bill and Melinda Gates for their active support of the Institute of Disease Modeling and their sponsorship through the Global Good Fund. JNK acknowledges support from the U.S. Air Force Office of Scientific Research (FA9550-09-0174).	Abraham R., 1988, APPL MATH SCI, V75; [Anonymous], 2008, 61 ANN M APS DIV FLU; Bagheri S, 2013, J FLUID MECH, V726, P596, DOI 10.1017/jfm.2013.249; Bai Z, 2015, AIAA J, V53, P920, DOI 10.2514/1.J053287; BANKS SP, 1992, INT J SYST SCI, V23, P663, DOI 10.1080/00207729208949241; Belson BA, 2014, ACM T MATH SOFTWARE, V40, DOI 10.1145/2616912; Berger E, 2015, ADV ROBOTICS, V29, P331, DOI 10.1080/01691864.2014.981292; Bongard J, 2007, P NATL ACAD SCI USA, V104, P9943, DOI 10.1073/pnas.0609476104; BROCKETT RW, 1976, AUTOMATICA, V12, P167, DOI 10.1016/0005-1098(76)90080-7; Brunton BW, 2016, J NEUROSCI METH, V258, P1, DOI 10.1016/j.jneumeth.2015.10.010; Brunton SL, 2015, J COMPUTATI IN PRESS; Brunton SL, 2015, PREPRINT; Brunton SL, 2015, APPL MECH REV, V67, DOI 10.1115/1.4031175; Brunton SL, 2014, SIAM J APPL DYN SYST, V13, P1716, DOI 10.1137/130949282; Budisic M, 2012, CHAOS, V22, DOI 10.1063/1.4772195; Budisic M, 2012, PHYSICA D, V241, P1255, DOI 10.1016/j.physd.2012.04.006; Budisic M, 2009, IEEE DECIS CONTR P, P3162, DOI 10.1109/CDC.2009.5400512; Carleman T, 1932, ACTA MATH-DJURSHOLM, V59, P63, DOI 10.1007/BF02546499; Dawson STM, 2015, PREPRINT; Dellnitz M, 2001, ERGODIC THEORY, ANALYSIS, AND EFFICIENT SIMULATION OF DYNAMICAL SYSTEMS, P145; Erichson N., 2015, PREPRINT; Froyland G, 2005, PHYSICA D, V200, P205, DOI 10.1016/j.physd.2004.11.008; Froyland G, 2014, SIAM J APPL DYN SYST, V13, P1816, DOI 10.1137/130943637; Froyland G, 2009, PHYSICA D, V238, P1507, DOI 10.1016/j.physd.2009.03.002; Gardner JP, 2006, SPACE SCI REV, V123, P485, DOI 10.1007/s11214-006-8315-7; Grilli M, 2012, J FLUID MECH, V700, P16, DOI 10.1017/jfm.2012.37; Grosek J., 2014, PREPRINT; Guckenheimer J., 1983, NONLINEAR OSCILLATIO, V42; Gueniat F, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4908073; Hemati M. S., 2015, PREPRINT; Hemati MS, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4901016; Holmes P, 2012, CAMB MG MEC, P1, DOI 10.1017/CBO9780511919701; Jovanovic MR, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4863670; Kevrekidis IG, 2003, COMMUNICATIONS MATH, V1, P715, DOI DOI 10.4310/CMS.2003.V1.N4.A5; Koon W.S., 2000, INT C DIFF EQ, P1167, DOI [10.1142/9789812792617_0222, DOI 10.1142/9789812792617_0222]; Koopman BO, 1932, P NATL ACAD SCI USA, V18, P255, DOI 10.1073/pnas.18.3.255; Koopman BO, 1931, P NATL ACAD SCI USA, V17, P315, DOI 10.1073/pnas.17.5.315; Kowalski Krzysztof, 1991, WORLD SCI; Koza JR, 1999, LECT NOTES COMPUT SC, V1598, P93; Kutz J. N., 2016, PREPRINT; Kutz JN, 2015, CRC HDB ROBUST LOW R; Lan YH, 2013, PHYSICA D, V242, P42, DOI 10.1016/j.physd.2012.08.017; Mackey A, 2014, MULTISCALE MODEL SIM, V12, P1800, DOI 10.1137/140965909; Mezic I, 2005, NONLINEAR DYNAM, V41, P309, DOI 10.1007/s11071-005-2824-x; Mezic I, 2004, PHYSICA D, V197, P101, DOI 10.1016/j.physd.2004.06.015; Mezic I, 1999, CHAOS, V9, P213, DOI 10.1063/1.166399; Mezic I, 2013, ANNU REV FLUID MECH, V45, P357, DOI 10.1146/annurev-fluid-011212-140652; Ozolins V, 2013, P NATL ACAD SCI USA, V110, P18368, DOI 10.1073/pnas.1318679110; Proctor JL, 2014, EUR PHYS J-SPEC TOP, V223, P2665, DOI 10.1140/epjst/e2014-02285-8; Proctor JL, 2015, SIAM J APPL IN PRESS; Proctor JL, 2015, INT HEALTH, V7, P139, DOI 10.1093/inthealth/ihv009; Rowley CW, 2009, J FLUID MECH, V641, P115, DOI 10.1017/S0022112009992059; Schaeffer H, 2013, P NATL ACAD SCI USA, V110, P6634, DOI 10.1073/pnas.1302752110; Schmid PJ, 2011, EXP FLUIDS, V50, P1123, DOI 10.1007/s00348-010-0911-3; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; STEEB WH, 1980, J MATH ANAL APPL, V77, P601, DOI 10.1016/0022-247X(80)90250-4; SVORONOS SA, 1994, CHEM ENG SCI, V49, P3263, DOI 10.1016/0009-2509(94)00141-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tu J.H., 2014, J COMPUT DYN, V1, P391, DOI [10.3934/jcd.2014.1.391, DOI 10.3934/JCD.2014.1.391]; Wang WX, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.154101; Williams MO, 2015, J NONLINEAR SCI, V25, P1307, DOI 10.1007/s00332-015-9258-5; Williams MO, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/40007; Williams MO, 2014, PREPRINT	64	176	177	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150171	10.1371/journal.pone.0150171	http://dx.doi.org/10.1371/journal.pone.0150171			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919740	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400096
J	McLean, S; Kerherve, H; Lovell, GP; Gorman, AD; Solomon, C				McLean, Scott; Kerherve, Hugo; Lovell, Geoff P.; Gorman, Adam D.; Solomon, Colin			The Effect of Recovery Duration on Vastus Lateralis Oxygenation, Heart Rate, Perceived Exertion and Time Motion Descriptors during Small Sided Football Games	PLOS ONE			English	Article							PLAYERS PHYSIOLOGICAL-RESPONSES; INTENSITY INTERMITTENT EXERCISE; NEAR-INFRARED SPECTROSCOPY; YOUTH SOCCER PLAYERS; PACING STRATEGIES; TECHNICAL ACTIVITIES; MUSCLE OXYGENATION; PASSIVE RECOVERY; PERFORMANCE; DEMANDS	Purpose Small sided games (SSG) of football are an effective and efficient format to simultaneously train the physiological, technical, and tactical components of football. The duration of the recovery period between bouts of SSG will affect the physiological response to subsequent bouts. It was hypothesised that decreasing the duration of recovery periods separating serial SSG bouts would increase physiological, and perceptual responses, and decrease high speed running, and distance during SSG bouts. Methods Twelve experienced footballers (mean +/- SD; age 21 +/- 3 yrs; VO2peak 64 +/- 7 ml.min.kg(-1); playing experience 15 +/- 3 yrs) completed two SSG sessions. Each SSG consisted of 3 vs. 3 players and 6 bouts of 2 min duration, with bouts separated by either 30 s recovery (REC-30) or 120 s recovery (REC-120). Deoxygenated haemoglobin (HHb) in the vastus lateralis (VL) (using near infrared spectroscopy), heart rate (HR) and time motion descriptors (TMD) (speed and distance) were measured continuously during the SSG sessions and perceived exertion (RPE) was measured for each bout. Results During the recovery periods, in REC-30 compared to REC-120, there was a significant (p < 0.05) main effect of a higher HHb and HR. During the bouts, in REC-30 compared to REC-120, there were no significant differences in HHb, HR, RPE, or TMD, but within both REC-30 and REC-120 there were significant increases as a function of bout number in RPE. Conclusions Although a four-fold increase in recovery period allowed a significant increase in the recovery of HHb and HR, this did not increase the physiological, and perceptual responses, or time motion descriptors during the bouts. These results could have been due to the regulation of effort (pacing), in these experienced players performing an exercise task to which they were well adapted.	[McLean, Scott; Kerherve, Hugo; Gorman, Adam D.; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Exercise Sci, Sippy Downs, Qld 4556, Australia; [Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Sippy Downs, Qld 4556, Australia; [Kerherve, Hugo] Univ Lyon, Lab Physiol Exercice, F-42023 St Etienne, France	University of the Sunshine Coast; University of the Sunshine Coast	McLean, S (corresponding author), Univ Sunshine Coast, Sch Hlth & Exercise Sci, Sippy Downs, Qld 4556, Australia.	smclean@usc.edu.au	Gorman, Adam/K-2415-2016; McLean, Scott/AAA-3891-2020	Gorman, Adam/0000-0003-2847-7268; McLean, Scott/0000-0002-7269-5847				Aguiar MVD, 2013, J STRENGTH COND RES, V27, P1287, DOI 10.1519/JSC.0b013e318267a35c; Aroso J, 2004, J SPORT SCI, V22, P522; Aslan A, 2013, J HUM KINET, V38, P95, DOI 10.2478/hukin-2013-0049; BALSOM PD, 1992, INT J SPORTS MED, V13, P528, DOI 10.1055/s-2007-1021311; Bangsbo J, 1994, Acta Physiol Scand Suppl, V619, P1; Billaut F, 2011, MED SCI SPORT EXER, V43, P665, DOI 10.1249/MSS.0b013e3181f6ee3b; Brandes M, 2012, J STRENGTH COND RES, V26, P1353, DOI 10.1519/JSC.0b013e318231ab99; Buchheit M, 2010, INT J SPORTS MED, V31, P402, DOI 10.1055/s-0030-1249620; Buchheit M, 2009, INT J SPORTS MED, V30, P418, DOI 10.1055/s-0028-1105933; Casamichana D, 2010, J SPORT SCI, V28, P1615, DOI 10.1080/02640414.2010.521168; Castellano J, 2013, J STRENGTH COND RES, V27, P1295, DOI 10.1519/JSC.0b013e318267a5d1; CHANCE B, 1992, AM J PHYSIOL, V262, pC766, DOI 10.1152/ajpcell.1992.262.3.C766; Dellal A, 2011, INT J SPORT PHYSIOL, V6, P322, DOI 10.1123/ijspp.6.3.322; Dellal A, 2011, J STRENGTH COND RES, V25, P2371, DOI 10.1519/JSC.0b013e3181fb4296; Dorge HC, 1999, SCAND J MED SCI SPOR, V9, P195; Fanchini M, 2011, J STRENGTH COND RES, V25, P453, DOI 10.1519/JSC.0b013e3181c1f8a2; Ferrari M, 2011, PHILOS T R SOC A, V369, P4577, DOI 10.1098/rsta.2011.0230; Gabbett TJ, 2015, INT J SPORT PHYSIOL, V10, P298, DOI 10.1123/ijspp.2013-0543; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gibson ASC, 2006, SPORTS MED, V36, P705; Hamaoka T, 2011, PHILOS T R SOC A, V369, P4591, DOI 10.1098/rsta.2011.0298; Hanson AM, 2008, J ATHL TRAINING, V43, P133, DOI 10.4085/1062-6050-43.2.133; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Helgerud J, 2001, MED SCI SPORT EXER, V33, P1925, DOI 10.1097/00005768-200111000-00019; Hill-Haas SV, 2011, SPORTS MED, V41, P199, DOI 10.2165/11539740-000000000-00000; Hill-Haas SV, 2010, J STRENGTH COND RES, V24, P2149, DOI 10.1519/JSC.0b013e3181af5265; HIRVONEN J, 1987, EUR J APPL PHYSIOL O, V56, P253, DOI 10.1007/BF00690889; Impellizzeri FM, 2006, INT J SPORTS MED, V27, P483, DOI 10.1055/s-2005-865839; Johnston RD, 2015, INT J SPORTS PHYSL P, V10; Katis A, 2009, J SPORT SCI MED, V8, P374; Kawaguchi K, 2001, EUR J APPL PHYSIOL, V84, P158, DOI 10.1007/s004210000352; Kelly DA, 2009, J SCI MED SPORT, V12, P475, DOI 10.1016/j.jsams.2008.01.010; Koklu Y, 2015, J SPORT MED PHYS FIT, V55, P430; Koklu Y, 2011, J STRENGTH COND RES, V25, P1522, DOI 10.1519/JSC.0b013e3181e06ee1; Little T, 2006, J STRENGTH COND RES, V20, P316; Mallo J, 2008, J SPORT MED PHYS FIT, V48, P166; Mauger AR, 2009, MED SCI SPORT EXER, V41, P451, DOI 10.1249/MSS.0b013e3181854957; Micklewright D, 2010, BRIT J SPORT MED, V44, P952, DOI 10.1136/bjsm.2009.057315; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Muthalib M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3309746; Ohya T, 2013, INT J SPORTS MED, V34, P616, DOI 10.1055/s-0032-1331717; Rampinini E, 2015, INT J SPORTS MED, V36, P49, DOI 10.1055/s-0034-1385866; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Sampaio J, 2007, J SPORTS SCI MED S10, V6, P121; Sampson JA, 2015, J SPORT SCI, V33, P85, DOI 10.1080/02640414.2014.925571; Seiler S, 2005, MED SCI SPORT EXER, V37, P1601, DOI 10.1249/01.mss.0000177560.18014.d8; Seiler S, 2004, SCAND J MED SCI SPOR, V14, P318, DOI 10.1046/j.1600-0838.2003.00353.x; Smith TB, 2011, MED SCI SPORT EXER, V43, P2155, DOI 10.1249/MSS.0b013e31821d3f8e; Stolen T, 2005, SPORTS MED, V35, P501; Tomlin DL, 2001, SPORTS MED, V31, P1, DOI 10.2165/00007256-200131010-00001; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Waldron M, 2014, SPORTS MED, V44, P1645, DOI 10.1007/s40279-014-0230-6; Williams K, 2007, J SPORTS SCI MED S10, V6, P100; Yoshida Takayoshi, 2002, Journal of Physiological Anthropology and Applied Human Science, V21, P247, DOI 10.2114/jpa.21.247	54	18	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150201	10.1371/journal.pone.0150201	http://dx.doi.org/10.1371/journal.pone.0150201			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919064	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400102
J	Sakurada, Y; Yoneyama, S; Sugiyama, A; Tanabe, N; Kikushima, W; Mabuchi, F; Kume, A; Kubota, T; Iijima, H				Sakurada, Yoichi; Yoneyama, Seigo; Sugiyama, Atsushi; Tanabe, Naohiko; Kikushima, Wataru; Mabuchi, Fumihiko; Kume, Atsuki; Kubota, Takeo; Iijima, Hiroyuki			Prevalence and Genetic Characteristics of Geographic Atrophy among Elderly Japanese with Age-Related Macular Degeneration	PLOS ONE			English	Article							POLYPOIDAL CHOROIDAL VASCULOPATHY; GENOME-WIDE ASSOCIATION; RETICULAR PSEUDODRUSEN; POPULATION; MACULOPATHY; SUBTYPES; EYES	Objective To investigate the prevalence and genetic characteristics of geographic atrophy (GA) among elderly Japanese with advanced age-related macular degeneration (AMD) in a clinic-based study. Methods Two-hundred and ninety consecutive patients with advanced AMD were classified into typical neovascular AMD, polypoidal choroidal vasculopathy (PCV), retinal angiomatous proliferation (RAP) or geographic atrophy (GA). Genetic variants of ARMS2 A69S (rs10490924) and CFH I62V (rs800292) were genotyped using TaqMan Genotyping Assays. The clinical and genetic characteristics were compared between patients with and without GA. Results The number of patients diagnosed as having typical neovascular AMD, PCV, RAP and GA were 98 (33.8%), 151 (52.1%), 22 (7.5%) and 19 (6.6%), respectively. Of 19 patients with GA, 13 patients (68.4%) had unilateral GA with exudative AMD in the contralateral eye. Patients with GA were significantly older, with a higher prevalence of reticular pseudodrusen, bilateral involvement of advanced AMD and T-allele frequency of ARMS2 A69S compared with those with typical AMD and PCV; although there were no differences in the genetic and clinical characteristics among patients with GA and RAP. Conclusions The prevalence of GA was 6.6% among elderly Japanese with AMD. Patients with GA and RAP exhibited genetic and clinical similarities.	[Sakurada, Yoichi; Yoneyama, Seigo; Sugiyama, Atsushi; Tanabe, Naohiko; Kikushima, Wataru; Mabuchi, Fumihiko; Kume, Atsuki; Iijima, Hiroyuki] Univ Yamanashi, Dept Ophthalmol, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan; [Kubota, Takeo] Univ Yamanashi, Dept Epigenet, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Sakurada, Y (corresponding author), Univ Yamanashi, Dept Ophthalmol, Fac Med, Chuo Ku, Tokyo, Yamanashi, Japan.	sakurada@yamanashi.ac.jp			Japan Society for the Promotion of Science KAKENHI [23791972]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 23791972 (YS).	Arakawa S, 2011, NAT GENET, V43, P1001, DOI 10.1038/ng.938; Chang YC, 2009, OPHTHAL SURG LAS IM, V40, P576, DOI 10.3928/15428877-20091030-07; Cohen SY, 2007, BRIT J OPHTHALMOL, V91, P354, DOI 10.1136/bjo.2006.101022; Fuse N, 2011, AM J OPHTHALMOL, V151, P550, DOI 10.1016/j.ajo.2010.08.048; Garg A, 2013, INVEST OPHTH VIS SCI, V54, P7075, DOI 10.1167/iovs.13-12474; Hayashi H, 2010, INVEST OPHTH VIS SCI, V51, P5914, DOI 10.1167/iovs.10-5554; Kawasaki R, 2010, OPHTHALMOLOGY, V117, P921, DOI 10.1016/j.ophtha.2009.10.007; Maruko I, 2007, AM J OPHTHALMOL, V144, P15, DOI 10.1016/j.ajo.2007.03.047; McBain VA, 2011, RETINA-J RET VIT DIS, V31, P1043, DOI 10.1097/IAE.0b013e3181fe54c7; MIMOUN G, 1990, J FR OPHTALMOL, V13, P511; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; Sakurada Y, 2011, OPHTHALMOLOGY, V118, P1402, DOI 10.1016/j.ophtha.2010.12.010; SCHATZ H, 1989, OPHTHALMOLOGY, V96, P1541; Scholl HPN, 2007, MOL VIS, V13, P196; Sobrin L, 2012, OPHTHALMOLOGY, V119, P1874, DOI 10.1016/j.ophtha.2012.03.014; Sunness JS, 1997, OPHTHALMOLOGY, V104, P1677, DOI 10.1016/S0161-6420(97)30079-7; Sunness JS, 1999, INVEST OPHTH VIS SCI, V40, P1761; Tamura H, 2012, AM J OPHTHALMOL, V154, P542, DOI 10.1016/j.ajo.2012.03.042; Tanaka K, 2011, MOL VIS, V17, P2751; Ueda-Arakawa N, 2014, AM J OPHTHALMOL, V157, P994, DOI 10.1016/j.ajo.2014.01.018; Ueda-Arakawa N, 2013, AM J OPHTHALMOL, V155, P260, DOI 10.1016/j.ajo.2012.08.011; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yoneyama S, 2014, GRAEF ARCH CLIN EXP, V252, P1435, DOI 10.1007/s00417-014-2601-y; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	25	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149978	10.1371/journal.pone.0149978	http://dx.doi.org/10.1371/journal.pone.0149978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918864	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400065
J	Wittenberg, AD; Azar, S; Klochendler, A; Stolovich-Rain, M; Avraham, S; Birnbaum, L; Gallimidi, AB; Katz, M; Dor, Y; Meyuhas, O				Wittenberg, Avigail Dreazen; Azar, Shahar; Klochendler, Agnes; Stolovich-Rain, Miri; Avraham, Shlomit; Birnbaum, Lea; Gallimidi, Adi Binder; Katz, Maximiliano; Dor, Yuval; Meyuhas, Oded			Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic beta-Cells	PLOS ONE			English	Article							MTOR PATHWAY; KINASE 1; EXPRESSION; GROWTH; ROLES; SIZE; SURVIVAL; REVEALS; PROLIFERATION; DISRUPTION	Constitutive expression of active Akt (Akt(tg)) drives hyperplasia and hypertrophy of pancreatic beta-cells, concomitantly with increased insulin secretion and improved glucose tolerance, and at a later stage the development of insulinoma. To determine which functions of Akt are mediated by ribosomal protein S6 (rpS6), an Akt effector, we generated mice that express constitutive Akt in beta-cells in the background of unphosphorylatable ribosomal protein S6 (rpS6(P-/-)). rpS6 phosphorylation deficiency failed to block Akt(tg)-induced hypertrophy and aneuploidy in beta-cells, as well as the improved glucose homeostasis, indicating that Akt carries out these functions independently of rpS6 phosphorylation. In contrast, rpS6 phosphorylation deficiency efficiently restrained the reduction in nuclear localization of the cell cycle inhibitor p27, as well as the development of Akt(tg)-driven hyperplasia and tumor formation in beta-cells. In vitro experiments with Akt(tg) and rpS6P-/-; Akt(tg) fibroblasts demonstrated that rpS6 phosphorylation deficiency leads to reduced translation fidelity, which might underlie its anti-tumorigenic effect in the pancreas. However, the role of translation infidelity in tumor suppression cannot simply be inferred from this heterologous experimental model, as rpS6 phosphorylation deficiency unexpectedly elevated the resistance of Akt(tg) fibroblasts to proteotoxic, genotoxic as well as autophagic stresses. In contrast, rpS6(P-/-) fibroblasts exhibited a higher sensitivity to these stresses upon constitutive expression of oncogenic Kras. The latter result provides a possible mechanistic explanation for the ability of rpS6 phosphorylation deficiency to enhance DNA damage and protect mice from Kras-induced neoplastic transformation in the exocrine pancreas. We propose that Akt1 and Kras exert their oncogenic properties through distinct mechanisms, even though both show addiction to rpS6 phosphorylation.	[Wittenberg, Avigail Dreazen; Azar, Shahar; Avraham, Shlomit; Birnbaum, Lea; Gallimidi, Adi Binder; Katz, Maximiliano; Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel; [Klochendler, Agnes; Stolovich-Rain, Miri; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Dev Biol & Canc Res, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Research Israel Canada, Dept Biochem & Mol Biol, IL-91010 Jerusalem, Israel.	meyuhas@cc.huji.ac.il			US-Israel Binational Science Foundation [2009054]; Israel Cancer Research Fund; Otto Stieber Foundation	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund; Otto Stieber Foundation	This work was supported by US-Israel Binational Science Foundation (No. 2009054), Israel Cancer Research Fund, and the Otto Stieber Foundation (to OM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by US-Israel Binational Science Foundation (No. 2009054); Israel Cancer Research Fund, and the Otto Stieber Foundation (to O.M.). We thank Dr. Dror Kolodkin-Gal from Hadassah Medical Center for the histochemical analysis of pancreatic slides for cleaved caspase 3, Dr. Morris J. Birnbaum from University of Pennsylvania School of Medicine for providing us with the RIP-myr-Akt1-expressing mice and the pLCNX myr-Akt expression plasmid; Dr. Tamar Ziv from the Smoler Proteomics Center at the TechnionIsrael Institute of Technology for conducting the proteomic analysis; Dr. Shu-Bing Qian from Cornell University for the firefly expression vectors [Fluc(WT), Fluc(R218S) and Fluc (Stop)]; Dr. Valery Krizhanovsky from the Weizmann Institute of Science for the pBABE-Kras<SUP>G12D</SUP> plasmid; and Dr. Lily Vardimon from Tel Aviv University for the Renilla luciferase expression vector.	Alliouachene S, 2008, J CLIN INVEST, V118, P3629, DOI 10.1172/JCI35237; Azarova AM, 2007, P NATL ACAD SCI USA, V104, P11014, DOI 10.1073/pnas.0704002104; Bachar-Wikstrom E, 2013, DIABETES, V62, P1227, DOI 10.2337/db12-1474; Balcazar N, 2009, J BIOL CHEM, V284, P7832, DOI 10.1074/jbc.M807458200; Belham C, 1999, CURR BIOL, V9, pR93, DOI 10.1016/S0960-9822(99)80058-X; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Calvo E, 2009, ONCOTARGETS THER, V2, P135; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Chang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101452; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chen JK, 2009, AM J PHYSIOL-RENAL, V297, pF585, DOI 10.1152/ajprenal.00186.2009; Cohen MM, 2013, AM J MED GENET A, V161, P2931, DOI 10.1002/ajmg.a.36101; Conn CS, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003520; Cowell IG, 2012, P NATL ACAD SCI USA, V109, P8989, DOI 10.1073/pnas.1204406109; Daugaard M, 2012, NAT STRUCT MOL BIOL, V19, P803, DOI 10.1038/nsmb.2314; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Elghazi L, 2010, DIABETES, V59, P2390, DOI 10.2337/db09-0851; Elghazi L, 2009, GASTROENTEROLOGY, V136, P1091, DOI 10.1053/j.gastro.2008.11.043; Fontaniere S, 2006, FAM CANCER, V5, P49, DOI 10.1007/s10689-005-2575-3; Grabocka E, 2015, CLIN CANCER RES, V21, P1243, DOI 10.1158/1078-0432.CCR-14-0650; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hogan B, 1994, MANIPULATING MOUSE E; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Kelsey I, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004632; Kenific CM, 2015, TRENDS CELL BIOL, V25, P37, DOI 10.1016/j.tcb.2014.09.001; Khalaileh A, 2013, CANCER RES, V73, P1811, DOI 10.1158/0008-5472.CAN-12-2014; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Leslie NR, 2002, CELL SIGNAL, V14, P285, DOI 10.1016/S0898-6568(01)00234-0; Ma JC, 2009, MOL CELL BIOCHEM, V331, P161, DOI 10.1007/s11010-009-0154-x; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Meyuhas O, 2015, INT REV CEL MOL BIO, V320, P41, DOI 10.1016/bs.ircmb.2015.07.006; Meyuhas O, 2009, PROG MOL BIOL TRANSL, V90, P109, DOI 10.1016/S1877-1173(09)90003-5; Miloslavski R, 2014, J MOL CELL BIOL, V6, P255, DOI 10.1093/jmcb/mju008; Montecucco A, 2007, CANCER LETT, V252, P9, DOI 10.1016/j.canlet.2006.11.005; Mostoslavsky G, 2005, MOL THER, V11, P932, DOI 10.1016/j.ymthe.2005.01.005; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; OLIVER MH, 1989, J CELL SCI, V92, P513; Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731; Patursky-Polischuk I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109410; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105; Ripka S, 2010, GUT, V59, P1101, DOI 10.1136/gut.2009.189720; Roy SK, 2010, J MOL SIGNALING, V5; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005618; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Sulima SO, 2014, P NATL ACAD SCI USA, V111, P5640, DOI 10.1073/pnas.1400247111; Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Volovelsky O, 2016, J AM SOC NEPHROL, V27, P1091, DOI 10.1681/ASN.2015040339; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Xie XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055096; Xu JX, 2015, KIDNEY INT, V87, P543, DOI 10.1038/ki.2014.302; Xu NH, 2012, J ONCOL, V2012, DOI 10.1155/2012/951724; Yamamoto S, 2004, CLIN CANCER RES, V10, P2846, DOI 10.1158/1078-0432.CCR-02-1441; Yao Z, 2002, PANCREAS, V24, P42, DOI 10.1097/00006676-200201000-00006	68	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149995	10.1371/journal.pone.0149995	http://dx.doi.org/10.1371/journal.pone.0149995			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919188	gold, Green Published			2022-12-27	WOS:000371274400067
J	Donati, M; Balboni, A; Laroucau, K; Aaziz, R; Vorimore, F; Borel, N; Morandi, F; Nepita, EV; Di Francesco, A				Donati, Manuela; Balboni, Andrea; Laroucau, Karine; Aaziz, Rachid; Vorimore, Fabien; Borel, Nicole; Morandi, Federico; Nepita, Edoardo Vecchio; Di Francesco, Antonietta			Tetracycline Susceptibility in Chlamydia suis Pig Isolates	PLOS ONE			English	Article							RESISTANCE	The aims of the present study were to assess the prevalence of Chlamydia suis in an Italian pig herd, determine the tetracycline susceptibility of C. suis isolates, and evaluate tet(C) and tetR(C) gene expression. Conjunctival swabs from 20 pigs were tested for C. suis by real-time polymerase chain reaction, and 55% (11) were positive. C. suis was then isolated from 11 conjunctival swabs resampled from the same herd. All positive samples and isolates were positive for the tet(C) resistance gene. The in vitro susceptibility to tetracycline of the C. suis isolates showed MIC values ranging from 0.5 to 4 mu g/mL. Tet(C) and tetR(C) transcripts were found in all the isolates, cultured both in the absence and presence of tetracycline. This contrasts with other Gram-negative bacteria in which both genes are repressed in the absence of the drug. Further investigation into tet gene regulation in C. suis is needed.	[Donati, Manuela; Nepita, Edoardo Vecchio] Univ Bologna, DIMES, Microbiol, I-40138 Bologna, Italy; [Balboni, Andrea; Di Francesco, Antonietta] Univ Bologna, Dept Vet Med Sci, Ozzano Emilia, Bologna, Italy; [Laroucau, Karine; Aaziz, Rachid; Vorimore, Fabien] Univ Paris Est, Anim Hlth Lab, Bacterial Zoonoses Unit, Anses, Maisons Alfort, France; [Borel, Nicole] Univ Zurich, Vetsuisse Fac, Inst Vet Pathol, CH-8057 Zurich, Switzerland; [Morandi, Federico] Parco Nazl Monti Sibillini, Visso, Macerata, Italy	University of Bologna; University of Bologna; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); University of Zurich	Di Francesco, A (corresponding author), Univ Bologna, Dept Vet Med Sci, Ozzano Emilia, Bologna, Italy.	antoniet.difrancesco@unibo.it	Balboni, Andrea/T-9418-2019; Borel, Nicole/GPP-1073-2022; Laroucau, Karine/GSO-1980-2022; Borel, Nicole/M-6204-2016; Aaziz, Rachid/GOE-4376-2022	Balboni, Andrea/0000-0002-8049-6645; Borel, Nicole/0000-0002-1556-9262; Laroucau, Karine/0000-0001-7605-8602; Borel, Nicole/0000-0002-1556-9262; 				Andersen A, 1998, CHLAMYDIAL INFECTION, P313, DOI DOI 10.1016/J.TTBDIS.2012.11.013; Borel N, 2012, VET MICROBIOL, V156, P143, DOI 10.1016/j.vetmic.2011.10.011; Di Francesco A, 2008, VET REC, V163, P253, DOI 10.1136/vr.163.8.251; Di Francesco A, 2006, VET REC, V159, P849; Donati M, 2002, J ANTIMICROB CHEMOTH, V50, P407, DOI 10.1093/jac/dkf145; Donati M, 2010, ANTIMICROB AGENTS CH, V54, P5379, DOI 10.1128/AAC.00553-10; Dugan J, 2004, ANTIMICROB AGENTS CH, V48, P3989, DOI 10.1128/AAC.48.10.3989-3995.2004; ECKERT B, 1989, J BACTERIOL, V171, P3557, DOI 10.1128/JB.171.6.3557-3559.1989; Ehricht R, 2006, MOL CELL PROBE, V20, P60, DOI 10.1016/j.mcp.2005.09.003; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Sandoz KM, 2010, FUTURE MICROBIOL, V5, P1427, DOI [10.2217/fmb.10.96, 10.2217/FMB.10.96]; SAYADA C, 1995, RES MICROBIOL, V146, P155, DOI 10.1016/0923-2508(96)80893-X; Schautteet K, 2013, J MED MICROBIOL, V62, P331, DOI 10.1099/jmm.0.042861-0; Schautteet K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-29; Suchland RJ, 2009, ANTIMICROB AGENTS CH, V53, P4604, DOI 10.1128/AAC.00477-09; Wanninger S, 2015, 3 EUR M AN CHLAM ZOO	17	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149914	10.1371/journal.pone.0149914	http://dx.doi.org/10.1371/journal.pone.0149914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913523	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700034
J	Garfin, PM; Nguyen, T; Sage, J				Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien			Loss of Pten Disrupts the Thymic Epithelium and Alters Thymic Function	PLOS ONE			English	Article							T-CELL DEVELOPMENT; AXON REGENERATION; COWDEN-DISEASE; FOXN1; GENE; BREAST; GROWTH; PROLIFERATION; INVOLUTION; MUTATIONS	The thymus is the site of T cell development and selection. In addition to lymphocytes, the thymus is composed of several types of stromal cells that are exquisitely organized to create the appropriate environment and microenvironment to support the development and selection of maturing T cells. Thymic epithelial cells (TECs) are one of the more important cell types in the thymic stroma, and they play a critical role in selecting functional T cell clones and supporting their development. In this study, we used a mouse genetics approach to investigate the consequences of deleting the Pten tumor suppressor gene in the TEC compartment of the developing thymus. We found that PTEN deficiency in TECs results in a smaller thymus with significantly disordered architecture and histology. Accordingly, loss of PTEN function also results in decreased T cells with a shift in the distribution of T cell subtypes towards CD8(+) T cells. These experiments demonstrate that PTEN is critically required for the development of a functional thymic epithelium in mice. This work may help better understand the effects that certain medical conditions or clinical interventions have upon the thymus and immune function.	[Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Garfin, Phillip M.; Nguyen, Thuyen; Sage, Julien] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Garfin, Phillip M.] Seattle Genet, Bothell, WA USA	Stanford University; Stanford University; Seattle Genetics	Sage, J (corresponding author), Stanford Univ, Dept Pediat, Stanford, CA 94305 USA.; Sage, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	julsage@stanford.edu			National Institutes of Health [1S10RR02933801]; Lucile Packard Foundation for Children's Health; Alex's Lemonade Stanford Foundation; NIH [1S10RR02933801]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; Alex's Lemonade Stanford Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some of the flow cytometry was performed on a BD FACS ARIA II purchased with an National Institutes of Health S10 Shared Instrument Grant (grant number: 1S10RR02933801). Research reported in this manuscript was supported by the Lucile Packard Foundation for Children's Health and the Alex's Lemonade Stanford Foundation. J.S is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases.; Some of the flow cytometry was performed on a BD FACS ARIA II purchased with an NIH S10 Shared Instrument Grant (grant number: 1S10RR02933801). We would like to thank Qiaozhi Wei for advice regarding immunofluorescence protocols and Nancy Manley and Lauren Ehrlich for their critical reading of the manuscript. Research reported in this manuscript was supported by the Lucile Packard Foundation for Children's Health and the Alex's Lemonade Stanford Foundation. J.S is the Harriet and Mary Zelencik Scientist in Children's Cancer and Blood Diseases. The authors declare no conflict of interest.	Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Boehm T, 2013, NAT REV IMMUNOL, V13, P831, DOI 10.1038/nri3534; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cunliffe VT, 2002, MAMM GENOME, V13, P245, DOI 10.1007/s00335-001-3079-6; FARR AG, 1985, J IMMUNOL, V134, P2971; Garfin PM, 2013, J EXP MED, V210, P1087, DOI 10.1084/jem.20121716; Gordon J, 2001, MECH DEVELOP, V103, P141, DOI 10.1016/S0925-4773(01)00333-1; Gordon J, 2011, DEVELOPMENT, V138, P3865, DOI 10.1242/dev.059998; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Lee EN, 2011, ANAT CELL BIOL, V44, P14, DOI 10.5115/acb.2011.44.1.14; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Lynch ED, 1997, AM J HUM GENET, V61, P1254, DOI 10.1086/301639; Manley NR, 2011, FRONT BIOSCI-LANDMRK, V16, P2461, DOI 10.2741/3866; McLelland BT, 2011, J IMMUNOL METHODS, V367, P85, DOI 10.1016/j.jim.2011.02.008; Miller JFAP, 2011, NAT REV IMMUNOL, V11, P489, DOI 10.1038/nri2993; Min D, 2007, BLOOD, V109, P2529, DOI 10.1182/blood-2006-08-043794; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nabarra Bernadette, 2002, Dev Immunol, V9, P223, DOI 10.1080/10446670310001593532; Napolitano LA, 2008, J CLIN INVEST, V118, P1085, DOI 10.1172/JCI32830; Palmer DB, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00316; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Ripen AM, 2011, EUR J IMMUNOL, V41, P1278, DOI 10.1002/eji.201041375; Romano R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00187; Rossi SW, 2007, BLOOD, V109, P3803, DOI 10.1182/blood-2006-10-049767; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; St-Pierre C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01860; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Sun LN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/206929; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; Tykocinski LO, 2008, ANN NY ACAD SCI, V1143, P105, DOI 10.1196/annals.1443.018; Ventevogel MS, 2013, CURR OPIN IMMUNOL, V25, P516, DOI 10.1016/j.coi.2013.06.002; Yano M, 2008, J EXP MED, V205, P2827, DOI 10.1084/jem.20080046; Zukor K, 2013, J NEUROSCI, V33, P15350, DOI 10.1523/JNEUROSCI.2510-13.2013	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149430	10.1371/journal.pone.0149430	http://dx.doi.org/10.1371/journal.pone.0149430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914657	Green Published, gold			2022-12-27	WOS:000371175700015
J	Barennes, H; Sayavong, E; Pussard, E				Barennes, Hubert; Sayavong, Eng; Pussard, Eric			High Mortality Risk in Hypoglycemic and Dysglycemic Children Admitted at a Referral Hospital in a Non Malaria Tropical Setting of a Low Income Country	PLOS ONE			English	Article							BLOOD-GLUCOSE; AFRICAN CHILDREN; FALCIPARUM-MALARIA; SUBLINGUAL SUGAR; QUININE; MANAGEMENT; ADMISSION; PREDICTORS; INDICATORS; KINETICS	Introduction Hypoglycemia is a recognized feature of severe malaria but its diagnosis and management remain problematic in resource-limited settings. There is limited data on the burden and prognosis associated with glycemia dysregulation in non-neonate children in non-malaria areas. We prospectively assessed the abnormal blood glucose prevalence and the outcome and risk factors of deaths in critically ill children admitted to a national referral hospital in Laos. Methods Consecutive children (1 month-15 years) admitted to the pediatric ward of Mahosot hospital, were categorized using the integrated management of childhood illness (IMCI). Blood glucose was assessed once on admission through a finger prick using a bedside glucometer. Glycemia levels: hypoglycemia: < 2.2 mmol/L (< 40 mg/dl), low glycemia: 2.2-4.4 mmol/L (40-79 mg/dl), euglycemia: 4.4-8.3 mmol/L (80-149 mg/dl), and hyperglycemia: > 8.3 mmol/L (>= 150 mg/dl), were related to the IMCI algorithm and case fatality using univariate and multivariate analysis. Results Of 350 children, 62.2% (n = 218) were severely ill and 49.1% (n = 172) had at least one IMCI danger sign. A total of 15 (4.2%, 95% CI: 2.4-6.9) had hypoglycemia, 99 (28.2%, 95% CI: 23.6-33.3) low glycemia, 201 (57.4%, 95% CI: 52.0-62.6) euglycemia and 35 (10.0%, 95% CI: 7.0-13.6) hyperglycemia. Hypoglycemia was associated with longer fasting (p = 0.001) and limited treatment before admission (p = 0.09). Hypoglycemia and hyperglycemia were associated with hypoxemia (SaO2) (p = 0.001). A total of 21 (6.0%) of the children died: 66.6% with hypoglycemic, 6.0% with low glycemic, 5.7% with hyperglycemic and 1.4% with euglycemic groups. A total of 9 (2.5%) deaths occurred during the first 24 hours of admission and 5 (1.7%) within 3 days of hospital discharge. Compared to euglycemic children, hypoglycemic and low glycemic children had a higher rate of early death (20%, p<0.001 and 5%, p = 0.008; respectively). They also had a higher risk of death (OR: 132; 95% CI: 29.0-596.5; p = 0.001; and OR: 4.2; 95% CI: 1.1-15.6; p = 0.02; respectively). In multivariate analyses, hypoglycemia (OR: 197; 95% CI: 33-1173.9), hypoxemia (OR: 5.3; 95% CI: 1.4-20), presence of hepatomegaly (OR: 8.7; 95% CI: 2.0-37.6) and having an illiterate mother (OR: 25.9; 95% CI: 4.2-160.6) were associated with increased risk of death. Conclusion Hypoglycemia is linked with a high risk of mortality for children in non malaria tropical settings. Blood sugar should be monitored and treatment provided for sick children, especially with danger signs and prolonged fasting. Further evaluations of intervention using thresholds including low glycemia is recommended in resource-limited settings. Research is also needed to determine the significance, prognosis and care of hyperglycemia.	[Barennes, Hubert; Sayavong, Eng] Inst Francophonie Med Trop, Viangchan, Laos; [Barennes, Hubert] Agence Natl Rech VIH & Ies Hepatites, Phnom Penh, Cambodia; [Barennes, Hubert] Bordeaux Univ, Ctr INSERM U897, ISPED, Epidemiol Biostat, Bordeaux, France; [Barennes, Hubert] Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia; [Pussard, Eric] Kremlin Bicetre Univ Hosp, Genet Mol Pharmacogenet & Hormonol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP	Barennes, H (corresponding author), Inst Francophonie Med Trop, Viangchan, Laos.; Barennes, H (corresponding author), Agence Natl Rech VIH & Ies Hepatites, Phnom Penh, Cambodia.; Barennes, H (corresponding author), Bordeaux Univ, Ctr INSERM U897, ISPED, Epidemiol Biostat, Bordeaux, France.; Barennes, H (corresponding author), Inst Pasteur, Epidemiol Unit, Phnom Penh, Cambodia.	barenneshub@yahoo.fr	PUSSARD, Eric/S-6059-2018					Achoki R, 2010, J TROP PEDIATRICS, V56, P227, DOI 10.1093/tropej/fmp109; Adebola O, 2014, AFR HEALTH SCI, V14, P397, DOI 10.4314/ahs.v14i2.16; Advanced Life Support Group, 2004, ADV PAED LIF SUPP; [Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Bandsma RHJ, 2010, PEDIATR RES, V68, P423, DOI 10.1203/PDR.0b013e3181f2b959; Barennes H, 2004, FOOD CHEM TOXICOL, V42, P809, DOI 10.1016/j.fct.2004.01.003; Barennes H, 2014, AM J TROP MED HYG; Barennes H, 2014, LANCET, V383, P1208, DOI 10.1016/S0140-6736(14)60601-2; Barennes H, 2010, LANCET INFECT DIS, V10, P141, DOI 10.1016/S1473-3099(10)70009-8; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2003, BRIT MED J, V326, P361, DOI 10.1136/bmj.326.7385.361; CIA, 2014, WORLD FACT BOOOK LAO; Clark B J 3rd, 2000, Heart Dis, V2, P354; Demers AM, 2000, PEDIATR INFECT DIS J, V19, P424, DOI 10.1097/00006454-200005000-00007; Dias E, 2014, J CLIN NEONATOL, V3, P35, DOI 10.4103/2249-4847.128729; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Elusiyan JBE, 2006, J TROP PEDIATRICS, V52, P96, DOI 10.1093/tropej/fmi068; English M, 1998, QJM-MON J ASSOC PHYS, V91, P191, DOI 10.1093/qjmed/91.3.191; Faustino E Vincent S, 2012, J Diabetes Sci Technol, V6, P48; Freckmann G, 2015, DIABETES TECHNOL THE, V17, P625, DOI 10.1089/dia.2015.0043; Graz B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-242; Haymond MW, 1999, ENDOCRIN METAB CLIN, V28, P663, DOI 10.1016/S0889-8529(05)70096-7; Idro R, 2006, ANN TROP MED PARASIT, V100, P95, DOI 10.1179/136485906X91459; Jaffar S, 1997, AM J TROP MED HYG, V57, P20, DOI 10.4269/ajtmh.1997.57.20; Jain A, 2010, INDIAN J PEDIATR, V77, P1137, DOI 10.1007/s12098-010-0175-1; Jallow M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045645; Jan IS, 2009, INT J INFECT DIS, V13, P570, DOI 10.1016/j.ijid.2008.08.026; KAWO NG, 1990, LANCET, V336, P454, DOI 10.1016/0140-6736(90)92009-7; Lang TF, 2014, ADV CLIN CHEM, V63, P211, DOI 10.1016/B978-0-12-800094-6.00006-6; Madrid L, 2015, EXPERT REV ANTI-INFE, V13, P267, DOI 10.1586/14787210.2015.995632; Maitland K, 2006, PLOS MED, V3, P2431, DOI 10.1371/journal.pmed.0030500; MANSOR SM, 1990, T ROY SOC TROP MED H, V84, P482, DOI 10.1016/0035-9203(90)90007-2; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mesotten D, 2015, LANCET DIABETES ENDO, V3, P723, DOI 10.1016/S2213-8587(15)00223-5; Nadjm B, 2013, AM J TROP MED HYG, V89, P232, DOI 10.4269/ajtmh.13-0016; Ogetii GN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-334; OKITOLONDA W, 1987, BMJ-BRIT MED J, V295, P716, DOI 10.1136/bmj.295.6600.716; Onyiriuka Alphonsus N, 2012, Med J Islam Repub Iran, V26, P78; Osier FHA, 2003, ARCH DIS CHILD, V88, P621, DOI 10.1136/adc.88.7.621; Oyedeji GA, 1995, E AFR MED J, V72, P523; Ravelomanana T, 2010, Bull Soc Pathol Exot, V103, P75, DOI 10.1007/s13149-010-0046-z; Reid SR, 2005, J EMERG MED, V29, P141, DOI 10.1016/j.jemermed.2005.02.004; Sambany E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065193; Sasidharan C. K., 2004, Ceylon Medical Journal, V49, P110; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; SOLOMON T, 1994, LANCET, V343, P149, DOI 10.1016/S0140-6736(94)90937-7; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; Tripathy R, 2007, PEDIATRICS, V120, pE454, DOI 10.1542/peds.2006-3171; Valerio G, 2001, ACTA PAEDIATR, V90, P618, DOI 10.1080/080352501750258658; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WALLER D, 1995, CLIN INFECT DIS, V21, P577, DOI 10.1093/clinids/21.3.577; WHITE NJ, 1983, NEW ENGL J MED, V309, P61, DOI 10.1056/NEJM198307143090201; WHITE NJ, 1987, LANCET, V1, P708; WHO, 2006, WHO TECH REP SER, V936, P1; Willcox ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102530; Willcox ML, 2010, TROP MED INT HEALTH, V15, P232, DOI 10.1111/j.1365-3156.2009.02444.x; Williams AF, 1997, B WORLD HEALTH ORGAN, V75, P261; World Health Organization, 2015, GLOB ACT PLAN ANT RE; Zhou W, 2014, J MATERN-FETAL NEO M, P1; Zijlmans W, 2008, AM J TROP MED HYG, V79, P605, DOI 10.4269/ajtmh.2008.79.605; Zijlmans WCWR, 2014, J PEDIATR ENDOCR MET, V27, P5, DOI 10.1515/jpem-2013-0165	61	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150076	10.1371/journal.pone.0150076	http://dx.doi.org/10.1371/journal.pone.0150076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910320	Green Submitted, gold, Green Published			2022-12-27	WOS:000371164700061
J	Cadier, B; Durand-Zaleski, I; Thomas, D; Chevreul, K				Cadier, Benjamin; Durand-Zaleski, Isabelle; Thomas, Daniel; Chevreul, Karine			Cost Effectiveness of Free Access to Smoking Cessation Treatment in France Considering the Economic Burden of Smoking-Related Diseases	PLOS ONE			English	Article							MALE BRITISH DOCTORS; PROGNOSTIC-FACTORS; 5-YEAR SURVIVAL; SERVICES; STROKE; MORTALITY; COMMUNITY; BENEFITS; IMPACT	Context In France more than 70,000 deaths from diseases related to smoking are recorded each year, and since 2005 prevalence of tobacco has increased. Providing free access to smoking cessation treatment would reduce this burden. The aim of our study was to estimate the incremental cost-effectiveness ratios (ICER) of providing free access to cessation treatment taking into account the cost offsets associated with the reduction of the three main diseases related to smoking: lung cancer, chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD). To measure the financial impact of such a measure we also conducted a probabilistic budget impact analysis. Methods and Findings We performed a cost-effectiveness analysis using a Markov state-transition model that compared free access to cessation treatment to the existing coverage of (sic)50 provided by the French statutory health insurance, taking into account the cost offsets among current French smokers aged 15-75 years. Our results were expressed by the incremental cost-effectiveness ratio in 2009 Euros per life year gained (LYG) at the lifetime horizon. We estimated a base case scenario and carried out a Monte Carlo sensitivity analysis to account for uncertainty. Assuming a participation rate of 7.3%, the ICER value for free access to cessation treatment was (sic)3,868 per LYG in the base case. The variation of parameters provided a range of ICER values from -(sic)736 to (sic)15,715 per LYG. In 99% of cases, the ICER for full coverage was lower than (sic)11,187 per LYG. The probabilistic budget impact analysis showed that the potential cost saving for lung cancer, COPD and CVD ranges from (sic)15 million to (sic)215 million at the five-year horizon for an initial cessation treatment cost of (sic)125 million to (sic)421 million. Conclusion The results suggest that providing medical support to smokers in their attempts to quit is very cost-effective and may even result in cost savings.	[Cadier, Benjamin; Durand-Zaleski, Isabelle; Chevreul, Karine] AP HP URC Eco Ile de France, Paris, France; [Cadier, Benjamin; Durand-Zaleski, Isabelle; Chevreul, Karine] INSERM, ECEVE, U1123, Paris, France; [Cadier, Benjamin; Durand-Zaleski, Isabelle; Chevreul, Karine] Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMRS 1123, Paris, France; [Thomas, Daniel] Univ Paris 06, Hop La Pitie Salpetriere, AP HP, Inst Cardiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Chevreul, K (corresponding author), AP HP URC Eco Ile de France, Paris, France.; Chevreul, K (corresponding author), INSERM, ECEVE, U1123, Paris, France.; Chevreul, K (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMRS 1123, Paris, France.	karine.chevreul@urc-eco.fr	chevreul, karine/AAN-2380-2020	THOMAS, Daniel/0000-0002-3231-9396	Assistance Publique-Hopitaux de Paris (AP-HP)	Assistance Publique-Hopitaux de Paris (AP-HP)	The research reported in this manuscript has been funded by the Assistance Publique-Hopitaux de Paris (AP-HP), the largest teaching hospital consortium in Europe. This work was done on the authors' research unit block grant budget. The funders of our unit had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, REP GLOB TOB EP 2011; Assurance maladie, 2011, COUT ALD 2009 POP RE; Assurance maladie, 2010, PERS ALD 2008 POINTS; Atsou K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024870; Aveyard P, 2012, TOB CONTROL, V21, P252, DOI 10.1136/tobaccocontrol-2011-050348; Beck F, 2011, NIVEAUX USAGE DROGUE; Berlin I, 2009, J SMOK CESS, V4, P102, DOI 10.1375/jsc.4.2.102; Bertram MY, 2007, TOB CONTROL, V16, P255, DOI 10.1136/tc.2006.017657; Briggs A, 2008, DECISON MODELLING HL, P1; Burns DM, 1997, CHANGES CIGARETTE RE, V8, P113; Callum C, 2011, HEALTH ECON POLICY L, V6, P489, DOI 10.1017/S1744133110000241; Canarelli T, 2010, DONNEES RECENTES REL; Chevreul K, 2012, COST EFFECTIVENESS O; Chinaud F, 2005, REV EPIDEMIOL SANTE, V53, P477, DOI 10.1016/S0398-7620(05)84725-X; Curry SJ, 1998, NEW ENGL J MED, V339, P673, DOI 10.1056/NEJM199809033391006; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Edejer T, 2003, MAKING CHOICES HLTH; Eisenberg MJ, 2008, CAN MED ASSOC J, V179, P135, DOI 10.1503/cmaj.070256; Federation nationale des observatoires regionaux de la sante (FNORS), MAL CARD REG FRANC; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Flack S., 2007, COST EFFECTIVENESS I; Fuhrman C, 2010, REV MAL RESPIR, V27, P160, DOI 10.1016/j.rmr.2009.08.003; Gao GQ, 2006, ANN THORAC SURG, V82, P806, DOI 10.1016/j.athoracsur.2006.04.032; Gibson JE, 2010, NICOTINE TOB RES, V12, pS64, DOI 10.1093/ntr/ntq119; Giraud A, 1996, INT J QUAL HEALTH C, V8, P291, DOI 10.1093/intqhc/8.3.291; Grignon M, EFFET INTERVENTIONS; Hankey GJ, 2000, STROKE, V31, P2080, DOI 10.1161/01.STR.31.9.2080; Hawkins J, 2010, NICOTINE TOB RES, V12, P1228, DOI 10.1093/ntr/ntq175; Hill C, 2010, B EPIDEMIOLOGIQUE HE; Hurley Susan F, 2007, Cost Eff Resour Alloc, V5, P2, DOI 10.1186/1478-7547-5-2; INPES, RAPP NAT ITC FRANC R; Institut de recherche et documentation en economie de la sante (IRDES), 2010, BAS EC FIN SANT; Institut Natinal de la Statistique et des Etudes Economiques (INSEE), 2014, ESP VIE DIV AG FRANC; Institut Natinal du Cancer (INcA), 2013, CANC FRANC ED 2013; Institut national de la statistique et des etudes economiques (INSEE), 2007, RES REC POP 2007 POP; Institut national de prevention et d'education pour la sante (INPES), 2005, BAR SANT 2005 ATT CO; Institut national de prevention et d'education pour la sante (INPES), 2010, PREM RES BAR SANT 20; Jamrozik K, 2011, TOB CONTROL, V20, P258, DOI 10.1136/tc.2010.039172; Jean A, 2003, THERAPIE, V58, P479; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Le Foll B, 2005, EUR PSYCHIAT, V20, P431, DOI 10.1016/j.eurpsy.2004.12.008; Le Pen C, 2008, GUIDE METHODOLOGIQUE; Lightwood JM, 1997, CIRCULATION, V96, P1089, DOI 10.1161/01.CIR.96.4.1089; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; Menn P, 2012, PHARMACOECONOMICS, V30, P825, DOI 10.2165/11591340-000000000-00000; Observatoire Francais des Drogues et des Toxicomanies (OFDT), 2009, TABL BORD MENS IND T; OCDE, CONS TAB POUC POP 15; Oddoux K, 2000, BAROMETRE SANTE 2000, V1; Office Francais des Drogues et Toxicomanies (OFDT), TABL BORD MENS IND T; Peto R, 2006, MORTALITY SMOKING DE; Pichetti S, 2011, QUEST EC SANTE, V167, P1; Rasmussen SR, 2004, EUR J PUBLIC HEALTH, V14, P95, DOI 10.1093/eurpub/14.1.95; Scemama O, 2007, STRATEGIES THERAPEUT; Service evaluation economique et sante publiq, 2010, EFF EFF HYP AN CTR S; Shavelle Robert M, 2009, Int J Chron Obstruct Pulmon Dis, V4, P137; The NHS Information Centre Lifestyles Statistics, 2011, STAT SMOK ENGL 2011; Tremblay M, 2009, REMBOURSEMENT AIDES; World Health Organization, 2003, WHO GUID COST EFF AN	60	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148750	10.1371/journal.pone.0148750	http://dx.doi.org/10.1371/journal.pone.0148750			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26909802	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700014
J	da Silva, M; Pinho, DB; Pereira, OL; Fernandes, FM; Barreto, RW				da Silva, Meiriele; Pinho, Danilo B.; Pereira, Olinto L.; Fernandes, Fernando M.; Barreto, Robert W.			Naming Potentially Endangered Parasites: Foliicolous Mycobiota of Dimorphandra wilsonii, a Highly Threatened Brazilian Tree Species	PLOS ONE			English	Article							BAYESIAN-INFERENCE; MYCOSPHAERELLA; LIKELIHOOD; FUNGI; MODEL	A survey of foliicolous fungi associated with Dimorphandra wilsonii and Dimorphandra mollis (Fabaceae) was conducted in the state of Minas Gerais, Brazil. Dimorphandra wilsonii is a tree species native to the Brazilian Cerrado that is listed as critically endangered. Fungi strictly depending on this plant species may be on the verge of co-extinction. Here, results of the pioneering description of this mycobiota are provided to contribute to the neglected field of microfungi conservation. The mycobiota of D. mollis, which is a common species with a broad geographical distribution that co-occurs with D. wilsonii, was examined simultaneously to exclude fungal species occurring on both species from further consideration for conservation because microfungi associated with D. wilsonii should not be regarded as under threat of co-extinction. Fourteen ascomycete fungal species were collected, identified, described and illustrated namely: Byssogene wilsoniae sp. nov., Geastrumia polystigmatis, Janetia dimorphandra-mollis sp. nov., Janetia wilsoniae sp. nov., Johansonia chapadiensis, Microcalliopsis dipterygis, Phillipsiella atra, Piricauda paraguayensis, Pseudocercospora dimorphandrae sp. nov., Pseudocercosporella dimorphandrae sp. nov., Ramichloridiopsis wilsoniae sp. and gen. nov., Stomiopeltis suttoniae, Trichomatomyces byrsonimae and Vesiculohyphomyces cerradensis. Three fungi were exclusively found on D. wilsonii and were regarded as potentially threatened of extinction: B. wilsoniae, J. wilsoniae and R. wilsoniae.	[da Silva, Meiriele; Pinho, Danilo B.; Pereira, Olinto L.; Barreto, Robert W.] Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil; [Fernandes, Fernando M.] Fundacao Zoo Bot Belo Horizonte, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa	Barreto, RW (corresponding author), Univ Fed Vicosa, Dept Fitopatol, BR-36570 Vicosa, MG, Brazil.	rbarreto@ufv.br	Pinho, Danilo Batista/D-3481-2014	Pinho, Danilo Batista/0000-0003-2624-302X	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil)	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil); Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil)	Conselho Nacional do Desenvolvimento Cientifico e Tecnologico (Brasil) provided the scholarship for MS; Fundacao de Amparo a Pesquisa do estado de Minas Gerais (Brasil) provided funding for field and laboratory work to RWB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzanlou M, 2007, STUD MYCOL, P57, DOI 10.3114/sim.2007.58.03; BARR ME, 1979, MYCOLOGIA, V71, P935, DOI 10.2307/3759283; Batista AC, 1962, PUB I MICOL U RECIFE, V343, P1; Batista AC., 1959, PUBLICACOES I MICOLO, V56, P1; Braun U, 1995, MONOGRAPH CERCOSPORE; Braun U, 2013, IMA FUNGUS, V4, P265, DOI 10.5598/imafungus.2013.04.02.12; Calduch M, 2002, MYCOLOGIA, V94, P355, DOI 10.2307/3761812; Carnegie AJ, 1997, MYCOL RES, V101, P843, DOI 10.1017/S095375629600305X; CHUPP C., 1954, A monograph of the fungus genus Cercospoia.; Cooke MC, 1878, GREVILLEA, V6, P129; Crous PW, 2013, STUD MYCOL, P37, DOI 10.3114/sim0005; Crous PW, 2010, IMA FUNGUS, V1, P117, DOI 10.5598/imafungus.2010.01.02.03; Crous Pedro W., 2000, Studies in Mycology, P107; Crous PW, 1996, MYCOLOGIA, V88, P441, DOI 10.2307/3760885; Crous PW, 2003, CBS BIODIVERSITY SER, V1, P1; da Silva M, 2012, MYCOTAXON, V119, P109, DOI 10.5248/119.109; Deighton FC, 1973, MYCOL PAP, V133, P1; Dhingra O.D., 1996, BASIC PLANT PATHOLOG; Dornelo-Silva D, 2004, MYCOLOGIA, V96, P879, DOI 10.2307/3762120; Dornelo-Silva D, 2003, MYCOLOGIA, V95, P1239, DOI 10.2307/3761924; Dunn RR, 2009, P ROY SOC B-BIOL SCI, V276, P3037, DOI 10.1098/rspb.2009.0413; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis M. B., 1976, More dematiaceous hyphomycetes.; Ellis MB, 1971, DEMATIACEOUS HYPHOMY; ERIKSSON O, 1981, OPERA BOT, V60, P1, DOI DOI 10.1111/J.1756-1051.1981.TB01167.X; Farr DF, FUNGAL DATABASES SYS; Fernandes FM, 2014, ACTA BOT BRAS, V28, P434, DOI 10.1590/0102-33062014abb3409; Fernandes FM, 2007, RECUPERANDO VERDE CI, P87; Goh TK, 1996, MYCOLOGIA, V88, P1014, DOI 10.2307/3761066; Griffith GW, 2012, TRENDS ECOL EVOL, V27, P1, DOI 10.1016/j.tree.2011.10.002; Hall T., BIOEDIT V7 0 9 BIOL; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hohnel F von, 1909, KAISERL AKAD WISS MN, V118, P349; Huelsenbeck JP, 2002, SYST BIOL, V51, P673, DOI 10.1080/10635150290102366; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; HUGHES S. J., 1960, CANADIAN JOUR BOT, V38, P921; HUGHES SJ, 1983, NEW ZEAL J BOT, V21, P177, DOI 10.1080/0028825X.1983.10428542; Hyde KD, 2013, FUNGAL DIVERS, V63, P1, DOI 10.1007/s13225-013-0263-4; KATUMOTO K, 1986, T MYCOL SOC JPN, V27, P1; Kirk PM., 2008, DICT FUNGI, V10th ed; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Lenza Eddie, 2011, Braz. J. Bot., V34, P247, DOI 10.1590/S0100-84042011000300002; LINK C. A., 2005, MEGADIVERSIDADE, V1, P147, DOI DOI 10.1590/S0100-69912009000400001; LUTTRELL ES, 1946, MYCOLOGIA, V38, P565, DOI 10.2307/3754996; Mau B, 1999, BIOMETRICS, V55, P1, DOI 10.1111/j.0006-341X.1999.00001.x; Minter D., 2010, FROM ANOTHER KINGDOM, P143; MULLER E., 1962, BEITR KRYPTOGAMENFL, V11, P1; Pereira JM, 2003, BIOL CONTROL, V26, P21, DOI 10.1016/S1049-9644(02)00112-3; Pereira-Carvalho RC, 2009, MYCOL RES, V113, P261, DOI 10.1016/j.mycres.2008.11.005; PIROZYNS.KA, 1971, MYCOLOGIA, V63, P897, DOI 10.2307/3758057; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Quaedvlieg W, 2014, PERSOONIA, V33, P1, DOI 10.3767/003158514X681981; Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/PL00006090; Rayner RW, 1970, MYCOLOGICAL COLOR CH; Reddy BS, 2004, PHILIPP J SCI, V133, P71; Rocha FB, 2010, MYCOLOGIA, V102, P1240, DOI 10.3852/09-178; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rodriguez RJ, 2004, MOL METHODS DISCRIMI, P77; Saccardo PA, 1882, SYLLOGE FUNGORUM OMN, V8, P844; Sano EE, 2010, ENVIRON MONIT ASSESS, V166, P113, DOI 10.1007/s10661-009-0988-4; Sierra AM, 2005, MYCOL RES, V109, P723, DOI 10.1017/S0953756205002522; SUTTON B C, 1988, Australian Systematic Botany, V1, P127, DOI 10.1071/SB9880127; Sydow H, 1922, ROBISSON PHILIPP J S, V21, P131; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor JE, 2000, MYCOL RES, V104, P618, DOI 10.1017/S0953756299001768; Thacker JI, 2006, ORYX, V40, P233, DOI 10.1017/S0030605306000123; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; VONARX JA, 1975, STUD MYCOL, V9, P1; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yuan ZQ, 1996, AUST SYST BOT, V9, P337, DOI 10.1071/SB9960337	70	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147895	10.1371/journal.pone.0147895	http://dx.doi.org/10.1371/journal.pone.0147895			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910334	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700006
J	Andrews, SS; Rutherford, S				Andrews, Steven S.; Rutherford, Suzannah			A Method and On-Line Tool for Maximum Likelihood Calibration of Immunoblots and Other Measurements That Are Quantified in Batches	PLOS ONE			English	Article							INVERSE REGRESSION METHODS; WESTERN BLOTS; BOOTSTRAP; RANGE	Experimental measurements require calibration to transform measured signals into physically meaningful values. The conventional approach has two steps: the experimenter deduces a conversion function using measurements on standards and then calibrates (or normalizes) measurements on unknown samples with this function. The deduction of the conversion function from only the standard measurements causes the results to be quite sensitive to experimental noise. It also implies that any data collected without reliable standards must be discarded. Here we show that a "1-step calibration method" reduces these problems for the common situation in which samples are measured in batches, where a batch could be an immunoblot (Western blot), an enzyme-linked immunosorbent assay (ELISA), a sequence of spectra, or a microarray, provided that some sample measurements are replicated across multiple batches. The 1-step method computes all calibration results iteratively from all measurements. It returns the most probable values for the sample compositions under the assumptions of a statistical model, making them the maximum likelihood predictors. It is less sensitive to measurement error on standards and enables use of some batches that do not include standards. In direct comparison of both real and simulated immunoblot data, the 1-step method consistently exhibited smaller errors than the conventional "2-step" method. These results suggest that the 1-step method is likely to be most useful for cases where experimenters want to analyze existing data that are missing some standard measurements and where experimenters want to extract the best results possible from their data. Open source software for both methods is available for download or on-line use.	[Andrews, Steven S.; Rutherford, Suzannah] Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Andrews, Steven S.] Seattle Univ, Dept Phys, Seattle, WA 98122 USA	Fred Hutchinson Cancer Center; Seattle University	Andrews, SS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1124 Columbia St, Seattle, WA 98104 USA.; Andrews, SS (corresponding author), Seattle Univ, Dept Phys, Seattle, WA 98122 USA.	steven.s.andrews@gmail.com	Rutherford, Suzannah/L-7355-2019	Rutherford, Suzannah/0000-0002-7809-3337	NIGMS [R01GM086615, R01GM097479, R01GM068873]; Damon Runyon-Walter Winchell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097479, R01GM086615, R01GM068873] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon-Walter Winchell Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for funding from: NIGMS grant R01GM086615, awarded to Roger Brent and Richard Yu, and NIGMS grant R01GM097479, awarded to Roger Brent, funded SSA; also a Scholar Award of the Damon Runyon-Walter Winchell Foundation and NIGMS grant R01GM068873 funded SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alegria-Schaffer A, 2009, METHOD ENZYMOL, V463, P573, DOI 10.1016/S0076-6879(09)63033-0; BONATE PL, 1993, ANAL CHEM, V65, P1367, DOI 10.1021/ac00058a012; Chang GA, 2009, J STAT ED, P17; Charette SJ, 2010, J IMMUNOL METHODS, V353, P148, DOI 10.1016/j.jim.2009.12.007; Eisenhart C, 1939, ANN MATH STAT, V10, P162, DOI 10.1214/aoms/1177732214; Gallagher S, 2008, CURR PROTOC MOL BIOL, V83; Gingrich JC, 2000, BIOTECHNIQUES, V29, P636, DOI 10.2144/00293pf02; Heidebrecht F, 2009, J IMMUNOL METHODS, V345, P40, DOI 10.1016/j.jim.2009.03.018; HOADLEY B, 1970, J AM STAT ASSOC, V65, P356, DOI 10.2307/2283598; Ideker T, 2000, J COMPUT BIOL, V7, P805, DOI 10.1089/10665270050514945; Jones G, 1996, ANAL CHEM, V68, P763, DOI 10.1021/ac950985g; KRUTCHKOFF RG, 1969, TECHNOMETRICS, V11, P605, DOI 10.2307/1267027; KRUTCHKOFF RG, 1967, TECHNOMETRICS, V9, P425, DOI 10.2307/1266511; Larsen R.J., 2012, INTRO MATH STAT ITS; Liao JJZ, 2005, J BIOPHARM STAT, V15, P3, DOI 10.1081/LBPS-200040800; MacPhee DJ, 2010, J PHARMACOL TOXICOL, V61, P171, DOI 10.1016/j.vascn.2009.12.001; MILLER JN, 1991, ANALYST, V116, P3, DOI 10.1039/an9911600003; OSBORNE C, 1991, INT STAT REV, V59, P309, DOI 10.2307/1403690; Schutz-Geschwender A, 2004, LI COR BIOSCIENCES, P1; SHUKLA GK, 1972, TECHNOMETRICS, V14, P547, DOI 10.2307/1267283; Theil H., 1950, P ROYAL NETHERLANDS, V53, P1397; Thomson TM, 2011, P NATL ACAD SCI USA, V108, P20265, DOI 10.1073/pnas.1004042108; Vetterling W.T., 1988, NUMERICAL RECIPES C; Whitcomb BW, 2010, EPIDEMIOLOGY, V21, pS44, DOI 10.1097/EDE.0b013e3181dceac2	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149575	10.1371/journal.pone.0149575	http://dx.doi.org/10.1371/journal.pone.0149575			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908370	gold, Green Published, Green Submitted			2022-12-27	WOS:000371163000016
J	Tham, ML; Chow, CO; Xu, YH; Ramli, N				Tham, Mau-Luen; Chow, Chee-Onn; Xu, Yi-Han; Ramli, Nordin			Two-Level Scheduling for Video Transmission over Downlink OFDMA Networks	PLOS ONE			English	Article							RESOURCE-ALLOCATION; OPTIMIZATION; SYSTEMS	This paper presents a two-level scheduling scheme for video transmission over downlink orthogonal frequency-division multiple access (OFDMA) networks. It aims to maximize the aggregate quality of the video users subject to the playback delay and resource constraints, by exploiting the multiuser diversity and the video characteristics. The upper level schedules the transmission of video packets among multiple users based on an overall target biterror- rate (BER), the importance level of packet and resource consumption efficiency factor. Instead, the lower level renders unequal error protection (UEP) in terms of target BER among the scheduled packets by solving a weighted sum distortion minimization problem, where each user weight reflects the total importance level of the packets that has been scheduled for that user. Frequency-selective power is then water-filled over all the assigned subcarriers in order to leverage the potential channel coding gain. Realistic simulation results demonstrate that the proposed scheme significantly outperforms the state-of-the-art scheduling scheme by up to 6.8 dB in terms of peak-signal-to-noise-ratio (PSNR). Further test evaluates the suitability of equal power allocation which is the common assumption in the literature.	[Tham, Mau-Luen; Chow, Chee-Onn] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Tham, Mau-Luen; Ramli, Nordin] MIMOS Berhad, Wireless Innovat, Technol Pk Malaysia, Kuala Lumpur, Malaysia; [Xu, Yi-Han] Nanjing Forestry Univ, Coll Informat Sci & Technol, Nanjing, Jiangsu, Peoples R China	Universiti Malaya; MIMOS Berhad; Nanjing Forestry University	Tham, ML (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.; Tham, ML (corresponding author), MIMOS Berhad, Wireless Innovat, Technol Pk Malaysia, Kuala Lumpur, Malaysia.	thammauluen@gmail.com	Chow, Chee-Onn/B-8408-2010; Tham, Mau-Luen/T-2968-2017; RAMLI, NORDIN/I-9524-2014	Chow, Chee-Onn/0000-0001-6044-2650; Tham, Mau-Luen/0000-0003-4600-9839; RAMLI, NORDIN/0000-0001-5358-284X	University of Malaya, Malaysia, under UMRG grant [RG064/11ICT]; MIMOS Berhad	University of Malaya, Malaysia, under UMRG grant; MIMOS Berhad	This project is supported by the University of Malaya, Malaysia, under UMRG grant (RG064/11ICT), and MIMOS Berhad. The funder MIMOS Berhad provided support in the form of salaries for authors MLT and NR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bertsekas, 1995, NONLINEAR PROGRAMMIN; Bohge M, P IEEE GLOBECOM C 20; Jang JH, 2003, IEEE J SEL AREA COMM, V21, P171, DOI 10.1109/JSAC.2002.807348; Ji X, 2009, IEEE T CIRC SYST VID, V19, P1549, DOI 10.1109/TCSVT.2009.2026812; Jiang TG, 2012, IEEE J SEL AREA COMM, V30, P1215, DOI 10.1109/JSAC.2012.120807; Khalek AA, 2012, IEEE J SEL AREA COMM, V30, P1157, DOI 10.1109/JSAC.2012.120802; Lai CF, 2013, IEEE WIREL COMMUN, V20, P62; Lee HW, 2008, IEEE T WIREL COMMUN, V7, P3738, DOI 10.1109/T-WC.2008.061110; Li F, 2012, IEEE T VEH TECHNOL, V61, P2753, DOI 10.1109/TVT.2012.2195511; Li F, 2009, IEEE T CIRC SYST VID, V19, P1908, DOI 10.1109/TCSVT.2009.2031457; Li P, 2011, IEEE T CONSUM ELECTR, V57, P1128, DOI 10.1109/TCE.2011.6018865; Liang YJ, 2008, IEEE T CIRC SYST VID, V18, P861, DOI 10.1109/TCSVT.2008.923139; Luo HY, 2010, IEEE COMMUN MAG, V48, P102, DOI 10.1109/MCOM.2010.5402671; Mokari N, 2010, IEEE T VEH TECHNOL, V59, P1011, DOI 10.1109/TVT.2009.2035131; Moon H, 2009, IEEE T COMMUN, V57, P943, DOI 10.1109/TCOMM.2009.04.060304; Pahalawatta P, 2007, IEEE J SEL AREA COMM, V25, P749, DOI 10.1109/JSAC.2007.070511; Qiu XX, 1999, IEEE T COMMUN, V47, P884, DOI 10.1109/26.771345; Rappaport T. S., 2002, WIRELESS COMMUNICATI; Seong K, P IEEE ISIT C 2006; Song GC, 2005, IEEE T WIREL COMMUN, V4, P625, DOI 10.1109/TWC.2004.843067; Wang C., 2014, IEEE ACM T IN PRESS; Wang DW, 2013, IEEE T COMMUN, V61, P2060, DOI 10.1109/TCOMM.2013.032013.120053; Yang Z, 2013, IEEE T CIRC SYST VID, V23, P212, DOI 10.1109/TCSVT.2012.2203216; Yen CM, 2010, IEEE T VEH TECHNOL, V59, P4105, DOI 10.1109/TVT.2010.2062546; Yu W, 2006, IEEE T COMMUN, V54, P1310, DOI 10.1109/TCOMM.2006.877962; Zhou LA, 2011, IEEE T VEH TECHNOL, V60, P692, DOI 10.1109/TVT.2010.2102782	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0148625	10.1371/journal.pone.0148625	http://dx.doi.org/10.1371/journal.pone.0148625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906398	Green Published, gold			2022-12-27	WOS:000371163000005
J	Dalsgaard, L; Astrup, R; Anton-Fernandez, C; Borgen, SK; Breidenbach, J; Lange, H; Lehtonen, A; Liski, J				Dalsgaard, Lise; Astrup, Rasmus; Anton-Fernandez, Clara; Borgen, Signe Kynding; Breidenbach, Johannes; Lange, Holger; Lehtonen, Aleksi; Liski, Jari			Modeling Soil Carbon Dynamics in Northern Forests: Effects of Spatial and Temporal Aggregation of Climatic Input Data	PLOS ONE			English	Article							EARTH SYSTEM MODELS; FINE-ROOT TURNOVER; NORWAY SPRUCE; PICEA-ABIES; UNDERSTOREY VEGETATION; C SEQUESTRATION; LINKING PLANT; STOCK CHANGES; BIOMASS; DECOMPOSITION	Boreal forests contain 30% of the global forest carbon with the majority residing in soils. While challenging to quantify, soil carbon changes comprise a significant, and potentially increasing, part of the terrestrial carbon cycle. Thus, their estimation is important when designing forest-based climate change mitigation strategies and soil carbon change estimates are required for the reporting of greenhouse gas emissions. Organic matter decomposition varies with climate in complex nonlinear ways, rendering data aggregation nontrivial. Here, we explored the effects of temporal and spatial aggregation of climatic and litter input data on regional estimates of soil organic carbon stocks and changes for upland forests. We used the soil carbon and decomposition model Yasso07 with input from the Norwegian National Forest Inventory (11275 plots, 1960-2012). Estimates were produced at three spatial and three temporal scales. Results showed that a national level average soil carbon stock estimate varied by 10% depending on the applied spatial and temporal scale of aggregation. Higher stocks were found when applying plot-level input compared to country-level input and when long-term climate was used as compared to annual or 5-year mean values. A national level estimate for soil carbon change was similar across spatial scales, but was considerably (60-70%) lower when applying annual or 5-year mean climate compared to long-term mean climate reflecting the recent climatic changes in Norway. This was particularly evident for the forest-dominated districts in the southeastern and central parts of Norway and in the far north. We concluded that the sensitivity of model estimates to spatial aggregation will depend on the region of interest. Further, that using long-term climate averages during periods with strong climatic trends results in large differences in soil carbon estimates. The largest differences in this study were observed in central and northern regions with strongly increasing temperatures.	[Dalsgaard, Lise; Astrup, Rasmus; Anton-Fernandez, Clara; Borgen, Signe Kynding; Breidenbach, Johannes; Lange, Holger] Norwegian Inst Bioecon Res NIBIO, As, Norway; [Lehtonen, Aleksi] Nat Resources Inst Finland LUKE, Helsinki, Finland; [Liski, Jari] Finnish Environm Inst SYKE, Helsinki, Finland	Norwegian Institute of Bioeconomy Research; Natural Resources Institute Finland (Luke); Finnish Environment Institute	Dalsgaard, L (corresponding author), Norwegian Inst Bioecon Res NIBIO, As, Norway.	lise.dalsgaard@nibio.no	Antón-Fernández, Clara/C-2427-2009; Liski, Jari/O-8494-2016; Lange, Holger/A-2458-2012	Antón-Fernández, Clara/0000-0001-5545-3320; Liski, Jari/0000-0002-0847-8207; Lange, Holger/0000-0001-7099-8740; Lehtonen, Aleksi/0000-0003-1388-0388	Norwegian Research Council [210464/O10]; Norwegian Environment Agency; Academy of Finland [138359]; Ministry of Environment in Finland	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Environment Agency; Academy of Finland(Academy of Finland); Ministry of Environment in Finland	This work was funded by the Norwegian Research Council (grant no. 210464/O10), the Norwegian Environment Agency, the Academy of Finland (decision 138359), and the Ministry of Environment in Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2003, FOREST ECOL MANAG, V174, P25, DOI 10.1016/S0378-1127(02)00025-7; Agren GI, 2008, BIOGEOCHEMISTRY, V89, P139, DOI 10.1007/s10533-007-9151-x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Andreassen K, 2006, FOREST ECOL MANAG, V222, P211, DOI 10.1016/j.foreco.2005.10.029; [Anonymous], 2014, M137 NORW ENV AG; Anton-Fernandez C, 2012, SCAND J FOREST RES, V27, P379, DOI 10.1080/02827581.2011.644576; Berg B, 2009, CAN J FOREST RES, V39, P962, DOI 10.1139/X09-022; Black K, 2014, GEODERMA, V232, P487, DOI 10.1016/j.geoderma.2014.05.022; CALE WG, 1983, J THEOR BIOL, V100, P539, DOI 10.1016/0022-5193(83)90446-0; Chapin FS, 2009, J ECOL, V97, P840, DOI 10.1111/j.1365-2745.2009.01529.x; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen JM, 2003, TELLUS B, V55, P622, DOI 10.1034/j.1600-0889.2003.00036.x; Conant RT, 2011, GLOBAL CHANGE BIOL, V17, P3392, DOI 10.1111/j.1365-2486.2011.02496.x; Davi H, 2006, AGR FOREST METEOROL, V139, P269, DOI 10.1016/j.agrformet.2006.07.007; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2014, GLOBAL CHANGE BIOL, V20, P3610, DOI 10.1111/gcb.12718; De Deyn GB, 2008, ECOL LETT, V11, P516, DOI 10.1111/j.1461-0248.2008.01164.x; De Vries W, 2006, GLOBAL CHANGE BIOL, V12, P1151, DOI 10.1111/j.1365-2486.2006.01151.x; de Wit HA, 2006, FOREST ECOL MANAG, V225, P15, DOI 10.1016/j.foreco.2005.12.023; de Wit HA, 2015, BIOGEOCHEMISTRY, V123, P147, DOI 10.1007/s10533-014-0060-5; DeAngelis D. L., 1981, Dynamic properties of forest ecosystems., P567; Didion M, 2014, ECOL MODEL, V291, P58, DOI 10.1016/j.ecolmodel.2014.07.028; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Genet H, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045016; Goll DS, 2015, GLOBAL BIOGEOCHEM CY, V29, P1511, DOI 10.1002/2014GB004988; Hakkinen M, 2011, BIOGEOSCIENCES, V8, P1279, DOI 10.5194/bg-8-1279-2011; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; KICKLIGHTER DW, 1994, J GEOPHYS RES-ATMOS, V99, P1303, DOI 10.1029/93JD02964; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Kleja DB, 2008, BIOGEOCHEMISTRY, V89, P7, DOI 10.1007/s10533-007-9136-9; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Lehtonen A, 2004, ECOL MODEL, V180, P305, DOI 10.1016/j.ecolmodel.2004.04.024; Liski J, 1998, EUR J SOIL SCI, V49, P407, DOI 10.1046/j.1365-2389.1998.4930407.x; Liski J, 2005, ECOL MODEL, V189, P168, DOI 10.1016/j.ecolmodel.2005.03.005; Liski J, 2002, FOREST ECOL MANAG, V169, P159, DOI 10.1016/S0378-1127(02)00306-7; Marklund LG, 1988, 45 SLU I SKOGST; Matamala R, 2003, SCIENCE, V302, P1385, DOI 10.1126/science.1089543; Meyn A, 2013, REG ENVIRON CHANGE, V13, P165, DOI 10.1007/s10113-012-0319-0; Miller BA, 2015, GEODERMA, V239, P97, DOI 10.1016/j.geoderma.2014.09.018; Monni S, 2007, CLIMATIC CHANGE, V81, P391, DOI 10.1007/s10584-006-9140-4; Muukkonen P, 2004, CAN J FOREST RES, V34, P2517, DOI [10.1139/x04-133, 10.1139/X04-133]; Muukkonen P, 2006, SILVA FENN, V40, P231, DOI 10.14214/sf.340; Muukkonen P, 2006, BOREAL ENVIRON RES, V11, P355; Nilsen P, 2008, FOREST ECOL MANAG, V256, P201, DOI 10.1016/j.foreco.2008.04.001; Nilsen P, 2013, SILVA FENN, V47, DOI 10.14214/sf.1024; Ortiz C, 2011, ECOL MODEL, V222, P3020, DOI 10.1016/j.ecolmodel.2011.05.034; Ortiz CA, 2013, ECOL MODEL, V251, P221, DOI 10.1016/j.ecolmodel.2012.12.017; Palosuo T, 2012, ENVIRON MODELL SOFTW, V35, P38, DOI 10.1016/j.envsoft.2012.02.004; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peltoniemi M, 2004, GLOBAL CHANGE BIOL, V10, P2078, DOI 10.1111/j.1365-2486.2004.00881.x; Peltoniemi M, 2006, FOREST ECOL MANAG, V232, P75, DOI 10.1016/j.foreco.2006.05.045; Petersson H, 2006, SCAND J FOREST RES, V21, P84, DOI 10.1080/14004080500486864; R Core Team, 2021, R LANGUAGE ENV STAT; Rantakari M, 2012, FOREST ECOL MANAG, V286, P137, DOI 10.1016/j.foreco.2012.08.041; RASTETTER EB, 1992, ECOL APPL, V2, P55, DOI 10.2307/1941889; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Reichstein M, 2014, P NATL ACAD SCI USA, V111, P13697, DOI 10.1073/pnas.1216065111; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Rypdal K, 2005, 1105 CICERO NIJOS SS; Saby NPA, 2008, GLOBAL CHANGE BIOL, V14, P2432, DOI 10.1111/j.1365-2486.2008.01658.x; Shaw CH, 2014, ECOL MODEL, V272, P323, DOI 10.1016/j.ecolmodel.2013.10.005; Solberg S, 2015, BOREAL ENVIRON RES, V20, P335; Svensson M, 2008, BIOGEOCHEMISTRY, V89, P95, DOI 10.1007/s10533-007-9134-y; Thum T, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001612; Thurig E, 2005, FOREST ECOL MANAG, V210, P337, DOI 10.1016/j.foreco.2005.02.030; Tierney GL, 2002, CAN J FOREST RES, V32, P1692, DOI [10.1139/x02-123, 10.1139/X02-123]; Todd-Brown KEO, 2014, BIOGEOSCIENCES, V11, P2341, DOI 10.5194/bg-11-2341-2014; Todd-Brown KEO, 2013, BIOGEOSCIENCES, V10, P1717, DOI 10.5194/bg-10-1717-2013; Tomter SM, 2010, NATIONAL FOREST INVENTORIES: PATHWAYS FOR COMMON REPORTING, P411, DOI 10.1007/978-90-481-3233-1_26; Tuomi M, 2011, ENVIRON MODELL SOFTW, V26, P1358, DOI 10.1016/j.envsoft.2011.05.009; Tuomi M, 2011, ECOL MODEL, V222, P709, DOI 10.1016/j.ecolmodel.2010.10.025; Tuomi M, 2009, ECOL MODEL, V220, P3362, DOI 10.1016/j.ecolmodel.2009.05.016; US Environmental Protection Agency, 2014, GREENHOUSE GAS EMISS; Vasques GM, 2010, SOIL SCI SOC AM J, V74, P870, DOI 10.2136/sssaj2009.0242; Vesterdal L, 2013, FOREST ECOL MANAG, V309, P4, DOI 10.1016/j.foreco.2013.01.017; Wang DD, 2010, PEDOSPHERE, V20, P525, DOI 10.1016/S1002-0160(10)60042-2; Zhang LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088622	77	6	6	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149902	10.1371/journal.pone.0149902	http://dx.doi.org/10.1371/journal.pone.0149902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901763	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100182
J	Delic, D; Eisele, C; Schmid, R; Baum, P; Wiech, F; Gerl, M; Zimdahl, H; Pullen, SS; Urquhart, R				Delic, Denis; Eisele, Claudia; Schmid, Ramona; Baum, Patrick; Wiech, Franziska; Gerl, Martin; Zimdahl, Heike; Pullen, Steven S.; Urquhart, Richard			Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients	PLOS ONE			English	Article							PROMOTES RENAL FIBROSIS; FALSE DISCOVERY RATE; GROWTH-FACTOR-BETA; TGF-BETA; POTENTIAL BIOMARKERS; IN-VIVO; EXPRESSION; MICRORNA; DISEASE; THROMBOSPONDIN-1	MicroRNAs (miRNAs) are short non-coding RNA species which are important post-transcriptional regulators of gene expression and play an important role in the pathogenesis of diabetic nephropathy. miRNAs are present in urine in a remarkably stable form packaged in extracellular vesicles, predominantly exosomes. In the present study, urinary exosomal miRNA profiling was conducted in urinary exosomes obtained from 8 healthy controls (C), 8 patients with type II diabetes (T2D) and 8 patients with type II diabetic nephropathy (DN) using Agilent's miRNA microarrays. In total, the expression of 16 miRNA species was deregulated (>2-fold) in DN patients compared to healthy donors and T2D patients: the expression of 14 miRNAs (miR-320c, miR-6068, miR-1234-5p, miR-6133, miR-4270, miR4739, miR-371b-5p, miR-638, miR-572, miR-1227-5p, miR-6126, miR-1915-5p, miR-47785p and miR-2861) was up-regulated whereas the expression of 2 miRNAs (miR-30d-5p and miR-30e-5p) was down-regulated. Most of the deregulated miRNAs are involved in progression of renal diseases. Deregulation of urinary exosomal miRNAs occurred in micro-albuminuric DN patients but not in normo-albuminuric DN patients. We used qRT-PCR based analysis of the most strongly up-regulated miRNAs in urinary exosomes from DN patients, miRNAs miR-320c and miR-6068. The correlation of miRNA expression and micro-albuminuria levels could be replicated in a confirmation cohort. In conclusion, urinary exosomal miRNA content is altered in type II diabetic patients with DN. Deregulated miR-320c, which might have an impact on the TGF-beta-signaling pathway via targeting thrombospondin 1 (TSP-1) shows promise as a novel candidate marker for disease progression in type II DN that should be evaluated in future studies.	[Delic, Denis; Eisele, Claudia; Schmid, Ramona; Baum, Patrick; Wiech, Franziska; Gerl, Martin] Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, Birkendorferstr 65, D-88397 Biberach, Germany; [Zimdahl, Heike] Boehringer Ingelheim Pharma GmbH & Co KG, R&D Project Management, Birkendorferstr 65, D-88397 Biberach, Germany; [Pullen, Steven S.] Boehringer Ingelheim Pharmaceut Inc, Cardiometab Dis Res, 900 Ridgebury Rd, Ridgefield, CT 06877 USA; [Urquhart, Richard] Boehringer Ingelheim Pharmaceut Inc, Translat Med & Clin Pharmacol, 900 Ridgebury Rd, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim	Delic, D (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Translat Med & Clin Pharmacol, Birkendorferstr 65, D-88397 Biberach, Germany.	denis.delic@boehringer-ingelheim.com			Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc	Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc	The funder, Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharmaceuticals Inc, provided support in the form of salaries for authors DD, CE, RS, PB, FW, MG, HZ, SSP, and RU, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ahamed J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006608; Alvarez ML, 2014, METHODS MOL BIOL, V1182, P145, DOI 10.1007/978-1-4939-1062-5_13; Alvarez ML, 2012, KIDNEY INT, V82, P1024, DOI 10.1038/ki.2012.256; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; ANDERSEN CL, 2014, CANCER RES, V64, P5245; Argyropoulos C, 2015, J CLIN MED, V4, P1498, DOI 10.3390/jcm4071498; Argyropoulos C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054662; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chan G, 2013, J ROY COLL PHYS EDIN, V43, P330, DOI 10.4997/JRCPE.2013.413; Chung ACK, 2013, INT J NEPHROL RENOV, V6, P169, DOI 10.2147/IJNRD.S37885; Chung ACK, 2010, J AM SOC NEPHROL, V21, P1317, DOI 10.1681/ASN.2010020134; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Erdbrugger U, 2016, J AM SOC NEPHROL, V27, P12, DOI 10.1681/ASN.2015010074; Fried LF, 2015, CLIN J AM SOC NEPHRO, V10, P1095, DOI 10.2215/CJN.01610215; Frolova EG, 2012, FASEB J, V26, P2363, DOI 10.1096/fj.11-190728; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glassock RJ, 2010, AM J NEPHROL, V31, P462, DOI 10.1159/000313553; Glowacki F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058014; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hamam D, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.462; HAMPEL FR, 1985, TECHNOMETRICS, V27, P95, DOI 10.2307/1268758; Harvey SJ, 2008, J AM SOC NEPHROL, V19, P2150, DOI 10.1681/ASN.2008020233; Hohenstein B, 2008, NEPHROL DIAL TRANSPL, V23, P3880, DOI 10.1093/ndt/gfn399; Kanasaki K, 2014, DIABETES, V63, P2120, DOI 10.2337/db13-1029; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Lambers Heerspink HJ, 2010, AM J NEPHROL, V31, P458, DOI 10.1159/000292501; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Romero P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-64; Lorenzen JM, 2012, CLIN J AM SOC NEPHRO, V7, P1528, DOI 10.2215/CJN.01170212; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu AL, 2011, AM J PATHOL, V178, P2573, DOI 10.1016/j.ajpath.2011.02.039; Lv LL, 2013, AM J PHYSIOL-RENAL, V305, pF1220, DOI 10.1152/ajprenal.00148.2013; Macconi D, 2012, J AM SOC NEPHROL, V23, P1496, DOI 10.1681/ASN.2011121144; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Meng XM, 2012, J PATHOL, V227, P175, DOI 10.1002/path.3976; Miranda KC, 2010, KIDNEY INT, V78, P191, DOI 10.1038/ki.2010.106; Nassirpour R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-485; Neal CS, 2011, NEPHROL DIAL TRANSPL, V26, P3794, DOI 10.1093/ndt/gfr485; Okada H, 2012, J AM SOC NEPHROL, V23, P1441, DOI 10.1681/ASN.2012070692; Patel V, 2012, CURR OPIN NEPHROL HY, V21, P410, DOI 10.1097/MNH.0b013e328354e559; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; R Development Core Team,, 2003, R LANG ENV STAT COMP; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Ramdas V, 2013, AM J PATHOL, V183, P1885, DOI 10.1016/j.ajpath.2013.08.027; Ramezani A, 2015, EUR J CLIN INVEST, V45, P394, DOI 10.1111/eci.12420; Sallustio F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068296; Sallustio F, 2013, KIDNEY INT, V83, P392, DOI 10.1038/ki.2012.413; Shantikumar S, 2014, J MOL CELL CARDIOL, V74, P196, DOI 10.1016/j.yjmcc.2014.05.014; Shi SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075572; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sole C, 2015, NEPHROL DIAL TRANSPL, V30, P1488, DOI 10.1093/ndt/gfv128; Stevens LA, 2006, CLIN J AM SOC NEPHRO, V1, P874, DOI 10.2215/CJN.00600206; Takahashi Y, 2010, CLIN SCI, V119, P395, DOI 10.1042/CS20100003; Tian ZM, 2008, GENOME RES, V18, P404, DOI 10.1101/gr.6587008; Ukai T, 2012, J ORTHOP RES, V30, P1915, DOI 10.1002/jor.22157; van Balkom BWM, 2011, KIDNEY INT, V80, P1138, DOI 10.1038/ki.2011.292; Wahab NA, 2005, DIABETOLOGIA, V48, P2650, DOI 10.1007/s00125-005-0006-5; Wang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep07610; Wang XH, 2014, J MOL CELL CARDIOL, V74, P139, DOI 10.1016/j.yjmcc.2014.05.001; Wang XueFei, 2013, Journal of Southwest Forestry University, V33, P69; Weir MR, 2010, AM J NEPHROL, V31, P469, DOI 10.1159/000292500; Wing MR, 2013, SEMIN NEPHROL, V33, P363, DOI 10.1016/j.semnephrol.2013.05.008; Wu JN, 2014, J AM SOC NEPHROL, V25, P92, DOI 10.1681/ASN.2012111101; Yan JD, 2009, ACTA PHARMACOL SIN, V30, P994, DOI 10.1038/aps.2009.56; Yang YY, 2013, MED HYPOTHESES, V81, P274, DOI 10.1016/j.mehy.2013.04.031	72	148	160	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150154	10.1371/journal.pone.0150154	http://dx.doi.org/10.1371/journal.pone.0150154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930277	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500107
J	Lim, HK; Park, ST; Ha, H; Choi, SY				Lim, Hyun Kyung; Park, Sung Tae; Ha, Hongil; Choi, Seo-youn			Thyroid Nodules Detected by Contrast-Enhanced Magnetic Resonance Angiography: Prevalence and Clinical Significance	PLOS ONE			English	Article							SYSTEM; CT; MR; 3T	Background and Purpose Incidental thyroid lesions are frequently found on contrast-enhanced magnetic resonance (CE-MR) angiography. The purpose of this study is to determine the prevalence of thyroid incidentalomas detected by CE-MR angiography and to evaluate their clinical significance by correlation with ultrasound (US) and cytopathological results. Materials and Methods We retrospectively reviewed 3,299 consecutive CE-MR angiography examinations performed at our institution between January 2010 and March 2013. Two radiologists evaluated the CE-MR angiography imaging in consensus regarding the presence, location, and vascularity of thyroid incidentaloma. We correlated these findings with follow-up US and cytopathologic results. Results The prevalence of thyroid incidentalomas detected by CE-MR angiography was 4.6% (152/3,299 patients). CE-MR angiography showed hypervascularity in 86.8% (145/167), isovascularity in 8.4% (14/167), and hypovascularity in 4.8% (8/167) of thyroid nodules compared to vascularity of thyroid parenchyma. Among the patients with thyroid incidentaloma, 34 patients (22.4%) were followed by US examination, and all 36 nodules on CE-MR angiography were detected on follow-up US. Of these nodules, 9 (25%) nodules were classified as probably benign, 26 (72.2%) as indeterminate, and 1 (2.8%) as suspicious malignant nodule. Among the 16 nodules with available cytopathologic results, 12 nodules were benign, 2 nodules were follicular neoplasm, and 2 nodules showed non-diagnostic results. Conclusion Incidental thyroid nodules were found in 4.6% of CE-MR angiography examinations. Because the high incidence of indeterminate US feature among thyroid incidentaloma, when a thyroid incidentaloma is detected on CE-MR angiography, further evaluation with US should be performed.	[Lim, Hyun Kyung; Park, Sung Tae] Soonchunhyang Univ, Dept Radiol, Neuroradiol Sect, Seoul Hosp,Coll Med, Seoul, South Korea; [Ha, Hongil] Hallym Univ, Sacred Heart Hosp, Dept Radiol, Med Ctr, Anyang, South Korea; [Choi, Seo-youn] Soonchunhyang Univ, Coll Med, Dept Radiol, Sect Neuroradiol,Bucheon Hosp, Bucheon, South Korea	Soonchunhyang University; Hallym University; Soonchunhyang University	Park, ST (corresponding author), Soonchunhyang Univ, Dept Radiol, Neuroradiol Sect, Seoul Hosp,Coll Med, Seoul, South Korea.	stpark@schmc.ac.kr			Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund (fund number: none). There was no additional external funding received for this study.	Bae JS, 2009, WORLD J SURG ONCOL, V7, DOI 10.1186/1477-7819-7-63; Chen WG, 2009, NUCL MED COMMUN, V30, P240, DOI 10.1097/MNM.0b013e328324b431; Choi N, 2012, KOREAN J RADIOL, V13, P275, DOI 10.3348/kjr.2012.13.3.275; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Jin J, 2009, AM J SURG, V197, P320, DOI 10.1016/j.amjsurg.2008.10.006; Kwak JY, 2008, AM J ROENTGENOL, V191, P598, DOI 10.2214/AJR.07.3443; Kwak JY, 2013, KOREAN J RADIOL, V14, P110, DOI 10.3348/kjr.2013.14.1.110; Lohan DG, 2008, AM J ROENTGENOL, V190, pW255, DOI 10.2214/AJR.07.3137; Moon WJ, 2008, RADIOLOGY, V247, P762, DOI 10.1148/radiol.2473070944; Moon WJ, 2011, KOREAN J RADIOL, V12, P1, DOI 10.3348/kjr.2011.12.1.1; Shetty SK, 2006, AM J ROENTGENOL, V187, P1349, DOI 10.2214/AJR.05.0468; Yoon DY, 2008, J COMPUT ASSIST TOMO, V32, P810, DOI 10.1097/RCT.0b013e318157fd38; Yousem DM, 1997, AM J NEURORADIOL, V18, P1423	14	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149811	10.1371/journal.pone.0149811	http://dx.doi.org/10.1371/journal.pone.0149811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919607	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400047
J	Shih, CC; Hii, HP; Tsao, CM; Chen, SJ; Ka, SM; Liao, MH; Wu, CC				Shih, Chih-Chin; Hii, Hiong-Ping; Tsao, Cheng-Ming; Chen, Shiu-Jen; Ka, Shuk-Man; Liao, Mei-Hui; Wu, Chin-Chen			Therapeutic Effects of Procainamide on Endotoxin-Induced Rhabdomyolysis in Rats	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; DNA METHYLATION; MUSCLE DAMAGE; BACTERIAL SEPSIS; LIPOPOLYSACCHARIDE; HYPERMETHYLATION; EXPRESSION; EXERCISE; METHYLTRANSFERASE; ATHEROSCLEROSIS	Overt systemic inflammatory response is a predisposing mechanism for infection-induced skeletal muscle damage and rhabdomyolysis. Aberrant DNA methylation plays a crucial role in the pathophysiology of excessive inflammatory response. The antiarrhythmic drug procainamide is a non-nucleoside inhibitor of DNA methyltransferase 1 (DNMT1) used to alleviate DNA hypermethylation. Therefore, we evaluated the effects of procainamide on the syndromes and complications of rhabdomyolysis rats induced by lipopolysaccharide (LPS). Rhabdomyolysis animal model was established by intravenous infusion of LPS (5 mg/kg) accompanied by procainamide therapy (50 mg/kg). During the experimental period, the changes of hemodynamics, muscle injury index, kidney function, blood gas, blood electrolytes, blood glucose, and plasma interleukin-6 (IL-6) levels were examined. Kidneys and lungs were exercised to analyze superoxide production, neutrophil infiltration, and DNMTs expression. The rats in this model showed similar clinical syndromes and complications of rhabdomyolysis including high levels of plasma creatine kinase, acute kidney injury, hyperkalemia, hypocalcemia, metabolic acidosis, hypotension, tachycardia, and hypoglycemia. The increases of lung DNMT1 expression and plasma IL-6 concentration were also observed in rhabdomyolysis animals induced by LPS. Treatment with procainamide not only inhibited the overexpression of DNMT1 but also diminished the overproduction of IL-6 in rhabdomyolysis rats. In addition, procainamide improved muscle damage, renal dysfunction, electrolytes disturbance, metabolic acidosis, hypotension, and hypoglycemia in the rats with rhabdomyolysis. Moreover, another DNMT inhibitor hydralazine mitigated hypoglycemia, muscle damage, and renal dysfunction in rhabdomyolysis rats. These findings reveal that therapeutic effects of procainamide could be based on the suppression of DNMT1 and pro-inflammatory cytokine in endotoxin-induced rhabdomyolysis.	[Shih, Chih-Chin] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Shih, Chih-Chin; Liao, Mei-Hui; Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Hii, Hiong-Ping] Chi Mei Med Ctr, Dept Surg, Tainan, Taiwan; [Tsao, Cheng-Ming] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Taipei 112, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Hlth Management, Elderly Soc, Taipei, Taiwan; [Ka, Shuk-Man] Natl Def Med Ctr, Grad Inst Aerosp & Undersea Med, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Chi Mei Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; National Defense Medical Center	Liao, MH; Wu, CC (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	cody1988@mail.ndmctsgh.edu.tw; ccwu@mail.ndmctsgh.edu.tw			National Defense Medical Center, R.O.C., Taiwan [103-M023, 103-M025]; MOST from the Ministry of Science and Technology, R.O.C., Taiwan [103-2320-B-016-020]	National Defense Medical Center, R.O.C., Taiwan; MOST from the Ministry of Science and Technology, R.O.C., Taiwan	This study was supported by grants 103-M023 (CCW) and 103-M025 (CCS) from National Defense Medical Center, R.O.C., Taiwan and MOST 103-2320-B-016-020 (CCW) from the Ministry of Science and Technology, R.O.C., Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DG, 2004, CLIN EXP PHARMACOL P, V31, P485, DOI 10.1111/j.1440-1681.2004.04032.x; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Baeza-Trinidad R, 2015, INTERN MED J, V45, P1173, DOI 10.1111/imj.12815; Betrosian A, 1999, INTENS CARE MED, V25, P469, DOI 10.1007/s001340050882; Bosch X, 2009, NEW ENGL J MED, V361, P62, DOI 10.1056/NEJMra0801327; Bruunsgaard H, 1997, J PHYSIOL-LONDON, V499, P833, DOI 10.1113/jphysiol.1997.sp021972; Cao Q, 2014, ENDOCRINOLOGY, V155, P4925, DOI 10.1210/en.2014-1595; Chatzizisis YS, 2008, EUR J INTERN MED, V19, P568, DOI 10.1016/j.ejim.2007.06.037; Cheng C, 2014, TOXICOL LETT, V225, P488, DOI 10.1016/j.toxlet.2013.12.023; CORNACCHIA E, 1988, J IMMUNOL, V140, P2197; Criddle Laura M, 2003, Crit Care Nurse, V23, P14; Deutsch M, 2008, EUR J INTERN MED, V19, P289, DOI 10.1016/j.ejim.2007.04.025; Dunn J, 2014, J CLIN INVEST, V124, P3187, DOI 10.1172/JCI74792; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Giannoglou GD, 2007, EUR J INTERN MED, V18, P90, DOI 10.1016/j.ejim.2006.09.020; Gunawardhana LP, 2014, EPIGENETICS-US, V9, P1302, DOI 10.4161/epi.33066; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jortay J, 2010, ENDOCRINOLOGY, V151, P4840, DOI 10.1210/en.2009-1462; Kovalchuk I, 2013, ENVIRON MOL MUTAGEN, V54, P421, DOI 10.1002/em.21787; Kumar AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007182; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Lee BH, 2005, J BIOL CHEM, V280, P40749, DOI 10.1074/jbc.M505593200; Li JJ, 2015, INT J MOL SCI, V16, P12560, DOI 10.3390/ijms160612560; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056331; Lin XH, 2001, CANCER RES, V61, P8611; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Nieman DC, 2005, BRAIN BEHAV IMMUN, V19, P398, DOI 10.1016/j.bbi.2005.03.008; Ojukwu IC, 2001, SCAND J INFECT DIS, V33, P227, DOI 10.1080/00365540151060969; Petejova N, 2014, CRIT CARE, V18, DOI 10.1186/cc13897; Raetzsch CF, 2009, HEPATOLOGY, V50, P592, DOI 10.1002/hep.22999; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Takahashi K, 2014, CELL MOL LIFE SCI, V71, P1045, DOI 10.1007/s00018-013-1487-x; Tolg C, 2012, EPIGENOMICS-UK, V4, P229, DOI [10.2217/EPI.12.5, 10.2217/epi.12.5]; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; Totsuka M, 2002, J APPL PHYSIOL, V93, P1280, DOI 10.1152/japplphysiol.01270.2001; Zhang XQ, 2013, MOL MED REP, V7, P1417, DOI 10.3892/mmr.2013.1405; Zimmerman JL, 2013, CHEST, V144, P1058, DOI 10.1378/chest.12-2016	40	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150319	10.1371/journal.pone.0150319	http://dx.doi.org/10.1371/journal.pone.0150319			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918767	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400124
J	Stranak, Z; Feyereislova, S; Cerna, M; Kollarova, J; Feyereisl, J				Stranak, Zbynek; Feyereislova, Simona; Cerna, Marcela; Kollarova, Jana; Feyereisl, Jaroslav			Limited Amount of Formula May Facilitate Breastfeeding: Randomized, Controlled Trial to Compare Standard Clinical Practice versus Limited Supplemental Feeding	PLOS ONE			English	Article								Objectives Breastfeeding is known to reduce infant morbidity and improve well-being. Nevertheless, breastfeeding rates remain low despite public health efforts. Our study aims to investigate the effect of controlled limited formula usage during birth hospitalisation on breastfeeding, using the primary hypothesis that early limited formula feeds in infants with early weight loss will not adversely affect the rate of exclusive or any breastfeeding as measured at discharge, 3 and 6 months of age. Material and Methods We randomly assigned 104 healthy term infants, 24 to 48 hours old, with >= 5% loss of birth weight to controlled limited formula (CLF) intervention (10 ml formula by syringe after each breastfeeding, discontinued at onset of lactation) or control group (standard approach, SA). Groups were compared for demographic data and breastfeeding rates at discharge, 3 months and 6 months of age (p-values adjusted for multiple testing). Results Fifty newborns were analysed in CLF and 50 in SA group. There were no differences in demographic data or clinical characteristics between groups. We found no evidence of difference between treatment groups in the rates of exclusive as well as any breastfeeding at discharge (p-value 0.2 and >0.99 respectively), 3 months (p-value 0.12 and 0.10) and 6 months of infants' age (p-value 0.45 and 0.34 respectively). The percentage weight loss during hospitalisation was significantly higher in the SA group (7.3% in CLF group, 8.4% in SA group, p = 0.002). Conclusion The study shows that controlled limited formula use does not have an adverse effect on rates of breastfeeding in the short and long term. Larger studies are needed to confirm a possible potential in controlled limited formula use to support establishing breastfeeding and to help to improve the rates of breastfeeding overall.	[Stranak, Zbynek] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Stranak, Zbynek; Feyereislova, Simona; Cerna, Marcela; Kollarova, Jana] Inst Care Mother & Child, Dept Neonatol, Prague, Czech Republic; [Feyereisl, Jaroslav] Inst Care Mother & Child, Dept Obstet & Gynecol, Prague, Czech Republic	Charles University Prague	Feyereislova, S (corresponding author), Inst Care Mother & Child, Dept Neonatol, Prague, Czech Republic.	simona.feyereislova@upmd.eu		Feyereisl, Jaroslav/0000-0002-5742-9006	state budget;  [PRVOUK32]	state budget; 	This work was funded by PRVOUK32. The Charles University Research Development Schemes (known under the Czech acronym PRVOUK) have been providing institutional support for research at Charles University since 2012. The schemes are financed from the funding received from the state budget to support the University's long-term strategic development as a research organization (known as 'institutional funding'). The aim of the schemes is to maintain and improve the quality and quantity of research outputs at the University - not only on a national level, but also internationally. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	27UNICEF/WHO, 2009, BAB FRIENDL HOSP IN; CDC, 2014, BREASTF REP CARD; Chen CF, 2011, PEDIATR NEONATOL, V52, P85, DOI 10.1016/j.pedneo.2011.02.010; Colin W Binns, 2002, Breastfeed Rev, V10, P13; DiGirolamo AM, 2008, PEDIATRICS, V122, pS43, DOI 10.1542/peds.2008-1315e; Flaherman VJ, 2013, PEDIATRICS, V131, P1059, DOI 10.1542/peds.2012-2809; Grey-Donald K, 1985, PEDIATRICS, V75, P18; Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1; Kramer M. S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003517; Perrine CG, 2015, MMWR-MORBID MORTAL W, V64, P1112, DOI 10.15585/mmwr.mm6439a5; UNICEF/WHO, EXCL BREASTF; World Health Organization, 10 FACTS BREASTF; World Health Organization (WHO), 2011, EXCLUSIVE BREASTFEED	13	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150053	10.1371/journal.pone.0150053	http://dx.doi.org/10.1371/journal.pone.0150053			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918700	gold, Green Published			2022-12-27	WOS:000371274400076
J	Tadic, V; Cooper, A; Cumberland, P; Lewando-Hundt, G; Rahi, JS				Tadic, Valerija; Cooper, Andrew; Cumberland, Phillippa; Lewando-Hundt, Gillian; Rahi, Jugnoo S.		Vision Related Quality Life VQoL	Measuring the Quality of Life of Visually Impaired Children: First Stage Psychometric Evaluation of the Novel VQoL_CYP Instrument	PLOS ONE			English	Article							FUNCTIONAL VISION; QUESTIONNAIRE; VALIDITY; IMPACT	Purpose To report piloting and initial validation of the VQoL_CYP, a novel age-appropriate vision-related quality of life (VQoL) instrument for self-reporting by children with visual impairment (VI). Methods Participants were a random patient sample of children with VI aged 10-15 years. 69 patients, drawn from patient databases at Great Ormond Street Hospital and Moorfields Eye Hospital, United Kingdom, participated in piloting of the draft 47-item VQoL instrument, which enabled preliminary item reduction. Subsequent administration of the instrument, alongside functional vision (FV) and generic health-related quality of life (HRQoL) self-report measures, to 101 children with VI comprising a nationally representative sample enabled further item reduction and evaluation of psychometric properties using Rasch analysis. Construct validity was assessed through Pearson correlation coefficients. Results Item reduction through piloting (8 items removed for skewness and individual item response pattern) and validation (1 item removed for skewness and 3 for misfit in Rasch) produced a 35-item scale, with fit values within acceptable limits, no notable differential item functioning, good measurement precision, ordered response categories and acceptable targeting in Rasch. The VQoL_CYP showed good construct validity, correlating strongly with HRQoL scores, moderately with FV scores but not with acuity. Conclusions Robust child-appropriate self-report VQoL measures for children with VI are necessary for understanding the broader impacts of living with a visual disability, distinguishing these from limited functioning per se. Future planned use in larger patient samples will allow further psychometric development of the VQoL_CYP as an adjunct to objective outcomes assessment.	[Tadic, Valerija; Cumberland, Phillippa; Rahi, Jugnoo S.] UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, Populat Policy & Practice Programme, London, England; [Cooper, Andrew] Univ London, Dept Psychol, Goldsmiths, London, England; [Lewando-Hundt, Gillian] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Rahi, Jugnoo S.] Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England; [Rahi, Jugnoo S.] UCL Inst Ophthalmol, London, England; [Tadic, Valerija; Rahi, Jugnoo S.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Cumberland, Phillippa; Rahi, Jugnoo S.] Ulverscroft Vis Res Grp, London, England	University of London; University College London; University of London; Goldsmiths University London; University of Warwick; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Rahi, JS (corresponding author), UCL, Inst Child Hlth, Life Course Epidemiol & Biostat Sect, Populat Policy & Practice Programme, London, England.; Rahi, JS (corresponding author), Moorfields Eye Hosp NHS Fdn Trust, Biomed Res Ctr, Natl Inst Hlth Res, London, England.; Rahi, JS (corresponding author), UCL Inst Ophthalmol, London, England.; Rahi, JS (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, London, England.; Rahi, JS (corresponding author), Ulverscroft Vis Res Grp, London, England.	j.rahi@ucl.ac.uk	Tadic, Val/AAL-3304-2020	Tadic, Val/0000-0003-3982-0340; Rahi, Jugnoo/0000-0002-5718-9209; Dale, Naomi/0000-0003-2195-1430; Cooper, Andrew/0000-0002-5897-2107; Khaw, Sir Peng Tee/0000-0002-8087-2268	Guide Dogs for the Blind Association [OR2006-03b]; Fight For Sight [2014]; National Institute of Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; NIHR Central and East London Comprehensive Research Network; Department of Health's NIHR Biomedical Research Centres; Ulverscroft Foundation; Medical Research Council as the MRC Centre of Epidemiology for Child Health [G0400546]; MRC [G0400546] Funding Source: UKRI; Medical Research Council [G0400546B, G0400546] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10101] Funding Source: researchfish; Fight for Sight [1321/22] Funding Source: researchfish	Guide Dogs for the Blind Association; Fight For Sight; National Institute of Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology; NIHR Central and East London Comprehensive Research Network; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); Ulverscroft Foundation; Medical Research Council as the MRC Centre of Epidemiology for Child Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight	The main funding was received from Guide Dogs for the Blind Association (Project Grant: OR2006-03b). Further support came from Fight For Sight (Project Grant: 2014), National Institute of Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, and NIHR Central and East London Comprehensive Research Network. The study was undertaken at University College London (UCL) Institute of Child Health (ICH) / Great Ormond Street Hospital and Moorfields Eye Hospital / UCL Institute of Ophthalmology, both of which receive a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. Members of the team are supported by the Ulverscroft Foundation. The Life Course Epidemiology and Biostatistics Section within the Population, Policy and Practice Programme at UCL Institute of Child Health was previously supported in part by the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health (award G0400546). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors have a financial interest to declare.	Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; ANDRICH D, 1978, PSYCHOMETRIKA, V43, P561, DOI 10.1007/BF02293814; [Anonymous], 2012, WINSTEPS RASCH MEASU; [Anonymous], 2012, IBM SPSS STAT WIND P; Bullinger M, 1995, EUR REV APPL PSYCHOL, V45, P245; CALMAN KC, 1984, J MED ETHICS, V10, P124, DOI 10.1136/jme.10.3.124; Cochrane GM, 2011, INVEST OPHTH VIS SCI, V52, P1632, DOI 10.1167/iovs.10-6079; Colenbrander A, 2010, ACTA OPHTHALMOL, V88, P163, DOI 10.1111/j.1755-3768.2009.01670.x; Darzi A., 2008, HIGH QUALITY CARE AL; Eiser C, 2001, QUAL LIFE RES, V10, P347, DOI 10.1023/A:1012253723272; Eiser C, 2000, CHILD CARE HLTH DEV, V26, P445, DOI 10.1046/j.1365-2214.2000.00177.x; Eiser C, 2001, Health Technol Assess, V5, P1; Fleishman JA, 2002, J GERONTOL B-PSYCHOL, V57, pS275, DOI 10.1093/geronb/57.5.S275; Hamblion EL, 2011, INVEST OPHTH VIS SCI, V52, P7981, DOI 10.1167/iovs.11-7890; Khadka J, 2011, INVEST OPHTH VIS SCI, V52, P6971, DOI 10.1167/iovs.11-7423; KUYKEN W, 1995, SOC SCI MED, V41, P1403, DOI 10.1016/0277-9536(95)00112-k; Marella M, 2010, INVEST OPHTH VIS SCI, V51, P2878, DOI 10.1167/iovs.09-4494; Patient-Centred Outcomes Research Insitute (P-CORI), 2013, NAT PRIOR RES AG PAT; Pesudovs K, 2007, OPTOMETRY VISION SCI, V84, P663, DOI 10.1097/OPX.0b013e318141fe75; Rahi JS, 2003, LANCET, V362, P1359, DOI 10.1016/S0140-6736(03)14631-4; Rahi JS, 2011, OPHTHALMOLOGY, V118, P819, DOI 10.1016/j.ophtha.2010.08.034; Rasch G, 1993, PROBABILISTIC MODELS; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tadic V, 2015, CHILD CARE HLTH DEV, V41, P239, DOI 10.1111/cch.12158; Tadic V, 2010, INVEST OPHTH VIS SCI, V51, P1886, DOI 10.1167/iovs.09-4522; Tadic V, 2013, OPHTHALMOLOGY, V120, P2725, DOI 10.1016/j.ophtha.2013.07.055; Tadic V, 2013, BRIT J OPHTHALMOL, V97, P1369, DOI 10.1136/bjophthalmol-2013-303350; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; World Health Organisation, 2003, INT STAT CLASS DIS R; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004	32	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0146225	10.1371/journal.pone.0146225	http://dx.doi.org/10.1371/journal.pone.0146225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918329	Green Accepted, Green Published, gold			2022-12-27	WOS:000371274400001
J	Salas, A; Acosta, D; Ferri, CP; Guerra, M; Huang, YQ; Jacob, KS; Jimenez-Velazquez, IZ; Rodriguez, JJL; Sosa, AL; Uwakwe, R; Williams, JD; Jotheeswaran, AT; Liu, ZR; Medina, AML; Salinas-Contreras, RM; Prince, MJ				Salas, Aquiles; Acosta, Daisy; Ferri, Cleusa P.; Guerra, Mariella; Huang, Yueqin; Jacob, K. S.; Jimenez-Velazquez, Ivonne Z.; Llibre Rodriguez, Juan J.; Sosa, Ana L.; Uwakwe, Richard; Williams, Joseph D.; Jotheeswaran, A. T.; Liu, Zhaorui; Lopez Medina, A. M.; Maria Salinas-Contreras, Rosa; Prince, Martin J.			The Prevalence, Correlates, Detection and Control of Diabetes among Older People in Low and Middle Income Countries. A 10/66 Dementia Research Group Population-Based Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; NATIONAL-HEALTH; ELDERLY-PEOPLE; RISK; COMMUNITY; MORTALITY; ADULTS	Background Little is known of the epidemiology of diabetes among older people in low and middle income countries. We aimed to study and compare prevalence, social patterning, correlates, detection, treatment and control of diabetes among older people in Latin America, India, China and Nigeria. Methods Cross-sectional surveys in 13 catchment area sites in nine countries. Diagnosed diabetes was assessed in all sites through self-reported diagnosis. Undiagnosed diabetes was assessed in seven Latin American sites through fasting blood samples (glucose > = 7mmol/L). Results Total diabetes prevalence in catchment sites in Cuba (prevalence 24.2%, SMR 116), Puerto Rico (43.4%, 197), and urban (27.0%, 125), and rural Mexico (23.7%, 111) already exceeds that in the USA, while that in Venezuela (20.9%, 100) is similar. Diagnosed diabetes prevalence varied very widely, between low prevalences in sites in rural China (0.9%), rural India (6.6%) and Nigeria (6.0%). and 32.1% in Puerto Rico, explained mainly by access to health services. Treatment coverage varied substantially between sites. Diabetes control (40 to 61% of those diagnosed) was modest in the Latin American sites where this was studied. Diabetes was independently associated with less education, but more assets. Hypertension, central obesity and hypertriglyceridaemia, but not hypercholesterolaemia were consistently associated with total diabetes. Conclusions Diabetes prevalence is already high in most sites. Identifying undiagnosed cases is essential to quantify population burden, particularly in least developed settings where diagnosis is uncommon. Metabolic risk factors and associated lifestyles may play an important part in aetiology, but this requires confirmation with longitudinal data. Given the high prevalence among older people, more population research is indicated to quantify the impact of diabetes, and to monitor the effect of prevention and health system strengthening on prevalence, treatment and control.	[Salas, Aquiles] Cent Univ Venezuela, Fac Med, Univ Hosp, Dept Med, Caracas, Venezuela; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Ferri, Cleusa P.] Univ Fedral Sao Paulo, Dept Psychobiol, Sao Paulo, Brazil; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Jacob, K. S.] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Jimenez-Velazquez, Ivonne Z.] Univ Puerto Rico, Sch Med, Geriatr Program, Dept Internal Med, Med Sci Campus, San Juan, PR 00936 USA; [Llibre Rodriguez, Juan J.] Med Univ Havana, Fac Med Finlay Albarran, Havana, Cuba; [Sosa, Ana L.; Maria Salinas-Contreras, Rosa] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Uwakwe, Richard] Nnamdi Azikiwe Univ, Teaching Hosp, Nnewi, Anambra State, Nigeria; [Williams, Joseph D.] Voluntary Hlth Serv, Dept Community Hlth, Madras, Tamil Nadu, India; [Jotheeswaran, A. T.] Publ Hlth Fdn India, New Delhi, India; [Lopez Medina, A. M.] Policlin 19 Abril, Havana, Cuba; [Prince, Martin J.] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England	University of Central Venezuela; Universidad Nacional Pedro Henriquez Urena; Peking University; Christian Medical College & Hospital (CMCH) Vellore; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Nacional Autonoma de Mexico; Public Health Foundation of India; University of London; King's College London	Prince, MJ (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, London WC2R 2LS, England.	martin.prince@kcl.ac.uk	Ferri, Cleusa Pinheiro/B-2922-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prince, Martin J/A-9170-2010; Llibre Rodriguez, Juan/D-2380-2010	Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prince, Martin J/0000-0003-1379-7146; Liu, Zhaorui/0000-0002-6536-7503; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Llibre Rodriguez, Juan/0000-0002-8215-3160; Guerra, Mariella/0000-0001-8923-349X	Wellcome Trust [GR066133, GR080002]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; FONACIT/CDCH/UCV; Puerto Rico Legislature; Pfizer Co., USA	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Puerto Rico Legislature; Pfizer Co., USA	Funded by Wellcome Trust (GR066133- Prevalence phase in Cuba; GR080002- Incidence phase in Peru, Mexico, Cuba, Dominican Republic, Venezuela and China and data analysis across all centres) - http://www.wellcome.ac.uk/, World Health Organization (data collection in India, Dominican Republic and China) - www.who.int, US Alzheimer's Association (IIRG - 04 - 1286 - data collection in Peru, and Mexico) - http://www.alz.org/research/alzheimers_grants/, FONACIT/CDCH/UCV (data collection in Venezuela) - http://www.fonacit.gob.ve/, Puerto Rico Legislature (data collection in Puerto Rico), and Pfizer Co., USA (blood sample collection in Puerto Rico) - www.pfizer.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Salinas CA, 2003, DIABETES CARE, V26, P2021, DOI 10.2337/diacare.26.7.2021; Barcelo A, 2006, J AGING HEALTH, V18, P224, DOI 10.1177/0898264305285728; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Beran D, 2005, DIABETES CARE, V28, P2136, DOI 10.2337/diacare.28.9.2136; Biggs ML, 2010, JAMA-J AM MED ASSOC, V303, P2504, DOI 10.1001/jama.2010.843; Centers for Disease Control and Prevention, 2008, NAT DIAB FACT SHEET; Cowie CC, 2006, DIABETES CARE, V29, P1263, DOI 10.2337/dc06-0062; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Jafar TH, 2009, ANN INTERN MED, V151, P593, DOI 10.7326/0003-4819-151-9-200911030-00004; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Liu LJ, 2011, ANN EPIDEMIOL, V21, P26, DOI 10.1016/j.annepidem.2010.10.012; Nyenwe EA, 2003, DIABETES RES CLIN PR, V62, P177, DOI 10.1016/j.diabres.2003.07.002; Olaiz G, 2003, ENCUESTA NACL SALUD; Pabon-Nau LP, 2010, J GEN INTERN MED, V25, P847, DOI 10.1007/s11606-010-1335-8; Perez CM, 2008, ETHNIC DIS, V18, P434; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Simmons RK, 2010, DIABETOLOGIA, V53, P600, DOI 10.1007/s00125-009-1620-4; Sousa RM, 2009, LANCET, V374, P1821, DOI 10.1016/S0140-6736(09)61829-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	19	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149616	10.1371/journal.pone.0149616	http://dx.doi.org/10.1371/journal.pone.0149616			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913752	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700022
J	Chen, SN; Hwang, JF; Wu, WC				Chen, San-Ni; Hwang, Jiunn-Feng; Wu, Wen-Chuan			Peripheral Retinal Vascular Patterns in Patients with Rhegmatogenous Retinal Detachment in Taiwan	PLOS ONE			English	Article							FAMILIAL EXUDATIVE VITREORETINOPATHY; CLINICAL CHARACTERISTICS; FLUORESCEIN ANGIOGRAPHY; MYOPIA; NONPERFUSION; ASTROCYTES; VESSELS; AREAS; EYES	This is an observational study of fluorescein angiography (FA) in consecutive patients with rhegmatogenous retinal detachment (RRD) in Changhua Christian Hospital to investigate the peripheral retinal vascular patterns in those patients. All patients had their age, sex, axial length (AXL), and refraction status (RF) recorded. According to the findings in FA of the peripheral retina, the eyes were divided into 4 groups: in group 1, there was a ramified pattern of peripheral retinal vasculature with gradual tapering; in group 2, there was an abrupt ending of peripheral vasculature with peripheral non-perfusion; in group 3, there was a curving route of peripheral vasculature forming vascular arcades or anastomosis; and in group 4, the same as in group 3, but with one or more wedge-shaped avascular notches. Comparisons of age, sex, AXL, and RF, association of breaks with lattice degeneration and retinal non-perfusion, surgical procedures utilized, and mean numbers of operations were made among the four groups. Of the 73 eyes studied, there were 13 eyes (17.8%) in group 1, 3 eyes (4.1%) in group 2, 40 eyes (54.8%) in group 3 and 17 eyes (23.3%) in group 4. Significant differences in age, AXL and RF, and association of retinal breaks to non-perfusion were noted among the four groups. Patients in group 1 had older ages, while younger ages were noted in groups 3 and 4. Eyes in group 1 had the shortest average AXL and were least myopic in contrast to the eyes in groups 3 and 4. Association of retinal breaks and retinal non-perfusion was significantly higher in groups 2, 3 and 4 than in group 1. In conclusion, peripheral vascular anomalies are common in cases with RRD. Patients with peripheral non-perfusion tend to be younger, with longer axial length and have the breaks associated with retinal non-perfusion.	[Chen, San-Ni; Hwang, Jiunn-Feng] Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan; [Chen, San-Ni; Wu, Wen-Chuan] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Chen, San-Ni; Hwang, Jiunn-Feng] Chung Shan Med Univ, Sch Med, Taichung, Taiwan	Changhua Christian Hospital; Kaohsiung Medical University; Chung Shan Medical University	Chen, SN (corresponding author), Changhua Christian Hosp, Dept Ophthalmol, Changhua, Taiwan.; Chen, SN (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.; Chen, SN (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.	108562@cch.org.tw						ASDOURIAN GK, 1979, ARCH OPHTHALMOL-CHIC, V97, P2316; Chang PY, 2005, AM J OPHTHALMOL, V139, P1067, DOI 10.1016/j.ajo.2005.01.027; Chen SN, 2006, RETINA-J RET VIT DIS, V26, P410, DOI 10.1097/00006982-200604000-00005; Chen SN, 2012, RETINA-J RET VIT DIS, V32, P220, DOI 10.1097/IAE.0b013e31821c3ec5; Chen TC, 2010, INVEST OPHTH VIS SCI, V51, P6140, DOI 10.1167/iovs.10-5234; Chou SC, 2007, EYE, V21, P1056, DOI 10.1038/sj.eye.6702397; Heimann H, 2001, RETINA, P2085; Kaneko Y, 2014, INVEST OPHTH VIS SCI, V55, P1432, DOI 10.1167/iovs.13-13706; Kashani AH, 2014, OPHTHALMOLOGY, V121, P2220, DOI 10.1016/j.ophtha.2014.05.029; Li XX, 2003, OPHTHALMOLOGY, V110, P2413, DOI 10.1016/S0161-6420(03)00867-4; PROVIS JM, 1995, GLIA, V14, P243, DOI 10.1002/glia.440140402; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Rowe JA, 1999, OPHTHALMOLOGY, V106, P154, DOI 10.1016/S0161-6420(99)90018-0; RUTNIN U, 1967, AM J OPHTHALMOL, V64, P840; Sheu SJ, 2006, RETINA-J RET VIT DIS, V26, P322, DOI 10.1097/00006982-200603000-00011; Sheu SJ, 2010, AM J OPHTHALMOL, V149, P113, DOI 10.1016/j.ajo.2009.08.006; Smith EL, 2011, OPTOMETRY VISION SCI, V88, P1029, DOI 10.1097/OPX.0b013e3182279cfa; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P829, DOI 10.1097/IAE.0b013e31820c841e; SPITZNAS M, 1977, A GRAEF ARCH KLIN EX, V203, P217, DOI 10.1007/BF00409828; STONE J, 1987, J COMP NEUROL, V255, P35, DOI 10.1002/cne.902550104; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Wang NK, 2005, OPHTHALMOLOGY, V112, P1891, DOI 10.1016/j.ophtha.2005.06.019; Wong TY, 1999, ARCH OPHTHALMOL-CHIC, V117, P379, DOI 10.1001/archopht.117.3.379; Yokoyama T, 2004, EYE, V18, P889, DOI 10.1038/sj.eye.6701341; Zhang YF, 1997, INVEST OPHTH VIS SCI, V38, P1653	25	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149176	10.1371/journal.pone.0149176	http://dx.doi.org/10.1371/journal.pone.0149176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909812	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700025
J	Das, NM; Hatsell, S; Nannuru, K; Huang, L; Wen, XL; Wang, LL; Wang, LH; Idone, V; Meganck, JA; Murphy, A; Economides, A; Xie, LQ				Das, Nanditha Mohan; Hatsell, Sarah; Nannuru, Kalyan; Huang, Lily; Wen, Xialing; Wang, Lili; Wang, Li-Hsien; Idone, Vincent; Meganck, Jeffrey A.; Murphy, Andrew; Economides, Aris; Xie, LiQin			In Vivo Quantitative Microcomputed Tomographic Analysis of Vasculature and Organs in a Normal and Diseased Mouse Model	PLOS ONE			English	Article							MICRO-CT; COMPUTED-TOMOGRAPHY; CONTRAST AGENTS; TUMOR ANGIOGENESIS; SMALL ANIMALS; SOFT-TISSUE; RADIATION; VCT	Non-bone in vivo micro-CT imaging has many potential applications for preclinical evaluation. Specifically, the in vivo quantification of changes in the vascular network and organ morphology in small animals, associated with the emergence and progression of diseases like bone fracture, inflammation and cancer, would be critical to the development and evaluation of new therapies for the same. However, there are few published papers describing the in vivo vascular imaging in small animals, due to technical challenges, such as low image quality and low vessel contrast in surrounding tissues. These studies have primarily focused on lung, cardiovascular and brain imaging. In vivo vascular imaging of mouse hind limbs has not been reported. We have developed an in vivo CT imaging technique to visualize and quantify vasculature and organ structure in disease models, with the goal of improved quality images. With 1-2 minutes scanning by a high speed in vivo micro-CT scanner (Quantum CT), and injection of a highly efficient contrast agent (Exitron nano 12000), vasculature and organ structure were semi-automatically segmented and quantified via image analysis software (Analyze). Vessels of the head and hind limbs, and organs like the heart, liver, kidneys and spleen were visualized and segmented from density maps. In a mouse model of bone metastasis, neoangiogenesis was observed, and associated changes to vessel morphology were computed, along with associated enlargement of the spleen. The in vivo CT image quality, voxel size down to 20 mu m, is sufficient to visualize and quantify mouse vascular morphology. With this technique, in vivo vascular monitoring becomes feasible for the preclinical evaluation of small animal disease models.	[Das, Nanditha Mohan; Hatsell, Sarah; Nannuru, Kalyan; Huang, Lily; Wen, Xialing; Wang, Lili; Wang, Li-Hsien; Idone, Vincent; Murphy, Andrew; Economides, Aris; Xie, LiQin] Regeneron Pharmaceut Inc, Therapeut Focus Areas, Dept Skeletal Dis, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Meganck, Jeffrey A.] PerkinElmer, Res & Dev, Hopkinton, MA USA	Regeneron	Xie, LQ (corresponding author), Regeneron Pharmaceut Inc, Therapeut Focus Areas, Dept Skeletal Dis, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.	LiQin.Xie@regeneron.com	wang, lili/HDL-7210-2022	Economides, Aris/0000-0002-6508-8942; Hatsell, Sarah/0000-0003-1103-6087; Idone, Vincent/0000-0002-5622-2011; Murphy, Andrew/0000-0003-4152-4081	Regeneron Pharmaceuticals Inc.; PerkinElmer	Regeneron Pharmaceuticals Inc.(Regeneron); PerkinElmer	This study received internal funding from Regeneron Pharmaceuticals Inc. and PerkinElmer, who provided support in the form of salaries for authors LX, NMD, SH, KN, LH, XW, LW, LHW, VI, AM, AE and JAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Annapragada Ananth V, 2012, Methodist Debakey Cardiovasc J, V8, P18; Badea CT, 2008, PHYS MED BIOL, V53, pR319, DOI 10.1088/0031-9155/53/19/R01; Bauerle T, 2008, NEOPLASIA, V10, P511, DOI 10.1593/neo.08220; Bazalova M, 2010, WORLD MOLECULAR IMAG; Boll H, 2013, ACAD RADIOL, V20, P1137, DOI 10.1016/j.acra.2013.06.002; Boll H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025692; Boone John M, 2004, Mol Imaging, V3, P149, DOI 10.1162/1535350042380326; Brasch RC, 2000, ACAD RADIOL, V7, P812, DOI 10.1016/S1076-6332(00)80630-3; Chien CC, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-10; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; Cole HA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097381; Conway EM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-207; Detombe SA, 2013, ACTA RADIOL, V54, P435, DOI 10.1177/0284185113475608; Dinkel J, 2008, CIRC-CARDIOVASC IMAG, V1, P235, DOI 10.1161/CIRCIMAGING.108.784702; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; Fiebig T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031179; Ford NL, 2003, MED PHYS, V30, P2869, DOI 10.1118/1.1617353; Gabra P, 2010, PHYSIOL MEAS, V31, P249, DOI 10.1088/0967-3334/31/2/010; Ghaghada KB, 2011, ACAD RADIOL, V18, P20, DOI 10.1016/j.acra.2010.09.003; Gregory LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068103; Hallouard F, 2010, BIOMATERIALS, V31, P6249, DOI 10.1016/j.biomaterials.2010.04.066; Hildebrandt IJ, 2008, ILAR J, V49, P17, DOI 10.1093/ilar.49.1.17; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Justice MJ, 2011, DIS MODEL MECH, V4, P305, DOI 10.1242/dmm.000901; Kagadis GC, 2010, MED PHYS, V37, P6421, DOI 10.1118/1.3515456; Kass DA, 1998, CIRC RES, V82, P519, DOI 10.1161/01.RES.82.4.519; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Kiessling F, 2010, EUR J NUCL MED MOL I, V37, pS4, DOI 10.1007/s00259-010-1450-0; Kraehenbuehl TP, 2010, BIOMED TECH, V55, P245, DOI 10.1515/BMT.2010.031; Lee S, 2014, MICROCIRCULATION, V21, P159, DOI 10.1111/micc.12102; Li X, 2013, BIOMATERIALS, V34, P481, DOI 10.1016/j.biomaterials.2012.09.026; Lusic H, 2013, CHEM REV, V113, P1641, DOI 10.1021/cr200358s; Missbach-Guentner J, 2011, INT J DEV BIOL, V55, P535, DOI 10.1387/ijdb.103229jm; Nebuloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086562; Nebuloni L, 2013, ACAD RADIOL, V20, P1247, DOI 10.1016/j.acra.2013.06.003; Nyangoga H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017336; Rothe JH, 2015, ACAD RADIOL, V22, P169, DOI 10.1016/j.acra.2014.07.022; Schambach SJ, 2010, METHODS, V50, P2, DOI 10.1016/j.ymeth.2009.08.007; Schambach SJ, 2009, STROKE, V40, P1444, DOI 10.1161/STROKEAHA.108.521740; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Vasquez SX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019099; Wathen CA, 2013, SENSORS-BASEL, V13, P6957, DOI 10.3390/s130606957; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Xie LQ, 2012, ARTHRITIS RHEUM-US, V64, P1899, DOI 10.1002/art.34370	46	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150085	10.1371/journal.pone.0150085	http://dx.doi.org/10.1371/journal.pone.0150085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910759	gold, Green Submitted, Green Published			2022-12-27	WOS:000371164700064
J	Munilla, I; Genovart, M; Paiva, VH; Velando, A				Munilla, Ignacio; Genovart, Meritxell; Paiva, Vitor H.; Velando, Alberto			Colony Foundation in an Oceanic Seabird	PLOS ONE			English	Article							SHEARWATER CALONECTRIS-DIOMEDEA; POLYMORPHIC MICROSATELLITE MARKERS; POPULATION-STRUCTURE; CORYS SHEARWATER; COLONIZATION SUCCESS; DISPERSAL PATTERNS; PUBLIC INFORMATION; HABITAT SELECTION; GENETIC DIVERSITY; PELAGIC SEABIRD	Seabirds are colonial vertebrates that despite their great potential for long-range dispersal and colonization are reluctant to establish in novel locations, often recruiting close to their natal colony. The foundation of colonies is therefore a rare event in most seabird species and little is known about the colonization process in this group. The Cory's shearwater (Calonectris diomedea) is a pelagic seabird that has recently established three new colonies in Galicia (NE Atlantic) thus expanding its distribution range 500 km northwards. This study aimed to describe the establishment and early progress of the new Galician populations and to determine the genetic and morphometric characteristics of the individuals participating in these foundation events. Using 10 microsatellite loci, we tested the predictions supported by different seabird colonization models. Possibly three groups of non-breeders, adding up to around 200 birds, started visiting the Galician colonies in the mid 2000' s and some of them eventually laid eggs and reproduced, thus establishing new breeding colonies. The Galician populations showed a high genetic diversity and a frequency of private alleles similar to or even higher than some of the large historical populations. Most individuals were assigned to several Atlantic populations and a few (if any) to Mediterranean colonies. Our study suggests that a large and admixed population is settling in Galicia, in agreement with predictions from island metapopulation models of colonization. Multiple source colonies imply that some birds colonizing Galicia were dispersing from very distant colonies (>1500 km). Long-distance colonizations undertaken by relatively large and admixed groups of colonizers can help to explain the low levels of genetic structure over vast areas that are characteristic of most oceanic seabird species.	[Munilla, Ignacio; Genovart, Meritxell] Univ Santiago de Compostela, Fac Biol, Dept Bot, Santiago De Compostela, Galicia, Spain; [Paiva, Vitor H.] Univ Coimbra, Dept Life Sci, Marine & Environm Sci Ctr, Coimbra, Portugal; [Velando, Alberto] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Galicia, Spain; [Genovart, Meritxell] Inst Mediterrani Estudis Avancats, Populat Ecol Grp, Esporles, Illes Balears, Spain	Universidade de Santiago de Compostela; Universidade de Coimbra; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA)	Munilla, I (corresponding author), Univ Santiago de Compostela, Fac Biol, Dept Bot, Santiago De Compostela, Galicia, Spain.; Velando, A (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Galicia, Spain.	ignacio.munilla@gmx.es; avelando@uvigo.es	Genovart, Meritxell/L-4873-2014; Paiva, Vitor H./J-1092-2019; Velando, Alberto/B-1701-2009; Paiva, Vitor Hugo/GRX-9179-2022	Genovart, Meritxell/0000-0003-2919-1288; Paiva, Vitor H./0000-0001-6368-9579; Velando, Alberto/0000-0001-8909-0724; 	Organismo Autonomo de Parques Nacionales of Spain [079/2009]; EU project [LIFE04NAT/PT/000213, LIFE09NAT/PT/000041]; BirdLife International partner in Portugal; Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/21557/2005, SFRH/BPD/85024/2012]	Organismo Autonomo de Parques Nacionales of Spain; EU project(European Commission); BirdLife International partner in Portugal; Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology)	This study was funded annually (20102013) by the Organismo Autonomo de Parques Nacionales of Spain (http://www.magrama.gob.es/es/parques-nacionales-oapn/programa-investigacion/) through the research project 079/2009. Financial support for the fieldwork in Azores, Madeira, Selvagens and Berlengas was provided by the EU project LIFE04NAT/PT/000213, coordinated by SPEA (Sociedade Portuguesa para o Estudo das Aves), the BirdLife International partner in Portugal. HP acknowledges the support given by the Fundacao para a Ciencia e Tecnologia (Portugal, SFRH/BD/21557/2005 and SFRH/BPD/85024/2012). Financial support for the fieldwork in Cima Islet was provided by the EU project LIFE09NAT/PT/000041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Santiago Barciela, Alvaro Barros, Paula Dominguez and David Alvarez were contracted for field data collection in Galicia.	Afan I, 2014, MAR BIOL, V161, P657, DOI 10.1007/s00227-013-2368-4; Ahlroth P, 2003, OECOLOGIA, V137, P617, DOI 10.1007/s00442-003-1344-y; Barbraud C, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140456; Barlow EJ, 2011, IBIS, V153, P768, DOI 10.1111/j.1474-919X.2011.01159.x; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Bicknell AWJ, 2014, DIVERS DISTRIB, V20, DOI 10.1111/ddi.12137; Boulinier T, 1996, J AVIAN BIOL, V27, P252, DOI 10.2307/3677230; Breton AR, 2006, ECOL MONOGR, V76, P133, DOI 10.1890/05-0704; Bried J, 2008, MOL ECOL RESOUR, V8, P602, DOI 10.1111/j.1471-8286.2007.02009.x; Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101; Burg TM, 2003, P ROY SOC B-BIOL SCI, V270, P979, DOI 10.1098/rspb.2002.2322; Burg TM, 2001, MOL ECOL, V10, P2647, DOI 10.1046/j.0962-1083.2001.01392.x; Cadiou B, 2011, CINQUIEME RECENSEMEN; Calabuig G, 2010, ANIM BEHAV, V80, P975, DOI 10.1016/j.anbehav.2010.08.016; Cassey P, 2004, P ROY SOC B-BIOL SCI, V271, pS405, DOI 10.1098/rsbl.2004.0199; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 1996, P NATL ACAD SCI USA, V93, P11723, DOI 10.1073/pnas.93.21.11723; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Falush D, 2003, GENETICS, V164, P1567; Fisher J., 1952, THE FULMAR; FORBES LS, 1994, OIKOS, V70, P377, DOI 10.2307/3545775; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Furness R.W., 1987, SEABIRD ECOLOGY; Gallo-Reynoso Juan-Pablo, 1996, Western Birds, V27, P70; Genovart M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070711; Gomez-Diaz E, 2006, MOL PHYLOGENET EVOL, V41, P322, DOI 10.1016/j.ympev.2006.05.006; Gomez-Diaz E, 2009, MAR ECOL PROG SER, V382, P197, DOI 10.3354/meps07974; Gonzalez EG, 2009, MOL ECOL RESOUR, V9, P1044, DOI 10.1111/j.1755-0998.2009.02563.x; Granadeiro J.P., 1991, Seabird, P30; Greene CM, 2001, ECOLOGY, V82, P2091; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hood G.M., 2010, POPTOOLS VERSION 3 2; Hufbauer RA, 2013, J EVOLUTION BIOL, V26, P1691, DOI 10.1111/jeb.12167; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jenouvrier S, 2008, OIKOS, V117, P620, DOI 10.1111/j.0030-1299.2008.16394.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kildaw S. Dean, 2005, Marine Ornithology, V33, P49; Kokko H, 2006, SCIENCE, V313, P789, DOI 10.1126/science.1128566; Le Corre V, 1998, J EVOLUTION BIOL, V11, P495, DOI 10.1007/s000360050102; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lisovski S, 2009, POLAR BIOL, V32, P1811, DOI 10.1007/s00300-009-0705-3; Luczak C, 2012, BIOL LETT; Magalhaes MC, 2008, MAR ECOL PROG SER, V359, P283, DOI 10.3354/meps07340; MARIN AM, 1984, AUK, V101, P192; Martinez-Abrain A, 2002, WATERBIRDS, V25, P221, DOI 10.1675/1524-4695(2002)025[0221:ACSBIA]2.0.CO;2; Mays Gilles, 2006, Ornithos, V13, P316; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; MOUGIN JL, 1992, CR ACAD SCI III-VIE, V315, P27; Munilla I, 2008, PLAN INTEGRAL RECUPE; Navarro J, 2009, BIOL LETTERS, V5, P545, DOI 10.1098/rsbl.2009.0150; NEI M, 1978, GENETICS, V89, P583; NICHOLS RA, 1994, HEREDITY, V72, P312, DOI 10.1038/hdy.1994.41; Oro D, 2001, J ANIM ECOL, V70, P527, DOI 10.1046/j.1365-2656.2001.00511.x; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Paiva VH, 2013, MAR ECOL PROG SER, V486, P277, DOI 10.3354/meps10332; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Peery MZ, 2006, ECOL APPL, V16, P1516, DOI 10.1890/1051-0761(2006)016[1516:CDACAT]2.0.CO;2; Peron G, 2010, J ANIM ECOL, V79, P317, DOI 10.1111/j.1365-2656.2009.01635.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pitman RL, 2002, WILSON BULL, V114, P11, DOI 10.1676/0043-5643(2002)114[0011:TCSOMB]2.0.CO;2; Pritchard JK, 2000, GENETICS, V155, P945; Pruett CL, 2005, MOL ECOL, V14, P1421, DOI 10.1111/j.1365-294X.2005.02493.x; Rabouam C, 1998, AUK, V115, P483; Ramirez O, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-28; Ramos R, 2013, DIVERS DISTRIB, V19, P1284, DOI 10.1111/ddi.12088; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rannala B., 2007, BAYESASS VERSION 3 0; Reed J. Michael, 1999, VVolume 15, P189; Reyes-Gonzalez JM, 2011, ENCICLOPEDIA VIRTUAL; RISTOW D, 1990, Vogelwelt, V111, P172; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Robb M, 2008, PETRELS NIGHT DAY; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sangster G, 2012, IBIS, V154, P874, DOI 10.1111/j.1474-919X.2012.01273.x; Schippers P, 2011, ECOL MODEL, V222, P3061, DOI 10.1016/j.ecolmodel.2011.05.022; Stamps JA, 1990, AM NAT, V131, P329; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; STOREY AE, 1985, AUK, V102, P395; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tait WC, 1887, IBIS, V5, P372; Takezaki N, 2014, MOL BIOL EVOL, V31, P1622, DOI 10.1093/molbev/msu093; Thibault JC, 1998, IBIS, V140, P523, DOI 10.1111/j.1474-919X.1998.tb04615.x; VANEERDEN MR, 1995, ARDEA, V83, P61; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; Whittington PA, 1999, IBIS, V141, P327, DOI 10.1111/j.1474-919X.1999.tb07555.x; Wilson GA, 2003, GENETICS, V163, P1177; Young LC, 2010, J ZOOL, V281, P232, DOI 10.1111/j.1469-7998.2010.00698.x; Zador SG, 2009, MAR ECOL PROG SER, V376, P283, DOI 10.3354/meps07797	100	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147222	10.1371/journal.pone.0147222	http://dx.doi.org/10.1371/journal.pone.0147222			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909694	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700002
J	Renzi, C; Vadilonga, V; Gandini, S; Perinel, G; Rotmensz, N; Didier, F; Rescigno, M; Pravettoni, G				Renzi, Chiara; Vadilonga, Valeria; Gandini, Sara; Perinel, Giada; Rotmensz, Nicole; Didier, Florence; Rescigno, Maria; Pravettoni, Gabriella			Stress Exposure in Significant Relationships Is Associated with Lymph Node Status in Breast Cancer	PLOS ONE			English	Article							PSYCHOSOCIAL FACTORS; LIFE EVENTS; ATTACHMENT; RISK; METASTASIS; EXPRESSION; RESPONSES; HEALTH	Objective Life stress exposure may impact on health and disease. Previous literature showed that stressful life events are associated with cancer incidence, survival and mortality. In animal models, patterns of maternal care have been shown to critically affect stress sensitivity and immunity trajectories later in life, by modifying DNA methylation during critical periods early in life. However, the role of parental care in breast cancer progression and survival has only limitedly been explored. Here, we investigated whether these factors may be linked to biological prognostic variables. Methods One hundred twenty-three women hospitalized for surgery of primary breast cancer completed a questionnaire assessing parental bonding. Stressful events throughout the life span were also assessed. Results We found that the absence of optimal parental relationships is significantly associated with an increased risk of lymph node involvement, adjusting for confounders, while cumulative stress in the area of sentimental relationships is borderline significantly associated with the same prognostic factor. Conclusions Our results suggest that parental bonding and sentimental relations may have a role in breast cancer progression. These variables represent an important evolutionary aspect which may modulate cancer progression through psycho-physiological stress pathways and influence the immune system.	[Renzi, Chiara; Vadilonga, Valeria; Perinel, Giada; Didier, Florence; Pravettoni, Gabriella] European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy; [Gandini, Sara; Rotmensz, Nicole] European Inst Oncol, Div Epidemiol & Biostat, Milan, Italy; [Rescigno, Maria] European Inst Oncol, Immunobiol Dendrit Cells & Immunotherapy Unit, Milan, Italy; [Rescigno, Maria; Pravettoni, Gabriella] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); IRCCS European Institute of Oncology (IEO); University of Milan	Renzi, C (corresponding author), European Inst Oncol, Appl Res Div Cognit & Psychol Sci, Milan, Italy.	chiara.renzi@ieo.it	didier, florence/AAS-4178-2020; Pravettoni, Gabriella/AAC-3500-2022; Renzi, Chiara/AAG-5403-2019; Pravettoni, Gabriella/C-6915-2011; gandini, sara/J-4916-2018; Rescigno, Maria/J-9704-2012	Renzi, Chiara/0000-0002-3451-0792; Pravettoni, Gabriella/0000-0002-4843-4663; gandini, sara/0000-0002-1348-4548; Rescigno, Maria/0000-0002-6464-509X	Fondazione Umberto Veronesi; Fondazione Istituto Europeo di Oncologia	Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Fondazione Istituto Europeo di Oncologia	CR was supported by a Fellowship of the Fondazione Umberto Veronesi. VV was supported by a Fellowship of the Fondazione Istituto Europeo di Oncologia.	Adenzato M, 2005, PSICOLOGIA EVOLUZION; Bierhaus A, 2003, P NATL ACAD SCI USA, V100, P1920, DOI 10.1073/pnas.0438019100; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Chen E, 2011, MOL PSYCHIATR, V16, P729, DOI 10.1038/mp.2010.53; Chida Y, 2008, NAT CLIN PRACT ONCOL, V5, P466, DOI 10.1038/ncponc1134; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Costa C, 2002, J CLIN PATHOL, V55, P429, DOI 10.1136/jcp.55.6.429; Donegan WL, 1997, CA-CANCER J CLIN, V47, P28, DOI 10.3322/canjclin.47.1.28; Duijts SFA, 2003, INT J CANCER, V107, P1023, DOI 10.1002/ijc.11504; Fava GA, 1982, NUOVI METODI PSICOME, P9; FEENEY JA, 1994, HEALTH PSYCHOL, V13, P334, DOI 10.1037/0278-6133.13.4.334; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; FORSEN A, 1991, PSYCHOTHER PSYCHOSOM, V55, P176, DOI 10.1159/000288427; GRASSI L, 1986, Journal of Psychosocial Oncology, V4, P53; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hilakivi-Clarke L, 2003, BREAST CANC RES TREA, V29, P141; Kaffman A, 2007, J CHILD PSYCHOL PSYC, V48, P224, DOI 10.1111/j.1469-7610.2007.01730.x; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Lillberg K, 2003, AM J EPIDEMIOL, V157, P415, DOI 10.1093/aje/kwg002; LUBACH GR, 1995, BRAIN BEHAV IMMUN, V9, P31, DOI 10.1006/brbi.1995.1004; Lutgendorf SK, 2011, PSYCHOSOM MED, V73, P724, DOI 10.1097/PSY.0b013e318235be76; Manassis K, 1999, AUST NZ J PSYCHIAT, V33, P559, DOI 10.1080/j.1440-1614.1999.00560.x; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; McKenna MC, 1999, HEALTH PSYCHOL, V18, P520, DOI 10.1037/0278-6133.18.5.520; McLaughlin KA, 2000, DEPRESS ANXIETY, V27, P1087; Metcalfe C, 2007, EUR J CANCER, V43, P1060, DOI 10.1016/j.ejca.2007.01.027; Miller GE, 2009, PSYCHOSOM MED, V71, P57, DOI 10.1097/PSY.0b013e318190d7de; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1, DOI 10.1111/j.2044-8341.1979.tb02487.x; PAYKEL ES, 1971, ARCH GEN PSYCHIAT, V25, P340, DOI 10.1001/archpsyc.1971.01750160052010; Quirin M, 2008, PSYCHONEUROENDOCRINO, V33, P581, DOI 10.1016/j.psyneuen.2008.01.013; Sarason IG, 1975, EMOTIONS THEIR PARAM, P499; Scinto A, 1999, Epidemiol Psichiatr Soc, V8, P276; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; Tacon A, 2001, FAM SYST HEALTH, V19, P319, DOI [10.1037/h0089455, DOI 10.1037/H0089455]; Tacon Anna M, 2002, Integr Cancer Ther, V1, P371, DOI 10.1177/1534735402238188; THOMAS CB, 1979, PSYCHOSOM MED, V41, P287, DOI 10.1097/00006842-197906000-00003; Thomas CB, 1998, ADV MIND BODY MED, V5, P42; Tripsianis G, 2014, NEOPLASMA, V61, P205, DOI 10.4149/neo_2014_026; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149443	10.1371/journal.pone.0149443	http://dx.doi.org/10.1371/journal.pone.0149443			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910901	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700033
J	Hellerstedt, R; Johansson, M				Hellerstedt, Robin; Johansson, Mikael			Competitive Semantic Memory Retrieval: Temporal Dynamics Revealed by Event-Related Potentials	PLOS ONE			English	Article							CUED-RECALL; EPISODIC MEMORY; BRAIN; ERP; RECOGNITION; INHIBITION; SUPPRESSION; SUCCESS	Memories compete for retrieval when they are related to a common retrieval cue. Previous research has shown that retrieval of a target memory may lead to subsequent retrieval-induced forgetting (RIF) of currently irrelevant competing memories. In the present study, we investigated the time course of competitive semantic retrieval and examined the neurocognitive mechanisms underlying RIF. We contrasted two theoretical accounts of RIF by examining a critical aspect of this memory phenomenon, namely the extent to which it depends on successful retrieval of the target memory. Participants first studied category-exemplar word-pairs (e.g. Fruit-Apple). Next, we recorded electrophysiological measures of brain activity while the participants performed a competitive semantic cued-recall task. In this task, the participants were provided with the studied categories but they were instructed to retrieve other unstudied exemplars (e.g. Fruit-Ma_?). We investigated the event-related potential (ERP) correlates of retrieval success by comparing ERPs from successful and failed retrieval trials. To isolate the ERP correlates of continuous retrieval attempts from the ERP correlates of retrieval success, we included an impossible retrieval condition, with incompletable word-stem cues (Drinks-Wy_) and compared it with a non-retrieval presentation baseline condition (Occupation-Dentist). The participants' memory for all the studied exemplars was tested in the final phase of the experiment. Taken together, the behavioural results suggest that RIF is independent of target retrieval. Beyond investigating the mechanisms underlying RIF, the present study also elucidates the temporal dynamics of semantic cued-recall by isolating the ERP correlates of retrieval attempt and retrieval success. The ERP results revealed that retrieval attempt is reflected in a late posterior negativity, possibly indicating construction of candidates for completing the word-stem cue and retrieval monitoring whereas retrieval success was reflected in an anterior positive slow wave.	[Hellerstedt, Robin; Johansson, Mikael] Lund Univ, Dept Psychol, Lund, Sweden	Lund University	Hellerstedt, R (corresponding author), Lund Univ, Dept Psychol, Lund, Sweden.	robin.hellerstedt@psy.lu.se	Johansson, Mikael/A-5338-2008	Johansson, Mikael/0000-0002-2903-6301; Hellerstedt, Robin/0000-0002-6433-4734	Swedish Research Council [VR 60229601]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Swedish Research Council (VR 60229601 to MJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan K, 1996, COGNITIVE BRAIN RES, V4, P251, DOI 10.1016/S0926-6410(96)00061-4; Allan K, 1998, NEUROREPORT, V9, P3463, DOI 10.1097/00001756-199810260-00023; Allan K, 1997, NEUROPSYCHOLOGIA, V35, P387, DOI 10.1016/S0028-3932(96)00094-2; Allan K, 2001, COGNITIVE BRAIN RES, V12, P289, DOI 10.1016/S0926-6410(01)00061-1; ANDERSON MC, 1994, J EXP PSYCHOL LEARN, V20, P1063, DOI 10.1037/0278-7393.20.5.1063; Anderson MC, 2014, TRENDS COGNITIVE SCI; Anderson MC, 2003, J MEMORY LANGUAGE; [Anonymous], 1990, NORSTEDTS SVENSKA OR; Bauml KH, 2002, PSYCHOL SCI, V13, P356, DOI 10.1111/1467-9280.00464; Bergstrom ZM, 2013, NEUROIMAGE, V68, P141, DOI 10.1016/j.neuroimage.2012.11.030; Bergstrom ZM, 2009, NEUROIMAGE, V48, P726, DOI 10.1016/j.neuroimage.2009.06.051; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Cansino S, 1999, INT J PSYCHOPHYSIOL, V31, P261, DOI 10.1016/S0167-8760(98)00059-2; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Duzel E, 1999, P NATL ACAD SCI USA, V96, P1794, DOI 10.1073/pnas.96.4.1794; Fay S, 2005, COGNITIVE BRAIN RES, V24, P615, DOI 10.1016/j.cogbrainres.2005.03.014; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Hellerstedt R, 2012, LUND PSYCHOL REPORTS, V12, P1; Hellerstedt R, 2014, CEREB CORTEX, V24, P1619, DOI 10.1093/cercor/bht019; Herron JE, 2006, NEUROIMAGE, V32, P863, DOI 10.1016/j.neuroimage.2006.03.046; Herron JE, 2004, NEUROIMAGE, V22, P1554, DOI 10.1016/j.neuroimage.2004.04.011; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Johansson M, 2003, BIOL PSYCHOL, V64, P91, DOI 10.1016/S0301-0511(03)00104-2; Johnson R, 1998, COGNITIVE BRAIN RES, V7, P119, DOI 10.1016/S0926-6410(98)00017-2; Kizilirmak JM, 2012, NEUROIMAGE, V59, P1830, DOI 10.1016/j.neuroimage.2011.08.041; Kizilirmak JM, 2015, BRAIN RES; Kuhl BA, 2007, NAT NEUROSCI, V10, P908, DOI 10.1038/nn1918; Lopez-Calderon J, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00213; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Mecklinger A, 2010, NEUROSCI BIOBEHAV R, V34, P1055, DOI 10.1016/j.neubiorev.2009.11.020; Mecklinger A, 2009, BRAIN RES, V1255, P132, DOI 10.1016/j.brainres.2008.11.073; Murayama K, 2014, PSYCHOL BULL, V140, P1383, DOI 10.1037/a0037505; Nessler D, 2003, PSYCHOPHYSIOLOGY, V40, P146, DOI 10.1111/1469-8986.00015; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Raaijmakers JGW, 2013, J MEM LANG, V68, P98, DOI 10.1016/j.jml.2012.10.002; Rass O, 2010, INT J PSYCHOPHYSIOL, V78, P136, DOI 10.1016/j.ijpsycho.2010.07.001; Storm BC, 2012, MEMORY COGNITION; Storm BC, 2006, PSYCHON B REV, V13, P1023, DOI 10.3758/BF03213919; Storm BC, 2010, MEMORY, V18, P99, DOI 10.1080/09658210903107853; TULVING E, 1963, J VERB LEARN VERB BE, V1, P321, DOI 10.1016/S0022-5371(63)80012-2; Verde MF, 2012, PSYCHOL LEARN MOTIV, V56, P47, DOI 10.1016/B978-0-12-394393-4.00002-9; Waldhauser GT, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00401	44	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0150091	10.1371/journal.pone.0150091	http://dx.doi.org/10.1371/journal.pone.0150091			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901865	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371276100205
J	Kelly, JD; Schlough, GW; Conteh, S; Barrie, MB; Kargbo, B; Giordano, TP				Kelly, J. Daniel; Schlough, Gabriel Warren; Conteh, Suleiman; Barrie, M. Bailor; Kargbo, Brima; Giordano, Thomas P.			The Majority of the Pre-Antiretroviral Population Who Were Lost to Follow-Up Stopped Their Care in Freetown, Sierra Leone: A 12-Month Prospective Cohort Study Starting with HIV Diagnosis	PLOS ONE			English	Article							INFECTED PATIENTS; THERAPY; PREVENTION; RETENTION; CONTINUUM; MORTALITY; PROGRAMS; AFRICA; UGANDA	Background The heterogeneity of the pre-antiretroviral (pre-ART) population calls for more granular depictions of the cascade of HIV care. Methods We studied a prospective cohort of persons newly diagnosed with HIV infection from a single center in Freetown, Sierra Leone, over a 12-month period and then traced those persons who were lost to follow-up (LTFU) during pre-ART care (before ART initiation). ART eligibility was based on a CD4 cell count result of <= 350 mm/cells and/or WHO clinical stage 3 or 4. Persons who attended an appointment in the final three months were considered to be retained in care. Adherence to ART was measured using pharmacy refill dates. "Effective HIV care" was defined as completion of the cascade of care at 12-months regardless of whether patients are on ART. Tracing outcomes were obtained for those who were LTFU during pre-ART care. Results 408 persons newly diagnosed with HIV infection were screened, 338 were enrolled, and 255 persons were staged for ART. ART-ineligible persons had higher retention rates than ART-eligible persons (59.6% vs 41.8%, p = 0.03). 77 (22.8%) of 338 persons received effective HIV care. Most attrition (61.9%) occurred with persons during pre-ART care. 123 of 138 persons (89.1%) who were LTFU prior to ART initiation were found, and 91 of those 123 (74.0%) were alive. Of the 74 persons who were alive and described their engagement in care, 40 (54.1%) stopped care. Nearly half (42.5%) of those 40 stopped after assessment of ART-eligibility but before ART initiation. The main limitation of this study was the lack of tracing outcomes for those lost during ART care. Conclusions The majority of the pre-ART LTFU population stopped their care, particularly after ART-eligibility but before ART initiation. Interventions to hasten ART initiation and retain this at-risk group may have significant downstream impact on effective HIV care.	[Kelly, J. Daniel; Giordano, Thomas P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Kelly, J. Daniel; Schlough, Gabriel Warren; Barrie, M. Bailor] Wellbody Alliance, Koidu Town, Sierra Leone; [Kelly, J. Daniel; Conteh, Suleiman; Kargbo, Brima] Natl HIV AIDS Secretariat, Freetown, Sierra Leone; [Conteh, Suleiman] Univ Sierra Leone, Coll Med & Allied Hlth Sci, Freetown, Sierra Leone	Baylor College of Medicine	Kelly, JD (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.; Kelly, JD (corresponding author), Wellbody Alliance, Koidu Town, Sierra Leone.; Kelly, JD (corresponding author), Natl HIV AIDS Secretariat, Freetown, Sierra Leone.	dan@wellbodyalliance.org		Giordano, Thomas/0000-0002-9346-5530	Fulbright Commission [48421297]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019105, P30MH062246] Funding Source: NIH RePORTER	Fulbright Commission; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Fulbright Commission supported this work (Grant ID 48421297; http://www.cies.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Geng EH, 2013, JAIDS-J ACQ IMM DEF, V63, pE64, DOI 10.1097/QAI.0b013e31828af5a6; Geng Elvin H, 2010, Curr HIV/AIDS Rep, V7, P234, DOI 10.1007/s11904-010-0061-5; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Giordano Thomas P, 2005, Curr HIV/AIDS Rep, V2, P177, DOI 10.1007/s11904-005-0013-7; Grossberg Robert, 2007, Curr HIV/AIDS Rep, V4, P187, DOI 10.1007/s11904-007-0027-4; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Mugavero MJ, 2012, JAIDS-J ACQ IMM DEF, V61, P574, DOI 10.1097/QAI.0b013e318273762f; Namusobya J, 2013, CLIN INFECT DIS, V57, P1343, DOI 10.1093/cid/cit490; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Skarbinski J, 2015, JAMA INTERN MED, V175, P588, DOI 10.1001/jamainternmed.2014.8180; Ware NC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001369; World Health Organization, 2008, UN ACC SCAL PRIOR HI	19	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149584	10.1371/journal.pone.0149584	http://dx.doi.org/10.1371/journal.pone.0149584			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901765	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100105
J	Martinez, M; Hinojosa, M; Trombly, D; Morin, V; Stein, J; Stein, G; Javed, A; Gutierrez, SE				Martinez, Milka; Hinojosa, Marcelo; Trombly, Daniel; Morin, Violeta; Stein, Janet; Stein, Gary; Javed, Amjad; Gutierrez, Soraya E.			Transcriptional Auto-Regulation of RUNX1 P1 Promoter	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; T-CELL DEVELOPMENT; ACUTE MYELOGENOUS LEUKEMIA; GENOME-WIDE ANALYSIS; HEMATOPOIETIC DEVELOPMENT; DEFINITIVE HEMATOPOIESIS; RUNX/CBFA/AML FACTORS; TARGETED DISRUPTION; AML1/RUNX1 GENE; SCL GENE	RUNX1 a member of the family of runt related transcription factors (RUNX), is essential for hematopoiesis. The expression of RUNX1 gene is controlled by two promoters; the distal P1 promoter and the proximal P2 promoter. Several isoforms of RUNX1 mRNA are generated through the use of both promoters and alternative splicing. These isoforms not only differs in their temporal expression pattern but also exhibit differences in tissue specificity. The RUNX1 isoforms derived from P2 are expressed in a variety of tissues, but expression of P1-derived isoform is restricted to cells of hematopoietic lineage. However, the control of hematopoietic-cell specific expression is poorly understood. Here we report regulation of P1-derived RUNX1 mRNA by RUNX1 protein. In silico analysis of P1 promoter revealed presence of two evolutionary conserved RUNX motifs, 0.6kb upstream of the transcription start site, and three RUNX motifs within 170bp of the 5'UTR. Transcriptional contribution of these RUNX motifs was studied in myeloid and T-cells. RUNX1 genomic fragment containing all sites show very low basal activity in both cell types. Mutation or deletion of RUNX motifs in the UTR enhances basal activity of the RUNX1 promoter. Chromatin immunoprecipitation revealed that RUNX1 protein is recruited to these sites. Overexpression of RUNX1 in non-hematopoietic cells results in a dose dependent activation of the RUNX1 P1 promoter. We also demonstrate that RUNX1 protein regulates transcription of endogenous RUNX1 mRNA in T-cell. Finally we show that SCL transcription factor is recruited to regions containing RUNX motifs in the promoter and the UTR and regulates activity of the RUNX1 P1 promoter in vitro. Thus, multiple lines of evidence show that RUNX1 protein regulates its own gene transcription.	[Martinez, Milka; Hinojosa, Marcelo; Morin, Violeta; Gutierrez, Soraya E.] Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile; [Trombly, Daniel; Stein, Janet; Stein, Gary] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, 55 Lake Ave North, Worcester, MA 01655 USA; [Stein, Janet; Stein, Gary] Univ Vermont, Coll Med, Dept Biochem, 89 Beaumont Ave, Burlington, VT 05405 USA; [Stein, Janet; Stein, Gary] Univ Vermont, Coll Med, Vermont Canc Ctr, 89 Beaumont Ave, Burlington, VT 05405 USA; [Javed, Amjad] Univ Alabama Birmingham, Sch Dent, Dept Oral & Maxillofacial Surg, Birmingham, AL 35294 USA	Universidad de Concepcion; University of Massachusetts System; University of Massachusetts Worcester; University of Vermont; University of Vermont; University of Alabama System; University of Alabama Birmingham	Gutierrez, SE (corresponding author), Univ Concepcion, Fac Ciencias Biol, Dept Bioquim & Biol Mol, Concepcion, Chile.	sgutierr@udec.cl		Javed, Amjad/0000-0002-0847-8266	SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico [1130697]; AJ National Institute of Health [R01AR062091]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030228] Funding Source: NIH RePORTER	SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico; AJ National Institute of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the SEG Fondo Nacional de Desarrollo Cientifico y Tecnologico grant number 1130697 and AJ National Institute of Health grant number R01AR062091.	Bakshi R, 2008, J CELL SCI, V121, P3981, DOI 10.1242/jcs.033431; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Durst KL, 2004, ONCOGENE, V23, P4220, DOI 10.1038/sj.onc.1207122; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Ferjoux G, 2007, DEV BIOL, V305, P726, DOI 10.1016/j.ydbio.2007.03.010; Fujita Y, 2001, BIOCHEM BIOPH RES CO, V281, P1248, DOI 10.1006/bbrc.2001.4513; Gering M, 1998, EMBO J, V17, P4029, DOI 10.1093/emboj/17.14.4029; Ghozi MC, 1996, P NATL ACAD SCI USA, V93, P1935, DOI 10.1073/pnas.93.5.1935; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Ichikawa M, 2013, INT J HEMATOL, V97, P726, DOI 10.1007/s12185-013-1347-3; Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925; Javed A, 1999, MOL CELL BIOL, V19, P7491; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Javed A, 2000, J CELL SCI, V113, P2221; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; KALLIANPUR AR, 1994, BLOOD, V83, P1200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kuvardina ON, 2015, BLOOD, V125, P3570, DOI 10.1182/blood-2014-11-610519; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li XG, 2005, J CELL BIOCHEM, V96, P795, DOI 10.1002/jcb.20548; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Mangan James K., 2011, Critical Reviews in Oncogenesis, V16, P77; Markova EN, 2011, J CELL BIOCHEM, V112, P1997, DOI 10.1002/jcb.23117; Michaud J, 2003, CANCER INVEST, V21, P105, DOI 10.1081/CNV-120018821; Michaud J, 2002, BLOOD, V99, P1364, DOI 10.1182/blood.V99.4.1364; Mikhail FM, 2006, J CELL PHYSIOL, V207, P582, DOI 10.1002/jcp.20538; MIYOSHI H, 1995, NUCLEIC ACIDS RES, V23, P2762, DOI 10.1093/nar/23.14.2762; North T, 1999, DEVELOPMENT, V126, P2563; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Ohgami RS, 2015, INT J LAB HEMATOL, V37, P122, DOI 10.1111/ijlh.12367; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Pozner A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-84; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Seo W, 2012, IMMUNOL CELL BIOL, V90, P827, DOI 10.1038/icb.2012.6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Sroczynska P, 2009, BLOOD, V114, P5279, DOI 10.1182/blood-2009-05-222307; Stuardo M, 2009, J CELL PHYSIOL, V218, P343, DOI 10.1002/jcp.21599; Sun LS, 2004, BLOOD, V103, P948, DOI 10.1182/blood-2003-07-2299; Tahirov TH, 2001, CELL, V104, P755, DOI 10.1016/S0092-8674(01)00271-9; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Telfer JC, 2001, DEV BIOL, V229, P363, DOI 10.1006/dbio.2000.9991; Tijssen MR, 2013, J THROMB HAEMOST, V11, P593, DOI 10.1111/jth.12131; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100	59	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149119	10.1371/journal.pone.0149119	http://dx.doi.org/10.1371/journal.pone.0149119			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901859	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100040
J	Teng, JA; Wu, SG; Chen, JX; Li, Q; Peng, F; Zhu, Z; Qin, J; He, ZY				Teng, Jia-An; Wu, San-Gang; Chen, Jia-Xin; Li, Qiang; Peng, Fang; Zhu, Zhou; Qin, Jian; He, Zhen-Yu			The Activation of ERK1/2 and JNK MAPK Signaling by Insulin/IGF-1 Is Responsible for the Development of Colon Cancer with Type 2 Diabetes Mellitus	PLOS ONE			English	Article							GROWTH-FACTOR-I; COLORECTAL-CANCER; DOWN-REGULATION; RODENT MODELS; RISK-FACTOR; PROLIFERATION; METAANALYSIS; PATHWAYS; P38	Previous studies showed that type 2 diabetes mellitus (T2DM) is linked to increased risk of developing colon cancer. Insulin and insulin-like growth factor 1 (IGF-1) are increased in patients with T2DM. The increased insulin and IGF-1 may be responsible for the developing of colon cancer. In this study, we investigated the effects and mechanisms of insulin and IGF-1 in colon cancer development in vitro and in vivo. Insulin and IGF-1 alone or together elevated proliferation and reduced apoptosis in colon cancer MC38 cells. Meanwhile, insulin and IGF-1 promoted the phosphorylation of extracellular-signal regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK). Treatment with ERK1/2 or JNK inhibitor in the presence of insulin and IGF-1 significantly decreased B-cell lymphoma 2 (Bcl-2) and increased Bcl-2-associated X protein (Bax) expression and finally increased apoptosis and inhibited the proliferation. Accelerative colon tumor growth was found in a mouse model of T2DM with db/db mice which got high level of endogenous insulin and IGF-1. Furthermore, the inhibition of ERK1/2 or JNK suppressed the development of colon tumor in vivo. These results suggest that the activation of ERK1/2 and JNK signaling by insulin and IGF-1, at least in part, is responsible for the development of colon cancer with T2DM.	[Teng, Jia-An] Peoples Hosp Guangxi Zhuang Autonomous Reg, Div Endocrinol & Metab, Dept Cadre Med, Nanning, Peoples R China; [Wu, San-Gang] Xiamen Univ, Dept Radiat Oncol, Xiamen Canc Ctr, Affiliated Hosp 1, Xiamen, Peoples R China; [Chen, Jia-Xin; Qin, Jian] Peoples Hosp Guangxi Zhuang Autonomous Reg, Ctr Clin Canc, Dept Radiat Oncol, Nanning, Peoples R China; [Li, Qiang] Cent S Univ, Xiangya Hosp 2, Dept Surg, Organ Transplantat Ctr, Changsha, Hunan, Peoples R China; [Peng, Fang] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Zhou] Peoples Hosp Guangxi Zhuang Autonomous Reg, Dept Gastrointestinal & Peripheral Vasc Surg, Nanning, Peoples R China; [He, Zhen-Yu] Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China	Xiamen University; Central South University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University	Qin, J (corresponding author), Peoples Hosp Guangxi Zhuang Autonomous Reg, Ctr Clin Canc, Dept Radiat Oncol, Nanning, Peoples R China.; He, ZY (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Canc Ctr,Dept Radiat Oncol, Guangzhou 510275, Guangdong, Peoples R China.	janusy@126.com; hezhy@sysucc.org.cn	Wu, San-Gang/AAA-8959-2022		National Natural Science Foundation of China [81160107]; Guangxi Science Research and Technique Development Plan Foundation [1104003B-69]; Guangxi Natural Science Foundation [2010GXNSFB013083]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Science Research and Technique Development Plan Foundation; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province)	This study is supported by the National Natural Science Foundation of China (No. 81160107, JAT), Guangxi Science Research and Technique Development Plan Foundation (No. 1104003B-69, JQ), and Guangxi Natural Science Foundation (No. 2010GXNSFB013083, JAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; Badrick E, 2014, EUR J CANCER, V50, P2119, DOI 10.1016/j.ejca.2014.04.032; Carlson CJ, 2003, DIABETES, V52, P634, DOI 10.2337/diabetes.52.3.634; CORBETT TH, 1975, CANCER RES, V35, P2434; Dasari A, 2010, CLIN CANCER RES, V16, P3811, DOI 10.1158/1078-0432.CCR-09-2283; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; GIOVANNUCCI E, 1995, CANCER CAUSE CONTROL, V6, P164, DOI 10.1007/BF00052777; Giovannucci E, 2001, J NUTR, V131, p3109S, DOI 10.1093/jn/131.11.3109S; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Gogg S, 2009, DIABETES, V58, P2238, DOI 10.2337/db08-0961; Hart LS, 2011, CELL CYCLE, V10, P2331, DOI 10.4161/cc.10.14.16418; Hirose Y, 2004, CARCINOGENESIS, V25, P821, DOI 10.1093/carcin/bgh059; Islam MS, 2009, METHOD FIND EXP CLIN, V31, P249, DOI 10.1358/mf.2009.31.4.1362513; Karlstad O, 2013, CURR DRUG SAF, V8, P333, DOI 10.2174/15680266113136660067; Khalili H, 2012, DIGEST DIS SCI, V57, P1427, DOI 10.1007/s10620-012-2175-7; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Lee J, 2012, NUTR CANCER, V64, P153, DOI 10.1080/01635581.2012.630161; LEROITH D, 1995, ANN INTERN MED, V122, P54, DOI 10.7326/0003-4819-122-1-199501010-00009; Li DH, 2011, CANCER CAUSE CONTROL, V22, P189, DOI 10.1007/s10552-010-9686-3; Liao SC, 2011, ASIAN PAC J CANCER P, V12, P1061; MCLAUGHLIN JK, 2013, FALSE POSITIVES CANC, V22, P11, DOI DOI 10.1158/1055-9965.EPI-12-0995; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Palmqvist R, 2002, GUT, V50, P642, DOI 10.1136/gut.50.5.642; Qin J, 2015, HORM METAB RES, V47, P861, DOI 10.1055/s-0034-1398564; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Stefansdottir G, 2011, DIABETOLOGIA, V54, P1608, DOI 10.1007/s00125-011-2104-x; Teng JA, 2011, HORM METAB RES, V43, P519, DOI 10.1055/s-0031-1280780; [滕家安 TENG Jiaan], 2010, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V37, P152; Tsilidis KK, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7607; Urosevic J, 2014, CELL CYCLE, V13, P2641, DOI 10.4161/15384101.2014.946374; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Vigneri PG, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00230; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang P, 2012, DIABETES-METAB RES, V28, P109, DOI 10.1002/dmrr.1291; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YX, 2004, GASTROENTEROLOGY, V127, P1044, DOI 10.1053/j.gastro.2004.07.011; Yuhara H, 2011, AM J GASTROENTEROL, V106, P1911, DOI 10.1038/ajg.2011.301; Zhou XH, 2010, DIABETOLOGIA, V53, P1867, DOI 10.1007/s00125-010-1796-7; Zhu CF, 2011, J CANCER RES CLIN, V137, P1587, DOI 10.1007/s00432-011-1049-2	44	35	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149822	10.1371/journal.pone.0149822	http://dx.doi.org/10.1371/journal.pone.0149822			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901856	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100160
J	Bruniche-Olsen, A; Austin, JJ; Jones, ME; Holland, BR; Burridge, CP				Brueniche-Olsen, Anna; Austin, Jeremy J.; Jones, Menna E.; Holland, Barbara R.; Burridge, Christopher P.			Detecting Selection on Temporal and Spatial Scales: A Genomic Time-Series Assessment of Selective Responses to Devil Facial Tumor Disease	PLOS ONE			English	Article							TASMANIAN DEVIL; INFECTIOUS-DISEASE; GENETIC DIVERSITY; POPULATION; HISTORY; TRANSMISSION; COEFFICIENTS; DYNAMICS; PATTERNS	Detecting loci under selection is an important task in evolutionary biology. In conservation genetics detecting selection is key to investigating adaptation to the spread of infectious disease. Loci under selection can be detected on a spatial scale, accounting for differences in demographic history among populations, or on a temporal scale, tracing changes in allele frequencies over time. Here we use these two approaches to investigate selective responses to the spread of an infectious cancer-devil facial tumor disease (DFTD)-that since 1996 has ravaged the Tasmanian devil (Sarcophilus harrisii). Using time-series 'restriction site associated DNA' (RAD) markers from populations pre- and post DFTD arrival, and DFTD free populations, we infer loci under selection due to DFTD and investigate signatures of selection that are incongruent among methods, populations, and times. The lack of congruence among populations influenced by DFTD with respect to inferred loci under selection, and the direction of that selection, fail to implicate a consistent selective role for DFTD. Instead genetic drift is more likely driving the observed allele frequency changes over time. Our study illustrates the importance of applying methods with different performance optima e.g. accounting for population structure and background selection, and assessing congruence of the results.	[Brueniche-Olsen, Anna; Jones, Menna E.; Burridge, Christopher P.] Univ Tasmania, Sch Biol Sci, Private Bag 55, Hobart, Tas 7001, Australia; [Austin, Jeremy J.] Univ Adelaide, Sch Earth & Environm Sci, North Terrace Campus, Adelaide, SA 5005, Australia; [Holland, Barbara R.] Univ Tasmania, Sch Phys Sci, Private Bag 37, Hobart, Tas 7001, Australia	University of Tasmania; University of Adelaide; University of Tasmania	Bruniche-Olsen, A (corresponding author), Univ Tasmania, Sch Biol Sci, Private Bag 55, Hobart, Tas 7001, Australia.	annabo@utas.edu.au	Austin, Jeremy J/F-8729-2010; Burridge, Christopher/J-2653-2012; Burridge, Chris/L-4392-2019; Holland, Barbara/G-1646-2013	Austin, Jeremy J/0000-0003-4244-2942; Burridge, Christopher/0000-0002-8185-6091; Jones, Menna/0000-0001-7558-9022; Bruniche-Olsen, Anna/0000-0002-3364-2064; Holland, Barbara/0000-0002-4628-7938	Holsworth Wildlife Endorsement; Save the Tasmanian Devil Appeal; Winifred Violet Scott Foundation; Australian Research Council [LP0989613]; Australian Research Council	Holsworth Wildlife Endorsement; Save the Tasmanian Devil Appeal; Winifred Violet Scott Foundation; Australian Research Council(Australian Research Council); Australian Research Council(Australian Research Council)	The authors are grateful for the funding they received from the Holsworth Wildlife Endorsement, the Save the Tasmanian Devil Appeal and the Winifred Violet Scott Foundation to undertake this project. An Australian Research Council Linkage Grant (LP0989613) supported this research. JJA, BRH and MEJ are supported by Australian Research Council Future Fellowships.	Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; Bank C, 2014, TRENDS GENET, V30, P540, DOI 10.1016/j.tig.2014.09.010; Baxter SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019315; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Bruniche-Olsen A, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0619; Bruniche-Olsen A, 2013, BIOL CONSERV, V165, P69, DOI 10.1016/j.biocon.2013.05.014; de Villemereuil P, 2014, MOL ECOL, V23, P2006, DOI 10.1111/mec.12705; DPIPWE, TASM DEV; Ellegren H, 2011, NAT REV GENET, V12, P157, DOI 10.1038/nrg2948; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2015, MOL ECOL RESOUR, V15, P87, DOI 10.1111/1755-0998.12280; Foll M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004185; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Geweke J., 1992, BAYESIAN STAT EVALUA; GUILER E R, 1970, Australian Journal of Zoology, V18, P63, DOI 10.1071/ZO9700063; Hamede RK, 2013, J ANIM ECOL, V82, P182, DOI 10.1111/j.1365-2656.2012.02025.x; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Karlsson EK, 2014, NAT REV GENET, V15, P379, DOI 10.1038/nrg3734; KIMURA M., 1964, J. appl. Prob., V1, P177, DOI 10.2307/3211856; Lachish S, 2011, HEREDITY, V106, P172, DOI 10.1038/hdy.2010.17; Lachish S, 2009, J ANIM ECOL, V78, P427, DOI 10.1111/j.1365-2656.2008.01494.x; Lanfear R, 2014, TRENDS ECOL EVOL, V29, P33, DOI 10.1016/j.tree.2013.09.009; Lotterhos KE, 2014, MOL ECOL, V23, P2178, DOI 10.1111/mec.12725; Malaspinas AS, 2012, GENETICS, V192, P599, DOI 10.1534/genetics.112.140939; Mathieson I, 2013, GENETICS, V193, P973, DOI 10.1534/genetics.112.147611; McCallum H, 2009, ECOLOGY, V90, P3379, DOI 10.1890/08-1763.1; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Murchison EP, 2012, CELL, V148, P780, DOI 10.1016/j.cell.2011.11.065; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; RDCT, 2011, R LAND ENV STAT COMP; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Robinson RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012215; Roesti M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-94; Siddle H.V., 2013, P NATL ACAD SCI USA; Smith KF, 2009, ANIM CONSERV, V12, P1, DOI 10.1111/j.1469-1795.2008.00228.x; Smith KF, 2006, CONSERV BIOL, V20, P1349, DOI 10.1111/j.1523-1739.2006.00524.x; Vitalis R, 2014, GENETICS, V196, P799, DOI 10.1534/genetics.113.152991; Whitlock M. C., 2009, ANAL BIOL DATA; Willoughby JR, 2015, BIOL CONSERV, V191, P495, DOI 10.1016/j.biocon.2015.07.025	43	13	13	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0147875	10.1371/journal.pone.0147875	http://dx.doi.org/10.1371/journal.pone.0147875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930198	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500008
J	Diaz, I; Cortey, M; Olvera, A; Segales, J				Diaz, Ivan; Cortey, Marti; Olvera, Alex; Segales, Joaquim			Use of H-Index and Other Bibliometric Indicators to Evaluate Research Productivity Outcome on Swine Diseases	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; PORCINE CIRCOVIRUS TYPE-2; EPIDEMIC DIARRHEA; HIRSCH-INDEX; SCIENTISTS; PIGS; CHALLENGE; RANKING; HUMANS; UPDATE	H-index is the most commonly applied tool to evaluate scientific productivity. In this study, the use of the H-index to evaluate scientific production in swine veterinary medicine was explored. A database of 137 pig infectious agents was constructed, including its taxonomic division, zoonotic potential, status as emerging pathogen and whether it was OIE-listed. The H-index and the total number of citations were calculated for those pathogens, the location of the affiliation of the first author of each paper included in the H-index core was registered and, for the ten pathogens with the highest H-index, evolution over time was measured. H-index values were compared to the M quotient, A-index, G-index, HG-index and the G/H ratio. H-indices were found to be severely affected by search accuracy and the database was hand curated. Swine pathogen H-indexes were highly dispersed ranging from 0 to 106 and were generally higher for pathogens causing endemic diseases in large pig producing countries. Indeed, the three top pathogens were Escherichia coli, Porcine reproductive and respiratory syndrome virus and Porcine circovirus type 2 with H-indices 106, 95 and 85, respectively. H-indices of viruses and bacteria were significantly higher (P<0.001) than other pathogen types. Also, non-zoonotic pathogens had higher H-indices than zoonotic pathogens (p<0.009) while no differences could be found for being listed by the OIE. For emerging diseases, only non-emerging viruses had higher H-index (p=0.02). The study of H-indexes over time revealed three general patterns and that they had increased mainly after the 1980's. As expected, there were strong geographic patterns in terms of authorship and North America (38%) and Europe (46%) coped the majority of the papers. Finally, in order to quantify the contribution of a subject to a specific field, a new index "Deciphering Citations Organized by Subject" (Dcos) is proposed.	[Diaz, Ivan; Cortey, Marti] Campus Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanitat Anim, CReSA,IRTA UAB, Barcelona 08193, Spain; [Olvera, Alex] IrsiCaixa HIVACAT, Inst Recerca Sida, Carretera Canyet S-N, Badalona 08916, Spain; [Segales, Joaquim] Campus Univ Autonoma Barcelona, UAB, Ctr Recerca Sanitat Anim, CReSA,IRTA UAB, Barcelona 08193, Spain; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra 08193, Cerdanyola Del, Spain	Autonomous University of Barcelona; IRTA; Institut de Recerca de la Sida - IrsiCaixa; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona	Diaz, I (corresponding author), Campus Univ Autonoma Barcelona, IRTA, Ctr Recerca Sanitat Anim, CReSA,IRTA UAB, Barcelona 08193, Spain.	Ivan.diaz@irta.cat	diaz, ivan/C-7043-2008; Segalés, Joaquim/AAB-4815-2020; luque, ivan diaz/I-2654-2015; Segalés, Joaquim/A-4933-2011	diaz, ivan/0000-0002-8090-1073; Segalés, Joaquim/0000-0002-1539-7261; luque, ivan diaz/0000-0002-8090-1073; Segalés, Joaquim/0000-0002-1539-7261; Olvera, Alex/0000-0002-9934-5759	MINECO [AGL2014-61204-JIN]; Hipra; Merial; MSD; SYVA	MINECO(Spanish Government); Hipra; Merial; MSD; SYVA	ID, AO and JS received no specific funding for this work. MC was funded by MINECO (Reference AGL2014-61204-JIN). Ministerio de Economia y Competitividad (MINECO) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank CONPRRS (platform created with the aim of developing PRRS control programs in Spain composed by researchers from UAB, UdL, UCM and IRTA, and supported by Hipra, Merial, MSD and SYVA) and W. Wolfe for technical support and advice.	Alonso S, 2010, SCIENTOMETRICS, V82, P391, DOI 10.1007/s11192-009-0047-5; Alonso S, 2009, J INFORMETR, V3, P273, DOI 10.1016/j.joi.2009.04.001; [Anonymous], 2013, R D MAGAZINE; [Anonymous], 2005, SCIENCE, V309, P1181; [Anonymous], 2014, EUROSTAT STAT EXPLAI; [Anonymous], 2011, ENHANCED INF DIS DAT; Ball P, 2005, NATURE, V436, P900, DOI 10.1038/436900a; Banks MG, 2006, SCIENTOMETRICS, V69, P161, DOI 10.1007/s11192-006-0146-5; Bornmann L, 2005, SCIENTOMETRICS, V65, P391, DOI 10.1007/s11192-005-0281-4; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P830, DOI 10.1002/asi.20806; Bornmann L, 2007, J AM SOC INF SCI TEC, V58, P1381, DOI 10.1002/asi.20609; Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233; Braun T, 2005, SCIENTIST, V19, P8; Carvajal A, 2015, PORCINE HEALTH MANAG, V1, DOI 10.1186/s40813-015-0007-9; CHASEY D, 1978, RES VET SCI, V25, P255, DOI 10.1016/S0034-5288(18)32994-1; COLE S, 1989, TRENDS BIOCHEM SCI, V14, P9; Cox R, 2016, TRANSBOUND EMERG DIS, V63, P79, DOI 10.1111/tbed.12221; Csajbok E, 2007, SCIENTOMETRICS, V73, P91, DOI 10.1007/s11192-007-1859-9; EGGHE L, 2006, ISSI NEWSLETTER, V2, P8; Egghe L, 2006, SCIENTOMETRICS, V69, P131, DOI 10.1007/s11192-006-0144-7; Derrick GE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018521; Eurostat Statistics Explained, 2015, EUROSTAT STAT EXPLAI; Foley S L, 2008, J Anim Sci, V86, pE149; Foley S L, 2008, J Anim Sci, V86, pE173; Glanzel W., 2006, SCI FOCUS, V1, P10; Gola J, 2014, REPROD BIOL, V14, P68, DOI 10.1016/j.repbio.2014.01.006; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Huang YW, 2010, VIRUS RES, V154, P141, DOI 10.1016/j.virusres.2010.07.020; International Committee on Taxonomy of Viruses (ICTV), 2015, VIR TAX CURR REL; International Organization for Standardization (ISO), 2015, ONL BROWS PLATF COUN; Jansen EJ, 1951, TIJDSCHR DIERGENEESK, V76, P815; Jin BH, 2007, CHINESE SCI BULL, V52, P855, DOI 10.1007/s11434-007-0145-9; Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017; Kahn RE, 2014, CURR TOP MICROBIOL, V385, P205, DOI 10.1007/82_2014_392; Kirkland PD, 2007, VIRUS RES, V129, P26, DOI 10.1016/j.virusres.2007.05.002; Knight-Jones TJD, 2013, PREV VET MED, V112, P161, DOI 10.1016/j.prevetmed.2013.07.013; Kwong JC, 2010, ONTARIO BURDEN INFEC; Lunney JK, 2010, VIRUS RES, V154, P1, DOI 10.1016/j.virusres.2010.10.009; Mateu E, 2008, VET J, V177, P345, DOI 10.1016/j.tvjl.2007.05.022; McIntyre KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103529; McIntyre KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019558; Meng XJ, 2012, TRANSBOUND EMERG DIS, V59, P85, DOI 10.1111/j.1865-1682.2011.01291.x; Merck Sharp & Dohme Corp, 2015, MERCK VET MANUAL; Mousing J, 1997, PREV VET MED, V29, P247, DOI 10.1016/S0167-5877(96)01082-3; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murtaugh MP, 2010, VIRUS RES, V154, P18, DOI 10.1016/j.virusres.2010.08.015; National Center for Biotecnology Information, 2015, TAX BROWS; National Institute for Public Health and the Environment, 2010, EM ZOON INF PRIOR SY; Neumann E.J., 2012, DIS SWINE, V10th ed., P141; OiE, 2015, OIE LIST DIS INF INF; Paiba G, 2011, VET REC, V169, P396, DOI 10.1136/vr.d6413; Perez AM, 2015, JAVMA-J AM VET MED A, V246, P1304, DOI 10.2460/javma.246.12.1304; Philbey AW, 1998, EMERG INFECT DIS, V4, P269, DOI 10.3201/eid0402.980214; Pig333.com, 2014, PIG333; Public Health Information and Resources, 2014, PUBL HLTH SOURC ZOON; Rousseau R., 2006, SCI FOCUS, V1, P23; Sanchez-Vizcaino JM, 2012, TRANSBOUND EMERG DIS, V59, P27, DOI 10.1111/j.1865-1682.2011.01293.x; SCImago Journal & Country Rank, 2015, SCIMAGO J COUNTRY RA; Segales J, 2015, EXPERT REV VACCINES, V14, P473, DOI 10.1586/14760584.2015.983084; Segales J, 2013, VET MICROBIOL, V165, P13, DOI 10.1016/j.vetmic.2012.12.033; State of Queensland. Department of Agriculture and Fisheries, 2014, A Z LIST SIGN AN PES; Thomson Reuters, 2015, OV WEB SCI V 5 16 1; Thomson Reuters, 2014, J CITATION REPORTS; van Duijkeren E, 2002, J CLIN MICROBIOL, V40, P3980, DOI 10.1128/JCM.40.11.3980-3985.2002; Van Raan, 2005, ARXIVPHYSICS0511206; World Organization for Animal Health (OIE), 2015, OIE A Z	68	16	17	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149690	10.1371/journal.pone.0149690	http://dx.doi.org/10.1371/journal.pone.0149690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930283	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500044
J	Liu, W; Chen, L; Blue, PR				Liu, Wen; Chen, Liang; Blue, Philip R.			Chinese Adaptation and Psychometric Properties of the Child Version of the Cognitive Emotion Regulation Questionnaire	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; OF-FIT INDEXES; REGULATION STRATEGIES; DEPRESSIVE SYMPTOMS; SENSITIVITY; TRANSLATION; CERQ	This study aimed to validate a Chinese's adaption of the Cognitive Emotion Regulation Questionnaire for children (CERQ-Ck). This self-report instrument evaluates nine cognitive emotion regulation strategies that can be used by children after experiencing a negative life event. The CERQ-Ck was evaluated in a sample of 1403 elementary students between the ages of 9 and 11 by using cluster sampling. All the item-correlation coefficients for CERQ-Ck were above 0.30. The internal consistencies of the nine factors suggested moderate reliability (0.66 to 0.73). Confirmatory factor analysis (CFA) indicated that the current version had the same structure as the original instrument (Tucker-Lewis index = 0.912, comparative fit index = 0.922, root mean square error of approximation = 0.032, standardized root mean square residual = 0.044). A second-order factor and a third-order factor structure were also found. Test-retest correlations (0.53 to 0.70, ps < 0.01) over a period of 1 month, which ranged from acceptable to moderately strong were obtained from a random and stratified subsample of elementary students (N = 76). In addition, we analyzed convergent validity in relation to CERQ-Ck and the Chinese version of the Children's Depression Inventory model dimensions with a subsample of 1083 elementary students. Multiple-group CFA confirmed the measurement invariance for both the male and female groups (Delta CFI < 0.01, Delta RMSEA < 0.015). Overall, results indicate that CERQ-Ck has similar psychometric properties to the original instrument as well as with adequate reliability and validity to investigate the nine cognitive emotion regulation strategies during late childhood developmental periods.	[Liu, Wen; Chen, Liang] Liaoning Normal Univ, Coll Psychol, Dalian, Liaoning Provin, Peoples R China; [Chen, Liang] Univ Sci & Technol Liaoning, Sch Marxism, Anshan, Liaoning Provin, Peoples R China; [Blue, Philip R.] Peking Univ, Ctr Brain & Cognit Sci, Beijing 100871, Peoples R China; [Blue, Philip R.] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China	Liaoning Normal University; University of Science & Technology Liaoning; Peking University; Peking University	Chen, L (corresponding author), Liaoning Normal Univ, Coll Psychol, Dalian, Liaoning Provin, Peoples R China.; Chen, L (corresponding author), Univ Sci & Technol Liaoning, Sch Marxism, Anshan, Liaoning Provin, Peoples R China.	chenlfly@126.com			Youth Program of Liaoning Province Philosophy and Social Science Planning Foundation [L15CSH004]; General Program of Humanities and Social Sciences Research of Department of Education of Liaoning Province [W2015221]; Youth Foundation of University of Science and Technology Liaoning [2014QN28]; Philosophy and Social Science Prosperity Foundation of University of Science and Technology Liaoning [2015FR11]; Innovative and Entrepreneurship Educational Reform Program of University of Science and Technology Liaoning [cxcy-2015-16]	Youth Program of Liaoning Province Philosophy and Social Science Planning Foundation; General Program of Humanities and Social Sciences Research of Department of Education of Liaoning Province; Youth Foundation of University of Science and Technology Liaoning; Philosophy and Social Science Prosperity Foundation of University of Science and Technology Liaoning; Innovative and Entrepreneurship Educational Reform Program of University of Science and Technology Liaoning	This research was supported by Youth Program of Liaoning Province Philosophy and Social Science Planning Foundation in 2015 (L15CSH004); General Program of Humanities and Social Sciences Research of Department of Education of Liaoning Province in 2015 (W2015221); Youth Foundation of University of Science and Technology Liaoning (2014QN28); Philosophy and Social Science Prosperity Foundation of University of Science and Technology Liaoning (2015FR11); Innovative and Entrepreneurship Educational Reform Program of University of Science and Technology Liaoning (cxcy-2015-16).	Abdi S, 2012, PROCD SOC BEHV, V32, P2, DOI 10.1016/j.sbspro.2012.01.001; [Anonymous], DISCOVERING STAT USI; BAND EB, 1988, DEV PSYCHOL, V24, P247, DOI 10.1037/0012-1649.24.2.247; Bariola E, 2011, CLIN CHILD FAM PSYCH, V14, P198, DOI 10.1007/s10567-011-0092-5; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Curran PJ, 1996, PSYCHOL METHODS, V1, P16, DOI 10.1037//1082-989X.1.1.16; Da-Wei Y, 2000, CHINESE, V04, P11; Dominguez-Sanchez FJ, 2011, ASSESSMENT, V20, P253, DOI 10.1177/1073191110397274; Finney S. J., 2006, 2 COURSE STRUCTURAL; Garnefski N, 2006, PERS INDIV DIFFER, V40, P1659, DOI 10.1016/j.paid.2005.12.009; Garnefski N, 2004, PERS INDIV DIFFER, V36, P267, DOI 10.1016/S0191-8869(03)00083-7; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Garnefski N, 2011, PERSONAL INDIVID DIF, V41, P1045; Garnefski N, 2007, EUR CHILD ADOLES PSY, V16, P1, DOI 10.1007/s00787-006-0562-3; Garnefski N, 2009, J ADOLESCENCE, V32, P449, DOI 10.1016/j.adolescence.2008.01.003; Garnefski N, 2008, J CLIN PSYCHOL MED S, V15, P270, DOI 10.1007/s10880-008-9136-5; GROSS JJ, 1995, CLIN PSYCHOL-SCI PR, V2, P151, DOI 10.1111/j.1468-2850.1995.tb00036.x; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 2001, CURR DIR PSYCHOL SCI, V10, P214, DOI 10.1111/1467-8721.00152; Hambleton RK, 2001, EUR J PSYCHOL ASSESS, V17, P164, DOI 10.1027//1015-5759.17.3.164; Hambleton RK, 2001, EUR J PSYCHOL ASSESS, V17, P147; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Jermann F, 2006, EUR J PSYCHOL ASSESS, V22, P126, DOI 10.1027/1015-5759.22.2.126; Kraaij V, 2008, J PSYCHOSOM OBST GYN, V29, P9, DOI 10.1080/01674820701505889; Lazarus R.S., 1984, EMOTION ADAPTATION; MacCallum RC, 1996, PSYCHOL METHODS, V1, P130, DOI 10.1037/1082-989X.1.2.130; MARDIA KV, 1983, COMMUN STAT-THEOR M, V12, P207, DOI 10.1080/03610928308828452; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Saarni C., 1999, DEV EMOTIONAL COMPET; Sass DA, 2011, J PSYCHOEDUC ASSESS, V29, P347, DOI 10.1177/0734282911406661; Schroevers M, 2008, BRIT J HEALTH PSYCH, V13, P551, DOI 10.1348/135910707X241497; Morris AS, 2007, SOC DEV, V16, P361, DOI 10.1111/j.1467-9507.2007.00389.x; Tuna E, 2012, J PSYCHOPATHOL BEHAV, V34, P564, DOI 10.1007/s10862-012-9303-8; Twenge JM, 2002, J ABNORM PSYCHOL, V111, P578, DOI 10.1037//0021-843X.111.4.578; VANDE V, 1996, EUR PSYCHOL, V2, P89, DOI DOI 10.1027/1016-9040.1.2.89; Watson D, 1997, PSYCHOL DEV ED, V2, P57; [吴文峰 Wu Wenfeng], 2010, [中国心理卫生杂志, Chinese Mental Health Journal], V24, P775; Zhu XZ, 2008, COGNITION EMOTION, V22, P288, DOI 10.1080/02699930701369035	42	15	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150206	10.1371/journal.pone.0150206	http://dx.doi.org/10.1371/journal.pone.0150206			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5WU	26925586	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200027
J	Schele, E; Bake, T; Rabasa, C; Dickson, SL				Schele, Erik; Bake, Tina; Rabasa, Cristina; Dickson, Suzanne L.			Centrally Administered Ghrelin Acutely Influences Food Choice in Rodents	PLOS ONE			English	Article							INCREASES; REWARD; EXPRESSION; DIET; PREFERENCES; SELECTION; PEPTIDE; MEAL	We sought to determine whether the orexigenic hormone, ghrelin, is involved in the intrinsic regulation of food choice in rats. Ghrelin would seem suited to serve such a role given that it signals hunger information from the stomach to brain areas important for feeding control, including the hypothalamus and reward system (e. g. ventral tegmental area, VTA). Thus, in rats offered a choice of palatable foods (sucrose pellets and lard) superimposed on regular chow for 2 weeks, we explored whether acute central delivery of ghrelin (intracerebroventricular (ICV) or intra-VTA) is able to redirect their dietary choice. The major unexpected finding is that, in rats with high baseline lard intake, acute ICV ghrelin injection increased their chow intake over 3-fold, relative to vehicle-injected controls, measured at both 3 hr and 6 hr after injection. Similar effects were observed when ghrelin was delivered to the VTA, thereby identifying the VTA as a likely contributing neurobiological substrate for these effects. We also explored food choice after an overnight fast, when endogenous ghrelin levels are elevated, and found similar effects of dietary choice to those described for ghrelin. These effects of fasting on food choice were suppressed in models of suppressed ghrelin signaling (i. e. peripheral injection of a ghrelin receptor antagonist to rats and ghrelin receptor (GHSR) knock-out mice), implicating a role for endogenous ghrelin in the changes in food choice that occur after an overnight fast. Thus, in line with its role as a gut-brain hunger hormone, ghrelin appears to be able to acutely alter food choice, with notable effects to promote "healthy" chow intake, and identify the VTA as a likely contributing neurobiological substrate for these effects.	[Schele, Erik; Bake, Tina; Rabasa, Cristina; Dickson, Suzanne L.] Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden	University of Gothenburg	Dickson, SL (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden.	Suzanne.Dickson@gu.se	Dickson, Suzanne L/U-4628-2019	Bake, Tina/0000-0003-0500-5129; Dickson, Suzanne/0000-0002-3822-5294	EC project "Nudge-it" [607310]; Swedish Research Council for Medicine (Vetenskapsradet) [2012-1758]; Avtal om Lakarutbildning och Forskning [ALFBGB-138741]; Novo Nordisk Fonden [NNF12OC1016479, NNF13OC0004819] Funding Source: researchfish	EC project "Nudge-it"; Swedish Research Council for Medicine (Vetenskapsradet); Avtal om Lakarutbildning och Forskning; Novo Nordisk Fonden(Novo Nordisk Foundation)	Research supported by the EC project "Nudge-it" ( grant agreement number 607310), by the Swedish Research Council for Medicine (Vetenskapsradet, grant number 2012-1758) and by Avtal om Lakarutbildning och Forskning (ALFBGB-138741). (SLD) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Bagnasco M, 2002, ENDOCRINOLOGY, V143, P726, DOI 10.1210/en.143.2.726; Bomberg EM, 2007, NEUROREPORT, V18, P591, DOI 10.1097/WNR.0b013e3280b07bb5; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Drewnowski A, 1997, ANNU REV NUTR, V17, P237, DOI 10.1146/annurev.nutr.17.1.237; Druce MR, 2006, INT J OBESITY, V30, P293, DOI 10.1038/sj.ijo.0803158; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; King SJ, 2011, HORM BEHAV, V60, P572, DOI 10.1016/j.yhbeh.2011.08.006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; la Fleur SE, 2007, INT J OBESITY, V31, P1286, DOI 10.1038/sj.ijo.0803570; la Fleur SE, 2010, INT J OBESITY, V34, P537, DOI 10.1038/ijo.2009.257; Laurenius A, 2013, EUR J CLIN NUTR, V67, P168, DOI 10.1038/ejcn.2012.208; Lucas F, 1996, CHEM SENSES, V21, P169, DOI 10.1093/chemse/21.2.169; Mela DJ, 1999, P NUTR SOC, V58, P513, DOI 10.1017/S0029665199000683; Merkestein M, 2012, OBESITY, V20, P963, DOI 10.1038/oby.2011.389; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; Perello M, 2015, J NEUROENDOCRINOL, V27, P424, DOI 10.1111/jne.12236; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Shimbara T, 2004, NEUROSCI LETT, V369, P75, DOI 10.1016/j.neulet.2004.07.060; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; Skibicka KP, 2013, NEUROPHARMACOLOGY, V73, P274, DOI 10.1016/j.neuropharm.2013.06.004; Skibicka KP, 2012, ENDOCRINOLOGY, V153, P1194, DOI 10.1210/en.2011-1606; Skibicka KP, 2011, PEPTIDES, V32, P2265, DOI 10.1016/j.peptides.2011.05.016; Skibicka KP, 2012, ADDICT BIOL, V17, P95, DOI 10.1111/j.1369-1600.2010.00294.x; Smith BK, 1997, PEPTIDES, V18, P207, DOI 10.1016/S0196-9781(96)00318-X; Toshinai K, 2001, BIOCHEM BIOPH RES CO, V281, P1220, DOI 10.1006/bbrc.2001.4518; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Ventura AK, 2013, CURR BIOL, V23, pR401, DOI 10.1016/j.cub.2013.02.037; Verhagen LAW, 2011, EUR NEUROPSYCHOPHARM, V21, P384, DOI 10.1016/j.euroneuro.2010.06.005; Wren AM, 2000, ENDOCRINOLOGY, V141, P4325, DOI 10.1210/en.141.11.4325; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823	34	39	39	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149456	10.1371/journal.pone.0149456	http://dx.doi.org/10.1371/journal.pone.0149456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925974	Green Submitted, gold, Green Published			2022-12-27	WOS:000371424200010
J	Keskin, I; Forsgren, E; Lange, DJ; Weber, M; Birve, A; Synofzik, M; Gilthorpe, JD; Andersen, PM; Marklund, SL				Keskin, Isil; Forsgren, Elin; Lange, Dale J.; Weber, Markus; Birve, Anna; Synofzik, Matthis; Gilthorpe, Jonathan D.; Andersen, Peter M.; Marklund, Stefan L.			Effects of Cellular Pathway Disturbances on Misfolded Superoxide Dismutase-1 in Fibroblasts Derived from ALS Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MUTANT SUPEROXIDE DISMUTASE-1; MOTOR-NEURON DISEASE; WILD-TYPE; OXIDATIVE-PHOSPHORYLATION; CULTURE MODEL; SPINAL-CORD; MOUSE MODEL; SOD1; MUTATIONS	Mutations in superoxide dismutase-1 (SOD1) are a common known cause of amyotrophic lateral sclerosis (ALS). The neurotoxicity of mutant SOD1s is most likely caused by misfolded molecular species, but disease pathogenesis is still not understood. Proposed mechanisms include impaired mitochondrial function, induction of endoplasmic reticulum stress, reduction in the activities of the proteasome and autophagy, and the formation of neurotoxic aggregates. Here we examined whether perturbations in these cellular pathways in turn influence levels of misfolded SOD1 species, potentially amplifying neurotoxicity. For the study we used fibroblasts, which express SOD1 at physiological levels under regulation of the native promoter. The cells were derived from ALS patients expressing 9 different SOD1 mutants of widely variable molecular characteristics, as well as from patients carrying the GGGGCC-repeat-expansion in C9orf72 and from non-disease controls. A specific ELISA was used to quantify soluble, misfolded SOD1, and aggregated SOD1 was analysed by western blotting. Misfolded SOD1 was detected in all lines. Levels were found to be much lower in non-disease control and the non-SOD1 C9orf72 ALS lines. This enabled us to validate patient fibroblasts for use in subsequent perturbation studies. Mitochondrial inhibition, endoplasmic reticulum stress or autophagy inhibition did not affect soluble misfolded SOD1 and in most cases, detergent-resistant SOD1 aggregates were not detected. However, proteasome inhibition led to uniformly large increases in misfolded SOD1 levels in all cell lines and an increase in SOD1 aggregation in some. Thus the ubiquitin-proteasome pathway is a principal determinant of misfolded SOD1 levels in cells derived both from patients and controls and a decline in activity with aging could be one of the factors behind the mid-to late-life onset of inherited ALS.	[Keskin, Isil; Forsgren, Elin; Birve, Anna; Gilthorpe, Jonathan D.; Andersen, Peter M.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Lange, Dale J.] Hosp Special Surg, Dept Neurol, New York, NY USA; [Lange, Dale J.] Weill Cornell Med Ctr, New York, NY USA; [Weber, Markus] Kantonsspital St Gallen, ALS Clin, Neuromusucular Dis Unit, St Gallen, Switzerland; [Synofzik, Matthis] Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Synofzik, Matthis] Univ Tubingen, German Res Ctr Neurodegenerat Dis DZNE, Tubingen, Germany; [Marklund, Stefan L.] Umea Univ, Dept Med Biosci, Clin Chem, Umea, Sweden	Umea University; Cornell University; Kantonsspital St. Gallen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Umea University	Marklund, SL (corresponding author), Umea Univ, Dept Med Biosci, Clin Chem, Umea, Sweden.	stefan.marklund@umu.se	Weber, Markus/AAI-7138-2020	KESKIN, ISIL/0000-0003-3690-3116; Gilthorpe, Jonathan/0000-0002-6884-4774; Synofzik, Matthis/0000-0002-2280-7273	Swedish Research Council; Knut and Alice Wallenberg Foundation; Bertil Hallsten Foundation; Torsten and Ragnar Soderberg Foundation; Swedish Brain Foundation; Stratneuro initiative; Vasterbotten County Council; Kempe Foundation; Neuroforbundet; Ulla-Carin Lindquist Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Bertil Hallsten Foundation; Torsten and Ragnar Soderberg Foundation; Swedish Brain Foundation; Stratneuro initiative; Vasterbotten County Council; Kempe Foundation; Neuroforbundet; Ulla-Carin Lindquist Foundation	The study was supported by the Swedish Research Council, the Knut and Alice Wallenberg Foundation, the Bertil Hallsten Foundation, the Torsten and Ragnar Soderberg Foundation, the Swedish Brain Foundation, the Stratneuro initiative, the Vasterbotten County Council, the Kempe Foundation, Neuroforbundet and the Ulla-Carin Lindquist Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto C, 2014, J MED GENET, V51, P419, DOI 10.1136/jmedgenet-2014-102360; Allen SP, 2014, NEUROBIOL AGING, V35, P1499, DOI 10.1016/j.neurobiolaging.2013.11.025; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Andersen PM, 2005, EUR J NEUROL, V12, P921, DOI 10.1111/j.1468-1331.2005.01351.x; Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Andersen PM, 1997, BRAIN, V120, P1723, DOI 10.1093/brain/120.10.1723; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bergh J, 2015, P NATL ACAD SCI USA, V112, P4489, DOI 10.1073/pnas.1419228112; Bishop NA, 2010, NATURE, V464, P529, DOI 10.1038/nature08983; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Brown JA, 2012, AMYOTROPH LATERAL SC, V13, P217, DOI 10.3109/17482968.2011.643899; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Charcot JM, 1873, LECONS MALADIES SYST, P163; Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004; Cheroni C, 2009, HUM MOL GENET, V18, P82, DOI 10.1093/hmg/ddn319; Ciechanover A, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.117; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Forsberg K, 2011, ACTA NEUROPATHOL, V121, P623, DOI 10.1007/s00401-011-0805-3; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Israelson A, 2010, NEURON, V67, P575, DOI 10.1016/j.neuron.2010.07.019; Jonsson PA, 2006, J NEUROPATH EXP NEUR, V65, P1126, DOI 10.1097/01.jnen.0000248545.36046.3c; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Kabashi E, 2012, AMYOTROPH LATERAL SC, V13, P367, DOI 10.3109/17482968.2012.686511; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kato S, 2000, AMYOTROPH LATERAL SC, V1, P163, DOI 10.1080/14660820050515160; Kikuchi H, 2006, P NATL ACAD SCI USA, V103, P6025, DOI 10.1073/pnas.0509227103; Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004; Li L, 2008, AUTOPHAGY, V4, P290, DOI 10.4161/auto.5524; Marklund SL, 1997, J NEUROCHEM, V69, P675; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Menzies FM, 2002, BRAIN, V125, P1522, DOI 10.1093/brain/awf167; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Paramore A, 2003, NAT REV DRUG DISCOV, V2, P611, DOI 10.1038/nrd1159; Pickles S, 2013, HUM MOL GENET, V22, P3947, DOI 10.1093/hmg/ddt249; Prudencio M, 2009, HUM MOL GENET, V18, P3217, DOI 10.1093/hmg/ddp260; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shibata N, 1996, J NEUROPATH EXP NEUR, V55, P481, DOI 10.1097/00005072-199604000-00011; Synofzik M, 2012, HUM MOL GENET, V21, P3568, DOI 10.1093/hmg/dds188; Synofzik M, 2010, J NEUROL NEUROSUR PS, V81, P764, DOI 10.1136/jnnp.2009.181719; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Wroe R, 2008, AMYOTROPH LATERAL SC, V9, P249, DOI 10.1080/17482960802146106; Zetterstrom P, 2013, NEUROMOL MED, V15, P147, DOI 10.1007/s12017-012-8204-z; Zetterstrom P, 2011, J NEUROCHEM, V117, P91, DOI 10.1111/j.1471-4159.2011.07177.x; Zhang FJ, 2007, J BIOL CHEM, V282, P16691, DOI 10.1074/jbc.M609743200	51	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150133	10.1371/journal.pone.0150133	http://dx.doi.org/10.1371/journal.pone.0150133			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919046	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400090
J	Shah, JD; Desai, PT; Zhang, Y; Scharber, SK; Baller, J; Xing, ZS; Cardona, CJ				Shah, Jigna D.; Desai, Prerak T.; Zhang, Ying; Scharber, Sarah K.; Baller, Joshua; Xing, Zheng S.; Cardona, Carol J.			Development of the Intestinal RNA Virus Community of Healthy Broiler Chickens	PLOS ONE			English	Article							ENTERIC VIRUSES; COMMERCIAL CHICKEN; POULT ENTERITIS; ROTAVIRUS	Several RNA viruses such as astrovirus, rotavirus, reovirus and parvovirus have been detected in both healthy and diseased commercial poultry flocks. The aim of this study was to characterize (a) the development of the RNA viral community in the small intestines of healthy broiler chickens from hatch through 6 weeks of age (market age) and (b) the contribution of the breeder source vs. bird age in development of the community structure. Intestinal tissue samples were harvested from breeders and their progeny, processed for viral RNA extraction and sequenced using Illumina Hiseq sequencing technology resulting in 100 bp PE reads. The results from this study indicated that the breeder source influenced the RNA viral community only at hatch but later environment i.e. bird age had the more significant effect. The most abundant RNA viral family detected at 2, 4 and 6 weeks of age was Astroviridae, which decreased in abundance with age while the abundance of Picornaviridae increased with age.	[Shah, Jigna D.; Scharber, Sarah K.; Xing, Zheng S.; Cardona, Carol J.] Univ Minnesota, Vet & Biomed Sci, St Paul, MN 55108 USA; [Zhang, Ying; Baller, Joshua] Univ Minnesota, Minnesota Supercomp Inst, St Paul, MN 55108 USA; [Desai, Prerak T.] Univ Calif Irvine, Microbiol & Mol Genet, Irvine, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Irvine	Cardona, CJ (corresponding author), Univ Minnesota, Vet & Biomed Sci, St Paul, MN 55108 USA.	ccardona@umn.edu	Xing, Zheng/O-3137-2015; Desai, Prerak/ABF-8529-2020	Xing, Zheng/0000-0002-7288-0268; Knack, Sarah/0000-0002-4220-0866; Zhang, Ying/0000-0003-3764-7329; Baller, Joshua/0000-0003-3936-7953	Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota	Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota	This work was partially supported by the funding received from the Emerging and Zoonotic Diseases Signature Program, College of Veterinary Medicine, University of Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Canelli E, 2012, AVIAN DIS, V56, P173, DOI 10.1637/9831-061311-Reg.1; Ciarlet M, 2001, CURR OPIN MICROBIOL, V4, P435, DOI 10.1016/S1369-5274(00)00232-0; Dhama K, 2015, VET QUART, V35, P211, DOI 10.1080/01652176.2015.1063023; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Gagic M, 1999, AVIAN DIS, V43, P293, DOI 10.2307/1592620; Heggen-Peay CL, 2002, AVIAN DIS, V46, P32, DOI 10.1637/0005-2086(2002)046[0032:IOARFP]2.0.CO;2; Jindal N, 2010, POULTRY SCI, V89, P217, DOI 10.3382/ps.2009-00424; Koo BS, 2013, POULTRY SCI, V92, P2876, DOI 10.3382/ps.2013-03280; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Pantin-Jackwood MJ, 2008, AVIAN DIS, V52, P235, DOI 10.1637/8174-111507-Reg.1; Pantin-Jackwood MJ, 2007, AVIAN DIS, V51, P674, DOI 10.1637/0005-2086(2007)51[674:PMOCTF]2.0.CO;2; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shah JD, 2014, J VIROL METHODS, V209, P15, DOI 10.1016/j.jviromet.2014.08.011; Tamehiro CY, 2003, BRAZ J MICROBIOL, V34, P349, DOI 10.1590/S1517-83822003000400013; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wylie KM, 2012, TRANSL RES, V160, P283, DOI 10.1016/j.trsl.2012.03.006; Zsak L, 2008, AVIAN PATHOL, V37, P435, DOI 10.1080/03079450802210648	19	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150094	10.1371/journal.pone.0150094	http://dx.doi.org/10.1371/journal.pone.0150094			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914580	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700053
J	Shorter, SK; Schnell, FJ; McMaster, SR; Pinelli, DF; Andargachew, R; Evavold, BD				Shorter, Shayla K.; Schnell, Frederick J.; McMaster, Sean R.; Pinelli, David F.; Andargachew, Rakieb; Evavold, Brian D.			Viral Escape Mutant Epitope Maintains TCR Affinity for Antigen yet Curtails CD8 T Cell Responses	PLOS ONE			English	Article							ALTERED PEPTIDE LIGANDS; REGULATORY FACTOR 4; EFFECTOR FUNCTION; CLONAL EXPANSION; SIGNALING PATHWAYS; CHRONIC INFECTION; RECEPTOR; ACTIVATION; DIFFERENTIATION; PROLIFERATION	T cells have the remarkable ability to recognize antigen with great specificity and in turn mount an appropriate and robust immune response. Critical to this process is the initial T cell antigen recognition and subsequent signal transduction events. This antigen recognition can be modulated at the site of TCR interaction with peptide: major histocompatibility (pMHC) or peptide interaction with the MHC molecule. Both events could have a range of effects on T cell fate. Though responses to antigens that bind sub-optimally to TCR, known as altered peptide ligands (APL), have been studied extensively, the impact of disrupting antigen binding to MHC has been highlighted to a lesser extent and is usually considered to result in complete loss of epitope recognition. Here we present a model of viral evasion from CD8 T cell immuno-surveillance by a lymphocytic choriomeningitis virus (LCMV) escape mutant with an epitope for which TCR affinity for pMHC remains high but where the antigenic peptide binds sub optimally to MHC. Despite high TCR affinity for variant epitope, levels of interferon regulatory factor-4 (IRF4) are not sustained in response to the variant indicating differences in perceived TCR signal strength. The CD8+ T cell response to the variant epitope is characterized by early proliferation and up-regulation of activation markers. Interestingly, this response is not maintained and is characterized by a lack in IL-2 and IFN. production, increased apoptosis and an abrogated glycolytic response. We show that disrupting the stability of peptide in MHC can effectively disrupt TCR signal strength despite unchanged affinity for TCR and can significantly impact the CD8+ T cell response to a viral escape mutant.	[Shorter, Shayla K.; Schnell, Frederick J.; McMaster, Sean R.; Pinelli, David F.; Andargachew, Rakieb; Evavold, Brian D.] Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University	Evavold, BD (corresponding author), Emory Univ, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	bevavol@emory.edu		Evavold, Brian/0000-0002-3561-3494	National Institute of Neurological Disorders and Stroke (NINDS) [5R01NS071518-03]; National Institute of Allergy and Infectious Diseases (NIAID) [1R01AI096879-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096879, T32AI007610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS071518] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016388] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Neurological Disorders and Stroke (NINDS) (http://www.ninds.nih.gov/) 5R01NS071518-03 and the National Institute of Allergy and Infectious Diseases (NIAID) (http://www.niaid.nih.gov/) 1R01AI096879-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au-Yeung BB, 2014, P NATL ACAD SCI USA, V111, pE3679, DOI 10.1073/pnas.1413726111; Auphan-Anezin N, 2003, J IMMUNOL, V170, P2442, DOI 10.4049/jimmunol.170.5.2442; Benczik M, 2004, IMMUNOL INVEST, V33, P109, DOI 10.1081/IMM-120030732; Bielekova B, 2000, NAT MED, V6, P1167, DOI 10.1038/80516; Blattman JN, 2009, J VIROL, V83, P4386, DOI 10.1128/JVI.02524-08; Boulter JM, 2007, EUR J IMMUNOL, V37, P798, DOI 10.1002/eji.200636743; Brodovitch A, 2015, EUR J IMMUNOL, V45, P1635, DOI 10.1002/eji.201445214; Bronke C, 2013, AIDS, V27, P899, DOI 10.1097/QAD.0b013e32835e1616; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buhrman JD, 2013, IMMUNOL RES, V55, P34, DOI 10.1007/s12026-012-8348-9; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CHAO DT, 1995, J EXP MED, V182, P821, DOI 10.1084/jem.182.3.821; Curtsinger JM, 2003, J IMMUNOL, V171, P5165, DOI 10.4049/jimmunol.171.10.5165; D'Souza WN, 2003, J IMMUNOL, V171, P5727, DOI 10.4049/jimmunol.171.11.5727; Edwards LJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00086; EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816; EVAVOLD BD, 1993, IMMUNOL TODAY, V14, P602, DOI 10.1016/0167-5699(93)90200-5; Gubser PM, 2013, NAT IMMUNOL, V14, P1064, DOI 10.1038/ni.2687; Guy CS, 2013, NAT IMMUNOL, V14, P262, DOI 10.1038/ni.2538; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hong JS, 2015, J IMMUNOL, V195, P3557, DOI 10.4049/jimmunol.1501407; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Katsara M, 2008, EXPERT OPIN BIOL TH, V8, P1873, DOI 10.1517/14712590802494501 ; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Lai YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007766; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Nikolich-Zugich J, 2004, NAT REV IMMUNOL, V4, P123, DOI 10.1038/nri1292; O'Sullivan D, 2015, TRENDS IMMUNOL, V36, P71, DOI 10.1016/j.it.2014.12.004; Palmer CS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00001; Park TS, 2011, TRENDS BIOTECHNOL, V29, P550, DOI 10.1016/j.tibtech.2011.04.009; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Raczkowski F, 2013, P NATL ACAD SCI USA, V110, P15019, DOI 10.1073/pnas.1309378110; Ream RM, 2010, J IMMUNOL, V184, P2401, DOI 10.4049/jimmunol.0902448; Rosenthal KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032562; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Schnell FJ, 2009, J IMMUNOL, V182, P1829, DOI 10.4049/jimmunol.0801798; Schrum AG, 2002, J EXP MED, V196, P793, DOI 10.1084/jem.20020158; Sereti I, 2000, CLIN IMMUNOL, V97, P266, DOI 10.1006/clim.2000.4929; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Stone JD, 2009, IMMUNOLOGY, V126, P165, DOI 10.1111/j.1365-2567.2008.03015.x; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; Wasserman HA, 2008, J IMMUNOL, V181, P6843, DOI 10.4049/jimmunol.181.10.6843; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zou CH, 2005, J BIOCHEM BIOPH METH, V64, P207, DOI 10.1016/j.jbbm.2005.08.001	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149582	10.1371/journal.pone.0149582	http://dx.doi.org/10.1371/journal.pone.0149582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915099	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700020
J	Gale, TM; Hawley, CJ; Butler, J; Morton, A; Singhal, A				Gale, Tim M.; Hawley, Christopher J.; Butler, John; Morton, Adrian; Singhal, Ankush			Perception of Suicide Risk in Mental Health Professionals	PLOS ONE			English	Article							DECISION-MAKING; TIME	This study employed an independent-groups design (4 conditions) to investigate possible biases in the suicide risk perception of mental health professionals. Four hundred participants comprising doctors, nurses and social workers viewed a vignette describing a fictitious patient with a long-term mental illness. The case was presented as being drawn from a sample of twenty similar clinical case reports, of which 10 were associated with an outcome of suicide. The participant tasks were (i) to decide whether the presented vignette was one of those cases or not, and (ii) to provide an assessment of confidence in that decision. The 4 conditions were used to investigate whether the presence of an associated face, and the nature of the emotional state expressed by that face, affected the response profile. In fact, there were no significant differences between conditions, but there was a significant bias across all conditions towards associating the vignette with suicide, despite the base rate being pre-determined at 50%. The bias was more pronounced in doctors and in male respondents. Moreover, many participants indicated substantial confidence in their decisions. The results are discussed in terms of availability bias and over-confidence bias.	[Gale, Tim M.] Hertfordshire Partnership Univ NHS Fdn Trust, Dept Res, Hatfield, Herts, England; [Gale, Tim M.] Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England; [Hawley, Christopher J.] Univ Hertfordshire, Dept Postgrad Med, Hatfield AL10 9AB, Herts, England; [Butler, John] Univ Cent Lancaster, Sch Hlth, Preston, Lancs, England; [Morton, Adrian] Reigate Psychol Serv, Reigate, Surrey, England; [Singhal, Ankush] Royal Oldham Hosp, Psychol Med Serv, Oldham, England	University of Hertfordshire; University of Hertfordshire; University of Central Lancashire	Gale, TM (corresponding author), Hertfordshire Partnership Univ NHS Fdn Trust, Dept Res, Hatfield, Herts, England.; Gale, TM (corresponding author), Univ Hertfordshire, Dept Psychol, Hatfield AL10 9AB, Herts, England.	t.gale@herts.ac.uk			Hertfordshire Partnership University NHS Foundation Trust	Hertfordshire Partnership University NHS Foundation Trust	This study was sponsored and funded by Hertfordshire Partnership University NHS Foundation Trust. The first author is employed by this organisation. The funding organisation had no role in the decision to publish this manuscript.	Angst J, 1999, J CLIN PSYCHIAT, V60, P57; Appleby L, 2001, SAFETY 1; Baldwin D, 2003, CLIN RISK, V9, P229; Bouch J., 2005, ADV PSYCHIAT TREATME, V11, P84, DOI [10.1192/apt.11.2.84, DOI 10.1192/APT.11.2.84]; Brock Anita, 2006, Health Stat Q, P6; Brunton Keith, 2005, Nurs Times, V101, P38; Cassells C, 2005, CRISIS, V26, P53, DOI 10.1027/0227-5910.26.2.53; CHANNOUF A., 2000, EUR REV APPL PSYCHOL, V50, P19; Department of Health, 1999, NAT SERV FRAM MENT H; Department of Health, 2002, NAT SUIC PREV STRAT; Department of Health, 2012, PREV SUIC ENGL CROSS; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Gale TM, 2011, PSYCHIAT DANUB, V23, pS198; Gale TM, 2002, INT J PSYCHIAT CLIN, V6, P73, DOI 10.1080/136515002753724063; Gale TM, 2003, J MENTAL HLTH, V12, P417; Hall RCW, 1999, PSYCHOSOMATICS, V40, P18, DOI 10.1016/S0033-3182(99)71267-3; Harris CR, 2006, JUDGM DECIS MAK, V1, P48; Hawley CJ, 2010, J MENT HEALTH, V19, P88, DOI 10.3109/09638230802523005; Hawley CJ, 2006, J MENT HEALTH, V15, P437, DOI DOI 10.1080/09638230600801462; Hawton K, 2013, J AFFECT DISORDERS, V147, P17, DOI 10.1016/j.jad.2013.01.004; Higgins N, 2005, PSYCHIATR BULL, V29, P131, DOI 10.1192/pb.29.4.131; Jefferies-Sewell K, 2015, J MENT HEALTH, V24, P20, DOI 10.3109/09638237.2014.951477; Lorant V, 2005, BRIT J PSYCHIAT, V187, P49, DOI 10.1192/bjp.187.1.49; Monkley-Poole S, 1998, MENTAL HLTH CARE, V21, P56; Morgan S., 2000, CLIN RISK MANAGEMENT; Mortensen PB, 2000, LANCET, V355, P9, DOI 10.1016/S0140-6736(99)06376-X; NICE, 2011, SELF HARM IN OVER 8S; NORDSTROM P, 1994, SUICIDE LIFE-THREAT, V24, P1; Office for National Statistics, 2014, SUIC UK 2012 REG; OSKAMP S, 1965, J CONSULT PSYCHOL, V29, P261, DOI 10.1037/h0022125; Qin P, 2003, AM J PSYCHIAT, V160, P765, DOI 10.1176/appi.ajp.160.4.765; Quinlivan L, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004732; Roberts SE, 2013, PSYCHOL MED, V43, P1231, DOI 10.1017/S0033291712002024; Skandrani-Marzouki I, 2010, SWISS J PSYCHOL, V69, P213, DOI 10.1024/1421-0185/a000025; Tiedens LZ, 2001, J PERS SOC PSYCHOL, V80, P86, DOI 10.1037//0022-3514.80.1.86; Undrill G., 2007, ADV PSYCHIAT TREATME, V357, P291, DOI [10.1192/apt.bp.106.003160, DOI 10.1192/APT.BP.106.003160]; Yin LJ, 2006, PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE ON AUTOMATIC FACE AND GESTURE RECOGNITION - PROCEEDINGS OF THE SEVENTH INTERNATIONAL CONFERENCE, P211	37	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149791	10.1371/journal.pone.0149791	http://dx.doi.org/10.1371/journal.pone.0149791			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26909886	Green Submitted, gold, Green Published			2022-12-27	WOS:000371164700048
J	Pivovarciova, A; Durdiakova, J; Babinska, K; Kubranska, A; Vokalova, L; Minarik, G; Celec, P; Murin, M; Ostatnikova, D				Pivovarciova, Anna; Durdiakova, Jaroslava; Babinska, Katarina; Kubranska, Aneta; Vokalova, Lenka; Minarik, Gabriel; Celec, Peter; Murin, Marianna; Ostatnikova, Daniela			Testosterone and Androgen Receptor Sensitivity in Relation to Hyperactivity Symptoms in Boys with Autism Spectrum Disorders	PLOS ONE			English	Article							BEHAVIOR RATING FORM; PERVASIVE DEVELOPMENTAL DISORDERS; SALIVARY TESTOSTERONE; DIGIT RATIO; CAG REPEAT; YOUNG-PEOPLE; CHILDREN; ADHD; GENE; ADOLESCENTS	Introduction Autism spectrum disorders (ASD) and hyperactivity symptoms exhibit an incidence that is male-biased. Thus androgen activity can be considered a plausible biological risk factor for these disorders. However, there is insufficient information about the association between increased androgen activity and hyperactivity symptoms in children with ASD. Methods In the present study, the relationship between parameters of androgenicity (plasmatic testosterone levels and androgen receptor sensitivity) and hyperactivity in 60 boys (age 3-15) with ASD is investigated. Given well documented differences in parent and trained examiners ratings of symptom severity, we employed a standardized parent's questionnaire (Nisonger Child Behavior Rating Form) as well as a direct examiner's rating (Autism diagnostic observation schedule) for assessment of hyperactivity symptoms. Results Although it was found there was no significant association between actual plasmatic testosterone levels and hyperactivity symptoms, the number of CAG triplets was significantly negatively correlated with hyperactivity symptoms (R-2 = 0.118, p = 0.007) in the sample, indicating increased androgen receptor sensitivity in association with hyperactivity symptoms. Direct trained examiner's assessment appeared to be a relevant method for evaluating of behavioral problems in the investigation of biological underpinnings of these problems in our study. Conclusions A potential ASD subtype characterized by increased rates of hyperactivity symptoms might have distinct etiopathogenesis and require a specific behavioral and pharmacological approach. We propose an increase of androgen receptor sensitivity as a biomarker for a specific ASD subtype accompanied with hyperactivity symptoms. Findings are discussed in terms of their implications for practice and future research.	[Pivovarciova, Anna; Durdiakova, Jaroslava; Babinska, Katarina; Kubranska, Aneta; Vokalova, Lenka; Ostatnikova, Daniela] Comenius Univ, Fac Med, Inst Physiol, Acad Res Ctr Autism, Bratislava, Slovakia; [Minarik, Gabriel] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Celec, Peter] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Murin, Marianna] Great Ormond St Hosp Sick Children, Social Commun Disorders Clin, Dept Child & Adolescent Mental Hlth, Great Ormond St, London WC1N 3JH, England	Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; Comenius University Bratislava; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Pivovarciova, A (corresponding author), Comenius Univ, Fac Med, Inst Physiol, Acad Res Ctr Autism, Bratislava, Slovakia.	anna.pivovarciova@gmail.com	Ostatnikova, Daniela/AAD-1359-2019; Celec, Peter/I-7103-2012; Babinská, Katarína/AAC-9817-2019	Celec, Peter/0000-0001-5883-3580; Babkova, Jaroslava/0000-0003-2492-8391; Babinska, Katarina/0000-0002-0385-025X; Ostatnikova, Daniela/0000-0002-4960-5057	University Science Park for Biomedicine Bratislava [ITMS 26240220087]; Slovak research and development agency [APVV 0254-11]; Ministry of Education of the Slovak Republic; Slovak Academy of Sciences [VEGA 1/0052/15]	University Science Park for Biomedicine Bratislava; Slovak research and development agency(Slovak Research and Development Agency); Ministry of Education of the Slovak Republic; Slovak Academy of Sciences(Slovak Academy of Sciences)	This study was supported by grants: University Science Park for Biomedicine Bratislava (ITMS 26240220087): JD, DO; Slovak research and development agency (APVV 0254-11) [http://www.apvv.sk/agentura]: AP, JD, KB, AK; The Scientific grant agency of the Ministry of Education of the Slovak Republic and of Slovak Academy of Sciences (VEGA 1/0052/15): DO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Aman MG, 1996, RES DEV DISABIL, V17, P41, DOI 10.1016/0891-4222(95)00039-9; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ames CS, 2011, J AUTISM DEV DISORD, V41, P357, DOI 10.1007/s10803-010-1049-0; Anckarsater H, 2006, AM J PSYCHIAT, V163, P1239, DOI 10.1176/appi.ajp.163.7.1239; Attermann J, 2012, EUR CHILD ADOLES PSY, V21, P503, DOI 10.1007/s00787-012-0287-4; Auyeung B, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-11; Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Brown EC, 2002, RES DEV DISABIL, V23, P45, DOI 10.1016/S0891-4222(01)00091-9; Bussing R, 2008, ASSESSMENT, V15, P317, DOI 10.1177/1073191107313888; Butovskaya ML, 2012, BEHAV GENET, V42, P647, DOI 10.1007/s10519-012-9533-2; Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012; Comings DE, 1999, NEUROREPORT, V10, P1589, DOI 10.1097/00001756-199905140-00036; DABBS JM, 1990, PHYSIOL BEHAV, V48, P83, DOI 10.1016/0031-9384(90)90265-6; Davies W, 2014, FRONT NEUROENDOCRIN, V35, P331, DOI 10.1016/j.yfrne.2014.03.003; De Los Reyes A, 2009, J ABNORM CHILD PSYCH, V37, P637, DOI 10.1007/s10802-009-9307-3; Ding DC, 2004, PROSTATE, V58, P23, DOI 10.1002/pros.10316; Durdiakova J, 2015, INTELLIGENCE, V48, P76, DOI 10.1016/j.intell.2014.11.002; Fairthorne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113430; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; Gadow KD, 2008, J AUTISM DEV DISORD, V38, P1710, DOI 10.1007/s10803-008-0556-8; Gadow KD, 2006, J AUTISM DEV DISORD, V36, P271, DOI 10.1007/s10803-005-0060-3; Giovannucci E, 1999, UROLOGY, V53, P121, DOI 10.1016/S0090-4295(98)00468-3; Greaves-Lord K, 2013, J AUTISM DEV DISORD, V43, P1784, DOI 10.1007/s10803-012-1724-4; Grzadzinski R, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-12; Hampson E, 2012, EVOL HUM BEHAV, V33, P557, DOI 10.1016/j.evolhumbehav.2012.02.003; Henningsson S, 2009, PSYCHONEUROENDOCRINO, V34, P752, DOI 10.1016/j.psyneuen.2008.12.007; Hickey T, 2002, J CLIN ENDOCR METAB, V87, P161, DOI 10.1210/jc.87.1.161; Horlin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106552; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; James WH, 2008, DEV MED CHILD NEUROL, V50, P15, DOI 10.1111/j.1469-8749.2007.02001.x; Kalyva E, 2010, J AUTISM DEV DISORD, V40, P1202, DOI 10.1007/s10803-010-0978-y; Kanne SM, 2009, J AUTISM DEV DISORD, V39, P827, DOI 10.1007/s10803-008-0688-x; Knickmeyer R, 2005, J CHILD PSYCHOL PSYC, V46, P198, DOI 10.1111/j.1469-7610.2004.00349.x; Krithivas K, 1999, J ENDOCRINOL, V162, P137, DOI 10.1677/joe.0.1620137; Lai MC, 2014, LANCET, V383, P896, DOI 10.1016/S0140-6736(13)61539-1; Lecavalier L, 2004, J AUTISM DEV DISORD, V34, P709, DOI 10.1007/s10803-004-5291-1; Lecavalier L, 2006, J AUTISM DEV DISORD, V36, P1101, DOI 10.1007/s10803-006-0147-5; Lemiere J, 2010, DEV MED CHILD NEUROL, V52, pE202, DOI 10.1111/j.1469-8749.2010.03684.x; Lord C, 2014, PATHOL BIOL, V62, P302, DOI 10.1016/j.patbio.2014.07.005; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Lord C., 2012, AUTISM DIAGNOSTIC OB; Majewska MD, 2014, EUR CHILD ADOLES PSY, V23, P485, DOI 10.1007/s00787-013-0472-0; Manning JT, 2002, MED HYPOTHESES, V59, P334, DOI 10.1016/S0306-9877(02)00181-0; Manning JT, 2001, DEV MED CHILD NEUROL, V43, P160, DOI 10.1017/S0012162201000317; Martel MM, 2009, HORM BEHAV, V55, P465, DOI 10.1016/j.yhbeh.2009.02.004; Meriggiola MC, 1996, HUM REPROD, V11, P248, DOI 10.1093/HUMREP/11.2.248; Miller DC, 1997, DEV PSYCHOL, V33, P814, DOI 10.1037/0012-1649.33.5.814; Neef NA, 2005, J APPL BEHAV ANAL, V38, P135, DOI 10.1901/jaba.2005.116-02; Neef NA, 2005, J APPL BEHAV ANAL, V38, P23, DOI 10.1901/jaba.2005.146-02; Offord DR, 1996, J AM ACAD CHILD PSY, V35, P1078, DOI 10.1097/00004583-199608000-00019; Pivovarciova A, 2015, PHYSIOL RES, V64, pS595, DOI 10.33549/physiolres.933221; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polderman TJC, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.84; Rajender S, 2008, INT J LEGAL MED, V122, P367, DOI 10.1007/s00414-008-0225-7; Rettew DC, 2011, J CHILD ADOL PSYCHOP, V21, P389, DOI 10.1089/cap.2010.0153; ROJAHN J, 1991, J AUTISM DEV DISORD, V21, P17, DOI 10.1007/BF02206994; Romero-Martinez A, 2017, J ATTEN DISORD, V21, P938, DOI 10.1177/1087054713482685; Rowe R, 2004, BIOL PSYCHIAT, V55, P546, DOI 10.1016/j.biopsych.2003.10.010; Ruta L, 2011, PSYCHONEUROENDOCRINO, V36, P1154, DOI 10.1016/j.psyneuen.2011.02.007; SCERBO AS, 1994, J AM ACAD CHILD PSY, V33, P1174, DOI 10.1097/00004583-199410000-00013; Schmidtova E, 2010, ENDOCRINOLOGIST, V20, P245, DOI 10.1097/TEN.0b013e3181f661d2; Stanford JL, 1997, CANCER RES, V57, P1194; STANGER C, 1993, J CLIN CHILD PSYCHOL, V22, P107, DOI 10.1207/s15374424jccp2201_11; Sucksmith E, 2011, NEUROPSYCHOL REV, V21, P360, DOI 10.1007/s11065-011-9183-9; Tasse MJ, 1996, RES DEV DISABIL, V17, P59, DOI 10.1016/0891-4222(95)00037-2; Teatero ML, 2013, J AUTISM DEV DISORD, V43, P2664, DOI 10.1007/s10803-013-1819-6; TORDJMAN S, 1995, J AUTISM DEV DISORD, V25, P295, DOI 10.1007/BF02179290; Tordjman S, 1997, AM J PSYCHIAT, V154, P1626; Wang LJ, 2011, WORLD J BIOL PSYCHIA, V12, P99, DOI 10.3109/15622975.2010.512090; Youngstrom E, 2000, J CONSULT CLIN PSYCH, V68, P1038, DOI 10.1037/0022-006X.68.6.1038	72	7	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149657	10.1371/journal.pone.0149657	http://dx.doi.org/10.1371/journal.pone.0149657			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910733	gold, Green Published			2022-12-27	WOS:000371164700042
J	Sistrom, M; Evans, B; Benoit, J; Balmer, O; Aksoy, S; Caccone, A				Sistrom, Mark; Evans, Benjamin; Benoit, Joshua; Balmer, Oliver; Aksoy, Serap; Caccone, Adalgisa			De Novo Genome Assembly Shows Genome Wide Similarity between Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense	PLOS ONE			English	Article							GENE-EXPRESSION; ALIGNMENT; RESISTANCE; DIVERSITY; PROTEINS; REVEALS; CROSS	Background Trypanosoma brucei is a eukaryotic pathogen which causes African trypanosomiasis. It is notable for its variant surface glycoprotein (VSG) coat, which undergoes antigenic variation enabled by a large suite of VSG pseudogenes, allowing for persistent evasion of host adaptive immunity. While Trypanosoma brucei rhodesiense (Tbr) and T. b gambiense (Tbg) are human infective, related T. b. brucei (Tbb) is cleared by human sera. A single gene, the Serum Resistance Associated (SRA) gene, confers Tbr its human infectivity phenotype. Potential genetic recombination of this gene between Tbr and non-human infective Tbb strains has significant epidemiological consequences for Human African Trypanosomiasis outbreaks. Results Using long and short read whole genome sequencing, we generated a hybrid de novo assembly of a Tbr strain, producing 4,210 scaffolds totaling approximately 38.8 megabases, which comprise a significant proportion of the Tbr genome, and thus represents a valuable tool for a comparative genomics analyses among human and non-human infective T. brucei and future complete genome assembly. We detected 5,970 putative genes, of which two, an alcohol oxidoreductase and a pentatricopeptide repeat-containing protein, were members of gene families common to all T. brucei subspecies, but variants specific to the Tbr strain sequenced in this study. Our findings confirmed the extremely high level of genomic similarity between the two parasite subspecies found in other studies. Conclusions We confirm at the whole genome level high similarity between the two Tbb and Tbr strains studied. The discovery of extremely minor genomic differentiation between Tbb and Tbr suggests that the transference of the SRA gene via genetic recombination could potentially result in novel human infective strains, thus all genetic backgrounds of T. brucei should be considered potentially human infective in regions where Tbr is prevalent.	[Sistrom, Mark] Univ Calif Merced, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA; [Evans, Benjamin; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06520 USA; [Benoit, Joshua; Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Balmer, Oliver] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland	University of California System; University of California Merced; Yale University; Yale University; University of Basel; Swiss Tropical & Public Health Institute	Sistrom, M (corresponding author), Univ Calif Merced, Sch Nat Sci, 5200 N Lake Rd, Merced, CA 95343 USA.	mark.sistrom@yale.edu	Aksoy, Serap/K-2244-2019; Caccone, Adalgisa/AAE-4238-2021; Balmer, Oliver/HHN-1110-2022	Aksoy, Serap/0000-0001-9941-143X; Caccone, Adalgisa/0000-0002-8949-9260; Balmer, Oliver/0000-0001-7572-7747; Evans, Benjamin/0000-0003-2069-4938	NIH R21 grant [AI094615-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094615, R01AI068932, T32AI007404, R21AI076879] Funding Source: NIH RePORTER	NIH R21 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH R21 grant AI094615-01 awarded to A.C. and S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH R21 grant AI094615-01 awarded to A.C. and S.A. The Yale University Biomedical High Performance Computing Center was used for all analyses.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews S., 2010, FASTQC QUALITY CONTR; Aphasizheva I, 2011, MOL CELL, V42, P106, DOI 10.1016/j.molcel.2011.02.021; Balmer O, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000961; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2002, MOL BIOCHEM PARASIT, V122, P131, DOI 10.1016/S0166-6851(02)00092-0; Brems S, 2005, MOL BIOCHEM PARASIT, V139, P163, DOI 10.1016/j.molbiopara.2004.11.004; Brun R, 2010, LANCET, V375, P148, DOI 10.1016/S0140-6736(09)60829-1; Campos FMF, 2009, ACTA TROP, V111, P56, DOI 10.1016/j.actatropica.2009.02.007; Capewell P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003686; Capewell P, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001287; Cong Q, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-82; Cross GAM, 2014, MOL BIOCHEM PARASIT, V195, P59, DOI 10.1016/j.molbiopara.2014.06.004; Duffy CW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002526; Echodu R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003353; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Geddy R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-130; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Gibson W.C., 1980, Advances in Parasitology, V18, P175, DOI 10.1016/S0065-308X(08)60400-5; GIBSON W C, 1986, Parasitology Today, V2, P255, DOI 10.1016/0169-4758(86)90011-6; GIBSON WC, 1989, PARASITOLOGY, V99, P391, DOI 10.1017/S0031182000059114; Gibson WC, 2005, PARASITOLOGY, V131, P143, DOI 10.1017/S0031182005007560; Gibson Wendy, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated, DOI 10.1186/1475-9292-2-10; Gibson W, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003665; Gibson W, 2002, INFECT GENET EVOL, V1, P207, DOI 10.1016/S1567-1348(02)00028-X; GODFREY DG, 1990, ADV PARASITOL, V29, P1; Goodhead I, 2013, MBIO, V4, DOI 10.1128/mBio.00197-13; Horn D, 1997, MOL BIOCHEM PARASIT, V84, P189, DOI 10.1016/S0166-6851(96)02794-6; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Jackson AP, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000658; Jannin J, 2004, CURR OPIN INFECT DIS, V17, P565, DOI 10.1097/00001432-200412000-00009; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; MacLeod A, 2001, PHILOS T R SOC B, V356, P1035, DOI 10.1098/rstb.2001.0892; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Nakamura K, 2010, PARASITOL INT, V59, P560, DOI 10.1016/j.parint.2010.07.006; Organization WH, UN COMB NEGL TROP DI; Rambaut A, 2007, FIGTREE GRAPHICAL VI; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Sistrom M, 2014, GENOME BIOL EVOL, V6, P2811, DOI 10.1093/gbe/evu222; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Uzureau P, 2013, NATURE, V501, P430, DOI 10.1038/nature12516; Xong HV, 1998, CELL, V95, P839, DOI 10.1016/S0092-8674(00)81706-7	48	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147660	10.1371/journal.pone.0147660	http://dx.doi.org/10.1371/journal.pone.0147660			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910229	Green Published, gold			2022-12-27	WOS:000371164700005
J	Ho, MF; Low, LM; Rose'Meyer, RB				Ho, Ming-Fen; Low, Leanne M.; Rose'Meyer, Roselyn B.			Pharmacology of the Adenosine A(3) Receptor in the Vasculature and Essential Hypertension	PLOS ONE			English	Article							A(2B) RECEPTORS; A(2A) RECEPTORS; SPLICE VARIANTS; BLOOD-PRESSURE; CORONARY FLOW; GROWTH; HEART; VASODILATION; INFLAMMATION; STIMULATION	Background Essential hypertension is considered to be a multifactorial disorder and its aetiology has yet to be clearly identified. As the adenosine receptors have a significant role in mediating vasodilation, alterations in their structures or signalling pathways may be involved in the development of hypertension. This study aimed to measure the expression of adenosine A(3) receptors in a range of cardiovascular tissues and determine whether they could be altered with essential hypertension, and to functionally test responses to adenosine A(3) receptor agonists in coronary blood vessels using the isolated perfused heart preparation. Methods mRNA samples from cardiovascular tissues and a range of blood vessels were collected from 10 week old male spontaneously hypertensive rats and age-gender matched Wistar rats (n = 8). The Langendorff heart perfusion preparation was used to characterise adenosine A(3) receptor mediated coronary vasodilation in the rat heart. Results Adenosine A(3) receptor agonists induced coronary vasodilation. The expression of adenosine A(3) receptors in cardiovascular tissues was altered in a tissue-specific pattern. Specifically, down-regulation of adenosine A(3) receptor expression occurred in hypertensive hearts, which might be associated with attenuated vasodilator responses observed in coronary vessels to adenosine A(3) receptor agonists. Conclusions This study demonstrated alterations in the expression of adenosine A(3) receptors occurred in a tissue specific mode, and reduced adenosine A(3) receptor mediated coronary vasodilation in hearts from spontaneously hypertensive rats. Our findings with regard to changes in the adenosine A(3) receptor in hypertensive hearts suggest that adenosine A(3) receptor might play a role in the physiopathology of essential hypertension and potentially open the way to pharmacologic manipulation of vasomotor activity by the use of adenosine A(3) receptor agonists.	[Ho, Ming-Fen; Low, Leanne M.; Rose'Meyer, Roselyn B.] Griffith Univ, Sch Med Sci, Heart Fdn Res Ctr, Gold Coast, Qld, Australia	Griffith University	Rose'Meyer, RB (corresponding author), Griffith Univ, Sch Med Sci, Heart Fdn Res Ctr, Gold Coast, Qld, Australia.	r.rosemeyer@griffith.edu.au	Low, Leanne/AAD-3310-2020; Low, Leanne/HGT-7958-2022	Low, Leanne/0000-0002-1976-3767; Low, Leanne/0000-0002-1976-3767	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS)	Griffith University International Postgraduate Research Scholarship (GUIPRS); Griffith University Postgraduate Research Scholarship (GUPRS)	This research is supported by a Griffith University International Postgraduate Research Scholarship (GUIPRS) and a Griffith University Postgraduate Research Scholarship (GUPRS).	Adair TH, 2005, AM J PHYSIOL-REG I, V289, pR283, DOI 10.1152/ajpregu.00840.2004; Auchampach JA, 2003, AM J PHYSIOL-HEART C, V285, DOI [10.1152/ajpheart.01001.02002, DOI 10.1152/AJPHEART.01001.02002]; AUTELITANO DJ, 1995, NEUROSCI LETT, V195, P1, DOI 10.1016/0304-3940(95)11756-M; Badyal D. K., 2003, Indian Journal of Pharmacology, V35, P349; CARRUTHERS AM, 1993, DRUG DEVELOP RES, V30, P147, DOI 10.1002/ddr.430300307; Chandrasekera PC, 2010, AM J PHYSIOL-HEART C, V299, pH2082, DOI 10.1152/ajpheart.00511.2010; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; CLUBB FJ, 1987, LAB INVEST, V56, P189; Cowley AW, 2006, NAT REV GENET, V7, P829, DOI 10.1038/nrg1967; Dankelman J, 1999, MED BIOL ENG COMPUT, V37, P742, DOI 10.1007/BF02513377; Dobson JG, 2008, AM J PHYSIOL-HEART C, V295, pH2364, DOI 10.1152/ajpheart.00927.2008; Dubey RK, 1997, CIRCULATION, V96, P2656, DOI 10.1161/01.CIR.96.8.2656; Feoktistov I, 1998, DRUG DEVELOP RES, V45, P198, DOI 10.1002/(SICI)1098-2299(199811/12)45:3/4<198::AID-DDR17>3.0.CO;2-#; Fresco P, 2004, CARDIOVASC RES, V63, P739, DOI 10.1016/j.cardiores.2004.05.015; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; HAYNES J, 1995, AM J PHYSIOL-HEART C, V268, pH1862; Ho MF, 2013, CURR VASC PHARMACOL, V11, P327, DOI 10.2174/1570161111311030007; Hove-Madsen L, 2006, CARDIOVASC RES, V72, P292, DOI 10.1016/j.cardiores.2006.07.020; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jenner TL, 2006, MECH AGEING DEV, V127, P264, DOI 10.1016/j.mad.2005.10.005; Kokubo M, 2005, HYPERTENS RES, V28, P601, DOI 10.1291/hypres.28.601; Kreth S, 2008, FASEB J, V22, P3276, DOI 10.1096/fj.07-101097; Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771; Lerman LO, 2005, J LAB CLIN MED, V146, P160, DOI 10.1016/j.lab.2005.05.005; LIANG BT, 1995, CIRC RES, V76, P242, DOI 10.1161/01.RES.76.2.242; Martin TC, 2008, W INDIAN MED J, V57, P337; Montecucco F, 2011, J NEPHROL, V24, P23, DOI 10.5301/JN.2010.4729; Nishat Shamama, 2012, Recent Pat Cardiovasc Drug Discov, V7, P59; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Okamoto K, 1966, Jpn Circ J, V30, P703; OKAMOTO KOZO, 1963, JAPAN CIRCULATION JOUR, V27, P282; Skrzypiec-Spring Monika, 2007, Journal of Pharmacological and Toxicological Methods, V55, P113, DOI 10.1016/j.vascn.2006.05.006; Sofola OA, 2002, J PHYSIOL-LONDON, V543, P255, DOI 10.1113/jphysiol.2002.022277; Tabrizchi R, 2001, PHARMACOL THERAPEUT, V91, P133, DOI 10.1016/S0163-7258(01)00152-8; TAPPARELLI C, 1993, TRENDS PHARMACOL SCI, V14, P366, DOI 10.1016/0165-6147(93)90095-2; Tawfik HE, 2005, AM J PHYSIOL-HEART C, V288, pH1411, DOI 10.1152/ajpheart.00684.2004; Wallen WJ, 2000, HYPERTENSION, V36, P774, DOI 10.1161/01.HYP.36.5.774; Willems L, 2007, PFLUG ARCH EUR J PHY, V453, P433, DOI 10.1007/s00424-006-0119-9; ZHOU QY, 1992, P NATL ACAD SCI USA, V89, P7432, DOI 10.1073/pnas.89.16.7432; Zucchi R, 2001, CARDIOVASC RES, V50, P56, DOI 10.1016/S0008-6363(00)00318-7	41	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150021	10.1371/journal.pone.0150021	http://dx.doi.org/10.1371/journal.pone.0150021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907173	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000029
J	Gutierrez-Heredia, L; Benzoni, F; Murphy, E; Reynaud, EG				Gutierrez-Heredia, Luis; Benzoni, Francesca; Murphy, Emma; Reynaud, Emmanuel G.			End to End Digitisation and Analysis of Three-Dimensional Coral Models, from Communities to Corallites	PLOS ONE			English	Article							SURFACE-AREAS; RECONSTRUCTION; PHOTOGRAMMETRY; DENSITY; FIELD	Coral reefs hosts nearly 25% of all marine species and provide food sources for half a billion people worldwide while only a very small percentage have been surveyed. Advances in technology and processing along with affordable underwater cameras and Internet availability gives us the possibility to provide tools and softwares to survey entire coral reefs. Holistic ecological analyses of corals require not only the community view (10s to 100s of meters), but also the single colony analysis as well as corallite identification. As corals are three-dimensional, classical approaches to determine percent cover and structural complexity across spatial scales are inefficient, time-consuming and limited to experts. Here we propose an end-to-end approach to estimate these parameters using low-cost equipment (GoPro, Canon) and freeware (123D Catch, Meshmixer and Netfabb), allowing every community to participate in surveys and monitoring of their coral ecosystem. We demonstrate our approach on 9 species of underwater colonies in ranging size and morphology. 3D models of underwater colonies, fresh samples and bleached skeletons with high quality texture mapping and detailed topographic morphology were produced, and Surface Area and Volume measurements (parameters widely used for ecological and coral health studies) were calculated and analysed. Moreover, we integrated collected sample models with micro-photogrammetry models of individual corallites to aid identification and colony and polyp scale analysis.	[Gutierrez-Heredia, Luis; Murphy, Emma; Reynaud, Emmanuel G.] Univ Coll Dublin, UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 2, Ireland; [Benzoni, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy	University College Dublin; University of Milano-Bicocca	Reynaud, EG (corresponding author), Univ Coll Dublin, UCD Sci Ctr, Sch Biol & Environm Sci, Dublin 2, Ireland.	emmanuel.reynaud@ucd.ie	Benzoni, Francesca/G-1304-2010; Reynaud, Emamnuel/H-2928-2019	Benzoni, Francesca/0000-0001-8906-1309; Reynaud, Emamnuel/0000-0003-1502-661X; Gutierrez Heredia, Luis/0000-0002-9380-8900	Consejo Nacional de Ciencia y Tecnologia, Mexico [215551]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Consejo Nacional de Ciencia y Tecnologia, Mexico, Abroad doctoral scholarship, ID: 215551, LGH, http://www.conacyt.mx/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo DA, 2006, J EXP MAR BIOL ECOL, V339, P120, DOI 10.1016/j.jembe.2006.07.015; Andono PN, 2012, INT CONF MULTIMED, P803, DOI 10.1109/ICMCS.2012.6320131; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Berquist RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034499; Brager S, 1999, PHOTOGRAMM REC, V16, P503, DOI 10.1111/0031-868X.00139; Brandou V., 2007, OCEANS 2007 - Europe, P1, DOI 10.1109/OCEANSE.2007.4302315; Bucher DJ, 1998, J EXP MAR BIOL ECOL, V228, P117, DOI 10.1016/S0022-0981(98)00020-3; Burns JHR, 2015, PEERJ, V3, DOI 10.7717/peerj.1077; Bythell JC, 2001, CORAL REEFS, V20, P193; Chindapol N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002849; Cocito S, 2003, J EXP MAR BIOL ECOL, V297, P57, DOI 10.1016/S0022-0981(03)00369-1; Courtney LA, 2007, J EXP MAR BIOL ECOL, V351, P234, DOI 10.1016/j.jembe.2007.06.021; Done T.J., 1982, Proceedings of the International Coral Reef Symposium, P315; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Faulwetter S, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.263.4261; Fisher WS, 2007, ENVIRON MONIT ASSESS, V125, P347, DOI 10.1007/s10661-006-9527-8; Gutierrez-Heredia L, 2015, LIMNOL OCEANOGR-METH, V13, P178, DOI 10.1002/lom3.10017; Harvey E, 1995, MAR TECHNOL SOC J, V29, P10; He H., 2012, P 12 INT COR REEF S, P1; Hogue A, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P5351, DOI 10.1109/IROS.2006.282097; Holmes G, 2008, J EXP MAR BIOL ECOL, V365, P67, DOI 10.1016/j.jembe.2008.07.045; HUGHES TP, 1987, MAR ECOL PROG SER, V35, P259, DOI 10.3354/meps035259; Jancosek M., 2011, 2011 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P3121, DOI 10.1109/CVPR.2011.5995693; Johnson-Roberson M, 2010, J FIELD ROBOT, V27, P21, DOI 10.1002/rob.20324; Jones AM, 2008, CORAL REEFS, V27, P521, DOI 10.1007/s00338-008-0354-y; Knudby A, 2007, PROG PHYS GEOG, V31, P421, DOI 10.1177/0309133307081292; Knudby A, 2013, REMOTE SENS-BASEL, V5, P1311, DOI 10.3390/rs5031311; Lavy A, 2015, METHODS ECOL EVOL, V6, P521, DOI 10.1111/2041-210X.12331; Leon JX, 2015, GEOMORPHOLOGY, V242, P21, DOI 10.1016/j.geomorph.2015.01.030; Maeder J, 2000, INT CORAL REEF S BAL, V2, P23; MCKINNON D, 2011, P OCEANS 2011 WAIK H, P1, DOI DOI 10.23919/OCEANS.2011.6106982; Mumby PJ, 1997, MAR BIOL, V130, P193, DOI 10.1007/s002270050238; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Nguyen CV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094346; NOAA, 2008, COR REEFS IMP PART O; Pennisi E, 1997, SCIENCE, V277, P491, DOI 10.1126/science.277.5325.491; Pittman Simon J., 2013, P145; Pizarro O, 2009, IEEE J OCEANIC ENG, V34, P150, DOI 10.1109/JOE.2009.2016071; Sedlazeck A, 2009, OCEANS 2009 EUROPE, P1, DOI DOI 10.1109/OCEANSE.2009.5278305; Shortis M.R., 1998, INT ARCH PHOTOGRAMM, V32, P792, DOI DOI 10.1017/CB09781107415324.004; Spalding M. D., 2001, WORLD ATLAS CORAL RE; Stone R, 2007, SCIENCE, V316, P678, DOI 10.1126/science.316.5825.678; Todd PA, 2001, RAFFLES B ZOOL, V49, P191; UNEP-WCMC, 2006, FRONT LIN SHOR PROT, P33; Veal CJ, 2010, LIMNOL OCEANOGR-METH, V8, P241, DOI 10.4319/lom.2010.8.241; Wilkinson C, 2008, STATUS CORAL REEFS W; Wu CC, 2013, 2013 INTERNATIONAL CONFERENCE ON 3D VISION (3DV 2013), P127, DOI 10.1109/3DV.2013.25	47	35	34	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149641	10.1371/journal.pone.0149641	http://dx.doi.org/10.1371/journal.pone.0149641			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901845	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100116
J	McCrary, J; Christensen, G; Fanelli, D				McCrary, Justin; Christensen, Garret; Fanelli, Daniele			Conservative Tests under Satisficing Models of Publication Bias	PLOS ONE			English	Article							EMPIRICAL-EVIDENCE; LIFE	Publication bias leads consumers of research to observe a selected sample of statistical estimates calculated by producers of research. We calculate critical values for statistical significance that could help to adjust after the fact for the distortions created by this selection effect, assuming that the only source of publication bias is file drawer bias. These adjusted critical values are easy to calculate and differ from unadjusted critical values by approximately 50%-rather than rejecting a null hypothesis when the t-ratio exceeds 2, the analysis suggests rejecting a null hypothesis when the t-ratio exceeds 3. Samples of published social science research indicate that on average, across research fields, approximately 30% of published t-statistics fall between the standard and adjusted cutoffs.	[McCrary, Justin] Univ Calif Berkeley, Sch Law, Boalt Hall, Berkeley, CA 94720 USA; [McCrary, Justin] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Christensen, Garret] Univ Calif Berkeley, BITSS, Berkeley, CA 94720 USA; [Christensen, Garret] Univ Calif Berkeley, BIDS, Berkeley, CA 94720 USA; [Fanelli, Daniele] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA	University of California System; University of California Berkeley; National Bureau of Economic Research; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Christensen, G (corresponding author), Univ Calif Berkeley, BITSS, Berkeley, CA 94720 USA.; Christensen, G (corresponding author), Univ Calif Berkeley, BIDS, Berkeley, CA 94720 USA.	garret@berkeley.edu		Christensen, Garret/0000-0003-2558-1609; Fanelli, Daniele/0000-0003-1780-1958				Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Ashenfelter O, 2004, AM ECON REV, V94, P454, DOI 10.1257/0002828041301984; Ashnfelter O., 1999, LABOUR ECON, V6, P453, DOI DOI 10.1016/S0927-5371(99)00041-X; Auspurg K, 2014, KOLNER Z SOZIOL SOZ, V66, P549, DOI 10.1007/s11577-014-0284-3; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Brodeur A, 2016, AM ECON J-APPL ECON, V8, P1, DOI 10.1257/app.20150044; CARD D, 1995, AM ECON REV, V85, P238; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Conley TG, 2011, REV ECON STAT, V93, P113, DOI 10.1162/REST_a_00049; COOLEY TF, 1981, AM ECON REV, V71, P825; De Angelis CD, 2005, NEW ENGL J MED, V352, P2436, DOI 10.1056/NEJMe058127; DELONG JB, 1992, J POLIT ECON, V100, P1257, DOI 10.1086/261860; DENTON FT, 1985, REV ECON STAT, V67, P124, DOI 10.2307/1928442; Donohue JJ, 2005, STANFORD LAW REV, V58, P791; FELLER W, 1948, ANN MATH STAT, V19, P177, DOI 10.1214/aoms/1177730243; Francis G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114255; Francis G, 2014, PSYCHON B REV, V21, P1180, DOI 10.3758/s13423-014-0601-x; Franco A, 2014, SCIENCE, V345, P1502, DOI 10.1126/science.1255484; Gerber A, 2008, Q J POLIT SCI, V3, P313, DOI 10.1561/100.00008024; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; Gerber AS, 2010, AM POLIT RES, V38, P591, DOI 10.1177/1532673X09350979; GERBER AS, 2001, POLIT ANAL, V0009; Goldberger A.S., 1991, COURSE ECONOMETRICS; Harvey CR, 2015, THE REVIEW OF FINANC; Hedges LV, 1998, STAT SCI, V3, P118, DOI [10.1214/ss/1177013013, DOI 10.1214/SS/1177013013]; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Iyengar S., 1988, STAT SCI, V3, P133, DOI [10.1214/ss/1177013019, DOI 10.1214/SS/1177013019]; Iyengar S., 1988, STAT SCI, V3, P109, DOI DOI 10.1214/SS/1177013012; Krawczyk M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127872; Leamer E. E., 1978, SPECIFICATION SEARCH; Leamer EE, 1983, HDB ECONOMETRICS, V1, P285, DOI DOI 10.1016/S1573-4412(83)01009-0; Leggett NC, 2013, Q J EXP PSYCHOL, V66, P2303, DOI 10.1080/17470218.2013.863371; LOVELL MC, 1983, REV ECON STAT, V65, P1, DOI 10.2307/1924403; MOULTON BR, 1990, REV ECON STAT, V72, P334, DOI 10.2307/2109724; National Institutes of Health, 2014, HHS AND NIH TAKE STE; Nosek BA, 2012, PERSPECT PSYCHOL SCI, V7, P615, DOI 10.1177/1745691612459058; Peters JL, 2010, J R STAT SOC A STAT, V173, P575, DOI 10.1111/j.1467-985X.2009.00629.x; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Ridley J, 2007, J EVOLUTION BIOL, V20, P1082, DOI 10.1111/j.1420-9101.2006.01291.x; Rose AK, 2005, J ECON SURV, V19, P347, DOI 10.1111/j.0950-0804.2005.00251.x; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosenthal R., 1988, STAT SCI, V3, P120, DOI DOI 10.1214/SS/1177013014; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simonsohn U, 2014, J EXP PSYCHOL GEN, V143, P534, DOI 10.1037/a0033242; SMIRNOV N, 1948, ANN MATH STAT, V19, P279, DOI 10.1214/aoms/1177730256; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; Sullivan R, 1999, J FINANC, V54, P1647, DOI 10.1111/0022-1082.00163; Sullivan R, 2001, J ECONOMETRICS, V105, P249, DOI 10.1016/S0304-4076(01)00077-X; Timmermann A, 2006, THE BLACKWELL ENCYCL, V4, P35; White H, 2000, ECONOMETRICA, V68, P1097, DOI 10.1111/1468-0262.00152	52	9	9	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149590	10.1371/journal.pone.0149590	http://dx.doi.org/10.1371/journal.pone.0149590			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901834	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100106
J	Rachlis, B; Naanyu, V; Wachira, J; Genberg, B; Koech, B; Kamene, R; Akinyi, J; Braitstein, P				Rachlis, Beth; Naanyu, Violet; Wachira, Juddy; Genberg, Becky; Koech, Beatrice; Kamene, Regina; Akinyi, Jackie; Braitstein, Paula			Community Perceptions of Community Health Workers (CHWs) and Their Roles in Management for HIV, Tuberculosis and Hypertension in Western Kenya	PLOS ONE			English	Article							CARE	Given shortages of health care providers and a rise in the number of people living with both communicable and non-communicable diseases, Community Health Workers (CHWs) are increasingly incorporated into health care programs. We sought to explore community perceptions of CHWs including perceptions of their roles in chronic disease management as part of the Academic Model Providing Access to Healthcare Program (AMPATH) in western Kenya. In depth interviews and focus group discussions were conducted between July 2012 and August 2013. Study participants were purposively sampled from three AMPATH sites: Chulaimbo, Teso and Turbo, and included patients within the AMPATH program receiving HIV, tuberculosis (TB), and hypertension (HTN) care, as well as caregivers of children with HIV, community leaders, and health care workers. Participants were asked to describe their perceptions of AMPATH CHWs, including identifying the various roles they play in engagement in care for chronic diseases including HIV, TB and HTN. Data was coded and various themes were identified. We organized the concepts and themes generated using the Andersen-Newman Framework of Health Services Utilization and considering CHWs as a potential enabling resource. A total of 207 participants including 110 individuals living with HIV (n = 50), TB (n = 39), or HTN (n = 21); 24 caregivers; 10 community leaders; and 34 healthcare providers participated. Participants identified several roles for CHWs including promoting primary care, encouraging testing, providing education and facilitating engagement in care. While various facilitating aspects of CHWs were uncovered, several barriers of CHWcare were raised, including issues with training and confidentiality. Suggested resources to help CHWs improve their services were also described. Our findings suggest that CHWs can act as catalysts and role models by empowering members of their communities with increased knowledge and support.	[Rachlis, Beth; Naanyu, Violet; Wachira, Juddy; Koech, Beatrice; Kamene, Regina; Akinyi, Jackie; Braitstein, Paula] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Rachlis, Beth; Braitstein, Paula] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rachlis, Beth] Ontario HIV Treatment Network, Toronto, ON, Canada; [Naanyu, Violet] Moi Univ, Coll Hlth Sci, Sch Med, Dept Behav Sci, Eldoret, Kenya; [Genberg, Becky] Brown Univ, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA; [Braitstein, Paula] Moi Univ, Coll Hlth Sci, Sch Med, Dept Med, Eldoret, Kenya	University of Toronto; Moi University; Brown University; Moi University	Rachlis, B (corresponding author), Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya.; Rachlis, B (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.; Rachlis, B (corresponding author), Ontario HIV Treatment Network, Toronto, ON, Canada.	brachlis@gmail.com	Naanyu, Violet/GNM-8783-2022; Naanyu, Violet/AAL-6106-2020	Naanyu, Violet/0000-0003-0182-1719; Naanyu, Violet/0000-0003-0182-1719; Genberg, Becky/0000-0002-9450-5311	Presidents Emergency Plan for AIDS Relief (PEPFAR) through USAID [AID-623-A-12-0001]; United States Agency for International Development (USAID); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060478] Funding Source: NIH RePORTER	Presidents Emergency Plan for AIDS Relief (PEPFAR) through USAID(United States Agency for International Development (USAID)); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research has been supported by the Presidents Emergency Plan for AIDS Relief (PEPFAR) through USAID under the terms of Cooperative Agreement No. AID-623-A-12-0001. It is made possible through joint support of the United States Agency for International Development (USAID). The contents of this research project are the sole responsibility of AMPATH and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afulani PA, 2012, HEALTH EDUC RES, V27, P1005, DOI 10.1093/her/cys083; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2008, WHO REP 2008 PRIM HL; Bangsberg DR, 2003, AIDS, V17, P1925, DOI 10.1097/00002030-200309050-00011; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Bloomfield GS, 2011, AM HEART J, V161, P842, DOI 10.1016/j.ahj.2010.12.020; Bott S, 2014, HLTH POLICY IN PRESS; Chalker John, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P193, DOI 10.1177/1545109708320687; Daniel OJ, 2006, NIGERIAN J MED, V15, P64; De Lima YV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049140; de-Graft Aikins Ama, 2010, Global Health, V6, P6, DOI 10.1186/1744-8603-6-6; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Government of Kenya Ministry of Health Health Sector Reform Secretariat, 2010, REV TRENDS NAT HLTH; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hensen B, 2014, AIDS IN PRESS; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jerome G, 2010, AIDS, V24, pS67, DOI 10.1097/01.aids.0000366084.75945.c9; Joint United Nations Programme on HIV/AIDS, 2013, GLOB FACTS FIG GLOB; Kimaiyo S, 2010, East Afr Med J, V87, P100; Liu A, 2011, MT SINAI J MED, V78, P419, DOI 10.1002/msj.20260; Maddison Andre R, 2010, Can J Infect Dis Med Microbiol, V21, pe64; MAMLIN J, 2004, PERSPECTIVES PRACTIC; Mathenge W, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-569; McCollum R, 2015, HLTH POLICY IN PRESS; Mireku M., 2014, CONTEXT ANAL CLOSE C; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Mwai GW, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18586; National AIDS/STD Control Programme Ministry of Health Kenya, 2008, IMPL FRAM HOM COMM B; Ndou T, 2013, GLOBAL HEALTH ACTION, V6, P213, DOI 10.3402/gha.v6i0.19228; Nyamogoba HDN, 2012, AFR HEALTH SCI, V12, P305, DOI 10.4314/ahs.v12i3.9; Ochieng BM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S4; Oliver M, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.27168; Pastakia SD, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-21; Perez F, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-28; Rachlis B, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.20548; Republic of Kenya Ministry of Health, 2006, TAK KEN ESS PACK HLT; Sander LD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/1478-4491-13-6; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Tuturu, 2020, COMM CONS HLTH ED; *WHO, 2005, MILL DEV GOALS HLTH; [WHO Global Health Workforce Alliance], 2008, SCAL SAV LIV TASK FO; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, TAK STOCK HLTH WORK; World Health Organization, 2019, GLOB TUB REP; World Health Organization, 2010, DAILY ITTEFAQ; World Health Organization, 2003, SCAL ANT THER RES LT; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Wouters E, 2009, AIDS PATIENT CARE ST, V23, P357, DOI 10.1089/apc.2008.0201; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; Zulliger R, 2014, AIDS CARE, V26, P626, DOI 10.1080/09540121.2013.841839	51	49	50	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149412	10.1371/journal.pone.0149412	http://dx.doi.org/10.1371/journal.pone.0149412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901854	Green Published, gold			2022-12-27	WOS:000371276100072
J	Baumbach, J; Pudake, RN; Johnson, C; Kleinhans, K; Ollhoff, A; Palmer, RG; Bhattacharyya, MK; Sandhu, D				Baumbach, Jordan; Pudake, Ramesh N.; Johnson, Callie; Kleinhans, Kaylin; Ollhoff, Alexandrea; Palmer, Reid G.; Bhattacharyya, Madan K.; Sandhu, Devinder			Transposon Tagging of a Male-Sterility, Female-Sterility Gene, St8, Revealed that the Meiotic MER3 DNA Helicase Activity Is Essential for Fertility in Soybean	PLOS ONE			English	Article							ANTHOCYANIN PIGMENTATION; UNSTABLE MUTATION; ALIGNMENT; MUTANTS; EXPRESSION; SYNAPSIS; EXCISION; IMPROPER; ELEMENT	The W4 locus in soybean encodes a dihydroflavonol-4-reductase (DFR2) that regulates pigmentation patterns in flowers and hypocotyl. The mutable w4-m allele that governs variegated flowers has arisen through insertion of a CACTA-type transposable element, Tgm9, in DFR2. In the w4-m line, reversion from variegated to purple flower indicates excision of Tgm9, and its insertion at a new locus. Previously, we have identified a male-sterile, female-sterile mutant among the selfed progenies of a revertant plant carrying only purple flowers. Co-segregation between Tgm9 and the sterility phenotype suggested that the mutant was generated by insertion of Tgm9 at the St8 locus. The transposon was localized to exon 10 of Glyma. 16G072300 that shows high identity to the MER3 DNA helicase involved in crossing over. Molecular analysis of fertile branches from two independent revertant plants confirmed precise excision of Tgm9 from the st8 allele, which restored fertility. In soybean, the gene is expressed in flower-buds, trifoliate leaves and stem. Phylogenetic analysis placed St8 in a clade with the Arabidopsis and rice MER3 suggesting that St8 is most likely the orthologous MER3 soybean gene. This study established the utility of Tgm9 in gene identification as well as in forward and reverse genetics studies.	[Baumbach, Jordan; Johnson, Callie; Kleinhans, Kaylin; Ollhoff, Alexandrea; Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Baumbach, Jordan; Pudake, Ramesh N.; Palmer, Reid G.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Sandhu, Devinder] USDA ARS, Salin Lab, 450 W Big Springs Rd, Riverside, CA 92507 USA; [Pudake, Ramesh N.] Amity Univ Uttar Pradesh, Amity Inst Nanotechnol, Noida 201303, UP, India	University of Wisconsin System; University of Wisconsin Stevens Point; Iowa State University; United States Department of Agriculture (USDA); Amity University Noida	Sandhu, D (corresponding author), Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA.; Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.; Sandhu, D (corresponding author), USDA ARS, Salin Lab, 450 W Big Springs Rd, Riverside, CA 92507 USA.	mbhattac@iastate.edu; devinder.sandhu@ars.usda.gov	Pudake, Ramesh Namdeo/F-1979-2015	Pudake, Ramesh Namdeo/0000-0003-0124-8537; Sandhu, Devinder/0000-0003-4193-3408	University of Wisconsin Stevens Point University Personnel Development Committee Funds; University of Wisconsin Stevens Point Student Research Funds; UWSP University Personnel Development Committee Funds; UWSP Student Research Funds	University of Wisconsin Stevens Point University Personnel Development Committee Funds; University of Wisconsin Stevens Point Student Research Funds; UWSP University Personnel Development Committee Funds; UWSP Student Research Funds	Devinder Sandhu was supported by University of Wisconsin Stevens Point University Personnel Development Committee Funds. Callie Johnson was supported by University of Wisconsin Stevens Point Student Research Funds.; This research project was supported by the UWSP University Personnel Development Committee Funds and UWSP Student Research Funds.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Chen CB, 2005, PLANT J, V43, P321, DOI 10.1111/j.1365-313X.2005.02461.x; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Franklin AE, 2003, CHROMOSOMA, V112, P17, DOI 10.1007/s00412-003-0242-8; FREY M, 1990, EMBO J, V9, P4037, DOI 10.1002/j.1460-2075.1990.tb07625.x; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Golubovskaya IN, 2011, J EXP BOT, V62, P1533, DOI 10.1093/jxb/erq292; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; GROOSE RW, 1990, THEOR APPL GENET, V79, P161, DOI 10.1007/BF00225946; GROOSE RW, 1988, J HERED, V79, P263, DOI 10.1093/oxfordjournals.jhered.a110507; Guiraldelli MF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003383; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; JOHNS C W, 1981, Nucleus (Calcutta), V24, P97; Kato KK, 2004, THEOR APPL GENET, V108, P577, DOI 10.1007/s00122-003-1482-y; Kato KK, 2003, J HERED, V94, P425, DOI 10.1093/jhered/esg085; Kaul, 1988, MALE STERILITY HIGHE; Kunze R, 1997, ADV BOT RES, V27, P331; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Nakagawa T, 2002, J BIOL CHEM, V277, P28019, DOI 10.1074/jbc.M204165200; Nakagawa T, 2002, MOL CELL BIOL, V22, P3281, DOI 10.1128/MCB.22.10.3281-3291.2002; Nakagawa T, 2001, J BIOL CHEM, V276, P31487, DOI 10.1074/jbc.M104003200; Palmer RG, 2008, THEOR APPL GENET, V117, P711, DOI 10.1007/s00122-008-0812-5; Palmer RG, 2008, GENOME, V51, P243, DOI 10.1139/G08-001; Palmer RG, 2000, J HERED, V91, P378, DOI 10.1093/jhered/91.5.378; Palmer RG, 2004, CROP SCI, V44, P2282, DOI 10.2135/cropsci2004.2282; PALMER RG, 1989, DEV GENET, V10, P542, DOI 10.1002/dvg.1020100613; Palmer RG., 2004, SOYBEANS IMPROVEMENT, P137, DOI DOI 10.2134/AGRONMONOGR16.3ED.C5; Raval J, 2013, FUNCT INTEGR GENOMIC, V13, P67, DOI 10.1007/s10142-012-0304-1; RHODES PR, 1988, GENETICS, V120, P597; Ross KJ, 1997, CHROMOSOME RES, V5, P551, DOI 10.1023/A:1018497804129; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sekhon RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061005; Severin AJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-160; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wang KJ, 2009, J CELL SCI, V122, P2055, DOI 10.1242/jcs.049080; Xu M, 2010, GENETICS, V184, P53, DOI 10.1534/genetics.109.107904; Zabala G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-124; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	39	8	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150482	10.1371/journal.pone.0150482	http://dx.doi.org/10.1371/journal.pone.0150482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930200	gold, Green Submitted, Green Published			2022-12-27	WOS:000371434500155
J	Murali, K; Kang, DY; Nazari, H; Scianmarello, N; Cadenas, E; Tai, YC; Kashani, A; Humayun, M				Murali, Karthik; Kang, Dongyang; Nazari, Hossein; Scianmarello, Nicholas; Cadenas, Enrique; Tai, Yu-Chong; Kashani, Amir; Humayun, Mark			Spatial Variations in Vitreous Oxygen Consumption	PLOS ONE			English	Article							ASCORBIC-ACID; EYE; DETACHMENT; TRANSPORT; KINETICS; TENSION; RETINA; RAT	We investigated the spatial variation of vitreous oxygen consumption in enucleated porcine eyes. A custom made oxygen source was fabricated that could be localized to either the mid or posterior vitreous cavity and steady state vitreous oxygen tension was measured as a function of distance from the source using a commercially available probe. The reaction rate constant of ascorbate oxidation was estimated ex vivo by measuring the change in oxygen tension over time using vitreous harvested from porcine eyes. Vitreous ascorbate from mid and posterior vitreous was measured spectrophotometrically. When the oxygen source was placed in either the mid-vitreous (N = 6) or the posterior vitreous (N = 6), we measured a statistically significant decrease in vitreous oxygen tension as a function of distance from the oxygen source when compared to control experiments without an oxygen source; (p<0.005 for mid-vitreous and p<0.018 for posterior vitreous at all distances). The mid-vitreous oxygen tension change was significantly different from the posterior vitreous oxygen tension change at 2 and 3mm distances from the respective oxygen source (p<0.001). We also found a statistically significant lower concentration of ascorbate in the mid-vitreous as compared to posterior vitreous (p = 0.02). We determined the reaction rate constant, k = 1.61 M(-1)s(-1) +/- 0.708 M(-1)s(-1) (SE), of the oxidation of ascorbate which was modeled following a second order rate equation. Our data demonstrates that vitreous oxygen consumption is higher in the posterior vitreous compared to the mid-vitreous. We also show spatial variations in vitreous ascorbate concentration.	[Murali, Karthik; Humayun, Mark] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Nazari, Hossein; Kashani, Amir] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA; [Cadenas, Enrique] Univ So Calif, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA USA; [Kang, Dongyang; Scianmarello, Nicholas; Tai, Yu-Chong] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Kashani, Amir; Humayun, Mark] Univ So Calif, Inst Eye, Los Angeles, CA USA; [Kashani, Amir; Humayun, Mark] Univ So Calif, Inst Biomed Therapeut, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; California Institute of Technology; University of Southern California; University of Southern California	Murali, K (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.; Kashani, A (corresponding author), Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA.; Kashani, A (corresponding author), Univ So Calif, Inst Eye, Los Angeles, CA USA.; Kashani, A (corresponding author), Univ So Calif, Inst Biomed Therapeut, Los Angeles, CA USA.	karthikm@usc.edu; ahkashan@med.usc.edu	Nazari, Hossein/GOK-8161-2022	Nazari, Hossein/0000-0002-8945-9680	National Institutes of Health; Whittier Foundation; Harrington Foundation; USC Eye Institute; Institute of Biomedical Therapeutics; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [R01EY022059] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whittier Foundation; Harrington Foundation; USC Eye Institute; Institute of Biomedical Therapeutics; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to thank the National Institutes of Health, Whittier Foundation, Harrington Foundation, USC Eye Institute, Institute of Biomedical Therapeutics, and the Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah W, 2011, INVEST OPHTH VIS SCI, V52, P1035, DOI 10.1167/iovs.09-4516; Beebe DC, 2014, JPN J OPHTHALMOL, V58, P225, DOI 10.1007/s10384-014-0318-4; Behndig A, 1998, INVEST OPHTH VIS SCI, V39, P471; CABELLI DE, 1983, J PHYS CHEM-US, V87, P1809, DOI 10.1021/j100233a031; DIMATTIO J, 1989, INVEST OPHTH VIS SCI, V30, P2320; EATON JW, 1991, FREE RADICAL BIO MED, V11, P207, DOI 10.1016/0891-5849(91)90173-Z; EISONPERCHONOK MH, 1982, J FOOD SCI, V47, P765, DOI 10.1111/j.1365-2621.1982.tb12710.x; ERNEST JT, 1979, INVEST OPHTH VIS SCI, V18, P1025; Filas BA, 2013, INVEST OPHTH VIS SCI, V54, P6549, DOI 10.1167/iovs.13-12609; FOULDS WS, 1987, EYE-T OPHTH SOC UK, V1, P641, DOI 10.1038/eye.1987.107; Johnson SW, 1936, BIOCHEM J, V30, P1430, DOI 10.1042/bj0301430; Kang DY, 2015, PROC IEEE MICR ELECT, P154, DOI 10.1109/MEMSYS.2015.7050909; Locci E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097773; Padh H, 1991, NUTR REV; Quiram PA, 2007, RETINA-J RET VIT DIS, V27, P1090, DOI 10.1097/IAE.0b013e3180654229; Rose RC, 1998, P SOC EXP BIOL MED, V217, P397, DOI 10.3181/00379727-217-44250; ROSE RC, 1991, COMP BIOCHEM PHYS A, V100, P273, DOI 10.1016/0300-9629(91)90470-W; SAKAUE H, 1989, INVEST OPHTH VIS SCI, V30, P1933; Salceda R, 2007, COMP BIOCHEM PHYS C, V146, P175, DOI 10.1016/j.cbpc.2007.02.015; SEBAG J, 1987, EYE, V1, P254, DOI 10.1038/eye.1987.45; Shui YB, 2006, INVEST OPHTH VIS SCI, V47, P1571, DOI 10.1167/iovs.05-1475; Shui YB, 2009, ARCH OPHTHALMOL-CHIC, V127, P475, DOI 10.1001/archophthalmol.2008.621; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Silverblatt E, 1943, J AM CHEM SOC, V65, P137, DOI 10.1021/ja01242a002; Skeie JM, 2011, JOVE-J VIS EXP, DOI 10.3791/2455; Stefansson E, 2006, ACTA OPHTHALMOL SCAN, V84, P718, DOI 10.1111/j.1600-0420.2006.00778.x; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Wangsa-Wirawan ND, 2003, ARCH OPHTHALMOL-CHIC, V121, P547, DOI 10.1001/archopht.121.4.547; Yu DY, 2001, PROG RETIN EYE RES, V20, P175, DOI 10.1016/S1350-9462(00)00027-6	30	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149961	10.1371/journal.pone.0149961	http://dx.doi.org/10.1371/journal.pone.0149961			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930281	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500079
J	Lengowski, MB; Zuber, KHR; Witzig, M; Mohring, J; Boguhn, J; Rodehutscord, M				Lengowski, Melanie B.; Zuber, Karin H. R.; Witzig, Maren; Moehring, Jens; Boguhn, Jeannette; Rodehutscord, Markus			Changes in Rumen Microbial Community Composition during Adaption to an In Vitro System and the Impact of Different Forages	PLOS ONE			English	Article							REAL-TIME PCR; PROTEIN-SYNTHESIS; RUMINAL FERMENTATION; DAIRY-COWS; BACTERIAL COMMUNITIES; VARIABLE COMPOSITION; CONTINUOUS-CULTURE; RUSITEC; DIGESTIBILITY; POPULATIONS	This study examined ruminal microbial community composition alterations during initial adaption to and following incubation in a rumen simulation system (Rusitec) using grass or corn silage as substrates. Samples were collected from fermenter liquids at 0, 2, 4, 12, 24, and 48 h and from feed residues at 0, 24, and 48 h after initiation of incubation (period 1) and on day 13 (period 2). Microbial DNA was extracted and real-time qPCR was used to quantify differences in the abundance of protozoa, methanogens, total bacteria, Fibrobacter succinogenes, Ruminococcus albus, Ruminobacter amylophilus, Prevotella bryantii, Selenomonas ruminantium, and Clostridium aminophilum. We found that forage source and sampling time significantly influenced the ruminal microbial community. The gene copy numbers of most microbial species (except C. aminophilum) decreased in period 1; however, adaption continued through period 2 for several species. The addition of fresh substrate in period 2 led to increasing copy numbers of all microbial species during the first 2-4 h in the fermenter liquid except protozoa, which showed a postprandial decrease. Corn silage enhanced the growth of R. amylophilus and F. succinogenes, and grass silage enhanced R. albus, P. bryantii, and C. aminophilum. No effect of forage source was detected on total bacteria, protozoa, S. ruminantium, or methanogens or on total gas production, although grass silage enhanced methane production. This study showed that the Rusitec provides a stable system after an adaption phase that should last longer than 48 h, and that the forage source influenced several microbial species.	[Lengowski, Melanie B.; Zuber, Karin H. R.; Witzig, Maren; Boguhn, Jeannette; Rodehutscord, Markus] Univ Hohenheim, Inst Nutztierwissensch, Baden, Switzerland; [Moehring, Jens] Univ Hohenheim, Inst Kulturpflanzenwissensch, Fachgebiet Biostat, Baden, Switzerland		Witzig, M (corresponding author), Univ Hohenheim, Inst Nutztierwissensch, Baden, Switzerland.	inst450@uni-hohenheim.de		Rodehutscord, Markus/0000-0003-3156-7889	Deutsche Forschungsgemeinschaft [BO2960/1-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft, Grant no. BO2960/1-2, Grant recipient: Jeannette Boguhn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE M, 1973, J ANIM SCI, V36, P941; AKIN DE, 1989, AGRON J, V81, P17, DOI 10.2134/agronj1989.00021962008100010004x; Belanche A, 2013, ANIM PROD SCI, V53, P1052, DOI 10.1071/AN12183; Belanche A, 2012, J NUTR, V142, P1684, DOI 10.3945/jn.112.159574; Boguhn J, 2006, J DAIRY SCI, V89, P1580, DOI 10.3168/jds.S0022-0302(06)72225-1; Boguhn J, 2010, ANIMAL, V4, P30, DOI 10. 1017/ S1751731109990735; Boguhn J, 2012, J ANIM PHYSL ANIM NU; BRANDT M, 1981, Z TIERPHYSIOL TIERER, V46, P39; Brask M, 2013, ANIM FEED SCI TECH, V184, P67, DOI 10.1016/j.anifeedsci.2013.06.006; Carro MD, 1999, BRIT J NUTR, V82, P149, DOI 10.1017/S0007114599001300; COTTA MA, 1992, APPL ENVIRON MICROB, V58, P48, DOI 10.1128/AEM.58.1.48-54.1992; COTTA MA, 1988, APPL ENVIRON MICROB, V54, P772, DOI 10.1128/AEM.54.3.772-776.1988; CRAIG WM, 1987, J NUTR, V117, P56, DOI 10.1093/jn/117.1.56; CZERKAWSKI JW, 1977, BRIT J NUTR, V38, P371, DOI 10.1079/BJN19770102; Denman SE, 2007, FEMS MICROBIOL ECOL, V62, P313, DOI 10.1111/j.1574-6941.2007.00394.x; Dewhurst RJ, 2001, J DAIRY SCI, V84, P2721, DOI 10.3168/jds.S0022-0302(01)74726-1; Geissler C., 1976, Archiv fur Tierernahrung, V26, P123; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Givens DI, 2004, ANIM FEED SCI TECH, V114, P1, DOI 10.1016/j.anifeedsci.2003.09.005; Griswold KE, 1996, J ANIM SCI, V74, P483; Hildebrand B, 2011, ANIMAL, V5, P537, DOI 10.1017/S1751731110002156; Hildebrand B, 2011, ANIMAL, V5, P528, DOI 10.1017/S1751731110002211; Hildebrand B, 2011, ARCH ANIM NUTR, V65, P402, DOI 10.1080/1745039X.2011.609751; Hristov AN, 2012, J DAIRY SCI, V95, P5299, DOI 10.3168/jds.2012-5533; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Jouany JP, 1996, J NUTR, V126, pS1335, DOI 10.1093/jn/126.suppl_4.1335S; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Kong YH, 2010, FEMS MICROBIOL ECOL, V74, P612, DOI 10.1111/j.1574-6941.2010.00977.x; Krause DO, 1996, APPL ENVIRON MICROB, V62, P815, DOI 10.1128/AEM.62.3.815-821.1996; Lee C, 2008, APPL MICROBIOL BIOT, V78, P371, DOI 10.1007/s00253-007-1300-6; Lee MRF, 2011, GRASS FORAGE SCI, V66, P196, DOI 10.1111/j.1365-2494.2010.00775.x; Lettat A, 2013, J DAIRY SCI, V96, P5237, DOI 10.3168/jds.2012-6481; Martinez ME, 2010, J DAIRY SCI, V93, P3699, DOI 10.3168/jds.2009-2934; Martinez ME, 2010, J DAIRY SCI, V93, P3684, DOI 10.3168/jds.2009-2933; MCDOUGALL EI, 1948, BIOCHEM J, V43, P99, DOI 10.1042/bj0430099; Morgavi DP, 2010, ANIMAL, V4, P1024, DOI 10.1017/S1751731110000546; Morgavi DP, 2012, BRIT J NUTR, V107, P388, DOI 10.1017/S0007114511002935; Muetzel S, 2009, ANIM FEED SCI TECHNO, V151, P32; PASTER BJ, 1993, INT J SYST BACTERIOL, V43, P107, DOI 10.1099/00207713-43-1-107; PATTERSON HD, 1997, STAT METHODS PLANT V, P139, DOI DOI 10.1007/978-94-009-1503-9_9; Popova M, 2010, FOLIA MICROBIOL, V55, P368, DOI 10.1007/s12223-010-0060-3; POTTER EL, 1973, APPL MICROBIOL, V26, P692, DOI 10.1128/AEM.26.5.692-698.1973; Ranilla MJ, 2011, EVOLUTION FERMENTATI; RUSSELL JB, 1985, APPL ENVIRON MICROB, V49, P572, DOI 10.1128/AEM.49.3.572-576.1985; Soliva CR, 2004, ANAEROBE, V10, P269, DOI 10.1016/j.anaerobe.2004.06.003; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Stewart CS., 1997, RUMEN MICROBIAL ECOS, P10, DOI [10.1007/978-94-009-1453-7_2, DOI 10.1007/978-94-009-1453-7_2]; SUEN G, 2011, PLOS ONE, V6; Sylvester JT, 2004, J NUTR, V134, P3378, DOI 10.1093/jn/134.12.3378; Valdez R. E., 1977, Tropical Animal Production, V2, P260; VDLUFA, 2006, CHEM UNTERSUCHUNG FU, VIII; Welkie DG, 2010, ANAEROBE, V16, P94, DOI 10.1016/j.anaerobe.2009.07.002; Williams G, 1997, RUMEN MICROBIAL ECOS, P73; Wischer G, 2013, ANIMAL, V7, P1796, DOI 10.1017/S1751731113001481; Wischer G, 2013, ARCH ANIM NUTR, V67, P219, DOI 10.1080/1745039X.2013.793050; Witzig M, 2010, ANAEROBE, V16, P412, DOI 10.1016/j.anaerobe.2010.05.002; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Ziemer CJ, 2000, ENVIRON MICROBIOL, V2, P632, DOI 10.1046/j.1462-2920.2000.00146.x	58	34	34	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150115	10.1371/journal.pone.0150115	http://dx.doi.org/10.1371/journal.pone.0150115			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928330	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200022
J	Yamanaka, K; Kakuta, Y; Miyagawa, S; Nakazawa, S; Kato, T; Abe, T; Imamura, R; Okumi, M; Maeda, A; Okuyama, H; Mizuno, M; Nonomura, N				Yamanaka, Kazuaki; Kakuta, Yoichi; Miyagawa, Shuji; Nakazawa, Shigeaki; Kato, Taigo; Abe, Toyofumi; Imamura, Ryoichi; Okumi, Masayoshi; Maeda, Akira; Okuyama, Hiroomi; Mizuno, Masashi; Nonomura, Norio			Depression of Complement Regulatory Factors in Rat and Human Renal Grafts Is Associated with the Progress of Acute T-Cell Mediated Rejection	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; LOCALLY PRODUCED COMPLEMENT; C3 GENE-EXPRESSION; FACTOR-B GENE; ALLOGRAFT-REJECTION; ISCHEMIA-REPERFUSION; TRANSPLANT REJECTION; EPITHELIAL-CELLS; IFN-GAMMA	Background The association of complement with the progression of acute T cell mediated rejection (ATCMR) is not well understood. We investigated the production of complement components and the expression of complement regulatory proteins (Cregs) in acute T-cell mediated rejection using rat and human renal allografts. Methods We prepared rat allograft and syngeneic graft models of renal transplantation. The expression of Complement components and Cregs was assessed in the rat grafts using quantitative real-time PCR (qRT-PCR) and immunofluorescent staining. We also administered antiCrry and anti-CD59 antibodies to the rat allograft model. Further, we assessed the relationship between the expression of membrane cofactor protein (MCP) by immunohistochemical staining in human renal grafts and their clinical course. Results qRT-PCR results showed that the expression of Cregs, CD59 and rodent-specific complement regulator complement receptor 1-related gene/protein-y (Crry), was diminished in the rat allograft model especially on day 5 after transplantation in comparison with the syngeneic model. In contrast, the expression of complement components and receptors: C3, C3a receptor, C5a receptor, Factor B, C9, C1q, was increased, but not the expression of C4 and C5, indicating a possible activation of the alternative pathway. When anti-Crry and anti-CD59 mAbs were administered to the allograft, the survival period for each group was shortened. In the human ATCMR cases, the group with higher MCP expression in the grafts showed improved serum creatinine levels after the ATCMR treatment as well as a better 5-year graft survival rate. Conclusions We conclude that the expression of Cregs in allografts is connected with ATCMR. Our results suggest that controlling complement activation in renal grafts can be a new strategy for the treatment of ATCMR.	[Yamanaka, Kazuaki; Kakuta, Yoichi; Nakazawa, Shigeaki; Kato, Taigo; Abe, Toyofumi; Imamura, Ryoichi; Nonomura, Norio] Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan; [Miyagawa, Shuji; Maeda, Akira; Okuyama, Hiroomi] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Surg, Suita, Osaka, Japan; [Okumi, Masayoshi] Tokyo Womens Med Univ, Dept Urol, Shinjuku Ku, Tokyo, Japan; [Mizuno, Masashi] Nagoya Univ, Grad Sch Med, Dept Nephrol & Renal Replacement Therapy, Nagoya, Aichi 4648601, Japan	Osaka University; Osaka University; Tokyo Women's Medical University; Nagoya University	Kakuta, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Urol, Suita, Osaka, Japan.; Miyagawa, S (corresponding author), Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Surg, Suita, Osaka, Japan.	kakuta@uro.med.osaka-u.ac.jp; miyagawa@orgtrp.med.osaka-u.ac.jp	Mizuno, Masashi/I-7347-2014	Kakuta, Yoichi/0000-0001-5339-4312; Maeda, Akira/0000-0001-7334-5438				Adams DH, 2001, XENOTRANSPLANTATION, V8, P36, DOI 10.1046/j.0908-665X.2000.00085.x; ALPER CA, 1980, CLIN IMMUNOL IMMUNOP, V16, P84, DOI 10.1016/0090-1229(80)90169-5; ANDREWS PA, 1994, TRANSPLANTATION, V58, P637, DOI 10.1097/00007890-199409150-00023; Bao LH, 2002, KIDNEY INT, V62, P2010, DOI 10.1046/j.1523-1755.2002.t01-1-00652.x; Benard M, 2004, J BIOL CHEM, V279, P43487, DOI 10.1074/jbc.M404124200; Brodsky SV, 2009, TRANSPLANTATION, V88, P457, DOI 10.1097/TP.0b013e3181b0517d; Colvin RB, 2007, J AM SOC NEPHROL, V18, P1046, DOI 10.1681/ASN.2007010073; COSIO FG, 1989, KIDNEY INT, V36, P100, DOI 10.1038/ki.1989.167; Craig TJ, 2009, J ALLERGY CLIN IMMUN, V124, P801, DOI 10.1016/j.jaci.2009.07.017; Cravedi P, 2014, J CLIN INVEST, V124, P2348, DOI 10.1172/JCI72273; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Fukushima T, 2005, TOXICOL SCI, V85, P675, DOI 10.1093/toxsci/kfi071; Gerritsma JSJ, 1996, MOL IMMUNOL, V33, P847, DOI 10.1016/0161-5890(96)84610-4; Gueler F, 2008, J AM SOC NEPHROL, V19, P2302, DOI 10.1681/ASN.2007111267; Hillmen P, 2004, NEW ENGL J MED, V350, P552, DOI 10.1056/NEJMoa031688; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Huang Y, 2002, J IMMUNOL, V169, P2627, DOI 10.4049/jimmunol.169.5.2627; Huang Y, 2001, EUR J IMMUNOL, V31, P3676, DOI 10.1002/1521-4141(200112)31:12<3676::AID-IMMU3676>3.0.CO;2-K; HUGHES TR, 1992, BIOCHEM J, V284, P169, DOI 10.1042/bj2840169; Kato C, 2013, J TOXICOL PATHOL, V26, P223, DOI 10.1293/tox.26.223; Kemper C, 2014, MOL IMMUNOL, V61, P56, DOI 10.1016/j.molimm.2014.07.004; Kwan WH, 2013, J EXP MED, V210, P257, DOI 10.1084/jem.20121525; Lalli PN, 2008, BLOOD, V112, P1759, DOI 10.1182/blood-2008-04-151068; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Li QJ, 2010, J AM SOC NEPHROL, V21, P1344, DOI 10.1681/ASN.2009090977; Liszewski MK, 1996, ADV IMMUNOL, V61, P201; Marsh JE, 2001, TRANSPLANTATION, V72, P1310, DOI 10.1097/00007890-200110150-00022; Miwa T, 2001, INT IMMUNOPHARMACOL, V1, P445, DOI 10.1016/S1567-5769(00)00043-6; Mizuno M, 1999, J IMMUNOL, V162, P5477; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; MOREL D, 1993, TRANSPLANTATION, V55, P773, DOI 10.1097/00007890-199304000-00017; MORRIS KM, 1982, J CLIN INVEST, V70, P906, DOI 10.1172/JCI110687; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; OGLESBY TJ, 1992, J EXP MED, V175, P1547, DOI 10.1084/jem.175.6.1547; Park P, 2001, J AM SOC NEPHROL, V12, P1383, DOI 10.1681/ASN.V1271383; PIRENNE J, 1994, NUCL MED BIOL, V21, P545, DOI 10.1016/0969-8051(94)90076-0; Pratt JR, 2002, NAT MED, V8, P582, DOI 10.1038/nm0602-582; Pratt JR, 2000, AM J PATHOL, V157, P825, DOI 10.1016/S0002-9440(10)64596-8; Qian ZP, 1999, AM J PATHOL, V155, P1293, DOI 10.1016/S0002-9440(10)65231-5; Quigg Richard J., 1998, J EXP MED, V188, P132; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Risitano AM, 2014, BLOOD, V123, P2094, DOI 10.1182/blood-2013-11-536573; Sacks S, 2003, J MOL MED-JMM, V81, P404, DOI 10.1007/s00109-003-0454-7; Sacks SH, 2003, AM J TRANSPLANT, V3, P927, DOI 10.1034/j.1600-6143.2003.00175.x; SACKS SH, 1993, IMMUNOLOGY, V79, P348; Serinsoz E, 2005, AM J TRANSPLANT, V5, P1490, DOI 10.1111/j.1600-6143.2005.00873.x; Sheerin NS, 1997, KIDNEY INT, V51, P703, DOI 10.1038/ki.1997.101; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Strainic MG, 2013, NAT IMMUNOL, V14, P162, DOI 10.1038/ni.2499; TAKIZAWA H, 1994, J IMMUNOL, V152, P3032; Tang S, 1999, J IMMUNOL, V162, P4336; Tilney N L, 1996, Ann Transplant, V1, P5; Tsutahara K, 2012, NEPHROL DIAL TRANSPL, V27, P3799, DOI 10.1093/ndt/gfs360; Venkatesha RT, 2005, MOL IMMUNOL, V42, P581, DOI 10.1016/j.molimm.2004.09.009; Watanabe M, 2000, KIDNEY INT, V58, P1569, DOI 10.1046/j.1523-1755.2000.00318.x; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621	57	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0148881	10.1371/journal.pone.0148881	http://dx.doi.org/10.1371/journal.pone.0148881			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928779	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200005
J	Chang, YM; Hadox, E; Szladovits, B; Garden, OA				Chang, Yu-Mei; Hadox, Erin; Szladovits, Balazs; Garden, Oliver A.			Serum Biochemical Phenotypes in the Domestic Dog	PLOS ONE			English	Article							AGE-RELATED-CHANGES; REFERENCE INTERVALS; CREATININE CONCENTRATIONS; VALUES; GREYHOUNDS; HEMATOLOGY; HEALTHY; ASSOCIATION; ANALYTES; PLASMA	The serum or plasma biochemical profile is essential in the diagnosis and monitoring of systemic disease in veterinary medicine, but current reference intervals typically take no account of breed-specific differences. Breed-specific hematological phenotypes have been documented in the domestic dog, but little has been published on serum biochemical phenotypes in this species. Serum biochemical profiles of dogs in which all measurements fell within the existing reference intervals were retrieved from a large veterinary database. Serum biochemical profiles from 3045 dogs were retrieved, of which 1495 had an accompanying normal glucose concentration. Sixty pure breeds plus a mixed breed control group were represented by at least 10 individuals. All analytes, except for sodium, chloride and glucose, showed variation with age. Total protein, globulin, potassium, chloride, creatinine, cholesterol, total bilirubin, ALT, CK, amylase, and lipase varied between sexes. Neutering status significantly impacted all analytes except albumin, sodium, calcium, urea, and glucose. Principal component analysis of serum biochemical data revealed 36 pure breeds with distinctive phenotypes. Furthermore, comparative analysis identified 23 breeds with significant differences from the mixed breed group in all biochemical analytes except urea and glucose. Eighteen breeds were identified by both principal component and comparative analysis. Tentative reference intervals were generated for breeds with a distinctive phenotype identified by comparative analysis and represented by at least 120 individuals. This is the first large-scale analysis of breed-specific serum biochemical phenotypes in the domestic dog and highlights potential genetic components of biochemical traits in this species.	[Chang, Yu-Mei] Univ London Royal Vet Coll, Res Off, Camden Campus,Royal Coll St, London NW1 OTU, England; [Hadox, Erin; Garden, Oliver A.] Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory T Cell Lab, Camden Campus,Royal Coll St, London NW1 OTU, England; [Szladovits, Balazs] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Campus, Hatfield AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Garden, OA (corresponding author), Univ London Royal Vet Coll, Dept Clin Sci & Serv, Regulatory T Cell Lab, Camden Campus,Royal Coll St, London NW1 OTU, England.	ogarden@rvc.ac.uk						Adler JA, 2007, J VET INTERN MED, V21, P1168, DOI 10.1892/06-270.1; Aroch I, 2007, VET CLIN PATH, V36, P40, DOI 10.1111/j.1939-165X.2007.tb00180.x; Bourdel-Marchasson I, 2010, MATURITAS, V66, P39, DOI 10.1016/j.maturitas.2010.02.004; Boyko AR, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-216; Chambers JC, 2011, NAT GENET, V43, P1131, DOI 10.1038/ng.970; Choi So-Young, 2011, Lab Anim Res, V27, P283, DOI 10.5625/lar.2011.27.4.283; Comazzi S, 2004, J SMALL ANIM PRACT, V45, P343, DOI 10.1111/j.1748-5827.2004.tb00246.x; Concordet D, 2008, VET CLIN PATH, V37, P96, DOI 10.1111/j.1939-165X.2008.00007.x; Cortadellas O, 2009, VET REC, V164, P487, DOI 10.1136/vr.164.16.487; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; Dunlop MM, 2011, J SMALL ANIM PRACT, V52, P4, DOI 10.1111/j.1748-5827.2010.01008.x; Elliott J., 2007, BSAVA MANUAL CANINE, P1; Feeman WE, 2003, VET CLIN PATH, V32, P40, DOI 10.1111/j.1939-165X.2003.tb00312.x; Franceschi C, 2007, NUTR REV, V65, pS173, DOI 10.1301/nr.2007.dec.S173-S176; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Griffin PM, 2014, J CLIN PATHOL, V67, P529, DOI 10.1136/jclinpath-2013-202155; GUO YS, 1989, J STEROID BIOCHEM, V33, P459, DOI 10.1016/0022-4731(89)90337-3; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; Harper JE H R, 2003, JAVMA-J AM VET MED A, V223, P1435; HILPPO M, 1986, NORD VET MED, V38, P148; Ichihara K, 2008, CLIN CHEM, V54, P356, DOI 10.1373/clinchem.2007.091843; IKEUCHI J, 1991, Journal of Toxicological Sciences, V16, P49; JENSEN AL, 1994, RES VET SCI, V56, P24, DOI 10.1016/0034-5288(94)90191-0; Jones Graham, 2008, Clin Biochem Rev, V29 Suppl 1, pS93; Jones P, 2008, GENETICS, V179, P1033, DOI 10.1534/genetics.108.087866; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Kestenbaum B, 2010, J AM SOC NEPHROL, V21, P1223, DOI 10.1681/ASN.2009111104; Lavoue R, 2013, VET CLIN PATH, V42, P346, DOI 10.1111/vcp.12067; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lequarre AS, 2011, VET J, V189, P155, DOI 10.1016/j.tvjl.2011.06.013; Levy JK, 2006, JAVMA-J AM VET MED A, V228, P1033, DOI 10.2460/javma.228.7.1033; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lopez I, 2005, VET REC, V157, P344, DOI 10.1136/vr.157.12.344; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; Miyagawa Y, 2010, J VET MED SCI, V72, P1129, DOI 10.1292/jvms.09-0443; NAP RC, 1994, VET QUART, V16, P50, DOI 10.1080/01652176.1994.9694417; Nielsen L, 2010, VET CLIN PATH, V39, P20, DOI 10.1111/j.1939-165X.2009.00186.x; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; Okamura T, 2008, J AM GERIATR SOC, V56, P529, DOI 10.1111/j.1532-5415.2007.01549.x; Park HS, 2007, PANCREAS, V34, P373, DOI 10.1097/MPA.0b013e3180327c2b; Roman VRG, 2012, CLIN VACCINE IMMUNOL, V19, P1322, DOI 10.1128/CVI.00170-12; Rortveit R, 2015, VET CLIN PATH, V44, P47, DOI 10.1111/vcp.12220; Rosset E, 2012, VET CLIN PATH, V41, P272, DOI 10.1111/j.1939-165X.2012.00415.x; Rubio AV, 2014, J ZOO WILDLIFE MED, V45, P589, DOI 10.1638/2013-0280R2.1; Sharkey L, 2009, VET CLIN PATH, V38, P375, DOI 10.1111/j.1939-165X.2009.00134.x; Steele AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097171; Stockham S, 2013, FUNDAMENTALS VET CLI; Thrall M. A., 2012, VET HEMATOLOGY CLIN, V2nd; Tiao JYH, 2002, CARDIOVASC SURG, V10, P445, DOI 10.1016/S0967-2109(02)00056-X; Uhrikova I, 2013, AUST VET J, V91, P452, DOI 10.1111/avj.12117; Ulleberg T, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-25; Visser M, 2005, AM J CLIN NUTR, V82, P531; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Walton RM, 2012, VET CLIN PATH, V41, P175, DOI 10.1111/j.1939-165X.2012.00414.x; Watts M, 2006, VET REC, V159, P128, DOI 10.1136/vr.159.4.128-b; WILDING P, 1972, CLIN CHIM ACTA, V41, P375, DOI 10.1016/0009-8981(72)90534-7; Zaldivar-Lopez S, 2011, VET CLIN PATH, V40, P414, DOI 10.1111/j.1939-165X.2011.00360.x; ZHAN Y, 1991, JPN J VET RES, V39, P39	58	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149650	10.1371/journal.pone.0149650	http://dx.doi.org/10.1371/journal.pone.0149650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919479	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000371274400032
J	Gerrits, NJHM; van Loenhoud, AC; van den Berg, SF; Berendse, HW; Foncke, EMJ; Klein, M; Stoffers, D; van der Werf, YD; van den Heuvel, OA				Gerrits, Niels J. H. M.; van Loenhoud, Anita C.; van den Berg, Stan F.; Berendse, Henk W.; Foncke, Elisabeth M. J.; Klein, Martin; Stoffers, Diederick; van der Werf, Ysbrand D.; van den Heuvel, Odile A.			Cortical Thickness, Surface Area and Subcortical Volume Differentially Contribute to Cognitive Heterogeneity in Parkinson's Disease	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MINI-MENTAL-STATE; IMPAIRMENT; DEMENTIA; INVENTORY; ATROPHY; MRI	Parkinson's disease (PD) is often associated with cognitive deficits, although their severity varies considerably between patients. Recently, we used voxel-based morphometry (VBM) to show that individual differences in gray matter (GM) volume relate to cognitive heterogeneity in PD. VBM does, however, not differentiate between cortical thickness (CTh) and surface area (SA), which might be independently affected in PD. We therefore re-analyzed our cohort using the surface-based method FreeSurfer, and investigated (i) CTh, SA, and (sub) cortical GM volume differences between 93 PD patients and 45 matched controls, and (ii) the relation between these structural measures and cognitive performance on six neuropsychological tasks within the PD group. We found cortical thinning in PD patients in the left pericalcarine gyrus, extending to cuneus, precuneus and lingual areas and left inferior parietal cortex, bilateral rostral middle frontal cortex, and right cuneus, and increased cortical surface area in the left pars triangularis. Within the PD group, we found negative correlations between (i) CTh of occipital areas and performance on a verbal memory task, (ii) SA and volume of the frontal cortex and visuospatial memory performance, and, (iii) volume of the right thalamus and scores on two verbal fluency tasks. Our primary findings illustrate that i) CTh and SA are differentially affected in PD, and ii) VBM and FreeSurfer yield non-overlapping results in an identical dataset. We argue that this discrepancy is due to technical differences and the subtlety of the PD-related structural changes.	[Gerrits, Niels J. H. M.; van Loenhoud, Anita C.; van den Berg, Stan F.; van den Heuvel, Odile A.] Vrije Univ Amsterdam, Med Ctr VUmc, Dept Anat & Neurosci, Amsterdam, Netherlands; [Berendse, Henk W.; Foncke, Elisabeth M. J.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Stoffers, Diederick] Netherlands Inst Neurosci, Amsterdam, Netherlands; [Klein, Martin] Vrije Univ Amsterdam Med Ctr, Dept Med Psychol, Amsterdam, Netherlands; [van Loenhoud, Anita C.; van den Heuvel, Odile A.] Vrije Univ Amsterdam Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [Gerrits, Niels J. H. M.; Berendse, Henk W.; van der Werf, Ysbrand D.; van den Heuvel, Odile A.] Neurosci Campus Amsterdam NCA, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gerrits, NJHM (corresponding author), Vrije Univ Amsterdam, Med Ctr VUmc, Dept Anat & Neurosci, Amsterdam, Netherlands.; Gerrits, NJHM (corresponding author), Neurosci Campus Amsterdam NCA, Amsterdam, Netherlands.	njhmgerrits@gmail.com	Klein, Martin/C-4192-2012	Klein, Martin/0000-0003-4160-5746; Berendse, Henk/0000-0002-9189-3662; Klein, Martin/0000-0001-5553-7911; van der Werf, Ysbrand/0000-0003-2370-9584; van den Heuvel, Odile/0000-0002-9804-7653				Aganj I, 2009, HUM BRAIN MAPP, V30, P3188, DOI 10.1002/hbm.20740; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Compta Y, 2013, PARKINSONISM RELAT D, V19, P717, DOI 10.1016/j.parkreldis.2013.03.009; CUMMINGS JL, 1993, JAMA-J AM MED ASSOC, V269, P2420, DOI 10.1001/jama.269.18.2420; Dalaker TO, 2011, MOVEMENT DISORD, V26, P297, DOI 10.1002/mds.23443; Dalaker TO, 2010, MOVEMENT DISORD, V25, P629, DOI 10.1002/mds.22867; Das SR, 2009, NEUROIMAGE, V45, P867, DOI 10.1016/j.neuroimage.2008.12.016; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Driemeyer J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002669; Eggert LD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045081; Engvig A, 2010, NEUROIMAGE, V52, P1667, DOI 10.1016/j.neuroimage.2010.05.041; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Focke NK, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00039; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freeman SH, 2008, J NEUROPATH EXP NEUR, V67, P1205, DOI 10.1097/NEN.0b013e31818fc72f; Gerrits NJ, 2013, EUR J NEUROL; Goldstein RZ, 2001, NEUROREPORT, V12, P2595, DOI 10.1097/00001756-200108080-00060; Hanganu A, 2014, BRAIN, V137, P1120, DOI 10.1093/brain/awu036; Hanganu A, 2013, MOVEMENT DISORD, V28, P1360, DOI 10.1002/mds.25541; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Henley SMD, 2010, AM J NEURORADIOL, V31, P711, DOI 10.3174/ajnr.A1939; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Ibarretxe-Bilbao N, 2011, J NEUROL SCI, V310, P70, DOI 10.1016/j.jns.2011.07.054; Ilg R, 2008, J NEUROSCI, V28, P4210, DOI 10.1523/JNEUROSCI.5722-07.2008; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Kehagia AA, 2010, LANCET NEUROL, V9, P1200, DOI 10.1016/S1474-4422(10)70212-X; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Klostermann F, 2013, FUNCTIONAL ROLES THA; Lemaitre H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.07.013; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; Martin WRW, 2009, MOVEMENT DISORD, V24, P1949, DOI 10.1002/mds.22680; Melzer TR, 2012, J NEUROL NEUROSUR PS, V83, P188, DOI 10.1136/jnnp-2011-300828; Menke RAL, 2014, HUM BRAIN MAPP, V35, P1681, DOI 10.1002/hbm.22282; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Nishio Y, 2010, EUR J NEUROL, V17, P1090, DOI 10.1111/j.1468-1331.2010.02980.x; O'Mara SM, 2013, ANTERIOR THALAMUS PR; Osterrieth P., 1944, ARCH PSYCHOL-GENEVE, V30, P206; Pagonabarraga J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054980; Pardoe HR, 2013, HUM BRAIN MAPP, V34, P3000, DOI 10.1002/hbm.22120; Pellicano C, 2012, EUR J NEUROL; Pereira JB, 2014, NEUROLOGY, P82; Pereira JB, 2014, NEUROLOGY, V82, P2017, DOI [10.1212/WNL.0000000000000483, 10.1212/01.wnl.0000457455.74798.9a]; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Rey A, 1964, LEXAMEN CLINIQUE PSY; Segura B, 2012, MOVEMENT DISORD, V29, P1495; Segura B, 2014, MOVEMENT DISORD, V29, P1495, DOI 10.1002/mds.25982; Song SK, 2011, MOVEMENT DISORD, V26, P289, DOI 10.1002/mds.23477; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tinaz S, 2011, MOVEMENT DISORD, V26, P436, DOI 10.1002/mds.23453; Van der Werf YD, 2001, COGNITIVE BRAIN RES, V11, P377, DOI 10.1016/S0926-6410(01)00010-6; Verhage F., 1983, CODEREN OPLEIDINGSNI; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028	64	35	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148852	10.1371/journal.pone.0148852	http://dx.doi.org/10.1371/journal.pone.0148852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919667	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400011
J	Paciorek, CJ; Goring, SJ; Thurman, AL; Cogbill, CV; Williams, JW; Mladenoff, DJ; Peters, JA; Zhu, J; McLachlan, JS				Paciorek, Christopher J.; Goring, Simon J.; Thurman, Andrew L.; Cogbill, Charles V.; Williams, John W.; Mladenoff, David J.; Peters, Jody A.; Zhu, Jun; McLachlan, Jason S.			Statistically-Estimated Tree Composition for the Northeastern United States at Euro-American Settlement	PLOS ONE			English	Article							MARKOV RANDOM-FIELDS; LINEAR MIXED MODELS; HISTORICAL LAND-USE; FOREST COMPOSITION; NEW-ENGLAND; VEGETATION; USA; MINNESOTA; PATTERNS; LEGACIES	We present a gridded 8 km-resolution data product of the estimated composition of tree taxa at the time of Euro-American settlement of the northeastern United States and the statistical methodology used to produce the product from trees recorded by land surveyors. Composition is defined as the proportion of stems larger than approximately 20 cm diameter at breast height for 22 tree taxa, generally at the genus level. The data come from settlement-era public survey records that are transcribed and then aggregated spatially, giving count data. The domain is divided into two regions, eastern (Maine to Ohio) and midwestern (Indiana to Minnesota). Public Land Survey point data in the midwestern region (ca. 0.8-km resolution) are aggregated to a regular 8 km grid, while data in the eastern region, from Town Proprietor Surveys, are aggregated at the township level in irregularly-shaped local administrative units. The product is based on a Bayesian statistical model fit to the count data that estimates composition on the 8 km grid across the entire domain. The statistical model is designed to handle data from both the regular grid and the irregularly-shaped townships and allows us to estimate composition at locations with no data and to smooth over noise caused by limited counts in locations with data. Critically, the model also allows us to quantify uncertainty in our composition estimates, making the product suitable for applications employing data assimilation. We expect this data product to be useful for understanding the state of vegetation in the northeastern United States prior to large-scale Euro-American settlement. In addition to specific regional questions, the data product can also serve as a baseline against which to investigate how forests and ecosystems change after intensive settlement. The data product is being made available at the NIS data portal as version 1.0.	[Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Goring, Simon J.] Univ Wisconsin, Dept Geog, Madison, WI 53706 USA; [Thurman, Andrew L.] Iowa City VAMC, VA Off Rural Hlth, Vet Rural Hlth Resource Ctr, Iowa City, IA USA; [Cogbill, Charles V.] Harvard Univ, Harvard Forest, Petersham, MA USA; [Williams, John W.] Univ Wisconsin, Ctr Climat Res, Madison, WI USA; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI USA; [Peters, Jody A.; McLachlan, Jason S.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Zhu, Jun] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Harvard University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Notre Dame; University of Wisconsin System; University of Wisconsin Madison	Paciorek, CJ (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	paciorek@stat.berkeley.edu		Goring, Simon/0000-0002-2700-4605; Thurman, Andrew/0000-0002-7777-4165	National Science Foundation MacroSystems Program [EF-1065702, EF-1065656, DEB-1241874, DEB-1241868]; Notre Dame Environmental Change Initiative; Direct For Biological Sciences [1241870] Funding Source: National Science Foundation	National Science Foundation MacroSystems Program; Notre Dame Environmental Change Initiative; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was carried out by the PalEON Project with support from the National Science Foundation MacroSystems Program (http://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503425) through grants EF-1065702, EF-1065656, DEB-1241874 and DEB-1241868, and from the Notre Dame Environmental Change Initiative (http://environmentalchange.nd.edu/).	[Anonymous], 2014, R LANG ENV STAT COMP; Banerjee S., 2004, HIERARCHICAL MODELIN; Black BA, 2006, CAN J FOREST RES, V36, P1266, DOI 10.1139/X06-027; BOURDO EA, 1956, ECOLOGY, V37, P754, DOI 10.2307/1933067; Christensen OF, 2006, J COMPUT GRAPH STAT, V15, P1, DOI 10.1198/106186006X100470; Cogbill CV, 2002, J BIOGEOGR, V29, P1279, DOI 10.1046/j.1365-2699.2002.00757.x; Cogbill CV, 2016, SETTLEMENT ERA TREE; Eddelbuettel D, 2011, J STAT SOFTW, V40, P1; Foster DR, 1998, ECOSYSTEMS, V1, P96, DOI 10.1007/s100219900008; Friedman SK, 2005, ECOL APPL, V15, P726, DOI 10.1890/04-0748; Furrer R, 2010, J STAT SOFTW, V36, P1; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x; GORING S. J., 2016, PLOS ONE IN PRESS; Goring SJ, 2016, SETTLEMENT ERA GRIDD; Gray AN, 2012, VEG DATABASES 21 CEN, P255; GRIMM EC, 1984, ECOL MONOGR, V54, P291, DOI 10.2307/1942499; Krnjajic M, 2014, STAT PROBABIL LETT, V88, P9, DOI 10.1016/j.spl.2014.01.023; Lindgren F, 2011, J R STAT SOC B, V73, P423, DOI 10.1111/j.1467-9868.2011.00777.x; Liu F, 2011, ECOL MONOGR, V81, P259, DOI 10.1890/10-0232.1; MCCULLOCH R, 1994, J ECONOMETRICS, V64, P207, DOI 10.1016/0304-4076(94)90064-7; Mladenoff DJ, 2002, ECOSYSTEMS, V5, P539, DOI 10.1007/s10021-002-0167-8; Munoz SE, 2014, J BIOGEOGR, V41, P2195, DOI 10.1111/jbi.12386; Paciorek CJ, 2013, ELECTRON J STAT, V7, P946, DOI 10.1214/13-EJS791; Paciorek CJ, 2016, SETTLEMENT ERA GRIDD; Pattison W.D., 1957, BEGINNINGS AM RECTAN; Rhemtulla JM, 2009, ECOL APPL, V19, P1061, DOI 10.1890/08-1453.1; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; RUE H., 2005, GAUSSIAN MARKOV RAND; Schulte LA, 2001, J FOREST, V99, P5; Shaby B, 2011, EXPLORING ADAPTIVE M, P2011; Shea M. E., 2014, Ecological Restoration, V32, P417, DOI 10.3368/er.32.4.417; Tan LSL, 2013, STAT SCI, V28, P168, DOI 10.1214/13-STS418; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Transeau EN, 1935, ECOLOGY, V16, P423, DOI 10.2307/1930078; Whitney GG, 1996, COASTAL WILDERNESS F	36	22	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150087	10.1371/journal.pone.0150087	http://dx.doi.org/10.1371/journal.pone.0150087			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918331	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400085
J	Perello, C; Llamas, E; Burlat, V; Ortiz-Alcaide, M; Phillips, MA; Pulido, P; Rodriguez-Concepcion, M				Perello, Catalina; Llamas, Ernesto; Burlat, Vincent; Ortiz-Alcaide, Miriam; Phillips, Michael A.; Pulido, Pablo; Rodriguez-Concepcion, Manuel			Differential Subplastidial Localization and Turnover of Enzymes Involved in Isoprenoid Biosynthesis in Chloroplasts	PLOS ONE			English	Article							METHYLERYTHRITOL 4-PHOSPHATE PATHWAY; SENESCENCE-ASSOCIATED VACUOLES; PROTEIN-QUALITY CONTROL; 1-DEOXY-D-XYLULOSE-5-PHOSPHATE SYNTHASE; 5-PHOSPHATE REDUCTOISOMERASE; COMPUTATIONAL ANALYSIS; PHOSPHATE-PATHWAY; EARLY STEPS; ARABIDOPSIS; PLASTIDS	Plastidial isoprenoids are a diverse group of metabolites with roles in photosynthesis, growth regulation, and interaction with the environment. The methylerythritol 4-phosphate (MEP) pathway produces the metabolic precursors of all types of plastidial isoprenoids. Proteomics studies in Arabidopsis thaliana have shown that all the enzymes of the MEP pathway are localized in the plastid stroma. However, immunoblot analysis of chloroplast subfractions showed that the first two enzymes of the pathway, deoxyxylulose 5-phosphate synthase (DXS) and reductoisomerase (DXR), can also be found in non-stromal fractions. Both transient and stable expression of GFP-tagged DXS and DXR proteins confirmed the presence of the fusion proteins in distinct subplastidial compartments. In particular, DXR-GFP was found to accumulate in relatively large vesicles that could eventually be released from chloroplasts, presumably to be degraded by an autophagy-independent process. Together, we propose that protein-specific mechanisms control the localization and turnover of the first two enzymes of the MEP pathway in Arabidopsis chloroplasts.	[Perello, Catalina; Llamas, Ernesto; Ortiz-Alcaide, Miriam; Phillips, Michael A.; Pulido, Pablo; Rodriguez-Concepcion, Manuel] UB, UAB, IRTA, Program Plant Metab & Metab Engn,CRAG,CSIC, Campus UAB Bellaterra, Barcelona 08193, Spain; [Burlat, Vincent] Univ Toulouse, CNRS, UMR 5546, BP 42617 Auzeville, F-31326 Castanet Tolosan, France; [Pulido, Pablo] Univ Munich, Dept Biol Bot 1, Grosshaderner Str 2-4, D-82152 Planegg Martinsried, Germany	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); IRTA; University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Munich	Rodriguez-Concepcion, M (corresponding author), UB, UAB, IRTA, Program Plant Metab & Metab Engn,CRAG,CSIC, Campus UAB Bellaterra, Barcelona 08193, Spain.	manuel.rodriguez@cragenomica.es	burlat, vincent/ABB-1802-2021; Rodriguez-Concepcion, Manuel/I-7229-2015; Pulido, Pablo/A-8093-2015; burlat, vincent/J-6831-2015	burlat, vincent/0000-0002-0897-6011; Rodriguez-Concepcion, Manuel/0000-0002-1280-2305; Pulido, Pablo/0000-0001-9092-3674; burlat, vincent/0000-0002-0897-6011; Llamas, Ernesto/0000-0001-9262-2402; Perello, Catalina/0000-0003-4662-7880	Generalitat de Catalunya [2014SGR-1434]; Spanish Ministerio de Economia y Competitividad [BIO2014-59092-P, BIO2015-71703-REDT]; European Commission [245143]; Spanish CSIC (JAE-PRE program); MINECO (FPI program); Mexican CONACYT predoctoral fellowship	Generalitat de Catalunya(Generalitat de Catalunya); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish CSIC (JAE-PRE program); MINECO (FPI program)(Spanish Government); Mexican CONACYT predoctoral fellowship	This work was funded by grants from Generalitat de Catalunya (2014SGR-1434), Spanish Ministerio de Economia y Competitividad (BIO2014-59092-P and BIO2015-71703-REDT), and European Commission FP7 (TiMet, contract 245143) to MRC. CP and MOA received predoctoral fellowships from Spanish CSIC (JAE-PRE program) and MINECO (FPI program), respectively. EL is supported by a Mexican CONACYT predoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2014, NAT PROD REP, V31, P1043, DOI 10.1039/c3np70124g; Beck G, 2013, PLANT MOL BIOL, V82, P393, DOI 10.1007/s11103-013-0070-z; Burlat V, 2001, PHYTOCHEMISTRY, V57, P883, DOI 10.1016/S0031-9422(01)00117-0; Carretero-Paulet L, 2006, PLANT MOL BIOL, V62, P683, DOI 10.1007/s11103-006-9051-9; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Croteau R., 2000, BIOCH MOL BIOL PLANT, P1250, DOI DOI 10.1201/B11003-3; Enfissi EMA, 2005, PLANT BIOTECHNOL J, V3, P17, DOI 10.1111/j.1467-7652.2004.00091.x; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Flores-Perez U, 2008, PLANT CELL, V20, P1303, DOI 10.1105/tpc.108.058768; Fung PK, 2010, CHEM BIODIVERS, V7, P1098, DOI 10.1002/cbdv.200900313; Hemmerlin A, 2013, PLANT SCI, V203, P41, DOI 10.1016/j.plantsci.2012.12.008; Hemmerlin A, 2012, PROG LIPID RES, V51, P95, DOI 10.1016/j.plipres.2011.12.001; Hsieh MH, 2008, PLANT MOL BIOL, V66, P663, DOI 10.1007/s11103-008-9297-5; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Izumi M, 2015, PLANT PHYSIOL, V167, P1307, DOI 10.1104/pp.114.254078; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Joyard J, 2009, MOL PLANT, V2, P1154, DOI 10.1093/mp/ssp088; Krushkal J, 2003, GENE, V313, P127, DOI 10.1016/S0378-1119(03)00668-1; Kuzuyama T, 1998, TETRAHEDRON LETT, V39, P7913, DOI 10.1016/S0040-4039(98)01755-9; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Llop-Tous I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019474; Mahmoud SS, 2001, P NATL ACAD SCI USA, V98, P8915, DOI 10.1073/pnas.141237298; Martinez DE, 2008, PLANT J, V56, P196, DOI 10.1111/j.1365-313X.2008.03585.x; Michaeli S, 2014, PLANT CELL, V26, P4084, DOI 10.1105/tpc.114.129999; Munoz-Bertomeu J, 2006, PLANT PHYSIOL, V142, P890, DOI 10.1104/pp.106.086355; Nakai M, 2015, BBA-BIOENERGETICS, V1847, P957, DOI 10.1016/j.bbabio.2015.02.011; Nishimura K, 2015, BBA-BIOENERGETICS, V1847, P915, DOI 10.1016/j.bbabio.2014.11.012; Oudin A, 2007, PLANT MOL BIOL, V65, P13, DOI 10.1007/s11103-007-9190-7; Perello C, 2014, METHODS MOL BIOL, V1153, P273, DOI 10.1007/978-1-4939-0606-2_20; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phillips MA, 2009, PLANT MOL BIOL REP, V27, P407, DOI 10.1007/s11105-008-0072-1; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Pulido P, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005824; Pulido P, 2013, PLANT CELL, V25, P4183, DOI 10.1105/tpc.113.113001; Pulido P, 2012, MOL PLANT, V5, P964, DOI 10.1093/mp/sss088; Ramundo S, 2014, PLANT CELL, V26, P2201, DOI 10.1105/tpc.114.124842; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rodriguez-Concepcion M, 2002, PLANT PHYSIOL, V130, P1079, DOI 10.1104/pp.007138; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Ruiz-Sola MA, 2016, NEW PHYTOL, V209, P252, DOI 10.1111/nph.13580; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Spitzer C, 2015, PLANT CELL, V27, P391, DOI 10.1105/tpc.114.135939; Stanne TM, 2009, BIOCHEM J, V417, P257, DOI 10.1042/BJ20081146; Steinbacher S, 2003, J BIOL CHEM, V278, P18401, DOI 10.1074/jbc.M300993200; Trosch R, 2015, BBA-BIOENERGETICS, V1847, P872, DOI 10.1016/j.bbabio.2015.01.002; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Vidi PA, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-4; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wang S, 2015, BIOPROTOCOL, V5, pe1405, DOI DOI 10.21769/; Wang SH, 2014, PLANT CELL, V26, P4875, DOI 10.1105/tpc.114.133116; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Wright LP, 2014, PLANT PHYSIOL, V165, P1488, DOI 10.1104/pp.114.245191; Yang JF, 2012, MOL BIOL REP, V39, P8287, DOI 10.1007/s11033-012-1676-y; Zhao LS, 2013, ANNU REV BIOCHEM, V82, P497, DOI 10.1146/annurev-biochem-052010-100934; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994; Zybailov B, 2009, MOL CELL PROTEOMICS, V8, P1789, DOI 10.1074/mcp.M900104-MCP200	56	27	27	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150539	10.1371/journal.pone.0150539	http://dx.doi.org/10.1371/journal.pone.0150539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919668	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400131
J	Arruda, BL; Arruda, PH; Magstadt, DR; Schwartz, KJ; Dohlman, T; Schleining, JA; Patterson, AR; Visek, CA; Victoria, JG				Arruda, Bailey L.; Arruda, Paulo H.; Magstadt, Drew R.; Schwartz, Kent J.; Dohlman, Tyler; Schleining, Jennifer A.; Patterson, Abby R.; Visek, Callie A.; Victoria, Joseph G.			Identification of a Divergent Lineage Porcine Pestivirus in Nursing Piglets with Congenital Tremors and Reproduction of Disease following Experimental Inoculation	PLOS ONE			English	Article							CEREBROSPINAL HYPOMYELINOGENESIS; DOMESTIC PIG; SWINE-FEVER	Congenital tremors is a sporadic disease of neonatal pigs characterized by action-related repetitive myoclonus. A majority of outbreaks of congenital tremors have been attributed to an unidentified virus. The objectives of this project were to 1) detect potential pathogen(s) in samples from piglets with congenital tremors and 2) develop an infection model to reproduce disease. Using next-generation sequencing, a divergent lineage pestivirus was detected in piglets with congenital tremors. The virus was originally most closely related to a bat pestivirus but is now more closely related to a recently published novel porcine pestivirus provisionally named atypical porcine pestivirus. A quantitative real-time PCR detected the virus in samples from neonatal piglets with congenital tremors from two separate farms, but not in samples from unaffected piglets from the same farm. To fulfill the second objective, pregnant sows were inoculated with either serum containing the pestivirus or PBS (control) by intravenous and intranasal routes simultaneously with direct inoculation of fetal amniotic vesicles by ultrasound-guided surgical technique. Inoculations were performed at either 45 or 62 days of gestation. All sows inoculated with the novel pestivirus farrowed piglets affected with congenital tremors while PBS-inoculated control piglets were unaffected. Tremor severity for each piglet was scored from videos taken 0, 1 and 2 days post-farrowing. Tremor severity remained relatively constant from 0 to 2 days post-farrowing for a majority of piglets. The prevalence of congenital tremors in pestivirus-inoculated litters ranged from 57% (4 out of 7 affected piglets) to 100% (10 out of 10 affected piglets). The virus was consistently detected by PCR in tissues from piglets with congenital tremors but was not detected in control piglets. Samples positive by PCR in greater than 90% of piglets sampled included brainstem (37 out of 41), mesenteric lymph node (37 out of 41), tracheobronchial lymph node (37 out of 41), and whole blood (19 out of 20). Although the first description of congenital tremors was in 1922, this is the first reported reproduction of congenital tremors following experimental inoculation with a divergent lineage porcine pestivirus. Studies investigating disease mechanism, epidemiology, and diagnostic assay development are needed to better understand the pathophysiology of congenital tremors due to this pestivirus.	[Arruda, Bailey L.; Arruda, Paulo H.; Magstadt, Drew R.; Schwartz, Kent J.; Dohlman, Tyler; Schleining, Jennifer A.] Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA; [Patterson, Abby R.; Visek, Callie A.; Victoria, Joseph G.] Boehringer Ingelheim Vetmed Inc, Ames, IA USA	Iowa State University; Boehringer Ingelheim	Arruda, BL (corresponding author), Iowa State Univ, Coll Vet Med, Dept Vet Diagnost & Prod Anim Med, Ames, IA USA.	wilberts@iastate.edu		Schleining, Jennifer/0000-0003-4536-6658	Boehringer Ingelheim Vetmedica, Inc	Boehringer Ingelheim Vetmedica, Inc(Boehringer Ingelheim)	The authors declare no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. Boehringer Ingelheim Vetmedica, Inc provided support in the form of salary for authors ARP, CAV, and JGV. A provisional patent on which authors ARP and JGV are named is pending relating to material pertinent to this article.	Bolin S. R., 1992, DIS SWINE, P247; Done S., 2012, DIS SWINE, P294; Fasano A, 2015, MOVEMENT DISORD, V30, P1557, DOI 10.1002/mds.26383; Govert F, 2015, CURR OPIN NEUROL, V28, P393, DOI 10.1097/WCO.0000000000000211; HARDING JDJ, 1973, VET REC, V92, P527, DOI 10.1136/vr.92.20.527; HARDING JDJ, 1966, VET REC, V79, P388, DOI 10.1136/vr.79.14.388; Hause BM, 2015, J GEN VIROL, V96, P2994, DOI 10.1099/jgv.0.000251; Hindmarch WL, 1973, AUST VET J, V13, P249; Kinsley A., 1922, VET MED, V17, P123; Kirkland P.D., 2012, DIS SWINE, P538; KNOX B, 1978, NORD VET MED, V30, P538; Lohse L, 2012, VET MICROBIOL, V159, P327, DOI 10.1016/j.vetmic.2012.04.026; Murphy F.A., 1999, VET VIROLOGY, V3rd ed., P555; Papatsiros V. G., 2012, American Journal of Animal and Veterinary Sciences, V7, P80; PATTERSON DS, 1973, J NEUROCHEM, V21, P397, DOI 10.1111/j.1471-4159.1973.tb04259.x; PAYEN BALLOT, 1934, Recueil de Medecine Veterinaire, V110, P84; Pond WG, 2000, P SOC EXP BIOL MED, V223, P102, DOI 10.1046/j.1525-1373.2000.22314.x; STROMBERG MW, 1958, AM J VET RES, V19, P377; SWEASEY D, 1976, J NEUROCHEM, V27, P375, DOI 10.1111/j.1471-4159.1976.tb12256.x; Truyen U., 2012, DIS SWINE, P447; Victoria JG, 2010, J VIROL, V84, P6033, DOI 10.1128/JVI.02690-09	21	96	111	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150104	10.1371/journal.pone.0150104	http://dx.doi.org/10.1371/journal.pone.0150104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909691	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700068
J	Bruni, R; Taffon, S; Equestre, M; Chionne, P; Madonna, E; Rizzo, C; Tosti, ME; Alfonsi, V; Ricotta, L; De Medici, D; Di Pasquale, S; Scavia, G; Pavoni, E; Losio, MN; Romano, L; Zanetti, AR; Morea, A; Pacenti, M; Palu, G; Capobianchi, MR; Chironna, M; Pompa, MG; Ciccaglione, AR				Bruni, Roberto; Taffon, Stefania; Equestre, Michele; Chionne, Paola; Madonna, Elisabetta; Rizzo, Caterina; Tosti, Maria Elena; Alfonsi, Valeria; Ricotta, Lara; De Medici, Dario; Di Pasquale, Simona; Scavia, Gaia; Pavoni, Enrico; Losio, Marina Nadia; Romano, Luisa; Zanetti, Alessandro Remo; Morea, Anna; Pacenti, Monia; Palu, Giorgio; Capobianchi, Maria Rosaria; Chironna, Maria; Pompa, Maria Grazia; Ciccaglione, Anna Rita		Italian Natl Task Force Hepatitis	Key Role of Sequencing to Trace Hepatitis A Viruses Circulating in Italy During a Large Multi-Country European Foodborne Outbreak in 2013	PLOS ONE			English	Article							EPIDEMIOLOGY; REGION	Background Foodborne Hepatitis A Virus (HAV) outbreaks are being recognized as an emerging public health problem in industrialized countries. In 2013 three foodborne HAV outbreaks occurred in Europe and one in USA. During the largest of the three European outbreaks, most cases occurred in Italy (>1,200 cases as of March 31, 2014). A national Task Force was established at the beginning of the outbreak by the Ministry of Health. Mixed frozen berries were early demonstrated to be the source of infection by the identity of viral sequences in patients and in food. In the present study the molecular characterization of HAV isolates from 355 Italian cases is reported. Methods Molecular characterization was carried out by PCR/sequencing (VP1/2A region), comparison with reference strains and phylogenetic analysis. Results A unique strain was responsible for most characterized cases (235/355, 66.1%). Molecular data had a key role in tracing this outbreak, allowing 110 out of the 235 outbreak cases (46.8%) to be recognized in absence of any other link. The data also showed background circulation of further unrelated strains, both autochthonous and travel related, whose sequence comparison highlighted minor outbreaks and small clusters, most of them unrecognized on the basis of epidemiological data. Phylogenetic analysis showed most isolates from travel related cases clustering with reference strains originating from the same geographical area of travel. Conclusions In conclusion, the study documents, in a real outbreak context, the crucial role of molecular analysis in investigating an old but re-emerging pathogen. Improving the molecular knowledge of HAV strains, both autochthonous and circulating in countries from which potentially contaminated foods are imported, will become increasingly important to control outbreaks by supporting trace back activities, aiming to identify the geographical source(s) of contaminated food, as well as public health interventions.	[Bruni, Roberto; Taffon, Stefania; Chionne, Paola; Madonna, Elisabetta; Ciccaglione, Anna Rita] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy; [Equestre, Michele] Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy; [Rizzo, Caterina; Tosti, Maria Elena; Alfonsi, Valeria; Ricotta, Lara] Ist Super Sanita, Natl Ctr Epidemiol Surveillance & Hlth Promot, Viale Regina Elena 299, I-00161 Rome, Italy; [De Medici, Dario; Di Pasquale, Simona; Scavia, Gaia] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, Viale Regina Elena 299, I-00161 Rome, Italy; [Pavoni, Enrico; Losio, Marina Nadia] Ist Zooprofilatt Sperimentale Lombardia & Emilia, Reparto Tecnol Acidi Nucl Applicata Alimenti, Brescia, Italy; [Romano, Luisa; Zanetti, Alessandro Remo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Morea, Anna; Chironna, Maria] Azienda Osped Univ Policlin Bari, Bari, Italy; [Pacenti, Monia] Padua Univ Hosp, Microbiol & Virol Unit, Padua, Italy; [Palu, Giorgio] Univ Padua, Dept Mol Med, Padua, Italy; [Capobianchi, Maria Rosaria] Ist Nazl Malattie Infett L Spallanzani, Virol Lab, Rome, Italy; [Pompa, Maria Grazia] Minist Hlth, Directorate Gen Prevent Hlth Care, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); IZS Lombardia e Emilia; University of Milan; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Padua; IRCCS Lazzaro Spallanzani	Bruni, R (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	roberto.bruni@iss.it	MADONNA, ELISABETTA/M-2962-2015; ricotta, lara/AAA-6399-2020; Equestre, Michele/AAC-2129-2019; Pavoni, Enrico/AAC-2849-2019; Tosti, Maria Elena/K-1424-2018; Di Pasquale, Simona/AAC-9150-2021; Rizzo, Caterina/H-4092-2012; Losio, Marina-Nadia/AAC-2797-2019; Bruni, Roberto/ABA-8555-2021; CICCAGLIONE, ANNA RITA/M-2956-2015; De Medici, Dario/C-4835-2015; Equestre, Michele/AAV-4993-2020; TAFFON, STEFANIA/M-2965-2015; DI PASQUALE, SIMONA/C-4841-2015; BRUNI, ROBERTO/M-2957-2015; Scognamiglio, Paola/B-4754-2017	MADONNA, ELISABETTA/0000-0003-3288-2346; ricotta, lara/0000-0002-3241-0261; Tosti, Maria Elena/0000-0003-1392-9874; Di Pasquale, Simona/0000-0002-7339-3736; Rizzo, Caterina/0000-0002-5583-7508; Bruni, Roberto/0000-0002-3035-5510; CICCAGLIONE, ANNA RITA/0000-0002-3791-3781; De Medici, Dario/0000-0002-6917-8478; Equestre, Michele/0000-0001-7883-1371; TAFFON, STEFANIA/0000-0002-5008-093X; DI PASQUALE, SIMONA/0000-0002-7339-3736; BRUNI, ROBERTO/0000-0002-3035-5510; Pavoni, Enrico/0000-0003-4367-0381; Losio, Marina Nadia/0000-0002-7434-6536; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Pacenti, Monia/0000-0002-9792-9195; MOREA, ANNA/0000-0002-3692-864X; Alfonsi, Valeria/0000-0003-1920-6773; Scognamiglio, Paola/0000-0002-7938-6457; chironna, maria/0000-0002-1043-1256				Capobianchi MR, 2014, MICROBES INFECT, V16, P362, DOI 10.1016/j.micinf.2014.01.003; Castkova J, 2009, EUROSURVEILLANCE, V14, P4; Chiapponi Chiara, 2014, Food Environ Virol, V6, P202, DOI 10.1007/s12560-014-9149-1; Collier MG, 2014, LANCET INFECT DIS, V14, P976, DOI 10.1016/S1473-3099(14)70883-7; Costa-Mattioli M, 2003, J GEN VIROL, V84, P3191, DOI 10.1099/vir.0.19532-0; European Centre for Disease Prevention and Control, 2014, OUTBR HEP A EU EEA C; European Centre for Disease Prevention and Control and European Food Safety Authority, 2013, EN459 EUR CDCP EUR F; European Centre for Disease Prevention and Control (ECDC) European Food Safety Authority (EFSA), 2013, OUTBR HEP A VIR INF; Gossner CM, 2014, EURO SURVEILL, V19; Holmberg SD, 2012, CLIN INFECT DIS, V54, P782, DOI 10.1093/cid/cir945; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Montano-Remacha C, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.37.20906; Petrignani M, 2014, EMERG INFECT DIS, V20, P596, DOI 10.3201/eid2004.130753; Rizzo C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.7.20518; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023	16	26	28	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149642	10.1371/journal.pone.0149642	http://dx.doi.org/10.1371/journal.pone.0149642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901877	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100117
J	Zhou, J; Li, X; Huang, KC; Jia, Y; Tang, FX; Sun, HY; Zhang, Y; Zhang, QH; Ma, D; Li, S				Zhou, Jin; Li, Xiong; Huang, Kecheng; Jia, Yao; Tang, Fangxu; Sun, Haiying; Zhang, Yuan; Zhang, Qinghua; Ma, Ding; Li, Shuang			Young Cervical Cancer Patients May Be More Responsive than Older Patients to Neoadjuvant Chemotherapy Followed by Radical Surgery	PLOS ONE			English	Article							STAGE IB; ONCOLOGY-GROUP; CARCINOMA; WOMEN; TRIAL; HYSTERECTOMY; PROGNOSIS; SURVIVAL; JAPAN; AGE	Objective To evaluate the effects of age and the clinical response to neoadjuvant chemotherapy (NACT) in patients with cervical cancer who received neoadjuvant chemotherapy followed by radical surgery. Methods A total of 1,014 patients with advanced cervical cancer who received NACT followed by radical surgery were retrospectively selected. Patients were divided into young (aged <= 35 years, n = 177) and older (aged >35 years, n = 837) groups. We compared the short-term responses and survival rates between the groups. The five-year disease-free survival (DFS) and overall survival (OS) rates were stratified by age, NACT response, and FIGO stage. Results The overall response rate was 86.8% in the young group and 80.9% in the older group. The young patients had an earlier FIGO stage (P<0.001), a higher rate of adenocarcinoma (P = 0.022), and more lymph node metastasis (P = 0.033) than the older patients. The presence of adenocarcinoma as the histological type (P = 0.024) and positive lymph node metastasis (P<0.001) were identified as independent risk factors for survival. When stratified by age and clinical response, young patients with no response to NACT had a worse clinicopathological condition compared with the other subgroups. Compared with non-responders, responders to NACT had a higher five-year DFS rate (80.1% versus 71.8%; P = 0.019) and OS rate (82.6% versus 71.8%; P = 0.003) among the young patients but not among the older patients. Conclusions Responders to NACT aged 35 years or younger benefitted the most from NACT, while the young non-responders benefitted the least. Age might represent an important factor to consider when performing NACT in patients with cervical cancer.	[Zhou, Jin; Li, Xiong; Huang, Kecheng; Jia, Yao; Tang, Fangxu; Sun, Haiying; Ma, Ding; Li, Shuang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China; [Zhou, Jin] Wuhan Univ, Ctr Canc, Renmin Hosp, Wuhan 430072, Hubei, Peoples R China; [Li, Xiong; Zhang, Qinghua] Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China; [Zhang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Wuhan University; Huazhong University of Science & Technology	Ma, D; Li, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Obstet & Gynecol, Wuhan 430074, Peoples R China.; Zhang, QH (corresponding author), Cent Hosp Wuhan, Dept Gynecol & Obstet, Wuhan, Peoples R China.	zhangqh66@qq.com; dma@tjh.tjmu.edu.cn; lee5190008@126.com	li, xiong/ABG-2578-2020	li, xiong/0000-0003-0203-2973; Li, Shuang/0000-0002-9193-0320	Key Basic Research and Development Program Foundation of China (973 Program) [2015CB553903]; National Natural Science Foundation of China [91529102, 81572571, 81402160, 81302267, 81230038, 81230052, 30973472, 81001151, 81071663, 30973205, 30973184, 81090414, 81272422, 81172464, 81101964]	Key Basic Research and Development Program Foundation of China (973 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was endorsed by the Key Basic Research and Development Program Foundation of China (973 Program; No. 2015CB553903) and was supported by grants from the National Natural Science Foundation of China (NO. 91529102; 81572571; 81402160; 81302267; 81230038; 81230052; 30973472; 81001151; 81071663; 30973205; 30973184; 81090414; 81272422; 81172464; 81101964).	[Anonymous], 2012, GLOBACAN 2012 DAT CE; Aoki Y, 2001, GYNECOL ONCOL, V83, P263, DOI 10.1006/gyno.2001.6371; Bamias A, 2005, ANN ONCOL, V16, P307, DOI 10.1093/annonc/mdi039; Benedetti-Panici P, 2002, J CLIN ONCOL, V20, P179, DOI 10.1200/JCO.20.1.179; Buda A, 2015, INT J GYNECOL CANCER, V25, P1468, DOI 10.1097/IGC.0000000000000515; Cai HB, 2010, INT J GYNECOL CANCER, V20, P1240, DOI 10.1111/IGC.0b013e3181ecec79; Chang TC, 2000, J CLIN ONCOL, V18, P1740, DOI 10.1200/JCO.2000.18.8.1740; Chemoradiotherapy for cervical cancer meta-analysis collaboration, 2008, J CLIN ONCOL, V26, P5802, DOI DOI 10.1200/JCO.2008.16.4368; Chen HJ, 2008, GYNECOL ONCOL, V110, P308, DOI 10.1016/j.ygyno.2008.05.026; deSouza NM, 2004, BRIT J CANCER, V90, P2326, DOI 10.1038/sj.bjc.6601870; HALL SW, 1983, LANCET, V2, P731; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Huang HJ, 2003, INT J GYNECOL CANCER, V13, P204, DOI 10.1046/j.1525-1438.2003.13004.x; Katsumata N, 2013, BRIT J CANCER, V108, P1957, DOI 10.1038/bjc.2013.179; Kokawa K, 2010, EUR J GYNAECOL ONCOL, V31, P37; Lai CH, 1999, INT J GYNECOL CANCER, V9, P28; Lau HY, 2009, INT J GYNECOL OBSTET, V107, P220, DOI 10.1016/j.ijgo.2009.07.029; Li S, 2013, ONCOLOGIST, V18, P1101, DOI 10.1634/theoncologist.2013-0123; Look KY, 1997, GYNECOL ONCOL, V67, P255, DOI 10.1006/gyno.1997.4886; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; POKA R, 1994, INT J GYNECOL OBSTET, V46, P33, DOI 10.1016/0020-7292(94)90306-9; STANHOPE CR, 1980, GYNECOL ONCOL, V10, P188, DOI 10.1016/0090-8258(80)90080-3; Wang J, 2015, MOL CLIN ONCOL, V3, P363, DOI 10.3892/mco.2014.465; Wen H, 2012, INT J GYNECOL CANCER, V22, P296, DOI 10.1097/IGC.0b013e31823610a1; World Health Organization, 1979, WHO HDB REP RES CANC, P16	25	2	4	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149534	10.1371/journal.pone.0149534	http://dx.doi.org/10.1371/journal.pone.0149534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901776	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100094
J	Peng, H; Cui, JK; Long, HB; Huang, WK; Kong, LA; Liu, SM; He, WT; Hu, XQ; Peng, DL				Peng, Huan; Cui, Jiangkuan; Long, Haibo; Huang, Wenkun; Kong, Lingan; Liu, Shiming; He, Wenting; Hu, Xianqi; Peng, Deliang			Novel Pectate Lyase Genes of Heterodera glycines Play Key Roles in the Early Stage of Parasitism	PLOS ONE			English	Article							SUBVENTRAL ESOPHAGEAL GLANDS; DOUBLE-STRANDED-RNA; MOLECULAR CHARACTERIZATION; DEVELOPMENTAL EXPRESSION; FUNCTIONAL-ANALYSIS; CELL WALLS; SEQUENCE; CLONING; NEMATODES; EFFICIENT	Pectate lyases are known to play a key role in pectin degradation by catalyzing the random cleavage of internal polymer linkages (endo-pectinases). In this paper, four novel cDNAs, designated Hg-pel-3, Hg-pel-4, Hg-pel-6 and Hg-pel-7, that encode pectate lyases were cloned and characterized from the soybean cyst nematode, Heterodera glycines. The predicted protein sequences of HG-PEL-3, HG-PEL-4 and HG-PEL-6 differed significantly in both their amino acid sequences and their genomic structures from other pectate lyases of H. glycines (HG-PEL-1, HG-PEL-2 and HG-PEL-7). A phylogenetic study revealed that the pectate lyase proteins of H. glycines are clustered into distinct clades and have distinct numbers and positioning of introns, which suggests that the pectate lyase genes of H. glycines may have evolved from at least two ancestral genes. A Southern blot analysis revealed that multiple Hg-pel-6-like genes were present in the H. glycines genome. In situ hybridization showed that four novel pectate lyases (Hg-pel-3, Hg-pel-4, Hg-pel-6 and Hg-pel-7) were actively transcribed in the subventral esophageal gland cells. A semi-quantitative RT-PCR assay supported the finding that the expression of these genes was strong in the egg, pre-parasitic second-stage juvenile (J2) and early parasitic J2 stages and that it declined in further developmental stages of the nematode. This expression pattern suggests that these proteins play a role in the migratory phase of the nematode life cycle. Knocking down Hg-pel-6 using in vitro RNA interference resulted in a 46.9% reduction of the number of nematodes that invaded the plants and a 61.5% suppression of the development of H. glycines females within roots compared to the GFP-dsRNA control. Plant hostderived RNAi induced the silencing of the Hg-pel-6gene, which significantly reduced the nematode infection levels at 7 Days post inoculation (dpi). Similarly, this procedure reduced the number of female adults at 40 dpi, which suggests the important roles of this gene in the early stages of parasitism. Our combined data suggest that two types of pectate lyases are present in the H. glycines genome and may have different roles during infection.	[Peng, Huan; Cui, Jiangkuan; Huang, Wenkun; Kong, Lingan; Liu, Shiming; He, Wenting; Peng, Deliang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Long, Haibo] Chinese Acad Trop Agr Sci, Key Lab Pests Comprehens Governance Trop Crops, Minist Agr, Environm & Plant Protect Inst, Danzhou, Peoples R China; [Hu, Xianqi] Yunnan Agr Univ, Natl Engn Res Ctr Agribiodivers Appl Technol, Kunming, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Yunnan Agricultural University	Peng, DL (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.; Hu, XQ (corresponding author), Yunnan Agr Univ, Natl Engn Res Ctr Agribiodivers Appl Technol, Kunming, Peoples R China.	xqhoo@126.com; dlpeng@ippcaas.cn	Liu, Shiming/AAG-9495-2020		National Natural Science Foundation of China [31301646]; Special Fund for Agro-scientific Research in the Public Interest [201503114]; National Key Basic Research Program of China (973 Program) [2013CB127502]; Genetically modified organisms breeding major projects [2012ZX08009004-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest; National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); Genetically modified organisms breeding major projects	This research work was supported by the National Natural Science Foundation of China (31301646), the Special Fund for Agro-scientific Research in the Public Interest (No. 201503114), National Key Basic Research Program of China (973 Program, 2013CB127502), and the Genetically modified organisms breeding major projects (2012ZX08009004-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; BIRD AF, 1983, INT J PARASITOL, V13, P343, DOI 10.1016/S0020-7519(83)80038-1; Bohlmann H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00089; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Chen Q, 2005, MOL PLANT MICROBE IN, V18, P621, DOI 10.1094/MPMI-18-0621; Cho HJ, 2000, PLANTA, V210, P195, DOI 10.1007/PL00008126; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; Davis EL, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P255, DOI 10.1007/978-94-007-0434-3_12; de Boer JM, 1998, J NEMATOL, V30, P309; De Boer JM, 2002, J NEMATOL, V34, P9; de Boer JM, 1999, MOL PLANT MICROBE IN, V12, P663, DOI 10.1094/MPMI.1999.12.8.663; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Doyle EA, 2002, MOL PLANT MICROBE IN, V15, P549, DOI 10.1094/MPMI.2002.15.6.549; Eves-van den Akker S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004391; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Herron SR, 2000, P NATL ACAD SCI USA, V97, P8762, DOI 10.1073/pnas.97.16.8762; Huang GZ, 2005, INT J PARASITOL, V35, P685, DOI 10.1016/j.ijpara.2005.01.006; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Karim N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-525; Kikuchi T, 2006, MOL PLANT MICROBE IN, V19, P280, DOI 10.1094/MPMI-19-0280; Kikuchi T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002219; Kudla U, 2007, MOL PLANT PATHOL, V8, P293, DOI 10.1111/J.1364-3703.2007.00394.X; Lilley CJ, 2012, PARASITOLOGY, V139, P630, DOI 10.1017/S0031182011002071; Lilley CJ, 2005, INT J PARASITOL, V35, P1577, DOI 10.1016/j.ijpara.2005.07.017; Long H, 2013, PLANT PATHOL, V62, P953, DOI 10.1111/ppa.12000; Murienne J, 2010, MOL PHYLOGENET EVOL, V57, P301, DOI 10.1016/j.ympev.2010.06.022; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Ou SQ, 2008, NEMATOLOGY, V10, P397, DOI 10.1163/156854108783900212; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Popeijus H, 2000, NATURE, V406, P36, DOI 10.1038/35017641; Sukno SA, 2007, J NEMATOL, V39, P145; Tamaru Y, 2001, P NATL ACAD SCI USA, V98, P4125, DOI 10.1073/pnas.071045598; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Vanholme B, 2007, MOL PLANT PATHOL, V8, P267, DOI 10.1111/J.1364-3703.2007.00392.X; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wrather JA, 2006, J NEMATOL, V38, P173; Wrather JA, 2001, CAN J PLANT PATHOL, V23, P115	42	10	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149959	10.1371/journal.pone.0149959	http://dx.doi.org/10.1371/journal.pone.0149959			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930215	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500078
J	Carciofo, R; Yang, JY; Song, N; Du, F; Zhang, K				Carciofo, Richard; Yang, Jiaoyan; Song, Nan; Du, Feng; Zhang, Kan			Psychometric Evaluation of Chinese-Language 44-Item and 10-Item Big Five Personality Inventories, Including Correlations with Chronotype, Mindfulness and Mind Wandering	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; NEO-PI-R; 5-FACTOR MODEL; SUSTAINED ATTENTION; COGNITIVE FAILURES; OLDER-ADULTS; RELIABILITY; VERSION; TRAITS; SCALES	The 44-item and 10-item Big Five Inventory (BFI) personality scales are widely used, but there is a lack of psychometric data for Chinese versions. Eight surveys (total N = 2,496, aged 18-82), assessed a Chinese-language BFI-44 and/or an independently translated Chinese-language BFI-10. Most BFI-44 items loaded strongly or predominantly on the expected dimension, and values of Cronbach's alpha ranged .698-. 807. Test-retest coefficients ranged .694-.770 (BFI-44), and .515-.873 (BFI-10). The BFI-44 and BFI-10 showed good convergent and discriminant correlations, and expected associations with gender (females higher for agreeableness and neuroticism), and age (older age associated with more conscientiousness and agreeableness, and also less neuroticism and openness). Additionally, predicted correlations were found with chronotype (morningness positive with conscientiousness), mindfulness (negative with neuroticism, positive with conscientiousness), and mind wandering/daydreaming frequency (negative with conscientiousness, positive with neuroticism). Exploratory analysis found that the Self-discipline facet of conscientiousness positively correlated with morningness and mindfulness, and negatively correlated with mind wandering/daydreaming frequency. Furthermore, Self-discipline was found to be a mediator in the relationships between chronotype and mindfulness, and chronotype and mind wandering/daydreaming frequency. Overall, the results support the utility of the BFI-44 and BFI-10 for Chinese-language big five personality research.	[Carciofo, Richard; Yang, Jiaoyan; Du, Feng; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Carciofo, Richard] Xian Jiaotong Liverpool Univ, Language Ctr, Suzhou, Peoples R China; [Song, Nan] Beijing Foreign Studies Univ, Sch English Specif Purposes, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Xi'an Jiaotong-Liverpool University; Beijing Foreign Studies University	Du, F (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	duf@psych.ac.cn		Du, Feng/0000-0002-5900-8002	National Natural Science Foundation of China [31470982, 31200766]; Chinese Academy of Sciences [KJZD-EW-L04-4]; scientific foundation of the Institute of Psychology, Chinese Academy of Sciences [Y4CX033008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); scientific foundation of the Institute of Psychology, Chinese Academy of Sciences	FD was supported by the National Natural Science Foundation of China (31470982 & 31200766 / http://www.nsfc.gov.cn/publish/portal1/), the Chinese Academy of Sciences (KJZD-EW-L04-4 / http://english.cas.cn/), and the scientific foundation of the Institute of Psychology, Chinese Academy of Sciences (Y4CX033008 / http://english.psych.cas.cn/). These funders had no role in study design, data collection, analysis and interpretation, manuscript preparation, or decision to publish.	ADAN A, 1991, PERS INDIV DIFFER, V12, P241, DOI 10.1016/0191-8869(91)90110-W; [Anonymous], PRACT ASSESS RES EVA; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Biss RK, 2012, EMOTION, V12, P437, DOI 10.1037/a0027071; BORKENAU P, 1990, PERS INDIV DIFFER, V11, P515, DOI 10.1016/0191-8869(90)90065-Y; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Carciofo R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091285; Carciofo R, 2014, BIOL RHYTHM RES, V45, P37, DOI 10.1080/09291016.2013.790651; Carciofo R, 2012, SLEEP BIOL RHYTHMS, V10, P310, DOI 10.1111/j.1479-8425.2012.00577.x; Carriere JSA, 2008, CONSCIOUS COGN, V17, P835, DOI 10.1016/j.concog.2007.04.008; Chelminski I, 2000, PERS INDIV DIFFER, V29, P469, DOI 10.1016/S0191-8869(99)00208-1; Cheung FM, 2001, J CROSS CULT PSYCHOL, V32, P407, DOI 10.1177/0022022101032004003; Cheyne JA, 2006, CONSCIOUS COGN, V15, P578, DOI 10.1016/j.concog.2005.11.009; Crede M, 2012, J PERS SOC PSYCHOL, V102, P874, DOI 10.1037/a0027403; DIGMAN JM, 1990, ANNU REV PSYCHOL, V41, P417, DOI 10.1146/annurev.psych.41.1.417; Donnellan AB, 2008, PSYCHOL AGING, V23, P558, DOI 10.1037/a0012897; Donnellan MB, 2006, PSYCHOL ASSESSMENT, V18, P192, DOI 10.1037/1040-3590.18.2.192; Franklin MS, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00583; Furnham A, 2008, PSYCHOL REP, V102, P312, DOI 10.2466/PR0.102.1.312-316; GIAMBRA LM, 1978, J CLIN PSYCHOL, V34, P14; Giluk TL, 2009, PERS INDIV DIFFER, V47, P805, DOI 10.1016/j.paid.2009.06.026; Gnambs T, 2014, J RES PERS, V52, P20, DOI 10.1016/j.jrp.2014.06.003; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Gosling SD, NOTE ALPHA RELIABILI; Herzberg PY, 2006, EUR J PSYCHOL ASSESS, V22, P139, DOI 10.1027/1015-5759.22.3.139; Hofmans J, 2008, PERS INDIV DIFFER, V45, P750, DOI 10.1016/j.paid.2008.08.004; Hogben AL, 2007, CHRONOBIOL INT, V24, P1249, DOI 10.1080/07420520701791596; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Howell AJ, 2008, PERS INDIV DIFFER, V45, P773, DOI 10.1016/j.paid.2008.08.005; Hsu CY, 2012, CHRONOBIOL INT, V29, P491, DOI 10.3109/07420528.2012.668995; Jackson JD, 2012, PSYCHOL AGING, V27, P106, DOI 10.1037/a0023933; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; John O. P., 2008, HDB PERSONALITY THEO, V3, P114; Killingsworth MA, 2010, SCIENCE, V330, P932, DOI 10.1126/science.1192439; Konstabel K, 2012, EUR J PERSONALITY, V26, P13, DOI 10.1002/per.813; Leung D. Y., 2013, J NURSING ED PRACTIC, V3, P1, DOI DOI 10.5430/jnep.v3n6p; Li SX, 2011, SLEEP BIOL RHYTHMS, V9, P19, DOI 10.1111/j.1479-8425.2010.00480.x; Marsh HW, 2013, DEV PSYCHOL, V49, P1194, DOI 10.1037/a0026913; Matsunaga M, 2010, INT J PSYCHOL RES, V3, P97, DOI 10.21500/20112084.854; McCrae RR, 2015, PERS SOC PSYCHOL REV, V19, P97, DOI 10.1177/1088868314541857; McCrae RR, 2011, PERS SOC PSYCHOL REV, V15, P28, DOI 10.1177/1088868310366253; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McCrae RR, 1996, J PERS SOC PSYCHOL, V70, P552, DOI 10.1037/0022-3514.70.3.552; McMillan RL, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00626; Mecacci L, 2004, PERS INDIV DIFFER, V37, P107, DOI 10.1016/j.paid.2003.08.004; Mrazek MD, 2012, EMOTION, V12, P442, DOI 10.1037/a0026678; Muck PM, 2007, EUR J PSYCHOL ASSESS, V23, P166, DOI 10.1027/1015-5759.23.3.166; Oshio A., 2013, PSYCHOLOGY, V4, P924, DOI [10.4236/psych.2013.412133, DOI 10.4236/PSYCH.2013.412133]; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Raykov T, 1998, PERS INDIV DIFFER, V24, P291, DOI 10.1016/S0191-8869(97)00159-1; Renau V, 2013, ALOMA, V31, P85; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; Sheehan, 1972, FUNCTION NATURE IMAG, P175; Singer J.L., 1966, DAYDREAMING INTRO EX; Singer JL, 1978, STREAM CONSCIOUSNESS, P187; Smallwood J, 2006, PSYCHOL BULL, V132, P946, DOI 10.1037/0033-2909.132.6.946; Smallwood J, 2009, EMOTION, V9, P271, DOI 10.1037/a0014855; Smilek D, 2010, NEUROPSYCHOLOGIA, V48, P2564, DOI 10.1016/j.neuropsychologia.2010.05.002; Soto CJ, 2011, J PERS SOC PSYCHOL, V100, P330, DOI 10.1037/a0021717; Soto CJ, 2009, J RES PERS, V43, P84, DOI 10.1016/j.jrp.2008.10.002; Stawarczyk D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00363; Stolarski M, 2013, BIOL RHYTHM RES, V44, P181, DOI 10.1080/09291016.2012.656248; Terracciano A, 2005, PSYCHOL AGING, V20, P493, DOI 10.1037/0882-7974.20.3.493; Thalmayer AG, 2011, PSYCHOL ASSESSMENT, V23, P995, DOI 10.1037/a0024165; Tsaousis I, 2010, EUR J PERSONALITY, V24, P356, DOI 10.1002/per.754; Woods SA, 2005, EUR J PERSONALITY, V19, P373, DOI 10.1002/per.542; Yang J, 1999, PSYCHOL ASSESSMENT, V11, P359, DOI 10.1037/1040-3590.11.3.359; Zhang LF, 2001, EUR J PERSONALITY, V15, P465, DOI 10.1002/per.429; Zheng LJ, 2008, PERS INDIV DIFFER, V45, P649, DOI 10.1016/j.paid.2008.07.009; Zhiyan T., 1997, IMAG COGN PERS, V16, P399, DOI [10.2190/ateh-96ev-exyx-2adb, DOI 10.2190/ATEH-96EV-EXYX-2ADB]; Zhou XY, 2009, J PERS, V77, P363, DOI 10.1111/j.1467-6494.2008.00551.x	78	93	97	13	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149963	10.1371/journal.pone.0149963	http://dx.doi.org/10.1371/journal.pone.0149963			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918618	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400063
J	Rice, DB; Thombs, BD				Rice, Danielle B.; Thombs, Brett D.			Risk of Bias from Inclusion of Currently Diagnosed or Treated Patients in Studies of Depression Screening Tool Accuracy: A Cross-Sectional Analysis of Recently Published Primary Studies and Meta-Analyses	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MAJOR DEPRESSION; RECOMMENDATIONS; TRENDS; SETTINGS; VALIDITY; ANXIETY; HEALTH; BREAST; CARE	Background Depression screening can improve upon usual care only if screening tools accurately identify depressed patients who would not otherwise be recognized by healthcare providers. Inclusion of patients already being treated for depression in studies of screening tool accuracy would inflate estimates of screening accuracy and yield. The present study investigated (1) the proportion of primary studies of depression screening tool accuracy that were recently published in journals listed in MEDLINE, which appropriately excluded currently diagnosed or treated patients; and (2) whether recently published meta-analyses identified the inclusion of currently diagnosed or treated patients as a potential source of bias. Methods MEDLINE was searched from January 1, 2013 through March 27, 2015 for primary studies and meta-analyses on depression screening tool accuracy. Results Only 5 of 89 (5.6%) primary studies excluded currently diagnosed or treated patients from any analyses and only 3 (3.4%) from main analyses. In 3 studies that reported the number of patients excluded due to current treatment, the number of excluded patients was more than twice the number of newly identified depression cases. None of 5 meta-analyses identified the inclusion of currently diagnosed and treated patients as a potential source of bias. Conclusions The inclusion of currently diagnosed and treated patients in studies of depression screening tool accuracy is a problem that limits the applicability of research findings for actual clinical practice. Studies are needed that evaluate the diagnostic accuracy of depression screening tools among only untreated patients who would potentially be screened in practice.	[Rice, Danielle B.; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Rice, Danielle B.; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Sch Nursing, Montreal, PQ, Canada.	brett.thombs@mcgill.ca	Rice, Danielle B/AAS-3681-2020		CIHR Frederick Banting and Charles Best Canada Graduate Scholarship; Arthritis Society	CIHR Frederick Banting and Charles Best Canada Graduate Scholarship(Canadian Institutes of Health Research (CIHR)); Arthritis Society	Ms. Rice was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. There was no specific funding for this study, and no funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors had full access to the data and can take responsibility for the integrity of the data and the accuracy of the data analysis.	Allaby M, 2010, SCREENING DEPRESSION; Benazon NR, 2005, PSYCHOSOM MED, V67, P916, DOI 10.1097/01.psy.0000188399.80167.aa; Burton C, 2013, PSYCHOL MED, V43, P529, DOI 10.1017/S0033291712001481; Canadian Diabetes Association Expert Panel Committee, 2013, CAN J DIABETES, V37, pS168, DOI DOI 10.1016/J.JCJD.2013.01.009; Centers for Medicare and Medicaid Services, 2010, MED PROGR PAYM POL P; Colquhoun DM, 2013, MED J AUSTRALIA, V198, P483, DOI 10.5694/mja13.10153; Coyne JC, 2004, GEN HOSP PSYCHIAT, V26, P121, DOI 10.1016/j.genhosppsych.2003.08.012; Czarny MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027671; Eskes G.A., 2015, INT J STROKE; Gilbody S, 2008, CAN MED ASSOC J, V178, P997, DOI 10.1503/cmaj.070281; Haddad M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078493; Holland JC, 2013, J NATL COMPR CANC NE, V11, P190, DOI 10.6004/jnccn.2013.0027; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Joffres M, 2013, CAN MED ASSOC J, V185, P775, DOI 10.1503/cmaj.130403; Keshavarz H, 2014, CMAJ OPEN, V1, pe159; Lewer D, 2015, BR J PSYCHIAT; Lichtman JH, 2008, CIRCULATION, V118, P1768, DOI 10.1161/CIRCULATIONAHA.108.190769; Meng XF, 2013, CAN J PSYCHIAT, V58, P426, DOI 10.1177/070674371305800708; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mojtabai R, 2014, NEW ENGL J MED, V370, P1180, DOI 10.1056/NEJMp1311047; Mojtabai R, 2014, J CLIN PSYCHIAT, V75, P169, DOI 10.4088/JCP.13m08443; Mojtabai R, 2013, PSYCHOTHER PSYCHOSOM, V82, P161, DOI 10.1159/000345968; Mojtabai R, 2011, HEALTH AFFAIR, V30, P1434, DOI 10.1377/hlthaff.2010.1024; National Collaborating Center for Mental Health, 2010, NICE GUID MAN TREATM; National Comprehensive Cancer Network, 2008, DISTR MAN NCCN CLIN; National Institute of Clinical Excellence, 2004, GUID CANC SERV IMPR; O'Connor EA, 2009, ANN INTERN MED, V151, P793, DOI 10.7326/0003-4819-151-11-200912010-00007; Patten SB, 2015, MULT SCLER J, V21, P1064, DOI 10.1177/1352458514559297; Stafford L, 2014, GEN HOSP PSYCHIAT, V36, P74, DOI 10.1016/j.genhosppsych.2013.08.010; Thombs BD, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-124; Thombs BD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1253; Thombs BD, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-13; Thombs BD, 2012, CAN MED ASSOC J, V184, P413, DOI 10.1503/cmaj.111035; Thombs BD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4825; US Preventive Serv Task Force, 2009, ANN INTERN MED, V151, P784, DOI 10.7326/0003-4819-151-11-200912010-00006; van Enst WA, 2014, J CLIN EPIDEMIOL, V67, P1192, DOI 10.1016/j.jclinepi.2014.05.008; Whiting P, 2004, ANN INTERN MED, V140, P189, DOI 10.7326/0003-4819-140-3-200402030-00010; Xie Z, 2015, INT PSYCHOGERIATR, V23, P1; Yang Y, 2014, COMPR PSYCHIAT, V55, P215, DOI 10.1016/j.comppsych.2013.08.012	39	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150067	10.1371/journal.pone.0150067	http://dx.doi.org/10.1371/journal.pone.0150067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919313	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400081
J	Roy, SK; Cho, SW; Kwon, SJ; Kamal, AM; Kim, SW; Oh, MW; Lee, MS; Chung, KY; Xin, ZG; Woo, SH				Roy, Swapan Kumar; Cho, Seong-Woo; Kwon, Soo Jeong; Kamal, Abu Hena Mostafa; Kim, Sang-Woo; Oh, Myeong-Won; Lee, Moon-Soon; Chung, Keun-Yook; Xin, Zhanguo; Woo, Sun-Hee			Morpho-Physiological and Proteome Level Responses to Cadmium Stress in Sorghum	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; INDUCED OXIDATIVE STRESS; ARABIDOPSIS-THALIANA; THLASPI-CAERULESCENS; METAL ACCUMULATION; ANALYSIS PROVIDES; PLANT-RESPONSE; ROOT PROTEOME; HEAVY-METALS; TOXICITY	Cadmium (Cd) stress may cause serious morphological and physiological abnormalities in addition to altering the proteome in plants. The present study was performed to explore Cd-induced morpho-physiological alterations and their potential associated mechanisms in Sorghum bicolor leaves at the protein level. Ten-day-old sorghum seedlings were exposed to different concentrations (0, 100, and 150 mu M) of CdCl2, and different morpho-physiological responses were recorded. The effects of Cd exposure on protein expression patterns in S. bicolor were investigated using two-dimensional gel electrophoresis (2-DE) in samples derived from the leaves of both control and Cd-treated seedlings. The observed morphological changes revealed that the plants treated with Cd displayed dramatically altered shoot lengths, fresh weights and relative water content. In addition, the concentration of Cd was markedly increased by treatment with Cd, and the amount of Cd taken up by the shoots was significantly and directly correlated with the applied concentration of Cd. Using the 2-DE method, a total of 33 differentially expressed protein spots were analyzed using MALDI-TOF/TOF MS. Of these, treatment with Cd resulted in significant increases in 15 proteins and decreases in 18 proteins. Major changes were absorbed in the levels of proteins known to be involved in carbohydrate metabolism, transcriptional regulation, translation and stress responses. Proteomic results revealed that Cd stress had an inhibitory effect on carbon fixation, ATP production and the regulation of protein synthesis. Our study provides insights into the integrated molecular mechanisms involved in responses to Cd and the effects of Cd on the growth and physiological characteristics of sorghum seedlings. We have aimed to provide a reference describing the mechanisms involved in heavy metal damage to plants.	[Roy, Swapan Kumar; Kwon, Soo Jeong; Kim, Sang-Woo; Woo, Sun-Hee] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Cho, Seong-Woo] Rural Dev Adm, Div Rice Res, Natl Inst Crop Sci, Suwon, South Korea; [Kamal, Abu Hena Mostafa] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA; [Oh, Myeong-Won] Rural Dev Adm, Natl Acad Agr Sci, Natl Agrobiodivers Ctr, Jeonju, South Korea; [Lee, Moon-Soon] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Chung, Keun-Yook] Chungbuk Natl Univ, Dept Environm & Biol Chem, Cheongju, South Korea; [Xin, Zhanguo] ARS, Plant Stress & Germplasm Dev Unit, USDA, 3810 4th St, Lubbock, TX USA	Chungbuk National University; Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; University of Texas System; University of Texas Arlington; Rural Development Administration (RDA), Republic of Korea; Chungbuk National University; Chungbuk National University; United States Department of Agriculture (USDA)	Woo, SH (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.; Lee, MS (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.	mslee416@chungbuk.ac.kr; shwoo@chungbuk.ac.kr	Roy, Swapan Kumar/R-2427-2016; Woo, Sun-Hee/P-9048-2016; Kamal, Abu Hena Mostafa/E-7520-2012	Roy, Swapan Kumar/0000-0002-3837-4011; Woo, Sun-Hee/0000-0002-6219-1688; Kamal, Abu Hena Mostafa/0000-0001-6750-0729; Xin, Zhanguo/0000-0003-1471-7785; Cho, Seong-Woo/0000-0001-7900-4781	Rural Development Administration, Republic of Korea [PJ009101012014]; ARS [ARS-0425249] Funding Source: Federal RePORTER	Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by a grant from the Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea. Grant No: PJ009101012014. URL: http://atis.rda.go.kr/rdais/main/main.vw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan N, 2007, CR BIOL, V330, P735, DOI 10.1016/j.crvi.2007.08.001; Aina R, 2007, ENVIRON EXP BOT, V59, P381, DOI 10.1016/j.envexpbot.2006.04.010; Ali B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123328; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Angelova V.R., 2011, J AGR SCI TECH-IRAN, V1, P693; Anjum NA, 2012, ENVIRON EXP BOT, V75, P307, DOI 10.1016/j.envexpbot.2011.07.002; ARDUINI I, 1994, PHYSIOL PLANTARUM, V92, P675, DOI 10.1111/j.1399-3054.1994.tb03039.x; Arnon, 1950, WATER CULTURE METHOD, V347, DOI DOI 10.1073/PNAS.1211132109; Bae W, 2004, MOL CELL PROTEOMICS, V3, P596, DOI 10.1074/mcp.M300122-MCP200; BAKER AJM, 1994, NEW PHYTOL, V127, P61, DOI 10.1111/j.1469-8137.1994.tb04259.x; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Benavides María P., 2005, Braz. J. Plant Physiol., V17, P21, DOI 10.1590/S1677-04202005000100003; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bozcaarmutlu A, 2007, TOXICOL IN VITRO, V21, P408, DOI 10.1016/j.tiv.2006.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaoui A, 1997, PLANT SCI, V127, P139, DOI 10.1016/S0168-9452(97)00115-5; Chen J, 2014, PROTEOMIC ANAL REVEA, DOI [10.1371/journal.pone.0102532, DOI 10.1371/JOURNAL.PONE.0102532]; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Cox AD, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00387; Cvjetko P, 2014, ARH HIG RADA TOKSIKO, V65, P1, DOI 10.2478/10004-1254-65-2014-2443; D'Alessandro A, 2013, J PROTEOME RES, V12, P4979, DOI 10.1021/pr400793e; Da-lin L, 2013, AFRICAN J BIOTECHNOL, V10, P15770; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; Deeba F, 2012, PLANT PHYSIOL BIOCH, V53, P6, DOI 10.1016/j.plaphy.2012.01.002; Dixon DP, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews3004; Epelde L, 2009, SOIL BIOL BIOCHEM, V41, P1788, DOI 10.1016/j.soilbio.2008.04.001; Fagioni M, 2009, J PROTEOME RES, V8, P2519, DOI 10.1021/pr8011182; Fang XP, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-26; Faruruwa D. M., 2013, GLOBAL ADV RES J ENV, V2, P82; FOY CD, 1978, ANNU REV PLANT PHYS, V29, P511, DOI 10.1146/annurev.pp.29.060178.002455; Zancheta ACF, 2015, INT J PHYTOREMEDIAT, V17, P298, DOI 10.1080/15226514.2014.883492; Gallego SM, 2012, ENVIRON EXP BOT, V83, P33, DOI 10.1016/j.envexpbot.2012.04.006; Glass DJ, 2000, PHYTOREMEDIATION OF TOXIC METALS, P15; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; Hajduch M, 2001, ELECTROPHORESIS, V22, P2824, DOI 10.1002/1522-2683(200108)22:13&lt;2824::AID-ELPS2824&gt;3.0.CO;2-C; Hossain Mohammad Anwar, 2010, Physiology and Molecular Biology of Plants, V16, P19, DOI 10.1007/s12298-010-0003-0; Hossain MA, 2009, AUST J CROP SCI, V3, P53; Hossain Z, 2012, AMINO ACIDS, V43, P2393, DOI 10.1007/s00726-012-1319-6; Hossain Z, 2012, J PROTEOMICS, V75, P4151, DOI 10.1016/j.jprot.2012.05.037; Hu WJ, 2014, INT J MOL SCI, V15, P4333, DOI 10.3390/ijms15034333; Huang XL, 2009, PROG NAT SCI-MATER, V19, P845, DOI 10.1016/j.pnsc.2008.07.024; Ji XL, 2009, PROTEOMICS, V9, P5328, DOI 10.1002/pmic.200900012; Kalpana Arora, 2009, Asian Journal of Experimental Sciences, V23, P341; Khan NA, 2007, J AGRON CROP SCI, V193, P435, DOI 10.1111/j.1439-037X.2007.00272.x; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Kieffer P, 2009, J PROTEOMICS, V72, P379, DOI 10.1016/j.jprot.2009.01.014; Kim YK, 2009, J KOREAN SOC APPL BI, V52, P428, DOI 10.3839/jksabc.2009.075; Kleckerova A, 2011, INT J ELECTROCHEM SC, V6, P6011; Kovacik J, 2008, PLANT CELL REP, V27, P605, DOI 10.1007/s00299-007-0490-9; Lee K, 2010, J PLANT PHYSIOL, V167, P161, DOI 10.1016/j.jplph.2009.09.006; Li GZ, 2013, J PROTEOME RES, V12, P4846, DOI 10.1021/pr4008283; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124304; Liu CP, 2015, INT J MOL SCI, V16, P13692, DOI 10.3390/ijms160613692; Lopes CA, 2015, ECOTOX ENVIRON SAFE, V119, P170, DOI 10.1016/j.ecoenv.2015.05.016; MALONE CP, 1978, CAN J BOT, V56, P277, DOI 10.1139/b78-034; Marmiroli M, 2013, CHEMOSPHERE, V93, P1333, DOI 10.1016/j.chemosphere.2013.07.065; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mendoza J, 2006, CHEMOSPHERE, V65, P2304, DOI 10.1016/j.chemosphere.2006.05.012; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Monni S, 2000, ENVIRON POLLUT, V109, P221, DOI 10.1016/S0269-7491(99)00264-X; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Muneer S, 2014, INT J MOL SCI, V15, P6343, DOI 10.3390/ijms15046343; Nepovim A, 2004, CHEMOSPHERE, V57, P1007, DOI 10.1016/j.chemosphere.2004.08.030; Ngara R, 2014, PROTEOMICS, V14, P611, DOI 10.1002/pmic.201300351; Ogawa I, 2009, PLANT SOIL, V325, P97, DOI 10.1007/s11104-009-0116-9; Oh MW, 2014, MOL BIOL REP, V41, P671, DOI 10.1007/s11033-013-2905-8; Ostrowski SR, 1999, TOXICOL IND HEALTH, V15, P602, DOI 10.1191/074823399678847005; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Pandey A, 2008, MOL CELL PROTEOMICS, V7, P88, DOI 10.1074/mcp.M700314-MCP200; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peng KJ, 2006, J ENVIRON SCI HEAL A, V41, P65, DOI 10.1080/10934520500298838; Pinto AP, 2006, J PLANT NUTR, V29, P1229, DOI 10.1080/01904160600767450; Rascio N, 2011, PLANT SCI, V180, P169, DOI 10.1016/j.plantsci.2010.08.016; Reeves RD, 2001, INT J PHYTOREMEDIAT, V3, P145, DOI 10.1080/15226510108500054; Rodriguez-Celma J, 2010, J PROTEOMICS, V73, P1694, DOI 10.1016/j.jprot.2010.05.001; Roth U, 2006, J EXP BOT, V57, P4003, DOI 10.1093/jxb/erl170; Rustichelli C, 2008, ENVIRON POLLUT, V156, P1121, DOI 10.1016/j.envpol.2008.04.010; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sanita di Toppi L, 1999, ENVIRON EXP BOT, V41, P105, DOI 10.1016/S0098-8472(98)00058-6; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Semane B, 2007, PHYSIOL PLANTARUM, V129, P519, DOI 10.1111/j.1399-3054.2006.00822.x; Semane B, 2010, J PLANT PHYSIOL, V167, P247, DOI 10.1016/j.jplph.2009.09.015; Seregin IV, 2011, RUSS J PLANT PHYSL+, V58, P721, DOI 10.1134/S1021443711040133; Seregin IV, 1997, RUSS J PLANT PHYSL+, V44, P791; Sergeant K, 2014, ENVIRON EXP BOT, V106, P112, DOI 10.1016/j.envexpbot.2014.01.007; Shin YH, 2002, BBA-GENE STRUCT EXPR, V1577, P164, DOI 10.1016/S0167-4781(02)00422-0; Small ID, 2000, TRENDS BIOCHEM SCI, V25, P46, DOI 10.1016/S0968-0004(99)01520-0; Smith AP, 2004, J BIOL CHEM, V279, P26098, DOI 10.1074/jbc.M402807200; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Tkalec M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087582; van Wijk KJ, 2001, PLANT PHYSIOL, V126, P501, DOI 10.1104/pp.126.2.501; Villiers F, 2011, PROTEOMICS, V11, P1650, DOI 10.1002/pmic.201000645; Wang R, 2013, INT J MOL SCI, V14, P11125, DOI 10.3390/ijms140611125; Weng ZX, 2013, TREES-STRUCT FUNCT, V27, P583, DOI 10.1007/s00468-012-0811-7; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Williams TD, 2006, ENVIRON SCI TECHNOL, V40, P6479, DOI 10.1021/es061142h; Wojtaszek P, 1997, BIOCHEM J, V322, P681, DOI 10.1042/bj3220681; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wu FB, 2003, COMMUN SOIL SCI PLAN, V34, P2003, DOI 10.1081/CSS-120023233; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Zawoznik MS, 2007, PLANT SCI, V173, P190, DOI 10.1016/j.plantsci.2007.05.004; Zechmann B., 2008, P193, DOI 10.1007/978-3-540-76326-0_9; Zeng XW, 2011, CHEMOSPHERE, V82, P321, DOI 10.1016/j.chemosphere.2010.10.030; Zhang AQ, 2015, AQUAT TOXICOL, V163, P1, DOI 10.1016/j.aquatox.2015.03.018; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; Zhuang P, 2009, J ENVIRON SCI-CHINA, V21, P1432, DOI 10.1016/S1001-0742(08)62436-5; Zou HX, 2015, ECOTOX ENVIRON SAFE, V111, P271, DOI 10.1016/j.ecoenv.2014.10.028	114	37	39	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150431	10.1371/journal.pone.0150431	http://dx.doi.org/10.1371/journal.pone.0150431			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919231	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400128
J	Beall, RF; Nickerson, JW; Kaplan, WA; Attaran, A				Beall, Reed F.; Nickerson, Jason W.; Kaplan, Warren A.; Attaran, Amir			Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products?	PLOS ONE			English	Article							ALBUTEROL INHALERS	Background Not all new drug products are truly new. Some are the result of marginal innovation and incremental patenting of existing products, but in such a way that confers no major therapeutic improvement. This phenomenon, pejoratively known as "evergreening", can allow manufacturers to preserve market exclusivity, but without significantly bettering the standard of care. Other studies speculate that evergreening is especially problematic for medicine/device combination products, because patents on the device component may outlast expired patents on the medicine component, and thereby keep competing, possibly less-expensive generic products off the market. Materials and Methods We focused on four common conditions that are often treated by medicine/device product combinations: asthma and chronic obstructive pulmonary disease (COPD), diabetes, and severe allergic reactions. The patent data for a sample of such products (n = 49) for treating these conditions was extracted fromthe United States Food and Drug Administration's Orange Book. Additional patent-related data (abstracts, claims, etc) were retrieved using LexisNexis TotalPatent. Comparisons were thenmade between each product's device patents and medicine patents. Results Unexpired device patents exist for 90 percent of the 49 medicine/device product combinations studied, and were the only sort of unexpired patent for 14 products. Overall, 55 percent of the 235 patents found by our study were device patents. Comparing the last-to-expire device patent to that of the last-to-expire active ingredient patent, the median additional years of patent protection afforded by device patents was 4.7 years (range: 1.3-15.2 years). Conclusion Incremental, patentable innovation in devices to extend the overall patent protection of medicine/device product combinations is very common. Whether this constitutes "evergreening" depends on whether these incremental innovations and the years of extra patent protection they confer are proportionately matched by therapeutic improvements in the standard of care, which is highly debatable.	[Beall, Reed F.; Attaran, Amir] Univ Ottawa, Fac Med, Populat Hlth Program, Ottawa, ON, Canada; [Beall, Reed F.; Attaran, Amir] Univ Ottawa, Fac Law, Ottawa, ON, Canada; [Nickerson, Jason W.] Bruyere Res Inst, Ottawa, ON, Canada; [Kaplan, Warren A.] Boston Univ, Sch Publ Hlth, WHO Collaborating Ctr Pharmaceut Policy, Ctr Global Hlth & Dev,Dept Global Hlth, Boston, MA USA	University of Ottawa; University of Ottawa; University of Ottawa; Boston University	Beall, RF (corresponding author), Univ Ottawa, Fac Med, Populat Hlth Program, Ottawa, ON, Canada.; Beall, RF (corresponding author), Univ Ottawa, Fac Law, Ottawa, ON, Canada.	Reed.Beall@uottawa.ca	Nickerson, Jason/AAP-6026-2021	Nickerson, Jason/0000-0003-3692-999X; Kaplan, Warren/0000-0001-6127-4820	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This article is a part of RFB's PhD dissertation research, which is funded through a Vanier Doctoral Scholarship by the Canadian Institutes of Health Research (CIHR). No direct funding was received for this project.	Attaran A, 2014, LANCET, V384, P477, DOI 10.1016/S0140-6736(13)60845-4; Bartholow M, 2013, TOP 200 DRUGS 2012 P; Burgt JAV, 2000, J ALLERGY CLIN IMMUN, V106, P1209, DOI [10.1067/mai.2000.111582, DOI 10.1067/MAI.2000.111582]; Drugs.com, 2014, US PHARM SAL TOP 100; Freudenheim M, 1991, NY TIMES; Gross NJ, 2007, NEW ENGL J MED, V356, P2749; Gupta H, 2010, J PHARM BIOALLIED SC, V2, P2, DOI 10.4103/0975-7406.62694; Hendeles L, 2007, NEW ENGL J MED, V356, P1344, DOI 10.1056/NEJMra050380; Hitchings AW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7941; HURWITZ MA, 1991, COLUMBIA LAW REV, V91, P1188, DOI 10.2307/1122848; Luo J, 2015, LANCET DIABETES ENDO, V3, P835, DOI 10.1016/S2213-8587(15)00364-2; MAHN TERRY G., 2013, ORANGE BOOK LISTING; Martin B, 2008, United States patent, Patent No. [US8387615, 8387615]; Rosenthal E., 2013, SOARING COST SIMPLE; ROSENTHAL E, 2014, EVEN SMALL MED ADV C; Ross S, 2015, HEALTH POLICY TECHN, V4, P168, DOI 10.1016/j.hlpt.2015.02.008; Ross S, 2008, J OBSTET GYNAECOL CA, V30, P508, DOI 10.1016/S1701-2163(16)32867-5; RxList, TOP 200 DRUGS US ONL; Steckel H, 2004, INT J PHARMACEUT, V284, P75, DOI 10.1016/j.ijpharm.2004.07.005; U.S. National Library of Medicine, 2015, PHARM STAT; United States Food and Drug Administration, 2015, OR BOOK APPR DRUG PR; United States Food and Drug Administration, 2015, DRUG TREATM ASTHM CH	22	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148939	10.1371/journal.pone.0148939	http://dx.doi.org/10.1371/journal.pone.0148939			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910128	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700016
J	Boodhoo, N; Sharif, S; Behboudi, S				Boodhoo, Nitish; Sharif, Shayan; Behboudi, Shahriar			1 alpha, 25(OH)(2) Vitamin D3 Modulates Avian T Lymphocyte Functions without Inducing CTL Unresponsiveness	PLOS ONE			English	Article							D-RECEPTOR EXPRESSION; 1,25-DIHYDROXYVITAMIN D-3; IN-VITRO; TRANSCRIPTIONAL REPRESSION; DIHYDROXYVITAMIN D-3; DENDRITIC CELLS; DOWN-REGULATION; MESSENGER-RNA; NITRIC-OXIDE; IFN-GAMMA	1,25-Dihydroxyvitamin D3 (Vitamin D) is a naturally synthesized fat soluble vitamin shown to have immunomodulatory, anti-inflammatory and cancer prevention properties in human and murine models. Here, we studied the effects of Vitamin D on the functional abilities of avian T lymphocytes using chicken Interferon (IFN)-gamma ELISPOT assay, BrdU proliferation assay, Annexin V apoptosis assay and PhosFlow for detecting phosphorylated signalling molecules. The results demonstrate that Vitamin D significantly inhibited the abilities of T lymphocytes to produce IFN-gamma and proliferate in vitro (P <= 0.05), but retained their ability to undergo degranulation, which is a maker for cytotoxicity of these cells. Similarly, Vitamin D did not inhibit Extracellular signal-Regulated Kinase (ERK) 1/2 phosphorylation, a key mediator in T cell signalling, in the stimulated T lymphocytes population, while reduced ERK1/2 phosphorylation levels in the unstimulated cells. Our data provide evidence that Vitamin D has immuno-modulatory properties on chicken T lymphocytes without inducing unresponsiveness and by limiting immuno-pathology can promote protective immunity against infectious diseases of poultry.	[Boodhoo, Nitish; Behboudi, Shahriar] Pirbright Inst, Ash Rd, Woking, Surrey, England; [Sharif, Shayan] Univ Guelph, Dept Pathobiol, Ontario Vet Coll, Guelph, ON, Canada	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; University of Guelph	Behboudi, S (corresponding author), Pirbright Inst, Ash Rd, Woking, Surrey, England.	shahriar.behboudi@pirbright.ac.uk		behboudi, shahriar/0000-0001-6455-4086	Biotechnology and Biological Sciences Research Council [BBS/E/I/00001825]; Biotechnology and Biological Sciences Research Council [BBS/E/I/00002529] Funding Source: researchfish; BBSRC [BBS/E/I/00001825, BBS/E/I/00002529] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by funding from the Biotechnology and Biological Sciences Research Council (award nos. BBS/E/I/00001825) to SB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alagarasu K, 2012, HUM IMMUNOL, V73, P1194, DOI 10.1016/j.humimm.2012.08.007; ALROY I, 1995, MOL CELL BIOL, V15, P5789; Au-Yeung BB, 2010, NAT IMMUNOL, V11, P1085, DOI 10.1038/ni.1955; Baeke F, 2010, J STEROID BIOCHEM, V121, P221, DOI 10.1016/j.jsbmb.2010.03.037; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; BRENNAN A, 1987, IMMUNOLOGY, V61, P457; Campbell GR, 2012, AUTOPHAGY, V8, P1523, DOI 10.4161/auto.21154; Campbell GR, 2011, J BIOL CHEM, V286, P18890, DOI 10.1074/jbc.M110.206110; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Chan KS, 2007, J IMMUNOL METHODS, V325, P20, DOI 10.1016/j.jim.2007.05.011; Chen J, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-6; Chen LF, 2005, J IMMUNOL, V174, P6144, DOI 10.4049/jimmunol.174.10.6144; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Correale J, 2010, J IMMUNOL, V185, P4948, DOI 10.4049/jimmunol.1000588; Correale J, 2009, BRAIN, V132, P1146, DOI 10.1093/brain/awp033; D'Ambrosio D, 1998, J CLIN INVEST, V101, P252, DOI 10.1172/JCI1050; Di Rosa M, 2011, IMMUNOLOGY, V134, P123, DOI 10.1111/j.1365-2567.2011.03482.x; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Gardner DH, 2015, J IMMUNOL, V195, P2657, DOI 10.4049/jimmunol.1500306; Gottfried E, 2006, BIOCHEM BIOPH RES CO, V349, P209, DOI 10.1016/j.bbrc.2006.08.034; Griffin MD, 2001, P NATL ACAD SCI USA, V98, P6800, DOI 10.1073/pnas.121172198; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Heaney RP, 2008, CLIN J AM SOC NEPHRO, V3, P1535, DOI 10.2215/CJN.01160308; Helming L, 2005, BLOOD, V106, P4351, DOI 10.1182/blood-2005-03-1029; Janssen R, 2007, J INFECT DIS, V196, P826, DOI 10.1086/520886; Jiang F, 2004, J BIOL CHEM, V279, P53213, DOI 10.1074/jbc.M410395200; KIZAKI M, 1991, BLOOD, V77, P1238; Kongsbak M, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0035-2; Kuhn J, 2015, J STEROID BIOCHEM, V148, P7, DOI 10.1016/j.jsbmb.2014.10.015; Kuhn J, 2014, NUTRITION, V30, P481, DOI 10.1016/j.nut.2013.10.002; Lang P.O., 2012, J AGING RES, V2012, P1, DOI [10.1155/2012/806198, DOI 10.1155/2012/806198]; LEMIRE JM, 1992, AUTOIMMUNITY, V12, P143, DOI 10.3109/08916939209150321; LEMIRE JM, 1995, J NUTR, V125, pS1704, DOI 10.1093/jn/125.suppl_6.1704S; LEMIRE JM, 1984, J CLIN INVEST, V74, P657, DOI 10.1172/JCI111465; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Mayne CG, 2011, EUR J IMMUNOL, V41, P822, DOI 10.1002/eji.201040632; McGuire TF, 2001, J BIOL CHEM, V276, P26365, DOI 10.1074/jbc.M010101200; Morris A, 2014, VET IMMUNOL IMMUNOP, V161, P265, DOI 10.1016/j.vetimm.2014.08.008; OHTA M, 1985, FEBS LETT, V185, P9, DOI 10.1016/0014-5793(85)80730-4; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Praslickova D, 2008, POULTRY SCI, V87, P1112, DOI 10.3382/ps.2008-00006; PROVVEDINI DM, 1983, SCIENCE, V221, P1181, DOI 10.1126/science.6310748; REICHEL H, 1987, P NATL ACAD SCI USA, V84, P3385, DOI 10.1073/pnas.84.10.3385; RIGBY WFC, 1984, J CLIN INVEST, V74, P1451, DOI 10.1172/JCI111557; Shan XC, 2001, MOL CELL BIOL, V21, P7137, DOI 10.1128/MCB.21.21.7137-7149.2001; Shanmugasundaram R, 2012, POULTRY SCI, V91, P1819, DOI 10.3382/ps.2011-02129; Shojadoost B, 2015, RES VET SCI, V100, P45, DOI 10.1016/j.rvsc.2015.03.009; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Staeva-Vieira TP, 2002, J IMMUNOL, V168, P1181, DOI 10.4049/jimmunol.168.3.1181; Tang J, 2009, J IMMUNOL, V182, P4624, DOI 10.4049/jimmunol.0801543; Tiosano D, 2013, J CLIN ENDOCR METAB, V98, P1685, DOI 10.1210/jc.2012-3858; Vahlne G, 2008, SCAND J IMMUNOL, V67, P1, DOI 10.1111/j.1365-3083.2007.02026.x; van Etten E, 2005, J STEROID BIOCHEM, V97, P93, DOI 10.1016/j.jsbmb.2005.06.002; Vervelde L, 2013, VET IMMUNOL IMMUNOP, V151, P337, DOI 10.1016/j.vetimm.2012.11.012; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wattrang E, 2015, J IMMUNOL METHODS, V419, P35, DOI 10.1016/j.jim.2015.02.011; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Yao X, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/953974; Ylikomi T, 2002, VITAM HORM, V64, P357, DOI 10.1016/S0083-6729(02)64010-5; Yuzefpolskiy Y, 2014, J NUTR, V144, P2073, DOI 10.3945/jn.114.202895; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	71	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150134	10.1371/journal.pone.0150134	http://dx.doi.org/10.1371/journal.pone.0150134			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910045	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700070
J	Letchford, A; Preis, T; Moat, HS				Letchford, Adrian; Preis, Tobias; Moat, Helen Susannah			Quantifying the Search Behaviour of Different Demographics Using Google Correlate	PLOS ONE			English	Article							WEB; PREDICTABILITY; NETWORKS; COMPLEX; TRENDS	Vast records of our everyday interests and concerns are being generated by our frequent interactions with the Internet. Here, we investigate how the searches of Google users vary across U.S. states with different birth rates and infant mortality rates. We find that users in states with higher birth rates search for more information about pregnancy, while those in states with lower birth rates search for more information about cats. Similarly, we find that users in states with higher infant mortality rates search for more information about credit, loans and diseases. Our results provide evidence that Internet search data could offer new insight into the concerns of different demographics.	[Letchford, Adrian; Preis, Tobias; Moat, Helen Susannah] Univ Warwick, Warwick Business Sch, Data Sci Lab, Behav Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Letchford, A (corresponding author), Univ Warwick, Warwick Business Sch, Data Sci Lab, Behav Sci, Coventry CV4 7AL, W Midlands, England.	Adrian.Letchford@wbs.ac.uk	Preis, Tobias/A-2874-2009	Preis, Tobias/0000-0001-9185-0892; Moat, Helen Susannah/0000-0001-8974-9277	Research Councils UK Digital Economy Theme [EP/K039830/1]; EPSRC [EP/K039830/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/K039830/1] Funding Source: researchfish	Research Councils UK Digital Economy Theme; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge the support of the Research Councils UK Digital Economy Theme via grant EP/K039830/1.	Alanyali M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03578; Askitas N., 2009, APPL EC Q, V55, P107, DOI [10.1016/1047-2797(94)90062-0, DOI 10.1016/1047-2797(94)90062-0, DOI 10.3790/AEQ.55.2.107]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Barchiesi D, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150046; Barchiesi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128470; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Botta F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135600; Botta F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150162; Brockmann D, 2013, SCIENCE, V342, P1337, DOI 10.1126/science.1245200; Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Curme C, 2014, P NATL ACAD SCI USA, V111, P11600, DOI 10.1073/pnas.1324054111; Ettredge M, 2005, COMMUN ACM, V48, P87, DOI 10.1145/1096000.1096010; Fisher RA, 1914, BIOMETRIKA, V10, P507; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Goncalves B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022656; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Halu A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/16002; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02713; Kumar S, 2011, GOOGLE CORRELATE WHI; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Letchford A, 2016, J INFORMETR, V10, P1, DOI 10.1016/j.joi.2015.11.001; Letchford A, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150266; Mestyan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071226; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Moat HS, 2014, NATO SCI PEACE SECUR, P47, DOI 10.1007/978-94-017-8704-8_4; Moat HS, 2014, BEHAV BRAIN SCI, V37, P92, DOI 10.1017/S0140525X13001817; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; Mocanu D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061981; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Noguchi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095209; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Perc M, 2012, J R SOC INTERFACE, V9, P3323, DOI 10.1098/rsif.2012.0491; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00313; Podobnik B, 2009, P NATL ACAD SCI USA, V106, P22079, DOI 10.1073/pnas.0911983106; Preis T, 2015, COMPUT SOC SCI, P85, DOI 10.1007/978-3-319-14011-7_5; Preis T, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140095; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Preis T, 2011, P NATL ACAD SCI USA, V108, P7674, DOI 10.1073/pnas.1019484108; Preis T, 2010, PHILOS T R SOC A, V368, P5707, DOI 10.1098/rsta.2010.0284; Roth C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015923; Santi P, 2014, P NATL ACAD SCI USA, V111, P13290, DOI 10.1073/pnas.1403657111; Seresinhe CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep16899; Vanderkam D, 2013, NEAREST NEIGHBOR SEA; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 2007, NATURE, V445, P489, DOI 10.1038/445489a; Yasseri T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038869	58	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149025	10.1371/journal.pone.0149025	http://dx.doi.org/10.1371/journal.pone.0149025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910464	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700019
J	Shaikh, AG; Otero-Millan, J; Kumar, P; Ghasia, FF				Shaikh, Aasef G.; Otero-Millan, Jorge; Kumar, Priyanka; Ghasia, Fatema F.			Abnormal Fixational Eye Movements in Amblyopia	PLOS ONE			English	Article							STRIATE CORTEX; MICROSACCADES; STABILITY; VISION; EXPLORATION; SACCADES	Purpose Fixational saccades shift the foveal image to counteract visual fading related to neural adaptation. Drifts are slow eye movements between two adjacent fixational saccades. We quantified fixational saccades and asked whether their changes could be attributed to pathologic drifts seen in amblyopia, one of the most common causes of blindness in childhood. Methods Thirty-six pediatric subjects with varying severity of amblyopia and eleven healthy age-matched controls held their gaze on a visual target. Eye movements were measured with high-resolution video-oculography during fellow eye-viewing and amblyopic eye-viewing conditions. Fixational saccades and drifts were analyzed in the amblyopic and fellow eye and compared with controls. Results We found an increase in the amplitude with decreased frequency of fixational saccades in children with amblyopia. These alterations in fixational eye movements correlated with the severity of their amblyopia. There was also an increase in eye position variance during drifts in amblyopes. There was no correlation between the eye position variance or the eye velocity during ocular drifts and the amplitude of subsequent fixational saccade. Our findings suggest that abnormalities in fixational saccades in amblyopia are independent of the ocular drift. Discussion This investigation of amblyopia in pediatric age group quantitatively characterizes the fixation instability. Impaired properties of fixational saccades could be the consequence of abnormal processing and reorganization of the visual system in amblyopia. Paucity in the visual feedback during amblyopic eye-viewing condition can attribute to the increased eye position variance and drift velocity.	[Shaikh, Aasef G.; Ghasia, Fatema F.] Louis Stokes Cleveland VA Med Ctr, Daroff DelOsso Ocular Motil Lab, Cleveland, OH USA; [Shaikh, Aasef G.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Shaikh, Aasef G.] Louis Stokes Cleveland VA Med Ctr, Neurol Serv, Cleveland, OH USA; [Otero-Millan, Jorge] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Kumar, Priyanka; Ghasia, Fatema F.] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Cleveland Clinic Foundation	Ghasia, FF (corresponding author), Louis Stokes Cleveland VA Med Ctr, Daroff DelOsso Ocular Motil Lab, Cleveland, OH USA.; Ghasia, FF (corresponding author), Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA.	fatemaghasia@gmail.com	Otero-Millan, Jorge/A-4193-2014	Otero-Millan, Jorge/0000-0002-9789-8392	Knights Templar Research F 405 oundation; Fight for Sight Foundation; Blind Children's Center; RPB Unrestricted grant CCLCM-CWRU; Dystonia Medical Research Foundation; Leon Levy Foundation; National Institute Health [R01 EY06717]; Knights Templar Research Foundation; NIH [R01 EY06717]; NATIONAL EYE INSTITUTE [R01EY006717] Funding Source: NIH RePORTER	Knights Templar Research F 405 oundation; Fight for Sight Foundation; Blind Children's Center; RPB Unrestricted grant CCLCM-CWRU; Dystonia Medical Research Foundation; Leon Levy Foundation; National Institute Health; Knights Templar Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from Knights Templar Research F 405 oundation (FG), and Fight for Sight Foundation (FG), Blind Children's Center (FG), RPB Unrestricted grant CCLCM-CWRU and Dystonia Medical Research Foundation clinical fellowship award (AS). JOM was supported by the Leon Levy Foundation. Some resources used for these experiments were supported by National Institute Health R01 EY06717 to Dr. R. John Leigh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from Knights Templar Research Foundation (FG), and Fight for Sight Foundation (FG), Blind Children's Center (FG), RPB Unrestricted grant CCLCM-CWRU and Dystonia Medical Research Foundation clinical fellowship award (AS). JOM was supported by the Leon Levy Foundation. Some resources used for these experiments were supported by NIH R01 EY06717 to Dr. R. John Leigh.	Castet E, 2012, SEEING PERCEIVING, V25, P449, DOI 10.1163/187847611X620955; Chung STL, 2015, VISION RES, V114, P87, DOI 10.1016/j.visres.2015.01.016; Collewijn H, 2008, J VISION, V8, DOI 10.1167/8.14.20; DITCHBURN RW, 1953, J PHYSIOL-LONDON, V119, P1; DITCHBURN RW, 1980, VISION RES, V20, P271, DOI 10.1016/0042-6989(80)90112-1; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; FLOM MC, 1966, AMER J OPT ARCH AM A, V43, P732; Gonzalez EG, 2012, INVEST OPHTH VIS SCI, V53, P5386, DOI 10.1167/iovs.12-9941; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Kiorpes L, 2006, STRABISMUS, V14, P3, DOI 10.1080/09273970500536193; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; Leigh R. J., 2006, NEUROLOGY EYE MOVEME; Levi DM, 2006, STRABISMUS, V14, P11, DOI 10.1080/09273970500536243; Martinez-Conde S, 2000, NAT NEUROSCI, V3, P251, DOI 10.1038/72961; Martinez-Conde S, 2006, PROG BRAIN RES, V154, P151; Martinez-Conde S, 2009, TRENDS NEUROSCI, V32, P463, DOI 10.1016/j.tins.2009.05.006; McCamy MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128428; McCamy MB, 2014, J PHYSIOL-LONDON, V592, P4381, DOI 10.1113/jphysiol.2014.279059; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; McKee SP, 2003, J VISION, V3, P380, DOI 10.1167/3.5.5; Mergenthaler K, 2010, EXP BRAIN RES, V203, P753, DOI 10.1007/s00221-010-2272-9; Otero-Millan J, 2014, J VISION, V14, DOI 10.1167/14.2.18; Otero-Millan J, 2013, P NATL ACAD SCI USA, V110, P6175, DOI 10.1073/pnas.1222715110; Otero-Millan J, 2011, J NEUROSCI, V31, P4379, DOI 10.1523/JNEUROSCI.2600-10.2011; Otero-Millan J, 2008, J VISION, V8, DOI 10.1167/8.14.21; Preslan MW, 1996, OPHTHALMOLOGY, V103, P105, DOI 10.1016/S0161-6420(96)30753-7; RATLIFF F, 1950, J EXP PSYCHOL, V40, P687, DOI 10.1037/h0057754; Rolfs M, 2009, VISION RES, V49, P2415, DOI 10.1016/j.visres.2009.08.010; Schneider RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056556; Shi XFF, 2012, RESTOR NEUROL NEUROS, V30, P445, DOI 10.3233/RNN-2012-129000; Steinman R M, 1982, Hum Neurobiol, V1, P97; Subramanian V, 2013, INVEST OPHTH VIS SCI, V54, P1998, DOI 10.1167/iovs.12-11054; Thaler L, 2013, VISION RES, V76, P31, DOI 10.1016/j.visres.2012.10.012; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	36	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149953	10.1371/journal.pone.0149953	http://dx.doi.org/10.1371/journal.pone.0149953			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930079	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500077
J	Munoz-Gonzalez, S; Perez-Simo, M; Colom-Cadena, A; Cabezon, O; Bohorquez, JA; Rosell, R; Perez, LJ; Marco, I; Lavin, S; Domingo, M; Ganges, L				Munoz-Gonzalez, Sara; Perez-Simo, Marta; Colom-Cadena, Andreu; Cabezon, Oscar; Alejandro Bohorquez, Jose; Rosell, Rosa; Josue Perez, Lester; Marco, Ignasi; Lavin, Santiago; Domingo, Mariano; Ganges, Llilianne			Classical Swine Fever Virus vs. Classical Swine Fever Virus: The Superinfection Exclusion Phenomenon in Experimentally Infected Wild Boar	PLOS ONE			English	Article							HEPATITIS-C VIRUS; VESICULAR STOMATITIS-VIRUS; T-CELL RESPONSES; RT-PCR ASSAY; INTERFERON-ALPHA; N-PRO; IMMUNE-RESPONSE; VIRAL PROTEIN; STRAIN; PROTECTION	Two groups with three wild boars each were used: Group A (animals 1 to 3) served as the control, and Group B (animals 4 to 6) was postnatally persistently infected with the Cat01 strain of CSFV (primary virus). The animals, six weeks old and clinically healthy, were inoculated with the virulent strain Margarita (secondary virus). For exclusive detection of the Margarita strain, a specific qRT-PCR assay was designed, which proved not to have cross-reactivity with the Cat01 strain. The wild boars persistently infected with CSFV were protected from superinfection by the virulent CSFV Margarita strain, as evidenced by the absence of clinical signs and the absence of Margarita RNA detection in serum, swabs and tissue samples. Additionally, in PBMCs, a well-known target for CSFV viral replication, only the primary infecting virus RNA (Cat01 strain) could be detected, even after the isolation in ST cells, demonstrating SIE at the tissue level in vivo. Furthermore, the data analysis of the Margarita qRT-PCR, by means of calculated Delta Ct values, supported that PBMCs from persistently infected animals were substantially protected from superinfection after in vitro inoculation with the Margarita virus strain, while this virus was able to infect naive PBMCs efficiently. In parallel, IFN-alpha values were undetectable in the sera from animals in Group B after inoculation with the CSFV Margarita strain. Furthermore, these animals were unable to elicit adaptive humoral (no E2-specific or neutralising antibodies) or cellular immune responses (in terms of IFN-gamma-producing cells) after inoculation with the second virus. Finally, a sequence analysis could not detect CSFV Margarita RNA in the samples tested from Group B. Our results suggested that the SIE phenomenon might be involved in the evolution and phylogeny of the virus, as well as in CSFV control by vaccination. To the best of our knowledge, this study was one of the first showing efficient suppression of superinfection in animals, especially in the absence of IFN-alpha, which might be associated with the lack of innate immune mechanisms.	[Munoz-Gonzalez, Sara; Perez-Simo, Marta; Colom-Cadena, Andreu; Cabezon, Oscar; Alejandro Bohorquez, Jose; Rosell, Rosa; Domingo, Mariano; Ganges, Llilianne] IRTA UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra 08193, Spain; [Colom-Cadena, Andreu; Cabezon, Oscar; Marco, Ignasi; Lavin, Santiago] Univ Autonoma Barcelona, Dept Med & Cirurgia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra 08193, Spain; [Rosell, Rosa] Generalitat Catalunya, Dept Agr Ramaderia Pesca Alimentacio & Med Nat, Barcelona 08007, Spain; [Josue Perez, Lester] Ctr Nacl Sanidad Agr CENSA, Havana, Cuba; [Domingo, Mariano] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim DAAM, E-08193 Barcelona, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Ganges, L (corresponding author), IRTA UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra 08193, Spain.	llilianne.ganges@irta.cat	Ganges, Llilianne/O-7342-2017; Perez, Lester J./A-1339-2016; Marco, Ignasi/E-8633-2015; Cabezón, Oscar/AAV-7876-2020; Lavín, Santiago/L-5975-2014; Cabezon, Oscar/L-3812-2014; Domingo, Mariano/A-1015-2009	Ganges, Llilianne/0000-0002-8644-3560; Perez, Lester J./0000-0002-5717-5181; Marco, Ignasi/0000-0001-7479-3419; Lavín, Santiago/0000-0001-5655-588X; Munoz-Gonzalez, Sara/0000-0002-7846-7001; Bohorquez Garzon, Jose Alejandro/0000-0002-6715-1757; Cabezon, Oscar/0000-0001-7543-8371; Rosell, Rosa/0000-0002-8294-1159; Domingo, Mariano/0000-0002-9623-4826	Spanish government [AGL2012-38343]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya [FI-DGR 2014]	Spanish government(Spanish GovernmentEuropean Commission); Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya)	This research was supported by grant AGL2012-38343 from the Spanish government. S.M. and A.C. had a predoctoral fellowship FI-DGR 2014 from Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Generalitat de Catalunya. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Allepuz A, 2007, VET REC, V160, P398, DOI 10.1136/vr.160.12.398; Bauhofer O, 2007, J VIROL, V81, P3087, DOI 10.1128/JVI.02032-06; Bergua M, 2014, J VIROL, V88, P11327, DOI 10.1128/JVI.01612-14; Cabezon O, 2015, TRANSBOUND EMERG DIS; Campbell CL, 2014, VIROLOGY, V464, P228, DOI 10.1016/j.virol.2014.07.009; Claus C, 2007, J GEN VIROL, V88, P2769, DOI 10.1099/vir.0.83092-0; Das A, 2011, J VET DIAGN INVEST, V23, P727, DOI 10.1177/1040638711407685; de Arce HD, 2005, VIRUS RES, V112, P123, DOI 10.1016/j.virusres.2005.03.018; de Arce HD, 1999, VIRUS RES, V64, P61, DOI 10.1016/S0168-1702(99)00077-5; DEARCE HD, 1992, VET IMMUNOL IMMUNOP, V30, P319, DOI 10.1016/0165-2427(92)90102-V; de Arce HD, 2009, VET MICROBIOL, V139, P245, DOI 10.1016/j.vetmic.2009.06.004; Drager C, 2015, VACCINE, V33, P3100, DOI 10.1016/j.vaccine.2015.04.103; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Formella S, 2000, J VIROL, V74, P7878, DOI 10.1128/JVI.74.17.7878-7883.2000; Gal-On A, 2006, NATURAL RESISTANCE MECHANISMS OF PLANTS TO VIRUSES, P261, DOI 10.1007/1-4020-3780-5_12; Ganges L, 2005, VACCINE, V23, P3741, DOI 10.1016/j.vaccine.2005.01.153; Ganges L, 2008, VET J, V177, P169, DOI 10.1016/j.tvjl.2007.01.030; Graham SP, 2012, VACCINE, V30, P2742, DOI 10.1016/j.vaccine.2012.02.029; Greiser-Wilke I, 2007, VACCINE, V25, P5524, DOI 10.1016/j.vaccine.2006.11.043; Gutierrez S, 2015, J VIROL, V89, P9665, DOI 10.1128/JVI.00537-15; Guzylack-Piriou L, 2004, IMMUNOLOGY, V112, P28, DOI 10.1111/j.1365-2567.2004.01856.x; Hoffmann B, 2005, J VIROL METHODS, V130, P36, DOI 10.1016/j.jviromet.2005.05.030; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Husser L, 2012, J INTERF CYTOK RES, V32, P221, DOI 10.1089/jir.2011.0068; Perez LJ, 2012, INFECT GENET EVOL, V12, P1405, DOI 10.1016/j.meegid.2012.04.030; Perez LJ, 2011, J VIROL METHODS, V174, P53, DOI 10.1016/j.jviromet.2011.03.022; Kaden V, 2004, J VET MED B, V51, P260, DOI 10.1111/j.1439-0450.2004.00766.x; Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997; KASZA L, 1972, RES VET SCI, V13, P46; Laliberte JP, 2014, J VIROL, V88, P9751, DOI 10.1128/JVI.00816-14; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Leifer I, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-33; Liu LH, 2011, J VIROL METHODS, V175, P170, DOI 10.1016/j.jviromet.2011.05.003; Lowings P, 1996, J GEN VIROL, V77, P1311, DOI 10.1099/0022-1317-77-6-1311; Julve JM, 2013, PLANT MOL BIOL, V81, P553, DOI 10.1007/s11103-013-0028-1; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Mittelholzer C, 1998, J GEN VIROL, V79, P2981, DOI 10.1099/0022-1317-79-12-2981; Munoz-Gonzalez S, 2015, VET RES, V46, DOI 10.1186/s13567-015-0209-9; Munoz-Gonzalez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125692; NOWACKI W, 1993, RES IMMUNOL, V144, P111, DOI 10.1016/0923-2494(93)80066-8; Peterhans E, 2013, BIOLOGICALS, V41, P39, DOI 10.1016/j.biologicals.2012.07.006; Ramirez S, 2010, J GEN VIROL, V91, P1183, DOI 10.1099/vir.0.018929-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Renson P, VET RES, V41, P7; Ruemenapf Till, 2008, P39; Schweizer M, 2014, ANNU REV ANIM BIOSCI, V2, P141, DOI 10.1146/annurev-animal-022513-114209; SIMON KO, 1990, VIROLOGY, V177, P375, DOI 10.1016/0042-6822(90)90494-C; SOLLER A, 1965, VIROLOGY, V26, P715, DOI 10.1016/0042-6822(65)90335-1; Summerfield A, 2006, J INTERF CYTOK RES, V26, P248, DOI 10.1089/jir.2006.26.248; Summerfield A, 1998, J VIROL, V72, P1853, DOI 10.1128/JVI.72.3.1853-1861.1998; Tamura T, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-47; Tarradas J, 2010, VET MICROBIOL, V142, P51, DOI 10.1016/j.vetmic.2009.09.043; Tarradas J, 2014, VIRUS RES, V185, P82, DOI 10.1016/j.virusres.2014.03.004; Tarradas J, 2011, VACCINE, V29, P4422, DOI 10.1016/j.vaccine.2011.03.095; TERPSTRA C, 1984, VET MICROBIOL, V9, P113, DOI 10.1016/0378-1135(84)90026-9; Thiel HJ, 2005, VIRUS TAXONOMY, P979; Thomas A. H., 1999, NUCL ACIDS S SERIES, p[41, 95]; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; van Oirschot JT, 2003, VET MICROBIOL, V96, P367, DOI 10.1016/j.vetmic.2003.09.008; Walters KA, 2004, J VIROL, V78, P7925, DOI 10.1128/JVI.78.15.7925-7937.2004; Webster B, 2013, J VIROL, V87, P13354, DOI 10.1128/JVI.02465-13; WENSVOORT G, 1986, VET MICROBIOL, V12, P101, DOI 10.1016/0378-1135(86)90072-6; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P137, DOI 10.1016/0042-6822(83)90540-8	63	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149469	10.1371/journal.pone.0149469	http://dx.doi.org/10.1371/journal.pone.0149469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919741	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400023
J	Ossoli, A; Neufeld, EB; Thacker, SG; Vaisman, B; Pryor, M; Freeman, LA; Brantner, CA; Baranova, I; Francone, NO; Demosky, SJ; Vitali, C; Locatelli, M; Abbate, M; Zoja, C; Franceschini, G; Calabresi, L; Remaley, AT				Ossoli, Alice; Neufeld, Edward B.; Thacker, Seth G.; Vaisman, Boris; Pryor, Milton; Freeman, Lita A.; Brantner, Christine A.; Baranova, Irina; Francone, Nicolas O.; Demosky, Stephen J., Jr.; Vitali, Cecilia; Locatelli, Monica; Abbate, Mauro; Zoja, Carlamaria; Franceschini, Guido; Calabresi, Laura; Remaley, Alan T.			Lipoprotein X Causes Renal Disease in LCAT Deficiency	PLOS ONE			English	Article							LECITHIN-CHOLESTEROL ACYLTRANSFERASE; APOLIPOPROTEIN-A-I; FAMILIAL LECITHIN; GLOMERULAR ENDOTHELIUM; MESANGIAL CELLS; METABOLISM; PODOCYTES; PATIENT; BIOLOGY; MICE	Human familial lecithin: cholesterol acyltransferase (LCAT) deficiency (FLD) is characterized by low HDL, accumulation of an abnormal cholesterol-rich multilamellar particle called lipoprotein-X (LpX) in plasma, and renal disease. The aim of our study was to determine if LpX is nephrotoxic and to gain insight into the pathogenesis of FLD renal disease. We administered a synthetic LpX, nearly identical to endogenous LpX in its physical, chemical and biologic characteristics, to wild-type and Lcat(-/-) mice. Our in vitro and in vivo studies demonstrated an apoA-I and LCAT-dependent pathway for LpX conversion to HDL-like particles, which likely mediates normal plasma clearance of LpX. Plasma clearance of exogenous LpX was markedly delayed in Lcat(-/-) mice, which have low HDL, but only minimal amounts of endogenous LpX and do not spontaneously develop renal disease. Chronically administered exogenous LpX deposited in all renal glomerular cellular and matrical compartments of Lcat(-/-) mice, and induced proteinuria and nephrotoxic gene changes, as well as all of the hallmarks of FLD renal disease as assessed by histological, TEM, and SEM analyses. Extensive in vivo EM studies revealed LpX uptake by macropinocytosis into mouse glomerular endothelial cells, podocytes, and mesangial cells and delivery to lysosomes where it was degraded. Endocytosed LpX appeared to be degraded by both human podocyte and mesangial cell lysosomal PLA(2) and induced podocyte secretion of pro-inflammatory IL-6 in vitro and renal Cxl10 expression in Lcat(-/-) mice. In conclusion, LpX is a nephrotoxic particle that in the absence of Lcat induces all of the histological and functional hallmarks of FLD and hence may serve as a biomarker for monitoring recombinant LCAT therapy. In addition, our studies suggest that LpX-induced loss of endothelial barrier function and release of cytokines by renal glomerular cells likely plays a role in the initiation and progression of FLD nephrosis.	[Ossoli, Alice; Vitali, Cecilia; Franceschini, Guido; Calabresi, Laura] Univ Milan, Ctr Grossi Paoletti, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Neufeld, Edward B.; Thacker, Seth G.; Vaisman, Boris; Pryor, Milton; Freeman, Lita A.; Francone, Nicolas O.; Demosky, Stephen J., Jr.; Remaley, Alan T.] NHLBI, Lipoprot Metab Sect, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA; [Brantner, Christine A.] NIH, NHLBI Elect Microscopy Core Facil, Bldg 10, Bethesda, MD 20892 USA; [Baranova, Irina] NIH, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Locatelli, Monica; Abbate, Mauro] IRCCS Ist Ric Farmacol Mario Negri, Ctr Anna Maria Astori, Sci & Technol Pk Kilometro Rosso, Bergamo, Italy	University of Milan; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Neufeld, EB (corresponding author), NHLBI, Lipoprot Metab Sect, Cardiovasc & Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	neufelde@mail.nih.gov	zoja, carlamaria/ABF-5896-2020; Vaisman, Boris L/B-3453-2008; Ossoli, Alice/K-5917-2016; Mauro, Abbate/ABH-3533-2020; Neufeld, Edward/R-3819-2019	zoja, carlamaria/0000-0003-2507-8894; Ossoli, Alice/0000-0002-9902-252X; Mauro, Abbate/0000-0002-2092-7474; Brantner, Christine/0000-0001-8172-901X; Locatelli, Monica/0000-0002-1395-3172	Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH [GGP14125]; Telethon - Italy; MedImmune, Inc. as a CRADA-NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006092, ZIAHL002058] Funding Source: NIH RePORTER	Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH; Telethon - Italy(Fondazione Telethon); MedImmune, Inc. as a CRADA-NIH Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research support for this study came from the Division of Intramural Research, National Heart, Lung and Blood Institute of the NIH, grant number: GGP14125. Funding Institution: Telethon - Italy (www.Telethon.it). Additional funding to ATR was provided by MedImmune, Inc. as a CRADA-NIH Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT F, 1991, KIDNEY INT, V40, P597, DOI 10.1038/ki.1991.250; Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Ahsan L., 2014, HDL HDB BIOL FUNCTIO, P159, DOI DOI 10.1016/B978-0-12-407867-3.00007-X; Aranda P, 2008, CLIN NEPHROL, V69, P213; Argraves KM, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-70; Asztalos BF, 2007, J LIPID RES, V48, P592, DOI 10.1194/jlr.M600403-JLR200; BORYSIEWICZ LK, 1982, Q J MED, V51, P411; BREWER HB, 1986, METHOD ENZYMOL, V128, P223; Calabresi L, 2005, ARTERIOSCL THROM VAS, V25, P1972, DOI 10.1161/01.ATV.0000175751.30616.13; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Fornoni A, 2014, NAT REV NEPHROL, V10, P379, DOI 10.1038/nrneph.2014.87; Genot E, 2014, EUR J CELL BIOL, V93, P367, DOI 10.1016/j.ejcb.2014.10.002; Glukhova A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7250; Haraldsson B, 2012, CURR OPIN NEPHROL HY, V21, P258, DOI 10.1097/MNH.0b013e3283522e7a; Haraldsson BS, 2014, KIDNEY INT, V85, P8, DOI 10.1038/ki.2013.317; IMBASCIATI E, 1986, AM J NEPHROL, V6, P66, DOI 10.1159/000167056; Jonas A, 2000, BBA-MOL CELL BIOL L, V1529, P245, DOI 10.1016/S1388-1981(00)00153-0; KANWAR YS, 1979, J CELL BIOL, V81, P137, DOI 10.1083/jcb.81.1.137; Kriz W, 2013, AM J PHYSIOL-RENAL, V304, pF333, DOI 10.1152/ajprenal.00478.2012; Lambert G, 2001, J BIOL CHEM, V276, P15090, DOI 10.1074/jbc.M008466200; Leonard M, 1999, KIDNEY INT, V56, P1366, DOI 10.1046/j.1523-1755.1999.00664.x; Lim JP, 2011, IMMUNOL CELL BIOL, V89, P836, DOI 10.1038/icb.2011.20; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Lynn EG, 1997, MOL CELL BIOCHEM, V175, P187, DOI 10.1023/A:1006865420286; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00169; Miarka P, 2011, CLIN EXP NEPHROL, V15, P424, DOI 10.1007/s10157-011-0409-1; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Naito S, 2013, ATHEROSCLEROSIS, V228, P193, DOI 10.1016/j.atherosclerosis.2013.02.034; New LA, 2014, CURR OPIN NEPHROL HY, V23, P420, DOI 10.1097/01.mnh.0000447018.28852.b6; Nishiwaki M, 2006, ARTERIOSCL THROM VAS, V26, P1370, DOI 10.1161/01.ATV.0000217910.90210.99; Nosadini R, 2011, NUTR METAB CARDIOVAS, V21, P79, DOI 10.1016/j.numecd.2010.10.002; O K, 1995, J LIPID RES, V36, P2344; O K, 1997, MOL CELL BIOCHEM, V173, P17, DOI 10.1023/A:1006836704042; Obeidat M, 2012, EXP CELL RES, V318, P964, DOI 10.1016/j.yexcr.2012.02.032; RITLAND S, 1975, SCAND J GASTROENTERO, V10, P785; Rousset X, 2010, J PHARMACOL EXP THER, V335, P140, DOI 10.1124/jpet.110.169540; RUBIESPRAT J, 1977, CLIN CHIM ACTA, V75, P117, DOI 10.1016/0009-8981(77)90506-X; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Santamarina-Fojo S, 2001, METABOLIC MOL BASES, P2817; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scindia YM, 2010, ADV DRUG DELIVER REV, V62, P1337, DOI 10.1016/j.addr.2010.08.011; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Sessa A, 2001, NEPHRON, V88, P268, DOI 10.1159/000046001; Shamburek RD, 2016, J CLIN LIPIDOLOGY; Shamburek RD, 2016, CIRC RES, V118, P73, DOI 10.1161/CIRCRESAHA.115.306223; Shamburek RD, 2013, CIRCULATION, V128; Shayman JA, 2013, BBA-MOL CELL BIOL L, V1831, P602, DOI 10.1016/j.bbalip.2012.08.013; Steenhard BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050745; Strom EH, 2011, ULTRASTRUCT PATHOL, V35, P139, DOI 10.3109/01913123.2010.551578; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Tsuchiya Y, 2011, CLIN NEPHROL, V76, P492, DOI 10.5414/CN107007; Vaisman BL, 2012, J LIPID RES, V53, P158, DOI 10.1194/jlr.M018713; Weber CL, 2007, NEPHROL DIAL TRANSPL, V22, P2084, DOI 10.1093/ndt/gfm233; Xu C, 2014, KIDNEY INT, V85, P72, DOI 10.1038/ki.2013.286; Yee MS, 2009, ATHEROSCLEROSIS, V205, P528, DOI 10.1016/j.atherosclerosis.2008.11.033; Zhu XH, 2004, AM J PATHOL, V165, P1269, DOI 10.1016/S0002-9440(10)63386-X; Zou J, 2006, VIRCHOWS ARCH, V448, P485, DOI 10.1007/s00428-005-0134-9	59	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150083	10.1371/journal.pone.0150083	http://dx.doi.org/10.1371/journal.pone.0150083			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919698	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400084
J	Pawelek, KA; Dor, D; Salmeron, C; Handel, A				Pawelek, Kasia A.; Dor, Daniel, Jr.; Salmeron, Cristian; Handel, Andreas			Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of Macrophages	PLOS ONE			English	Article							ALVEOLAR EPITHELIAL-CELLS; AVIAN H5N1 INFLUENZA; A VIRUS; NEURAMINIDASE INHIBITORS; IMMUNE-RESPONSE; METAANALYSIS; OSELTAMIVIR; MORTALITY; DYNAMICS; KINETICS	The World Health Organization identifies influenza as a major public health problem. While the strains commonly circulating in humans usually do not cause severe pathogenicity in healthy adults, some strains that have infected humans, such as H5N1, can cause high morbidity and mortality. Based on the severity of the disease, influenza viruses are sometimes categorized as either being highly pathogenic (HP) or having low pathogenicity (LP). The reasons why some strains are LP and others HP are not fully understood. While there are likely multiple mechanisms of interaction between the virus and the immune response that determine LP versus HP outcomes, we focus here on one component, namely macrophages (MP). There is some evidence that MP may both help fight the infection and become productively infected with HP influenza viruses. We developed mathematical models for influenza infections which explicitly included the dynamics and action of MP. We fit these models to viral load and macrophage count data from experimental infections of mice with LP and HP strains. Our results suggest that MP may not only help fight an influenza infection but may contribute to virus production in infections with HP viruses. We also explored the impact of combination therapies with antivirals and anti-inflammatory drugs on HP infections. Our study suggests a possible mechanism of MP in determining HP versus LP outcomes, and how different interventions might affect infection dynamics.	[Pawelek, Kasia A.; Salmeron, Cristian] Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC USA; [Dor, Daniel, Jr.] Univ South Carolina Beaufort, Dept Nat Sci, Bluffton, SC USA; [Handel, Andreas] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Pawelek, KA (corresponding author), Univ South Carolina Beaufort, Dept Math & Computat Sci, Bluffton, SC USA.; Handel, A (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.	kpawelek@uscb.edu; ahandel@uga.edu		Handel, Andreas/0000-0002-4622-1146	National Institute of General Medical Sciences, SC INBRE [P20GM103499]; University of South Carolina Mini Grant Program; SC EPSCoR/IDeA Scientific Advocate Network; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U19AI117891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103499] Funding Source: NIH RePORTER; Division Of Undergraduate Education [1259283] Funding Source: National Science Foundation	National Institute of General Medical Sciences, SC INBRE; University of South Carolina Mini Grant Program; SC EPSCoR/IDeA Scientific Advocate Network; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU))	This publication was partially supported by a grant from the National Institute of General Medical Sciences, P20GM103499, SC INBRE (KAP and DD). The research of CS was partially supported by the University of South Carolina Mini Grant Program and SC EPSCoR/IDeA Scientific Advocate Network. AH was partially supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U19AI117891. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Belser JA, 2013, VIROLOGY, V439, P42, DOI 10.1016/j.virol.2013.01.017; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Dobrovolny HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013811; Dobrovolny HM, 2011, J THEOR BIOL, V269, P234, DOI 10.1016/j.jtbi.2010.10.017; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; ELHELU MA, 1983, J NATL MED ASSOC, V75, P314; Govorkova EA, 2013, ANTIVIR RES, V98, P297, DOI 10.1016/j.antiviral.2013.02.013; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1083; Handel A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002989; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hofmann P, 1997, J LEUKOCYTE BIOL, V61, P408, DOI 10.1002/jlb.61.4.408; Janeway Jr A, 2001, IMMUNOBIOLOGY; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Johnson S.G., NLOPT NONLINEAR OPTI; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; PATTERSON KD, 1991, B HIST MED, V65, P4; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Quinlivan M, 2007, VACCINE, V25, P7056, DOI 10.1016/j.vaccine.2007.07.059; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Sakabe S, 2011, J GEN VIROL, V92, P1428, DOI 10.1099/vir.0.030346-0; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Smallman-Raynor M, 2007, EMERG INFECT DIS, V13, P510, DOI 10.3201/eid1303.060849; Smith AM, 2011, WIRES SYST BIOL MED, V3, P429, DOI 10.1002/wsbm.129; Smith AM, 2011, J THEOR BIOL, V276, P106, DOI 10.1016/j.jtbi.2011.01.052; Smith AM, 2010, CRIT REV IMMUNOL, V30, P291, DOI 10.1615/CritRevImmunol.v30.i3.60; Smith AM, 2010, J MATH BIOL, V60, P711, DOI 10.1007/s00285-009-0281-8; Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09; White NJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000091; WHO, HUM INF AV INFL A H7; Wickham H., 2018, GRAMMAR DATA MANIPUL; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	55	20	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150568	10.1371/journal.pone.0150568	http://dx.doi.org/10.1371/journal.pone.0150568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918620	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400135
J	Vaara, ST; Lakkisto, P; Immonen, K; Tikkanen, I; Ala-Kokko, T; Pettila, V				Vaara, Suvi T.; Lakkisto, Paivi; Immonen, Katariina; Tikkanen, Ilkka; Ala-Kokko, Tero; Pettila, Ville		FINNAKI Study Grp	Urinary Biomarkers Indicative of Apoptosis and Acute Kidney Injury in the Critically Ill	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; CELL-FREE DNA; SEVERE SEPSIS; MORTALITY; DYSFUNCTION; MECHANISMS; MARKER; SERUM; SHOCK	Background Apoptosis is a key mechanism involved in ischemic acute kidney injury (AKI), but its role in septic AKI is controversial. Biomarkers indicative of apoptosis could potentially detect developing AKI prior to its clinical diagnosis. Methods As a part of the multicenter, observational FINNAKI study, we performed a pilot study among critically ill patients who developed AKI (n = 30) matched to critically ill patients without AKI (n = 30). We explored the urine and plasma levels of cytokeratin-18 neoepitope M30 (CK-18 M30), cell-free DNA, and heat shock protein 70 (HSP70) at intensive care unit (ICU) admission and 24h thereafter, before the clinical diagnosis of AKI defined by the Kidney Disease: Improving Global Outcomes - creatinine and urine output criteria. Furthermore, we performed a validation study in 197 consecutive patients in the FINNAKI cohort and analyzed the urine sample at ICU admission for CK-18 M30 levels. Results In the pilot study, the urine or plasma levels of measured biomarkers at ICU admission, at 24h, or their maximum value did not differ significantly between AKI and non-AKI patients. Among 20 AKI patients without severe sepsis, the urine CK-18 M30 levels were significantly higher at 24h (median 116.0, IQR [32.3-233.0] U/L) than among those 20 patients who did not develop AKI (46.0 [0.0-54.0] U/L), P = 0.020. Neither urine cell-free DNA nor HSP70 levels significantly differed between AKI and non-AKI patients regardless of the presence of severe sepsis. In the validation study, urine CK-18 M30 level at ICU admission was not significantly higher among patients developing AKI compared to non-AKI patients regardless of the presence of severe sepsis or CKD. Conclusions Our findings do not support that apoptosis detected with CK-18 M30 level would be useful in assessing the development of AKI in the critically ill. Urine HSP or cell-free DNA levels did not differ between AKI and non-AKI patients.	[Vaara, Suvi T.] Univ Helsinki, Div Intens Care Med, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; [Vaara, Suvi T.; Lakkisto, Paivi; Tikkanen, Ilkka; Pettila, Ville] Helsinki Univ Hosp, Helsinki, Finland; [Lakkisto, Paivi; Immonen, Katariina; Tikkanen, Ilkka] Minerva Fdn, Helsinki, Finland; [Lakkisto, Paivi] Univ Helsinki, Dept Clin Chem & Hematol, Helsinki, Finland; [Tikkanen, Ilkka] Univ Helsinki, Abdominal Ctr, Nephrol, Helsinki, Finland; [Ala-Kokko, Tero] Univ Oulu, Dept Anaesthesiol, Oulu, Finland; [Ala-Kokko, Tero] Oulu Univ Hosp, Med Res Ctr Oulu, Div Intens Care Med, Oulu, Finland; [Pettila, Ville] Univ Bern, Inselspital, Univ Hosp Bern, Dept Intens Care Med, CH-3010 Bern, Switzerland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu; University of Bern; University Hospital of Bern	Vaara, ST (corresponding author), Univ Helsinki, Div Intens Care Med, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland.; Vaara, ST (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	suvi.vaara@helsinki.fi		Gaddnas, Fiia/0000-0002-9825-5014; Lakkisto, Paivi/0000-0001-9935-6573; Reinikainen, Matti/0000-0001-6878-3740	Academy of Finland; Sigrid Juselius Foundation; Paivikki and Sakari Sohlberg Foundation; University Hospital of Helsinki grant	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Paivikki and Sakari Sohlberg Foundation; University Hospital of Helsinki grant	The following foundations have supported the study: The Academy of Finland (www.aka.fi), the Sigrid Juselius Foundation (www.sigridjuselius.fi), the Paivikki and Sakari Sohlberg Foundation (www.psssaatio.fi), and a University Hospital of Helsinki grant (www.hus.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, KIDNEY INT S, P1; Barrera-Chimal J, 2011, EMBO MOL MED, V3, P5, DOI 10.1002/emmm.201000105; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bruemmer-Smith S, 2001, INTENS CARE MED, V27, P1835, DOI 10.1007/s00134-001-1131-3; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Christopher KB, 2014, CRIT CARE MED, V42, P992, DOI 10.1097/CCM.0000000000000088; Chu PG, 2002, HISTOPATHOLOGY, V40, P403, DOI 10.1046/j.1365-2559.2002.01387.x; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Fisher MB, 2009, CANCER GENE THER, V16, P567, DOI 10.1038/cgt.2009.2; Gomez H, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000052; Langenberg C, 2014, CRIT CARE MED, V42, pE58, DOI 10.1097/CCM.0b013e3182a639da; Lebherz-Eichinger D, 2012, CLIN CHIM ACTA, V413, P282, DOI 10.1016/j.cca.2011.10.010; Leedahl DD, 2014, CLIN J AM SOC NEPHRO, V9, P1168, DOI 10.2215/CJN.09360913; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Morales-Buenrostro LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109407; Murray PT, 2014, KIDNEY INT, V85, P513, DOI 10.1038/ki.2013.374; Okkonen M, 2011, CRIT CARE, V15, DOI 10.1186/cc10357; Ortega-Trejo JA, 2015, BIOMARKERS, P1; Poukkanen M, 2013, ACTA ANAESTH SCAND, V57, P863, DOI 10.1111/aas.12133; Roth GA, 2004, SHOCK, V22, P218, DOI 10.1097/01.shk.0000136098.49672.0e; Saukkonen K, 2007, INTENS CARE MED, V33, P1624, DOI 10.1007/s00134-007-0686-z; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Waikar SS, 2010, KIDNEY INT, V78, P486, DOI 10.1038/ki.2010.165; Zhong XY, 2001, ANN NY ACAD SCI, V945, P250	26	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149956	10.1371/journal.pone.0149956	http://dx.doi.org/10.1371/journal.pone.0149956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918334	Green Published, gold			2022-12-27	WOS:000371274400061
J	Yan, YW; Fan, J; Bai, SL; Hou, WJ; Li, X; Tong, H				Yan, Ya-Wei; Fan, Jun; Bai, Shu-Ling; Hou, Wei-Jian; Li, Xiang; Tong, Hao			Zinc Prevents Abdominal Aortic Aneurysm Formation by Induction of A20-Mediated Suppression of NF-kappa B Pathway	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; INFLAMMATORY CYTOKINES; GENE-EXPRESSION; TRANSPLANT ARTERIOSCLEROSIS; KINASE-BETA; IN-VITRO; INHIBITION; A20; WALL; RAT	Chronic inflammation and degradation of elastin are the main processes in the development of abdominal aortic aneurysm (AAA). Recent studies show that zinc has an anti-inflammatory effect. Based on these, zinc may render effective therapy for the treatment of the AAA. Currently, we want to investigate the effects of zinc on AAA progression and its related molecular mechanism. Rat AAA models were induced by periaortic application of CaCl2. AAA rats were treated by daily intraperitoneal injection of ZnSO4 or vehicle alone. The aorta segments were collected at 4 weeks after surgery. The primary rat aortic vascular smooth muscle cells (VSMCs) were stimulated with TNF-alpha alone or with ZnSO4 for 3 weeks. The results showed that zinc supplementation significantly suppressed the CaCl2-induced expansion of the abdominal aortic diameter, as well as a preservation of medial elastin fibers in the aortas. Zinc supplementation also obviously attenuated infiltration of the macrophages and lymphocytes in the aortas. In addition, zinc reduced MMP-2 and MMP-9 production in the aortas. Most importantly, zinc treatment significantly induced A20 expression, along with inhibition of the NF-kappa B canonical signaling pathway in vitro in VSMCs and in vivo in rat AAA. This study demonstrated, for the first time, that zinc supplementation could prevent the development of rat experimental AAA by induction of A20-mediated inhibition of the NF-kappa B canonical signaling pathway.	[Yan, Ya-Wei; Fan, Jun; Bai, Shu-Ling; Hou, Wei-Jian; Tong, Hao] China Med Univ, Sch Fundamental Sci, Dept Tissue Engn, Shenyang 110001, Peoples R China; [Li, Xiang] China Med Univ, Coll Basic Med, Dept Cell Biol, Shenyang 110001, Peoples R China	China Medical University; China Medical University	Bai, SL (corresponding author), China Med Univ, Sch Fundamental Sci, Dept Tissue Engn, Shenyang 110001, Peoples R China.	baishuling@hotmail.com			National Natural Science Foundation of China [81571919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Contract (No. 81571919) for FJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvelo MB, 1999, TRANSPLANT P, V31, P858, DOI 10.1016/S0041-1345(98)01804-1; Baltaci AK, 2003, BIOL TRACE ELEM RES, V96, P237, DOI 10.1385/BTER:96:1-3:237; Bao B, 2008, TRANSL RES, V152, P67, DOI 10.1016/j.trsl.2008.06.001; Bao B, 2010, AM J CLIN NUTR, V91, P1634, DOI 10.3945/ajcn.2009.28836; Beyaert R, 2000, BIOCHEM PHARMACOL, V60, P1143, DOI 10.1016/S0006-2952(00)00404-4; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Cheng WT, 2013, ASIAN PAC J TROP MED, V6, P570, DOI 10.1016/S1995-7645(13)60098-X; Chiou AC, 2001, J SURG RES, V99, P371, DOI 10.1006/jsre.2001.6207; Ciavarella C, 2015, CIRC J, V79, P1460, DOI 10.1253/circj.CJ-14-0857; Damrauer SM, 2010, ATHEROSCLEROSIS, V211, P404, DOI 10.1016/j.atherosclerosis.2010.03.029; Daugherty Alan, 2002, Curr Atheroscler Rep, V4, P222, DOI 10.1007/s11883-002-0023-5; Foster M, 2012, NUTRIENTS, V4, P676, DOI 10.3390/nu4070676; Gasparini C, 2014, CELL MOL LIFE SCI, V71, P2083, DOI 10.1007/s00018-013-1545-4; Hance KA, 2002, J VASC SURG, V35, P254, DOI 10.1067/mva.2002.120382; Hurks R, 2014, ATHEROSCLEROSIS, V235, P632, DOI 10.1016/j.atherosclerosis.2014.05.928; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Jayaraman T, 2008, VASC HEALTH RISK MAN, V4, P805, DOI 10.2147/VHRM.S2700; KAHARI VM, 1992, J BIOL CHEM, V267, P26134; Kuang PP, 2002, AM J PHYSIOL-CELL PH, V283, pC58, DOI 10.1152/ajpcell.00314.2001; Kunter U, 2003, TRANSPLANTATION, V75, P3, DOI 10.1097/00007890-200301150-00002; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li W, 2010, BIOL REPROD, V83, P481, DOI 10.1095/biolreprod.109.082578; Livingstone C, 2015, NUTR CLIN PRACT, V30, P371, DOI 10.1177/0884533615570376; Longo GM, 2002, J CLIN INVEST, V110, P625, DOI 10.1172/JCI200215334; Metz RP, 2012, METHODS MOL BIOL, V843, P169, DOI 10.1007/978-1-61779-523-7_16; Mi T, 2011, J HUAZHONG U SCI-MED, V31, P602, DOI 10.1007/s11596-011-0568-z; Miyake T, 2006, GENE THER, V13, P695, DOI 10.1038/sj.gt.3302704; Nakashima H, 2004, CIRCULATION, V109, P132, DOI 10.1161/01.CIR.0000105725.61763.A2; Ozturk A, 2003, BIOL TRACE ELEM RES, V96, P247, DOI 10.1385/BTER:96:1-3:247; Piechota-Polanczyk A, 2012, EUR J VASC ENDOVASC, V44, P133, DOI 10.1016/j.ejvs.2012.04.020; Prasad AS, 2008, EXP GERONTOL, V43, P370, DOI 10.1016/j.exger.2007.10.013; Prasad AS, 2011, NUTRITION, V27, P816, DOI 10.1016/j.nut.2010.08.010; Prasad AS, 2004, FREE RADICAL BIO MED, V37, P1182, DOI 10.1016/j.freeradbiomed.2004.07.007; PRASAD AS, 1979, AM J PHYSIOL, V236, pE272, DOI 10.1152/ajpendo.1979.236.3.E272; Prasad AS, 1996, J LAB CLIN MED, V128, P51, DOI 10.1016/S0022-2143(96)90113-4; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen HY, 2008, J AM COLL NUTR, V27, P577, DOI 10.1080/07315724.2008.10719741; Shih CJ, 2013, INFLAMMATION, V36, P616, DOI 10.1007/s10753-012-9583-x; Siracuse JJ, 2012, TRANSPLANTATION, V93, P373, DOI 10.1097/TP.0b013e3182419829; Skaug B, 2011, MOL CELL, V44, P559, DOI 10.1016/j.molcel.2011.09.015; Sproul EP, 2013, MATRIX BIOL, V32, P86, DOI 10.1016/j.matbio.2012.11.004; Takacs P, 2012, INT UROGYNECOL J, V23, P1775, DOI 10.1007/s00192-012-1807-y; Treska V, 2002, CYTOKINES CELL MOL T, V7, P91, DOI 10.1080/13684730310001652; Trollope A, 2011, CARDIOVASC PATHOL, V20, P114, DOI 10.1016/j.carpath.2010.01.001; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; von Bulow V, 2007, J IMMUNOL, V179, P4180, DOI 10.4049/jimmunol.179.6.4180; Wang J, 2015, J VASC SURG, V62, P1615, DOI 10.1016/j.jvs.2014.06.004; Xiong J, 2013, CHINESE MED J-PEKING, V126, P437, DOI 10.3760/cma.j.issn.0366-6999.20122151; Zhang Q, 2011, J SURG RES, V167, pE385, DOI 10.1016/j.jss.2011.01.017	49	29	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148536	10.1371/journal.pone.0148536	http://dx.doi.org/10.1371/journal.pone.0148536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918963	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400006
J	Adane, K; Spigt, M; Ferede, S; Asmelash, T; Abebe, M; Dinant, GJ				Adane, Kelemework; Spigt, Mark; Ferede, Semaw; Asmelash, Tsehaye; Abebe, Markos; Dinant, Geert-Jan			Half of Pulmonary Tuberculosis Cases Were Left Undiagnosed in Prisons of the Tigray Region of Ethiopia: Implications for Tuberculosis Control	PLOS ONE			English	Article							PREVALENCE; POPULATION; AFRICA	Introduction Prison settings have been often identified as important but neglected reservoirs for TB. This study was designed to determine the prevalence of undiagnosed pulmonary TB and assess the potential risk factors for such TB cases in prisons of the Tigray region. Method A cross-sectional study was conducted between August 2013 and February 2014 in nine prisons. A standardized symptom-based questionnaire was initially used to identify presumptive TB cases. From each, three consecutive sputum samples were collected for acid-fast bacilli (AFB) microscopy and culture. Blood samples were collected from consented participants for HIV testing. Result Out of 809 presumptive TB cases with culture result, 4.0% (95% CI: 2.65-5.35) were confirmed to have undiagnosed TB. The overall estimated point prevalence of undiagnosed TB was found to be 505/100,000 prisoners (95% CI: 360-640). Together with the 27 patients who were already on treatment, the overall estimated point prevalence of TB would be 793/100,000 prisoners (95% CI: 610-970), about four times higher than in the general population. The ratio of active to passive case detection was 1.18: 1. The prevalence of HIV was 4.4% (36/809) among presumptive TB cases and 6.3% (2/32) among undiagnosed TB cases. In a multivariate logistic regression analysis, chewing Khat (adjusted OR = 2.81; 95% CI: 1.02-7.75) and having had a close contact with a TB patient (adjusted OR = 2.18; 95% CI: 1.05-4.51) were found to be predictors of undiagnosed TB among presumptive TB cases. Conclusions This study revealed that at least half of symptomatic pulmonary TB cases in Northern Ethiopian prisons remain undiagnosed and hence untreated. The prevalence of undiagnosed TB in the study prisons was more than two folds higher than in the general population of Tigray. This may indicate the need for more investment and commitment to improving TB case detection in the study prisons.	[Adane, Kelemework; Asmelash, Tsehaye] Mekelle Univ, Coll Hlth Sci, Dept Med Microbiol & Immunol, Mekelle, Ethiopia; [Adane, Kelemework; Spigt, Mark; Dinant, Geert-Jan] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands; [Ferede, Semaw] Mekelle Univ, Dept Publ Hlth, Coll Hlth Sci, Mekelle, Ethiopia; [Abebe, Markos] Armauer Hansen Res Inst, Addis Ababa, Ethiopia	Mekelle University; Maastricht University; Mekelle University	Adane, K (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Med Microbiol & Immunol, Mekelle, Ethiopia.; Adane, K (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Family Med, NL-6200 MD Maastricht, Netherlands.	ingoldmlt@gmail.com	Kempker, Russell/F-5776-2017		Maastricht University through Nuffic scholarship; Mekelle University through NORAD collaboration project; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	Maastricht University through Nuffic scholarship; Mekelle University through NORAD collaboration project; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was financially supported by Maastricht University through Nuffic scholarship and Mekelle University through NORAD collaboration project. Moreover, Armauer Hasen Research Institute (AHRI) provided us reagent and bench work supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2002, ETHIOPIAN MED J, V40, P79; Abbink JG, 1998, NE AFRICAN STUDIES, P59; Abebe DS, 2011, INT J TUBERC LUNG D, V15, P668, DOI 10.5588/ijtld.10.0363; [Anonymous], 2009, EP FACT SHEET HIV AI; [Anonymous], 2014, HUMAN RIGHTS ANAL RE; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Berhe G, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-448; Berile, 2012, STATUS HUMAN RIGHTS; Breen RAM, 2006, DRUGS, V66, P2299, DOI 10.2165/00003495-200666180-00003; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; den Boon S, 2006, INT J TUBERC LUNG D, V10, P876; Henostroza G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067338; Koffi N, 1997, INT J TUBERC LUNG D, V1, P250; Leung CC, 2005, INT J TUBERC LUNG D, V9, P627; Masoud D, 2009, GUIDELINES CONTROL T; Melchers NVSV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053644; Moges B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-352; Nyangulu DS, 1997, LANCET, V350, P1284, DOI 10.1016/S0140-6736(97)05023-X; O'Grady J, 2011, SAMJ S AFR MED J, V101, P107, DOI 10.7196/SAMJ.4629; O'Grady J, 2011, TUBERCULOSIS, V91, P173, DOI 10.1016/j.tube.2010.12.002; Ormerod P, 2000, THORAX, V55, P887; RUTTA E, 1994, INT J TUBERC LUNG D, V2001, P703; Saunders DL, 2001, PUBLIC HEALTH REP, V116, P210, DOI 10.1016/S0033-3549(04)50036-5; Ssengooba W, 2012, TUBERC RES TREAT, V2012; Telisinghe L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087262; Thapa B., 2013, INT J INFECT MICROBI, V2, P68; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; Walmsley R, 2010, WORLD PRISON POPULAT, Veleventh, P15; Ward HA, 2004, INT J TUBERC LUNG D, V8, P593; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2009, GLOBAL TUBERCULOSIS; WHO, 2007, STAT PAP PRIS TUB; World Health Organization, 1995, PHYS STAT US INT ANT; World Health Organization, 2014, GLOB TUB REP	35	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149453	10.1371/journal.pone.0149453	http://dx.doi.org/10.1371/journal.pone.0149453			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914770	Green Submitted, gold, Green Published			2022-12-27	WOS:000371175700016
J	Mclay, JS; Pallivalappila, AR; Shetty, A; Pande, B; Al Hail, M; Stewart, D				McLay, James S.; Pallivalappila, Abdul R.; Shetty, Ashalatha; Pande, Binita; Al Hail, Moza; Stewart, Derek			'Asking the Right Question'. A Comparison of Two Approaches to Gathering Data on 'Herbals' Use in Survey Based Studies	PLOS ONE			English	Article							ALTERNATIVE MEDICINE CAM; GENERAL-POPULATION; COMPLEMENTARY; PREVALENCE; PRODUCTS; WOMEN	Background Over the last decade academic interest in the prevalence and nature of herbal medicines use by pregnant women has increased significantly. Such data are usually collected by means of an administered questionnaire survey, however a key methodological limitation using this approach is the need to clearly define the scope of 'herbals' to be investigated. The majority of published studies in this area neither define 'herbals' nor provide a detailed checklist naming specific 'herbals' and CAM modalities, which limits inter-study comparison, generalisability and the potential for meta-analyses. The aim of this study was to compare the self-reported use of herbs, herbal medicines and herbal products using two different approaches implemented in succession. Methods Cross-sectional questionnaire surveys of women attending for their mid-trimester scan or attending the postnatal unit following live birth at the Royal Aberdeen Maternity Hospital, North-East Scotland. The questionnaire utilised two approaches to collect data on 'herbals' use, a single closed yes/no answer to the question "have you used herbs, herbal medicines and herbal products in the last three months"; and a request to tick which of a list of 40 'herbals' they had used in the same time period. Results A total of 889 responses were obtained of which 4.3% (38) answered 'yes' to herbal use via the closed question. However, using the checklist 39% (350) of respondents reported the use of one or more specific 'herbals' (p<0.0001). The 312 respondents who reported 'no' to 'herbals' use via the closed question but "yes" via the checklist consumed a total of 20 different 'herbals' (median 1, interquartile range 1-2, range 1-6). Conclusions This study demonstrates that the use of a single closed question asking about the use of `herbals', as frequently reported in published studies, may not yield valid data resulting in a gross underestimation of actual use.	[McLay, James S.] Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland; [Pallivalappila, Abdul R.] Womens Hosp HMC, Dept Pharm, Doha, Qatar; [Shetty, Ashalatha] Univ Aberdeen, Dept Obstet & Gynaecol, Aberdeen AB25 2ZD, Scotland; [Pande, Binita] NHS Tayside, Ninewells Hosp & Med Sch, Dept Obstet & Gynaecol, Dundee DD1 9SY, Scotland; [Al Hail, Moza] Hamad Med Corp, Post Box 3050, Doha, Qatar; [Stewart, Derek] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen AB10 7GJ, Scotland	University of Aberdeen; University of Aberdeen; University of Dundee; Hamad Medical Corporation; Robert Gordon University	Mclay, JS (corresponding author), Univ Aberdeen, Div Appl Hlth Sci, Aberdeen AB25 2ZD, Scotland.	j.mclay@abdn.ac.uk		Pallivalappila, Abdul Rouf/0000-0002-6924-8245; Stewart, Derek/0000-0001-7360-8592; Alhail, Moza/0000-0002-7442-3773				[Anonymous], 2014, GUIDANCE HERBAL MED; [Anonymous], 2001, J ETHNOPHARMACOL, V75, P141; [Anonymous], 2015, GEN GUID METH RES EV; Boivin J, 2009, HUM REPROD, V24, P1626, DOI 10.1093/humrep/dep077; Briggs GG., 2012, DRUGS PREGNANCY LACT; Chuang CH, 2006, DRUG SAFETY, V29, P537, DOI 10.2165/00002018-200629060-00006; Cuzzolin L, 2010, PHARMACOEPIDEM DR S, V19, P1151, DOI 10.1002/pds.2040; Dillman D.A., 2014, TAILORED DESIGN METH; Dugoua Jean-Jacques, 2006, Can J Clin Pharmacol, V13, pe277; Dunn Jeffrey D, 2005, J Manag Care Pharm, V11, P252; Eardley S, 2012, FORSCH KOMPLEMENTMED, V19, P18, DOI 10.1159/000342708; Ernst E, 2000, B WORLD HEALTH ORGAN, V78, P252; Ernst PE, 2002, BJOG-INT J OBSTET GY, V109, P227; Facchinetti F, 2012, HUM REPROD, V27, P3161, DOI 10.1093/humrep/des303; Fischer FH, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-46; Frass M, 2012, OCHSNER J, V12, P45; Fugh-Berman A, 2003, REPROD TOXICOL, V17, P137, DOI 10.1016/S0890-6238(02)00128-4; Harris PE, 2012, INT J CLIN PRACT, V66, P924, DOI 10.1111/j.1742-1241.2012.02945.x; Holst Lone, 2009, Complement Ther Clin Pract, V15, P204, DOI 10.1016/j.ctcp.2009.05.003; Johnson JR, 2009, REPROD SCI, V16, P605, DOI 10.1177/1933719109332823; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Langhammer AJ, 2014, PHYTOTHER RES, V28, P603, DOI 10.1002/ptr.5037; Marcus DM, 2005, OBSTET GYNECOL, V105, P1119, DOI 10.1097/01.AOG.0000158858.79134.ea; Moussally K, 2010, EUR J OBSTET GYN R B, V150, P107, DOI 10.1016/j.ejogrb.2010.02.001; Nardi P.M., 2015, DOING SURVEY RES; Pallivalapila AR, 2015, OBSTET GYNECOL, V125, P204, DOI 10.1097/AOG.0000000000000596; Pallivalappila AR, 2014, EUR J OBSTET GYN R B, V181, P251, DOI 10.1016/j.ejogrb.2014.08.017; Pallivalappila AR, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/205639; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Re Meike Lo, 2012, BMC Complement Altern Med, V12, P259, DOI 10.1186/1472-6882-12-259; Rossi E., 2015, J MED PERSON, V13, P45; Rossi PH., 2013, HDB SURVEY RES, P145; Smeriglio A, 2014, PHYTOTHER RES, V28, P1107, DOI 10.1002/ptr.5106	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150140	10.1371/journal.pone.0150140	http://dx.doi.org/10.1371/journal.pone.0150140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914792	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700055
J	Varrella, S; Romano, G; Costantini, S; Ruocco, N; Ianora, A; Bentley, MG; Costantini, M				Varrella, Stefano; Romano, Giovanna; Costantini, Susan; Ruocco, Nadia; Ianora, Adrianna; Bentley, Matt G.; Costantini, Maria			Toxic Diatom Aldehydes Affect Defence Gene Networks in Sea Urchins	PLOS ONE			English	Article							NF-KAPPA-B; EXPRESSION; APOPTOSIS; STRESS; P53; INHIBITION; RESPONSES; PATHWAYS; CELLS; MODEL	Marine organisms possess a series of cellular strategies to counteract the negative effects of toxic compounds, including the massive reorganization of gene expression networks. Here we report the modulated dose-dependent response of activated genes by diatom polyunsaturated aldehydes (PUAs) in the sea urchin Paracentrotus lividus. PUAs are secondary metabolites deriving from the oxidation of fatty acids, inducing deleterious effects on the reproduction and development of planktonic and benthic organisms that feed on these unicellular algae and with anti-cancer activity. Our previous results showed that PUAs target several genes, implicated in different functional processes in this sea urchin. Using interactomic Ingenuity Pathway Analysis we now show that the genes targeted by PUAs are correlated with four HUB genes, NF-kappa B, p53, delta-2-catenin and HIF1A, which have not been previously reported for P. lividus. We propose a working model describing hypothetical pathways potentially involved in toxic aldehyde stress response in sea urchins. This represents the first report on gene networks affected by PUAs, opening new perspectives in understanding the cellular mechanisms underlying the response of benthic organisms to diatom exposure.	[Varrella, Stefano; Ruocco, Nadia; Costantini, Maria] Sdn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy; [Romano, Giovanna; Ianora, Adrianna] Sdn Zool Anton Dohrn, Dept Integrat Marine Ecol, Naples, Italy; [Costantini, Susan] IRCCS, Ist Nazl Tumori Fdn G Pascale, CROM, Naples, Italy; [Bentley, Matt G.] Bournemouth Univ, Fac Sci & Technol, Talbot Campus, Poole BH12 5BB, Dorset, England	Stazione Zoologica Anton Dohrn di Napoli; Stazione Zoologica Anton Dohrn di Napoli; IRCCS Fondazione Pascale; Bournemouth University	Costantini, M (corresponding author), Sdn Zool Anton Dohrn, Dept Biol & Evolut Marine Organisms, Naples, Italy.	maria.costantini@szn.it	Ruocco, Nadia/HGA-2143-2022; Romano, Giovanna/F-4561-2015; Costantini, Susan/J-9914-2018; Costantini, Maria/AGH-4080-2022; Varrella, Stefano/ABI-5401-2020; Ianora, Adrianna/O-3408-2019; Varrella, Stefano/GXF-3079-2022	Romano, Giovanna/0000-0002-4898-7153; Varrella, Stefano/0000-0002-8582-3502; Costantini, Susan/0000-0002-7538-4657	Stazione Zoologica Anton Dohrn PhD fellowship	Stazione Zoologica Anton Dohrn PhD fellowship	SV has been supported by a Stazione Zoologica Anton Dohrn PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonaventura R, 2005, BIOCHEM BIOPH RES CO, V328, P150, DOI 10.1016/j.bbrc.2004.12.161; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Caldwell GS, 2009, MAR DRUGS, V7, P367, DOI 10.3390/md7030367; Caldwell GS, 2002, AQUAT TOXICOL, V60, P123, DOI 10.1016/S0166-445X(01)00277-6; Carotenuto Y, 2005, LIMNOL OCEANOGR, V50, P449, DOI 10.4319/lo.2005.50.2.0449; Casano C, 2003, CELL STRESS CHAPERON, V8, P70, DOI 10.1379/1466-1268(2003)8<70:SUDITA>2.0.CO;2; Clarke AR, 1997, ONCOGENE, V14, P2015, DOI 10.1038/sj.onc.1201040; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; de-Leon SB, 2013, DEV BIOL, V374, P245, DOI 10.1016/j.ydbio.2012.11.013; Fulda S., 2010, INT J CELL BIOL; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gilmore TD, 2012, IMMUNOL REV, V246, P14, DOI 10.1111/j.1600-065X.2012.01096.x; Goldstone JV, 2006, DEV BIOL, V300, P366, DOI 10.1016/j.ydbio.2006.08.066; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Griffiths SD, 1997, ONCOGENE, V14, P523, DOI 10.1038/sj.onc.1200871; Guenther J, 2009, MAR ECOL PROG SER, V385, P137, DOI 10.3354/meps08034; Hale AJ, 1996, EUR J BIOCHEM, V236, P1, DOI 10.1111/j.1432-1033.1996.00001.x; Hibino T, 2006, DEV BIOL, V300, P349, DOI 10.1016/j.ydbio.2006.08.065; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Ianora A, 2004, NATURE, V429, P403, DOI 10.1038/nature02526; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Kozlowsky-Suzuki B, 2009, HARMFUL ALGAE, V8, P395, DOI 10.1016/j.hal.2008.08.025; Lesser MP, 2003, J EXP BIOL, V206, P4097, DOI 10.1242/jeb.00621; Marrone V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031750; Miralto A, 1999, NATURE, V402, P173, DOI 10.1038/46023; Murphy SH, 2011, P NATL ACAD SCI USA, V108, P17117, DOI 10.1073/pnas.1114420108; Nayak RR, 2014, NUCLEIC ACIDS RES, V42, P1757, DOI 10.1093/nar/gkt999; New LG, 1998, TRENDS CARDIOVAS MED, V8, P220, DOI 10.1016/S1050-1738(98)00012-7; Obata T, 2000, CRIT CARE MED, V28, pN67, DOI 10.1097/00003246-200004001-00008; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Puszynski K, 2009, IET SYST BIOL, V3, P356, DOI 10.1049/iet-syb.2008.0172; Ravi R, 2000, GENE DEV, V14, P34; Renzing J, 1996, J CELL SCI, V109, P1105; Romano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025980; Romano G, 2010, MAR DRUGS, V8, P950, DOI 10.3390/md8040950; Russo R, 2014, MAR ENVIRON RES, V93, P85, DOI 10.1016/j.marenvres.2013.08.006; Sansone C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101220; Simon CA, 2010, AQUACULTURE, V310, P52, DOI 10.1016/j.aquaculture.2010.10.031; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; van Uden P, 2008, BIOCHEM J, V412, P477, DOI 10.1042/BJ20080476; Varrella S, 2014, MAR DRUGS, V12, P2089, DOI 10.3390/md12042089; Vidoudez C, 2011, MAR DRUGS, V9, P345, DOI 10.3390/md9030345; Zhang Q, 2007, PLOS COMPUT BIOL, V3, P345, DOI 10.1371/journal.pcbi.0030024; Zhao LM, 2009, J MED ENTOMOL, V46, P1361, DOI 10.1603/033.046.0615	50	25	26	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149734	10.1371/journal.pone.0149734	http://dx.doi.org/10.1371/journal.pone.0149734			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914213	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000371175700025
J	Wright, AD; Jarrett, M; Vavasour, I; Shahinfard, E; Kolind, S; van Donkelaar, P; Taunton, J; Li, D; Rauscher, A				Wright, Alexander D.; Jarrett, Michael; Vavasour, Irene; Shahinfard, Elham; Kolind, Shannon; van Donkelaar, Paul; Taunton, Jack; Li, David; Rauscher, Alexander			Myelin Water Fraction Is Transiently Reduced after a Single Mild Traumatic Brain Injury - A Prospective Cohort Study in Collegiate Hockey Players	PLOS ONE			English	Article							SPORTS-RELATED CONCUSSION; TENSOR IMAGING FINDINGS; WHITE-MATTER INTEGRITY; DIFFUSE AXONAL INJURY; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; UNMYELINATED AXONS; N-ACETYLASPARTATE; NERVOUS-SYSTEM; DAMAGE	Impact-related mild traumatic brain injuries (mTBI) are a major public health concern, and remain as one of the most poorly understood injuries in the field of neuroscience. Currently, the diagnosis and management of such injuries are based largely on patient-reported symptoms. An improved understanding of the underlying pathophysiology of mTBI is urgently needed in order to develop better diagnostic and management protocols. Specifically, dynamic post-injury changes to the myelin sheath in the human brain have not been examined, despite 'compromised white matter integrity' often being described as a consequence of mTBI. In this preliminary cohort study, myelin water imaging was used to prospectively evaluate changes in myelin water fraction, derived from the T2 decay signal, in two varsity hockey teams (45 players) over one season of athletic competition. 11 players sustained a concussion during competition, and were scanned at 72 hours, 2 weeks, and 2 months post-injury. Results demonstrated a reduction in myelin water fraction at 2 weeks post-injury in several brain areas relative to preseason scans, including the splenium of the corpus callosum, right posterior thalamic radiation, left superior corona radiata, left superior longitudinal fasciculus, and left posterior limb of the internal capsule. Myelin water fraction recovered to pre-season values by 2 months post-injury. These results may indicate transient myelin disruption following a single mTBI, with subsequent remyelination of affected neurons. Myelin disruption was not apparent in the athletes who did not experience a concussion, despite exposure to repetitive subconcussive trauma over a season of collegiate hockey. These findings may help to explain many of the metabolic and neurological deficits observed clinically following mTBI.	[Wright, Alexander D.] Univ British Columbia, MD PhD Program, Vancouver, BC V5Z 1M9, Canada; [Wright, Alexander D.] Univ British Columbia Okanagan, Southern Med Program, Kelowna, BC, Canada; [Wright, Alexander D.] Univ British Columbia, Dept Expt Med, Vancouver, BC V5Z 1M9, Canada; [Jarrett, Michael; Vavasour, Irene; Shahinfard, Elham; Rauscher, Alexander] Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada; [Kolind, Shannon] Univ British Columbia, Div Neurol, Fac Med, Vancouver, BC V5Z 1M9, Canada; [van Donkelaar, Paul] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Taunton, Jack] Univ British Columbia, Fac Med, Div Sports Med, Vancouver, BC, Canada; [Li, David] Univ British Columbia, Fac Med, Dept Radiol, Vancouver, BC, Canada; [Rauscher, Alexander] Univ British Columbia, Dept Pediat, Div Neurol, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia; University of British Columbia	Rauscher, A (corresponding author), Univ British Columbia, UBC MRI Res Ctr, Vancouver, BC V5Z 1M9, Canada.	rauscher@physics.ubc.ca		Jarrett, Michael/0000-0002-3702-2014; Shahinfard, Elham/0000-0002-3526-0086; Rauscher, Alexander/0000-0002-1961-8252	London Drugs Award for Research Excellence in Radiology; Canadian Institutes for Health Research (CIHR) [201109MSH-261306-183304]; Vanier Canada Graduate Scholarships program	London Drugs Award for Research Excellence in Radiology; Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarships program	This research was funded by a London Drugs Award for Research Excellence in Radiology (no grant number) and by a New Investigator Award to Alexander Rauscher from the Canadian Institutes for Health Research (CIHR, grant #201109MSH-261306-183304). Alexander Rauscher is also a Canada Research Chair in Developmental Neuroimaging. Alexander D. Wright was supported by the Vanier Canada Graduate Scholarships program. No persons other than the listed authors had substantial scientific input into this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong R.C., 2015, EXP NEUROL; Bailes JE, 2014, PROG NEUROL SURG, V28, P50, DOI 10.1159/000358765; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Benarroch EE, 2009, NEUROLOGY, V72, P1779, DOI 10.1212/WNL.0b013e3181a6b123; Berger RP, 2006, J HEAD TRAUMA REHAB, V21, P315, DOI 10.1097/00001199-200607000-00004; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Blennow K, 2011, ACTA NEUROL SCAND, V123, P245, DOI 10.1111/j.1600-0404.2010.01408.x; Chong CD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0485-0; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10186; Faisal A.A., 2011, BMC NEUROSCI, V12, pP100, DOI [10.1186/1471-2202-12-S1-P100, DOI 10.1186/1471-2202-12-S1-P100]; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gareau PJ, 2000, J MAGN RESON IMAGING, V11, P586, DOI 10.1002/1522-2586(200006)11:6<586::AID-JMRI3>3.0.CO;2-V; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hsieh S-T, 1993, BRAIN PATHOL, V3, P307; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Kozlowski P, 2008, MAGN RESON MED, V59, P796, DOI 10.1002/mrm.21527; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lange RT, 2012, J HEAD TRAUMA REHAB, V27, P188, DOI 10.1097/HTR.0b013e318217f0ad; Laule C, 2006, MULT SCLER, V12, P747, DOI 10.1177/1352458506070928; Laule C, 2007, NEUROTHERAPEUTICS, V4, P460, DOI 10.1016/j.nurt.2007.05.004; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Liang ALW, 2012, J NEUROL, V259, P1151, DOI 10.1007/s00415-011-6318-0; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Liu MC, 2006, J NEUROCHEM, V98, P700, DOI 10.1111/j.1471-4159.2006.03882.x; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; MacKay A, 2006, MAGN RESON IMAGING, V24, P515, DOI 10.1016/j.mri.2005.12.037; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Maxwell WL, 2015, J NEUROTRAUMA; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MEHTA V, 1995, MOL BRAIN RES, V31, P151, DOI 10.1016/0169-328X(95)00044-S; Meier TB, 2015, JAMA NEUROL; Meyers SM, 2013, J MAGN RESON IMAGING, V38, P1445, DOI 10.1002/jmri.24106; Meyers SM, 2009, MAGN RESON IMAGING, V27, P1096, DOI 10.1016/j.mri.2009.02.001; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miyamoto N, 2013, STROKE, V44, P3516, DOI 10.1161/STROKEAHA.113.002813; Narayanan S, 1997, ANN NEUROL, V41, P385, DOI 10.1002/ana.410410314; NG HK, 1994, CLIN NEUROL NEUROSUR, V96, P24, DOI 10.1016/0303-8467(94)90025-6; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Nordengen K, 2015, BRAIN STRUCT FUNCT, V220, P899, DOI 10.1007/s00429-013-0691-7; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Oh J, 2007, J NEUROIMAGING, V17, P156, DOI 10.1111/j.1552-6569.2007.00098.x; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prasloski T, 2012, NEUROIMAGE, V63, P533, DOI 10.1016/j.neuroimage.2012.06.064; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Sanchez I, 1996, J NEUROSCI, V16, P5095; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shi H., 2015, EXP NEUROL; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stanisz GJ, 2004, MAGNET RESON MED, V51, P473, DOI 10.1002/mrm.20008; STEWART WA, 1993, MAGNET RESON MED, V29, P767, DOI 10.1002/mrm.1910290608; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Tsunoda I, 2002, SPRINGER SEMIN IMMUN, V24, P105, DOI 10.1007/s00281-002-0105-z; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vavasour IM, 2009, J NEUROL SCI, V276, P49, DOI 10.1016/j.jns.2008.08.022; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; WAXMAN SG, 1977, ARCH NEUROL-CHICAGO, V34, P585, DOI 10.1001/archneur.1977.00500220019003; Webb S, 2003, MAGNET RESON MED, V49, P638, DOI 10.1002/mrm.10411; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	81	56	56	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150215	10.1371/journal.pone.0150215	http://dx.doi.org/10.1371/journal.pone.0150215			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26913900	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700062
J	Ko, YC; Hwang, DK; Chen, WT; Lee, CC; Liu, CJ				Ko, Yu-Chieh; Hwang, De-Kuang; Chen, Wei-Ta; Lee, Ching-Chih; Liu, Catherine J.			Impact of Socioeconomic Status on the Diagnosis of Primary Open-Angle Glaucoma and Primary Angle Closure Glaucoma: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							OPTIC-NERVE HEAD; HEALTH-INSURANCE; VISUAL-FIELD; BLINDNESS; ADULTS; PREVALENCE; DISPARITY; KNOWLEDGE; DISEASE; MYOPIA	Purpose To understand the impact of socioeconomic status (SES) on the diagnosis of primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG) in Taiwan. Methods Subjects with glaucoma were identified from the National Health Insurance Research Database of year 2006, which included one million randomly selected insurants. Individuals who had >= 4 ambulatory visits within one year which had the diagnosis code of POAG (ICD-9-CM 365.11 or 365.12) or PACG (365.23) and concurrent prescription of anti-glaucoma medication or surgery were selected. Individual SES was represented by monthly income calculated from the insurance premium. Neighborhood SES was defined based on neighborhood household income averages. Urbanization level of habitation was categorized into 3 levels. The odds ratio of having POAG or PACG in subjects with different SES was evaluated by using multiple logistic regression analysis. Results In total, 752 and 561 subjects with POAG and PACG, respectively, who were treated on a regular basis, were identified. The diagnosis of glaucoma was affected by age, gender, frequency of healthcare utilization, individual SES, and urbanization level of habitation. With the adjustment of age, gender, healthcare utilization, neighborhood SES and level of urbanization, subjects with lower income were more likely to be diagnosed as PACG, but less likely as POAG. Conclusions Subjects with more frequent healthcare utilization were more likely to be diagnosed with glaucoma. Subjects with low SES were more susceptible to PACG, but subjects with high SES were more likely to be diagnosed as POAG. This information is useful for the design and target participant setting in glaucoma education and screening campaign to maximize the efficacy of limited resources in preventing glaucoma blindness.	[Ko, Yu-Chieh; Liu, Catherine J.] Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Ko, Yu-Chieh; Hwang, De-Kuang; Chen, Wei-Ta; Liu, Catherine J.] Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan; [Ko, Yu-Chieh] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Hwang, De-Kuang] Taichung Vet Gen Hosp, Dept Ophthalmol, Taichung, Taiwan; [Chen, Wei-Ta] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Lee, Ching-Chih] Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan; [Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University	Liu, CJ (corresponding author), Taipei Vet Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.; Liu, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Fac Med, Taipei 112, Taiwan.; Lee, CC (corresponding author), Dalin Tzu Chi Hosp, Dept Otolaryngol, Buddhist Tzu Chi Med Fdn, Chiayi, Taiwan.; Lee, CC (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.	hematcd2@hotmail.com; jlliu@vghtpe.gov.tw	Hwang, DK De-Kuang/J-3931-2016	Hwang, DK De-Kuang/0000-0001-6346-8485	Taipei Veterans General Hospital, Taipei, Taiwan [V104C-180]; Ministry of Science and Technology, Taiwan [MOST 103-2628-B-075-001-MY3]	Taipei Veterans General Hospital, Taipei, Taiwan(Taipei Veterans General Hospital); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The project was supported by grant V104C-180 from the Taipei Veterans General Hospital, Taipei, Taiwan (http://www.vghtpe.gov.tw/doce/) and grant MOST 103-2628-B-075-001-MY3 from Ministry of Science and Technology, Taiwan (https://www.most.gov.tw/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, J POPUL STUD; Attebo K, 1997, AUST NZ J OPHTHALMOL, V25, P283, DOI 10.1111/j.1442-9071.1997.tb01516.x; Boland MV, 2008, OPHTHALMOLOGY, V115, P239, DOI 10.1016/j.ophtha.2007.03.086; Buys YM, 2013, CAN J OPHTHALMOL, P4883; Chen PP, 2003, OPHTHALMOLOGY, V110, P726, DOI 10.1016/S0161-6420(02)01974-7; Chen YY, 2013, EYE, V27, P1070, DOI 10.1038/eye.2013.127; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Ernest PJ, 2013, OPHTHALMOLOGY, V120, P512, DOI 10.1016/j.ophtha.2012.09.005; Foster PJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1105, DOI 10.1001/archopht.118.8.1105; Gogate P, 2011, INDIAN J OPHTHALMOL, V59, P29, DOI 10.4103/0301-4738.73720; Hennis A, 2007, OPHTHALMOLOGY, V114, P1816, DOI 10.1016/j.ophtha.2007.06.013; Hoevenaars JGMM, 2006, ACTA OPHTHALMOL SCAN, V84, P84, DOI 10.1111/j.1600-0420.2005.00587.x; Hwang DK, 2014, JAMA OPHTHALMOL, V132, P1446, DOI 10.1001/jamaophthalmol.2014.3333; Jin YP, 2011, CAN J OPHTHALMOL, V46, P133, DOI 10.3129/i10-120; Ko YC, 2015, OPHTHAL EPIDEMIOL, V22, P109, DOI 10.3109/09286586.2015.1012270; Ko YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107660; Lee S, 2014, INVEST OPHTH VIS SCI, V55, P4378, DOI 10.1167/iovs.14-14227; Lee YY, 2013, INVEST OPHTH VIS SCI, V54, P1026, DOI 10.1167/iovs.12-10480; Leung VC, 2015, J GLAUCOMA, V24, P69, DOI 10.1097/IJG.0000000000000081; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Liu LF, 2012, HEALTH POLICY, V108, P246, DOI 10.1016/j.healthpol.2012.08.022; Marcus MW, 2011, OPHTHALMOLOGY, V118, P1989, DOI 10.1016/j.ophtha.2011.03.012; Mitry D, 2010, INVEST OPHTH VIS SCI, V51, P4963, DOI 10.1167/iovs.10-5400; Ng WS, 2010, BRIT J OPHTHALMOL, V94, P85, DOI 10.1136/bjo.2008.153312; Ulldemolins AR, 2012, INDIAN J OPHTHALMOL, V60, P368, DOI 10.4103/0301-4738.100529; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Topouzis F, 2008, AM J OPHTHALMOL, V145, P327, DOI 10.1016/j.ajo.2007.09.013; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WANG Y, 2013, PLOS ONE, V2013; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wong TY, 2002, BRIT J OPHTHALMOL, V86, P963, DOI 10.1136/bjo.86.9.963; Xu L, 2008, AM J OPHTHALMOL, V145, P929, DOI 10.1016/j.ajo.2008.01.004; Xu L, 2010, GRAEF ARCH CLIN EXP, V248, P49, DOI 10.1007/s00417-009-1204-5; Yip JLY, 2011, OPHTHAL EPIDEMIOL, V18, P217, DOI 10.3109/09286586.2011.602507; Zhang XZ, 2013, JAMA OPHTHALMOL, V131, P1198, DOI 10.1001/jamaophthalmol.2013.4694	36	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149698	10.1371/journal.pone.0149698	http://dx.doi.org/10.1371/journal.pone.0149698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905307	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000019
J	Schneider, BC; Dumith, SD; Lopes, C; Severo, M; Assuncao, MCF				Schneider, Bruna Celestino; Dumith, Samuel de Carvalho; Lopes, Carla; Severo, Milton; Formoso Assuncao, Maria Cecilia			How Do Tracking and Changes in Dietary Pattern during Adolescence Relate to the Amount of Body Fat in Early Adulthood?	PLOS ONE			English	Article							CHILDREN; OVERWEIGHT; OBESITY; MASS	Background Few studies have addressed the influence of dietary patterns (DP) during adolescence on the amount of body fat in early adulthood. Objective To analyze the associations between DP tracking and changes in the period between 15 and 18 years of age and the percentage of body fat (%BF) at age 18 years. Methods We used data from 3,823 members of the 1993 Pelotas (Brazil) birth cohort. Body density was measured at age 18 years by air displacement plethysmograph (BOD POD) and the %BF was calculated applying the Siri equation. Based on the estimates from the FFQ, we identified DP at ages 15 ("Varied", "Traditional", "Dieting" and "Processed meats") and 18 years ("Varied", "Traditional", "Dieting" and " Fish, fast food and alcohol"). The DP tracking was defined as the individual's adherence to the same DP at both ages. Associations were tested using multiple linear regression models stratified by sex. Results The mean %BF was 25.0%(95% CI: 24.7 to 25.4), significantly greater for girls than boys (p<0.001). The adherence to any DP at age 15 years was not associated with the %BF at age 18 years. However, individuals who adhered to a "Dieting" DP at age 18 years showed greater %BF (1.30 and 1.91 percentage points in boys and girls, respectively) in comparison with those who adhered to a "Varied" DP. Boys who presented tracking of a "Dieting" DP presented greater average %BF in comparison with others DP, as well as girls who changed from the "Traditional" or "Processed meats" DP to a "Dieting" DP. Conclusion These results may support public health policies and strategies focused on improving dietary habits of adolescents and young adults and preventing accumulation of body fat, especially among the adolescents with restrictive dietary habits.	[Schneider, Bruna Celestino; Formoso Assuncao, Maria Cecilia] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Dumith, Samuel de Carvalho] Fed Univ Rio Grande, Postgrad Program Publ Hlth, Rio Grande, Brazil; [Lopes, Carla; Severo, Milton] Univ Porto, Sch Med, Inst Publ Hlth, Dept Clin Epidemiol Prevent Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Universidade Federal de Pelotas; Universidade Federal do Rio Grande; Universidade do Porto	Schneider, BC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	brucelsch@yahoo.com.br	Schneider, Bruna/I-5688-2018; Lopes, Carla/U-9327-2017; Severo, Milton/I-3497-2012	Lopes, Carla/0000-0003-1524-852X; Severo, Milton/0000-0002-5787-4871; Celestino Schneider, Bruna/0000-0002-1035-0106; Dumith, Samuel/0000-0002-5994-735X	Wellcome Trust; European Union, National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); European Union, National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Ministry of Health	This article is based on data from the study "Pelotas Birth Cohort, 1993" conducted by Postgraduate Program in Epidemiology at Universidade Federal de Pelotas with the collaboration of the Brazilian Public Health Association (ABRASCO). From 2004 to 2013, the Wellcome Trust supported the 1993 birth cohort study. The European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), and the Brazilian Ministry of Health supported previous phases of the study.	[Anonymous], 2003, Saudi Med J, V24, P1154; Beechy L, 2012, PHYSIOL BEHAV, V107, P154, DOI 10.1016/j.physbeh.2012.04.013; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P174, DOI 10.1093/jpepsy/jst084; Collins CE, 2010, INT J OBESITY, V34, P1103, DOI 10.1038/ijo.2009.241; Cutler GJ, 2012, BRIT J NUTR, V108, P349, DOI 10.1017/S0007114511005435; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Ellis KJ, 2000, PHYSIOL REV, V80, P649, DOI 10.1152/physrev.2000.80.2.649; Fraser LK, 2011, INT J OBESITY, V35, P1325, DOI 10.1038/ijo.2011.120; Gallagher AM, 2006, PUBLIC HEALTH NUTR, V9, P1027, DOI 10.1017/PHN2006969; Goncalves H, 2014, INT J EPIDEMIOLOGY; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Lanfer A, 2010, BUNDESGESUNDHEITSBLA, V53, P690, DOI 10.1007/s00103-010-1086-z; Lee SY, 2008, CURR OPIN CLIN NUTR, V11, P566, DOI 10.1097/MCO.0b013e32830b5f23; Matsudo S, 2001, ATIVIDADE FISICA SAU, V6; Oellingrath IM, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-106; POF, 2010, PESQ ORC FAM 2008 20; Sichieri R, 1998, NUTR RES, V18, P1649, DOI 10.1016/S0271-5317(98)00151-1; Singhal Atul, 2014, Nestle Nutr Inst Workshop Ser, V78, P123, DOI 10.1159/000354951; Siri W., 1961, TECHNIQUES MEASURING, P223; The DHS Program, 2015, DEM HLTH SURV; Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Wells JCK, 2002, INT J OBESITY, V26, P947, DOI 10.1038/sj.ijo.0802027; WHO, 2003, DIET NUTR PREVENTION, V916; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2003, PROC GLOB STRAT DIET; World Health Organization, 2015, AD HLTH; Zafon C, 2007, OBES REV, V8, P525, DOI 10.1111/j.1467-789X.2007.00377.x	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149299	10.1371/journal.pone.0149299	http://dx.doi.org/10.1371/journal.pone.0149299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907178	gold, Green Submitted, Green Published			2022-12-27	WOS:000371163000008
J	Szabat, M; Gudanis, D; Kotkowiak, W; Gdaniec, Z; Kierzek, R; Pasternak, A				Szabat, Marta; Gudanis, Dorota; Kotkowiak, Weronika; Gdaniec, Zofia; Kierzek, Ryszard; Pasternak, Anna			Thermodynamic Features of Structural Motifs Formed by beta-L-RNA	PLOS ONE			English	Article							HETEROCHIRAL DNA; NUCLEIC-ACIDS; HYBRIDIZATION PROPERTIES; OLIGONUCLEOTIDES; STABILITY; APTAMER; BINDING; INTERFERENCE; PARAMETERS; CANCER	This is the first report to provide comprehensive thermodynamic and structural data concerning duplex, hairpin, quadruplex and i-motif structures in beta-L-RNA series. Herein we confirm that, within the limits of experimental error, the thermodynamic stability of enantiomeric structural motifs is the same as that of naturally occurring D-RNA counterparts. In addition, formation of D-RNA/L-RNA heterochiral duplexes is also observed; however, their thermodynamic stability is significantly reduced in reference to homochiral D-RNA duplexes. The presence of three locked nucleic acid (LNA) residues within the D-RNA strand diminishes the negative effect of the enantiomeric, complementary L-RNA strand in the formation of heterochiral RNA duplexes. Similar behavior is also observed for heterochiral LNA-2'-O-methyl- D-RNA/L-RNA duplexes. The formation of heterochiral duplexes was confirmed by H-1 NMR spectroscopy. The CD curves of homochiral L-RNA structural motifs are always reversed, whereas CD curves of heterochiral duplexes present individual features dependent on the composition of chiral strands.	[Szabat, Marta; Gudanis, Dorota; Kotkowiak, Weronika; Gdaniec, Zofia; Kierzek, Ryszard; Pasternak, Anna] Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland	Polish Academy of Sciences	Kierzek, R; Pasternak, A (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Noskowskiego 12-14, PL-61704 Poznan, Poland.	rkierzek@ibch.poznan.pl; apa@ibch.poznan.pl	Szabat, Marta/AAD-1372-2021; Pasternak, Anna/H-9411-2013; Gudanis, Dorota/AAY-7057-2021; Gdaniec, Zofia/D-2649-2015	Szabat, Marta/0000-0001-5772-0808; Gdaniec, Zofia/0000-0003-2955-1829; Gudanis, Dorota/0000-0001-5046-9761; Kierzek, Ryszard/0000-0002-7644-0016; Pasternak, Anna/0000-0002-9666-4148; Kotkowiak, Weronika/0000-0002-9776-0924	Polish National Science Center [UMO-2014/13/B/ST5/04144, UMO-2013/08/A/ST5/00295, UMO-2013/10/E/NZ1/00741, UMO-2012/05/D/ST5/03599]; Polish Ministry of Science and Higher Education, under the KNOW program; Institute of Bioorganic Chemistry for young researchers and PhD students	Polish National Science Center; Polish Ministry of Science and Higher Education, under the KNOW program; Institute of Bioorganic Chemistry for young researchers and PhD students	This work was supported by Polish National Science Center grants UMO-2014/13/B/ST5/04144 to ZG, UMO-2013/08/A/ST5/00295 to RK, UMO-2013/10/E/NZ1/00741 and UMO-2012/05/D/ST5/03599 to AP. This publication was also supported by the Polish Ministry of Science and Higher Education, under the KNOW program, and a grant from the Institute of Bioorganic Chemistry for young researchers and PhD students.	ASHLEY GW, 1992, J AM CHEM SOC, V114, P9731, DOI 10.1021/ja00051a001; Baranowski DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137674; DAMHA MJ, 1994, BIOCHEMISTRY-US, V33, P7877, DOI 10.1021/bi00191a015; Eckstein F, 2014, NUCLEIC ACID THER, V24, P374, DOI 10.1089/nat.2014.0506; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Frieden M, 2006, IDRUGS, V9, P706; Garbesi A, 1998, NUCLEOS NUCLEOT, V17, P1275, DOI 10.1080/07328319808004239; GARBESI A, 1993, NUCLEIC ACIDS RES, V21, P5286, DOI 10.1093/nar/21.22.5286; Jensen TB, 2011, BIOORGAN MED CHEM, V19, P4739, DOI 10.1016/j.bmc.2011.06.087; Kawakami J, 2005, ANAL SCI, V21, P77, DOI 10.2116/analsci.21.77; KAWASAKI AM, 1993, J MED CHEM, V36, P831, DOI 10.1021/jm00059a007; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kotkowiak W, 2014, BIOCHEM J, V464, P203, DOI 10.1042/BJ20141023; Manoharan M, 2004, CURR OPIN CHEM BIOL, V8, P570, DOI 10.1016/j.cbpa.2004.10.007; Nolte A, 1996, NAT BIOTECHNOL, V14, P1116, DOI 10.1038/nbt0996-1116; Pasternak A, 2011, ORG BIOMOL CHEM, V9, P3591, DOI 10.1039/c0ob01085e; Pasternak A, 2011, BIOORG MED CHEM LETT, V21, P752, DOI 10.1016/j.bmcl.2010.11.106; Sczepanski JT, 2013, J AM CHEM SOC, V135, P13290, DOI 10.1021/ja406634g; Shu Y, 2014, ADV DRUG DELIVER REV, V66, P74, DOI 10.1016/j.addr.2013.11.006; Szabat M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143354; Teplova M, 1999, NAT STRUCT BIOL, V6, P535; URATA H, 1993, J AM CHEM SOC, V115, P9852, DOI 10.1021/ja00074a083; Urata H, 2003, BIOCHEM BIOPH RES CO, V309, P79, DOI 10.1016/S0006-291X(03)01531-6; Urata H, 1996, TETRAHEDRON LETT, V37, P5551, DOI 10.1016/0040-4039(96)01153-7; Vallazza M, 2004, ACTA CRYSTALLOGR D, V60, P1, DOI 10.1107/S0907444903027690; Vater A, 2013, J BIOL CHEM, V288, P21136, DOI 10.1074/jbc.M112.444414; Wyszko E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086673; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425	29	16	16	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149478	10.1371/journal.pone.0149478	http://dx.doi.org/10.1371/journal.pone.0149478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908023	Green Published, gold			2022-12-27	WOS:000371163000013
J	Hong, J; Li, D; Cao, WB				Hong, Jie; Li, Dan; Cao, Weibiao			Rho Kinase ROCK2 Mediates Acid-Induced NADPH Oxidase NOX5-S Expression in Human Esophageal Adenocarcinoma Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PROTON PUMP INHIBITORS; BARRETTS-ESOPHAGUS; REACTIVE OXYGEN; SMOOTH-MUSCLE; NEOPLASTIC PROGRESSION; FOCAL ADHESIONS; UP-REGULATION; IN-VITRO; BINDING	Mechanisms of the progression from Barrett's esophagus (BE) to esophageal adenocarcinoma (EA) are not fully understood. We have shown that NOX5-S may be involved in this progression. However, how acid upregulates NOX5-S is not well known. We found that acid-induced increase in NOX5-S expression was significantly decreased by the Rho kinase (ROCK) inhibitor Y27632 in BE mucosal biopsies and FLO-1 EA cells. In addition, acid treatment significantly increased the Rho kinase activity in FLO-1 cells. The acid-induced increase in NOX5-S expression and H2O2 production was significantly decreased by knockdown of Rho kinase ROCK2, but not by knockdown of ROCK1. Conversely, the overexpression of the constitutively active ROCK2, but not the constitutively active ROCK1, significantly enhanced the NOX5-S expression and H2O2 production. Moreover, the acid-induced increase in Rho kinase activity and in NOX5-S mRNA expression was blocked by the removal of calcium in both FLO-1 and OE33 cells. The calcium ionophore A23187 significantly increased the Rho kinase activity and NOX5-S mRNA expression. We conclude that acid-induced increase in NOX5-S expression and H2O2 production may depend on the activation of ROCK2, but not ROCK1, in EA cells. The acid-induced activation of Rho kinase may be mediated by the intracellular calcium increase. It is possible that persistent acid reflux present in BE patients may increase the intracellular calcium, activate ROCK2 and thereby upregulate NOX5-S. High levels of reactive oxygen species derived from NOX5-S may cause DNA damage and thereby contribute to the progression from BE to EA.	[Hong, Jie; Li, Dan; Cao, Weibiao] Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA; [Hong, Jie; Li, Dan; Cao, Weibiao] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Cao, Weibiao] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA; [Hong, Jie] Shanghai Jiao Tong Univ, Dept Gastroenterol, Sch Med, Renji Hosp,Shanghai Inst Digest Dis, Shanghai 200030, Peoples R China	Lifespan Health Rhode Island; Rhode Island Hospital; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Shanghai Jiao Tong University	Cao, WB (corresponding author), Rhode Isl Hosp, Dept Med, Providence, RI 02903 USA.; Cao, WB (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.; Cao, WB (corresponding author), Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA.	wcao@hotmail.com			NIDDK [R01 DK080703]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080703] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK R01 DK080703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Brar SS, 2003, AM J PHYSIOL-CELL PH, V285, pC353, DOI 10.1152/ajpcell.00525.2002; Cao WB, 2003, AM J PHYSIOL-GASTR L, V285, pG86, DOI 10.1152/ajpgi.00156.2002; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Danen EHJ, 2000, J CELL BIOL, V151, P1413, DOI 10.1083/jcb.151.7.1413; Das KM, 2011, INT J CANCER, V128, P274, DOI 10.1002/ijc.25343; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; Falk GW, 2002, GASTROENTEROLOGY, V122, P1569, DOI 10.1053/gast.2002.33427; Farhadi A, 2002, AM J GASTROENTEROL, V97, P22; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Fountoulakis A, 2004, DIGEST DIS SCI, V49, P914, DOI 10.1023/B:DDAS.0000034548.89117.d6; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Fu XY, 2006, J BIOL CHEM, V281, P20368, DOI 10.1074/jbc.M603353200; HAGGITT RC, 1994, HUM PATHOL, V25, P982, DOI 10.1016/0046-8177(94)90057-4; Hong J, 2011, AM J PHYSIOL-CELL PH, V301, pC413, DOI 10.1152/ajpcell.00027.2011; Hong J, 2010, AM J PHYSIOL-GASTR L, V299, pG697, DOI 10.1152/ajpgi.00186.2010; Hughes SJ, 1997, CANCER RES, V57, P5571; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Kahrilas PJ, 2011, NEW ENGL J MED, V365, P1437, DOI 10.1056/NEJMe1108435; Kastelein F, 2013, CLIN GASTROENTEROL H, V11, P382, DOI 10.1016/j.cgh.2012.11.014; Kim JS, 2005, EXP MOL MED, V37, P575, DOI 10.1038/emm.2005.71; Kim R, 1997, CANCER EPIDEM BIOMAR, V6, P369; Koksel O, 2005, EUR J PHARMACOL, V510, P135, DOI 10.1016/j.ejphar.2004.12.010; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li D, 2014, AM J PHYSIOL-GASTR L, V306, pG863, DOI 10.1152/ajpgi.00321.2013; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; OLYAEE M, 1995, GUT, V37, P168, DOI 10.1136/gut.37.2.168; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pohl H, 2013, AM J GASTROENTEROL, V108, P200, DOI 10.1038/ajg.2012.387; PRESSMAN BC, 1976, ANNU REV BIOCHEM, V45, P501, DOI 10.1146/annurev.bi.45.070176.002441; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Si J, 2007, J BIOL CHEM, V282, P16244, DOI 10.1074/jbc.M700297200; Sihvo EIT, 2003, J THORAC CARDIOV SUR, V126, P1952, DOI 10.1016/j.jtcvs.2003.08.014; Somlyo AV, 2003, FASEB J, V17, P223, DOI 10.1096/fj.02-0655com; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Sriwai W, 2008, BIOCHEM J, V411, P543, DOI [10.1042/BJ20071299, 10.1042/bj20071299]; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Tselepis C, 2003, GUT, V52, P174, DOI 10.1136/gut.52.2.174; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Wetscher G J, 1997, Dis Esophagus, V10, P29; Wetscher GJ, 1997, DIS ESOPHAGUS, V10, P3; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Yoshioka K, 1999, CANCER RES, V59, P2004; Zhang HY, 2009, CANCER RES, V69, P9083, DOI 10.1158/0008-5472.CAN-09-2518	57	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149735	10.1371/journal.pone.0149735	http://dx.doi.org/10.1371/journal.pone.0149735			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901778	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100137
J	Aryal, B; Shimizu, T; Kadono, J; Furoi, A; Komokata, T; Inoue, M; Ikeda, S; Fukukura, Y; Nakamura, M; Yamakuchi, M; Hashiguchi, T; Imoto, Y				Aryal, Bibek; Shimizu, Toshiaki; Kadono, Jun; Furoi, Akira; Komokata, Teruo; Inoue, Maki; Ikeda, Shunichiro; Fukukura, Yoshihiko; Nakamura, Masatoshi; Yamakuchi, Munekazu; Hashiguchi, Teruto; Imoto, Yutaka			A Switch in the Dynamics of Intra-Platelet VEGF-A from Cancer to the Later Phase of Liver Regeneration after Partial Hepatectomy in Humans	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MAJOR HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; SERUM-LEVELS; INTERLEUKIN-6; PROLIFERATION; ANGIOGENESIS; EXPRESSION; RECEPTOR; SIGNALS	Background Liver regeneration (LR) involves an early inductive phase characterized by the proliferation of hepatocytes, and a delayed angiogenic phase distinguished by the expansion of non-parenchymal compartment. The interest in understanding the mechanism of LR has lately shifted from the proliferation and growth of parenchymal cells to vascular remodeling during LR. Angiogenesis accompanied by LR exerts a pivotal role to accomplish the process. Vascular endothelial growth factor (VEGF) has been elucidated as the most dynamic regulator of angiogenesis. From this perspective, platelet derived/Intra-platelet (IP) VEGF-A should be associated with LR. Material and Methods Thirty-seven patients diagnosed with hepatocellular carcinoma and undergoing partial hepatectomy (PH) were enrolled in the study. Serum and IP VEGF-A was monitored preoperatively and at four weeks of PH. Liver volumetry was determined on computer models derived from computed tomography (CT) scan. Results Serum and IP VEGF-A was significantly elevated at four weeks of PH. Preoperative IP VEGF-A was higher in patients with advanced cancer and vascular invasion. Postoperative IP VEGF-A was higher after major liver resection. There was a statistically significant correlation between postoperative IP VEGF-A and the future remnant liver volume. Moreover, the soluble vascular endothelial growth factor receptor-1 (sVEGFR1) was distinctly down-regulated suggesting a fine-tuned angiogenesis at the later phase of LR. Conclusion IP VEGF-A is overexpressed during later phase of LR suggesting its implications in inducing angiogenesis during LR.	[Aryal, Bibek; Kadono, Jun; Imoto, Yutaka] Kagoshima Univ, Grad Sch Med & Dent Sci, Cardiovasc & Gastroenterol Surg, Kagoshima 890, Japan; [Shimizu, Toshiaki; Yamakuchi, Munekazu; Hashiguchi, Teruto] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan; [Furoi, Akira; Inoue, Maki] Kirishima Med Ctr, Dept Surg, Kirishima, Japan; [Komokata, Teruo] Natl Hosp Org, Kagoshima Med Ctr, Dept Surg, Kagoshima, Japan; [Ikeda, Shunichiro] Kirishima Med Ctr, Dept Radiol, Kirishima, Japan; [Fukukura, Yoshihiko] Kagoshima Univ, Dept Radiol, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nakamura, Masatoshi] Kagoshima Univ, Med & Dent Hosp, Dept Clin Lab, Kagoshima 890, Japan	Kagoshima University; Kagoshima University; Kagoshima University; Kagoshima University	Hashiguchi, T (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Lab & Vasc Med, Kagoshima 890, Japan.	terutoha@m3.kufm.kagoshima-u.ac.jp		ARYAL, BIBEK/0000-0003-0257-7439				Adachi T, 2005, HEPATOLOGY, V41, P1272, DOI 10.1002/hep.20719; Bockhorn M, 2007, J SURG RES, V138, P291, DOI 10.1016/j.jss.2006.07.027; Bondestam J, 2000, AM J SURG, V179, P57, DOI 10.1016/S0002-9610(99)00253-6; Brouwers J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064850; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Dankbar B, 2000, BLOOD, V95, P2630, DOI 10.1182/blood.V95.8.2630; DeLeve LD, 2013, J CLIN INVEST, V123, P1861, DOI 10.1172/JCI66025; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Goubran HA, 2014, SEMIN THROMB HEMOST, V40, P296, DOI 10.1055/s-0034-1370767; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hashiguchi T, 2000, MUSCLE NERVE, V23, P1051, DOI 10.1002/1097-4598(200007)23:7<1051::AID-MUS7>3.0.CO;2-V; Hastings JM, 2003, ENDOCRINOLOGY, V144, P326, DOI 10.1210/en.2002-220641; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Huang SP, 2004, J BIOMED SCI, V11, P517, DOI 10.1159/000077902; Karayiannakis AJ, 2002, ANN SURG, V236, P37, DOI 10.1097/00000658-200207000-00007; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kim SJ, 2004, JPN J CLIN ONCOL, V34, P184, DOI 10.1093/jjco/hyh039; Kirschbaum M, 2015, BLOOD, V126, P798, DOI 10.1182/blood-2014-09-600312; Kraizer Y, 2001, BIOCHEM BIOPH RES CO, V287, P209, DOI 10.1006/bbrc.2001.5548; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Matsuo R, 2011, ANN SURG, V253, P759, DOI 10.1097/SLA.0b013e318211caf8; Meyer J, 2015, J HEPATOL, V63, P1263, DOI 10.1016/j.jhep.2015.07.002; Michalopoulos GK, 2010, AM J PATHOL, V176, P2, DOI 10.2353/ajpath.2010.090675; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; NAGASUE N, 1987, ANN SURG, V206, P30, DOI 10.1097/00000658-198707000-00005; Panes O, 2007, BLOOD, V109, P5242, DOI 10.1182/blood-2006-06-030619; Peterson JE, 2012, ANGIOGENESIS, V15, P265, DOI 10.1007/s10456-012-9259-z; Pomfret EA, 2003, TRANSPLANTATION, V76, P5, DOI 10.1097/01.TP.0000079064.08263.8E; Poon RTP, 2003, CANCER RES, V63, P3121; Salgado R, 2002, BRIT J CANCER, V87, P1437, DOI 10.1038/sj.bjc.6600655; Sato T, 2001, J HEPATOL, V34, P690, DOI 10.1016/S0168-8278(00)00109-4; Shibuya M, 1995, ADV CANCER RES, V67, P281, DOI 10.1016/S0065-230X(08)60716-2; Shirabe K, 1999, J AM COLL SURGEONS, V188, P304, DOI 10.1016/S1072-7515(98)00301-9; Starlinger P, 2016, HEPATOLOGY, V63, P1675, DOI 10.1002/hep.28331; Starlinger P, 2014, HEPATOLOGY, V60, P257, DOI 10.1002/hep.26950; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Sudo K, 2008, BBA-MOL BASIS DIS, V1782, P671, DOI 10.1016/j.bbadis.2008.09.010; Uda Y, 2013, SURGERY, V153, P70, DOI 10.1016/j.surg.2012.06.021; Verheul HMW, 1997, CLIN CANCER RES, V3, P2187; Wu F. P. K., 2003, Angiogenesis, V6, P255, DOI 10.1023/B:AGEN.0000029410.32264.b0; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441	43	16	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150446	10.1371/journal.pone.0150446	http://dx.doi.org/10.1371/journal.pone.0150446			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930285	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500149
J	Ma, L; Li, ZQ; Bian, L; Cai, XM; Luo, ZX; Zhang, YJ; Chen, ZM				Ma, Long; Li, Zhao-Qun; Bian, Lei; Cai, Xiao-Ming; Luo, Zong-Xiu; Zhang, Yong-Jun; Chen, Zong-Mao			Identification and Comparative Study of Chemosensory Genes Related to Host Selection by Legs Transcriptome Analysis in the Tea Geometrid Ectropis obliqua	PLOS ONE			English	Article							ODORANT-BINDING PROTEINS; CANDIDATE TASTE RECEPTORS; IMMUNOCYTOCHEMICAL LOCALIZATION; OVIPOSITION STIMULANTS; GUSTATORY RECEPTORS; EXPRESSION PATTERN; ANTENNAL SENSILLA; MOLECULAR-CLONING; CAFFEINE RESPONSE; LIGAND-BINDING	Host selection by female moths is fundamental to the survival of their larvae. Detecting and perceiving the non-volatile chemicals of the plant surface involved in gustatory detection determine the host preference. In many lepidopteran species, tarsal chemosensilla are sensitive to non-volatile chemicals and responsible for taste detection. The tea geometrid Ectropis obliqua is one devastating chewing pest selectively feeding on limited plants, requiring the specialized sensors to forage certain host for oviposition. In present study, we revealed the distribution of chemosensilla in the ventral side of female fifth tarsomere in E. obliqua. To investigate its molecular mechanism of gustatory perception, we performed HiSeq 2500 sequencing of the male- and female- legs transcriptome and identified 24 candidate odorant binding proteins (OBPs), 21 chemosensory proteins (CSPs), 2 sensory neuron membrane proteins (SNMPs), 3 gustatory receptors (GRs) and 4 odorant receptors (ORs). Several leg-specific or enriched chemosensory genes were screened by tissue expression analysis, and clustered with functionally validated genes from other moths, suggesting the potential involvement in taste sensation or other physiological processes. The RPKM value analysis revealed that 9 EoblOBPs showed sex discrepancy in the leg expression, 8 being up-regulated in female and only 1 being over expressed in male. These female-biased EoblOBPs indicated an ecological adaption related with host-seeking and oviposition behaviors. Our work will provide basic knowledge for further studies on the molecular mechanism of gustatory perception, and enlighten a host-selection-based control strategy of insect pests.	[Ma, Long; Li, Zhao-Qun; Bian, Lei; Cai, Xiao-Ming; Luo, Zong-Xiu; Chen, Zong-Mao] Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China; [Zhang, Yong-Jun] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Chen, ZM (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Minist Agr, Key Lab Tea Biol & Resources Utilizat, Hangzhou, Zhejiang, Peoples R China.; Zhang, YJ (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	yjzhang@ippcaas.cn; zmchen2006@163.com			Modern Agricultural Industry Technology System [CARS-23]; Open Foundation of State Key laboratory for Biology of Plant Diseases and Insect Pests [SKLOF201517]; Zhejiang Provincial Natural Science Foundation [LY16C140003]	Modern Agricultural Industry Technology System; Open Foundation of State Key laboratory for Biology of Plant Diseases and Insect Pests; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by Modern Agricultural Industry Technology System (CARS-23), Open Foundation of State Key laboratory for Biology of Plant Diseases and Insect Pests (SKLOF201517) and Zhejiang Provincial Natural Science Foundation (LY16C140003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ban LP, 2002, BIOCHEM BIOPH RES CO, V293, P50, DOI 10.1016/S0006-291X(02)00185-7; Bauerfeind SS, 2005, J INSECT PHYSIOL, V51, P545, DOI 10.1016/j.jinsphys.2005.02.002; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BLANEY WM, 1990, J INSECT PHYSIOL, V36, P743, DOI 10.1016/0022-1910(90)90048-K; Blomquist GJ, 2003, INSECT PHEROMONE BIO, P391; Briscoe AD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003620; Calas D, 2006, J CHEM ECOL, V32, P2443, DOI 10.1007/s10886-006-9155-3; Calas D, 2009, ENTOMOL EXP APPL, V133, P186, DOI 10.1111/j.1570-7458.2009.00921.x; Calvello M, 2003, CELL MOL LIFE SCI, V60, P1933, DOI 10.1007/s00018-003-3186-5; Carter M, 1998, PHYSIOL ENTOMOL, V23, P303, DOI 10.1046/j.1365-3032.1998.00100.x; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; CHUN MW, 1973, ENTOMOL EXP APPL, V16, P343, DOI 10.1007/BF00334245; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; Dethier V., 1976, THE HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Feeny P, 1983, HERBIVOROUS INSECTS, P26; Galindo K, 2001, GENETICS, V159, P1059; Gong DP, 2007, INSECT BIOCHEM MOLEC, V37, P266, DOI 10.1016/j.ibmb.2006.11.012; Gu SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13800; Gu SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103420; Gu SH, 2013, J INSECT PHYSIOL, V59, P430, DOI 10.1016/j.jinsphys.2013.02.003; Iovinella I, 2013, CHEM SENSES, V38, P409, DOI 10.1093/chemse/bjt012; Jacobs SP, 2005, INSECT MOL BIOL, V14, P423, DOI 10.1111/j.1365-2583.2005.00573.x; Jacquin-Joly E, 2001, CHEM SENSES, V26, P833, DOI 10.1093/chemse/26.7.833; Jeong YT, 2013, NEURON, V79, P725, DOI 10.1016/j.neuron.2013.06.025; Jiang XJ, 2015, INSECT BIOCHEM MOLEC, V60, P39, DOI 10.1016/j.ibmb.2015.03.002; Jiao Y, 2007, P NATL ACAD SCI USA, V104, P14110, DOI 10.1073/pnas.0702421104; Jin X, 2005, CELL MOL LIFE SCI, V62, P1156, DOI 10.1007/s00018-005-5014-6; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Kitabayashi AN, 1998, INSECT BIOCHEM MOLEC, V28, P785, DOI 10.1016/S0965-1748(98)00058-7; KLIJNSTRA JW, 1986, ENTOMOL EXP APPL, V40, P71, DOI 10.1007/BF00187025; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Lartigue A, 2002, J BIOL CHEM, V277, P32094, DOI 10.1074/jbc.M204371200; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lee Y, 2009, P NATL ACAD SCI USA, V106, P4495, DOI 10.1073/pnas.0811744106; Li ZQ, 2015, J CHEM ECOL, V41, P473, DOI 10.1007/s10886-015-0574-x; Ling F, 2014, J NEUROSCI, V34, P7148, DOI 10.1523/JNEUROSCI.0649-14.2014; Liu YL, 2014, J EXP BIOL, V217, P1821, DOI 10.1242/jeb.102020; Maher N, 2006, PHYSIOL ENTOMOL, V31, P14, DOI 10.1111/j.1365-3032.2005.00476.x; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Matsuo T, 2008, J NEUROGENET, V22, P195, DOI 10.1080/01677060802298483; MCKENNA MP, 1994, J BIOL CHEM, V269, P16340; MILLER T, 1982, Journal of the Lepidopterists' Society, V36, P207; Miyamoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056304; Monteforti G, 2002, ARTHROPOD STRUCT DEV, V30, P195, DOI 10.1016/S1467-8039(01)00036-6; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayama T, 2003, J CHEM ECOL, V29, P1621, DOI 10.1023/A:1024274814402; Ozaki K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1548; OZAKI M, 1995, EUR J BIOCHEM, V230, P298; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111; Qiu YT, 1998, ENTOMOL EXP APPL, V87, P143, DOI 10.1023/A:1003296514369; RENOU M, 1983, ANN SOC ENTOMOL FR, V19, P101; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Ryuda M, 2013, J NEUROSCI, V33, P914, DOI 10.1523/JNEUROSCI.1405-12.2013; SCHNEIDER D, 1964, ANNU REV ENTOMOL, V9, P103, DOI 10.1146/annurev.en.09.010164.000535; SCHOONHOVEN L. M., 1966, ARCH NEER ZOOL, V16, P497; Schoonhoven L. M., 2005, Insect-plant biology; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Sun XL, 2014, J CHEM ECOL, V40, P1080, DOI 10.1007/s10886-014-0502-5; Sun YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030040; Swarup S, 2014, CHEM SENSES, V39, P125, DOI 10.1093/chemse/bjt061; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Xu W, 2012, J CHEM ECOL, V38, P1513, DOI 10.1007/s10886-012-0221-8; Yasukawa J, 2010, GENE, V467, P25, DOI 10.1016/j.gene.2010.07.006; Zhang YF, 2010, J EXP BIOL, V213, P2889, DOI 10.1242/jeb.042705; Zhang ZhengQun, 2012, Acta Phytophylacica Sinica, V39, P541; Zhou SH, 2008, J APPL ENTOMOL, V132, P439, DOI 10.1111/j.1439-0418.2007.01255.x; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681; Zhou XH, 2013, BIOL CHEM, V394, P43, DOI 10.1515/hsz-2012-0114	78	36	46	4	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149591	10.1371/journal.pone.0149591	http://dx.doi.org/10.1371/journal.pone.0149591			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930056	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500035
J	Mo, C; Xia, TS; Qin, KX; Mo, L				Mo, Ce; Xia, Tiansheng; Qin, Kaixin; Mo, Lei			Natural Tendency towards Beauty in Humans: Evidence from Binocular Rivalry	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; MORAL JUDGMENT; APPEARANCE; ALTRUISM; INFANTS; FACES; BIAS	Although human preference for beauty is common and compelling in daily life, it remains unknown whether such preference is essentially subserved by social cognitive demands or natural tendency towards beauty encoded in the human mind intrinsically. Here we demonstrate experimentally that humans automatically exhibit preference for visual and moral beauty without explicit cognitive efforts. Using a binocular rivalry paradigm, we identified enhanced gender-independent perceptual dominance for physically attractive persons, and the results suggested universal preference for visual beauty based on perceivable forms. Moreover, we also identified perceptual dominance enhancement for characters associated with virtuous descriptions after controlling for facial attractiveness and vigilance-related attention effects, which suggested a similar implicit preference for moral beauty conveyed in prosocial behaviours. Our findings show that behavioural preference for beauty is driven by an inherent natural tendency towards beauty in humans rather than explicit social cognitive processes.	[Mo, Ce; Qin, Kaixin; Mo, Lei] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China; [Xia, Tiansheng] Sun Yat Sen Univ, Sch Business, Guangzhou 510275, Guangdong, Peoples R China	South China Normal University; Sun Yat Sen University	Mo, L (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	molei@scnu.edu.cn			National Natural Science Foundation of China [31200785]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by National Natural Science Foundation of China (31200785).	Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alpers GW, 2006, COGNITION EMOTION, V20, P596, DOI 10.1080/02699930500282249; Anderson E, 2011, SCIENCE, V332, P1446, DOI 10.1126/science.1201574; Andrews TJ, 1997, P NATL ACAD SCI USA, V94, P9905, DOI 10.1073/pnas.94.18.9905; Bannerman RL, 2008, OPHTHAL PHYSL OPT, V28, P317, DOI 10.1111/j.1475-1313.2008.00568.x; Bargh JA, 2012, TRENDS COGN SCI, V16, P593, DOI 10.1016/j.tics.2012.10.002; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Blake R, 2002, NAT REV NEUROSCI, V3, P13, DOI 10.1038/nrn701; Blake R., 2001, BRAIN MIND, V2, P5, DOI [https://doi.org/10.1023/A:1017925416289, DOI 10.1023/A:1017925416289, 10.1023/A:1017925416289]; Bliss-Moreau E, 2008, EMOTION, V8, P479, DOI 10.1037/1528-3542.8.4.479; Botwin MD, 1997, J PERS, V65, P107, DOI 10.1111/j.1467-6494.1997.tb00531.x; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Dawes CT, 2007, NATURE, V446, P794, DOI 10.1038/nature05651; Diessner R, 2006, J MORAL EDUC, V35, P301, DOI 10.1080/03057240600874430; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fitts DA, 2010, BEHAV RES METHODS, V42, P3, DOI 10.3758/BRM.42.1.3; Frick RW, 1998, BEHAV RES METH INS C, V30, P690, DOI 10.3758/BF03209488; Gerger G, 2011, PSYCHOL AESTHET CREA, V5, P241, DOI 10.1037/a0024154; Gildersleeve K, 2014, PSYCHOL BULL, V140, P1205, DOI 10.1037/a0035438; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Guo K, 2011, PERCEPTION, V40, P191, DOI 10.1068/p6849; Haidt J, 2003, FLOURISHING: POSITIVE PSYCHOLOGY AND THE LIFE WELL-LIVED, P275, DOI 10.1037/10594-012; Haidt J, 2003, SER AFFECTIVE SCI, P852; Haidt J, 2003, FLOURISHING POSITIVE; Haidt J., 2004, CHARACTER STRENGTHS, P537; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Haidt J, 2004, DAEDALUS-US, V133, P55, DOI 10.1162/0011526042365555; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; HOLLINS M, 1980, PERCEPT PSYCHOPHYS, V27, P550, DOI 10.3758/BF03198684; Ishai A, 2007, INT J PSYCHOPHYSIOL, V63, P181, DOI 10.1016/j.ijpsycho.2006.03.010; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Keltner D, 2003, COGNITION EMOTION, V17, P297, DOI 10.1080/02699930302297; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Leder H, 2010, Q J EXP PSYCHOL, V63, P1858, DOI 10.1080/17470211003605142; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Maner JK, 2003, J PERS SOC PSYCHOL, V85, P1107, DOI 10.1037/0022-3514.85.6.1107; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; McDonald PR, 2008, PERCEPTION, V37, P1054, DOI 10.1068/p5774; Olson IR, 2005, EMOTION, V5, P498, DOI 10.1037/1528-3542.5.4.498; Penton-Voak IS, 2004, EVOL HUM BEHAV, V25, P229, DOI 10.1016/j.evolhumbehav.2004.04.003; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Pfann GA, 2000, ECON LETT, V67, P201, DOI 10.1016/S0165-1765(99)00255-4; Pratto F, 1991, J PERSONALITY SOC PS, V380; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; SHAHANI C, 1993, BASIC APPL SOC PSYCH, V14, P317, DOI 10.1207/s15324834basp1403_5; Shannon ML, 2003, SOC BEHAV PERSONAL, V31, P613, DOI 10.2224/sbp.2003.31.6.613; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Sui J, 2009, PSYCHON B REV, V16, P276, DOI 10.3758/PBR.16.2.276; Tong F, 2006, TRENDS COGN SCI, V10, P502, DOI 10.1016/j.tics.2006.09.003; Wang J, 2015, INT J PSYCHOL; Wang T, 2014, SOCIAL COGNITIVE AFF; Wang TT, 2015, SOC COGN AFFECT NEUR, V10, P814, DOI 10.1093/scan/nsu123; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024	61	10	10	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150147	10.1371/journal.pone.0150147	http://dx.doi.org/10.1371/journal.pone.0150147			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930202	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500106
J	Shvedova, AA; Yanamala, N; Kisin, ER; Khailullin, TO; Birch, ME; Fatkhutdinova, LM				Shvedova, Anna A.; Yanamala, Naveena; Kisin, Elena R.; Khailullin, Timur O.; Birch, M. Eileen; Fatkhutdinova, Liliya M.			Integrated Analysis of Dysregulated ncRNA and mRNA Expression Profiles in Humans Exposed to Carbon Nanotubes	PLOS ONE			English	Article							LONG NONCODING RNAS; PULMONARY TOXICITY; EPITHELIAL-CELLS; POTENTIAL ROLE; CLIP-SEQ; LUNG; MICRORNAS; CANCER; GROWTH; MICE	Background As the application of carbon nanotubes (CNT) in consumer products continues to rise, studies have expanded to determine the associated risks of exposure on human and environmental health. In particular, several lines of evidence indicate that exposure to multi-walled carbon nanotubes (MWCNT) could pose a carcinogenic risk similar to asbestos fibers. However, to date the potential markers of MWCNT exposure are not yet explored in humans. Methods In the present study, global mRNA and ncRNA expression profiles in the blood of exposed workers, having direct contact with MWCNT aerosol for at least 6 months (n = 8), were compared with expression profiles of non-exposed (n = 7) workers (e.g., professional and/or technical staff) from the same manufacturing facility. Results Significant changes in the ncRNA and mRNA expression profiles were observed between exposed and non-exposed worker groups. An integrative analysis of ncRNA-mRNA correlations was performed to identify target genes, functional relationships, and regulatory networks in MWCNT-exposed workers. The coordinated changes in ncRNA and mRNA expression profiles revealed a set of miRNAs and their target genes with roles in cell cycle regulation/progression/control, apoptosis and proliferation. Further, the identified pathways and signaling networks also revealed MWCNT potential to trigger pulmonary and cardiovascular effects as well as carcinogenic outcomes in humans, similar to those previously described in rodents exposed to MWCNTs. Conclusion This study is the first to investigate aberrant changes in mRNA and ncRNA expression profiles in the blood of humans exposed to MWCNT. The significant changes in several miRNAs and mRNAs expression as well as their regulatory networks are important for getting molecular insights into the MWCNT-induced toxicity and pathogenesis in humans. Further large-scale prospective studies are necessary to validate the potential applicability of such changes in mRNAs and miRNAs as prognostic markers of MWCNT exposures in humans.	[Shvedova, Anna A.; Yanamala, Naveena; Kisin, Elena R.] NIOSH, Exposure Assessment Branch, HELD, CDC, Morgantown, WV 26505 USA; [Shvedova, Anna A.; Khailullin, Timur O.] W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26505 USA; [Birch, M. Eileen] NIOSH, CDC, 4676 Columbia Pkwy, Cincinnati, OH 45226 USA; [Khailullin, Timur O.; Fatkhutdinova, Liliya M.] Kazan State Med Univ, Dept Hyg & Occupat Hlth, Ul Butlerova 49, Kazan 420012, Russia	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Kazan State Medical University	Shvedova, AA (corresponding author), NIOSH, Exposure Assessment Branch, HELD, CDC, Morgantown, WV 26505 USA.; Shvedova, AA (corresponding author), W Virginia Univ, Dept Physiol & Pharmacol, Morgantown, WV 26505 USA.	ats1@cdc.gov	Yanamala, Naveena/AAA-6729-2022; Khaliullin, Timur/H-8927-2019; Fatkhutdinova, Liliya M/C-4294-2016	Khaliullin, Timur/0000-0003-1638-9228; Fatkhutdinova, Liliya M/0000-0001-9506-563X; Yanamala, Naveena/0000-0002-4454-4240	Government of Tatarstan Republic; EC-FP-7-NANOSOLUTIONS; NORA [939051G]; NTRC [939011K]	Government of Tatarstan Republic; EC-FP-7-NANOSOLUTIONS; NORA; NTRC	Grant of the Government of Tatarstan Republic "Algarysh" for prospective area "Nanotechnology" (2008-2009), LF; EC-FP-7-NANOSOLUTIONS, AS; NORA 939051G, AS and NTRC 939011K, AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928; Berber S, 2000, PHYS REV LETT, V84, P4613, DOI 10.1103/PhysRevLett.84.4613; Bottini M, 2006, TOXICOL LETT, V160, P121, DOI 10.1016/j.toxlet.2005.06.020; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cao Y, 2014, TOXICOL SCI, V138, P104, DOI 10.1093/toxsci/kft328; Chen DQ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-014-0707-0; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Choi H, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-110; Cummins JM, 2006, ONCOGENE, V25, P6220, DOI 10.1038/sj.onc.1209914; Dahm MM, 2015, ANN OCCUP HYG, V59, P705, DOI 10.1093/annhyg/mev020; Davis BN, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-18; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; Di Sotto A, 2009, TOXICOL LETT, V184, P192, DOI 10.1016/j.toxlet.2008.11.007; Dinicola S, 2015, TOXICOL IN VITRO, V29, P1298, DOI 10.1016/j.tiv.2015.05.006; Donaldson K, 2007, J NANOSCI NANOTECHNO, V7, P4607, DOI 10.1166/jun.2007.003; Donaldson K, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-5; Erdely A, 2009, NANO LETT, V9, P36, DOI 10.1021/nl801828z; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fatkhutdinova L. M., 2013, Kazanskii Meditsinskii Zhurnal, V94, P770; Fortunato O, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/756975; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Grosse Y, 2014, LANCET ONCOL, V15, P1427, DOI 10.1016/S1470-2045(14)71109-X; Gubala Elzbieta, 2005, Endokrynol Pol, V56, P752; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI [10.1080/08958370801942238, 10.1080/08958370801942238 ]; Harries LW, 2012, BIOCHEM SOC T, V40, P902, DOI 10.1042/BST20120020; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; He XQ, 2011, CHEM RES TOXICOL, V24, P2237, DOI 10.1021/tx200351d; Heyman L, 2008, TUMOR BIOL, V29, P231, DOI 10.1159/000152941; Heyman L, 2010, CELL BIOL INT, V34, P493, DOI 10.1042/CBI20090331; Heyns M, 2015, ONCOTARGET, V6, P23055, DOI 10.18632/oncotarget.5048; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishikawa N, 2012, RESPIR INVESTIG, V50, P3, DOI 10.1016/j.resinv.2012.02.001; Kato T, 2003, CELL TISSUE RES, V311, P47, DOI 10.1007/s00441-002-0647-3; Ke Y, 2013, FEBS LETT, V587, P3153, DOI 10.1016/j.febslet.2013.08.010; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim JS, 2012, ARCH TOXICOL, V86, P553, DOI 10.1007/s00204-011-0770-6; Kisin ER, 2011, TOXICOL APPL PHARM, V252, P1, DOI 10.1016/j.taap.2011.02.001; Kohno Nobuoki, 1999, Journal of Medical Investigation, V46, P151; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Lam CW, 2006, CRIT REV TOXICOL, V36, P189, DOI 10.1080/10408440600570233; Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243; Lee JH, 2010, INHAL TOXICOL, V22, P369, DOI 10.3109/08958370903367359; Lee JK, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-14; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; Liao HY, 2014, NANOTOXICOLOGY, V8, P100, DOI 10.3109/17435390.2013.858793; Liou SH, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-0878-5; Luanpitpong S, 2014, ONCOTARGET, V5, P3541, DOI 10.18632/oncotarget.1956; Maeda Y, 2005, J AM CHEM SOC, V127, P10287, DOI 10.1021/ja051774o; Manikandan J, 2008, BIOINFORMATION, V2, P330, DOI 10.6026/97320630002330; Mao X, 2006, J INVEST DERMATOL, V126, P1388, DOI 10.1038/sj.jid.5700224; Martin-Gallego M, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-610; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; Mercer RR, 2008, AM J PHYSIOL-LUNG C, V294, pL87, DOI 10.1152/ajplung.00186.2007; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Mercer RR, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-28; Mills NL, 2006, AM J RESP CRIT CARE, V173, P426, DOI 10.1164/rccm.200506-865OC; Mitchell LA, 2009, NAT NANOTECHNOL, V4, P451, DOI [10.1038/nnano.2009.151, 10.1038/NNANO.2009.151]; Mitchell LA, 2007, TOXICOL SCI, V100, P203, DOI 10.1093/toxsci/kfm196; Mogilyansky E, 2013, CELL DEATH DIFFER, V20, P1603, DOI 10.1038/cdd.2013.125; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Muller J, 2008, CARCINOGENESIS, V29, P427, DOI 10.1093/carcin/bgm243; Murphy FA, 2011, AM J PATHOL, V178, P2587, DOI 10.1016/j.ajpath.2011.02.040; Nakao S, 2003, J IMMUNOL, V170, P5704, DOI 10.4049/jimmunol.170.11.5704; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; NIOSH, 2013, PUBLICATION, V2013-145; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2013, NANOTOXICOLOGY, V7, P1179, DOI 10.3109/17435390.2012.719649; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; Poulsen SS, 2015, TOXICOL APPL PHARM, V284, P16, DOI 10.1016/j.taap.2014.12.011; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sargent LM, 2012, MUTAT RES-GEN TOX EN, V745, P28, DOI 10.1016/j.mrgentox.2011.11.017; Sargent LM, 2009, ENVIRON MOL MUTAGEN, V50, P708, DOI 10.1002/em.20529; Sargent LM, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-3; Schlecht PC, 2006, PUBLICATION, V94-113; Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P2262, DOI 10.1158/1055-9965.EPI-11-0326; Shvedova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL698, DOI 10.1152/ajplung.00084.2005; Shvedova AA, 2015, CANCER RES, V75, P1615, DOI 10.1158/0008-5472.CAN-14-2376; Shvedova AA, 2013, SMALL, V9, P1691, DOI 10.1002/smll.201201470; Simeonova Petia P, 2009, Inhal Toxicol, V21 Suppl 1, P68, DOI 10.1080/08958370902942566; Snyder-Talkington BN, 2016, J APPL TOXICOL, V36, P161, DOI 10.1002/jat.3157; Snyder-Talkington BN, 2013, TOXICOL APPL PHARM, V272, P476, DOI 10.1016/j.taap.2013.06.026; Stapleton PA, 2011, TOXICOLOGIST, pA194; Teeguarden JG, 2011, TOXICOL SCI, V120, P123, DOI 10.1093/toxsci/kfq363; Tochitani S, 2008, BIOCHEM BIOPH RES CO, V372, P691, DOI 10.1016/j.bbrc.2008.05.127; Tzouvelekis A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-78; Urankar RN, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-38; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vlassov VV, 2015, MOL BIOL+, V49, P48, DOI 10.1134/S0026893315010161; Wang LY, 2014, NANOTOXICOLOGY, V8, P485, DOI 10.3109/17435390.2013.801089; Wang LY, 2011, NANO LETT, V11, P2796, DOI 10.1021/nl2011214; Wang M, 2012, MOL MED REP, V5, P1514, DOI 10.3892/mmr.2012.828; Wang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113401; Wang W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/518609; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Wozniak MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125026; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu LF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103698; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeni O, 2015, NANOMEDICINE-UK, V10, P351, DOI 10.2217/nnm.14.34; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zumwalde RD, OCCUPATIONAL EXPOSUR, Vxxiv	120	54	58	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150628	10.1371/journal.pone.0150628	http://dx.doi.org/10.1371/journal.pone.0150628			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930275	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500177
J	Frahm, GE; Pochopsky, AWT; Clarke, TM; Johnston, MJW				Frahm, Grant E.; Pochopsky, Alex W. T.; Clarke, Tessa M.; Johnston, Michael J. W.			Evaluation of Microflow Digital Imaging Particle Analysis for Sub-Visible Particles Formulated with an Opaque Vaccine Adjuvant	PLOS ONE			English	Article							SUBVISIBLE PARTICLES; THERAPEUTIC PROTEINS; MONOCLONAL-ANTIBODY; PHYSICAL STABILITY; MALARIA VACCINE; IMMUNOGENICITY; AGGREGATION; PROGRESS; GLASS; MICE	Microflow digital imaging (MDI) has become a widely accepted method for assessing sub-visible particles in pharmaceutical formulations however, to date; no data have been presented on the utility of this methodology when formulations include opaque vaccine adjuvants. This study evaluates the ability of MDI to assess sub-visible particles under these conditions. A Fluid Imaging Technologies Inc. FlowCAM1 instrument was used to assess a number of sub-visible particle types in solution with increasing concentrations of AddaVax, a nanoscale squalene-based adjuvant. With the objective (10X) used and the limitations of the sensor resolution, the instrument was incapable of distinguishing between sub-visible particles and AddaVax T droplets at particle sizes less than 5 mu m. The instrument was capable of imaging all particle types assessed (polystyrene beads, borosilicate glass, cellulose, polyethylene protein aggregate mimics, and lysozyme protein aggregates) at sizes greater than 5 mu m in concentrations of AddaVax T up to 50% (vol: vol). Reduced edge gradients and a decrease in measured particle sizes were noted as adjuvant concentrations increased. No significant changes in particle counts were observed for polystyrene particle standards and lysozyme protein aggregates, however significant reductions in particle counts were observed for borosilicate (80% of original) and cellulose (92% of original) particles. This reduction in particle counts may be due to the opaque adjuvant masking translucent particles present in borosilicate and cellulose samples. Although the results suggest that the utility of MDI for assessing sub-visible particles in high concentrations of adjuvant may be highly dependent on particle morphology, we believe that further investigation of this methodology to assess sub-visible particles in challenging formulations is warranted.	[Frahm, Grant E.; Pochopsky, Alex W. T.; Clarke, Tessa M.; Johnston, Michael J. W.] Hlth Canada, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada; [Pochopsky, Alex W. T.] Univ Ottawa, Dept Biochem, Ottawa, ON, Canada; [Clarke, Tessa M.] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada	Health Canada; University of Ottawa; University of Ottawa	Johnston, MJW (corresponding author), Hlth Canada, Biol & Genet Therapies Directorate, Ottawa, ON K1A 0L2, Canada.	michael.johnston@hc-sc.gc.ca			Government of Canada	Government of Canada(CGIAR)	The work was supported by the Government of Canada.	Barber TA, 1990, PDA J PHARM SCI TECH, V44, P185; Breman JG, 2009, J INFECT DIS, V200, P317, DOI 10.1086/600121; Carpenter John, 2010, Biologicals, V38, P602, DOI 10.1016/j.biologicals.2010.07.002; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Filipe V, 2010, PHARM RES-DORDR, V27, P796, DOI 10.1007/s11095-010-0073-2; Fradkin AH, 2011, J PHARM SCI-US, V100, P4953, DOI 10.1002/jps.22683; Freitag AJ, 2015, PHARM RES-DORDR, V32, P430, DOI 10.1007/s11095-014-1472-6; Goff PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079194; Goyal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115877; Hamborg M, 2013, J PHARM SCI-US, V102, P3567, DOI 10.1002/jps.23669; Hermeling S, 2006, J PHARM SCI-US, V95, P1084, DOI 10.1002/jps.20599; Kramer RM, 2013, J PHARM SCI-US, V102, P4305, DOI 10.1002/jps.23749; Narhi LO, 2015, J PHARM SCI-US, V104, P1899, DOI 10.1002/jps.24437; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Reed ZH, 2006, CURR MOL MED, V6, P231, DOI 10.2174/156652406776055195; RIPPLE D, 2012, AM PHARM REV, V14, P90; Ripple DC, 2015, J PHARM SCI-US, V104, P666, DOI 10.1002/jps.24287; Ripple DC, 2012, J PHARM SCI-US, V101, P3568, DOI 10.1002/jps.23242; Seidl A, 2012, PHARM RES-DORDR, V29, P1454, DOI 10.1007/s11095-011-0621-4; Sharma DK, 2011, INT J PHARMACEUT, V416, P293, DOI 10.1016/j.ijpharm.2011.05.078; Sharma DK, 2010, AAPS J, V12, P455, DOI 10.1208/s12248-010-9205-1; Sharma DK, 2010, J PHARM SCI-US, V99, P2628, DOI 10.1002/jps.22046; Skowronski DM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7297; Van Beers MMC, 2012, J PHARM SCI-US, V101, P187, DOI 10.1002/jps.22744; Wang W, 2012, INT J PHARMACEUT, V431, P1, DOI 10.1016/j.ijpharm.2012.04.040; Weinbuch D, 2013, J PHARM SCI-US, V102, P2152, DOI 10.1002/jps.23552; Werk T, 2014, EUR J PHARM SCI, V53, P95, DOI 10.1016/j.ejps.2013.12.014; Wuchner K, 2010, J PHARM SCI-US, V99, P3343, DOI 10.1002/jps.22123; Zolls S, 2013, J PHARM SCI-US, V102, P1434, DOI 10.1002/jps.23479	31	6	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150229	10.1371/journal.pone.0150229	http://dx.doi.org/10.1371/journal.pone.0150229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925777	Green Submitted, gold, Green Published			2022-12-27	WOS:000371424200028
J	Schweitzer, MH; Moyer, AE; Zheng, WX				Schweitzer, Mary Higby; Moyer, Alison E.; Zheng, Wenxia			Testing the Hypothesis of Biofilm as a Source for Soft Tissue and Cell-Like Structures Preserved in Dinosaur Bone	PLOS ONE			English	Article							ARCHAEOLOGICAL BONE; PROTEIN SEQUENCES; BLOOD-VESSELS; FUNGAL HYPHAE; ANCIENT; DECAY; EVOLUTION; MASTODON; DEGRADATION; SURVIVAL	Recovery of still-soft tissue structures, including blood vessels and osteocytes, from dinosaur bone after demineralization was reported in 2005 and in subsequent publications. Despite multiple lines of evidence supporting an endogenous source, it was proposed that these structures arose from contamination from biofilm-forming organisms. To test the hypothesis that soft tissue structures result from microbial invasion of the fossil bone, we used two different biofilm-forming microorganisms to inoculate modern bone fragments from which organic components had been removed. We show fundamental morphological, chemical and textural differences between the resultant biofilm structures and those derived from dinosaur bone. The data do not support the hypothesis that biofilm-forming microorganisms are the source of these structures.	[Schweitzer, Mary Higby; Moyer, Alison E.; Zheng, Wenxia] N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary Higby] North Carolina Museum Nat Sci, Raleigh, NC USA	University of North Carolina; North Carolina State University	Schweitzer, MH (corresponding author), N Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Schweitzer, MH (corresponding author), North Carolina Museum Nat Sci, Raleigh, NC USA.	schweitzer@ncsu.edu	Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010	schweitzer, mary h/0000-0002-0427-3829	David and Lucile Packard Foundation [30533]; National Science Foundation INSPIRE program [EAR-1344198]; National Science Foundation GRFP [DGE-1252376]; Directorate For Geosciences [1344198] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation INSPIRE program; National Science Foundation GRFP(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was funded by grants to MHS from the David and Lucile Packard Foundation (30533), to MHS and WZ from the National Science Foundation INSPIRE program (EAR-1344198), and to AEM from the National Science Foundation GRFP (DGE-1252376). The EAR-1344198 was given to only MHS as PI. WZ is funded off of this grant, but she is not a PI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Avci R, 2005, LANGMUIR, V21, P3584, DOI 10.1021/la047682e; Bartnicki-Garcia S, 2000, BIOPHYS J, V79, P2382, DOI 10.1016/S0006-3495(00)76483-6; Boyd CA, 2011, ZOOMORPHOLOGY, V130, P305, DOI 10.1007/s00435-011-0136-x; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; Briggs DEG, 2003, FOSSIL AND RECENT BIOFILMS, P281; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; CHILD AM, 1995, STUD CONSERV, V40, P19, DOI 10.2307/1506608; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Cleland TP, 2015, J PROTEOME RES, V14, P5252, DOI 10.1021/acs.jproteome.5b00675; COATES M, 1980, TEX REP BIOL MED, V40, P9; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226; Elkaim R, 2008, J PERIODONTAL RES, V43, P224, DOI 10.1111/j.1600-0765.2007.01018.x; Gutierrez G, 1998, MOL BIOL EVOL, V15, P926, DOI 10.1093/oxfordjournals.molbev.a025998; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hardison R, 1998, J EXP BIOL, V201, P1099; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Iniesto M, 2015, FRONTIERS EARTH SCI, P3; Jans MME, 2002, ARCHAEOMETRY, V44, P343, DOI 10.1111/1475-4754.t01-1-00067; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindgren J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0614; Lindgren J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019445; Liu J, 2004, METH MOLEC MED, V95, P71; MECHAM RP, 1991, ANN NY ACAD SCI, V624, P137, DOI 10.1111/j.1749-6632.1991.tb17013.x; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Peterson JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013334; Pitre MC, 2013, J ARCHAEOL SCI, V40, P24, DOI 10.1016/j.jas.2012.06.022; RAFF EC, 2008, P NATL ACAD SCI USA, V105, P1936, DOI DOI 10.1146/ANNUREV.EARTH.31.100901.144746; Raff EC, 2013, EVOL DEV, V15, P243, DOI 10.1111/ede.12028; Rhoads D D, 2008, J Wound Care, V17, P502; Riding R, 2000, SEDIMENTOLOGY, V47, P179, DOI 10.1046/j.1365-3091.2000.00003.x; ROSENBLOOM J, 1993, FASEB J, V7, P1208, DOI 10.1096/fasebj.7.13.8405806; Schweitzer MH, 2015, BIOESSAYS, V37, P1174, DOI 10.1002/bies.201500061; Schweitzer MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2741; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2013, BONE, V52, P414, DOI 10.1016/j.bone.2012.10.010; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Singh R, 2006, TRENDS MICROBIOL, V14, P389, DOI 10.1016/j.tim.2006.07.001; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Stoodley P, 1997, BIOFILMS COMMUNITY I, P1; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; TANAKA Y, 1976, AM J ANAT, V145, P485, DOI 10.1002/aja.1001450407; Tanaka-Kamioka K, 1998, J BONE MINER RES, V13, P1555, DOI 10.1359/jbmr.1998.13.10.1555; Vito RP, 2003, ANNU REV BIOMED ENG, V5, P413, DOI 10.1146/annurev.bioeng.5.011303.120719; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Willerslev E, 2005, P ROY SOC B-BIOL SCI, V272, P3, DOI 10.1098/rspb.2004.2813	62	19	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150238	10.1371/journal.pone.0150238	http://dx.doi.org/10.1371/journal.pone.0150238			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926069	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200030
J	Aliuos, P; Schulze, J; Schomaker, M; Reuter, G; Stolle, SRO; Werner, D; Ripken, T; Lenarz, T; Warnecke, A				Aliuos, Pooyan; Schulze, Jennifer; Schomaker, Markus; Reuter, Guenter; Stolle, Stefan R. O.; Werner, Darja; Ripken, Tammo; Lenarz, Thomas; Warnecke, Athanasia			Magnetic Beads Enhance Adhesion of NIH 3T3 Fibroblasts: A Proof-of-Principle In Vitro Study for Implant-Mediated Long-Term Drug Delivery to the Inner Ear	PLOS ONE			English	Article							SPIRAL-GANGLION NEURONS; NEUROTROPHIC FACTOR; ELECTRICAL-STIMULATION; COCHLEAR IMPLANTATION; NEURITE OUTGROWTH; CELL SURVIVAL; BDNF; NANOPARTICLES; PERCEPTION; CESSATION	Introduction Long-term drug delivery to the inner ear may be achieved by functionalizing cochlear implant (CI) electrodes with cells providing neuroprotective factors. However, effective strategies in order to coat implant surfaces with cells need to be developed. Our vision is to make benefit of electromagnetic field attracting forces generated by CI electrodes to bind BDNF-secreting cells that are labelled with magnetic beads (MB) onto the electrode surfaces. Thus, the effect of MB-labelling on cell viability and BDNF production were investigated. Materials and Methods Murine NIH 3T3 fibroblasts-genetically modified to produce BDNF-were labelled with MB. Results Atomic force and bright field microscopy illustrated the internalization of MB by fibroblasts after 24 h of cultivation. Labelling cells with MB did not expose cytotoxic effects on fibroblasts and allowed adhesion on magnetic surfaces with sufficient BDNF release. Discussion Our data demonstrate a novel approach for mediating enhanced long-term adhesion of BDNF-secreting fibroblasts on model electrode surfaces for cell-based drug delivery applications in vitro and in vivo. This therapeutic strategy, once transferred to cells suitable for clinical application, may allow the biological modifications of CI surfaces with cells releasing neurotrophic or other factors of interest.	[Aliuos, Pooyan; Schulze, Jennifer; Reuter, Guenter; Stolle, Stefan R. O.; Werner, Darja; Lenarz, Thomas; Warnecke, Athanasia] Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany; [Aliuos, Pooyan; Schulze, Jennifer; Ripken, Tammo; Lenarz, Thomas; Warnecke, Athanasia] Cluster Excellence Hearing4All, Hannover, Germany; [Schomaker, Markus; Ripken, Tammo] Laser Zentrum Hannover eV, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otorhinolaryngol Head & Neck Surg, Hannover, Germany.; Warnecke, A (corresponding author), Cluster Excellence Hearing4All, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022		German Research Foundation	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation, Project Group "Medical Technology". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agterberg MJH, 2009, JARO-J ASSOC RES OTO, V10, P355, DOI 10.1007/s10162-009-0170-2; Budenz CL, 2012, ANAT REC, V295, P1896, DOI 10.1002/ar.22586; Burkhardt O, 2002, ANN ANAT, V184, P55, DOI 10.1016/S0940-9602(02)80036-X; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Calmels MN, 2004, INT J PEDIATR OTORHI, V68, P347, DOI 10.1016/j.ijporl.2003.11.006; Coco A, 2007, HEARING RES, V225, P60, DOI 10.1016/j.heares.2006.12.004; Evans AJ, 2009, J BIOMED MATER RES A, V91A, P241, DOI 10.1002/jbm.a.32228; Gallo J, 2013, CHEM SOC REV, V42, P7816, DOI 10.1039/c3cs60149h; Gillespie LN, 2015, J CONTROL RELEASE, V198, P26, DOI 10.1016/j.jconrel.2014.11.026; Gillespie LN, 2003, J NEUROSCI RES, V71, P785, DOI 10.1002/jnr.10542; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Huang JH, 2010, J BIOMED MATER RES A, V93A, P164, DOI 10.1002/jbm.a.32511; Huang T, 2000, INT J DEV NEUROSCI, V18, P259, DOI 10.1016/S0736-5748(99)00094-5; Jorgensen JR, 2012, EXP NEUROL, V233, P172, DOI 10.1016/j.expneurol.2011.09.027; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Kishino A, 2001, NEUROREPORT, V12, P1067, DOI 10.1097/00001756-200104170-00040; Leake PA, 2013, JARO-J ASSOC RES OTO, V14, P187, DOI 10.1007/s10162-013-0372-5; LEFEBVRE PP, 1994, NEUROREPORT, V5, P865, DOI 10.1097/00001756-199404000-00003; Lenarz T, 2013, CURR PHARM BIOTECHNO, V14, P112; Lynam DA, 2015, ACTA BIOMATER, V18, P128, DOI 10.1016/j.actbio.2015.02.014; McGuinness SL, 2005, OTOL NEUROTOL, V26, P1064, DOI 10.1097/01.mao.0000185063.20081.50; Miller JM, 1997, INT J DEV NEUROSCI, V15, P631, DOI 10.1016/S0736-5748(96)00117-7; Murphy J, 2007, LARYNGOSCOPE, V117, P1412, DOI 10.1097/MLG.0b013e318068b594; Nagahara AH, 2011, NAT REV DRUG DISCOV, V10, P209, DOI 10.1038/nrd3366; O'Leary SJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055002; Peng SC, 2008, EAR HEARING, V29, P336, DOI 10.1097/AUD.0b013e318168d94d; Pierzchalski A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074745; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Richardson RT, 2009, BIOMATERIALS, V30, P2614, DOI 10.1016/j.biomaterials.2009.01.015; Scheper V, 2009, J NEUROSCI RES, V87, P1389, DOI 10.1002/jnr.21964; Shepherd RK, 2008, HEARING RES, V242, P100, DOI 10.1016/j.heares.2007.12.005; Staecker H, 1998, OTOLARYNG HEAD NECK, V119, P7, DOI 10.1016/S0194-5998(98)70194-9; Tietze R, 2013, NANOMED-NANOTECHNOL, V9, P961, DOI 10.1016/j.nano.2013.05.001; Tjelle TE, 1998, J CELL SCI, V111, P141; UGELSTAD J, 1993, BLOOD PURIFICAT, V11, P349, DOI 10.1159/000170129; Ugelstad J., 1976, RUBBER CHEM TECHNOL, V49, P536, DOI DOI 10.5254/1.3534976; Warnecke A, 2007, NEUROREPORT, V18, P1683, DOI 10.1097/WNR.0b013e3282f0b5d7; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; Wrzeszcz A, 2014, J BIOMED MATER RES A, V102, P442, DOI 10.1002/jbm.a.34719; Xu HX, 2012, ACTA OTO-LARYNGOL, V132, P482, DOI 10.3109/00016489.2011.647361; Yilmaz A, 2013, EUR HEART J, V34, P462, DOI 10.1093/eurheartj/ehs366; YLIKOSKI J, 1993, HEARING RES, V65, P69, DOI 10.1016/0378-5955(93)90202-C; Zhao M, 2013, DRUG DELIV, V20, P95, DOI 10.3109/10717544.2013.779328	43	4	4	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150057	10.1371/journal.pone.0150057	http://dx.doi.org/10.1371/journal.pone.0150057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918945	gold, Green Submitted, Green Published			2022-12-27	WOS:000371274400078
J	Carroll, R; Metcalfe, C; Steeg, S; Davies, NM; Cooper, J; Kapur, N; Gunnell, D				Carroll, Robert; Metcalfe, Chris; Steeg, Sarah; Davies, Neil M.; Cooper, Jayne; Kapur, Nav; Gunnell, David			Psychosocial Assessment of Self-Harm Patients and Risk of Repeat Presentation: An Instrumental Variable Analysis Using Time of Hospital Presentation	PLOS ONE			English	Article							BIAS	Background Clinical guidelines have recommended psychosocial assessment of self-harm patients for years, yet estimates of its impact on the risk of repeat self-harm vary. Assessing the association of psychosocial assessment with risk of repeat self-harm is challenging due to the effects of confounding by indication. Methods We analysed data from a cohort study of 15,113 patients presenting to the emergency departments of three UK hospitals to investigate the association of psychosocial assessment with risk of repeat hospital presentation for self-harm. Time of day of hospital presentation was used as an instrument for psychosocial assessment, attempting to control for confounding by indication. Results Conventional regression analysis suggested psychosocial assessment was not associated with risk of repeat self-harm within 12 months (Risk Difference (RD) 0.00 95% confidence interval (95% CI) -0.01 to 0.02). In contrast, IV analysis suggested risk of repeat self-harm was reduced by 18% (RD -0.18, 95% CI -0.32 to -0.03) in those patients receiving a psychosocial assessment. However, the instrument of time of day did not remove all potential effects of confounding by indication, suggesting the IV effect estimate may be biased. Conclusions We found that psychosocial assessments reduce risk of repeat self-harm. This is in-line with other non-randomised studies based on populations in which allocation to assessment was less subject to confounding by indication. However, as our instrument did not fully balance important confounders across time of day, the IV effect estimate should be interpreted with caution.	[Carroll, Robert; Metcalfe, Chris; Davies, Neil M.; Gunnell, David] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Steeg, Sarah; Cooper, Jayne; Kapur, Nav] Univ Manchester, Ctr Suicide Prevent, Manchester, Lancs, England; [Kapur, Nav] Manchester Mental Hlth & Social Care Trust, Manchester, Lancs, England; [Davies, Neil M.] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Gunnell, David] Univ Hosp Bristol NHS Fdn Trust, Natl Inst Hlth Res Collaborat Leadership Appl Hlt, Bristol, Avon, England	University of Bristol; University of Manchester; Open University - UK; University of Bristol; University of Bristol	Metcalfe, C (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	Chris.Metcalfe@Bristol.ac.uk	Gunnell, David/ABE-6653-2020	Gunnell, David/0000-0002-0829-6470; Kapur, Nav/0000-0002-3100-3234; Metcalfe, Chris/0000-0001-8318-8907; Davies, Neil/0000-0002-2460-0508; Steeg, Sarah/0000-0002-7935-1414	Department of Health (England) as part of the Multi-Centre Study of Self-harm; Manchester Mental Health and Social Care Trust; NIHR; Medical Research Council; University of Bristol [MC_UU_12013/9]; Economics and Social Research Council (ESRC) [ES/N000757/1]; MRC [MC_UU_12013/9, MC_UU_12013/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/1, MC_UU_12013/9] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10068, DRF-2012-05-189] Funding Source: researchfish	Department of Health (England) as part of the Multi-Centre Study of Self-harm; Manchester Mental Health and Social Care Trust; NIHR(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bristol; Economics and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The MASH Project is funded by the Department of Health (England) as part of the Multi-Centre Study of Self-harm. NK is supported by Manchester Mental Health and Social Care Trust. RC was funded by a NIHR doctoral research fellowship. DG's time is supported by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care West (NIHR CLAHRC West). The Integrative Epidemiology Unit is supported by the Medical Research Council and the University of Bristol [MC_UU_12013/9]. NMD is supported by the Economics and Social Research Council (ESRC) via a Future Research Leaders Fellowship (ES/N000757/1). The funders had no role in study design, the collection, analysis and interpretation of data, the writing of the report, and the decision to submit the paper for publication. The views and opinions expressed within this paper are those of the authors and do not necessarily reflect those of the NIHR, MRC, ESRC or the Department of Health.	Baum CF, 2003, STATA J, V3, P1, DOI 10.1177/1536867X0300300101; Bennewith O, 2005, J AFFECT DISORDERS, V89, P91, DOI 10.1016/j.jad.2005.08.011; Bergen H, 2010, BRIT J PSYCHIAT, V197, P493, DOI 10.1192/bjp.bp.110.077651; Bickley H, 2013, MANCHEST SELF HARM P; Brookhart M Alan, 2007, Int J Biostat, V3, P14; Burgess S, 2011, INT J EPIDEMIOL, V40, P755, DOI 10.1093/ije/dyr036; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Clarke PS, 2012, J AM STAT ASSOC, V107, P1638, DOI 10.1080/01621459.2012.734171; Clarke PS, 2010, BIOSTATISTICS, V11, P756, DOI 10.1093/biostatistics/kxq024; Cooper J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003444; Davies NM, 2013, J CLIN EPIDEMIOL, V66, P1386, DOI 10.1016/j.jclinepi.2013.06.008; Greenland S, 2000, INT J EPIDEMIOL, V29, P1102, DOI 10.1093/oxfordjournals.ije.a019909; HAUSMAN JA, 1978, ECONOMETRICA, V46, P1251, DOI 10.2307/1913827; Hawton K, 2015, J AFFECT DISORDERS, V175, P147, DOI 10.1016/j.jad.2014.12.062; Ho V, 2000, HEALTH SERV RES, V34, P1499; Kapur N, 2005, BMJ-BRIT MED J, V330, P394, DOI 10.1136/bmj.38337.584225.82; Kapur N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070434; Kapur N, 2008, J AFFECT DISORDERS, V106, P285, DOI 10.1016/j.jad.2007.07.010; Larkin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084282; National Institute for Clinical Excellence, 2004, SELF HARM SHORT TERM; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; O'Donnell HC, 2014, ACAD PEDIATR, V14, P84, DOI 10.1016/j.acap.2013.09.010; Royal College of Psychiatrists, 2004, ASS FOLL SELF HARM A; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	26	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149713	10.1371/journal.pone.0149713	http://dx.doi.org/10.1371/journal.pone.0149713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918579	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400039
J	Lamar, KM; Miller, T; Dellefave-Castillo, L; McNally, EM				Lamar, Kay-Marie; Miller, Tamari; Dellefave-Castillo, Lisa; McNally, Elizabeth M.			Genotype-Specific Interaction of Latent TGF beta Binding Protein 4 with TGF beta	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MUSCULAR-DYSTROPHY; HEART-FAILURE; TRANSFORMING GROWTH-FACTOR-BETA-1; DILATED CARDIOMYOPATHY; EXTRACELLULAR-MATRIX; MUSCLE DYSFUNCTION; COLORECTAL-CANCER; SKELETAL-MUSCLE; EXPRESSION	Latent TGF beta binding proteins are extracellular matrix proteins that bind latent TGF beta to form the large latent complex. Nonsynonymous polymorphisms in LTBP4, a member of the latent TGF beta binding protein gene family, have been linked to several human diseases, underscoring the importance of TGF beta regulation for a range of phenotypes. Because of strong linkage disequilibrium across the LTBP4 gene, humans have two main LTBP4 alleles that differ at four amino acid positions, referred to as IAAM and VTTT for the encoded residues. VTTT is considered the "risk" allele and associates with increased intracellular TGF beta signaling and more deleterious phenotypes in muscular dystrophy and other diseases. We now evaluated LTBP4 nsSNPs in dilated cardiomyopathy, a distinct disorder associated with TGF beta signaling. We stratified based on self-identified ethnicity and found that the LTBP4 VTTT allele is associated with increased risk of dilated cardiomyopathy in European Americans extending the diseases that associate with LTBP4 genotype. However, the association of LTBP4 SNPs with dilated cardiomyopathy was not observed in African Americans. To elucidate the mechanism by which LTBP4 genotype exerts this differential effect, TGF beta's association with LTBP4 protein was examined. LTBP4 protein with the IAAM residues bound more latent TGF beta compared to the LTBP4 VTTT protein. Together these data provide support that LTBP4 genotype exerts its effect through differential avidity for TGF beta accounting for the differences in TGF beta signaling attributed to these two alleles.	[Lamar, Kay-Marie; Miller, Tamari; McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Dellefave-Castillo, Lisa; McNally, Elizabeth M.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA	University of Chicago; Northwestern University; Feinberg School of Medicine	McNally, EM (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.; McNally, EM (corresponding author), Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA.	elizabeth.mcnally@northwestern.edu	McNally, Elizabeth/W-4909-2019	McNally, Elizabeth/0000-0002-1221-719X; Lamar, Kay-Marie/0000-0001-9572-8384	National Institutes of Health [NS047726, HL128075]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061322, T32HL007381, R01HL128075, R01HL122109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS072027, R01NS047726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health, NS047726, HL128075.	Accornero F, 2014, HUM MOL GENET, V23, P6903, DOI 10.1093/hmg/ddu413; Aharinejad S, 2005, AM J TRANSPLANT, V5, P2185, DOI 10.1111/j.1600-6143.2005.01006.x; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Anderson SB, 2008, J BIOL CHEM, V283, P7027, DOI 10.1074/jbc.M706678200; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Barp A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141240; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; BASCOM CC, 1989, MOL CELL BIOL, V9, P5508, DOI 10.1128/MCB.9.12.5508; Beffagna G, 2005, CARDIOVASC RES, V65, P366, DOI 10.1016/j.cardiores.2004.10.005; Bello L, 2015, ANN NEUROL, V77, P684, DOI 10.1002/ana.24370; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Briest W, 2004, HYPERTENSION, V44, P410, DOI 10.1161/01.HYP.0000141414.87026.4d; Brooks A, 2003, HEART, V89, P1255, DOI 10.1136/heart.89.10.1255; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Fahrenbach JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090408; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Forsti A, 2010, GENE CHROMOSOME CANC, V49, P270, DOI 10.1002/gcc.20738; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Giltay R, 1997, FEBS LETT, V411, P164, DOI 10.1016/S0014-5793(97)00685-6; Goldstein JA, 2014, HUM MOL GENET, V23, P6722, DOI 10.1093/hmg/ddu390; Goldstein JA, 2011, HUM MOL GENET, V20, P894, DOI 10.1093/hmg/ddq528; Hersh CP, 2006, AM J RESP CRIT CARE, V173, P977, DOI 10.1164/rccm.200509-1452OC; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Holweg CTJ, 2001, J HEART LUNG TRANSPL, V20, P979, DOI 10.1016/S1053-2498(01)00296-0; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Khan S, 2014, CIRC J, V78, P2711, DOI 10.1253/circj.CJ-14-0511; Koli K, 2004, J CELL BIOL, V167, P123, DOI 10.1083/jcb.200403067; LEVINE JH, 1993, AM J PATHOL, V143, P368; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; Nelson CA, 2011, AM J PATHOL, V178, P2611, DOI 10.1016/j.ajpath.2011.02.024; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; ROBERTS AB, 1992, MOL REPROD DEV, V32, P91, DOI 10.1002/mrd.1080320203; ROBERTS AB, 1990, ANN NY ACAD SCI, V593, P43, DOI 10.1111/j.1749-6632.1990.tb16098.x; Saharinen J, 1998, J BIOL CHEM, V273, P18459, DOI 10.1074/jbc.273.29.18459; Sanderson JE, 2001, HEART, V86, P701, DOI 10.1136/heart.86.6.701; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Sterner-Kock A, 2002, GENE DEV, V16, P2264, DOI 10.1101/gad.229102; Thompson AR, 2010, ATHEROSCLEROSIS, V209, P367, DOI 10.1016/j.atherosclerosis.2009.09.073; van den Bergen JC, 2015, J NEUROL NEUROSUR PS, V86, P1060, DOI 10.1136/jnnp-2014-308409; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wissing ER, 2014, HUM MOL GENET, V23, P5452, DOI 10.1093/hmg/ddu270; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	52	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150358	10.1371/journal.pone.0150358	http://dx.doi.org/10.1371/journal.pone.0150358			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918958	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400126
J	Manoukis, NC				Manoukis, Nicholas C.			To Catch a Fly: Landing and Capture of Ceratitis capitata in a Jackson Trap with and without an Insecticide	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLIES; EFFECTIVE ATTRACTION RADIUS; BACTROCERA-DORSALIS; DIPTERA TEPHRITIDAE; METHYL EUGENOL; PLASTIC MATRIX; MALE LURES; TRIMEDLURE; ERADICATION; POPULATIONS	Attractant-based traps are a cornerstone of detection, delimitation and eradication programs for pests such as tephritid fruit flies. The ideal trap and lure combination has high attraction (it brings insects to the trap from a distance) and high capture efficiency (it has a high probability of capturing the insect once it arrives at the trap). We examined the effect of an insecticide (DDVP) in combination with a pheromone lure (trimedlure) on capture of Ceratitis capitata using 1) digital images of surfaces of a Jackson trap analyzed via computer vision, and 2) counts of the number of flies caught in the trap and in the area under the trap. Our results indicate no significant difference in trap capture without or with insecticide (means +/- SD = 324 +/- 135 and 356 +/- 108, respectively). However, significantly more dead flies were found around the trap with insecticide (92 +/- 53 with insecticide compared with 35 +/- 22 without), suggesting a possible decrease in trap efficiency due to mortality before insects enter the trap. Indeed, the average number of flies detected on all surfaces of the traps with insecticide was lower than that for lure-only (4.15 +/- 0.39 vs 8.30 +/- 1.18), and both were higher than control (no lure: 0.76 +/- 0.08). We found that the majority of fly sightings, 71% of the total, occurred on the inside panels of the lure-only traps, suggesting that increased efficiency of the Jackson trap may be obtained by adding a contact insecticide to those surfaces.	[Manoukis, Nicholas C.] USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA	United States Department of Agriculture (USDA)	Manoukis, NC (corresponding author), USDA ARS, Daniel K Inouye US Pacific Basin Agr Res Ctr, Hilo, HI USA.	nicholas.manoukis@ars.usda.gov	Manoukis, Nicholas C./V-9063-2019	Manoukis, Nicholas C./0000-0001-5062-7256	USDA-ARS; intramural research arm of USDA	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); intramural research arm of USDA	This study was funded by USDA-ARS, the intramural research arm of USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; [Anonymous], 1992, FRUIT FLIES EC SIGNI; Apple J. L., 1976, INTEGRATED PEST MANA, DOI 10.1007/978-1-4615-7269-5; BAKKE A, 1985, Z ANGEW ENTOMOL, V99, P33; BYERS JA, 1989, J CHEM ECOL, V15, P749, DOI 10.1007/BF01014716; Cam N, 1990, 9010 EH CA DEP FOOD; CHENIER JVR, 1989, CAN ENTOMOL, V121, P159, DOI 10.4039/Ent121159-2; Cunningham RT, 1981, MANAGEMENT INSECT PE, P95; Denning J, 1944, MO DEP AG B, V42; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; Gilbert A., 2013, INSECT TRAPPING GUID; HENDRICHS J, 1989, INSECT SCI APPL, V10, P285, DOI 10.1017/S1742758400003519; Hiramoto Matthew K., 2006, Proceedings of the Hawaiian Entomological Society, V38, P103; Jang EB, 2011, J APPL ENTOMOL, V135, P456, DOI 10.1111/j.1439-0418.2010.01557.x; Jang EB, 2013, J ECON ENTOMOL, V106, P727, DOI 10.1603/EC12371; KATSOYANNOS BI, 1994, J APPL ENTOMOL, V118, P442, DOI 10.1111/j.1439-0418.1994.tb00823.x; Manoukis NC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07015; Manoukis NC, 2013, ANN ENTOMOL SOC AM, V106, P136, DOI 10.1603/AN12095; MCGOVERN TP, 1987, J ECON ENTOMOL, V80, P617, DOI 10.1093/jee/80.3.617; McPheron BA, 1996, FRUIT FLY PESTS WORL; Muirhead-Thompson R.C., 1991, TRAP RESPONSES FLYIN; NAKAGAWA S, 1970, J ECON ENTOMOL, V63, P227, DOI 10.1093/jee/63.1.227; NAKAGAWA S, 1975, J ECON ENTOMOL, V68, P405, DOI 10.1093/jee/68.3.405; National Oceanic and Atmospheric Administration (NOAA), 2011, NOAAS 1981 2010 CLIM; Ros JP, 2007, DEV IMPR ATTR THEIR, P27; SCHLYTER F, 1992, J APPL ENTOMOL, V114, P439, DOI 10.1111/j.1439-0418.1992.tb01150.x; Severin HHP, 1913, J ECON ENTOMOL, V6, P347, DOI 10.1093/jee/6.4.347; Shelly T., 2014, TRAPPING DETECTION C; SHELLY TE, 1993, ANN ENTOMOL SOC AM, V86, P341, DOI 10.1093/aesa/86.3.341; Shelly Todd E., 2013, Proceedings of the Hawaiian Entomological Society, V45, P119; STEINER LF, 1961, J ECON ENTOMOL, V54, P30, DOI 10.1093/jee/54.1.30; TANAKA N, 1969, J ECON ENTOMOL, V62, P967, DOI 10.1093/jee/62.4.967; vanRossum G., 1995, PYTHON TUTORIAL; Vargas RI, 2015, J ECON ENTOMOL, V108, P1612, DOI 10.1093/jee/tov137; Vargas RI, 2009, J ECON ENTOMOL, V102, P552, DOI 10.1603/029.102.0212; WALL C, 1987, ENTOMOL EXP APPL, V44, P5, DOI 10.1007/BF00361302; WIJESURYA SR, 1995, J AUST ENTOMOL SOC, V34, P273	38	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149869	10.1371/journal.pone.0149869	http://dx.doi.org/10.1371/journal.pone.0149869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918513	Green Submitted, gold, Green Published			2022-12-27	WOS:000371274400051
J	Saleem, Z; Saeed, H; Ahmad, M; Yousaf, M; Hassan, HB; Javed, A; Anees, N; Maharjan, S				Saleem, Zikria; Saeed, Hamid; Ahmad, Mobasher; Yousaf, Mahrukh; Hassan, Hafsa Binte; Javed, Ayesha; Anees, Nida; Maharjan, Sonu			Antibiotic Self-Prescribing Trends, Experiences and Attitudes in Upper Respiratory Tract Infection among Pharmacy and Non-Pharmacy Students: A Study from Lahore	PLOS ONE			English	Article							NONMEDICAL UNIVERSITY-STUDENTS; MEDICAL-STUDENTS; PHYSICIANS; COUNTRIES; KARACHI; CARE	Pharmacists are the custodians of drugs; hence their education, training, behaviors and experiences would affect the future use of drugs at community and hospital pharmacies. Therefore, we aimed at evaluating the self-prescribing antibiotic trends, knowledge and attitudes among pharmacy and non-pharmacy students. We found that pharmacy students had higher risks of experiencing URIs related symptoms such as cough (RR; 1.7, p = 0.002), allergy (RR; 2.07, p = 0.03) and running nose (RR; 3.17, p<0.005), compared to non-pharmacy students-resulting in higher probabilities of selecting cough syrups (OR; 2.3, p<0.005), anti-histamines (OR; 1.8, p = 0.036) and anti-inflammatory/anti-pyretic (OR; 2.4, p<0.005) drugs. Likewise, bachelor's degree pupils (OR; 2, p = 0.045), urban area residents (OR; 2.44; p = 0.002) and pharmacy students (OR; 2.9, p<0.005) exhibited higher propensities of antibiotic self-use-notable classes include, b-lactams (45.9%) followed by macrolides (26.5%) and augmentin (28.94%), respectively. Surprisingly, pharmacy and non-pharmacy students had higher odds of using antibiotics in common cold (OR; 3.2, p<0.005) and pain (OR; 2.37, p = 0.015), respectively. Unlike non-pharmacy students, pharmacy students were likely to select alternative therapy, such as Joshanda (OR; 2.22, p = 0.011) and were well acquainted with antibiotic hazards, with 77% reduction in risk of antibiotics re-use. In conclusion, university students exhibited antibiotic self-prescribing trends in conditions that does not warrant their use, thus are irrational users. The pharmacy education confers very little benefit to rational self-prescribing practices among students, while non-pharmacy students are more vulnerable to repeated antibiotic usage. Thus, the educational and training modules should be designed for university students to disseminate targeted information regarding the potential hazards of antibiotic self-use and importance of consultation with qualified and registered medical doctor/pharmacist before starting with antibiotics.	[Saleem, Zikria; Saeed, Hamid; Ahmad, Mobasher; Yousaf, Mahrukh; Hassan, Hafsa Binte; Javed, Ayesha; Anees, Nida; Maharjan, Sonu] Univ Punjab, Clin Pharm Sect, Univ Coll Pharm, AllamaIqbal Campus, Lahore 54000, Pakistan	University of Punjab	Saeed, H (corresponding author), Univ Punjab, Clin Pharm Sect, Univ Coll Pharm, AllamaIqbal Campus, Lahore 54000, Pakistan.	hamid.pharmacy@pu.edu.pk	Saleem, Zikria/AAB-5786-2022	Saleem, Zikria/0000-0003-3202-6347				Abay SM, 2010, J YOUNG PHARM, V2, P306, DOI 10.4103/0975-1483.66798; Aljinovic-Vucic V, 2005, CROAT MED J, V46, P74; Appelbaum P, 1977, LANCET, V310, P995; Ashraf S, 2010, J PAK MED ASSOC, V60, P1015; Balbisi EA, 2005, AM J HEALTH-SYST PH, V62, P2508, DOI 10.2146/ajhp050007; Barden LS, 1998, CLIN PEDIATR, V37, P665, DOI 10.1177/000992289803701104; Benson V, 1994, VITAL HLTH STAT, V189, P1; Burak LJ, 2000, J AM COLL HEALTH, V49, P118, DOI 10.1080/07448480009596293; Choudhry AJ, 1997, MOTHER CHILD, V35, P84; Dabney D A, 2001, J Am Pharm Assoc (Wash), V41, P392; Gonzales R, 1997, JAMA-J AM MED ASSOC, V278, P901, DOI 10.1001/jama.278.11.901; Grimsmo A, 2001, SCAND J PRIM HEALTH, V19, P76; Gulliford M, 2009, J PUBLIC HEALTH-UK, V31, P512, DOI 10.1093/pubmed/fdp081; Hem E, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-16; James H, 2008, INT J CLIN PHARM TH, V46, P23; Jaruseviciene L, 2013, UPSALA J MED SCI, V118, P98, DOI 10.3109/03009734.2013.778925; Kafle K, 1993, SELF MEDICATION ITS; Mainous AG, 1998, ARCH FAM MED, V7, P45, DOI 10.1001/archfami.7.1.45; MCAULIFFE WE, 1986, NEW ENGL J MED, V315, P805, DOI 10.1056/NEJM198609253151305; McCaig LF, 2002, JAMA-J AM MED ASSOC, V287, P3096, DOI 10.1001/jama.287.23.3096; Mumtaz Y, 2011, J LIAQUAT UNIV MED H, V10, P102; Nalini G. K., 2010, British Journal of Medical Practitioners, V3, P325; Napolitano F, 2013, PUBLIC KNOWLEDGE ATT; Pandya RN, 2013, INT J BASIC CLINPHAR, V2, P275; Sawalha AF, 2008, RES SOC ADMIN PHARM, V4, P164, DOI 10.1016/j.sapharm.2007.04.004; Shah SJ, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-74; Sharif SI, 2012, AM J PHARMACOLTOXICO, V7, P135, DOI DOI 10.3844/AJPTSP.2012.135.140; Tomasi Elaine, 2007, Rev. bras. epidemiol., V10, P66; TOMSON G, 1986, LANCET, V2, P620; Van der Linden MW, 2004, 2 NATL STUDY DIS ACT; Wise R, 1998, BMJ-BRIT MED J, V317, P609, DOI 10.1136/bmj.317.7159.609; Yamada K, 2015, PHARMACOTHERAPY, V5, P4; Zafar Syed Nabeel, 2008, J Pak Med Assoc, V58, P214; Zafar SN, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-162	34	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149929	10.1371/journal.pone.0149929	http://dx.doi.org/10.1371/journal.pone.0149929			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919465	Green Published, gold			2022-12-27	WOS:000371274400058
J	Chiang, ER; Ma, HL; Wang, JP; Liu, CL; Chen, TH; Hung, SC				Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh			Allogeneic Mesenchymal Stem Cells in Combination with Hyaluronic Acid for the Treatment of Osteoarthritis in Rabbits	PLOS ONE			English	Article							SYNOVIAL-CELLS; KNEE; MODEL; CARTILAGE; TRANSPLANTATION; MEDICINE; THERAPY; CULTURE	Mesenchymal stem cell (MSC)-based therapies may aid in the repair of articular cartilage defects. The purpose of this study was to investigate the effects of intraarticular injection of allogeneic MSCs in an in vivo anterior cruciate ligament transection (ACLT) model of osteoarthritis in rabbits. Allogeneic bone marrow-derived MSCs were isolated and cultured under hypoxia (1% O-2). After 8 weeks following ACLT, MSCs suspended in hyaluronic acid (HA) were injected into the knees, and the contralateral knees were injected with HA alone. Additional controls consisted of a sham operation group as well as an untreated osteoarthritis group. The tissues were analyzed by macroscopic examination as well as histologic and immunohistochemical methods at 6 and 12 weeks post-transplantation. At 6 and 12 weeks, the joint surface showed less cartilage loss and surface abrasion after MSC injection as compared to the tissues receiving HA injection alone. Significantly better histological scores and cartilage content were observed with the MSC transplantation. Furthermore, engraftment of allogenic MSCs were evident in surface cartilage. Thus, injection of the allogeneic MSCs reduced the progression of osteoarthritis in vivo.	[Chiang, En-Rung; Wang, Jung-Pan; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan; [Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung] Natl Yang Ming Univ, Sch Med, Dept Surg, Taipei 112, Taiwan; [Chiang, En-Rung; Ma, Hsiao-Li; Wang, Jung-Pan; Liu, Chien-Lin; Chen, Tain-Hsiung; Hung, Shih-Chieh] Taipei Vet Gen Hosp, Orthopaed & Traumatol, Taipei 112, Taiwan; [Hung, Shih-Chieh] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Hung, Shih-Chieh] China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung 404, Taiwan; [Hung, Shih-Chieh] China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan; [Hung, Shih-Chieh] China Med Univ, Inst Clin Med, Taichung 404, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Academia Sinica - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.; Hung, SC (corresponding author), Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan.; Hung, SC (corresponding author), Taipei Vet Gen Hosp, Orthopaed & Traumatol, Taipei 112, Taiwan.; Hung, SC (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.; Hung, SC (corresponding author), China Med Univ Hosp, Integrat Stem Cell Ctr, Taichung 404, Taiwan.; Hung, SC (corresponding author), China Med Univ Hosp, Dept Orthoped, Taichung 404, Taiwan.; Hung, SC (corresponding author), China Med Univ, Inst Clin Med, Taichung 404, Taiwan.	hung3340@gmail.com			Taipei Veterans General Hospital [102DHA0100340]; National Science Council [NSC 101-2314-B-075-002]; National Yang-Ming University, Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); National Yang-Ming University, Ministry of Education	This study was supported in part by grants from Taipei Veterans General Hospital (102DHA0100340), National Science Council (NSC 101-2314-B-075-002) and National Yang-Ming University, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; ARMSTRONG S, 1994, J RHEUMATOL, V21, P680; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Deng MW, 2014, CELL TRANSPLANT; Edouard P, 2013, PHYS THER SPORT, V14, P116, DOI 10.1016/j.ptsp.2013.02.001; Eliopoulos N, 2005, BLOOD, V106, P4057, DOI 10.1182/blood-2005-03-1004; Gallagher B, 2014, AM J SPORTS MED; Huang WH, 2014, CARDIOVASC RES, V101, P266, DOI 10.1093/cvr/cvt250; Kavalkovich KW, 2002, IN VITRO CELL DEV-AN, V38, P457; Knudson CB, 2004, CLIN ORTHOP RELAT R, pS152, DOI 10.1097/01.blo.0000143804.26638.82; Lo GH, 2003, JAMA-J AM MED ASSOC, V290, P3115, DOI 10.1001/jama.290.23.3115; Maijenburg MW, 2012, STEM CELLS DEV, V21, P19, DOI 10.1089/scd.2011.0270; Maniwa S, 2001, ACTA ORTHOP SCAND, V72, P299, DOI 10.1080/00016470152846664; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; Ren GW, 2012, STEM CELL TRANSL MED, V1, P51, DOI 10.5966/sctm.2011-0019; Sato M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3735; Saw KY, 2011, ARTHROSCOPY, V27, P493, DOI 10.1016/j.arthro.2010.11.054; Shieh DB, 2005, BIOMATERIALS, V26, P7183, DOI 10.1016/j.biomaterials.2005.05.020; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Stebulis JA, 2005, J RHEUMATOL, V32, P301; ter Huurne M, 2012, ARTHRITIS RHEUM-US, V64, P3604, DOI 10.1002/art.34626; Toghraie FS, 2011, KNEE, V18, P71, DOI 10.1016/j.knee.2010.03.001; Wei CC, 2014, CELL TRANSPLANT, V23, P505, DOI 10.3727/096368914X678328; Williams JM, 1997, OSTEOARTHR CARTILAGE, V5, P235, DOI 10.1016/S1063-4584(97)80019-2; Yoshioka M, 1997, OSTEOARTHR CARTILAGE, V5, P251, DOI 10.1016/S1063-4584(97)80021-0; Yoshioka M, 1996, OSTEOARTHR CARTILAGE, V4, P87, DOI 10.1016/S1063-4584(05)80318-8	29	69	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149835	10.1371/journal.pone.0149835	http://dx.doi.org/10.1371/journal.pone.0149835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915044	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700032
J	Haroun, D; El Saleh, O; Wood, L; Mechli, R; Al Marzouqi, N; Anouti, S				Haroun, Dalia; El Saleh, Ola; Wood, Lesley; Mechli, Rola; Al Marzouqi, Nada; Anouti, Samir			Assessing Knowledge of, and Attitudes to, HIV/AIDS among University Students in the United Arab Emirates	PLOS ONE			English	Article							COLLEGE-STUDENTS; TURKISH	Background The Middle East and North Africa (MENA) region is among the top two regions in the world with the fastest growing HIV epidemic. In this context, risks and vulnerability are high as the epidemic is on the rise with evidence indicating significantly increasing HIV prevalence, new HIV infections and AIDS-related deaths. Objective The aim of the survey was to assess HIV/AIDS knowledge and attitudes related to HIV/AIDS among a wide group of university students in the United Arab Emirates (UAE). Methods In a cross-sectional survey, a total sample of 2,294 students (406 male; 1,888 female) from four universities in three different Emirates in the UAE were approached to take part in the study. Students self-completed a questionnaire that was designed to measure their knowledge and attitudes to HIV/AIDS. Results The overall average knowledge score of HIV. AIDS was 61%. Non-Emirati and postgraduates demonstrated higher levels of knowledge compared to Emirati and undergraduate students respectively. No significant differences between males and females; and marital status were found. Eighty-five percent of students expressed negative attitudes towards people living with HIV, with Emirati and single students significantly holding more negative attitudes compared to non-Emiratis and those that are married respectively. Conclusions The findings provide strong evidence that there is a need to advocate for appropriate National HIV/AIDS awareness raising campaigns in universities to reduce the gaps in knowledge and decrease stigmatizing attitudes towards people living with HIV/AIDS.	[Haroun, Dalia; El Saleh, Ola; Wood, Lesley; Anouti, Samir] UNICEF Gulf Area Off, Programs, Dubai, U Arab Emirates; [Haroun, Dalia; Mechli, Rola] Zayed Univ, Nat Sci & Publ Hlth, Dubai, U Arab Emirates; [Al Marzouqi, Nada] Minist Hlth, Prevent Med, Dubai, U Arab Emirates	Zayed University	Haroun, D (corresponding author), UNICEF Gulf Area Off, Programs, Dubai, U Arab Emirates.; Haroun, D (corresponding author), Zayed Univ, Nat Sci & Publ Hlth, Dubai, U Arab Emirates.	Dalia.haroun@zu.ac.ae			UNICEF Regional and Gulf Area office	UNICEF Regional and Gulf Area office	The study was funded by UNICEF Regional and Gulf Area office and was carried out in partnership with UAE Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jabri AA, 2003, SAUDI MED J, V24, P273; Badahdah A. M., 2010, Eastern Mediterranean Health Journal, V16, P901; Badahdah AM, 2010, J TRANSCULT NURS, V21, P386, DOI 10.1177/1043659609360873; Barss P, 2009, JAIDS-J ACQ IMM DEF, V52, P86, DOI 10.1097/QAI.0b013e31819c153f; Bektas HA, 2007, AIDS CARE, V19, P888, DOI 10.1080/09540120701203352; Bhatta D N, 2013, Kathmandu Univ Med J (KUMJ), V11, P158; Ellepola ANB, 2011, EUR J DENT EDUC, V15, P165, DOI 10.1111/j.1600-0579.2010.00652.x; Ganczak M, 2007, J ADOLESCENT HEALTH, V40, pCOVER1, DOI 10.1016/j.jadohealth.2007.01.011; Ibrahim N, 2012, PREV MED, V55, P505, DOI 10.1016/j.ypmed.2012.09.003; Kocken P, 2001, EUR J PUBLIC HEALTH, V11, P153, DOI 10.1093/eurpub/11.2.153; Premadasa G, 2015, J INVESTIG CLIN DENT, V6, P147, DOI 10.1111/jicd.12080; Tavoosi A, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-17; Thato R, 2013, J PEDIATR ADOL GYNEC, V26, P58, DOI 10.1016/j.jpag.2012.09.011; Turhan O, 2010, INT J OCCUP MED ENV, V23, P153, DOI 10.2478/v10001-010-0008-5; UNAIDS, 2014, 2014 FACT SHEETS; UNICEF, 2011, MULT IND CLUST COUNT; UNICEF, 2014, 2014 STAT UPD CHILDR	17	42	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149920	10.1371/journal.pone.0149920	http://dx.doi.org/10.1371/journal.pone.0149920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26913902	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700036
J	Kavet, R; Wyman, MT; Klimley, AP				Kavet, Robert; Wyman, Megan T.; Klimley, A. Peter			Modeling Magnetic Fields from a DC Power Cable Buried Beneath San Francisco Bay Based on Empirical Measurements	PLOS ONE			English	Article							SALMON ONCORHYNCHUS-TSHAWYTSCHA; GREEN STURGEON; MOVEMENTS; ORIENTATION; SMOLTS	The Trans Bay Cable (TBC) is a +/- 200-kilovolt (kV), 400 MW 85-km long High Voltage Direct Current (DC) buried transmission line linking Pittsburg, CA with San Francisco, CA (SF) beneath the San Francisco Estuary. The TBC runs parallel to the migratory route of various marine species, including green sturgeon, Chinook salmon, and steelhead trout. In July and August 2014, an extensive series of magnetic field measurements were taken using a pair of submerged Geometrics magnetometers towed behind a survey vessel in four locations in the San Francisco estuary along profiles that cross the cable's path; these included the San Francisco-Oakland Bay Bridge (BB), the Richmond-San Rafael Bridge (RSR), the Benicia-Martinez Bridge (Ben) and an area in San Pablo Bay (SP) in which a bridge is not present. In this paper, we apply basic formulas that ideally describe the magnetic field from a DC cable summed vectorially with the background geomagnetic field (in the absence of other sources that would perturb the ambient field) to derive characteristics of the cable that are otherwise not immediately observable. Magnetic field profiles from measurements taken along 170 survey lines were inspected visually for evidence of a distinct pattern representing the presence of the cable. Many profiles were dominated by field distortions unrelated to the cable caused by bridge structures or other submerged objects, and the cable's contribution to the field was not detectable. BB, with 40 of the survey lines, did not yield usable data for these reasons. The unrelated anomalies could be up to 100 times greater than those from the cable. In total, discernible magnetic field profiles measured from 76 survey lines were regressed against the equations, representing eight days of measurement. The modeled field anomalies due to the cable (the difference between the maximum and minimum field along the survey line at the cable crossing) were virtually identical to the measured values. The modeling yielded a pooled cable depth below the bay floor of 2.06 m (+/- 1.46 std dev), and estimated the angle to the horizontal of the imaginary line connecting the cross-sectional center of the cable's two conductors (0.1143 m apart) as 178.9 degrees +/- 61.9 degrees (std dev) for Ben, 78.6 degrees +/- 37.0 degrees (std dev) for RSR, and 139.9 degrees +/- 27.4 degrees (std dev) for SP. The mean of the eight daily average currents derived from the regressions was 986 +/- 185 amperes (A) (std dev), as compared to 722 +/- 95 A (std dev) provided by Trans Bay Cable LLC. Overall, the regressions based on fundamental principles (Biot Savart law) and the vectorial summation of cable and geomagnetic fields provide estimates of cable characteristics consistent with plausible expectations.	[Kavet, Robert] Elect Power Res Inst, Environm Sector, Palo Alto, CA USA; [Wyman, Megan T.; Klimley, A. Peter] Univ Calif Davis, Biotelemetry Lab, Dept Fish Wildlife & Conservat Biol, Davis, CA 95616 USA	Electric Power Research Institute (EPRI); University of California System; University of California Davis	Kavet, R (corresponding author), Elect Power Res Inst, Environm Sector, Palo Alto, CA USA.	rkavet@epri.com			United States Department of Energy [DE-EE0006382]; Electric Power Research Institute; DOE, EPRI Project [1-105902]; U.S. Department of Energy [DE-EE0006382]; Electric Power Research Institute [1-105902]	United States Department of Energy(United States Department of Energy (DOE)); Electric Power Research Institute; DOE, EPRI Project; U.S. Department of Energy(United States Department of Energy (DOE)); Electric Power Research Institute	MTW, PK: United States Department of Energy DE-EE0006382; http://www.energy.gov/. RK: Electric Power Research Institute, costshare agreement with DOE, EPRI Project 1-105902 www.epri.com.; We would like to kindly thank Trans Bay Cable LLC for providing cable load data for our study. We also thank the boat operators and crew who helped conduct the magnetometer survey (Ryan Battleson, Tommy Agosta, Eric Chapman, Matt Pagel, Mike Thomas, Gabe Singer, and Jamilynn Poletto) and the staff at Geometrics for their training and support (especially Mikhail Tchernychev, Ross Johnson, Randl Rivera, and Naiema Jackson). This work was supported under award DE-EE0006382 from the U.S. Department of Energy with a cost share agreement with the Electric Power Research Institute (Project 1-105902).	[Anonymous], J ICHTHYOLOGY; Cada GF, 2012, ORNLTM2012119; Chapman ED, 2013, ENVIRON BIOL FISH, V96, P273, DOI 10.1007/s10641-012-0001-x; Gill AB, 2005, J APPL ECOL, V42, P605, DOI 10.1111/j.1365-2664.2005.01060.x; Haugh CV, 1998, J NAVIGATION, V51, P35, DOI 10.1017/S0373463397007595; Hearn AR, 2014, ENVIRON BIOL FISH, V97, P851, DOI 10.1007/s10641-013-0184-9; Heublein JC, 2009, ENVIRON BIOL FISH, V84, P245, DOI 10.1007/s10641-008-9432-9; Michel CJ, 2013, ENVIRON BIOL FISH, V96, P257, DOI 10.1007/s10641-012-9990-8; QUINN TP, 1982, J COMP PHYSIOL, V147, P547, DOI 10.1007/BF00612020; QUINN TP, 1983, CAN J FISH AQUAT SCI, V40, P1598, DOI 10.1139/f83-185; Singer GP, 2013, ENVIRON BIOL FISH, V96, P363, DOI 10.1007/s10641-012-0037-y; TAYLOR PB, 1986, J FISH BIOL, V28, P607, DOI 10.1111/j.1095-8649.1986.tb05196.x; TEETER JH, 1980, J COMP PHYSIOL, V138, P213, DOI 10.1007/BF00657039; Teo SLH, 2013, ENVIRON BIOL FISH, V96, P175, DOI 10.1007/s10641-011-9938-4; Thomas MJ, 2013, N AM J FISH MANAGE, V33, P287, DOI 10.1080/02755947.2012.758201	15	15	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148543	10.1371/journal.pone.0148543	http://dx.doi.org/10.1371/journal.pone.0148543			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915084	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700007
J	Mueller, S; Carlsohn, A; Mueller, J; Baur, H; Mayer, F				Mueller, Steffen; Carlsohn, Anja; Mueller, Juliane; Baur, Heiner; Mayer, Frank			Influence of Obesity on Foot Loading Characteristics in Gait for Children Aged 1 to 12 Years	PLOS ONE			English	Article							PLANTAR PRESSURE DISTRIBUTION; BODY-MASS INDEX; CHILDHOOD OBESITY; SPEED; OVERWEIGHT; WALKING; FORCES; ADOLESCENTS; PREVALENCE; FOOTPRINTS	Background Overweight and obesity are increasing health problems that are not restricted to adults only. Childhood obesity is associated with metabolic, psychological and musculoskeletal comorbidities. However, knowledge about the effect of obesity on the foot function across maturation is lacking. Decreased foot function with disproportional loading characteristics is expected for obese children. The aim of this study was to examine foot loading characteristics during gait of normal-weight, overweight and obese children aged 1-12 years. Methods A total of 10382 children aged one to twelve years were enrolled in the study. Finally, 7575 children (m/f: n = 3630/3945; 7.0 +/- 2.9yr; 1.23 +/- 0.19m; 26.6 +/- 10.6kg; BMI: 17.1 +/- 2.4kg/m(2)) were included for (complete case) data analysis. Children were categorized to normalweight (>= 3rd and <90th percentile; n = 6458), overweight (>= 90rd and <97th percentile; n = 746) or obese (>97th percentile; n = 371) according to the German reference system that is based on age and gender-specific body mass indices (BMI). Plantar pressure measurements were assessed during gait on an instrumented walkway. Contact area, arch index (AI), peak pressure (PP) and force time integral (FTI) were calculated for the total, fore-, mid-and hindfoot. Data was analyzed descriptively (mean +/- SD) followed by ANOVA/Welch-test (according to homogeneity of variances: yes/no) for group differences according to BMI categorization (normal-weight, overweight, obesity) and for each age group 1 to 12yrs (post-hoc Tukey Kramer/Dunnett's C; alpha = 0.05). Results Mean walking velocity was 0.95 +/- 0.25 m/s with no differences between normal-weight, overweight or obese children (p = 0.0841). Results show higher foot contact area, arch index, peak pressure and force time integral in overweight and obese children (p< 0.001). Obese children showed the 1.48-fold (1 year-old) to 3.49-fold (10 year-old) midfoot loading (FTI) compared to normal-weight. Conclusion Additional body mass leads to higher overall load, with disproportional impact on the midfoot area and longitudinal foot arch showing characteristic foot loading patterns. Already the feet of one and two year old children are significantly affected. Childhood overweight and obesity is not compensated by the musculoskeletal system. To avoid excessive foot loading with potential risk of discomfort or pain in childhood, prevention strategies should be developed and validated for children with a high body mass index and functional changes in the midfoot area. The presented plantar pressure values could additionally serve as reference data to identify suspicious foot loading patterns in children.	[Mueller, Steffen; Mueller, Juliane; Mayer, Frank] Univ Potsdam, Univ Outpatient Clin, Sports Med & Sports Orthopaed, Potsdam, Germany; [Carlsohn, Anja] Univ Educ Schwabisch Gmund, Inst Hlth Sci, Schwabisch Gmund, Germany; [Baur, Heiner] Bern Univ Appl Sci, Hlth, Physiotherapy, Bern, Switzerland	University of Potsdam	Mueller, S (corresponding author), Univ Potsdam, Univ Outpatient Clin, Sports Med & Sports Orthopaed, Potsdam, Germany.	stefmue@uni-potsdam.de	Baur, Heiner/A-8673-2017; Müller, Juliane/P-2457-2019; Baur, Heiner/M-9995-2019	Baur, Heiner/0000-0002-4780-225X; Müller, Juliane/0000-0002-4184-5427; 	Federation of the German Footwear Industry (HDS, Offenbach, Germany); RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany); University of Potsdam (Potsdam, Germany); Deutsche Forschungsgemeinschaft; University of Potsdam	Federation of the German Footwear Industry (HDS, Offenbach, Germany); RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany); University of Potsdam (Potsdam, Germany); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Potsdam	This study was supported by the Federation of the German Footwear Industry (HDS, Offenbach, Germany; URL: www.hdsl.eu/Home-en), the RICOSTA Schuhfabriken GmbH (Donaueschingen, Germany; URL: www.ricosta.de/en.html) and the University of Potsdam (Potsdam, Germany; URL: www.uni-potsdam.de/en/index.html). The funding was received by Prof. Frank Mayer as the head of the University Outpatient Clinic Potsdam. We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Browning RC, 2007, MED SCI SPORT EXER, V39, P1632, DOI 10.1249/mss.0b013e318076b54b; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; CAVANAGH PR, 1980, J BIOMECH, V13, P397, DOI 10.1016/0021-9290(80)90033-0; CAVANAGH PR, 1987, FOOT ANKLE, V7, P262, DOI 10.1177/107110078700700502; Cousins SD, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-36; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Dowling AM, 2004, INT J OBESITY, V28, P1514, DOI 10.1038/sj.ijo.0802729; DUFEK JS, 1990, MED SCI SPORT EXER, V22, P370; Echarri JJ, 2003, J PEDIATR ORTHOP B, V12, P141, DOI 10.1097/00009957-200303000-00012; Filippin NT, 2007, REV BRAS FISIOTER, V11, P495, DOI 10.1590/S1413-35552007000600012; Filippin NT, 2008, FOOT ANKLE INT, V29, P1141, DOI 10.3113/FAI.2008.1141; Frey C, 2007, FOOT ANKLE INT, V28, P996, DOI 10.3113/FAI.2007.0996; Glasser N, 2011, EUR J CLIN NUTR, V65, P151, DOI 10.1038/ejcn.2010.245; Gross KD, 2011, ARTHRIT CARE RES, V63, P937, DOI 10.1002/acr.20431; Gurney JK, 2008, GAIT POSTURE, V27, P706, DOI 10.1016/j.gaitpost.2007.07.002; Hills AP, 2001, INT J OBESITY, V25, P1674, DOI 10.1038/sj.ijo.0801785; HRELJAC A, 1995, J BIOMECH, V28, P669, DOI 10.1016/0021-9290(94)00120-S; Jacob HAC, 2001, CLIN BIOMECH, V16, P783, DOI 10.1016/S0268-0033(01)00070-5; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Li L, 1999, HUM MOVEMENT SCI, V18, P67, DOI 10.1016/S0167-9457(98)00034-7; Mauch M, 2008, INT J OBESITY, V32, P1068, DOI 10.1038/ijo.2008.52; Michelson JD, 2002, FOOT ANKLE INT, V23, P629, DOI 10.1177/107110070202300708; Mickle KJ, 2006, INT J PEDIATR OBES, V1, P183, DOI 10.1080/17477160600881734; Mickle KJ, 2015, GAIT POSTURE, V42, P442, DOI 10.1016/j.gaitpost.2015.07.013; Muller J, 2013, GAIT POSTURE, V38, P631, DOI 10.1016/j.gaitpost.2013.02.011; Muller S, 2012, GAIT POSTURE, V35, P389, DOI 10.1016/j.gaitpost.2011.10.357; Pfeiffer M, 2006, PEDIATRICS, V118, P634, DOI 10.1542/peds.2005-2126; Phethean J, 2012, GAIT POSTURE, V36, P287, DOI 10.1016/j.gaitpost.2012.03.012; Pulgaron ER, 2013, CLIN THER, V35, pA18, DOI 10.1016/j.clinthera.2012.12.014; Razeghi M, 2002, GAIT POSTURE, V15, P282, DOI 10.1016/S0966-6362(01)00151-5; Riddiford-Harland DL, 2015, MED SCI SPORT EXER, V47, P357, DOI 10.1249/MSS.0000000000000403; Riddiford-Harland DL, 2000, INT J OBESITY, V24, P541, DOI 10.1038/sj.ijo.0801192; Tudor A, 2009, PEDIATRICS, V123, pe386, DOI 10.1542/peds.2008-2262; Villarroya MA, 2009, EUR J PEDIATR, V168, P559, DOI 10.1007/s00431-008-0789-8; Wearing SC, 2006, OBES REV, V7, P209, DOI 10.1111/j.1467-789X.2006.00216.x; Yan SH, 2013, GAIT POSTURE, V37, P37, DOI 10.1016/j.gaitpost.2012.05.018	37	27	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149924	10.1371/journal.pone.0149924	http://dx.doi.org/10.1371/journal.pone.0149924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914211	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700038
J	Antoniou, M; Jorgensen, AL; Kolamunnage-Dona, R				Antoniou, Miranta; Jorgensen, Andrea L.; Kolamunnage-Dona, Ruwanthi			Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review	PLOS ONE			English	Article							CLINICAL-TRIALS; PREDICTIVE BIOMARKERS; STATISTICAL CONSIDERATIONS; BONFERRONI PROCEDURE; ENRICHMENT DESIGNS; TARGETED THERAPY; DRUG DEVELOPMENT; NEXT-GENERATION; 2-STAGE DESIGNS; MULTIPLE TESTS	Background Personalized medicine is a growing area of research which aims to tailor the treatment given to a patient according to one or more personal characteristics. These characteristics can be demographic such as age or gender, or biological such as a genetic or other biomarker. Prior to utilizing a patient's biomarker information in clinical practice, robust testing in terms of analytical validity, clinical validity and clinical utility is necessary. A number of clinical trial designs have been proposed for testing a biomarker's clinical utility, including Phase II and Phase III clinical trials which aim to test the effectiveness of a biomarker-guided approach to treatment; these designs can be broadly classified into adaptive and non-adaptive. While adaptive designs allow planned modifications based on accumulating information during a trial, non-adaptive designs are typically simpler but less flexible. Methods and Findings We have undertaken a comprehensive review of biomarker-guided adaptive trial designs proposed in the past decade. We have identified eight distinct biomarker-guided adaptive designs and nine variations from 107 studies. Substantial variability has been observed in terms of how trial designs are described and particularly in the terminology used by different authors. We have graphically displayed the current biomarker-guided adaptive trial designs and summarised the characteristics of each design. Conclusions Our in-depth overview provides future researchers with clarity in definition, methodology and terminology for biomarker-guided adaptive trial designs.	[Antoniou, Miranta; Jorgensen, Andrea L.; Kolamunnage-Dona, Ruwanthi] MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England; [Antoniou, Miranta; Jorgensen, Andrea L.; Kolamunnage-Dona, Ruwanthi] Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool L69 3GL, Merseyside, England	University of Liverpool	Antoniou, M (corresponding author), MRC North West Hub Trials Methodol Res, Liverpool, Merseyside, England.; Antoniou, M (corresponding author), Univ Liverpool, Inst Translat Med, Dept Biostat, Liverpool L69 3GL, Merseyside, England.	Miranta.Antoniou@liverpool.ac.uk	Kolamunnage-Dona, Ruwanthi/W-7979-2019	Kolamunnage-Dona, Ruwanthi/0000-0003-3886-6208; Antoniou, Miranta/0000-0002-0173-1257	MRC [MR/L004933/1, MR/L004933/2, MR/K025635/1] Funding Source: UKRI; Medical Research Council [MR/L004933/1, MR/L004933/2, MR/K025635/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alexander BM, 2013, NEURO-ONCOLOGY, V15, P972, DOI 10.1093/neuonc/not088; An MW, 2012, CLIN CANCER RES, V18, P4225, DOI 10.1158/1078-0432.CCR-12-0686; Ananthakrishnan R, 2013, CRIT REV ONCOL HEMAT, V88, P144, DOI 10.1016/j.critrevonc.2013.03.007; Andre F, 2010, STUDY CTKI258A2202 M; Ang MK, 2010, EXPERT REV ANTICANC, V10, P427, DOI 10.1586/ERA.09.178; Baker SG, 2012, DISCOV MED, V13, P187; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barthel FMS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-21; Barthel FMS, 2009, STATA J, V9, P505, DOI 10.1177/1536867X0900900401; Beckman RA, 2011, NAT REV DRUG DISCOV, V10, P735, DOI 10.1038/nrd3550; Berry DA, 2006, NAT REV DRUG DISCOV, V5, P27, DOI 10.1038/nrd1927; Berry DA, 2012, NAT REV CLIN ONCOL, V9, P199, DOI 10.1038/nrclinonc.2011.165; Berry DA, 2012, CLIN CANCER RES, V18, P638, DOI 10.1158/1078-0432.CCR-11-2018; Bradley E, 2012, NAT BIOTECHNOL, V30, P596, DOI 10.1038/nbt.2296; Brannath W, 2007, PHARM STAT, V6, P205, DOI 10.1002/pst.302; Brannath W, 2009, STAT MED, V28, P1445, DOI 10.1002/sim.3559; Buyse M, 2007, EJC SUPPL, V5, P89, DOI 10.1016/S1359-6349(07)70028-9; Buyse M, 2013, CURR OPIN ONCOL, V25, P289, DOI 10.1097/CCO.0b013e32835ff2fe; Buyse M, 2011, EXPERT REV MOL DIAGN, V11, P171, DOI [10.1586/erm.10.120, 10.1586/ERM.10.120]; Buyse M, 2010, NAT REV CLIN ONCOL, V7, P309, DOI 10.1038/nrclinonc.2010.43; Chabner Bruce, 2008, Clin Adv Hematol Oncol, V6, P42; Chen JJ, 2014, TRANSL CANCER RES, V3, P279, DOI 10.3978/j.issn.2218-676X.2014.05.04; Chow SC, 2005, J BIOPHARM STAT, V15, P575, DOI 10.1081/BIP-200062277; Chow SC, 2012, CH CRC BIOSTAT SER, P1; Chow SC, 2007, J BIOPHARM STAT, V17, P1163, DOI 10.1080/10543400701645249; Chow SC, 2014, ANNU REV MED, V65, P405, DOI 10.1146/annurev-med-092012-112310; Chow SC, 2008, J FORMOS MED ASSOC, V107, pS52, DOI 10.1016/S0929-6646(09)60009-7; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Coffey CS, 2008, DRUGS R&D, V9, P229, DOI 10.2165/00126839-200809040-00003; Copeland LJ, 2003, GYNECOL ONCOL, V90, pS1, DOI 10.1016/S0090-8258(03)00337-8; Coyle VM, 2010, NAT REV CLIN ONCOL, V7, P90, DOI 10.1038/nrclinonc.2009.214; Daniel J. S., 2011, ADV PERSONALIZED CAN, P30, DOI [DOI 10.2217/EBO.11.87, 10.2217/ebo.11.87]; DeMets DL, 2012, STAT MED, V31, P2944, DOI 10.1002/sim.5405; Di Maio M, 2010, LUNG CANCER, V67, P127, DOI 10.1016/j.lungcan.2009.10.001; Dimairo M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0958-9; Dragalin V, 2011, EUR NEUROPSYCHOPHARM, V21, P153, DOI 10.1016/j.euroneuro.2010.09.004; Eickhoff JC, 2010, CLIN TRIALS, V7, P546, DOI 10.1177/1740774510372657; ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147; Emerson SC, 2011, STAT MED, V30, P1199, DOI 10.1002/sim.4156; Emerson SS, 2010, J BIOPHARM STAT, V20, P1150, DOI 10.1080/10543406.2010.514457; European Medicines Agency, 2011, REFLECTION PAPER ON; Ferraldeschi R, 2013, CLIN CHEM, V59, P75, DOI 10.1373/clinchem.2012.185157; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; Fraser GAM, 2007, BIOMARK MED, V1, P387, DOI 10.2217/17520363.1.3.387; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Freidlin B, 2014, NAT REV CLIN ONCOL, V11, P81, DOI 10.1038/nrclinonc.2013.218; Freidlin B, 2014, CLIN TRIALS, V11, P19, DOI 10.1177/1740774513503739; Freidlin B, 2013, J CLIN ONCOL, V31, P3158, DOI 10.1200/JCO.2012.48.3826; Freidlin B, 2012, J CLIN ONCOL, V30, P3304, DOI 10.1200/JCO.2012.43.3946; Freidlin B, 2010, PHARMACOGENOMICS, V11, P1679, DOI 10.2217/PGS.10.153; Freidlin B, 2010, CLIN CANCER RES, V16, P691, DOI 10.1158/1078-0432.CCR-09-1357; Galanis E, 2011, CURR ONCOL REP, V13, P42, DOI 10.1007/s11912-010-0144-x; Gallo P, 2006, J BIOPHARM STAT, V16, P275, DOI 10.1080/10543400600614742; George SL, 2008, CLIN CANCER RES, V14, P5954, DOI 10.1158/1078-0432.CCR-07-4537; Gold KA, 2011, CANCER PREV RES, V4, P962, DOI 10.1158/1940-6207.CAPR-11-0232; Gosho M, 2012, SENSORS-BASEL, V12, P8966, DOI 10.3390/s120708966; Heckman-Stoddard Brandy M, 2014, Semin Oncol Nurs, V30, P109, DOI 10.1016/j.soncn.2014.03.004; Ho TW, 2012, CEPHALALGIA, V32, P750, DOI 10.1177/0333102412451358; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hoering A, 2008, CLIN CANCER RES, V14, P4358, DOI 10.1158/1078-0432.CCR-08-0288; Hung HMJ, 2007, J BIOPHARM STAT, V17, P1201, DOI 10.1080/10543400701645405; Inoue LYT, 2002, BIOMETRICS, V58, P823, DOI 10.1111/j.0006-341X.2002.00823.x; Jennison C, 2007, J BIOPHARM STAT, V17, P1135, DOI 10.1080/10543400701645215; Jiang W, 2007, J NATL CANCER I, V99, P1036, DOI 10.1093/jnci/djm022; Jones CL, 2007, CONTEMP CLIN TRIALS, V28, P654, DOI 10.1016/j.cct.2007.02.008; Kairalla JA, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-145; Kaplan R, 2013, J CLIN ONCOL, V31, P4562, DOI 10.1200/JCO.2013.50.7905; Karuri SW, 2012, STAT MED, V31, P901, DOI 10.1002/sim.4462; Kelloff GJ, 2012, NAT REV DRUG DISCOV, V11, P201, DOI 10.1038/nrd3651; Korn EL, 2011, J CLIN ONCOL, V29, P771, DOI 10.1200/JCO.2010.31.1423; Lai TL, 2013, CONTEMP CLIN TRIALS, V36, P651, DOI 10.1016/j.cct.2013.08.007; Lai TL, 2012, CLIN TRIALS, V9, P141, DOI 10.1177/1740774512437252; Lee CK, 2009, MED J AUSTRALIA, V190, P631, DOI 10.5694/j.1326-5377.2009.tb02592.x; Lee JJ, 2012, STAT MED, V31, P2955, DOI 10.1002/sim.5404; Lee JJ, 2010, CLIN TRIALS, V7, P584, DOI 10.1177/1740774510373120; Lin JA, 2015, BRIT MED BULL, V114, P17, DOI 10.1093/bmb/ldv011; Liu AY, 2010, CLIN TRIALS, V7, P537, DOI 10.1177/1740774510378695; London WB, 2005, STAT MED, V24, P2597, DOI 10.1002/sim.2139; Magirr D, 2012, BIOMETRIKA, V99, P494, DOI 10.1093/biomet/ass002; Mahajan R, 2010, INDIAN J PHARMACOL, V42, P201, DOI 10.4103/0253-7613.68417; Maharaj R, 2011, CONTEMP CLIN TRIALS, V32, P924, DOI 10.1016/j.cct.2011.07.010; Mandrekar SJ, 2013, CONTEMP CLIN TRIALS, V36, P597, DOI 10.1016/j.cct.2013.05.001; Mandrekar Sumithra J, 2011, Clin Investig (Lond), V1, P1629; Mandrekar SJ, 2010, CLIN TRIALS, V7, P567, DOI 10.1177/1740774510368574; Mandrekar SJ, 2009, J CLIN ONCOL, V27, P4027, DOI 10.1200/JCO.2009.22.3701; Mandrekar SJ, 2009, J BIOPHARM STAT, V19, P530, DOI 10.1080/10543400902802458; Matsui S, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/865980; McShane LM, 2009, CLIN CANCER RES, V15, P1898, DOI 10.1158/1078-0432.CCR-08-2033; Medical Research Council, 2007, RAND PLAC CONTR TRIA; Mehta C, 2014, STAT MED, V33, P4515, DOI 10.1002/sim.6272; Moye LA, 2001, CONTROL CLIN TRIALS, V22, P605, DOI 10.1016/S0197-2456(01)00180-5; Nallapareddy S., 2010, PHASE 2 TRIAL SARACA; National Cancer Institute, 2008, PHAS 2 TRIAL AZD0530; Novartis Pharmaceuticals, 2009, MULT OP LAB PHAS 2 T; Orloff JJ, 2011, ANN I SUPER SANITA, V47, P8, DOI 10.4415/ANN_11_01_03; Parmar MKB, 2008, JNCI-J NATL CANCER I, V100, P1204, DOI 10.1093/jnci/djn267; Pihlstrom BL, 2010, J DENT RES, V89, P759, DOI 10.1177/0022034510374737; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1677, DOI 10.1093/jnci/djt282; Pusztai L, 2007, CLIN CANCER RES, V13, P6080, DOI 10.1158/1078-0432.CCR-07-0809; QuantumLeap Healthcare Collaborative, 2009, I SPY 2 TRIAL INV SE; Rigatto Claudio, 2009, V473, P137, DOI 10.1007/978-1-59745-385-1_8; Royston P, 2003, STAT MED, V22, P2239, DOI 10.1002/sim.1430; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Sato Y, 2010, CURR PHARM DESIGN, V16, P2232, DOI 10.2174/138161210791792886; Scher HI, 2011, CLIN CANCER RES, V17, P6634, DOI 10.1158/1078-0432.CCR-11-1105; Shi Q, 2012, SCAND J GASTROENTERO, V47, P356, DOI 10.3109/00365521.2012.640836; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Simon N, 2013, BIOSTATISTICS, V14, P613, DOI 10.1093/biostatistics/kxt010; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; SIMON R, 2001, CANC PRINCIPLES PRAC, P521; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Simon R, 2008, J STAT PLAN INFER, V138, P308, DOI 10.1016/j.jspi.2007.06.010; Simon R, 2014, CHIN CLIN ONCOL, V3, DOI 10.3978/j.issn.2304-3865.2014.02.03; Simon R, 2013, PERS MED, V10, P485, DOI 10.2217/pme.13.36; Simon R, 2012, STAT MED, V31, P3031, DOI 10.1002/sim.5401; Simon R, 2009, CURR BREAST CANCER R, V1, P216, DOI 10.1007/s12609-009-0030-4; Simon R, 2010, CLIN TRIALS, V7, P516, DOI 10.1177/1740774510366454; Simon R, 2010, PERS MED, V7, P33, DOI 10.2217/PME.09.49; Simon Richard, 2008, Expert Opin Med Diagn, V2, P721, DOI 10.1517/17530059.2.6.721; Smith CT, 2014, BEST PRACT RES CL RH, V28, P247, DOI 10.1016/j.berh.2014.03.004; Sydes MR, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-39; Tajik P, 2013, CLIN CANCER RES, V19, P4578, DOI 10.1158/1078-0432.CCR-12-3722; THALL PF, 1994, CONTROL CLIN TRIALS, V15, P463, DOI 10.1016/0197-2456(94)90004-3; Tournoux-Facon C, 2011, STAT MED, V30, P801, DOI 10.1002/sim.4148; U. S. Food and Drug Administration, 2010, GUID IND AD IN PRESS; Van Schaeybroeck S, 2011, NAT REV CLIN ONCOL, V8, P222, DOI 10.1038/nrclinonc.2011.15; Vandemeulebroecke M, 2008, BIOMETRICAL J, V50, P541, DOI 10.1002/bimj.200710436; Wang S-J, 2008, J FORMOS MED ASSOC, V107, pS18; Wang SJ, 2007, PHARM STAT, V6, P283, DOI 10.1002/pst.316; Wang SJ, 2007, PHARM STAT, V6, P227, DOI 10.1002/pst.300; Wang SJ, 2011, EUR NEUROPSYCHOPHARM, V21, P159, DOI 10.1016/j.euroneuro.2010.09.003; Wang SJ, 2009, BIOMETRICAL J, V51, P358, DOI 10.1002/bimj.200900003; Wang SJ, 2008, J FORMOS MED ASSOC, V107, pS19, DOI 10.1016/S0929-6646(09)60005-X; Wason J, 2014, BRIT J CANCER, V110, P1950, DOI 10.1038/bjc.2014.156; Wason JMS, 2014, STAT MED, V33, P2206, DOI 10.1002/sim.6086; Wason JMS, 2012, STAT MED, V31, P4269, DOI 10.1002/sim.5513; Wason JMS, 2015, BRIT J CANC; Wu WT, 2011, SEMIN ONCOL, V38, P598, DOI 10.1053/j.seminoncol.2011.05.014; Younes A, 2012, NAT REV CLIN ONCOL, V9, P643, DOI 10.1038/nrclinonc.2012.156; Young KY, 2010, CLIN TRIALS, V7, P557, DOI 10.1177/1740774510370497; Zhou X, 2008, CLIN TRIALS, V5, P181, DOI 10.1177/1740774508091815	142	64	65	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149803	10.1371/journal.pone.0149803	http://dx.doi.org/10.1371/journal.pone.0149803			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910238	Green Published, gold			2022-12-27	WOS:000371164700050
J	Gleize, Y; Mendisco, F; Pemonge, MH; Hubert, C; Groppi, A; Houix, B; Deguilloux, MF; Breuil, JY				Gleize, Yves; Mendisco, Fanny; Pemonge, Marie-Helene; Hubert, Christophe; Groppi, Alexis; Houix, Bertrand; Deguilloux, Marie-France; Breuil, Jean-Yves			Early Medieval Muslim Graves in France: First Archaeological, Anthropological and Palaeogenomic Evidence	PLOS ONE			English	Article								The rapid Arab-Islamic conquest during the early Middle Ages led to major political and cultural changes in the Mediterranean world. Although the early medieval Muslim presence in the Iberian Peninsula is now well documented, based in the evaluation of archeological and historical sources, the Muslim expansion in the area north of the Pyrenees has only been documented so far through textual sources or rare archaeological data. Our study provides the first archaeo-anthropological testimony of the Muslim establishment in South of France through the multidisciplinary analysis of three graves excavated at Nimes. First, we argue in favor of burials that followed Islamic rites and then note the presence of a community practicing Muslim traditions in Nimes. Second, the radiometric dates obtained from all three human skeletons (between the 7th and the 9th centuries AD) echo historical sources documenting an early Muslim presence in southern Gaul (i.e., the first half of 8th century AD). Finally, palaeogenomic analyses conducted on the human remains provide arguments in favor of a North African ancestry of the three individuals, at least considering the paternal lineages. Given all of these data, we propose that the skeletons from the Nimes burials belonged to Berbers integrated into the Umayyad army during the Arab expansion in North Africa. Our discovery not only discusses the first anthropological and genetic data concerning the Muslim occupation of the Visigothic territory of Septimania but also highlights the complexity of the relationship between the two communities during this period.	[Gleize, Yves] French Natl Inst Prevent Archaeol Res INRAP, Bron, France; [Gleize, Yves; Mendisco, Fanny; Pemonge, Marie-Helene; Deguilloux, Marie-France] Univ Bordeaux, UMR PACEA 5199, Equipe Anthropol Populat Passees & Presentes, Allee Geoffroy ST Hilaire, Pessac, France; [Hubert, Christophe] Univ Bordeaux, Plateforme Genome Transcriptome, Ctr Genom Fonct Bordeaux, Bordeaux, France; [Groppi, Alexis] Univ Bordeaux, Bordeaux Bioinformat Ctr CBiB, Bordeaux, France; [Houix, Bertrand; Breuil, Jean-Yves] French Natl Inst Prevent Archaeol Res INRAP, Nimes, France; [Houix, Bertrand; Breuil, Jean-Yves] Archeol Soc Mediterraneennes, UMR 5140, Lattes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Gleize, Y (corresponding author), French Natl Inst Prevent Archaeol Res INRAP, Bron, France.; Gleize, Y; Mendisco, F (corresponding author), Univ Bordeaux, UMR PACEA 5199, Equipe Anthropol Populat Passees & Presentes, Allee Geoffroy ST Hilaire, Pessac, France.	yves.gleize@inrap.fr; fanny.mendisco@gmail.com		Gleize, Yves/0000-0003-4270-2388; Groppi, Alexis/0000-0002-3341-8281	city of Nimes, France (INRAP) [FB11045601]; CNRS (Centre National de la Recherche Scientifique; PEPS APEGE); Research National Agency [ANR-10-LABX-52]	city of Nimes, France (INRAP); CNRS (Centre National de la Recherche Scientifique; PEPS APEGE); Research National Agency	This study benefitted from excavation grant support from the city of Nimes, France (INRAP; FB11045601). The paleogenomic analyses were made possible by funding from the CNRS (Centre National de la Recherche Scientifique; PEPS APEGE) and from the Research National Agency as a program of prospects investments ANR-10-LABX-52 (CAP project; dir. MFD; University of Bordeaux, LaScArBx-ANR; 2012-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez L, 2009, AM J HUM BIOL, V21, P407, DOI 10.1002/ajhb.20888; [Anonymous], 1862, AL JAMIU S SAHIH, V3; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Bagnera A., 2004, MEFRM, V116, P231; BELLO FIERRO, 2000, LURBANISME LOCCIDENT, P153; Bouiron M, 2001, LACYDON FAUBOURG SAI; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; Burnett SE, 2011, CLIN ANAT, V24, P188, DOI 10.1002/ca.21086; Capelli C, 2009, EUR J HUM GENET, V17, P848, DOI 10.1038/ejhg.2008.258; Cardini Franco., 2001, EUROPE AND ISLAM; Casas MJ, 2006, AM J PHYS ANTHROPOL, V131, P539, DOI 10.1002/ajpa.20463; Chavet M., 2006, MURICA, V22, P149; Clement F, 2006, HIST ISLAM MUSULMANS, P16; Cleuvenot Emmanuel, 1993, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V5, P245, DOI 10.3406/bmsap.1993.2354; COCKSHOT.WP, 1969, J BONE JOINT SURG AM, VA 51, P778, DOI 10.2106/00004623-196951040-00019; Collins Roger, 1989, ARAB CONQUEST SPAIN; Di Gaetano C, 2009, EUR J HUM GENET, V17, P91, DOI 10.1038/ejhg.2008.120; DUDAY H, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P29, DOI 10.3406/bmsap.1990.1740; Duday H., 2009, ARCHAEOLOGY DEAD LEC, P145; FARO Jose Antonio, 2007, VILLES CAMPAGNES TAR, P97, DOI [10.4000/books.pumi.25663, DOI 10.4000/BOOKS.PUMI.25663]; Flores C, 2004, EUR J HUM GENET, V12, P855, DOI 10.1038/sj.ejhg.5201225; Glick T., 1979, ISLAMIC CHRISTIAN SP; Gonzalez AM, 2003, AM J PHYS ANTHROPOL, V120, P391, DOI 10.1002/ajpa.10168; GUTIERREZ LLORET Sonia, 2007, VILLA 2 VILLES CAMPA, P275, DOI 10.4000/books.pumi.25763; Jomier J, 1954, ARABICA, V1, P212; Jomier J, 1972, ARABICA, V19, P316; Kennedy H., 2010, GREAT ARAB CONQUESTS; Le Bars D, 2005, ARQUEOLOGIA MEDIEVAL, V9, P233; Magnou Nortier E, 1974, SOC LAIQUE EGLISE PR; Moreno EM, 2010, NEW CAMBRIDGE HISTORY OF ISLAM, VOL I: THE FORMATION OF THE ISLAMIC WORLD SIXTH TO ELEVENTH CENTURIES, P581; Marichal R, 2007, VILLES CAMPAGNES AL, P76; Mastnak T., 2002, CRUSADING PEACE CHRI; Maufras O, 2007, PLACE CHAPITRE SES A; Mendisco F, 2011, ELECTROPHORESIS, V32, P386, DOI 10.1002/elps.201000483; MURAIL P, 2005, B MEM SOC ANTHRO PAR, V17, P167, DOI DOI 10.4000/BMSAP.1157; Parverie M, 2007, AQUITANIA, V23, P239; Parverie Marc, 2012, ANN MIDI REV ARCHEOL, P165; Paz de Miguel Ibanez M., 2007, VILLES CAMPAGNES TAR, P183; Petersen A., 2013, OXFORD HDB OFTHE ARC, P241, DOI [10.1093/oxfordhb/9780199569069.013.0014, DOI 10.1093/OXFORDHB/9780199569069.013.0014]; Prevedorou E., 2010, DENT ANTHR, V23, P42, DOI DOI 10.26575/daj.v23i2.74; Ragib Y., 1992, ARABICA, V39, P393; Richard C, 2007, ANN HUM BIOL, V34, P68, DOI 10.1080/03014460601076098; Romero Rameta A., 2009, REV ESP ANTROP FIS, V29, P1; Schmitt Aurore, 2005, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V17, P89; Senac P, 2000, PAYS CATHARE RELIG M, P163; Senac P, 2002, STUD ISLAMICA, V95, P37; SENAC P, 1983, CAHIERS FANJEAUX, V18, P43; Senac Philipe, 2010, AL-QANTARA, V31, P225; Senac Philippe, 2015, CHARLEMAGNE MAHOMET; Serrano Pena JL, 2000, ARQUEOLOGIA TERRITOR, V7, P93; Tritton A.S., 1938, B SCH ORIENTAL STUDI, V9, P653; Watson William E., 1993, STUDIES W CIVILIZATI, V2; Wolf P, 1983, CAHIERS FANJEAUX, V18, P29; Zadora-Rio E, 2003, MEDIEV ARCHAEOL, V47, P1, DOI DOI 10.1179/MED.2003.47.1.1	54	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148583	10.1371/journal.pone.0148583	http://dx.doi.org/10.1371/journal.pone.0148583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF2IA	26910855	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700010
J	Hofstetter, AR; De La Cruz, JA; Cao, WP; Patel, J; Belser, JA; McCoy, J; Liepkalns, JS; Amoah, S; Cheng, GJ; Ranjan, P; Diebold, BA; Shieh, WJ; Zaki, S; Katz, JM; Sambhara, S; Lambeth, JD; Gangappa, S				Hofstetter, Amelia R.; De La Cruz, Juan A.; Cao, Weiping; Patel, Jenish; Belser, Jessica A.; McCoy, James; Liepkalns, Justine S.; Amoah, Samuel; Cheng, Guangjie; Ranjan, Priya; Diebold, Becky A.; Shieh, Wun-Ju; Zaki, Sherif; Katz, Jacqueline M.; Sambhara, Suryaprakash; Lambeth, J. David; Gangappa, Shivaprakash			NADPH Oxidase 1 Is Associated with Altered Host Survival and T Cell Phenotypes after Influenza A Virus Infection in Mice	PLOS ONE			English	Article							DENDRITIC CELLS; REACTIVE OXYGEN; ANTIBODY-RESPONSE; NOX ENZYMES; PATHOGENESIS; MEMORY; LUNG; DIFFERENTIATION; EXPRESSION; EFFECTOR	The role of the reactive oxygen species-producing NADPH oxidase family of enzymes in the pathology of influenza A virus infection remains enigmatic. Previous reports implicated NADPH oxidase 2 in influenza A virus-induced inflammation. In contrast, NADPH oxidase 1 (Nox1) was reported to decrease inflammation in mice within 7 days post-influenza A virus infection. However, the effect of NADPH oxidase 1 on lethality and adaptive immunity after influenza A virus challenge has not been explored. Here we report improved survival and decreased morbidity in mice with catalytically inactive NADPH oxidase 1 (Nox1(*/Y)) compared with controls after challenge with A/PR/8/34 influenza A virus. While changes in lung inflammation were not obvious between Nox1(*/Y) and control mice, we observed alterations in the T cell response to influenza A virus by day 15 post-infection, including increased interleukin-7 receptor-expressing virus-specific CD8(+) T cells in lungs and draining lymph nodes of Nox1(*/Y), and increased cytokine-producing T cells in lungs and spleen. Furthermore, a greater percentage of conventional and interstitial dendritic cells from Nox1(*/Y) draining lymph nodes expressed the co-stimulatory ligand CD40 within 6 days post-infection. Results indicate that NADPH oxidase 1 modulates the innate and adaptive cellular immune response to influenza virus infection, while also playing a role in host survival. Results suggest that NADPH oxidase 1 inhibitors may be beneficial as adjunct therapeutics during acute influenza infection.	[Hofstetter, Amelia R.; De La Cruz, Juan A.; Cao, Weiping; Patel, Jenish; Belser, Jessica A.; Liepkalns, Justine S.; Amoah, Samuel; Ranjan, Priya; Katz, Jacqueline M.; Sambhara, Suryaprakash; Gangappa, Shivaprakash] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Hofstetter, Amelia R.; McCoy, James; Cheng, Guangjie; Diebold, Becky A.; Lambeth, J. David] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Shieh, Wun-Ju; Zaki, Sherif] Ctr Dis Control & Prevent, Infect Dis Pathol Branch, Atlanta, GA USA; [Cheng, Guangjie] UAB Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL USA	Centers for Disease Control & Prevention - USA; Emory University; Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham	Gangappa, S (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA.; Lambeth, JD (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	noxdoc@mac.com; sgangappa@cdc.gov	Sambhara, Suryaprakash/AAC-4428-2021; Hofstetter, Amelia Ruth/AAM-4896-2020	Hofstetter, Amelia Ruth/0000-0003-4113-5473; Cao, Weiping/0000-0002-5794-9685	National Institutes of Health [AI102197-01, T32 DK00771]; Centers for Disease Control and Prevention; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI102197, R33AI102197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health Grants AI102197-01 (JDL) (http://report.nih.gov/quicklinks.aspx), T32 DK00771 (http://report.nih.gov/quicklinks.aspx), and Centers for Disease Control and Prevention intramural funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE T, 1990, J CLIN INVEST, V85, P739, DOI 10.1172/JCI114499; Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Arens R, 2010, IMMUNOL REV, V235, P190, DOI 10.1111/j.0105-2896.2010.00899.x; Balish A.L., 2013, CURR PROTOC MICROBIO, V29, p15G.1.1, DOI [10.1002/9780471729259.mc15g01s29, DOI 10.1002/9780471729259.MC15G01S29]; Ballesteros-Tato A, 2013, J EXP MED, V210, P1591, DOI 10.1084/jem.20130097; Ballesteros-Tato A, 2010, NAT IMMUNOL, V11, P216, DOI 10.1038/ni.1838; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; BENDER BS, 1992, J EXP MED, V175, P1143, DOI 10.1084/jem.175.4.1143; BENDER BS, 1991, IMMUNOLOGY, V72, P514; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Boyden AW, 2014, IMMUNOL RES, V59, P73, DOI 10.1007/s12026-014-8541-0; Braciale TJ, 2012, NAT REV IMMUNOL, V12, P295, DOI 10.1038/nri3166; Brown DM, 2004, SEMIN IMMUNOL, V16, P171, DOI 10.1016/j.smim.2004.02.004; Cao WP, 2012, J IMMUNOL, V189, P2257, DOI 10.4049/jimmunol.1200168; Carnesecchi S, 2012, CELL MOL LIFE SCI, V69, P2373, DOI 10.1007/s00018-012-1013-6; Ciancio BC, 2014, SURVEILLANCE FOR SEA, P41; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]; Davis AM, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-167; Doherty PC, 1997, IMMUNOL REV, V159, P105, DOI 10.1111/j.1600-065X.1997.tb01010.x; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; Hamilton SE, 2007, IMMUNITY, V27, P180, DOI 10.1016/j.immuni.2007.08.003; Han SN, 2000, J INFECT DIS, V182, pS74, DOI 10.1086/315915; Hayden FG, 2013, INFLUENZA OTHER RESP, V7, P63, DOI 10.1111/irv.12045; Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jones B, 2012, B WORLD HEALTH ORGAN, V90, P252, DOI 10.2471/BLT.12.030412; Kannanganat S, 2007, J VIROL, V81, P8468, DOI 10.1128/JVI.00228-07; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; La Gruta NL, 2004, J IMMUNOL, V172, P5553, DOI 10.4049/jimmunol.172.9.5553; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lee BO, 2005, J IMMUNOL, V175, P5827, DOI 10.4049/jimmunol.175.9.5827; Lefrancois L, 2010, IMMUNOL REV, V235, P206, DOI 10.1111/j.0105-2896.2010.00895.x; Leoni G, 2013, J CLIN INVEST, V123, P443, DOI 10.1172/JCI65831; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Mosmann T R, 1997, Semin Immunol, V9, P87, DOI 10.1006/smim.1997.0065; Obar JJ, 2011, J IMMUNOL, V187, P4967, DOI 10.4049/jimmunol.1102335; ODA T, 1989, SCIENCE, V244, P974, DOI 10.1126/science.2543070; Olson MR, 2014, J IMMUNOL, V193, P5420, DOI 10.4049/jimmunol.1303359; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Poovorawan Y, 2013, PATHOG GLOB HEALTH, V107, P217, DOI 10.1179/2047773213Y.0000000103; Rada Balazs, 2008, V15, P164, DOI 10.1159/000136357; Rainsford K. D., 2006, Inflammopharmacology, V14, P2, DOI 10.1007/s10787-006-0002-5; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sealy R, 2003, IMMUNOLOGY, V108, P431, DOI 10.1046/j.1365-2567.2003.01615.x; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Selemidis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060792; Shirey KA, 2013, NATURE, V497, P498, DOI 10.1038/nature12118; Snelgrove RJ, 2006, EUR J IMMUNOL, V36, P1364, DOI 10.1002/eji.200635977; Sun J, 2013, CURR OPIN VIROL, V3, P425, DOI 10.1016/j.coviro.2013.05.001; Trocme C, 2015, J PATHOL, V235, P65, DOI 10.1002/path.4423; Vlahos R, 2014, MOL PHARMACOL, V86, P747, DOI 10.1124/mol.114.095216; Vlahos R, 2012, TRENDS PHARMACOL SCI, V33, P3, DOI 10.1016/j.tips.2011.09.001; Vlahos R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001271; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang CH, 2014, CRIT CARE MED, V42, P313, DOI 10.1097/CCM.0b013e3182a2727d; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Xu LM, 2004, J IMMUNOL, V173, P721, DOI 10.4049/jimmunol.173.2.721; YAP KL, 1978, SCAND J IMMUNOL, V7, P73, DOI 10.1111/j.1365-3083.1978.tb00428.x; Zheng BJ, 2008, P NATL ACAD SCI USA, V105, P8091, DOI 10.1073/pnas.0711942105	68	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149864	10.1371/journal.pone.0149864	http://dx.doi.org/10.1371/journal.pone.0149864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910342	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700051
J	Le Velly, G; Dutilly, C				Le Velly, Gwenole; Dutilly, Celine			Evaluating Payments for Environmental Services: Methodological Challenges	PLOS ONE			English	Review							PROTECTED AREAS; ECOSYSTEM SERVICES; FOREST COVER; INSTRUMENTAL VARIABLES; CONCEPTUAL-FRAMEWORK; POLICY INSTRUMENTS; LOCAL LIVELIHOODS; IMPACT EVALUATION; COSTA-RICA; CONSERVATION	Over the last fifteen years, Payments for Environmental Services (PES) schemes have become very popular environmental policy instruments, but the academic literature has begun to question their additionality. The literature attempts to estimate the causal effect of these programs by applying impact evaluation (IE) techniques. However, PES programs are complex instruments and IE methods cannot be directly applied without adjustments. Based on a systematic review of the literature, this article proposes a framework for the methodological process of designing an IE for PES schemes. It revises and discusses the methodological choices at each step of the process and proposes guidelines for practitioners.	[Le Velly, Gwenole] Univ Auvergne, CERDI, Clermont Ferrand, France; [Dutilly, Celine] CIRAD, SELMET, Montpellier, France; [Le Velly, Gwenole] CERDI, 65 Blvd Francois Mitterrand, F-63000 Clermont Ferrand, France	Universite Clermont Auvergne (UCA); CIRAD	Le Velly, G (corresponding author), Univ Auvergne, CERDI, Clermont Ferrand, France.; Le Velly, G (corresponding author), CERDI, 65 Blvd Francois Mitterrand, F-63000 Clermont Ferrand, France.	gwenole.le_velly1@udamail.fr			French national funder Agence Nationale de la Recherche (Convention) [2009-STRA-008.01]	French national funder Agence Nationale de la Recherche (Convention)(French National Research Agency (ANR))	This research is part of the PESMIX project (Paiements pour services environnementaux: nouvelle panacee ou auxiliaire pour gerer les territoires?), funded by the French national funder Agence Nationale de la Recherche (Convention 2009-STRA-008.01), part of the 2009 Systerra call for research proposals.	Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Aldashev G, 2017, ECON J, V127, P873, DOI 10.1111/ecoj.12321; Alix-Garcia J, 2007, J ENVIRON ECON MANAG, V53, P141, DOI 10.1016/j.jeem.2006.09.004; Alix-Garcia J, 2013, REV ECON STAT, V95, P417, DOI 10.1162/REST_a_00349; Alix-Garcia JM, 2015, AM ECON J-ECON POLIC, V7, P1, DOI 10.1257/pol.20130139; Alix-Garcia JM, 2012, LAND ECON, V88, P613, DOI 10.3368/le.88.4.613; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andam KS, 2010, P NATL ACAD SCI USA, V107, P9996, DOI 10.1073/pnas.0914177107; Angelsen A, 1999, WORLD BANK RES OBSER, V14, P73, DOI 10.1093/wbro/14.1.73; Angrist JD, 1996, J AM STAT ASSOC, V91, P444, DOI 10.2307/2291629; [Anonymous], P ROYAL SOC LONDON B; Arriagada RA., 2008, PRIVATE PROVISION OF; Arriagada RA, 2012, LAND ECON, V88, P382, DOI 10.3368/le.88.2.382; ASHENFELTER O, 1978, REV ECON STAT, V60, P47, DOI 10.2307/1924332; Aukland L, 2003, CLIM POLICY, V3, P123; Bauch SC, 2014, WORLD DEV, V64, pS135, DOI 10.1016/j.worlddev.2014.03.009; Baylis K, 2015, CONSERVATION LETT; Blackman A., 2012, EX POSTEVALUATION FO, P12; BOUND J, 1995, J AM STAT ASSOC, V90, P443, DOI 10.2307/2291055; Brimont L, 2015, FORESTS, V6, P748, DOI 10.3390/f6030748; Bruggeman D, 2015, LAND USE POLICY, V42, P151, DOI 10.1016/j.landusepol.2014.07.012; Busch J, 2015, P NATL ACAD SCI USA, V112, P1328, DOI 10.1073/pnas.1412514112; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Caplow S, 2011, ENVIRON SCI POLICY, V14, P152, DOI 10.1016/j.envsci.2010.10.003; Chabe-Ferret S, 2013, J ENVIRON ECON MANAG, V65, P12, DOI 10.1016/j.jeem.2012.09.003; Cisneros E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136402; Clements T, 2015, CONSERV BIOL, V29, P78, DOI 10.1111/cobi.12423; Clements T, 2014, WORLD DEV, V64, pS125, DOI 10.1016/j.worlddev.2014.03.008; Clements T, 2013, BIOL CONSERV, V157, P50, DOI 10.1016/j.biocon.2012.07.020; Corbera E, 2009, ECOL ECON, V68, P743, DOI 10.1016/j.ecolecon.2008.06.008; Costedoat S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119881; Craigie ID, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0283; Cuenca P, 2016, ENVIRON SCI POLICY, V56, P56, DOI 10.1016/j.envsci.2015.10.014; Darling ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113614; Deaton AS, 2009, INSTRUMENTS DEV RAND; Desbureaux S, 2015, ECOL ECON, V118, P10, DOI 10.1016/j.ecolecon.2015.07.002; Ferraro P., 2009, ENV PROGRAM POLICY E, P75, DOI [10.1002/ev.297, DOI 10.1002/EV.297]; Ferraro PJ, 2008, ECOL ECON, V65, P810, DOI 10.1016/j.ecolecon.2007.07.029; Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0267; Ferraro PJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/025011; Ferraro PJ, 2013, RESOUR ENERGY ECON, V35, P356, DOI 10.1016/j.reseneeco.2013.04.001; Ferraro PJ, 2011, CONSERV BIOL, V25, P1134, DOI 10.1111/j.1523-1739.2011.01791.x; Ferraro PJ, 2011, P NATL ACAD SCI USA, V108, P13913, DOI 10.1073/pnas.1011529108; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Gertler PJ, 2011, IMPACT EVALUATION IN PRACTICE, P1, DOI 10.1596/978-0-8213-8541-8; Hanauer MM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0272; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Haruna A, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/035007; Heckman J, 2004, REV ECON STAT, V86, P30, DOI 10.1162/003465304323023660; Heckman JJ, 2010, J ECONOMETRICS, V156, P27, DOI 10.1016/j.jeconom.2009.09.006; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Honey-Roses J, 2011, CONSERV BIOL, V25, P1032, DOI 10.1111/j.1523-1739.2011.01729.x; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jack BK, 2015, J PUBLIC ECON, V122, P80, DOI 10.1016/j.jpubeco.2014.10.003; Jack BK, 2009, ECOL ECON, V68, P1813, DOI 10.1016/j.ecolecon.2008.12.002; Jayachandran S, 2013, AM ECON REV, V103, P309, DOI 10.1257/aer.103.3.309; Jones KW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141380; Karsenty A., 2011, PERSPECTIVE ENV POLI; Karsenty A., 2014, INSTRUMENTATION ACTI, P161; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Lambin EF, 2014, GLOBAL ENVIRON CHANG, V28, P129, DOI 10.1016/j.gloenvcha.2014.06.007; Le Velly G, 2015, PES IMPACT AND LEAKA, P29; Miranda JJ, 2016, WORLD DEV, V78, P288, DOI 10.1016/j.worlddev.2015.10.026; Miteva DA, 2015, ECOL ECON, V119, P127, DOI 10.1016/j.ecolecon.2015.08.005; Miteva DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129675; Miteva DA, 2012, OXFORD REV ECON POL, V28, P69, DOI 10.1093/oxrep/grs009; Muradian R, 2013, CONSERV LETT, V6, P274, DOI 10.1111/j.1755-263X.2012.00309.x; Naidoo R, 2011, IMPACT EVALUATION CA; Nelson A, 2009, EVALUATION BRIEF, V7, P31; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Pattanayak SK, 2010, REV ENV ECON POLICY, V4, P254, DOI 10.1093/reep/req006; Persson UM, 2013, WORLD DEV, V43, P124, DOI 10.1016/j.worlddev.2012.10.006; Pfaff A, 2014, 2014 ANN M JUL 27 29; Pfaff A, 2008, PAYMENTS ENV SERVICE; Pfaff A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0273; Pfaff A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129460; Pfaff A, 2014, WORLD DEV, V55, P7, DOI 10.1016/j.worlddev.2013.01.011; Pfaff A, 2009, BE J ECON ANAL POLI, V9, DOI 10.2202/1935-1682.1990; Pirard R, 2010, IDDRI ANALYSES, V4; Rasolofoson RA, 2015, BIOL CONSERV, V184, P271, DOI 10.1016/j.biocon.2015.01.027; Ravallion M, 2008, HBK ECON, V9, P3787, DOI 10.1016/S1573-4471(07)04059-4; Ravallion M, 2009, WORLD BANK RES OBSER, V24, P29, DOI 10.1093/wbro/lkp002; Robalino J, 2008, ENV DEV; Robalino J, 2014, ENV DEV; Robalino J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124910; Robalino J, 2013, LAND ECON, V89, P432, DOI 10.3368/le.89.3.432; Rode J, 2015, ECOL ECON, V117, P270, DOI 10.1016/j.ecolecon.2014.11.019; Rueda X, 2015, REG ENVIRON CHANGE, V15, P25, DOI 10.1007/s10113-014-0607-y; Sauer J, 2012, IDENTIFICATION MEASU; Schmook B, 2009, WORLD DEV, V37, P1015, DOI 10.1016/j.worlddev.2008.09.006; Sharma BP, REDD IMPACTS EVIDENC; Sills EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132590; Simonet G, 2015, PAYING SMALLHOLDERS, P14; Sims KRE, 2014, CONSERV BIOL, V28, P1151, DOI 10.1111/cobi.12318; Sims KRE, 2014, ENVIRON RESOUR ECON, V58, P303, DOI 10.1007/s10640-013-9707-2; Sims KRE, 2010, J ENVIRON ECON MANAG, V60, P94, DOI 10.1016/j.jeem.2010.05.003; Sunderlin W, 2010, TECHNICAL GUIDELINES; Takahashi R, 2012, ENVIRON MANAGE, V50, P396, DOI 10.1007/s00267-012-9887-5; Wendland KJ, 2015, LAND ECON, V91, P149, DOI 10.3368/le.91.1.149; White H, 2009, J DEV EFFECT, V1, P271, DOI 10.1080/19439340903114628; Wu JJ, 2000, AM J AGR ECON, V82, P979, DOI 10.1111/0002-9092.00096; Wunder S, 2015, ECOLOGICAL IN PRESS; Yanez-Pagans P, 2013, 2013 ANN M AUG 4 6 W; Zhao Z, 2004, REV ECON STAT, V86, P91, DOI 10.1162/003465304323023705	106	27	27	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149374	10.1371/journal.pone.0149374	http://dx.doi.org/10.1371/journal.pone.0149374			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910850	Green Published, gold			2022-12-27	WOS:000371164700032
J	Oikkonen, J; Kuusi, T; Peltonen, P; Raijas, P; Ukkola-Vuoti, L; Karma, K; Onkamo, P; Jarvela, I				Oikkonen, Jaana; Kuusi, Tuire; Peltonen, Petri; Raijas, Pirre; Ukkola-Vuoti, Liisa; Karma, Kai; Onkamo, Paivi; Jarvela, Irma			Creative Activities in Music - A Genome-Wide Linkage Analysis	PLOS ONE			English	Article							LONG-TERM DEPRESSION; BRAIN; AMPA; ASSOCIATION; IDENTIFICATION; PERFORMANCE; GENERATION; APTITUDE; GENE; FMRI	Creative activities in music represent a complex cognitive function of the human brain, whose biological basis is largely unknown. In order to elucidate the biological background of creative activities in music we performed genome-wide linkage and linkage disequilibrium (LD) scans in musically experienced individuals characterised for self-reported composing, arranging and non-music related creativity. The participants consisted of 474 individuals from 79 families, and 103 sporadic individuals. We found promising evidence for linkage at 16p12.1-q12.1 for arranging (LOD 2.75, 120 cases), 4q22.1 for composing (LOD 2.15, 103 cases) and Xp11.23 for non-music related creativity (LOD 2.50, 259 cases). Surprisingly, statistically significant evidence for linkage was found for the opposite phenotype of creative activity in music (neither composing nor arranging; NCNA) at 18q21 (LOD 3.09, 149 cases), which contains cadherin genes like CDH7 and CDH19. The locus at 4q22.1 overlaps the previously identified region of musical aptitude, music perception and performance giving further support for this region as a candidate region for broad range of music-related traits. The other regions at 18q21 and 16p12.1-q12.1 are also adjacent to the previously identified loci with musical aptitude. Pathway analysis of the genes suggestively associated with composing suggested an overrepresentation of the cerebellar long-term depression pathway (LTD), which is a cellular model for synaptic plasticity. The LTD also includes cadherins and AMPA receptors, whose component GSG1L was linked to arranging. These results suggest that molecular pathways linked to memory and learning via LTD affect music-related creative behaviour. Musical creativity is a complex phenotype where a common background with musicality and intelligence has been proposed. Here, we implicate genetic regions affecting music-related creative behaviour, which also include genes with neuropsychiatric associations. We also propose a common genetic background for music-related creative behaviour and musical abilities at chromosome 4.	[Oikkonen, Jaana; Peltonen, Petri; Ukkola-Vuoti, Liisa; Jarvela, Irma] Univ Helsinki, Dept Med Genet, Helsinki, Finland; [Kuusi, Tuire; Karma, Kai] Univ Arts Helsinki, Sibelius Acad, Helsinki, Finland; [Raijas, Pirre] Conservatory Joensuu, Joensuu, Finland; [Onkamo, Paivi] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Ukkola-Vuoti, Liisa] Univ Helsinki, FIMM, Helsinki, Finland	University of Helsinki; University of the Arts Helsinki; University of Helsinki; University of Helsinki	Oikkonen, J (corresponding author), Univ Helsinki, Dept Med Genet, Helsinki, Finland.	jaana.oikkonen@helsinki.fi	Ukkola-Vuoti, Liisa/E-6564-2016; Jarvela, Irma/L-5836-2013	Ukkola-Vuoti, Liisa/0000-0002-0770-361X; Kuusi, Tuire/0000-0003-2757-6328; Jarvela, Irma/0000-0002-1770-6187; Oikkonen, Jaana/0000-0002-1063-2736	Academy of Finland [137713]; Finnish Cultural Foundation	Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science)	This work was supported by the Academy of Finland (137713) and the Finnish Cultural Foundation to IJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abraham A, 2016, BRAIN IMAGING BEHAV, V10, P609, DOI 10.1007/s11682-015-9410-8; Amaducci L, 2002, EUR J NEUROL, V9, P75, DOI 10.1046/j.1468-1331.2002.00351.x; Asher JE, 2009, AM J HUM GENET, V84, P279, DOI 10.1016/j.ajhg.2009.01.012; Bachner-Melman R, 2005, PLOS GENET, V1, P394, DOI 10.1371/journal.pgen.0010042; Baer J, 2008, J CREATIVE BEHAV, V42, P75, DOI 10.1002/j.2162-6057.2008.tb01289.x; Baer LH, 2015, NEUROIMAGE, V109, P130, DOI 10.1016/j.neuroimage.2014.12.076; Bengtsson SL, 2007, J COGNITIVE NEUROSCI, V19, P830, DOI 10.1162/jocn.2007.19.5.830; Berkowitz AL, 2008, NEUROIMAGE, V41, P535, DOI 10.1016/j.neuroimage.2008.02.028; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buckner RL, 2013, NEURON, V80, P807, DOI 10.1016/j.neuron.2013.10.044; Carson S, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00771; Chen N, 2014, J PROTEOME RES, V13, P5695, DOI 10.1021/pr500697b; Cirulli ET, 2010, EUR J HUM GENET, V18, P815, DOI 10.1038/ejhg.2010.2; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; De Backer J, 2014, MUSIC MUSIC THERAPY; de Manzano O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010670; Dietrich A, 2010, PSYCHOL BULL, V136, P822, DOI 10.1037/a0019749; Fassio A, 2011, HUM MOL GENET, V20, P2297, DOI 10.1093/hmg/ddr122; Fenster C, 2012, BRAIN RES BULL, V87, P21, DOI 10.1016/j.brainresbull.2011.10.011; Gertz EM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-47; Gordon E.E., 1979, PRIMARY MEASURES MUS; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Hennessey BA, 2010, ANNU REV PSYCHOL, V61, P569, DOI 10.1146/annurev.psych.093008.100416; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Honing H, 2015, PHILOS T R SOC B, V370, P5, DOI 10.1098/rstb.2014.0088; Jerde TA, 2011, NEUROIMAGE, V57, P1572, DOI 10.1016/j.neuroimage.2011.05.061; Kanduri C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09506; Kanduri C, 2015, PEERJ, V3, DOI 10.7717/peerj.830; Karma K., 2007, PSYCHOMUSICOLOGY, V19, P79, DOI [10.1037/h0094033, DOI 10.1037/H0094033]; Keri S, 2009, PSYCHOL SCI, V20, P1070, DOI 10.1111/j.1467-9280.2009.02398.x; Kiehn MT, 2003, J RES MUSIC EDUC, V51, P278, DOI 10.2307/3345655; Koelsch S, 2014, HUM BRAIN MAPP, V35, P3485, DOI 10.1002/hbm.22416; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Kyaga S, 2013, J PSYCHIATR RES, V47, P83, DOI 10.1016/j.jpsychires.2012.09.010; Laland KN, 2010, NAT REV GENET, V11, P137, DOI 10.1038/nrg2734; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee K, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0130-1; Levitin DJ, 2012, NEURON, V73, P633, DOI 10.1016/j.neuron.2012.01.017; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Liu SY, 2012, SCI REP-UK, V2, DOI 10.1038/srep00834; Madsen P., 2013, USERS GUIDE DMU VERS; Matise TC, 2007, GENOME RES, V17, P1783, DOI 10.1101/gr.7156307; Matsunaga E, 2008, J COMP NEUROL, V508, P329, DOI 10.1002/cne.21676; Mayseless N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00502; Mills F, 2014, P NATL ACAD SCI USA, V111, P8631, DOI 10.1073/pnas.1404670111; Mosing MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113874; Murphy M, 2013, CREATIVITY RES J, V25, P147, DOI 10.1080/10400419.2013.752305; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oikkonen J, 2015, MOL PSYCHIATR, V20, P275, DOI 10.1038/mp.2014.8; Park H, 2012, J MED GENET, V49, P747, DOI 10.1136/jmedgenet-2012-101209; Parks TN, 2000, HEARING RES, V147, P77, DOI 10.1016/S0378-5955(00)00122-2; Petsche H, 1997, INT J PSYCHOPHYSIOL, V26, P77, DOI 10.1016/S0167-8760(97)00757-5; Pohjannoro U, 2014, MUSIC SCI, V18, P166, DOI 10.1177/1029864914520848; Power RA, 2013, AM J MED GENET B, V162, P521, DOI 10.1002/ajmg.b.32180; Pulli K, 2008, J MED GENET, V45, P451, DOI 10.1136/jmg.2007.056366; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Reuter M, 2006, BRAIN RES, V1069, P190, DOI 10.1016/j.brainres.2005.11.046; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Salimpoor VN, 2015, TRENDS COGN SCI, V19, P86, DOI 10.1016/j.tics.2014.12.001; Schwenk J, 2014, NEURON, V84, P41, DOI 10.1016/j.neuron.2014.08.044; Seashore CE, 1960, SEASHORE MEASURES OF; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shanks NF, 2012, CELL REP, V1, P590, DOI 10.1016/j.celrep.2012.05.004; Sillivan SE, 2013, BIOL PSYCHIAT, V74, P511, DOI 10.1016/j.biopsych.2013.04.012; St Pourcain B, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-34; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Theusch E, 2009, AM J HUM GENET, V85, P112, DOI 10.1016/j.ajhg.2009.06.010; Tolgyesi B, 2014, J NEUROL SCI, V343, P76, DOI 10.1016/j.jns.2014.05.036; Torrance E. P., 1981, THINKING CREATIVELY; Ukkola LT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005534; Ukkola-Vuoti L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056356; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Vinkhuyzen AAE, 2009, BEHAV GENET, V39, P380, DOI 10.1007/s10519-009-9260-5; Wang C, 1985, MEASURES CREAT UNPUB; Webster P. R., 1983, LOYOL S CREAT NEW OR; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Wiggins GA, 2015, PHILOS T R SOC B, V370, P129, DOI 10.1098/rstb.2014.0099; Xie PX, 2013, BIOL PSYCHIAT, V74, P656, DOI 10.1016/j.biopsych.2013.04.013; ZATORRE RJ, 1993, NEUROPSYCHOLOGIA, V31, P221, DOI 10.1016/0028-3932(93)90086-F	84	20	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148679	10.1371/journal.pone.0148679	http://dx.doi.org/10.1371/journal.pone.0148679			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DF2IA	26909693	gold, Green Published			2022-12-27	WOS:000371164700013
J	Sauguet, L; Fourati, Z; Prange, T; Delarue, M; Colloc'h, N				Sauguet, Ludovic; Fourati, Zeineb; Prange, Thierry; Delarue, Marc; Colloc'h, Nathalie			Structural Basis for Xenon Inhibition in a Cationic Pentameric Ligand-Gated Ion Channel	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; ANESTHETIC-GASES XENON; X-RAY-STRUCTURE; NITROUS-OXIDE; NOBLE-GASES; COMPETITIVE-INHIBITION; HYDROPHOBIC CAVITY; BINDING-SITES; NMDA RECEPTORS; BRAIN-DAMAGE	GLIC receptor is a bacterial pentameric ligand-gated ion channel whose action is inhibited by xenon. Xenon has been used in clinical practice as a potent gaseous anaesthetic for decades, but the molecular mechanism of interactions with its integral membrane receptor targets remains poorly understood. Here we characterize by X-ray crystallography the xenon-binding sites within both the open and "locally-closed" (inactive) conformations of GLIC. Major binding sites of xenon, which differ between the two conformations, were identified in three distinct regions that all belong to the trans-membrane domain of GLIC: 1) in an intra-subunit cavity, 2) at the interface between adjacent subunits, and 3) in the pore. The pore site is unique to the locally-closed form where the binding of xenon effectively seals the channel. A putative mechanism of the inhibition of GLIC by xenon is proposed, which might be extended to other pentameric cationic ligand-gated ion channels.	[Sauguet, Ludovic; Fourati, Zeineb; Delarue, Marc] Inst Pasteur, CNRS, Unite Dynam Struct Macromol, UMR 3528, Paris, France; [Prange, Thierry] CNRS, UMR 8015, Lab Cristallog & RMN Biol, Paris, France; [Colloc'h, Nathalie] GIP Cyceron, ISTCT CERVOxy Grp, CNRS, UMR 6301, Caen, France; [Colloc'h, Nathalie] Normandie Univ, UMR ISTCT 6301, UNICAEN, Caen, France; [Colloc'h, Nathalie] CEA, DSV I2BM, UMR ISTCT 6301, Caen, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Universite de Caen Normandie; CEA	Delarue, M (corresponding author), Inst Pasteur, CNRS, Unite Dynam Struct Macromol, UMR 3528, Paris, France.	marc.delarue@pasteur.fr	Colloc'h, Nathalie/L-1570-2015; Prangé, Thierry/AAA-4009-2022	Prangé, Thierry/0000-0002-7129-7396; Fourati, Zaineb/0000-0002-2316-4142	Agence Nationale pour la Recherche (ANR) [ANR 13 BSV8 0020]	Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR))	Zeineb Fourati-Kammoun was supported by a fellowship from Agence Nationale pour la Recherche (ANR), grant ANR 13 BSV8 0020.	Abraini JH, 2014, ANESTHESIOLOGY, V121, P1018, DOI 10.1097/ALN.0000000000000435; Abraini JH, 2005, ANN NY ACAD SCI, V1053, P289, DOI 10.1196/annals.1344.025; Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Armstrong SP, 2012, ANESTHESIOLOGY, V117, P38, DOI 10.1097/ALN.0b013e31825ada2e; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banks P, 2010, ANESTHESIOLOGY, V112, P614, DOI 10.1097/ALN.0b013e3181cea398; Blanc E., 2011, BUSTER VERSION 2 11; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Booker RD, 2013, BBA-BIOMEMBRANES, V1828, P1347, DOI 10.1016/j.bbamem.2013.01.016; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Chen Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep13833; Colloc'h N, 2011, CURRENT TRENDS IN X-RAY CRYSTALLOGRAPHY, P285; Colloc'h N, 2014, FEBS LETT, V588, P1715, DOI 10.1016/j.febslet.2014.03.017; Colloc'h N, 2007, BIOPHYS J, V92, P217, DOI 10.1529/biophysj.106.093807; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; CULLEN SC, 1951, SCIENCE, V113, P580, DOI 10.1126/science.113.2942.580; David HN, 2008, FASEB J, V22, P1275, DOI 10.1096/fj.07-9420com; David HN, 2010, J CEREBR BLOOD F MET, V30, P718, DOI 10.1038/jcbfm.2009.275; David HN, 2003, J CEREBR BLOOD F MET, V23, P1168, DOI 10.1097/01.WCB.0000087342.31689.18; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756, DOI 10.1097/01.anes.0000287061.77674.71; Dickinson R, 2010, CRIT CARE, V14, DOI 10.1186/cc9051; Eckenhoff R G, 2001, Mol Interv, V1, P258; Eckenhoff RG, 1997, PHARMACOL REV, V49, P343; Forman SA, 2011, CAN J ANESTH, V58, P191, DOI 10.1007/s12630-010-9419-9; Fourati Z, 2015, ACTA CRYSTALLOGR D, V71, P454, DOI 10.1107/S1399004714026698; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Gielen M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7829; Gruss M, 2004, MOL PHARMACOL, V65, P443, DOI 10.1124/mol.65.2.443; Harris K, 2013, ANESTHESIOLOGY, V119, P1137, DOI 10.1097/ALN.0b013e3182a2a265; Harris PD, 2008, ANAESTHESIA, V63, P284, DOI 10.1111/j.1365-2044.2007.05253.x; Hayakawa N, 2008, J MOL BIOL, V384, P812, DOI 10.1016/j.jmb.2008.09.075; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2010, NAT STRUCT MOL BIOL, V17, P1330, DOI 10.1038/nsmb.1933; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Homi HM, 2003, ANESTHESIOLOGY, V99, P876, DOI 10.1097/00000542-200310000-00020; Howard RJ, 2014, PHARMACOL REV, V66, P396, DOI 10.1124/pr.113.007468; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; Imai T, 2007, J PHYS CHEM B, V111, P11585, DOI 10.1021/jp074865b; Jayakar SS, 2013, J BIOL CHEM, V288, P6178, DOI 10.1074/jbc.M112.435909; Johansson JS, 2005, FEBS J, V272, P573, DOI 10.1111/j.1742-4658.2004.04500.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Landon C, 2001, PROTEIN SCI, V10, P762, DOI 10.1110/ps.47001; LeBard DN, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002532; Liu LT, 2010, J PHYS CHEM B, V114, P9010, DOI 10.1021/jp101687j; Ma DQ, 2006, J CEREBR BLOOD F MET, V26, P199, DOI 10.1038/sj.jcbfm.9600184; Ma DQ, 2005, ANN NEUROL, V58, P182, DOI 10.1002/ana.20547; Mann G, 2000, J MOL BIOL, V302, P979, DOI 10.1006/jmbi.2000.4064; Marassio G, 2011, FASEB J, V25, P2266, DOI 10.1096/fj.11-183046; Miller KW, 2002, BRIT J ANAESTH, V89, P17, DOI 10.1093/bja/aef167; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Petrenko AB, 2014, EUR J PHARMACOL, V723, P29, DOI 10.1016/j.ejphar.2013.11.039; Prange T, 1998, PROTEINS, V30, P61, DOI 10.1002/(SICI)1097-0134(19980101)30:1<61::AID-PROT6>3.0.CO;2-N; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Quillin ML, 2000, J MOL BIOL, V302, P955, DOI 10.1006/jmbi.2000.4063; Rubin SM, 2002, J MOL BIOL, V322, P425, DOI 10.1016/S0022-2836(02)00739-8; Salmi E, 2008, ANESTH ANALG, V106, P129, DOI 10.1213/01.ane.0000287658.14763.13; Sanders RD, 2004, BRIT MED BULL, V71, P115, DOI 10.1093/bmb/ldh034; Sanders RD, 2003, BRIT J ANAESTH, V91, P709, DOI 10.1093/bja/aeg232; Sanders RD, 2005, CURR OPIN ANESTHESIO, V18, P405, DOI 10.1097/01.aco.0000174957.97759.f6; Sauguet L, 2015, BBA-GEN SUBJECTS, V1850, P511, DOI 10.1016/j.bbagen.2014.05.007; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; SCHILTZ M, 1994, J APPL CRYSTALLOGR, V27, P950, DOI 10.1107/S0021889894005923; Schiltz M, 2003, METHOD ENZYMOL, V374, P83, DOI 10.1016/S0076-6879(03)74004-X; SCHOENBORN BP, 1966, MOL PHARMACOL, V2, P495; Seto T, 2008, ANESTH ANALG, V107, P1223, DOI 10.1213/ane.0b013e31817f1317; Spurny R, 2013, J BIOL CHEM, V288, P8355, DOI 10.1074/jbc.M112.424507; Stimson LM, 2005, CELL MOL BIOL LETT, V10, P563; TILTON RF, 1986, J MOL BIOL, V192, P443, DOI 10.1016/0022-2836(86)90374-8; TILTON RF, 1988, J MOL BIOL, V199, P195, DOI 10.1016/0022-2836(88)90389-0; Ulens C, 2014, STRUCTURE, V22, P1399, DOI 10.1016/j.str.2014.07.013; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Yamakura T, 2000, ANESTHESIOLOGY, V93, P1095, DOI 10.1097/00000542-200010000-00034; Yamamoto E, 2012, J PHYS CHEM B, V116, P8989, DOI 10.1021/jp303330c; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429	78	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149795	10.1371/journal.pone.0149795	http://dx.doi.org/10.1371/journal.pone.0149795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910105	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700049
J	Shiba, M; Kato, T; Funasako, M; Nakane, E; Miyamoto, S; Izumi, T; Haruna, T; Inoko, M				Shiba, Masayuki; Kato, Takao; Funasako, Moritoshi; Nakane, Eisaku; Miyamoto, Shoichi; Izumi, Toshiaki; Haruna, Tetsuya; Inoko, Moriaki			Association between Psoriasis Vulgaris and Coronary Heart Disease in a Hospital-Based Population in Japan	PLOS ONE			English	Article							MAJOR CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; RISK-FACTORS; STROKE; PREVALENCE; MORTALITY; COHORT; SUSCEPTIBILITY; DISORDERS; ARTHRITIS	Background Psoriasis vulgaris is a chronic inflammatory skin disease with an immune-genetic background. It has been reported as an independent risk factor for coronary heart disease (CHD) in the United States and Europe. The purpose of this study was to investigate the association between psoriasis and CHD in a hospital-based population in Japan. Methods For 113,065 in-hospital and clinic patients at our institution between January 1, 2011 and January 1, 2013, the diagnostic International Classification of Diseases (ICD)-10 codes for CHD, hypertension, dyslipidemia, diabetes, and psoriasis vulgaris were extracted using the medical accounting system and electronic medical record, and were analyzed. Results The prevalence of CHD (n = 5,167, 4.5%), hypertension (n = 16,476, 14.5%), dyslipidemia (n = 9,236, 8.1%), diabetesmellitus (n = 11,555, 10.2%), and psoriasis vulgaris (n = 1,197, 1.1%) were identified. The prevalence of CHD in patients with hypertension, dyslipidemia, diabetes, and psoriasis vulgaris were 21.3%, 22.2%, 21.1%, and 9.0%, respectively. In 1,197 psoriasis patients, those with CHD were older, more likely to be male, and had more number of the diseases surveyed by ICD-10 codes. Multivariate analysis showed that psoriasis vulgaris was an independent associated factor for CHD (adjusted odds ratio [OR]: 1.27; 95% confidence interval [CI]: 1.01-1.58; p = 0.0404) along with hypertension (adjusted OR: 7.78; 95% CI: 7.25-8.36; p < 0.0001), dyslipidemia (adjusted OR: 2.35; 95% CI: 2.19-2.52; p < 0.0001), and diabetes (adjusted OR: 2.86; 95% CI: 2.67-3.06; p < 0.0001). Conclusion Psoriasis vulgaris was independently associated with CHD in a hospital-based population in Japan.	[Shiba, Masayuki] Hyogo Prefectural Amagasaki Gen Med Ctr, Dept Cardiovasc Med, Amagasaki, Hyogo, Japan; [Shiba, Masayuki; Kato, Takao; Funasako, Moritoshi; Nakane, Eisaku; Miyamoto, Shoichi; Izumi, Toshiaki; Haruna, Tetsuya; Inoko, Moriaki] Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Osaka, Japan; [Kato, Takao] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan	Kitano Hospital; Kyoto University	Kato, T (corresponding author), Kitano Hosp, Tazuke Kofukai Med Res Inst, Cardiovasc Ctr, Osaka, Japan.	tkato75@kuhp.kyoto-u.ac.jp		Kato, Takao/0000-0001-8213-7999				Ahlehoff O, 2015, J EUR ACAD DERMATOL, V29, P1128, DOI 10.1111/jdv.12768; Ahlehoff O, 2011, J INTERN MED, V270, P147, DOI 10.1111/j.1365-2796.2010.02310.x; Ahlehoff O, 2012, EUR HEART J, V33, P2054, DOI 10.1093/eurheartj/ehr285; Ahlehoff O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036342; Ahlehoff O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018125; Armstrong AW, 2012, AM J CARDIOL, V109, P976, DOI 10.1016/j.amjcard.2011.11.025; Boehncke WH, 2012, CURR RHEUMATOL REP, V14, P343, DOI 10.1007/s11926-012-0260-8; Brauchli YB, 2009, BRIT J DERMATOL, V160, P1048, DOI 10.1111/j.1365-2133.2008.09020.x; Cohen AD, 2001, ACTA DERM-VENEREOL, V81, P347; Di Meglio P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017160; Dowlatshahi EA, 2013, J INVEST DERMATOL, V133, P2347, DOI 10.1038/jid.2013.131; Dregan A, 2014, CIRCULATION, V130, P837, DOI 10.1161/CIRCULATIONAHA.114.009990; Furuhashi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054895; Gelfand JM, 2005, ARCH DERMATOL, V141, P1537, DOI 10.1001/archderm.141.12.1537; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Huerta C, 2007, ARCH DERMATOL, V143, P1559, DOI 10.1001/archderm.143.12.1559; Iso H, 2007, STROKE, V38, P1744, DOI 10.1161/STROKEAHA.106.469072; Jain S, 2009, J MED MICROBIOL, V58, P180, DOI 10.1099/jmm.0.003939-0; Kawano H, 2006, CIRC J, V70, P513, DOI 10.1253/circj.70.513; Kaye JA, 2008, BRIT J DERMATOL, V159, P895, DOI 10.1111/j.1365-2133.2008.08707.x; Kubota K, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006450; Kurd SK, 2009, J AM ACAD DERMATOL, V60, P218, DOI 10.1016/j.jaad.2008.09.022; Li GL, 2007, ENDOCRINOLOGY, V148, P3356, DOI 10.1210/en.2006-1441; Ludwig RJ, 2007, BRIT J DERMATOL, V156, P271, DOI 10.1111/j.1365-2133.2006.07562.x; Mahiques-Santos L, 2015, ACTAS DERMO-SIFILOGR, V106, P112, DOI [10.1016/j.ad.2014.08.002, 10.1016/j.adengl.2014.12.014]; Maradit-Kremers H, 2013, INT J DERMATOL, V52, P32, DOI 10.1111/j.1365-4632.2011.05430.x; Mattozzi C, 2013, DERMATOLOGY, V227, P134, DOI 10.1159/000353398; McMichael AJ, 2012, J DRUGS DERMATOL, V11, P478; Medrano MJ, 2007, REV ESP CARDIOL, V60, P1250, DOI 10.1157/13113930; Mehta NN, 2010, EUR HEART J, V31, P1000, DOI 10.1093/eurheartj/ehp567; Ministry of Health Labour and Welfare, DAT SOURC NAT HLTH N; Mudigonda Parvathi, 2012, Dermatol Online J, V18, P1; Nickoloff BJ, 2004, J CLIN INVEST, V113, P1664, DOI 10.1172/JCI200422147; Ogdie A, 2015, J INVEST DERMATOL, V135, P2148, DOI 10.1038/jid.2015.218; Ogdie A, 2015, ANN RHEUM DIS, V74, P326, DOI 10.1136/annrheumdis-2014-205675; Okada Y, 2014, AM J HUM GENET, V95, P162, DOI 10.1016/j.ajhg.2014.07.002; Parisi R, 2015, J INVEST DERMATOL, V135, P2189, DOI 10.1038/jid.2015.87; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Pietrzak A, 2013, INT J DERMATOL, V52, P153, DOI 10.1111/j.1365-4632.2012.05584.x; Qi M, 2014, DNA CELL BIOL, V33, P234, DOI 10.1089/dna.2013.2252; Rachakonda TD, 2014, J AM ACAD DERMATOL, V70, P512, DOI 10.1016/j.jaad.2013.11.013; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; Salihbegovic Eldina Malkic, 2015, Mater Sociomed, V27, P15, DOI 10.5455/msm.2014.27.15-17; Samarasekera EJ, 2013, J INVEST DERMATOL, V133, P2340, DOI 10.1038/jid.2013.149; Setty AR, 2007, ARCH INTERN MED, V167, P1670, DOI 10.1001/archinte.167.15.1670; Stern RS, 2011, J INVEST DERMATOL, V131, P1159, DOI 10.1038/jid.2010.399; Tablazon ILD, 2013, AM J CLIN DERMATOL, V14, P1, DOI 10.1007/s40257-012-0005-5; Tzellos T, 2013, J EUR ACAD DERMATOL, V27, P622, DOI 10.1111/j.1468-3083.2012.04500.x; Wakkee M, 2010, J INVEST DERMATOL, V130, P962, DOI 10.1038/jid.2009.321; Wu SW, 2014, JAMA DERMATOL, V150, P957, DOI 10.1001/jamadermatol.2013.9957; Zhang XJ, 2004, INT J DERMATOL, V43, P181, DOI 10.1111/j.1365-4632.2004.02098.x	51	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149316	10.1371/journal.pone.0149316	http://dx.doi.org/10.1371/journal.pone.0149316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910469	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700029
J	Szczepanek, SM; Roberts, S; Rogers, K; Cotte, C; Adami, AJ; Bracken, SJ; Salmon, S; Secor, ER; Thrall, RS; Andemariam, B; Metzger, DW				Szczepanek, Steven M.; Roberts, Sean; Rogers, Kara; Cotte, Christina; Adami, Alexander J.; Bracken, Sonali J.; Salmon, Sharon; Secor, Eric R., Jr.; Thrall, Roger S.; Andemariam, Biree; Metzger, Dennis W.			Poor Long-Term Efficacy of Prevnar-13 in Sickle Cell Disease Mice Is Associated with an Inability to Sustain Pneumococcal-Specific Antibody Titers	PLOS ONE			English	Article							MEMORY B-CELLS; STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; PENICILLIN PROPHYLAXIS; CONJUGATE VACCINE; CHILDREN; INFECTIONS; EXPRESSION; MORTALITY; RESPONSES	Background One of the most common causes of morbidity and mortality in children with sickle cell disease (SCD) is infection with the pneumococcal bacterium (Streptococcus pneumoniae). Unfortunately, the polysaccharide-conjugate vaccine appears to be less effective in individuals with SCD when compared to the general population. We sought to better understand the relative efficacy of pneumococcal vaccination in a SCD mouse challenge model. Methods Transgenic control and SCD mice were monitored for mortality after intranasal pneumococcal infection or pneumococcal vaccination with Prevnar-13 and type-matched challenge. Anti-pneumococcal antibody titers were measured by ELISA and opsonophagocytosis was measured in vitro. Results Mortality after pneumococcal infection was similar between control and SCD mice. However, after three intramuscular polysaccharide-conjugate vaccinations, all control mice were protected following high-dose intranasal infection, whereas 60% of SCD mice died. Anti-pneumococcal antibody titers showed initial IgG and IgM responses in both groups, but waning titers were observed in the SCD group, even after boosting. When functionally assayed in vitro, serum from SCD mice 13 weeks after a second booster shot maintained little to no ability to opsonize pneumococci, while serum from control mice sustained a significantly higher capacity opsonization. Thus, it appears that SCD mice do not maintain antibody responses to pneumococcal polysaccharides after Prevnar-13 vaccination, thereby leaving them susceptible to mortality after type-matched infection. Conclusion Our results emphasize the need to better understand the correlates of immune protection in SCD so that pneumococcal vaccines can be improved and mortality reduced in this susceptible population.	[Szczepanek, Steven M.; Rogers, Kara; Cotte, Christina] Univ Connecticut, Dept Pathobiol & Vet Sci, Ctr Excellence Vaccine Res, Storrs, CT 06269 USA; [Roberts, Sean; Salmon, Sharon; Metzger, Dennis W.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Adami, Alexander J.; Bracken, Sonali J.; Thrall, Roger S.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT 06030 USA; [Secor, Eric R., Jr.] Hartford Hosp, Helen & Harry Gray Canc Ctr, Hartford, CT 06106 USA; [Secor, Eric R., Jr.] Hartford Hosp, Dept Med, Div Integrat Med, Hartford, CT 06106 USA; [Andemariam, Biree] Univ Connecticut, Ctr Hlth, Neag Comprehens Canc Ctr, Leas Fdn Ctr Hematol Disorders, Farmington, CT 06030 USA	University of Connecticut; Albany Medical College; University of Connecticut; Hartford Hospital; Hartford Hospital; University of Connecticut	Szczepanek, SM (corresponding author), Univ Connecticut, Dept Pathobiol & Vet Sci, Ctr Excellence Vaccine Res, Storrs, CT 06269 USA.	steven.szczepanek@uconn.edu	Metzger, Dennis W/I-2771-2019	Metzger, Dennis W/0000-0002-8000-9907; Roberts, Sean/0000-0001-9867-1483; Adami, Alexander/0000-0002-8233-9547; , Christina/0000-0002-8385-1921	University of Connecticut	University of Connecticut	Startup funding from the University of Connecticut provided to Biree Andemariam and Steven Szczepanek was used to purchase the mice and for analysis tools. Indirect cost recoveries to Dennis Metzger and Roger Thrall were used to purchase reagents, vaccines, and cover animal care costs.	Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; Amoateng-Adjepong Y, 2010, EPIDEMIOLOGY, V21, P347, DOI 10.1097/EDE.0b013e3181d7e1f4; Bjornson AB, 1996, J PEDIATR-US, V129, P828, DOI 10.1016/S0022-3476(96)70026-4; BJORNSON AB, 1987, J CLIN INVEST, V79, P388, DOI 10.1172/JCI112824; BRILES DE, 1981, NATURE, V294, P88, DOI 10.1038/294088a0; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; Cafini F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012041; Carsetti Rita, 2004, Methods Mol Biol, V271, P25; Carter R, 2014, CELL HOST MICROBE, V15, P587, DOI 10.1016/j.chom.2014.04.005; De Montalembert M, 2015, PEDIATR BLOOD CANCER, V62, P1427, DOI 10.1002/pbc.25502; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kuppers R, 2008, IMMUNOL CELL BIOL, V86, P635, DOI 10.1038/icb.2008.59; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; McCavit TL, 2012, PEDIATR BLOOD CANCER, V58, P945, DOI 10.1002/pbc.23259; Miller ML, 2007, J INFECT DIS, V195, P581, DOI 10.1086/510626; Neves M, 2011, AUTOIMMUN REV, V10, P375, DOI 10.1016/j.autrev.2010.12.007; Overturf G D, 1999, Adv Pediatr Infect Dis, V14, P191; Poehling KA, 2010, EPIDEMIOLOGY, V21, P340, DOI 10.1097/EDE.0b013e3181d61af8; Ramos-Sevillano E, 2012, ANTIMICROB AGENTS CH, V56, P5534, DOI 10.1128/AAC.01470-12; Ramos-Sevillano E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044135; RAO SP, 1995, J PEDIATR-US, V127, P590, DOI 10.1016/S0022-3476(95)70119-2; RomeroSteiner S, 1997, CLIN DIAGN LAB IMMUN, V4, P415, DOI 10.1128/CDLI.4.4.415-422.1997; Rosado MM, 2013, EUR J IMMUNOL, V43, P2659, DOI 10.1002/eji.201343577; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Spets H, 2002, EUR J HAEMATOL, V69, P76, DOI 10.1034/j.1600-0609.2002.01549.x; Szczepanek SM, 2013, PEDIATR RES, V74, P141, DOI 10.1038/pr.2013.85; Szczepanek SM, 2012, AM J PATHOL, V181, P1725, DOI 10.1016/j.ajpath.2012.07.034; William BM, 2007, HEMATOLOGY, V12, P1, DOI 10.1080/10245330600938422	31	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149261	10.1371/journal.pone.0149261	http://dx.doi.org/10.1371/journal.pone.0149261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910228	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700027
J	Kim, HJ; Lee, SY; Shin, YR; Park, CS; Kim, K				Kim, Hyun-Jung; Lee, So-Yeon; Shin, Yu Ri; Park, Chang Suk; Kim, Kijun			The Value of Diffusion-Weighted Imaging in the Differential Diagnosis of Ovarian Lesions: A Meta-Analysis	PLOS ONE			English	Article							PUBLICATION BIAS; ADNEXAL LESIONS; BENIGN; MRI; TUMORS; ACCURACY; MASSES; COEFFICIENTS; ENDOMETRIAL; ADC	Objectives The ability of contrast-enhanced MRI to distinguish between malignant and benign ovarian masses is limited. The aim of this meta-analysis is to evaluate the diagnostic performance of diffusion-weighted imaging (DWI) in differentiating malignant from benign ovarian masses. Methods A comprehensive literature search was performed in several authoritative databases to identify relevant articles. The weighted mean difference (WMD) and corresponding 95% confidence interval (95% CI) were calculated. We also used subgroup analysis to analyze study heterogeneity, and evaluated publication bias. Results The meta-analysis is based on 21 studies, which reported the findings for 731 malignant and 918 benign ovarian masses. There was no significant difference in apparent diffusion coefficient (ADC) values for DWI between benign and malignant lesions (WMD = 0.22, 95% CI = -0.02-0.47, p = 0.08). Subgroup analysis by benign tumor type revealed higher ADC values (or a trend toward higher values) for cysts, cystadenomas and other benign tumors compared to malignant masses (cyst: WMD = 0.54, 95% CI = -0.05-1.12, p = 0.07; cystadenoma: WMD = 0.73, 95% CI = 0.38-1.07, p < 0.0001; other benign tumor: WMD = 0.16, 95% CI = -0.13-0.46, p = 0.28). On the other hand, lower ADC values (or a trend toward lower values) were observed for endometrioma and teratoma compared to malignant masses (endometrioma: WMD = -0.09, 95% CI = -0.47-0.29, p = 0.64; teratoma: WMD = -0.49, 95% CI = -0.85-0.12, p = 0.009). Subgroup analysis by mass property revealed higher ADC values in cystic tumor types than in solid types for both benign and malignant tumors. Significant study heterogeneity was observed. There was no notable publication bias. Conclusions Quantitative DWI is not a reliable diagnostic method for differentiation between benign and malignant ovarian masses. This knowledge is essential in avoiding misdiagnosis of ovarian masses.	[Kim, Hyun-Jung] Korea Univ, Coll Med, Dept Prevent Med, Seoul 136705, South Korea; [Lee, So-Yeon] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Shin, Yu Ri; Park, Chang Suk; Kim, Kijun] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Radiol, Incheon, South Korea	Korea University; Korea University Medicine (KU Medicine); Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Shin, YR (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Radiol, Incheon, South Korea.	crystal57@daum.net		Lee, So-Yeon/0000-0002-0109-0998				Bakir B, 2011, BRIT J RADIOL, V84, P600, DOI 10.1259/bjr/90706205; Cappabianca S, 2013, TUMORI J, V99, P210, DOI 10.1700/1283.14194; Chilla B, 2011, EUR RADIOL, V21, P1301, DOI 10.1007/s00330-010-2018-x; Coats JS, 2009, PEDIATR NEUROL, V41, P263, DOI 10.1016/j.pediatrneurol.2009.04.013; Fujii S, 2008, J MAGN RESON IMAGING, V28, P1149, DOI 10.1002/jmri.21575; Glas AS, 2003, J CLIN EPIDEMIOL, V56, P1129, DOI 10.1016/S0895-4356(03)00177-X; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Inci E, 2011, TURK KLIN TIP BILIM, V31, P86, DOI 10.5336/medsci.2009-15860; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Katayama M, 2002, J COMPUT ASSIST TOMO, V26, P250, DOI 10.1097/00004728-200203000-00015; Kierans AS, 2013, J MAGN RESON IMAGING, V37, P164, DOI 10.1002/jmri.23794; Koc Z, 2012, J MAGN RESON IMAGING, V35, P650, DOI 10.1002/jmri.22871; Koh DM, 2007, AM J ROENTGENOL, V188, P1622, DOI 10.2214/AJR.06.1403; Kozawa E, 2014, CLIN IMAG, V38, P483, DOI 10.1016/j.clinimag.2014.01.014; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Li WH, 2012, ABDOM IMAGING, V37, P897, DOI 10.1007/s00261-011-9814-x; Mironov S, 2007, RADIOL CLIN N AM, V45, P149, DOI 10.1016/j.rcl.2006.10.012; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moteki T, 2002, MAGN RESON IMAGING, V20, P463, DOI 10.1016/S0730-725X(02)00524-6; Moteki T, 2000, J MAGN RESON IMAGING, V12, P1014, DOI 10.1002/1522-2586(200012)12:6<1014::AID-JMRI29>3.3.CO;2-K; Nakayama T, 2005, J MAGN RESON IMAGING, V22, P271, DOI 10.1002/jmri.20369; NYBERG DA, 1987, J COMPUT ASSIST TOMO, V11, P664, DOI 10.1097/00004728-198707000-00021; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Song FJ, 1998, BRIT MED J, V316, P471; Takeuchi M, 2013, ACTA RADIOL, V54, P231, DOI 10.1258/ar.2012.120516; Takeuchi M, 2011, J COMPUT ASSIST TOMO, V35, P343, DOI 10.1097/RCT.0b013e318218c09e; Takeuchi M, 2010, J COMPUT ASSIST TOMO, V34, P173, DOI 10.1097/RCT.0b013e3181c2f0a2; Tamai K, 2008, EUR RADIOL, V18, P723, DOI 10.1007/s00330-007-0787-7; Tamai K, 2007, J MAGN RESON IMAGING, V26, P682, DOI 10.1002/jmri.20997; Thoeny HC, 2007, EUR RADIOL, V17, P1385, DOI 10.1007/s00330-006-0547-0; Thomassin-Naggara I, 2009, EUR RADIOL, V19, P1544, DOI 10.1007/s00330-009-1299-4; Vamvakas EC, 1998, ARCH PATHOL LAB MED, V122, P675; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yamashita Y, 1998, JMRI-J MAGN RESON IM, V8, P367, DOI 10.1002/jmri.1880080216; Zhang H, 2014, ARCH GYNECOL OBSTET, V289, P357, DOI 10.1007/s00404-013-2990-x; Zhang H, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-58; Zhang H, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-33; Zhang JL, 2010, RADIOLOGY, V254, P783, DOI 10.1148/radiol.09090891; Zhang P, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-237; 허숙희, 2005, [Journal of the Korean Society of Radiology (JKSR), 대한영상의학회지], V52, P191	42	56	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149465	10.1371/journal.pone.0149465	http://dx.doi.org/10.1371/journal.pone.0149465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907919	Green Submitted, Green Published, gold			2022-12-27	WOS:000371163000012
J	Tardif, KD; Pyne, MT; Malmberg, E; Lunt, TC; Schlaberg, R				Tardif, Keith D.; Pyne, Michael T.; Malmberg, Elisabeth; Lunt, Tatum C.; Schlaberg, Robert			Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; CANCER; AMERICAN; PERFORMANCE; PROGRAM; ATHENA; MEDIA; WOMEN	None of the commercial HPV tests are U.S. FDA-approved for testing of cervical cytology specimens in SurePath preservative. Still, similar to 30% of HPV testing is performed on specimens in this formalin-containing preservative. Formalin-induced DNA fragmentation and cross-linking may interfere with HPV detection. We evaluated analytical sensitivity and specimen stability of the cobas 4800 HPV (Roche) and Hybrid Capture 2 HPV (HC2, Qiagen) tests with residual cervical cytology samples in SurePath preservative available within 1 week of collection. Cobas testing was performed with and without heating samples at 120 degrees C for 20 min diluted 1: 1 in an alkaline environment (pretreatment) to revert DNA crosslinking. Stability was tested after 2 weeks of storage at ambient temperature followed by <= 10 weeks at 4 degrees C. Analytical sensitivity and positivity rates (HC2, 18%; cobas pretreated, 46%; cobas untreated, 47%) were greater for cobas than HC2 (n = 682). After 6 weeks of storage, mean HC2 ratios were lower (mean 0.9, SD 6.3) but high variability limited statistical power to detect trends. Cobas threshold cycles (Ct's) increased in untreated (mean 2.1) but not pretreated samples (mean 0.3; n = 110; p <= 0.0001). Overall, cobas had greater analytical sensitivity for samples in SurePath preservative. Although pretreatment introduced a manual sample transfer step and 30 min of incubation times, it improved stability without negatively affecting analytical sensitivity. While awaiting results of large trials to evaluate the clinical performance of cobas, the addition of the pretreatment step may improve the detection of HPV, especially after prolonged sample storage.	[Tardif, Keith D.; Pyne, Michael T.; Malmberg, Elisabeth; Lunt, Tatum C.; Schlaberg, Robert] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA; [Schlaberg, Robert] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; ARUP Laboratories; Utah System of Higher Education; University of Utah	Schlaberg, R (corresponding author), ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA.; Schlaberg, R (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT USA.	robert.schlaberg@path.utah.edu			Roche Molecular Systems; Roche Diagnostics; ARUP Institute for Clinical and Experimental Pathology; Roche Diagnostics and Hologic	Roche Molecular Systems; Roche Diagnostics; ARUP Institute for Clinical and Experimental Pathology; Roche Diagnostics and Hologic	This study was funded in part by Roche Molecular Systems, which provided financial, instrumentation, and reagent support. This work was sponsored in part by Roche Diagnostics and the ARUP Institute for Clinical and Experimental Pathology. RS has received research support from Roche Diagnostics and Hologic, speaker honorarium from Roche Diagnostics, and an advisory board member for Roche Diagnostics. Study design, sample testing, data collection, data analysis, and manuscript preparation were not influenced by funders.	Agreda PM, 2013, J CLIN MICROBIOL, V51, P2702, DOI 10.1128/JCM.00759-13; Anttila A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1804; BD Diagnostics, 2012, BD SUMM B SUREPATH S; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Campos PF, 2012, METHODS MOL BIOL, V840, P81, DOI 10.1007/978-1-61779-516-9_11; Castle PE, 2003, CANCER CYTOPATHOL, V99, P320, DOI 10.1002/cncr.11723; Castle PE, 2003, CANCER CYTOPATHOL, V99, P89, DOI 10.1002/cncr.11058; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Cui M, 2014, J CLIN MICROBIOL, V52, P2210, DOI 10.1128/JCM.00883-14; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; Duval K, 2010, FORENSIC SCI INT-GEN, V4, P80, DOI 10.1016/j.fsigen.2009.06.003; Eversole GM, 2010, ARCH PATHOL LAB MED, V134, P331, DOI 10.1043/1543-2165-134.3.331; Gage JC, 2012, J CLIN MICROBIOL, V50, P61, DOI 10.1128/JCM.05989-11; Gilbert L, 2013, J CLIN MICROBIOL, V51, P3412, DOI 10.1128/JCM.01391-13; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Naryshkin S, 2012, DRUG HEALTHC PATIENT, V4, P167, DOI 10.2147/DHPS.S37273; Naucler P, 2007, NEW ENGL J MED, V357, P1589, DOI 10.1056/NEJMoa073204; Negri G, 2004, AM J CLIN PATHOL, V122, P90, DOI 10.1309/RUDE6NRH2NGENYRR; Powell N, 2006, J VIROL METHODS, V137, P58, DOI 10.1016/j.jviromet.2006.05.033; Rao A, 2013, J CLIN VIROL, V58, P161, DOI 10.1016/j.jcv.2013.06.041; Research WHOaDoRHa, 2008, WHORHR0814; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Rowe LR, 2002, DIAGN CYTOPATHOL, V27, P312, DOI 10.1002/dc.10193; Saslow D, 2012, CA-CANCER J CLIN, V62, P147, DOI 10.3322/caac.21139; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Szarewski A, 2012, J CLIN MICROBIOL, V50, P1867, DOI 10.1128/JCM.00181-12	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149611	10.1371/journal.pone.0149611	http://dx.doi.org/10.1371/journal.pone.0149611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905067	Green Submitted, gold, Green Published			2022-12-27	WOS:000371163000017
J	Sainju, UM				Sainju, Upendra M.			A Global Meta-Analysis on the Impact of Management Practices on Net Global Warming Potential and Greenhouse Gas Intensity from Cropland Soils (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							IRRIGATED CROPPING SYSTEMS; NITROUS-OXIDE EMISSIONS; CARBON SEQUESTRATION; TILLAGE; AGRICULTURE; MITIGATION; FERTILIZER; ROTATION; FLUXES; RICE	Management practices, such as tillage, crop rotation, and N fertilization, may affect net global warming potential (GWP) and greenhouse gas intensity (GHGI), but their global impact on cropland soils under different soil and climatic conditions need further evaluation. Available global data from 57 experiments and 225 treatments were evaluated for individual and combined effects of tillage, cropping systems, and N fertilization rates on GWP and GHGI which accounted for CO2 equivalents from N2O and CH4 emissions with or without equivalents from soil C sequestration rate (Delta SOC), farm operations, and N fertilization. The GWP and GHGI were 66 to 71% lower with no-till than conventional till and 168 to 215% lower with perennial than annual cropping systems, but 41 to 46% greater with crop rotation than monocroppping. With no-till vs. conventional till, GWP and GHGI were 2.6- to 7.4-fold lower when partial than full accounting of all sources and sinks of greenhouse gases (GHGs) were considered. With 100 kg N ha(-1), GWP and GHGI were 3.2 to 11.4 times greater with partial than full accounting. Both GWP and GHGI increased curvilinearly with increased N fertilization rate. Net GWP and GHGI were 70 to 87% lower in the improved combined management that included no-till, crop rotation/perennial crop, and reduced N rate than the traditional combined management that included conventional till, monocopping/annual crop, and recommended N rate. An alternative soil respiration method, which replaces Delta SOC by soil respiration and crop residue returned to soil in the previous year, similarly reduced GWP and GHGI by 133 to 158% in the improved vs. the traditional combined management. Changes in GWP and GHGI due to improved vs. traditional management varied with the duration of the experiment and inclusion of soil and climatic factors in multiple linear regressions improved their relationships. Improved management practices reduced GWP and GHGI compared with traditional management practices and combined management practices were even more effective than individual management practices in reducing net GHG emissions from cropland soils. Partial accounting overestimated GWP and GHGI values as sinks or sources of net GHGs compared with full accounting when evaluating the effect of management practices.	[Sainju, Upendra M.] ARS, USDA, Northern Plain Agr Res Lab, 1500 North Cent Ave, Sidney, MT 59270 USA	United States Department of Agriculture (USDA)	Sainju, UM (corresponding author), ARS, USDA, Northern Plain Agr Res Lab, 1500 North Cent Ave, Sidney, MT 59270 USA.	upendra.sainju@ars.usda.gov			ARS [ARS-0425353] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Adviento-Borbe MAA, 2007, GLOBAL CHANGE BIOL, V13, P1972, DOI 10.1111/j.1365-2486.2007.01421.x; Adviento-Borbe MA, 2013, J ENVIRON QUAL, V42, P1623, DOI 10.2134/jeq2013.05.0167; Alvarez R, 2005, SOIL USE MANAGE, V21, P38, DOI 10.1079/SUM2005291; Angers DA, 2008, SOIL SCI SOC AM J, V72, P1370, DOI 10.2136/sssaj2007.0342; Archer DW, 2010, SOIL SCI SOC AM J, V74, P446, DOI 10.2136/sssaj2009.0080; Barsotti JL, 2013, SOIL SCI SOC AM J, V77, P1012, DOI 10.2136/sssaj2012.0386; Bhatia A, 2005, ATMOS ENVIRON, V39, P6976, DOI 10.1016/j.atmosenv.2005.07.052; BRONSON KF, 1994, BIOL FERT SOILS, V17, P263, DOI 10.1007/BF00383979; Cavigelli MA, 2012, MANAGING AGRICULTURAL GREENHOUSE GASES: COORDINATED AGRICULTURAL RESEARCH THROUGH GRACENET TO ADDRESS OUR CHANGING CLIMATE, P129, DOI 10.1016/B978-0-12-386897-8.00009-7; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Crutzen PJ, 2008, ATMOS CHEM PHYS, V8, P389, DOI 10.5194/acp-8-389-2008; Curtin D, 2000, SOIL SCI SOC AM J, V64, P2080, DOI 10.2136/sssaj2000.6462080x; Dusenbury MP, 2008, J ENVIRON QUAL, V37, P542, DOI 10.2134/jeq2006.0395; Follett RF, 2001, SOIL TILL RES, V61, P77, DOI 10.1016/S0167-1987(01)00180-5; Greenhouse Gas Working Group, 2010, AGR ROL GREENH GAS E; Halvorson AD, 2002, SOIL SCI SOC AM J, V66, P906, DOI 10.2136/sssaj2002.0906; Halvorson AD, 2012, MANAGING AGRICULTURAL GREENHOUSE GASES: COORDINATED AGRICULTURAL RESEARCH THROUGH GRACENET TO ADDRESS OUR CHANGING CLIMATE, P167, DOI 10.1016/B978-0-12-386897-8.00010-3; Huang T, 2013, BIOGEOSCIENCES, V10, P7897, DOI 10.5194/bg-10-7897-2013; IPCC (Intergovernmental Panel on Climate Change), 2007, 4 IPCC SECR; Jensen ES, 2012, AGRON SUSTAIN DEV, V32, P329, DOI 10.1007/s13593-011-0056-7; Johnson JMF, 2011, J ENVIRON QUAL, V40, P1551, DOI 10.2134/jeq2011.0105; Kim DG, 2013, AGR ECOSYST ENVIRON, V168, P53, DOI 10.1016/j.agee.2012.02.021; Lal R, 2004, ENVIRON INT, V30, P981, DOI 10.1016/j.envint.2004.03.005; Lemke RL, 2007, AGRON J, V99, P1719, DOI 10.2134/agronj2006.0327s; Lemke RL, 1999, CAN J SOIL SCI, V79, P15, DOI 10.4141/S98-013; Li B, 2015, ATMOS ENVIRON, V100, P10, DOI 10.1016/j.atmosenv.2014.10.034; Liebig MA, 2010, SOIL SCI SOC AM J, V74, P358, DOI 10.2136/sssaj2008.0368; Liebig MA, 2005, SOIL TILL RES, V83, P25, DOI 10.1016/j.still.2005.02.008; Linquist B, 2012, GLOBAL CHANGE BIOL, V18, P194, DOI 10.1111/j.1365-2486.2011.02502.x; Littell R, 1991, SAS SYSTEM LINEAR MO; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Ma YC, 2013, AGR ECOSYST ENVIRON, V164, P209, DOI 10.1016/j.agee.2012.11.003; Ma Z, 2000, BIOMASS BIOENERG, V18, P105, DOI 10.1016/S0961-9534(99)00076-8; Mosier AR, 2005, NUTR CYCL AGROECOSYS, V72, P67, DOI 10.1007/s10705-004-7356-0; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Peterson GA, 1998, SOIL TILL RES, V47, P207, DOI 10.1016/S0167-1987(98)00107-X; Pittelkow CM, 2013, AGR ECOSYST ENVIRON, V177, P10, DOI 10.1016/j.agee.2013.05.011; Piva JT, 2012, PLANT SOIL, V361, P359, DOI 10.1007/s11104-012-1244-1; Popp M, 2011, AGRON J, V103, P1132, DOI 10.2134/agronj2010.0517; Qin RJ, 2004, AGRON J, V96, P1523, DOI 10.2134/agronj2004.1523; Robertson G. Philip, 2004, Environment Development and Sustainability, V6, P51, DOI 10.1023/B:ENVI.0000003629.32997.9e; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Robertson GP, 1999, SCIENCE, V285, P1852; Ruan LL, 2013, GLOBAL CHANGE BIOL, V19, P2478, DOI 10.1111/gcb.12216; Sainju UM, 2014, SOIL SCI SOC AM J, V78, P936, DOI 10.2136/sssaj2013.12.0514; Sainju UM, 2014, J ENVIRON QUAL, V43, P777, DOI 10.2134/jeq2013.10.0405; Sainju UM, 2014, SOIL SCI SOC AM J, V78, P248, DOI 10.2136/sssaj2013.08.0325; Sainju UM, 2012, J ENVIRON QUAL, V41, P1774, DOI 10.2134/jeq2012.0176; Sainju UM, 2010, J ENVIRON QUAL, V39, P935, DOI 10.2134/jeq2009.0223; Schlesinger WH, 2006, SCIENCE, V314, P1217, DOI 10.1126/science.1137177; Shang QY, 2011, GLOBAL CHANGE BIOL, V17, P2196, DOI 10.1111/j.1365-2486.2010.02374.x; Six J, 2004, GLOBAL CHANGE BIOL, V10, P155, DOI 10.1111/j.1529-8817.2003.00730.x; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P3089, DOI 10.1111/j.1365-2486.2011.02458.x; West TO, 2002, AGR ECOSYST ENVIRON, V91, P217, DOI 10.1016/S0167-8809(01)00233-X; West TO, 2002, SOIL SCI SOC AM J, V66, P1930, DOI 10.2136/sssaj2002.1930	55	42	44	12	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148527	10.1371/journal.pone.0148527	http://dx.doi.org/10.1371/journal.pone.0148527			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901827	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100018
J	Horstmann, S; Sonneck, R				Horstmann, Sebastian; Sonneck, Rainer			Contact Bioassays with Phenoxybenzyl and Tetrafluorobenzyl Pyrethroids against TargetSite and Metabolic Resistant Mosquitoes	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS SAY; VECTOR ANOPHELES-FUNESTUS; SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; AEDES-AEGYPTI; DELTAMETHRIN RESISTANCE; SAUDI-ARABIA; INSECTICIDES; DDT; PYRIPROXYFEN	Background Mosquito strains that exhibit increased tolerance to the chemical class of compounds with a sodium channel modulator mode of action (pyrethroids and pyrethrins) are typically described as "pyrethroid resistant". Resistance to pyrethroids is an increasingly important challenge in the control of mosquito-borne diseases, such as malaria or dengue, because one of the main interventions (the distribution of large numbers of long-lasting insecticide-treated bed nets) currently relies entirely on long-lasting pyrethroids. Increasing tolerance of target insects against this class of insecticides lowers their impact in vector control. The current study suggests that the level of metabolic resistance depends on the structure of the molecule and that structurally different compounds may still be effective because detoxifying enzymes are unable to bind to these uncommon structures. Methods Treated surface contact bioassays were performed on susceptible Aedes aegypti, East African knockdown resistance (kdr) Anopheles gambiae (strain RSP-H) and metabolically resistant Anopheles funestus (strain FUMOZ-R) with different pyrethroids, such as cypermethrin, beta-cyfluthrin, deltamethrin, permethrin and transfluthrin (alone and in combination with the synergist piperonyl butoxide). The nonfluorinated form of transfluthrin was also assessed as a single agent and in combination with piperonyl butoxide. Results Although the dosages for pyrethroids containing a phenoxybenzyl moiety have exhibited differences in terms of effectiveness among the three tested mosquito species, the structurally different transfluthrin with a polyfluorobenzyl moiety remained active in mosquitoes with upregulated P450 levels. In trials with transfluthrin mixed with piperonyl butoxide, the added synergist exhibited no efficacy-enhancing effect. Conclusion The results of this study suggest that transfluthrin has the potential to control P450-mediated metabolically resistant mosquitoes because the structural formula of transfluthrin differs from that of the tested pyrethroids, which are used in vector control. The P450-detoxifying enzymes of the Anopheles funestus FUMOZ-R mosquitoes seem to bind preferably at the phenoxybenzyl moiety and appear to be unable to degrade transfluthrin with its tetrafluorobenzyl moiety. Inhibition of the class of monooxygenases by piperonyl butoxide revealed no increase of efficacy of the pure transfluthrin compound, which also indicates that the P450 enzymes potentially do not impact the efficacy of transfluthrin.	[Horstmann, Sebastian; Sonneck, Rainer] Bayer CropSci AG, Monheim, Germany	Bayer AG; Bayer CropScience	Horstmann, S (corresponding author), Bayer CropSci AG, Monheim, Germany.	Sebastian.Horstmann@bayer.com			Bayer CropScience AG	Bayer CropScience AG(Bayer AG)	The authors of the present study are employees of Bayer CropScience AG at the time laboratory studies were conducted. Bayer CropScience AG acts as employer and provided support in the form of salaries for the authors [SH and RS], but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN AM, 1989, B ENTOMOL RES, V79, P361, DOI 10.1017/S0007485300018356; Barile J., 2008, P 6 INT C URB PESTS; Bass C, 2011, PEST MANAG SCI, V67, P886, DOI 10.1002/ps.2189; Bhupinder PSK, 2002, PYRETHROID INSECTICI, V4, P49; Bong LJ, 2013, J ECON ENTOMOL, V106, P2530, DOI 10.1603/EC13198; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Fang FJ, 2015, PARASITOL RES, V114, P4421, DOI 10.1007/s00436-015-4683-9; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; How YF, 2011, PEST MANAG SCI, V67, P734, DOI 10.1002/ps.2123; Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005; Hunt RH, 2005, MED VET ENTOMOL, V19, P271, DOI 10.1111/j.1365-2915.2005.00574.x; Jones Susan C, 2012, Insects, V3, P593, DOI 10.3390/insects3030593; Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948; Liu Nannan, 2006, Insect Science, V13, P159, DOI 10.1111/j.1744-7917.2006.00078.x; Ma W, 2010, J ECON ENTOMOL, V103, P158, DOI 10.1603/EC09122; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Perry T, 2011, INSECT BIOCHEM MOLEC, V41, P411, DOI 10.1016/j.ibmb.2011.03.003; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Scott JG, 2001, PEST MANAG SCI, V57, P958, DOI 10.1002/ps.354; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; Soderlund DM, 2003, INSECT BIOCHEM MOLEC, V33, P563, DOI 10.1016/S0965-1748(03)00023-7; Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003; Tan JG, 2007, PEST MANAG SCI, V63, P960, DOI 10.1002/ps.1419; Toews MD, 2003, J ECON ENTOMOL, V96, P1967, DOI 10.1603/0022-0493-96.6.1967; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; Wakeling EN, 2012, PYRETHROIDS THEIR EF; Weerasinghe IS, 2001, J PESTIC SCI, V26, P158; Wege PJ, 1999, P 3 INT C URB PESTS; Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67; Xu QA, 2006, GENE, V379, P62, DOI 10.1016/j.gene.2006.04.013; Yoshida T, 2013, J CHROMATOGR B, V913, P77, DOI 10.1016/j.jchromb.2012.11.025; Zhang L, 1998, ARCH INSECT BIOCHEM, V37, P215, DOI 10.1002/(SICI)1520-6327(1998)37:3&lt;215::AID-ARCH4&gt;3.0.CO;2-R; Zhu F, 2010, ARCH INS BIOCH PHYS, V73, P1; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	35	21	22	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149738	10.1371/journal.pone.0149738	http://dx.doi.org/10.1371/journal.pone.0149738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930058	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500049
J	Bezerra-Silva, PC; Dutra, KA; Santos, GKN; Silva, RCS; Iulek, J; Milet-Pinheiro, P; Navarro, DMAF				Bezerra-Silva, Patricia C.; Dutra, Kamilla A.; Santos, Geanne K. N.; Silva, Rayane C. S.; Iulek, Jorge; Milet-Pinheiro, Paulo; Navarro, Daniela M. A. F.			Evaluation of the Activity of the Essential Oil from an Ornamental Flower against Aedes aegypti: Electrophysiology, Molecular Dynamics and Behavioral Assays	PLOS ONE			English	Article							ODORANT-BINDING-PROTEIN; YELLOW-FEVER MOSQUITO; CHEMICAL-COMPOSITION; REPELLENT ACTIVITY; ANOPHELES-GAMBIAE; OVIPOSITION; DIPTERA; CULICIDAE; IDENTIFICATION; ATTRACTANTS	Dengue fever has spread worldwide and affects millions of people every year in tropical and subtropical regions of Africa, Asia, Europe and America. Since there is no effective vaccine against the dengue virus, prevention of disease transmission depends entirely on regulating the vector (Aedes aegypti) or interrupting human-vector contact. The aim of this study was to assess the oviposition deterrent activity of essential oils of three cultivars of torch ginger (Etlingera elatior, Zingiberaceae) against the dengue mosquito. Analysis of the oils by gas chromatography (GC)-mass spectrometry revealed the presence of 43 constituents, of which a-pinene, dodecanal and n-dodecanol were the major components in all cultivars. Solutions containing 100 ppm of the oils exhibited oviposition deterrent activities against gravid Ae. aegypti females. GC analysis with electroantennographic detection indicated that the oil constituents n-decanol, 2-undecanone, undecanal, dodecanal, trans-caryophyllene, (E)-beta-farnesene, alpha-humulene, n-dodecanol, isodaucene and dodecanoic acid were able to trigger antennal depolarization in Ae. aegypti females. Bioassays confirmed that solutions containing 50 ppm of n-dodecanol or dodecanal exhibited oviposition deterrent activities, while a solution containing the alcohol and aldehyde in admixture at concentrations representative of the oil presented an activity similar to that of the 100 ppm oil solution. Docking and molecular dynamics simulations verified that the interaction energies of the long-chain oil components and Ae. aegypti odorant binding protein 1 were quite favorable, indicating that the protein is a possible oviposition deterrent receptor in the antenna of Ae. aegypti.	[Bezerra-Silva, Patricia C.; Dutra, Kamilla A.; Santos, Geanne K. N.; Silva, Rayane C. S.; Milet-Pinheiro, Paulo; Navarro, Daniela M. A. F.] Univ Fed Pernambuco, Dept Quim Fundamental, Lab Ecol Quim, BR-50670901 Recife, PE, Brazil; [Iulek, Jorge] Univ Estadual Ponta Grossa, Dept Quim, Lab Purificacao & Determinacao Estruturas Prot, BR-84070900 Ponta Grossa, PR, Brazil; [Dutra, Kamilla A.] Univ Fed Rural Pernambuco, Dept Agron, Lab Entomol Agr, BR-52171900 Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Estadual de Ponta Grossa; Universidade Federal Rural de Pernambuco (UFRPE)	Bezerra-Silva, PC (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Lab Ecol Quim, BR-50670901 Recife, PE, Brazil.	patricia.c.bezerra@hotmail.com	Bezerra-Silva, Patricia C/E-8746-2016; Pinheiro, Paulo Milet/P-7035-2015; Navarro, Daniela Maria do Amaral Ferraz/C-4975-2013; Navarro, Daniela Maria do Amaral Ferraz/GXM-4019-2022; Santos, Geanne K N/Q-8702-2016; Iulek, Jorge/G-4356-2019	Bezerra-Silva, Patricia C/0000-0002-3774-8528; Pinheiro, Paulo Milet/0000-0002-4929-2177; Navarro, Daniela Maria do Amaral Ferraz/0000-0003-0158-7221; Iulek, Jorge/0000-0002-2293-4950; Silva, Rayane Cristine Santos da/0000-0002-4765-7283	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco : Pronex/FACEPE/CNPq [APQ-0981-1.06/08]; FACEPE/PPSUS [APQ-1336-4.00/08]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Dengue Institute/CNPq [15204 CNPQ/ICB/DBI/DENGUE]	Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco : Pronex/FACEPE/CNPq; FACEPE/PPSUS(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Dengue Institute/CNPq	This work was supported by Fundacao de Amparo a Ciencia e Tecnologia de Pernambuco (http://facepe.br/): Pronex/FACEPE/CNPq (APQ-0981-1.06/08); FACEPE/PPSUS-2008 (APQ-1336-4.00/08); and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://www.cnpq.br/): Dengue Institute/CNPq (15204 CNPQ/ICB/DBI/DENGUE).	Abdelmageed AHA, 2011, J MED PLANTS RES, V5, P3432; ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Adams R. P, 2009, IDENTIFICATION ESSEN; [Anonymous], 2009, WHOHTMNTDDEN20091; [Anonymous], 1980, OLFACTION TASTE; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; BENTLEY MD, 1989, ANNU REV ENTOMOL, V34, P401, DOI 10.1146/annurev.en.34.010189.002153; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Blank Arie F., 2007, Rev. bras. farmacogn., V17, P557, DOI 10.1590/S0102-695X2007000400014; Cadavid-Restrepo G, 2012, MEM I OSWALDO CRUZ, V107, P74, DOI 10.1590/S0074-02762012000100010; Campbell CJ, 2009, ANAL ESSENTIAL EDIBL; Campbell C, 2011, ENTOMOL EXP APPL, V138, P21, DOI 10.1111/j.1570-7458.2010.01072.x; Carvalho E, 2015, BRASIL TEM 745 9 MIL; Case DA, 2012, AMBER 14; Choochote W, 2007, FITOTERAPIA, V78, P359, DOI 10.1016/j.fitote.2007.02.006; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; Cooperband MF, 2008, J INSECT PHYSIOL, V54, P1184, DOI 10.1016/j.jinsphys.2008.05.003; Dekker T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-183; Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; Gil A, 2002, J AGR FOOD CHEM, V50, P2870, DOI 10.1021/jf011128i; Gopal JV, 2013, INTERDISCIP SCI, V5, P280, DOI 10.1007/s12539-013-0152-2; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HWANG YS, 1984, J CHEM ECOL, V10, P145, DOI 10.1007/BF00987651; HWANG YS, 1980, J CHEM ECOL, V6, P71, DOI 10.1007/BF00987528; Ishida Y, 2004, NATURWISSENSCHAFTEN, V91, P426, DOI 10.1007/s00114-004-0551-7; Jaafar FM, 2007, J ANAL SCI, V10, P269; Jakalian A, 2000, J COMPUT CHEM, V21, P132, DOI 10.1002/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kline DL, 2006, J AM MOSQUITO CONTR, V22, P490, DOI 10.2987/8756-971X(2006)22[490:TATTFA]2.0.CO;2; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Lagarde A, 2011, J MOL BIOL, V414, P401, DOI 10.1016/j.jmb.2011.10.005; Leal WS., 2003, INSECT PHEROMONE BIO; Leite NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008006; Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131; Mao Y, 2010, P NATL ACAD SCI USA, V107, P19102, DOI 10.1073/pnas.1012274107; Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015; Milam CD, 2000, ARCH ENVIRON CON TOX, V39, P324, DOI 10.1007/s002440010111; Milet-Pinheiro P, 2014, CHEMOECOLOGY; Navarro D.M.A.F., 2013, NAT PROD J, V3, P1; Navarro DMAF, 2003, J APPL ENTOMOL, V127, P46, DOI 10.1046/j.1439-0418.2003.00690.x; Oliferenko PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064547; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Pohlit AM, 2011, PLANTA MED, V77, P618, DOI 10.1055/s-0030-1270949; Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531; Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007; PUTIEVSKY E, 1986, J NAT PROD, V49, P326, DOI 10.1021/np50044a023; Rezza G, 2014, EMERG INFECT DIS ELS; Sant'Ana AL, 2003, AVALIACAO EXTRACAO I; Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020; Saude M da, 2015, BOL EPIDEMIOLOGICO, P7; Sivakumar R, 2011, ASIAN PAC J TROP MED, V4, P706, DOI 10.1016/S1995-7645(11)60178-8; Aguiar RWS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116765; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; Tawatsin A, 2001, J VECTOR ECOL, V26, P76; Tawatsin Apiwat, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P915; Tripathi A.K., 2009, J PHARMACOGNOSY PHYT, V30, P52; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; vanderWerf HMG, 1996, AGR ECOSYST ENVIRON, V60, P81, DOI 10.1016/S0167-8809(96)01096-1; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Ziemba BP, 2013, PROTEIN SCI, V22, P11, DOI 10.1002/pro.2179; Zoghbi MDGB, 2005, J ESSENT OIL RES, V17, P209	67	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150008	10.1371/journal.pone.0150008	http://dx.doi.org/10.1371/journal.pone.0150008			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927837	Green Published, gold			2022-12-27	WOS:000371424200019
J	Venugopal, PD; Dively, GP; Herbert, A; Malone, S; Whalen, J; Lamp, WO				Venugopal, P. Dilip; Dively, Galen P.; Herbert, Ames; Malone, Sean; Whalen, Joanne; Lamp, William O.			Contrasting Role of Temperature in Structuring Regional Patterns of Invasive and Native Pestilential Stink Bugs	PLOS ONE			English	Article							HALYOMORPHA-HALYS HEMIPTERA; LIFE TABLE ANALYSIS; CLIMATE-CHANGE; PENTATOMIDAE; ECOLOGY; HETEROPTERA; MANAGEMENT; DISPERSAL; BIOLOGY; EMERGENCE	Objectives Assessment and identification of spatial structures in the distribution and abundance of invasive species is important for unraveling the underlying ecological processes. The invasive agricultural insect pest Halyomorpha halys that causes severe economic losses in the United States is currently expanding both within United States and across Europe. We examined the drivers of H. halys invasion by characterizing the distribution and abundance patterns of H. halys and native stink bugs (Chinavia hilaris and Euschistus servus) across eight different spatial scales. We then quantified the interactive and individual influences of temperature, and measures of resource availability and distance from source populations, and their relevant spatial scales. We used Moran's Eigenvector Maps based on Gabriel graph framework to quantify spatial relationships among the soybean fields in mid-Atlantic Unites States surveyed for stink bugs. Findings Results from the multi-spatial scale, multivariate analyses showed that temperature and its interaction with resource availability and distance from source populations structures the patterns in H. halys at very broad spatial scale. H. halys abundance decreased with increasing average June temperature and distance from source population. H. halys were not recorded at fields with average June temperature higher than 23.5 degrees C. In parts with suitable climate, high H. halys abundance was positively associated with percentage developed open area and percentage deciduous forests at 250m scale. Broad scale patterns in native stink bugs were positively associated with increasing forest cover and, in contrast to the invasive H. halys, increasing mean July temperature. Our results identify the contrasting role of temperature in structuring regional patterns in H. halys and native stink bugs, while demonstrating its interaction with resource availability and distance from source populations for structuring H. halys patterns. Conclusion These results help predicting the pest potential of H. halys and vulnerability of agricultural systems at various regions, given the climatic conditions, and its interaction with resource availability and distance from source populations. Monitoring and control efforts within parts of the United States and Europe with more suitable climate could focus in areas of periurban developments with deciduous forests and other host plants, along with efforts to reduce propagule pressure.	[Venugopal, P. Dilip; Dively, Galen P.; Lamp, William O.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Herbert, Ames; Malone, Sean] Virginia Polytech Inst & State Univ, Tidewater Agr Res & Educ Ctr, Suffolk, VA USA; [Whalen, Joanne] Univ Delaware, Dept Entomol & Wildlife Ecol, Newark, DE USA	University System of Maryland; University of Maryland College Park; Virginia Polytechnic Institute & State University; University of Delaware	Venugopal, PD (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	venugopal.dilip@gmail.com		Venugopal, Dilip/0000-0001-6339-5087	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education Graduate Student grant [GNE-12-047]; Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food Agriculture [MD-ENTM-1016]	United Soybean Board; Maryland Soybean Board; Maryland Grain Producers Utilization Board; Cosmos Club Foundation; Northeast Sustainable Agriculture Research and Education Graduate Student grant; Dept. of Entomology, Univ. of Maryland; United States Department of Agriculture - National Institute of Food Agriculture	The work was supported by the following: United Soybean Board, http://unitedsoybean.org/ (GPD PDV); Maryland Soybean Board, http://mdsoy.com/ (GPD); Maryland Grain Producers Utilization Board, http://www.marylandgrain.com/ (GPD); Cosmos Club Foundation, http://www.cosmosclubfoundation.org/ (PDV); Northeast Sustainable Agriculture Research and Education Graduate Student grant - GNE-12-047, http://www.nesare.org/ (PDV, WOL, GPD); Arthur B. Gahan Fellowship, Dept. of Entomology, Univ. of Maryland, http://entomology.umd.edu/academics/graduate/awardopportunities/gahanfellowshipfund (PDV); and United States Department of Agriculture - National Institute of Food & Agriculture Hatch Project #MD-ENTM-1016, http://www.csrees.usda.gov/ (WOL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrewartha H.G., 1986, ECOLOGICAL WEB MORE; [Anonymous], 1946, PHYSIOGRAPHIC DIVISI; Aukema JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024587; Bacon SJ, 2014, DIVERS DISTRIB, V20, P84, DOI 10.1111/ddi.12149; Bakken AJ, 2015, ENVIRON ENTOMOL, V44, P1011, DOI 10.1093/ee/nvv092; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Bivand R, 2015, J STAT SOFTW, V63, P1; Blanchet FG, 2008, ECOLOGY, V89, P2623, DOI 10.1890/07-0986.1; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; BREWER FD, 1985, ANN ENTOMOL SOC AM, V78, P620, DOI 10.1093/aesa/78.5.620; Catford JA, 2010, DIVERS DISTRIB, V16, P20, DOI 10.1111/j.1472-4642.2009.00631.x; Catford JA, 2009, DIVERS DISTRIB, V15, P22, DOI 10.1111/j.1472-4642.2008.00521.x; Commonwealth of Australia, 2015, BROWN MARM STINK BUG; Crespo-Perez V, 2011, LANDSCAPE ECOL, V26, P1447, DOI 10.1007/s10980-011-9649-4; Da Silva Paul G, 2014, J Econ Entomol, V107, P166, DOI 10.1603/EC13272; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S., 2013, SPACEMAKER SPATIAL M; Dray S., 2009, PACKFOR FORWARD SELE; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; ESRI, 2011, ARCGIS DESKT REL 10; Foxcroft LC, 2009, DIVERS DISTRIB, V15, P367, DOI 10.1111/j.1472-4642.2008.00544.x; Fraterrigo JM, 2014, ECOL LETT, V17, P1447, DOI 10.1111/ele.12352; Funayama K, 2013, J ECON ENTOMOL, V106, P2141, DOI 10.1603/EC13240; Gariepy TD, 2015, J PEST SCI, V88, P451, DOI 10.1007/s10340-015-0672-0; Gariepy TD, 2014, J PEST SCI, V87, P17, DOI 10.1007/s10340-013-0529-3; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Han WG, 2014, J GEOGR, V113, P129, DOI 10.1080/00221341.2013.838286; Han WG, 2012, COMPUT ELECTRON AGR, V84, P111, DOI 10.1016/j.compag.2012.03.005; Haye T, 2014, J PEST SCI, V87, P407, DOI 10.1007/s10340-014-0560-z; Haye T, 2015, J PEST SCI, V88, P665, DOI 10.1007/s10340-015-0670-2; Hirose E, 2006, NEOTROP ENTOMOL, V35, P757, DOI 10.1590/S1519-566X2006000600006; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hufbauer RA, 2012, EVOL APPL, V5, P89, DOI 10.1111/j.1752-4571.2011.00211.x; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jones AL, 2014, BIOL CONTROL, V78, P61, DOI 10.1016/j.biocontrol.2014.07.011; JONES WA, 1981, ENVIRON ENTOMOL, V10, P409, DOI 10.1093/ee/10.3.409; Kamminga KL, 2012, J INTEGR PEST MANAG, V3, DOI 10.1603/IPM12006; Karl TR, 1984, 43 NAT CLIM DAT CTR, P39; Kenis M, 2009, BIOL INVASIONS, V11, P21, DOI 10.1007/s10530-008-9318-y; KOGAN M, 1987, ANNU REV ENTOMOL, V32, P507, DOI 10.1146/annurev.en.32.010187.002451; Lee DH, 2014, J INSECT BEHAV, V27, P639, DOI 10.1007/s10905-014-9456-2; Lee DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091575; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; LEGENDRE P, 1989, VEGETATIO, V80, P107, DOI 10.1007/BF00048036; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Leskey TC, 2015, ENVIRON ENTOMOL, V44, P746, DOI 10.1093/ee/nvv049; McIntire EJB, 2009, ECOLOGY, V90, P46, DOI 10.1890/07-2096.1; McPherson J.E., 2000, STINK BUGS EC IMPORT; Menke SB, 2007, ECOLOGY, V88, P3164, DOI 10.1890/07-0122.1; Munoz F, 2009, ECOL MODEL, V220, P2683, DOI 10.1016/j.ecolmodel.2009.07.008; National Centers for Environmental Information, 2015, CLIM DAT ONL; Nielsen AL, 2008, ENVIRON ENTOMOL, V37, P348, DOI 10.1603/0046-225X(2008)37[348:DREALT]2.0.CO;2; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Niva CC, 2003, ZOOL SCI, V20, P963, DOI 10.2108/zsj.20.963; O'Neill KM, 2002, J AGR URBAN ENTOMOL, V19, P125; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ollier S, 2006, BIOMETRICS, V62, P471, DOI 10.1111/j.1541-0420.2005.00497.x; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; R Core Team, 2021, R LANGUAGE ENV STAT; Reisig DD, 2013, ENVIRON ENTOMOL, V42, P1184, DOI 10.1603/EN13166; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; Rouget M, 2003, AM NAT, V162, P713, DOI 10.1086/379204; Rouget Mathieu, 2002, Biological Invasions, V4, P397, DOI 10.1023/A:1023611713339; Roura-Pascual N, 2011, P NATL ACAD SCI USA, V108, P220, DOI 10.1073/pnas.1011723108; Shelford VE, 1918, SCIENCE, V48, P225, DOI 10.1126/science.48.1235.225; SIMMONS AM, 1988, ENVIRON ENTOMOL, V17, P527, DOI 10.1093/ee/17.3.527; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Storch D, 2008, ECOL LETT, V11, P771, DOI 10.1111/j.1461-0248.2008.01206.x; Swinton J., 2013, VENNERABLE VENN EULE; Toyama M, 2006, APPL ENTOMOL ZOOL, V41, P309, DOI 10.1303/aez.2006.309; Venugopal PD, 2015, J ECON ENTOMOL, V108, P2231, DOI 10.1093/jee/tov188; Venugopal PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109917; Wagner HH, 2005, ECOLOGY, V86, P1975, DOI 10.1890/04-0914; Wallner AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095691; Ward N, 2013, SURVEILLANCE, V40, P38; Wiman NG, 2015, J PEST SCI, V88, P37, DOI 10.1007/s10340-014-0582-6; With KA, 2002, CONSERV BIOL, V16, P1192, DOI 10.1046/j.1523-1739.2002.01064.x; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	83	9	9	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150649	10.1371/journal.pone.0150649	http://dx.doi.org/10.1371/journal.pone.0150649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928562	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200043
J	Brath, H; Grabovac, I; Schalk, H; Degen, O; Dorner, TE				Brath, Helmut; Grabovac, Igor; Schalk, Horst; Degen, Olaf; Dorner, Thomas E.			Prevalence and Correlates of Smoking and Readiness to Quit Smoking in People Living with HIV in Austria and Germany	PLOS ONE			English	Article							CIGARETTE-SMOKING; CESSATION; HEALTH; ASSOCIATION; SMOKERS; INDIVIDUALS; POPULATION; AIDS; MEN; STRATEGIES	We aimed to investigate the prevalence and correlates of smoking in people living with HIV (PLWHIV) in Germany and Austria and their readiness to quit. A total of 447 consecutive patients with confirmed positive HIV status who were treated in different outpatient HIV centres in Austria and Germany were included. Nicotine dependence and stages of change were assessed by standardized questionnaires, and this was confirmed by measuring exhaled carbon monoxide. Prevalence of smoking was 49.4%. According to a multivariate logistic regression analysis, higher age (for each year of life OR = 0.96; 95% CI 0.92-1.00) and tertiary education level (OR = 0.43; 95% CI 0.15-0.79) were associated with a lower chance, and occasional (OR = 3.75; 95% CI 1.74-8.07) and daily smoking of the partner (OR 8.78; 95% CI 4.49-17.17) were significantly associated with a higher chance of smoking. Moderate (OR = 3.41; 95% CI = 1.30-9.05) and higher nicotine dependency level (OR = 3.40; 95% CI 1.46-7.94), were significantly associated with higher chance, and older age (for each year of life OR = 0.95; 95% CI = 0.91-0.99), with lower chance for readiness to quit smoking. Those results may be used to address preventive measures to quit smoking aimed at PLWHIV and the importance of addressing smoking habits.	[Brath, Helmut] Hlth Ctr South, Vienna, Austria; [Grabovac, Igor] Med Univ Vienna, Univ Clin Internal Med 2, Inst Occupat Med, Vienna, Austria; [Schalk, Horst] Schalk Pichler Grp Practice, Vienna, Austria; [Degen, Olaf] Univ Clin Hamburg Eppendorf, Outpatient Ctr, Hamburg, Germany; [Dorner, Thomas E.] Med Univ Vienna, Inst Social Med, Ctr Publ Hlth, Vienna, Austria	Medical University of Vienna; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Vienna	Grabovac, I (corresponding author), Med Univ Vienna, Univ Clin Internal Med 2, Inst Occupat Med, Vienna, Austria.	igor.grabovac@meduniwien.ac.at	Grabovac, Igor/F-9210-2017	Grabovac, Igor/0000-0001-9605-1467; Dorner, Thomas Ernst/0000-0002-5218-1160	OGNA (Osterreichische Gesellschaft niedergelassener Arzte zur Betreuung HIV-Infizierter); DAGNA (Deutsche Arbeitsgemeinschaft niedergelassener Arzte in der Versorgung HIV-Infizierter); ViiV healthcare Germany; GSK Austria; Schalk-Pichler Group Practice	OGNA (Osterreichische Gesellschaft niedergelassener Arzte zur Betreuung HIV-Infizierter); DAGNA (Deutsche Arbeitsgemeinschaft niedergelassener Arzte in der Versorgung HIV-Infizierter); ViiV healthcare Germany; GSK Austria; Schalk-Pichler Group Practice	The study was funded by: OGNA (Osterreichische Gesellschaft niedergelassener Arzte zur Betreuung HIV-Infizierter) and DAGNA (Deutsche Arbeitsgemeinschaft niedergelassener Arzte in der Versorgung HIV-Infizierter). OGNA and DAGNA received a grant by: ViiV healthcare Germany and GSK Austria. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Schalk-Pichler Group Practice provided support in the form of a salary for HS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aung MN, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-419; Austrian Society of Physicians for HIV Care (OGNA), OSTERREICHISCHE HIV; Banks E, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0281-z; Bostan PP, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0131-y; Brown L, 2003, AIDS EDUC PREV, V15, P49, DOI 10.1521/aeap.15.1.49.23844; Collins RL, 2001, HEALTH PSYCHOL, V20, P351, DOI 10.1037//0278-6133.20.5.351; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deveci SE, 2004, RESP MED, V98, P551, DOI 10.1016/j.rmed.2003.11.018; Dorner TE, 2013, WIEN KLIN WOCHENSCHR, V125, P261, DOI 10.1007/s00508-013-0360-0; Dorner TE, 2011, NICOTINE TOB RES, V13, P1068, DOI 10.1093/ntr/ntr179; Eichinger M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126010; Elzi L, 2006, ANTIVIR THER, V11, P787; Etter JF, 1997, PREV MED, V26, P580, DOI 10.1006/pmed.1997.0179; Feldman JG, 2006, AM J PUBLIC HEALTH, V96, P1060, DOI 10.2105/AJPH.2005.062745; Fingeret MC, 2007, BODY IMAGE, V4, P201, DOI 10.1016/j.bodyim.2007.01.005; Fuster M, 2009, HIV MED, V10, P614, DOI 10.1111/j.1468-1293.2009.00735.x; Hannover W, 2003, ELEKTRONISCHES HANDB; Harris JK, 2010, AM J PUBLIC HEALTH, V100, P1245, DOI 10.2105/AJPH.2009.172460; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Hodgetts Geoffrey, 2004, BMC Fam Pract, V5, P12, DOI 10.1186/1471-2296-5-12; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Humfleet GL, 2009, AIDS EDUC PREV, V21, P54, DOI 10.1521/aeap.2009.21.3_supp.54; Kowall B, 2010, EUR J EPIDEMIOL, V25, P393, DOI 10.1007/s10654-010-9452-6; Lampert T, 2013, BUNDESGESUNDHEITSBLA, V56, P631, DOI 10.1007/s00103-012-1663-4; Lampinen TM, 2006, J URBAN HEALTH, V83, P1143, DOI 10.1007/s11524-006-9125-7; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Marshall MM, 2009, AIDS EDUC PREV, V21, P28, DOI 10.1521/aeap.2009.21.3_supp.28; Martinelli Patricia Merly, 2014, Rev. bras. epidemiol., V17, P989, DOI 10.1590/1809-4503201400040016; McKirnan DJ, 2006, SUBST USE MISUSE, V41, P1197, DOI 10.1080/10826080500514503; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Neuberger M, 2013, LANCET, V382, P394, DOI 10.1016/S0140-6736(13)61668-2; Pines H, 2011, AIDS BEHAV, V15, P243, DOI 10.1007/s10461-010-9682-3; Prochaska J O, 1992, Prog Behav Modif, V28, P183; Reynolds NR, 2004, J ASSOC NURSE AIDS C, V15, P37, DOI 10.1177/1055329003261969; Robert Koch Institut, 2014, HIV AIDS IN DEUTSCHL; Rodriguez-Penney AT, 2013, AIDS PATIENT CARE ST, V27, P5, DOI 10.1089/apc.2012.0329; Ruge J, 2008, INT J BEHAV MED, V15, P328, DOI 10.1080/10705500802365607; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Schneider Eileen, 2008, Morbidity and Mortality Weekly Report, V57, P1; Schoberberger R, 1995, Wien Med Wochenschr, V145, P70; Schoberberger R, 1998, Wien Med Wochenschr, V148, P52; Skinner D, 2004, SAHARA J, V1, P157; Statistik Austria, MAIN RESULTS OF THE; Tesoriero JM, 2010, AIDS BEHAV, V14, P824, DOI 10.1007/s10461-008-9449-2; Tooley EM, 2014, BEHAV MED, V9, P1; Tron L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107451; UNAIDS, COUNTRY PROGRESS REP; Vidrine DJ, 2007, AIDS PATIENT CARE ST, V21, P659, DOI 10.1089/apc.2007.0022; Vidrine DJ, 2009, AIDS EDUC PREV, V21, P3, DOI 10.1521/aeap.2009.21.3_supp.3; Vijayaraghavan M, 2014, AIDS BEHAV, V18, P535, DOI 10.1007/s10461-013-0576-z; Webb MS, 2007, J BEHAV MED, V30, P371, DOI 10.1007/s10865-007-9112-9; World Health Organization, WHO REPORT ON THE GL; World Health Organization, EUROPEAN COUNTRY PRO; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193	55	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150553	10.1371/journal.pone.0150553	http://dx.doi.org/10.1371/journal.pone.0150553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919722	Green Published, gold			2022-12-27	WOS:000371274400132
J	Choi, JA; Kim, JS; Jeong, HJ; Lee, JA; Park, CK				Choi, Jin A.; Kim, Jung-Sub; Jeong, Hyun Jin; Lee, Jin Ah; Park, Chan Kee			Ocular Dominance Is Associated with the Ganglion Cell-Inner Plexiform Layer Thickness Profile in the Macula	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPTICAL COHERENCE TOMOGRAPHY; AMBLYOPIC EYES; GLAUCOMA; LATERALITY	Purpose To investigate the characteristics of macular ganglion cell-inner plexiform layer (GCIPL) thickness profiles associated with ocular dominance. Setting Private practice, Seoul, Republic of Korea. Design Comparative case-control study. Methods Both eyes of 199 participants with no ophthalmic abnormalities were included. Participants were imaged by spectral-domain optical coherence tomography, and underwent dominant eye testing using a hole-in-a-card test (sighting dominance) at the same visit. Macular GCIPL, as well as circumpapillary retinal nerve fiber layer (RNFL) thickness were compared for individual patients, according to ocular dominance. Results Ocular dominance occurred predominantly in the right eye (right vs. left: 72.36 vs. 27.60%; P < 0.001). In the comparison of macular GCIPL thickness, the average (81.27 +/- 5.01 mu m vs. 80.66 +/- 6.31 mu m in dominant vs. non-dominant eyes), inferonasal (81.39 +/- 5.47 mu m vs. 80.33 +/- 6.82 mu m, and inferior sectors (77.95 +/- 6.05 mu m vs. 76.97 +/- 8.15 mu m) were significantly different between dominant and non-dominant eyes (P = 0.040, 0.005, and 0.032, respectively). Significant predictors of average GCIPL thickness were spherical equivalent (beta = 1.37, P<0.001), astigmatic power (beta = 1.44, P = 0.009), disc area (beta = 3.90, P < 0.001), average RNFL thickness (beta = 0.22, P<0.001), average cup-to-disc ratio (beta = 5.74, P = 0.002), difference between the inferior and superior quadrant RNFL thicknesses (beta = 0.08, P = 0.024), and ocular dominance (beta = 2.10, P = 0.020). On multivariate regression analysis, ocular dominance was correlated with average GCIPL thickness after adjusting for potential confounders (beta = 1.63, P = 0.048). Conclusions Dominant eyes accompanied significantly thicker average macular GCIPL. This information suggests that macular GCIPL thickness may provide an indicator of the relative dominance of an eye.	[Choi, Jin A.; Lee, Jin Ah] Catholic Univ Korea, Dept Ophthalmol, St Vincents Hosp, Coll Med, Suwon, South Korea; [Kim, Jung-Sub] B & VIIT Eye Ctr, Seoul, South Korea; [Jeong, Hyun Jin; Park, Chan Kee] Catholic Univ Korea, Dept Ophthalmol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Dept Ophthalmol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea.	ckpark@catholic.ac.kr			Catholic Medical Center Research Foundation [5-2014-B0001-00184]	Catholic Medical Center Research Foundation	The authors wish to acknowledge the financial support of the Catholic Medical Center Research Foundation made in the program year of 2014 (5-2014-B0001-00184): The Catholic University of Korea, Seoul, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaza Eriko, 2007, Nippon Ganka Gakkai Zasshi, V111, P322; Altintas O, 2005, J PEDIAT OPHTH STRAB, V42, P216; Baddini-Caramelli C, 2001, J AAPOS, V5, P82, DOI 10.1067/mpa.2001.112678; Bozkurt Banu, 2003, Strabismus, V11, P1, DOI 10.1076/stra.11.1.1.14091; CAPRIOLI J, 1991, AM J OPHTHALMOL, V111, P235, DOI 10.1016/S0002-9394(14)72266-4; Chia A, 2007, INVEST OPHTH VIS SCI, V48, P3533, DOI 10.1167/iovs.06-1489; Choi JA, 2014, NEUROSCI LETT, V558, P197, DOI 10.1016/j.neulet.2013.10.054; Colen T P, 2000, Binocul Vis Strabismus Q, V15, P141; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dickmann A, 2011, J AAPOS, V15, P338, DOI 10.1016/j.jaapos.2011.03.019; Ehrenstein WH, 2005, GRAEF ARCH CLIN EXP, V243, P926, DOI 10.1007/s00417-005-1128-7; Gipponi S, 2013, NEUROL SCI, V34, P841, DOI 10.1007/s10072-012-1103-0; Handa T, 2005, J CATARACT REFR SURG, V31, P1588, DOI 10.1016/j.jcrs.2005.01.015; Huynh SC, 2009, OPHTHALMOLOGY, V116, P1604, DOI 10.1016/j.ophtha.2009.03.013; Jensen BH, 2015, NEUROREPORT, V26, P1071, DOI 10.1097/WNR.0000000000000470; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P7872, DOI 10.1167/iovs.11-7896; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; Repka MX, 2006, AM J OPHTHALMOL, V142, P247, DOI 10.1016/j.ajo.2006.02.030; Rombouts SARB, 1996, NEUROSCI LETT, V221, P1, DOI 10.1016/S0304-3940(96)13260-2; Seijas O, 2007, AM J OPHTHALMOL, V144, P209, DOI 10.1016/j.ajo.2007.03.053; Seong M, 2010, INVEST OPHTH VIS SCI, V51, P1446, DOI 10.1167/iovs.09-4258	23	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150035	10.1371/journal.pone.0150035	http://dx.doi.org/10.1371/journal.pone.0150035			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918335	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400073
J	Jiang, SS; Dai, L; Qin, Y; Xiong, L; Sun, QJ				Jiang, Suisui; Dai, Lei; Qin, Yang; Xiong, Liu; Sun, Qingjie			Preparation and Characterization of Octenyl Succinic Anhydride Modified Taro Starch Nanoparticles	PLOS ONE			English	Article							PHYSICOCHEMICAL PROPERTIES; NANOCRYSTALS; ESTERIFICATION; FILMS; RICE; OSA	The polar surface and hydrophilicity of starch nanoparticles (SNPs) result in their poor dispersibility in nonpolar solvent and poor compatibility with hydrophobic polymers, which limited the application in hydrophobic system. To improve their hydrophobicity, SNPs prepared through self-assembly of short chain amylose debranched from cooked taro starch, were modified by octenyl succinic anhydride (OSA). Size via dynamic light scattering of OSA-SNPs increased compared with SNPs. Fourier transform infrared spectroscopy data indicated the OSA-SNPs had a new absorption peak at 1727 cm(-1), which was the characteristic peak of carbonyl, indicating the formation of the ester bond. The dispersibility of the modified SNPs in the mixture of water with nonpolar solvent increased with increasing of degree of substitution (DS). OSA-SNPs appear to be a potential agent to stabilize the oil-water systems.	[Jiang, Suisui; Dai, Lei; Qin, Yang; Xiong, Liu; Sun, Qingjie] Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China; [Dai, Lei] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China	Qingdao Agricultural University; China Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Sch Food Sci & Engn, Qingdao, Shandong, Peoples R China.	phdsun@163.com	Dai, Lei/HCH-4898-2022	Dai, Lei/0000-0002-9491-6567				Abbas S, 2014, ULTRASON SONOCHEM, V21, P1265, DOI 10.1016/j.ultsonch.2013.12.017; Bao JS, 2003, J AGR FOOD CHEM, V51, P2283, DOI 10.1021/jf020371u; Chen Y, 2008, CARBOHYD POLYM, V73, P8, DOI 10.1016/j.carbpol.2007.10.015; Dai L, 2015, FOOD CHEM, V174, P82, DOI 10.1016/j.foodchem.2014.11.005; Duan B, 2011, STARCH-STARKE, V63, P528, DOI 10.1002/star.201000136; Garcia NL, 2012, POLYM DEGRAD STABIL, V97, P2021, DOI 10.1016/j.polymdegradstab.2012.03.032; Garcia NL, 2011, CARBOHYD POLYM, V84, P203, DOI 10.1016/j.carbpol.2010.11.024; He GQ, 2006, J AGR FOOD CHEM, V54, P2775, DOI 10.1021/jf052981a; Jeon YS, 1999, STARCH-STARKE, V51, P90, DOI 10.1002/(SICI)1521-379X(199903)51:2<90::AID-STAR90>3.3.CO;2-D; Jivan MJ, 2013, FOOD CHEM, V141, P1661, DOI 10.1016/j.foodchem.2013.04.071; Mahadevan B, 2014, FOOD CHEM TOXICOL, V72, P83, DOI 10.1016/j.fct.2014.07.009; Mayol L, 2014, CARBOHYD POLYM, V102, P110, DOI 10.1016/j.carbpol.2013.11.003; Miao M, 2014, FOOD CHEM, V151, P154, DOI 10.1016/j.foodchem.2013.11.043; Namazi H, 2010, CARBOHYD POLYM, V79, P731, DOI 10.1016/j.carbpol.2009.09.033; Payyappilly SS, 2014, SOFT MATTER, V10, P2150, DOI 10.1039/c3sm52699b; Ren LL, 2014, IND CROP PROD, V59, P115, DOI 10.1016/j.indcrop.2014.05.014; Ren LL, 2010, CARBOHYD POLYM, V82, P1010, DOI 10.1016/j.carbpol.2010.05.041; Simsek S, 2012, CARBOHYD POLYM, V90, P1204, DOI 10.1016/j.carbpol.2012.06.039; Song SW, 2008, J APPL POLYM SCI, V107, P418, DOI 10.1002/app.27076; Sweedman MC, 2013, CARBOHYD POLYM, V92, P905, DOI 10.1016/j.carbpol.2012.09.040; Tizzotti MJ, 2013, FOOD HYDROCOLLOID, V31, P365, DOI 10.1016/j.foodhyd.2012.11.023; Wang C, 2014, ARAB J SCI ENG, V39, P6703, DOI 10.1007/s13369-014-1201-9; Wang C, 2013, FOOD CHEM, V141, P3381, DOI 10.1016/j.foodchem.2013.06.029; Wang JP, 2010, J SCI FOOD AGR, V90, P424, DOI 10.1002/jsfa.3832; Xu YF, 2015, FOOD HYDROCOLLOID, V48, P55, DOI 10.1016/j.foodhyd.2015.02.010; Xu Y, 2010, CARBOHYD POLYM, V80, P1078, DOI 10.1016/j.carbpol.2010.01.027; Yusoff A, 2011, FOOD HYDROCOLLOID, V25, P42, DOI 10.1016/j.foodhyd.2010.05.004; Zare Y, 2013, WASTE MANAGE, V33, P598, DOI 10.1016/j.wasman.2012.07.031; Zhang B, 2011, CARBOHYD POLYM, V84, P1276, DOI 10.1016/j.carbpol.2011.01.020; Zheng H, 2009, POLYM COMPOSITE, V30, P474, DOI 10.1002/pc.20612; Zhu J, 2013, FOOD HYDROCOLLOID, V32, P1, DOI 10.1016/j.foodhyd.2012.11.033; Zou JW, 2011, CARBOHYD POLYM, V85, P824, DOI 10.1016/j.carbpol.2011.04.006	32	36	38	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150043	10.1371/journal.pone.0150043	http://dx.doi.org/10.1371/journal.pone.0150043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918568	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400075
J	Steinach, M; Kohlberg, E; Maggioni, MA; Mendt, S; Opatz, O; Stahn, A; Gunga, HC				Steinach, Mathias; Kohlberg, Eberhard; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Gunga, Hanns-Christian			Sleep Quality Changes during Overwintering at the German Antarctic Stations Neumayer II and III: The Gender Factor	PLOS ONE			English	Article							SEASONAL AFFECTIVE-DISORDER; RESTING ENERGY-EXPENDITURE; FAT-FREE MASS; PHYSICAL-ACTIVITY; CIRCADIAN PHASE; SENSEWEAR ARMBAND; ACTIVITY MONITORS; BODY-COMPOSITION; SEX-DIFFERENCES; NATURAL LIGHT	Purpose Antarctic residence holds many challenges to human physiology, like increased psychosocial tension and altered circadian rhythm, known to influence sleep. We assessed changes in sleep patterns during 13 months of overwintering at the German Stations Neumayer II and III from 2008 to 2014, with focus on gender, as many previous investigations were inconclusive regarding gender-based differences or had only included men. Materials & Methods Time in bed, sleep time, sleep efficiency, number of arousals, sleep latency, sleep onset, sleep offset, and physical activity level were determined twice per month during seven overwintering campaigns of n = 54 participants (37 male, 17 female) using actimetry. Data were analyzed using polynomial regression and analysis of covariance for change over time with the covariates gender, inhabited station, overwintering season and influence of physical activity and local sunshine radiation. Results We found overall longer times in bed (p = 0.004) and sleep time (p = 0.014) for women. The covariate gender had a significant influence on time in bed (p<0.001), sleep time (p<0.001), number of arousals (p = 0.04), sleep latency (p = 0.04), and sleep onset (p<0.001). Women separately (p = 0.02), but not men (p = 0.165), showed a linear increase in number of arousals. Physical activity decreased over overwintering time for men (p = 0.003), but not for women (p = 0.174). The decline in local sunshine radiation led to a 48 minutes longer time in bed (p<0.001), 3.8% lower sleep efficiency (p<0.001), a delay of 32 minutes in sleep onset (p<0.001), a delay of 54 minutes in sleep offset (p<0.001), and 11% less daily energy expenditure (p<0.001), for all participants in reaction to the Antarctic winter's darkness-phase. Conclusions Overwinterings at the Stations Neumayer II and III are associated with significant changes in sleep patterns, with dependences from overwintering time and local sunshine radiation. Gender appears to be an influence, as women showed a declining sleep quality, despite that their physical activity remained unchanged, suggesting other causes such as a higher susceptibility to psycho-social stress and changes in environmental circadian rhythm during long-term isolation in Antarctica.	[Steinach, Mathias; Maggioni, Martina Anna; Mendt, Stefan; Opatz, Oliver; Stahn, Alexander; Gunga, Hanns-Christian] Charite, Ctr Space Med & Extreme Environm Berlin, Inst Physiol, D-13353 Berlin, Germany; [Kohlberg, Eberhard] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Maggioni, Martina Anna] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Milan	Steinach, M (corresponding author), Charite, Ctr Space Med & Extreme Environm Berlin, Inst Physiol, D-13353 Berlin, Germany.	mathias.steinach@charite.de	Maggioni, Martina Anna/P-1351-2019; Maggioni, Martina Anna A/M-2931-2016	Maggioni, Martina Anna/0000-0002-6319-8566; Maggioni, Martina Anna A/0000-0002-6319-8566; Mendt, Stefan/0000-0001-8227-9655	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne) [AZ50WB0724, AZ50WB1030, AZ50WB1330]	Federal Ministry for Economic Affairs and Energy (BMWi, Berlin); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne)	All Grants received by the Federal Ministry for Economic Affairs and Energy (BMWi, Berlin, website: http://www.bmwi.de/en); German Space Administration (Raumfahrtmanagement DLR, Bonn-Oberkassel, website: http://www.dlr.de/rd/en); German Aerospace Center (Deutsches Zentrum fur Luft- und Raumfahrt DLR, Cologne, website: http://www.dlr.de/dlr/en) [Grant numbers: "Aktenzeichen 50 Forschung unter Weltraumbedingungen 0724" (AZ50WB0724), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1030" (AZ50WB1030), "Aktenzeichen 50 Forschung unter Weltraumbedingungen 1330" (AZ50WB1330) (to HCG)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert K, 2015, PSYCHONEUROENDOCRINO, V59, P14, DOI 10.1016/j.psyneuen.2015.04.022; Almeida GJM, 2011, PHYS THER, V91, P1367, DOI 10.2522/ptj.20100291; ANGUS RG, 1979, AVIAT SPACE ENVIR MD, V50, P692; Arendt J, 2012, CHRONOBIOL INT, V29, P379, DOI 10.3109/07420528.2012.668997; AWI, 2012, A WEG I POL MAR RES; Barger LK, 2014, LANCET NEUROL, V13, P904, DOI 10.1016/S1474-4422(14)70122-X; Belavy DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060090; Bhattacharyya M, 2008, INT J BIOMETEOROL, V52, P869, DOI 10.1007/s00484-008-0183-2; BIERSNER RJ, 1984, J RES PERS, V18, P491, DOI 10.1016/0092-6566(84)90007-2; BodyMedia Inc., 2010, SENSEWEAR ARMB DISPL; BOGOSLOV.MM, 1974, LANCET, V1, P503, DOI 10.1016/S0140-6736(74)92803-7; Bollinger T, 2010, GERONTOLOGY, V56, P574, DOI 10.1159/000281827; BROADWAY J, 1987, NEUROSCI LETT, V79, P185, DOI 10.1016/0304-3940(87)90694-X; BUGUET A, 1987, SLEEP, V10, P374, DOI 10.1093/sleep/10.4.374; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carvalho FG, 2014, CHRONOBIOL INT, V31, P442, DOI 10.3109/07420528.2013.846350; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; Chae KY, 2009, SLEEP MED, V10, P621, DOI 10.1016/j.sleep.2008.07.009; Conradt R, 1997, Pneumologie, V51 Suppl 3, P721; Corbett RW, 2012, NEUROSCI LETT, V525, P146, DOI 10.1016/j.neulet.2012.06.046; Duffy JF, 2005, J BIOL RHYTHM, V20, P326, DOI 10.1177/0748730405277983; DUNCAN R, 1988, EUR J APPL PHYSIOL, V57, P514, DOI 10.1007/BF00418001; Fields DA, 2002, AM J CLIN NUTR, V75, P453, DOI 10.1093/ajcn/75.3.453; Finan PH, 2015, SLEEP, V38, P1735, DOI 10.5665/sleep.5154; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Goel N, 2005, CHRONOBIOL INT, V22, P905, DOI 10.1080/07420520500263235; Goel N, 2014, J WOMENS HEALTH, V23, P975, DOI 10.1089/jwh.2014.4911; GUNDERSON EK, 1963, ARCH GEN PSYCHIAT, V9, P362; Gunga H. -C., 2015, HUMAN PHYSL EXTREME, P273, DOI [10.1016/B978-0-12-386947-0.00007-1, DOI 10.1016/B978-0-12-386947-0.00007-1]; Hankin BL, 2009, J CLIN CHILD ADOLESC, V38, P460, DOI 10.1080/15374410902976288; Hanninen V, 1996, SOC SCI MED, V43, P1453, DOI 10.1016/0277-9536(96)00045-7; Harb F, 2015, CHRONOBIOL INT, V32, P368, DOI 10.3109/07420528.2014.982757; Ikegawa M, 1998, AVIAT SPACE ENVIR MD, V69, P452; Illner K, 2000, AM J PHYSIOL-ENDOC M, V278, pE308, DOI 10.1152/ajpendo.2000.278.2.E308; Jakicic JM, 2004, MED SCI SPORT EXER, V36, P897, DOI 10.1249/01.MSS.0000126805.32659.43; JOERN AT, 1970, ARCH INTERN MED, V125, P649, DOI 10.1001/archinte.125.4.649; Jones V, 2011, INT J TELEMED APPL, V2011, DOI 10.1155/2011/671040; KAUPPILA A, 1987, J CLIN ENDOCR METAB, V65, P823, DOI 10.1210/jcem-65-5-823; KENNAWAY DJ, 1991, AM J PHYSIOL, V260, pR1137, DOI 10.1152/ajpregu.1991.260.6.R1137; King GA, 2004, MED SCI SPORT EXER, V36, P1244, DOI 10.1249/01.MSS.0000132379.09364.F8; Kobayashi R, 1998, PSYCHIAT CLIN NEUROS, V52, P186, DOI 10.1111/j.1440-1819.1998.tb01021.x; KOKHANOVSKY A.A., 2006, CLOUD OPTICS; Kraft NO, 2002, AVIAT SPACE ENVIR MD, V73, P1089; Kredlow MA, 2015, J BEHAV MED, V38, P427, DOI 10.1007/s10865-015-9617-6; Lee HJ, 2011, J AFFECT DISORDERS, V133, P573, DOI 10.1016/j.jad.2011.04.046; LEWY AJ, 1980, SCIENCE, V210, P1267, DOI 10.1126/science.7434030; Lorton D, 2006, NEUROIMMUNOMODULAT, V13, P357, DOI 10.1159/000104864; Lucht M., 1999, ARCH WOMEN MENT HLTH, V2, P83, DOI DOI 10.1007/S007370050040; Magnusson A, 2003, CHRONOBIOL INT, V20, P189, DOI 10.1081/CBI-120019310; Middleton B, 2002, NEUROSCI LETT, V329, P41, DOI 10.1016/S0304-3940(02)00574-8; Mottram V, 2011, J SLEEP RES, V20, P154, DOI 10.1111/j.1365-2869.2010.00875.x; Moyer D B, 1976, US Navy Med, V67, P19; NASA Quest Website, 2015, INF LIV ANT HDB MCMU; NATANI K, 1970, ARCH INTERN MED, V125, P655, DOI 10.1001/archinte.125.4.655; Nedeltcheva AV, 2014, CURR OPIN ENDOCRINOL, V21, P293, DOI 10.1097/MED.0000000000000082; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; O'Driscoll DM, 2013, SLEEP BREATH, V17, P139, DOI 10.1007/s11325-012-0662-x; Oginska H, 2014, CHRONOBIOL INT, V31, P523, DOI 10.3109/07420528.2013.874355; Palinkas L A, 2000, Int J Circumpolar Health, V59, P63; Palinkas L A, 1989, Med Anthropol, V10, P235; PALINKAS LA, 1992, SOC SCI MED, V35, P651, DOI 10.1016/0277-9536(92)90004-A; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; Palinkas LA, 2000, AVIAT SPACE ENVIR MD, V71, pA29; Palinkas Lawrence A, 2004, Int J Circumpolar Health, V63, P157; Palinkas LA, 2008, LANCET, V371, P153, DOI 10.1016/S0140-6736(07)61056-3; PALMAI G, 1963, BRIT J PSYCHIAT, V109, P364, DOI 10.1192/bjp.109.460.364; PATERSON RA, 1975, LANCET, V1, P468, DOI 10.1016/S0140-6736(75)91552-4; POLOSATOV MV, 1973, SOVIET ANTARCTICA EX, V86, P69; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; Reitz CJ, 2015, CURR PHARM DESIGN, V21, P3505, DOI 10.2174/1381612821666150706105926; Roane BM, 2015, J SLEEP RES, V24, P714, DOI 10.1111/jsr.12317; Roosli M, 2014, NOISE HEALTH, V16, P197, DOI 10.4103/1463-1741.137036; Rosnet E, 2004, AVIAT SPACE ENVIR MD, V75, pC10; ROTHBLUM ED, 1990, J PSYCHOL, V124, P253, DOI 10.1080/00223980.1990.10543221; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Schneider S, 2010, BEHAV BRAIN RES, V211, P208, DOI 10.1016/j.bbr.2010.03.034; Serreze MC, 2005, ARCTIC CLIMATE SYSTE, P120; Shayler DJ, 2005, WOMEN SPACE FOLLOWIN; Shearer WT, 2002, J ALLERGY CLIN IMMUN, V109, P854, DOI 10.1067/mai.2002.123873; Sherrill DL, 1998, ARCH INTERN MED, V158, P1894, DOI 10.1001/archinte.158.17.1894; Shin M, 2015, SLEEP SCI, V8, P9, DOI 10.1016/j.slsci.2015.02.003; Simpson A, 2010, INT J CIRCUMPOL HEAL, V69, P220, DOI 10.3402/ijch.v69i3.17625; Soric M, 2013, SLEEP MED, V14, P201, DOI 10.1016/j.sleep.2012.11.003; Stahn A, 2012, HDB ANTHROPOMETRY PH, P49; Steinach M., 2012, STRESS CHALLENGES IM, P87; Steinach M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144130; STRANGE RE, 1971, ANTARCT J US, V6, P255; Strassl H, 1951, POLARFORSCHUNG, V21, P40; STROUD MA, 1993, EUR J APPL PHYSIOL O, V67, P375, DOI 10.1007/BF00357638; Suedfeld P, 2000, ENVIRON BEHAV, V32, P7, DOI 10.1177/00139160021972405; Sun SS, 2003, AM J CLIN NUTR, V77, P331, DOI 10.1093/ajcn/77.2.331; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Tsuno N, 2005, J CLIN PSYCHIAT, V66, P1254, DOI 10.4088/JCP.v66n1008; Voderholzer U, 2003, DEPRESS ANXIETY, V17, P162, DOI 10.1002/da.10101; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Weess H-G, 2009, PRAXIS SCHLAFMEDIZIN, P23; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Welk GJ, 2007, OBESITY, V15, P918, DOI 10.1038/oby.2007.624; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wright KP, 2013, CURR BIOL, V23, P1554, DOI 10.1016/j.cub.2013.06.039; Yoneyama S, 1999, AM J PHYSIOL-REG I, V277, pR1091, DOI 10.1152/ajpregu.1999.277.4.R1091; Zavalko I M, 2013, Fiziol Cheloveka, V39, P45	103	21	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150099	10.1371/journal.pone.0150099	http://dx.doi.org/10.1371/journal.pone.0150099			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918440	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400086
J	Taba, ST; Hossain, L; Heard, R; Brennan, P; Lee, W; Lewis, S				Taba, Seyedamir Tavakoli; Hossain, Liaquat; Heard, Robert; Brennan, Patrick; Lee, Warwick; Lewis, Sarah			Personal and Network Dynamics in Performance of Knowledge Workers: A Study of Australian Breast Radiologists	PLOS ONE			English	Article							SOCIAL NETWORKS; SELF-ESTEEM; DIVERSITY; FEEDBACK; TASK; JOB	Materials and Methods In this paper, we propose a theoretical model based upon previous studies about personal and social network dynamics of job performance. We provide empirical support for this model using real-world data within the context of the Australian radiology profession. An examination of radiologists' professional network topology through structural-positional and relational dimensions and radiologists' personal characteristics in terms of knowledge, experience and self-esteem is provided. Thirty one breast imaging radiologists completed a purpose designed questionnaire regarding their network characteristics and personal attributes. These radiologists also independently read a test set of 60 mammographic cases: 20 cases with cancer and 40 normal cases. A Jackknife free response operating characteristic (JAFROC) method was used to measure the performance of the radiologists' in detecting breast cancers. Results Correlational analyses showed that reader performance was positively correlated with the social network variables of degree centrality and effective size, but negatively correlated with constraint and hierarchy. For personal characteristics, the number of mammograms read per year and self-esteem (self-evaluation) positively correlated with reader performance. Hierarchical multiple regression analysis indicated that the combination of number of mammograms read per year and network's effective size, hierarchy and tie strength was the best fitting model, explaining 63.4% of the variance in reader performance. The results from this study indicate the positive relationship between reading high volumes of cases by radiologists and expertise development, but also strongly emphasise the association between effective social/professional interactions and informal knowledge sharing with high performance.	[Taba, Seyedamir Tavakoli; Hossain, Liaquat] Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW, Australia; [Hossain, Liaquat] Univ Hong Kong, Div Informat & Technol Studies, Fac Educ, Hong Kong, Hong Kong, Peoples R China; [Heard, Robert] Univ Sydney, Hlth Syst & Global Populat Res Grp, Fac Hlth Sci, Sydney, NSW, Australia; [Brennan, Patrick; Lee, Warwick; Lewis, Sarah] Univ Sydney, Med Image Optimisat & Percept Grp MIOPeG, Fac Hlth Sci, Sydney, NSW, Australia	University of Sydney; University of Hong Kong; University of Sydney; University of Sydney	Taba, ST (corresponding author), Univ Sydney, Fac Engn & IT, Complex Syst Res Grp, Sydney, NSW, Australia.	amir.tavakoli@sydney.edu.au	Brennan, Patrick/AAC-7774-2019; /E-7946-2010	Brennan, Patrick/0000-0001-8611-7258; /0000-0002-7616-9182	BREAST Australia from National Breast Cancer Foundation; National Breast Cancer Foundation [IF-12-02] Funding Source: researchfish	BREAST Australia from National Breast Cancer Foundation; National Breast Cancer Foundation	This study was supported by the BREAST Australia Infrastructure through funding from the National Breast Cancer Foundation.	Alcantara SB, 2014, EUR J CANCER CARE, V23, P616, DOI 10.1111/ecc.12169; BALZER WK, 1989, PSYCHOL BULL, V106, P410, DOI 10.1037/0033-2909.106.3.410; Bdeir F., 2013, NETWORKS INTERORGANI; Bernardin H.J., 1984, PERFORMANCE APPRAISA; Borgatti SP., 2006, E NET SOFTWARE ANAL; Burt R. S, 1992, STRUCTURAL HOLES; Burt RS, 2012, BMJ QUAL SAF, V21, P992, DOI 10.1136/bmjqs-2011-000521; Burt RS, 2000, RES ORGAN BEHAV, V22, P345, DOI 10.1016/S0191-3085(00)22009-1; BURT RS, 1984, SOC NETWORKS, V6, P293, DOI 10.1016/0378-8733(84)90007-8; Campbell J. P., 1993, PERSONNEL SELECTION, P35; Campbell J.P., 1996, FRONT IND ORG PSYCH, V1st, P258; Chakraborty DP, 2004, MED PHYS, V31, P2313, DOI 10.1118/1.1769352; Chung KSK, 2009, PROJ MANAG J, V40, P34, DOI 10.1002/pmj.20115; Cleveland, 1983, PERFORMANCE MEASUREM, P257; COLEMAN J, 1957, SOCIOMETRY, V20, P253, DOI 10.2307/2785979; Cross R, 2004, ACAD MANAGE J, V47, P928, DOI 10.2307/20159632; Gardner DG, 1998, GROUP ORGAN MANAGE, V23, P48, DOI 10.1177/1059601198231004; Garton L, 1997, J COMPUT-MEDIAT COMM, V3; Halgin D.S., 2012, CONNECTIONS, VVol. 32, P37; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Hegarty M, 2010, J EXP PSYCHOL LEARN, V36, P37, DOI 10.1037/a0017683; Knoke D., 2008, SOCIAL NETWORK ANAL; KRACKHARDT D, 1988, SOC PSYCHOL QUART, V51, P123, DOI 10.2307/2786835; MARSDEN PV, 1990, ANNU REV SOCIOL, V16, P435, DOI 10.1146/annurev.so.16.080190.002251; Marsden PV, 2002, SOC NETWORKS, V24, P407, DOI 10.1016/S0378-8733(02)00016-3; McCrae R. R., 1996, 5 FACTOR MODEL PERSO, P51; Meisel MK, 2013, ADDICTION, V108, P584, DOI 10.1111/add.12014; Miglioretti DL, 2007, J NATL CANCER I, V99, P1854, DOI 10.1093/jnci/djm238; Motowidlo SJ, 1997, HUM PERFORM, V10, P71, DOI 10.1207/s15327043hup1002_1; P/L AsH, 2008, ROL RAD MULT CAR TEA; PIERCE JL, 1989, ACAD MANAGE J, V32, P622, DOI 10.2307/256437; Quinones MA, 1995, PERS PSYCHOL, V48, P887, DOI 10.1111/j.1744-6570.1995.tb01785.x; Rawashdeh M, 2013, IMPACT USING JAFROC; Rawashdeh MA, 2013, RADIOLOGY, V269, P61, DOI 10.1148/radiol.13122581; Reagans R, 2003, ADMIN SCI QUART, V48, P240, DOI 10.2307/3556658; Reagans R, 2001, ORGAN SCI, V12, P502, DOI 10.1287/orsc.12.4.502.10637; Reed WM, 2010, ACAD RADIOL, V17, P1409, DOI 10.1016/j.acra.2010.06.016; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Suleiman WI, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.1.015503; TEACHMAN JD, 1980, SOCIOL METHOD RES, V8, P341, DOI 10.1177/004912418000800305; Uzzi B, 2005, AM J SOCIOL, V111, P447, DOI 10.1086/432782; Van Deven T, 2013, EUR J RADIOL, V82, P883, DOI 10.1016/j.ejrad.2012.12.001; Waldie KE, 1996, AM J MENT RETARD, V100, P620; WEGENER B, 1991, AM SOCIOL REV, V56, P60, DOI 10.2307/2095673; West E, 1999, SOC SCI MED, V48, P633, DOI 10.1016/S0277-9536(98)00361-X	45	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150186	10.1371/journal.pone.0150186	http://dx.doi.org/10.1371/journal.pone.0150186			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918644	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400099
J	Wang, J; Li, X; Lu, D; Du, Y; Ma, L; Li, WJ; Chen, JH; Li, FL; Fan, Y; Hu, GR; Wang, JF				Wang, Jie; Li, Xin; Lu, Dong; Du, Yan; Ma, Liang; Li, Wenjian; Chen, Jihong; Li, Fuli; Fan, Yong; Hu, Guangrong; Wang, Jufang			Photosynthetic Effect in Selenastrum capricornutum Progeny after Carbon-Ion Irradiation	PLOS ONE			English	Article							CHLOROPHYLL FLUORESCENCE; XANTHOPHYLL CYCLE; MUTATION-RATE; PHOTOPROTECTION; MUTANTS; COMPLEX; NANNOCHLOROPSIS; INDUCTION; SPECTRUM; STRESS	A large proportion of mutants with altered pigment features have been obtained via exposure to heavy-ion beams, a technique that is efficient for trait improvement in the breeding of plants and algae. However, little is known about the underlying mechanisms by which the photosynthetic pigments are altered by heavy-ion irradiation. In our study, the photosynthetic characteristics of progenies from carbon-ion irradiated Selenastrum capricornutum were investigated. Five progenies deficient in chlorophyll a were isolated after carbon-ion exposure. Photosynthetic characteristics, photoprotection capacity and gene expression of the light-harvesting complex in these progenies were further characterized by the measurement of chlorophyll fluorescence parameters (Fv/Fm,.PSII, NPQ, ETR), the de-epoxidation state of the xanthophyll cycle, the amount of lutein and quantitative real-time PCR. High maximum quantum yield of photosystem II at day 10 and high thermal dissipation ability were observed in progenies #23 and #37 under normal culture condition. Progenies #18, #19 and #20 showed stronger resistance against high levels of light steps than the control group (612-1077 mu mol photons m(-2) s(-1), p< 0.05). The progenies #20 and #23 exhibited strong photoprotection by thermal dissipation and quenching of (3)Chl* after 24 h of high light treatment. The mRNA levels of Lhcb5, Lhcbm5 and Lhcbm1 of the light-harvesting complex revealed markedly differential expression in the five progenies irradiated by carbon-ion beams. This work indicates that photosynthetic efficiency, photoprotection ability and the expression of light-harvesting antennae in unicellular green algae can be markedly influenced by irradiation. To our knowledge, this is the first report on changes in the photosynthetic pigments of green algae after treatment with carbon-ion beams.	[Wang, Jie; Li, Xin; Lu, Dong; Du, Yan; Ma, Liang; Li, Wenjian; Chen, Jihong; Wang, Jufang] Chinese Acad Sci, Inst Modern Phys, Gansu Key Lab Space Radiobiol & Microbial Resourc, Lanzhou, Peoples R China; [Wang, Jie] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Fuli; Fan, Yong; Hu, Guangrong] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, Qingdao, Peoples R China	Chinese Academy of Sciences; Institute of Modern Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Wang, JF (corresponding author), Chinese Acad Sci, Inst Modern Phys, Gansu Key Lab Space Radiobiol & Microbial Resourc, Lanzhou, Peoples R China.	jufangwang@impcas.ac.cn	Li, Fu-Li/B-5894-2015; Li, Fu-Li/X-4669-2019	Li, Fu-Li/0000-0003-0381-2234; Li, Fu-Li/0000-0003-0381-2234	National Nature Science Foundation of China [U1232126]; Chinese Academy of Sciences, China [Y306010XB0]; Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences [Y506050STS]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences, China(Chinese Academy of Sciences); Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences	This study was supported by the National Nature Science Foundation of China (U1232126), Western Talent Training Program of the Chinese Academy of Sciences, China (Y306010XB0), and also supported by Science and Technology Service Network Initiative Project of the Chinese Academy of Sciences (Y506050STS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2002, J RADIAT RES, V43, pS157; Angelini G, 2001, PHYS MEDICA, V17, P267; Bae CH, 2001, ANN BOT-LONDON, V88, P545, DOI 10.1006/anbo.2001.1495; Bae CH, 2000, PLANT SCI, V151, P93, DOI 10.1016/S0168-9452(99)00205-8; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Bonente G, 2012, J BIOL CHEM, V287, P5833, DOI 10.1074/jbc.M111.304279; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; De Micco V, 2011, RADIAT ENVIRON BIOPH, V50, P1, DOI 10.1007/s00411-010-0343-8; Demming-Adams B, 2014, NONPHOTOCHEMICAL QUE; Erickson E, 2015, PLANT J, V82, P449, DOI 10.1111/tpj.12825; Esnault MA, 2010, ENVIRON EXP BOT, V68, P231, DOI 10.1016/j.envexpbot.2010.01.007; Ferrante P, 2012, J BIOL CHEM, V287, P16276, DOI 10.1074/jbc.M111.316729; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; He JY, 2011, NUCL SCI TECH, V22, P77; Henriques M., 2007, COMMUNICATING CURREN, VVolume 1, P586; Hu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060700; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Liu BY, 2011, ECOTOX ENVIRON SAFE, V74, P1027, DOI 10.1016/j.ecoenv.2011.01.022; Ma YB, 2013, BIORESOURCE TECHNOL, V136, P360, DOI 10.1016/j.biortech.2013.03.020; Matuo Y, 2006, MUTAT RES-FUND MOL M, V602, P7, DOI 10.1016/j.mrfmmm.2006.07.001; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Murchie EH, 2013, J EXP BOT, V64, P3983, DOI 10.1093/jxb/ert208; Natali A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119211; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; Niwa K, 2009, PHYCOL RES, V57, P194, DOI 10.1111/j.1440-1835.2009.00539.x; Ocampo-Alvarez H, 2013, BBA-BIOENERGETICS, V1827, P427, DOI 10.1016/j.bbabio.2012.12.006; Ota S, 2013, BIORESOURCE TECHNOL, V149, P432, DOI 10.1016/j.biortech.2013.09.079; Pinnola A, 2013, PLANT CELL, V25, P3519, DOI 10.1105/tpc.113.114538; Quaas T, 2015, J PLANT PHYSIOL, V172, P92, DOI 10.1016/j.jplph.2014.07.023; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ramundo S, 2013, PLANT CELL, V25, P167, DOI 10.1105/tpc.112.103051; SARTORY DP, 1984, HYDROBIOLOGIA, V114, P177, DOI 10.1007/BF00031869; Schmollinger S, 2014, PLANT CELL, V26, P1410, DOI 10.1105/tpc.113.122523; Shikazono N, 2003, GENETICS, V163, P1449; Tanaka A, 2010, J RADIAT RES, V51, P223, DOI 10.1269/jrr.09143; Doan TTY, 2012, ALGAL RES, V1, P17, DOI 10.1016/j.algal.2012.03.001; Yoshihara R, 2013, J RADIAT RES, V54, P1050, DOI 10.1093/jrr/rrt074	37	4	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149381	10.1371/journal.pone.0149381	http://dx.doi.org/10.1371/journal.pone.0149381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919351	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400019
J	Wang, ZW; Qu, YF; Dong, SH; Wen, P; Li, JJ; Tan, K; Menzel, R				Wang, Zhengwei; Qu, Yufeng; Dong, Shihao; Wen, Ping; Li, Jianjun; Tan, Ken; Menzel, Randolf			Honey Bees Modulate Their Olfactory Learning in the Presence of Hornet Predators and Alarm Component	PLOS ONE			English	Article							PROBOSCIS EXTENSION RESPONSE; VESPA-VELUTINA; APIS-CERANA; DEFENSIVE BEHAVIOR; MINI-BRAIN; HYMENOPTERA; MEMORY; WASP; RECOGNITION; PHEROMONE	In Southeast Asia the native honey bee species Apis cerana is often attacked by hornets (Vespa velutina), mainly in the period from April to November. During the co-evolution of these two species honey bees have developed several strategies to defend themselves such as learning the odors of hornets and releasing alarm components to inform other mates. However, so far little is known about whether and how honey bees modulate their olfactory learning in the presence of the hornet predator and alarm components of honey bee itself. In the present study, we test for associative olfactory learning of A. cerana in the presence of predator odors, the alarm pheromone component isopentyl acetate (IPA), or a floral odor (hexanal) as a control. The results show that bees can detect live hornet odors, that there is almost no association between the innately aversive hornet odor and the appetitive stimulus sucrose, and that IPA is less well associated with an appetitive stimulus when compared with a floral odor. In order to imitate natural conditions, e.g. when bees are foraging on flowers and a predator shows up, or alarm pheromone is released by a captured mate, we tested combinations of the hornet odor and floral odor, or IPA and floral odor. Both of these combinations led to reduced learning scores. This study aims to contribute to a better understanding of the prey-predator system between A. cerana and V. velutina.	[Wang, Zhengwei; Qu, Yufeng; Wen, Ping; Li, Jianjun; Tan, Ken] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China; [Dong, Shihao; Tan, Ken] Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China; [Menzel, Randolf] Free Univ Berlin, Inst Biol & Neurobiol, Berlin, Germany	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS; Yunnan Agricultural University; Free University of Berlin	Tan, K (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Peoples R China.; Tan, K (corresponding author), Yunnan Agr Univ, Eastern Bee Res Inst, Kunming, Peoples R China.	kentan@xtbg.ac.cn			Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science, China National Research Fund [31260585]; CSC-DAAD	Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden; Chinese Academy of Science, China National Research Fund; CSC-DAAD	This work was supported by the Key Laboratory of Tropical Forest Ecology, Xishuangbanna Tropical Botanical Garden, and the CAS 135 program (XTBGT01) of Chinese Academy of Science, China National Research Fund (31260585) to Ken Tan. Thanks to the support of CSC-DAAD Postdoc scholarship to Zhengwei Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; BOCH R, 1962, NATURE, V195, P1018, DOI 10.1038/1951018b0; BOCH R, 1971, J INSECT PHYSIOL, V17, P2277, DOI 10.1016/0022-1910(71)90077-1; Bos N, 2010, ANIM BEHAV, V80, P839, DOI 10.1016/j.anbehav.2010.08.001; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Giurfa M, 2003, BEE WORLD, V84, P5, DOI 10.1080/0005772X.2003.11099566; Giurfa M, 2012, LEARN MEMORY, V19, P54, DOI 10.1101/lm.024711.111; HEINRICH B, 1979, J EXP BIOL, V80, P217; Ignell R, 2004, METHODS INSECT SENSO, P319; Kaspi R, 2013, APIDOLOGIE, V44, P100, DOI 10.1007/s13592-012-0160-y; Ken T, 2005, NATURWISSENSCHAFTEN, V92, P492, DOI 10.1007/s00114-005-0026-5; KOENIGER N, 1979, J INSECT PHYSIOL, V25, P467, DOI 10.1016/S0022-1910(79)80004-9; Li JJ, 2014, ANIM BEHAV, V97, P69, DOI 10.1016/j.anbehav.2014.08.015; Li JJ, 2014, J EXP BIOL, V217, P3512, DOI 10.1242/jeb.110171; Li T, 1993, EXPLOITATION UTILITY; Matsumoto Y, 2012, J NEUROSCI METH, V211, P159, DOI 10.1016/j.jneumeth.2012.08.018; Menzel R, 2001, TRENDS COGN SCI, V5, P62, DOI 10.1016/S1364-6613(00)01601-6; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R., 1990, NEUROBIOLOGY COMP CO, P237; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Monceau K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066492; Monceau K, 2013, APIDOLOGIE, V44, P209, DOI 10.1007/s13592-012-0172-7; Muller U, 2006, CELL MOL LIFE SCI, V63, P961, DOI 10.1007/s00018-006-6021-y; ONO M, 1995, NATURE, V377, P334, DOI 10.1038/377334a0; ONO M, 1987, EXPERIENTIA, V43, P1031, DOI 10.1007/BF01952231; Ono Masato, 1996, Honeybee Science, V17, P27; Perrard A, 2009, ANN SOC ENTOMOL FR, V45, P119, DOI 10.1080/00379271.2009.10697595; Pirk C.W.W., 2011, PHEROMONES, P207; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Roussel E, 2012, ANIM COGN, V15, P135, DOI 10.1007/s10071-011-0426-1; Salisbury E., 1984, Verhandlungen der Deutschen Zoologischen Gesellschaft, V77, P235; Sandoz JC, 2001, J COMP PHYSIOL A, V187, P559, DOI 10.1007/s003590100228; Schiestl FP, 2010, ECOL LETT, V13, P643, DOI 10.1111/j.1461-0248.2010.01451.x; Stabentheiner A, 2002, J EXP BIOL, V205, P2637; Tan K, 2007, NATURWISSENSCHAFTEN, V94, P469, DOI 10.1007/s00114-006-0210-2; Tan K, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14102; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066295; Tan K, 2013, NATURWISSENSCHAFTEN, V100, P245, DOI 10.1007/s00114-013-1019-4; Tan K, 2012, ANIM BEHAV, V83, P879, DOI 10.1016/j.anbehav.2011.12.031; Tan K, 2012, APIDOLOGIE, V43, P195, DOI 10.1007/s13592-011-0098-5; Urlacher E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113630; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; Villemant C, 2011, BIOL CONSERV, V144, P2142, DOI 10.1016/j.biocon.2011.04.009; Wager BR, 2000, ANN ENTOMOL SOC AM, V93, P1329, DOI 10.1603/0013-8746(2000)093[1329:DHBSAP]2.0.CO;2; Wang ZW, 2014, APIDOLOGIE, V45, P45, DOI 10.1007/s13592-013-0228-3	50	20	20	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150399	10.1371/journal.pone.0150399	http://dx.doi.org/10.1371/journal.pone.0150399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919132	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400127
J	Xiao, DL; Wang, L; Huang, XH; Li, Y; Dasgupta, C; Zhang, LB				Xiao, DaLiao; Wang, Lei; Huang, Xiaohui; Li, Yong; Dasgupta, Chiranjib; Zhang, Lubo			Protective Effect of Antenatal Antioxidant on Nicotine-Induced Heart Ischemia-Sensitive Phenotype in Rat Offspring	PLOS ONE			English	Article							PKC-EPSILON GENE; GLYCOGEN-SYNTHASE KINASE-3-BETA; LOW-PROTEIN DIET; OXIDATIVE STRESS; BLOOD-PRESSURE; N-ACETYLCYSTEINE; REPERFUSION INJURY; DNA METHYLATION; EPIGENETIC REPRESSION; VASCULAR DYSFUNCTION	Fetal nicotine exposure increased risk of developing cardiovascular disease later in life. The present study tested the hypothesis that perinatal nicotine-induced programming of heart ischemia-sensitive phenotype is mediated by enhanced reactive oxygen species (ROS) in offspring. Nicotine was administered to pregnant rats via subcutaneous osmotic minipumps from day 4 of gestation to day 10 after birth, in the absence or presence of a ROS inhibitor, N-acetyl-cysteine (NAC) in drinking water. Experiments were conducted in 8 month old age male offspring. Isolated hearts were perfused in a Langendorff preparation. Perinatal nicotine treatment significantly increased ischemia and reperfusion-induced left ventricular injury, and decreased post-ischemic recovery of left ventricular function and coronary flow rate. In addition, nicotine enhanced cardiac ROS production and significantly attenuated protein kinase Ce (PKCe) protein abundance in the heart. Although nicotine had no effect on total cardiac glycogen synthase kinase-3 beta (GSK3 beta) protein expression, it significantly increased the phosphorylation of GSK3 beta at serine 9 residue in the heart. NAC inhibited nicotine-mediated increase in ROS production, recovered PKCe gene expression and abrogated increased phosphorylation of GSK3 beta. Of importance, NAC blocked perinatal nicotine-induced increase in ischemia and reperfusion injury in the heart. These findings provide novel evidence that increased oxidative stress plays a causal role in perinatal nicotine-induced developmental programming of ischemic sensitive phenotype in the heart, and suggest potential therapeutic targets of anti-oxidative stress in the treatment of ischemic heart disease.	[Xiao, DaLiao; Wang, Lei; Huang, Xiaohui; Li, Yong; Dasgupta, Chiranjib; Zhang, Lubo] Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA USA; [Wang, Lei] Shanghai Putuo Dist Peoples Hosp, Dept Tradit Chinese Med, Shanghai, Peoples R China	Loma Linda University	Xiao, DL (corresponding author), Loma Linda Univ, Sch Med, Dept Basic Sci, Ctr Perinatal Biol, Loma Linda, CA USA.	Dxiao@llu.edu	Xiao, DaLiao/AAY-1800-2020	Xiao, DaLiao/0000-0003-0147-2758; Zhang, Lubo/0000-0002-9386-8938	National Institutes of Health [HL118861, DA032510]; Regents of the University of California Tobacco Related Disease Research Program (TRDRP) [22XT-0022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032510] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California Tobacco Related Disease Research Program (TRDRP); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health Grants HL118861 (LZ), DA032510 (DX), and by the Regents of the University of California Tobacco Related Disease Research Program (TRDRP) grant 22XT-0022 (DX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NP, 2001, J AM COLL CARDIOL, V37, P117, DOI 10.1016/S0735-1097(00)01093-7; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Bae S, 2005, BRIT J PHARMACOL, V144, P900, DOI 10.1038/sj.bjp.0706129; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; Beratis NG, 1996, J PEDIATR-US, V128, P806, DOI 10.1016/S0022-3476(96)70333-5; Blake KV, 2000, EARLY HUM DEV, V57, P137, DOI 10.1016/S0378-3782(99)00064-X; Bruin JE, 2008, FREE RADICAL BIO MED, V44, P1919, DOI 10.1016/j.freeradbiomed.2008.02.010; Bruin JE, 2012, J DIABETES, V4, P297, DOI 10.1111/j.1753-0407.2012.00195.x; Buhimschi IA, 2003, AM J OBSTET GYNECOL, V188, P203, DOI 10.1067/mob.2003.112; Cambonie G, 2007, AM J PHYSIOL-REG I, V292, pR1236, DOI 10.1152/ajpregu.00227.2006; Campos ACE, 2007, NEOPLASIA, V9, P1111, DOI 10.1593/neo.07712; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Cohen G, 2008, CIRCULATION, V118, P1848, DOI 10.1161/CIRCULATIONAHA.108.783902; Elmes MJ, 2008, LIFE SCI, V82, P149, DOI 10.1016/j.lfs.2007.10.022; Elmes MJ, 2007, BRIT J NUTR, V98, P93, DOI 10.1017/S000711450769182X; Franco MD, 2009, LIFE SCI, V85, P327, DOI 10.1016/j.lfs.2009.06.013; Franco MDP, 2003, CARDIOVASC RES, V59, P767, DOI 10.1016/S0008-6363(03)00461-9; Franco R, 2008, CANCER LETT, V266, P6, DOI 10.1016/j.canlet.2008.02.026; Gao YJ, 2008, EUR J PHARMACOL, V590, P264, DOI 10.1016/j.ejphar.2008.05.044; Garrett BE, 2013, MMWR SURVEILL SUMM S, V62, P381; Gray MO, 2004, J BIOL CHEM, V279, P3596, DOI 10.1074/jbc.M311459200; Gregory KN, 2004, J MOL CELL CARDIOL, V36, P313, DOI 10.1016/j.yjmcc.2003.12.001; Haleagrahara N, 2011, CARDIOVASC TOXICOL, V11, P373, DOI 10.1007/s12012-011-9132-0; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Kelly G S, 1998, Altern Med Rev, V3, P114; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Lassegue B, 2010, ARTERIOSCL THROM VAS, V30, P653, DOI 10.1161/ATVBAHA.108.181610; Lawrence J, 2008, J PHARMACOL EXP THER, V324, P331, DOI 10.1124/jpet.107.132175; Lawrence J, 2011, CARDIOVASC RES, V89, P89, DOI 10.1093/cvr/cvq270; Li GH, 2004, AM J PHYSIOL-HEART C, V286, pH1712, DOI 10.1152/ajpheart.00898.2003; Mayhan WG, 1999, J APPL PHYSIOL, V86, P1126, DOI 10.1152/jappl.1999.86.4.1126; Meyer K, 2009, J MOL CELL CARDIOL, V47, P504, DOI 10.1016/j.yjmcc.2009.06.004; Noakes PS, 2007, THORAX, V62, P714, DOI 10.1136/thx.2006.061630; Palpant NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126259; Patterson AJ, 2012, CARDIOVASC RES, V93, P302, DOI 10.1093/cvr/cvr322; Pausova Z, 2003, KIDNEY INT, V64, P829, DOI 10.1046/j.1523-1755.2003.00172.x; Roghair RD, 2011, CLIN SCI, V121, P427, DOI 10.1042/CS20110153; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Tao HH, 2013, PEPTIDES, V44, P111, DOI 10.1016/j.peptides.2013.02.019; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; Wang CF, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/189785; Wang YH, 2009, DIABETES, V58, P1391, DOI 10.2337/db08-1697; WEITZMAN SA, 1994, P NATL ACAD SCI USA, V91, P1261, DOI 10.1073/pnas.91.4.1261; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2007, J PHARMACOL EXP THER, V320, P654, DOI 10.1124/jpet.106.113332; Xiao DL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132381; Xiao DL, 2014, CARDIOVASC RES, V101, P373, DOI 10.1093/cvr/cvt264; Xiao DL, 2013, HYPERTENSION, V61, P1246, DOI 10.1161/HYPERTENSIONAHA.113.01152; Xiao DL, 2011, BRIT J PHARMACOL, V164, P1400, DOI 10.1111/j.1476-5381.2011.01437.x; Xiong FX, 2012, FASEB J, V26, P2753, DOI 10.1096/fj.11-199422; Xu DX, 2005, TOXICOL SCI, V88, P525, DOI 10.1093/toxsci/kfi300; Xue Q, 2009, J PHARMACOL EXP THER, V330, P624, DOI 10.1124/jpet.109.153239; Yzydorczyk C, 2006, AM J PHYSIOL-REG I, V291, pR1060, DOI 10.1152/ajpregu.00798.2005; Zhai PY, 2011, CIRC RES, V109, P502, DOI 10.1161/CIRCRESAHA.111.249532; Zhang HT, 2007, MOL PHARMACOL, V71, P1319, DOI 10.1124/mol.106.032011	59	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150557	10.1371/journal.pone.0150557	http://dx.doi.org/10.1371/journal.pone.0150557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918336	gold, Green Published			2022-12-27	WOS:000371274400133
J	Rietz, A; Petrov, DP; Bartolowits, M; DeSmet, M; Davisson, VJ; Androphy, EJ				Rietz, Anne; Petrov, Dino P.; Bartolowits, Matthew; DeSmet, Marsha; Davisson, V. Jo; Androphy, Elliot J.			Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors	PLOS ONE			English	Article							PAPILLOMAVIRUS TYPE-16 E6; CERVICAL-CARCINOMA CELLS; MAMMARY EPITHELIAL-CELLS; STRUCTURAL BASIS; DNA-BINDING; ONCOPROTEIN; P53; APOPTOSIS; IDENTIFICATION; DEGRADATION	The human papillomavirus (HPV) HPV E6 protein has emerged as a central oncoprotein in HPV-associated cancers in which sustained expression is required for tumor progression. A majority of the E6 protein interactions within the human proteome use an alpha-helix groove interface for binding. The UBE3A/E6AP HECT domain ubiquitin ligase binds E6 at this helix-groove interface. This enables formation of a trimeric complex with p53, resulting in destruction of this tumor suppressor. While recent x-ray crystal structures are useful, examples of small molecule probes that can modulate protein interactions at this interface are limited. To develop insights useful for potential structure-based design of ligands for HPV E6, a series of 2,6-disubstituted benzopyranones were prepared and tested as competitive antagonists of E6-E6AP helix-groove interactions. These small molecule probes were used in both binding and functional assays to evaluate recognition features of the E6 protein. Evidence for an ionic functional group interaction within the helix groove was implicated by the structure-activity among the highest affinity ligands. The molecular topographies of these protein-ligand interactions were evaluated by comparing the binding and activities of single amino acid E6 mutants with the results of molecular dynamic simulations. A group of arginine residues that form a rim-cap over the E6 helix groove offer compensatory roles in binding and recognition of the small molecule probes. The flexibility and impact on the overall helix-groove shape dictated by these residues offer new insights for structure-based targeting of HPV E6.	[Rietz, Anne; DeSmet, Marsha; Androphy, Elliot J.] Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA; [Petrov, Dino P.; Bartolowits, Matthew; Davisson, V. Jo] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, W Lafayette, IN 47907 USA	Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Androphy, EJ (corresponding author), Indiana Univ Sch Med, Dept Dermatol, Indianapolis, IN 46202 USA.	eandro@iu.edu			National Cancer Institute [R01CA107394]; Indiana Clinical Translational Sciences Institute NIH [5UL1TR001108]; Simon Cancer Center; Purdue Center for Cancer Research (NIH/NCI) [P30 CA023168]; NATIONAL CANCER INSTITUTE [R01CA107394, R01CA119904, P30CA023168] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Indiana Clinical Translational Sciences Institute NIH; Simon Cancer Center; Purdue Center for Cancer Research (NIH/NCI); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grants from the National Cancer Institute R01CA107394 to EJA, Indiana Clinical Translational Sciences Institute NIH grant 5UL1TR001108 to EJA and VJD, the Simon Cancer Center to EJA, and the Purdue Center for Cancer Research (NIH/NCI P30 CA023168). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baleja JD, 2006, ANTIVIR RES, V72, P49, DOI 10.1016/j.antiviral.2006.03.014; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; Bowers KJ, 2006, P ACM IEEE SC 2006 C; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Cherry JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084506; Chung CH, 2009, CLIN CANCER RES, V15, P6758, DOI 10.1158/1078-0432.CCR-09-0784; Filippova M, 2004, J BIOL CHEM, V279, P25729, DOI 10.1074/jbc.M401172200; Filippova M, 2002, J BIOL CHEM, V277, P21730, DOI 10.1074/jbc.M200113200; Gagnon D, 2015, METHODS MOL BIOL, V1249, P111, DOI 10.1007/978-1-4939-2013-6_8; Garnett TO, 2006, CELL DEATH DIFFER, V13, P1915, DOI 10.1038/sj.cdd.4401886; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071453; Horner SM, 2004, J VIROL, V78, P4063, DOI 10.1128/JVI.78.8.4063-4073.2004; Hu Y, 2009, CANCER INVEST, V27, P298, DOI 10.1080/07357900802350798; Huang YJ, 2014, ACS CHEM BIOL, V9, P802, DOI 10.1021/cb400728e; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IMAI Y, 1989, BIOCHEM BIOPH RES CO, V164, P1402, DOI 10.1016/0006-291X(89)91826-3; Karlsson OA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09382; Kumar S, 2015, INTERDISCIP SCI, V7, P136, DOI 10.1007/s12539-015-0008-z; Kumar Satish, 2014, Genomics & Informatics, V12, P64, DOI 10.5808/GI.2014.12.2.64; LECHNER MS, 1994, J VIROL, V68, P4262, DOI 10.1128/JVI.68.7.4262-4273.1994; Liu Y, 1999, J VIROL, V73, P7297, DOI 10.1128/JVI.73.9.7297-7307.1999; Liu YQ, 2004, BIOCHEMISTRY-US, V43, P7421, DOI 10.1021/bi049552a; Malecka KA, 2014, ACS CHEM BIOL, V9, P1603, DOI 10.1021/cb500229d; Manzo-Merino J, 2013, EXPERT OPIN THER TAR, V17, P1357, DOI 10.1517/14728222.2013.832204; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Novokhatny V, 1997, PROTEIN SCI, V6, P141; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Ramirez J, 2015, ANGEW CHEM INT EDIT, V54, P7958, DOI 10.1002/anie.201502646; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Sekaric P, 2008, J VIROL, V82, P71, DOI 10.1128/JVI.01776-07; Shamanin VA, 2008, J VIROL, V82, P3912, DOI 10.1128/JVI.02466-07; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Stutz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132339; Sun DQ, 2014, J MED CHEM, V57, P1454, DOI 10.1021/jm401753e; Vande Pol SB, 2013, VIROLOGY, V445, P115, DOI 10.1016/j.virol.2013.04.026; Xie X, 2014, ONCOGENE, V33, P1037, DOI 10.1038/onc.2013.25; Yuan CH, 2012, BIOORG MED CHEM LETT, V22, P2125, DOI 10.1016/j.bmcl.2011.12.145; Zanier K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112514; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2012, STRUCTURE, V20, P604, DOI 10.1016/j.str.2012.02.001; Zimmermann H, 1999, J VIROL, V73, P6209, DOI 10.1128/JVI.73.8.6209-6219.1999; zur Hausen H, 1999, P ASSOC AM PHYSICIAN, V111, P581, DOI 10.1046/j.1525-1381.1999.99723.x	49	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149845	10.1371/journal.pone.0149845	http://dx.doi.org/10.1371/journal.pone.0149845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915086	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700033
J	Song, HZ; Zheng, ZH; Wu, JA; Lai, J; Chu, Q; Zheng, XD				Song, Haizhao; Zheng, Zihuan; Wu, Jianan; Lai, Jia; Chu, Qiang; Zheng, Xiaodong			White Pitaya (Hylocereus undatus) Juice Attenuates Insulin Resistance and Hepatic Steatosis in Diet-Induced Obese Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC SYNDROME; RED; POLYRHIZUS; MECHANISMS; INCREASES; FGF-21	Insulin resistance and hepatic steatosis are the most common complications of obesity. Pitaya is an important source of phytochemicals such as polyphenols, flavonoid and vitamin C which are related to its antioxidant activity. The present study was conducted to evaluate the influence of white pitaya juice (WPJ) on obesity-related metabolic disorders (e.g. insulin resistance and hepatic steatosis) in high-fat diet-fed mice. Forty-eight male C57BL/6J mice were assigned into four groups and fed low-fat diet with free access to water or WPJ, or fed high-fat diet with free access to water or WPJ for 14 weeks. Our results showed that administration of WPJ improved high-fat diet-induced insulin resistance, hepatic steatosis and adipose hypertrophy, but it exerted no influence on body weight gain in mice. Hepatic gene expression analysis indicated that WPJ supplement not only changed the expression profile of genes involved in lipid and cholesterol metabolism (Srebp1, HMGCoR, Cpt1b, HL, Insig1 and Insig2) but also significantly increased the expression levels of FGF21-related genes (Klb, FGFR2, Egr1 and cFos). In conclusion, WPJ protected from diet-induced hepatic steatosis and insulin resistance, which was associated with the improved FGF21 resistance and lipid metabolism.	[Song, Haizhao; Zheng, Zihuan; Wu, Jianan; Lai, Jia; Chu, Qiang; Zheng, Xiaodong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Song, Haizhao; Zheng, Xiaodong] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Zheng, XD (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Zheng, XD (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xdzhengzju@yahoo.com	Wu, Jianan/I-1666-2017	Wu, Jianan/0000-0002-6513-4769; Chu, Qiang/0000-0003-3075-3444	National Key Technology R&D Program of China [2012BAD33B08]; Zhejiang Provincial Natural Science Foundation of China [Z14C200006]; Foundation of Fuli Institute of Food Science, Zhejiang University [KY201301]	National Key Technology R&D Program of China(National Key Technology R&D Program); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Fuli Institute of Food Science, Zhejiang University	This work was supported by National Key Technology R&D Program of China (Grant No. 2012BAD33B08, http://program.most.gov.cn/, received by XDZ), Zhejiang Provincial Natural Science Foundation of China (Grant No. Z14C200006, http://www.zjnsf.gov.cn/, received by XDZ) and the Foundation of Fuli Institute of Food Science, Zhejiang University (Grant No. KY201301, http://fifs.zju.edu.cn/content/detail.php?sid=3&cid=642, received by XDZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BORNEO SCI; Auinger A, 2013, BRIT J NUTR, V109, P810, DOI 10.1017/S0007114512002656; Balkau B, 2005, LANCET, V366, P1921, DOI 10.1016/S0140-6736(05)67777-X; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Beaton MD, 2012, CAN J GASTROENTEROL, V26, P353, DOI 10.1155/2012/725468; Brennan AM, 2006, NAT CLIN PRACT ENDOC, V2, P318, DOI 10.1038/ncpendmet0196; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Espin JC, 2007, PHYTOCHEMISTRY, V68, P2986, DOI 10.1016/j.phytochem.2007.09.014; Chang JJ, 2013, J AGR FOOD CHEM, V61, P6069, DOI 10.1021/jf401171k; Charlton M, 2004, CLIN GASTROENTEROL H, V2, P1048, DOI 10.1016/S1542-3565(04)00440-9; Chavez AO, 2009, DIABETES CARE, V32, P1542, DOI 10.2337/dc09-0684; Cuevas-Ramos D, 2012, CURR OPIN PEDIATR, V24, P523, DOI 10.1097/MOP.0b013e3283557d22; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Dembinska-Kiec A, 2008, BRIT J NUTR, V99, pES109, DOI 10.1017/S000711450896579X; Diez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293; Doria A, 2008, CELL METAB, V8, P186, DOI 10.1016/j.cmet.2008.08.006; Esquivel P, 2007, Z NATURFORSCH C, V62, P636; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kruszynska YT, 1996, J INVEST MED, V44, P413; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Liu RH, 2003, AM J CLIN NUTR, V78, p517S, DOI 10.1093/ajcn/78.3.517S; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Omidizadeh A, 2014, RSC ADV, V4, P62978, DOI 10.1039/c4ra10789f; Ramli NS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-189; Ruzlan N, 2008, ANTIOXIDANT STUDY PU; Seymour EM, 2008, J MED FOOD, V11, P252, DOI 10.1089/jmf.2007.658; Singleton VL, 1999, METHOD ENZYMOL, V299, P152; Suh DH, 2014, J AGR FOOD CHEM, V62, P8764, DOI 10.1021/jf5020704; Timmers S, 2013, ANN NY ACAD SCI, V1290, P83, DOI 10.1111/nyas.12185; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wybraniec S, 2002, J AGR FOOD CHEM, V50, P6086, DOI 10.1021/jf020145k; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yusof RM, 2009, ANN NUTR METAB, V55, P92; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	45	35	38	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149670	10.1371/journal.pone.0149670	http://dx.doi.org/10.1371/journal.pone.0149670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914024	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700024
J	Zhou, X; Guo, YL; Kong, H; Zuo, J; Huang, QX; Jia, RZ; Guo, AP; Xu, L				Zhou, Xia; Guo, Yunling; Kong, Hua; Zuo, Jiao; Huang, Qixing; Jia, Ruizong; Guo, Anping; Xu, Lin			A Comprehensive Assessment of the Effects of Transgenic Cry1Ac/Cry1Ab Rice Huahui 1 on Adult Micraspis discolor (Fabricius) (Coleoptera: Coccinellidae)	PLOS ONE			English	Article							SYNTHETIC CRY1AB GENE; BACILLUS-THURINGIENSIS; BT RICE; POLLEN; CONSUMPTION; CRY3BB1; PROTEIN; IMPACT	Micraspis discolor (Fabricius) (Coleoptera: Coccinellidae) is a widely distributed coleoptera predator in southern Asia in rice ecosystem, and adult M. discolor feed on both rice pollen and soft-bodied arthropods. Bitrophic bioassay and tritrophic bioassay were conducted to evaluate the potential impact of Cry1Ac/Cry1Ab-expressing rice Huahui 1 and its non-transgenic counterpart Minghui 63 on fitness parameters of adult M. discolor. The results showed that the survival, and fecundity of this beetle' adults were not different when they fed on Bt rice or non-Bt rice pollen or Nilaparvata lugens (Stal) reared on Bt rice or non-Bt rice. Toxicity assessment to ensure M. discolor adults were not sensitive to Cry1Ab or Cry1Ac protein independent from the pollen background, M. discolor adults were fed with an artificial diet containing Cry1Ac, Cry1Ab or both protein approximately 10 times higher concentration than in Huahui 1 rice pollen. No difference was detected for any of the lifetable parameters tested between Cry protein-containing and pure diet. Artificial diet containing E-64 (N-(trans-Epoxysuccinyl)-L-leucine 4-guanidinobutylamide) was included as a positive control. In contrast, the pre-oviposition and fecundity of M. discolor were significantly adversely affected by feeding on E-64-containing diet. In both bioassays, the uptakes of Cry protein by adult M. discolor were tested by ELISA measurements. These results indicated that adults of M. discolor are not affected by Cry1Ab-or Cry1Ac-expressing rice pollen and are not sensitive to Cry protein at concentrations exceeding the levels in rice pollen in Huahui1. This suggests that M. discolor adults would not be harmed by Cry1Ac/Cry1Ab rice if Bt rice Huahui 1 were commercialized.	[Zhou, Xia; Guo, Yunling; Kong, Hua; Zuo, Jiao; Huang, Qixing; Jia, Ruizong; Guo, Anping; Xu, Lin] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Guo, AP (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China.	gap211@126.com			National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area [2013ZX08012- 004]; Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China [201403075]	National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area; Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China	This work was supported by National Important Project of Scientific and Technical Supporting Programs- Transgenic crop's monitoring and control in crop winter multiplication area (Grant No. 2013ZX08012- 004 awarded to Anping Guo) and the Special Fund for Agro-scientific Research in the Public Interest of the people's Republic of China (Grant No. 201403075 awarded to Anping Guo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2012, ENVIRON ENTOMOL, V41, P1687, DOI 10.1603/EN12032; Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; Ara Begum M., 2002, J BIOL SCI, V2, P630, DOI DOI 10.3923/JBS.2002.630.632; Bai YY, 2005, J PEST SCI, V78, P123, DOI 10.1007/s10340-004-0078-x; Chen X N., 2003, BROWN PLANTHOPPER OC, P1; Cohen Michael B., 2008, V5, P223, DOI 10.1007/978-1-4020-8373-0_8; Conway G., 1997, DOUBLY GREEN REVOLUT; CONWAY GR, 1991, UNWELCOME HARVEST AG; Cui JinJie, 1999, Acta Gossypii Sinica, V11, P84; Dale D, 1994, BIOL MANAGEMENT RICE, P388; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Huang JK, 2005, SCIENCE, V308, P688, DOI 10.1126/science.1108972; JEPSON PC, 1994, MOL ECOL, V3, P81, DOI 10.1111/j.1365-294X.1994.tb00049.x; JIANG YC, 1985, ACTA ENTOMOL SINICA, V28, P115; Jiang YC, 1995, ENTOMOLOGICAL KNOWLE, V32, P114; Li Y, 2011, ABSTR APPL ANAL, V22, P1, DOI DOI 10.1371/J0URNAL.P0NE.0026656; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002909; Lou YG, 2014, BIOL CONTROL, V68, P103, DOI 10.1016/j.biocontrol.2013.09.018; Ministry of Agriculture of the People's Republic of China (MAPRC), 2009, 2 LIST APPR AGR GEN; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Pushpendra KS, 2010, INDIAN NEW YORK SCI, V3, P112; Rattanapun W, 2012, Commun Agric Appl Biol Sci, V77, P541; Riddick EW, 1998, ANN ENTOMOL SOC AM, V91, P303, DOI 10.1093/aesa/91.3.303; Shanker C, 2013, J APPL ENTOMOL, V137, P601, DOI 10.1111/jen.12035; [盛承发 Sheng Chengfa], 2002, [自然灾害学报, Journal of Natural Disasters], V11, P103; Shu QY, 2000, MOL BREEDING, V6, P433, DOI 10.1023/A:1009658024114; Sims SR, 1995, SOUTHWEST ENTOMOL, V20, P493; Singh Manoj Kumar, 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P613, DOI 10.1007/s40011-014-0329-4; Tanaka K, 2000, APPL ENTOMOL ZOOL, V35, P177, DOI 10.1303/aez.2000.177; Tian JC, 2010, ENVIRON ENTOMOL, V39, P1369, DOI 10.1603/EN10003; Tu JM, 2000, NAT BIOTECHNOL, V18, P1101, DOI 10.1038/80310; Wang EH, 2014, FOOD CHEM TOXICOL, V65, P312, DOI 10.1016/j.fct.2013.11.045; Wang YM, 2010, CROP PROT, V29, P128, DOI 10.1016/j.cropro.2009.10.004; Wang YY, 2012, BIOL CONTROL, V61, P246, DOI 10.1016/j.biocontrol.2012.02.011; Wu Gang, 2001, Scientia Agricultura Sinica, V34, P496; Ye GY, 2001, J ECON ENTOMOL, V94, P271, DOI 10.1603/0022-0493-94.1.271; Zhang SM, 1982, NAUTRAL ENEMIES INSE, V4, P28	38	3	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0142714	10.1371/journal.pone.0142714	http://dx.doi.org/10.1371/journal.pone.0142714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914608	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700002
J	Paul-Clark, M; Elsheikh, W; Kirkby, N; Chan, M; Devchand, P; Agbor, TA; Flannigan, KL; Cheadle, C; Freydin, M; Ianaro, A; Mitchell, JA; Wallace, JL				Paul-Clark, Mark; Elsheikh, Wagdi; Kirkby, Nicholas; Chan, Melissa; Devchand, Pallavi; Agbor, Terence A.; Flannigan, Kyle L.; Cheadle, Charlotte; Freydin, Maxim; Ianaro, Angela; Mitchell, Jane A.; Wallace, John L.			Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APC(Min/+) Mouse Model of Intestinal Tumorigenesis	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLORECTAL-CANCER; S-SULFHYDRATION; TUMOR-CELLS; EXPRESSION; GENE; PREVENTION; INHIBITORS; ADENOMAS; COLITIS	Nonsteroidal anti-inflammatory drugs have been shown to reduce the incidence of gastrointestinal cancers, but the propensity of these drugs to cause ulcers and bleeding limits their use. H2S has been shown to be a powerful cytoprotective and anti-inflammatory substance in the digestive system. This study explored the possibility that a H2S-releasing nonsteroidal anti-inflammatory drug (ATB-346) would be effective in a murine model of hereditary intestinal cancer (APC(Min+) mouse) and investigated potential mechanisms of action via transcriptomics analysis. Daily treatment with ATB-346 was significantly more effective at preventing intestinal polyp formation than naproxen. Significant beneficial effects were seen with a treatment period of only 3-7 days, and reversal of existing polyps was observed in the colon. ATB-346, but not naproxen, significantly decreased expression of intestinal cancerassociated signaling molecules (cMyc, beta-catenin). Transcriptomic analysis identified 20 genes that were up-regulated in APC(Min+) mice, 18 of which were reduced to wild-type levels by one week of treatment with ATB-346. ATB-346 is a novel, gastrointestinal-sparing antiinflammatory drug that potently and rapidly prevents and reverses the development of precancerous lesions in a mouse model of hereditary intestinal tumorigenesis. These effects may be related to the combined effects of suppression of cyclooxygenase and release of H2S, and correction of most of the APC(Min+)-associated alterations in the transcriptome. ATB-346 may represent a promising agent for chemoprevention of tumorigenesis in the GI tract and elsewhere.	[Paul-Clark, Mark; Kirkby, Nicholas; Cheadle, Charlotte; Freydin, Maxim; Mitchell, Jane A.] Univ London Imperial Coll Sci Technol & Med, London, England; [Elsheikh, Wagdi; Agbor, Terence A.; Flannigan, Kyle L.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Chan, Melissa] Univ London St Bartholomews Hosp Med Coll, Coll Med, William Harvey Res Inst, London EC1M 6BQ, England; [Devchand, Pallavi] Mt Sinai Hosp, Icahn Med Inst, New York, NY 10029 USA; [Ianaro, Angela] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy; [Wallace, John L.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Wallace, John L.] Univ Camilo Castelo Branco, Fac Med, Sao Paulo, SP, Brazil	Imperial College London; McMaster University; University of London; Queen Mary University London; Icahn School of Medicine at Mount Sinai; University of Naples Federico II; University of Calgary; Universidade Brasil	Wallace, JL (corresponding author), Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Wallace, JL (corresponding author), Univ Camilo Castelo Branco, Fac Med, Sao Paulo, SP, Brazil.	altapharm@hotmail.com	ianaro, angela/ABC-2713-2020; Wallace, John/AAL-3763-2021	Cheadle, Charlotte/0000-0002-0293-1840; Kirkby, Nicholas/0000-0003-3509-8549	Canadian Institutes of Health Research grant; Canadian Institutes of Health Research	Canadian Institutes of Health Research grant(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was funded by a Canadian Institutes of Health Research grant to JLW. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Webb McKnight and Lu Wang for their assistance in performing these studies. This research was supported by a research grant from the Canadian Institutes of Health Research.	Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; Blackler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035196; Chattopadhyay M, 2012, BIOCHEM BIOPH RES CO, V419, P523, DOI 10.1016/j.bbrc.2012.02.051; Chattopadhyay M, 2012, BIOCHEM PHARMACOL, V83, P715, DOI 10.1016/j.bcp.2011.12.018; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Elsheikh W, 2014, NITRIC OXIDE-BIOL CH, V41, P131, DOI 10.1016/j.niox.2014.04.006; Farrugia G, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/504230; Fijneman RJA, 2012, CANCER SCI, V103, P593, DOI 10.1111/j.1349-7006.2011.02189.x; Fiorucci S, 2007, BRIT J PHARMACOL, V150, P996, DOI 10.1038/sj.bjp.0707193; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; Gemici B, 2015, NITRIC OXIDE-BIOL CH, V46, P25, DOI 10.1016/j.niox.2014.11.010; Iwama T, 2009, J GASTROENTEROL, V44, P72, DOI 10.1007/s00535-008-2265-7; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Kashfi K, 2014, ANTIOXID REDOX SIGN, V20, P831, DOI 10.1089/ars.2013.5308; Kearney PM, 2006, BMJ-BRIT MED J, V332, P1302, DOI 10.1136/bmj.332.7553.1302; Kimura H, 2012, ANTIOXID REDOX SIGN, V17, P45, DOI 10.1089/ars.2011.4345; Kishimoto Y, 2002, J GASTROENTEROL, V37, P186, DOI 10.1007/s005350200019; KUDO T, 1980, GANN, V71, P260; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; LOGAN RFA, 1993, BRIT MED J, V307, P285, DOI 10.1136/bmj.307.6899.285; Macadam RCA, 2000, BRIT J CANCER, V83, P188; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000464; Narushima Y, 1997, GENE, V185, P159, DOI 10.1016/S0378-1119(96)00589-6; Palinkas Z, 2015, BRIT J PHARMACOL, V172, P1516, DOI 10.1111/bph.12769; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; SEYAMA K, 1994, J CANCER RES CLIN, V120, P213, DOI 10.1007/BF01372559; Solomon SD, 2006, CIRCULATION, V114, P1028, DOI 10.1161/CIRCULATIONAHA.106.636746; Teicher BA, 2015, BIOCHEM PHARMACOL, V96, P1, DOI 10.1016/j.bcp.2015.04.008; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Valladares-Ayerbes M, 2008, CANCER DETECT PREV, V32, P236, DOI 10.1016/j.cdp.2008.08.002; Wallace J. L., 2008, United States Patent Application, Patent No. [WO/2008/009127, 2008009127]; Wallace JL, 2007, FASEB J, V21, P4070, DOI 10.1096/fj.07-8669com; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Wallace JL, 2015, NAT REV DRUG DISCOV, V14, P329, DOI 10.1038/nrd4433; Wallace JL, 2013, DIGEST DIS SCI, V58, P3088, DOI 10.1007/s10620-013-2777-8; Wallace JL, 2013, WORLD J GASTROENTERO, V19, P1861, DOI 10.3748/wjg.v19.i12.1861; Wallace JL, 2011, GASTROENTEROLOGY, V141, P1314, DOI 10.1053/j.gastro.2011.06.075; Wallace JL, 2010, BRIT J PHARMACOL, V159, P1236, DOI 10.1111/j.1476-5381.2009.00611.x; Wallace JL, 2009, GASTROENTEROLOGY, V137, P569, DOI 10.1053/j.gastro.2009.04.012; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Whiteman Matthew, 2011, Expert Rev Clin Pharmacol, V4, P13, DOI 10.1586/ecp.10.134; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Yang GD, 2013, ANTIOXID REDOX SIGN, V18, P1906, DOI 10.1089/ars.2012.4645; Yang GD, 2012, J MOL CELL CARDIOL, V52, P677, DOI 10.1016/j.yjmcc.2011.12.004; Zhu Y, 2001, Respir Res, V2, P300, DOI 10.1186/rr73	50	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147289	10.1371/journal.pone.0147289	http://dx.doi.org/10.1371/journal.pone.0147289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910063	Green Published, gold			2022-12-27	WOS:000371164700004
J	Wang, X; Luo, Y; Masci, PP; Crawford, R; Xiao, Y				Wang, Xin; Luo, Yan; Masci, Paul P.; Crawford, Ross; Xiao, Yin			Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing	PLOS ONE			English	Article							RICH PLASMA; FRACTURE HEMATOMA; FIBRIN STRUCTURE; CROSS-LINKING; GAMMA-CHAIN; POLYMERIZATION; MECHANISMS; THROMBOSIS; IL-1-BETA; STABILITY	Objectives Hematoma quality (especially the fibrin matrix) plays an important role in the bone healing process. Here, we investigated the effect of interleukin-1 beta (IL-1 beta) on fibrin clot formation from platelet-poor plasma (PPP). Methods Five-milliliter of rat whole-blood samples were collected from the hepatic portal vein. All blood samples were firstly standardized via a thrombelastograph (TEG), blood cell count, and the measurement of fibrinogen concentration. PPP was prepared by collecting the top two-fifths of the plasma after centrifugation under 400 x g for 10 min at 20 degrees C. The effects of IL-1 beta cytokines on artificial fibrin clot formation from PPP solutions were determined by scanning electronic microscopy (SEM), confocal microscopy (CM), turbidity, and clot lysis assays. Results The lag time for protofibril formation was markedly shortened in the IL-1 beta treatment groups (243.8 +/- 76.85 in the 50 pg/mL of IL-1 beta and 97.5 +/- 19.36 in the 500 pg/mL of IL-1 beta) compared to the control group without IL-1 beta (543.8 +/- 205.8). Maximal turbidity was observed in the control group. IL-1 beta (500 pg/mL) treatment significantly decreased fiber diameters resulting in smaller pore sizes and increased density of the fibrin clot structure formed from PPP (P < 0.05). The clot lysis assay revealed that 500 pg/mL IL-1 beta induced a lower susceptibility to dissolution due to the formation of thinner and denser fibers. Conclusion IL-1 beta can significantly influence PPP fibrin clot structure, which may affect the early bone healing process.	[Wang, Xin] Zunyi Med Coll, Dept Spine, Affiliated Hosp, Zunyi, Guizhou Provinc, Peoples R China; [Wang, Xin; Luo, Yan; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Wang, Xin; Luo, Yan; Crawford, Ross; Xiao, Yin] Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld 4001, Australia; [Wang, Xin; Masci, Paul P.] Univ Queensland, Sch Med, Translat Res Inst, Brisbane, Qld, Australia	Zunyi Medical University; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Queensland	Xiao, Y (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia.; Xiao, Y (corresponding author), Queensland Univ Technol, Australia China Ctr Tissue Engn & Regenerat Med, Brisbane, Qld 4001, Australia.	yin.xiao@qut.edu.au	Xiao, Yin/AAM-4033-2020; Wang, Xin/GMW-8059-2022	Xiao, Yin/0000-0003-1785-3491; Crawford, Ross/0000-0001-6079-1316				Aggrey AA, 2013, J IMMUNOL, V190, P4685, DOI 10.4049/jimmunol.1202672; Albanese A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-23; Bateman RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043660; Calori GM, 2008, INJURY, V39, P1391, DOI 10.1016/j.injury.2008.08.011; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Collen A, 1998, Angiogenesis, V2, P153, DOI 10.1023/A:1009240522808; Collet JP, 2000, ARTERIOSCL THROM VAS, V20, P1354, DOI 10.1161/01.ATV.20.5.1354; Duval C, 2014, THROMB HAEMOSTASIS, V111, P842, DOI 10.1160/TH13-10-0855; Echeverri LF, 2015, B MATH BIOL, V77, P156, DOI 10.1007/s11538-014-0055-3; EINHORN TA, 1995, J BONE MINER RES, V10, P1272; Engelmann B, 2013, NAT REV IMMUNOL, V13, P34, DOI 10.1038/nri3345; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gersh KC, 2009, THROMB HAEMOSTASIS, V102, P1169, DOI 10.1160/TH09-03-0199; Ghanaati Shahram, 2013, Ann Maxillofac Surg, V3, P126, DOI 10.4103/2231-0746.119221; GRUNDNES O, 1993, ACTA ORTHOP SCAND, V64, P340, DOI 10.3109/17453679308993640; Hatakeyama I, 2014, TISSUE ENG PT A, V20, P874, DOI [10.1089/ten.tea.2013.0058, 10.1089/ten.TEA.2013.0058]; Hengartner NE, 2013, MOL MED, V19, P36, DOI 10.2119/molmed.2012.00058; Hernandez-Fernandez A, 2013, INJURY, V44, P901, DOI 10.1016/j.injury.2012.10.018; Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147; Koga T, 2013, INT ORTHOP, V37, P961, DOI 10.1007/s00264-013-1813-9; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Konings J, 2011, BLOOD, V118, P3942, DOI 10.1182/blood-2011-03-339572; Lai BFL, 2010, BIOMATERIALS, V31, P5749, DOI 10.1016/j.biomaterials.2010.03.076; Lange J, 2010, J ORTHOP RES, V28, P778, DOI 10.1002/jor.21061; Li CH, 1998, PATTERN RECOGN LETT, V19, P771, DOI 10.1016/S0167-8655(98)00057-9; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Lord ST, 2011, ARTERIOSCL THROM VAS, V31, P494, DOI 10.1161/ATVBAHA.110.213389; Mackie IJ, 2003, BRIT J HAEMATOL, V121, P396, DOI 10.1046/j.1365-2141.2003.04256.x; Morais JM, 2010, AAPS J, V12, P188, DOI 10.1208/s12248-010-9175-3; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; Mountziaris PM, 2008, TISSUE ENG PART B-RE, V14, P179, DOI 10.1089/ten.teb.2008.0038; Naik Balaram, 2013, J Conserv Dent, V16, P284, DOI 10.4103/0972-0707.114344; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Perrien DS, 2004, TOXICOL SCI, V82, P656, DOI 10.1093/toxsci/kfi002; Plachokova AS, 2007, CLIN ORAL IMPLAN RES, V18, P244, DOI 10.1111/j.1600-0501.2006.01327.x; River C, 1984, CHARLES RIVER TECHNI, V3; Sahni A, 2004, BLOOD, V104, P409, DOI 10.1182/blood-2004-01-0126; Sahni A, 2003, J THROMB HAEMOST, V1, P1271, DOI 10.1046/j.1538-7836.2003.00228.x; Saluja Harish, 2011, Ann Maxillofac Surg, V1, P53, DOI 10.4103/2231-0746.83158; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Shiu HT, 2014, J MATER CHEM B, V2, P3009, DOI 10.1039/c4tb00009a; Soffer E, 2003, ORAL SURG ORAL MED O, V95, P521, DOI 10.1067/moe.2003.152; Stevic I, 2013, BLOOD, V122, P578; Talens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041966; Textor JA, 2014, AM J VET RES, V75, P392, DOI 10.2460/ajvr.75.4.392; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; VARADI A, 1986, BIOCHEMISTRY-US, V25, P519, DOI 10.1021/bi00351a001; Viennet C, 2014, J WOUND CARE, V23, P66, DOI 10.12968/jowc.2014.23.2.66; von Bruhl ML, 2012, J EXP MED, V209, P819, DOI 10.1084/jem.20112322; Willie BM, 2010, SOFT MATTER, V6, P4976, DOI 10.1039/c0sm00262c; Wohlauer MV, 2011, SHOCK, V36, P524, DOI 10.1097/SHK.0b013e31822dc518; Zucker M, 2014, J THROMB HAEMOST, V12, P1121, DOI 10.1111/jth.12600	53	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149775	10.1371/journal.pone.0149775	http://dx.doi.org/10.1371/journal.pone.0149775			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909757	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700047
J	Ullinger, HL; Kennedy, MJ; Schneider, WH; Miller, CM				Ullinger, Heather L.; Kennedy, Marla J.; Schneider, William H.; Miller, Christopher M.			Exploratory Disposal and Reuse Feasibility Analysis of Winter Maintenance Wash Water	PLOS ONE			English	Article							EMISSIONS; WEAR	The Ohio Department of Transportation has more than 60 facilities without sewer access generating approximately 19 million gallons of winter maintenance wash water. Off-site disposal is costly, creating the need for sustainable management strategies. The objective of this study was to conduct an exploratory feasibility analysis to assess wash water disposal and potential reuse as brine. Based on a comprehensive literature review and relevant environmental chemistry, a sampling protocol consisting of 31 water quality constituents was utilized for monthly sampling at three geographically distinct Ohio Department of Transportation garages during the winter of 2012. Results were compared to local disposal and reuse guidance limits. Three constituents, including a maximum copper concentration of 858 ppb, exceeded disposal limits, and many constituents also failed to meet reuse limits. Some concentrations were orders of magnitude higher than reuse limits and suggest pretreatment would be necessary if wash water were reused as brine. These water quality results, in conjunction with copper chemical equilibrium modeling, show pH and dissolved carbon both significantly impact the total dissolved copper concentration and should be measured to assess reuse potential. The sampling protocol and specific obstacles highlighted in this paper aid in the future development of sustainable wash water management strategies.	[Ullinger, Heather L.; Kennedy, Marla J.; Schneider, William H.; Miller, Christopher M.] Univ Akron, Dept Civil Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Miller, CM (corresponding author), Univ Akron, Dept Civil Engn, Akron, OH 44325 USA.	cmmiller@uakron.edu			Federal Highway Administration [SJN 134629]	Federal Highway Administration	This work was supported by the Federal Highway Administration, SJN 134629 (CMM WHS). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alleman JE, 2004, PUBLICATION FHWA IN; APHA, 1995, STANDARD METHODS EXA, Vnineteenth; Benjamin M. M., 2002, WATER CHEM; Budai P, 2011, TRANSPORT RES D-TR E, V16, P244, DOI 10.1016/j.trd.2010.12.003; Davis AP, 2001, CHEMOSPHERE, V44, P997, DOI 10.1016/S0045-6535(00)00561-0; Fitch GM, 2005, TRANSPORT RES REC, V1911, P124; Garg BD, 2000, ENVIRON SCI TECHNOL, V34, P4463, DOI 10.1021/es001108h; Harrison RM, 2012, ENVIRON SCI TECHNOL, V46, P6523, DOI 10.1021/es300894r; Hjortenkrans DST, 2007, ENVIRON SCI TECHNOL, V41, P5224, DOI 10.1021/es070198o; Hull & Associates Inc., 2010, PROC PLAN BEN REUS W; Jang YC, 2010, SCI TOTAL ENVIRON, V408, P1878, DOI 10.1016/j.scitotenv.2010.01.036; Jang YC, 2009, J ENVIRON MANAGE, V91, P320, DOI 10.1016/j.jenvman.2009.08.018; Johansson C, 2009, ATMOS ENVIRON, V43, P4681, DOI 10.1016/j.atmosenv.2008.10.024; Luhana L, 2004, MEASUREMENT NONEXHAU; Miller CM, 2015, PUBLIC WORKS MANAG P, V20, P80, DOI 10.1177/1087724X14522601; Snoeyink VL., 1980, WATER CHEM; USEPA, 2007, EPA822R07001 OFF WAT; Westerlund K.-G., 2001, METAL EMISSIONS STOC	18	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149500	10.1371/journal.pone.0149500	http://dx.doi.org/10.1371/journal.pone.0149500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908148	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000014
J	Taschereau-Dumouchel, V; Hetu, S; Bagramian, A; Labrecque, A; Racine, M; Chagnon, YC; Jackson, PL				Taschereau-Dumouchel, Vincent; Hetu, Sebastien; Bagramian, Anait; Labrecque, Alexandre; Racine, Marion; Chagnon, Yvon C.; Jackson, Philip L.			BDNF Val(66)Met Polymorphism Is Associated with Self-Reported Empathy	PLOS ONE			English	Article							OXYTOCIN RECEPTOR GENE; ACTIVITY-DEPENDENT SECRETION; VAL66MET POLYMORPHISM; NEUROTROPHIC FACTOR; PAIN; OXTR; NEUROSCIENCE; MECHANISMS; EVOLUTION; OTHERS	Empathy is an important driver of human social behaviors and presents genetic roots that have been studied in neuroimaging using the intermediate phenotype approach. Notably, the Val(66)Met polymorphism of the Brain-derived neurotrophic factor (BDNF) gene has been identified as a potential target in neuroimaging studies based on its influence on emotion perception and social cognition, but its impact on self-reported empathy has never been documented. Using a neurogenetic approach, we investigated the association between the BDNF Val(66)Met polymorphism and self-reported empathy (Davis' Interpersonal Reactivity Index; IRI) in a sample of 110 young adults. Our results indicate that the BDNF genotype is significantly associated with the linear combination of the four facets of the IRI, one of the most widely used self-reported empathy questionnaire. Crucially, the effect of BDNF Val(66)Met goes beyond the variance explained by two polymorphisms of the oxytocin transporter gene previously associated with empathy and its neural underpinnings (OXTR rs53576 and rs2254298). These results represent the first evidence suggesting a link between the BDNF gene and self-reported empathy and warrant further studies of this polymorphism due to its potential clinical significance.	[Taschereau-Dumouchel, Vincent; Bagramian, Anait; Labrecque, Alexandre; Racine, Marion; Jackson, Philip L.] Univ Laval, Ecole Psychol, Quebec City, PQ, Canada; [Taschereau-Dumouchel, Vincent; Jackson, Philip L.] CIRRIS, Quebec City, PQ, Canada; [Taschereau-Dumouchel, Vincent; Chagnon, Yvon C.; Jackson, Philip L.] CRIUSMQ, Quebec City, PQ, Canada; [Hetu, Sebastien] Virginia Tech, Human Neuroimaging Lab, Caril Res Inst, Roanoke, VA USA; [Chagnon, Yvon C.] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada	Laval University; Laval University; Virginia Polytechnic Institute & State University; Laval University	Taschereau-Dumouchel, V (corresponding author), Univ Laval, Ecole Psychol, Quebec City, PQ, Canada.; Taschereau-Dumouchel, V (corresponding author), CIRRIS, Quebec City, PQ, Canada.; Taschereau-Dumouchel, V (corresponding author), CRIUSMQ, Quebec City, PQ, Canada.	vincent.taschereau-dumouchel.1@ulaval.ca		Jackson, Philip/0000-0001-8991-3217	National Science and Engineering Research Council (NSERC); Quebec Bio-Imaging Network (QBIN); NSERC; Centre thematique de recherche en neurosciences; Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Canadian Institute of Health Research (CIHR); Fond de recherche Quebec-Sante (FRQS); CIHR; FRQS	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Quebec Bio-Imaging Network (QBIN); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre thematique de recherche en neurosciences; Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fond de recherche Quebec-Sante (FRQS); CIHR(Canadian Institutes of Health Research (CIHR)); FRQS	This work was supported by grants from the National Science and Engineering Research Council (NSERC) and from the Quebec Bio-Imaging Network (QBIN). Vincent Taschereau-Dumouchel was supported by scholarships from the NSERC, the Centre thematique de recherche en neurosciences, Center for Interdisciplinary Research in Rehabilitation and Social Integration (CIRRIS) and the Canadian Institute of Health Research (CIHR). Sebastien Hetu was supported by scholarship from the Fond de recherche Quebec-Sante (FRQS) and CIHR. Philip L. Jackson was supported by a New Investigator Award from the CIHR and a Chercheur-Boursier Senior Award from the FRQS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2010, ANN NY ACAD SCI, V1191, P42, DOI 10.1111/j.1749-6632.2010.05445.x; Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Byrne RW, 2007, CURR BIOL, V17, pR714, DOI 10.1016/j.cub.2007.05.069; Carlson JM, 2014, CEREB CORTEX, V24, P2249, DOI 10.1093/cercor/bht089; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; COCHRAN WG, 1948, ANN MATH STAT, V19, P151, DOI 10.1214/aoms/1177730242; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Fan Y, 2011, NEUROSCI BIOBEHAV R, V35, P903, DOI 10.1016/j.neubiorev.2010.10.009; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gonzalez-Liencres C, 2013, NEUROSCI BIOBEHAV R, V37, P1537, DOI 10.1016/j.neubiorev.2013.05.001; Inoue H, 2010, BIOL PSYCHIAT, V68, P1066, DOI 10.1016/j.biopsych.2010.07.019; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Leung CY, 1999, J MULTIVARIATE ANAL, V71, P111, DOI 10.1006/jmva.1999.1827; Montag C, 2007, SCHIZOPHR RES, V92, P85, DOI 10.1016/j.schres.2007.01.024; Montag C, 2008, NEUROIMAGE, V42, P1554, DOI 10.1016/j.neuroimage.2008.06.008; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; Notaras M, 2015, NEUROSCI BIOBEHAV R, V51, P15, DOI 10.1016/j.neubiorev.2014.12.016; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rodrigues SM, 2009, P NATL ACAD SCI USA, V106, P21437, DOI 10.1073/pnas.0909579106; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Smith KE, 2014, SOC NEUROSCI-UK, V9, P1, DOI 10.1080/17470919.2013.863223; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Tost H, 2011, BIOL PSYCHIAT, V70, pE37, DOI 10.1016/j.biopsych.2011.06.034; Tost H, 2010, P NATL ACAD SCI USA, V107, P13936, DOI 10.1073/pnas.1003296107; Uzefovsky F, 2015, HORM BEHAV, V67, P60, DOI 10.1016/j.yhbeh.2014.11.007; Wade M, 2014, GENES BRAIN BEHAV, V13, P603, DOI 10.1111/gbb.12148; Wu N, 2012, J AFFECT DISORDERS, V138, P468, DOI 10.1016/j.jad.2012.01.009	42	10	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149911	10.1371/journal.pone.0149911	http://dx.doi.org/10.1371/journal.pone.0149911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3VL	26901829	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100183
J	Garcia-Gutierrez, E; Chidlaw, AC; Le Gall, G; Bowden, SD; Tedin, K; Kelly, DJ; Thompson, A				Garcia-Gutierrez, Enriqueta; Chidlaw, Amanda C.; Le Gall, Gwenaelle; Bowden, Steven D.; Tedin, Karsten; Kelly, David J.; Thompson, Arthur			A Comparison of the ATP Generating Pathways Used by S. Typhimurium to Fuel Replication within Human and Murine Macrophage and Epithelial Cell Lines	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; LACTATE-DEHYDROGENASE; ORAL STREPTOCOCCI; MEMBRANE ATPASES; GENE-EXPRESSION; MESSENGER-RNA; VIRULENCE	The metabolism of S. Typhimurium within infected host cells plays a fundamental role in virulence since it enables intracellular proliferation and dissemination and affects the innate immune response. An essential requirement for the intracellular replication of S. Typhimurium is the need to regenerate ATP. The metabolic route used to fulfil this requirement is the subject of the present study. For infection models we used human and murine epithelial and macrophage cell lines. The epithelial cell lines were mIC(c12), a transimmortalised murine colon enterocyte cell line that shows many of the characteristics of a primary epithelial cell line, and HeLa cells. The model macrophage cell lines were THP-1A human monocyte/macrophages and RAW 264.7 murine macrophages. Using a mutational approach combined with an exometabolomic analysis, we showed that neither fermentative metabolism nor anaerobic respiration play major roles in energy generation in any of the cell lines studied. Rather, we identified overflow metabolism to acetate and lactate as the foremost route by which S. Typhimurium fulfils its energy requirements.	[Garcia-Gutierrez, Enriqueta; Chidlaw, Amanda C.; Le Gall, Gwenaelle; Thompson, Arthur] Inst Food Res, Norwich NR4 7UA, Norfolk, England; [Bowden, Steven D.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA; [Tedin, Karsten] Free Univ Berlin, Inst Microbiol & Epizoot, Ctr Infect Med, D-14163 Berlin, Germany; [Kelly, David J.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Minnesota System; University of Minnesota Twin Cities; Free University of Berlin; University of Sheffield	Thompson, A (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.; Kelly, DJ (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	d.kelly@sheffield.ac.uk; arthur.thompson@ifr.ac.uk	Gutierrez, Enriqueta Garcia/B-8901-2018; Garcia-Gutierrez, Enriqueta/O-2866-2019; Le+Gall, Gwenaelle/AAC-6938-2019	Gutierrez, Enriqueta Garcia/0000-0001-5683-7924; Garcia-Gutierrez, Enriqueta/0000-0001-5683-7924; Le+Gall, Gwenaelle/0000-0002-1379-2196	Biotechnology and Biological Sciences Research Council [BB/J001007/1]; BBSRC [BB/J001007/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, grant number BB/J001007/1 to AT and DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042007; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BENDER GR, 1987, APPL ENVIRON MICROB, V53, P2124, DOI 10.1128/AEM.53.9.2124-2128.1987; BENDER GR, 1986, INFECT IMMUN, V53, P331, DOI 10.1128/IAI.53.2.331-338.1986; Bens M, 1996, AM J PHYSIOL-CELL PH, V270, pC1666, DOI 10.1152/ajpcell.1996.270.6.C1666; BOCK A, 1996, FERMENTATION, P262; Bowden SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096266; Bowden SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013871; Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09; Chimalizeni Y, 2010, ADV EXP MED BIOL, V659, P33, DOI 10.1007/978-1-4419-0981-7_3; Dandekar T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00164; DONG JM, 1993, J BACTERIOL, V175, P6671, DOI 10.1128/jb.175.20.6671-6678.1993; Durant JA, 2000, J APPL MICROBIOL, V89, P63, DOI 10.1046/j.1365-2672.2000.01089.x; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; El-Mansi M, 2004, J IND MICROBIOL BIOT, V31, P295, DOI 10.1007/s10295-004-0149-2; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Fraenkel DG, 1996, GLYCOLYSIS; FUTAI M, 1977, J BIOL CHEM, V252, P5820; Gotz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010586; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; Keseler IM, 2013, NUCLEIC ACIDS RES, V41, pD605, DOI 10.1093/nar/gks1027; Knodler LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084681; Kotarsky K, 2010, MUCOSAL IMMUNOL, V3, P40, DOI 10.1038/mi.2009.115; KOTLARZ D, 1975, BIOCHIM BIOPHYS ACTA, V381, P257, DOI 10.1016/0304-4165(75)90232-9; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lee EJ, 2013, CELL, V154, P146, DOI 10.1016/j.cell.2013.06.004; Lee EJ, 2012, NATURE, V486, P271, DOI 10.1038/nature11090; LUKACS GL, 1990, J BIOL CHEM, V265, P21099; Malik-Kale P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038732; MATJAN F, 1989, J BACTERIOL, V171, P342, DOI 10.1128/jb.171.1.342-348.1989; Meganathan R, 2009, EcoSal Plus, V3, DOI 10.1128/ecosalplus.3.6.3.3; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Morita T, 2003, J BIOL CHEM, V278, P15608, DOI 10.1074/jbc.M300177200; Naftalin Richard J, 2014, F1000Res, V3, P304, DOI 10.12688/f1000research.5934.1; Paczia N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-122; Pontes MH, 2015, J MOL BIOL, V427, P2586, DOI 10.1016/j.jmb.2015.06.021; Pui C. F., 2011, International Food Research Journal, V18, P465; Que FX, 2013, CURR MICROBIOL, V66, P582, DOI 10.1007/s00284-013-0307-8; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Rishi P, 2005, J ENVIRON SCI HEAL B, V40, P645, DOI 10.1081/PFC-200061576; Shi L, 2009, INFECT IMMUN, V77, P3227, DOI 10.1128/IAI.00063-09; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Trchounian A, 2004, BIOCHEM BIOPH RES CO, V315, P1051, DOI 10.1016/j.bbrc.2004.02.005; Valgepea K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-166; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Yang YT, 1999, BIOTECHNOL BIOENG, V65, P291, DOI 10.1002/(SICI)1097-0290(19991105)65:3<291::AID-BIT6>3.0.CO;2-F	52	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150687	10.1371/journal.pone.0150687	http://dx.doi.org/10.1371/journal.pone.0150687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930214	gold, Green Published, Green Accepted			2022-12-27	WOS:000371434500183
J	Hadaegh, F; Derakhshan, A; Mozaffary, A; Hasheminia, M; Khalili, D; Azizi, F				Hadaegh, Farzad; Derakhshan, Arash; Mozaffary, Amirhossein; Hasheminia, Mitra; Khalili, Davood; Azizi, Fereidoun			Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; CIGARETTE-SMOKING; BLOOD-GLUCOSE; LIFE-STYLE; FOLLOW-UP; PREVALENCE; TRENDS; METAANALYSIS	Introduction To examine the associations between smoking and cardiovascular disease (CVD)/coronary heart disease (CHD) and all-cause mortality events in men with and without type 2 diabetes (T2D) in a Middle Eastern cohort during a median follow-up of 12 years. Methods The study population included 2230 subjects aged >= 40 years, free from CVD, comprised of 367 participants with diabetes (21.2% current smokers) and 1863 without (27.3% current smokers). Multivariate Hazard ratios (HR) and 95% confidence intervals (CI) were calculated for smoking (considering different definitions) for those with and without diabetes. Potential confounding factors including age, body mass index, estimated Glomerular Filtration Rate, hypertension, hypercholesterolemia and educational level were entered in themultivariate analysis. Results In men with diabetes, the HR (95% CI) of comparing current and non-smokers was 1.25 (0.74-2.12) for incident CHD, 1.52 (0.96-2.40) for CVD and 2.10 (1.27-3.47) for mortality events; the corresponding values for men without diabetes were 1.65 (1.24-2.20), 1.70 (1.30-2.22) and 1.72 (1.14-2.58), respectively (all P values for interactions > 0.46). After pooling past smokers with current smokers, among diabetic individuals there was no significant risk for CVD [1.29 (0.89-1.86)] or mortality events [1.25 (0.81-1.92)]; however, among non-diabetic individuals the HRs of current/past smokers reached significant levels for CVD [1.53 (1.23-1.91)] but not for mortality outcomes (all P values for interactions > 0.51). Conclusions The strength of the associations between smoking habits and incident CVD/CHD and mortality events from all causes did not differ significantly among diabetic and non-diabetic participants. Therefore, a comprehensive community-based smoking prevention program is important, given the increasing trend of smoking among the Iranian population regardless of diabetes status.	[Hadaegh, Farzad; Derakhshan, Arash; Mozaffary, Amirhossein; Hasheminia, Mitra; Khalili, Davood] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Prevent Metab Disorders Res Ctr, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Khalili, Davood/T-2913-2017; hadaegh, farzad/K-2460-2017; Azizi, Fereidoun/ABD-4136-2021; Derakhshan, Arash/AAD-7505-2019	Khalili, Davood/0000-0003-4956-1039; Azizi, Fereidoun/0000-0002-6470-2517; Derakhshan, Arash/0000-0001-7335-1918; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by grant No. 121 from the National Research Council of the Islamic Republic of Iran.	Adlerberth AM, 1998, DIABETES CARE, V21, P539, DOI 10.2337/diacare.21.4.539; Agaku Israel, 2012, Morbidity and Mortality Weekly Report, V61, P889; Al-Delaimy WK, 2002, ARCH INTERN MED, V162, P273, DOI 10.1001/archinte.162.3.273; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2015, DIABETES CARE, V38, pS20, DOI 10.2337/dc15-S007; [Anonymous], 2006, HLTH CONSEQUENCES IN; Azizi F., 2000, IRAN J ENDOCRINOL ME, V2, P77; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; BALKAU B, 1993, BRIT MED J, V307, P295, DOI 10.1136/bmj.307.6899.295; BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; Barzin M, 2015, PUBLIC HEALTH NUTR, V18, P2981, DOI 10.1017/S1368980015000269; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; DUPREE EA, 1980, AM J EPIDEMIOL, V112, P100, DOI 10.1093/oxfordjournals.aje.a112959; Ehteshami-Afshar S, 2014, ANN HUM BIOL, V41, P249, DOI 10.3109/03014460.2013.853834; Erlich DR, 2014, AM FAM PHYSICIAN, V89, P256; Esteghamati A, 2011, J PHYS ACT HEALTH, V8, P27, DOI 10.1123/jpah.8.1.27; Ezzati M, 2005, CIRCULATION, V112, P489, DOI 10.1161/CIRCULATIONAHA.104.521708; Fagard RH, 2009, DIABETES CARE, V32, pS429, DOI 10.2337/dc09-S354; Ford ES, 2011, DIABETES CARE, V34, P1337, DOI 10.2337/dc10-2251; FORD ES, 1991, AM J EPIDEMIOL, V133, P1220, DOI 10.1093/oxfordjournals.aje.a115834; Ghafouri Nasim, 2011, BMC Res Notes, V4, P496, DOI 10.1186/1756-0500-4-496; Hadaegh F, 2006, EUR J CARDIOV PREV R, V13, P571, DOI 10.1097/01.hjr.0000216552.81882.ca; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Howard G, 1998, JAMA-J AM MED ASSOC, V279, P119, DOI 10.1001/jama.279.2.119; Hughes JR, 2010, AM J PREV MED, V39, P285, DOI 10.1016/j.amepre.2010.05.002; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Jahangiri-Noudeh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112639; KANNEL WB, 1979, CIRCULATION, V59, P8, DOI 10.1161/01.CIR.59.1.8; KEEN H, 1981, DIABETES, V30, P49, DOI 10.2337/diab.30.2.S49; Kengne AP, 2009, J DIABETES, V1, P173, DOI 10.1111/j.1753-0407.2009.00028.x; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Levey A, 2000, SIMPLIFIED EQUATION; Li Q, 2011, NEW ENGL J MED, V364, P2469, DOI 10.1056/NEJMc1102459; Moosazadeh Mahmood, 2013, Addict Health, V5, P140; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; OSTRANDER LD, 1981, ARTERIOSCLEROSIS, V1, P33, DOI 10.1161/01.ATV.1.1.33; Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Qin R, 2013, INT J CARDIOL, V167, P342, DOI 10.1016/j.ijcard.2011.12.100; Ramachandran A, 1999, DIABETES RES CLIN PR, V44, P207, DOI 10.1016/S0168-8227(99)00024-8; Ridderstrale M, 2006, J INTERN MED, V259, P314, DOI 10.1111/j.1365-2796.2006.01617.x; Rodu B, 2013, SCAND J PUBLIC HEALT, V41, P808, DOI 10.1177/1403494813504836; Samaranayaka S, 2013, PRIM CARE DIABETES, V7, P193, DOI 10.1016/j.pcd.2013.04.010; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Sibai AM, 2011, ANN NUTR METAB, V57, P193, DOI 10.1159/000321527; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; SUAREZ L, 1984, AM J EPIDEMIOL, V120, P670, DOI 10.1093/oxfordjournals.aje.a113933; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Yoon U, 2013, METABOLISM, V62, P303, DOI 10.1016/j.metabol.2012.07.009	52	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149780	10.1371/journal.pone.0149780	http://dx.doi.org/10.1371/journal.pone.0149780			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930192	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500057
J	Khosa, S; Hoeppner, A; Gohlke, H; Schmitt, L; Smits, SHJ				Khosa, Sakshi; Hoeppner, Astrid; Gohlke, Holger; Schmitt, Lutz; Smits, Sander H. J.			Structure of the Response Regulator NsrR from Streptococcus agalactiae, Which Is Involved in Lantibiotic Resistance	PLOS ONE			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; DNA-BINDING DOMAIN; VANCOMYCIN-INTERMEDIATE RESISTANCE; VRAFG ABC TRANSPORTER; MYCOBACTERIUM-TUBERCULOSIS; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; LACTOCOCCUS-LACTIS; HISTIDINE KINASES; NISIN RESISTANCE	Lantibiotics are antimicrobial peptides produced by Gram-positive bacteria. Interestingly, several clinically relevant and human pathogenic strains are inherently resistant towards lantibiotics. The expression of the genes responsible for lantibiotic resistance is regulated by a specific two-component system consisting of a histidine kinase and a response regulator. Here, we focused on a response regulator involved in lantibiotic resistance, NsrR from Streptococcus agalactiae, and determined the crystal structures of its N-terminal receiver domain and C-terminal DNA-binding effector domain. The C-terminal domain exhibits a fold that classifies NsrR as a member of the OmpR/PhoB subfamily of regulators. Amino acids involved in phosphorylation, dimerization, and DNA-binding were identified and demonstrated to be conserved in lantibiotic resistance regulators. Finally, a model of the full-length NsrR in the active and inactive state provides insights into protein dimerization and DNA-binding.	[Khosa, Sakshi; Schmitt, Lutz; Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany; [Hoeppner, Astrid] Univ Dusseldorf, Xray Facil & Crystal Farm, Univ Str 1, D-40225 Dusseldorf, Germany; [Gohlke, Holger] Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, D-40225 Dusseldorf, Germany.	sander.smits@hhu.de		Hoeppner, Astrid/0000-0002-7076-5936	IgraspSeed (a university internal graduate school); Heinrich Heine International Graduate School of Protein Science and Technology (iGRASPseed)	IgraspSeed (a university internal graduate school); Heinrich Heine International Graduate School of Protein Science and Technology (iGRASPseed)	This work was funded by IgraspSeed (a university internal graduate school).; We are grateful to Diana Kleinschrodt and Iris Fey for technical assistance. We acknowledge the European Synchrotron Radiation Facility (ESRF Grenoble) and EMBL Hamburg for provision of synchrotron radiation facilities and are grateful to the staff of ESRF ID23-2 and ID29 for support during data collection, especially Christoph Mueller-Dieckmann for his enormous patience, assistance, and support. We are also thankful to Heinrich Heine International Graduate School of Protein Science and Technology (iGRASPseed) for providing a scholarship to S.K.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AlKhatib Z, 2014, MICROBIOLOGYOPEN, V3, P752, DOI 10.1002/mbo3.205; Alkhatib Z, 2012, J BIOTECHNOL, V159, P145, DOI 10.1016/j.jbiotec.2012.01.032; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Appleby JL, 1998, J BACTERIOL, V180, P3563, DOI 10.1128/JB.180.14.3563-3569.1998; Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006; Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529; Bellsolell L, 1996, J MOL BIOL, V257, P116, DOI 10.1006/jmbi.1996.0151; Bierbaum G, 1996, APPL ENVIRON MICROB, V62, P385, DOI 10.1128/AEM.62.2.385-392.1996; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boakes S, 2008, DRUG DIS DEVEL, V27, P22; Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YH, 2003, J BACTERIOL, V185, P262, DOI 10.1128/JB.185.1.262-273.2003; Choudhury HG, 2013, PROTEIN SCI, V22, P1287, DOI 10.1002/pro.2311; Christ NA, 2012, J BIOL CHEM, V287, P35286, DOI 10.1074/jbc.M112.401620; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; Cotter PD, 2005, CURR PROTEIN PEPT SC, V6, P61, DOI 10.2174/1389203053027584; Cotter PD, 1999, J BACTERIOL, V181, P6840, DOI 10.1128/JB.181.21.6840-6843.1999; DeLano WL, 2002, THE PYMOL MOLECULAR; Dintner S, 2011, J BACTERIOL, V193, P3851, DOI 10.1128/JB.05175-11; Dischinger J, 2014, INT J MED MICROBIOL, V304, P51, DOI 10.1016/j.ijmm.2013.09.003; Draper LA, 2015, MICROBIOL MOL BIOL R, V79, P171, DOI 10.1128/MMBR.00051-14; Dyballa N, 2009, J VISUALIZED EXPT JO; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGELKE G, 1994, APPL ENVIRON MICROB, V60, P814, DOI 10.1128/AEM.60.3.814-825.1994; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Guder A, 2002, APPL ENVIRON MICROB, V68, P106, DOI 10.1128/AEM.68.1.106-113.2002; Guillet V, 2002, J BIOL CHEM, V277, P42003, DOI 10.1074/jbc.M204789200; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawada-Matsuo M, 2013, APPL ENVIRON MICROB, V79, P4751, DOI 10.1128/AEM.00780-13; Khosa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18679; Khosa S, 2015, ACTA CRYSTALLOGR F, V71, P1322, DOI 10.1107/S2053230X15016441; Khosa S, 2013, BIOL CHEM, V394, P1543, DOI 10.1515/hsz-2013-0167; King-Scott J, 2007, J BIOL CHEM, V282, P37717, DOI 10.1074/jbc.M705081200; Kleerebezem M, 1997, MOL MICROBIOL, V24, P895, DOI 10.1046/j.1365-2958.1997.4251782.x; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Leonard PG, 2013, P NATL ACAD SCI USA, V110, P8525, DOI 10.1073/pnas.1302819110; Li Y-C, 2014, NUCL ACIDS RES; LUKAT GS, 1993, J CELL BIOCHEM, V51, P41, DOI 10.1002/jcb.240510109; Mack TR, 2009, J MOL BIOL, V389, P349, DOI 10.1016/j.jmb.2009.04.014; Mandin P, 2005, MOL MICROBIOL, V57, P1367, DOI 10.1111/j.1365-2958.2005.04776.x; MartinezHackert E, 1997, J MOL BIOL, V269, P301, DOI 10.1006/jmbi.1997.1065; MartinezHackert E, 1997, STRUCTURE, V5, P109, DOI 10.1016/S0969-2126(97)00170-6; Mascher T, 2006, FEMS MICROBIOL LETT, V264, P133, DOI 10.1111/j.1574-6968.2006.00444.x; McBride SM, 2011, INFECT IMMUN, V79, P167, DOI 10.1128/IAI.00731-10; MCCLEARY WR, 1994, J BIOL CHEM, V269, P31567; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Menon S, 2011, BIOCHEMISTRY-US, V50, P5948, DOI 10.1021/bi2005575; Narayanan A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4282; Neoh HM, 2008, ANTIMICROB AGENTS CH, V52, P45, DOI 10.1128/AAC.00534-07; Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Ohki R, 2003, MOL MICROBIOL, V49, P1135, DOI 10.1046/j.1365-2958.2003.03653.x; Okajima T, 2008, FEBS LETT, V582, P3434, DOI 10.1016/j.febslet.2008.09.007; Ouyang J, 2010, ANTIMICROB AGENTS CH, V54, P3895, DOI 10.1128/AAC.01802-09; Pozzi R., 2015, ENV MICROBIOL; Rietkotter E, 2008, MOL MICROBIOL, V68, P768, DOI 10.1111/j.1365-2958.2008.06194.x; Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003; Sahl HG, 1998, ANNU REV MICROBIOL, V52, P41, DOI 10.1146/annurev.micro.52.1.41; Saris PEJ, 1996, ANTON LEEUW INT J G, V69, P151, DOI 10.1007/BF00399420; Sola M, 1999, J MOL BIOL, V285, P675, DOI 10.1006/jmbi.1998.2326; Solovjev V, 2011, METAGENOMICITAPP, P61; Staron A, 2011, ANTIMICROB AGENTS CH, V55, P515, DOI 10.1128/AAC.00352-10; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; STOCK AM, 1993, BIOCHEMISTRY-US, V32, P13375, DOI 10.1021/bi00212a001; Suarez JM, 2013, J BACTERIOL, V195, P2621, DOI 10.1128/JB.00166-13; Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805; Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059; Wang S, 2007, BIOCHEMISTRY-US, V46, P14751, DOI 10.1021/bi700970a; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wolter AC, 2015, BIOMOL NMR ASSIGN; Yamane T, 2008, PROTEINS, V71, P1970, DOI 10.1002/prot.21874; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696; Zhu XY, 1997, J BIOL CHEM, V272, P5000, DOI 10.1074/jbc.272.8.5000	85	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149903	10.1371/journal.pone.0149903	http://dx.doi.org/10.1371/journal.pone.0149903			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930060	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500070
J	Chiatante, G; Meriggi, A				Chiatante, Gianpasquale; Meriggi, Alberto			The Importance of Rotational Crops for Biodiversity Conservation in Mediterranean Areas	PLOS ONE			English	Article							BIRD SPECIES RICHNESS; PROTECTED AREAS; FARMLAND BIRDS; AGRICULTURAL INTENSIFICATION; LANDSCAPE HETEROGENEITY; FRUGIVOROUS BIRDS; POPULATION TRENDS; GAP ANALYSIS; HOT-SPOTS; DIVERSITY	Nowadays we are seeing the largest biodiversity loss since the extinction of the dinosaurs. To conserve biodiversity it is essential to plan protected areas using a prioritization approach, which takes into account the current biodiversity value of the sites. Considering that in the Mediterranean Basin the agro-ecosystems are one of the most important parts of the landscape, the conservation of crops is essential to biodiversity conservation. In the framework of agro-ecosystem conservation, farmland birds play an important role because of their representativeness, and because of their steady decline in the last Century in Western Europe. The main aim of this research was to define if crop dominated landscapes could be useful for biodiversity conservation in a Mediterranean area in which the landscape was modified by humans in the last thousand years and was affected by the important biogeographical phenomenon of peninsula effect. To assess this, we identify the hotspots and the coldspots of bird diversity in southern Italy both during the winter and in the breeding season. In particular we used a scoring method, defining a biodiversity value for each cell of a 1-km grid superimposed on the study area, using data collected by fieldwork following a stratified random sampling design. This value was analysed by a multiple linear regression analysis and was predicted in the whole study area. Then we defined the hotspots and the coldspots of the study area as 15% of the cells with higher and lower value of biodiversity, respectively. Finally, we used GAP analysis to compare hotspot distribution with the current network of protected areas. This study showed that the winter hotspots of bird diversity were associated with marshes and water bodies, shrublands, and irrigated crops, whilst the breeding hotspots were associated with more natural areas (e.g. transitional wood/shrubs), such as open areas (natural grasslands, pastures and not irrigated crops). Moreover, the results underlined the negative effects of permanent crops, such as vineyards, olive groves, and orchards, in particular during the winter season. This research highlights the importance of farmland areas mainly for wintering species and the importance of open areas for breeding species in the Mediterranean Basin. This may be true even when the species' spatial distribution could be affected by biogeography. An important result showed that the hotspots for breeding species cannot be used as a surrogate for the wintering species, which were often not considered in the planning of protected areas.	[Chiatante, Gianpasquale; Meriggi, Alberto] Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy	University of Pavia	Chiatante, G (corresponding author), Univ Pavia, Dept Earth & Environm Sci, Via Ferrata 1, I-27100 Pavia, Italy.	harrier84@libero.it	Chiatante, Gianpasquale/AAF-9928-2020	Chiatante, Gianpasquale/0000-0002-4570-9350	project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy); project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy)	project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy); project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy)	This study was funded by the project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District "Bari", Apulia, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Giovanni Ferrara of Hunting District "Bari" for his help during the project. This study was funded by the project "Aggiornamento della carta delle vocazioni faunistiche dell'Ambito Territoriale di Caccia Bari e Barletta-Andria-Trani" (Hunting District"Bari", Apulia, Italy). We appreciate the improvements in English usage made by Andrew Sturgeon. We thank three anonymous referees for reviewing the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Andelman SJ, 2003, ECOL LETT, V6, P818, DOI 10.1046/j.1461-0248.2003.00503.x; Araujo MB, 2001, CONSERV BIOL, V15, P1710, DOI 10.1046/j.1523-1739.2001.99450.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P17, DOI 10.1111/j.1466-822X.2004.00128.x; Araujo MB, 2007, CONSERV BIOL, V21, P1423, DOI 10.1111/j.1523-1739.2007.00827.x; Bacaro G, 2011, BIODIVERS CONSERV, V20, P1677, DOI 10.1007/s10531-011-0054-8; Baccetti Nicola, 2002, Biologia e Conservazione della Fauna, V111, P1; Barabesi L, 2013, ENVIRON ECOL STAT, V20, P215, DOI 10.1007/s10651-012-0216-1; Benayas JMR, 2003, BIOL CONSERV, V114, P357, DOI 10.1016/S0006-3207(03)00064-8; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BirdLife International, 2004, BIRDS EUR POP EST TR; Bishop JA, 2005, ECOL INDIC, V5, P33, DOI 10.1016/j.ecolind.2004.10.001; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Boucheker A, 2011, OSTRICH, V82, P167, DOI 10.2989/00306525.2011.607856; Brambilla M, 2010, BIOL CONSERV, V143, P2770, DOI 10.1016/j.biocon.2010.07.025; BROWN JW, 1990, J BIOGEOGR, V17, P615, DOI 10.2307/2845143; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Burfield I., 2005, ECOLOGY CONSERVATION, P119; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campedelli T, 2015, AGR ECOSYST ENVIRON, V213, P32, DOI 10.1016/j.agee.2015.07.012; Campedelli T, 2010, ARDEOLA, V57, P51; Castro-Caro JC, 2014, J ORNITHOL, V155, P357, DOI 10.1007/s10336-013-1010-z; Cerezo A, 2011, BIODIVERS CONSERV, V20, P2649, DOI 10.1007/s10531-011-0096-y; Chamberlain D, 2014, BIRD STUDY, V61, P121, DOI 10.1080/00063657.2013.870527; Chamberlain DE, 2000, J APPL ECOL, V37, P771, DOI 10.1046/j.1365-2664.2000.00548.x; Chuman T, 2010, LANDSCAPE URBAN PLAN, V98, P200, DOI 10.1016/j.landurbplan.2010.08.003; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; COMINS JS, 1993, LANDSCAPE URBAN PLAN, V23, P155, DOI 10.1016/0169-2046(93)90065-L; Covas R, 1998, IBIS, V140, P395, DOI 10.1111/j.1474-919X.1998.tb04600.x; Crawley M.J., 1993, GLIM ECOLOGISTS; Danielsen F, 2004, ANIM CONSERV, V7, P79, DOI 10.1017/S1367943003001215; Das A, 2006, BIOL CONSERV, V133, P16, DOI 10.1016/j.biocon.2006.05.023; de la Montana E, 2011, BIOL CONSERV, V144, P2468, DOI 10.1016/j.biocon.2011.07.001; Donald PF, 2002, AGR ECOSYST ENVIRON, V89, P167, DOI 10.1016/S0167-8809(01)00244-4; Estrada A, 2011, BIOL CONSERV, V144, P1120, DOI 10.1016/j.biocon.2010.12.031; Farina A, 1997, LANDSCAPE ECOL, V12, P365, DOI 10.1023/A:1007934518160; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fornasari Lorenzo, 2010, Avocetta, V34, P5; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Frazee SR, 2003, BIOL CONSERV, V112, P275, DOI 10.1016/S0006-3207(02)00400-7; FRETWELL S D, 1972, P217; Fuller RJ, 1995, CONSERV BIOL, V9, P1425, DOI 10.1046/j.1523-1739.1995.09061425.x; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Genghini M, 2006, BIODIVERS CONSERV, V15, P3077, DOI 10.1007/s10531-005-5400-2; Gil-Tena A, 2015, AGR ECOSYST ENVIRON, V205, P79, DOI 10.1016/j.agee.2015.03.013; Gill F, 2014, IOC WORLD BIRD LIST; GOUTNER V, 1992, BIOL CONSERV, V62, P131, DOI 10.1016/0006-3207(92)90934-F; Guisan A, 2002, ECOL MODEL, V157, P89, DOI 10.1016/S0304-3800(02)00204-1; Haslem A, 2008, ECOL APPL, V18, P185, DOI 10.1890/07-0692.1; Hoctor TS, 2000, CONSERV BIOL, V14, P984, DOI 10.1046/j.1523-1739.2000.99075.x; Huertas DL, 2001, CAN J ZOOL, V79, P279, DOI 10.1139/cjz-79-2-279; Jackson SF, 2009, BIODIVERS CONSERV, V18, P2143, DOI 10.1007/s10531-009-9578-6; Jeliazkov A, 2016, AGR ECOSYST ENVIRON, V216, P9, DOI 10.1016/j.agee.2015.09.017; Jiguet F, 2005, BIODIVERS CONSERV, V14, P3305, DOI 10.1007/s10531-004-0448-y; Kati V, 2004, BIOL CONSERV, V120, P471, DOI 10.1016/j.biocon.2004.03.020; Kerr JT, 1997, CONSERV BIOL, V11, P1094, DOI 10.1046/j.1523-1739.1997.96089.x; Krebs CJ., 1999, ECOLOGICAL METHODOLO; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAWLOR TE, 1983, AM NAT, V121, P432, DOI 10.1086/284071; Legendre P., 2012, NUMERICAL ECOLOGY; Liordos V, 2014, ZOOL STUD, V53, DOI 10.1186/1810-522X-53-12; Lombard AT, 1995, S AFR J ZOOL, V30, P145; Magurran A.E, 2004, MEASURING BIOL DIVER; Maiorano L, 2007, CONSERV BIOL, V21, P1433, DOI 10.1111/j.1523-1739.2007.00831.x; Maiorano L, 2006, BIOL CONSERV, V133, P455, DOI 10.1016/j.biocon.2006.07.015; Marfil-Daza C, 2013, ANIM CONSERV, V16, P60, DOI 10.1111/j.1469-1795.2012.00569.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Mendoza AM, 2014, BIODIVERS CONSERV, V23, P909, DOI 10.1007/s10531-014-0642-5; Meynard CN, 2009, BIODIVERS CONSERV, V18, P3061, DOI 10.1007/s10531-009-9625-3; Mezquida ET, 2006, ORNIS FENNICA, V83, P11; Mihoub JB, 2010, BIOL CONSERV, V143, P839, DOI 10.1016/j.biocon.2009.12.026; Morelli F, 2013, ECOL INDIC, V34, P372, DOI 10.1016/j.ecolind.2013.05.021; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Newton I, 2004, IBIS, V146, P579, DOI 10.1111/j.1474-919X.2004.00375.x; Oldfield TEE, 2004, BIOL CONSERV, V120, P303, DOI 10.1016/j.biocon.2004.03.003; Olsvig-Whittaker L, 2005, ISR J PLANT SCI, V53, P149, DOI 10.1560/A1QK-KN7P-0DUY-FL4B; Pace RM, 2000, J WILDLIFE MANAGE, V64, P933, DOI 10.2307/3803201; Peronace Valentina, 2012, Avocetta, V36, P11; PETIT DR, 1989, J FIELD ORNITHOL, V60, P241; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Reif J, 2008, IBIS, V150, P596, DOI 10.1111/j.1474-919X.2008.00829.x; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Rey PJ, 2011, J APPL ECOL, V48, P228, DOI 10.1111/j.1365-2664.2010.01902.x; REY PJ, 1993, ARDEA, V81, P151; Rippa D, 2011, IBIS, V153, P721, DOI 10.1111/j.1474-919X.2011.01156.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Santos KC, 2008, LANDSCAPE URBAN PLAN, V84, P140, DOI 10.1016/j.landurbplan.2007.07.004; SAVIN NE, 1977, ECONOMETRICA, V45, P1989, DOI 10.2307/1914122; Schouten MA, 2010, BIODIVERS CONSERV, V19, P2517, DOI 10.1007/s10531-010-9857-2; SCOTT J M, 1993, WILDLIFE MONOGR, V123, P3, DOI DOI 10.1016/0006-3207(94)90022-1; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; Serra P, 2008, APPL GEOGR, V28, P189, DOI 10.1016/j.apgeog.2008.02.001; Shi H, 2005, CONSERV BIOL, V19, P1273, DOI 10.1111/j.1523-1739.2005.00225.x; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Solymos P, 2005, CONSERV BIOL, V19, P1084, DOI 10.1111/j.1523-1739.2005.00193.x; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; Stralberg D, 2011, BIODIVERS CONSERV, V20, P19, DOI 10.1007/s10531-010-9943-5; Suarez-Seoane S, 2002, BIOL CONSERV, V105, P333, DOI 10.1016/S0006-3207(01)00213-0; Thompson BC, 2001, BIOL CONSERV, V100, P229, DOI 10.1016/S0006-3207(01)00026-X; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; Troupin D, 2014, BIOL CONSERV, V169, P158, DOI 10.1016/j.biocon.2013.11.009; Tucker GM, 1994, BIRDS EUROPE THEIR C, V3; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; Wiersma YF, 2009, BIOL CONSERV, V142, P1639, DOI 10.1016/j.biocon.2009.02.034; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Williams PH, 2003, BIODIVERS CONSERV, V12, P1297, DOI 10.1023/A:1023092100942; Wilson JD, 1999, AGR ECOSYST ENVIRON, V75, P13, DOI 10.1016/S0167-8809(99)00064-X; Wilson KA, 2005, BIOL CONSERV, V122, P99, DOI 10.1016/j.biocon.2004.07.004; Wretenberg J, 2006, J APPL ECOL, V43, P1110, DOI 10.1111/j.1365-2664.2006.01216.x; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Yip JY, 2004, BIODIVERS CONSERV, V13, P943, DOI 10.1023/B:BIOC.0000014463.32427.cf; Zenatello M, 2014, RISULTATI CENSIMENTI; Zuur Alain F., 2009, P1	118	8	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149323	10.1371/journal.pone.0149323	http://dx.doi.org/10.1371/journal.pone.0149323			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918960	gold, Green Submitted, Green Published			2022-12-27	WOS:000371274400016
J	Curie, A; Brun, A; Cheylus, A; Reboul, A; Nazir, T; Bussy, G; Delange, K; Paulignan, Y; Mercier, S; David, A; Marignier, S; Merle, L; de Freminville, B; Prieur, F; Till, M; Mortemousque, I; Toutain, A; Bieth, E; Touraine, R; Sanlaville, D; Chelly, J; Kong, J; Ott, D; Kassai, B; Hadjikhani, N; Gollub, RL; des Portes, V				Curie, Aurore; Brun, Amandine; Cheylus, Anne; Reboul, Anne; Nazir, Tatjana; Bussy, Gerald; Delange, Karine; Paulignan, Yves; Mercier, Sandra; David, Albert; Marignier, Stephanie; Merle, Lydie; de Freminville, Benedicte; Prieur, Fabienne; Till, Michel; Mortemousque, Isabelle; Toutain, Annick; Bieth, Eric; Touraine, Renaud; Sanlaville, Damien; Chelly, Jamel; Kong, Jian; Ott, Daniel; Kassai, Behrouz; Hadjikhani, Nouchine; Gollub, Randy L.; des Portes, Vincent			A Novel Analog Reasoning Paradigm: New Insights in Intellectually Disabled Patients	PLOS ONE			English	Article							FRAGILE-X-SYNDROME; RAVEN PROGRESSIVE MATRICES; LINKED MENTAL-RETARDATION; DOWN-SYNDROME; DEVELOPMENTAL DISORDERS; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; YOUNG MALES; TERM-MEMORY; CHILDREN	Background Intellectual Disability (ID) is characterized by deficits in intellectual functions such as reasoning, problem-solving, planning, abstract thinking, judgment, and learning. As new avenues are emerging for treatment of genetically determined ID (such as Down's syndrome or Fragile X syndrome), it is necessary to identify objective reliable and sensitive outcome measures for use in clinical trials. Objective We developed a novel visual analogical reasoning paradigm, inspired by the Progressive Raven's Matrices, but appropriate for Intellectually Disabled patients. This new paradigm assesses reasoning and inhibition abilities in ID patients. Methods We performed behavioural analyses for this task (with a reaction time and error rate analysis, Study 1) in 96 healthy controls (adults and typically developed children older than 4) and 41 genetically determined ID patients (Fragile X syndrome, Down syndrome and ARX mutated patients). In order to establish and quantify the cognitive strategies used to solve the task, we also performed an eye-tracking analysis (Study 2). Results Down syndrome, ARX and Fragile X patients were significantly slower and made significantly more errors than chronological age-matched healthy controls. The effect of inhibition on error rate was greater than the matrix complexity effect in ID patients, opposite to findings in adult healthy controls. Interestingly, ID patients were more impaired by inhibition than mental age-matched healthy controls, but not by the matrix complexity. Eye-tracking analysis made it possible to identify the strategy used by the participants to solve the task. Adult healthy controls used a matrix-based strategy, whereas ID patients used a response-based strategy. Furthermore, etiologic-specific reasoning differences were evidenced between ID patients groups. Conclusion We suggest that this paradigm, appropriate for ID patients and developmental populations as well as adult healthy controls, provides an objective and quantitative assessment of visual analogical reasoning and cognitive inhibition, enabling testing for the effect of pharmacological or behavioural intervention in these specific populations.	[Curie, Aurore; Brun, Amandine; Bussy, Gerald; Delange, Karine; Marignier, Stephanie; des Portes, Vincent] Hosp Civils Lyon, Hop Femme Mere Enfant, Deficiences Intellectuelles Causes Rares, Ctr Reference, Bron, France; [Curie, Aurore; Brun, Amandine; Cheylus, Anne; Reboul, Anne; Nazir, Tatjana; Bussy, Gerald; Delange, Karine; Paulignan, Yves; des Portes, Vincent] CNRS, UMR 5304, L2C2, Inst Cognit Sci, Bron, France; [Curie, Aurore; des Portes, Vincent] Univ Lyon, Fac Med Lyon Sud Charles Merieux, Lyon, France; [Curie, Aurore; Kong, Jian; Ott, Daniel; Hadjikhani, Nouchine; Gollub, Randy L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Curie, Aurore; Kassai, Behrouz] Univ Lyon, LBBE, UMR5558, INSERM,EPICIME CIC 1407, Lyon, France; [Mercier, Sandra; David, Albert] CHU Nantes, Genet, F-44035 Nantes 01, France; [Merle, Lydie] CH Ie Vinatier, Ctr Rech Neurosci Lyon, INSERM, U1028,CNRS,UMR5292, Lyon, France; [de Freminville, Benedicte; Prieur, Fabienne; Touraine, Renaud] Ctr Hosp Univ, Genet, St Etienne, France; [Till, Michel] Hop St Luc St Joseph, Med Interne, Lyon, France; [Mortemousque, Isabelle; Toutain, Annick] CHU Tours, Genet, Tours, France; [Bieth, Eric] Ctr Hosp Univ, Genet, Toulouse, France; [Sanlaville, Damien] Univ Lyon 1, Hop Femme Mere Enfant, Hosp Civils Lyon, Serv Genet,CRNL,CNRS,UMR5292,INSERM,U1028, F-69365 Lyon, France; [Chelly, Jamel] Univ Strasbourg, Hop Univ Strasbourg, IGBMC, Strasbourg, France; [Hadjikhani, Nouchine] Gillberg Neuropsychiatr Ctr, Gothenburg, Sweden	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut National de la Sante et de la Recherche Medicale (Inserm); VetAgro Sup; Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de St Etienne; CHU Tours; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Curie, A (corresponding author), Hosp Civils Lyon, Hop Femme Mere Enfant, Deficiences Intellectuelles Causes Rares, Ctr Reference, Bron, France.; Curie, A (corresponding author), CNRS, UMR 5304, L2C2, Inst Cognit Sci, Bron, France.; Curie, A (corresponding author), Univ Lyon, Fac Med Lyon Sud Charles Merieux, Lyon, France.; Curie, A (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.; Curie, A (corresponding author), Univ Lyon, LBBE, UMR5558, INSERM,EPICIME CIC 1407, Lyon, France.	aurorecurie@yahoo.fr	Cheylus, Anne/GSD-3809-2022; Chelly, Jamel/J-7528-2015; Sanlaville, Damien/M-4716-2014; Hadjikhani, Nouchine/C-2018-2008; Mercier, Sandra/E-8922-2018; Touraine, Renaud/AAV-1605-2020	Cheylus, Anne/0000-0002-4243-3686; Chelly, Jamel/0000-0002-0939-8719; Sanlaville, Damien/0000-0001-9939-2849; Hadjikhani, Nouchine/0000-0003-4075-3106; Paulignan, Yves/0000-0001-9474-3080; Kassai, Behrouz/0000-0002-1712-120X; Toutain, Annick/0000-0002-5999-5300; Nazir, Tatjana/0000-0002-6313-9259; Curie, Aurore/0000-0001-7823-290X; Gollub, Randy L./0000-0002-9434-4044	French Ministry of Health; CNRS / Hospice Civils de Lyon; Fondation Jerome-Lejeune; Xtraordinaire Association; Novartis Pharmaceuticals; ARRENNE association; French XLMR parents' association "Xtraordinaire"; French Fragile X parents' association "Le Goeland"; association "Xtraordinaire"	French Ministry of Health; CNRS / Hospice Civils de Lyon; Fondation Jerome-Lejeune; Xtraordinaire Association; Novartis Pharmaceuticals(Novartis); ARRENNE association; French XLMR parents' association "Xtraordinaire"; French Fragile X parents' association "Le Goeland"; association "Xtraordinaire"	Financial support was provided from the French Ministry of Health (grant PHRC 2008, VDP), the CNRS / Hospice Civils de Lyon (research fellow post-graduate grant for AC), the Fondation Jerome-Lejeune (grant for AC), the Xtraordinaire Association (grant for AC), Novartis Pharmaceuticals and the ARRENNE association (grant for AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors received funding from Novartis Pharmaceuticals. But Novartis was not involved in the study design, collection, analysis, and interpretation of data, writing of the paper nor decision to submit for publication.; Authors are indebted to patients and their families and caregivers. Special thanks for the support of the French XLMR parents' association "Xtraordinaire" and of the French Fragile X parents' association "Le Goeland". Financial support was provided from the French Ministry of Health (grant PHRC 2008, VDP), the CNRS / Hospice Civils de Lyon (research fellow postgraduate grant for AC), the Fondation Jerome-Lejeune (grant for AC), the association "Xtraordinaire" (grant for AC), Novartis Pharmaceuticals and the ARRENNE association (grant for AC).	Adleman NE, 2002, NEUROIMAGE, V16, P61, DOI 10.1006/nimg.2001.1046; Berry-Kravis E, 2013, J DEV BEHAV PEDIATR, V34, P508, DOI 10.1097/DBP.0b013e31829d1f20; BETHELLFOX CE, 1984, INTELLIGENCE, V8, P205, DOI 10.1016/0160-2896(84)90009-6; Bienvenu T, 2002, HUM MOL GENET, V11, P981, DOI 10.1093/hmg/11.8.981; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; CARPENTER PA, 1990, PSYCHOL REV, V97, P404, DOI 10.1037/0033-295X.97.3.404; Cornish KM, 1999, CORTEX, V35, P263, DOI 10.1016/S0010-9452(08)70799-8; Curie A, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-25; Danielsson H, 2012, RES DEV DISABIL, V33, P600, DOI 10.1016/j.ridd.2011.11.004; Danielsson H, 2010, RES DEV DISABIL, V31, P1299, DOI 10.1016/j.ridd.2010.07.012; Durston S, 2003, BIOL PSYCHIAT, V53, P871, DOI 10.1016/S0006-3223(02)01904-2; Ellis N.R., 1982, RES PERSPECTIVES MEN, P121; Frenkel S, 2009, J INTELL DISABIL RES, V53, P152, DOI 10.1111/j.1365-2788.2008.01139.x; Gligorovic M, 2014, J INTELL DISABIL RES, V58, P233, DOI 10.1111/jir.12000; Greenspan S, 2014, CURR OPIN PSYCHIATR, V27, P110, DOI 10.1097/YCO.0000000000000037; Hooper SR, 2008, NEUROPSYCHOLOGY, V22, P36, DOI 10.1037/0894-4105.22.1.36; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Jarrold C, 2007, CORTEX, V43, P233, DOI 10.1016/S0010-9452(08)70478-7; Jensen, 1987, SPEED INFORMATION PR, P74; Karatekin C, 2007, DEV REV, V27, P283, DOI 10.1016/j.dr.2007.06.006; Karmiloff-Smith A, 2009, DEV PSYCHOL, V45, P56, DOI 10.1037/a0014506; Lanfranchi S, 2010, J INTELL DISABIL RES, V54, P308, DOI 10.1111/j.1365-2788.2010.01262.x; Lott IT, 2010, LANCET NEUROL, V9, P623, DOI 10.1016/S1474-4422(10)70112-5; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Munir F, 2000, NEUROPSYCHOLOGIA, V38, P1261, DOI 10.1016/S0028-3932(00)00036-1; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Paus T, 2005, TRENDS COGN SCI, V9, P60, DOI 10.1016/j.tics.2004.12.008; Picker JD, 2013, ANN NEUROL, V74, P382, DOI 10.1002/ana.24002; Schalock R., 2021, INTELLECTUAL DISABIL; Stromme P, 2002, NAT GENET, V30, P441, DOI 10.1038/ng862; Sullivan K, 2007, AM J MED GENET B, V144B, P517, DOI 10.1002/ajmg.b.30504; Tamm L, 2002, J AM ACAD CHILD PSY, V41, P1231, DOI 10.1097/00004583-200210000-00013; Thomas MSC, 2009, J SPEECH LANG HEAR R, V52, P336, DOI 10.1044/1092-4388(2009/07-0144); Vakil E, 2012, RES DEV DISABIL, V33, P645, DOI 10.1016/j.ridd.2011.11.009; Van der Molen MJW, 2010, RES DEV DISABIL, V31, P426, DOI 10.1016/j.ridd.2009.10.013; Verguts T, 1999, INTELLIGENCE, V27, P329, DOI 10.1016/S0160-2896(99)00023-9; Vicari S, 2001, Downs Syndr Res Pract, V7, P35; Vicari S, 2006, BEHAV GENET, V36, P355, DOI 10.1007/s10519-006-9057-8; Vigneau F, 2006, INTELLIGENCE, V34, P261, DOI 10.1016/j.intell.2005.11.003; Willner P, 2010, J INTELL DISABIL RES, V54, P366, DOI 10.1111/j.1365-2788.2010.01249.x; Woodcock KA, 2009, COGN NEUROPSYCHOL, V26, P172, DOI 10.1080/02643290802685921; Zigler E., 1982, MENTAL RETARDATION D	42	7	7	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149717	10.1371/journal.pone.0149717	http://dx.doi.org/10.1371/journal.pone.0149717			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918704	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400040
J	Deschamps, I; Hasson, U; Tremblay, P				Deschamps, Isabelle; Hasson, Uri; Tremblay, Pascale			The Structural Correlates of Statistical Information Processing during Speech Perception	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; BRAIN STRUCTURE; NONADJACENT DEPENDENCIES; FUNCTIONAL NEUROANATOMY; REPETITION SUPPRESSION; SUPRAMARGINAL GYRUS; STRUCTURE PREDICTS; WORD SEGMENTATION	The processing of continuous and complex auditory signals such as speech relies on the ability to use statistical cues (e.g. transitional probabilities). In this study, participants heard short auditory sequences composed either of Italian syllables or bird songs and completed a regularity-rating task. Behaviorally, participants were better at differentiating between levels of regularity in the syllable sequences than in the bird song sequences. Inter-individual differences in sensitivity to regularity for speech stimuli were correlated with variations in surface-based cortical thickness (CT). These correlations were found in several cortical areas including regions previously associated with statistical structure processing (e.g. bilateral superior temporal sulcus, left precentral sulcus and inferior frontal gyrus), as well other regions (e.g. left insula, bilateral superior frontal gyrus/sulcus and supramarginal gyrus). In all regions, this correlation was positive suggesting that thicker cortex is related to higher sensitivity to variations in the statistical structure of auditory sequences. Overall, these results suggest that inter-individual differences in CT within a distributed network of cortical regions involved in statistical structure processing, attention and memory is predictive of the ability to detect structural structure in auditory speech sequences.	[Deschamps, Isabelle; Tremblay, Pascale] Univ Laval, Dept Readaptat, Quebec City, PQ, Canada; [Deschamps, Isabelle; Tremblay, Pascale] Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Hasson, Uri] Univ Trent, Ctr Mind & Brain Sci CIMeC, Mattarello, TN, Italy	Laval University; Laval University; University of Trento	Tremblay, P (corresponding author), Univ Laval, Dept Readaptat, Quebec City, PQ, Canada.; Tremblay, P (corresponding author), Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada.	pascale.tremblay@fmed.ulaval.ca		Hasson, Uri/0000-0002-8530-5051	European Research Council (ERC-STG) [263318]; Natural Sciences and Engineering Research Council of Canada (NSERC) [1958126]; Social Sciences and Humanities Research Council of Canada (SSHRC) [430-2013-1084]; "Fonds de Recherche du Quebec - Sante" (FRQS); "Fonds de Recherche du Quebec-Sante" (FRQS)	European Research Council (ERC-STG)(European Research Council (ERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Social Sciences and Humanities Research Council of Canada (SSHRC)(Social Sciences and Humanities Research Council of Canada (SSHRC)CGIAR); "Fonds de Recherche du Quebec - Sante" (FRQS)(Fonds de la Recherche en Sante du Quebec); "Fonds de Recherche du Quebec-Sante" (FRQS)	This study was supported by a research grant from the European Research Council under the 7th framework starting grant program (ERC-STG #263318) to U. Hasson and by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC #1958126) and Social Sciences and Humanities Research Council of Canada (SSHRC #430-2013-1084) to P. Tremblay. P. Tremblay holds a Career Award from the "Fonds de Recherche du Quebec - Sante" (FRQS).; This study was supported by a research grant from the European Research Council under the 7th framework starting grant program (ERC-STG #263318) to U. Hasson and by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC #1958126) and Social Sciences and Humanities Research Council of Canada (SSHRC #430-2013-1084) to P. Tremblay. P. Tremblay holds a Career Award from the "Fonds de Recherche du Quebec-Sante" (FRQS). We thank Margaret Moreno for her help collecting data, the MRI staff of the Functional Neuroimaging Lab at the Center for Mind & Brain Sciences (CIMeC) at the University of Trento, and all the participants. The data presented in this article can be accessed from the Research Registry of the University of Trento at http://hdl.handle.net/11572/134214	Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Bilodeau-Mercure M, 2015, BRAIN STRUCT FUNCT, V220, P979, DOI 10.1007/s00429-013-0695-3; Bledowski C, 2009, J NEUROSCI, V29, P13735, DOI 10.1523/JNEUROSCI.2547-09.2009; Braver TS, 1997, NEUROIMAGE, V5, P49, DOI 10.1006/nimg.1996.0247; Celsis P, 1999, NEUROIMAGE, V9, P135, DOI 10.1006/nimg.1998.0389; Chen ZJ, 2008, CEREB CORTEX, V18, P2374, DOI 10.1093/cercor/bhn003; Church JA, 2011, J COGNITIVE NEUROSCI, V23, P1475, DOI 10.1162/jocn.2010.21515; Collins CE, 2010, P NATL ACAD SCI USA, V107, P15927, DOI 10.1073/pnas.1010356107; Conway CM, 2005, J EXP PSYCHOL LEARN, V31, P24, DOI 10.1037/0278-7393.31.1.24; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crottaz-Herbette S, 2005, HIPPOCAMPUS, V15, P132, DOI 10.1002/hipo.20039; Cunillera T, 2009, NEUROIMAGE, V48, P541, DOI 10.1016/j.neuroimage.2009.06.069; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deschamps I, 2011, NEUR LANG C WASH US; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreher JC, 2002, EUR J NEUROSCI, V16, P1609, DOI 10.1046/j.1460-9568.2002.02212.x; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Francois C, 2014, HEARING RES, V308, P122, DOI 10.1016/j.heares.2013.08.018; Furl N, 2011, NEUROIMAGE, V54, P2267, DOI 10.1016/j.neuroimage.2010.10.038; Gaser C, 2003, J NEUROSCI, V23, P9240; Gebhart AL, 2009, PSYCHON B REV, V16, P486, DOI 10.3758/PBR.16.3.486; Golestani N, 2002, NEURON, V35, P997, DOI 10.1016/S0896-6273(02)00862-0; Golestani N, 2007, CEREB CORTEX, V17, P575, DOI 10.1093/cercor/bhk001; Grahn JA, 2013, CEREB CORTEX, V23, P913, DOI 10.1093/cercor/bhs083; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Hasson U, 2006, J COGNITIVE NEUROSCI, V18, P2013, DOI 10.1162/jocn.2006.18.12.2013; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Hoch L, 2013, PSYCHON B REV, V20, P142, DOI 10.3758/s13423-012-0309-8; Hoeft F, 2007, P NATL ACAD SCI USA, V104, P4234, DOI 10.1073/pnas.0609399104; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Kadosh KC, 2013, CEREB CORTEX, V23, P1630, DOI 10.1093/cercor/bhs150; Kanai R, 2011, NAT REV NEUROSCI, V12, P231, DOI 10.1038/nrn3000; Karuza EA, 2013, BRAIN LANG, V127, P46, DOI 10.1016/j.bandl.2012.11.007; Kim H, 2014, HUM BRAIN MAPP, V35, P2265, DOI 10.1002/hbm.22326; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Lopez-Barroso D, 2013, P NATL ACAD SCI USA, V110, P13168, DOI 10.1073/pnas.1301696110; Lopez-Barroso D, 2011, CEREB CORTEX, V21, P2742, DOI 10.1093/cercor/bhr064; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; McNealy K, 2006, J NEUROSCI, V26, P7629, DOI 10.1523/JNEUROSCI.5501-05.2006; McNealy K, 2010, DEVELOPMENTAL SCI, V13, P385, DOI 10.1111/j.1467-7687.2009.00895.x; Misyak JB, 2012, LANG LEARN, V62, P302, DOI 10.1111/j.1467-9922.2010.00626.x; Mizuno K, 2012, NEUROPSYCHOLOGIA, V50, P1998, DOI 10.1016/j.neuropsychologia.2012.04.025; Nastase S, 2014, HUM BRAIN MAPP, V35, P1111, DOI 10.1002/hbm.22238; Neger TM, 2014, FRONT HUM NEUROSCI, P8; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Nyberg L, 2010, P NATL ACAD SCI USA, V107, P22682, DOI 10.1073/pnas.1012651108; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Overath T, 2007, PLOS BIOL, V5, P2723, DOI 10.1371/journal.pbio.0050288; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Perruchet P, 1998, J MEM LANG, V39, P246, DOI 10.1006/jmla.1998.2576; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Ravizza SM, 2004, NEUROIMAGE, V22, P562, DOI 10.1016/j.neuroimage.2004.01.039; Richardson FM, 2010, J COGNITIVE NEUROSCI, V22, P943, DOI 10.1162/jocn.2009.21238; Saad ZS, 2012, NEUROIMAGE, V62, P768, DOI 10.1016/j.neuroimage.2011.09.016; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Tillmann B, 2004, J EXP PSYCHOL LEARN, V30, P1131, DOI 10.1037/0278-7393.30.5.1131; Tobia MJ, 2012, NEUROIMAGE, V63, P1730, DOI 10.1016/j.neuroimage.2012.08.017; Tobia MJ, 2012, NEUROIMAGE, V60, P991, DOI 10.1016/j.neuroimage.2012.01.041; Todorovic A, 2012, J NEUROSCI, V32, P13389, DOI 10.1523/JNEUROSCI.2227-12.2012; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Tremblay P, 2013, NEUROIMAGE, V66, P318, DOI 10.1016/j.neuroimage.2012.10.055; Tremblay P, STRUCTURAL BRA UNPUB; Tremblay P, 2013, NEUROBIOL AGING, V34, P1935, DOI 10.1016/j.neurobiolaging.2013.02.004; Westlye LT, 2009, NEUROIMAGE, V47, P1545, DOI 10.1016/j.neuroimage.2009.05.084; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045	87	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149375	10.1371/journal.pone.0149375	http://dx.doi.org/10.1371/journal.pone.0149375			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919234	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400018
J	Lovero, G; Borghi, E; Balbino, S; Cirasola, D; De Giglio, O; Perdoni, F; Caggiano, G; Morace, G; Montagna, MT				Lovero, Grazia; Borghi, Elisa; Balbino, Stella; Cirasola, Daniela; De Giglio, Osvalda; Perdoni, Federica; Caggiano, Giuseppina; Morace, Giulia; Montagna, Maria Teresa			Molecular Identification and Echinocandin Susceptibility of Candida parapsilosis Complex Bloodstream Isolates in Italy, 2007-2014	PLOS ONE			English	Article							ANTIFUNGAL SUSCEPTIBILITY; ORTHOPSILOSIS; METAPSILOSIS; INFECTIONS; EPIDEMIOLOGY; PREVALENCE; PROFILES	The Candida parapsilosis group encompasses three species: C. parapsilosis, C. orthopsilosis, and C. metapsilosis. Here, we describe the incidence and echinocandin susceptibility profile of bloodstream isolates of these three species collected from patients admitted to an Italian university hospital from 2007 to 2014. Molecular identification of cryptic species of the C. parapsilosis complex was performed using polymerase chain reaction amplification of the gene encoding secondary alcohol dehydrogenase, followed by digestion with the restriction enzyme BanI. Minimum inhibitory concentrations were determined using the broth microdilution method according to European Committee for Antimicrobial Susceptibility Testing (EUCAST EDef 7.2) and Clinical Laboratory Standards Institute (CLSI M27-A3) guidelines, and the results were compared with those obtained using the E-test and Sensititre methods. Of the 163 C. parapsilosis complex isolates, 136 (83.4%) were identified as C. parapsilosis, and 27 (16.6%) as C. orthopsilosis. The species-specific incidences were 2.9/10,000 admissions for C. parapsilosis and 0.6/10,000 admissions for C. orthopsilosis. No resistance to echinocandins was detected with any of the methods. The percent essential agreement (EA) between the EUCAST and E-test/Sensititre methods for anidulafungin, caspofungin, and micafungin susceptibility was, respectively, as follows: C. parapsilosis, 95.6/97.8, 98.5/88.2, and 93.4/96.3; C. orthopsilosis, 92.6/92.6, 96.3/77.8, and 63.0/66.7. The EA between the CLSI and E-test/Sensititre methods was, respectively, as follows: C. parapsilosis, 99.3/100, 98.5/89.0, and 96.3/98.5; C. orthopsilosis, 96.3/92.6, 100/81.5, and 92.6/88.9. Only minor discrepancies, ranging from 16.9% (C. parapsilosis) to 11.1% (C. orthopsilosis), were observed between the CLSI and E-test/Sensititre methods. In conclusion, this epidemiologic study shows a typical C. parapsilosis complex species distribution, no echinocandin resistance, and it reinforces the relevance of using commercially available microbiological methods to assess antifungal susceptibility. These data improve our knowledge of the national distribution of species of the psilosis group, as there are very few studies of these species in Italy.	[Lovero, Grazia; Balbino, Stella; De Giglio, Osvalda; Caggiano, Giuseppina; Montagna, Maria Teresa] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Hyg Sect, Bari, Italy; [Borghi, Elisa; Cirasola, Daniela; Perdoni, Federica; Morace, Giulia] Univ Milan, Dept Hlth Sci, Milan, Italy	Universita degli Studi di Bari Aldo Moro; University of Milan	Montagna, MT (corresponding author), Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Hyg Sect, Bari, Italy.	mariateresa.montagna@uniba.it	Borghi, Elisa/I-8811-2012	Borghi, Elisa/0000-0002-1893-0455; De Giglio, Osvalda/0000-0002-0297-9502; Morace, Giulia/0000-0003-1696-1183; Montagna, Maria Teresa/0000-0002-2958-5458	Pfizer Italia	Pfizer Italia(Pfizer)	This study was supported by an unrestricted educational grant from Pfizer Italia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendrup MC, 2014, MYCOSES, V57, P377, DOI 10.1111/myc.12170; Asadzadeh M, 2009, J MED MICROBIOL, V58, P745, DOI 10.1099/jmm.0.008235-0; Aydin F, 2011, MED MYCOL, V49, P316, DOI 10.3109/13693786.2010.512023; Bonfietti LX, 2012, J MED MICROBIOL, V61, P1003, DOI 10.1099/jmm.0.037812-0; Borghi E, 2011, EUR J CLIN MICROBIOL, V30, P1437, DOI 10.1007/s10096-011-1242-x; Caggiano G, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/256580; Canton E, 2011, ANTIMICROB AGENTS CH, V55, P5590, DOI 10.1128/AAC.00466-11; Chen YC, 2010, DIAGN MICR INFEC DIS, V68, P284, DOI 10.1016/j.diagmicrobio.2010.07.004; Clinical and Laboratory Standards Institute, 2012, M27S4 CLSI, VM27-S4; CLSI, 1908, M27A3 CLSI; de Toro M, 2011, CLIN MICROBIOL INFEC, V17, P418, DOI 10.1111/j.1469-0691.2010.03302.x; Garcia-Effron G, 2012, J ANTIMICROB CHEMOTH, V67, P2739, DOI 10.1093/jac/dks271; Gomez-Lopez A, 2008, ANTIMICROB AGENTS CH, V52, P1506, DOI 10.1128/AAC.01595-07; Guinea J, 2014, ANTIMICROB AGENTS CH, V58, P1529, DOI 10.1128/AAC.02155-13; Lattif AA, 2010, INT J MED MICROBIOL, V300, P265, DOI 10.1016/j.ijmm.2009.09.001; Montagna MT, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0442-4; Montagna MT, 2012, INT J MOL SCI, V13, P774, DOI 10.3390/ijms13010774; Nemeth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068704; Nucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059373; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Orsi CF, 2010, MED MYCOL, V48, P1024, DOI 10.3109/13693786.2010.489233; Ozsevik SN, 2015, J PEDIAT HEMATOL ONC, V37, pE69, DOI 10.1097/MPH.0000000000000225; Rycovska A, 2004, MICROBIOL-SGM, V150, P1571, DOI 10.1099/mic.0.26988-0; Silva AP, 2009, J CLIN MICROBIOL, V47, P2392, DOI 10.1128/JCM.02379-08; Spreghini E, 2012, J ANTIMICROB CHEMOTH, V67, P2195, DOI 10.1093/jac/dks180; Taj-Aldeen SJ, 2014, INFECTION, V42, P393, DOI 10.1007/s15010-013-0570-4; Tavanti A, 2005, J CLIN MICROBIOL, V43, P284, DOI 10.1128/JCM.43.1.284-292.2005; Trevino-Rangel RDJ, 2012, MED MYCOL, V50, P781, DOI 10.3109/13693786.2012.675526; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; Tumbarello M, 2007, J CLIN MICROBIOL, V45, P1843, DOI 10.1128/JCM.00131-07	30	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150218	10.1371/journal.pone.0150218	http://dx.doi.org/10.1371/journal.pone.0150218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919294	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400104
J	Marcsisin, RA; Lewis, ERG; Barbour, AG				Marcsisin, Renee A.; Lewis, Eric R. G.; Barbour, Alan G.			Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; LYME-DISEASE; ANTIGENIC VARIATION; SURFACE PROTEIN; LINEAR PLASMIDS; BINDING PROTEIN; ARRAY REVEALS; NORTH-AMERICA; MOUSE MODEL; IN-VITRO	Borrelia hermsii, a spirochete and cause of relapsing fever, is notable for its immune evasion by multiphasic antigenic variation within its vertebrate host. This is based on a diverse repertoire of surface antigen genes, only one of which is expressed at a time. Another major surface protein, the Variable Tick Protein (Vtp), is expressed in the tick vector and is invariable at its genetic locus. Given the limited immune systems of ticks, the finding of considerable diversity among the Vtp proteins of different strains of B. hermsii was unexpected. We investigated one explanation for this diversity of Vtp proteins, namely expression of the protein in mammals and a consequent elicitation of a specific immune response. Mice were infected with B. hermsii of either the HS1 or CC1 strain, which have antigenically distinctive Vtp proteins but otherwise have similar repertoires of the variable surface antigens. Subsequently collected sera were examined for antibody reactivities against Vtp and other antigens using Western blot analysis, dot blot, and protein microarray. Week-6 sera of infected mice contained antibodies that were largely specific for the Vtp of the infecting strain and were not attributable to antibody cross-reactivities. The antibody responses of the mice infected with different strains were otherwise similar. Further evidence of in vivo expression of the vtp gene was from enumeration of cDNA sequence reads that mapped to a set of selected B. hermsii genes. This measure of transcription of the infecting strain's vtp gene was similar to 10% of that for the abundantly-expressed, serotype-defining variable antigen gene but similar to that of genes known for in vivo expression. The findings of Vtp expression in a vertebrate host and elicitation of a specific anti-Vtp antibody response support the view that balancing selection by host adaptive immunity accounts in part for the observed diversity of Vtp proteins.	[Barbour, Alan G.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Lewis, Eric R. G.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of Texas System; University of Texas Medical Branch Galveston	Barbour, AG (corresponding author), Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA.	abarbour@uci.edu		Barbour, Alan/0000-0002-0719-5248	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R37 AI24424]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024424] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AGB received funding from grant R37 AI24424 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (http://www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Barbour A, 2005, TICK BORNE DIS HUMAN, P220; Barbour A.G., 2010, BORRELIA MOL BIOL HO, P333; BARBOUR AG, 1982, J EXP MED, V156, P1312, DOI 10.1084/jem.156.5.1312; BARBOUR AG, 1984, INFECT IMMUN, V45, P94, DOI 10.1128/IAI.45.1.94-100.1984; Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; BARBOUR AG, 1983, INFECT IMMUN, V41, P795, DOI 10.1128/IAI.41.2.795-804.1983; Barbour AG, 2008, INFECT IMMUN, V76, P3374, DOI 10.1128/IAI.00048-08; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Barbour AG, 2010, MBIO, V1, DOI 10.1128/mBio.00153-10; Baum E, 2014, CLIN VACCINE IMMUNOL, V21, P838, DOI 10.1128/CVI.00018-14; Baum E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067445; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Bunikis J, 2004, J INFECT DIS, V189, P1515, DOI 10.1086/382594; Bunikis J, 1996, INFECT IMMUN, V64, P5111, DOI 10.1128/IAI.64.12.5111-5116.1996; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; Casjens S., 2010, BORRELIA GENOMICS CH, P27; Dai Q., 2007, THESIS U CALIFORNIA; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Hovis KM, 2004, J BACTERIOL, V186, P2612, DOI 10.1128/JB.186.9.2612-2618.2004; Hynes WL, 2014, BIOL TICKS, V2, P129; Krajacich BJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1170-1; Krause PJ, 2015, CLIN MICROBIOL INFEC, V21, P631, DOI 10.1016/j.cmi.2015.02.006; LEBECH AM, 1991, J CLIN MICROBIOL, V29, P731, DOI 10.1128/JCM.29.4.731-737.1991; Lee SH, 2003, FEMS MICROBIOL LETT, V222, P51, DOI 10.1016/S0378-1097(03)00237-4; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Lewis ERG, 2014, INFECT IMMUN, V82, P2520, DOI 10.1128/IAI.01582-14; LIVEY I, 1995, MOL MICROBIOL, V18, P257, DOI 10.1111/j.1365-2958.1995.mmi_18020257.x; Marcsisin RA, 2010, THESIS U CALIFORNIA; Marcsisin RA, 2012, INFECT IMMUN, V80, P1881, DOI 10.1128/IAI.06419-11; Miller SC, 2013, J BACTERIOL, V195, P3629, DOI 10.1128/JB.00347-13; Nally JE, 2001, INFECT IMMUN, V69, P400, DOI 10.1128/IAI.69.1.400-404.2001; Pennington PM, 1997, INFECT IMMUN, V65, P285, DOI 10.1128/IAI.65.1.285-292.1997; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Raffel SJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004056; RESTREPO BI, 1992, MOL MICROBIOL, V6, P3299, DOI 10.1111/j.1365-2958.1992.tb02198.x; Sadziene A, 1996, J INFECT DIS, V173, P1184, DOI 10.1093/infdis/173.5.1184; SADZIENE A, 1994, INFECT IMMUN, V62, P2037, DOI 10.1128/IAI.62.5.2037-2045.1994; Schwan TG, 2002, EMERG INFECT DIS, V8, P115, DOI 10.3201/eid0802.010198; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 1998, SCIENCE, V280, P1938, DOI 10.1126/science.280.5371.1938; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; STOENNER HG, 1982, J EXP MED, V156, P1297, DOI 10.1084/jem.156.5.1297; THOMPSON RS, 1969, J AMER MED ASSOC, V210, P1045, DOI 10.1001/jama.210.6.1045; Travinsky B, 2010, EMERG INFECT DIS, V16, P1147, DOI 10.3201/eid1607.091452; Tsao JI, 2004, P NATL ACAD SCI USA, V101, P18159, DOI 10.1073/pnas.0405763102; Wang IN, 1999, GENETICS, V151, P15; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhong JM, 2004, MOL MICROBIOL, V51, P729, DOI 10.1046/j.1365-2958.2003.03849.x	56	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149889	10.1371/journal.pone.0149889	http://dx.doi.org/10.1371/journal.pone.0149889			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918760	Green Published, gold			2022-12-27	WOS:000371274400053
J	Mo, JQ; Zhang, W; Zhong, DY; Xu, H; Wang, L; Yu, J; Luo, ZP				Mo, Jianqiang; Zhang, Wen; Zhong, Dongyan; Xu, Hao; Wang, Lan; Yu, Jia; Luo, Zongping			Is Preventative Long-Segment Surgery for Multi-Level Spondylolysis Necessary? A Finite Element Analysis Study	PLOS ONE			English	Article							LUMBAR INTERBODY FUSION; LEVEL ISTHMIC SPONDYLOLISTHESIS; BIOMECHANICAL ANALYSIS; DIRECT REPAIR; NATURAL-HISTORY; SPINE; ADJACENT; FIXATION; DEGENERATION; CAGE	Objective For multi-level spondylolysis patients, surgeons commonly choose to fix all the segments with pars interarticularis defect even those without slippage and not responsible for clinical symptoms. In this study, we tried to study the necessity of the preventative long-segment surgery for the defected segment without slippage in treatment of multi-level spondylolysis patients from a biomechanical perspective. Method We established a bi-level spondylolysis model with pars defects at L4 and L5 segments, and simulated posterior lumbar interbody fusion (PLIF) and pedicle screw fixation at L5-S1 level. Then we compared the biomechanical changes at L4 segment before and after surgery in neutral, flexion, extension, lateral bending and axial rotation position. Results The stress on L4 pars interarticularis was very similar before and after surgery, and reached the highest in axial rotation. The L3-L4 intradiscal pressure was almost the same, while L4-L5 intradiscal pressure changed a little in lateral bending (increase from 1.993 to 2.160 MPa) and axial rotation (decrease from 1.639 to 1.307 MPa) after surgery. The PLIF surgery caused a little increase of range of motion at adjacent L4-L5 and L3-L4 levels, but the change is very tiny (1 degree). Conclusion The PLIF surgery will not cause significant biomechanical change at adjacent segment with pars defect in multi-level spondylolysis. On the contrary, excessive long-segment surgery will damage surrounding soft tissues which are important for maintaining the stability of spine. So a preventative long-segment surgery is not necessary for multi-level spondylolysis as long as there are no soft tissue degeneration signs at adjacent level.	[Mo, Jianqiang; Zhang, Wen; Zhong, Dongyan; Xu, Hao; Wang, Lan; Yu, Jia; Luo, Zongping] Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Inst Orthoped,Med Coll, Suzhou, Jiangsu, Peoples R China	Soochow University - China	Luo, ZP (corresponding author), Soochow Univ, Affiliated Hosp 1, Dept Orthoped, Inst Orthoped,Med Coll, Suzhou, Jiangsu, Peoples R China.	zongping_luo@yahoo.com		Yu, Jia/0000-0002-0159-060X	National Natural Science Foundation of China [81320108018, 31270995, 61304123]; Jiangsu Provincial Special Program of Medical Science [BL2012004]; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; Jiangsu Provincial Clinical Orthopedic Center; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by National Natural Science Foundation of China (http://www.nsfc.gov.cn/) grants of No. 81320108018 to ZL, No. 31270995 to ZL, No. 61304123 to LW; Jiangsu Provincial Special Program of Medical Science (http://jsycw.ec.js.edu.cn/) grant of No. BL2012004 to ZL; Jiangsu Provincial Clinical Orthopedic Center, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (http://fyy.sdfyy.cn/Main/NewsView_B255_A10003.html); The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Tetsu, 2013, Case Rep Orthop, V2013, P472968, DOI 10.1155/2013/472968; Beutler WJ, 2003, SPINE, V28, P1027, DOI 10.1097/00007632-200305150-00014; Boszczyk BM, 2006, EUR SPINE J, V15, P965, DOI 10.1007/s00586-005-0986-3; Cabello J, 2013, ARCH ORTHOP TRAUM SU, V133, P443, DOI 10.1007/s00402-013-1685-x; Cavalier R, 2006, J AM ACAD ORTHOP SUR, V14, P417, DOI 10.5435/00124635-200607000-00004; Chen CS, 2001, MED ENG PHYS, V23, P483; Chen SH, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-72; Chosa E, 2004, J SPINAL DISORD TECH, V17, P134, DOI 10.1097/00024720-200404000-00010; Chosa E, 2004, J ORTHOP RES, V22, P158, DOI 10.1016/S0736-0266(03)00160-8; Chung CH, 2007, J SPINAL DISORD TECH, V20, P399, DOI 10.1097/01.bsd.0000211253.67576.90; Goto Keisuke, 2003, J Orthop Sci, V8, P577, DOI 10.1007/s00776-003-0675-1; Hersh DS, 2011, BULL HOSP JT DIS, V69, P339; Hongo M, 2009, SPINE J, V9, P846, DOI [10.1016/j.spinee.2009.06.015, 10.1016/j.spinee.2009.06.019]; Kim YT., 2012, J SPINAL DISORD TECH, DOI [10.1097/BSD.0b013e31827069e4 ., DOI 10.1097/BSD.0B013E31827069E4]; Kuo CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-151; Lee GW, 2015, SPINE, V40, pE234, DOI 10.1097/BRS.0000000000000714; Lee SH, 2009, INDIAN J ORTHOP, V43, P197, DOI 10.4103/0019-5413.41870; Liu XY, 2015, J NEUROSURG-SPINE, V22, P283, DOI 10.3171/2014.10.SPINE14415; Moo IH, 2015, INT J SURG CASE REP, V8, P120, DOI 10.1016/j.ijscr.2014.10.018; Ozcan-Eksi EE, 2016, MUSCLE NERVE, V53, P422, DOI 10.1002/mus.24759; Park WM, 2014, MANUAL THER, V19, P527, DOI 10.1016/j.math.2014.05.004; RAVICHANDRAN G, 1980, SPINE, V5, P552, DOI 10.1097/00007632-198011000-00011; Rohlmann A, 2009, J BIOMECH, V42, P1520, DOI 10.1016/j.jbiomech.2009.03.048; Sairyo K, 2006, CLIN BIOMECH, V21, P1020, DOI 10.1016/j.clinbiomech.2006.06.011; Sairyo K, 2006, EUR SPINE J, V15, P930, DOI 10.1007/s00586-005-1033-0; Sairyo K, 2009, ARCH ORTHOP TRAUM SU, V129, P1433, DOI 10.1007/s00402-008-0795-3; Sakai T, 2010, J ORTHOP SCI, V15, P281, DOI 10.1007/s00776-010-1454-4; Sakai T, 2009, SPINE, V34, P2346, DOI 10.1097/BRS.0b013e3181b4abbe; SHARMA M, 1995, SPINE, V20, P887, DOI 10.1097/00007632-199504150-00003; Song DY, 2015, CLIN NEUROL NEUROSUR, V138, P111, DOI 10.1016/j.clineuro.2015.08.012; Song DY, 2014, J NEUROSURG-SPINE, V20, P396, DOI 10.3171/2013.12.SPINE13521; Standaert CJ, 2000, BRIT J SPORT MED, V34, P415, DOI 10.1136/bjsm.34.6.415; Terai T, 2011, ARCH ORTHOP TRAUM SU, V131, P1187, DOI 10.1007/s00402-010-1257-2; Wong Leong C, 2004, J Can Chiropr Assoc, V48, P142; Xiao ZT, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-31; Xu H, 2013, NEUROSURGERY, V73, P198, DOI 10.1227/01.neu.0000430320.39870.f7; [张文 Zhang Wen], 2014, [医用生物力学, Journal of Medical Biomechanics], V29, P405; Zhong ZC, 2006, MED ENG PHYS, V28, P90, DOI 10.1016/j.medengphy.2005.03.007; Zhu ZQ, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-014-0142-z	39	3	5	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149707	10.1371/journal.pone.0149707	http://dx.doi.org/10.1371/journal.pone.0149707			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918333	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400037
J	Zhang-Haagen, B; Biehl, R; Nagel-Steger, L; Radulescu, A; Richter, D; Willbold, D				Zhang-Haagen, Bo; Biehl, Ralf; Nagel-Steger, Luitgard; Radulescu, Aurel; Richter, Dieter; Willbold, Dieter			Monomeric Amyloid Beta Peptide in Hexafluoroisopropanol Detected by Small Angle Neutron Scattering	PLOS ONE			English	Article							X-RAY-SCATTERING; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; CONFORMATIONAL TRANSITION; PROTEIN; OLIGOMERS; AGGREGATION; TOXICITY; HYDRATION; DYNAMICS	Small proteins like amyloid beta (A beta) monomers are related to neurodegenerative disorders by aggregation to insoluble fibrils. Small angle neutron scattering (SANS) is a nondestructive method to observe the aggregation process in solution. We show that SANS is able to resolve monomers of small molecular weight like A beta for aggregation studies. We examine A beta monomers after prolonged storing in d-hexafluoroisopropanol (dHFIP) by using SANS and dynamic light scattering (DLS). We determined the radius of gyration from SANS as 1.0+/-0.1 nm for A beta(1-40) and 1.6+/-0.1 nm for A beta(1-42) in agreement with 3D NMR structures in similar solvents suggesting a solvent surface layer with 5% increased density. After initial dissolution in dHFIP A beta aggregates sediment with a major component of pure monomers showing a hydrodynamic radius of 1.8+/-0.3 nm for A beta(1-40) and 3.2+/-0.4 nm for A beta(1-42) including a surface layer of dHFIP solvent molecules.	[Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, Julich Ctr Neutron Sci, Julich, Germany; [Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, Inst Complex Syst, Neutron Scattering JCNS 1, Julich, Germany; [Zhang-Haagen, Bo; Biehl, Ralf; Richter, Dieter] Res Ctr Julich, ICS 1, Julich, Germany; [Zhang-Haagen, Bo; Nagel-Steger, Luitgard; Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Nagel-Steger, Luitgard; Willbold, Dieter] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, Julich, Germany; [Radulescu, Aurel] Res Ctr Julich, MLZ JCNS MLZ, Outstn, Julich Ctr Neutron Sci, Garching, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich	Biehl, R (corresponding author), Res Ctr Julich, Julich Ctr Neutron Sci, Julich, Germany.; Biehl, R (corresponding author), Res Ctr Julich, Inst Complex Syst, Neutron Scattering JCNS 1, Julich, Germany.; Biehl, R (corresponding author), Res Ctr Julich, ICS 1, Julich, Germany.	ra.biehl@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Biehl, Ralf/J-9464-2013; Richter, Dieter/H-3701-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Biehl, Ralf/0000-0002-1999-547X; Richter, Dieter/0000-0003-0719-8470; Willbold, Dieter/0000-0002-0065-7366; Radulescu, Aurel/0000-0002-6050-0176				Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Beaucage G, 1995, J APPL CRYSTALLOGR, V28, P717, DOI 10.1107/S0021889895005292; Beaucage G, 1996, J APPL CRYSTALLOGR, V29, P134, DOI 10.1107/S0021889895011605; Biehl R, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/50/503103; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Bolisetty S, 2011, SOFT MATTER, V7, P493, DOI 10.1039/c0sm00502a; Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020; Calvetti D, 2004, NUMER ALGORITHMS, V35, P301, DOI 10.1023/B:NUMA.0000021764.16526.47; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Fezoui Y, 2000, AMYLOID, V7, P166, DOI 10.3109/13506120009146831; Fezoui Y, 2002, J BIOL CHEM, V277, P36948, DOI 10.1074/jbc.M204168200; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Hamley IW, 2012, CHEM REV, V112, P5147, DOI 10.1021/cr3000994; Hammouda B, 2010, J APPL CRYSTALLOGR, V43, P1474, DOI 10.1107/S0021889810033856; IBEL K, 1975, J MOL BIOL, V93, P255, DOI 10.1016/0022-2836(75)90131-X; JACROT B, 1976, REP PROG PHYS, V39, P911, DOI 10.1088/0034-4885/39/10/001; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; Jeng US, 2006, PHYSICA B, V385-86, P865, DOI 10.1016/j.physb.2006.05.128; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Larson ME, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07478.x; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Merzel F, 2002, P NATL ACAD SCI USA, V99, P5378, DOI 10.1073/pnas.082335099; MORRISON ID, 1985, LANGMUIR, V1, P496, DOI 10.1021/la00064a016; Murphy RM, 2002, ANNU REV BIOMED ENG, V4, P155, DOI 10.1146/annurev.bioeng.4.092801.094202; Nag S, 2011, J BIOL CHEM, V286, P13827, DOI 10.1074/jbc.M110.199885; Nichols MR, 2005, J BIOL CHEM, V280, P2471, DOI 10.1074/jbc.M410553200; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Radulescu A, 2012, J PHYS CONF SER, V351, DOI 10.1088/1742-6596/351/1/012026; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rubinson KA, 2008, J APPL CRYSTALLOGR, V41, P456, DOI 10.1107/S0021889808004950; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; SELKOE DJ, 1994, ANNU REV NEUROSCI, V17, P489, DOI 10.1146/annurev.neuro.17.1.489; Sigurdsson E. M., 2005, AMYLOID PROTEINS MET; Sommer B, 2002, CURR OPIN PHARMACOL, V2, P87, DOI 10.1016/S1471-4892(01)00126-6; SOTO C, 1994, J NEUROCHEM, V63, P1191; Stadler AM, 2014, J AM CHEM SOC, V136, P6987, DOI 10.1021/ja502343b; Stanley CB, 2011, BIOPHYS J, V100, P2504, DOI 10.1016/j.bpj.2011.04.022; STICHT H, 1995, EUR J BIOCHEM, V233, P293, DOI 10.1111/j.1432-1033.1995.293_1.x; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; van der Linden E, 2007, CURR OPIN COLLOID IN, V12, P158, DOI 10.1016/j.cocis.2007.07.010; Vivekanandan S, 2011, BIOCHEM BIOPH RES CO, V411, P312, DOI 10.1016/j.bbrc.2011.06.133; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wolff M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127865; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899; Zagorski MG, 1999, METHOD ENZYMOL, V309, P189	57	23	24	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150267	10.1371/journal.pone.0150267	http://dx.doi.org/10.1371/journal.pone.0150267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919121	Green Published, gold			2022-12-27	WOS:000371274400114
J	Pinheiro, ESD; de Queiros, FC; Montoya, P; Santos, CL; do Nascimento, MA; Ito, CH; Silva, M; Santos, DBN; Benevides, S; Miranda, JGV; Sa, KN; Baptista, AF				dos Santos Pinheiro, Eulalia Silva; de Queiros, Fernanda Costa; Montoya, Pedro; Santos, Cleber Luz; do Nascimento, Marion Alves; Ito, Clara Hikari; Silva, Manuela; Nunes Santos, David Barros; Benevides, Silvia; Vivas Miranda, Jose Garcia; Sa, Katia Nunes; Baptista, Abrahao Fontes			Electroencephalographic Patterns in Chronic Pain: A Systematic Review of the Literature	PLOS ONE			English	Article							NEUROPATHIC PAIN; EVOKED-POTENTIALS; PHARMACO-EEG; MUSCLE PAIN; OTHERS PAIN; STIMULATION; RESPONSES; CORTEX; POWER; REPRESENTATION	The main objective of this study is to review and summarize recent findings on electroencephalographic patterns in individuals with chronic pain. We also discuss recent advances in the use of quantitative Electroencephalography (qEEG) for the assessment of pathophysiology and biopsychosocial factors involved in its maintenance over time. Data collection took place from February 2014 to July 2015 in PubMed, SciELO and PEDro databases. Data from cross-sectional studies and longitudinal studies, as well as clinical trials involving chronic pain participants were incorporated into the final analysis. Our primary findings related to chronic pain were an increase of theta and alpha EEG power at rest, and a decrease in the amplitude of evoked potentials after sensory stimulation and cognitive tasks. This review suggests that qEEG could be considered as a simple and objective tool for the study of brain mechanisms involved in chronic pain, as well as for identifying the specific characteristics of chronic pain condition. In addition, results show that qEEG probably is a relevant outcome measure for assessing changes in therapeutic studies.	[dos Santos Pinheiro, Eulalia Silva; do Nascimento, Marion Alves; Ito, Clara Hikari; Silva, Manuela; Baptista, Abrahao Fontes] Univ Fed Bahia, Sch Med, Grad Program Med & Hlth, Salvador, BA, Brazil; [dos Santos Pinheiro, Eulalia Silva; de Queiros, Fernanda Costa; Santos, Cleber Luz; do Nascimento, Marion Alves; Ito, Clara Hikari; Silva, Manuela; Nunes Santos, David Barros; Benevides, Silvia; Sa, Katia Nunes; Baptista, Abrahao Fontes] Univ Fed Bahia, Inst Hlth Sci, Lab Funct Electrostimulat, Salvador, BA, Brazil; [Montoya, Pedro] Univ Balearic Isl, Res Inst Hlth Sci, Palma De Mallorca, Spain; [Benevides, Silvia] Univ Fed Bahia, Inst Hlth Sci, Dept Speech Language Therapy & Audiol, Salvador, BA, Brazil; [Vivas Miranda, Jose Garcia] Univ Fed Bahia, Inst Phys, Salvador, BA, Brazil; [Sa, Katia Nunes; Baptista, Abrahao Fontes] Bahiana Sch Med & Publ Hlth, Grad & Res Program, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universitat de les Illes Balears; Universidade Federal da Bahia; Universidade Federal da Bahia	Baptista, AF (corresponding author), Univ Fed Bahia, Sch Med, Grad Program Med & Hlth, Salvador, BA, Brazil.; Baptista, AF (corresponding author), Univ Fed Bahia, Inst Hlth Sci, Lab Funct Electrostimulat, Salvador, BA, Brazil.; Baptista, AF (corresponding author), Bahiana Sch Med & Publ Hlth, Grad & Res Program, Salvador, BA, Brazil.	afbaptista@ufba.br	Sá, Katia Nunes/N-9279-2016; Montoya, Pedro/A-4666-2009; Miranda, Jose/HCI-6099-2022; Sá, Katia Nunes/X-5547-2019; Benevides, Silvia/HGV-1050-2022; Baptista, Abrahão F/N-8036-2018	Sá, Katia Nunes/0000-0002-0255-4379; Montoya, Pedro/0000-0001-8652-948X; Sá, Katia Nunes/0000-0002-0255-4379; Baptista, Abrahão F/0000-0001-7870-3820; do Nascimento, Marion/0000-0003-4917-6923	Brazilian National Council for Scientific and Technological Development (CNPq); CAPES Foundation (CAPES/CNPq) [2947/2013]; Spanish Ministry of Economy and Competitiveness; European Regional Development Funds [PSI2013-48260-C31-R]; Foundation for Research Support of the Bahia State, Brazil (FAPESB)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES Foundation (CAPES/CNPq); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Regional Development Funds(European Commission); Foundation for Research Support of the Bahia State, Brazil (FAPESB)	PM and FQ were supported by fellowships from the Brazilian National Council for Scientific and Technological Development (CNPq)(http://www.cnpq.br/) and CAPES Foundation (CAPES/CNPq#2947/2013)(http://www.capes.gov.br/). PM was also supported by a grant from the Spanish Ministry of Economy and Competitiveness and European Regional Development Funds (#PSI2013-48260-C31-R). EP and CHI were supported by MSc fellowships from Foundation for Research Support of the Bahia State, Brazil (FAPESB)(http://www.fapesb.ba.gov.br/).	Angelakis E, 2004, CLIN NEUROPHYSIOL, V115, P887, DOI 10.1016/j.clinph.2003.11.034; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; ArendtNielsen L, 1997, MUSCLE NERVE, V20, P1311, DOI 10.1002/(SICI)1097-4598(199710)20:10<1311::AID-MUS15>3.0.CO;2-5; Bae SH, 2013, J PHYS THER SCI, V25, P1367, DOI 10.1589/jpts.25.1367; Baliki MN, 2015, NEURON, V87, P474, DOI 10.1016/j.neuron.2015.06.005; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Baliki MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026010; Bentley DE, 2002, CLIN NEUROPHYSIOL, V113, P1351, DOI 10.1016/S1388-2457(02)00149-9; Berryman C, 2013, PAIN, V154, P1181, DOI 10.1016/j.pain.2013.03.002; Bjork M, 2011, CEPHALALGIA, V31, P444, DOI 10.1177/0333102410385582; Bjork MH, 2009, J HEADACHE PAIN, V10, P331, DOI 10.1007/s10194-009-0140-4; Boord P, 2008, SPINAL CORD, V46, P118, DOI 10.1038/sj.sc.3102077; Chang PF, 2005, INT J PSYCHOPHYSIOL, V55, P73, DOI 10.1016/j.ijpsycho.2004.06.006; Chang PF, 2003, BRAIN RES BULL, V59, P533, DOI 10.1016/S0361-9230(02)00950-4; Chizh BA, 2009, BRAIN RES REV, V60, P243, DOI 10.1016/j.brainresrev.2008.12.016; Coghill RC, 2001, J NEUROPHYSIOL, V85, P2602, DOI 10.1152/jn.2001.85.6.2602; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Davis KD, 2012, PAIN, V153, P1555, DOI 10.1016/j.pain.2012.02.037; de Vries M, 2013, J PAIN RES, V6, P815, DOI 10.2147/JPR.S50919; Del Percio C, 2006, NEUROIMAGE, V31, P1268, DOI 10.1016/j.neuroimage.2006.01.013; Downian R, 2008, CLIN NEUROPHYSIOL, V119, P1201, DOI 10.1016/j.clinph.2008.01.019; Drewes AM, 2008, WORLD J GASTROENTERO, V14, P4020, DOI 10.3748/wjg.14.4020; Eijkemans M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050775; Flor H, 1997, PAIN, V73, P413, DOI 10.1016/S0304-3959(97)00137-1; Flor H, 2004, NEUROSCI LETT, V361, P147, DOI 10.1016/j.neulet.2003.12.064; Gonzalez-Roldan AM, 2013, J PAIN, V14, P709, DOI 10.1016/j.jpain.2013.01.775; Gram M, 2013, BRIT J CLIN PHARMACO, V76, P951, DOI 10.1111/bcp.12120; Graversen C, 2012, BRIT J CLIN PHARMACO, V73, P363, DOI 10.1111/j.1365-2125.2011.04104.x; Hashmi JA, 2013, BRAIN, V136, P2751, DOI 10.1093/brain/awt211; Herzog R, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-154; Hoshiyama M, 2000, CLIN NEUROPHYSIOL, V111, P717, DOI 10.1016/S1388-2457(99)00299-0; Hunter AM, 2014, PSYCHO-ONCOLOGY, V23, P713, DOI 10.1002/pon.3487; Jarcho JM, 2012, PAIN, V153, P744, DOI 10.1016/j.pain.2012.01.002; Juottonen K, 2002, PAIN, V98, P315, DOI 10.1016/S0304-3959(02)00119-7; Kurt P, 2014, BEHAV NEUROL, V2014, DOI 10.1155/2014/268967; LeBlanc BW, 2014, PAIN, V155, P773, DOI 10.1016/j.pain.2014.01.013; Lelic Dina, 2014, World J Gastrointest Pathophysiol, V5, P33, DOI 10.4291/wjgp.v5.i1.33; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lorenz J, 1997, EVOKED POTENTIAL, V104, P514, DOI 10.1016/S0168-5597(97)00064-6; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; Martinez-Jauand M, 2012, BRAIN RES, V1467, P48, DOI 10.1016/j.brainres.2012.05.055; Mendonca-de-Souza M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00207; Mo J, 2013, PAIN, V154, P1150, DOI 10.1016/j.pain.2013.02.013; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Moore HCF, 2014, SUPPORT CARE CANCER, V22, P2127, DOI 10.1007/s00520-014-2197-0; Ngernyam N, 2015, CLIN NEUROPHYSIOL, V126, P382, DOI 10.1016/j.clinph.2014.05.034; Niddam DM, 2002, NEUROIMAGE, V17, P1437, DOI 10.1006/nimg.2002.1270; Nir RR, 2010, BRAIN RES, V1344, P77, DOI 10.1016/j.brainres.2010.05.004; Palermo A, 2011, EXP BRAIN RES, V212, P101, DOI 10.1007/s00221-011-2701-4; Peng WW, 2015, BIOL PSYCHOL, V109, P141, DOI 10.1016/j.biopsycho.2015.05.004; Prichep LS, 2011, PAIN MED, V12, P1241, DOI 10.1111/j.1526-4637.2011.01191.x; Raij TT, 2004, NEUROIMAGE, V23, P569, DOI 10.1016/j.neuroimage.2004.06.036; Rajapakse D, 2014, ARCH DIS CHILD, V99, P474, DOI 10.1136/archdischild-2013-304207; Reyns N, 2013, CLIN NEUROPHYSIOL, V124, P761, DOI 10.1016/j.clinph.2012.10.011; Riquelme I, 2010, CLIN NEUROPHYSIOL, V121, P1314, DOI 10.1016/j.clinph.2010.03.010; Sarnthein J, 2006, BRAIN, V129, P55, DOI 10.1093/brain/awh631; Sarnthein J, 2008, NEUROIMAGE, V39, P1910, DOI 10.1016/j.neuroimage.2007.10.019; Schmidt S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031138; Silen T, 2000, NEUROIMAGE, V12, P707, DOI 10.1006/nimg.2000.0660; Silva JG, 2014, J PHYS THER SCI, V26, P349, DOI 10.1589/jpts.26.349; Sitges C, 2007, J AFFECT DISORDERS, V104, P73, DOI 10.1016/j.jad.2007.02.024; Sitges C, 2010, INT J PSYCHOPHYSIOL, V77, P176, DOI 10.1016/j.ijpsycho.2010.05.010; Spronk D, 2011, J AFFECT DISORDERS, V128, P41, DOI 10.1016/j.jad.2010.06.021; Stern J, 2006, NEUROIMAGE, V31, P721, DOI 10.1016/j.neuroimage.2005.12.042; Valeriani M, 2002, NEUROSCI LETT, V329, P329, DOI 10.1016/S0304-3940(02)00671-7; van den Broeke EN, 2013, PAIN MED, V14, P1893, DOI 10.1111/pme.12216; Vecsei L, 2015, CNS NEUROL DISORD-DR, V14, P664, DOI 10.2174/1871527314666150429114040; Veldhuijzen DS, 2006, PAIN, V121, P60, DOI 10.1016/j.pain.2005.12.004; Vlaeyen JWS, 2015, PAIN, V156, pS86, DOI 10.1097/j.pain.0000000000000107; Vossen CJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000865; Vuckovic A, 2014, J PAIN, V15, P645, DOI 10.1016/j.jpain.2014.02.005; Wang Y, 2014, NEURORADIOLOGY, V56, P685, DOI 10.1007/s00234-014-1376-5; Wartolowska K, 2009, NEUROTHERAPEUTICS, V6, P755, DOI 10.1016/j.nurt.2009.08.003; Wells G., 2014, S SYST REV BAS; Yener GG, 2014, BRAIN RES, V1585, P141, DOI 10.1016/j.brainres.2014.08.038	77	106	119	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149085	10.1371/journal.pone.0149085	http://dx.doi.org/10.1371/journal.pone.0149085			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914356	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700012
J	Kang, B; Kojcev, R; Sinibaldi, E				Kang, Byungjeon; Kojcev, Risto; Sinibaldi, Edoardo			The First Interlaced Continuum Robot, Devised to Intrinsically Follow the Leader	PLOS ONE			English	Article							MINIMALLY INVASIVE SURGERY; SYSTEM; DESIGN	Flexible probes that are safely deployed to hard-to-reach targets while avoiding critical structures are strategic in several high-impact application fields, including the biomedical sector and the sector of inspections at large. A critical problem for these tools is the best approach for deploying an entire tool body, not only its tip, on a sought trajectory. A probe that achieves this deployment is considered to follow the leader (or to achieve follow-the-leader deployment) because its body sections follow the track traced by its tip. Follow-the-leader deployment through cavities is complicated due to a lack of external supports. Currently, no definitive implementation for a probe that is intrinsically able to follow the leader, i.e., without relying on external supports, has been achieved. In this paper, we present a completely new device, namely the first interlaced continuum robot, devised to intrinsically follow the leader. We developed the interlaced configuration by pursuing a conceptual approach irrespective of application-specific constraints and assuming two flexible tools with controllable stiffness. We questioned the possibility of solving the previously mentioned deployment problem by harnessing probe symmetry during the design process. This study examines the entire development of the novel interlaced probe: model-based conceptual design, detailed design and prototyping, and preliminary experimental assessment. Our probe can build a track with a radius of curvature that is as small as twice the probe diameter, which enables it to outperform state-of-the-art tools that are aimed at follow-the-leader deployment. Despite the limitations that are inherently associated with its original character, this study provides a prototypical approach to the design of interlaced continuum systems and demonstrates the first interlaced continuum probe, which is intrinsically able to follow the leader.	[Kang, Byungjeon; Kojcev, Risto; Sinibaldi, Edoardo] Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy; [Kang, Byungjeon; Kojcev, Risto] Scuola Super Sant Anna, BioRobot Inst, Pontedera, Italy	Istituto Italiano di Tecnologia - IIT; Scuola Superiore Sant'Anna	Sinibaldi, E (corresponding author), Ist Italiano Tecnol, Ctr MicrobioRobot, Pontedera, Italy.	edoardo.sinibaldi@iit.it	Sinibaldi, Edoardo/AAV-9599-2021	Sinibaldi, Edoardo/0000-0002-9755-3431				Antman SS, 2005, NONLINEAR PROBLEMS E, V2; Ayvali E, 2012, INT J ROBOT RES, V31, P588, DOI 10.1177/0278364912442429; Bajo A, 2012, IEEE T ROBOT, V28, P291, DOI 10.1109/TRO.2011.2175761; Bergeles C, 2014, IEEE T BIO-MED ENG, V61, P1565, DOI 10.1109/TBME.2013.2293815; Breedveld P, 2005, IEEE ENG MED BIOL, V24, P40, DOI 10.1109/MEMB.2005.1549729; Bryson CE, 2014, IEEE INT CONF ROBOT, P778, DOI 10.1109/ICRA.2014.6906943; Chen Y, 2014, IEEE INT CONF ROBOT, P5393, DOI 10.1109/ICRA.2014.6907652; Choset H, 1999, J AEROSPACE ENG, V12, P65, DOI 10.1061/(ASCE)0893-1321(1999)12:2(65); Cianchetti M, 2014, SOFT ROBOT, V1, P122, DOI 10.1089/soro.2014.0001; Degani A, 2006, IEEE INT CONF ROBOT, P4167, DOI 10.1109/ROBOT.2006.1642343; Ding JN, 2013, IEEE-ASME T MECH, V18, P1612, DOI 10.1109/TMECH.2012.2209671; Dupont PE, 2010, IEEE T ROBOT, V26, P209, DOI 10.1109/TRO.2009.2035740; GBI Research, 2012, ENDOSCOPY DEVICES MA; Gilbert HB, 2015, IEEE T ROBOT, V31, P246, DOI 10.1109/TRO.2015.2394331; Hamedon Z, 2014, J MATER PROCESS TECH, V214, P945, DOI 10.1016/j.jmatprotec.2013.11.016; Jain N, 2012, ANAL NONDESTRUCTIVE; Khoshnam M, 2014, IEEE INT C INT ROBOT, P3509, DOI 10.1109/IROS.2014.6943052; Kim YJ, 2013, IEEE T ROBOT, V29, P1031, DOI 10.1109/TRO.2013.2256313; Ko SY, 2013, IEEE T BIO-MED ENG, V60, P910, DOI 10.1109/TBME.2012.2227741; Ko SY, 2013, IEEE T ROBOTICS, V27, P970; Loeve AJ, 2012, IEEE T BIO-MED ENG, V59, P542, DOI 10.1109/TBME.2011.2175730; Mahvash M, 2011, IEEE T ROBOT, V27, P334, DOI 10.1109/TRO.2011.2105410; Moses MS, 2013, IEEE INT CONF ROBOT, P4008, DOI 10.1109/ICRA.2013.6631142; Ota T, 2009, ANN THORAC SURG, V87, P1253, DOI 10.1016/j.athoracsur.2008.10.026; Park W, 2010, IEEE INT CONF ROBOT, P3703, DOI 10.1109/ROBOT.2010.5509380; Reed KB, 2013, IEEE ROBOTICS AUTOMA, V18, P35; Research and Markets, 2011, FLEX END GLOB PIP AN; Rone WS, 2014, J MECH ROBOT, V6, DOI 10.1115/1.4027235; Rone WS, 2014, IEEE T ROBOT, V30, P275, DOI 10.1109/TRO.2013.2281564; Searle TC, 2013, IEEE INT CONF ROBOT, P4415, DOI 10.1109/ICRA.2013.6631203; Sears P, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P2850, DOI 10.1109/IROS.2006.282072; Simaan N, 2009, INT J ROBOT RES, V28, P1134, DOI 10.1177/0278364908104278; Sinibaldi E, 2015, Italian Patent Application, Patent No. [TO2015A 000233, 2015000233]; Striegel J, 2011, SURG ENDOSC, V25, P636, DOI 10.1007/s00464-010-1245-1; Swaney PJ, 2013, PROCEEDINGS OF THE ASME 5TH ANNUAL DYNAMIC SYSTEMS AND CONTROL DIVISION CONFERENCE AND JSME 11TH MOTION AND VIBRATION CONFERENCE, DSCC 2012, VOL 3, P387; Thakkar S, 2015, SURG INNOV, V22, P274, DOI 10.1177/1553350614554232; Timoshenko SP, 2001, THEORY ELASTICITY; Vrooijink GJ, 2014, INT J ROBOT RES, V33, P1361, DOI 10.1177/0278364914526627; Walker Ian D., 2013, ISRN Robotics, P1, DOI 10.5402/2013/726506; Webster RJ, 2009, IEEE T ROBOT, V25, P67, DOI 10.1109/TRO.2008.2006868; Wood N. A., 2013, 2013 IEEE International Conference on Mechatronics (ICM), P237, DOI 10.1109/ICMECH.2013.6518542; Wood R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006949; Xu K, 2006, IEEE INT CONF ROBOT, P4148, DOI 10.1109/ROBOT.2006.1642340	43	30	30	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150278	10.1371/journal.pone.0150278	http://dx.doi.org/10.1371/journal.pone.0150278			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914328	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700065
J	Bergmann, EJ; Venugopal, PD; Martinson, HM; Raupp, MJ; Shrewsbury, PM				Bergmann, Erik J.; Venugopal, P. Dilip; Martinson, Holly M.; Raupp, Michael J.; Shrewsbury, Paula M.			Host Plant Use by the Invasive Halyomorpha halys (Stal) on Woody Ornamental Trees and Shrubs	PLOS ONE			English	Article							MARMORATED STINK BUG; HEMIPTERA-PENTATOMIDAE; HETEROPTERA-PENTATOMIDAE; SOYBEAN FIELDS; WILD HOSTS; ABUNDANCE; PEST; AVAILABILITY; MANAGEMENT; NURSERIES	The brown marmorated stink bug, Halyomorpha halys (Stal) (Hemiptera: Pentatomidae) is an invasive plant-feeding insect native to eastern Asia. This herbivore is highly polyphagous, feeding on and damaging diverse plants, including field crops, vegetables, tree fruits, and ornamentals. Woody ornamental plants provide early-and late-season resources for adults emerging from and returning to overwintering sites, as well as feeding and breeding sites for H. halys throughout the growing season. In this study, we quantify the use of diverse plants by H. halys in two commercial nurseries in Maryland, recording data on the abundance of egg masses, early and late instar nymphs, and adults over a three-year study period. Our specific goals were to provide a quantitative comparison of the use of diverse plant species and cultivated varieties, identify non-hosts that could be used to create landscapes refractory to H. halys, and determine whether the use of plants varied across life stages of H. halys or the taxonomic status of plants. We found broad use of diverse plants in this study, identifying 88 host plants used by all life stages of H. halys. We also highlight the 43 plant taxa that did not support any life stage of H. halys and are thus classified as nonhosts. Interestingly, some of these plants were congeners of highly-used plants, underscoring high intrageneric and intraspecific variation in the use of plants by this polyphagous herbivore. We discuss how the selective planting of non-hosts, especially gymnosperms, may aid in reducing the agricultural and nuisance pest status of this invasive insect.	[Bergmann, Erik J.; Venugopal, P. Dilip; Martinson, Holly M.; Raupp, Michael J.; Shrewsbury, Paula M.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Shrewsbury, PM (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	pshrewsbury@umd.edu		Martinson, Holly/0000-0003-1462-0051; Venugopal, Dilip/0000-0001-6339-5087	United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative [2011-51181-30937]; United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant [MD-ENTM-04168757]	United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative; United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant	This work was supported by the United States Department of Agriculture-National Institute of Food and Agriculture, Specialty Crop Research Initiative; Award 2011-51181-30937 (http://nifa.usda.gov/funding-opportunity/specialty-crop-research-initiative-scri) to HMM, MJR, and PMS, and the United States Department of Agriculture-National Institute of Food and Agriculture, McIntire Stennis Capacity Grant; MD-ENTM-04168757 (http://nifa.usda.gov/program/mcintire-stennis-capacity-grant) to MJR.	Bakken AJ, 2015, ENVIRON ENTOMOL, V44, P1011, DOI 10.1093/ee/nvv092; Bernard G, 2004, TLS-TIMES LIT SUPPL, P17; Callot Henry, 2013, Entomologiste (Paris), V69, P69; Cayuela L, 2012, METHODS ECOL EVOL, V3, P1078, DOI 10.1111/j.2041-210X.2012.00232.x; Clapp J. Casey, 2014, Arboricultural Journal, V36, P161, DOI 10.1080/03071375.2014.950861; Commonwealth of Australia, 2015, BROWN MARM STINK BUG; Cooper R., 2010, BROWN MARMORATED STI, P15; Dirr MA, 2009, MANUAL WOODY LANDSCA, VIII; Fujisawa T., 2001, JPN AGR TECHNOL, V45, P42; Funayama K, 2005, JPN J APPL ENTOMOL Z, V49, P265, DOI 10.1303/jjaez.2005.265; Funayama K, 2002, JPN J APPL ENTOMOL Z, V46, P1, DOI 10.1303/jjaez.2002.1; Hamilton George C., 2009, American Entomologist, V55, P19; Haye T., 2014, Proceedings of the 8th International Conference on Urban Pests, 20-23 July 2014, Zurich, Switzerland, P309; Heckmann Ralf, 2012, Heteropteron, V36, P17; Herms DA, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P217, DOI 10.1007/0-306-47596-0_10; Hiruki C, 1999, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.1999.496.6; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; KAWADA H, 1983, JPN J APPL ENTOMOL Z, V27, P304, DOI 10.1303/jjaez.27.304; Kuhar T.P., 2012, PLANT HLTH PROG, V13, P41, DOI [10.1094/PHP-2012-0523-01-BR, DOI 10.1094/PHP-2012-0523-01-BR]; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; MacLellan R., 2013, Surveillance (Wellington), V40, P34; Marrotte EL, 2004, WHY FRUIT TREES FAIL; Martinson HM, 2015, J PEST SCI, V88, P461, DOI 10.1007/s10340-015-0677-8; Martinson HM, 2013, ANN ENTOMOL SOC AM, V106, P47, DOI 10.1603/AN12088; Maxwell F.G., 1980, BREEDING PLANTS RESI; Milonas P. G., 2014, Bulletin OEPP, V44, P183, DOI 10.1111/epp.12129; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Northeastern IPM Center, 2015, WHER IS BMBS; Oda M., 1980, B NARA AGR EXP STATI, V11, P53; Oda M., 1982, B NARA AGR EXP STN, V13, P66; Painter RH, 1951, INSECT RESISTANCE CR; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Pansa M. G., 2013, Informatore Agrario, V69, P60; Potter DA, 1986, ADV URBAN PEST MANAG, P219; Qin W., 1990, PLANT PROT, V16, P22; R Development Core Team, 2014, R LANG ENV STAT COMP; RAUPP MJ, 1992, ANNU REV ENTOMOL, V37, P561, DOI 10.1146/annurev.en.37.010192.003021; Rice KB, 2014, J INTEGR PEST MANAG, V5, DOI 10.1603/IPM14002; VELASCO LRI, 1992, ENVIRON ENTOMOL, V21, P751, DOI 10.1093/ee/21.4.751; Venugopal PD, 2015, J ECON ENTOMOL, V108, P2231, DOI 10.1093/jee/tov188; Venugopal PD, 2015, ENVIRON ENTOMOL, V44, P474, DOI 10.1093/ee/nvv061; Venugopal PD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109917; Vetek G, 2014, ZOOTAXA, V 3780, P194, DOI 10.11646/zootaxa.3780.1.8; Wermelinger B, 2008, ENTOMOL GESELLSCHAFT, V81, P1, DOI DOI 10.5169/SEALS-402954; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu Y., 2007, INT WORKSH BIOL CONT, P20; Yanagi T., 1980, PLANT PROTECTION, V34, P315; Zhang Jun-Ming, 2007, Chinese Bulletin of Entomology, V44, P898	52	62	67	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149975	10.1371/journal.pone.0149975	http://dx.doi.org/10.1371/journal.pone.0149975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906399	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000026
J	Anderson, GS; Bell, LS				Anderson, Gail S.; Bell, Lynne S.			Impact of Marine Submergence and Season on Faunal Colonization and Decomposition of Pig Carcasses in the Salish Sea	PLOS ONE			English	Article							NATURAL WHALE FALL; DEEP-SEA; BRITISH-COLUMBIA; FOOD ODOR; ATLANTIC; CONSUMPTION; SUCCESSION; AMPHIPODS; CARRION; CANADA	Pig carcasses, as human proxies, were placed on the seabed at a depth of 300 m, in the Strait of Georgia and observed continuously by a remotely operated camera and instruments. Two carcasses were deployed in spring and two in fall utilizing Ocean Network Canada's Victoria Experimental Network under the Sea (formerly VENUS) observatory. A trial experiment showed that bluntnose sixgill sharks could rapidly devour a carcass so a platform was designed which held two matched carcasses, one fully exposed, the other covered in a barred cage to protect it from sharks, while still allowing invertebrates and smaller vertebrates access. The carcasses were deployed under a frame which supported a video camera, and instruments which recorded oxygen, temperature, salinity, density, pressure, conductivity, sound speed and turbidity at per minute intervals. The spring exposed carcass was briefly fed upon by sharks, but they were inefficient feeders and lost interest after a few bites. Immediately after deployment, all carcasses, in both spring and fall, were very rapidly covered in vast numbers of lyssianassid amphipods. These skeletonized the carcasses by Day 3 in fall and Day 4 in spring. A dramatic, very localized drop in dissolved oxygen levels occurred in fall, exactly coinciding with the presence of the amphipods. Oxygen levels returned to normal once the amphipods dispersed. Either the physical presence of the amphipods or the sudden draw down of oxygen during their tenure, excluded other fauna. The amphipods fed from the inside out, removing the skin last. After the amphipods had receded, other fauna colonized such as spot shrimp and a few Dungeness crabs but by this time, all soft tissue had been removed. The amphipod activity caused major bioturbation in the local area and possible oxygen depletion. The spring deployment carcasses became covered in silt and a black film formed on them and on the silt above them whereas the fall bones remained uncovered and hence continued to be attractive to large numbers of spot shrimp. The carcass remains were recovered after 166 and 134 days respectively for further study.	[Anderson, Gail S.; Bell, Lynne S.] Simon Fraser Univ, Sch Criminol, Ctr Forens Res, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Anderson, GS (corresponding author), Simon Fraser Univ, Sch Criminol, Ctr Forens Res, Burnaby, BC V5A 1S6, Canada.	ganderso@sfu.ca			Canadian Police Research Centre [CPRC-02-2012]	Canadian Police Research Centre(Natural Resources Canada)	This work was financially supported by the Canadian Police Research Centre, CPRC-02-2012, A Data Rich Investigation into Deep Sea Taphonomy & Faunal Succession using Pig Proxies, which is led by Defence Research and Development Canada's Centre for Security Science in partnership with Public Safety Canada. The project was led by Simon Fraser University. Principal Investigator GSA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon DJ, 2013, DEEP-SEA RES PT II, V92, P87, DOI 10.1016/j.dsr2.2013.01.028; Anderson GS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110710; Anderson GS, 2004, INT J LEGAL MED, V118, P206, DOI 10.1007/s00414-004-0447-2; Baco AR, 2003, MAR ECOL PROG SER, V260, P109, DOI 10.3354/meps260109; Bergstrom BI, 2000, ADV MAR BIOL, V38, P55, DOI 10.1016/S0065-2881(00)38003-8; Boyle S, 1997, FORENSIC TAPHONOMY P, P605; Castner JL, 2009, FORENSIC ENTOMOLOGY, P201; DAHL E, 1979, OIKOS, V33, P167, DOI 10.2307/3543994; Dahlgren TG, 2006, CAH BIOL MAR, V47, P385; Danise S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5789; De Robertis A, 2001, MAR ECOL PROG SER, V219, P221, DOI 10.3354/meps219221; DEARBORN J.H., 1967, NZ DEP SCI IND RES B, V176, P31; Dewey R, SCIENCE; Diaz RJ, 1995, OCEANOGR MAR BIOL, V33, P245; Dumser TK, 2008, J FORENSIC SCI, V53, P1049, DOI 10.1111/j.1556-4029.2008.00816.x; EBERT DA, 1986, COPEIA, P131; Fujiwara Y, 2007, MAR ECOL-EVOL PERSP, V28, P219, DOI 10.1111/j.1439-0485.2007.00150.x; HAGLUND WD, 1993, J FORENSIC SCI, V38, P806; HAGLUND WD, 2001, ADV FORENSIC TAPHONO; Higgs ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096016; Hobischak NR, 2002, J FORENSIC SCI, V47, P142; Hobischak NR, 1999, CAN SOC FORENSIC SCI, p[32, 97], DOI DOI 10.1080/00085030.1999.10757492; Ide K, 2007, J EXP MAR BIOL ECOL, V340, P70, DOI 10.1016/j.jembe.2006.08.005; Jones EG, 1998, P ROY SOC B-BIOL SCI, V265, P1119, DOI 10.1098/rspb.1998.0407; Kemp KM, 2006, MAR ECOL PROG SER, V310, P65, DOI 10.3354/meps310065; Klages M, 2002, DEEP-SEA RES PT I, V49, P143, DOI 10.1016/S0967-0637(01)00047-4; Klages N, 2001, POLAR BIOL, V24, P292, DOI 10.1007/s003000000199; Lundsten L, 2010, DEEP-SEA RES PT I, V57, P918, DOI 10.1016/j.dsr.2010.04.006; Magni PA, 2015, FORENSIC SCI INT, V247, pE6, DOI 10.1016/j.forsciint.2014.11.016; MOORE PG, 1995, J EXP MAR BIOL ECOL, V189, P143, DOI 10.1016/0022-0981(95)00021-I; MOORE PG, 1994, MAR ECOL PROG SER, V113, P29, DOI 10.3354/meps113029; Petrik MS, 2004, CAN SOC FORENSIC SCI, V37, P9, DOI DOI 10.1080/00085030.2004.10757565; Premke K, 2003, J EXP MAR BIOL ECOL, V285, P283, DOI 10.1016/S0022-0981(02)00533-6; Reisdorf AG, 2014, PALAEOBIO PALAEOENV, V94, P487, DOI 10.1007/s12549-014-0162-z; Reisdorf Achim G., 2012, Palaeobiodiversity Palaeoenvironments, V92, P67, DOI 10.1007/s12549-011-0067-z; Sainte-Marie B, 1992, NATO ASI SER, V360, P105; SHULENBERGER E, 1974, MAR BIOL, V28, P185, DOI 10.1007/BF00387296; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Smith KE, 2014, DEEP-SEA RES PT I, V90, P76, DOI 10.1016/j.dsr.2014.04.013; SMITH KL, 1982, MAR BIOL, V68, P287, DOI 10.1007/BF00409595; Sorg Marcella H., 1997, P567; Sweetman AK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.2210; Teather RG., 2013, ENCY UNDERWATER INVE, V2nd ed.; Tomberlin J.K., 2015, FORENSIC ENTOMOLOGY; Wallace JR., 2015, CARRION ECOLOGY EVOL; Williams GD, 2010, T AM FISH SOC, V139, P108, DOI 10.1577/T09-045.1; Yamamoto J, 2008, MAR BIOL, V153, P311, DOI 10.1007/s00227-007-0807-9	47	21	22	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149107	10.1371/journal.pone.0149107	http://dx.doi.org/10.1371/journal.pone.0149107			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930206	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500015
J	Arkun, Y				Arkun, Yaman			Dynamic Modeling and Analysis of the CrossTalk between Insulin/AKT and MAPK/ERK Signaling Pathways	PLOS ONE			English	Article							CELL-CYCLE ARREST; PROTEIN-KINASE B; RECEPTOR SUBSTRATE-1; ENDOTHELIAL-CELLS; NITRIC-OXIDE; AKT; RAF; PHOSPHORYLATION; ACTIVATION; CANCER	Feedback loops play a key role in the regulation of the complex interactions in signal transduction networks. By studying the network of interactions among the biomolecules present in signaling pathways at the systems level, it is possible to understand how the biological functions are regulated and how the diseases emerge from their deregulations. This paper identifies the key feedback loops involved in the cross-talk among the insulin-AKT and MAPK/ERK signaling pathways. We developed a mathematical model that can be used to study the steady-state and dynamic behavior of the interactions among these two important signaling pathways. Modeling analysis and simulation case studies identify the key interaction parameters and the feedback loops that determine the normal and disease phenotypes.	[Arkun, Yaman] Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, TR-34450 Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Rumeli Feneri Yolu, TR-34450 Istanbul, Turkey.	yarkun@ku.edu.tr						Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Angeli D, 2004, P NATL ACAD SCI USA, V101, P1822, DOI 10.1073/pnas.0308265100; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; Cizmeci D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083640; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhooge A., 2006, MATCONT CL MATCONT C; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Giri Lopamudra, 2004, Theor Biol Med Model, V1, P2, DOI 10.1186/1742-4682-1-2; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kim D, 2007, BIOESSAYS, V29, P85, DOI 10.1002/bies.20511; Kiyatkin A, 2006, J BIOL CHEM, V281, P19925, DOI 10.1074/jbc.M600482200; Kohno M, 2006, ANN MED, V38, P200, DOI 10.1080/07853890600551037; Kolch W, 2005, FEBS LETT, V579, P1891, DOI 10.1016/j.febslet.2005.02.002; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Liao Y, 2010, AM J TRANSL RES, V2, P19; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mattoon DR, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-24; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; McCubrey JA, 2009, EXPERT OPIN EMERG DR, V14, P633, DOI 10.1517/14728210903232633; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mirza AM, 2004, MOL CELL BIOL, V24, P10868, DOI 10.1128/MCB.24.24.10868-10881.2004; Moelling K, 2002, J BIOL CHEM, V277, P31099, DOI 10.1074/jbc.M111974200; Nayak S, 2011, IET SYST BIOL, V5, P2, DOI 10.1049/iet-syb.2009.0065; Nazari Hossein, 2007, J Med Invest, V54, P19, DOI 10.2152/jmi.54.19; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Paz K, 1999, J BIOL CHEM, V274, P28816, DOI 10.1074/jbc.274.40.28816; Pfeuty B, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/4/046013; Qiao L, 2007, PLOS COMPUT BIOL, V3; Roovers K, 2000, BIOESSAYS, V22, P818, DOI 10.1002/1521-1878(200009)22:9<818::AID-BIES7>3.3.CO;2-Y; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; SOWERS JR, 1990, MOL CELL ENDOCRINOL, V74, pC87, DOI 10.1016/0303-7207(90)90110-T; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Velloso LA, 2006, DIABETES-METAB RES, V22, P98, DOI 10.1002/dmrr.611; Wang GY, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/046015; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	54	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149684	10.1371/journal.pone.0149684	http://dx.doi.org/10.1371/journal.pone.0149684			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930065	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500042
J	Li, WY; Zheng, YF; Zhao, XH; Ge, YJ; Chen, T; Liu, YS; Zhou, YS				Li, Wenyue; Zheng, Yunfei; Zhao, Xianghui; Ge, Yanjun; Chen, Tong; Liu, Yunsong; Zhou, Yongsheng			Osteoinductive Effects of Free and Immobilized Bone Forming Peptide-1 on Human Adipose-Derived Stem Cells	PLOS ONE			English	Article							IN-VITRO; TISSUE; DEGRADATION; INDUCTION; SCAFFOLDS; PRODOMAIN; PROTEINS; ADHESION; POLYMER; MARROW	Most synthetic polymeric materials currently used for bone tissue engineering lack specific signals through which cells can identify and interact with the surface, resulting in incompatibility and compromised osteogenic activity. Soluble inductive factors also have issues including a short half-live in vivo. Bone forming peptide-1 is a truncated peptide from the immature form of bone morphogenetic protein-7 (BMP-7) that displays higher osteogenic activity than full-length, mature BMP-7. In this study, we used a mussel-inspired immobilization strategy mediated by polymerization of dopamine to introduce recently discovered stimulators of bone forming peptide-1 (BFP-1) onto the surface of poly-lactic-co-glycolic acid (PLGA) substrate to form a biomaterial that overcomes these challenges. Human adipose-derived stem cells (hASCs), being abundant and easy accessible, were used to test the osteogenic activity of BFP-1 and the novel biomaterial. Under osteoinductive conditions, cells treated with both BFP-1 alone and BFP-1-coated biomaterials displayed elevated expression of the osteogenic markers alkaline phosphatase (ALP), osteocalcin (OC), and RUNX2. Furthermore, hASCs associated with poly-dopamine-assisted BFP-1-immobilized PLGA (pDA-BFP-1-PLGA) scaffolds promoted in vivo bone formation in nude mice. Our novel materials may hold great promise for future bone tissue engineering applications.	[Li, Wenyue; Zhao, Xianghui; Ge, Yanjun; Chen, Tong; Liu, Yunsong; Zhou, Yongsheng] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Zheng, Yunfei] Peking Univ, Dept Oral & Maxillofacial Surg, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Zhou, Yongsheng] Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Liu, YS; Zhou, YS (corresponding author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.; Zhou, YS (corresponding author), Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	kqliuyunsong@163.com; kqzhouysh@hsc.pku.edu.cn	zheng, yunfei/M-4172-2018		National Natural Science Foundation of China [2011/81170937, 2013/81400484]; Ministry of Education of China [NCET-11-0026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by the National Natural Science Foundation of China (2011/81170937 to YZhou, 2013/81400484 to YG), (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Program for New Century Excellent Talents in University from Ministry of Education of China (NCET-11-0026 to YZhou), (http://www.moe.edu.cn/publicfiles/business/htmlfiles/moe/A16/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; Ball V, 2012, J COLLOID INTERF SCI, V386, P366, DOI 10.1016/j.jcis.2012.07.030; Balmayor ER, 2015, ADV DRUG DELIVER REV, V94, P13, DOI 10.1016/j.addr.2015.04.022; BANG G, 1967, ARCH SURG-CHICAGO, V94, P781; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chrastil J, 2013, SPINE, V38, pE1020, DOI 10.1097/BRS.0b013e3182982f8e; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dick A, 2000, DEVELOPMENT, V127, P343; Dormer NH, 2013, MAT SCI ENG C-MATER, V33, P4343, DOI 10.1016/j.msec.2013.06.026; Ducy P, 2000, KIDNEY INT, V57, P2207, DOI 10.1046/j.1523-1755.2000.00081.x; Gao X, 2015, INT J NANOMED, V10, P7109, DOI 10.2147/IJN.S94045; Garcia-Gareta E, 2015, BONE, V81, P112, DOI 10.1016/j.bone.2015.07.007; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; Kim HK, 2012, BIOMATERIALS, V33, P7057, DOI 10.1016/j.biomaterials.2012.06.036; Ko E, 2013, BIOMACROMOLECULES, V14, P3202, DOI 10.1021/bm4008343; Ku SH, 2010, BIOMATERIALS, V31, P2535, DOI 10.1016/j.biomaterials.2009.12.020; Lee H, 2007, SCIENCE, V318, P426, DOI 10.1126/science.1147241; Lee JS, 2014, MACROMOL BIOSCI, V14, P1181, DOI 10.1002/mabi.201400052; Lee YJ, 2013, BIOMATERIALS, V34, P5059, DOI 10.1016/j.biomaterials.2013.03.051; Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002; Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014; Lu L, 2000, BIOMATERIALS, V21, P1837, DOI 10.1016/S0142-9612(00)00047-8; Lv LW, 2015, BIOMATERIALS, V39, P193, DOI 10.1016/j.biomaterials.2014.11.002; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Peroni D, 2008, EXP CELL RES, V314, P603, DOI 10.1016/j.yexcr.2007.10.007; Poh CK, 2010, BIOMATERIALS, V31, P1578, DOI 10.1016/j.biomaterials.2009.11.042; Puetzer JL, 2010, TISSUE ENG PART B-RE, V16, P435, DOI [10.1089/ten.teb.2009.0705, 10.1089/ten.TEB.2009.0705]; Roach P, 2010, SURF SCI REP, V65, P145, DOI 10.1016/j.surfrep.2010.07.001; Ronziere MC, 2010, BIO-MED MATER ENG, V20, P145, DOI 10.3233/BME-2010-0626; Sena P, 2012, HISTOL HISTOPATHOL, V27, P485, DOI 10.14670/HH-27.485; Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066; Ventre M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0687; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yang K, 2012, BIOMATERIALS, V33, P6952, DOI 10.1016/j.biomaterials.2012.06.067; Yin WN, 2014, J MATER CHEM B, V2, P8434, DOI 10.1039/c4tb01548g; Zhang H, 2014, BIOMATERIALS, V35, P711, DOI 10.1016/j.biomaterials.2013.10.017	36	12	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150294	10.1371/journal.pone.0150294	http://dx.doi.org/10.1371/journal.pone.0150294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930062	gold, Green Published			2022-12-27	WOS:000371434500126
J	Ma, DY; Ma, AJ; Huang, ZH; Wang, GN; Wang, T; Xia, DD; Ma, BH				Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe			Transcriptome Analysis for Identification of Genes Related to Gonad Differentiation, Growth, Immune Response and Marker Discovery in The Turbot (Scophthalmus maximus)	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; ACID-BINDING PROTEINS; SALMO-SALAR L.; SEX-DIFFERENTIATION; RAINBOW-TROUT; EXPRESSION PATTERNS; MOLECULAR-STRUCTURE; INNATE IMMUNITY; CANDIDATE GENES; CARCASS TRAITS	Background Turbot Scophthalmus maximus is an economically important species extensively aquacultured in China. The genetic selection program is necessary and urgent for the sustainable development of this industry, requiring more and more genome background knowledge. Transcriptome sequencing is an excellent alternative way to identify transcripts involved in specific biological processes and exploit a considerable quantity of molecular makers when no genome sequences are available. In this study, a comprehensive transcript dataset for major tissues of S. maximus was produced on basis of an Illumina platform. Results Total RNA was isolated from liver, spleen, kidney, cerebrum, gonad (testis and ovary) and muscle. Equal quantities of RNA from each type of tissues were pooled to construct two cDNA libraries (male and female). Using the Illumina paired-end sequencing technology, nearly 44.22 million clean reads in length of 100 bp were generated and then assembled into 106,643 contigs, of which 71,107 were named unigenes with an average length of 892 bp after the elimination of redundancies. Of these, 24,052 unigenes (33.83% of the total) were successfully annotated. GO, KEGG pathway mapping and COG analysis were performed to predict potential genes and their functions. Based on our sequence analysis and published documents, many candidate genes with fundamental roles in sex determination and gonad differentiation (dmrt1), growth (ghrh, myf5, prl/prlr) and immune response (TLR1/TLR21/TLR22, IL-15/IL-34), were identified for the first time in this species. In addition, a large number of credible genetic markers, including 21,192 SSRs and 8,642 SNPs, were identified in the present dataset. Conclusion This informative transcriptome provides valuable new data to increase genomic resources of Scophthalmus maximus. The future studies of corresponding gene functions will be very useful for the management of reproduction, growth and disease control in turbot aquaculture breeding programs. The molecular markers identified in this database will aid in genetic linkage analyses, mapping of quantitative trait loci, and acceleration of marker assisted selection programs.	[Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe] Chinese Acad Fishery Sci, Qingdao Key Lab Marine Fish Breeding & Biotechnol, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst,Minist Agr, Qingdao 266071, Peoples R China; [Ma, Deyou; Ma, Aijun; Huang, Zhihui; Wang, Guangning; Wang, Ting; Xia, Dandan; Ma, Benhe] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China; [Ma, Deyou] Dalian Ocean Univ, Dalian 116023, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Qingdao National Laboratory for Marine Science & Technology; Dalian Ocean University	Ma, AJ (corresponding author), Chinese Acad Fishery Sci, Qingdao Key Lab Marine Fish Breeding & Biotechnol, Key Lab Sustainable Dev Marine Fisheries, Yellow Sea Fisheries Res Inst,Minist Agr, Qingdao 266071, Peoples R China.; Ma, AJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao 266071, Peoples R China.	maaj@ysfri.ac.cn			Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-50-G01]; National High Technology Research and Development Program of China (863 Program) [12AA10A408-8]; Qingdao Postdoctoral Science Foundation [ZQ51201415036]	Earmarked Fund for Modern Agro-Industry Technology Research System; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Qingdao Postdoctoral Science Foundation	Both the Earmarked Fund for Modern Agro-Industry Technology Research System (No. CARS-50-G01) (URL: http://119.253.58.231/) and the National High Technology Research and Development Program of China (863 Program) (No. 12AA10A408-8) (URL: http://www.most.gov.cn/bszn/new/863/bslc/) were received by AM, had roles in data collection and analysis of trancriptome. The decision to publish and preparation of the manuscript were sponsored by the 2014 Qingdao Postdoctoral Science Foundation ( No. ZQ51201415036, received by AM, URL: http://www.qdhrss.gov.cn/pages/zczs/zcfgk/bmzcfg/17589.html).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alvarez-Pellitero P, 2008, VET IMMUNOL IMMUNOP, V126, P171, DOI 10.1016/j.vetimm.2008.07.013; Alves E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020970; Bei JX, 2006, MOL IMMUNOL, V43, P860, DOI 10.1016/j.molimm.2005.06.040; Bouza C, 2007, GENETICS, V177, P2457, DOI 10.1534/genetics.107.075416; Bouza C, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-54; Cal RM, 2006, AQUACULTURE, V251, P99, DOI 10.1016/j.aquaculture.2005.05.010; Carmichael SN, 2013, BIOMED RES INT, V14, P408, DOI DOI 10.1155/2014/291067; Chen SL, 2014, NAT GENET, V46, P253, DOI 10.1038/ng.2890; Chen YH, 2001, GENESIS, V29, P22, DOI 10.1002/1526-968X(200101)29:1<22::AID-GENE1002>3.0.CO;2-Z; Chen ZZ, 2005, PROG BIOCHEM BIOPHYS, V32, P187; Cheong HS, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-35; Chou MY, 2002, J COMP PHYSIOL B, V172, P109, DOI 10.1007/s00360-001-0231-2; Cnaani A, 2009, SEX DEV, V3, P164, DOI 10.1159/000223080; Cui ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082156; De-Santis C, 2007, AQUACULTURE, V272, P22, DOI 10.1016/j.aquaculture.2007.08.036; DEVAUCHELLE N, 1988, AQUACULTURE, V69, P159, DOI 10.1016/0044-8486(88)90194-9; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Ekblom R, 2011, HEREDITY, V107, P1, DOI 10.1038/hdy.2010.152; Fang W, 2007, FISH SHELLFISH IMMUN, V23, P119, DOI 10.1016/j.fsi.2006.09.011; Gross R, 1999, AQUACULTURE, V173, P73, DOI 10.1016/S0044-8486(98)00470-0; Guiguen Y, 2010, GEN COMP ENDOCR, V165, P352, DOI 10.1016/j.ygcen.2009.03.002; Haffray P, 2009, AQUACULTURE, V294, P30, DOI 10.1016/j.aquaculture.2009.05.004; Hardie LJ, 1998, CYTOKINE, V10, P555, DOI 10.1006/cyto.1997.0334; Harms CA, 2000, FISH SHELLFISH IMMUN, V10, P61, DOI 10.1006/fsim.1999.0230; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; Her GM, 2004, GENESIS, V38, P26, DOI 10.1002/gene.10248; Herpin A, 2011, FEBS J, V278, P1010, DOI 10.1111/j.1742-4658.2011.08030.x; Hickford JGH, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2009.01965.x; Ikenishi K, 1997, DEV GROWTH DIFFER, V39, P625; Imsland AK, 1997, AQUAC RES, V28, P101; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kang JH, 2002, FISHERIES SCI, V68, P494, DOI 10.1046/j.1444-2906.2002.00453.x; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kent J, 1996, DEVELOPMENT, V122, P2813; Kohli G, 2003, ENDOCRINOLOGY, V144, P1931, DOI 10.1210/en.2002-0126; Li C, 2004, J ANIM SCI, V82, P1; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li Q, 2008, BIOL CELL, V100, P453, DOI 10.1042/BC20070114; Li SH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058627, 10.1371/journal.pone.0076131]; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Liu QY, 2012, COMP BIOCHEM PHYS B, V163, P86, DOI 10.1016/j.cbpb.2012.05.004; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Lv JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094055; Ma KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039727; Magnadottir B, 2010, MAR BIOTECHNOL, V12, P361, DOI 10.1007/s10126-010-9279-x; Martinez P, 2009, GENETICS, V183, P1443, DOI 10.1534/genetics.109.107979; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mittapalli O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013708; Moriyama S, 2000, BIOSCI BIOTECH BIOCH, V64, P1553, DOI 10.1271/bbb.64.1553; Navajas-Perez R, 2012, MOL ECOL RESOUR, V12, P706, DOI 10.1111/j.1755-0998.2012.03126.x; Navarro-Martin L, 2009, MOL CELL ENDOCRINOL, V299, P240, DOI 10.1016/j.mce.2008.11.013; Navarro-Martin L, 2012, COMP BIOCHEM PHYS B, V163, P316, DOI 10.1016/j.cbpb.2012.08.004; Ng P, 2005, NAT METHODS, V2, P105, DOI 10.1038/NMETH733; Pardo BG, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-37; Pereiro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035369; Piferrer F, 2004, AQUACULTURE, V238, P403, DOI 10.1016/j.aquaculture.2004.05.009; Piferrer F, 2008, REV FISH SCI, V16, P35, DOI 10.1080/10641260802324644; POOMPUANG S, 1997, REV FISH SCI, V5, P253, DOI DOI 10.1080/10641269709388600; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Power DM, 2005, GEN COMP ENDOCR, V142, P25, DOI 10.1016/j.ygcen.2004.10.003; Qi ZZ, 2009, AQUACULTURE, V290, P15, DOI 10.1016/j.aquaculture.2009.02.012; Ribas L, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-180; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robledo D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1149; Rodriguez-Ramilo ST, 2014, MAR BIOTECHNOL, V16, P265, DOI 10.1007/s10126-013-9544-x; Rodriguez-Ramilo ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-541; Sanchez-Molano E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-473; Sandra O, 2000, J MOL ENDOCRINOL, V24, P215, DOI 10.1677/jme.0.0240215; Sawatari E, 2010, COMP BIOCHEM PHYS A, V155, P183, DOI 10.1016/j.cbpa.2009.10.030; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Seipp MT, 2007, J MOL DIAGN, V9, P284, DOI 10.2353/jmoldx.2007.060136; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Sheng Y, 2014, MOL BIOL REP, V41, P1237, DOI 10.1007/s11033-013-2968-6; Shepherd BS, 1997, P NATL ACAD SCI USA, V94, P2068, DOI 10.1073/pnas.94.5.2068; Sundaram AYM, 2012, MOL BIOL REP, V39, P8965, DOI 10.1007/s11033-012-1765-y; Tan XG, 2006, COMP BIOCHEM PHYS B, V145, P204, DOI 10.1016/j.cbpb.2006.07.008; [唐永凯 TANG Yongkai], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P44; Tao WJ, 2003, HEREDITY, V91, P60, DOI 10.1038/sj.hdy.6800281; Torstensen BE, 2009, AQUACULT NUTR, V15, P440, DOI 10.1111/j.1365-2095.2008.00609.x; Vera M, 2013, INT J MOL SCI, V14, P5694, DOI 10.3390/ijms14035694; Wang JPZ, 2004, BIOINFORMATICS, V20, P2973, DOI 10.1093/bioinformatics/bth342; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Ting, 2014, Oceanologia et Limnologia Sinica / Hai Yang Yu Hu Chao, V45, P1300; Wang XL, 2010, COMP BIOCHEM PHYS B, V155, P327, DOI 10.1016/j.cbpb.2009.12.001; Wargelius A, 2005, GEN COMP ENDOCR, V142, P163, DOI 10.1016/j.ygcen.2004.12.005; Watts M, 2001, AUST VET J, V79, P570, DOI 10.1111/j.1751-0813.2001.tb10753.x; Wei YC, 2011, VET IMMUNOL IMMUNOP, V141, P173, DOI 10.1016/j.vetimm.2011.02.016; Winkler C, 2004, MECH DEVELOP, V121, P997, DOI 10.1016/j.mod.2004.03.018; Wu Lian, 2012, Agricultural Science & Technology - Hunan, V13, P2464; Wu XY, 2008, INT J IMMUNOGENET, V35, P215, DOI 10.1111/j.1744-313X.2008.00759.x; Xia XH, 2010, J GENET, V89, P183, DOI 10.1007/s12041-010-0024-z; Yada T, 2004, GEN COMP ENDOCR, V136, P298, DOI 10.1016/j.ygcen.2004.01.003; Yada T, 2002, J ENDOCRINOL, V173, DOI 10.1677/joe.0.1730483; Yamaguchi T, 2007, BIOCHEM BIOPH RES CO, V359, P935, DOI 10.1016/j.bbrc.2007.05.208; Yang BY, 1999, MOL REPROD DEV, V53, P127, DOI 10.1002/(SICI)1098-2795(199906)53:2&lt;127::AID-MRD1&gt;3.0.CO;2-H; Yi ZA, 2014, CYTOKINE GROWTH F R, V25, P147, DOI 10.1016/j.cytogfr.2013.12.002; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	103	29	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149414	10.1371/journal.pone.0149414	http://dx.doi.org/10.1371/journal.pone.0149414			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925843	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200009
J	Zhong, FF; Bi, R; Yu, BH; Yang, F; Yang, WT; Shui, RH				Zhong, Fangfang; Bi, Rui; Yu, Baohua; Yang, Fei; Yang, Wentao; Shui, Ruohong			A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PROLIFERATIVE ACTIVITY; PRIMARY THERAPY; KI-67; EXPRESSION; REPRODUCIBILITY; CHEMOTHERAPY; PROGNOSIS; ACCURACY; MARKER	Background Ki67 labeling index (LI) is critical for treatment options and prognosis evaluation in breast cancer. Visual assessment (VA) is widely used to assess Ki67 LI, but has some limitations. In this study, we compared the consistency between VA and automated digital image analysis (DIA) of Ki67 LI in breast cancer, and to evaluate the application value of DIA in Ki67 LI assessment. Methods Ki67 immunostained slides of 155 cases of primary invasive breast cancer were eyeballing assessed by five breast pathologists and automated digital image analyzed by one breast pathologist respectively. Two score methods, hot-spot score and average score, were used to choose score areas. The intra-class correlation coefficient (ICC) was used to analyze the consistency between VA and DIA, and Wilcoxon signed-rank test was used to compare the median of paired-difference between VA and DIA values. Results (1) A perfect agreement was demonstrated between VA and DIA of Ki67 LI by ICC analysis (P<0.0001) in the whole cohort. A perfect agreement between VA and DIA of Ki67 LI was also showed in G2-G3, ER positive/HER2 negative cases. Average score and hot-spot score methods both demonstrated a perfect concordance between VA and DIA of Ki67 LI. (2) All cases were classified into three groups by VA values (<= 10%, 11%-30% and >30% Ki67 LI). The concordance was relatively lower in intermediate Ki67 LI group (11%-30%) compared with high (>30%) Ki67 LI groups according to both methods. (3) All cases were classified into three groups by paired-difference (d) between VA values of hot-spot score and average score (d<5, 5 <= d<10, d >= 10) to evaluate the correlation between Ki67 staining distribution (heterogeneous or homogenous) and reproducibility of assessment. A perfect agreement was all demonstrated in three groups, and a slightly better Ki67 LI agreement between VA and DIA was indicated in homogenous staining slides than in heterogeneous staining ones. (4) VA values were relatively smaller than DIA values (average score: median of paired-difference -3.72; hot-spot score: median of paired-difference -9.12). Conclusions An excellent agreement between VA and DIA of Ki67 LI in breast cancer was demonstrated in the whole mixed cohort, suggesting that VA and DIA both could be used to assess Ki67 LI in clinical practice. Average score and hot-spot score methods both demonstrated a perfect concordance between VA and DIA of Ki67 LI. The almost perfect agreement between VA and DIA was observed in high Ki67 LI cases, displaying a homogenous staining pattern. The consistency between VA and DIA was relatively low in intermediate Ki67 LI group. The heterogeneity of tumors may slightly affect the concordance between VA and DIA of Ki67 LI. Assessment of VA provides lower Ki67 values than DIA, the biological importance of these values are not known at the moment.	[Zhong, Fangfang; Bi, Rui; Yu, Baohua; Yang, Fei; Yang, Wentao; Shui, Ruohong] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Zhong, Fangfang; Bi, Rui; Yu, Baohua; Yang, Fei; Yang, Wentao; Shui, Ruohong] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Shui, RH (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China.; Shui, RH (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China.	shuiruohong2014@163.com		Zhong, Fangfang/0000-0002-8772-5009	Science and Technology Commission of Shanghai Municipality [15411965100]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by Research Project of the Science and Technology Commission of Shanghai Municipality (15411965100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Colleoni M, 2010, EUR J CANCER, V46, P2216, DOI 10.1016/j.ejca.2010.04.008; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; GERDES J, 1984, J IMMUNOL, V133, P1710; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Kim KI, 2014, J BREAST CANCER, V17, P40, DOI 10.4048/jbc.2014.17.1.40; Konsti J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-3; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; Laurinavicius A, 2012, ANAL CELL PATHOL, V35, P75, DOI [10.1155/2012/243416, 10.3233/ACP-2011-0033]; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Mohammed ZMA, 2012, BRIT J CANCER, V106, P383, DOI 10.1038/bjc.2011.569; Nielsen PS, 2014, APPL IMMUNOHISTO M M, V22, P568, DOI 10.1097/PAI.0b013e3182a84b99; Penault-Llorca F, 2009, J CLIN ONCOL, V27, P2809, DOI 10.1200/JCO.2008.18.2808; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Selz J, 2012, INT J RADIAT ONCOL, V84, P1123, DOI 10.1016/j.ijrobp.2012.02.047; Shui RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125131; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Varga Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123435; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Voros A, 2015, PATHOL ONCOL RES, V21, P147, DOI 10.1007/s12253-014-9800-z; Voros A, 2014, PATHOL ONCOL RES, V20, P391, DOI 10.1007/s12253-013-9708-z; Voros A, 2013, PATHOBIOLOGY, V80, P111, DOI 10.1159/000343795; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1	30	39	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150505	10.1371/journal.pone.0150505	http://dx.doi.org/10.1371/journal.pone.0150505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928407	Green Published, gold			2022-12-27	WOS:000371424200042
J	Bremm, C; Carvalho, PCF; Fonseca, L; Amaral, GA; Mezzalira, JC; Perez, NB; Nabinger, C; Laca, EA				Bremm, Carolina; Carvalho, Paulo C. F.; Fonseca, Lidiane; Amaral, Glaucia A.; Mezzalira, Jean C.; Perez, Naylor B.; Nabinger, Carlos; Laca, Emilio A.			Diet Switching by Mammalian Herbivores in Response to Exotic Grass Invasion	PLOS ONE			English	Article							TUSSOCK SWARD HEIGHT; FLORISTIC COMPOSITION; SPATIAL-DISTRIBUTION; INGESTIVE BEHAVIOR; NATURAL GRASSLANDS; NARDUS GRASSLAND; GRAZING BEHAVIOR; BITE DIMENSIONS; PATCH SELECTION; HERBAGE INTAKE	Invasion by exotic grasses is a severe threat to the integrity of grassland ecosystems all over the world. Because grasslands are typically grazed by livestock and wildlife, the invasion is a community process modulated by herbivory. We hypothesized that the invasion of native South American grasslands by Eragrostis plana Nees, an exotic tussock-forming grass from Africa, could be deterred by grazing if grazers switched dietary preferences and included the invasive grass as a large proportion of their diets. Bos taurus (heifers) and Ovis aries (ewes) grazed plots with varying degrees of invasion by E. plana in a replicated manipulative experiment. Animal positions and species grazed were observed every minute in 45-min grazing session. Proportion of bites and steps in and out of E. plana tussocks were measured and used to calculate several indices of selectivity. Both heifers and ewes exhibited increasing probability of grazing E. plana as the proportion of area covered by tussocks increased, but they behaved differently. In agreement with expectations based on the allometry of dietary preferences and morphology, ewes consumed a low proportion of E. plana, except in areas that had more than 90% E. plana cover. Heifers consumed proportionally more E. plana than ewes. Contrary to our hypothesis, herbivores did not exhibit dietary switching towards the invasive grass. Moreover, they exhibited avoidance of the invasive grass and preference for short-statured native species, both of which should tend to enhance invasion. Unless invasive plants are highly palatable to livestock, the effect of grazing to deter the invasion is limited, due to the inherent avoidance of the invasive grass by the main grazers in the ecosystem, particularly sheep.	[Bremm, Carolina; Carvalho, Paulo C. F.; Fonseca, Lidiane; Amaral, Glaucia A.; Mezzalira, Jean C.; Nabinger, Carlos] Univ Fed Rio Grande do Sul, Grazing Ecol Res Grp, Porto Alegre, RS, Brazil; [Perez, Naylor B.] Embrapa Southern Reg Anim Husb, Bage, RS, Brazil; [Laca, Emilio A.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	Universidade Federal do Rio Grande do Sul; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of California System; University of California Davis	Bremm, C (corresponding author), Univ Fed Rio Grande do Sul, Grazing Ecol Res Grp, Porto Alegre, RS, Brazil.	carolina.bremm@yahoo.com.br	de Faccio Carvalho, Paulo César/A-7381-2012; Bremm, Carolina/ABC-5134-2020	de Faccio Carvalho, Paulo César/0000-0002-7020-3001; Bremm, Carolina/0000-0002-7612-2771; Laca, Emilio/0000-0002-7551-0721	CNPq, Brazil; Brazilian Agricultural Research Corporation (EMBRAPA)	CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Agricultural Research Corporation (EMBRAPA)	This research was funded by a doctoral scholarship grant from CNPq, Brazil, and by the Brazilian Agricultural Research Corporation (EMBRAPA).	Armstrong RH, 1997, GRASS FORAGE SCI, V52, P219, DOI 10.1111/j.1365-2494.1997.tb02352.x; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Barthram G., 1985, EXPT TECHNIQUES HFRO; Benvenutti MA, 2009, LIVEST SCI, V126, P229, DOI 10.1016/j.livsci.2009.07.006; Bergman CM, 2001, J ANIM ECOL, V70, P289, DOI 10.1046/j.1365-2656.2001.00496.x; Bouwman AF, 2005, AGR SYST, V84, P121, DOI 10.1016/j.agsy.2004.05.006; Bremm C, 2012, APPL ANIM BEHAV SCI, V141, P108, DOI 10.1016/j.applanim.2012.08.008; Briske DD, 2003, J APPL ECOL, V40, P601, DOI 10.1046/j.1365-2664.2003.00837.x; Chapman DF, 2007, CROP SCI, V47, P399, DOI 10.2135/cropsci2006.01.0036; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Common TG, 1998, GRASS FORAGE SCI, V53, P260, DOI 10.1046/j.1365-2494.1998.00138.x; Cruz P, 2010, RANGELAND ECOL MANAG, V63, P350, DOI 10.2111/08-016.1; Carvalho PCD, 2009, LIVEST SCI, V120, P158, DOI 10.1016/j.livsci.2008.04.012; DISTEL RA, 1995, APPL ANIM BEHAV SCI, V45, P11, DOI 10.1016/0168-1591(95)00593-H; Dumont B, 2000, GRASS FORAGE SCI, V55, P138, DOI 10.1046/j.1365-2494.2000.00207.x; Edouard N, 2010, APPL ANIM BEHAV SCI, V126, P27, DOI 10.1016/j.applanim.2010.05.008; EDWARDS GR, 1994, J ANIM ECOL, V63, P816, DOI 10.2307/5259; Fraser MD, 2009, AGR ECOSYST ENVIRON, V129, P182, DOI 10.1016/j.agee.2008.08.013; Gendron F, 2007, PLANT ECOL, V191, P199, DOI 10.1007/s11258-006-9237-x; Goncalves EN, 2009, REV BRAS ZOOTECN, V38, P1655, DOI 10.1590/S1516-35982009000900003; Gong Y, 1996, NEW ZEAL J AGR RES, V39, P63, DOI 10.1080/00288233.1996.9513163; Gordon I. J., 2000, Grassland ecophysiology and grazing ecology, P191, DOI 10.1079/9780851994529.0191; Grant SA, 1996, J APPL ECOL, V33, P1053, DOI 10.2307/2404685; GRANT SA, 1985, J ECOL, V73, P987, DOI 10.2307/2260163; Gregorini P, 2009, J ANIM SCI, V87, P3817, DOI 10.2527/jas.2009-2094; Hodgson J., 1981, Occasional Symposium, British Grassland Society, P41; HODGSON J, 1991, J APPL ECOL, V28, P205, DOI 10.2307/2404126; Hodgson J, 1990, LONGMAN HDB AGR; Holland JP, 2008, GRASS FORAGE SCI, V63, P48, DOI 10.1111/j.1365-2494.2007.00613.x; Illius AW, 1999, ECOLOGY, V80, P1008, DOI 10.1890/0012-9658(1999)080[1008:DSIGAT]2.0.CO;2; ILLIUS AW, 1992, OECOLOGIA, V89, P428, DOI 10.1007/BF00317422; ILLIUS AW, 1987, J ANIM ECOL, V56, P989, DOI 10.2307/4961; Isbell FI, 2011, PLANT ECOL, V212, P1663, DOI 10.1007/s11258-011-9939-6; Laca E.A., 1996, P137; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; Laca Emilio A., 2008, V23, P81; Laliberte E, 2013, OECOLOGIA, V171, P439, DOI 10.1007/s00442-012-2417-6; Manchester SJ, 2000, J APPL ECOL, V37, P845, DOI 10.1046/j.1365-2664.2000.00538.x; MCNAUGHTON SJ, 1976, SCIENCE, V191, P92, DOI 10.1126/science.191.4222.92; Metera E, 2010, ANIM SCI PAP REP, V28, P315; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Mladek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069800; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; NEWMAN JA, 1994, GRASS FORAGE SCI, V49, P502, DOI 10.1111/j.1365-2494.1994.tb02028.x; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; Olofsson J, 2004, OIKOS, V106, P324, DOI 10.1111/j.0030-1299.2004.13224.x; PENNING PD, 1993, APPL ANIM BEHAV SCI, V37, P101, DOI 10.1016/0168-1591(93)90103-V; Pinheiro J, 2001, MIXED EFFECTS MODELS; Pykala J, 2003, BIODIVERS CONSERV, V12, P2211, DOI 10.1023/A:1024558617080; R Core Team, 2013, R LANG ENV STAT COMP; Rook AJ, 2004, BIOL CONSERV, V119, P137, DOI 10.1016/j.biocon.2003.11.010; Rueda M, 2013, OECOLOGIA, V172, P449, DOI 10.1007/s00442-012-2501-y; SENFT RL, 1989, ECOL MODEL, V46, P283, DOI 10.1016/0304-3800(89)90023-9; Soder KJ, 2007, CROP SCI, V47, P416, DOI 10.2135/cropsci2006.01.0061; Stephens D.W., 1986, pi; Svensson JR, 2010, ECOLOGY, V91, P3069, DOI 10.1890/09-0671.1; UNGAR ED, 1991, AGRON J, V83, P973, DOI 10.2134/agronj1991.00021962008300060010x; Utsumi Santiago A., 2009, BMC Ecology, V9, P9, DOI 10.1186/1472-6785-9-9; WallisDeVries MF, 1999, OECOLOGIA, V121, P355, DOI 10.1007/s004420050939; Whalley RDB, 2000, FIELD AND LABORATORY METHODS FOR GRASSLAND AND ANIMAL PRODUCTION RESEARCH, P67, DOI 10.1079/9780851993515.0067; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilsey BJ, 2011, PERSPECT PLANT ECOL, V13, P265, DOI 10.1016/j.ppees.2011.07.002; Wilsey BJ, 2009, ECOL LETT, V12, P432, DOI 10.1111/j.1461-0248.2009.01298.x; Wilson J. W, 1960, NEW PHYTOL, V59, P1, DOI [10.1111/J.1469-8137.1960.tb06195.x, DOI 10.1111/J.1469-8137.1960.TB06195.X]	64	8	8	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150167	10.1371/journal.pone.0150167	http://dx.doi.org/10.1371/journal.pone.0150167			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919613	Green Published, gold			2022-12-27	WOS:000371274400094
J	Emery, M; Nanchen, N; Preitner, F; Ibberson, M; Roduit, R				Emery, Martine; Nanchen, Natacha; Preitner, Frederic; Ibberson, Mark; Roduit, Raphael			Biological Characterization of Gene Response to Insulin-Induced Hypoglycemia in Mouse Retina	PLOS ONE			English	Article							MUTATION; LACTATE; METABOLISM; PIGMENTOSA; LENGSIN; PROTEIN; DEATH; LENS	Glucose is the most important metabolic substrate of the retina and maintenance of normoglycemia is an essential challenge for diabetic patients. Chronic, exaggerated, glycemic excursions could lead to cardiovascular diseases, nephropathy, neuropathy and retinopathy. We recently showed that hypoglycemia induced retinal cell death in mouse via caspase 3 activation and glutathione (GSH) decrease. Ex vivo experiments in 661W photoreceptor cells confirmed the low-glucose induction of death via superoxide production and activation of caspase 3, which was concomitant with a decrease of GSH content. We evaluate herein retinal gene expression 4 h and 48 h after insulin-induced hypoglycemia. Microarray analysis demonstrated clusters of genes whose expression was modified by hypoglycemia and we discuss the potential implication of those genes in retinal cell death. In addition, we identify by gene set enrichment analysis, three important pathways, including lysosomal function, GSH metabolism and apoptotic pathways. Then we tested the effect of recurrent hypoglycemia (three successive 4h periods of hypoglycemia spaced by 48 h recovery) on retinal cell death. Interestingly, exposure to multiple hypoglycemic events prevented GSH decrease and retinal cell death, or adapted the retina to external stress by restoring GSH level comparable to control situation. We hypothesize that scavenger GSH is a key compound in this apoptotic process, and maintaining "normal" GSH level, as well as a strict glycemic control, represents a therapeutic challenge in order to avoid side effects of diabetes, especially diabetic retinopathy.	[Emery, Martine; Nanchen, Natacha; Roduit, Raphael] IRO, Sion, Switzerland; [Preitner, Frederic] Univ Lausanne, Ctr Integrat Genom, Mouse Metab Evaluat Facil, Lausanne, Switzerland; [Ibberson, Mark] Univ Lausanne, Swiss Inst Bioinformat, Vital IT Grp, Lausanne, Switzerland; [Roduit, Raphael] Univ Lausanne, Jules Gonin Eye Hosp, Fdn Asile Aveugles, Dept Ophthalmol, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne	Roduit, R (corresponding author), IRO, Sion, Switzerland.; Roduit, R (corresponding author), Univ Lausanne, Jules Gonin Eye Hosp, Fdn Asile Aveugles, Dept Ophthalmol, Lausanne, Switzerland.	raphael.roduit@unil.ch	Roduit, Raphael/AAC-3890-2021	Roduit, Raphael/0000-0001-7440-2799; Ibberson, Mark/0000-0003-3152-5670	La Fondation Art Vie; La Fondation Romande pour la Recherche sur le Diabete; La Fondation Charles et Ruth Rouffy; UniL/CHUV (Universite de Lausanne (CH)); UniL/CHUV (Centre Hospitalier Universitaire Vaudois (CHUV))	La Fondation Art Vie; La Fondation Romande pour la Recherche sur le Diabete; La Fondation Charles et Ruth Rouffy; UniL/CHUV (Universite de Lausanne (CH)); UniL/CHUV (Centre Hospitalier Universitaire Vaudois (CHUV))	RR was support by "La Fondation Art & Vie", "La Fondation Romande pour la Recherche sur le Diabete" (www.fondationromande-diabete.ch) and "La Fondation Charles et Ruth Rouffy". The Mouse Metabolic Facility (FP) is supported by the UniL/CHUV (Universite de Lausanne (CH) and Centre Hospitalier Universitaire Vaudois (CHUV)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2014, J CLIN INVEST, V124, P425, DOI 10.1172/JCI69404; Balmer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074162; Barragan I, 2005, INT J MOL MED, V16, P1163; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Cryer PE, 2013, NEW ENGL J MED, V369, P362, DOI 10.1056/NEJMra1215228; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; Davis Stephen N, 2014, Trans Am Clin Climatol Assoc, V125, P281; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Emery M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021586; Grassi F, 2006, BIOCHEM BIOPH RES CO, V350, P424, DOI 10.1016/j.bbrc.2006.09.062; Hamann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055372; Herzog RI, 2013, J CLIN INVEST, V123, P1988, DOI 10.1172/JCI65105; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kanan Y, 2014, J BIOL CHEM, V289, P13419, DOI 10.1074/jbc.M114.562157; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Khan MI, 2011, VISION RES, V51, P1623, DOI 10.1016/j.visres.2011.05.003; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; Luo XM, 2001, INVEST OPHTH VIS SCI, V42, P2695; Nakatsugawa M, 2009, CANCER SCI, V100, P1485, DOI 10.1111/j.1349-7006.2009.01187.x; Nguyen TT, 2009, CURR DIABETES REP, V9, P277, DOI 10.1007/s11892-009-0043-4; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Riazuddin SA, 2010, AM J HUM GENET, V87, P523, DOI 10.1016/j.ajhg.2010.08.013; Roduit R, HDB NUTR DIET EYE201; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Templeton JP, 2013, EXP EYE RES, V116, P129, DOI 10.1016/j.exer.2013.08.001; Umino Y, 2006, P NATL ACAD SCI USA, V103, P19541, DOI 10.1073/pnas.0604478104; Umino Y, 2012, INVEST OPHTH VIS SCI, V53, P915, DOI 10.1167/iovs.11-8787; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Wyss MT, 2011, J NEUROSCI, V31, P7477, DOI 10.1523/JNEUROSCI.0415-11.2011; Zeevalk GD, 2000, J NEUROCHEM, V75, P1027, DOI 10.1046/j.1471-4159.2000.0751027.x	33	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150266	10.1371/journal.pone.0150266	http://dx.doi.org/10.1371/journal.pone.0150266			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918849	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400113
J	Hong, CH; Kuo, TBJ; Huang, BC; Lin, YC; Kuo, KL; Chern, CM; Yang, CCH				Hong, Cian-Hui; Kuo, Terry B. J.; Huang, Bo-Chi; Lin, Yu-Cheng; Kuo, Kuan-Liang; Chern, Chang-Ming; Yang, Cheryl C. H.			Cold Exposure Can Induce an Exaggerated Early-Morning Blood Pressure Surge in Young Prehypertensives	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SYMPATHETIC-NERVOUS-SYSTEM; HEART-RATE-VARIABILITY; CEREBROVASCULAR-DISEASE; CIRCADIAN VARIATION; SLEEP; RISK; HYPERTENSION; FREQUENCY	Prehypertension is related to a higher risk of cardiovascular events than normotension. Our previous study reported that cold exposure elevates the amplitude of the morning blood pressure surge (MBPS) and is associated with a sympathetic increase during the final sleep transition, which might be critical for sleep-related cardiovascular events in normotensives. However, few studies have explored the effects of cold exposure on autonomic function during sleep transitions and changes of autonomic function among prehypertensives. Therefore, we conducted an experiment for testing the effects of cold exposure on changes of autonomic function during sleep and the MBPS among young prehypertensives are more exaggerate than among young normotensives. The study groups consisted of 12 normotensive and 12 prehypertensive male adults with mean ages of 23.67 +/- 0.70 and 25.25 +/- 0.76 years, respectively. The subjects underwent cold (16 degrees C) and warm (23 degrees C) conditions randomly. The room temperature was maintained at either 23 degrees C or 16 degrees C by central air conditioning and recorded by a heat-sensitive sensor placed on the forehead and extended into the air. BP was measured every 30 minutes by using an autonomic BP monitor. Electroencephalograms, electrooculograms, electromyograms, electrocardiograms, and near body temperature were recorded by miniature polysomnography. Under cold exposure, a significantly higher amplitude of MBPS than under the warm condition among normotensives; however, this change was more exaggerated in prehypertensives. Furthermore, there was a significant decrease in parasympathetic-related RR and HF during the final sleep transition and a higher early-morning surge in BP and in LF% among prehypertensives, but no such change was found in normotensives. Our study supports that cold exposure might increase the risk of sleep-related cardiovascular events in prehypertensives.	[Hong, Cian-Hui; Kuo, Terry B. J.; Lin, Yu-Cheng; Chern, Chang-Ming; Yang, Cheryl C. H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Hong, Cian-Hui; Kuo, Terry B. J.; Lin, Yu-Cheng; Yang, Cheryl C. H.] Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan; [Huang, Bo-Chi] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Chern, Chang-Ming] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Kuo, Kuan-Liang] Taipei City Hosp, Dept Family Med, Taipei, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan; [Kuo, Terry B. J.; Yang, Cheryl C. H.] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Kuo, Terry B. J.] Natl Cent Univ, Inst Translat & Interdisciplinary Med, Taoyuan, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei City Hospital; National Yang Ming Chiao Tung University; Taipei City Hospital; National Central University	Yang, CCH (corresponding author), Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan.; Yang, CCH (corresponding author), Natl Yang Ming Univ, Sleep Res Ctr, Taipei 112, Taiwan.; Yang, CCH (corresponding author), Natl Yang Ming Univ, Brain Res Ctr, Taipei 112, Taiwan.; Yang, CCH (corresponding author), Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan.	cchyang@ym.edu.tw			Ministry of Education, Aim for the Top University Plan [101AC-B3]; National Science Council (Taiwan) [NSC-100-2627-B-010-002, 98-2314-B-010-022-MY3]; Taipei City Hospital [98001-62-006]; Science Park Administration, National Science Council [102MG09]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan); National Science Council (Taiwan)(Ministry of Science and Technology, Taiwan); Taipei City Hospital; Science Park Administration, National Science Council	This research was supported by a grant (101AC-B3) from the Ministry of Education, Aim for the Top University Plan, grants (NSC-100-2627-B-010-002) and (98-2314-B-010-022-MY3) from the National Science Council (Taiwan), a grant (98001-62-006) from Taipei City Hospital and a grant (102MG09) from Science Park Administration, National Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGENTINO C, 1990, STROKE, V21, P387, DOI 10.1161/01.STR.21.3.387; Camm AJ, 1996, CIRCULATION, V93, P1043; Grotto I, 2006, HYPERTENSION, V48, P254, DOI 10.1161/01.HYP.0000227507.69230.fc; Joyner MJ, 2008, EXP PHYSIOL, V93, P715, DOI 10.1113/expphysiol.2007.039545; Kario K, 2005, HYPERTENSION, V45, P485, DOI 10.1161/01.HYP.0000158313.57142.3f; Kario K, 2004, AM J HYPERTENS, V17, P668, DOI 10.1016/j.amjhyper.2004.04.001; Kario K, 2003, CIRCULATION, V107, P1401, DOI 10.1161/01.CIR.0000056521.67546.AA; Kario K, 2010, HYPERTENSION, V56, P765, DOI 10.1161/HYPERTENSIONAHA.110.157149; KEMP B, 1992, ELECTROEN CLIN NEURO, V82, P391, DOI 10.1016/0013-4694(92)90009-7; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Kuo TBJ, 2005, J CARDIOVASC ELECTR, V16, P864, DOI 10.1111/j.1540-8167.2005.40656.x; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1999, AM J PHYSIOL-HEART C, V277, pH2233, DOI 10.1152/ajpheart.1999.277.6.H2233; Kuo TBJ, 2014, SLEEP MED, V15, P986, DOI 10.1016/j.sleep.2014.03.022; Kuo TBJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/937986; Kuo TBJ, 2012, CLIN NEUROPHYSIOL, V123, P1338, DOI 10.1016/j.clinph.2011.11.003; Kuo TBJ, 2009, EXP NEUROL, V217, P38, DOI 10.1016/j.expneurol.2009.01.012; LANGEWITZ W, 1994, AM HEART J, V127, P122, DOI 10.1016/0002-8703(94)90517-7; Li Y, 2009, EUR J APPL PHYSIOL, V107, P673, DOI 10.1007/s00421-009-1176-5; Lo Martire V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047032; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Manfredini R, 2005, CHRONOBIOL INT, V22, P417, DOI 10.1081/CBI-200062927; MARCHANT B, 1993, BRIT HEART J, V69, P385; MITLER MM, 1988, SLEEP, V11, P100, DOI 10.1093/sleep/11.1.100; Modesti PA, 2013, HYPERTENSION, V61, P908, DOI 10.1161/HYPERTENSIONAHA.111.00315; Parati G, 2012, EUR HEART J, V33, P1058, DOI 10.1093/eurheartj/ehs041; Pimenta E, 2010, NAT REV NEPHROL, V6, P21, DOI 10.1038/nrneph.2009.191; Pletcher MJ, 2008, ANN INTERN MED, V149, P91, DOI 10.7326/0003-4819-149-2-200807150-00005; Rechtschaffen A, 1968, MANUAL STANDARDIZED; SOMERS VK, 1993, SLEEP, V16, pS30, DOI 10.1093/sleep/16.suppl_8.S30; Spencer FA, 1998, J AM COLL CARDIOL, V31, P1226, DOI 10.1016/S0735-1097(98)00098-9; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Vasan RS, 2001, LANCET, V358, P1682, DOI 10.1016/S0140-6736(01)06710-1; Wang HB, 2002, INT J BIOMETEOROL, V47, P13, DOI 10.1007/s00484-002-0147-x; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wolk R, 2005, CURR PROB CARDIOLOGY, V30, P625, DOI 10.1016/j.cpcardiol.2005.07.002; Wu SL, 2013, INT J CARDIOL, V167, P2196, DOI 10.1016/j.ijcard.2012.05.123; Yang CCH, 2002, NEUROSCI LETT, V329, P213, DOI 10.1016/S0304-3940(02)00661-4	38	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150136	10.1371/journal.pone.0150136	http://dx.doi.org/10.1371/journal.pone.0150136			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919177	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400091
J	Laurie, LE; Kokubo, H; Nakamura, M; Saga, Y; Funato, N				Laurie, Lindsay E.; Kokubo, Hiroki; Nakamura, Masataka; Saga, Yumiko; Funato, Noriko			The Transcription Factor Hand1 Is Involved In Runx2-Ihh-Regulated Endochondral Ossification	PLOS ONE			English	Article							LIMB DEVELOPMENT; INDIAN-HEDGEHOG; BONE-FORMATION; DNA-BINDING; EXPRESSION; DIFFERENTIATION; GROWTH; RUNX2; LOOP; BUD	The developing long bone is a model of endochondral ossification that displays the morphological layers of chondrocytes toward the ossification center of the diaphysis. Indian hedgehog (Ihh), a member of the hedgehog family of secreted molecules, regulates chondrocyte proliferation and differentiation, as well as osteoblast differentiation, through the process of endochondral ossification. Here, we report that the basic helix-loop-helix transcription factor Hand1, which is expressed in the cartilage primordia, is involved in proper osteogenesis of the bone collar via its control of Ihh production. Genetic overexpression of Hand1 in the osteochondral progenitors resulted in prenatal hypoplastic or aplastic ossification in the diaphyses, mimicking an Ihh loss-of-function phenotype. Ihh expression was downregulated in femur epiphyses of Hand1-overexpressing mice. We also confirmed that Hand1 downregulated Ihh gene expression in vitro by inhibiting Runx2 transactivation of the Ihh proximal promoter. These results demonstrate that Hand1 in chondrocytes regulates endochondral ossification, at least in part through the Runx2-Ihh axis.	[Laurie, Lindsay E.; Nakamura, Masataka; Funato, Noriko] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan; [Kokubo, Hiroki; Saga, Yumiko] Natl Inst Genet, Div Mammalian Dev, Mishima, Shizuoka 411, Japan; [Kokubo, Hiroki; Saga, Yumiko] Grad Univ Adv Studies, Dept Genet, Mishima, Shizuoka, Japan; [Kokubo, Hiroki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Cardiovasc Physiol & Med, Minami Ku, Hiroshima, Japan	Tokyo Medical & Dental University (TMDU); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Hiroshima University	Funato, N (corresponding author), Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Bunkyo Ku, Tokyo, Japan.	noriko-funato@umin.ac.jp	Funato, Noriko/AAY-5113-2020	Funato, Noriko/0000-0002-1320-3304	Japan Society for the Promotion of Science KAKENHI [22390340, 15K11004]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) KAKENHI (22390340, 15K11004) to N.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Charite J, 2000, DEVELOPMENT, V127, P2461; Fernandez-Teran M, 2003, DEV DYNAM, V226, P690, DOI 10.1002/dvdy.10271; Funato N, 1998, LAB INVEST, V78, P477; Funato N, 2003, J BIOL CHEM, V278, P7486, DOI 10.1074/jbc.M212248200; Funato N, 2009, DEVELOPMENT, V136, P615, DOI 10.1242/dev.029355; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Long FX, 2004, DEVELOPMENT, V131, P1309, DOI 10.1242/dev.01006; McFadden DG, 2005, DEVELOPMENT, V132, P189, DOI 10.1242/dev.01562; McFadden DG, 2002, DEVELOPMENT, V129, P3077; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Osterwalder M, 2014, DEV CELL, V31, P345, DOI 10.1016/j.devcel.2014.09.018; Otsuka T, 2005, AM J MED GENET A, V134A, P330, DOI 10.1002/ajmg.a.30643; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tamura M, 2013, HUM MOL GENET, V22, P2471, DOI 10.1093/hmg/ddt099; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491	22	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150263	10.1371/journal.pone.0150263	http://dx.doi.org/10.1371/journal.pone.0150263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918743	Green Published, gold			2022-12-27	WOS:000371274400112
J	Chiu, CY; Yeh, KW; Lin, G; Chiang, MH; Yang, SC; Chao, WJ; Yao, TC; Tsai, MH; Hua, MC; Liao, SL; Lai, SH; Cheng, ML; Huang, JL				Chiu, Chih-Yung; Yeh, Kuo-Wei; Lin, Gigin; Chiang, Meng-Han; Yang, Shu-Chen; Chao, Wei-Ju; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Cheng, Mei-Ling; Huang, Jing-Long			Metabolomics Reveals Dynamic Metabolic Changes Associated with Age in Early Childhood	PLOS ONE			English	Article							SKELETAL-MUSCLE; NITROGEN-METABOLISM; CROSS-VALIDATION; HEALTHY-SUBJECTS; SYSTEMS BIOLOGY; DISEASE; GENDER; DIET; RAT; METABONOMICS	Objectives A detailed understanding of the metabolic processes governing rapid growth in early life is still lacking. The aim of this study was to investigate the age-related metabolic changes in healthy children throughout early childhood. Methods Healthy children from a birth cohort were enrolled in this study from birth through 4 years of age. Urinary metabolites were assessed at 6 months, and 1, 2, 3, and 4 yr of age by using H-1-nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical analysis including principal components analysis (PCA) and partial least-squares discriminant analysis (PLS-DA). Metabolic pathway analysis was performed using the MetPA web tool. Results A total of 105 urine samples from 30 healthy children were collected and analyzed. Metabolites contributing to the discrimination between age groups were identified by using supervised PLS-DA (Q(2) = 0.60; R-2 = 0.66). A significantly higher urinary trimethylamine N-oxide (TMAO) and betaine level was found in children aged 6 months. Urinary glycine and glutamine levels declined significantly after 6 months of age and there was a concomitant compensatory increase in urinary creatine and creatinine. Metabolic pathway analysis using MetPA revealed similar nitrogen metabolism associated energy production across all ages assessed. Pathways associated with amino acid metabolism were significantly different between infants aged 6 months and 1 year, whereas pathways associated with carbohydrate metabolism were significantly different between children at ages 2 and 3 years. Conclusions Urine metabolomics ideally represents dynamic metabolic changes across age. Urinary metabolic profiles change significantly within the first year of life, which can potentially provide crucial information about infant nutrition and growth.	[Chiu, Chih-Yung; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling] Chang Gung Mem Hosp Keelung, Dept Pediat, Taoyuan, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Lin, Gigin; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Univ, Taoyuan, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Chiang, Meng-Han; Yao, Tsung-Chieh; Tsai, Ming-Han; Hua, Man-Chin; Liao, Sui-Ling; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan; [Chiu, Chih-Yung; Yeh, Kuo-Wei; Yao, Tsung-Chieh; Lai, Shen-Hao; Huang, Jing-Long] Chang Gung Mem Hosp Linkou, Dept Pediat, Taoyuan, Taiwan; [Lin, Gigin] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Yang, Shu-Chen; Chao, Wei-Ju] Chang Gung Mem Hosp, Dept Nutr Therapy, Keelung, Taiwan; [Cheng, Mei-Ling] Chang Gung Univ, Grad Inst Med Biotechnol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Huang, JL (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.; Huang, JL (corresponding author), Chang Gung Mem Hosp, Community Med Res Ctr, Keelung, Taiwan.; Huang, JL (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Taoyuan, Taiwan.; Cheng, ML (corresponding author), Chang Gung Univ, Grad Inst Med Biotechnol, Taoyuan, Taiwan.	chengm@mail.cgu.edu.tw; long@adm.cgmh.org.tw	Chiu, CY/Q-4238-2019; Lin, Gigin/A-2676-2017; Yeh, Kuo-Wei/V-3725-2019	Lin, Gigin/0000-0001-7246-1058; Huang, Jing-Long/0000-0002-3530-7753; Huang, Jing-Long/0000-0001-9280-920X	Chang Gung Medical foundation, Chang Gung University, Taiwan [CMRPG2B0050-53]	Chang Gung Medical foundation, Chang Gung University, Taiwan	This work was supported by CMRPG2B0050-53 from the Chang Gung Medical foundation, Chang Gung University, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Shmais GA, 2012, J NEURODEV DISORD, V4, DOI 10.1186/1866-1955-4-4; Ali Syed Sadat, 2013, Adv Biomed Res, V2, P91, DOI 10.4103/2277-9175.122523; Ascher E, 2001, SURGERY, V129, P231, DOI 10.1067/msy.2001.112594; BALSOM PD, 1995, ACTA PHYSIOL SCAND, V154, P303, DOI 10.1111/j.1748-1716.1995.tb09914.x; BELL JD, 1991, MAGN RESON MED, V17, P414, DOI 10.1002/mrm.1910170213; Chiu CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115216; Da M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110072; Fanos V, 2013, SEMIN FETAL NEONAT M, V18, P3, DOI 10.1016/j.siny.2012.10.014; Fanos V, 2013, CURR OPIN PEDIAT; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gu HW, 2009, NMR BIOMED, V22, P826, DOI 10.1002/nbm.1395; Heavner DL, 2006, J PHARMACEUT BIOMED, V40, P928, DOI 10.1016/j.jpba.2005.08.008; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JUNG E, 1985, AM J CLIN NUTR, V42, P182, DOI 10.1093/ajcn/42.2.182; Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145; Kristal Bruce S, 2007, Methods Mol Biol, V371, P393; Lin GG, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/625095; Lunden A, 2002, J DAIRY RES, V69, P383, DOI 10.1017/S002202990200568X; Mihalik SJ, 2012, DIABETES CARE, V35, P605, DOI [10.2337/DC11-1577, 10.2337/dc11-1577]; Mittendorfer B, 2001, AM J PHYSIOL-ENDOC M, V280, pE323, DOI 10.1152/ajpendo.2001.280.2.E323; Moco S, 2013, PEDIATR RES, V73, P570, DOI 10.1038/pr.2013.1; Moltu SJ, 2014, NUTRIENTS, V6, P1913, DOI 10.3390/nu6051913; Muller C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5703; Phipps AN, 1998, XENOBIOTICA, V28, P527, DOI 10.1080/004982598239443; Psihogios NG, 2008, NMR BIOMED, V21, P195, DOI 10.1002/nbm.1176; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588; STANKO RT, 1992, AM J CLIN NUTR, V55, P771, DOI 10.1093/ajcn/55.4.771; Szymanska E, 2012, METABOLOMICS, V8, pS3, DOI 10.1007/s11306-011-0330-3; Tang WHW, 2015, CIRC RES, V116, P448, DOI 10.1161/CIRCRESAHA.116.305360; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Triba MN, 2015, MOL BIOSYST, V11, P13, DOI 10.1039/c4mb00414k; Vinayavekhin N, 2010, ACS CHEM BIOL, V5, P91, DOI 10.1021/cb900271r; Weckwerth W, 2003, ANNU REV PLANT BIOL, V54, P669, DOI 10.1146/annurev.arplant.54.031902.135014; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Williams RE, 2005, MOL BIOSYST, V1, P166, DOI 10.1039/b500852b; Xu EY, 2009, CURR OPIN DRUG DISC, V12, P40; Yao P, 2013, EMBO MOL MED, V5, P332, DOI 10.1002/emmm.201100626; Yao TC, 2011, J ASTHMA, V48, P503, DOI 10.3109/02770903.2011.576743; YAYHA ZAH, 1994, CLIN SCI, V87, P213, DOI 10.1042/cs0870213; Zeisel SH, 2006, ANNU REV NUTR, V26, P229, DOI 10.1146/annurev.nutr.26.061505.111156	41	46	47	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149823	10.1371/journal.pone.0149823	http://dx.doi.org/10.1371/journal.pone.0149823			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914934	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700031
J	Dudo, A; Besley, JC				Dudo, Anthony; Besley, John C.			Scientists' Prioritization of Communication Objectives for Public Engagement	PLOS ONE			English	Article							CULTURAL COGNITION; SCIENCE; PARTICIPATION; POPULARIZATION; DELIBERATION; INCIVILITY; ATTITUDES; FAIRNESS; OPINION; ONLINE	Amid calls from scientific leaders for their colleagues to become more effective public communicators, this study examines the objectives that scientists' report drive their public engagement behaviors. We explore how scientists evaluate five specific communication objectives, which include informing the public about science, exciting the public about science, strengthening the public's trust in science, tailoring messages about science, and defending science from misinformation. We use insights from extant research, the theory of planned behavior, and procedural justice theory to identify likely predictors of scientists' views about these communication objectives. Results show that scientists most prioritize communication designed to defend science from misinformation and educate the public about science, and least prioritize communication that seeks to build trust and establish resonance with the public. Regression analyses reveal factors associated with scientists who prioritize each of the five specific communication objectives. Our findings highlight the need for communication trainers to help scientists select specific communication objectives for particular contexts and audiences.	[Dudo, Anthony] Univ Texas Austin, Moody Coll Commun, Stan Richards Sch Advertising & Publ Relat, Austin, TX 78712 USA; [Besley, John C.] Michigan State Univ, Dept Advertising & Publ Relat, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; Michigan State University	Dudo, A (corresponding author), Univ Texas Austin, Moody Coll Commun, Stan Richards Sch Advertising & Publ Relat, Austin, TX 78712 USA.	dudo@utexas.edu	Besley, John C/N-7845-2013	Besley, John/0000-0002-8778-4973	National Science Foundation [AISL-1421723, AISL-1421214]; Direct For Education and Human Resources [1421723] Funding Source: National Science Foundation; Division Of Research On Learning [1421214] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR)); Division Of Research On Learning(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This material is based in part upon work supported by the National Science Foundation under Grant Nos. AISL-1421723 and AISL-1421214. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Barrett S, 2013, COMMUNICATION; Bauer MW, 2007, PUBLIC UNDERST SCI, V16, P79, DOI 10.1177/0963662506071287; Bauer MW, 2011, PUBLIC UNDERST SCI, V20, P3, DOI 10.1177/0963662510394457; Besley JC, 2013, PUBLIC UNDERST SCI, V22, P971, DOI 10.1177/0963662512459315; Besley JC, 2013, PUBLIC UNDERST SCI, V22, P644, DOI 10.1177/0963662511418743; Bies RJ, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P85; Brooks DJ, 2007, AM J POLIT SCI, V51, P1, DOI 10.1111/j.1540-5907.2007.00233.x; Brossard D, SCIENCE, V4, P40; Brossard D, 2007, INT J PUBLIC OPIN R, V19, P24, DOI 10.1093/ijpor/edl003; Brossard D, 2013, P NATL ACAD SCI USA, V110, P14096, DOI 10.1073/pnas.1212744110; Burkhalter S, 2002, COMMUN THEOR, V12, P398, DOI 10.1093/ct/12.4.398; Carpini MXD, 2004, ANNU REV POLIT SCI, V7, P315, DOI 10.1146/annurev.polisci.7.121003.091630; Carsten LD, 2002, IEEE T PROF COMMUN, V45, P153, DOI 10.1109/TPC.2002.801632; Cicerone R, 2006, CELEBRATING RETHINKI, P1; Cicerone RJ, 2010, SCIENCE, V327, P624, DOI 10.1126/science.1187612; Colquitt JA, 2005, HANDBOOK OF ORGANIZATIONAL JUSTICE, P3; COMPASSonline, 2013, GRADSCICOMM WORKSH S; Craig JL, 2008, IEEE T PROF COMMUN, V51, P280, DOI 10.1109/TPC.2008.2001253; Crone WC, 2011, INNOVATIVE HIGHER ED, V36; Dietz T., 2008, PUBLIC PARTICIPATION; Druckman JN, 2011, J COMMUN, V61, P659, DOI 10.1111/j.1460-2466.2011.01562.x; Dudo A, 2014, NAT NANOTECHNOL, V9, P841, DOI [10.1038/nnano.2014.194, 10.1038/NNANO.2014.194]; Dudo A, 2013, SCI COMMUN, V35, P476, DOI 10.1177/1075547012460845; Dunwoody S., 1982, IEEE T PROFESSIONAL, V25, P196; Dunwoody S, 2009, J MASS COMMUN Q, V86, P299, DOI 10.1177/107769900908600203; Durant J., 1999, SCI PUBL POLICY, V26, P313, DOI [10.3152/147154399781782329, DOI 10.3152/147154399781782329]; Einsiedel EF, 2002, PUBLIC UNDERST SCI, V11, P315, DOI 10.1088/0963-6625/11/4/301; Fiske ST, 2014, P NATL ACAD SCI USA, V111, P13593, DOI 10.1073/pnas.1317505111; Franken Al, 2004, LIES LYING LIARS WHO; Grunig J.E., 1992, EXCELLENCE PUBLIC RE, V73, P117; Gutmann A., 2004, WHY DELIBERATIVE DEM; Ham B, 2012, AAAS 2012 ANN M NEWS; Heath RL, 2009, HDB RISK CRISIS COMM, P557; Ho SS, 2008, INT J PUBLIC OPIN R, V20, P171, DOI 10.1093/ijpor/edn017; Holland EM, 2007, SCIENCE, V317, P1168; Jensen P, 2011, PUBLIC UNDERST SCI, V20, P26, DOI 10.1177/0963662510383632; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahan DM, 2009, NAT NANOTECHNOL, V4, P87, DOI [10.1038/nnano.2008.341, 10.1038/NNANO.2008.341]; Kreimer P, 2011, PUBLIC UNDERST SCI, V20, P37, DOI 10.1177/0963662510383924; Lapinski MK, 2007, HEALTH COMMUN, V22, P133, DOI 10.1080/10410230701454049; Lauber TB, 1999, SOC NATUR RESOUR, V12, P19, DOI 10.1080/089419299279867; Leshner AI, 2003, SCIENCE, V299, P977, DOI 10.1126/science.299.5609.977; Leshner AI, 2015, SCIENCE, V347, P459, DOI 10.1126/science.aaa7477; Lind E.A., 1988, SOCIAL PSYCHOL PROCE; Logan RA, 2001, SCI COMMUN, V23, P135, DOI 10.1177/1075547001023002004; Maibach E, 1995, DESIGNING HLTH MESSA; Marcinkowski F, 2014, SCI COMMUN, V36, P56, DOI 10.1177/1075547013494022; McComas K., 2009, HDB RISK CRISIS COMM; McComas KA, 2011, RISK ANAL, V31, P1749, DOI 10.1111/j.1539-6924.2011.01676.x; Mutz DC, 2005, AM POLIT SCI REV, V99, P1, DOI 10.1017/S0003055405051452; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; National Academy of Sciences, 2013, PUBL INT LIF SCI; National Science Board, 2014, SCI TECHN PUBL ATT P; Nelkin D, 1995, SELLING SCI PRESS CO; Nisbet MC, 2010, NEW AGENDAS COMMUN, P40; Nisbet MC, 2009, AM J BOT, V96, P1767, DOI 10.3732/ajb.0900041; Oreskes N., 2010, MERCHANTS DOUBT; Peters HP, 2014, EMBO REP, V15, P749, DOI 10.15252/embr.201438979; Peters HP, 2013, P NATL ACAD SCI USA, V110, P14102, DOI 10.1073/pnas.1212745110; Pew Research Center, 2009, PUBL PRAIS SCI SCI F; Poliakoff E, 2007, SCI COMMUN, V29, P242, DOI 10.1177/1075547007308009; Public Interfaces of the Life Sciences Initiative, 2014, SUST INFR LIFE SCI C; Reddy C, 2009, SCIENCE, V323, P1405, DOI 10.1126/science.1173003; Revkin A, 2009, CLIMATE CHANGE SCI W; Royal Society, 2006, SURV FACT AFF SCI CO; Salmon C.T., 2013, PUBLIC COMMUNICATION, P99; Scott A, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-126; Smyth JoleneD., 2008, INTERNET MAIL MIXED; Specter M., 2009, DENIALISM IRRATIONAL; Thorson K, 2010, MASS COMMUN SOC, V13, P289, DOI 10.1080/15205430903225571; Verba S., 1995, VOICE EQUALITY CIVIC; Webler T., 2013, EFFECTIVE RISK COMMU, P124, DOI 10.4324/9780203109861; Webler T, 2006, POLICY STUD J, V34, P699, DOI 10.1111/j.1541-0072.2006.00198.x	74	147	148	19	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148867	10.1371/journal.pone.0148867	http://dx.doi.org/10.1371/journal.pone.0148867			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26913869	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700010
J	Labonte, LE; Bourbeau, J; Daskalopoulou, SS; Zhang, M; Coulombe, P; Garland, K; Baglole, CJ				Labonte, Laura E.; Bourbeau, Jean; Daskalopoulou, Stella S.; Zhang, Michele; Coulombe, Patrick; Garland, Katie; Baglole, Carolyn J.			Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients	PLOS ONE			English	Article							NF-KAPPA-B; SURFACTANT PROTEIN-D; PULSE-WAVE VELOCITY; OBSTRUCTIVE PULMONARY-DISEASE; CARDIOVASCULAR RISK; EXPRESSION; SERUM; BIOMARKERS; CC16; MORTALITY	Background Exacerbations of chronic obstructive pulmonary disease (COPD) are acute events of worsened respiratory symptoms that may increase the risk of cardiovascular disease (CVD), a leading cause of mortality amongst COPD patients. The utility of lung-specific inflammatory mediators such as club cell protein-16 (CC-16) and surfactant protein D (SPD) and that of a novel marker of CV outcomes in COPD-RelB-in predicting adverse cardiovascular events during exacerbation is not known. Methods Thirty-eight subjects with COPD admitted to the hospital for severe exacerbation were included in this analysis. Clinical, physiological and arterial stiffness measurements were performed within 72 hours of admission; this was followed by measurements taken every 3 days until hospital discharge, then once a week until 30 days after discharge, and then again at 90 and 180 days. Plasma concentrations of inflammatory mediators were measured from peripheral venous blood taken at admission, and at days 15, 30, 90 and 180. Results CC-16 and RelB concentrations were increased at day 15 of exacerbations whereas SPD concentrations were decreased. The course of change in CC-16 and RelB levels over time was inversely associated with that of carotid-femoral pulse wave velocity, the gold-standard measure of arterial stiffness. Increases in CC-16 could predict a decreased number of subsequent exacerbations during follow-up. Conclusions Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time. CC-16 can predict subsequent exacerbations in subjects with severe COPD and may be an important biomarker of pulmonary and systemic stress in COPD.	[Labonte, Laura E.; Bourbeau, Jean; Daskalopoulou, Stella S.; Baglole, Carolyn J.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Labonte, Laura E.; Bourbeau, Jean; Zhang, Michele; Coulombe, Patrick; Garland, Katie] McGill Univ, Ctr Hlth, Res Inst, Resp Epidemiol & Clin Res Unit, Montreal, PQ, Canada; [Baglole, Carolyn J.] McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Baglole, CJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pathol, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada.; Baglole, CJ (corresponding author), McGill Univ, Meakins Christie Labs, Montreal, PQ, Canada.	carolyn.baglole@mcgill.ca			GlaxoSmithKline Canada Ltd.; Canadian Institute of Health Research; Fonds de Recherche du Quebec-Sante (FRQ-S)	GlaxoSmithKline Canada Ltd.; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQ-S)	This study was funded as an investigator-initiated grant by GlaxoSmithKline Canada Ltd. LL was funded by a Canadian Institute of Health Research Doctoral Award. Infrastructure for this project was supported by the Canada Foundation for Innovation (CFI) -Leaders Opportunities Fund (CJB). CJB was supported by a salary award from the Fonds de Recherche du Quebec-Sante (FRQ-S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammon C, 2000, BIOCHEM BIOPH RES CO, V268, P99, DOI 10.1006/bbrc.1999.2083; ASMAR R, 1995, HYPERTENSION, V26, P485, DOI 10.1161/01.HYP.26.3.485; Baglole CJ, 2008, J BIOL CHEM, V283, P28944, DOI 10.1074/jbc.M800685200; BERNARD A, 1992, EUR RESPIR J, V5, P1231; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Braam B, 2004, AM J PHYSIOL-HEART C, V287, pH1977, DOI 10.1152/ajpheart.00323.2004; Broeckaert F, 2000, CLIN EXP ALLERGY, V30, P469; Calverley PMA, 2010, THORAX, V65, P719, DOI 10.1136/thx.2010.136077; CARRASCO D, 1993, DEVELOPMENT, V118, P1221; Cruickshank K, 2002, CIRCULATION, V106, P2085, DOI 10.1161/01.CIR.0000033824.02722.F7; de Souza AR, 2014, TOXICOL SCI, V140, P204, DOI 10.1093/toxsci/kfu068; Dickens JA, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-146; Donaldson GC, 2010, CHEST, V137, P1091, DOI 10.1378/chest.09-2029; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Korfhagen TR, 1998, J BIOL CHEM, V273, P28438, DOI 10.1074/jbc.273.43.28438; Labonte L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112965; Lakind JS, 2007, BIOMARKERS, V12, P445, DOI 10.1080/13547500701359327; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Lindner V, 1998, PATHOBIOLOGY, V66, P311, DOI 10.1159/000028039; Lomas DA, 2008, THORAX, V63, P1058, DOI 10.1136/thx.2008.102574; Lomas DA, 2009, EUR RESPIR J, V34, P95, DOI 10.1183/09031936.00156508; Lomas DA, 2012, J CLIN PHARMACOL, V52, P416, DOI 10.1177/0091270010397050; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mason RJ, 1998, AM J PHYSIOL-LUNG C, V275, pL1, DOI 10.1152/ajplung.1998.275.1.L1; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; Mattsson J, 2005, TRANSPLANTATION, V79, P1411, DOI 10.1097/01.TP.0000158354.39635.AB; McMillan DH, 2011, AM J PATHOL, V179, P125, DOI 10.1016/j.ajpath.2011.03.030; Millet P, 2013, J LEUKOCYTE BIOL, V94, P941, DOI 10.1189/jlb.0513305; Moreno D, 2014, RECENT PATENTS ENDOC, V8, P42, DOI 10.2174/1872214808666140209142640; Park HY, 2013, AM J RESP CRIT CARE, V188, P1413, DOI 10.1164/rccm.201305-0892OC; Patel ARC, 2013, AM J RESP CRIT CARE, V188, P1091, DOI 10.1164/rccm.201306-1170OC; Rosenberg SR, 2012, TRANSL RES, V159, P228, DOI 10.1016/j.trsl.2012.01.019; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Shijubo N, 1997, EUR RESPIR J, V10, P1108, DOI 10.1183/09031936.97.10051108; Shijubo N, 1999, AM J RESP CRIT CARE, V160, P930, DOI 10.1164/ajrccm.160.3.9803113; Sin Don D, 2007, BMC Pulm Med, V7, P13, DOI 10.1186/1471-2466-7-13; Sin DD, 2008, CHEST, V133, P1296, DOI 10.1378/chest.08-0455; Sin Don D, 2009, Proc Am Thorac Soc, V6, P543, DOI 10.1513/pats.200904-019DS; Sin Don D, 2008, Ther Adv Respir Dis, V2, P65, DOI 10.1177/1753465808088903; Sinden NJ, 2010, THORAX, V65, P930, DOI 10.1136/thx.2009.130260; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Tully JE, 2012, AM J RESP CELL MOL, V47, P497, DOI 10.1165/rcmb.2012-0014OC; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Wedzicha JA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-181; White AJ, 2003, THORAX, V58, P73, DOI 10.1136/thorax.58.1.73; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020; Zielinski J, 1997, Monaldi Arch Chest Dis, V52, P43	49	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149974	10.1371/journal.pone.0149974	http://dx.doi.org/10.1371/journal.pone.0149974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914709	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700042
J	Put, K; Brisse, E; Avau, A; Imbrechts, M; Mitera, T; Janssens, R; Proost, P; Fallarino, F; Wouters, CH; Matthys, P				Put, Karen; Brisse, Ellen; Avau, Anneleen; Imbrechts, Maya; Mitera, Tania; Janssens, Rik; Proost, Paul; Fallarino, Francesca; Wouters, Carine H.; Matthys, Patrick			IDO1 Deficiency Does Not Affect Disease in Mouse Models of Systemic Juvenile Idiopathic Arthritis and Secondary Hemophagocytic Lymphohistiocytosis	PLOS ONE			English	Article							MACROPHAGE ACTIVATION SYNDROME; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; ARYL-HYDROCARBON RECEPTOR; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; INTERFERON-GAMMA; TRYPTOPHAN CATABOLISM; DENDRITIC CELLS; TOLERANCE	Objectives Indoleamine 2,3-dioxygenase-1 (IDO1) is an immune-modulatory enzyme that catalyzes the degradation of tryptophan (Trp) to kynurenine (Kyn) and is strongly induced by interferon (IFN)-gamma We previously reported highly increased levels of IFN-gamma and corresponding IDO activity in patients with hemophagocytic lymphohistiocytosis (HLH), a hyper-inflammatory syndrome. On the other hand, IFN-gamma and IDO were low in patients with systemic juvenile idiopathic arthritis (sJIA), an autoinflammatory syndrome. As HLH can occur as a complication of sJIA, the opposing levels of both IFN-gamma and IDO are remarkable. In animal models for sJIA and HLH, the role of IFN-gamma differs from being protective to pathogenic. In this study, we aimed to unravel the role of IDO1 in the pathogenesis of sJIA and HLH. Methods Wild-type and IDO1-knockout (IDO1-KO) mice were used in 3 models of sJIA or HLH: complete Freund's adjuvant (CFA)-injected mice developed an sJIA-like syndrome and secondary HLH (sHLH) was evoked by either repeated injection of unmethylated CpG oligonucleotide or by primary infection with mouse cytomegalovirus (MCMV). An anti-CD3-induced cytokine release syndrome was used as a non-sJIA/HLH control model. Results No differences were found in clinical, laboratory and hematological features of sJIA/HLH between wild-type and IDO1-KO mice. As IDO modulates the immune response via induction of regulatory T cells and inhibition of T cell proliferation, we investigated both features in a T cell-triggered cytokine release syndrome. Again, no differences were observed in serum cytokine levels, percentages of regulatory T cells, nor of proliferating or apoptotic thymocytes and lymph node cells. Conclusions Our data demonstrate that IDO1 deficiency does not affect inflammation in sJIA, sHLH and a T cell-triggered cytokine release model. We hypothesize that other tryptophan-catabolizing enzymes like IDO2 and tryptophan 2,3-dioxygenase (TDO) might compensate for the lack of IDO1.	[Put, Karen; Brisse, Ellen; Avau, Anneleen; Imbrechts, Maya; Mitera, Tania; Matthys, Patrick] KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Immunobiol Lab, Leuven, Belgium; [Janssens, Rik; Proost, Paul] KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Lab Mol Immunol, Leuven, Belgium; [Fallarino, Francesca] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy; [Wouters, Carine H.] KU Leuven Univ Leuven, Univ Hosp Leuven, Lab Pediat Immunol, Leuven, Belgium	KU Leuven; KU Leuven; University of Perugia; KU Leuven; University Hospital Leuven	Matthys, P (corresponding author), KU Leuven Univ Leuven, Dept Immunol & Microbiol, Rega Inst Med Res, Immunobiol Lab, Leuven, Belgium.	patrick.matthys@kuleuven.be	Janssens, Rik/S-7744-2017; Matthys, Patrick/B-4813-2018; Proost, Paul/V-3052-2017; Imbrechts, Maya/E-5264-2018; Fallarino, Francesca/O-3358-2013	Janssens, Rik/0000-0003-1428-3921; Matthys, Patrick/0000-0002-9685-6836; Proost, Paul/0000-0002-0133-5545; Imbrechts, Maya/0000-0002-4467-9831; Wouters, Carine/0000-0002-6426-8845; Fallarino, Francesca/0000-0002-8501-2136	Fund for Scientific Research-Flanders (FWO-Vlaanderen) [G.0515.12N, G.OD66.13]; Regional Government of Flanders (GOA program) [GOA13/014]; Interuniversity Attraction Poles (IAP) [IAP P7/39]; FWO-Vlaanderen; Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)	Fund for Scientific Research-Flanders (FWO-Vlaanderen)(FWO); Regional Government of Flanders (GOA program); Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); FWO-Vlaanderen(FWO); Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Fund for Scientific Research-Flanders (FWO-Vlaanderen, www.fwo.be, G.0515.12N and G.OD66.13), the Regional Government of Flanders (GOA program, www.kuleuven.be, GOA13/014) and the Interuniversity Attraction Poles (IAP, www.belspo.be, IAP P7/39). AA and KP received a fellowship from the FWO-Vlaanderen. EB received a fellowship from the Institute for the Promotion of Innovation through Science and Technology Flanders (IWT-Vlaanderen).	Avau A, 2015, PHARMACEUTI IN PRESS, V8; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Behrens EM, 2007, J RHEUMATOL, V34, P1133; Behrens EM, 2011, J CLIN INVEST, V121, P2264, DOI 10.1172/JCI43157; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Brisse E, 2014, J CLIN IMMUNOL, V34, P139; Brisse E, 2015, CYTOKINE GROWTH F R, V26, P263, DOI 10.1016/j.cytogfr.2014.10.001; Canna SW, 2012, PEDIATR CLIN N AM, V59, P329, DOI 10.1016/j.pcl.2012.03.002; Cobbold SP, 2009, P NATL ACAD SCI USA, V106, P12055, DOI 10.1073/pnas.0903919106; Criado G, 2009, ARTHRITIS RHEUM-US, V60, P1342, DOI 10.1002/art.24446; De Benedetti F, 2010, TXB PEDIAT RHEUMATOL, P236; Divanovic S, 2012, J INFECT DIS, V205, P152, DOI 10.1093/infdis/jir621; Fatokun AA, 2013, AMINO ACIDS, V45, P1319, DOI 10.1007/s00726-013-1602-1; Grom AA., 2010, TXB PEDIAT RHEUMATOL, V6th edn, P674; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kaufman KM, 2014, ARTHRITIS RHEUMATOL, V66, P3486, DOI 10.1002/art.38793; Kelchtermans H, 2008, TRENDS IMMUNOL, V29, P479, DOI 10.1016/j.it.2008.07.002; MATTHYS P, 1995, J IMMUNOL, V155, P3823; Mellins ED, 2011, NAT REV RHEUMATOL, V7, P416, DOI 10.1038/nrrheum.2011.68; Mellor AL, 2003, J IMMUNOL, V171, P1652, DOI 10.4049/jimmunol.171.4.1652; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Metz R, 2014, INT IMMUNOL, V26, P357, DOI 10.1093/intimm/dxt073; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Osugi Y, 1997, BLOOD, V89, P4100, DOI 10.1182/blood.V89.11.4100; Pachlopnik SJ, 2009, EMBO MOL MED, V1, P112, DOI DOI 10.1002/EMMM.200900009; Pallotta MT, 2011, NAT IMMUNOL, V12, P870, DOI 10.1038/ni.2077; Put K, 2015, RHEUMATOLOGY, V54, P1507, DOI 10.1093/rheumatology/keu524; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Sakurai K, 2002, J NEUROIMMUNOL, V129, P186, DOI 10.1016/S0165-5728(02)00176-5; Santambrogio P, 2000, PROTEIN EXPRES PURIF, V19, P212, DOI 10.1006/prep.2000.1212; Shimizu M, 2015, CLIN IMMUNOL, V160, P277, DOI 10.1016/j.clim.2015.06.005; Szanto S, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2205; Takada H, 2003, CLIN EXP IMMUNOL, V133, P448, DOI 10.1046/j.1365-2249.2003.02237.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zhang MC, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0439-2	42	12	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150075	10.1371/journal.pone.0150075	http://dx.doi.org/10.1371/journal.pone.0150075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914138	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700050
J	Meier, V; Guscetti, F; Roos, M; Ohlerth, S; Pruschy, M; Bley, CR				Meier, Valeria; Guscetti, Franco; Roos, Malgorzata; Ohlerth, Stefanie; Pruschy, Martin; Bley, Carla Rohrer			Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant Neoplasia	PLOS ONE			English	Article							FRACTIONATED RADIATION-THERAPY; POWER DOPPLER ULTRASONOGRAPHY; MEASURED OXYGENATION LEVELS; SQUAMOUS-CELL CARCINOMAS; TUMOR HYPOXIA; RETROSPECTIVE ANALYSIS; GLUCOSE-TRANSPORTER; IX EXPRESSION; DOGS; GLUCOSE-TRANSPORTER-1	For various types of tumor therapy, it is suggested that co-targeting of tumor microenvironment, mainly tumor vasculature, mediates tumor response mechanisms. Immunohistochemistry for glucose transporter-1 (GLUT-1), carbonic anhydrase-IX (CAIX), Ki-67, and von Willebrand factor VIII for microvessel density (MVD) were performed on formalin-fixed paraffin-embedded samples of canine oral malignant neoplasms. Polarographic oxygen measurements (median pO2) and perfusion data via contrast-enhanced power Doppler ultrasound (median vascularity, median blood volume) provided additional information. Ninety-two samples were analyzed: sarcomas (n = 32), carcinomas (n = 30), and malignant melanomas (n = 30). Polarographic oxygen and perfusion data was available in 22.8%(sarcomas n = 9, carcinomas n = 7, melanomas n = 5), and 27.1% (sarcomas n = 10, carcinomas n = 8, melanomas n = 7) of cases, respectively. GLUT-1 expression was detected in 46.7% of all samples, and was generally weak. CAIX expression was found in 34.8% of all samples. Median Ki-67 score and MVD count was 19% and 17, respectively. The evaluation of the GLUT-1 score and continuous data showed significantly lower GLUT-1 levels in sarcomas (mean 5.1%, SD 6.2) versus carcinomas and melanomas (mean 16.5%/19.0%, SD 17.3/20.9, p = 0.001). The expression of CAIX correlated mildly positively with GLUT-1 (p = 0.018, rho = 0.250) as well as with Ki-67 (p = 0.014, rho = 0.295). MVD showed a significantly lower level in melanomas (mean 12.6, SD 7.7) versus sarcomas and carcinomas (mean 21.8/26.9, SD 13.0/20.4, p = 0.001). Median vascularity and blood volume were significantly lower in sarcomas (mean 10.4%, SD 11.0, and mean 6.3%, SD 6.5, respectively) versus carcinomas (mean 39.2%, SD 16.4 and mean 33.0%, SD 25.6, respectively) and melanomas (mean 36.0%, SD 18.3, and 31.5%, SD 24.5). Between the 3 histological groups, there was neither a significant difference in the GLUT-1 and CAIX score and continuous data, nor the Ki67 score, or polarographic oxygen measurements. GLUT-1 continuous data and Ki-67 (p<0.001, rho = 0.403), as well as Ki-67 and MVD (p = 0.029, rho = 0.228) correlated positively and a mild correlation was found between vascularity and GLUT-1 (p =	[Meier, Valeria; Bley, Carla Rohrer] Univ Zurich, Vetsuisse Fac, Div Radiat Oncol, Zurich, Switzerland; [Guscetti, Franco] Univ Zurich, Inst Vet Pathol, Zurich, Switzerland; [Roos, Malgorzata] Univ Zurich, Fac Med, Dept Biostat, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Ohlerth, Stefanie] Univ Zurich, Clin Diagnost Imaging, Vetsuisse Fac, Zurich, Switzerland; [Pruschy, Martin] Univ Zurich Hosp, Lab Mol Radiobiol, Radiat Oncol, CH-8091 Zurich, Switzerland	University of Zurich; University of Zurich; University of Geneva; University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital	Meier, V (corresponding author), Univ Zurich, Vetsuisse Fac, Div Radiat Oncol, Zurich, Switzerland.	vmeier@vetclinics.uzh.ch	Rohrer Bley, Carla/G-1192-2013; Guscetti, Franco/C-2672-2018	Rohrer Bley, Carla/0000-0002-5733-2722; Roos, Malgorzata/0000-0001-9878-6969; Guscetti, Franco/0000-0002-3173-4811; Pruschy, Martin/0000-0002-3124-9015	Swiss National Science Foundation (SNSF) [320030_132441]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This study was funded by the Swiss National Science Foundation (SNSF; recipient: CRB, grant number: 320030_132441, URL: http://www.snf.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbondati E, 2013, VET PATHOL, V50, P1063, DOI 10.1177/0300985813486810; Achermann R, 2002, IN VIVO, V16, P431; Achermann RE, 2004, STRAHLENTHER ONKOL, V180, P297, DOI 10.1007/s00066-004-1193-6; Airley R, 2001, CLIN CANCER RES, V7, P928; Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Barnes K, 2002, J CELL SCI, V115, P2433; Bergin IL, 2011, VET PATHOL, V48, P41, DOI 10.1177/0300985810388947; Bley CR, 2007, EUR J CANCER, V43, P963, DOI 10.1016/j.ejca.2006.12.007; Bley CR, 2006, STRAHLENTHER ONKOL, V182, P518, DOI 10.1007/s00066-006-1519-7; Bley CR, 2009, STRAHLENTHER ONKOL, V185, P756, DOI 10.1007/s00066-009-1988-6; Boado RJ, 2002, J NEUROCHEM, V80, P552, DOI 10.1046/j.0022-3042.2001.00756.x; Brown JM, 2008, INT J RADIAT ONCOL, V71, P324, DOI 10.1016/j.ijrobp.2008.02.003; Brown JM, 2014, INT J RADIAT ONCOL, V88, P254, DOI 10.1016/j.ijrobp.2013.07.022; Fulton AJ, 2013, JAVMA-J AM VET MED A, V243, P696, DOI 10.2460/javma.243.5.696; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Gardner H, 2015, VET COMP ONCOL, V13, P40, DOI 10.1111/vco.12017; Grabmaier K, 2004, ONCOGENE, V23, P5624, DOI 10.1038/sj.onc.1207764; Grosse N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-203; Hedley D, 2003, CLIN CANCER RES, V9, P5666; Joiner Michael, 2009, BASIC CLIN RADIOBIOL, DOI DOI 10.1201/B15450; Keller SM, 2007, J VET DIAGN INVEST, V19, P652, DOI 10.1177/104063870701900606; Khanna C, 2006, NAT BIOTECHNOL, V24, P1065, DOI 10.1038/nbt0906-1065b; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Loncaster JA, 2001, CANCER RES, V61, P6394; Madewell BR, 2001, J VET INTERN MED, V15, P334, DOI 10.1892/0891-6640(2001)015&lt;0334:CPITAR&gt;2.3.CO;2; Mayer A, 2005, CLIN CANCER RES, V11, P2768, DOI 10.1158/1078-0432.CCR-04-2344; Mayer A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-760; Mees G, 2011, RES VET SCI, V91, pE125, DOI 10.1016/j.rvsc.2011.01.014; Ohlerth S, 2010, VET J, V186, P58, DOI 10.1016/j.tvjl.2009.07.006; Ohlerth S, 2010, VET J, V183, P58, DOI 10.1016/j.tvjl.2008.08.026; Osthus RC, 2000, J BIOL CHEM, V275, P21797, DOI 10.1074/jbc.C000023200; Petty JC, 2008, VET COMP ONCOL, V6, P133, DOI 10.1111/j.1476-5829.2007.00155.x; PIRHONEN JP, 1995, CANCER-AM CANCER SOC, V76, P67, DOI 10.1002/1097-0142(19950701)76:1<67::AID-CNCR2820760109>3.0.CO;2-0; Potter CPS, 2003, BRIT J CANCER, V89, P2, DOI 10.1038/sj.bjc.6600936; Proulx DR, 2003, VET RADIOL ULTRASOUN, V44, P352, DOI 10.1111/j.1740-8261.2003.tb00468.x; Rademakers SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-167; Rademakers SE, 2008, MOL ONCOL, V2, P41, DOI 10.1016/j.molonc.2008.03.006; Ramos-Vara JA, 2010, VET PATHOL, V47, P725, DOI 10.1177/0300985810364528; Sakata KI, 2006, STRAHLENTHER ONKOL, V182, P511, DOI 10.1007/s00066-006-1532-x; Smedley RC, 2011, VET PATHOL, V48, P54, DOI 10.1177/0300985810390717; Song DY, 2004, ONCOLOGY-NY, V18, P1419; Song DY, 2004, ONCOLOGY WILLISTON P, V30, P32; Thrall DE, 2012, INT J HYPERTHER, V28, P431, DOI 10.3109/02656736.2012.689087; Tuohy JL, 2014, JAVMA-J AM VET MED A, V245, P1266, DOI 10.2460/javma.245.11.1266; Webster JD, 2007, VET PATHOL, V44, P298, DOI 10.1354/vp.44-3-298; WEIDNER N, 1993, AM J PATHOL, V143, P401; Woldemeskel M, 2010, VET RES COMMUN, V34, P153, DOI 10.1007/s11259-010-9341-1; Wolfesberger B, 2012, RES VET SCI, V92, P444, DOI 10.1016/j.rvsc.2011.04.018; Wolfesberger B, 2008, RES VET SCI, V85, P56, DOI 10.1016/j.rvsc.2007.07.008	49	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149993	10.1371/journal.pone.0149993	http://dx.doi.org/10.1371/journal.pone.0149993			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906567	gold, Green Published, Green Accepted			2022-12-27	WOS:000371163000027
J	Mewalal, R; Mizrachi, E; Coetzee, B; Mansfield, SD; Myburg, AA				Mewalal, Ritesh; Mizrachi, Eshchar; Coetzee, Berdine; Mansfield, Shawn D.; Myburg, Alexander A.			The Arabidopsis Domain of Unknown Function 1218 (DUF1218) Containing Proteins, MODIFYING WALL LIGNIN-1 and 2 (At1g31720/MWL-1 and At4g19370/MWL-2) Function Redundantly to Alter Secondary Cell Wall Lignin Content	PLOS ONE			English	Article							EXPRESSION; GENES; IDENTIFICATION; BIOLOGY; MALATE	DUF1218 is a land plant-specific innovation and has previously been shown to be associated with cell wall biology, vasculature patterning and abiotic/biotic stress response. The Arabidopsis genome encodes 15 members, two of which (At1g31720 and At4g27435) are preferentially expressed in the secondary cell wall depositing inflorescence stems. To further our understanding of the roles of DUF1218-containing proteins in secondary cell wall biology, we functionally characterized At1g31720 (herein referred to as MODIFYING WALL LIGNIN-1 or MWL-1). Since related gene family members may contribute to functional redundancy, we also characterized At4g19370 (MWL-2), the most closely related gene to MWL-1 in the protein family. Subcellular localization revealed that both Arabidopsis proteins are targeted to the cell periphery. The single T-DNA knockout lines, mwl-1 and mwl-2, and independent overexpression lines showed no significant differences in plant growth or changes in total lignin content relative to wild-type (WT) control plants. However, the double homozygous mutant, mwl-1/mwl-2, had smaller rosettes with a significant decrease in rosette fresh weight and stem height relative to the WT control at four weeks and six weeks, respectively. Moreover, mwl-1/mwl-2 showed a significant reduction in total lignin content (by ca. 11% relative to WT) and an increase in syringyl/guaiacyl (S/G) monomer ratio relative to the control plants. Our study has identified two additional members of the DUF1218 family in Arabidopsis as novel contributors to secondary cell wall biology, specifically lignin biosynthesis, and these proteins appear to function redundantly.	[Mewalal, Ritesh; Mizrachi, Eshchar; Myburg, Alexander A.] Univ Pretoria, FABI, Dept Genet, Private Bag X20, ZA-0028 Pretoria, South Africa; [Coetzee, Berdine] Univ Pretoria, Dept Chem Engn, Private Bag X20, ZA-0028 Pretoria, South Africa; [Coetzee, Berdine] Sappi Southern Africa, POB 12796, ZA-0087 Pretoria, South Africa; [Mansfield, Shawn D.] Univ British Columbia, Fac Forestry, Dept Wood Sci, Forest Sci Ctr, 4030-2424 Main Mall, Vancouver, BC V6T 1Z4, Canada; [Mewalal, Ritesh] Oak Ridge Natl Lab, Biosci Div, BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA	University of Pretoria; University of Pretoria; University of British Columbia; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC)	Myburg, AA (corresponding author), Univ Pretoria, FABI, Dept Genet, Private Bag X20, ZA-0028 Pretoria, South Africa.	zander.myburg@fabi.up.ac.za	Myburg, Alexander A/C-5426-2008; Mizrachi, Eshchar/N-3179-2014	Myburg, Alexander A/0000-0003-0644-5003; Mansfield, Shawn/0000-0002-0175-554X; Mizrachi, Eshchar/0000-0002-3126-9593; Mewalal, Ritesh/0000-0002-0153-2434	Sappi through Forest Molecular Genetics (FMG) Programme; Technology and Human Resources for Industry Programme (THRIP) [UID 80118]; National Research Foundation (NRF) of South Africa [UID 71255, 86936]; NRF	Sappi through Forest Molecular Genetics (FMG) Programme; Technology and Human Resources for Industry Programme (THRIP); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); NRF	The work presented here was supported by Sappi through the Forest Molecular Genetics (FMG) Programme, the Technology and Human Resources for Industry Programme (THRIP, UID 80118), and the National Research Foundation (NRF, UID 71255 and 86936) of South Africa. RM acknowledges an NRF Ph.D. Prestige and Equity Scholarship. Sappi also provided support in the form of salary for one of the authors (BC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Derikvand MM, 2008, PLANTA, V227, P943, DOI 10.1007/s00425-007-0669-x; Do CT, 2007, PLANTA, V226, P1117, DOI 10.1007/s00425-007-0558-3; Dunkley TPJ, 2006, P NATL ACAD SCI USA, V103, P6518, DOI 10.1073/pnas.0506958103; Guo JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044908; Hooper CM, 2014, BIOINFORMATICS, V30, P3356, DOI 10.1093/bioinformatics/btu550; Huang X, 2012, PLANT CELL REP, V31, P339, DOI 10.1007/s00299-011-1169-9; Jones AM, 2014, SCIENCE, V344, P711, DOI 10.1126/science.1251358; Kalluri UC, 2014, PLANT BIOTECHNOL J, V12, P1207, DOI 10.1111/pbi.12283; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maloney VJ, 2010, PLANT BIOTECHNOL J, V8, P294, DOI 10.1111/j.1467-7652.2009.00483.x; Mandadi KK, 2012, PLANT PHYSIOL, V160, P1432, DOI 10.1104/pp.112.204362; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Oda S, 2010, GENES GENET SYST, V85, P107, DOI 10.1266/ggs.85.107; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Robinson AR, 2009, PLANT J, V58, P706, DOI 10.1111/j.1365-313X.2009.03808.x; Roschzttardtz H, 2014, PLANT PHYSIOL, V166, P889, DOI 10.1104/pp.114.246314; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Sibout R, 2012, CURR BIOL, V22, pR533, DOI 10.1016/j.cub.2012.05.005; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanz SK, 2012, NUCLEIC ACIDS RES; Ubeda-Tomas S, 2007, PHYSIOL PLANTARUM, V129, P415, DOI 10.1111/j.1399-3054.2006.00817.x; Wolf S, 2012, ANNU REV PLANT BIOL, V63, P381, DOI 10.1146/annurev-arplant-042811-105449	31	12	14	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150254	10.1371/journal.pone.0150254	http://dx.doi.org/10.1371/journal.pone.0150254			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930070	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500119
J	Signorini, C; De Felice, C; Leoncini, S; Moller, RS; Zollo, G; Buoni, S; Cortelazzo, A; Guerranti, R; Durand, T; Ciccolil, L; D'Esposite, M; Ravn, K; Hayek, J				Signorini, Cinzia; De Felice, Claudio; Leoncini, Silvia; Moller, Rikke S.; Zollo, Gloria; Buoni, Sabrina; Cortelazzo, Alessio; Guerranti, Roberto; Durand, Thierry; Ciccolil, Lucia; D'Esposite, Maurizio; Ravn, Kirstine; Hayek, Joussef			MECP2 Duplication Syndrome: Evidence of Enhanced Oxidative Stress. A Comparison with Rett Syndrome	PLOS ONE			English	Article							MOUSE MODEL; MITOCHONDRIAL DYSFUNCTION; MENTAL-RETARDATION; MUTATIONS; PHENOTYPE; F-2-DIHOMO-ISOPROSTANES; CHOLESTEROL; BIOMARKERS; SEVERITY; SYMPTOMS	Rett syndrome (RTT) and MECP2 duplication syndrome (MDS) are neurodevelopmental disorders caused by alterations in the methyl-CpG binding protein 2 (MECP2) gene expression. A relationship between MECP2 loss-of-function mutations and oxidative stress has been previously documented in RTT patients and murine models. To date, no data on oxidative stress have been reported for the MECP2 gain-of-function mutations in patients with MDS. In the present work, the pro-oxidant status and oxidative fatty acid damage in MDS was investigated (subjects n = 6) and compared to RTT (subjects n = 24) and healthy condition (subjects n = 12). Patients with MECP2 gain-of-function mutations showed increased oxidative stress marker levels (plasma non-protein bound iron, intraerythrocyte non-protein bound iron, F-2-isoprostanes, and F-4-neuroprostanes), as compared to healthy controls (P <= 0.05). Such increases were similar to those observed in RTT patients except for higher plasma F-2-isoprostanes levels (P < 0.0196). Moreover, plasma levels of F-2-isoprostanes were significantly correlated (P = 0.0098) with the size of the amplified region. The present work shows unique data in patients affected by MDS. For the first time MECP2 gain-of-function mutations are indicated to be linked to an oxidative damage and related clinical symptoms overlapping with those of MECP2 loss-of-function mutations. A finely tuned balance of MECP2 expression appears to be critical to oxidative stress homeostasis, thus shedding light on the relevance of the redox balance in the central nervous system integrity.	[Signorini, Cinzia; Leoncini, Silvia; Zollo, Gloria; Ciccolil, Lucia] Univ Siena, Dept Mol & Dev Med, Via Laterina 8, I-53100 Siena, Italy; [De Felice, Claudio] Azienda Osped Univ Senese, Neonatal Intens Care Unit, Siena, Italy; [Leoncini, Silvia; Zollo, Gloria; Buoni, Sabrina; Cortelazzo, Alessio; Hayek, Joussef] Azienda Osped Univ Senese, Child Neuropsychiat Unit, Siena, Italy; [Moller, Rikke S.] Danish Epilepsy Ctr, Dianalund, Denmark; [Moller, Rikke S.] Univ Southern Denmark, Inst Reg Hlth Serv, Odense, Denmark; [Guerranti, Roberto] Univ Siena, Dept Med Biotechnol, Via Laterina 8, I-53100 Siena, Italy; [Durand, Thierry] ENSCM, CNRS, UMR 5247, IBMM,UM, Montpellier, France; [D'Esposite, Maurizio] Inst Genet & Biophys Buzzati Traverso, Naples, Italy; [D'Esposite, Maurizio] IRCSS Neuromed, Pozzilli, Italy; [Ravn, Kirstine] Rigshosp, Copenhagen Univ Hosp, Dept Clin Genet, DK-2100 Copenhagen, Denmark	University of Siena; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena; University of Southern Denmark; University of Siena; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Neuromed; Rigshospitalet; University of Copenhagen	Signorini, C (corresponding author), Univ Siena, Dept Mol & Dev Med, Via Laterina 8, I-53100 Siena, Italy.; De Felice, C (corresponding author), Azienda Osped Univ Senese, Neonatal Intens Care Unit, Siena, Italy.	cinzia.signorini@unisi.it; geniente@gmail.com	Leoncini, Silvia/ABG-5652-2020; De Felice, Claudio/AAB-6859-2022; Cortelazzo, Alessio/Q-4005-2016	Leoncini, Silvia/0000-0002-7027-1207; De Felice, Claudio/0000-0002-9881-3119; Cortelazzo, Alessio/0000-0003-1010-5255; Moller, Rikke S./0000-0002-9664-1448	Tuscan Region (Bando Salute; "Antioxidants-omega-3 polyunsaturated Fatty Acids, lipoic acid-supplementation in Rett syndrome: A novel approach to therapy) [142]	Tuscan Region (Bando Salute; "Antioxidants-omega-3 polyunsaturated Fatty Acids, lipoic acid-supplementation in Rett syndrome: A novel approach to therapy)	The present work was funded by the Tuscan Region (Bando Salute 2009; "Antioxidants-omega-3 polyunsaturated Fatty Acids, lipoic acid-supplementation in Rett syndrome: A novel approach to therapy," RT no. 142). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bajic D, 2012, NEUROSCIENCE, V226, P165, DOI 10.1016/j.neuroscience.2012.09.028; Bao XH, 2008, J CHILD NEUROL, V23, P22, DOI 10.1177/0883073807307077; Bauer M, 2015, J CLIN IMMUNOL, V35, P168, DOI 10.1007/s10875-015-0129-5; Cardaioli E, 1999, J SUBMICR CYTOL PATH, V31, P301; Carvalho CMB, 2009, HUM MOL GENET, V18, P2188, DOI 10.1093/hmg/ddp151; Caselli R, 2007, J HUM GENET, V52, P535, DOI 10.1007/s10038-007-0151-4; Christodoulou J., 2001, GENEREVIEWS; De Felice C, 2014, NEUROBIOL DIS, V68, P66, DOI 10.1016/j.nbd.2014.04.006; De Felice C, 2012, ANN NY ACAD SCI, V1259, P121, DOI 10.1111/j.1749-6632.2012.06611.x; De Felice C, 2011, J LIPID RES, V52, P2287, DOI 10.1194/jlr.P017798; De Felice C, 2009, FREE RADICAL BIO MED, V47, P440, DOI 10.1016/j.freeradbiomed.2009.05.016; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; El Chehadeh S, 2015, AM J MED GENET A, V9999A, P1; Gold WA, 2014, MITOCHONDRION, V15, P10, DOI 10.1016/j.mito.2014.02.012; Halliwell B., 2015, FREE RADICALS BIOL M; Harris N, 1996, CLIN CHEM, V42, P738; Hill VL, 2009, LABMEDICINE, V40, P709, DOI 10.1309/T0FJYP2RBXEHX4; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Janc OA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00056; Jiang S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004824; Kishi N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10520; Kriaucionis S, 2006, MOL CELL BIOL, V26, P5033, DOI 10.1128/MCB.01665-05; Kuo HC, 2015, INT J NEUROSCI, V125, P747, DOI 10.3109/00207454.2014.971787; Lugtenberg D, 2009, EUR J HUM GENET, V17, P444, DOI 10.1038/ejhg.2008.208; Muller M, 2014, BIOCHEM SOC T, V42, P959, DOI 10.1042/BST20140071; Munoz Pablo, 2012, Commun Integr Biol, V5, P166, DOI 10.4161/cib.18710; Musiek ES, 2004, J CHROMATOGR B, V799, P95, DOI 10.1016/j.jchromb.2003.10.036; Na ES, 2013, NEUROPSYCHOPHARMACOL, V38, P212, DOI 10.1038/npp.2012.116; Neul JL, 2008, NEUROLOGY, V70, P1313, DOI 10.1212/01.wnl.0000291011.54508.aa; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Pecorelli A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/137629; Piva E, 2007, CLIN BIOCHEM, V40, P491, DOI 10.1016/j.clinbiochem.2006.12.002; Pozzo-Miller L, 2015, NEUROTHERAPEUTICS, V12, P631, DOI 10.1007/s13311-015-0353-y; Ramocki MB, 2010, AM J MED GENET A, V152A, P1079, DOI 10.1002/ajmg.a.33184; Ravn K, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-58; Samaco RC, 2011, J NEUROSCI, V31, P7951, DOI 10.1523/JNEUROSCI.0169-11.2011; Shichiri M, 2014, J CLIN BIOCHEM NUTR, V54, P151, DOI 10.3164/jcbn.14-10; Shimada S, 2013, BRAIN DEV-JPN, V35, P411, DOI 10.1016/j.braindev.2012.07.010; Signorini C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/195935; Signorini C, 2011, CLIN CHIM ACTA, V412, P1399, DOI 10.1016/j.cca.2011.04.016; Song CD, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-17; TIETZ NW, 1995, CLIN GUIDE LAB TESTS, P610; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Van Esch H, 2011, MOL SYNDROMOL, V2, P128, DOI 10.1159/000329580; VanRollins M, 2008, J LIPID RES, V49, P995, DOI 10.1194/jlr.M700503-JLR200; Wagner C., 1998, CLIN LAB DIAGNOSTICS, P609	49	17	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150101	10.1371/journal.pone.0150101	http://dx.doi.org/10.1371/journal.pone.0150101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930212	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500099
J	Zhang, B; Song, Y; Jin, J; Zhou, LQ; He, ZS; Shen, C; He, Q; Li, J; Liu, LB; Wang, C; Chen, XY; Fan, Y; Hu, S; Zhang, L; Yu, W; Han, WK				Zhang, Bo; Song, Yi; Jin, Jie; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Wang, Cong; Chen, Xiao-Yu; Fan, Yu; Hu, Shuai; Zhang, Lei; Yu, Wei; Han, Wen-Ke			Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; ARISTOLOCHIC ACID; EUROPEAN COHORT; SURVIVAL; CANCER; METASTASIS; GROWTH; PLATELETS; TAIWAN	Background Increased plasma fibrinogen is thought to contribute to tumor progression and metastasis. The association of plasma fibrinogen with clinicopathological characteristics, and the optimal cutoff with an ideal predictive value has not been fully determined in patients with upper tract urothelial carcinoma (UTUC). We aimed to investigate the clinical significance of this parameter in a Chinese cohort of patients with UTUC. Methods A retrospective study was conducted to analyze the clinical data of 184 operable UTUC patients in a Chinese cohort with a high incidence of chronic kidney disease (CKD). An optimal cutoff was set for further analysis according to validated web-based software. The associations of plasma fibrinogen with clinicopathological characteristics and survival were assessed. Multivariate analyses were performed to determine the independent prognostic factors. Results Elevated plasma fibrinogen was significantly associated with tumor necrosis, lymph node involvement, and a higher preoperative CKD stage, pathological tumor stage and grade (all P < 0.05). Kaplan-Meier analysis showed that plasma fibrinogen >= 3.54 g/L predicted a poorer overall and cancer-specific survival than < 3.54 g/L (P < 0.001 for both). Multivariate analyses revealed that elevated preoperative plasma fibrinogen was an independent negative prognostic factor for overall survival (HR = 2.026; 95% CI: 1.226-3.349; P = 0.006) and cancer-specific survival (HR = 1.886; 95% CI: 1.019-3.490; P = 0.043). Conclusions Increased plasma fibrinogen was an independent prognostic risk factor for poor outcomes in UTUC. This parameter may serve as an effective biomarker with easy accessibility for evaluating prognosis for patients with UTUC.	[Zhang, Bo; Song, Yi; Jin, Jie; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Yu, Wei; Han, Wen-Ke] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Song, Yi; Jin, Jie; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Yu, Wei; Han, Wen-Ke] Peking Univ, Inst Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Song, Yi; Jin, Jie; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Yu, Wei; Han, Wen-Ke] Natl Urol Canc Ctr, Beijing, Peoples R China; [Wang, Cong; Chen, Xiao-Yu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Yu, W; Han, WK (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China.; Yu, W; Han, WK (corresponding author), Peking Univ, Inst Urol, Beijing 100871, Peoples R China.; Yu, W; Han, WK (corresponding author), Natl Urol Canc Ctr, Beijing, Peoples R China.	yuweif@126.com; hanwenke@medmail.com.cn	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [81200548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China to Wei Yu (http://www.nsfc.gov.cn/publish/portal1/) (grant nos. 81200548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobek V, 2004, BIOMED PHARMACOTHER, V58, P213, DOI 10.1016/j.biopha.2003.11.007; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; Chen CY, 2007, J FORMOS MED ASSOC, V106, P992, DOI 10.1016/S0929-6646(08)60074-1; Chen CH, 2013, INT J CANCER, V133, P14, DOI 10.1002/ijc.28013; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Erdem S, 2014, UROL ONCOL-SEMIN ORI, V32, P1031, DOI 10.1016/j.urolonc.2014.03.013; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Kawai K, 2014, SURG TODAY, V44, P797, DOI 10.1007/s00595-013-0606-5; Lai MN, 2010, JNCI-J NATL CANCER I, V102, P179, DOI 10.1093/jnci/djp467; Lee SE, 2012, J GASTRIC CANCER, V12, P81, DOI [10.5230/jgc.2012.12.2.81, 10.5230/jgc.2012.12.2.88]; Lee SE, 2007, JPN J CLIN ONCOL, V37, P49, DOI 10.1093/jjco/hyl123; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Novara G, 2010, EUR UROL, V57, P1064, DOI 10.1016/j.eururo.2009.12.029; Palumbo JS, 2005, BLOOD, V105, P178, DOI 10.1182/blood-2004-06-2272; Palumbo JS, 2002, CANCER RES, V62, P6966; Pichler M, 2013, BRIT J CANCER, V109, P1123, DOI 10.1038/bjc.2013.443; Pichler M, 2014, J UROLOGY, V191, P920, DOI 10.1016/j.juro.2013.10.073; Porten S, 2014, CANCER-AM CANCER SOC, V120, P1794, DOI 10.1002/cncr.28655; Qayyum Tahir, 2013, Curr Urol, V6, P189, DOI 10.1159/000343537; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Roupret M, 2011, EUR UROL, V59, P584, DOI 10.1016/j.eururo.2010.12.042; Sahni A, 2000, BLOOD, V96, P3772, DOI 10.1182/blood.V96.12.3772.h8003772_3772_3778; Sahni A, 2008, J THROMB HAEMOST, V6, P176; Song SW, 2006, ANN THORAC SURG, V81, P1974, DOI 10.1016/j.athoracsur.2006.01.032; Sung HH, 2015, BJU INT, V115, P587, DOI 10.1111/bju.12846; Takeuchi H, 2007, J GASTROEN HEPATOL, V22, P2222, DOI 10.1111/j.1440-1746.2006.04736.x; Tanaka N, 2013, BJU INT, V111, P857, DOI 10.1111/j.1464-410X.2012.11353.x; Tsimafeyeu IV, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-30; Wang HY, 2014, PLATELETS, V25, P382, DOI 10.3109/09537104.2013.827782; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7; Zheng S, 2009, CANCER SCI, V100, P859, DOI 10.1111/j.1349-7006.2009.01115.x	34	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150193	10.1371/journal.pone.0150193	http://dx.doi.org/10.1371/journal.pone.0150193			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930207	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500113
J	Callender, KL; Roy, S; Khasa, DP; Whyte, LG; Greer, CW				Callender, Katrina L.; Roy, Sebastien; Khasa, Damase P.; Whyte, Lyle G.; Greer, Charles W.			Actinorhizal Alder Phytostabilization Alters Microbial Community Dynamics in Gold Mine Waste Rock from Northern Quebec: A Greenhouse Study	PLOS ONE			English	Article							OIL SANDS; NITROGEN-FIXATION; ALNUS-INCANA; HEAVY-METAL; ECTOMYCORRHIZAL FUNGI; IN-VITRO; BACTERIAL; TAILINGS; FRANKIA; DIVERSITY	Phytotechnologies are rapidly replacing conventional ex-situ remediation techniques as they have the added benefit of restoring aesthetic value, important in the reclamation of mine sites. Alders are pioneer species that can tolerate and proliferate in nutrient-poor, contaminated environments, largely due to symbiotic root associations with the N-2-fixing bacteria, Frankia and ectomycorrhizal (ECM) fungi. In this study, we investigated the growth of two Frankia-inoculated (actinorhizal) alder species, A. crispa and A. glutinosa, in gold mine waste rock from northern Quebec. Alder species had similar survival rates and positively impacted soil quality and physico-chemical properties in similar ways, restoring soil pH to neutrality and reducing extractable metals up to two-fold, while not hyperaccumulating them into above-ground plant biomass. A. glutinosa outperformed A. crispa in terms of growth, as estimated by the seedling volume index (SVI), and root length. Pyrosequencing of the bacterial 16S rRNA gene for bacteria and the ribosomal internal transcribed spacer (ITS) region for fungi provided a comprehensive, direct characterization of microbial communities in gold mine waste rock and fine tailings. Plant-and treatment-specific shifts in soil microbial community compositions were observed in planted mine residues. Shannon diversity and the abundance of microbes involved in key ecosystem processes such as contaminant degradation (Sphingomonas, Sphingobium and Pseudomonas), metal sequestration (Brevundimonas and Caulobacter) and N-2-fixation (Azotobacter, Mesorhizobium, Rhizobium and Pseudomonas) increased over time, i. e., as plants established in mine waste rock. Acetate mineralization and most probable number (MPN) assays showed that revegetation positively stimulated both bulk and rhizosphere communities, increasing microbial density (biomass increase of 2 orders of magnitude) and mineralization (five-fold). Genomic techniques proved useful in investigating tripartite (plant-bacteria-fungi) interactions during phytostabilization, contributing to our knowledge in this field of study.	[Callender, Katrina L.; Whyte, Lyle G.] McGill Univ, Dept Nat Resource Sci, Ste Anne De Bellevue, PQ, Canada; [Callender, Katrina L.; Greer, Charles W.] Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada; [Roy, Sebastien] Univ Sherbrooke, Dept Biol, Quebec City, PQ, Canada; [Khasa, Damase P.] Univ Laval, Quebec City, PQ, Canada	McGill University; National Research Council Canada; University of Sherbrooke; Laval University	Greer, CW (corresponding author), Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada.	charles.greer@nrc-cnrc.gc.ca	Roy, Sébastien/A-5615-2008	Roy, Sébastien/0000-0001-7183-0691; Khasa, Damase/0000-0002-9336-7770	Natural Sciences and Engineering Research Council (NSERC) [STPGP 396879-10]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided through a Natural Sciences and Engineering Research Council (NSERC) Strategic Project Grant, STPGP 396879-10, awarded to DPK, CWG and SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu AG, 2013, J HAZARD MATER, V250, P477, DOI 10.1016/j.jhazmat.2013.02.014; BAKER D, 1979, NATURE, V281, P76, DOI 10.1038/281076a0; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Belanger P-A, 2015, CHEMOSPHERE IN PRESS; Belanger PA, 2013, BOTANY, V91, P218, DOI 10.1139/cjb-2012-0184; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Bent E, 2011, APPL ENVIRON MICROB, V77, P3351, DOI 10.1128/AEM.02575-10; Bissonnette C, 2014, ECOL ENG, V68, P167, DOI 10.1016/j.ecoleng.2014.03.061; BOND G, 1967, PLANT SOIL, V27, P447, DOI 10.1007/BF01376337; Bourret MM, 2009, J ENVIRON QUAL, V38, P693, DOI 10.2134/jeq2008.0153; Brady NC, 1991, NATURE PROPERTIES SO, P881; Bruneel O, 2006, APPL ENVIRON MICROB, V72, P551, DOI 10.1128/AEM.72.1.551-556.2006; Butkus D., 2007, EKOLOGIJA, V53, P68; Cerda A, 1997, J ARID ENVIRON, V36, P37, DOI 10.1006/jare.1995.0198; Chodak M, 2013, APPL SOIL ECOL, V64, P7, DOI 10.1016/j.apsoil.2012.11.004; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Davis N, 2008, P HIGH ALT REV C REV, P35; Ding GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065112; Epelde L, 2009, J ENVIRON QUAL, V38, P2041, DOI 10.2134/jeq2009.0006; Epelde L, 2009, SOIL BIOL BIOCHEM, V41, P1788, DOI 10.1016/j.soilbio.2008.04.001; Fernandez DA, 2012, MICROB ECOL, V63, P794, DOI 10.1007/s00248-011-9972-y; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Franklin JA, 2002, J ENVIRON QUAL, V31, P648, DOI 10.2134/jeq2002.0648; Greer CW, 2005, P REM TECHN S P REM; Guo ZH, 2009, BIORESOURCE TECHNOL, V100, P3831, DOI 10.1016/j.biortech.2009.02.043; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hadwin AKM, 2006, FEMS MICROBIOL ECOL, V55, P68, DOI 10.1111/j.1574-6941.2005.00009.x; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Hansel CM, 2008, APPL ENVIRON MICROB, V74, P1620, DOI 10.1128/AEM.01787-07; He YJ, 2013, FOREST ECOL MANAG, V295, P193, DOI 10.1016/j.foreco.2013.01.020; HILGER A B, 1991, New Forests, V5, P35, DOI 10.1007/BF00037549; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hur M, 2012, J MICROBIOL, V50, P910, DOI 10.1007/s12275-012-2491-9; International Council on Mining and Metals (ICMM), 2011, PROJ MIN CLOS LEG; Johnson DB, 2012, FEMS MICROBIOL ECOL, V81, P2, DOI 10.1111/j.1574-6941.2011.01293.x; Kabata-Pendias A, 2010, TRACE ELEMENTS SOILS, Vfourth, DOI [DOI 10.1201/B10158, 10.1201/9781420039900]; Kernaghan G, 2002, RESTOR ECOL, V10, P43, DOI 10.1046/j.1526-100X.2002.10105.x; Khasa DP, 2014, CANADIAN RECLAMATION, V14, P36; Khasa PD, 2002, FOREST ECOL MANAG, V165, P257, DOI 10.1016/S0378-1127(01)00623-5; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Kramer PA, 2000, J ENVIRON QUAL, V29, P1762, DOI 10.2134/jeq2000.00472425002900060005x; Kuang JL, 2013, ISME J, V7, P1038, DOI 10.1038/ismej.2012.139; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lefrancois E, 2010, APPL SOIL ECOL, V46, P183, DOI 10.1016/j.apsoil.2010.08.010; Legendre P, 2001, OECOLOGIA, V129, P271, DOI 10.1007/s004420100716; Liao M, 2007, ECOTOX ENVIRON SAFE, V66, P217, DOI 10.1016/j.ecoenv.2005.12.013; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; Lorenc-Plucinska G, 2013, ECOL ENG, V58, P214, DOI 10.1016/j.ecoleng.2013.07.002; Mains D, 2006, INT J PHYTOREMEDIAT, V8, P163, DOI 10.1080/15226510600742559; Mallet P., 2014, J PETROLEUM ENV BIOT, V5, P1, DOI [10.4172/2157-7463.1000180, DOI 10.4172/2157-7463.1000180]; Marco D, 2010, METAGENOMICS: THEORY, METHODS AND APPLICATIONS, P1; Markham JH, 2005, CAN J BOT, V83, P1384, DOI 10.1139/b05-108; Markham JH, 2007, CAN J BOT, V85, P787, DOI 10.1139/B07-075; Martin KJ, 2003, PLANT SOIL, V254, P187, DOI 10.1023/A:1024955232386; Mendez Monica O., 2008, Reviews in Environmental Science and Bio/Technology, V7, P47, DOI 10.1007/s11157-007-9125-4; Mijangos I, 2006, ENZYME MICROB TECH, V40, P100, DOI 10.1016/j.enzmictec.2005.10.043; Ministere de l'Environnement et de la Faune, 1992, SOIL PROT CONT SIT R; Munshower FF., 1994, PRACTICAL HDB DISTUR; NEEFS JM, 1993, NUCLEIC ACIDS RES, V21, P3025, DOI 10.1093/nar/21.13.3025; NITTAYAJARN A, 1989, PLANT SOIL, V118, P199, DOI 10.1007/BF02232807; Nossov DR, 2011, J ECOL, V99, P621, DOI 10.1111/j.1365-2745.2010.01792.x; Nouri J, 2009, ENVIRON EARTH SCI, V59, P315, DOI 10.1007/s12665-009-0028-2; Orfanoudakis MZ, 2004, SYMBIOSIS, V36, P69; PDAC and The Mining Association of Canada (MAC), 2012, MIN 100 INN MIN IND; Pereira LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096605; Phillips LA, 2006, SOIL BIOL BIOCHEM, V38, P2823, DOI 10.1016/j.soilbio.2006.04.038; Polme S, 2013, NEW PHYTOL, V198, P1239, DOI 10.1111/nph.12170; Prouzova P, 2012, 5TH INTERNATIONAL SYMPOSIUM ON BIOSORPTION AND BIOREMEDIATION, P60; Pulford ID, 2003, ENVIRON INT, V29, P529, DOI 10.1016/S0160-4120(02)00152-6; Quoreshi A. M., 2007, Native Plants Journal, V8, P271, DOI 10.2979/NPJ.2007.8.3.271; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Redfield E, 2003, J ENVIRON QUAL, V32, P1008, DOI 10.2134/jeq2003.1008; Reid NB, 2005, RESTOR ECOL, V13, P594, DOI 10.1111/j.1526-100X.2005.00076.x; Rillig MC, 2006, NEW PHYTOL, V171, P41, DOI 10.1111/j.1469-8137.2006.01750.x; Rosselli W, 2003, PLANT SOIL, V256, P265, DOI 10.1023/A:1026100707797; ROVIRA AD, 1965, ANNU REV MICROBIOL, V19, P241, DOI 10.1146/annurev.mi.19.100165.001325; Roy S, 2005, PLANT SOIL, V272, P277, DOI 10.1007/s11104-004-5295-9; Roy S, 2007, CAN J BOT, V85, P237, DOI 10.1139/B07-017; Russo R. O., 1993, Journal of Sustainable Forestry, V1, P93; Sanchez-Andrea I, 2011, APPL ENVIRON MICROB, V77, P6085, DOI 10.1128/AEM.00654-11; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schwencke J, 1998, RECENT ADV FRANKIA P, P121; Seghers D, 2004, APPL ENVIRON MICROB, V70, P1475, DOI 10.1128/AEM.70.3.1475-1482.2004; Shi SJ, 2015, MBIO, V6, DOI 10.1128/mBio.00746-15; Siciliano SD, 2003, APPL ENVIRON MICROB, V69, P483, DOI 10.1128/AEM.69.1.483-489.2003; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; SMITH SE, 1997, MYCORRHIZAL SYMBIOSI, P605; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sprent J.I., 2001, NODULATION LEGUMES; Sprent JI, 2000, FIELD CROP RES, V65, P183, DOI 10.1016/S0378-4290(99)00086-6; SRIDHAR KR, 2000, FUNGAL DIVERS, V5, P119; Steven B, 2007, J MICROBIOL METH, V71, P275, DOI 10.1016/j.mimet.2007.09.009; Tiedje JM, 1988, MICROORGANISMS, V717, P179; United States National Research Council, 2005, MIN TOL AN, P510; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; WARMAN PR, 1988, LANDSCAPE URBAN PLAN, V16, P283, DOI 10.1016/0169-2046(88)90074-6; Weisskopf L, 2008, SOIL BIOL BIOCHEM, V40, P1772, DOI 10.1016/j.soilbio.2008.02.018; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wrenn BA, 1996, CAN J MICROBIOL, V42, P252, DOI 10.1139/m96-037; Wu DY, 2009, NATURE, V462, P1056, DOI 10.1038/nature08656; Xiang XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03829; Yamanaka T, 2003, PLANT SOIL, V254, P179, DOI 10.1023/A:1024938712822; Yan W, 2008, SOIL BIOL BIOCHEM, V40, P544, DOI 10.1016/j.soilbio.2007.09.001; Yergeau E, 2012, APPL ENVIRON MICROB, V78, P7626, DOI 10.1128/AEM.02036-12; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; Yergeau E, 2012, ISME J, V6, P692, DOI 10.1038/ismej.2011.124	110	14	15	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150181	10.1371/journal.pone.0150181	http://dx.doi.org/10.1371/journal.pone.0150181			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928913	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200026
J	Tang, XQ; Li, W; Xing, J; Sheng, XZ; Zhan, WB				Tang, Xiaoqian; Li, Wei; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin			SUMO and SUMO-Conjugating Enzyme E2 UBC9 Are Involved in White Spot Syndrome Virus Infection in Fenneropenaeus chinensis	PLOS ONE			English	Article							BETA-INTEGRIN; PROTEIN; SUMOYLATION; EXPRESSION; SHRIMP; WSSV; INTERACTS; FEATURES; GENES; CRAB	In previous work, small ubiquitin-like modifier (SUMO) in hemocytes of Chinese shrimp Fenneropenaeus chinensis was found to be up-regulated post-white spot syndrome virus (WSSV) infection using proteomic approach. However, the role of SUMO in viral infection is still unclear. In the present work, full length cDNAs of SUMO (FcSUMO) and SUMO-conjugating enzyme E2 UBC9 (FcUBC9) were cloned from F. chinensis using rapid amplification of cDNA ends approach. The open reading frame (ORF) of FcSUMO encoded a 93 amino acids peptide with the predicted molecular weight (M. W) of 10.55 kDa, and the UBC9 ORF encoded a 160 amino acids peptide with the predicted M. W of 18.35 kDa. By quantitative real-time RT-PCR, higher mRNA transcription levels of FcSUMO and FcUBC9 were detected in hemocytes and ovary of F. chinensis, and the two genes were significantly upregulated post WSSV infection. Subsequently, the recombinant proteins of FcSUMO and FcUBC9 were expressed in Escherichia coli BL21 (DE3), and employed as immunogens for the production of polyclonal antibody (PAb). Indirect immunofluorescence assay revealed that the FcSUMO and UBC9 proteins were mainly located in the hemocytes nuclei. By western blotting, a 13.5 kDa protein and a 18.7 kDa protein in hemocytes were recognized by the PAb against SUMO or UBC9 respectively. Furthermore, gene silencing of FcSUMO and FcUBC9 were performed using RNA interference, and the results showed that the number of WSSV copies and the viral gene expressions were inhibited by knockdown of either SUMO or UBC9, and the mortalities of shrimp were also reduced. These results indicated that FcSUMO and FcUBC9 played important roles in WSSV infection.	[Tang, Xiaoqian; Li, Wei; Xing, Jing; Sheng, Xiuzhen; Zhan, Wenbin] Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Yushan Rd 5, Qingdao 266003, Peoples R China; [Zhan, Wenbin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, 1 Wenhai Rd, Qingdao 266071, Peoples R China	Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Zhan, WB (corresponding author), Ocean Univ China, Lab Pathol & Immunol Aquat Anim, Yushan Rd 5, Qingdao 266003, Peoples R China.; Zhan, WB (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, 1 Wenhai Rd, Qingdao 266071, Peoples R China.	wbzhan@ouc.edu.cn			National Basic Research Program of China [2012CB114405]; Key Technology R&D Program of China [2012BAD17B01]; Taishan Scholar Program of Shandong Province; Special Fund for Agro-scientific Research in the Public Interest [201103034]	National Basic Research Program of China(National Basic Research Program of China); Key Technology R&D Program of China(National Key Technology R&D Program); Taishan Scholar Program of Shandong Province; Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the National Basic Research Program of China ( grant 2012CB114405), Key Technology R&D Program of China ( grant 2012BAD17B01), Taishan Scholar Program of Shandong Province, and Special Fund for Agro-scientific Research in the Public Interest ( grant 201103034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettermann K, 2012, CANCER LETT, V316, P113, DOI 10.1016/j.canlet.2011.10.036; Boggio R, 2006, CURR OPIN MICROBIOL, V9, P430, DOI 10.1016/j.mib.2006.06.008; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Chen AJ, 2013, J VIROL, V87, P636, DOI 10.1128/JVI.01671-12; Chiu MW, 2007, J BIOMED SCI, V14, P429, DOI 10.1007/s11373-007-9151-9; Dai YB, 2012, GENE, V503, P260, DOI 10.1016/j.gene.2012.04.056; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Hayashi T, 2002, EXP CELL RES, V280, P212, DOI 10.1006/excr.2002.5634; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kovalenko OV, 1996, P NATL ACAD SCI USA, V93, P2958, DOI 10.1073/pnas.93.7.2958; Kuwata T, 2008, GENES CELLS, V13, P931, DOI 10.1111/j.1365-2443.2008.01216.x; Laoong-U-Thai Y, 2009, INT J BIOL SCI, V5, P205; Lee J, 2007, PLANT J, V49, P79, DOI 10.1111/j.1365-313X.2006.02947.x; Li DF, 2007, VIROLOGY, V368, P122, DOI 10.1016/j.virol.2007.06.027; Li Q, 2007, FISH SHELLFISH IMMUN, V23, P982, DOI 10.1016/j.fsi.2007.03.008; Li W, 2013, PLOS ONE, V9; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415; Ongvarrasopone C, 2008, MAR BIOTECHNOL, V10, P374, DOI 10.1007/s10126-007-9073-6; Rout N, 2005, AQUACULTURE, V245, P31, DOI 10.1016/j.aquaculture.2004.11.040; Sanchez-Martinez JG, 2007, AQUAC RES, V38, P1339, DOI 10.1111/j.1365-2109.2007.01827.x; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Su HL, 2002, GENE, V296, P65, DOI 10.1016/S0378-1119(02)00843-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang XQ, 2012, AQUACULTURE, V368, P1, DOI 10.1016/j.aquaculture.2012.08.004; Ulrich Helle D., 2009, V497, P3, DOI 10.1007/978-1-59745-566-4_1; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang Q, 2012, GENE, V501, P135, DOI 10.1016/j.gene.2012.04.016; Wilson VG, 2001, EXP CELL RES, V271, P57, DOI 10.1006/excr.2001.5366; Zhong RJ, 2013, FISH SHELLFISH IMMUN, V35, P539, DOI 10.1016/j.fsi.2013.05.004	33	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150324	10.1371/journal.pone.0150324	http://dx.doi.org/10.1371/journal.pone.0150324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927328	Green Published, gold			2022-12-27	WOS:000371424200036
J	Troup, LJ; Bastidas, S; Nguyen, MT; Andrzejewski, JA; Bowers, M; Nomi, JS				Troup, Lucy J.; Bastidas, Stephanie; Nguyen, Maia T.; Andrzejewski, Jeremy A.; Bowers, Matthew; Nomi, Jason S.			An Event-Related Potential Study on the Effects of Cannabis on Emotion Processing	PLOS ONE			English	Article							VISUAL SELECTIVE ATTENTION; ENDOCANNABINOID SYSTEM; FACIAL EXPRESSIONS; P300; STIMULI; USERS; P3A; DELTA(9)-THC; PERCEPTION; VALENCE	The effect of cannabis on emotional processing was investigated using event-related potential paradigms (ERPs). ERPs associated with emotional processing of cannabis users, and non-using controls, were recorded and compared during an implicit and explicit emotional expression recognition and empathy task. Comparisons in P3 component mean amplitudes were made between cannabis users and controls. Results showed a significant decrease in the P3 amplitude in cannabis users compared to controls. Specifically, cannabis users showed reduced P3 amplitudes for implicit compared to explicit processing over centro-parietal sites which reversed, and was enhanced, at fronto-central sites. Cannabis users also showed a decreased P3 to happy faces, with an increase to angry faces, compared to controls. These effects appear to increase with those participants that self-reported the highest levels of cannabis consumption. Those cannabis users with the greatest consumption rates showed the largest P3 deficits for explicit processing and negative emotions. These data suggest that there is a complex relationship between cannabis consumption and emotion processing that appears to be modulated by attention.	[Troup, Lucy J.; Bastidas, Stephanie; Nguyen, Maia T.; Andrzejewski, Jeremy A.; Bowers, Matthew] Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA; [Nomi, Jason S.] Univ Miami, Dept Psychol, Miami, FL USA	Colorado State University; University of Miami	Troup, LJ (corresponding author), Colorado State Univ, Dept Psychol, Ft Collins, CO 80523 USA.	Lucy.Troup@colostate.edu	Troup, Lucy J/AAD-9747-2019	Troup, Lucy/0000-0001-6992-498X	Colorado State University Libraries Open Access Research and Scholarship Fund	Colorado State University Libraries Open Access Research and Scholarship Fund	The authors would like to acknowledge the Colorado State University Libraries Open Access Research and Scholarship Fund in providing funding for the publication of this article.	Ballard ME, 2012, J PSYCHOPHARMACOL, V26, P1289, DOI 10.1177/0269881112446530; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bocker KBE, 2010, PHARMACOL BIOCHEM BE, V96, P67, DOI 10.1016/j.pbb.2010.04.008; Bossong MG, 2013, EUR NEUROPSYCHOPHARM, V23, P1687, DOI 10.1016/j.euroneuro.2013.06.009; Campos-Outcalt D, 2014, ADHS12017291 COL DEP; CHAPMAN RM, 1964, NATURE, V203, P1155, DOI 10.1038/2031155a0; Compumedics Neuroscan, 2003, OFFL AN ACQ DAT SCAN, VII; Conroy MA, 2007, COGNITION EMOTION, V21, P891, DOI 10.1080/02699930600926752; Crean AD, 2011, J ADDICT MED, V5, P1, DOI [10.1097/ADM.0b013e31820c23fa, DOI 10.1097/ADM.0B013E31820C23FA]; D'Souza DC, 2012, NEUROPSYCHOPHARMACOL, V37, P1632, DOI 10.1038/npp.2012.8; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Delplanque S, 2006, INT J PSYCHOPHYSIOL, V60, P315, DOI 10.1016/j.ijpsycho.2005.06.006; Gilman JM, 2014, J NEUROSCI, V34, P5529, DOI 10.1523/JNEUROSCI.4745-13.2014; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hindocha CN, 2014, EUR NEUROPSYCHOPHARM; JOHNSTON VS, 1986, PSYCHOPHYSIOLOGY, V23, P684, DOI 10.1111/j.1469-8986.1986.tb00694.x; Kempel P, 2003, NEUROPSYCHOBIOLOGY, V48, P95, DOI 10.1159/000072884; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Krolak-Salmon P, 2001, EUR J NEUROSCI, V13, P987, DOI 10.1046/j.0953-816x.2001.01454.x; LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; LAURIAN S, 1991, INT J PSYCHOPHYSIOL, V10, P231, DOI 10.1016/0167-8760(91)90033-T; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Moreira FA, 2008, ADDICT BIOL, V13, P196, DOI 10.1111/j.1369-1600.2008.00104.x; Morgan CJA, 2012, PSYCHOL MED, V42, P391, DOI 10.1017/S0033291711001322; Nicholls C, 2015, BIOL PSYCHOL, V110, P115, DOI 10.1016/j.biopsycho.2015.07.013; Nomi JS, 2013, NEUROREPORT, V24, P813, DOI 10.1097/WNR.0b013e3283647682; Platt B, 2010, DRUG ALCOHOL DEPEN, V112, P27, DOI 10.1016/j.drugalcdep.2010.05.004; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2003, BRAIN TOPOGR, V15, P141, DOI 10.1023/A:1022637732495; Polich J., 2003, DETECTION CHANGE EVE, P83, DOI DOI 10.1007/978-1-4615-0294-4_; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rellecke J, 2012, BIOL PSYCHOL, V90, P23, DOI 10.1016/j.biopsycho.2012.02.002; Roschke J, 2003, NEUROPSYCHOPHARMACOL, V28, pS9, DOI 10.1038/sj.npp.1300139; Rossignol M, 2005, NEUROSCI LETT, V377, P115, DOI 10.1016/j.neulet.2004.11.091; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SOLOWIJ N, 1995, LIFE SCI, V56, P2119, DOI 10.1016/0024-3205(95)00197-E; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Theunissen EL, 2012, PSYCHOPHARMACOLOGY, V220, P341, DOI 10.1007/s00213-011-2479-x; Troup LJ, EDORIUM J PSYCHOL, V1, P9, DOI [10.5348/P13-2015-2-OA-2, DOI 10.5348/P13-2015-2-0A-2]; Weiland BJ, 2015, J NEUROSCI, V35, P1505, DOI 10.1523/JNEUROSCI.2946-14.2015; Weiser M., 2015, PSYCHIAT RES	45	13	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149764	10.1371/journal.pone.0149764	http://dx.doi.org/10.1371/journal.pone.0149764			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926868	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200015
J	Padayachee, T; Khamiakova, T; Shkedy, Z; Perola, M; Salo, P; Burzykowski, T				Padayachee, Trishanta; Khamiakova, Tatsiana; Shkedy, Ziv; Perola, Markus; Salo, Perttu; Burzykowski, Tomasz			The Detection of Metabolite-Mediated Gene Module Co-Expression Using Multivariate Linear Models	PLOS ONE			English	Article							LIKELIHOOD RATIO; EXPRESSION DATA; EQUALITY	Investigating whether metabolites regulate the co-expression of a predefined gene module is one of the relevant questions posed in the integrative analysis of metabolomic and transcriptomic data. This article concerns the integrative analysis of the two high-dimensional datasets by means of multivariate models and statistical tests for the dependence between metabolites and the co-expression of a gene module. The general linear model (GLM) for correlated data that we propose models the dependence between adjusted gene expression values through a block-diagonal variance-covariance structure formed by metabolic-subset specific general variance-covariance blocks. Performance of statistical tests for the inference of conditional co-expression are evaluated through a simulation study. The proposed methodology is applied to the gene expression data of the previously characterized lipid-leukocyte module. Our results show that the GLM approach improves on a previous approach by being less prone to the detection of spurious conditional co-expression.	[Padayachee, Trishanta; Khamiakova, Tatsiana; Shkedy, Ziv; Burzykowski, Tomasz] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat Biostat, Diepenbeek, Belgium; [Perola, Markus; Salo, Perttu] Natl Inst Hlth & Welf, Unit Publ Hlth Genom, Helsinki, Finland	Hasselt University; Finland National Institute for Health & Welfare	Padayachee, T (corresponding author), Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat Biostat, Diepenbeek, Belgium.	trishanta.padayachee@uhasselt.be	Shkedy, Ziv/AAQ-3096-2020; Burzykowski, Tomasz/T-2222-2018	Shkedy, Ziv/0000-0002-6306-0823; Burzykowski, Tomasz/0000-0003-3378-975X	European Union [305280]; IAP Research Network of the Belgian state (Belgian Science Policy) [P7/06]	European Union(European Commission); IAP Research Network of the Belgian state (Belgian Science Policy)(Belgian Federal Science Policy Office)	This research was funded by the MIMOmics grant of the European Union's Seventh Framework Programme (FP7-Health-F5-2012) under the grant agreement number 305280. The support of the IAP Research Network of the Belgian state (Belgian Science Policy) P7/06 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Chen J, 2011, BIOMETRICS, V67, P299, DOI 10.1111/j.1541-0420.2010.01413.x; Cole N, 1968, 66 U N CAR; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Furlotte NA, 2011, BIOINFORMATICS, V27, pI288, DOI 10.1093/bioinformatics/btr221; Galecki A, 2013, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-1-4614-3900-4; Gill PS, 2004, BIOMETRICS, V60, P525, DOI 10.1111/j.0006-341X.2004.00199.x; Gillis J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-306; Haldermans P, 2007, STAT APPL GENET MOL, V6; Inouye M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.93; Inouye M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001113; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Kayano M, 2014, IEEE ACM T COMPUT BI, V11, P154, DOI 10.1109/TCBB.2013.2297921; Larntz K., 1985, RAPPORT TECHNIQUE, P141; Lewis J, 2000, ESTIMATING REG UNPUB; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Lin D., 2012, MODELING DOSE RESPON; MODARRES R, 1992, COMMUN STAT-THEOR M, V21, P2107, DOI 10.1080/03610929208830901; Molenberghs G, 2011, LINEAR MIXED MODELS; Pooi AH, 2003, COMMUN STAT-SIMUL C, V32, P411, DOI 10.1081/SAC-120017498; Southworth LK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000776; Tesson BM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-497; Wilks SS, 1938, ANN MATH STAT, V9, P60, DOI 10.1214/aoms/1177732360; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520	25	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150257	10.1371/journal.pone.0150257	http://dx.doi.org/10.1371/journal.pone.0150257			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918614	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400111
J	Pesonen, AK; Lahti, M; Kuusinen, T; Tuovinen, S; Villa, P; Hamalainen, E; Laivuori, H; Kajantie, E; Raikkonen, K				Pesonen, Anu-Katriina; Lahti, Marius; Kuusinen, Tiina; Tuovinen, Soile; Villa, Pia; Hamalainen, Esa; Laivuori, Hannele; Kajantie, Eero; Raikkonen, Katri			Maternal Prenatal Positive Affect, Depressive and Anxiety Symptoms and Birth Outcomes: The PREDO Study	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PRETERM BIRTH; PSYCHOLOGICAL DISTRESS; PREGNANCY; STRESS; RISK; METAANALYSIS; POSTPARTUM; GESTATION; IMPACT	Background We investigated whether maternal prenatal emotions are associated with gestational length and birth weight in the large PREDO Study with multiple measurement points of emotions during gestation. Methods Altogether 3376 pregnant women self-assessed their positive affect (PA, Positive and Negative Affect Schedule) and depressive (Center for Epidemiologic Studies Depression Scale, CES-D) and anxiety (Spielberger State Anxiety Scale, STAI) symptoms up to 14 times during gestation. Birth characteristics were derived from the National Birth Register and from medical records. Results One standard deviation (SD) unit higher PA during the third pregnancy trimester was associated with a 0.05 SD unit longer gestational length, whereas one SD unit higher CES-D and STAI scores during the third trimester were associated with 0.04-0.05 SD unit shorter gestational lengths (P-values <= 0.02), corresponding to only 0.1-0.2% of the variation in gestational length. Higher PA during the third trimester was associated with a significantly decreased risk for preterm (< 37 weeks) delivery (for each SD unit higher positive affect, odds ratio was 0.8-fold (P = 0.02). Mothers with preterm delivery showed a decline in PA and an increase in CES-D and STAI during eight weeks prior to delivery. Post-term birth (>= 42 weeks), birth weight and fetal growth were not associated with maternal prenatal emotions. Conclusions This study with 14 measurements of maternal emotions during pregnancy show modest effects of prenatal emotions during the third pregnancy trimester, particularly in the weeks close to delivery, on gestational length. From the clinical perspective, the effects were negligible. No associations were detected between prenatal emotions and birth weight.	[Pesonen, Anu-Katriina; Lahti, Marius; Kuusinen, Tiina; Tuovinen, Soile; Raikkonen, Katri] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Villa, Pia] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, Dept Clin Chem, SF-00100 Helsinki, Finland; [Hamalainen, Esa] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Med Genet, Helsinki, Finland; [Laivuori, Hannele] Helsinki Univ Hosp, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Obstet & Gynecol, Helsinki, Finland; [Laivuori, Hannele] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland; [Kajantie, Eero] Natl Inst Hlth & Welf, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Childrens Hosp, Cent Hosp, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu	Pesonen, AK; Raikkonen, K (corresponding author), Univ Helsinki, Inst Behav Sci, Helsinki, Finland.	anukatriina.pesonen@helsinki.fi; katri.raikkonen@helsinki.fi	Laivuori, Hannele/F-2953-2011	Laivuori, Hannele/0000-0003-3212-7826	Academy of Finland; Emil Aaltonen Foundation, EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation; Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation; Novo Nordisk Fonden [NNF15OC0016362, NNF12OC1016374] Funding Source: researchfish	Academy of Finland(Academy of Finland); Emil Aaltonen Foundation, EVO; Finnish Medical Foundation; Jane and Aatos Erkko Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Paivikki and Sakari Sohlberg Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by Academy of Finland, the Emil Aaltonen Foundation, EVO (a special state subsidy for health, science research), the Finnish Medical Foundation, the Jane and Aatos Erkko Foundation, the Novo Nordisk Foundation, the Paivikki and Sakari Sohlberg Foundation, the Sigrid Juselius Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, AM J EPIDEMIOL, V159, P872, DOI 10.1093/aje/kwh122; Bussieres EL, 2015, DEV REV, V36, P179, DOI 10.1016/j.dr.2015.04.001; Ding XX, 2014, J AFFECT DISORDERS, V159, P103, DOI 10.1016/j.jad.2014.02.027; Dole N, 2003, AM J EPIDEMIOL, V157, P14, DOI 10.1093/aje/kwf176; EDWARDS CRW, 1993, LANCET, V341, P355, DOI 10.1016/0140-6736(93)90148-A; Field T, 2008, INT J NEUROSCI, V118, P1181, DOI 10.1080/00207450701820944; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE321, DOI 10.4088/JCP.12r07968; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Henrichs J, 2010, PSYCHOL MED, V40, P633, DOI 10.1017/S0033291709990894; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Huizink AC, 2014, J PSYCHOSOM OBST GYN, V35, P92, DOI 10.3109/0167482X.2014.944498; Kertes DA, 2016, CHILD DEV, V87, P61, DOI 10.1111/cdev.12487; Korhonen M, 2012, J AFFECT DISORDERS, V136, P680, DOI 10.1016/j.jad.2011.10.007; Kramer MS, 2009, AM J EPIDEMIOL, V169, P1319, DOI 10.1093/aje/kwp061; Lobel M, 2000, HEALTH PSYCHOL, V19, P544, DOI 10.1037/0278-6133.19.6.544; Lockwood CJ, 1999, AM J OBSTET GYNECOL, V180, pS264, DOI 10.1016/S0002-9378(99)70713-1; Mancuso RA, 2004, PSYCHOSOM MED, V66, P762, DOI 10.1097/01.psy.0000138284.70670.d5; Moisiadis VG, 2014, NAT REV ENDOCRINOL, V10, P403, DOI 10.1038/nrendo.2014.74; Molyneaux E, 2014, OBSTET GYNECOL, V123, P857, DOI 10.1097/AOG.0000000000000170; O'Donnell KJ, 2014, DEV PSYCHOPATHOL, V26, P393, DOI 10.1017/S0954579414000029; O'Keane V, 2011, J AFFECT DISORDERS, V130, P300, DOI 10.1016/j.jad.2010.10.004; Orr ST, 2012, MATERN CHILD HLTH J, V16, P973, DOI 10.1007/s10995-011-0822-9; Palma-Gudiel H, 2015, EPIGENETICS-US, V10, P893, DOI 10.1080/15592294.2015.1088630; Pearson RM, 2013, JAMA PSYCHIAT, V70, P1312, DOI 10.1001/jamapsychiatry.2013.2163; Pihkala J, 1989, Duodecim, V105, P1540; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raikkonen K, 2015, PSYCHOL MED, V45, P3217, DOI 10.1017/S003329171500121X; Raikkonen K, 2014, CLIN ENDOCRINOL, V81, P175, DOI 10.1111/cen.12412; Raisanen S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004883; Reynolds R. M., 2015, PSYCHOL MED, P1; Reynolds RM, 2013, PSYCHONEUROENDOCRINO, V38, P1, DOI 10.1016/j.psyneuen.2012.08.012; Rich-Edwards JW, 2008, J CLIN ENDOCR METAB, V93, P1946, DOI 10.1210/jc.2007-2535; Rini CK, 1999, HEALTH PSYCHOL, V18, P333, DOI 10.1037/0278-6133.18.4.333; Sandman CA, 1997, ANN NY ACAD SCI, V814, P266, DOI 10.1111/j.1749-6632.1997.tb46162.x; Spielberger CD, 1983, MANUAL FOR THE STATE; Van Batenburg-Eddes T, 2013, J CHILD PSYCHOL PSYC, V54, P591, DOI 10.1111/jcpp.12023; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Villa PM, 2013, BJOG-INT J OBSTET GY, V120, P64, DOI 10.1111/j.1471-0528.2012.03493.x; Voellmin A, 2013, J PSYCHOSOM RES, V75, P336, DOI 10.1016/j.jpsychores.2013.06.031; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	42	29	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150058	10.1371/journal.pone.0150058	http://dx.doi.org/10.1371/journal.pone.0150058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919119	Green Published, gold			2022-12-27	WOS:000371274400079
J	Pitt, JM; Blankley, S; Potempa, K; Graham, CM; Moreira-Teixeira, L; McNab, FW; Howes, A; Stavropoulos, E; Pascual, V; Banchereau, J; Chaussabel, D; O'Garra, A				Pitt, Jonathan M.; Blankley, Simon; Potempa, Krzysztof; Graham, Christine M.; Moreira-Teixeira, Lucia; McNab, Finlay W.; Howes, Ashleigh; Stavropoulos, Evangelos; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien; O'Garra, Anne			Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling	PLOS ONE			English	Article							SUPPRESS MACROPHAGE ACTIVATION; IFN-GAMMA; INNATE IMMUNITY; DI-AMP; INDUCTION; BACTERIA; APOPTOSIS; MICE; TUBERCULOSIS; LYMPHOCYTES	Analysis of the mouse transcriptional response to Listeria monocytogenes infection reveals that a large set of genes are perturbed in both blood and tissue and that these transcriptional responses are enriched for pathways of the immune response. Further we identified enrichment for both type I and type II interferon (IFN) signaling molecules in the blood and tissues upon infection. Since type I IFN signaling has been reported widely to impair bacterial clearance we examined gene expression from blood and tissues of wild type (WT) and type I IFN alpha beta receptor-deficient (Ifnar1(-/-)) mice at the basal level and upon infection with L. monocytogenes. Measurement of the fold change response upon infection in the absence of type I IFN signaling demonstrated an upregulation of specific genes at day 1 post infection. A less marked reduction of the global gene expression signature in blood or tissues from infected Ifnar1(-/-) as compared to WT mice was observed at days 2 and 3 after infection, with marked reduction in key genes such as Oasg1 and Stat2. Moreover, on in depth analysis, changes in gene expression in uninfected mice of key IFN regulatory genes including Irf9, Irf7, Stat1 and others were identified, and although induced by an equivalent degree upon infection this resulted in significantly lower final gene expression levels upon infection of Ifnar1(-/-) mice. These data highlight how dysregulation of this network in the steady state and temporally upon infection may determine the outcome of this bacterial infection and how basal levels of type I IFN-inducible genes may perturb an optimal host immune response to control intracellular bacterial infections such as L. monocytogenes.	[Pitt, Jonathan M.; Blankley, Simon; Potempa, Krzysztof; Graham, Christine M.; Moreira-Teixeira, Lucia; McNab, Finlay W.; Howes, Ashleigh; Stavropoulos, Evangelos; O'Garra, Anne] Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England; [Pascual, Virginia] INSERM, Baylor Inst Immunol Res, ANRS Ctr Human Vaccines, Dallas, TX USA; [Banchereau, Jacques] Jackson Lab Genom Med, 263 Farmington Ave, Farmington, CT 06030 USA; [Chaussabel, Damien] Benaroya Res Inst, Syst Immunol, Seattle, WA USA; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [O'Garra, Anne] Univ London Imperial Coll Sci Technol & Med, NHLI, Dept Med, London, England	Francis Crick Institute; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Jackson Laboratory; Benaroya Research Institute; Sidra Medical & Research Center; Imperial College London	O'Garra, A (corresponding author), Francis Crick Inst, Mill Hill Lab, Lab Immunoregulat & Infect, London, England.; O'Garra, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, NHLI, Dept Med, London, England.	anne.ogarra@crick.ac.uk	Chaussabel, Damien/AAX-1909-2020; Moreira-Teixeira, Lúcia/AAH-4216-2020; Pascual, Virginia/ABD-3099-2020	Moreira-Teixeira, Lúcia/0000-0002-4817-8196; Chaussabel, Damien/0000-0002-6131-7242; Graham, Christine/0000-0001-9329-6231; Blankley, Simon/0000-0001-9602-9075; O'Garra, Anne/0000-0001-9845-6134	Medical Research Council, United Kingdom [U117565642]; Francis Crick Institute, Mill Hill Laboratory [10126]; European Research Council [294682-TB-PATH]; UK Medical Research Council (MRC); UK Department for International Development (DFID) under MRC/DFID [MR/J010723/1]; MRC [MR/J010723/1, MC_U117565642] Funding Source: UKRI; Medical Research Council [1365570, 1105853, MC_U117565642, MR/J010723/1] Funding Source: researchfish; The Francis Crick Institute [10126, 10127] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute, Mill Hill Laboratory; European Research Council(European Research Council (ERC)European Commission); UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Medical Research Council, United Kingdom (U117565642), The Francis Crick Institute, Mill Hill Laboratory (Crick 10126) and the European Research Council (294682-TB-PATH). SB was in part jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement (MR/J010723/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Asselin-Paturel C, 2005, J EXP MED, V201, P1157, DOI 10.1084/jem.20041930; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Auerbuch V, 2004, J EXP MED, V200, P527, DOI 10.1084/jem.20040976; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bloom CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046191; BUCHMEIER NA, 1985, P NATL ACAD SCI USA, V82, P7404, DOI 10.1073/pnas.82.21.7404; Carrero JA, 2006, J EXP MED, V203, P933, DOI 10.1084/jem.20060045; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Carrero JA, 2004, J IMMUNOL, V172, P4866, DOI 10.4049/jimmunol.172.8.4866; Carrero JA, 2008, J IMMUNOL, V181, P1365, DOI 10.4049/jimmunol.181.2.1365; Carrero JA, 2012, ADV IMMUNOL, V113, P157, DOI 10.1016/B978-0-12-394590-7.00001-4; Chen YL, 2013, J EXP MED, V210, P2515, DOI 10.1084/jem.20130536; Dai WJ, 1997, J IMMUNOL, V158, P2259; Dresing P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015567; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Kadowaki N, 2000, J EXP MED, V192, P219, DOI 10.1084/jem.192.2.219; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Leber JH, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040006; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Ning S, 2011, GENES IMMUN, V12, P399, DOI 10.1038/gene.2011.21; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pankla R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r127; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rayamajhi M, 2010, VIRULENCE, V1, P418, DOI 10.4161/viru.1.5.12787; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Reutterer B, 2008, CELL MICROBIOL, V10, P1116, DOI 10.1111/j.1462-5822.2007.01114.x; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Stockinger S, 2004, J IMMUNOL, V173, P7416, DOI 10.4049/jimmunol.173.12.7416; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Witte CE, 2012, ADV IMMUNOL, V113, P135, DOI 10.1016/B978-0-12-394590-7.00002-6; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801	52	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150251	10.1371/journal.pone.0150251	http://dx.doi.org/10.1371/journal.pone.0150251			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918359	Green Published, gold			2022-12-27	WOS:000371274400109
J	Yokota, S; Oshio, S; Moriya, N; Takeda, K				Yokota, Satoshi; Oshio, Shigeru; Moriya, Nozomu; Takeda, Ken			Social Isolation-Induced Territorial Aggression in Male Offspring Is Enhanced by Exposure to Diesel Exhaust during Pregnancy	PLOS ONE			English	Article							IN-UTERO EXPOSURE; BRAIN MONOAMINE TURNOVER; PRENATAL EXPOSURE; PARTICULATE MATTER; OXIDATIVE STRESS; GENE DISRUPTION; BEHAVIOR; PARTICLES; ULTRAFINE; SEROTONIN	Diesel exhaust particles are a major component of ambient particulate matter, and concern about the health effects of exposure to ambient particulate matter is growing. Previously, we found that in utero exposure to diesel exhaust affected locomotor activity and motor coordination, but there are also indications that such exposure may contribute to increased aggression in offspring. Therefore, the aim of the present study was to test the effects of prenatal diesel exhaust exposure on social isolation-induced territorial aggression. Pregnant mice were exposed to low concentrations of diesel exhaust (DE; mass concentration of 90 mu g/m(3): DE group: n = 15) or clean air (control group: n = 15) for 8 h/day during gestation. Basal locomotion of male offspring was measured at 10 weeks of age. Thereafter, male offspring were individually housed for 2 weeks and subsequently assessed for aggression using the resident-intruder test at 12 weeks of age, and blood and brain tissue were collected from the male offspring on the following day for measuring serum testosterone levels and neurochemical analysis. There were no significant differences in locomotion between control and DE-exposed mice. However, DE-exposed mice showed significantly greater social isolation-induced territorial aggressive behavior than control mice. Additionally, socially-isolated DE-exposed mice expressed significantly higher concentrations of serum testosterone levels than control mice. Neurochemical analysis revealed that dopamine levels in the prefrontal cortex and nucleus accumbens were higher in socially isolated DE-exposed mice. Serotonin levels in the nucleus accumbens, amygdala, and hypothalamus were also lower in the socially isolated DE-exposed mice than in control mice. Thus, even at low doses, prenatal exposure to DE increased aggression and serum testosterone levels, and caused neurochemical changes in male socially isolated mice. These results may have serious implications for pregnant women living in regions with high levels of traffic-related air pollution.	[Yokota, Satoshi; Takeda, Ken] Tokyo Univ Sci, Ctr Environm Hlth Sci Next Generat, Res Inst Sci & Technol, Noda, Chiba 278, Japan; [Yokota, Satoshi; Oshio, Shigeru] Ohu Univ, Dept Hyg Chem, Sch Pharmaceut Sci, Koriyama, Fukushima, Japan; [Moriya, Nozomu] Hyogo Univ Hlth Sci, Dept Biopharmaceut, Kobe, Hyogo, Japan	Tokyo University of Science	Yokota, S (corresponding author), Tokyo Univ Sci, Ctr Environm Hlth Sci Next Generat, Res Inst Sci & Technol, Noda, Chiba 278, Japan.	satoshi_yokota1008@yahoo.co.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare;  [22. 5895]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); 	This work was supported by a Grant-in-Aid for JSPS Fellows (Satoshi Yokota, 22. 5895) and in part by a Grant-in-Aid for Science Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by a Grant-in Aid for the Private University Science Research Upgrade Promotion Business "Academic Frontier Project, a Grant-in Aid for Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, from the Ministry of Health, Labor, and Welfare" and a Grant-in Aid for MEXT-Supported Program for the Strategic Research Foundation at Private Universities.	Anstrom KK, 2009, NEUROSCIENCE, V161, P3, DOI 10.1016/j.neuroscience.2009.03.023; Antonini JM, 2009, NEUROTOXICOLOGY, V30, P915, DOI 10.1016/j.neuro.2009.09.006; Araujo JA, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-24; Bannai M, 2007, PSYCHOPHARMACOLOGY, V193, P295, DOI 10.1007/s00213-007-0780-5; Biswas P, 2005, J AIR WASTE MANAGE, V55, P708, DOI 10.1080/10473289.2005.10464656; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Brunner D, 1997, ANN NY ACAD SCI, V836, P81, DOI 10.1111/j.1749-6632.1997.tb52356.x; BUTTE JC, 1976, J ENDOCRINOL, V68, P235, DOI 10.1677/joe.0.0680235; Claxton LD, 2015, MUTAT RES-REV MUTAT, V763, P30, DOI 10.1016/j.mrrev.2014.09.002; Cologer-Clifford A, 1999, PHYSIOL BEHAV, V65, P823; CologerClifford A, 1997, PHARMACOL BIOCHEM BE, V58, P425, DOI 10.1016/S0091-3057(97)00295-5; Donaldson K, 2005, PART FIBRE TOXICOL, V2, DOI 10.1186/1743-8977-2-10; Elder A, 2006, ENVIRON HEALTH PERSP, V114, P1172, DOI 10.1289/ehp.9030; HADFIELD MG, 1988, BEHAV BRAIN RES, V31, P93, DOI 10.1016/0166-4328(88)90163-5; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hartz AMS, 2008, FASEB J, V22, P2723, DOI 10.1096/fj.08-106997; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HILAKIVI LA, 1989, PHARMACOL BIOCHEM BE, V33, P371, DOI 10.1016/0091-3057(89)90516-9; Hougaard KS, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-3; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Hussain S, 2009, TOXICOLOGY, V260, P142, DOI 10.1016/j.tox.2009.04.001; JONES GH, 1992, PHARMACOL BIOCHEM BE, V43, P17, DOI 10.1016/0091-3057(92)90635-S; Kleinman MT, 2008, TOXICOL LETT, V178, P127, DOI 10.1016/j.toxlet.2008.03.001; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Koike H, 2009, BEHAV BRAIN RES, V202, P114, DOI 10.1016/j.bbr.2009.03.028; Krivoshto IN, 2008, J AM BOARD FAM MED, V21, P55, DOI 10.3122/jabfm.2008.01.070139; Kumamoto T, 2013, J TOXICOL SCI, V38, P245, DOI 10.2131/jts.38.245; LASLEY SM, 1985, PSYCHOPHARMACOLOGY, V87, P313, DOI 10.1007/BF00432714; Leng A, 2004, PHARMACOL BIOCHEM BE, V77, P371, DOI 10.1016/j.pbb.2003.11.011; Levesque S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-105; Matsui Y, 2009, SPECTROCHIM ACTA B, V64, P796, DOI 10.1016/j.sab.2009.06.017; MIACHON S, 1993, BRAIN RES BULL, V32, P611, DOI 10.1016/0361-9230(93)90162-5; MILLER BL, 1979, NEUROPSYCHOBIOLOGY, V5, P11, DOI 10.1159/000117658; Miura H, 2002, SYNAPSE, V46, P116, DOI 10.1002/syn.10133; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Oberdorster G, 2004, INHAL TOXICOL, V16, P437, DOI 10.1080/08958370490439597; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5058, DOI 10.1210/en.139.12.5058; Ogawa S, 1997, P NATL ACAD SCI USA, V94, P1476, DOI 10.1073/pnas.94.4.1476; Ono N, 2007, INHAL TOXICOL, V19, P275, DOI 10.1080/08958370601069257; Pagani JH, 2015, GENES BRAIN BEHAV, V14, P167, DOI 10.1111/gbb.12202; Palanza P, 1999, PHARMACOL BIOCHEM BE, V64, P665, DOI 10.1016/S0091-3057(99)00151-3; Paxinos G, 2001, MOUSE BRAIN STEREOTA; SAYEGH J F, 1990, Steroids, V55, P79, DOI 10.1016/0039-128X(90)90029-B; SCHLINGER BA, 1990, GEN COMP ENDOCR, V79, P39, DOI 10.1016/0016-6480(90)90086-2; SCHNEIDER R, 1992, BEHAV NEURAL BIOL, V57, P198, DOI 10.1016/0163-1047(92)90150-3; Silverman DT, 2012, JNCI-J NATL CANCER I, V104, P855, DOI 10.1093/jnci/djs034; Simon NG, 1998, NEUROSCI BIOBEHAV R, V23, P325, DOI 10.1016/S0149-7634(98)00034-7; Sugamata M, 2006, J HEALTH SCI, V52, P82, DOI 10.1248/jhs.52.82; Suzuki T, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-7; Takeda Ken, 2004, Environ Sci, V11, P33; van Erp AMM, 2000, J NEUROSCI, V20, P9320; Wallace LA, 2004, ENVIRON SCI TECHNOL, V38, P2304, DOI 10.1021/es0306260; Win-Shwe TT, 2012, NANOTOXICOLOGY, V6, P543, DOI 10.3109/17435390.2011.590904; Wongwitdecha N, 1996, BEHAV BRAIN RES, V75, P27, DOI 10.1016/0166-4328(96)00181-7; Yokota S, 2015, NEUROTOXICOLOGY, V50, P108, DOI 10.1016/j.neuro.2015.08.009; Yokota S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070145; Yokota S, 2013, J TOXICOL SCI, V38, P13, DOI 10.2131/jts.38.13; Yokota S, 2009, NEUROSCI LETT, V449, P38, DOI 10.1016/j.neulet.2008.09.085; Yoshida Seiichi, 2006, Environmental Sciences, V13, P139	59	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149737	10.1371/journal.pone.0149737	http://dx.doi.org/10.1371/journal.pone.0149737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919122	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400043
J	Fong, SW; Lin, HC; Wu, MF; Chen, CC; Huang, YS				Fong, Sitt Wai; Lin, Hsiu-Chen; Wu, Meng-Fang; Chen, Chih-Cheng; Huang, Yi-Shuian			CPEB3 Deficiency Elevates TRPV1 Expression in Dorsal Root Ganglia Neurons to Potentiate Thermosensation	PLOS ONE			English	Article							INFLAMMATORY THERMAL HYPERALGESIA; COMPLETE FREUNDS-ADJUVANT; VANILLOID RECEPTOR TRPV1; PROTEIN-KINASE-C; CAPSAICIN-RECEPTOR; MESSENGER-RNA; TRANSLATIONAL CONTROL; SYNAPTIC PLASTICITY; SENSORY NEURONS; NMDA RECEPTORS	Cytoplasmic polyadenylation element binding protein 3 (CPEB3) is a sequence-specific RNA-binding protein that downregulates translation of multiple plasticity-related proteins (PRPs) at the glutamatergic synapses. Activity-induced synthesis of PRPs maintains long-lasting synaptic changes that are critical for memory consolidation and chronic pain manifestation. CPEB3-knockout (KO) mice show aberrant hippocampus-related plasticity and memory, so we investigated whether CPEB3 might have a role in nociception-associated plasticity. CPEB3 is widely expressed in the brain and peripheral afferent sensory neurons. CPEB3-KO mice with normal mechanosensation showed hypersensitivity to noxious heat. In the complete Freund's adjuvant (CFA)-induced inflammatory pain model, CPEB3-KO animals showed normal thermal hyperalgesia and transiently enhanced mechanical hyperalgesia. Translation of transient receptor potential vanilloid 1 (TRPV1) RNA was suppressed by CPEB3 in dorsal root ganglia (DRG), whereas CFA-induced inflammation reversed this inhibition. Moreover, CPEB3/TRPV1 double-KO mice behaved like TRPV1-KO mice, with severely impaired thermosensation and thermal hyperalgesia. An enhanced thermal response was recapitulated in non-inflamed but not inflamed conditional-KO mice, with cpeb3 gene ablated mostly but not completely, in small-diameter nociceptive DRG neurons. CPEB3-regulated translation of TRPV1 RNA may play a role in fine-tuning thermal sensitivity of nociceptors.	[Fong, Sitt Wai; Lin, Hsiu-Chen; Wu, Meng-Fang; Chen, Chih-Cheng; Huang, Yi-Shuian] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan	Academia Sinica - Taiwan	Huang, YS (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.	yishuian@ibms.sinica.edu.tw	Huang, Yi-Shuian/P-2824-2018; Chen, Chih-Cheng/S-7015-2018; Chen, Chih-Cheng/AAT-1062-2021	Huang, Yi-Shuian/0000-0001-9000-7748; Chen, Chih-Cheng/0000-0003-4768-5660; Chen, Chih-Cheng/0000-0003-4768-5660	Ministry of Science and Technology [MOST 102-2628-B-001-007-MY3, MOST102-2321-B-001-058]; Academia Sinica in Taiwan [AS-103-TP-B05]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Academia Sinica in Taiwan(Academia Sinica - Taiwan)	This work was supported by Ministry of Science and Technology [MOST 102-2628-B-001-007-MY3 and MOST102-2321-B-001-058 to YSH] and Academia Sinica [AS-103-TP-B05 to YSH] in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Baker KB, 2010, GENES BRAIN BEHAV, V9, P562, DOI 10.1111/j.1601-183X.2010.00585.x; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Bogen O, 2012, J NEUROSCI, V32, P2018, DOI 10.1523/JNEUROSCI.5138-11.2012; Bonin RP, 2014, NAT NEUROSCI, V17, P1043, DOI 10.1038/nn.3758; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Carlton SM, 2001, NEUROSCI LETT, V310, P53, DOI 10.1016/S0304-3940(01)02093-6; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Chao HW, 2012, NUCLEIC ACIDS RES, V40, P8484, DOI 10.1093/nar/gks598; Chen PJ, 2012, EMBO J, V31, P959, DOI 10.1038/emboj.2011.448; Cohen MR, 2014, CURR TOP MEMBR, V74, P181, DOI 10.1016/B978-0-12-800181-3.00007-5; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; de Moura JC, 2014, BRIT J PHARMACOL, V171, P4289, DOI 10.1111/bph.12786; Ferrari LF, 2014, P NATL ACAD SCI USA, V111, P18363, DOI 10.1073/pnas.1420601111; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2005, J PHARMACOL EXP THER, V313, P474, DOI 10.1124/jpet.104.079855; Graber TE, 2013, LEARN MEMORY, V20, P518, DOI 10.1101/lm.027664.112; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2008, CURR PHARM DESIGN, V14, P32; Hong SS, 2008, J NEUROCHEM, V105, P1212, DOI 10.1111/j.1471-4159.2008.05220.x; Hong SS, 2005, J BIOL CHEM, V280, P618, DOI 10.1074/jbc.M408500200; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Kidd BL, 2001, BRIT J ANAESTH, V87, P3, DOI 10.1093/bja/87.1.3; Leung L, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-27; Luo H, 2004, NEUROREPORT, V15, P655, DOI 10.1097/00001756-200403220-00016; Lutz BM, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0030-5; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Obara I, 2012, CURR OPIN PHARMACOL, V12, P42, DOI 10.1016/j.coph.2011.10.005; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Price TJ, 2007, J NEUROSCI, V27, P13958, DOI 10.1523/JNEUROSCI.4383-07.2007; Richter JD, 2009, GENE DEV, V23, P1, DOI 10.1101/gad.1735809; Sandkuhler J, 2013, TRENDS NEUROSCI, V36, P343, DOI 10.1016/j.tins.2013.03.004; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Stirling LC, 2005, PAIN, V113, P27, DOI 10.1016/j.pain.2004.08.015; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Szabo A, 2005, J PHARMACOL EXP THER, V314, P111, DOI 10.1124/jpet.104.082487; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tsai LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084978; Vandewauw I, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-21; Vellani V, 2001, J PHYSIOL-LONDON, V534, P813, DOI 10.1111/j.1469-7793.2001.00813.x; Wang CF, 2012, MOL CELL BIOL, V32, P3321, DOI 10.1128/MCB.00296-12; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61	57	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148491	10.1371/journal.pone.0148491	http://dx.doi.org/10.1371/journal.pone.0148491			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915043	gold, Green Published			2022-12-27	WOS:000371175700006
J	Mielgo-Ayuso, J; Aparicio-Ugarriza, R; Castillo, A; Ruiz, E; Avila, JM; Aranceta-Batrina, J; Gil, A; Ortega, RM; Serra-Majem, L; Varela-Moreiras, G; Gonzalez-Gross, M				Mielgo-Ayuso, Juan; Aparicio-Ugarriza, Raquel; Castillo, Adrian; Ruiz, Emma; Manuel Avila, Jose; Aranceta-Batrina, Javier; Gil, Angel; Ortega, Rosa M.; Serra-Majem, Lluis; Varela-Moreiras, Gregorio; Gonzalez-Gross, Marcela			Physical Activity Patterns of the Spanish Population Are Mostly Determined by Sex and Age: Findings in the ANIBES Study	PLOS ONE			English	Article							LEISURE-TIME; ACTIVITY RECOMMENDATIONS; ACTIVITY INTERVENTION; ENERGY-BALANCE; OLDER-ADULTS; FOLLOW-UP; HEALTH; FITNESS; OBESITY; TRENDS	Background Representative data for the Spanish population regarding physical activity (PA) behaviors are scarce and seldom comparable due to methodological inconsistencies. Aim Our objectives were to describe the PA behavior by means of the standardized self-reported International Physical Activity Questionnaire (IPAQ) and to know the proportion of the Spanish population meeting and not meeting international PA recommendations. Material and Methods PA was assessed using the IPAQ in a representative sample of 2285 individuals (males, 50.4%) aged 9-75 years and living in municipalities of at least 2,000 inhabitants. Data were analyzed according to: age groups 9-12, 13-17, 18-64, and 65-75 years; sex; geographical distribution; locality size and educational levels. Results Mean total PA was 868.8+/-660.9 min/wk, mean vigorous PA 146.4+/-254.1 min/wk, and mean moderate PA 398.1+/-408.0 min/wk, showing significant differences between sexes (p<0.05). Children performed higher moderate-vigorous PA than adolescents and seniors (p<0.05), and adults than adolescents and seniors (p<0.05). Compared to recommendations, 36.2% of adults performed <150 min/week of moderate PA, 65.4% <75 min/week of vigorous PA and 27.0% did not perform any PA at all, presenting significant differences between sexes (p<0.05). A total of 55.4% of children and adolescents performed less than 420 min/week of MVPA, being higher in the later (62.6%) than in the former (48.4%). Highest non-compliance was observed in adolescent females (86.5%). Conclusion Sex and age are the main influencing factors on PA in the Spanish population. Males engage in more vigorous and light PA overall, whereas females perform more moderate PA. PA behavior differs between age groups and no clear lineal increase with age could be observed. Twenty-seven percent of adults and 55.4% of children and adolescents do not meet international PA recommendations. Identified target groups should be addressed to increase PA in the Spanish population.	[Mielgo-Ayuso, Juan; Aparicio-Ugarriza, Raquel; Gonzalez-Gross, Marcela] Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain; [Castillo, Adrian; Ruiz, Emma; Manuel Avila, Jose; Varela-Moreiras, Gregorio] Spanish Nutr Fdn FEN, Madrid, Spain; [Aranceta-Batrina, Javier] Univ Navarra, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Aranceta-Batrina, Javier; Gil, Angel; Serra-Majem, Lluis; Gonzalez-Gross, Marcela] Inst Salud Carlos III ISCIII, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain; [Gil, Angel] Univ Granada, Dept Biochem & Mol Biol 2, Granada, Spain; [Gil, Angel] Univ Granada, Inst Nutr & Food Sci, Granada, Spain; [Ortega, Rosa M.] Univ Complutense Madrid, Fac Pharm, Dept Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Res Inst Biomed & Hlth Sci, Las Palmas Gran Canaria, Spain; [Varela-Moreiras, Gregorio] CEU San Pablo Univ, Dept Pharmaceut & Hlth Sci, Fac Pharm, Madrid, Spain	Universidad Politecnica de Madrid; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Granada; University of Granada; Complutense University of Madrid; Universidad de Las Palmas de Gran Canaria; San Pablo CEU University	Gonzalez-Gross, M (corresponding author), Tech Univ Madrid, Dept Hlth & Human Performance, ImFINE Res Grp, Madrid, Spain.; Gonzalez-Gross, M (corresponding author), Inst Salud Carlos III ISCIII, CIBEROBN Physiopathol Obes & Nutr CB12 03 30038, Madrid, Spain.	marcela.gonzalez.gross@upm.es	Gil, Angel/ABA-7621-2020; Serra-Majem, Lluis/I-6708-2019; Aparicio-Ugarriza, Raquel/AAE-8946-2020; Gil, Angel/L-2275-2014; Ortega, Rosa M/S-5760-2016; Moreno, Emma Ruiz/S-7210-2018; Mielgo-Ayuso, Juan/E-7525-2019; Gonzalez-Gross, Marcela/W-8000-2018	Gil, Angel/0000-0001-7663-0939; Serra-Majem, Lluis/0000-0002-9658-9061; Gil, Angel/0000-0001-7663-0939; Ortega, Rosa M/0000-0003-3837-9450; Moreno, Emma Ruiz/0000-0003-3662-4440; Mielgo-Ayuso, Juan/0000-0002-6554-4602; Gonzalez-Gross, Marcela/0000-0001-7757-3235; VARELA-MOREIRAS, GREGORIO/0000-0001-5158-4999	Coca-Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	Coca-Cola Iberia through Spanish Nutrition Foundation (FEN); Coca-Cola Iberia	The ANIBES study was financially supported by a grant from Coca-Cola Iberia through an agreement with the Spanish Nutrition Foundation (FEN). The funding sponsor had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Coca-Cola Iberia for its support, particularly Dr. Rafael Urrialde and Isabel de Julian.	[Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Aparicio-Ugarriza R, 2015, NUTR HOSP, V31, P219, DOI 10.3305/nh.2015.31.sup3.8769; Balboa-Castillo T, 2011, AM J PREV MED, V40, P39, DOI 10.1016/j.amepre.2010.10.005; Carlson S. A., 2008, Morbidity and Mortality Weekly Report, V57, P1297; Casado-Perez C, 2015, MATURITAS, V80, P391, DOI 10.1016/j.maturitas.2014.12.014; Celis-Morales C, 2015, J PUBLIC HLTH OXF, P1; Chillon P, 2013, INT J BEHAV MED, V20, P529, DOI 10.1007/s12529-012-9267-9; Chodzko-Zajko WJ, 2012, GAC SANIT, V26, P525, DOI [10.1016/j.gaceta.2012.10.019, 10.1016/j.gaceta.2011.10.019]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Currie C., 2012, SOCIAL DETERMINANTS; Donnelly JE, 2009, MED SCI SPORT EXER, V41, P459, DOI 10.1249/MSS.0b013e3181949333; European Commission, 2010, EUR 72 3 SPORT PHYS; European Commission, 2014, SPEC EUR 412 SPORT P; Ferrus M.A., 2015, REV COMCIENT FICO AE, V21, P45; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gerovasili V, 2015, PREV MED, V81, P87, DOI 10.1016/j.ypmed.2015.08.005; Guallar-Castillon P, 2004, MED CLIN-BARCELONA, V123, P606, DOI 10.1157/13068435; Gutin B, 2008, INT J PEDIATR OBES, V3, P3, DOI 10.1080/17477160801896457; Hagstromer M, 2008, INT J OBESITY, V32, pS42, DOI 10.1038/ijo.2008.182; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Haskell WL, 2007, MED SCI SPORT EXER, V39, P1423, DOI [10.1249/mss.0b013e3180616b27, 10.1161/CIRCULATIONAHA.107.185649]; Kruger J., 2007, Morbidity and Mortality Weekly Report, V56, P1209; Lakka TA, 2005, HANDB EXP PHARM, V170, P137; Lamonte MJ, 2001, MED SCI SPORT EXER, V33, pS370, DOI 10.1097/00005768-200106001-00006; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Martinez-Gomez D, 2009, NUTR HOSP, V24, P226; Martinez-Gomez D, 2009, REV ESP SALUD PUBLIC, V83, P427, DOI 10.1590/s1135-57272009000300008; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; Meseguer CM, 2011, REV ESP CARDIOL, V64, P21, DOI [10.1016/j.recesp.2010.07.007, 10.1016/j.rec.2010.06.010]; Ministerio de Sanidad Consumo Igualdad y Servicios Sociales, 2012, ENC NAC SAL 2011 201; Owen N, 2012, PHYSIOL MEAS, V33, P1801, DOI 10.1088/0967-3334/33/11/1801; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Palacios-Cena D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-799; Pardo A, 2014, J SCI MED SPORT, V17, P188, DOI 10.1016/j.jsams.2013.04.002; Pedrero-Chamizo R, 2012, ARCH GERONTOL GERIAT, V55, P406, DOI 10.1016/j.archger.2012.02.004; Perez-Rios M, 2015, GAC SANIT, V29, P127, DOI 10.1016/j.gaceta.2014.09.007; Roman B, 2009, NUTR REV, V67, pS94, DOI 10.1111/j.1753-4887.2009.00168.x; Roman-Vinas B, 2010, EUR J SPORT SCI, V10, P297, DOI 10.1080/17461390903426667; Ruiz E, 2015, NUTRIENTS, V7, P970, DOI 10.3390/nu7020970; Salanave B, 2012, PUBLIC HEALTH NUTR, V15, P2054, DOI 10.1017/S1368980012003278; Schnohr C, 2004, SCAND J PUBLIC HEALT, V32, P250, DOI 10.1177/140349480403200403; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Smith LP, 2014, SOC SCI MED, V120, P126, DOI 10.1016/j.socscimed.2014.09.010; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Moreiras GV, 2015, NUTR HOSP, V31, P101, DOI 10.3305/nh.2015.31.sup3.8758; Varela-Moreiras G, 2013, NUTR HOSP, V28, P1, DOI 10.3305/nh.2013.28.sup5.6913; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104; World Health Organization, 2010, SOC DET HLTH IN CHIL	49	74	78	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149969	10.1371/journal.pone.0149969	http://dx.doi.org/10.1371/journal.pone.0149969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914609	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700041
J	van der Kroef, S; Noordam, R; Deelen, J; Akintola, AA; Jansen, SWM; Postmus, I; Wijsman, CA; Beekman, M; Mooijaart, SP; Slagboom, PE; van Heemst, D				van der Kroef, Sabrina; Noordam, Raymond; Deelen, Joris; Akintola, Abimbola A.; Jansen, Steffy W. M.; Postmus, Iris; Wijsman, Carolien A.; Beekman, Marian; Mooijaart, Simon P.; Slagboom, P. Eline; van Heemst, Diana			Association between the rs7903146 Polymorphism in the TCF7L2 Gene and Parameters Derived with Continuous Glucose Monitoring in Individuals without Diabetes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; PANCREATIC BETA-CELLS; NONDIABETIC INDIVIDUALS; GLYCEMIC VARIABILITY; BODY-COMPOSITION; FASTING GLUCOSE; WEIGHT-LOSS; RISK LOCI; TYPE-2; VARIANTS	Background The rs7903146-T allele in the transcription factor 7-like 2 (TCF7L2) gene has been associated with impaired pancreatic insulin secretion, enhanced liver glucose production, and an increased risk of type 2 diabetes. Nevertheless, the impact of rs7903146 on daily glucose trajectories remains unclear. Continuous glucose monitoring (CGM) can estimate glycemia and glycemic variability based on consecutive glucose measurements collected over several days. The purpose of the present study was to investigate the associations of rs7903146 with glycemia and glycemic variability in middle-aged participants without diabetes. Methods Complete data from 235 participants without diabetes from the Leiden Longevity Study were available. Participants were divided into two groups based on rs7903146 genotype; rs7903146-CC genotype carriers (N = 123) and rs7903146-CT/TT genotype carriers (N = 112). Validated parameters of glycemia (e.g., mean 24h glucose level) and glycemic variability (e.g., 24h standard deviation) were derived from data collected with a CGM system for a 72-hour period. Results The study population was on average 64.7 years old (standard deviation = 5.9) and composed of 49.8% of women. Compared with rs7903146-CC carriers, rs7903146-CT/TT carriers exhibited a trend towards a higher mean 24-hour glucose level (5.21 versus 5.32 mmol/L; p-value = 0.15) and a significantly higher mean nocturnal glucose (3: 00 am-6: 00am; 4.48 versus 4.67 mmol/L; p-value = 0.03) that was explained for 34.6% by body weight and percentage body fat. No differences in measures of glycemic variability between the genotype groups were observed. Conclusion Despite limited sample size, our study indicates that the rs7903146-T allele in TCF7L2 was associated with a higher mean nocturnal glucose dependent on body composition, which might suggest that rs7902146 affects liver-specific aspects of glucose metabolism.	[van der Kroef, Sabrina; Noordam, Raymond; Akintola, Abimbola A.; Jansen, Steffy W. M.; Postmus, Iris; Wijsman, Carolien A.; Mooijaart, Simon P.; van Heemst, Diana] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Deelen, Joris; Beekman, Marian; Slagboom, P. Eline] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Sect Mol Epidemiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Heemst, D (corresponding author), Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands.	D.van_Heemst@lumc.nl	Akintola, Abi/T-5361-2019; Deelen, Joris/H-3201-2019; Slagboom, P. Eline/R-4790-2016; Mooijaart, Simon P./A-5306-2008; Beekman, Marian/L-3004-2019	Deelen, Joris/0000-0003-4483-3701; Slagboom, P. Eline/0000-0002-2875-4723; Mooijaart, Simon P./0000-0003-3106-3568; Beekman, Marian/0000-0003-0585-6206; Noordam, Raymond/0000-0001-7801-809X	European Commission [Health-2013-INNOVATION-1-602757, Health-F2-2010-259772]; Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO) [050-060-810. NCHA]	European Commission(European CommissionEuropean Commission Joint Research Centre); Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by the European Commission funded projects Health and the Understanding of Metabolism, Aging and Nutrition (HUMAN, FP7, Health-2013-INNOVATION-1-602757) and Switchbox (FP7, Health-F2-2010-259772) and the Netherlands Genomics Initiative/Netherlands Organization for scientific research (NGI/NWO; 050-060-810. NCHA). The funders had no role in the design of the study, data collection and analysis, decision to publish, or preparation of the manuscript.	Akintola AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139973; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boj SF, 2012, CELL, V151, P1595, DOI 10.1016/j.cell.2012.10.053; Borg R, 2010, DIABETOLOGIA, V53, P1608, DOI 10.1007/s00125-010-1741-9; Cauchi S, 2007, J MOL MED, V85, P777, DOI 10.1007/s00109-007-0203-4; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haupt A, 2010, DIABETES, V59, P747, DOI 10.2337/db09-1050; Le Bacquer O, 2012, DIABETOLOGIA, V55, P2677, DOI 10.1007/s00125-012-2660-8; Lyssenko V, 2008, CURR OPIN CLIN NUTR, V11, P385, DOI 10.1097/MCO.0b013e328304d970; Lyssenko V, 2007, J CLIN INVEST, V117, P2155, DOI 10.1172/JCI30706; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Mastrototaro J J, 2000, Diabetes Technol Ther, V2 Suppl 1, pS13, DOI 10.1089/15209150050214078; Mattei J, 2012, AM J CLIN NUTR, V96, P1129, DOI 10.3945/ajcn.112.038125; McCarthy MI, 2013, CELL METAB, V17, P157, DOI 10.1016/j.cmet.2013.01.011; McDonnell C M, 2005, Diabetes Technol Ther, V7, P253, DOI 10.1089/dia.2005.7.253; Prunier C, 2004, GROWTH FACTORS, V22, P141, DOI 10.1080/08977190410001720860; Rodbard D, 2009, DIABETES TECHNOL THE, V11, P551, DOI 10.1089/dia.2009.0015; Rodbard D, 2009, DIABETES TECHNOL THE, V11, pS55, DOI 10.1089/dia.2008.0132; Rosengren AH, 2012, DIABETES, V61, P1726, DOI 10.2337/db11-1516; Saxena R, 2006, DIABETES, V55, P2890, DOI 10.2337/db06-0381; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SERVICE FJ, 1980, DIABETES CARE, V3, P58, DOI 10.2337/diacare.3.1.58; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smith-Palmer J, 2014, DIABETES RES CLIN PR, V105, P273, DOI 10.1016/j.diabres.2014.06.007; Takamoto I, 2014, DIABETOLOGIA, V57, P542, DOI 10.1007/s00125-013-3131-6; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wijsman CA, 2013, AGING CELL, V12, P207, DOI 10.1111/acel.12042; Yan Y, 2010, DIABETES-METAB RES, V26, P371, DOI 10.1002/dmrr.1087; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	33	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149992	10.1371/journal.pone.0149992	http://dx.doi.org/10.1371/journal.pone.0149992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914832	Green Published, gold			2022-12-27	WOS:000371175700043
J	Guha, TK; Hausner, G				Guha, Tuhin Kumar; Hausner, Georg			Using Group II Introns for Attenuating the In Vitro and In Vivo Expression of a Homing Endonuclease	PLOS ONE			English	Article							DNA-POLYMERASE GENE; ESCHERICHIA-COLI; RNA; IDENTIFICATION; MAGNESIUM; INTEIN; CRISPR-CAS9; DISRUPTION; INHIBITION; TRANSPORT	In Chaetomium thermophilum (DSM 1495) within the mitochondrial DNA (mtDNA) small ribosomal subunit (rns) gene a group IIA1 intron interrupts an open reading frame (ORF) encoded within a group I intron (mS1247). This arrangement offers the opportunity to examine if the nested group II intron could be utilized as a regulatory element for the expression of the homing endonuclease (HEase). Constructs were generated where the codon-optimized ORF was interrupted with either the native group IIA1 intron or a group IIB type intron. This study showed that the expression of the HEase (in vivo) in Escherichia coli can be regulated by manipulating the splicing efficiency of the HEase ORF-embedded group II introns. Exogenous magnesium chloride (MgCl2) stimulated the expression of a functional HEase but the addition of cobalt chloride (CoCl2) to growth media antagonized the expression of HEase activity. Ultimately the ability to attenuate HEase activity might be useful in precision genome engineering, minimizing off target activities, or where pathways have to be altered during a specific growth phase.	[Guha, Tuhin Kumar; Hausner, Georg] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Hausner, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	hausnerg@cc.umanitoba.ca	Hausner, Georg/X-5517-2019	Guha, Tuhin/0000-0003-0683-3751	Natural Sciences and Engineering Research Council of Canada; University of Manitoba Faculty of Science Graduate Award; University of Manitoba Faculty of Graduate Studies GETS program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Manitoba Faculty of Science Graduate Award; University of Manitoba Faculty of Graduate Studies GETS program	This research is supported by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada to GH. The authors also gratefully acknowledge support for TKG from a University of Manitoba Faculty of Science Graduate Award and the University of Manitoba Faculty of Graduate Studies GETS program.	Bae H, 2009, FEMS MICROBIOL LETT, V297, P180, DOI 10.1111/j.1574-6968.2009.01671.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Belfort M, 1995, J BIOL CHEM, V270, P30237, DOI 10.1074/jbc.270.51.30237; Bonen L, 2008, MITOCHONDRION, V8, P26, DOI 10.1016/j.mito.2007.09.005; Candales MA, 2012, NUCLEIC ACIDS RES, V40, pD187, DOI 10.1093/nar/gkr1043; Chan YS, 2011, GENETICS, V188, P33, DOI 10.1534/genetics.111.127506; Choudhary PK, 2014, RNA, V20, P36, DOI 10.1261/rna.039909.113; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalgaard JZ, 1997, NUCLEIC ACIDS RES, V25, P4626, DOI 10.1093/nar/25.22.4626; Dave UP, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000491; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Donghi D, 2013, NUCLEIC ACIDS RES, V41, P2489, DOI 10.1093/nar/gks1179; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; Edgell DR, 2000, J BACTERIOL, V182, P5281, DOI 10.1128/JB.182.19.5281-5289.2000; Enyeart PJ, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-2; Gao HR, 2010, PLANT J, V61, P176, DOI 10.1111/j.1365-313X.2009.04041.x; Gimble FS, 2000, FEMS MICROBIOL LETT, V185, P99; Gordon PM, 2007, CHEM BIOL, V14, P607, DOI 10.1016/j.chembiol.2007.05.008; Gordon PM, 2001, NAT STRUCT BIOL, V8, P893, DOI 10.1038/nsb1001-893; Grizot S, 2010, NUCLEIC ACIDS RES, V38, P2006, DOI 10.1093/nar/gkp1171; Guha TK, 2014, FUNGAL GENET BIOL, V65, P57, DOI 10.1016/j.fgb.2014.01.004; Hafez M, 2013, FUNGAL GENET BIOL, V53, P71, DOI 10.1016/j.fgb.2013.01.005; Hafez M, 2012, GENOME, V55, P553, DOI [10.1139/G2012-049, 10.1139/g2012-049]; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hausner G, 2012, ORGANELLE GENETICS: EVOLUTION OF ORGANELLE GENOMES AND GENE EXPRESSION, P329, DOI 10.1007/978-3-642-22380-8_13; Hoefel T, 2012, BIOTECHNOL J, V7, P1277, DOI 10.1002/biot.201200046; Hollander V, 1999, NUCLEIC ACIDS RES, V27, P2339, DOI 10.1093/nar/27.11.2339; Ishijima S, 2015, BBA-BIOMEMBRANES, V1848, P1376, DOI 10.1016/j.bbamem.2015.03.005; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kim H, 2014, NAT REV GENET, V15, P321, DOI 10.1038/nrg3686; KUCK U, 1990, NUCLEIC ACIDS RES, V18, P2691, DOI 10.1093/nar/18.9.2691; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lambowitz AM, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003616; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lamech LT, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002028; Li YF, 2015, METAB ENG, V31, P13, DOI 10.1016/j.ymben.2015.06.006; Liu JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110852; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merendino L, 2006, NUCLEIC ACIDS RES, V34, P262, DOI 10.1093/nar/gkj429; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; Mueller JE, 1996, GENE DEV, V10, P2158, DOI 10.1101/gad.10.17.2158; Muir RS, 1997, J MOL BIOL, V274, P722, DOI 10.1006/jmbi.1997.1419; NELSON DL, 1972, P NATL ACAD SCI USA, V69, P1091, DOI 10.1073/pnas.69.5.1091; NELSON DL, 1971, J BIOL CHEM, V246, P3042; Nihongaki Y, 2015, NAT BIOTECHNOL, V33, P755, DOI 10.1038/nbt.3245; Nishioka M, 1998, NUCLEIC ACIDS RES, V26, P4409, DOI 10.1093/nar/26.19.4409; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; Olga F, 2007, BIOL CHEM, V388, P665; Pattanayak V, 2014, METHOD ENZYMOL, V546, P47, DOI 10.1016/B978-0-12-801185-0.00003-9; Posey KL, 2002, BIOCHEMISTRY-US, V41, P2184, DOI 10.1021/bi015944v; Pul U, 2010, MOL MICROBIOL, V75, P1495, DOI 10.1111/j.1365-2958.2010.07073.x; Pyle AM, 2006, COLD SPRING HARB MON, V43, P469; Pyne ME, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/s13068-014-0163-1; Quiroga C, 2011, RNA, V17, P2212, DOI 10.1261/rna.028886.111; Sigel RKO, 2005, EUR J INORG CHEM, P2281, DOI 10.1002/ejic.200401007; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Sternberg SH, 2015, MOL CELL, V58, P568, DOI 10.1016/j.molcel.2015.02.032; Stoddard BL, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-7; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Takeuchi R, 2011, P NATL ACAD SCI USA, V108, P13077, DOI 10.1073/pnas.1107719108; Thakker C, 2016, BIOTECHNOL J, V11, P80, DOI 10.1002/biot.201500205; Toor N, 2002, RNA, V8, P1373, DOI 10.1017/S1355838202023087; Toor N, 2008, SCIENCE, V320, P77, DOI 10.1126/science.1153803; Truong DM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005422; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; Westra ER, 2010, MOL MICROBIOL, V77, P1380, DOI 10.1111/j.1365-2958.2010.07315.x; Windbichler N, 2007, NUCLEIC ACIDS RES, V35, P5922, DOI 10.1093/nar/gkm632; Yao J, 2007, APPL ENVIRON MICROB, V73, P2735, DOI 10.1128/AEM.02829-06; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang L, 2002, SCIENCE, V295, P2084, DOI 10.1126/science.1069268; Zhong J, 2003, NUCLEIC ACIDS RES, V31, P1656, DOI 10.1093/nar/gkg248; Zimmerly S, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0037-5	73	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150097	10.1371/journal.pone.0150097	http://dx.doi.org/10.1371/journal.pone.0150097			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909494	gold, Green Submitted, Green Published			2022-12-27	WOS:000371164700067
J	Herens, M; Bakker, EJ; van Ophem, J; Wagemakers, A; Koelen, M				Herens, Marion; Bakker, Evert Jan; van Ophem, Johan; Wagemakers, Annemarie; Koelen, Maria			Health-Related Quality of Life, Self-Efficacy and Enjoyment Keep the Socially Vulnerable Physically Active in Community-Based Physical Activity Programs: A Sequential Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; OLDER-ADULTS; ACTIVITY BEHAVIOR; GROUP-DYNAMICS; VALIDITY; MAINTENANCE; EXERCISE; MODEL; INTERVENTION; PROMOTION	Physical inactivity is most commonly found in socially vulnerable groups. Dutch policies target these groups through community-based health-enhancing physical activity (CBHEPA) programs. As robust evidence on the effectiveness of this approach is limited, this study investigated whether CBHEPA programs contribute to an increase in and the maintenance of physical activity in socially vulnerable groups. In four successive cohorts, starting at a six-month interval, 268 participants from 19 groups were monitored for twelve months in seven CBHEPA programs. Data collection was based on repeated questionnaires. Socio-economic indicators, program participation and coping ability were measured at baseline. Physical activity, health-related quality of life and on-going program participation were measured three times. Self-efficacy and enjoyment were measured at baseline and at twelve months. Statistical analyses were based on a quasi-RCT design (independent t-tests), a comparison of participants and dropouts (Mann-Whitney test), and multilevel modelling to assess change in individual physical activity, including group level characteristics. Participants of CBHEPA programs are socially vulnerable in terms of low education (48.6%), low income (52.4%), non-Dutch origin (64.6%) and health-related quality of life outcomes. Physical activity levels were not below the Dutch average. No increase in physical activity levels over time was observed. The multilevel models showed significant positive associations between health-related quality of life, self-efficacy and enjoyment, and leisure-time physical activity over time. Short CBHEPA programs (10-13 weeks) with multiple trainers and gender- homogeneous groups were associated with lower physical activity levels over time. At twelve months, dropouts' leisure-time physical activity levels were significantly lower compared to continuing participants, as were health-related quality of life, self-efficacy and enjoyment outcomes. BMI and care consumption scored significantly higher among dropouts. In conclusion, Dutch CBHEPA programs reach socially vulnerable, but not necessarily inactive, groups in terms of socio-economic and health-related quality of life outcomes. Our findings suggest that CBHEPA programs particularly contribute to physical activity maintenance in socially vulnerable groups, rather than to an increase in physical activity behaviour over time.	[Herens, Marion; Wagemakers, Annemarie; Koelen, Maria] Wageningen Univ, Social Sci Grp, Hlth & Soc, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands; [Bakker, Evert Jan] Wageningen Univ, Plant Sci Grp, Math & Stat Methods, Droevendaalsesteeg 1, NL-6700 AA Wageningen, Netherlands; [van Ophem, Johan] Wageningen Univ, Social Sci Grp, Econ Consumers & Households, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Herens, M (corresponding author), Wageningen Univ, Social Sci Grp, Hlth & Soc, Hollandseweg 1,POB 8130, NL-6700 EW Wageningen, Netherlands.	marion.herens@wur.nl			ZonMw, the Netherlands Organisation for Health Research and Development [50-51505-98-103]	ZonMw, the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	The study is funded by ZonMw, the Netherlands Organisation for Health Research and Development (project number: 50-51505-98-103), www.zonmw.nl. NISB developed the Communities on the Move program and is the collaborating agency, www.nisb.nl.	Antonovsky A, 1996, ISRAEL J MED SCI, V32, P170; Antonovsky A, 1996, HEALTH PROMOT INT, V11, P11, DOI 10.1093/heapro/11.1.11; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Bauman AE, 2014, HEALTH PROMOT INT, V29, P143, DOI 10.1093/heapro/dau049; Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Blokstra A, 2011, MEASURING NETHERLAND; Bonevski B, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-42; Bowling A, 2005, HDB HLTH RES METHODS; Boynton PM, 2004, BMJ-BRIT MED J, V328, P1433, DOI 10.1136/bmj.328.7453.1433; Burke SM, 2006, PSYCHOL SPORT EXERC, V7, P1, DOI 10.1016/j.psychsport.2005.03.002; Cawley J, 2004, AM J PREV MED, V27, P117, DOI 10.1016/j.amepre.2004.06.012; Cerin E, 2010, J PHYS ACT HEALTH, V7, P451, DOI 10.1123/jpah.7.4.451; Chen YM, 2006, INT J OBESITY, V30, P918, DOI 10.1038/sj.ijo.0803220; Claes C, 2015, EVAL PROGRAM PLANN, V48, P132, DOI 10.1016/j.evalprogplan.2014.08.002; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Crawford R, 2006, HEALTH, V10, P401, DOI 10.1177/1363459306067310; Creswell JohnW., 2006, RES SCH, V13, P1; de Hollander EL, 2012, J CLIN EPIDEMIOL, V65, P73, DOI 10.1016/j.jclinepi.2011.05.005; Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741; Dholakia UM, 2010, REV MARKET RES, V7, P145, DOI 10.1108/S1548-6435(2010)0000007009; Duncan SC, 2007, ANN BEHAV MED, V33, P80, DOI 10.1207/s15324796abm3301_9; Eriksson M, 2005, J EPIDEMIOL COMMUN H, V59, P460, DOI 10.1136/jech.2003.018085; Estabrooks PA, 2004, J AGING PHYS ACTIV, V12, P232, DOI 10.1123/japa.12.3.232; Estabrooks PA, 2011, INT J SPORT EXERC PS, V9, P4, DOI 10.1080/1612197X.2011.563123; Estabrooks PA, 2012, SOC PERSONAL PSYCHOL, V6, P18, DOI 10.1111/j.1751-9004.2011.00409.x; Feskens R, 2006, FIELD METHOD, V18, P284, DOI 10.1177/1525822X06288756; Fisher KJ, 2004, J AGING PHYS ACTIV, V12, P45, DOI 10.1123/japa.12.1.45; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Hagberg LA, 2009, SCAND J MED SCI SPOR, V19, P740, DOI 10.1111/j.1600-0838.2008.00844.x; Hagger MS, 2002, J SPORT EXERCISE PSY, V24, P3, DOI 10.1123/jsep.24.1.3; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Heck RH, 2014, QUANT METH SER, P1; Herens M, 2015, TSG, V93, P93, DOI DOI 10.1007/S12508-015-0040-8; Herens M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2515-6; Herens M, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2327; Hildebrandt V, 2013, TREND REPORT PHYS AC; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Humpel N, 2002, AM J PREV MED, V22, P188, DOI 10.1016/S0749-3797(01)00426-3; Kassavou A, 2014, HEALTH PSYCHOL, V33, P752, DOI 10.1037/hea0000015; King AC, 2002, AM J PREV MED, V23, P15, DOI 10.1016/S0749-3797(02)00470-1; Koelen MA, 2001, J EPIDEMIOL COMMUN H, V55, P257, DOI 10.1136/jech.55.4.257; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Konerding U, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0181-5; Kuroda Y, 2012, GLOB HEALTH PROMOT, V19, P14, DOI 10.1177/1757975911423073; Lehnert K, 2012, EUR REV AGING PHYS A, V9, P87, DOI 10.1007/s11556-012-0095-3; LEVIE WH, 1982, ECTJ-EDUC COMMUN TEC, V30, P195; Lewis BA, 2002, AM J PREV MED, V23, P26, DOI 10.1016/S0749-3797(02)00471-3; Li FZ, 2005, J AGING PHYS ACTIV, V13, P145, DOI 10.1123/japa.13.2.145; Lundberg O., 1995, EUR J PUBLIC HEALTH, V5, P56, DOI DOI 10.1093/EURPUB/5.1.56; Maas CJM, 2003, QUAL QUANT, V37, P71, DOI 10.1023/A:1022545930672; Marcus BH, 2000, HEALTH PSYCHOL, V19, P32, DOI 10.1037/0278-6133.19.Suppl1.32; Mason P, 2013, MENT HEALTH PHYS ACT, V6, P111, DOI 10.1016/j.mhpa.2013.06.005; Mercer SL, 2007, AM J PREV MED, V33, P139, DOI 10.1016/j.amepre.2007.04.005; Ministry of Health Welfare and Sports, 2012, SPORT BEW BUURT; Ministry of Health Welfare and Sports: Samen voor sport [Together for sport], 2006, IMPL PROGR 2006 2010; Mohnen SM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-116; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; National Institute for Public Health and the Environment (RIVM), LOC NAT HLTH MON; Nigg CR, 2008, APPL PSYCHOL-INT REV, V57, P544, DOI 10.1111/j.1464-0597.2008.00343.x; Nusselder A., 2012, TIJDSCHR PRAKTIJKOND, V7, P66; Olsson M, 2009, J EPIDEMIOL COMMUN H, V63, P166, DOI 10.1136/jech.2007.063420; Pawlowski T, 2011, EUR REV AGING PHYS A, V8, P93, DOI 10.1007/s11556-011-0085-x; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Pratt M, 2004, AM J PREV MED, V27, P136, DOI 10.1016/j.amepre.2004.06.015; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rabin R., 2011, EQ 5D 5L USER GUIDE, P22; Raedeke TD, 2007, J APPL SPORT PSYCHOL, V19, P105, DOI 10.1080/10413200601113638; Rhodes RE, 2006, PSYCHOL SPORT EXERC, V7, P15, DOI 10.1016/j.psychsport.2005.08.011; Rimer B, 2005, THEORY GLANCE GUIDE; Rodrigues AM, 2015, HEALTH PSYCHOL, V34, P61, DOI 10.1037/hea0000104; Romero-Corral A, 2008, INT J OBESITY, V32, P959, DOI 10.1038/ijo.2008.11; Rutten A, 2010, HEALTH ASSETS IN A GLOBAL CONTEXT: THEORY, METHODS, ACTION, P197, DOI 10.1007/978-1-4419-5921-8_11; Sallis JF, 2013, ANN BEHAV MED, V45, pS14, DOI 10.1007/s12160-012-9415-0; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Schwarzer R, 2008, APPL PSYCHOL-INT REV, V57, P1, DOI 10.1111/j.1464-0597.2007.00325.x; SHERMAN SJ, 1980, J PERS SOC PSYCHOL, V39, P211, DOI 10.1037/0022-3514.39.2.211; Sniehotta FF, 2005, PSYCHOL HEALTH, V20, P143, DOI 10.1080/08870440512331317670; StatWeb, AV INC PERS PRIV HOU; StatWeb, AV INC PRIV HOUS VAR; StatWeb, LAB FORC LEV ED ETHN; Stiggelbout M, 2006, HEALTH EDUC RES, V21, P1, DOI 10.1093/her/cyh037; Stiggelbout M, 2005, J AGING PHYS ACTIV, V13, P409, DOI 10.1123/japa.13.4.409; Subramanian S. V., 2003, Neighborhoods and health, P65; Super S, 2014, J EPIDEMIOL COMMUN H, V68, P411, DOI 10.1136/jech-2013-203085; Szende A, 2014, SELF REPORTED POPULA, DOI DOI 10.1007/978-94-007-7596-1; Twisk JW, 2013, APPL LONGITUDINAL DA; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Van den Brink C, 2011, TIJDSCHRIFT GEZONDHE, V89, P83, DOI [10.1007/s12508-011-0030-4, DOI 10.1007/S12508-011-0030-4]; van Stralen MM, 2009, HEALTH PSYCHOL REV, V3, P147, DOI 10.1080/17437190903229462; Wagemakers A, 2010, EVAL PROGRAM PLANN, V33, P428, DOI 10.1016/j.evalprogplan.2009.12.008; Wendel-Vos GCW, 2009, AM J PREV MED, V37, P50, DOI 10.1016/j.amepre.2009.03.015; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; White JL, 2005, WOMEN HEALTH, V41, P123, DOI 10.1300/J013v41n04_07; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams DM, 2006, J SPORT EXERCISE PSY, V28, P300, DOI 10.1123/jsep.28.3.300; World Health Organization, 2012, WHO DISC PAP	98	11	11	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150025	10.1371/journal.pone.0150025	http://dx.doi.org/10.1371/journal.pone.0150025			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26909696	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700057
J	Lv, N; Wang, C; Karmonik, C; Fang, YB; Xu, JY; Yu, Y; Cao, W; Liu, JM; Huang, QH				Lv, Nan; Wang, Chi; Karmonik, Christof; Fang, Yibin; Xu, Jinyu; Yu, Ying; Cao, Wei; Liu, Jianmin; Huang, Qinghai			Morphological and Hemodynamic Discriminators for Rupture Status in Posterior Communicating Artery Aneurysms	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; CLINICAL RISK-FACTORS; CEREBRAL ANEURYSMS; SACCULAR ANEURYSM; SHEAR-STRESS; ENVIRONMENT; COHORT; RATIO; FLOW	Background and Purpose The conflicting findings of previous morphological and hemodynamic studies on intracranial aneurysm rupture may be caused by the relatively small sample sizes and the variation in location of the patient-specific aneurysm models. We aimed to determine the discriminators for aneurysm rupture status by focusing on only posterior communicating artery (PCoA) aneurysms. Materials and Methods In 129 PCoA aneurysms (85 ruptured, 44 unruptured), clinical, morphological and hemodynamic characteristics were compared between the ruptured and unruptured cases. Multivariate logistic regression analysis was performed to determine the discriminators for rupture status of PCoA aneurysms. Results While univariate analyses showed that the size of aneurysm dome, aspect ratio (AR), size ratio (SR), dome-to-neck ratio (DN), inflow angle (IA), normalized wall shear stress (NWSS) and percentage of low wall shear stress area (LSA) were significantly associated with PCoA aneurysm rupture status. With multivariate analyses, significance was only retained for higher IA (OR = 1.539, p < 0.001) and LSA (OR = 1.393, p = 0.041). Conclusions Hemodynamics and morphology were related to rupture status of intracranial aneurysms. Higher IA and LSA were identified as discriminators for rupture status of PCoA aneurysms.	[Lv, Nan; Wang, Chi; Fang, Yibin; Xu, Jinyu; Yu, Ying; Cao, Wei; Liu, Jianmin; Huang, Qinghai] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Karmonik, Christof] Houston Methodist, Dept Neurosurg, Cerebrovasc Ctr, Houston, TX USA	Naval Medical University; The Methodist Hospital System; The Methodist Hospital - Houston	Huang, QH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	ocinhqh@163.com			National Natural Science Foundation of China [81301004, 81571118]; National Science-technology Support Plan Projects [2011BAI08B06]; Key Project of Shanghai Science and Technology Committee [13411950300]; Key Project of Shanghai Municipal Health Bureau [2013ZYJB007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science-technology Support Plan Projects; Key Project of Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Key Project of Shanghai Municipal Health Bureau	This work was supported by the National Natural Science Foundation of China (No. 81301004) received by YF and by (No. 81571118) received by QH, the National Science-technology Support Plan Projects (No. 2011BAI08B06) received by JL, the Key Project of Shanghai Science and Technology Committee (No. 13411950300) received by JL, and the Key Project of Shanghai Municipal Health Bureau (No. 2013ZYJB007) received by JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Bor ASE, 2015, STROKE, V46, P42, DOI 10.1161/STROKEAHA.114.005963; Can A, 2016, NEUROSURGERY, V78, P510, DOI 10.1227/NEU.0000000000001083; Cebral JR, 2011, AM J NEURORADIOL, V32, P145, DOI 10.3174/ajnr.A2419; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Duan GL, 2016, J NEUROINTERV SURG, V8, P47, DOI 10.1136/neurintsurg-2014-011450; Forget TR, 2001, NEUROSURGERY, V49, P1322, DOI 10.1097/00006123-200112000-00006; Golshani Kiarash, 2010, Surg Neurol Int, V1, P88, DOI 10.4103/2152-7806.74147; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Ho A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094837; Hoh BL, 2007, NEUROSURGERY, V61, P716, DOI 10.1227/01.NEU.0000298899.77097.BF; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Matsukawa H, 2014, J NEUROSURG, V120, P104, DOI 10.3171/2013.9.JNS13921; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Miura Y, 2013, STROKE, V44, P519, DOI 10.1161/STROKEAHA.112.675306; Morita A, 2012, NEW ENGL J MED, V366, P2474, DOI 10.1056/NEJMoa1113260; Ruiz DS, 2006, AM J NEURORADIOL, V27, P504; San MRD, 2006, AM J NEURORADIOL, V27, P504; Sato K, 2008, MED ENG PHYS, V30, P774, DOI 10.1016/j.medengphy.2007.09.006; Takao H, 2012, STROKE, V43, P1436, DOI 10.1161/STROKEAHA.111.640995; Turjman AS, 2014, CIRCULATION, V129, P373, DOI 10.1161/CIRCULATIONAHA.113.001444; Ujiie H, 2001, NEUROSURGERY, V48, P495, DOI 10.1097/00006123-200103000-00007; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Xiang JP, 2011, STROKE, V42, P144, DOI 10.1161/STROKEAHA.110.592923; Xu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055413, 10.1371/journal.pone.0059050]; Zhang Y, 2016, J NEUROINTERV SURG, V8, P808, DOI 10.1136/neurintsurg-2015-011865	27	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149906	10.1371/journal.pone.0149906	http://dx.doi.org/10.1371/journal.pone.0149906			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910518	Green Published, gold			2022-12-27	WOS:000371164700053
J	Han, C; House, L; Leman, SC				Han, Chao; House, Leanna; Leman, Scotland C.			Expert-Guided Generative Topographical Modeling with Visual to Parametric Interaction	PLOS ONE			English	Article								Introduced by Bishop et al. in 1996, Generative Topographic Mapping (GTM) is a powerful nonlinear latent variable modeling approach for visualizing high-dimensional data. It has shown useful when typical linear methods fail. However, GTM still suffers from drawbacks. Its complex parameterization of data make GTM hard to fit and sensitive to slight changes in the model. For this reason, we extend GTM to a visual analytics framework so that users may guide the parameterization and assess the data from multiple GTM perspectives. Specifically, we develop the theory and methods for Visual to Parametric Interaction (V2PI) with data using GTM visualizations. The result is a dynamic version of GTM that fosters data exploration. We refer to the new version as V2PI-GTM. In this paper, we develop V2PI-GTM in stages and demonstrate its benefits within the context of a text mining case study.	[Han, Chao; House, Leanna; Leman, Scotland C.] Virginia Tech, Dept Stat, Blacksburg, VA USA; [Han, Chao] SAS Inst, Cary, NC USA	Virginia Polytechnic Institute & State University; SAS Institute Inc	House, L (corresponding author), Virginia Tech, Dept Stat, Blacksburg, VA USA.	lhouse@vt.edu			National Science Foundation, Computer and Communications Foundations [0937071]; Division of Undergraduate Education [1141096]; Div Of Information & Intelligent Systems [1447416] Funding Source: National Science Foundation	National Science Foundation, Computer and Communications Foundations(National Science Foundation (NSF)); Division of Undergraduate Education(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This research was funded by the National Science Foundation, Computer and Communications Foundations #0937071 and Division of Undergraduate Education #1141096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop CM, 1998, NEURAL COMPUT, V10, P215, DOI 10.1162/089976698300017953; Buja A, 2008, J COMPUT GRAPH STAT, V17, P444, DOI 10.1198/106186008X318440; Cruz-Barbosa R, 2008, LECT NOTES ARTIF INT, V5271, P392, DOI 10.1007/978-3-540-87656-4_49; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Gisbrecht A, 2011, NEUROCOMPUTING, V74, P1351, DOI 10.1016/j.neucom.2010.12.015; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Jeong DH, 2009, COMPUT GRAPH FORUM, V28, P767, DOI 10.1111/j.1467-8659.2009.01475.x; Kaban A, 2005, ITCC 2005: International Conference on Information Technology: Coding and Computing, Vol 1, P51, DOI 10.1109/ITCC.2005.34; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lee JA, 2007, INFORM SCI STAT, P1; Leman SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050474; Loader C., 1999, LOCAL REGRESSION LIK; Olier I., 2010, ESANN 2010, P481; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pike WA, 2009, INFORM VISUALIZATION, V5, P78; Schiffman SS, 1981, INTRO MULTIDIMENSION; SPARCKJONES K, 1972, J DOC, V28, P11, DOI 10.1108/eb026526; Svensen M., 1998, THESIS ASTON U; Weiss S. M., 2005, TEXT MINING PREDICTI, DOI [10.1007/978-0-387-34555-0, DOI 10.1007/978-0-387-34555-0]; Yi JS, 2005, INFORM VISUALIZATION, P1	20	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0129122	10.1371/journal.pone.0129122	http://dx.doi.org/10.1371/journal.pone.0129122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905728	Green Published, Green Submitted, gold			2022-12-27	WOS:000371163000001
J	Taskesen, E; Reinders, MJT				Taskesen, Erdogan; Reinders, Marcel J. T.			2D Representation of Transcriptomes by t-SNE Exposes Relatedness between Human Tissues	PLOS ONE			English	Article								The GTEx Consortium reported that hierarchical clustering of RNA profiles from 25 unique tissue types among 1641 individuals accurately distinguished the tissue types, but a multidimensional scaling failed to generate a 2D projection of the data that separates tissue-subtypes. In this study we show that a projection by t-Distributed Stochastic Neighbor Embedding is in line with the cluster analysis which allows a more detailed examination and visualization of human tissue relationships.	[Taskesen, Erdogan; Reinders, Marcel J. T.] Delft Univ Technol, DBL, NL-2628 CD Delft, Netherlands	Delft University of Technology	Reinders, MJT (corresponding author), Delft Univ Technol, DBL, NL-2628 CD Delft, Netherlands.	M.J.T.Reinders@tudelft.nl	Taskesen, Erdogan/N-4983-2015	Taskesen, Erdogan/0000-0002-3430-9618	Netherlands Genomics Initiative (NGI) [BIOPATH BR 2.5]	Netherlands Genomics Initiative (NGI)	Publication costs for this article were sourced from the BioRange program of the Netherlands Bioinformatics Centre (NBIC), which is supported by the Netherlands Genomics Initiative (NGI, Project: BIOPATH BR 2.5).	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Pierson E, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004220; SOKAL ROBERT R., 1962, TAXON, V11, P33, DOI 10.2307/1217208; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579	8	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149853	10.1371/journal.pone.0149853	http://dx.doi.org/10.1371/journal.pone.0149853			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906061	Green Submitted, gold, Green Published			2022-12-27	WOS:000371163000024
J	Wang, ZX; Feng, TJ; Lau, JTF; Kim, Y				Wang, Zixin; Feng, Tiejian; Lau, Joseph T. F.; Kim, Yoona			Acceptability of Voluntary Medical Male Circumcision (VMMC) among Male Sexually Transmitted Diseases Patients (MSTDP) in China	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RISK HUMAN-PAPILLOMAVIRUS; HONG-KONG; HIV INTERVENTION; WESTERN CHINA; GENITAL WARTS; SOUTH-AFRICA; YOUNG MEN; HEALTH; SEX	Voluntary Medical Male circumcision (VMMC) is an evidence-based, yet under-utilized biomedical HIV intervention in China. No study has investigated acceptability of VMMC among male sexually transmitted diseases patients (MSTDP) who are at high risk of HIV transmission. A cross-sectional survey interviewed 350 HIV negative heterosexual MSTDP in Shenzhen, China; 12.0% (n = 42) of them were circumcised at the time of survey. When the uncircumcised participants (n = 308) were informed that VMMC could reduce the risk of HIV infection via heterosexual intercourse by 50%, the prevalence of acceptability of VMMC in the next six months was 46.1%. Adjusted for significant background variables, significant factors of acceptability of VMMC included: 1) emotional variables: the Emotional Representation Subscale (adjusted odds ratios, AOR = 1.13, 95%CI: 1.06-1.18), 2) cognitive variables derived from Health Belief Model (HBM): perceived some chance of having sex with HIV positive women in the next 12 months (AOR = 2.48, 95%CI: 1.15-5.33) (perceived susceptibility), perceived severity of STD infection (AOR = 1.06, 95%CI: 1.02-1.10), perceived benefit of VMMC in risk reduction (AOR = 1.29, 95%CI: 1.16-1.42) and sexual performance (AOR = 1.45, 95% CI: 1.26-1.71), perceived barriers against taking up VMMC (AOR = 0.88, 95% CI: 0.81-0.95), and perceived cue to action (AOR = 1.41, 95%CI: 1.23-1.61) and self-efficacy (AOR = 1.38, 95%CI: 1.26-1.35) related to taking up VMMC. The association between perceived severity of STD infection and acceptability was fully mediated by emotional representation of STD infection. The relatively low prevalence of circumcision and high acceptability suggested that the situation was favorable for implementing VMMC as a means of HIV intervention among MSTDP in China. HBM is a potential suitable framework to guide the design of future VMMC promotion. Future implementation programs should be conducted in STD clinic settings, taking the important findings of this study into account.	[Wang, Zixin; Lau, Joseph T. F.; Kim, Yoona] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behaviours Res, Hong Kong, Hong Kong, Peoples R China; [Wang, Zixin; Lau, Joseph T. F.] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China; [Feng, Tiejian] Shenzhen Ctr Chron Dis Control, Shenzhen, Peoples R China; [Lau, Joseph T. F.] Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen; Sun Yat Sen University	Lau, JTF (corresponding author), Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Ctr Hlth Behaviours Res, Hong Kong, Hong Kong, Peoples R China.; Lau, JTF (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Peoples R China.; Lau, JTF (corresponding author), Sun Yat Sen Univ, Ctr Med Anthropol & Behav Hlth, Guangzhou 510275, Guangdong, Peoples R China.	jlau@cuhk.edu.hk	Wang, Zhiquan/HHS-6768-2022; Kim, Yoona/AAB-8207-2020	Kim, Yoona/0000-0003-3473-8516	National Natural Science Foundation of China [81373054]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by National Natural Science Foundation of China (Ref# 81373054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, UNAIDS MAL CIRC GLOB; [Anonymous], 2013, 2013 SHENZH STAT YB; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Auvert B, 2009, J INFECT DIS, V199, P14, DOI 10.1086/595566; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Ben Kun-Long, 2009, Zhonghua Nan Ke Xue, V15, P395; Ben Kun-Long, 2008, Zhonghua Nan Ke Xue, V14, P291; Brito MO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007687; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Cai Y, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-205; Chen WT, 2007, ADV NURS SCI, V30, P329, DOI 10.1097/01.ANS.0000300182.48854.65; Feng Nan, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P281; Fortenberry JD, 2002, AM J PUBLIC HEALTH, V92, P378, DOI 10.2105/AJPH.92.3.378; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gittelsohn J, 2006, HEALTH EDUC BEHAV, V33, P25, DOI 10.1177/1090198105282412; Golub SA, 2013, AIDS PATIENT CARE ST, V27, P248, DOI 10.1089/apc.2012.0419; Goswami P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002183; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Gray RH, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.069; Gu J, 2011, PUBLIC HEALTH, V125, P275, DOI 10.1016/j.puhe.2011.01.010; Hao C, 2012, AIDS BEHAV, V16, P1138, DOI 10.1007/s10461-012-0141-1; Huang J, 2013, INT J STD AIDS, V24, P541, DOI 10.1177/0956462412473893; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Jiang JJ, 2013, AIDS RES HUM RETROV, V29, P1582, DOI [10.1089/aid.2013.0156, 10.1089/AID.2013.0156]; Lau JTF, 2014, ARCH SEX BEHAV, V43, P789, DOI 10.1007/s10508-013-0172-3; Lau JTF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057204; Lau JTF, 2012, J SEX MED, V9, P1904, DOI 10.1111/j.1743-6109.2010.02050.x; Araujo MAL, 2009, AIDS PATIENT CARE ST, V23, P663, DOI 10.1089/apc.2008.0123; Luo Hao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P313, DOI 10.3881/j.issn.1000-503X.2011.03.020; Madhivanan P, 2011, SEX TRANSM DIS, V38, P571, DOI 10.1097/OLQ.0b013e318219c930; McAninch JW, 2013, SMITH TANAGHOS GEN U; Mehta P, 2014, INT Q COMMUNITY HEAL, V34, P101, DOI 10.2190/IQ.34.1.h; MILLER WR, 1983, BEHAV PSYCHOTHER, V11, P147, DOI 10.1017/S0141347300006583; Ministry of Health of China, 2012, EST HIV AIDS EP CHIN; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nilsson D, 2007, EUR J MARKETING, V41, P367, DOI 10.1108/03090560710728381; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Reback Cathy J, 2010, Open AIDS J, V4, P116, DOI 10.2174/1874613601004030116; Rozema H, 2009, PSYCHO-ONCOLOGY, V18, P849, DOI 10.1002/pon.1488; Scott BE, 2005, AIDS CARE, V17, P304, DOI 10.1080/09540120412331299744; Serwadda D, 2010, J INFECT DIS, V201, P1463, DOI 10.1086/652185; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Sobngwi-Tambekou J, 2009, SEX TRANSM INFECT, V85, P116, DOI 10.1136/sti.2008.032334; Tobian AAR, 2009, NEW ENGL J MED, V360, P1298, DOI 10.1056/NEJMoa0802556; Valente TW, 2006, SEX TRANSM DIS, V33, pS23, DOI 10.1097/01.olq.0000221018.32533.6d; Wang B, 2009, EPIDEMIC SEXUALLY TR; Wang QQ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-955; Wang Z, 2015, AIDS BEHAV; Wang ZX, 2013, VACCINE, V31, P4675, DOI 10.1016/j.vaccine.2013.06.090; Wang ZX, 2012, AIDS BEHAV, V16, P1836, DOI 10.1007/s10461-011-0088-7; Weiss HA, 2006, SEX TRANSM INFECT, V82, P101, DOI 10.1136/sti.2005.017442; WHO/UNAIDS Technical Consultation, 2007, MAL CIRC HIV PREV RE; WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276; Wiysonge CS, 2011, COCHRANE DB SYST REV, V15; Wu XiaoBing, 2009, China Tropical Medicine, V9, P1856; Xu Yan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P987; Yang DZ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059020, 10.1371/journal.pone.0054495, 10.1371/journal.pone.0062329]; Yang HT, 2010, SEX TRANSM DIS, V37, P208, DOI 10.1097/OLQ.0b013e3181d13c59; Yang XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030198	61	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149801	10.1371/journal.pone.0149801	http://dx.doi.org/10.1371/journal.pone.0149801			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2HK	26905739	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000022
J	Pirro, S; Zanella, L; Kenzo, M; Montesano, C; Minutolo, A; Potesta, M; Sobze, MS; Canini, A; Cirilli, M; Muleo, R; Colizzi, V; Galgani, A				Pirro, Stefano; Zanella, Letizia; Kenzo, Maurice; Montesano, Carla; Minutolo, Antonella; Potesta, Marina; Sobze, Martin Sanou; Canini, Antonella; Cirilli, Marco; Muleo, Rosario; Colizzi, Vittorio; Galgani, Andrea			MicroRNA from Moringa oleifera: Identification by High Throughput Sequencing and Their Potential Contribution to Plant Medicinal Value	PLOS ONE			English	Article							SMALL RNAS; EXPRESSION PROFILE; AUXIN RESPONSE; METABOLISM; PREDICTION; HOMOLOG; MIRNAS; GENOME; ROLES	Moringa oleifera is a widespread plant with substantial nutritional and medicinal value. We postulated that microRNAs (miRNAs), which are endogenous, noncoding small RNAs regulating gene expression at the post-transcriptional level, might contribute to the medicinal properties of plants of this species after ingestion into human body, regulating human gene expression. However, the knowledge is scarce about miRNA in Moringa. Furthermore, in order to test the hypothesis on the pharmacological potential properties of miRNA, we conducted a high-throughput sequencing analysis using the Illumina platform. A total of 31,290,964 raw reads were produced from a library of small RNA isolated from M. oleifera seeds. We identified 94 conserved and two novel miRNAs that were validated by qRT-PCR assays. Results from qRT-PCR trials conducted on the expression of 20 Moringa miRNA showed that are conserved across multiple plant species as determined by their detection in tissue of other common crop plants. In silico analyses predicted target genes for the conserved miRNA that in turn allowed to relate the miRNAs to the regulation of physiological processes. Some of the predicted plant miRNAs have functional homology to their mammalian counterparts and regulated human genes when they were transfected into cell lines. To our knowledge, this is the first report of discovering M. oleifera miRNAs based on high throughput sequencing and bioinformatics analysis and we provided new insight into a potential cross-species control of human gene expression. The widespread cultivation and consumption of M. oleifera, for nutritional and medicinal purposes, brings humans into close contact with products and extracts of this plant species. The potential for miRNA transfer should be evaluated as one possible mechanism of action to account for beneficial properties of this valuable species.	[Pirro, Stefano; Zanella, Letizia; Montesano, Carla; Minutolo, Antonella; Potesta, Marina; Canini, Antonella; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Kenzo, Maurice] SOCOPOMO SC 46 PA de Lingang, Dschang, Cameroon; [Sobze, Martin Sanou] Univ Dschang, Dschang, Cameroon; [Galgani, Andrea] Univ Roma Tor Vergata, Stn Tecnol Anim, Ctr Serv Interdipartimentale, Rome, Italy; [Pirro, Stefano; Colizzi, Vittorio; Galgani, Andrea] Mir Nat Srl, Rome, Italy; [Cirilli, Marco; Muleo, Rosario] Univ Tuscia, Dept Agr & Forest Sci, Viterbo, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; Tuscia University	Galgani, A (corresponding author), Univ Roma Tor Vergata, Stn Tecnol Anim, Ctr Serv Interdipartimentale, Rome, Italy.; Galgani, A (corresponding author), Mir Nat Srl, Rome, Italy.	galgani@scienze.uniroma2.it	MINUTOLO, ANTONELLA/AAA-1788-2020; Muleo, Rosario/AAI-7439-2020; Pirro, Stefano/AAA-9898-2019	Montesano, Carla/0000-0002-9865-6619; Pirro, Stefano/0000-0002-8601-722X; minutolo, antonella/0000-0003-4784-4297	Mir-Nat s. r. l.	Mir-Nat s. r. l.	The authors received no specific funding for this work. Mir-Nat s. r. l. provided support in the form of salaries for authors SP, VC and AG and provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrew ss, 2010, FASTQC QUALITY CONTR; Anwar F, 2007, PHYTOTHER RES, V21, P17, DOI 10.1002/ptr.2023; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bian HW, 2012, NEW PHYTOL, V196, P149, DOI 10.1111/j.1469-8137.2012.04248.x; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cardon GH, 1997, PLANT J, V12, P367, DOI 10.1046/j.1365-313X.1997.12020367.x; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chen ZH, 2011, PLANT MOL BIOL, V77, P619, DOI 10.1007/s11103-011-9838-1; Coronnello C, 2013, NUCLEIC ACIDS RES, V41, pW159, DOI 10.1093/nar/gkt379; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Dietrich D, 2004, PLANT J, V40, P488, DOI 10.1111/j.1365-313X.2004.02224.x; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fahlgren N, 2009, RNA, V15, P992, DOI 10.1261/rna.1473809; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Fuchs RT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126049; Gismondi A, 2013, INT J ONCOL, V43, P956, DOI 10.3892/ijo.2013.2001; Gonfloni S, 2014, BIOCHEM PHARMACOL, V92, P149, DOI 10.1016/j.bcp.2014.08.034; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Jensen JK, 2011, PLANT J, V66, P387, DOI 10.1111/j.1365-313X.2010.04475.x; Jha A., 2013, PLOS ONE, V8; Jia L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104409; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Jung IL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095492; Lanet E, 2009, PLANT CELL, V21, P1762, DOI 10.1105/tpc.108.063412; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li HT, 2010, BRIT J PHARMACOL, V160, P1352, DOI 10.1111/j.1476-5381.2010.00785.x; Ma ZX, 2015, INFLAMM RES, V64, P885, DOI 10.1007/s00011-015-0870-5; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Minutolo A, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.97; Mlotshwa S, 2015, CELL RES, V25, P521, DOI 10.1038/cr.2015.25; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017; Pulido A, 2010, J EXP BOT, V61, P1277, DOI 10.1093/jxb/erp397; Razis AFA, 2014, ASIAN PAC J CANCER P, V15, P8571, DOI 10.7314/APJCP.2014.15.20.8571; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Ronen R, 2010, BIOINFORMATICS, V26, P2615, DOI 10.1093/bioinformatics/btq493; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shahzad U, 2013, CONSERV GENET, V14, P1161, DOI 10.1007/s10592-013-0503-x; Shu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140587; Sun ZF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-423; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Thiebaut F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-290; Tian Y, 2015, SCI CHINA LIFE SCI, V58, P627, DOI 10.1007/s11427-015-4872-x; Xie FL, 2012, PLANT MOL BIOL, V80, P75, DOI 10.1007/s11103-012-9885-2; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xing TJ, 2015, INT J CLIN EXP MED, V8, P5611; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang RX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057233; Zhang TQ, 2015, PLANT CELL, V27, P349, DOI 10.1105/tpc.114.135186	64	37	38	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149495	10.1371/journal.pone.0149495	http://dx.doi.org/10.1371/journal.pone.0149495			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930203	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500029
J	Takemoto, N; Yoshimura, T; Miyazaki, S; Tashiro, F; Miyazaki, J				Takemoto, Noriaki; Yoshimura, Takuji; Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi			Gtsf1l and Gtsf2 Are Specifically Expressed in Gonocytes and Spermatids but Are Not Essential for Spermatogenesis	PLOS ONE			English	Article							MOUSE; PIWI; MILI; DOMAIN; CELLS; GENE; DIFFERENTIATION; MEMBER; MIWI	The unknown protein family 0224 (UPF0224) includes three members that are expressed in germ-line cells in mice: Gtsf1, Gtsf1l, and BC048502 (Gtsf2). These genes produce proteins with two repeats of the CHHC Zn-finger domain, a predicted RNA-binding motif, in the N terminus. We previously reported that Gtsf1 is essential for spermatogenesis and retrotransposon suppression. In this study, we investigated the expression patterns and functions of Gtsf1l and Gtsf2. Interestingly, Gtsf1l and Gtsf2 were found to be sequentially but not simultaneously expressed in gonocytes and spermatids. Pull-down experiments showed that both GTSF1L and GTSF2 can interact with PIWI-protein complexes. Nevertheless, knocking out Gtsf1, Gtsf2, or both did not cause defects in spermatogenesis or retrotransposon suppression in mice.	[Takemoto, Noriaki; Yoshimura, Takuji; Miyazaki, Satsuki; Tashiro, Fumi; Miyazaki, Jun-ichi] Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Yoshimura, Takuji] Osaka Univ, Sch Med, Lab Reprod Engn, Inst Expt Anim Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Miyazaki, J (corresponding author), Osaka Univ, Grad Sch Med, Div Stem Cell Regulat Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	jimiyaza@nutri.med.osaka-u.ac.jp	Miyazaki, Jun-ichi/N-1976-2015	Miyazaki, Jun-ichi/0000-0003-2475-589X; Yoshimura, Takuji/0000-0002-7856-0679; Miyazaki, Satsuki/0000-0003-1781-1590	Grants-in-Aid for Scientific Research [25460364] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abraham LK, 2012, HISTOLOGY CELL BIOL, P587; Andreeva A, 2008, BIOINFORMATICS, V24, P2277, DOI 10.1093/bioinformatics/btn431; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Chuma S, 2006, P NATL ACAD SCI USA, V103, P15894, DOI 10.1073/pnas.0601878103; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Donertas D, 2013, GENE DEV, V27, P1693, DOI 10.1101/gad.221150.113; Hara K, 2014, CELL STEM CELL, V14, P658, DOI 10.1016/j.stem.2014.01.019; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Mashiko D, 2013, SCI REP-UK, V3, DOI 10.1038/srep03355; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Ohtani H, 2013, GENE DEV, V27, P1656, DOI 10.1101/gad.221515.113; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107; Yoshimura T, 2007, GENE EXPR PATTERNS, V8, P27, DOI 10.1016/j.modgep.2007.08.003; Yoshimura T, 2009, DEV BIOL, V335, P216, DOI 10.1016/j.ydbio.2009.09.003	25	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150390	10.1371/journal.pone.0150390	http://dx.doi.org/10.1371/journal.pone.0150390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930067	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500140
J	Abou Rajab, Y; Leuschner, C; Barus, H; Tjoa, A; Hertel, D				Abou Rajab, Yasmin; Leuschner, Christoph; Barus, Henry; Tjoa, Aiyen; Hertel, Dietrich			Cacao Cultivation under Diverse Shade Tree Cover Allows High Carbon Storage and Sequestration without Yield Losses	PLOS ONE			English	Article							THEOBROMA-CACAO; BIODIVERSITY CONSERVATION; AGROFORESTRY SYSTEMS; ROOT BIOMASS; CENTRAL SULAWESI; COCOA; FOREST; DEFORESTATION; COFFEE; STOCKS	One of the main drivers of tropical forest loss is their conversion to oil palm, soy or cacao plantations with low biodiversity and greatly reduced carbon storage. Southeast Asian cacao plantations are often established under shade tree cover, but are later converted to non-shaded monocultures to avoid resource competition. We compared three co-occurring cacao cultivation systems (3 replicate stands each) with different shade intensity (non-shaded monoculture, cacao with the legume Gliricidia sepium shade trees, and cacao with several shade tree species) in Sulawesi (Indonesia) with respect to above-and belowground biomass and productivity, and cacao bean yield. Total biomass C stocks (aboveand belowground) increased fivefold from the monoculture to the multi-shade tree system (from 11 to 57 Mg ha(-1)), total net primary production rose twofold (from 9 to 18 Mg C ha(-1) yr(-1)). This increase was associated with a 6fold increase in aboveground biomass, but only a 3.5fold increase in root biomass, indicating a clear shift in C allocation to aboveground tree organs with increasing shade for both cacao and shade trees. Despite a canopy cover increase from 50 to 93%, cacao bean yield remained invariant across the systems (variation: 1.1-1.2 Mg C ha(-1) yr(-1)). The monocultures had a twice as rapid leaf turnover suggesting that shading reduces the exposure of cacao to atmospheric drought, probably resulting in greater leaf longevity. Thus, contrary to general belief, cacao bean yield does not necessarily decrease under shading which seems to reduce physical stress. If planned properly, cacao plantations under a shade tree cover allow combining high yield with benefits for carbon sequestration and storage, production system stability under stress, and higher levels of animal and plant diversity.	[Abou Rajab, Yasmin; Leuschner, Christoph; Hertel, Dietrich] Univ Gottingen, Plant Ecol & Ecosyst Res, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany; [Barus, Henry; Tjoa, Aiyen] Tadulako Univ, Fac Agr Sci, Dept Agrotechnol, Palu, Sulawesi Tengah, Indonesia	University of Gottingen; Universitas Tadulako	Abou Rajab, Y (corresponding author), Univ Gottingen, Plant Ecol & Ecosyst Res, Albrecht von Haller Inst Plant Sci, D-37073 Gottingen, Germany.	abourajab@yahoo.de		Barus, Henry/0000-0003-2351-2132	German Research Foundation (DFG); collaborative research center CRC990	German Research Foundation (DFG)(German Research Foundation (DFG)); collaborative research center CRC990	This study was financed by the German Research Foundation (DFG) in the framework of the interdisciplinary German-Indonesian research project ELUC ('Environmental and land-use change in Sulawesi, Indonesia') and the collaborative research center CRC990 'Ecological and Socioeconomic Functions of Tropical Lowland Rainforest Transformation Systems (Sumatra, Indonesia)', subproject B04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard F, 2002, SCIENCE, V297, P999, DOI 10.1126/science.1070656; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Baker TR, 2004, GLOBAL CHANGE BIOL, V10, P545, DOI 10.1111/j.1365-2486.2004.00751.x; BALASIMHA D, 1991, AGR FOREST METEOROL, V55, P15, DOI 10.1016/0168-1923(91)90019-M; Baligar VC, 2008, PHOTOSYNTHETICA, V46, P216, DOI 10.1007/s11099-008-0035-7; BEER J, 1987, AGROFOREST SYST, V5, P3, DOI 10.1007/BF00046410; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; BEER J, 1990, AGROFOREST SYST, V12, P229, DOI 10.1007/BF00137286; Belsky JM, 2003, AGR HUM VALUES, V20, P277, DOI 10.1023/A:1026100714149; Bisseleua DHB, 2009, CONSERV BIOL, V23, P1176, DOI 10.1111/j.1523-1739.2009.01220.x; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Bos MM, 2007, AGR ECOSYST ENVIRON, V120, P201, DOI 10.1016/j.agee.2006.09.004; Bowers J.H., 2001, PLANT HLTH PROG, V2, P12, DOI DOI 10.1094/PHP-2001-0709-01-RV; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clough Y, 2009, CONSERV LETT, V2, P197, DOI 10.1111/j.1755-263X.2009.00072.x; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Duguma B, 2001, AGROFOREST SYST, V51, P177, DOI 10.1023/A:1010747224249; Ewel JJ, 2008, P NATL ACAD SCI USA, V105, P18836, DOI 10.1073/pnas.0807216105; Frimpong Eric A., 2011, Journal of Pollination Ecology, V5, P74; Fuentes-Talavera FJ, 2011, MADERA BOSQUES, V17, P37; Gockowski J, 2011, ENVIRON MANAGE, V48, P307, DOI 10.1007/s00267-010-9602-3; Gordon C, 2007, AGR ECOSYST ENVIRON, V118, P256, DOI 10.1016/j.agee.2006.05.023; Groeneveld JH, 2010, PERSPECT PLANT ECOL, V12, P183, DOI 10.1016/j.ppees.2010.02.005; Hairiah K, 2001, ASB LECT NOTE, P32; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hertel D, 2002, PLANT SOIL, V239, P237, DOI 10.1023/A:1015030320845; Hertel D, 2013, J ECOL, V101, DOI 10.1111/1365-2745.12124; Houghton RA, 2000, NATURE, V403, P301, DOI 10.1038/35002062; Isaac ME, 2007, PLANT SOIL, V298, P243, DOI 10.1007/s11104-007-9362-x; Johns ND, 1999, ENVIRON MANAGE, V23, P31, DOI 10.1007/s002679900166; Kessler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047192; Klein AM, 2002, BIODIVERS CONSERV, V11, P683, DOI 10.1023/A:1015548426672; Kohler M, 2014, AGROFOREST SYST, V88, P63, DOI 10.1007/s10457-013-9656-3; Kohler M, 2009, ECOHYDROLOGY, V2, P520, DOI 10.1002/eco.67; Kotowska MM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00191; Lehmann J, 2003, PLANT SOIL, V255, P319, DOI 10.1023/A:1026195527076; Leuschner C, 2001, OECOLOGIA, V126, P276, DOI 10.1007/s004420000507; Leuschner C, 2013, AGROFOREST SYST, V87, P1173, DOI 10.1007/s10457-013-9628-7; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Margono BA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034010; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Miyaji KI, 1997, NEW PHYTOL, V135, P445, DOI 10.1046/j.1469-8137.1997.00667.x; Montagnini F, 2004, AGROFOREST SYST, V61-2, P281, DOI 10.1023/B:AGFO.0000029005.92691.79; Moser G, 2010, AGROFOREST SYST, V79, P171, DOI 10.1007/s10457-010-9303-1; Nair PKR, 2010, ADV AGRONOMY, P237; Obiri BD, 2007, AGROFOREST SYST, V71, P139, DOI 10.1007/s10457-007-9058-5; ONG CK, 1991, FOREST ECOL MANAG, V45, P45, DOI 10.1016/0378-1127(91)90205-A; Ong CK, 2004, ECOLOGICAL INTERACTI, P1; Perfecto I, 2007, ENVIRON SCI ENG, P227; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; PERSSON H, 1980, Acta Phytogeographica Suecica, V68, P101; Philpott SM, 2009, ECOL APPL, V19, P1858, DOI 10.1890/08-1928.1; Rice RA, 2000, AMBIO, V29, P167, DOI 10.1579/0044-7447-29.3.167; Ruf F., 1995, Cocoa cycles: the economics of cocoa supply., P339; Saatchi SS, 2011, P NATL ACAD SCI USA, V108, P9899, DOI 10.1073/pnas.1019576108; Saj S, 2013, AGROFOREST SYST, V87, P1309, DOI 10.1007/s10457-013-9639-4; Schroth G, 2002, FOREST ECOL MANAG, V163, P131, DOI 10.1016/S0378-1127(01)00537-0; Schroth G, 2007, BIODIVERS CONSERV, V16, P2237, DOI 10.1007/s10531-007-9195-1; Schwendenmann L, 2010, GLOBAL CHANGE BIOL, V16, P1515, DOI 10.1111/j.1365-2486.2009.02034.x; Siebert SF, 2002, BIODIVERS CONSERV, V11, P1889, DOI 10.1023/A:1020804611740; Smiley GL, 2010, AGROFOREST SYST, V78, P97, DOI 10.1007/s10457-009-9259-1; Somarriba E, 2013, AGR ECOSYST ENVIRON, V173, P46, DOI 10.1016/j.agee.2013.04.013; Steffan-Dewenter I, 2007, P NATL ACAD SCI USA, V104, P4973, DOI 10.1073/pnas.0608409104; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; van Noordwijk M, 2002, ECOL MODEL, V149, P41, DOI 10.1016/S0304-3800(01)00513-0; VANPRAAG HJ, 1988, PLANT SOIL, V105, P87, DOI 10.1007/BF02371146; Vogt KA, 1998, DEV PLANT SOIL SCI, V82, P687; Wade ASI, 2010, AGR ECOSYST ENVIRON, V138, P324, DOI 10.1016/j.agee.2010.06.007; Wielgoss A, 2012, J APPL ECOL, V49, P465, DOI 10.1111/j.1365-2664.2012.02122.x; Wilcove DS, 2013, TRENDS ECOL EVOL, V28, P531, DOI 10.1016/j.tree.2013.04.005; YOUNG AM, 1982, J APPL ECOL, V19, P47, DOI 10.2307/2402990	76	48	48	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149949	10.1371/journal.pone.0149949	http://dx.doi.org/10.1371/journal.pone.0149949			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927428	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200017
J	Klima, CL; Cook, SR; Zaheer, R; Laing, C; Gannon, VP; Xu, Y; Rasmussen, J; Potter, A; Hendrick, S; Alexander, TW; McAllister, TA				Klima, Cassidy L.; Cook, Shaun R.; Zaheer, Rahat; Laing, Chad; Gannon, Vick P.; Xu, Yong; Rasmussen, Jay; Potter, Andrew; Hendrick, Steve; Alexander, Trevor W.; McAllister, Tim A.			Comparative Genomic Analysis of Mannheimia haemolytica from Bovine Sources	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; CONJUGATIVE ELEMENT ICE; TOXIN-ANTITOXIN SYSTEMS; MICROBIAL PAN-GENOME; RESPIRATORY-DISEASE; PASTEURELLA HAEMOLYTICA; MOLECULAR EVOLUTION; BACTERIAL PATHOGENS; ESCHERICHIA-COLI; MULTIDRUG-RESISTANCE	Bovine respiratory disease is a common health problem in beef production. The primary bacterial agent involved, Mannheimia haemolytica, is a target for antimicrobial therapy and at risk for associated antimicrobial resistance development. The role ofM. haemolytica in pathogenesis is linked to serotype with serotypes 1 (S1) and 6 (S6) isolated frompneumonic lesions and serotype 2 (S2) found in the upper respiratory tract of healthy animals. Here, we sequenced the genomes of 11 strains ofM. haemolytica, representing all three serotypes and performed comparative genomics analysis to identify genetic features that may contribute to pathogenesis. Possible virulence associated genes were identified within 14 distinct prophage, including a periplasmic chaperone, a lipoprotein, peptidoglycan glycosyltransferase and a stress response protein. Prophage content ranged from 2-8 per genome, but was higher in S1 and S6 strains. A type I-C CRISPR-Cas system was identified in each strain with spacer diversity and organization conserved among serotypes. The majority of spacers occur in S1 and S6 strains and originate from phage suggesting that serotypes 1 and 6 may be more resistant to phage predation. However, two spacers complementary to the host chromosome targeting a UDP-N-acetylglucosamine 2-epimerase and a glycosyl transferases group 1 gene are present in S1 and S6 strains only indicating these serotypes may employ CRISPR-Cas to regulate gene expression to avoid host immune responses or enhance adhesion during infection. Integrative conjugative elements are present in nine of the eleven genomes. Three of these harbor extensive multi-drug resistance cassettes encoding resistance against the majority of drugs used to combat infection in beef cattle, including macrolides and tetracyclines used in human medicine. The findings here identify key features that are likely contributing to serotype related pathogenesis and specific targets for vaccine design intended to reduce the dependency on antibiotics to treat respiratory infection in cattle.	[Klima, Cassidy L.; Cook, Shaun R.; Zaheer, Rahat; Rasmussen, Jay; Alexander, Trevor W.; McAllister, Tim A.] Agr & Agri Food Canada, Res Ctr, Lethbridge, AB T1J 4B1, Canada; [Klima, Cassidy L.; Hendrick, Steve] Univ Saskatoon, Western Colledge Verterinary Med, Dept Large Anim Clinial Sci, Saskatoon, SK, Canada; [Laing, Chad; Gannon, Vick P.] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Lethbridge, AB, Canada; [Xu, Yong] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Potter, Andrew] Univ Saskatchewan, Dept Vet Microbiol, Vaccine & Infect Dis Org, Saskatoon, SK S7N 0W0, Canada	Agriculture & Agri Food Canada; University of Saskatchewan; Public Health Agency of Canada; University of Lethbridge; University of Saskatchewan	Alexander, TW; McAllister, TA (corresponding author), Agr & Agri Food Canada, Res Ctr, Lethbridge, AB T1J 4B1, Canada.	trevor.alexander@agr.gc.ca; Tim.McAllister@agr.gc.ca	Rasmussen, Jay/P-8200-2018; McAllister, Tim A./R-9201-2017	Rasmussen, Jay/0000-0001-6905-745X; Zaheer, Rahat/0000-0003-3307-4666; McAllister, Tim A./0000-0002-8266-6513; Klima, Cassidy/0000-0002-8762-2448	Genome Alberta	Genome Alberta	Genome Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ghamdi GM, 2000, J VET DIAGN INVEST, V12, P576, DOI 10.1177/104063870001200617; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angata T, 2000, GLYCOBIOLOGY, V10, P431, DOI 10.1093/glycob/10.4.431; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Busby B, 2013, ENVIRON MICROBIOL, V15, P307, DOI 10.1111/j.1462-2920.2012.02886.x; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Confer Anthony W., 2009, Animal Health Research Reviews, V10, P145, DOI 10.1017/S1466252309990193; Confer AW, 2006, VACCINE, V24, P2248, DOI 10.1016/j.vaccine.2005.11.036; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies RL, 2003, VET MICROBIOL, V92, P263, DOI 10.1016/S0378-1135(02)00408-X; Davies RL, 2002, J BACTERIOL, V184, P266, DOI 10.1128/JB.184.1.266-277.2002; Davies RL, 2001, J BACTERIOL, V183, P1394, DOI 10.1128/JB.183.4.1394-1404.2001; De Maayer P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-404; Derouaux A, 2008, J BACTERIOL, V190, P1831, DOI 10.1128/JB.01377-07; Edgar R, 2010, J BACTERIOL, V192, P6291, DOI 10.1128/JB.00644-10; Eidam C, 2015, J ANTIMICROB CHEMOTH, V70, P93, DOI 10.1093/jac/dku361; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Gioia J, 2006, J BACTERIOL, V188, P7257, DOI 10.1128/JB.00675-06; Griffin D, 2010, VET CLIN N AM-FOOD A, V26, P57, DOI 10.1016/j.cvfa.2009.10.010; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Guglielmini J, 2014, NUCLEIC ACIDS RES, V42, P5715, DOI 10.1093/nar/gku194; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Highlander SK, 2000, INFECT IMMUN, V68, P3916, DOI 10.1128/IAI.68.7.3916-3922.2000; Highlander SK, 2001, FRONT BIOSCI-LANDMRK, V6, pD1128, DOI 10.2741/Highland; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Juhas M, 2015, MICROBIOL RES, V170, P10, DOI 10.1016/j.micres.2014.06.007; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Katsuda K, 2008, VET J, V178, P146, DOI 10.1016/j.tvjl.2007.07.019; Keen EC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00161; Kellner H, 2008, SOIL BIOL BIOCHEM, V40, P638, DOI 10.1016/j.soilbio.2007.09.013; Klima CL, 2011, VET MICROBIOL, V149, P390, DOI 10.1016/j.vetmic.2010.11.018; Klima CL, 2014, J CLIN MICROBIOL, V52, P438, DOI 10.1128/JCM.02485-13; Klima CL, 2014, CAN J VET RES, V78, P38; KLIMA CL, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GENOMEA.00051-13; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Kupczok A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-663; Larney FJ, 2014, CAN J SOIL SCI, V94, P515, DOI [10.4141/CJSS2013-114, 10.4141/cjss2013-114]; Larson RL, 2012, VET CLIN N AM-FOOD A, V28, P97, DOI 10.1016/j.cvfa.2011.12.005; Lawrence PK, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-535; Lawrence PK, 2010, J BACTERIOL, V192, P1167, DOI 10.1128/JB.01527-09; Lee I, 2011, MICROBIOL-SGM, V157, P123, DOI 10.1099/mic.0.041236-0; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lubbers BV, 2013, J VET DIAGN INVEST, V25, P413, DOI 10.1177/1040638713485227; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marrero J, 2007, J BACTERIOL, V189, P6469, DOI 10.1128/JB.00522-07; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Michael GB, 2012, J ANTIMICROB CHEMOTH, V67, P91, DOI 10.1093/jac/dkr411; NAGARAJA TG, 1981, J ANIM SCI, V53, P206, DOI 10.2527/jas1981.531206x; Peng X, 2003, J BACTERIOL, V185, P2410, DOI 10.1128/JB.185.8.2410-2417.2003; Petersen SO, 2007, LIVEST SCI, V112, P180, DOI 10.1016/j.livsci.2007.09.001; Rice J. A., 2007, Animal Health Research Reviews, V8, P117, DOI 10.1017/S1466252307001375; Rida S, 1996, J BACTERIOL, V178, P94, DOI 10.1128/jb.178.1.94-102.1996; Sampson TR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003621; Sampson TR, 2013, NATURE, V497, P254, DOI 10.1038/nature12048; Sanchez R, 2011, NUCLEIC ACIDS RES, V39, pW470, DOI 10.1093/nar/gkr408; Sathiamoorthy S, 2011, FEMS MICROBIOL LETT, V325, P148, DOI 10.1111/j.1574-6968.2011.02422.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Siegele DA, 2005, J BACTERIOL, V187, P6253, DOI 10.1128/JB.187.18.6253-6254.2005; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Szczepankowska A, 2012, ADV VIRUS RES, V82, P289, DOI 10.1016/B978-0-12-394621-8.00011-X; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Vernikos G, 2015, CURR OPIN MICROBIOL, V23, P148, DOI 10.1016/j.mib.2014.11.016; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wang XX, 2011, APPL ENVIRON MICROB, V77, P5577, DOI 10.1128/AEM.05068-11; Watts JL, 2010, VET CLIN N AM-FOOD A, V26, P79, DOI 10.1016/j.cvfa.2009.10.009; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhao YB, 2014, BIOINFORMATICS, V30, P1297, DOI 10.1093/bioinformatics/btu017; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	78	30	30	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149520	10.1371/journal.pone.0149520	http://dx.doi.org/10.1371/journal.pone.0149520			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926339	gold, Green Published, Green Submitted			2022-12-27	WOS:000371424200012
J	Miquelajauregui, Y; Cumming, SG; Gauthier, S				Miquelajauregui, Yosune; Cumming, Steven G.; Gauthier, Sylvie			Modelling Variable Fire Severity in Boreal Forests: Effects of Fire Intensity and Stand Structure	PLOS ONE			English	Article							BURN SEVERITY; BLACK SPRUCE; TREE; BEHAVIOR; DECOMPOSITION; RECRUITMENT; MANAGEMENT; MORTALITY; DYNAMICS; WILDFIRE	It is becoming clear that fires in boreal forests are not uniformly stand-replacing. On the contrary, marked variation in fire severity, measured as tree mortality, has been found both within and among individual fires. It is important to understand the conditions under which this variation can arise. We integrated forest sample plot data, tree allometries and historical forest fire records within a diameter class-structured model of 1.0 ha patches of mono-specific black spruce and jack pine stands in northern Quebec, Canada. The model accounts for crown fire initiation and vertical spread into the canopy. It uses empirical relations between fire intensity, scorch height, the percent of crown scorched and tree mortality to simulate fire severity, specifically the percent reduction in patch basal area due to fire-caused mortality. A random forest and a regression tree analysis of a large random sample of simulated fires were used to test for an effect of fireline intensity, stand structure, species composition and pyrogeographic regions on resultant severity. Severity increased with intensity and was lower for jack pine stands. The proportion of simulated fires that burned at high severity (e.g. >75% reduction in patch basal area) was 0.80 for black spruce and 0.11 for jack pine. We identified thresholds in intensity below which there was a marked sensitivity of simulated fire severity to stand structure, and to interactions between intensity and structure. We found no evidence for a residual effect of pyrogeographic region on simulated severity, after the effects of stand structure and species composition were accounted for. The model presented here was able to produce variation in fire severity under a range of fire intensity conditions. This suggests that variation in stand structure is one of the factors causing the observed variation in boreal fire severity.	[Miquelajauregui, Yosune; Cumming, Steven G.] Univ Laval, Ctr Etud Foret, Dept Sci Bois & Foret, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada; [Gauthier, Sylvie] Laurentian Forestry Ctr, Canadian Forest Serv, Quebec City, PQ, Canada	Laval University; Natural Resources Canada; Canadian Forest Service	Miquelajauregui, Y (corresponding author), Univ Laval, Ctr Etud Foret, Dept Sci Bois & Foret, Fac Foresterie Geog & Geomat, Quebec City, PQ, Canada.	yosune.miquelajauregui-graf.1@ulaval.ca	Miquelajauregui, Yosune/O-4617-2018; Gauthier, Sylvie/J-3923-2019	Gauthier, Sylvie/0000-0001-6720-0195	Natural Sciences and Engineering Research Council of Canada [CGSD2-409323-2011]; Natural Sciences and Engineering Research Council of Canada (NSERC); Centre for Forest Research (CEF)	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre for Forest Research (CEF)	Funded by Natural Sciences and Engineering Research Council of Canada/CGSD2-409323-2011 (http://www.nserc-crsng.gc.ca/Students-Etudiants/PG-CS/BellandPostgrad-BelletSuperieures_eng.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ministere des Forets, de la Faune et des Parcs (MFFP) and the Societe de protection des forets contre le feu (SOPFEU) for allowing us to use the inventory and historical forest fire archives. This project was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC). We thank also the Centre for Forest Research (CEF) for financial and technical support as well as to all the members of the C*FIRE project at Universite Laval. Special thanks to U. Valis for his help with the formatting of the graphs.	Alexander M., 1985, P 8 C FIR FOR MET, V29, P85; Alexander ME, 2012, INT J WILDLAND FIRE, V21, P709, DOI 10.1071/WF11153; Alexander ME, 2012, INT J WILDLAND FIRE, V21, P95, DOI 10.1071/WF11001; ALEXANDER ME, 1982, CAN J BOT, V60, P349, DOI 10.1139/b82-048; Alexander ME, 1995, P 1994 SOC AM FOR CA, P185; Amoroso MM, 2011, FOREST ECOL MANAG, V262, P2240, DOI 10.1016/j.foreco.2011.08.016; Andrews PL., 2009, BEHAVEPLUS FIRE MODE, P1; Angers VA, 2010, FOREST ECOL MANAG, V259, P246, DOI 10.1016/j.foreco.2009.09.026; [Anonymous], 2009, ORDRE INGENIEURS FOR; [Anonymous], FIRE ENV INNOVATIONS; Bacaro G., 2014, Forests, Trees and Livelihoods, V23, P211, DOI 10.1080/14728028.2013.844933; Beck JA, 2002, INT J WILDLAND FIRE, V11, P173, DOI 10.1071/WF02002; Belisle AC, 2011, SILVA FENN, V45, P889, DOI 10.14214/sf.77; Bergeron Y, 2002, SILVA FENN, V36, P81, DOI 10.14214/sf.553; Bergeron Y, 2001, CAN J FOREST RES, V31, P384, DOI 10.1139/cjfr-31-3-384; BESSIE WC, 1995, ECOLOGY, V76, P747, DOI 10.2307/1939341; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Boiffin J, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00038.1; Bond-Lamberty B, 2008, ECOSYSTEMS, V11, P831, DOI 10.1007/s10021-008-9163-y; Boucher D, 2003, FOREST CHRON, V79, P318, DOI 10.5558/tfc79318-2; Boulanger Y, 2011, CAN J FOREST RES, V41, P370, DOI 10.1139/X10-218; Byram G.M., 1959, FOREST FIRE CONTROL, P61; CATCHPOLE EA, 1992, CAN J FOREST RES, V22, P968, DOI 10.1139/x92-129; Cruz MG, 2005, CAN J FOREST RES, V35, P1626, DOI 10.1139/X05-085; Cruz MG, 2003, INT J WILDLAND FIRE, V12, P39, DOI 10.1071/WF02024; Dalrymple GN, 2004, NORX393; Forestry Canada Fire Danger Group, 1992, DEV STRUCT CAN FOR F, P1; Gardner R. H., 1999, Spatial modeling of forest landscape change: approaches and applications. Papers presented at a symposium in Albuquerque, New Mexico, USA, 1997., P163; Gauthier S., 2009, FOREST ECOSYSTEM MAN; Greene DF, 2004, CAN J FOREST RES, V34, P1845, DOI 10.1139/X04-059; Hall RJ, 2008, INT J WILDLAND FIRE, V17, P476, DOI 10.1071/WF08013; Hall SA, 2006, FOREST ECOL MANAG, V227, P102, DOI 10.1016/j.foreco.2006.02.022; Harper Karen, 2003, Environmental Reviews, V11, pS79, DOI 10.1139/a03-013; Harvey BD, 2003, TOWARDS SUSTAINABLE MANAGEMENT OF THE BOREAL FOREST, P395; Hirsch K.G., 1996, CANADIAN FOREST FIRE; Hirsch KG, 1997, FOREST SCI, V44, P539; HOLDAWAY MR, 1986, FOREST CHRON, V62, P451, DOI 10.5558/tfc62451-5; Hood SM, 2007, INT J WILDLAND FIRE, V16, P679, DOI 10.1071/WF06122; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Johnson E.A., 1992, FIRE VEGETATION DYNA; Johnstone J, 2006, ECOSYSTEMS, V9, P14, DOI 10.1007/s10021-004-0042-x; Johnstone JF, 2011, LANDSCAPE ECOL, V26, P487, DOI 10.1007/s10980-011-9574-6; Kafka V, 2001, INT J WILDLAND FIRE, V10, P119, DOI 10.1071/WF01012; Keane R.E., 2015, WILDLAND FUEL FUNDAM, DOI DOI 10.1007/978-3-319-09015-3; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kurz WA, 2009, ECOL MODEL, V220, P480, DOI 10.1016/j.ecolmodel.2008.10.018; Laganiere J, 2011, SOIL SCI SOC AM J, V75, P1125, DOI 10.2136/sssaj2010.0275; Lambert MC, 2005, CAN J FOREST RES, V35, P1996, DOI 10.1139/X05-112; Lecomte N, 2006, ECOSYSTEMS, V9, P1215, DOI 10.1007/s10021-004-0168-x; Mansuy N, 2010, INT J WILDLAND FIRE, V19, P1083, DOI 10.1071/WF09144; Ministere des Ressources Naturelles du Quebec, 2008, FOR INV NORMS; Moon K, 2013, 20 INT C MOD SIM AD; Mruzik L., 2001, TFM15351; Parsons RA, 2011, ECOL MODEL, V222, P679, DOI 10.1016/j.ecolmodel.2010.10.023; Pelletier G, 2009, CLASSIFICATION FORES; Peng C., 1999, NONLINEAR HEIGHT DIA, P1; PETERSON DL, 1985, CAN J FOREST RES, V15, P596, DOI 10.1139/x85-097; Purdon M, 2004, APPL VEG SCI, V7, P49, DOI 10.1111/j.1654-109X.2004.tb00595.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Reinhardt E., 2003, FIRE FUELS EXTENSION, P1; Reinhardt E, 2006, CAN J FOREST RES, V36, P2803, DOI 10.1139/X06-157; Rossi S, 2009, FOREST ECOL MANAG, V258, P2153, DOI 10.1016/j.foreco.2009.08.023; ROWE J. S., 1972, FOREST REGIONS CANAD; Ryan KC, 2002, SILVA FENN, V36, P13, DOI 10.14214/sf.548; Saucier J.-P., 1998, REGIONS ECOLOGIQUES, P1; Sikkink P, 2012, PREDICTING FIRE SEVE; Simard A., 1975, WILDLAND FIRE OCCURR, P1; Skowronski NS, 2011, REMOTE SENS ENVIRON, V115, P703, DOI 10.1016/j.rse.2010.10.012; Smith D.M., 1997, PRACTICE SILVICULTUR; SOPFEU, 2012, PLAN STRAT 2012 2015, P1; Staudhammer CL, 2001, CAN J FOREST RES, V31, P1105, DOI 10.1139/x01-033; STOCKS BJ, 1980, CAN J FOREST RES, V10, P498, DOI 10.1139/x80-081; Thies WG, 2006, INT J WILDLAND FIRE, V15, P19, DOI 10.1071/WF05025; Thompson JR, 2009, FOREST ECOL MANAG, V258, P1684, DOI 10.1016/j.foreco.2009.07.031; Van Wagner CE., 1983, ROLE FIRE NO CIRCUMP, P65; VANWAGNER CE, 1982, FOREST SCI, V28, P852; VANWAGNER CE, 1978, CAN J FOREST RES, V8, P220, DOI 10.1139/x78-034; Wagner C. E. van, 1977, Canadian Journal of Forest Research, V7, P23, DOI 10.1139/x77-004; Wagner C. E. van, 1973, Canadian Journal of Forest Research, V3, P373, DOI 10.1139/x73-055; Whelan R.J.., 1995, ECOLOGY FIRE; Wotton BM, 2009, UPDATES REVISIONS 19, P1	81	12	13	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150073	10.1371/journal.pone.0150073	http://dx.doi.org/10.1371/journal.pone.0150073			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919456	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400082
J	Swartz, AM; Cho, Y; Welch, WA; Strath, SJ				Swartz, Ann M.; Cho, Young; Welch, Whitney A.; Strath, Scott J.			Movement Discordance between Healthy and Non-Healthy US Adults	PLOS ONE			English	Article							TOTAL ACTIVITY COUNTS; PHYSICAL-ACTIVITY; SEDENTARY BEHAVIOR; ACCELEROMETRY; PREVALENCE	Introduction Physical activity is known to significantly impact cardiometabolic health. Accelerometer data, as a measure of physical activity, can be used to objectively identify a disparity in movement (movement discordance) between healthy and unhealthy adults. The purpose of this study was to examine the Movement Discordance between healthy and unhealthy adults in a large US population sample. Methods Demographic, health and accelerometer data from the National Health and Nutrition Examination Study (NHANES) 2003-2004 and 2005-2006 cohorts were used for this study. Participants were classified as either having a "normal" or "abnormal" value for each cardiometabolic health parameter examined, based on published criteria. Linear regression analyses were performed to determine significance of each abnormal health parameter (risk factor) in its unique effect on the accelerometer counts, controlling for age and gender. Average accelerometer counts per minute (cpm) by gender and age categories were estimated separately for the groups of normal and abnormal cardiometabolic risk. Results Average cpm for those with healthy levels of each individual cardiometabolic health parameter range from 296 cpm (for C reactive protein) to 337 cpm (for waist circumference), while average cpm for those with abnormal levels of each individual cardiometabolic health parameter range from 216 cpm (for insulin) to 291 cpm (for LDL-cholesterol). After controlling for age and gender, waist circumference, HbA1c, Insulin, Homocysteine, and HDL-Cholesterol were the cardiometabolic health parameters that showed significant, unique and independent effects on cpm. Overall, individuals who have abnormal values for all significant cardiometabolic health parameters ("unhealthy") averaged 267 cpm (SE = 15 cpm), while the healthy sample of this study averaged 428 cpm (SE = 10 cpm). The difference in cpm between the unhealthy and healthy groups is similar between males and females. Further, for both males and females, the cpm gap between unhealthy and healthy is largest in the 30s (males: 183 cpm; females 144 cpm) and lessens as age increases, with the lowest gap seen in those 80+ years (males, 81 cpm; females, 85 cpm). Conclusion This Movement Discordance between healthy and unhealthy adults represents a gap in movement that needs to be closed to improve the health of individuals with, or at risk for cardiometabolic disease.	[Swartz, Ann M.; Welch, Whitney A.; Strath, Scott J.] Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA; [Swartz, Ann M.; Cho, Young; Strath, Scott J.] Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA; [Cho, Young] Univ Wisconsin, Zilber Sch Publ Hlth, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Swartz, AM (corresponding author), Univ Wisconsin, Dept Kinesiol, Milwaukee, WI 53201 USA.; Swartz, AM (corresponding author), Univ Wisconsin, Ctr Aging & Translat Res, Milwaukee, WI 53201 USA.	aswartz@uwm.edu	Cho, Young/AAC-1633-2019	Cho, Young/0000-0003-4632-0934				Achermann JC, 2011, WILLIAMS TXB ENDOCRI, V12th, P868; American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Bassett DR, 2015, MED SCI SPORT EXER, V47, P833, DOI 10.1249/MSS.0000000000000468; Butler EN, 2014, TOP STROKE REHABIL, V21, P246, DOI 10.1310/tsr2103-246; Centers for Disease Control and Prevention, 2007, NAT HLTH NUTR EX SUR; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Copeland JL, 2009, J AGING PHYS ACTIV, V17, P17, DOI 10.1123/japa.17.1.17; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; Evenson KR, 2014, J CARDIOPULM REHABIL, V34, P406, DOI 10.1097/HCR.0000000000000064; Ferri F., 2012, LAB TESTS INTERPRETA; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hawkins MS, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-31; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Johnson Clifford L, 2013, Vital Health Stat 2, P1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SIEGEL PZ, 1995, AM J PUBLIC HEALTH, V85, P706, DOI 10.2105/AJPH.85.5.706; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P694, DOI 10.1123/jpah.2013-0463; Wolff-Hughes DL, 2015, J PHYS ACT HEALTH, V12, P447, DOI 10.1123/jpah.2013-0464	20	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150325	10.1371/journal.pone.0150325	http://dx.doi.org/10.1371/journal.pone.0150325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918868	gold, Green Published			2022-12-27	WOS:000371274400125
J	Yang, M; Chen, JC; Shen, T; Kang, Y; Deng, DM; Lin, XM; Wu, HP; Chen, QW; Ye, XL; Li, JQ; Yan, JH				Yang, Min; Chen, Jingchang; Shen, Tao; Kang, Ying; Deng, Daming; Lin, Xiaoming; Wu, Heping; Chen, Qiwen; Ye, Xuelian; Li, Jianqun; Yan, Jianhua			Single Stage Surgical Outcomes for Large Angle Intermittent Exotropia	PLOS ONE			English	Article							LATERAL RECTUS RECESSION; SURGERY; STRABISMUS; CHILDREN	Although there were many prior studies about exotropia, few focused on large-angle intermittent exotropia. The goal of this study was to evaluate single-stage surgical outcomes for large-angle intermittent exotropia and analyze risk factors that may affect the success of surgery. Records from intermittent exotropia patients with exodeviations >60 prism diopters (PD) who were surgically treated at the Zhongshan Ophthalmic Center, of Sun Yat-Sen University were reviewed. Included within this review were data on, pre- and post-operative ocular motility, primary alignment, binocular vision and complications. Patients with exodeviations <= 70PD received two-muscle surgery, while those with exodeviations >70PD were subjected to a three-muscle procedure. A total of 40 records were reviewed. The mean exodeviation was 73+/-9PD at distance and 75+/-26PD at near. There were 25 patients received two-muscle surgery and 15 the three-muscle procedure. Orthophoria (deviation within 8PD) was obtained in 77.5% of these patients and the ratios of surgical under-correction and over-correction were 15% and 7.5% respectively. However, when combining ocular alignment with binocular vision as the success criteria, success rates decreased to 30%. No statistically significant differences in success rates were obtained between the two-and three-muscle surgery groups. Seven subjects experienced an abduction deficit during the initial postoperative stages, but eventually showed a full recovery. One patient required a second surgery for overcorrection. No statistically significant risk factors for poor outcome were revealed. Our data showed that single-stage two-and three-muscle surgeries for large-angle intermittent exotropia are effective in achieving a favorable outcome.	[Yang, Min; Chen, Jingchang; Shen, Tao; Kang, Ying; Deng, Daming; Lin, Xiaoming; Wu, Heping; Chen, Qiwen; Ye, Xuelian; Li, Jianqun; Yan, Jianhua] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Dept Strabismus & Amblyopia, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Min] Tongde Hosp Zhejiang Prov, Dept Strabismus & Amblyopia, Hangzhou, Zhejiang, Peoples R China	Sun Yat Sen University	Yan, JH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Dept Strabismus & Amblyopia, Guangzhou 510275, Guangdong, Peoples R China.	yanjh2011@126.com		yan, jian hua/0000-0001-7564-8491	Research Foundation of Science and Technology Plan Project, Guangdong, China [2013B021800128]	Research Foundation of Science and Technology Plan Project, Guangdong, China	This work was supported by the Research Foundation of Science and Technology Plan Project, Guangdong, China (grant number: 2013B021800128). Jianhua Yan received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanis D, 2006, J FR OPHTALMOL, V29, P37, DOI 10.1016/S0181-5512(06)73745-7; BURIAN HM, 1965, AM J OPHTHALMOL, V59, P603, DOI 10.1016/0002-9394(65)93991-7; Celebi S, 2001, EUR J OPHTHALMOL, V11, P6, DOI 10.1177/112067210101100102; Cho YA, 1987, J KOREAN OPHTHALMOL, V28, P1315; Currie ZI, 2003, EYE, V17, P334, DOI 10.1038/sj.eye.6700347; Ekdawi NS, 2009, J AAPOS, V13, P4, DOI 10.1016/j.jaapos.2008.06.001; Ganguly S, 2011, NEPAL J OPHTHALMOL, V3, P27, DOI 10.3126/nepjoph.v3i1.4275; Govindan M, 2005, OPHTHALMOLOGY, V112, P104, DOI 10.1016/j.ophtha.2004.07.033; Isenberg SJ, 2009, BRIT J OPHTHALMOL, V93, P443, DOI 10.1136/bjo.2007.136382; JAMPOLSKY A, 1958, AM J OPHTHALMOL, V46, P646, DOI 10.1016/0002-9394(58)91261-3; Jeoung JW, 2006, AM J OPHTHALMOL, V141, P683, DOI 10.1016/j.ajo.2005.11.021; Jung Jae-Wook, 2010, Korean J Ophthalmol, V24, P96, DOI 10.3341/kjo.2010.24.2.96; Kim KE, 2014, AM J OPHTHALMOL, V157, P1214, DOI 10.1016/j.ajo.2014.02.038; Lau FHS, 2010, EYE, V24, P1171, DOI 10.1038/eye.2010.5; Li JH, 2013, J AAPOS, V17, P578, DOI 10.1016/j.jaapos.2013.07.015; Livir-Rallatos G, 2002, J AAPOS, V6, P77, DOI 10.1067/mpa.2002.122059; Millan T, 2009, CLINICS, V64, P303, DOI 10.1590/S1807-59322009000400006; MULBERGER RD, 1954, AMA ARCH OPHTHALMOL, V52, P664; Peters Elyssa R, 2007, Am Orthopt J, V57, P104, DOI 10.3368/aoj.57.1.104; RAAB EL, 1969, ARCH OPHTHALMOL-CHIC, V82, P203, DOI 10.1001/archopht.1969.00990020205010; Saleem Quratul Ain, 2013, BMC Res Notes, V6, P257, DOI 10.1186/1756-0500-6-257; SCHWARTZ RL, 1980, J PEDIAT OPHTH STRAB, V17, P359; Simon JW, 2005, PEDIAT OPHTHALMOLOGY, P171; Thomas S, 2010, STRABISMUS, V18, P129, DOI 10.3109/09273972.2010.525778	24	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150508	10.1371/journal.pone.0150508	http://dx.doi.org/10.1371/journal.pone.0150508			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919493	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400130
J	Alldred, M; Baines, SB; Findlay, S				Alldred, Mary; Baines, Stephen B.; Findlay, Stuart			Effects of Invasive-Plant Management on Nitrogen-Removal Services in Freshwater Tidal Marshes	PLOS ONE			English	Article							PHRAGMITES-AUSTRALIS; ECOSYSTEM SERVICES; COMMON REED; WETLANDS; DENITRIFICATION; CONSEQUENCES; BIODIVERSITY; IMPACT	Establishing relationships between biodiversity and ecosystem function is an ongoing endeavor in contemporary ecosystem and community ecology, with important practical implications for conservation and the maintenance of ecosystem services. Removal of invasive plant species to conserve native diversity is a common management objective in many ecosystems, including wetlands. However, substantial changes in plant community composition have the potential to alter sediment characteristics and ecosystem services, including permanent removal of nitrogen from these systems via microbial denitrification. A balanced assessment of costs associated with keeping and removing invasive plants is needed to manage simultaneously for biodiversity and pollution targets. We monitored small-scale removals of Phragmites australis over four years to determine their effects on potential denitrification rates relative to three untreated Phragmites sites and adjacent sites dominated by native Typha angustifolia. Sediment ammonium increased following the removal of vegetation from treated sites, likely as a result of decreases in both plant uptake and nitrification. Denitrification potentials were lower in removal sites relative to untreated Phragmites sites, a pattern that persisted at least two years following removal as native plant species began to re-colonize treated sites. These results suggest the potential for a trade-off between invasive-plant management and nitrogen-removal services. A balanced assessment of costs associated with keeping versus removing invasive plants is needed to adequately manage simultaneously for biodiversity and pollution targets.	[Alldred, Mary; Baines, Stephen B.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA; [Findlay, Stuart] Cary Inst Ecosyst Studies, Millbrook, NY USA; [Alldred, Mary] CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cary Institute of Ecosystem Studies; City University of New York (CUNY) System; Baruch College (CUNY)	Alldred, M (corresponding author), SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA.; Alldred, M (corresponding author), CUNY, Baruch Coll, Dept Nat Sci, New York, NY 10021 USA.	malldred1@gmail.com			ENY Chapter of the Nature Conservancy; Hudson River Foundation; New York Sea Grant [R/CMC-10]; Robert R. Sokal Award for Research in Statistical Biology; Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University; Direct For Biological Sciences [1119739] Funding Source: National Science Foundation	ENY Chapter of the Nature Conservancy; Hudson River Foundation; New York Sea Grant; Robert R. Sokal Award for Research in Statistical Biology; Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the ENY Chapter of the Nature Conservancy (www.nature.org), a Tibor T. Polgar Fellowship and Graduate Research Fellowship from the Hudson River Foundation (www.hudsonriver.org), New York Sea Grant (R/CMC-10, seagrant.sunysb.edu), a Robert R. Sokal Award for Research in Statistical Biology, and a Lawrence Slobodkin Award for Research in Ecology from the Department of Ecology and Evolution, Stony Brook University (life.bio.sunysb.edu/ee). The ENY Chapter of the Nature Conservancy selected sites for initial invasive-plant management. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldred M, 2015, ECOLOGICAL APPL; Alldred M, 2011, INVASIVE SPECIES REM; [Anonymous], 2002, METHODS DETERMINATIO; [Anonymous], 1989, JMP R JMP R VERS 11; ARMSTRONG J, 1990, NEW PHYTOL, V114, P121, DOI 10.1111/j.1469-8137.1990.tb00382.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benoit LK, 1999, WETLANDS, V19, P194, DOI 10.1007/BF03161749; Bertness MD, 2002, P NATL ACAD SCI USA, V99, P1395, DOI 10.1073/pnas.022447299; Chambers RM, 1999, AQUAT BOT, V64, P261, DOI 10.1016/S0304-3770(99)00055-8; Corp P-E, 1991, 2400 SER 2 CHNS O AN; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Fell PE, 2003, ESTUARIES, V26, P534, DOI 10.1007/BF02823729; Findlay SEG, 2002, AQUAT SCI, V64, P107, DOI 10.1007/s00027-002-8059-8; Findlay S, 2003, WETL ECOL MANAG, V11, P157, DOI 10.1023/A:1024255827418; Groffman PM, 2006, ECOL APPL, V16, P2091, DOI 10.1890/1051-0761(2006)016[2091:MFMDDA]2.0.CO;2; Hansson LA, 2005, FRESHWATER BIOL, V50, P705, DOI 10.1111/j.1365-2427.2005.01352.x; Hazelton ELG, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu001; HESSLEIN RH, 1976, LIMNOL OCEANOGR, V21, P912, DOI 10.4319/lo.1976.21.6.0912; JONES MN, 1984, WATER RES, V18, P643, DOI 10.1016/0043-1354(84)90215-X; Keller Barbara E. M., 2000, Wetlands Ecology and Management, V8, P391, DOI 10.1023/A:1026505817409; Kettenring KM, 2011, J APPL ECOL, V48, P970, DOI 10.1111/j.1365-2664.2011.01979.x; Kettenring KM, 2012, AOB PLANTS, V2012, P1, DOI DOI 10.1093/A0BPLA/PLS040; Kiviat E, 2006, 01200A HUDS RIV FDN; Kiviat E, 2013, AOB PLANTS, V5, DOI 10.1093/aobpla/plt008; Kremen C, 2005, ECOL LETT, V8, P468, DOI 10.1111/j.1461-0248.2005.00751.x; Lalli C.M., 1984, MANUAL CHEM BIOL MET, P7; Lombard KB, 2012, NORTHEAST NAT, V19, P181, DOI 10.1656/045.019.s614; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martin LJ, 2013, ESTUAR COAST, V36, P626, DOI 10.1007/s12237-013-9593-4; Meyerson L. A., 1999, Biological Invasions, V1, P129, DOI 10.1023/A:1010005724468; Meyerson LA, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P827; Meyerson LA, 2000, WETLANDS ECOLOGY MAN, V8, P89, DOI DOI 10.1023/A:1008432200133; Mozdzer TJ, 2010, ESTUAR COAST, V33, P784, DOI 10.1007/s12237-009-9254-9; Orson R. A., 1999, Biological Invasions, V1, P149, DOI 10.1023/A:1010047731369; Otto S, 1999, J ENVIRON QUAL, V28, P1252, DOI 10.2134/jeq1999.00472425002800040028x; Pike N, 2011, METHODS ECOL EVOL, V2, P278, DOI 10.1111/j.2041-210X.2010.00061.x; Rooth J. E., 2000, Wetlands Ecology and Management, V8, P173, DOI 10.1023/A:1008444502859; Saltonstall K, 2002, P NATL ACAD SCI USA, V99, P2445, DOI 10.1073/pnas.032477999; Silliman BR, 2004, CONSERV BIOL, V18, P1424, DOI 10.1111/j.1523-1739.2004.00112.x; Simberloff D, 2015, F1000PRIME REPORTS, V7, DOI 10.12703/P7-47; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Solomon KR, 2003, J TOXICOL ENV HEAL B, V6, P289, DOI 10.1080/10937400306468; Stein C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0075396; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Truitt AM, 2015, ENVIRON MANAGE, V55, P1217, DOI 10.1007/s00267-015-0465-5; Wainger LA, 2010, ECOL ECON, V69, P978, DOI 10.1016/j.ecolecon.2009.12.011; Wickham H., 2015, GGPLOT2 ELEGANT GRAP; Windham L, 2003, ESTUARIES, V26, P452, DOI 10.1007/BF02823722; Windham L, 2003, ECOL APPL, V13, P883, DOI 10.1890/02-5005; Windham L, 2001, MAR POLLUT BULL, V42, P811, DOI 10.1016/S0025-326X(00)00224-1; Zedler JB, 2003, FRONT ECOL ENVIRON, V1, P65, DOI 10.1890/1540-9295(2003)001[0065:WAYSRI]2.0.CO;2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zedler JB, 2004, CRIT REV PLANT SCI, V23, P431, DOI 10.1080/07352680490514673; Zimmerman C, 2009, HUDSON RIVER INVASIV; Zimmerman C, 2013, TRAJECTORY VEGETATIO	55	20	20	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149813	10.1371/journal.pone.0149813	http://dx.doi.org/10.1371/journal.pone.0149813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914688	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700029
J	He, YY; Yu, SJ; Hu, JW; Cui, Y; Liu, PG				He, Yanyu; Yu, Sijiu; Hu, Junwei; Cui, Yan; Liu, Penggang			Changes in the Anatomic and Microscopic Structure and the Expression of HIF-1 alpha and VEGF of the Yak Heart with Aging and Hypoxia	PLOS ONE			English	Article							MAMMALIAN CARDIAC MUSCLE; HUMAN CORONARY-ARTERIES; ONE-LUNG VENTILATION; POLARIZATION MICROSCOPY; AREA-COMPOSITA; HIGH ALTITUDES; COLLAGEN; FAILURE; CELLS; MYOCARDIUM	The study aimed to identify the changes of anatomic and microscopic structure and the expression and localization of hypoxia-inducible factor (HIF)-1 alpha and vascular endothelial growth factor (VEGF) in the myocardium and coronary artery of the yak heart adapted to chronic hypoxia with aging. Thirty-two yaks (1 day, 6 months, 1 year, 2 years, and 5 year old) were included, and immunoelectronmicroscopy, immunohistochemistry, and enzyme-linked immunosorbent assay (ELISA) were used. Right ventricular hypertrophy was not present in yaks with aging. There was no intima thickening phenomenon in the coronary artery. The ultrastructure of myofibrils, mitochondria, and collagen fibers and the diameter and quantity of collagen changed significantly with aging. The enzymatic activity of complexes I, II, and V increased with age. Immunogold labeling showed the localization of HIF-1 alpha protein in the cytoplasm and nuclei of endothelial cells and cytoplasm of cardiac muscle cells, and VEGF protein in the nuclei and perinuclei areas of smooth muscle cells of coronary artery, and in the cytoplasm and nuclei of endothelial cells. ELISA results showed that HIF-1 alpha secretion significantly increased in the myocardium and coronary artery from an age of 1 day to 2 years of yaks and decreased in old yaks. However, VEGF protein always increased with aging. The findings of this study suggest that 6 months is a key age of yak before which there are some adaptive changes to deal with low-oxygen environment, and there is a maturation of the yak heart from the age of 6 months to 2 years.	[He, Yanyu; Yu, Sijiu; Hu, Junwei; Cui, Yan; Liu, Penggang] Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China	Gansu Agricultural University	Cui, Y (corresponding author), Gansu Agr Univ, Coll Vet Med, Lanzhou 730070, Gansu, Peoples R China.	Cuiyan369@sina.com			Nature Science Foundation of China [30960270, 31360594]; Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University	This study was supported by Nature Science Foundation of China (grant No. 30960270, 31360594) and by the Fostering Foundation for the Excellent PhD Dissertation of Gansu Agricultural University (2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER AF, 1959, AM J VET RES, V20, P680; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; BROOK WH, 1983, J ANAT, V137, P729; Chantler PD, 2006, HEART, V92, P686, DOI 10.1136/hrt.2005.063578; Collier P, 2012, J MOL CELL CARDIOL, V52, P148, DOI 10.1016/j.yjmcc.2011.10.002; Crick SJ, 1998, J ANAT, V193, P105, DOI 10.1046/j.1469-7580.1998.19310105.x; Dai Y, 2007, J MOL CELL CARDIOL, V42, P1036, DOI 10.1016/j.yjmcc.2007.04.001; de Souza RR, 2002, BIOGERONTOLOGY, V3, P325, DOI 10.1023/A:1021312027486; Debessa CRG, 2001, MECH AGEING DEV, V122, P1049; Duan DY, 2012, ANAT REC, V295, P2045, DOI 10.1002/ar.22591; EGHBALI M, 1989, CARDIOVASC RES, V23, P723, DOI 10.1093/cvr/23.8.723; Eleftheriadis SG, 2010, ANTICANCER RES, V30, P1143; Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003; Ge RL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2860; HE J-f, 2008, CHINESE VET SCI, V12; He YY, 2010, ANAT REC, V293, P1519, DOI 10.1002/ar.21201; HEATH D, 1984, CARDIOVASC RES, V18, P133, DOI 10.1093/cvr/18.3.133; JUNQUEIRA LCU, 1978, ARCH HISTOL JAPON, V41, P267, DOI 10.1679/aohc1950.41.267; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; Li LY, 1966, ANATOMY DOMESTIC ANI; Lin F, 2015, LIFE SCI, V124, P50, DOI 10.1016/j.lfs.2014.12.020; Salazar BL, 2006, REV ESP CARDIOL, V59, P1047, DOI 10.1157/13093982; Lubkemeier I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0348-y; MacDonald AA, 2007, J ANAT, V211, P64, DOI 10.1111/j.1469-7580.2007.00743.x; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; MEDUGORAC I, 1980, CARDIOVASC RES, V14, P551, DOI 10.1093/cvr/14.9.551; MOORE DH, 1957, J BIOPHYS BIOCHEM CY, V3, P261, DOI 10.1083/jcb.3.2.261; OLIVETTI G, 1991, CIRC RES, V68, P1560, DOI 10.1161/01.RES.68.6.1560; Pieperhoff S, 2008, EUR J CELL BIOL, V87, P413, DOI 10.1016/j.ejcb.2008.02.005; Poynter JA, 2011, SURGERY, V150, P278, DOI 10.1016/j.surg.2011.06.006; RECAVARREN S, 1964, BRIT HEART J, V26, P806; Sakabe Masahide, 2006, Acta Anatomica Nipponica, V81, P117; Shao SX, 2001, PROGR ANATOMICAL SCI, V1, P30; Shimada T, 1994, MED ELECT MICROSCOPY, V27, P227; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; SIMS FH, 1990, CORONARY ARTERY DIS, V1, P205, DOI 10.1097/00019501-199003000-00009; SIMS FH, 1989, AM HEART J, V118, P32, DOI 10.1016/0002-8703(89)90068-9; STENGER RJ, 1961, J BIOPHYS BIOCHEM CY, V9, P325, DOI 10.1083/jcb.9.2.325; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Tipoe GL, 2003, RESP PHYSIOL NEUROBI, V138, P143, DOI 10.1016/S1569-9048(03)00188-5; Serrano FV, 2007, EUR HEART J, V28, P653; Vasan RS, 2001, NEW ENGL J MED, V344, P56, DOI 10.1056/NEJM200101043440111; VERZAR F, 1964, GERONTOLOGY, V9, P209, DOI 10.1159/000211257; Wessels A, 2003, PHYSIOL GENOMICS, V15, P165, DOI 10.1152/physiolgenomics.00033.2003; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; [周金星 Zhou Jinxing], 2015, [中国兽医学报, Chinese Journal of Veterinary Science], V35, P1840; Zhou JX, 2013, ANAT REC, V296, P1775, DOI 10.1002/ar.22790	48	17	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149947	10.1371/journal.pone.0149947	http://dx.doi.org/10.1371/journal.pone.0149947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914488	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700040
J	Devarajan, N; Laffite, A; Mulaji, CK; Otamonga, JP; Mpiana, PT; Mubedi, JI; Prabakar, K; Ibelings, BW; Pote, J				Devarajan, Naresh; Laffite, Amandine; Mulaji, Crispin Kyela; Otamonga, Jean-Paul; Mpiana, Pius Tshimankinda; Mubedi, Josue Ilunga; Prabakar, Kandasamy; Ibelings, Bastiaan Willem; Pote, John			Occurrence of Antibiotic Resistance Genes and Bacterial Markers in a Tropical River Receiving Hospital and Urban Wastewaters	PLOS ONE			English	Article							LAKE GENEVA; WASTE-WATER; CLASS-1 INTEGRONS; BETA-LACTAMASE; TOXIC METALS; SEDIMENTS; ACCUMULATION; CAUVERY; DISSEMINATION; EFFLUENTS	The occurrence of emerging biological contaminants including antibiotic resistance genes (ARGs) and Faecal Indicator Bacteria (FIB) is still little investigated in developing countries under tropical conditions. In this study, the total bacterial load, the abundance of FIB (E. coli and Enterococcus spp. (ENT)), Pseudomonas spp. and ARGs (bla(TEM), bla(CTX-M), bla(SHV), bla(NDM) and aadA) were quantified using quantitative PCR in the total DNA extracted from the sediments recovered from hospital outlet pipes (HOP) and the Cauvery River Basin (CRB), Tiruchirappalli, Tamil Nadu, India. The abundance of bacterial marker genes were 120, 104 and 89 fold higher for the E. coli, Enterococcus spp. and Pseudomonas spp., respectively at HOP when compared with CRB. The ARGs aadA and blaTEM were most frequently detected in higher concentration than other ARGs at all the sampling sites. The ARGs blaSHV and blaNDM were identified in CRB sediments contaminated by hospital and urban wastewaters. The ARGs abundance strongly correlated (r >= 0.36, p < 0.05, n = 45) with total bacterial load and E. coli in the sediments, indicating a common origin and extant source of contamination. Tropical aquatic ecosystems receiving wastewaters can act as reservoir of ARGs, which could potentially be transferred to susceptible bacterial pathogens at these sites.	[Devarajan, Naresh; Laffite, Amandine; Ibelings, Bastiaan Willem; Pote, John] Univ Geneva, Inst FA Forel, Geneva, Switzerland; [Devarajan, Naresh; Laffite, Amandine; Ibelings, Bastiaan Willem; Pote, John] Univ Geneva, Inst Environm Sci, Geneva, Switzerland; [Mulaji, Crispin Kyela; Mpiana, Pius Tshimankinda; Pote, John] Univ Kinshasa UNIKIN, Fac Sci, Dept Chem, Kinshasa XI, DEM REP CONGO; [Otamonga, Jean-Paul; Mubedi, Josue Ilunga; Pote, John] UPN, Croisement Route Matadi & Ave Liberat, Kinshasa, DEM REP CONGO; [Prabakar, Kandasamy] Jamal Mohamed Coll, Postgrad & Res Dept Zool, Tiruchirappalli 620020, Tamil Nadu, India	University of Geneva; University of Geneva; Universite de Kinshasa; Jamal Mohamed College	Pote, J (corresponding author), Univ Geneva, Inst FA Forel, Geneva, Switzerland.; Pote, J (corresponding author), Univ Geneva, Inst Environm Sci, Geneva, Switzerland.; Pote, J (corresponding author), Univ Kinshasa UNIKIN, Fac Sci, Dept Chem, Kinshasa XI, DEM REP CONGO.; Pote, J (corresponding author), UPN, Croisement Route Matadi & Ave Liberat, Kinshasa, DEM REP CONGO.	john.pote@unige.ch	Devarajan, Naresh/L-5718-2019; Ha, Dat Thinh/D-4995-2015; Devarajan, Naresh/W-4594-2018	Devarajan, Naresh/0000-0002-2823-3952; Ha, Dat Thinh/0000-0003-4260-4876; Devarajan, Naresh/0000-0002-2823-3952; prabakar, kandasamy/0000-0003-4498-2328; Mulaji, Crispin/0000-0002-9406-3277; PRABAKAR, KANDASAMY/0000-0002-7055-7299	Swiss National Science Foundation [31003A_150163/1]; Ernst and Lucie Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ernst and Lucie Schmidheiny Foundation	The authors are grateful to financial sources: the Swiss National Science Foundation (grant no. 31003A_150163/1); Bourse Augustin Lombard 2013 for field sampling. Naresh Devarajan is a Ph.D. student supported by Ernst and Lucie Schmidheiny Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahammad ZS, 2014, ENVIRON SCI TECHNOL, V48, P3014, DOI 10.1021/es405348h; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Berglund B, 2015, ENVIRON TOXICOL CHEM, V34, P192, DOI 10.1002/etc.2784; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; CCME, 1999, 98E CCME EPC; Centers for Disease Control, 2013, ANTIBIOTIC RESISTANC; Chen BW, 2013, WATER RES, V47, P2811, DOI 10.1016/j.watres.2013.02.042; Czekalski N, 2014, ISME J, V8, P1381, DOI 10.1038/ismej.2014.8; Dekov VM, 1998, SCI TOTAL ENVIRON, V212, P89, DOI 10.1016/S0048-9697(97)00132-0; Demaneche S, 2008, P NATL ACAD SCI USA, V105, P3957, DOI 10.1073/pnas.0800072105; Devarajan N, 2015, ENVIRON SCI POLLUT R, V22, P12941, DOI 10.1007/s11356-015-4457-z; Devarajan N, 2015, ENVIRON SCI TECHNOL, V49, P6528, DOI 10.1021/acs.est.5b01031; Dhanakumar S, 2015, ECOTOX ENVIRON SAFE, V113, P145, DOI 10.1016/j.ecoenv.2014.11.032; GELDREICH EE, 1976, CRIT REV ENV CONTR, V6, P349, DOI 10.1080/10643387609381645; Haller L, 2009, WATER AIR SOIL POLL, V203, P217, DOI 10.1007/s11270-009-0005-0; Haller L, 2009, ECOL INDIC, V9, P540, DOI 10.1016/j.ecolind.2008.08.001; Keil RG, 2014, TREATISE GEOCHEMISTR, P337, DOI DOI 10.1016/B978-0-08-095975-7.01024-X; Khan GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062712; Kummerer K, 2004, J ANTIMICROB CHEMOTH, V54, P311, DOI 10.1093/jac/dkh325; Lachmayr KL, 2009, APPL ENVIRON MICROB, V75, P203, DOI 10.1128/AEM.01254-08; Laht M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103705; Mubedi JI, 2013, CHEMOSPHERE, V93, P1070, DOI 10.1016/j.chemosphere.2013.05.080; Mwanamoki PM, 2014, ENVIRON MONIT ASSESS, V186, P6821, DOI 10.1007/s10661-014-3891-6; Nardelli M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039223; Ouattara NK, 2011, ENVIRON MONIT ASSESS, V183, P243, DOI 10.1007/s10661-011-1918-9; Pachepsky Y, 2011, ADV AGRON, V113, P73, DOI 10.1016/B978-0-12-386473-4.00007-5; Pei RT, 2006, WATER RES, V40, P2427, DOI 10.1016/j.watres.2006.04.017; Pote J, 2008, BIORESOURCE TECHNOL, V99, P7122, DOI 10.1016/j.biortech.2007.12.075; Pote J, 2007, ECOTOX ENVIRON SAFE, V68, P293, DOI 10.1016/j.ecoenv.2006.11.004; Pote J, 2010, ECOL INDIC, V10, P234, DOI 10.1016/j.ecolind.2009.05.002; Poza M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044105; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Quinteira S, 2005, ANTIMICROB AGENTS CH, V49, P2140, DOI 10.1128/AAC.49.5.2140-2141.2005; Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Skariyachan S, 2015, ENV MONITORING ASSES, V187; Spindler A, 2012, ANTON LEEUW INT J G, V102, P73, DOI 10.1007/s10482-012-9714-2; Srinivasan V, 2008, MICROB ECOL, V55, P184, DOI 10.1007/s00248-007-9266-6; Srinivasan V, 2007, INT J ANTIMICROB AG, V29, P254, DOI 10.1016/j.ijantimicag.2006.08.040; Stoll C, 2012, ENVIRON SCI TECHNOL, V46, P9716, DOI 10.1021/es302020s; Storteboom H, 2010, ENVIRON SCI TECHNOL, V44, P1947, DOI 10.1021/es902893f; Thevenon F, 2012, CHEMOSPHERE, V86, P468, DOI 10.1016/j.chemosphere.2011.09.048; Verlicchi P, 2010, J HYDROL, V389, P416, DOI 10.1016/j.jhydrol.2010.06.005; Walk ST, 2007, ENVIRON MICROBIOL, V9, P2274, DOI 10.1111/j.1462-2920.2007.01341.x; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization (WHO), ANTIMICROBIAL RESIST; Zhang ST, 2013, J ENVIRON BIOL, V34, P345; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	50	71	75	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149211	10.1371/journal.pone.0149211	http://dx.doi.org/10.1371/journal.pone.0149211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910062	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700026
J	Ihara, Y; Tomonoh, Y; Deshimaru, M; Zhang, B; Uchida, T; Ishii, A; Hirose, S				Ihara, Yukiko; Tomonoh, Yuko; Deshimaru, Masanobu; Zhang, Bo; Uchida, Taku; Ishii, Atsushi; Hirose, Shinichi			Retigabine, a K(v)7.2/K(v)7.3-Channel Opener, Attenuates Drug-Induced Seizures in Knock-In Mice Harboring Kcnq2 Mutations	PLOS ONE			English	Article							FAMILIAL NEONATAL CONVULSIONS; KCNQ2/KCNQ3 K+ CHANNELS; ANTICONVULSANT RETIGABINE; EPILEPTIC ENCEPHALOPATHY; POTASSIUM CHANNELS; NEURONAL EXCITABILITY; RAT HIPPOCAMPUS; MOUSE MODELS; EZOGABINE; CURRENTS	The hetero-tetrameric voltage-gated potassium channel K(v)7.2/K(v)7.3, which is encoded by KCNQ2 and KCNQ3, plays an important role in limiting network excitability in the neonatal brain. K(v)7.2/K(v)7.3 dysfunction resulting from KCNQ2 mutations predominantly causes self-limited or benign epilepsy in neonates, but also causes early onset epileptic encephalopathy. Retigabine (RTG), a K(v)7.2/K(v)7.3-channel opener, seems to be a rational antiepileptic drug for epilepsies caused by KCNQ2 mutations. We therefore evaluated the effects of RTG on seizures in two strains of knock-in mice harboring different Kcnq2 mutations, in comparison to the effects of phenobarbital (PB), which is the first-line antiepileptic drug for seizures in neonates. The subjects were heterozygous knock-in mice (Kcnq2(Y284C/+) and Kcnq2(A306T/+)) bearing the Y284C or A306T Kcnq2 mutation, respectively, and their wildtype (WT) littermates, at 63-100 days of age. Seizures induced by intraperitoneal injection of kainic acid (KA, 12mg/kg) were recorded using a video-electroencephalography (EEG) monitoring system. Effects of RTG on KA-induced seizures of both strains of knock-in mice were assessed using seizure scores from a modified Racine's scale and compared with those of PB. The number and total duration of spike bursts on EEG and behaviors monitored by video recording were also used to evaluate the effects of RTG and PB. Both Kcnq2(Y284C/+) and Kcnq2(A306T/+) mice showed significantly more KA-induced seizures than WT mice. RTG significantly attenuated KA-induced seizure activities in both Kcnq2(Y284C/+) and Kcnq2(A306T/+) mice, and more markedly than PB. This is the first reported evidence of RTG ameliorating KA-induced seizures in knock-in mice bearing mutations of Kcnq2, with more marked effects than those observed with PB. RTG or other K(v)7.2-channel openers may be considered as first-line antiepileptic treatments for epilepsies resulting from KCNQ2 mutations.	[Ihara, Yukiko; Tomonoh, Yuko; Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan; [Deshimaru, Masanobu] Fukuoka Univ, Fac Sci, Dept Chem, Fukuoka 81401, Japan; [Zhang, Bo] Fukuoka Univ, Sch Med, Dept Biochem, Fukuoka 81401, Japan; [Uchida, Taku; Hirose, Shinichi] Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan	Fukuoka University; Fukuoka University; Fukuoka University; Fukuoka University	Hirose, S (corresponding author), Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan.; Hirose, S (corresponding author), Fukuoka Univ, Cent Res Inst Mol Pathomech Epilepsy, Fukuoka 81401, Japan.	hirose@fukuoka-u.ac.jp		HIROSE, Shinichi/0000-0001-6796-3790	Japan Society for the Promotion of Science Foundation [23791201, 24249060, 25670481]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [221S0002, 25129708]; MEXT; Ministry of Health, Labor, and Welfare, an Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [H26-Nanji-Ippan-051, 049, 24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Kobayashi Magobei Foundation; Kurozumi medical foundation; Japan Epilepsy Research Foundation Grant; Kaibara Medical Foundation; Grants-in-Aid for Scientific Research [15H02548] Funding Source: KAKEN	Japan Society for the Promotion of Science Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, an Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation(Takeda Science Foundation (TSF)); Kobayashi Magobei Foundation; Kurozumi medical foundation(Kurozumi Medical Foundation); Japan Epilepsy Research Foundation Grant; Kaibara Medical Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aids for Young Scientists (B) (23791201; A. I, and 26870781; T.U.), a Grant-in-Aid for Scientific Research (A) (24249060; S.H.), a Grant-in-Aid for Challenging Exploratory Research (25670481; S.H.) from the Japan Society for the Promotion of Science Foundation, and Grants for Scientific Research on Innovative Areas (221S0002 and 25129708; A. I and S.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (H26-Nanji-Ippan-051 and 049; S.H.) from the Ministry of Health, Labor, and Welfare, an Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.), the Takeda Scientific Foundation (S.H.), the Kobayashi Magobei Foundation (A.I.), the Kurozumi medical foundation (A.I.), the Japan Epilepsy Research Foundation Grant (T.U. and A.I.) and the Kaibara Medical Foundation (T.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by a Grant-in-Aid for Young Scientists (B) (23791201; A. I, and 26870781; T.U.), a Grant-in-Aid for Scientific Research (A) (24249060; S.H.), a Grant-in-Aid for Challenging Exploratory Research (25670481; S.H.) from the Japan Society for the Promotion of Science Foundation, and Grants for Scientific Research on Innovative Areas (221S0002 and 25129708; A. I and S.H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), the MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (H26-Nanji-Ippan-051 and 049; S.H.) from the Ministry of Health, Labor, and Welfare, an Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.), the Takeda Scientific Foundation (S.H.), the Kobayashi Magobei Foundation (A. I.), the Kurozumi medical foundation (A.I.), the Japan Epilepsy Research Foundation Grant (T.U. and A.I.) and the Kaibara Medical Foundation (T.U.).	Abidi A, 2015, NEUROBIOL DIS, V80, P80, DOI 10.1016/j.nbd.2015.04.017; [Anonymous], 2013, Prescrire Int, V22, P269; [Anonymous], 2015, COUNTREG PROC SAS ST; [Anonymous], 2015, LOGISTIC PROC SAS ST; Bassi MT, 2005, NEUROGENETICS, V6, P185, DOI 10.1007/s10048-005-0012-2; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Borgatti R, 2004, NEUROLOGY, V63, P57, DOI 10.1212/01.WNL.0000132979.08394.6D; Brooks-Kayal AR, 1998, J NEUROCHEM, V70, P1017; Dedek K, 2003, EPILEPSY RES, V54, P21, DOI 10.1016/S0920-1211(03)00037-8; Derry JMC, 2004, J NEUROCHEM, V88, P1431, DOI 10.1046/j.1471-4159.2003.02264.x; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; Fukuda A, 2005, NAT MED, V11, P1153, DOI 10.1038/nm1105-1153; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Harris JA, 2011, THER ADV CHRONIC DIS, V2, P371, DOI 10.1177/2040622311421542; Hirose S, 2005, EPILEPSIA, V46, P38, DOI 10.1111/j.0013-9580.2005.461011.x; Hirose S, 2014, PROG BRAIN RES, V213, P55, DOI 10.1016/B978-0-444-63326-2.00003-X; Ishii A, 2012, EPILEPSY RES, V102, P122, DOI 10.1016/j.eplepsyres.2012.07.011; Ishii A, 2009, BRAIN DEV-JPN, V31, P27, DOI 10.1016/j.braindev.2008.05.010; JENSEN FE, 1995, EPILEPSIA, V36, P966, DOI 10.1111/j.1528-1157.1995.tb00954.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalappa BI, 2015, J NEUROSCI, V35, P8829, DOI 10.1523/JNEUROSCI.5176-14.2015; Kanaumi T, 2008, BRAIN DEV-JPN, V30, P362, DOI 10.1016/j.braindev.2007.11.003; Kaneko S, 2002, EPILEPSIA, V43, P16, DOI 10.1046/j.1528-1157.43.s.9.5.x; Kapur J, 1999, MOL PHARMACOL, V55, P444; Kato M, 2013, EPILEPSIA, V54, P1282, DOI 10.1111/epi.12200; King CH, 2014, J COMP NEUROL, V522, P3262, DOI 10.1002/cne.23595; Kurahashi H, 2009, NEUROLOGY, V73, P1214, DOI 10.1212/WNL.0b013e3181bc0158; Kurahashi H., 1993, GENEREVIEWS R; Lange W, 2009, MOL PHARMACOL, V75, P272, DOI 10.1124/mol.108.052282; Large CH, 2012, EPILEPSIA, V53, P425, DOI 10.1111/j.1528-1167.2011.03364.x; Lerche H, 1999, ANN NEUROL, V46, P305, DOI 10.1002/1531-8249(199909)46:3<305::AID-ANA5>3.0.CO;2-5; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Luttjohann A, 2009, PHYSIOL BEHAV, V98, P579, DOI 10.1016/j.physbeh.2009.09.005; Main MJ, 2000, MOL PHARMACOL, V58, P253, DOI 10.1124/mol.58.2.253; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Maljevic S, 2011, HUM MUTAT, V32, pE2283, DOI 10.1002/humu.21554; Milh M, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-80; Morel JG, 2012, OEVERDISPERSION MODE; Nardou R, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00016; Okada M, 2003, EPILEPSY RES, V53, P81, DOI 10.1016/S0920-1211(02)00249-8; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Otto JF, 2009, EPILEPSIA, V50, P1752, DOI 10.1111/j.1528-1167.2009.02100.x; Otto JE, 2004, EPILEPSIA, V45, P1009, DOI 10.1111/j.0013-9580.2004.65703.x; Otto JF, 2006, J NEUROSCI, V26, P2053, DOI 10.1523/JNEUROSCI.1575-05.2006; Peretz A, 2010, P NATL ACAD SCI USA, V107, P15637, DOI 10.1073/pnas.0911294107; Raol YH, 2009, ANN NEUROL, V65, P326, DOI 10.1002/ana.21593; Robbins J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071809; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Rundfeldt C, 2000, NEUROSCI LETT, V282, P73, DOI 10.1016/S0304-3940(00)00866-1; Schenzer A, 2005, J NEUROSCI, V25, P5051, DOI 10.1523/JNEUROSCI.0128-05.2005; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Shkolnik TG, 2014, JAMA DERMATOL, V150, P984, DOI 10.1001/jamadermatol.2013.8895; Silverstein FS, 2007, ANN NEUROL, V62, P112, DOI 10.1002/ana.21167; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Steinlein OK, 2000, CURR OPIN GENET DEV, V10, P286, DOI 10.1016/S0959-437X(00)00079-4; Stokes M.E., 2012, CATEGORICAL DATA ANA; Swann J, 1997, EPILEPSY COMPREHENSI, P467; Talos DM, 2006, J COMP NEUROL, V497, P61, DOI 10.1002/cne.20978; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Tomonoh Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088549; Tzingounis AV, 2008, P NATL ACAD SCI USA, V105, P19974, DOI 10.1073/pnas.0810535105; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Weckhuysen S, 2012, ANN NEUROL, V71, P15, DOI 10.1002/ana.22644; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Wickenden AD, 2000, MOL PHARMACOL, V58, P591, DOI 10.1124/mol.58.3.591; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wuttke TV, 2007, NEUROLOGY, V69, P2045, DOI 10.1212/01.wnl.0000275523.95103.36; Yang Y, 2003, HUM MOL GENET, V12, P975, DOI 10.1093/hmg/ddg118; Zhu G, 2000, NEUROSCI LETT, V294, P53, DOI 10.1016/S0304-3940(00)01522-6	74	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150095	10.1371/journal.pone.0150095	http://dx.doi.org/10.1371/journal.pone.0150095			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910900	gold, Green Published			2022-12-27	WOS:000371164700066
J	Sun, LH; Perakyla, J; Kovalainen, A; Ogawa, KH; Karhunen, PJ; Hartikainen, KM				Sun, Lihua; Perakyla, Jari; Kovalainen, Anselmi; Ogawa, Keith H.; Karhunen, Pekka J.; Hartikainen, Kaisa M.			Human Brain Reacts to Transcranial Extraocular Light	PLOS ONE			English	Article							STIMULI COMPETE; BRIGHT LIGHT; ATTENTION; TISSUE; PHOTORECEPTORS; P300; ENCEPHALOPSIN; PERFORMANCE; RESPONSES; SYMPTOMS	Transcranial extraocular light affects the brains of birds and modulates their seasonal changes in physiology and behavior. However, whether the human brain is sensitive to extraocular light is unknown. To test whether extraocular light has any effect on human brain functioning, we measured brain electrophysiology of 18 young healthy subjects using event-related potentials while they performed a visual attention task embedded with emotional distractors. Extraocular light delivered via ear canals abolished normal emotional modulation of attention related brain responses. With no extraocular light delivered, emotional distractors reduced centro-parietal P300 amplitude compared to neutral distractors. This phenomenon disappeared with extraocular light delivery. Extraocular light delivered through the ear canals was shown to penetrate at the base of the scull of a cadaver. Thus, we have shown that extraocular light impacts human brain functioning calling for further research on the mechanisms of action of light on the human brain.	[Sun, Lihua; Perakyla, Jari; Kovalainen, Anselmi; Hartikainen, Kaisa M.] Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland; [Ogawa, Keith H.] St Marys Coll Calif, John Magaddino Neurosci Lab, Moraga, CA USA; [Karhunen, Pekka J.] Tampere Univ, Tampere Univ Hosp, Sch Med, Dept Forens Med, FIN-33101 Tampere, Finland; [Karhunen, Pekka J.] Fimlab Labs, Tampere, Finland; [Hartikainen, Kaisa M.] Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland	Tampere University; Tampere University Hospital; Saint Mary's College of California; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital	Hartikainen, KM (corresponding author), Tampere Univ Hosp, Behav Neurol Res Unit, Tampere, Finland.; Hartikainen, KM (corresponding author), Tampere Univ Hosp, Dept Neurosci & Rehabil, Tampere, Finland.	kaisa.hartikainen@uta.fi	Kovalainen, Anselmi/GQZ-4190-2022	Kovalainen, Anselmi/0000-0002-5461-8338; Hartikainen, Kaisa/0000-0001-7278-9635; Sun, Lihua/0000-0002-9931-9497	Pirkanmaa Hospital District Competitive Research Fund [32 500, 13 665]	Pirkanmaa Hospital District Competitive Research Fund	The work was supported by the following: Pirkanmaa Hospital District Competitive Research Fund (32 500 and 13 665), http://www.pshp.fi/default.aspx?contentid=22524, http://www.pshp.fi/default.aspx?contentid=43373; Academy of Finland.	Asaumi Y, 2014, PSYCHIAT CLIN NEUROS, V68, P558, DOI 10.1111/pcn.12162; Barrett DW, 2013, NEUROSCIENCE, V230, P13, DOI 10.1016/j.neuroscience.2012.11.016; Benoit J, 1935, CR SOC BIOL, V118, P669; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Bromundt V, 2014, CHRONOBIOL INT, V31, P343, DOI 10.3109/07420528.2013.854250; Chen ACH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022453; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Consortium CAD, 2015, NATURE GENETICS; Fernandes AM, 2012, CURR BIOL, V22, P2042, DOI 10.1016/j.cub.2012.08.016; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Flyktman A, 2015, J EXP BIOL, V218, P1521, DOI 10.1242/jeb.111864; FOSTER RG, 1985, NATURE, V313, P50, DOI 10.1038/313050a0; FOSTER RG, 1994, NEUROSCI BIOBEHAV R, V18, P541, DOI 10.1016/0149-7634(94)90009-4; Hanifin John P., 2007, Journal of Physiological Anthropology, V26, P87, DOI 10.2114/jpa2.26.87; Hansenne M, 2003, NEUROPSYCHOBIOLOGY, V48, P77, DOI 10.1159/000072881; Hartikainen KM, 2007, NEUROREPORT, V18, P1929, DOI 10.1097/WNR.0b013e3282f1ca18; Hartikainen KM, 2014, J CLIN EXP NEUROPSYC, V36, P540, DOI 10.1080/13803395.2014.913554; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; Hartikainen KM, 2010, NEUROREPORT, V21, P344, DOI 10.1097/WNR.0b013e328336eeb3; Hartikainen KM, 2000, NEUROPSYCHOLOGIA, V38, P1576, DOI 10.1016/S0028-3932(00)00072-5; Ilveskoski E, 1999, CIRCULATION, V100, P608, DOI 10.1161/01.CIR.100.6.608; Isotalo K, 2012, BRAIN PATHOL, V22, P765, DOI 10.1111/j.1750-3639.2012.00586.x; Jurvelin H, 2015, AEROSP MED HUM PERF, V86, P344, DOI 10.3357/AMHP.4139.2015; Jurvelin H, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0288-6; Kok E, 2009, ANN NEUROL, V65, P650, DOI 10.1002/ana.21696; Kouider S, 2013, SCIENCE, V340, P376, DOI 10.1126/science.1232509; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Lawrence MA, 2013, EZ EASY ANAL VISUALI; LeGates TA, 2014, NAT REV NEUROSCI, V15, P443, DOI 10.1038/nrn3743; Luck S.J., 2005, INTRO EVENT RELATED; Naeser MA, 2014, J NEUROTRAUM, V31, P1008, DOI 10.1089/neu.2013.3244; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; SIOPES TD, 1974, POULTRY SCI, V53, P2035, DOI 10.3382/ps.0532035; Tedford CE, 2015, LASER SURG MED, V47, P312, DOI 10.1002/lsm.22343; Van Brunt EE, PENETRATION LIGHT BR; Vandewalle G, 2007, CEREB CORTEX, V17, P2788, DOI 10.1093/cercor/bhm007; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2013, J COGNITIVE NEUROSCI, V25, P2072, DOI 10.1162/jocn_a_00450; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2001, NEUROREPORT, V12, P1119, DOI 10.1097/00001756-200105080-00014; WADE PD, 1988, P NATL ACAD SCI USA, V85, P9322, DOI 10.1073/pnas.85.23.9322	47	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149525	10.1371/journal.pone.0149525	http://dx.doi.org/10.1371/journal.pone.0149525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910350	gold, Green Published			2022-12-27	WOS:000371164700039
J	Guttikonda, SK; Marri, P; Mammadov, J; Ye, L; Soe, K; Richey, K; Cruse, J; Zhuang, MB; Gao, ZF; Evans, C; Rounsley, S; Kumpatla, SP				Guttikonda, Satish K.; Marri, Pradeep; Mammadov, Jafar; Ye, Liang; Soe, Khaing; Richey, Kimberly; Cruse, James; Zhuang, Meibao; Gao, Zhifang; Evans, Clive; Rounsley, Steve; Kumpatla, Siva P.			Molecular Characterization of Transgenic Events Using Next Generation Sequencing Approach	PLOS ONE			English	Article							DISCOVERY	Demand for the commercial use of genetically modified (GM) crops has been increasing in light of the projected growth of world population to nine billion by 2050. A prerequisite of paramount importance for regulatory submissions is the rigorous safety assessment of GM crops. One of the components of safety assessment is molecular characterization at DNA level which helps to determine the copy number, integrity and stability of a transgene; characterize the integration site within a host genome; and confirm the absence of vector DNA. Historically, molecular characterization has been carried out using Southern blot analysis coupled with Sanger sequencing. While this is a robust approach to characterize the transgenic crops, it is both time- and resource-consuming. The emergence of next-generation sequencing (NGS) technologies has provided highly sensitive and cost- and labor-effective alternative for molecular characterization compared to traditional Southern blot analysis. Herein, we have demonstrated the successful application of both whole genome sequencing and target capture sequencing approaches for the characterization of single and stacked transgenic events and compared the results and inferences with traditional method with respect to key criteria required for regulatory submissions.	[Guttikonda, Satish K.; Marri, Pradeep; Mammadov, Jafar; Ye, Liang; Soe, Khaing; Richey, Kimberly; Cruse, James; Zhuang, Meibao; Gao, Zhifang; Evans, Clive; Rounsley, Steve; Kumpatla, Siva P.] Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA	Dow Chemical Company	Guttikonda, SK (corresponding author), Dow AgroSci LLC, 9330 Zionsville Rd, Indianapolis, IN 46268 USA.	SKGuttikonda@dow.com						Abel HJ, 2013, CANCER GENET-NY, V206, P432, DOI 10.1016/j.cancergen.2013.11.002; BHAT S, 2012, PLANT SCI, V163, P673; Claros Manuel Gonzalo, 2012, Biology (Basel), V1, P439, DOI 10.3390/biology1020439; Fritsch L, 2015, TRANSGENIC RES, V24, P615, DOI 10.1007/s11248-015-9864-x; Ji Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096650; Kovalic D, 2012, PLANT GENOME-US, V5, P149, DOI 10.3835/plantgenome2012.10.0026; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Latham JR, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/25376; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Memelink J., 1994, PLANT MOL BIOL M SPR, P273, DOI [10.1007/978-94-011-0511-8_19, DOI 10.1007/978-94-011-0511-8_19]; Mertes F, 2011, BRIEF FUNCT GENOMICS, V10, P374, DOI 10.1093/bfgp/elr033; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nekrutenko A, 2012, NAT REV GENET, V13, P667, DOI 10.1038/nrg3305; Pauwels K, 2015, TRENDS FOOD SCI TECH, V45, P319, DOI 10.1016/j.tifs.2015.07.009; Privalle LS, 2012, J AGR FOOD CHEM, V60, P10179, DOI 10.1021/jf302706e; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards E, 1994, CURR PROTOC MOL BIOL, V27, P2, DOI [10.1002/0471142727.mb0203-27, DOI 10.1002/0471142727.MB0203-27, 10.1002/0471142727.mb0203s27, DOI 10.1002/0471142727.MB0203S27]; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Srivastava A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-367; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Yang L, 2013, SCI REP, V3, P2389; Zastrow-Hayes GM, 2015, PLANT GENOME-US, V8, DOI 10.3835/plantgenome2014.08.0037; Zhang R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050348	25	36	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149515	10.1371/journal.pone.0149515	http://dx.doi.org/10.1371/journal.pone.0149515			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26908260	Green Published, gold			2022-12-27	WOS:000371163000015
J	Hwang, SM; Jeon, TY; Yoo, SY; Kim, JH; Kang, B; Choe, YH; Choi, H; Kim, JS				Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye; Kang, Ben; Choe, Yon Ho; Choi, Haeyon; Kim, Jung Sun			Alagille Syndrome Candidates for Liver Transplantation: Differentiation from End-Stage Biliary Atresia Using Preoperative CT	PLOS ONE			English	Article							PORTAL VENOUS SYSTEM; HEPATOCELLULAR-CARCINOMA; ARTERIOHEPATIC DYSPLASIA; HUMAN JAGGED1; CHILDREN; PORTOENTEROSTOMY; HEPATOCARCINOMA; MUTATIONS; CIRRHOSIS; FEATURES	Purpose To compare preoperative CT findings before liver transplantation between patients with Alagille syndrome (AGS) and those with end-stage biliary atresia (BA). Materials and Methods The institutional review board approved this retrospective study. Eleven children with AGS (median age, 19.0 +/- 13.0 months; male to female ratio, 3:8) and 109 children with end-stage BA (median age, 17.9 +/- 25.8 months; male to female ratio, 37:72) who underwent abdomen CT as candidates for liver transplant were included. CT images were reviewed focusing on hepatic parenchymal changes, vascular changes, presence of focal lesions, and signs of portal hypertension. Results Hepatic parenchymal changes were present in 27% (3/11) of AGS patients and 100% (109/109) of end-stage BA patients (P < .001). The hepatic artery diameter was significantly smaller (1.9 mm versus 3.6 mm, P = 008), whereas portal vein diameter was larger (6.8 mm versus 5.0 mm, P < .001) in patients with AGS compared with patients with end-stage BA. No focal lesion was seen in patients with AGS, whereas 44% (48/109) of patients with endstage BA had intrahepatic biliary cysts (39%, 43/109) and hepatic tumors (8%, 9/109) (P = .008). Splenomegaly was commonly seen in both groups (P = .082), and ascites (9% [1/11] versus 50% [54/109], P = .010) and gastroesophageal varix (0% [0/11] versus 80% [87/ 109], P < .001) were less common in patients with AGS than in patients with end-stage BA. Conclusion Fibrotic or cirrhotic changes of the liver, presence of focal lesions, and relevant portal hypertension were less common in patients with AGS than in patients with end-stage BA.	[Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea; [Hwang, Sook Min; Jeon, Tae Yeon; Yoo, So-Young; Kim, Ji Hye] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea; [Kang, Ben; Choe, Yon Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pediat, Seoul 135710, South Korea; [Choi, Haeyon; Kim, Jung Sun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul 135710, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea.; Jeon, TY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea.	hathor97.jeon@samsung.com		Hwang, Sook Min/0000-0003-1755-4846; Kang, Ben/0000-0002-8516-9803				ALAGILLE D, 1987, J PEDIATR-US, V110, P195, DOI 10.1016/S0022-3476(87)80153-1; BEKASSY AN, 1992, MED PEDIATR ONCOL, V20, P78, DOI 10.1002/mpo.2950200118; Berrocal T, 1997, EUR RADIOL, V7, P115, DOI 10.1007/s003300050122; Bhadri VA, 2005, J PEDIATR GASTR NUTR, V41, P676, DOI 10.1097/01.mpg.0000179759.60048.c4; Carpino G, 2015, J HEPATOL, V63, P1220, DOI 10.1016/j.jhep.2015.06.018; Caruso S, 2010, EUR RADIOL, V20, P1468, DOI 10.1007/s00330-009-1681-2; Castaneda C, 1992, G E N, V46, P341; CHIARETTI A, 1992, ACTA PAEDIATR, V81, P937, DOI 10.1111/j.1651-2227.1992.tb12141.x; Cho JM, 2015, PEDIATR INT, V57, P552, DOI 10.1111/ped.12602; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Fabris L, 2007, AM J PATHOL, V171, P641, DOI 10.2353/ajpath.2007.070073; HALVORSEN RA, 1995, ABDOM IMAGING, V20, P191, DOI 10.1007/BF00200391; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; HERNANDEZCANO AM, 1987, J PEDIATR SURG, V22, P519, DOI 10.1016/S0022-3468(87)80211-7; HOFFENBERG EJ, 1995, J PEDIATR-US, V127, P220, DOI 10.1016/S0022-3476(95)70298-9; Inoue Y, 2008, J PEDIATR SURG, V43, P2165, DOI 10.1016/j.jpedsurg.2008.08.039; Jeon TY, 2013, CLIN RADIOL, V68, P588, DOI 10.1016/j.crad.2012.12.004; KAUFMAN SS, 1987, AM J DIS CHILD, V141, P698, DOI 10.1001/archpedi.1987.04460060114050; Kim B, 2005, PATHOL RES PRACT, V201, P55, DOI 10.1016/j.prp.2004.11.007; Kim WS, 2007, RADIOLOGY, V245, P549, DOI 10.1148/radiol.2452061093; LAFORTUNE M, 1984, RADIOLOGY, V151, P27, DOI 10.1148/radiology.151.1.6701328; Lanzoni G, 2015, HEPATOLOGY; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lykavieris P, 2001, GUT, V49, P431, DOI 10.1136/gut.49.3.431; Nagula S, 2006, J HEPATOL, V44, P111, DOI 10.1016/j.jhep.2005.07.036; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Piccoli DA, 2001, SEMIN LIVER DIS, V21, P525, DOI 10.1055/s-2001-19036; PRASSOPOULOS P, 1994, ACTA RADIOL, V35, P152; RABINOVITZ M, 1989, J PEDIATR GASTR NUTR, V8, P26, DOI 10.1097/00005176-198901000-00006; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Tainaka T, 2008, PEDIATR SURG INT, V24, P265, DOI 10.1007/s00383-007-2099-z; Uflacker R, 2004, CARDIOVASC INTER RAD, V27, P486, DOI 10.1007/s00270-004-2636-2; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wetli SC, 2010, PEDIATR RADIOL, V40, P1696, DOI 10.1007/s00247-010-1784-6; Yoon HJ, 2014, CLIN RADIOL, V69, pE113, DOI 10.1016/j.crad.2013.10.017; Yu CY, 2009, PEDIATR TRANSPLANT, V13, P984, DOI 10.1111/j.1399-3046.2008.01100.x; Zen Y, 2014, HISTOPATHOLOGY, V64, P671, DOI 10.1111/his.12312; Zhou HY, 2015, CLIN RES HEPATOL GAS, V39, P351, DOI 10.1016/j.clinre.2014.09.012	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149681	10.1371/journal.pone.0149681	http://dx.doi.org/10.1371/journal.pone.0149681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901874	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100128
J	Nuss, A; Carlos, CJ; Moreno, IB; Fagundes, NJR				Nuss, Andressa; Carlos, Caio J.; Moreno, Ignacio B.; Fagundes, Nelson J. R.			Population Genetic Structure of the Magnificent Frigatebird Fregata magnificens (Aves, Suliformes) Breeding Colonies in the Western Atlantic Ocean	PLOS ONE			English	Article							DIFFERENTIATION; CONSERVATION; LOCI; INDIVIDUALS; MOVEMENTS; INFERENCE; SOFTWARE; PRIMERS; RATES	The Magnificent Frigatebird Fregata magnificens has a pantropical distribution, nesting on islands along the Atlantic and Pacific coasts. In the Caribbean, there is little genetic structure among colonies; however, the genetic structure among the colonies off Brazil and its relationship with those in the Caribbean are unknown. In this study, we used mtDNA and microsatellite markers to infer population structure and evolutionary history in a sample of F. magnificens individuals collected in Brazil, Grand Connetable (French Guyana), and Barbuda. Virtually all Brazilian individuals had the same mtDNA haplotype. There was no haplotype sharing between Brazil and the Caribbean, though Grand Connetable shared haplotypes with both regions. A Bayesian clustering analysis using microsatellite data found two genetic clusters: one associated with Barbuda and the other with the Brazilian populations. Grand Connetable was more similar to Barbuda but had ancestry from both clusters, corroborating its "intermediate" position. The Caribbean and Grand Connetable populations showed higher genetic diversity and effective population size compared to the Brazilian population. Overall, our results are in good agreement with an effect of marine winds in isolating the Brazilian meta-population.	[Nuss, Andressa; Fagundes, Nelson J. R.] Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil; [Carlos, Caio J.; Moreno, Ignacio B.] Univ Fed Rio Grande do Sul, Inst Biosci, Dept Zool, Lab Sistemat & Ecol Aves & Mamiferos Marinhos LAB, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Fagundes, NJR (corresponding author), Univ Fed Rio Grande do Sul, Dept Genet, Inst Biosci, Porto Alegre, RS, Brazil.	nelson.fagundes@ufrgs.br	Carlos, Caio J/G-4345-2010; Moreno, Ignacio b/I-3235-2012; Fagundes, Nelson/F-7490-2014	Carlos, Caio J/0000-0001-9071-1444; Moreno, Ignacio b/0000-0001-9854-6033; Fagundes, Nelson/0000-0003-0456-0323	Petrobras; CNPq; PPGBM/UFRGS	Petrobras(Fundacao de Amparo a Pesquisa do Amapa (FAPEAP)Petrobras); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); PPGBM/UFRGS	The authors thank Petrobras, CNPq and PPGBM/UFRGS for financial support. Part of the results of this study will be included in the project "Projeto Ilhas do Rio", performed by "Instituto Mar Adentro" and sponsored by Petrobras, through the grant "Programa Petrobras Ambiental". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2003, MOL ECOL, V12, P2953, DOI 10.1046/j.1365-294X.2003.01980.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Baumgartner MF, 2001, FISH B-NOAA, V99, P219; BirdLife International, 2012, IUCN RED LIST THREAT, V2012; BirdLife International, 2014, SPEC FACTSH FREG MAG; Boutin-Ganache I, 2001, BIOTECHNIQUES, V31, P24, DOI 10.2144/01311bm02; Brohede J, 2004, MUTAT RES-FUND MOL M, V545, P73, DOI 10.1016/j.mrfmmm.2003.09.012; CARLOS C.J., 2009, SEA SWALLOW, V58, P17; Dearborn DC, 2003, MOL ECOL, V12, P2835, DOI 10.1046/j.1365-294X.2003.01931.x; Dearborn DC, 2008, MOL ECOL RESOUR, V8, P1399, DOI 10.1111/j.1755-0998.2008.02351.x; Diamond A.W., 2002, BIRDS N AM ONLINE; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond A., 2011, GENEIOUS V5 5; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Faria PJ, 2010, J AVIAN BIOL, V41, P378, DOI 10.1111/j.1600-048X.2009.04902.x; Fraser DJ, 2001, MOL ECOL, V10, P2741, DOI 10.1046/j.1365-294X.2001.t01-1-01411.x; Friesen VL, 2007, MOL ECOL, V16, P1765, DOI 10.1111/j.1365-294X.2006.03197.x; Fu YX, 1997, GENETICS, V147, P915; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gonzalez-Jaramillo M, 2011, BIOCHEM SYST ECOL, V39, P392, DOI 10.1016/j.bse.2011.05.014; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Hailer F, 2011, P ROY SOC B-BIOL SCI, V278, P817, DOI 10.1098/rspb.2010.1342; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Kushlan J.A., 2002, WATERBIRD CONSERVATI; Levin II, 2012, ECOL EVOL, V2, P2775, DOI 10.1002/ece3.386; Masters BS, 2011, BIOL LETTERS, V7, P127, DOI 10.1098/rsbl.2010.0643; MEDRANO JF, 1990, BIOTECHNIQUES, V8, P43; Milot E, 2008, MOL ECOL, V17, P1658, DOI 10.1111/j.1365-294X.2008.03700.x; Morris-Pocock JA, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-14; Nimer E., 1989, CLIMATOLOGIA BRASIL, Vsecond; Ortego J, 2008, MUTAT RES-FUND MOL M, V648, P82, DOI 10.1016/j.mrfmmm.2008.09.012; PALACIO F J, 1982, Boletim do Instituto Oceanografico, V31, P69; PENNYCUICK CJ, 1983, J EXP BIOL, V102, P307; Pook CE, 2000, MOL PHYLOGENET EVOL, V15, P269, DOI 10.1006/mpev.1999.0756; Rocha-Olivares A, 2014, REV MEX BIODIVERS, V85, P532, DOI 10.7550/rmb.40246; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schreiber Elizabeth, 2002, BIOL MARINE BIRDS, DOI 10.1201/9781420036305; TAJIMA F, 1989, GENETICS, V123, P585; Tomczak M, 1993, REGIONAL OCEANOGRAPH; Van Oosterhout C, 2004, MICROCHECKER MICROCH; Weimerskirch H, 2006, CONDOR, V108, P220, DOI 10.1650/0010-5422(2006)108[0220:PMOFTW]2.0.CO;2; Weimerskirch H, 2003, NATURE, V421, P333, DOI 10.1038/421333a; Wilson GA, 2003, GENETICS, V163, P1177	46	7	7	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149834	10.1371/journal.pone.0149834	http://dx.doi.org/10.1371/journal.pone.0149834			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901878	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100161
J	Vasques, ER; Cunha, JEM; Coelho, AMM; Sampietre, SN; Patzina, RA; Abdo, EE; Nader, HB; Tersariol, ILS; Lima, MA; Godoy, CMG; Rodrigues, T; Chaib, E; D'Albuquerque, LAC				Vasques, Enio Rodrigues; Monteiro Cunha, Jose Eduardo; Mendonca Coelho, Ana Maria; Sampietre, Sandra N.; Patzina, Rosely Antunes; Abdo, Emilio Elias; Nader, Helena B.; Tersariol, Ivarne L. S.; Lima, Marcelo Andrade; Godoy, Carlos M. G.; Rodrigues, Tiago; Chaib, Eleazar; D'Albuquerque, Luiz A. C.			Trisulfate Disaccharide Decreases Calcium Overload and Protects Liver Injury Secondary to Liver Ischemia/Reperfusion	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MOLECULAR-WEIGHT HEPARIN; HEPATIC ISCHEMIA; RAT-LIVER; LIPID-PEROXIDATION; CYTOSOLIC CALCIUM; EXCHANGER; APOPTOSIS; PEPTIDE; DAMAGE	Background Ischemia and reperfusion (I/R) causes tissue damage and intracellular calcium levels are a factor of cell death. Sodium calcium exchanger (NCX) regulates calcium extrusion and Trisulfated Disaccharide (TD) acts on NCX decreasing intracellular calcium through the inhibition of the exchange inhibitory peptide (XIP). Objectives The aims of this research are to evaluate TD effects in liver injury secondary to I/R in animals and in vitro action on cytosolic calcium of hepatocytes cultures under calcium overload. Methods Wistar rats submitted to partial liver ischemia were divided in groups: Control: (n = 10): surgical manipulation with no liver ischemia; Saline: (n = 15): rats receiving IV saline before reperfusion; and TD: (n = 15): rats receiving IV TD before reperfusion. Four hours after reperfusion, serum levels of AST, ALT, TNF-alpha, IL-6, and IL-10 were measured. Liver tissue samples were collected for mitochondrial function and malondialdehyde (MDA) content. Pulmonary vascular permeability and histologic parameters of liver were determined. TD effect on cytosolic calcium was evaluated in BRL3A hepatic rat cell cultures stimulated by thapsigargin pre and after treatment with TD. Results AST, ALT, cytokines, liver MDA, mitochondrial dysfunction and hepatic histologic injury scores were less in TD group when compared to Saline Group (p<0.05) with no differences in pulmonary vascular permeability. In culture cells, TD diminished the intracellular calcium raise and prevented the calcium increase pre and after treatment with thapsigargin, respectively. Conclusion TD decreases liver cell damage, preserves mitochondrial function and increases hepatic tolerance to I/R injury by calcium extrusion in Ca2+ overload situations.	[Vasques, Enio Rodrigues; Monteiro Cunha, Jose Eduardo; Mendonca Coelho, Ana Maria; Sampietre, Sandra N.; Patzina, Rosely Antunes; Abdo, Emilio Elias; Chaib, Eleazar; D'Albuquerque, Luiz A. C.] Univ Sao Paulo, Sch Med, Dept Gastroenterol LIM 37, Sao Paulo, Brazil; [Nader, Helena B.; Tersariol, Ivarne L. S.; Lima, Marcelo Andrade] Fed Univ Sao Paulo UNIFESP, Dept Biochem, Sao Paulo, Brazil; [Godoy, Carlos M. G.] Fed Univ Sao Paulo UNIFESP, Dept Sci & Technol, Sao Paulo, Brazil; [Rodrigues, Tiago] Fed Univ ABC, Ctr Nat & Human Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal do ABC (UFABC)	Vasques, ER (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol LIM 37, Sao Paulo, Brazil.	evasques@globo.com	D'Albuquerque, Luiz A Carneiro/I-4011-2012; Rodrigues, Tiago/AAG-1121-2020; Dos Santos Tersariol, Ivarne Luis/G-4042-2012; de Godoy, Carlos Marcelo Gurjão/P-4538-2019; Chaib, Eleazar/G-3446-2012; de Godoy, Carlos Marcelo MG Gurjão/A-2563-2013; Rodrigues, Tiago/B-8459-2012; Nader, Helena Bonciani/D-9253-2012; VASQUES, ENIO/E-2285-2013	D'Albuquerque, Luiz A Carneiro/0000-0001-7607-7168; Rodrigues, Tiago/0000-0003-1277-0224; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; de Godoy, Carlos Marcelo Gurjão/0000-0001-8846-3242; de Godoy, Carlos Marcelo MG Gurjão/0000-0001-8846-3242; Rodrigues, Tiago/0000-0003-1277-0224; NADER, HELENA/0000-0002-7569-2166; VASQUES, ENIO/0000-0002-8424-2669				Abdel-Salam OME, 2005, PHARMACOL RES, V51, P59, DOI 10.1016/j.phrs.2004.04.009; Amberger A, 2001, TRANSPLANTATION, V71, P1821, DOI 10.1097/00007890-200106270-00019; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Canedo Leonardo Fernandes, 2012, Rev. Col. Bras. Cir., V39, P216; CARINI R, 1995, BIOCHEM BIOPH RES CO, V208, P813, DOI 10.1006/bbrc.1995.1409; Chan CC, 2014, J GASTROEN HEPATOL, V29, P603, DOI 10.1111/jgh.12366; CHANCE B, 1955, NATURE, V175, P1120, DOI 10.1038/1751120a0; Chang WJ, 2010, J INVEST SURG, V23, P228, DOI 10.3109/08941939.2010.496036; Chattopadhyay P, 2010, APPL BIOCHEM BIOTECH, V160, P1968, DOI 10.1007/s12010-009-8761-2; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Clavien PA, 2004, J GASTROINTEST SURG, V8, P313, DOI 10.1016/j.gassur.2003.12.006; Coelho AMM, 1997, BRAZ J MED BIOL RES, V30, P947, DOI 10.1590/S0100-879X1997000800006; Crisostomo PR, 2006, J AM COLL SURGEONS, V202, P797, DOI 10.1016/j.jamcollsurg.2005.12.002; DIETRICH CP, 1968, BIOCHEM J, V108, P647, DOI 10.1042/bj1080647; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Teixeira ARF, 2009, ACTA CIR BRAS, V24, P52, DOI 10.1590/S0102-86502009000100011; Harada N, 2006, CRIT CARE MED, V34, P1883, DOI 10.1097/01.CCM.0000220764.10155.03; JANCAR S, 1988, PROSTAGLANDINS, V35, P757, DOI 10.1016/0090-6980(88)90148-7; Kim JA, 2000, FREE RADICAL RES, V33, P267, DOI 10.1080/10715760000301431; Kukner A, 2010, ANN HEPATOL, V9, P445, DOI 10.1016/S1665-2681(19)31621-7; Kupiec-Weglinski JW, TRANSPLANT P, V37, P1653; Li J, 2015, EUR REV MED PHARMACO, V19, P2036; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Coelho AMM, 2011, J GASTROINTEST SURG, V15, P1679, DOI 10.1007/s11605-011-1648-x; Moussa M E, 1996, Liver Transpl Surg, V2, P461, DOI 10.1002/lt.500020609; Nicoud IB, 2007, AM J PHYSIOL-GASTR L, V293, pG623, DOI 10.1152/ajpgi.00521.2006; Nogueira MA, 2014, WORLD J GASTROENTERO, V20, P15319, DOI 10.3748/wjg.v20.i41.15319; Quireze C, 2006, J INVEST SURG, V19, P229, DOI 10.1080/08941930600778206; Seabra ALR, 2012, ABCD-ARQ BRAS CIR DI, V25, P105, DOI 10.1590/S0102-67202012000200009; Figueira ERR, 2010, SURGERY, V147, P415, DOI 10.1016/j.surg.2009.10.018; Camara-Lemarroy CR, 2014, ARCH MED RES, V45, P210, DOI 10.1016/j.arcmed.2014.02.001; Sakamoto K, 2009, J PHYSIOL-LONDON, V587, P5345, DOI 10.1113/jphysiol.2009.172080; Schwartz J, 2013, TOXICOL APPL PHARM, V273, P172, DOI 10.1016/j.taap.2013.08.027; Serracino-Inglott F, 2001, AM J SURG, V181, P160, DOI 10.1016/S0002-9610(00)00573-0; Shinjo SK, 2002, J BIOL CHEM, V277, P48227, DOI 10.1074/jbc.M205867200; Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008; Taha MO, 2009, TRANSPL P, V41, P812, DOI 10.1016/j.transproceed.2009.02.042; TOLEDOPEREYRA LH, 1975, AM J SURG, V129, P513, DOI 10.1016/0002-9610(75)90308-6; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; van Golen RF, 2015, J HEPATOL, V62, P975, DOI 10.1016/j.jhep.2014.12.014; Wheeler MD, 2003, ALCOHOL RES HEALTH, V27, P300; Xing WJ, 2011, CLIN EXP PHARMACOL P, V38, P605, DOI 10.1111/j.1440-1681.2011.05559.x; Yamanaka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122214; Yan Y, 2006, ACTA PHARMACOL SIN, V27, P821, DOI 10.1111/j.1745-7254.2006.00390.x; Yener AU, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-35; Zhang WX, 2011, HEPATOB PANCREAT DIS, V10, P78, DOI 10.1016/S1499-3872(11)60011-8; Zhou T, 2002, WORLD J GASTROENTERO, V8, P897, DOI 10.3748/wjg.v8.i5.897	49	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149630	10.1371/journal.pone.0149630	http://dx.doi.org/10.1371/journal.pone.0149630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901764	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000371276100115
J	Bradshaw, CJA; Brook, BW				Bradshaw, Corey J. A.; Brook, Barry W.			How to Rank Journals	PLOS ONE			English	Article							IMPACT FACTOR; H-INDEX; CONS; PROS; PERFORMANCE	There are now many methods available to assess the relative citation performance of peer-reviewed journals. Regardless of their individual faults and advantages, citation-based metrics are used by researchers to maximize the citation potential of their articles, and by employers to rank academic track records. The absolute value of any particular index is arguably meaningless unless compared to other journals, and different metrics result in divergent rankings. To provide a simple yet more objective way to rank journals within and among disciplines, we developed a kappa-resampled composite journal rank incorporating five popular citation indices: Impact Factor, Immediacy Index, Source-Normalized Impact Per Paper, SCImago Journal Rank and Google 5-year h-index; this approach provides an index of relative rank uncertainty. We applied the approach to six sample sets of scientific journals from Ecology (n = 100 journals), Medicine (n = 100), Multidisciplinary (n = 50); Ecology + Multidisciplinary (n = 25), Obstetrics & Gynaecology (n = 25) and Marine Biology & Fisheries (n = 25). We then cross-compared the kappa-resampled ranking for the Ecology + Multidisciplinary journal set to the results of a survey of 188 publishing ecologists who were asked to rank the same journals, and found a 0.68-0.84 Spearman's. correlation between the two rankings datasets. Our composite index approach therefore approximates relative journal reputation, at least for that discipline. Agglomerative and divisive clustering and multidimensional scaling techniques applied to the Ecology + Multidisciplinary journal set identified specific clusters of similarly ranked journals, with only Nature & Science separating out from the others. When comparing a selection of journals within or among disciplines, we recommend collecting multiple citation-based metrics for a sample of relevant and realistic journals to calculate the composite rankings and their relative uncertainty windows.	[Bradshaw, Corey J. A.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Brook, Barry W.] Univ Tasmania, Sch Biol Sci, Private Bag 55, Hobart, Tas 7001, Australia	University of Adelaide; University of Tasmania	Bradshaw, CJA (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.	corey.bradshaw@adelaide.edu.au	Bradshaw, Corey J.A./A-1311-2008; Brook, Barry W./G-2686-2011	Bradshaw, Corey J.A./0000-0002-5328-7741; Brook, Barry W./0000-0002-2491-1517	Australian Research Council [FT110100306]	Australian Research Council(Australian Research Council)	This work was supported by Australian Research Council (arc.gov.au) Future Fellowship grant FT110100306 (CJAB).	Adam D, 2002, NATURE, V415, P726, DOI 10.1038/415726a; Althouse BM, 2009, J AM SOC INF SCI TEC, V60, P27, DOI 10.1002/asi.20936; [Anonymous], 2006, PLOS MED, V3, pe291, DOI 10.1371/journal.pmed.0030291; Bergstrom CT, 2008, J NEUROSCI, V28, P11433, DOI 10.1523/JNEUROSCI.0003-08.2008; Bontis N, 2009, J KNOWL MANAG, V13, P16, DOI 10.1108/13673270910931134; Braun T, 2006, SCIENTOMETRICS, V69, P169, DOI 10.1007/s11192-006-0147-4; Brown L., 2003, REV QUANTITATIVE FIN, V20, P291, DOI DOI 10.1023/A:1023628613622; Delgado-Lopez-Cozar E, 2013, LEARN PUBL, V26, P101, DOI 10.1087/20130206; East J. W., 2006, Australian Academic & Research Libraries, V37, P3; Falagas ME, 2008, FASEB J, V22, P2623, DOI 10.1096/fj.08-107938; Fersht A, 2009, P NATL ACAD SCI USA, V106, P6883, DOI 10.1073/pnas.0903307106; Gonzalez-Pereira B, 2010, J INFORMETR, V4, P379, DOI 10.1016/j.joi.2010.03.002; Guerrero-Bote VP, 2012, J INFORMETR, V6, P674, DOI 10.1016/j.joi.2012.07.001; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Hudson J, 2013, ECON J, V123, pF202, DOI 10.1111/ecoj.12064; Iglesias JE, 2007, SCIENTOMETRICS, V73, P303, DOI 10.1007/s11192-007-1805-x; Jacso P, 2008, ONLINE INFORM REV, V32, P524, DOI 10.1108/14684520810897403; Jacso P, 2008, ONLINE INFORM REV, V32, P437, DOI 10.1108/14684520810889718; Jacso P, 2008, ONLINE INFORM REV, V32, P266, DOI 10.1108/14684520810879872; Jacso P, 2008, ONLINE INFORM REV, V32, P673, DOI 10.1108/14684520810914043; Kodrzycki YK, 2006, BE J ECON ANAL POLI, V5, P1935; Korobkin R, 1998, FLA ST U L REV, V26, P851; Lehmann G., 2006, INSIGHT J; Maechler M., 2021, CLUSTER CLUSTER ANAL; Malesios CC, 2014, QUAL QUANT, V48, P521, DOI 10.1007/s11135-012-9785-1; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Mingers J, 2007, EUR J INFORM SYST, V16, P303, DOI 10.1057/palgrave.ejis.3000696; Moed HF, 2010, J INFORMETR, V4, P265, DOI 10.1016/j.joi.2010.01.002; Neff BD, 2010, BIOSCIENCE, V60, P455, DOI 10.1525/bio.2010.60.6.9; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Podlubny I, 2005, SCIENTOMETRICS, V64, P95, DOI 10.1007/s11192-005-0240-0; Pudovkin AI, 2004, P ASIST ANNU, V41, P507, DOI 10.1002/meet.1450410159; Pujol F, 2008, J PUBLIC ECON THEORY, V10, P55, DOI 10.1111/j.1467-9779.2008.00351.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez AM, 2000, SCIENTOMETRICS, V47, P3, DOI 10.1023/A:1005600807292; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Salinas S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115451; Seglen PO, 1997, BRIT MED J, V314, P498; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Smith R, 2006, INT J EPIDEMIOL, V35, P1129, DOI 10.1093/ije/dyl191; Suzuki R., PVCLUST HIERARCHICAL; Tibshirani R, 2015, BOOTSTRAP FUNCTIONS; van Raan AFJ, 2005, MEAS-INTERDISCIP RES, V3, P1, DOI 10.1207/s15366359mea0301_1; Vanclay JK, 2012, SCIENTOMETRICS, V92, P211, DOI 10.1007/s11192-011-0561-0; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14; Zitt M, 2008, J AM SOC INF SCI TEC, V59, P1856, DOI 10.1002/asi.20880	46	34	36	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149852	10.1371/journal.pone.0149852	http://dx.doi.org/10.1371/journal.pone.0149852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930052	Green Published, gold			2022-12-27	WOS:000371434500063
J	Abadjieva, D; Kistanova, E				Abadjieva, Desislava; Kistanova, Elena			Tribulus terrestris Alters the Expression of Growth Differentiation Factor 9 and Bone Morphogenetic Protein 15 in Rabbit Ovaries of Mothers and F-1 Female Offspring	PLOS ONE			English	Article							GENE-EXPRESSION; FOLLICULAR DEVELOPMENT; SYNERGISTIC ROLES; OOCYTE; MOUSE; EXTRACT; RAT; RECEPTOR; BMP15; GDF9	Although previous research has demonstrated the key role of the oocyte-derived factors, bone morphogenetic protein (BMP) 15 and growth differentiation factor (GDF) 9, in follicular development and ovulation, there is a lack of knowledge on the impact of external factors, which females are exposed to during folliculogenesis, on their expression. The present study investigated the effect of the aphrodisiac Tribulus terrestris on the GDF9 and BMP15 expression in the oocytes and cumulus cells at mRNA and protein levels during folliculogenesis in two generations of female rabbits. The experiment was conducted with 28 New Zealand rabbits. Only the diet of the experimental mothers group was supplemented with a dry extract of T. terrestris for the 45 days prior to insemination. The expression of BMP15 and GDF9 genes in the oocytes and cumulus cells of mothers and F1 female offspring was analyzed using real-time polymerase chain reaction (RT-PCR). The localization of the GDF9 and BMP15 proteins in the ovary tissues was determined by immunohistochemical analysis. The BMP15 and GDF9 transcripts were detected in the oocytes and cumulus cells of rabbits from all groups. T. terrestris caused a decrease in the BMP15 mRNA level in the oocytes and an increase in the cumulus cells. The GDF9 mRNA level increased significantly in both oocytes and cumulus cells. The downregulated expression of BMP15 in the treated mothers' oocytes was inherited in the F1 female offspring born to treated mothers. BMP15 and GDF9 show a clearly expressed sensitivity to the bioactive compounds of T. terrestris.	[Abadjieva, Desislava; Kistanova, Elena] Bulgarian Acad Sci, Inst Biol & Immunol Reprod, BU-1113 Sofia, Bulgaria	Bulgarian Academy of Sciences	Kistanova, E (corresponding author), Bulgarian Acad Sci, Inst Biol & Immunol Reprod, BU-1113 Sofia, Bulgaria.	kistanova@gmail.com	Kistanova, Elena K/J-3532-2016	Kistanova, Elena K/0000-0002-5239-1715	Seventh frame work program (FP7), ReProForce [GA245641]; FP7 Post-Grant Open Access Pilot	Seventh frame work program (FP7), ReProForce; FP7 Post-Grant Open Access Pilot	Funding provided by the Seventh frame work program (FP7), ReProForce, GA245641-EK, DA, and a FP7 Post-Grant Open Access Pilot "Support in charging of publication fee." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaay M.H., 2012, J MAT ENV SCI, V3, P1153; Adaikan P. G., 2000, Annals Academy of Medicine Singapore, V29, P22; Adailkan P. G., 2001, AGING MALE, V4, P163, DOI DOI 10.1080/tam.4.3.163.169; Akram M, 2011, J MED PLANTS RES, V5, P3601; Brown GA, 2001, INT J VITAM NUTR RES, V71, P293, DOI 10.1024/0300-9831.71.5.293; Chhatre Saurabh, 2014, Pharmacogn Rev, V8, P45, DOI 10.4103/0973-7847.125530; Cordier AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063101; Daniel-Carlier N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060451; Daoud NM, 2012, ANIM REPROD SCI, V136, P121, DOI 10.1016/j.anireprosci.2012.09.011; Dehghan A, 2012, REPROD DOMEST ANIM, V47, pe12, DOI 10.1111/j.1439-0531.2011.01877.x; Demars J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003482; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Elvin JA, 1999, MOL ENDOCRINOL, V13, P1035, DOI 10.1210/me.13.6.1035; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Esfandiari A, 2011, J ANIM VET ADV, V10, P883, DOI 10.3923/javaa.2011.883.886; Feeney A, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-48; Findlay JK, 2002, MOL CELL ENDOCRINOL, V191, P35, DOI 10.1016/S0303-7207(02)00053-9; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gama CRB, 2014, CLIN MED INSIGHTS-WO, V7, P45, DOI 10.4137/CMWH.S17853; Gauthaman K, 2005, J ETHNOPHARMACOL, V96, P127, DOI 10.1016/j.jep.2004.08.030; Gauthaman K, 2002, LIFE SCI, V71, P1385, DOI 10.1016/S0024-3205(02)01858-1; Gueripel X, 2006, BIOL REPROD, V75, P836, DOI 10.1095/biolreprod.106.055574; Halvorson LM, 1999, REPROD ENDOCRINOLOGY, P81; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Hosoe M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-33; Huang Q, 2009, AM J PHYSIOL-ENDOC M, V296, pE1344, DOI 10.1152/ajpendo.90929.2008; Koncic MZ, 2013, CURR DRUG TARGETS, V14, P1079, DOI 10.2174/1389450111314090016; Kostova I., 2005, Phytochemistry Reviews, V4, P111, DOI 10.1007/s11101-005-2833-x; Liao WX, 2003, J BIOL CHEM, V278, P3713, DOI 10.1074/jbc.M210598200; Lieberman S, 1996, J CLIN ENDOCR METAB, V81, P850, DOI 10.1210/jc.81.2.850; Martino-Andrade AJ, 2010, J ETHNOPHARMACOL, V127, P165, DOI 10.1016/j.jep.2009.09.031; Mazerbourg S, 2004, MOL ENDOCRINOL, V18, P653, DOI 10.1210/me.2003-0393; McMahon HE, 2008, ENDOCRINOLOGY, V149, P2807, DOI 10.1210/en.2007-1550; Nikolova M., 2010, Biotechnology in Animal Husbandry, V26, P259; Orisaka M, 2006, MOL ENDOCRINOL, V20, P2456, DOI 10.1210/me.2005-0357; Otsuka F, 2000, J BIOL CHEM, V275, P39523, DOI 10.1074/jbc.M007428200; Otsuka F, 2001, J BIOL CHEM, V276, P11387, DOI 10.1074/jbc.M010043200; Otsuka F, 2002, P NATL ACAD SCI USA, V99, P8060, DOI 10.1073/pnas.122066899; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x; Persani L, 2014, HUM REPROD UPDATE, V20, P869, DOI 10.1093/humupd/dmu036; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pisani LF, 2008, REPRODUCTION, V136, P303, DOI 10.1530/REP-07-0394; Qureshi Ahmed, 2014, Journal of Dietary Supplements, V11, P64, DOI 10.3109/19390211.2014.887602; Ramos-Vara JA, 2005, VET PATHOL, V42, P405, DOI 10.1354/vp.42-4-405; Sandeep PM, 2015, METAB SYNDR RELAT D, V13, P248, DOI 10.1089/met.2014.0136; Sharov AA, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-24; Stocco C, 2008, STEROIDS, V73, P473, DOI 10.1016/j.steroids.2008.01.017; Su YQ, 2004, DEV BIOL, V276, P64, DOI 10.1016/j.ydbio.2004.08.020; Sugiura K, 2010, MOL ENDOCRINOL, V24, P2303, DOI 10.1210/me.2010-0260; Sun WJ, 2002, NAT PROD LETT, V16, P243, DOI 10.1080/10575630290020541; Tabakova P., 2012, KIRKOUA SOFIA CLIN S; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Vitt UA, 2002, BIOL REPROD, V67, P473, DOI 10.1095/biolreprod67.2.473; Wu G, 1996, PHYTOCHEMISTRY, V42, P1677, DOI 10.1016/0031-9422(96)00182-3; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yeo CX, 2009, BIOL REPROD, V80, P1072, DOI 10.1095/biolreprod.108.073908; Yin Ping, 2008, Zoological Research, V29, P603, DOI 10.3724/SP.J.1141.2008.06603	59	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150400	10.1371/journal.pone.0150400	http://dx.doi.org/10.1371/journal.pone.0150400			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928288	Green Published, gold			2022-12-27	WOS:000371424200041
J	Chowdhury, MQ; De Ridder, M; Beeckman, H				Chowdhury, Md. Qumruzzaman; De Ridder, Maaike; Beeckman, Hans			Climatic Signals in Tree Rings of Heritiera fomes Buch.-Ham. in the Sundarbans, Bangladesh	PLOS ONE			English	Article							GROWTH RINGS; TROPICAL TREES; MANGROVES; VARIABILITY; FOREST; DENDROCHRONOLOGY; PERIODICITY; DYNAMICS; BIOMASS; IMPACT	Mangroves occur along the coastlines throughout the tropics and sub-tropics, supporting a wide variety of resources and services. In order to understand the responses of future climate change on this ecosystem, we need to know how mangrove species have responded to climate changes in the recent past. This study aims at exploring the climatic influences on the radial growth of Heritiera fomes from a local to global scale. A total of 40 stem discs were collected at breast height position from two different zones with contrasting salinity in the Sundarbans, Bangladesh. All specimens showed distinct tree rings and most of the trees (70%) could be visually and statistically crossdated. Successful crossdating enabled the development of two zone-specific chronologies. The mean radial increment was significantly higher at low salinity (eastern) zone compared to higher salinity (western) zone. The two zone-specific chronologies synchronized significantly, allowing for the construction of a regional chronology. The annual and monsoon precipitation mainly influence the tree growth of H. fomes. The growth response to local precipitation is similar in both zones except June and November in the western zone, while the significant influence is lacking. The large-scale climatic drivers such as sea surface temperature (SST) of equatorial Pacific and Indian Ocean as well as the El Nio-Southern Oscillation (ENSO) revealed no teleconnection with tree growth. The tree rings of this species are thus an indicator for monsoon precipitation variations in Bangladesh. The wider distribution of this species from the South to South East Asian coast presents an outstanding opportunity for developing a large-scale tree-ring network of mangroves.	[Chowdhury, Md. Qumruzzaman; De Ridder, Maaike; Beeckman, Hans] RMCA, Wood Biol Serv, Leuvensesteenweg 13, B-3080 Tervuren, Belgium; [Chowdhury, Md. Qumruzzaman] Shahjalal Univ Sci & Technol, Dept Forestry & Environm Sci, Sylhet 3114, Bangladesh	Royal Museum for Central Africa; Shahjalal University of Science & Technology (SUST)	Chowdhury, MQ (corresponding author), RMCA, Wood Biol Serv, Leuvensesteenweg 13, B-3080 Tervuren, Belgium.; Chowdhury, MQ (corresponding author), Shahjalal Univ Sci & Technol, Dept Forestry & Environm Sci, Sylhet 3114, Bangladesh.	qumrul-for@sust.edu	Beeckman, Hans/I-7653-2019; Chowdhury, Qumruzzaman/H-5118-2019	Beeckman, Hans/0000-0001-8954-6277; Chowdhury, Qumruzzaman/0000-0002-1766-1185	Belgian Federal Science Policy office - Marie Curie Actions from the European Commission	Belgian Federal Science Policy office - Marie Curie Actions from the European Commission	MQC was supported by a mobility grant from the Belgian Federal Science Policy office co-funded by the Marie Curie Actions from the European Commission. The funders had no role in study design, data collection and analysis or preparation of the manuscript.	Agrawala S, 2003, DEVELOPMENT; Ahasan MN, 2010, J HYDRO, P7, DOI 10.3126/jhm.v7i1.5612; AMOBI CC, 1974, ANN BOT-LONDON, V38, P931, DOI 10.1093/oxfordjournals.aob.a084887; BAILLIE M G L, 1973, Tree-Ring Bulletin, V33, P7; Bhattacharyya A, 2009, IAWA J, V30, P361, DOI 10.1163/22941932-90000224; Biondi F, 2004, COMPUT GEOSCI-UK, V30, P303, DOI 10.1016/j.cageo.2003.11.004; Biswas SR, 2007, FOREST ECOL MANAG, V245, P1, DOI 10.1016/j.foreco.2007.02.011; Biswas SR, 2012, J PLANT ECOL, V5, P157, DOI 10.1093/jpe/rtr050; Brienen RJW, 2010, GLOBAL CHANGE BIOL, V16, P2001, DOI 10.1111/j.1365-2486.2009.02059.x; Briffa K.R., 1990, METHODS DENDROCHRONO, P137, DOI DOI 10.1007/978-94-015-7879-0; Briffa KR, 1998, PHILOS T ROY SOC B, V353, P65, DOI 10.1098/rstb.1998.0191; Buckley BM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023745; Cash BA, 2010, J CLIMATE, V23, P2817, DOI 10.1175/2009JCLI2512.1; Chaudhuri A. B., 1994, MANGROVES SUNDARBANS, V1, P1; Chowdhury MQ, 2008, IAWA J, V29, P265; Chowdhury MQ, 2015, TREES, DOI 10.1007/s00468-015-1292-2; Chowdhury MR, 2003, THEOR APPL CLIMATOL, V76, P105, DOI 10.1007/s00704-003-0001-z; Cook E.R., 2013, METHODS DENDROCHRONO; D'Arrigo R, 2011, GEOPHYS RES LETT, P38, DOI 10.1029/2011GL049927; Dahdouh-Guebas F, 2005, CURR BIOL, V15, pR443, DOI 10.1016/j.cub.2005.06.008; Day P.R., 1965, METHODS SOIL ANAL 1, P545, DOI DOI 10.2134/AGRONMONOGR9.1.C43; De Ridder M, 2013, FOREST ECOL MANAG, V304, P417, DOI 10.1016/j.foreco.2013.05.007; De Ridder M, 2013, TREES-STRUCT FUNCT, V27, P1225, DOI 10.1007/s00468-013-0871-3; Devoe NN, 1998, FOREST ECOL MANAG, V103, P33, DOI 10.1016/S0378-1127(97)00176-X; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; DOUGLASS A. E., 1941, JOUR FOREST, V39, P825; Estrada GCD, 2008, TREES-STRUCT FUNCT, V22, P663, DOI 10.1007/s00468-008-0224-9; Eckstein D, 1969, FORSTWISSENSCHAFTLIC, V88, P230, DOI DOI 10.1007/BF02741777; Ellison AM, 2000, J ECOL, V88, P813, DOI 10.1046/j.1365-2745.2000.00500.x; Fritts H. C., 1976, TREE RINGS CLIMATE; Gopal B, 2006, AQUAT SCI, V68, P338, DOI 10.1007/s00027-006-0868-8; Iftekhar M. S., 2008, Wetlands Ecology and Management, V16, P119, DOI 10.1007/s11273-007-9060-8; Islam MS, 2005, HYDROBIOLOGIA, V542, P165, DOI 10.1007/s10750-004-0756-y; Islam Shafi Noor, 2008, Frontiers of Earth Science in China, V2, P439, DOI 10.1007/s11707-008-0049-2; IUCN, 2003, STATUS; IUCN, 2001, BANGL SUND PHOT REAL; Kathiresan K, 2001, ADV MAR BIOL, V40, P81, DOI 10.1016/S0065-2881(01)40003-4; Kennedy JJ, 2011, J GEOPHYS RES, P116; KENNEDY JJ, 2011, J GEOPHYS RES-ATMOS, V116, DOI DOI 10.1029/2010JD015220; Krauss KW, 2006, HYDROBIOLOGIA, V569, P311, DOI 10.1007/s10750-006-0139-7; Kripalani RH, 1996, INT J CLIMATOL, V16, P689, DOI 10.1002/(SICI)1097-0088(199606)16:6&lt;689::AID-JOC36&gt;3.0.CO;2-K; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Loucks C, 2010, CLIMATIC CHANGE, V98, P291, DOI 10.1007/s10584-009-9761-5; Mbow C, 2013, DENDROCHRONOLOGIA, V31, P41, DOI 10.1016/j.dendro.2012.06.001; Mirza MMQ, 1998, ENVIRON MANAGE, V22, P711, DOI 10.1007/s002679900141; Misra V, 2012, CLIM DYNAM, V39, P1149, DOI 10.1007/s00382-012-1319-y; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; MWANGI T, 1999, J ECOL, V37, P180; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Proseus TE, 2005, ANN BOT-LONDON, V95, P967, DOI 10.1093/aob/mci113; Pumijumnong N, 2013, TREES-STRUCT FUNCT, V27, P343, DOI 10.1007/s00468-012-0775-7; Rahman MA, 2003, TOP; RAO RV, 1987, IAWA BULL, V8, P337; Rinn F., 2003, TSAP WINTM USER REFE; Robert EMR, 2011, TREES-STRUCT FUNCT, V25, P49, DOI 10.1007/s00468-010-0487-9; Rozendaal DMA, 2011, TREES-STRUCT FUNCT, V25, P3, DOI 10.1007/s00468-010-0480-3; Santini NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080116; Sarker SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep21234; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmitz Nele, 2007, Dendrochronologia, V25, P87, DOI 10.1016/j.dendro.2006.08.001; Schongart J, 2004, GLOBAL CHANGE BIOL, V10, P683, DOI 10.1111/j.1529-8817.2003.00754.x; Schweingruber FH, 1988, TREE; Schweingruber FH, 1996, FOREST SNOW LANDSCAP; Shahid S.A., 2013, DEV SOIL SALINITY AS, P3; Siddiqi NA, 2001, ENV SCI; Solomon S, 2007, CLIMATE CHANGE 2007, V4; Srivastava R, 2001, IAWA J, V22, P85, DOI 10.1163/22941932-90000271; Sun Qiang, 2000, Acta Phytotaxonomica et Geobotanica, V51, P37; Tomlinson PB, 1994, BOT MANGROVES; Trenberth KE, 2001, J CLIMATE, V14, P1697, DOI 10.1175/1520-0442(2001)014<1697:LIOENO>2.0.CO;2; Trouet V, 2013, TREE-RING RES, V69, P3, DOI 10.3959/1536-1098-69.1.3; Trouet V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047364; Trouet V, 2010, DENDROCHRONOLOGIA, V28, P161, DOI 10.1016/j.dendro.2009.10.002; Ummenhofer CC, 2013, CLIM DYNAM, V40, P1319, DOI 10.1007/s00382-012-1458-1; van Oldenborgh GJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023110; Verheyden A, 2005, NEW PHYTOL, V167, P425, DOI 10.1111/j.1469-8137.2005.01415.x; Verheyden A, 2004, ANN BOT-LONDON, V94, P59, DOI 10.1093/aob/mch115; Vliet G. J. C. M. van, 1976, Wood structure in biological and technological research (Leiden Botanical Series No. 3)., P20; Wang B, 1999, B AM METEOROL SOC, V80, P629, DOI 10.1175/1520-0477(1999)080<0629:COSASM>2.0.CO;2; Wils THG, 2011, TREES-STRUCT FUNCT, V25, P71, DOI 10.1007/s00468-010-0475-0; Worbes M, 1995, IAWA J, V16, P337, DOI 10.1163/22941932-90001424; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Yu KF, 2007, NUCL INSTRUM METH B, V255, P399, DOI 10.1016/j.nimb.2006.11.127	85	24	24	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149788	10.1371/journal.pone.0149788	http://dx.doi.org/10.1371/journal.pone.0149788			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927229	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200016
J	Beiki, F; Busquets, A; Gomila, M; Rahimian, H; Lalucat, J; Garcia-Valdes, E				Beiki, Farid; Busquets, Antonio; Gomila, Margarita; Rahimian, Heshmat; Lalucat, Jorge; Garcia-Valdes, Elena			New Pseudomonas spp. Are Pathogenic to Citrus	PLOS ONE			English	Article							SP NOV.; BACTERIA; IDENTIFICATION; PHYLOGENY; NAMES; LIST	Five putative novel Pseudomonas species shown to be pathogenic to citrus have been characterized in a screening of 126 Pseudomonas strains isolated from diseased citrus leaves and stems in northern Iran. The 126 strains were studied using a polyphasic approach that included phenotypic characterizations and phylogenetic multilocus sequence analysis. The pathogenicity of these strains against 3 cultivars of citrus is demonstrated in greenhouse and field studies. The strains were initially grouped phenotypically and by their partial rpoD gene sequences into 11 coherent groups in the Pseudomonas fluorescens phylogenetic lineage. Fifty-three strains that are representatives of the 11 groups were selected and analyzed by partial sequencing of their 16S rRNA and gyrB genes. The individual and concatenated partial sequences of the three genes were used to construct the corresponding phylogenetic trees. The majority of the strains were identified at the species level: P. lurida (5 strains), P. monteilii (2 strains), P. moraviensis (1 strain), P. orientalis (16 strains), P. simiae (7 strains), P. syringae (46 strains, distributed phylogenetically in at least 5 pathovars), and P. viridiflava (2 strains). This is the first report of pathogenicity on citrus of P. orientalis, P. simiae, P. lurida, P. moraviensis and P. monteilii strains. The remaining 47 strains that could not be identified at the species level are considered representatives of at least 5 putative novel Pseudomonas species that are not yet described.	[Beiki, Farid] Agr Res Educ & Extens Org AREEO, Iranian Res Inst Plant Protect, Tehran, Iran; [Busquets, Antonio; Gomila, Margarita; Lalucat, Jorge; Garcia-Valdes, Elena] Univ Illes Balears, Dept Biol Microbiol, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain; [Rahimian, Heshmat] Univ Sari, Agr Sci & Nat Resources, Mazandaran, Iran; [Rahimian, Heshmat] Sari Agr Sci & Nat Resources Univ, Dept Plant Protect, POB 578, Mazandaran, SaSari, Iran; [Lalucat, Jorge; Garcia-Valdes, Elena] CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain	Universitat de les Illes Balears; Sari Agricultural Sciences & Natural Resources University (SANRU); Sari Agricultural Sciences & Natural Resources University (SANRU); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona	Garcia-Valdes, E (corresponding author), Univ Illes Balears, Dept Biol Microbiol, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.; Garcia-Valdes, E (corresponding author), CSIC UIB, Inst Mediterrani Estudis Avancats IMEDEA, Crtra Valldemossa Km 7-5, Palma De Mallorca 07122, Spain.	elena.garciavaldes@uib.es	Gomila, Margarita/H-3314-2015; Lalucat, Jorge/K-1127-2014; Garcia-Valdes, Elena/K-1143-2014; Busquets Bisbal, Antonio/K-9206-2014	Gomila, Margarita/0000-0001-8725-190X; Lalucat, Jorge/0000-0002-8350-6087; Garcia-Valdes, Elena/0000-0001-5829-0002; Busquets Bisbal, Antonio/0000-0002-2793-1388	Spanish Ministry of Economy and Competitiveness MINECO [BOS2011 CGL24318, CSD2009-00006]	Spanish Ministry of Economy and Competitiveness MINECO(Spanish Government)	The work was supported by BOS2011 CGL24318 and Consolider CSD2009-00006 from Spanish Ministry of Economy and Competitiveness MINECO.	Behrendt U, 2007, INT J SYST EVOL MICR, V57, P979, DOI 10.1099/ijs.0.64793-0; Berge O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105547; Brent K. J., 1998, FUNGICIDE RESISTANCE; Bull CT, 2012, J PLANT PATHOL, V94, P21; Bull CT, 2010, J PLANT PATHOL, V92, P551; Cladera AM, 2004, J BACTERIOL, V186, P5239, DOI 10.1128/JB.186.16.5239-5248.2004; Dabboussi F, 1999, RES MICROBIOL, V150, P303, DOI 10.1016/S0923-2508(99)80056-4; Edwards C. A., 1993, The pesticide question: environment, economics and ethics., P13, DOI 10.1007/978-0-585-36973-0_2; Elomari M, 1997, INT J SYST BACTERIOL, V47, P846, DOI 10.1099/00207713-47-3-846; Ewing JH, 1960, SYST EVOL MICROBIOL, V10, P223; Hojo H, 2008, MICROBIOL-SGM, V154, P2920, DOI 10.1099/mic.0.2008/021097-0; KING EO, 1954, J LAB CLIN MED, V44, P301; KLEMENT Z, 1964, PHYTOPATHOLOGY, V54, P474; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; LELLIOTT RA, 1966, J APPL BACTERIOL, V29, P470, DOI 10.1111/j.1365-2672.1966.tb03499.x; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Martinez-Rosales C, 2011, POLAR RES, V30, DOI 10.3402/polar.v30i0.7123; Masuda M, 2007, EXTREMOPHILES, V11, P355, DOI 10.1007/s00792-006-0047-9; Mishra PK, 2009, BIOL RES, V42, P305, DOI [/S0716-97602009000300005, 10.4067/S0716-97602009000300005]; Moore ERB, 1996, SYST APPL MICROBIOL, V19, P478, DOI 10.1016/S0723-2020(96)80021-X; Mulet M, 2008, INT J SYST EVOL MICR, V58, P2309, DOI 10.1099/ijs.0.65797-0; Mulet M, 2012, SYST APPL MICROBIOL, V35, P455, DOI 10.1016/j.syapm.2012.08.007; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Mulet M, 2009, MOL CELL PROBE, V23, P140, DOI 10.1016/j.mcp.2009.02.001; Parkinson N, 2011, PLANT PATHOL, V60, P338, DOI 10.1111/j.1365-3059.2010.02366.x; Razinataj M, 2004, IRAN J AGR SCI, V35, P253; Schaad NW, 2001, LAB GUIDE IDENTIFICA, P373; Scotta C, 2012, EUR J CLIN MICROBIOL, V31, P2133, DOI 10.1007/s10096-012-1547-4; Selvakumar G, 2011, WORLD J MICROB BIOT, V27, P1129, DOI 10.1007/s11274-010-0559-4; Shams-Bakhsh M, 1997, IRANIAN J PLANT PATH, V33, P132; STEAD DE, 1992, INT J SYST BACTERIOL, V42, P281, DOI 10.1099/00207713-42-2-281; Taghavi S. M., 2003, Journal of Science and Technology of Agriculture and Natural Resources, V7, P199; Timmer L.W., 2000, COMPENDIUM CITRUS DI, V2nd; Vela AI, 2006, INT J SYST EVOL MICR, V56, P2671, DOI 10.1099/ijs.0.64378-0; Whiteside JO, 1989, COMPENDIUM CITRUS DI; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Young JM, 2010, J PLANT PATHOL, V92, pS5	37	19	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148796	10.1371/journal.pone.0148796	http://dx.doi.org/10.1371/journal.pone.0148796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919540	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400010
J	Han, C; Yang, B; Zuo, WS; Zheng, G; Yang, L; Zheng, MZ				Han, Chao; Yang, Ben; Zuo, Wen-Shu; Zheng, Gang; Yang, Li; Zheng, Mei-Zhu			The Feasibility and Oncological Safety of Axillary Reverse Mapping in Patients with Breast Cancer: A Systematic Review and Meta-Analysis of Prospective Studies	PLOS ONE			English	Review							PREVENTING LYMPHEDEMA; LYMPHATIC DRAINAGE; ARM; DISSECTION; IDENTIFY; SURGERY; NODES; BIAS	Objective The axillary reverse mapping (ARM) technique has recently been developed to prevent lymphedema by preserving the arm lymphatic drainage during sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND) procedures. The objective of this systematic review and meta-analysis was to evaluate the feasibility and oncological safety of ARM. Methods We searched Medline, Embase, Web of science, Scopus, and the Cochrane Library for relevant prospective studies. The identification rate of ARM nodes, the crossover rate of SLN-ARM nodes, the proportion of metastatic ARM nodes, and the incidence of complications were pooled into meta-analyses by the random-effects model. Results A total of 24 prospective studies were included into meta-analyses, of which 11 studies reported ARM during SLNB, and 18 studies reported ARM during SLNB. The overall identification rate of ARM nodes was 38.2% (95% CI 32.9%-43.8%) during SLNB and 82.8% (78.0%-86.6%) during ALND, respectively. The crossover rate of SLN-ARM nodes was 19.6% (95% CI 14.4%-26.1%). The metastatic rate of ARM nodes was 16.9% (95% CI 14.2%-20.1%). The pooled incidence of lymphedema was 4.1% (95% CI 2.9-5.9%) for patients undergoing ARM procedure. Conclusions The ARM procedure was feasible during ALND. Nevertheless, it was restricted by low identification rate of ARM nodes during SLNB. ARM was beneficial for preventing lymphedema. However, this technique should be performed with caution given the possibility of crossover SLN-ARM nodes and metastatic ARM nodes. ARM appeared to be unsuitable for patients with clinically positive breast cancer due to oncological safety concern.	[Han, Chao; Yang, Ben; Zuo, Wen-Shu; Zheng, Gang; Yang, Li; Zheng, Mei-Zhu] Shandong Canc Hosp & Inst, Breast Canc Ctr, Dept Surg 2, Jinan, Shandong, Peoples R China; [Han, Chao] Univ Jinan, Shandong Acad Med Sci, Sch Med & Life Sci, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zuo, WS (corresponding author), Shandong Canc Hosp & Inst, Breast Canc Ctr, Dept Surg 2, Jinan, Shandong, Peoples R China.	sdwenshu_z@126.com						Bedrosian I, 2010, CANCER-AM CANCER SOC, V116, P2543, DOI 10.1002/cncr.25096; Beek MA, 2015, EJSO-EUR J SURG ONC, V41, P59, DOI 10.1016/j.ejso.2014.09.012; Boneti C, 2012, Minerva Ginecol, V64, P421; Boneti C, 2008, J AM COLL SURGEONS, V206, P1038, DOI 10.1016/j.jamcollsurg.2007.12.022; Boneti C, 2009, AM J SURG, V198, P482, DOI 10.1016/j.amjsurg.2009.06.008; Casabona F, 2009, ANN SURG ONCOL, V16, P2459, DOI 10.1245/s10434-009-0554-x; Connor C, 2013, ANN SURG ONCOL, V20, P3303, DOI 10.1245/s10434-013-3113-4; Deng HR, 2011, J CANCER RES CLIN, V137, P1869, DOI 10.1007/s00432-011-1064-3; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; DiSipio T, 2013, LANCET ONCOL, V14, P500, DOI 10.1016/S1470-2045(13)70076-7; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gandhi SJ, 2014, CLIN NUCL MED, V39, pE428, DOI 10.1097/RLU.0000000000000256; Gennaro M, 2013, EJSO-EUR J SURG ONC, V39, P1341, DOI 10.1016/j.ejso.2013.09.022; Gobardhan PD, 2012, EJSO-EUR J SURG ONC, V38, P657, DOI 10.1016/j.ejso.2012.04.012; Gradishar WJ, 2015, J NATL COMPR CANC NE, V13, P448, DOI 10.6004/jnccn.2015.0060; Han JW, 2012, J BREAST CANCER, V15, P91, DOI 10.4048/jbc.2012.15.1.91; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ikeda K, 2014, EJSO-EUR J SURG ONC, V40, P818, DOI 10.1016/j.ejso.2014.03.023; Ikeda K, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-233; Khandelwal Rohan, 2014, Breast Dis, V34, P151, DOI 10.3233/BD-140371; Klompenhouwer EG, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-111; Kuusk U, 2014, J SURG ONCOL, V110, P791, DOI 10.1002/jso.23720; Lyman GH, 2014, J CLIN ONCOL, V32, P1365, DOI 10.1200/JCO.2013.54.1177; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Noguchi M, 2015, EJSO-EUR J SURG ONC, V41, P442, DOI 10.1016/j.ejso.2015.01.029; Noguchi M, 2010, J SURG ONCOL, V101, P217, DOI 10.1002/jso.21473; Noguchi M, 2012, J SURG ONCOL, V105, P229, DOI 10.1002/jso.22094; Nos C, 2008, ANN SURG ONCOL, V15, P2550, DOI 10.1245/s10434-008-0030-z; Nos C, 2007, ANN SURG ONCOL, V14, P2490, DOI 10.1245/s10434-007-9450-4; Ochoa D, 2014, SURGERY, V156, P1261, DOI 10.1016/j.surg.2014.05.011; Pasko JL, 2015, AM J SURG, V209, P890, DOI 10.1016/j.amjsurg.2015.01.011; Pavlista D, 2012, EJSO-EUR J SURG ONC, V38, P390, DOI 10.1016/j.ejso.2012.01.010; Pavlista D, 2012, ANN SURG ONCOL, V19, P3410, DOI 10.1245/s10434-012-2363-x; Ponzone R, 2009, J CLIN ONCOL, V27, P5547, DOI 10.1200/JCO.2009.22.1846; Rubio IT, 2012, J SURG ONCOL, V106, P89, DOI 10.1002/jso.23048; Sakurai T, 2014, J SURG ONCOL, V109, P612, DOI 10.1002/jso.23528; Schunemann E, 2014, ANN SURG ONCOL, V21, P2197, DOI 10.1245/s10434-014-3626-5; Senkus E, 2013, ANN ONCOL, V24, P7, DOI 10.1093/annonc/mdt284; Seyednejad N, 2014, EXPERT REV ANTICANC, V14, P771, DOI 10.1586/14737140.2014.896209; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tausch C, 2013, EJSO-EUR J SURG ONC, V39, P880, DOI 10.1016/j.ejso.2013.05.009; Thompson M, 2007, ANN SURG ONCOL, V14, P1890, DOI 10.1245/s10434-007-9412-x; Yue T, 2015, CLIN BREAST CANCER, V15, P301, DOI 10.1016/j.clbc.2015.01.010; Zeng Xiantao, 2015, J Evid Based Med, V8, P2, DOI 10.1111/jebm.12141	45	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150285	10.1371/journal.pone.0150285	http://dx.doi.org/10.1371/journal.pone.0150285			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919589	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400118
J	Han, J; Jyoti, MA; Song, HY; Jang, WS				Han, Juhye; Jyoti, Md. Anirban; Song, Ho-Yeon; Jang, Woong Sik			Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp	PLOS ONE			English	Article							HUMAN SALIVARY HISTATIN-5; ANTIMICROBIAL PEPTIDES; IN-VITRO; ALBICANS; TRANSLOCATION; HALOCIDIN; TUNICATE; FLUCONAZOLE; PATHOGENS; MELITTIN	The candidacidal activity of histatin 5 is initiated through cell wall binding, followed by translocation and intracellular targeting, while the halocidin peptide exerts its activity by attacking the Candida cell membrane. To improve antimicrobial activities and to understand the killing mechanism of two peptides, six hybrid peptides were designed by conjugating histatin 5 and halocidin. A comparative approach was established to study the activity, salt tolerance, cell wall glucan binding assay, cytotoxicity, generation of ROS and killing kinetics. CD spectrometry was conducted to evaluate secondary structures of these hybrid peptides. Furthermore the cellular localization of hybrid peptides was investigated by confocal fluorescence microscopy. Of the six hybrid congeners, di-PH2, di-WP2 and HHP1 had stronger activities than other hybrid peptides against all tested Candida strains. The MIC values of these peptides were 1-2, 2-4 and 2-4 mu g/ml, respectively. Moreover, none of the hybrid peptides was cytotoxic in the hemolytic assay and cell-based cytotoxicity assay. Confocal laser microscopy showed that di-PH2 and HHP1 were translocated into cytoplasm whereas di-WP2 was accumulated on surface of C. albicans to exert their candidacidal activity. All translocated peptides (Hst 5, P113, di-PH2) were capable of generating intracellular ROS except HHP1. Additionally, the KFH residues at C-terminal end of these peptides were assumed for core sequence for active translocation.	[Han, Juhye; Jyoti, Md. Anirban; Song, Ho-Yeon] Soonchunhyang Univ, Sch Med, Dept Microbiol & Immunol, Cheonan 31151, Chungnam, South Korea; [Song, Ho-Yeon; Jang, Woong Sik] Soonchunhyang Univ, Reg Innovat Ctr, Asan 31538, Chungnam, South Korea	Soonchunhyang University; Soonchunhyang University	Song, HY (corresponding author), Soonchunhyang Univ, Sch Med, Dept Microbiol & Immunol, Cheonan 31151, Chungnam, South Korea.; Song, HY; Jang, WS (corresponding author), Soonchunhyang Univ, Reg Innovat Ctr, Asan 31538, Chungnam, South Korea.	songmic@sch.ac.kr; plasmid18@sch.ac.kr	Song, Ho-Yeon/G-7168-2016		National Research Foundation of Korea, Republic of Korea [NRF 2013R1A1A1075979]; Soonchunhyang University Research Fund	National Research Foundation of Korea, Republic of Korea(National Research Foundation of Korea); Soonchunhyang University Research Fund	This work was supported by a grant from the National Research Foundation of Korea, Republic of Korea (NRF 2013R1A1A1075979) URLs: http://www.nrf.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Research Foundation of Korea, Republic of Korea (NRF 2013R1A1A1075979) and the Soonchunhyang University Research Fund.	Arendrup MC, 2014, CLIN MICROBIOL INFEC, V20, P76, DOI 10.1111/1469-0691.12360; Baev D, 2003, INFECT IMMUN, V71, P3251, DOI 10.1128/IAI.71.6.3251-3260.2003; Batoni G, 2011, CURR MED CHEM, V18, P256, DOI 10.2174/092986711794088399; Brewer D, 2002, BIOCHEMISTRY-US, V41, P5526, DOI 10.1021/bi015926d; Chai LYA, 2010, CRIT REV MICROBIOL, V36, P282, DOI 10.3109/1040841X.2010.489506; DEGRADO WF, 1982, BIOPHYS J, V37, P329, DOI 10.1016/S0006-3495(82)84681-X; Dwyer DJ, 2014, P NATL ACAD SCI USA, V111, pE2100, DOI 10.1073/pnas.1401876111; Eliassen LT, 2006, INT J CANCER, V119, P493, DOI 10.1002/ijc.21886; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Helmerhorst EJ, 1999, J BIOL CHEM, V274, P7286, DOI 10.1074/jbc.274.11.7286; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Jang WS, 2008, ANTIMICROB AGENTS CH, V52, P497, DOI 10.1128/AAC.01199-07; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Jang WS, 2006, FEBS LETT, V580, P1490, DOI 10.1016/j.febslet.2006.01.041; Jang WS, 2003, ANTIMICROB AGENTS CH, V47, P2481, DOI 10.1128/AAC.47.8.2481-2486.2003; Jang WS, 2002, FEBS LETT, V521, P81, DOI 10.1016/S0014-5793(02)02827-2; Jensen RH, 2011, J CLIN MICROBIOL, V49, P549, DOI 10.1128/JCM.02071-10; Kobayashi S, 2004, BIOCHEMISTRY-US, V43, P15610, DOI 10.1021/bi048206q; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lupetti A, 2002, ANTIMICROB AGENTS CH, V46, P1634, DOI 10.1128/AAC.46.6.1634-1639.2002; Mochon AB, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000190; Ordonez SR, 2014, ANTIMICROB AGENTS CH, V58, P2240, DOI 10.1128/AAC.01670-13; RAJ PA, 1990, J BIOL CHEM, V265, P3898; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Rothstein DM, 2001, ANTIMICROB AGENTS CH, V45, P1367, DOI 10.1128/AAC.45.5.1367-1373.2001; Ruissen ALA, 2001, BIOCHEM J, V356, P361, DOI 10.1042/0264-6021:3560361; Sanchis M, 2014, ANTIMICROB AGENTS CH, V58, P6255, DOI 10.1128/AAC.03051-14; Saugar JM, 2002, ANTIMICROB AGENTS CH, V46, P875, DOI 10.1128/AAC.46.3.875-878.2002; Scheinpflug K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125056; Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276; Sipsas NV, 2009, CANCER-AM CANCER SOC, V115, P4745, DOI 10.1002/cncr.24507; Situ H, 2000, ANTIMICROB AGENTS CH, V44, P1485, DOI 10.1128/AAC.44.6.1485-1493.2000; Steinberg D A, 1997, Methods Mol Biol, V78, P169; Takahashi D, 2010, BIOCHIMIE, V92, P1236, DOI 10.1016/j.biochi.2010.02.023; Veerman ECI, 2004, BIOCHEM J, V381, P447, DOI 10.1042/BJ20040208; Vylkova S, 2007, PURINERG SIGNAL, V3, P91, DOI 10.1007/s11302-006-9040-0; Wang CW, 2009, FEMS YEAST RES, V9, P967, DOI 10.1111/j.1567-1364.2009.00531.x; Wei GX, 2004, J ANTIMICROB CHEMOTH, V53, P750, DOI 10.1093/jac/dkh181; Wunder D, 2004, ANTIMICROB AGENTS CH, V48, P110, DOI 10.1128/AAC.48.1.110-115.2004; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; Yang YL, 2010, MED MYCOL, V48, P328, DOI 10.3109/13693780903154070; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	43	37	40	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150196	10.1371/journal.pone.0150196	http://dx.doi.org/10.1371/journal.pone.0150196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918792	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400100
J	Louis, S; Tappu, RM; Damms-Machado, A; Huson, DH; Bischoff, SC				Louis, Sandrine; Tappu, Rewati-Mukund; Damms-Machado, Antje; Huson, Daniel H.; Bischoff, Stephan C.			Characterization of the Gut Microbial Community of Obese Patients Following a Weight-Loss Intervention Using Whole Metagenome Shotgun Sequencing	PLOS ONE			English	Article							DIET; INFLAMMATION; IMPACT; MICE; NOV.; TOOL	Background/Objectives Cross-sectional studies suggested that obesity is promoted by the gut microbiota. However, longitudinal data on taxonomic and functional changes in the gut microbiota of obese patients are scarce. The aim of this work is to study microbiota changes in the course of weight loss therapy and the following year in obese individuals with or without co-morbidities, and to asses a possible predictive value of the gut microbiota with regard to weight loss maintenance. Subjects/Methods Sixteen adult patients, who followed a 52-week weight-loss program comprising low calorie diet, exercise and behavioral therapy, were selected according to their weight-loss course. Over two years, anthropometric and metabolic parameters were assessed and microbiota from stool samples was functionally and taxonomically analyzed using DNA shotgun sequencing. Results Overall the microbiota responded to the dietetic and lifestyle intervention but tended to return to the initial situation both at the taxonomical and functional level at the end of the intervention after one year, except for an increase in Akkermansia abundance which remained stable over two years (12.7x10(3) counts, 95% CI: 322-25100 at month 0; 141x10(3) counts, 95% CI: 49-233x10(3) at month 24; p = 0.005). The Firmicutes/Bacteroidetes ratio was higher in obese subjects with metabolic syndrome (0.64, 95% CI: 0.34-0.95) than in the "healthy obese" (0.27, 95% CI: 0.08-0.45, p = 0.04). Participants, who succeeded in losing their weight consistently over the two years, had at baseline a microbiota enriched in Alistipes, Pseudoflavonifractor and enzymes of the oxidative phosphorylation pathway compared to patients who were less successful in weight reduction. Conclusions Successful weight reduction in the obese is accompanied with increased Akkermansia numbers in feces. Metabolic co-morbidities are associated with a higher Firmicutes/Bacteroidetes ratio. Most interestingly, microbiota differences might allow discrimination between successful and unsuccessful weight loss prior to intervention.	[Louis, Sandrine; Damms-Machado, Antje; Bischoff, Stephan C.] Univ Hohenheim, Inst Clin Nutr, Stuttgart, Germany; [Tappu, Rewati-Mukund; Huson, Daniel H.] Univ Tubingen, Algorithms Bioinformat, Tubingen, Germany; [Damms-Machado, Antje] German Canc Res Ctr, Heidelberg, Germany	University Hohenheim; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ)	Bischoff, SC (corresponding author), Univ Hohenheim, Inst Clin Nutr, Stuttgart, Germany.	bischoff.stephan@uni-hohenheim.de	Huson, Daniel H./AAC-5494-2019		Federal Ministry of Education and Research (Germany) from the "Competence Network Obesity" project [01GI1122H]	Federal Ministry of Education and Research (Germany) from the "Competence Network Obesity" project	This work was supported by the Federal Ministry of Education and Research (Germany): Funding number 01GI1122H from the "Competence Network Obesity" project, obtained by SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bajaj JS, 2012, AM J PHYSIOL-GASTR L, V303, pG675, DOI 10.1152/ajpgi.00152.2012; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6; Bischoff SC, 2012, INT J OBESITY, V36, P614, DOI 10.1038/ijo.2011.107; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dinh DM, 2015, J INFECT DIS, V211, P19, DOI 10.1093/infdis/jiu409; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; Hevia A, 2014, MBIO, V5, DOI 10.1128/mBio.01548-14; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Irigaray P, 2006, FEBS J, V273, P1362, DOI 10.1111/j.1742-4658.2006.05159.x; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kim HW, 2014, ENVIRON RES, V135, P354, DOI 10.1016/j.envres.2014.08.032; Landig J, 1998, CLIN NUTR, V17, P113, DOI 10.1016/S0261-5614(98)80004-6; Leifer CA, 2014, IMMUNOL LETT, V162, P3, DOI 10.1016/j.imlet.2014.07.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-26; Mishra P, 2007, AM J GASTROENTEROL, V102, P2716, DOI 10.1111/j.1572-0241.2007.01520.x; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rautio M, 2003, SYST APPL MICROBIOL, V26, P182, DOI 10.1078/072320203322346029; Roberts DW, 2015, LABDSV ORDINATION MU; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63; Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Simoes CD, 2014, EUR J NUTR, V53, P1421, DOI 10.1007/s00394-013-0645-0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Venables W., 2013, MODERN APPL STAT S P, DOI DOI 10.1007/978-0-387-21706-2; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Xu J, 2015, ISME J, V9, P552, DOI 10.1038/ismej.2014.177; Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127; Zhang HK, 2012, NUCLEIC ACIDS RES, V40, pW569, DOI 10.1093/nar/gks576; Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106	48	152	160	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149564	10.1371/journal.pone.0149564	http://dx.doi.org/10.1371/journal.pone.0149564			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919743	Green Submitted, gold, Green Published			2022-12-27	WOS:000371274400024
J	Mishra, S; Bansal, S; Mishra, B; Sangwan, RS; Jadaun, AJS; Sangwan, NS				Mishra, Smrati; Bansal, Shilpi; Mishra, Bhawana; Sangwan, Rajender Singh; Jadaun, Asha Jyoti Singh; Sangwan, Neelam S.			RNAi and Homologous Over-Expression Based Functional Approaches Reveal Triterpenoid Synthase Gene-Cycloartenol Synthase Is Involved in Downstream Withanolide Biosynthesis in Withania somnifera	PLOS ONE			English	Article							MOLECULAR-CLONING; OXIDOSQUALENE CYCLASES; STEROIDAL LACTONES; PROMOTER ANALYSIS; PLANT; REDUCTION; ROOTS; CDNA	Withania somnifera Dunal, is one of the most commonly used medicinal plant in Ayurvedic and indigenous medicine traditionally owing to its therapeutic potential, because of major chemical constituents, withanolides. Withanolide biosynthesis requires the activities of several enzymes in vivo. Cycloartenol synthase (CAS) is an important enzyme in the withanolide biosynthetic pathway, catalyzing cyclization of 2, 3 oxidosqualene into cycloartenol. In the present study, we have cloned full-length WsCAS from Withania somnifera by homology-based PCR method. For gene function investigation, we constructed three RNAi gene-silencing constructs in backbone of RNAi vector pGSA and a full-length over-expression construct. These constructs were transformed in Agrobacterium strain GV3101 for plant transformation in W. somnifera. Molecular and metabolite analysis was performed in putative Withania transformants. The PCR and Southern blot results showed the genomic integration of these RNAi and overexpression construct(s) in Withania genome. The qRT-PCR analysis showed that the expression of WsCAS gene was considerably downregulated in stable transgenic silenced Withania lines compared with the non-transformed control and HPLC analysis showed that withanolide content was greatly reduced in silenced lines. Transgenic plants over expressing CAS gene displayed enhanced level of CAS transcript and withanolide content compared to non-transformed controls. This work is the first full proof report of functional validation of any metabolic pathway gene inW. somnifera at whole plant level as per our knowledge and it will be further useful to understand the regulatory role of different genes involved in the biosynthesis of withanolides.	[Mishra, Smrati; Bansal, Shilpi; Mishra, Bhawana; Sangwan, Rajender Singh; Jadaun, Asha Jyoti Singh; Sangwan, Neelam S.] CSIR Cent Inst Med & Aromat Plants CSIR CIMAP, Dept Metab & Struct Biol, PO CIMAP, Lucknow, Uttar Pradesh, India; [Sangwan, Rajender Singh] Ctr Innovat & Appl Bioproc CIAB, Ind Area, C-127,Phase 8, Mohali, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Department of Biotechnology (DBT) India; Center of Innovative & Applied Bioprocessing (CIAB)	Sangwan, NS (corresponding author), CSIR Cent Inst Med & Aromat Plants CSIR CIMAP, Dept Metab & Struct Biol, PO CIMAP, Lucknow, Uttar Pradesh, India.	nss.cimap@gmail.com	Jadaun, Dr Jyoti/GQA-8219-2022	Jadaun, Dr Jyoti/0000-0001-9276-4865; Mishra, Bhawana/0000-0002-0777-8830; sangwan, Neelam singh/0000-0003-2761-702X	Department of Biotechnology, New Delhi, NMITLI, Government of India [BT/PR10715/AGR/36/602/2008]; CSIR, New Delhi;  [BSC 203]	Department of Biotechnology, New Delhi, NMITLI, Government of India; CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); 	This work was supported by grant No. BT/PR10715/AGR/36/602/2008 from the Department of Biotechnology, New Delhi, NMITLI, Government of India to NSS and RSS. The authors are also thankful to BSC 203 grant for supporting completion of work. SB is thankful to CSIR, New Delhi for Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeeva I, TRANSGENIC PLANTS AD; Akhtar N, 2013, PROTOPLASMA, V250, P613, DOI 10.1007/s00709-012-0450-2; Basyuni M, 2007, BIOSCI BIOTECH BIOCH, V71, P1788, DOI 10.1271/bbb.70113; Bhat WW, 2012, GENE, V499, P25, DOI 10.1016/j.gene.2012.03.004; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chaurasiya ND, 2012, PLANT CELL REP, V31, P1889, DOI 10.1007/s00299-012-1302-4; Coleman HD, 2008, P NATL ACAD SCI USA, V105, P4501, DOI 10.1073/pnas.0706537105; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; D'Ambrosio C, 2011, TRANSGENIC RES, V20, P47, DOI 10.1007/s11248-010-9387-4; Dhar N, 2013, MOL BIOL REP, V40, P7007, DOI 10.1007/s11033-013-2820-z; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Gas-Pascual E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109156; Gupta P, 2013, PROTOPLASMA, V250, P285, DOI 10.1007/s00709-012-0410-x; Gupta P, 2011, PLANT GROWTH REGUL, V65, P93, DOI 10.1007/s10725-011-9578-x; Han JY, 2006, PLANT CELL PHYSIOL, V47, P1653, DOI 10.1093/pcp/pcl032; Han JY, 2010, PHYTOCHEMISTRY, V71, P36, DOI 10.1016/j.phytochem.2009.09.031; Hayashi H, 2000, BIOL PHARM BULL, V23, P231, DOI 10.1248/bpb.23.231; Hayashi H, 2001, BIOL PHARM BULL, V24, P912, DOI 10.1248/bpb.24.912; Hoffmann T, 2006, PLANT J, V48, P818, DOI 10.1111/j.1365-313X.2006.02913.x; Hoque M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068390; Jiang F, 2013, J PLANT GROWTH REGUL, V32, P182, DOI 10.1007/s00344-012-9289-1; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Kushwaha AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074777; Ma C, 2011, PLANT MOL BIOL REP, V29, P117, DOI 10.1007/s11105-010-0211-3; Madina BR, 2007, BBA-PROTEINS PROTEOM, V1774, P1199, DOI 10.1016/j.bbapap.2007.06.015; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra S, 2016, J PLANT BIOCHEM BIOT, V25, P191, DOI 10.1007/s13562-015-0324-8; Mohanpuria P, 2011, MOL BIOTECHNOL, V48, P235, DOI 10.1007/s12033-010-9364-4; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Morita M, 1997, BIOL PHARM BULL, V20, P770, DOI 10.1248/bpb.20.770; Moses T, 2015, PLANT CELL, V27, P286, DOI 10.1105/tpc.114.134486; Pan QF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043038; Rana S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057068; Razdan S, 2013, MOL BIOL REP, V40, P905, DOI 10.1007/s11033-012-2131-9; Runguphan W, 2009, P NATL ACAD SCI USA, V106, P13673, DOI 10.1073/pnas.0903393106; Sabir F, 2013, PROTOPLASMA, V250, P539, DOI 10.1007/s00709-012-0438-y; Sambrook J., 2001, MOL CLONING LAB MANU; Sangwan N.S., 2013, RECENT PATENT BIOTEC, V8, P25; Sangwan NS, 2014, PLANT CELL MONOGR, V22, P325, DOI 10.1007/978-3-642-41787-0_11; Sangwan NS, 2013, CROP SCI; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Sangwan RS, 2004, CURR SCI INDIA, V86, P461; Sawai S, 2011, FEBS LETT, V585, P1031, DOI 10.1016/j.febslet.2011.02.037; Senthil K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1214-0; Shinozaki J, 2008, FEBS LETT, V582, P310, DOI 10.1016/j.febslet.2007.12.023; Sil B, 2015, PROTOPLASMA, V252, P1097, DOI 10.1007/s00709-014-0743-8; Singh R, 2007, CHEM PHARM BULL, V55, P1371, DOI 10.1248/cpb.55.1371; Srivastava S, 2015, PROTOPLASMA, V252, P1421, DOI 10.1007/s00709-015-0766-9; Sunilkumar G, 2006, P NATL ACAD SCI USA, V103, P18054, DOI 10.1073/pnas.0605389103; Takagi K, 2011, PLANT CELL REP, V30, P1835, DOI 10.1007/s00299-011-1091-1; Verpoorte R, 2002, CURR OPIN BIOTECH, V13, P181, DOI 10.1016/S0958-1669(02)00308-7; Wang P, 2008, J BIOSCIENCES, V33, P177, DOI 10.1007/s12038-008-0035-6; Wang ZH, 2010, J BIOL CHEM, V285, P29703, DOI 10.1074/jbc.M109.098871; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Zarate R, 2013, BIOTECHNOLOGY MED PL, P359	56	21	23	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149691	10.1371/journal.pone.0149691	http://dx.doi.org/10.1371/journal.pone.0149691			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919744	gold, Green Published			2022-12-27	WOS:000371274400035
J	Toia, F; Buccheri, S; Anfosso, A; Moschella, F; Dieli, F; Meraviglia, S; Cordova, A				Toia, Francesca; Buccheri, Simona; Anfosso, Ampelio; Moschella, Francesco; Dieli, Francesco; Meraviglia, Serena; Cordova, Adriana			Skewed Differentiation of Circulating V gamma 9V delta 2 T Lymphocytes in Melanoma and Impact on Clinical Outcome	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; RECEPTOR GAMMA-DELTA; METASTATIC MELANOMA; IMPAIRED FUNCTION; CELLS; CANCER; IMMUNOTHERAPY; INTERLEUKIN-2; ZOLEDRONATE; ACTIVATION	Objective The aim of this study was to evaluate over time circulating gamma delta T lymphocytes in melanoma patients in terms of frequency, effector functions, and relationship with clinical stage and evolution, by comparing preoperative values to those obtained at a mean follow-up of 36 months or in the event of recurrence or disease progression, and to those of healthy controls. Also, we correlated the presence of tumor-infiltrating gamma delta T lymphocytes with clinical evolution of melanoma. Results Mean frequencies of circulating gamma delta T cells before and after melanoma removal were very similar and comparable to healthy subjects, but patients who progressed to stage III or IV showed a significantly decreased frequency of circulating V gamma 9V delta 2 T cells. The distribution of V gamma 9V delta 2 memory and effector subsets was similar in healthy subjects and melanoma patients at diagnosis, but circulating gamma delta T cells of patients after melanoma removal had a skewed terminally-differentiated effector memory phenotype. Highly suggestive of progressive differentiation toward a cytotoxic phenotype, V gamma 9V delta 2T cells from patients at follow up had increased cytotoxic potential and limited cytokine production capability, while the opposite pattern was detected in V gamma 9V delta 2T cells from patients before melanoma removal. Conclusions Follow-up data also showed that tumor infiltrating gamma delta T cells were significantly associated with lower mortality and relapse rates, suggesting that they may serve as a prognostic biomarker, for human melanoma.	[Toia, Francesca; Anfosso, Ampelio; Moschella, Francesco] Univ Palermo, Dept Surg Oncol & Oral Sci DICHIRONS, Palermo, Italy; [Buccheri, Simona; Dieli, Francesco; Meraviglia, Serena] Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Palermo, Italy; [Buccheri, Simona; Dieli, Francesco; Meraviglia, Serena] Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy; [Buccheri, Simona] Mediterranean Inst Transplantat & Adv Specialized, Dept Treatment & Study Abdominal Dis & Transplant, Palermo, Italy	University of Palermo; University of Palermo; University of Palermo; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Dieli, F (corresponding author), Univ Palermo, Dept Biopathol & Med Biotechnol DIBIMED, Palermo, Italy.; Dieli, F (corresponding author), Univ Palermo, Cent Lab Adv Diag & Biomed Res CLADIBIOR, Palermo, Italy.	francesco.dieli@unipa.it	Meraviglia, Serena/K-5164-2016; Toia, Francesca/AAH-4246-2021	Dieli, Francesco/0000-0002-6685-352X				Argentati K, 2003, J INVEST DERMATOL, V120, P829, DOI 10.1046/j.1523-1747.2003.12141.x; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Becker JC, 2000, CLIN EXP DERMATOL, V25, P503, DOI 10.1046/j.1365-2230.2000.00690.x; Bedane C, 2013, CURR MED RES OPIN, V29, P1297, DOI 10.1185/03007995.2013.820693; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Boring C C, 1991, Bol Asoc Med P R, V83, P225; Buccheri S, 2014, J BIOL REG HOMEOS AG, V28, P81; Caccamo N, 2006, J LEUKOCYTE BIOL, V79, P663, DOI 10.1189/jlb.1105640; Campillo JA, 2007, DERMATOLOGY, V214, P283, DOI 10.1159/000100878; Cipponi A, 2011, CANCER IMMUNOL IMMUN, V60, P1153, DOI 10.1007/s00262-011-1026-2; Cordova A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049878; Coscia M, 2012, BLOOD, V120, P3271, DOI 10.1182/blood-2012-03-417519; Dieli F, 2003, J EXP MED, V198, P391, DOI 10.1084/jem.20030235; Dieli F, 2007, CANCER RES, V67, P7450, DOI 10.1158/0008-5472.CAN-07-0199; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Fisher JPH, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27572; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500; Gooden MJM, 2011, BRIT J CANCER, V105, P93, DOI 10.1038/bjc.2011.189; GROH V, 1989, J EXP MED, V169, P1277, DOI 10.1084/jem.169.4.1277; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; ITOH K, 1986, CANCER RES, V46, P3011; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Khammari A, 2007, CANCER IMMUNOL IMMUN, V56, P1853, DOI 10.1007/s00262-007-0340-1; Mandala M, 2014, VIRCHOWS ARCH, V464, P265, DOI 10.1007/s00428-013-1526-x; Maus MV, 2014, ANNU REV IMMUNOL, V32, P189, DOI 10.1146/annurev-immunol-032713-120136; Meraviglia S, 2010, CLIN EXP IMMUNOL, V161, P290, DOI 10.1111/j.1365-2249.2010.04167.x; MOTULSKY H, 1995, INTUITIVE BIOSTATIST, P199; MUUL LM, 1987, J IMMUNOL, V138, P989; Nunes C, 2012, CLIN CANCER RES, V18, P678, DOI 10.1158/1078-0432.CCR-11-2630; Oberg HH, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00643; Oberg HH, 2014, CANCER RES, V74, P1349, DOI 10.1158/0008-5472.CAN-13-0675; Oelke M, 2005, DRUG TODAY, V41, P13, DOI 10.1358/dot.2005.41.1.875775; Petrini I, 2011, EUR J CLIN INVEST, V41, P1186, DOI 10.1111/j.1365-2362.2011.02524.x; Poccia F, 1997, J LEUKOCYTE BIOL, V62, P287, DOI 10.1002/jlb.62.3.287; Provinciali M, 2010, SCAND J IMMUNOL, V72, P142, DOI 10.1111/j.1365-3083.2010.02413.x; Saleh FH, 2001, INT J CANCER, V94, P551, DOI 10.1002/ijc.1491; Sasada T, 2011, IMMUNOTHERAPY-UK, V3, P1235, DOI [10.2217/imt.11.106, 10.2217/IMT.11.106]; Sicard H, 2005, J IMMUNOL, V175, P5471, DOI 10.4049/jimmunol.175.8.5471; Sireci G, 1997, HUM IMMUNOL, V58, P70, DOI 10.1016/S0198-8859(97)00211-5; Sireci G, 2001, EUR J IMMUNOL, V31, P1628, DOI 10.1002/1521-4141(200105)31:5<1628::AID-IMMU1628>3.0.CO;2-T; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; TEFANY FJ, 1991, J INVEST DERMATOL, V97, P197, DOI 10.1111/1523-1747.ep12479662; Tinhofer I, 2009, J IMMUNOTHER, V32, P302, DOI 10.1097/CJI.0b013e318197b5e4; Varela-Rohena A, 2008, IMMUNOL RES, V42, P166, DOI 10.1007/s12026-008-8057-6; Welton JL, 2013, ONCOLOGIST, V18, pE22, DOI 10.1634/theoncologist.2013-0097	48	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149570	10.1371/journal.pone.0149570	http://dx.doi.org/10.1371/journal.pone.0149570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915072	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700019
J	Foy, SP; Sennino, B; dela Cruz, T; Cote, JJ; Gordon, EJ; Kemp, F; Xavier, V; Franzusoff, A; Rountree, RB; Mandl, SJ				Foy, Susan P.; Sennino, Barbara; dela Cruz, Tracy; Cote, Joseph J.; Gordon, Evan J.; Kemp, Felicia; Xavier, Veronica; Franzusoff, Alex; Rountree, Ryan B.; Mandl, Stefanie J.			Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice	PLOS ONE			English	Article							RESISTANT PROSTATE-CANCER; PHASE-II; T-CELLS; EXPRESSION; VACCINE; RESPONSES; ANTIGEN; PSA; IMMUNORESISTANCE; IMMUNIZATION	Poxvirus-based active immunotherapies mediate anti-tumor efficacy by triggering broad and durable Th1 dominated T cell responses against the tumor. While monotherapy significantly delays tumor growth, it often does not lead to complete tumor regression. It was hypothesized that the induced robust infiltration of IFN gamma-producing T cells into the tumor could provoke an adaptive immune evasive response by the tumor through the upregulation of PD-L1 expression. In therapeutic CT26-HER-2 tumor models, MVA-BN-HER2 poxvirus immunotherapy resulted in significant tumor growth delay accompanied by a robust, tumor-infiltrating T cell response that was characterized by low to mid-levels of PD-1 expression on T cells. As hypothesized, this response was countered by significantly increased PD-L1 expression on the tumor and, unexpectedly, also on infiltrating T cells. Synergistic benefit of anti-tumor therapy was observed when MVA-BN-HER2 immunotherapy was combined with PD-1 immune checkpoint blockade. Interestingly, PD-1 blockade stimulated a second immune checkpoint molecule, LAG-3, to be expressed on T cells. Combining MVA-BN-HER2 immunotherapy with dual PD-1 plus LAG-3 blockade resulted in comprehensive tumor regression in all mice treated with the triple combination therapy. Subsequent rejection of tumors lacking the HER-2 antigen by treatment-responsive mice without further therapy six months after the original challenge demonstrated long lasting memory and suggested that effective T cell immunity to novel, non-targeted tumor antigens (antigen spread) had occurred. These data support the clinical investigation of this triple therapy regimen, especially in cancer patients harboring PD-L1(neg/low) tumors unlikely to benefit from immune checkpoint blockade alone.	[Foy, Susan P.; Sennino, Barbara; dela Cruz, Tracy; Cote, Joseph J.; Gordon, Evan J.; Kemp, Felicia; Xavier, Veronica; Franzusoff, Alex; Rountree, Ryan B.; Mandl, Stefanie J.] Bavarian Nord Inc, Redwood City, CA USA	Bavarian Nordic	Foy, SP (corresponding author), Bavarian Nord Inc, Redwood City, CA USA.	SusanPFoy@gmail.com		Kemp, Felicia/0000-0001-8400-3089	Bavarian Nordic, Inc.	Bavarian Nordic, Inc.	The authors received no specific funding for this work. Bavarian Nordic, Inc. provided support in the form of salaries for authors [SPF, BS, TC, JC, EJG, FK, VX, AF, RBR, SJM] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akagi J, 1997, J IMMUNOTHER, V20, P38, DOI 10.1097/00002371-199701000-00004; Baitsch L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030852; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Crane CA, 2009, ONCOGENE, V28, P306, DOI 10.1038/onc.2008.384; Durham NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109080; Fleury S G, 1991, Semin Immunol, V3, P177; FOX BA, 1990, J BIOL RESP MODIF, V9, P499; Foy SP, 2014, J CLIN ONCOL S, V32; Grosso JF, 2007, J CLIN INVEST, V117, P3383, DOI 10.1172/JCI31184; Grosso JF, 2009, J IMMUNOL, V182, P6659, DOI 10.4049/jimmunol.0804211; Gulley JL, 2014, CANCER IMMUNOL RES, V2, P133, DOI 10.1158/2326-6066.CIR-13-0108; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hodge JW, 1999, CANCER RES, V59, P5800; HUARD B, 1994, IMMUNOGENETICS, V39, P213; Inai T, 2004, AM J PATHOL, V165, P35, DOI 10.1016/S0002-9440(10)63273-7; Jochems C, 2014, CANCER IMMUNOL IMMUN, V63, P407, DOI 10.1007/s00262-014-1524-0; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kisielow M, 2005, EUR J IMMUNOL, V35, P2081, DOI 10.1002/eji.200526090; Kouo T, 2015, CANCER IMMUNOL RES, V3, P412, DOI 10.1158/2326-6066.CIR-14-0150; Kudo-Saito C, 2005, CLIN CANCER RES, V11, P2416, DOI 10.1158/1078-0432.CCR-04-1380; Li ZJ, 2010, J VIROL METHODS, V169, P87, DOI 10.1016/j.jviromet.2010.07.003; Madan RA, 2012, SEMIN ONCOL, V39, P296, DOI 10.1053/j.seminoncol.2012.02.010; Madan RA, 2012, LANCET ONCOL, V13, P501, DOI 10.1016/S1470-2045(12)70006-2; Madan RA, 2009, EXPERT OPIN INV DRUG, V18, P1001, DOI 10.1517/13543780902997928; Mandl SJ, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/s40425-014-0034-0; Mandl SJ, 2012, CANCER IMMUNOL IMMUN, V61, P19, DOI 10.1007/s00262-011-1077-4; MOEBIUS U, 1993, P NATL ACAD SCI USA, V90, P8259, DOI 10.1073/pnas.90.17.8259; Morse MA, 2013, ANN SURG, V258, P879, DOI 10.1097/SLA.0b013e318292919e; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Penichet ML, 1999, LAB ANIM SCI, V49, P179; Renard V, 2003, J IMMUNOL, V171, P1588, DOI 10.4049/jimmunol.171.3.1588; Schalper KA, 2014, CLIN CANCER RES, V20, P2773, DOI 10.1158/1078-0432.CCR-13-2702; Sega EI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086551; Singh H, 2015, J CLIN ONCOL, V33; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; TRIEBEL F, 1990, J EXP MED, V171, P1393, DOI 10.1084/jem.171.5.1393; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Villaruz LC, 2014, TRANSL LUNG CANCER R, V3, P2, DOI 10.3978/j.issn.2218-6751.2013.10.13; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Workman CJ, 2004, J IMMUNOL, V172, P5450, DOI 10.4049/jimmunol.172.9.5450; Workman CJ, 2009, J IMMUNOL, V182, P1885, DOI 10.4049/jimmunol.0800185	49	27	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150084	10.1371/journal.pone.0150084	http://dx.doi.org/10.1371/journal.pone.0150084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910562	gold, Green Submitted, Green Published			2022-12-27	WOS:000371164700063
J	Hwang, M; Song, JS; Lee, YS; Li, C; Shim, EB; Pak, HN				Hwang, Minki; Song, Jun-Seop; Lee, Young-Seon; Li, Changyong; Shim, Eun Bo; Pak, Hui-Nam			Electrophysiological Rotor Ablation in In-Silico Modeling of Atrial Fibrillation: Comparisons with Dominant Frequency, Shannon Entropy, and Phase Singularity	PLOS ONE			English	Article							COMPLEX FRACTIONATED ELECTROGRAMS; RADIOFREQUENCY CATHETER ABLATION; PULMONARY VEIN ISOLATION; OPEN-CHEST DOGS; VENTRICULAR-FIBRILLATION; CARDIAC FIBRILLATION; IONIC DETERMINANTS; MOTHER ROTORS; MECHANISMS; REENTRY	Background Although rotors have been considered among the drivers of atrial fibrillation (AF), the rotor definition is inconsistent. We evaluated the nature of rotors in 2D and 3D in- silico models of persistent AF (PeAF) by analyzing phase singularity (PS), dominant frequency (DF), Shannon entropy (ShEn), and complex fractionated atrial electrogram cycle length (CFAE-CL) and their ablation. Methods Mother rotor was spatiotemporally defined as stationary reentries with a meandering tip remaining within half the wavelength and lasting longer than 5 s. We generated 2D- and 3D-maps of the PS, DF, ShEn, and CFAE-CL during AF. The spatial correlations and ablation outcomes targeting each parameter were analyzed. Results 1. In the 2D PeAF model, we observed a mother rotor that matched relatively well with DF (>9 Hz, 71.0%, p<0.001), ShEn (upper 2.5%, 33.2%, p<0.001), and CFAE-CL (lower 2.5%, 23.7%, p<0.001). 2. The 3D-PeAF model also showed mother rotors that had spatial correlations with DF (>5.5 Hz, 39.7%, p<0.001), ShEn (upper 8.5%, 15.1%, p <0.001), and CFAE (lower 8.5%, 8.0%, p = 0.002). 3. In both the 2D and 3D models, virtual ablation targeting the upper 5% of the DF terminated AF within 20 s, but not the ablations based on long-lasting PS, high ShEn area, or lower CFAE-CL area. Conclusion Mother rotors were observed in both 2D and 3D human AF models. Rotor locations were well represented by DF, and their virtual ablation altered wave dynamics and terminated AF.	[Hwang, Minki; Song, Jun-Seop; Lee, Young-Seon; Li, Changyong; Pak, Hui-Nam] Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea; [Shim, Eun Bo] Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea	Yonsei University; Yonsei University Health System; Kangwon National University	Pak, HN (corresponding author), Yonsei Univ Hlth Syst, Div Cardiol, Seoul, South Korea.; Shim, EB (corresponding author), Kangwon Natl Univ, Dept Mech & Biomed Engn, Chunchon, Kangwon Do, South Korea.	ebshim@kangwon.ac.kr; hnpak@yuhs.ac	Lee, Young-Seon/L-3636-2013; Pak, Hui-Nam/C-4266-2015	Lee, Young-Seon/0000-0003-1396-2172; Pak, Hui-Nam/0000-0002-3256-3620; Song, Jun-Seop/0000-0002-5886-4210	Korea Health 21 R&D Project, Ministry of Health and Welfare [A085136]; Basic Science Research Program run by the National Research Foundation of Korea (NRF), Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2014R1A1A2059391]	Korea Health 21 R&D Project, Ministry of Health and Welfare; Basic Science Research Program run by the National Research Foundation of Korea (NRF), Ministry of Science, ICT & Future Planning (MSIP); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Korea Health 21 R&D Project, Ministry of Health and Welfare (https://www.htdream.kr/) [A085136 to HNP], the Basic Science Research Program run by the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/nrf_eng_cms/) which is funded by the Ministry of Science, ICT & Future Planning (MSIP) [NRF-2013R1A2A2A01014634 to HNP], and Basic Science Research Program through the National Research Foundation of Korea (NRF) (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education [2014R1A1A2059391 to MH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atienza F, 2014, J AM COLL CARDIOL, V64, P2455, DOI 10.1016/j.jacc.2014.09.053; Berenfeld O, 2014, CARDIOL CLIN, V32, P495, DOI 10.1016/j.ccl.2014.07.001; Buch Eric, 2016, Heart Rhythm, V13, P636, DOI 10.1016/j.hrthm.2015.10.031; Calvo CJ, 2014, BIOPHYS J, V106, P1811, DOI 10.1016/j.bpj.2014.02.030; Chou CC, 2011, J AM COLL CARDIOL, V58, P158, DOI 10.1016/j.jacc.2011.02.045; Courtemanche M, 1998, AM J PHYSIOL-HEART C, V275, pH301, DOI 10.1152/ajpheart.1998.275.1.H301; Dewire J, 2013, NAT REV CARDIOL, V10, P599, DOI 10.1038/nrcardio.2013.121; Ganesan AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110662; Ganesan AN, 2013, CIRC-ARRHYTHMIA ELEC, V6, P48, DOI 10.1161/CIRCEP.112.976654; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Haissaguerre M, 2014, CIRCULATION, V130, P530, DOI 10.1161/CIRCULATIONAHA.113.005421; Hwang M, 2015, IEEE T BIO-MED ENG, V62, P673, DOI 10.1109/TBME.2014.2363669; Hwang M, 2014, PROG BIOPHYS MOL BIO, V116, P40, DOI 10.1016/j.pbiomolbio.2014.09.006; Iyer AN, 2001, ANN BIOMED ENG, V29, P47, DOI 10.1114/1.1335538; Jacquemet V, 2003, J CARDIOVASC ELECTR, V14, pS172, DOI 10.1046/j.1540.8167.90308.x; Jalife J, 2000, ANNU REV PHYSIOL, V62, P25, DOI 10.1146/annurev.physiol.62.1.25; Jalife J, 2002, CARDIOVASC RES, V54, P204, DOI 10.1016/S0008-6363(02)00223-7; Jalife J, 1998, J CARDIOVASC ELECTR, V9, pS2; Kalifa JM, 2006, CIRCULATION, V113, P626, DOI 10.1161/CIRCULATIONAHA.105.575340; Keldermann RH, 2009, AM J PHYSIOL-HEART C, V296, pH370, DOI 10.1152/ajpheart.00952.2008; Konings K., 1994, CIRCULATION, V1994, P1665; Kuklik P, 2015, IEEE T BIO-MED ENG, V62, P296, DOI 10.1109/TBME.2014.2350029; Labarthe S, 2014, EUROPACE, V16, P21, DOI 10.1093/europace/euu256; McDowell KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117110; MOE GK, 1962, ARCH INT PHARMACOD T, V140, P183; Nademanee K, 2004, J AM COLL CARDIOL, V43, P2044, DOI 10.1016/j.jacc.2003.12.054; Narayan SM, 2012, J AM COLL CARDIOL, V60, P628, DOI 10.1016/j.jacc.2012.05.022; Pak HN, 2003, CIRCULATION, V108, P3149, DOI 10.1161/01.CIR.0000104563.12408.12; Pak HN, 2008, CIRC J, V72, P1185, DOI 10.1253/circj.72.1185; Pak HN, 2006, J CARDIOVASC ELECTR, V17, P777, DOI 10.1111/j.1540-8167.2006.00511.x; Pandit SV, 2013, CIRC RES, V112, P849, DOI 10.1161/CIRCRESAHA.111.300158; Pandit SV, 2005, BIOPHYS J, V88, P3806, DOI 10.1529/biophysj.105.060459; PERTSOV AM, 1993, CIRC RES, V72, P631, DOI 10.1161/01.RES.72.3.631; Rappel WJ, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1325, DOI 10.1161/CIRCEP.115.002956; Sommer P, 2016, J CARDIOVASC ELECTR, V27, P274, DOI 10.1111/jce.12874; Spector P, 2013, CIRC-ARRHYTHMIA ELEC, V6, P655, DOI 10.1161/CIRCEP.113.000311; Vaquero M, 2008, HEART RHYTHM, V5, P872, DOI 10.1016/j.hrthm.2008.02.034; Verma A, 2011, J CARDIOVASC ELECTR, V22, P1309, DOI 10.1111/j.1540-8167.2011.02128.x; Weinberg S, 2008, BIOPHYS J, V95, P1138, DOI 10.1529/biophysj.107.128207; Wynn GJ, 2014, CIRC-ARRHYTHMIA ELEC, V7, P841, DOI 10.1161/CIRCEP.114.001759; Xie F, 1998, PHYS REV E, V58, P6355, DOI 10.1103/PhysRevE.58.6355; Yun Y, 2014, J KOREAN MED SCI, V29, P370, DOI 10.3346/jkms.2014.29.3.370; Zlochiver S, 2008, HEART RHYTHM, V5, P846, DOI 10.1016/j.hrthm.2008.03.010	43	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149695	10.1371/journal.pone.0149695	http://dx.doi.org/10.1371/journal.pone.0149695			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909492	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700045
J	Modebadze, T; Morgan, NH; Peres, IAA; Hadid, RD; Amada, N; Hill, C; Williams, C; Stanford, IM; Morris, CM; Jones, RSG; Whalley, BJ; Woodhall, GL				Modebadze, Tamara; Morgan, Nicola H.; Peres, Isabelle A. A.; Hadid, Rebecca D.; Amada, Naoki; Hill, Charlotte; Williams, Claire; Stanford, Ian M.; Morris, Christopher M.; Jones, Roland S. G.; Whalley, Benjamin J.; Woodhall, Gavin L.			A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; PILOCARPINE-INDUCED EPILEPSY; ELECTRICAL STIMULATION; ENTORHINAL CORTEX; SPATIAL MEMORY; SEIZURES; RECEPTORS; GLUTAMATE; KETAMINE; DEFICITS	Animal models of acquired epilepsies aim to provide researchers with tools for use in understanding the processes underlying the acquisition, development and establishment of the disorder. Typically, following a systemic or local insult, vulnerable brain regions undergo a process leading to the development, over time, of spontaneous recurrent seizures. Many such models make use of a period of intense seizure activity or status epilepticus, and this may be associated with high mortality and/or global damage to large areas of the brain. These undesirable elements have driven improvements in the design of chronic epilepsy models, for example the lithium-pilocarpine epileptogenesis model. Here, we present an optimised model of chronic epilepsy that reduces mortality to 1% whilst retaining features of high epileptogenicity and development of spontaneous seizures. Using local field potential recordings from hippocampus in vitro as a probe, we show that the model does not result in significant loss of neuronal network function in area CA3 and, instead, subtle alterations in network dynamics appear during a process of epileptogenesis, which eventually leads to a chronic seizure state. The model's features of very low mortality and high morbidity in the absence of global neuronal damage offer the chance to explore the processes underlying epileptogenesis in detail, in a population of animals not defined by their resistance to seizures, whilst acknowledging and being driven by the 3Rs (Replacement, Refinement and Reduction of animal use in scientific procedures) principles.	[Modebadze, Tamara; Morgan, Nicola H.; Stanford, Ian M.; Woodhall, Gavin L.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Peres, Isabelle A. A.; Hadid, Rebecca D.; Amada, Naoki; Hill, Charlotte; Williams, Claire; Whalley, Benjamin J.] Univ Reading, Sch Pharm, Hopkins Life Sci Bldg, Reading, Berks, England; [Jones, Roland S. G.] Univ Bath, Dept Pharmacol, Bath BA2 7AY, Avon, England; [Morris, Christopher M.] Newcastle Univ, Med Toxicol Ctr, Claremont Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Aston University; University of Reading; University of Bath; Newcastle University - UK	Woodhall, GL (corresponding author), Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England.	g.l.woodhall@aston.ac.uk	Jones, Roland/K-1539-2016	Jones, Roland/0000-0002-3072-7505; Morris, Christopher/0000-0002-3749-0993; Stanford, Ian M/0000-0002-5677-8538; Hadid, Rebecca/0000-0002-4995-8493; woodhall, gavin/0000-0003-1281-9008	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK) [G0700639/1]; NC3Rs [G0700639/1]	National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK)(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs))	This work was supported by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) (UK; grant number G0700639/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NC3Rs grant number G0700639/1	Arida RM, 1999, EPILEPSY RES, V34, P99, DOI 10.1016/S0920-1211(98)00092-8; Bajorat R, 2011, EPILEPSIA, V52, pE118, DOI 10.1111/j.1528-1167.2011.03200.x; Cook LL, 1998, PERCEPT MOTOR SKILL, V86, P1288, DOI 10.2466/pms.1998.86.3c.1288; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Farrimond JA, 2009, BEHAV RES METHODS, V41, P446, DOI 10.3758/BRM.41.2.446; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; FUJIKAWA DG, 1995, EPILEPSIA, V36, P186, DOI 10.1111/j.1528-1157.1995.tb00979.x; Glien M, 2001, EPILEPSY RES, V46, P111, DOI 10.1016/S0920-1211(01)00272-8; GODDARD GV, 1969, EXP NEUROL, V25, P295, DOI 10.1016/0014-4886(69)90128-9; Huang X, 2012, NEUROSCIENCE, V215, P90, DOI 10.1016/j.neuroscience.2012.04.011; JONES RSG, 1988, J NEUROPHYSIOL, V59, P1476, DOI 10.1152/jn.1988.59.5.1476; JOPE RS, 1986, EXP NEUROL, V91, P471, DOI 10.1016/0014-4886(86)90045-2; JOY RM, 1983, PHARMACOL BIOCHEM BE, V19, P345, DOI 10.1016/0091-3057(83)90063-1; Karbowski LM, 2013, EPILEPSY BEHAV, V27, P18, DOI 10.1016/j.yebeh.2012.12.021; LEMOS T, 1995, EXP BRAIN RES, V102, P423; LOUIS ED, 1990, ELECTROEN CLIN NEURO, V75, P548, DOI 10.1016/0013-4694(90)90141-6; Mora GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005759; MOSER VC, 1988, FUND APPL TOXICOL, V11, P189, DOI 10.1016/0272-0590(88)90144-3; Polascheck N, 2010, EXP NEUROL, V224, P219, DOI 10.1016/j.expneurol.2010.03.014; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rice AC, 1998, EPILEPSIA, V39, P1148, DOI 10.1111/j.1528-1157.1998.tb01305.x; Samoriski GM, 1997, J NEUROSCI, V17, P5581; Santi SA, 2001, INT J NEUROSCI, V107, P63, DOI 10.3109/00207450109149757; Sloviter RS, 2005, CR BIOL, V328, P143, DOI 10.1016/j.crvi.2004.10.010; STARZL TE, 1953, J NEUROPATH EXP NEUR, V12, P262, DOI 10.1097/00005072-195307000-00006; Tang FR, 2007, NEUROPHARMACOLOGY, V53, P821, DOI 10.1016/j.neuropharm.2007.08.012; Tatum WO, 2013, NEUROLOGY, V80, pS12, DOI 10.1212/WNL.0b013e3182797325; Thompson SE, 2006, NEUROSIGNALS, V15, P202, DOI 10.1159/000098515; Tremblay E, 1984, Rev Electroencephalogr Neurophysiol Clin, V14, P241, DOI 10.1016/S0370-4475(84)80011-8; TURSKI WA, 1983, BEHAV BRAIN RES, V9, P315, DOI 10.1016/0166-4328(83)90136-5; Yang J, 2006, J NEUROSCI, V26, P406, DOI 10.1523/JNEUROSCI.4413-05.2006	31	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0147265	10.1371/journal.pone.0147265	http://dx.doi.org/10.1371/journal.pone.0147265			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909803	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371164700003
J	Panouilleres, MTN; Tofaris, GK; Brown, P; Jenkinson, N				Panouilleres, Muriel T. N.; Tofaris, George K.; Brown, Peter; Jenkinson, Ned			Intact Acquisition and Short-Term Retention of Non-Motor Procedural Learning in Parkinson's Disease	PLOS ONE			English	Article							REACTION-TIME-TASK; MOTOR ADAPTATION; OLDER-ADULTS; AGE-DIFFERENCES; SENSORIMOTOR ADAPTATION; VISUOMOTOR ADAPTATION; SERIAL PATTERNS; MEMORY; SKILL; IMPLICIT	Procedural learning is a form of memory where people implicitly acquire a skill through repeated practice. People with Parkinson's disease (PD) have been found to acquire motor adaptation, a form of motor procedural learning, similarly to healthy older adults but they have deficits in long-term retention. A similar pattern of normal learning on initial exposure with a deficit in retention seen on subsequent days has also been seen in mirror-reading, a form of non-motor procedural learning. It is a well-studied fact that disrupting sleep will impair the consolidation of procedural memories. Given the prevalence of sleep disturbances in PD, the lack of retention on following days seen in these studies could simply be a side effect of this well-known symptom of PD. Because of this, we wondered whether people with PD would present with deficits in the short-term retention of a non-motor procedural learning task, when the test of retention was done the same day as the initial exposure. The aim of the present study was then to investigate acquisition and retention in the immediate short term of cognitive procedural learning using the mirror-reading task in people with PD. This task involved two conditions: one where triads of mirror-inverted words were always new that allowed assessing the learning of mirror-reading skill and another one where some of the triads were presented repeatedly during the experiment that allowed assessing the word-specific learning. People with PD both ON and OFF their normal medication were compared to healthy older adults and young adults. Participants were re-tested 50 minutes break after initial exposure to probe for short-term retention. The results of this study show that all groups of participants acquired and retained the two skills (mirror-reading and wordspecific) similarly. These results suggest that neither healthy ageing nor the degeneration within the basal ganglia that occurs in PD does affect the mechanisms that underpin the acquisition of these new non-motor procedural learning skills and their short-term memories.	[Panouilleres, Muriel T. N.; Tofaris, George K.; Brown, Peter; Jenkinson, Ned] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Jenkinson, Ned] Univ Birmingham, Sch Sport Exercise & Rehabil Sci, Birmingham, W Midlands, England	University of Oxford; University of Birmingham	Panouilleres, MTN (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	muriel.panouilleres@psy.ox.ac.uk	Brown, Peter/J-4307-2016; Jenkinson, Ned/B-1718-2009	Brown, Peter/0000-0002-5201-3044; Jenkinson, Ned/0000-0002-6803-486X; Tofaris, George/0000-0002-9252-5933; Panouilleres, Muriel/0000-0003-0264-2093	Parkinson's UK/Oddfellows Trust [G-1108]; Medical Research Council UK the Oxford Biomedical Research Centre [R/J004588/1]; NIHR Oxford Cognitive Health CRF; Medical Research Council [MR/J004588/1] Funding Source: researchfish; Parkinson&quot;s UK [G-1108, J-1403, H-1402, J-0901] Funding Source: researchfish	Parkinson's UK/Oddfellows Trust; Medical Research Council UK the Oxford Biomedical Research Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Oxford Cognitive Health CRF; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	This study was funded by a research grant from Parkinson's UK/Oddfellows Trust (G-1108), by the Medical Research Council UK (R/J004588/1) the Oxford Biomedical Research Centre and the NIHR Oxford Cognitive Health CRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2011, J COGNITIVE NEUROSCI, V23, P11, DOI 10.1162/jocn.2010.21451; Arroyo-Anllo EM, 2015, J ALZHEIMERS DIS, V45, P205, DOI 10.3233/JAD-142271; Ashby FG, 2010, TRENDS COGN SCI, V14, P208, DOI 10.1016/j.tics.2010.02.001; Beauchamp MH, 2008, BRAIN COGNITION, V68, P134, DOI 10.1016/j.bandc.2008.03.008; Bedard P, 2011, EXP BRAIN RES, V209, P385, DOI 10.1007/s00221-011-2561-y; Bo J, 2010, EXP BRAIN RES, V201, P837, DOI 10.1007/s00221-009-2098-5; Bock O, 2006, EXP BRAIN RES, V169, P400, DOI 10.1007/s00221-005-0153-4; BONDI MW, 1991, J CLIN EXP NEUROPSYC, V13, P339, DOI 10.1080/01688639108401048; Buch ER, 2003, LEARN MEMORY, V10, P55, DOI 10.1101/lm.50303; CHERRY KE, 1995, PSYCHOL AGING, V10, P379, DOI 10.1037/0882-7974.10.3.379; Cohen H, 2007, EXP BRAIN RES, V179, P703, DOI 10.1007/s00221-006-0827-6; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Dagher A, 2001, BRAIN, V124, P1020, DOI 10.1093/brain/124.5.1020; FERRARO FR, 1993, BRAIN COGNITION, V21, P163, DOI 10.1006/brcg.1993.1013; Garcia-Borreguero D, 2003, SLEEP MED REV, V7, P115, DOI 10.1053/smrv.2002.0229; Hardwick RM, 2014, NEUROBIOL AGING, V35, P2217, DOI 10.1016/j.neurobiolaging.2014.03.030; HARRINGTON DL, 1990, J CLIN EXP NEUROPSYC, V12, P323, DOI 10.1080/01688639008400978; Heuer H, 2011, J NEUROPHYSIOL, V106, P2078, DOI 10.1152/jn.00043.2011; HOWARD DV, 1989, PSYCHOL AGING, V4, P357, DOI 10.1037/0882-7974.4.3.357; HOWARD DV, 1992, PSYCHOL AGING, V7, P232, DOI 10.1037/0882-7974.7.2.232; Huang HJ, 2014, J NEUROPHYSIOL, V111, P135, DOI 10.1152/jn.00401.2013; JACKSON GM, 1995, NEUROPSYCHOLOGIA, V33, P577, DOI 10.1016/0028-3932(95)00010-Z; Joundi R, 2012, NEUR CONTR MOV 22 AN; Ketcham CJ, 2003, MOVEMENT CONTROL OLD, P64; Koenig O, 1999, NEUROPSYCHOLOGIA, V37, P1103, DOI 10.1016/S0028-3932(99)00040-8; Langan J, 2011, BEHAV BRAIN RES, V225, P160, DOI 10.1016/j.bbr.2011.07.014; LEES AJ, 1988, CLIN NEUROPHARMACOL, V11, P512, DOI 10.1097/00002826-198812000-00004; Leow LA, 2012, EXP BRAIN RES, V218, P295, DOI 10.1007/s00221-012-3060-5; Marinelli L, 2009, PARKINSONISM RELAT D, V15, P6, DOI 10.1016/j.parkreldis.2008.02.012; MARTONE M, 1984, ARCH NEUROL-CHICAGO, V41, P965, DOI 10.1001/archneur.1984.04050200071020; Muslimovic D, 2007, BRAIN, V130, P2887, DOI 10.1093/brain/awm211; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Panouilleres MTN, 2015, J PHYSIOL-LONDON, V593, P3645, DOI 10.1113/JP270484; PASCUALLEONE A, 1993, ANN NEUROL, V34, P594, DOI 10.1002/ana.410340414; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; SAINTCYR JA, 1988, BRAIN, V111, P941, DOI 10.1093/brain/111.4.941; Sato E, 2014, NEUROPSYCHOBIOLOGY, V70, P165, DOI 10.1159/000365485; Schonell FJ, 1971, READING SPELLING TES; Seidler RD, 2006, BRAIN RES BULL, V70, P337, DOI 10.1016/j.brainresbull.2006.06.008; Shadmehr R, 2010, ANNU REV NEUROSCI, V33, P89, DOI 10.1146/annurev-neuro-060909-153135; Smith J, 2001, BRAIN COGNITION, V45, P378, DOI 10.1006/brcg.2001.1286; Sommer M, 1999, J NEUROL NEUROSUR PS, V67, P27, DOI 10.1136/jnnp.67.1.27; Stefanova ED, 2000, MOVEMENT DISORD, V15, P1095, DOI 10.1002/1531-8257(200011)15:6<1095::AID-MDS1006>3.0.CO;2-R; Stickgold R, 2005, SLEEP, V28, P1225, DOI 10.1093/sleep/28.10.1225; Yamadori A, 1996, COGNITIVE BRAIN RES, V5, P49, DOI 10.1016/S0926-6410(96)00040-7	45	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149224	10.1371/journal.pone.0149224	http://dx.doi.org/10.1371/journal.pone.0149224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2HK	26906905	Green Published, gold			2022-12-27	WOS:000371163000007
J	Hai, J; Serradji, N; Mouton, L; Redeker, V; Cornu, D; Chahine, JME; Verbeke, P; Hemadi, M				Hai, Jun; Serradji, Nawal; Mouton, Ludovic; Redeker, Virginie; Cornu, David; Chahine, Jean-Michel El Hage; Verbeke, Philippe; Hemadi, Miryana			Targeted Delivery of Amoxicillin to C. trachomatis by the Transferrin Iron Acquisition Pathway	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; DRUG-DELIVERY; INTRACELLULAR PATHOGEN; DEVELOPMENTAL CYCLE; SERUM-TRANSFERRIN; ENDOCYTIC PATHWAY; EPITHELIAL-CELLS; IN-VITRO; RECEPTOR; MECHANISM	Weak intracellular penetration of antibiotics makes some infections difficult to treat. The Trojan horse strategy for targeted drug delivery is among the interesting routes being explored to overcome this therapeutic difficulty. Chlamydia trachomatis, as an obligate intracellular human pathogen, is responsible for both trachoma and sexually transmitted diseases. Chlamydia develops in a vacuole and is therefore protected by four membranes (plasma membrane, bacterial inclusion membrane, and bacterial membranes). In this work, the irontransport protein, human serum-transferrin, was used as a Trojan horse for antibiotic delivery into the bacterial vacuole. Amoxicillin was grafted onto transferrin. The transferrin-amoxicillin construct was characterized by mass spectrometry and absorption spectroscopy. Its affinity for transferrin receptor 1, determined by fluorescence emission titration [KaffTf-amox = (1.3 +/- 1.0) x 10(8)], is very close to that of transferrin [4.3 x 10(8)]. Transmission electron and confocal microscopies showed a co-localization of transferrin with the bacteria in the vacuole and were also used to evaluate the antibiotic capability of the construct. It is significantly more effective than amoxicillin alone. These promising results demonstrate targeted delivery of amoxicillin to suppress Chlamydia and are of interest for Chlamydiaceae and maybe other intracellular bacteria therapies.	[Hai, Jun; Serradji, Nawal; Mouton, Ludovic; Chahine, Jean-Michel El Hage; Hemadi, Miryana] Univ Paris Diderot, ITODYS Interfaces Traitements Org & Dynam Syst, Sorbonne Paris Cite, CNRS UMR 7086, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France; [Redeker, Virginie] CNRS, Paris Saclay Inst Neurosci, UMR 9197, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Cornu, David] CNRS, Serv Identificat & Caracterisat Prot, UMR 9198, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France; [Verbeke, Philippe] Univ Paris Diderot, Sorbonne Paris Cite, Fac Med, UMR 1149,Inserm,CNRS,ERL 8252,Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chahine, JME; Hemadi, M (corresponding author), Univ Paris Diderot, ITODYS Interfaces Traitements Org & Dynam Syst, Sorbonne Paris Cite, CNRS UMR 7086, 15 Rue Jean Antoine de Baif, F-75205 Paris 13, France.; Verbeke, P (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Fac Med, UMR 1149,Inserm,CNRS,ERL 8252,Site Bichat, 16 Rue Henri Huchard, F-75018 Paris, France.	chahine@univ-paris-diderot.fr; philippe.verbeke@inserm.fr; hemadi@univ-paris-diderot.fr	Redeker, Virginie/L-8929-2018; Hai, Jun/F-9392-2018; Serradji, Nawal/AAJ-9599-2020; Hémadi, Miryana/R-9308-2018	Redeker, Virginie/0000-0003-2694-8388; Hai, Jun/0000-0002-7466-4649; Hémadi, Miryana/0000-0002-2658-859X				AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Al-Younes HM, 2001, CELL MICROBIOL, V3, P427, DOI 10.1046/j.1462-5822.2001.00125.x; BALI PK, 1991, BIOCHEMISTRY-US, V30, P324, DOI 10.1021/bi00216a003; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Brizzolara S S, 1990, Hawaii Med J, V49, P335; Brizzolara SS, 1990, HAWAII MED J, V49, P335; Brizzolara SS, 1990, HAWAII MED J, V49, P339; Chahine JME, 2012, BBA-GEN SUBJECTS, V1820, P334, DOI 10.1016/j.bbagen.2011.07.008; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; CROSA JH, 1989, MICROBIOL REV, V53, P517, DOI 10.1128/MMBR.53.4.517-530.1989; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Dumoux M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083511; el-Shourbagy M, 1996, J Obstet Gynaecol Res, V22, P467; Hemadi M, 2004, BIOCHEMISTRY-US, V43, P1736, DOI 10.1021/bi030142g; Hemadi M, 2003, BIOCHEMISTRY-US, V42, P3120, DOI 10.1021/bi020627p; Hemadi M, 2006, J MOL BIOL, V358, P1125, DOI 10.1016/j.jmb.2006.02.055; Hogemann-Savellano D, 2003, NEOPLASIA, V5, P495; Hu VH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002020; Ibrahim HR, 2015, EUR J PHARM SCI, V66, P59, DOI 10.1016/j.ejps.2014.10.005; Jacquier N, 2015, FEMS MICROBIOL REV, V39, P262, DOI 10.1093/femsre/fuv001; Kakuta K, 1997, COMP BIOCHEM PHYS A, V118, P165, DOI 10.1016/S0300-9629(96)00403-3; Klockner A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5201; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; MAKEY DG, 1976, BIOCHIM BIOPHYS ACTA, V453, P250, DOI 10.1016/0005-2795(76)90270-1; Moos T, 2007, J NEUROCHEM, V103, P1730, DOI 10.1111/j.1471-4159.2007.04976.x; Mpiga P, 2006, MICROBIOL RES, V161, P9, DOI 10.1016/j.micres.2005.04.004; NEILANDS JB, 1981, ANNU REV BIOCHEM, V50, P715, DOI 10.1146/annurev.bi.50.070181.003435; Ojcius DM, 1997, INFECT IMMUN, V65, P2437, DOI 10.1128/IAI.65.6.2437-2442.1997; Ouellette SP, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00112; Pakdaman R, 1999, J MOL BIOL, V293, P1273, DOI 10.1006/jmbi.1999.3238; Pakdaman R, 1996, EUR J BIOCHEM, V236, P922, DOI 10.1111/j.1432-1033.1996.00922.x; Piraux H, 2013, BBA-GEN SUBJECTS, V1830, P4254, DOI 10.1016/j.bbagen.2013.04.035; PUNGETTI D, 1988, Acta Europaea Fertilitatis, V19, P93; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Schachter J, 1991, MANUAL CLIN MICROBIO, P1045; Schuler J, 1999, BIOPHYS J, V77, P1117, DOI 10.1016/S0006-3495(99)76962-6; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, J CELL BIOL, V134, P363, DOI 10.1083/jcb.134.2.363; Scidmore Marci A, 2005, Curr Protoc Microbiol, VChapter 11, DOI 10.1002/9780471729259.mc11a01s00; Skaar EP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000949; Somani Jyoti, 2000, Journal of Infectious Diseases, V181, P1421, DOI 10.1086/315372; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Taraska T, 1996, INFECT IMMUN, V64, P3713, DOI 10.1128/IAI.64.9.3713-3727.1996; TURKEWITZ AP, 1988, J BIOL CHEM, V263, P8318; vanOoij C, 1997, INFECT IMMUN, V65, P758, DOI 10.1128/IAI.65.2.758-766.1997; Whittington WLH, 2001, SEX TRANSM DIS, V28, P117, DOI 10.1097/00007435-200102000-00011; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004; Wyrick PB, 2010, J INFECT DIS, V201, pS88, DOI 10.1086/652394; Yewale C, 2013, EXPERT OPIN DRUG DEL, V10, P1429, DOI 10.1517/17425247.2013.805200	53	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150031	10.1371/journal.pone.0150031	http://dx.doi.org/10.1371/journal.pone.0150031			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919720	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400072
J	Hu, MG; Li, W; Li, LF; Houston, D; Wu, J				Hu, Maogui; Li, Wei; Li, Lianfa; Houston, Douglas; Wu, Jun			Refining Time-Activity Classification of Human Subjects Using the Global Positioning System	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; AIR-POLLUTION; ACCELEROMETER DATA; RANDOM FORESTS; ULTRAFINE PARTICLES; GPS TRACKING; EXPOSURE; TRAVEL; LOCATION; DISEASE	Background Detailed spatial location information is important in accurately estimating personal exposure to air pollution. Global Position System (GPS) has been widely used in tracking personal paths and activities. Previous researchers have developed time-activity classification models based on GPS data, most of them were developed for specific regions. An adaptive model for time-location classification can be widely applied to air pollution studies that use GPS to track individual level time-activity patterns. Methods Time-activity data were collected for seven days using GPS loggers and accelerometers from thirteen adult participants from Southern California under free living conditions. We developed an automated model based on random forests to classify major time-activity patterns (i.e. indoor, outdoor-static, outdoor-walking, and in-vehicle travel). Sensitivity analysis was conducted to examine the contribution of the accelerometer data and the supplemental spatial data (i.e. roadway and tax parcel data) to the accuracy of time-activity classification. Our model was evaluated using both leave-one-fold-out and leave-one-subject-out methods. Results Maximum speeds in averaging time intervals of 7 and 5 minutes, and distance to primary highways with limited access were found to be the three most important variables in the classification model. Leave-one-fold-out cross-validation showed an overall accuracy of 99.71%. Sensitivities varied from 84.62% (outdoor walking) to 99.90% (indoor). Specificities varied from 96.33% (indoor) to 99.98% (outdoor static). The exclusion of accelerometer and ambient light sensor variables caused a slight loss in sensitivity for outdoor walking, but little loss in overall accuracy. However, leave-one-subject-out cross-validation showed considerable loss in sensitivity for outdoor static and outdoor walking conditions. Conclusions The random forests classification model can achieve high accuracy for the four major time-activity categories. The model also performed well with just GPS, road and tax parcel data. However, caution is warranted when generalizing the model developed from a small number of subjects to other populations.	[Hu, Maogui; Li, Lianfa; Wu, Jun] Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA; [Li, Wei] Texas A&M Univ, Dept Landscape Architecture & Urban Planning, College Stn, TX USA; [Houston, Douglas] Univ Calif Irvine, Sch Social Ecol, Dept Planning Policy & Design, Irvine, CA USA; [Hu, Maogui; Li, Lianfa] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing, Peoples R China; [Hu, Maogui] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing, Jiangsu, Peoples R China	University of California System; University of California Irvine; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Irvine; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wu, J (corresponding author), Univ Calif Irvine, Program Publ Hlth, Coll Hlth Sci, Irvine, CA USA.	junwu@uci.edu	Hu, Maogui/N-7105-2013	Hu, Maogui/0000-0002-7671-7863	UCI Academic Senate Council on Research, Computing and Libraries (CORCL); Active Living Accelerometer Loan Program	UCI Academic Senate Council on Research, Computing and Libraries (CORCL); Active Living Accelerometer Loan Program	The research was supported by the UCI Academic Senate Council on Research, Computing and Libraries (CORCL) Faculty Research and Travel Grant, and the research was supported by the Active Living Accelerometer Loan Program. Staff support was provided by the California Department of Transportation. It would not have been possible without the study participants who generously allowed us to track their activities for multiple days.	Ali Z, 2013, REC ADV SPAC TECHN R; Audrey S, 2013, EUR J PUBLIC HEALTH, V23, P475, DOI 10.1093/eurpub/cks081; Barrett J, 2009, 50 AIAA ASME ASCE AH, P1; Bohte W, 2009, TRANSPORT RES C-EMER, V17, P285, DOI 10.1016/j.trc.2008.11.004; Breen MS, 2014, J EXPO SCI ENV EPID, V24, P412, DOI 10.1038/jes.2014.13; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggs DJ, 2008, ENVIRON INT, V34, P12, DOI 10.1016/j.envint.2007.06.011; Brondeel R, 2015, MED SCI SPORTS EXERC; Brook Robert D., 2007, Reviews on Environmental Health, V22, P115; CHAN CC, 1991, ENVIRON SCI TECHNOL, V25, P964, DOI 10.1021/es00017a021; Chen Hong, 2008, Reviews on Environmental Health, V23, P243; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Chung EH, 2005, TRANSPORT PLAN TECHN, V28, P381, DOI 10.1080/03081060500322599; Cooper AR, 2010, AM J PREV MED, V38, P178, DOI 10.1016/j.amepre.2009.10.036; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Du J, 2007, TRANSPORT RES A-POL, V41, P220, DOI 10.1016/j.tra.2006.05.001; Duncan JS, 2009, J SCI MED SPORT, V12, P583, DOI 10.1016/j.jsams.2008.09.010; Duncan MJ, 2007, MED SCI SPORT EXER, V39, P1851, DOI 10.1249/mss.0b013e31811ff31e; Duncan MJ, 2007, AM J PREV MED, V33, P51, DOI 10.1016/j.amepre.2007.02.042; Elgethun K, 2007, J EXPO SCI ENV EPID, V17, P196, DOI 10.1038/sj.jes.7500496; Ellis K., 2013, P 4 INT SENSECAM PER, P88, DOI [10.1145/2526667.2526685, DOI 10.1145/2526667.2526685]; Ellis K, 2014, PHYSIOL MEAS, V35, P2191, DOI 10.1088/0967-3334/35/11/2191; Ellis K, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00036; eMarketer, 2014, WORLDW SMARTPH US GR; Englert N, 2004, TOXICOL LETT, V149, P235, DOI 10.1016/j.toxlet.2003.12.035; Evenson KR, 2013, MED SCI SPORT EXER, V45, P1981, DOI 10.1249/MSS.0b013e318293330e; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gong L, 2014, PROCD SOC BEHV, V138, P557, DOI 10.1016/j.sbspro.2014.07.239; Gonzalez PA, 2010, IET INTELL TRANSP SY, V4, P37, DOI 10.1049/iet-its.2009.0029; Hapfelmeier A, 2013, COMPUT STAT DATA AN, V60, P50, DOI 10.1016/j.csda.2012.09.020; Houston D, 2013, ATMOS ENVIRON, V71, P148, DOI 10.1016/j.atmosenv.2013.02.002; Hurvitz PM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00002; Kang B, 2013, MED SCI SPORT EXER, V45, P1419, DOI 10.1249/MSS.0b013e318285f202; Kohla B, 2014, ADV DATA MIN DATABAS, P134, DOI 10.4018/978-1-4666-6170-7.ch009; Kuhnlein M, 2014, REMOTE SENS ENVIRON, V141, P129, DOI 10.1016/j.rse.2013.10.026; Larsson P, 2001, MED SCI SPORT EXER, V33, P1919, DOI 10.1097/00005768-200111000-00018; Lee J, 2015, J APPL STAT, V42, P676, DOI 10.1080/02664763.2014.978270; Nethery E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-33; Norton TT, 2013, EXP EYE RES, V114, P48, DOI 10.1016/j.exer.2013.05.004; Oreskovic NM, 2012, GEOSPATIAL HEALTH, V6, P263, DOI 10.4081/gh.2012.144; Park YS, 2013, ECOL INFORM, V13, P40, DOI 10.1016/j.ecoinf.2012.10.008; Pelucchi C, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-453; Phillips ML, 2001, J EXPO ANAL ENV EPID, V11, P207, DOI 10.1038/sj.jea.7500161; Rainham D, 2010, SOC SCI MED, V70, P668, DOI 10.1016/j.socscimed.2009.10.035; RCore Team, 2020, R LANG ENV STAT COMP; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Rodriguez DA, 2012, J PHYS ACT HEALTH, V9, P421, DOI 10.1123/jpah.9.3.421; Schantz P, 2009, MED SCI SPORT EXER, V41, P472, DOI 10.1249/MSS.0b013e3181877aaf; Schuessler N, 2009, TRANSPORT RES REC, P28, DOI 10.3141/2105-04; Sreenivas K, 2014, J INDIAN SOC REMOTE, V42, P577, DOI 10.1007/s12524-013-0332-x; Stillerman KP, 2008, REPROD SCI, V15, P631, DOI 10.1177/1933719108322436; Stopher P, 2008, TRANSPORT RES C-EMER, V16, P350, DOI 10.1016/j.trc.2007.10.002; Stumpf A, 2011, REMOTE SENS ENVIRON, V115, P2564, DOI 10.1016/j.rse.2011.05.013; Suh HH, 2000, ENVIRON HEALTH PERSP, V108, P625, DOI 10.2307/3454398; Tandon PS, 2013, AM J PREV MED, V44, P85, DOI 10.1016/j.amepre.2012.09.052; Thierry B, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-14; Van Dierendonck A. J., 1992, Navigation. Journal of the Institute of Navigation, V39, P265; Vitale M, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-1992-z; Westerdahl D, 2005, ATMOS ENVIRON, V39, P3597, DOI 10.1016/j.atmosenv.2005.02.034; Wu J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-47; Wu J, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-101; Wu J, 2010, ENVIRON HEALTH INSIG, V4, P93, DOI 10.4137/EHI.S6246; Xu X, 2005, J EXPO ANAL ENV EPID, V15, P6, DOI 10.1038/sj.jea.7500374; Zheng Y, 2008, 11 INT C WORLD WID W; Zhu YF, 2007, ENVIRON SCI TECHNOL, V41, P2138, DOI 10.1021/es0618797	65	10	11	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148875	10.1371/journal.pone.0148875	http://dx.doi.org/10.1371/journal.pone.0148875			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919723	Green Published, gold			2022-12-27	WOS:000371274400012
J	Kim, K; Bang, SY; Yoo, DH; Cho, SK; Choi, CB; Sung, YK; Kim, TH; Jun, JB; Kang, YM; Suh, CH; Shim, SC; Lee, SS; Lee, J; Chung, WT; Kim, SK; Choe, JY; Nath, SK; Lee, HS; Bae, SC				Kim, Kwangwoo; Bang, So-Young; Yoo, Dae Hyun; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Kang, Young Mo; Suh, Chang-Hee; Shim, Seung-Cheol; Lee, Shin-Seok; Lee, Jisoo; Chung, Won Tae; Kim, Seong-Kyu; Choe, Jung-Yoon; Nath, Swapan K.; Lee, Hye-Soon; Bae, Sang-Cheol			Imputing Variants in HLA-DR Beta Genes Reveals That HLA-DRB1 Is Solely Associated with Rheumatoid Arthritis and Systemic Lupus Erythematosus	PLOS ONE			English	Article							EXPRESSION; MHC; HLA-DR-BETA-1; INDIVIDUALS; HAPLOTYPE; MOLECULES; EXPLAIN	The genetic association of HLA-DRB1 with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) is well documented, but association with other HLA-DR beta genes (HLA-DRB3, HLA-DRB4 and HLA-DRB5) has not been thoroughly studied, despite their similar functions and chromosomal positions. We examined variants in all functional HLA-DR beta genes in RA and SLE patients and controls, down to the amino-acid level, to better understand disease association with the HLA-DR locus. To this end, we improved an existing HLA reference panel to impute variants in all protein-coding HLA-DR beta genes. Using the reference panel, HLA variants were inferred from high-density SNP data of 9,271 RA-control subjects and 5,342 SLE-control subjects. Disease association tests were performed by logistic regression and log-likelihood ratio tests. After imputation using the newly constructed HLA reference panel and statistical analysis, we observed that HLA-DRB1 variants better accounted for the association between MHC and susceptibility to RA and SLE than did the other three HLA-DRB variants. Moreover, there were no secondary effects in HLA-DRB3, HLA-DRB4, or HLA-DRB5 in RA or SLE. Of all the HLA-DR beta chain paralogs, those encoded by HLA-DRB1 solely or dominantly influence susceptibility to RA and SLE.	[Kim, Kwangwoo; Bang, So-Young; Yoo, Dae Hyun; Cho, Soo-Kyung; Choi, Chan-Bum; Sung, Yoon-Kyoung; Kim, Tae-Hwan; Jun, Jae-Bum; Lee, Hye-Soon; Bae, Sang-Cheol] Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea; [Kang, Young Mo] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Div Rheumatol, Daegu, South Korea; [Suh, Chang-Hee] Ajou Univ, Sch Med, Dept Rheumatol, Suwon 441749, South Korea; [Shim, Seung-Cheol] Chungnam Natl Univ Hosp, Daejeon Rheumatoid & Degenerat Arthrit Ctr, Div Rheumatol, Daejeon, South Korea; [Lee, Shin-Seok] Chonnam Natl Univ, Med Sch & Hosp, Dept Internal Med, Div Rheumatol, Gwangju, South Korea; [Lee, Jisoo] Ewha Womans Univ, Sch Med, Dept Internal Med, Div Rheumatol, Seoul, South Korea; [Chung, Won Tae] Dong A Univ, Dept Internal Med, Div Rheumatol, Busan, South Korea; [Kim, Seong-Kyu; Choe, Jung-Yoon] Catholic Univ, Daegu Sch Med, Arthrit & Autoimmun Res Ctr, Div Rheumatol,Dept Internal Med, Daegu, South Korea; [Nath, Swapan K.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	Hanyang University; Kyungpook National University; Ajou University; Chungnam National University; Chungnam National University Hospital; Chonnam National University; Ewha Womans University; Dong A University; Catholic University of Daegu; Oklahoma Medical Research Foundation	Bae, SC (corresponding author), Hanyang Univ, Hosp Rheumat Dis, Dept Rheumatol, Seoul 133791, South Korea.	scbae@hanyang.ac.kr	Suh, Chang-Hee/H-9723-2019; Yoo, Dae Hyun/M-3924-2017; Choi, Chan-Bum/M-4110-2017; Lee, Shin-Seok/AAC-6779-2021	Suh, Chang-Hee/0000-0001-6156-393X; Choi, Chan-Bum/0000-0002-4691-5455; Shim, Seung cheol/0000-0002-3199-359X; Bae, Sang-Cheol/0000-0003-4658-1093; Kim, Kwangwoo/0000-0001-8926-6216	National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1C1A1A02036527]; US National Institutes of Health [R01MD007909, R01AR060366]; Korea Healthcare Technology R&D Project of the Ministry for Health Welfare [HI13C2124]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060366] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD007909] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Ministry of Education; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Healthcare Technology R&D Project of the Ministry for Health Welfare; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1C1A1A02036527 to Dr. Kwangwoo Kim), the US National Institutes of Health (R01MD007909 and R01AR060366 to Dr. Swapan K. Nath), and the Korea Healthcare Technology R&D Project of the Ministry for Health & Welfare (HI13C2124 to Dr. Sang-Cheol Bae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON G, 1994, IMMUNOL TODAY, V15, P58, DOI 10.1016/0167-5699(94)90134-1; Andersson Goran, 1998, Frontiers in Bioscience, V3, pD739; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; COTNER T, 1989, J BIOL CHEM, V264, P11107; Czerwony G, 1999, HUM IMMUNOL, V60, P1, DOI 10.1016/S0198-8859(98)00096-2; Hohjoh H, 2003, IMMUNOGENETICS, V54, P856, DOI 10.1007/s00251-003-0539-z; Jia XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064683; Kim K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6902; Kim K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112546; Kim K, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204749; Okada Y, 2014, HUM MOL GENET, V23, P6916, DOI 10.1093/hmg/ddu387; Prat E, 2005, J NEUROIMMUNOL, V167, P108, DOI 10.1016/j.jneuroim.2005.04.027; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Reche PA, 2003, J MOL BIOL, V331, P623, DOI 10.1016/S0022-2836(03)00750-2; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Satta Y, 1996, HUM IMMUNOL, V51, P1, DOI 10.1016/S0198-8859(96)00155-3	16	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150283	10.1371/journal.pone.0150283	http://dx.doi.org/10.1371/journal.pone.0150283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919467	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400117
J	Li, XY; Chen, YQ; Gao, WG; Ouyang, WW; Wei, J; Wen, ZH				Li, Xiaoyan; Chen, Yunqin; Gao, Weiguo; Ouyang, Wenwei; Wei, Jia; Wen, Zehuai			Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MANAGEMENT; PATHOGENS; EFFICACY; SAFETY; EUROPE; TIGECYCLINE; DAPTOMYCIN; VANCOMYCIN	Complicated skin and soft tissue infections (cSSTI) are some of the most commonly treated infections in hospitals, and place heavy economic burdens on patients and society. Here we report the findings from an analysis of cSSTI based on a retrospective study which was conducted within the Chinese inpatient population. We focused our research on the analysis of the patient population, antibiotic treatment, clinical outcome and economic burden. The study population comprised 527 selected patients hospitalized between 2008 and 2013. Among the hospitalizations with microbiological diagnoses, 61.41%(n = 113) were diagnosed as infected with Gram-positive bacteria, while 46.20%(n = 85) were infected with Gram-negative bacteria. The most commonly found Gram-positive bacteria was Staphylococcus aureus (40.76%, n = 75), and the most common Gram-negative bacteria was Escherichia coli (14.13%, n = 26). About 20% of the Staphylococcus aureus were methicillin-resistant. The resistance rate of isolated Staphylococcus aureus or Escherichia coli to penicillin was around 90%; in contrast, the resistance rate to vancomycin, linezolid or imipenem was low (<20%). A large percentage of patients were treated with cephalosporins and fluoroquinolones, while vancomycin and imipenem were also included to treat drug-resistant pathogens. Over half of the hospitalizations (58.43%, n = 336) experienced treatment modifications. The cost to patients with antibiotic modifications was relatively higher than to those without. In conclusion, our study offers an analysis of the disease characteristics, microbiological diagnoses, treatment patterns and clinical outcomes of cSSTI in four hospitals in Guangdong Province, and sheds lights on the current clinical management of cSSTI in China.	[Li, Xiaoyan; Ouyang, Wenwei; Wen, Zehuai] Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China; [Chen, Yunqin; Gao, Weiguo; Wei, Jia] AstraZeneca, R&D Informat China, 199 Liangjing Rd, Shanghai 201203, Peoples R China	Guangzhou University of Chinese Medicine; AstraZeneca	Wen, ZH (corresponding author), Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, 111 Dade Rd, Guangzhou 510120, Guangdong, Peoples R China.; Wei, J (corresponding author), AstraZeneca, R&D Informat China, 199 Liangjing Rd, Shanghai 201203, Peoples R China.	jenny.wei@astrazeneca.com; wenzh@gzucm.edu.cn	Wen, Zehuai/A-5103-2015	Wen, Zehuai/0000-0002-1797-2047				Bassetti M, 2014, CLIN MICROBIOL INFEC, V20, P3, DOI 10.1111/1469-0691.12463; Chuang YC, 2011, J MICROBIOL IMMUNOL, V44, P116, DOI 10.1016/j.jmii.2010.04.002; Cornia PB, 2008, EXPERT OPIN PHARMACO, V9, P717, DOI 10.1517/14656566.9.5.717; Fritz SA, 2013, ANTIMICROB AGENTS CH, V57, P559, DOI 10.1128/AAC.01633-12; Garau J, 2013, CLIN MICROBIOL INFEC, V19, pE377, DOI 10.1111/1469-0691.12235; Gonzalez-Ruiz A, 2013, INT J ANTIMICROB AG, V41, P372, DOI 10.1016/j.ijantimicag.2012.12.017; Heizmann WR, 2013, J ANTIMICROB CHEMOTH, V68, pii45, DOI 10.1093/jac/dkt144; Karaiskos I, 2014, EXPERT OPIN PHARMACO, V15, P1351, DOI 10.1517/14656566.2014.914172; Lai CC, 2012, J MICROBIOL IMMUNOL, V45, P52, DOI 10.1016/j.jmii.2011.09.018; Lee Su Young, 2005, Surg Infect (Larchmt), V6, P283, DOI 10.1089/sur.2005.6.283; Lin DF, 2008, INT J ANTIMICROB AG, V32, P241, DOI 10.1016/j.ijantimicag.2008.04.004; Lipsky BA, 2014, DIAGN MICR INFEC DIS, V79, P273, DOI 10.1016/j.diagmicrobio.2014.02.011; May AK, 2009, SURG INFECT, V10, P467, DOI 10.1089/sur.2009.012; Merlino James I, 2007, Cleve Clin J Med, V74 Suppl 4, pS21; Nathwani D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-476; Nichols RL, 1999, J ANTIMICROB CHEMOTH, V44, P19, DOI 10.1093/jac/44.suppl_1.19; Ostermann Helmut, 2014, J Med Econ, V17, P719, DOI 10.3111/13696998.2014.940423; Puzniak LA, 2014, DIAGN MICR INFEC DIS, V78, P295, DOI 10.1016/j.diagmicrobio.2013.11.001; Rajan S, 2012, CLEV CLIN J MED, V79, P57, DOI 10.3949/ccjm.79a.11044; Stevens DL, 2005, CLIN INFECT DIS, V41, P1373, DOI 10.1086/497143; Szczypinska E, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-696; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Zervos MJ, 2012, J CLIN MICROBIOL, V50, P238, DOI 10.1128/JCM.05817-11; Zilberberg MD, 2009, INFECT CONT HOSP EP, V30, P1203, DOI 10.1086/648083	24	15	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149960	10.1371/journal.pone.0149960	http://dx.doi.org/10.1371/journal.pone.0149960			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918456	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400062
J	Stone, HR; McGreevy, PD; Starling, MJ; Forkman, B				Stone, Holly R.; McGreevy, Paul D.; Starling, Melissa J.; Forkman, Bjorn			Associations between Domestic-Dog Morphology and Behaviour Scores in the Dog Mentality Assessment	PLOS ONE			English	Article							PERSONALITY-TRAITS; SKULL SHAPE; SEX; AGE	The domestic dog shows a wide range of morphologies, that humans have selected for in the process of creating unique breeds. Recent studies have revealed correlations between changes in morphology and behaviour as reported by owners. For example, as height and weight decrease, many undesirable behaviours (non-social fear, hyperactivity and attention seeking) become more apparent. The current study aimed to explore more of these correlations, but this time used reports from trained observers. Phenotypic measurements were recorded from a range of common dog breeds (n = 45) and included cephalic index (CI: the ratio of skull width to skull length), bodyweight, height and sex. These data were then correlated with results from the Dog Mentality Assessment (DMA), which involves trained observers scoring a dog's reaction to stimuli presented over 10 standardised subtests. Each subtest is designed to evoke a behavioural response. Backward elimination and weighted step-wise regression revealed that shorter dogs demonstrated more aggressive tendencies, reacting defensively toward both assistants dressed as ghosts (p = 0.045), and to a dummy (p = 0.008). Taller dogs were more affectionate when greeting and being handled by humans (p = 0.007, p = < 0.001, respectively). Taller dogs were also more cooperative (p = < 0.001), and playful (p = 0.001) with humans than shorter dogs. Heavier dogs were more inquisitive toward a dummy (p = 0.011), to the source of a metallic noise (p = 0.010) and to an assistant (p = 0.003). Heavier dogs were also more attentive to the ghosts (p = 0.013). In comparison, lighter dogs were cautious of a dummy (p = < 0.001) and fearful of the sound of a gunshot (p = < 0.001). Lighter dogs were also cautious of, and demonstrated prolonged fearfulness toward, the source of metallic noise (p = < 0.001, p = < 0.034, respectively). With a far larger sample and the advantage of third-party reporting (which overcomes potential owner bias), the current findings build on previous studies in this field, further supporting covariance between morphology and behaviour.	[Stone, Holly R.; McGreevy, Paul D.; Starling, Melissa J.] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Forkman, Bjorn] Univ Copenhagen, Copenhagen, Denmark	University of Sydney; University of Copenhagen	Stone, HR (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	hsto8847@uni.sydney.edu.au		McGreevy, Paul/0000-0001-7220-8378; Forkman, Bjorn/0000-0002-0153-6240	University of Sydney	University of Sydney(University of Sydney)	$200 funding from the University of Sydney was used to support statistical analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cafazzo S, 2010, BEHAV ECOL, V21, P443, DOI 10.1093/beheco/arq001; Drake AG, 2008, P ROY SOC B-BIOL SCI, V275, P71, DOI 10.1098/rspb.2007.1169; Evans H.E., 1993, MILLERS ANATOMY DOG; Fogle B, 1995, ENCY DOG; Franco Fernanda Catharino Menezes, 2013, Dental Press J Orthod, V18, P159; Gacsi M, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-31; Georgevsky D, 2014, J VET BEHAV, V9, P228, DOI 10.1016/j.jveb.2014.04.007; Martinez AG, 2011, J VET BEHAV, V6, P225, DOI 10.1016/j.jveb.2011.01.006; Goodloe L P, 1998, J Appl Anim Welf Sci, V1, P303, DOI 10.1207/s15327604jaws0104_1; Hecht J, 2015, ANTHROZOOS, V28, P153, DOI 10.2752/089279315X14129350722217; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Kleiman DG, 2011, BEHAV GENET, V41, P803, DOI 10.1007/s10519-011-9459-0; Ley JM, 2009, APPL ANIM BEHAV SCI, V116, P220, DOI 10.1016/j.applanim.2008.09.009; LOMBER SG, 2005, J VISION, V5, P49; McGreevy P, 2004, BRAIN BEHAV EVOLUT, V63, P13, DOI 10.1159/000073756; McGreevy PD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080529; McGreevy PD, 2012, J VET BEHAV, V7, P103, DOI 10.1016/j.jveb.2011.06.001; McGreevy PD, 2009, A MODERN DOGS LIFE; Overall KL, 2014, J VET BEHAV, V9, P1, DOI 10.1016/j.jveb.2013.12.001; Payne E, 2015, PSYCHOL RES BEHAV MA, V8, P71, DOI 10.2147/PRBM.S74972; Roberts T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011946; Rooney NJ, 2002, APPL ANIM BEHAV SCI, V75, P161, DOI 10.1016/S0168-1591(01)00192-7; Schoenebeck JJ, 2013, GENETICS, V193, P317, DOI 10.1534/genetics.112.145284; Schoenebeck JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002849; Scott JP., 1965, GENETICS SOCIAL BEHA; Serpell J.A., 2014, DOMESTIC DOG COGNITI, DOI [10.1007/978-3-642-53994-7_2, DOI 10.1007/978-3-642-53994-7_2]; Starling MJ, 2013, VET J, V197, P868, DOI 10.1016/j.tvjl.2013.05.019; Svartberg K, 2005, ANIM BEHAV, V69, P283, DOI 10.1016/j.anbehav.2004.04.011; Svartberg K, 2002, APPL ANIM BEHAV SCI, V79, P133, DOI 10.1016/S0168-1591(02)00121-1; Svartberg K, 2007, BEHAV BIOL DOGS, P190; The Kennel Club, 2014, HIST KENN CLUB; van Rooy Diane, 2014, Canine Genet Epidemiol, V1, P7, DOI 10.1186/2052-6687-1-7	32	32	32	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149403	10.1371/journal.pone.0149403	http://dx.doi.org/10.1371/journal.pone.0149403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919495	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400020
J	Sun, CY; Zhu, YM; Chu, CY; Yang, F; Liu, WY; Korenberg, JR; Hsu, EW				Sun, Chang-Yu; Zhu, Yue-min; Chu, Chun-yu; Yang, Feng; Liu, Wan-yu; Korenberg, Julie R.; Hsu, Edward W.			Assessment of the Characteristics of Orientation Distribution Functions in HARDI Using Morphological Metrics	PLOS ONE			English	Article							DIFFUSION; RESOLUTION; RECONSTRUCTION; MODEL; ARCHITECTURE	Orientation distribution functions (ODFs) are widely used to resolve fiber crossing problems in high angular resolution diffusion imaging (HARDI). The characteristics of the ODFs are often assessed using a visual criterion, although the use of objective criteria is also reported, which are directly borrowed from classic signal and image processing theory because they are intuitive and simple to compute. However, they are not always pertinent for the characterization of ODFs. We propose a more general paradigm for assessing the characteristics of ODFs. The idea consists in regarding an ODF as a three-dimensional (3D) point cloud, projecting the 3D point cloud onto an angle-distance map, constructing an angle-distance matrix, and calculating metrics such as length ratio, separability, and uncertainty. The results from both simulated and real data show that the proposed metrics allow for the assessment of the characteristics of ODFs in a quantitative and relatively complete manner.	[Sun, Chang-Yu; Zhu, Yue-min] Univ Lyon, CNRS UMR 5220, CREATIS, INSA Lyon,Inserm U1044, Villeurbanne, France; [Chu, Chun-yu; Liu, Wan-yu] Harbin Inst Technol, Harbin 150006, Peoples R China; [Yang, Feng] Beijing JiaoTong Univ, Sch Comp & Informat Technol, Beijing, Peoples R China; [Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Hsu, Edward W.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; Harbin Institute of Technology; Beijing Jiaotong University; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Liu, WY (corresponding author), Harbin Inst Technol, Harbin 150006, Peoples R China.	liu.wanyu@gmail.com	Sun, Changyu/N-8400-2019; Zhu, Yuemin/K-7292-2014	Sun, Changyu/0000-0001-8102-7130; Zhu, Yuemin/0000-0001-6814-1449	French ANR under MOSIFAH [ANR-13-MONU-0009-01]; National Basic Research Program of China [61301002]; NIMH/NICHD [5R01MH100635]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100635] Funding Source: NIH RePORTER	French ANR under MOSIFAH(French National Research Agency (ANR)); National Basic Research Program of China(National Basic Research Program of China); NIMH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the French ANR under MOSIFAH ANR-13-MONU-0009-01 to Yue-min Zhu, the National Basic Research Program of China under Grant No. 61301002 to Feng Yang, and the NIMH/NICHD grant #5R01MH100635 "Multiscale Genetic Connectivity of Primate Social Circuits" to Julie R Korenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Chu CY, 2015, PHYS MED BIOL, V60, P2339, DOI 10.1088/0031-9155/60/6/2339; Cohen-Adad J, 2011, J MAGN RESON IMAGING, V33, P1194, DOI 10.1002/jmri.22535; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Dolui S, 2011, I S BIOMED IMAGING, P1597, DOI 10.1109/ISBI.2011.5872708; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Jian B, 2007, NEUROIMAGE, V37, P164, DOI 10.1016/j.neuroimage.2007.03.074; Jian B, 2009, MATH VIS, P39, DOI 10.1007/978-3-540-88378-4_3; Kezele I, 2010, MED IMAGE ANAL, V14, P332, DOI 10.1016/j.media.2010.01.002; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P101, DOI 10.1002/cmr.a.20048; Michailovich O, 2011, IEEE T MED IMAGING, V30, P1100, DOI 10.1109/TMI.2011.2142189; Michailovich O, 2010, IEEE T IMAGE PROCESS, V19, P461, DOI 10.1109/TIP.2009.2035886; Ozarslan E, 2005, MAGN RESON MED, V53, P866, DOI 10.1002/mrm.20411; Ozarslan E, 2006, NEUROIMAGE, V31, P1086, DOI 10.1016/j.neuroimage.2006.01.024; Reisert M, 2011, IEEE T MED IMAGING, V30, P1274, DOI 10.1109/TMI.2011.2112769; Schwab Evan, 2013, Inf Process Med Imaging, V23, P705, DOI 10.1007/978-3-642-38868-2_59; Seunarine KK, 2007, IEEE I CONF COMP VIS, P2649; Sun CY, 2015, PHYS MED BIOL, V60, P8417, DOI 10.1088/0031-9155/60/21/8417; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Welsh CL, 2013, MAGN RESON MED, V70, P429, DOI 10.1002/mrm.24486; Zhan L, 2009, MED IMAGE COMPUT COM, P256	29	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150161	10.1371/journal.pone.0150161	http://dx.doi.org/10.1371/journal.pone.0150161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919477	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400093
J	Garrido-Sanz, D; Meier-Kolthoff, JP; Goker, M; Martin, M; Rivilla, R; Redondo-Nieto, M				Garrido-Sanz, Daniel; Meier-Kolthoff, Jan P.; Goeker, Markus; Martin, Marta; Rivilla, Rafael; Redondo-Nieto, Miguel			Genomic and Genetic Diversity within the Pseudomonas fluorescens Complex	PLOS ONE			English	Article							DNA-DNA HYBRIDIZATION; ESCHERICHIA-COLI; SYSTEMIC RESISTANCE; PHENAZINE COMPOUNDS; SPECIES DEFINITION; GENUS PSEUDOMONAS; PHENYLACETIC ACID; CHLORORAPHIS O6; INSECT TOXIN; PLANT	The Pseudomonas fluorescens complex includes Pseudomonas strains that have been taxonomically assigned to more than fifty different species, many of which have been described as plant growth-promoting rhizobacteria (PGPR) with potential applications in biocontrol and biofertilization. So far the phylogeny of this complex has been analyzed according to phenotypic traits, 16S rDNA, MLSA and inferred by whole-genome analysis. However, since most of the type strains have not been fully sequenced and new species are frequently described, correlation between taxonomy and phylogenomic analysis is missing. In recent years, the genomes of a large number of strains have been sequenced, showing important genomic heterogeneity and providing information suitable for genomic studies that are important to understand the genomic and genetic diversity shown by strains of this complex. Based on MLSA and several whole-genome sequence-based analyses of 93 sequenced strains, we have divided the P. fluorescens complex into eight phylogenomic groups that agree with previous works based on type strains. Digital DDH (dDDH) identified 69 species and 75 subspecies within the 93 genomes. The eight groups corresponded to clustering with a threshold of 31.8% dDDH, in full agreement with our MLSA. The Average Nucleotide Identity (ANI) approach showed inconsistencies regarding the assignment to species and to the eight groups. The small core genome of 1,334 CDSs and the large pangenome of 30,848 CDSs, show the large diversity and genetic heterogeneity of the P. fluorescens complex. However, a low number of strains were enough to explain most of the CDSs diversity at core and strain-specific genomic fractions. Finally, the identification and analysis of group-specific genome and the screening for distinctive characters revealed a phylogenomic distribution of traits among the groups that provided insights into biocontrol and bioremediation applications as well as their role as PGPR.	[Garrido-Sanz, Daniel; Martin, Marta; Rivilla, Rafael; Redondo-Nieto, Miguel] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, C Darwin 2, E-28049 Madrid, Spain; [Meier-Kolthoff, Jan P.; Goeker, Markus] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany	Autonomous University of Madrid; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ)	Redondo-Nieto, M (corresponding author), Univ Autonoma Madrid, Fac Ciencias, Dept Biol, C Darwin 2, E-28049 Madrid, Spain.	miguel.redondo@uam.es	Meier-Kolthoff, Jan P./GOP-1205-2022; martin, marta/H-2169-2015; Redondo-Nieto, Miguel/A-6169-2011; Rivilla, Rafael/A-1659-2008; Meier-Kolthoff, Jan Philipp/AAX-6799-2021; Garrido-Sanz, Daniel/W-7473-2019; Göker, Markus/AAX-6258-2021; Basanta, Marta Martin/AAI-5459-2020	martin, marta/0000-0003-2498-9768; Redondo-Nieto, Miguel/0000-0002-3361-520X; Rivilla, Rafael/0000-0003-0701-2939; Meier-Kolthoff, Jan Philipp/0000-0001-9105-9814; Göker, Markus/0000-0002-5144-6200; Basanta, Marta Martin/0000-0003-2498-9768; Garrido-Sanz, Daniel/0000-0003-3279-6421	Ministerio de Economia y Competitividad [BIO2012-31634]; Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain; FPU fellowship program from Ministerio de Educacion, Cultura y Deporte, Spain [FPU14/03965]; MINECO [BIO2012-31634]	Ministerio de Economia y Competitividad(Spanish Government); Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain; FPU fellowship program from Ministerio de Educacion, Cultura y Deporte, Spain; MINECO(Spanish Government)	Research was funded by: 1) Grant BIO2012-31634 from Ministerio de Economia y Competitividad to MM; 2) Research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain to RR; 3) DGS was granted by FPU fellowship program (FPU14/03965) from Ministerio de Educacion, Cultura y Deporte, Spain.; We thank Dr. Jacob Malone for the critical reading of the manuscript. Research was funded by Grant BIO2012-31634 from MINECO and the research program MICROAMBIENTE-CM from Comunidad de Madrid, Spain. DGS was granted by FPU fellowship program (FPU14/03965) from Ministerio de Educacion, Cultura y Deporte, Spain. We thank Centro de Computacion Cientifica from UAM for giving us access to their computational facilities.	Adekambi T, 2009, TRENDS MICROBIOL, V17, P37, DOI 10.1016/j.tim.2008.09.008; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Auch AF, 2010, STAND GENOMIC SCI, V2, P117, DOI 10.4056/sigs.531120; Bakker PAHM, 2007, PHYTOPATHOLOGY, V97, P239, DOI 10.1094/PHYTO-97-2-0239; Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Boucher Y, 2004, J BACTERIOL, V186, P3980, DOI 10.1128/JB.186.12.3980-3990.2004; Brodhagen M, 2005, APPL ENVIRON MICROB, V71, P6900, DOI 10.1128/AEM.71.11.6900-6909.2005; Budzikiewicz H, 2004, PROG CH ORG NAT PROD, V87, P81; Calderon CE, 2013, MOL PLANT MICROBE IN, V26, P554, DOI 10.1094/MPMI-01-13-0012-R; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cao L, 2013, J HAZARD MATER, V261, P246, DOI 10.1016/j.jhazmat.2013.07.019; Capdevila S, 2004, MICROBIOL-SGM, V150, P3889, DOI 10.1099/mic.0.27362-0; Chin-A-Woeng TFC, 2000, MOL PLANT MICROBE IN, V13, P1340, DOI 10.1094/MPMI.2000.13.12.1340; Chun J, 2014, INT J SYST EVOL MICR, V64, P316, DOI 10.1099/ijs.0.054171-0; COOK AM, 1984, J AGR FOOD CHEM, V32, P581, DOI 10.1021/jf00123a040; Cowan D, 1998, EXTREMOPHILES, V2, P207, DOI 10.1007/s007920050062; Dagan T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-118; Daubner SC, 2002, P NATL ACAD SCI USA, V99, P2702, DOI 10.1073/pnas.052527799; De Maayer P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-404; Dean CR, 1996, J BACTERIOL, V178, P5361, DOI 10.1128/jb.178.18.5361-5369.1996; Delaney SM, 2001, J BACTERIOL, V183, P318, DOI 10.1128/JB.183.1.318-327.2001; Deloger M, 2009, J BACTERIOL, V191, P91, DOI 10.1128/JB.01202-08; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Devi KK, 2009, FEMS MICROBIOL LETT, V300, P195, DOI 10.1111/j.1574-6968.2009.01782.x; Duan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058640; Ellis RJ, 2000, ENVIRON MICROBIOL, V2, P274, DOI 10.1046/j.1462-2920.2000.00102.x; Expert D, 1996, TRENDS MICROBIOL, V4, P232, DOI 10.1016/0966-842X(96)10038-X; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferrandez A, 1998, J BIOL CHEM, V273, P25974, DOI 10.1074/jbc.273.40.25974; FOX GE, 1992, INT J SYST BACTERIOL, V42, P166, DOI 10.1099/00207713-42-1-166; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Gevers D, 2005, NAT REV MICROBIOL, V3, P733, DOI 10.1038/nrmicro1236; Ghiglione JF, 2002, FEMS MICROBIOL ECOL, V39, P121, DOI 10.1111/j.1574-6941.2002.tb00913.x; Ghirardi S, 2012, MICROB ECOL, V64, P725, DOI 10.1007/s00248-012-0065-3; Goker M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006319; Gomila M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00214; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Gross H, 2009, NAT PROD REP, V26, P1408, DOI 10.1039/b817075b; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Han SH, 2006, MOL PLANT MICROBE IN, V19, P924, DOI 10.1094/MPMI-19-0924; Henz SR, 2005, BIOINFORMATICS, V21, P2329, DOI 10.1093/bioinformatics/bth324; Hider RC, 2010, NAT PROD REP, V27, P637, DOI 10.1039/b906679a; HOWELL CR, 1980, PHYTOPATHOLOGY, V70, P712, DOI 10.1094/Phyto-70-712; Ivanova EP, 2009, INT J SYST EVOL MICR, V59, P2476, DOI 10.1099/ijs.0.009654-0; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Jousset A, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00322-14; Kaas RS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-577; Kampfer P, 2012, ENVIRON MICROBIOL, V14, P291, DOI 10.1111/j.1462-2920.2011.02615.x; KANDA N, 1975, J ANTIBIOT, V28, P935, DOI 10.7164/antibiotics.28.935; Kang BR, 2006, CURR MICROBIOL, V52, P473, DOI 10.1007/s00284-005-0427-x; Kim YO, 2004, CURR MICROBIOL, V48, P312, DOI 10.1007/s00284-003-4193-3; KITAHARA T, 1975, J ANTIBIOT, V28, P943, DOI 10.7164/antibiotics.28.943; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuiper I, 2001, MOL PLANT MICROBE IN, V14, P1096, DOI 10.1094/MPMI.2001.14.9.1096; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; LESSIE TG, 1984, ANNU REV MICROBIOL, V38, P359, DOI 10.1146/annurev.mi.38.100184.002043; Li A, 2012, J BACTERIOL, V194, P5720, DOI 10.1128/JB.01376-12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li QA, 2010, J BIOTECHNOL, V149, P115, DOI 10.1016/j.jbiotec.2009.12.015; Loper JE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002784; Makarova KS, 2006, BIOINFORMATICS, V22, P2581, DOI 10.1093/bioinformatics/btl418; Marchi M, 2013, ENV MICROBIOL REP, V5, P393, DOI 10.1111/1758-2229.12048; MAURHOFER M, 1992, PHYTOPATHOLOGY, V82, P190, DOI 10.1094/Phyto-82-190; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Mazurier S, 2009, ISME J, V3, P977, DOI 10.1038/ismej.2009.33; Mehnaz S, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01108-13; Meier-Kolthoff JP, 2014, CONCURR COMP-PRACT E, V26, P1715, DOI 10.1002/cpe.3112; Meier-Kolthoff JP, 2014, INT J SYST EVOL MICR, V64, P352, DOI 10.1099/ijs.0.056994-0; Meier-Kolthoff JP, 2014, STAND GENOMIC SCI, V9, DOI [10.1186/1944-3277-9-2, 10.4056/sigs.4207886]; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Mirleau P, 2001, APPL ENVIRON MICROB, V67, P2627, DOI 10.1128/AEM.67.6.2627-2635.2001; Mulet M, 2012, SYST APPL MICROBIOL, V35, P455, DOI 10.1016/j.syapm.2012.08.007; Mulet M, 2010, ENVIRON MICROBIOL, V12, P1513, DOI 10.1111/j.1462-2920.2010.02181.x; Muriel C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132242; Nandi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123184; Nayyar H, 2005, BOT B ACAD SINICA, V46, P6; Nowak-Thompson B, 2003, J BACTERIOL, V185, P860, DOI 10.1128/JB.185.3.860-869.2003; Nowak-Thompson B, 1999, J BACTERIOL, V181, P2166, DOI 10.1128/JB.181.7.2166-2174.1999; Olcott MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012504; Olivera ER, 1998, P NATL ACAD SCI USA, V95, P6419, DOI 10.1073/pnas.95.11.6419; Owen JG, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-218; Palleroni NJ, 1984, BERGEYS MANUAL SYSTE, V2, P279; Parte AC, 2014, NUCLEIC ACIDS RES, V42, pD613, DOI 10.1093/nar/gkt1111; Patil Kaustubh R, 2013, Genome Biol Evol, V5, P1470, DOI 10.1093/gbe/evt105; Pechy-Tarr M, 2008, ENVIRON MICROBIOL, V10, P2368, DOI 10.1111/j.1462-2920.2008.01662.x; Pechy-Tarr M, 2013, ENVIRON MICROBIOL, V15, P736, DOI 10.1111/1462-2920.12050; PHILIPPOT L, 1995, APPL ENVIRON MICROB, V61, P1426, DOI 10.1128/AEM.61.4.1426-1430.1995; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Prosen H, 2005, ENVIRON POLLUT, V133, P517, DOI 10.1016/j.envpol.2004.06.015; R Core Team, 2021, R LANGUAGE ENV STAT; Raaijmakers JM, 2002, ANTON LEEUW INT J G, V81, P537, DOI 10.1023/A:1020501420831; Raaijmakers JM, 2001, APPL ENVIRON MICROB, V67, P2545, DOI 10.1128/AEM.67.6.2545-2554.2001; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ramette A, 2011, SYST APPL MICROBIOL, V34, P180, DOI 10.1016/j.syapm.2010.10.005; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; Redondo-Nieto M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-54; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Roy P, 2005, PLANT SCI, V168, P583, DOI 10.1016/j.plantsci.2004.08.014; Sagarkar S, 2014, J ENVIRON MANAGE, V139, P208, DOI 10.1016/j.jenvman.2014.02.016; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samolski I, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-217; Seaton S. C., 2014, GENOMICS PLANT ASS B, P99; SHANAHAN P, 1992, APPL ENVIRON MICROB, V58, P353, DOI 10.1128/AEM.58.1.353-358.1992; Sheets TJ, 1963, WEED SCI SOC AM, V11, P6; Shen WY, 2000, PLANT PHYSIOL, V124, P431, DOI 10.1104/pp.124.1.431; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silby MW, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r51; Simon S, 2011, PLANT SCI, V180, P454, DOI 10.1016/j.plantsci.2010.12.007; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI [10.1099/ijs.0.02360-0, 10.1099/00207713-52-3-1043]; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TAKEDA R, 1958, J AM CHEM SOC, V80, P4749, DOI 10.1021/ja01550a093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tayeb LA, 2005, RES MICROBIOL, V156, P763, DOI 10.1016/j.resmic.2005.02.009; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Van Wees SCM, 2008, CURR OPIN PLANT BIOL, V11, P443, DOI 10.1016/j.pbi.2008.05.005; Walsh UF, 2001, CURR OPIN BIOTECH, V12, P289, DOI 10.1016/S0958-1669(00)00212-3; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Wasi S, 2013, ENVIRON MONIT ASSESS, V185, P8147, DOI 10.1007/s10661-013-3163-x; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463, DOI 10.1099/00207713-37-4-463; Weller DM, 2007, PLANT BIOLOGY, V9, P4, DOI 10.1055/s-2006-924473; Wong BT, 2014, J BIOSCI BIOENG, V117, P71, DOI 10.1016/j.jbiosc.2013.06.006; Wu DQ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-438; Wu XA, 2011, FEMS MICROBIOL REV, V35, P299, DOI 10.1111/j.1574-6976.2010.00249.x; Yamamoto S, 2000, MICROBIOL-SGM, V146, P2385, DOI 10.1099/00221287-146-10-2385; Yi Huiguang, 2013, Nucleic Acids Res, V41, pe75, DOI 10.1093/nar/gkt003; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Zhang Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00110; Zhao LF, 2013, BRAZ J MICROBIOL, V44, P629, DOI 10.1590/S1517-83822013000200043; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	136	132	133	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150183	10.1371/journal.pone.0150183	http://dx.doi.org/10.1371/journal.pone.0150183			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915094	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700059
J	Harte, SE; Meyers, JB; Donahue, RR; Taylor, BK; Morrow, TJ				Harte, Steven E.; Meyers, Jessica B.; Donahue, Renee R.; Taylor, Bradley K.; Morrow, Thomas J.			Mechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior	PLOS ONE			English	Article							STRETCHED ATTEND POSTURE; EMOTIONAL DECISION-MAKING; NEUROPATHIC PAIN; RAT MODEL; RECEPTOR ANTAGONIST; NERVE INJURY; PHARMACOLOGICAL CHARACTERIZATION; ESCAPE/AVOIDANCE BEHAVIOR; PERIPHERAL MONONEUROPATHY; OBSTRUCTION METHOD	A new operant test for preclinical pain research, termed the Mechanical Conflict System (MCS), is presented. Rats were given a choice either to remain in a brightly lit compartment or to escape to a dark compartment by crossing an array of height-adjustable nociceptive probes. Latency to escape the light compartment was evaluated with varying probe heights (0,.5, 1, 2, 3, and 4 mm above compartment floor) in rats with neuropathic pain induced by constriction nerve injury (CCI) and in naive control rats. Escape responses in CCI rats were assessed following intraperitoneal administration of pregabalin (10 and 30 mg/kg), morphine (2.5 and 5 mg/kg), and the tachykinin NK1 receptor antagonist, RP 67580 (1 and 10 mg/kg). Results indicate that escape latency increased as a function of probe height in both naive and CCI rats. Pregabalin (10 and 30 mg/kg) and morphine (5 mg/kg), but not RP 67580, decreased latency to escape in CCI rats suggesting an antinociceptive effect. In contrast, morphine (10 mg/kg) but not pregabalin (30 mg/kg) increased escape latency in naive rats suggesting a possible anxiolytic action of morphine in response to light-induced fear. No order effects following multiple test sessions were observed. We conclude that the MCS is a valid method to assess behavioral signs of affective pain in rodents.	[Harte, Steven E.] Univ Michigan, Dept Anesthesiol, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48109 USA; [Harte, Steven E.] Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA; [Meyers, Jessica B.; Morrow, Thomas J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Harte, Steven E.; Meyers, Jessica B.; Morrow, Thomas J.] Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA; [Donahue, Renee R.; Taylor, Bradley K.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Taylor, Bradley K.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Kentucky; University of Kentucky	Harte, SE (corresponding author), Univ Michigan, Dept Anesthesiol, Chron Pain & Fatigue Res Ctr, Ann Arbor, MI 48109 USA.; Harte, SE (corresponding author), Univ Michigan, Dept Internal Med, Div Rheumatol, Ann Arbor, MI 48109 USA.; Harte, SE (corresponding author), Vet Affairs Ann Arbor Healthcare Syst, Neurol Serv, Ann Arbor, MI USA.	seharte@med.umich.edu	Harte, Steven/P-4840-2019; Donahue, Renee/AAI-3512-2020	Donahue, Renee/0000-0002-3344-5650	Department of Veterans Affairs; National Institutes of Health [R01 NS 046406, R01NS6236, R01NS45954, R01DA37621]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045954, R01NS046406, R01NS062306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA037621] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Department of Veterans Affairs and the National Institutes of Health, including R01 NS 046406 to TJM and R01NS6236, R01NS45954, and R01DA37621 to BKT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anseloni VCZ, 1999, EXP BRAIN RES, V129, P260, DOI 10.1007/s002210050896; Apkarian AV, 2004, PAIN, V108, P129, DOI 10.1016/j.pain.2003.12.015; Baastrup C, 2011, BRAIN RES, V1370, P129, DOI 10.1016/j.brainres.2010.11.008; Baliki M, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-18; Bardin L, 2010, NEUROSCI RES, V66, P135, DOI 10.1016/j.neures.2009.10.009; BEAUJOUAN JC, 1993, BRIT J PHARMACOL, V108, P793, DOI 10.1111/j.1476-5381.1993.tb12880.x; Bender G, 2010, J PHARMACOL EXP THER, V334, P599, DOI 10.1124/jpet.110.166074; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BORSZCZ GS, 1992, PHYSIOL BEHAV, V52, P1055, DOI 10.1016/0031-9384(92)90459-F; Boyce S, 2000, P 9 WORLD C PAIN PRO, V16; Campbell BA, 1969, PUNISHMENT AND AVERS; Chapman V, 1996, J NEUROPHYSIOL, V76, P1817, DOI 10.1152/jn.1996.76.3.1817; Cobos EJ, 2012, PAIN, V153, P876, DOI 10.1016/j.pain.2012.01.016; Coudore-Civiale MA, 2000, EUR J PHARMACOL, V401, P47, DOI 10.1016/S0014-2999(00)00314-9; COURTEIX C, 1993, EUR J PHARMACOL, V241, P267, DOI 10.1016/0014-2999(93)90213-2; Donahue RR, 2012, SOC NEUR ABST, V575, P15; Dooley DJ, 2007, TRENDS PHARMACOL SCI, V28, P75, DOI 10.1016/j.tips.2006.12.006; Dworkin RH, 2003, NEUROLOGY, V60, P1274, DOI 10.1212/01.WNL.0000055433.55136.55; Field MJ, 2001, BRIT J PHARMACOL, V132, P1, DOI 10.1038/sj.bjp.0703794; FONG TM, 1992, J BIOL CHEM, V267, P25664; FRANKLIN KBJ, 1989, NEUROMETHODS, V13, P145, DOI DOI 10.1385/0-89603-129-2:145; Freeman GL, 1939, AM J PSYCHOL, V52, P629, DOI 10.2307/1416477; Fuchs PN, 2012, J INTEGR NEUROSCI, V11, P61, DOI 10.1142/S0219635212500045; Galan-Arriero I, 2015, NEUROSCI LETT, V604, P69, DOI 10.1016/j.neulet.2015.07.044; GARRET C, 1991, P NATL ACAD SCI USA, V88, P10208, DOI 10.1073/pnas.88.22.10208; Goldstein DJ, 2001, CLIN NEUROPHARMACOL, V24, P16, DOI 10.1097/00002826-200101000-00004; Gregoire S, 2012, PAIN, V153, P1657, DOI 10.1016/j.pain.2012.04.023; Gregory NS, 2013, J PAIN, V14, P1255, DOI 10.1016/j.jpain.2013.06.008; Grewal SS, 1997, PSYCHOPHARMACOLOGY, V133, P29, DOI 10.1007/s002130050367; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Gunduz O, 2011, NEUROL SCI, V32, P1135, DOI 10.1007/s10072-011-0761-7; Hama AT, 2005, PHARMACOL BIOCHEM BE, V81, P170, DOI 10.1016/j.pbb.2005.03.009; Harte SE, 2010, J PAIN, V11, pS28; Hebert MA, 1999, PHYSIOL BEHAV, V67, P99, DOI 10.1016/S0031-9384(99)00042-6; Hill R, 2000, TRENDS PHARMACOL SCI, V21, P244, DOI 10.1016/S0165-6147(00)01502-9; IRWIN S, 1951, J PHARMACOL EXP THER, V101, P132; Jabakhanji R, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-1; KAESERMANN HP, 1986, PSYCHOPHARMACOLOGY, V89, P31; KIM SH, 1993, PAIN, V55, P85, DOI 10.1016/0304-3959(93)90187-T; King T, 2009, NAT NEUROSCI, V12, P1364, DOI 10.1038/nn.2407; Kitanaka J, 2015, J EXP NEUROSCI, V9, P27, DOI 10.4137/JEN.S25057; LaBuda CJ, 2000, EXP NEUROL, V163, P490, DOI 10.1006/exnr.2000.7395; LaBuda CJ, 2000, NEUROSCI LETT, V290, P137, DOI 10.1016/S0304-3940(00)01340-9; LAIRD JMA, 1993, BRIT J PHARMACOL, V109, P713, DOI 10.1111/j.1476-5381.1993.tb13632.x; Lau D, 2012, NEUROREHAB NEURAL RE, V26, P889, DOI 10.1177/1545968312445637; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Ma QP, 1997, EUR J PHARMACOL, V322, P165, DOI 10.1016/S0014-2999(97)00014-9; Ma QP, 1998, PAIN, V77, P49, DOI 10.1016/S0304-3959(98)00081-5; Mao JR, 2012, TRENDS PHARMACOL SCI, V33, P568, DOI 10.1016/j.tips.2012.08.001; Mauderli AP, 2000, J NEUROSCI METH, V97, P19, DOI 10.1016/S0165-0270(00)00160-6; Max MB, 2008, NAT REV DRUG DISCOV, V7, P647, DOI 10.1038/nrd2595; MELZACK R, 1968, P423; Miyazaki R, 2012, ANESTH ANALG, V115, P182, DOI 10.1213/ANE.0b013e31824f94ca; Mogil JS, 2009, NAT REV NEUROSCI, V10, P283, DOI 10.1038/nrn2606; Mogil JS, 2004, PAIN, V112, P12, DOI 10.1016/j.pain.2004.09.028; Moore RA, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007076.pub2; MORGAN MM, 1992, BRAIN RES, V582, P154, DOI 10.1016/0006-8993(92)90331-3; Moss FA, 1924, J EXP PSYCHOL, V7, P165, DOI 10.1037/h0070966; NA HS, 1993, J NEUROPHYSIOL, V70, P522, DOI 10.1152/jn.1993.70.2.522; Negus SS, 2006, J PHARMACOL EXP THER, V319, P507, DOI 10.1124/jpet.106.106377; Neubert JK, 2005, PAIN, V116, P386, DOI 10.1016/j.pain.2005.05.011; NIST/SEMATECH, 2003, E HDB STAT METH; Nolan TA, 2011, BEHAV BRAIN RES, V217, P477, DOI 10.1016/j.bbr.2010.10.022; Pais-Vieira M, 2009, NEUROSCIENCE, V161, P671, DOI 10.1016/j.neuroscience.2009.04.011; PAPP M, 1987, BEHAV BRAIN RES, V23, P221, DOI 10.1016/0166-4328(87)90022-2; Patti CL, 2006, PSYCHOPHARMACOLOGY, V184, P1, DOI 10.1007/s00213-005-0238-6; Paulson PE, 2002, PAIN, V95, P31, DOI 10.1016/S0304-3959(01)00370-0; POLLARD GT, 1988, PSYCHOPHARMACOLOGY, V94, P433; Roeska K, 2008, PAIN, V139, P349, DOI 10.1016/j.pain.2008.05.003; Roeska K, 2009, NEUROSCI LETT, V464, P160, DOI 10.1016/j.neulet.2009.08.031; RUPNIAK NMJ, 1993, BRIT J PHARMACOL, V110, P1607, DOI 10.1111/j.1476-5381.1993.tb14008.x; SHEEN K, 1993, BRAIN RES, V610, P62, DOI 10.1016/0006-8993(93)91217-G; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Stevenson GW, 2009, LIFE SCI, V85, P309, DOI 10.1016/j.lfs.2009.06.006; Vierck CJ, 2008, PAIN, V135, P7, DOI 10.1016/j.pain.2007.12.008; Vierck CJ, 2015, NEUROSCI BIOBEHAV R, V51, P223, DOI 10.1016/j.neubiorev.2015.01.022; VOGEL JR, 1971, PSYCHOPHARMACOLOGIA, V21, P1, DOI 10.1007/BF00403989; Wallace VCJ, 2008, NEUROSCI LETT, V448, P153, DOI 10.1016/j.neulet.2008.10.005; Walteros C, 2011, J PSYCHOSOM RES, V70, P294, DOI 10.1016/j.jpsychores.2010.07.013; Warden CJ, 1928, J COMP PSYCHOL, V8, P325, DOI 10.1037/h0071919; Warner LH, 1928, J COMP PSYCHOL, V8, P273, DOI 10.1037/h0074197; Weiner B., 1992, HUMAN MOTIVATION MET; Whiteside GT, 2008, NEUROPHARMACOLOGY, V54, P767, DOI 10.1016/j.neuropharm.2008.01.001; Yoshimura M, 2006, NEUROSCI RES, V56, P21, DOI 10.1016/j.neures.2006.04.015; Zhou S, 2012, NOVEL OPERANT METHOD, V80, P3; Zohar J, 2008, EUR NEUROPSYCHOPHARM, V18, P653, DOI 10.1016/j.euroneuro.2008.04.009	86	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150164	10.1371/journal.pone.0150164	http://dx.doi.org/10.1371/journal.pone.0150164			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915030	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700057
J	Shimoni, S; Bar, I; Meledin, V; Derazne, E; Gandelman, G; George, J				Shimoni, Sara; Bar, Iris; Meledin, Valery; Derazne, Estela; Gandelman, Gera; George, Jacob			Circulating Endothelial Progenitor Cells and Clinical Outcome in Patients with Aortic Stenosis	PLOS ONE			English	Article							VALVULAR HEART-DISEASE; STANDARDS COMMITTEE; VALVE STENOSIS; EARLY LESION; TASK-FORCE; RECOMMENDATIONS; NUMBER; ECHOCARDIOGRAPHY; QUANTIFICATION	Background Aortic stenosis (AS) is the most common valvular disease. Endothelial progenitor cells (EPCs) have a role in the repair of endothelial surfaces after injury. Reduced numbers of EPCs are associated with endothelial dysfunction and adverse clinical events, suggesting that endothelial injury in the absence of sufficient repair by circulating EPCs promotes the progression of vascular and possibly valvular disorders. The aim of this study was to assess EPC number in patients with AS and to study the predictive value of their circulating levels on prognosis. Methods The number of EPCs was determined by flow cytometry in 241 patients with AS and a control group of 73 pts. Thirty-eight, 52 and 151 patients had mild, moderate and severe AS, respectively. We evaluated the association between baseline levels of EPCs and death from cardiovascular causes during follow up. Results EPC level was significantly higher in patients with AS compared to the control group (p = 0.017). Two hundred and three patients with moderate and severe AS were followed for a median of 20 months. One hundred and twenty patients underwent an intervention. Thirty four patients died during follow up, 20 patients died due to cardiac causes. Advanced age, the presence of coronary artery disease, AS severity index (combination of high NYHA class, smaller aortic valve area and elevated pulmonary artery pressure) and a low EPC number were predictors of cardiac death in the univariate analysis. Multivariate logistic regression model identified low EPCs number and AS severity index as associated with cardiac death during follow up (p = 0.026 and p = 0.037, respectively). Conclusions EPC number is increased in patients with AS. However, in patients with moderate or severe AS a relatively low number of EPCs is associated with cardiac death at follow up. These results may help to identify AS patients at increased cardiovascular risk.	[Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Kaplan Med Ctr, Inst Heart, Rehovot, Israel; [Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Hebrew Univ Jerusalem, Jerusalem, Israel; [Shimoni, Sara; Bar, Iris; Meledin, Valery; Gandelman, Gera; George, Jacob] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Derazne, Estela] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine	Shimoni, S (corresponding author), Kaplan Med Ctr, Inst Heart, Rehovot, Israel.; Shimoni, S (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.; Shimoni, S (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel.	Sara_s@clalit.org.il			Clalit Research Institute of Clalit Health Services, Israel	Clalit Research Institute of Clalit Health Services, Israel	The study was supported by the Clalit Research Institute of Clalit Health Services, Israel. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner H, 2009, EUR J ECHOCARDIOGR, V10, P1, DOI 10.1093/ejechocard/jen303; Bhattacharyya S, 2012, EUR HEART J, V33, P2377, DOI 10.1093/eurheartj/ehs190; Davies PF, 2004, ARTERIOSCL THROM VAS, V24, P1331, DOI 10.1161/01.ATV.0000130659.89433.c1; Deanfield JE, 2007, CIRCULATION, V115, P1285, DOI 10.1161/CIRCULATIONAHA.106.652859; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Freeman RV, 2005, CIRCULATION, V111, P3316, DOI 10.1161/CIRCULATIONAHA.104.486738; George J, 2006, TISSUE ENG, V12, P331, DOI 10.1089/ten.2006.12.331; Gossl M, 2012, J AM COLL CARDIOL, V60, P1945, DOI 10.1016/j.jacc.2012.07.042; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kapadia SR, 2000, J AM COLL CARDIOL, V36, P208, DOI 10.1016/S0735-1097(00)00721-X; Lamirault G, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt382; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Massa M, 2005, BLOOD, V105, P199, DOI 10.1182/blood-2004-05-1831; Matsumoto Y, 2009, EUR HEART J, V30, P346, DOI 10.1093/eurheartj/ehn501; Mazzone A, 2004, J AM COLL CARDIOL, V43, P1670, DOI 10.1016/j.jacc.2003.12.041; Michowitz Y, 2007, HEART, V93, P1046, DOI 10.1136/hrt.2006.102657; Mirzaie Masoud, 2002, Ann Thorac Cardiovasc Surg, V8, P24; OBrien KD, 1996, ARTERIOSCL THROM VAS, V16, P523, DOI 10.1161/01.ATV.16.4.523; OTTO CM, 1994, CIRCULATION, V90, P844, DOI 10.1161/01.CIR.90.2.844; Quinones MA, 2002, J AM SOC ECHOCARDIOG, V15, P167, DOI 10.1067/mje.2002.120202; Redondo S, 2012, J CARDIOTHORAC SURG, V7, DOI 10.1186/1749-8090-7-2; Skowasch D, 2005, EUR HEART J, V26, P2576, DOI 10.1093/eurheartj/ehi458; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Stewart BF, 1997, J AM COLL CARDIOL, V29, P630, DOI 10.1016/S0735-1097(96)00563-3; Thomas HE, 2008, ARTERIOSCL THROM VAS, V28, pE21, DOI 10.1161/ATVBAHA.107.160317; Valgimigli M, 2004, CIRCULATION, V110, P1209, DOI 10.1161/01.CIR.0000136813.89036.21; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Yu ZQ, 2011, J PHARMACOL EXP THER, V337, P16, DOI 10.1124/jpet.110.177915	31	9	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148766	10.1371/journal.pone.0148766	http://dx.doi.org/10.1371/journal.pone.0148766			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913741	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700009
J	Ambrosio, LJ; Baeza, JA				Ambrosio, Louis J.; Antonio Baeza, J.			Territoriality and Conflict Avoidance Explain Asociality (Solitariness) of the Endosymbiotic Pea Crab Tunicotheres moseri	PLOS ONE			English	Article							PAGURUS-POLLICARIS SAY; IN-HOUSE CRICKETS; SEA-ANEMONE; LARVAL SETTLEMENT; HERMIT-CRAB; COMPETITION; BEHAVIOR; CRUSTACEA; SHRIMP; BRACHYURA	Host monopolization theory predicts symbiotic organisms inhabiting morphologically simple, relatively small and scarce hosts to live solitarily as a result of territorial behaviors. We tested this prediction with Tunicotheres moseri, an endosymbiotic crab dwelling in the atrial chamber of the morphologically simple, small, and relatively scarce ascidian Styela plicata. As predicted, natural populations of T. moseri inhabit ascidian hosts solitarily with greater frequency than expected by chance alone. Furthermore, laboratory experiments demonstrated that intruder crabs take significantly longer to colonize previously infected compared to uninfected hosts, indicating as expected, that resident crabs exhibit monopolization behaviors. While territoriality does occur, agonistic behaviors employed by T. moseri do not mirror the overt behaviors commonly reported for other territorial crustaceans. Documented double and triple cohabitations in the field coupled with laboratory observations demonstrating the almost invariable success of intruder crabs colonizing occupied hosts, suggest that territoriality is ineffective in completely explaining the solitary social habit of this species. Additional experiments showed that T. moseri juveniles and adults, when searching for ascidians use chemical cues to avoid hosts occupied by conspecifics. This conspecific avoidance behavior reported herein is a novel strategy most likely employed to preemptively resolve costly territorial conflicts. In general, this study supports predictions central to host monopolization theory, but also implies that alternative behavioral strategies (i.e., conflict avoidance) may be more important than originally thought in explaining the host use pattern of symbiotic organisms.	[Ambrosio, Louis J.; Antonio Baeza, J.] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Antonio Baeza, J.] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL USA; [Antonio Baeza, J.] Univ Catolica Norte, Fac Ciencias Mar, Dept Biol Marina, Larrondo, Coquimbo, Chile	Clemson University; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidad Catolica del Norte	Ambrosio, LJ (corresponding author), Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA.	ljambro@g.clemson.edu		Baeza, Juan Antonio/0000-0002-2573-6773				ABELE LG, 1976, SCIENCE, V192, P461, DOI 10.1126/science.192.4238.461; ADAMS ES, 1990, ANIM BEHAV, V39, P706, DOI 10.1016/S0003-3472(05)80382-3; Allison P. D., 1995, SURVIVAL ANAL USING; Ambrosio LJ, 2011, SYMBIOSIS, V53, P53, DOI 10.1007/s13199-011-0112-8; Anderson JA, 2010, J EXP MAR BIOL ECOL, V384, P87, DOI 10.1016/j.jembe.2009.12.014; Baeza JA, 2011, INVERTEBR BIOL, V130, P351, DOI 10.1111/j.1744-7410.2011.00244.x; Arnott G, 2008, ANIM BEHAV, V76, P529, DOI 10.1016/j.anbehav.2008.04.019; Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; BACH CE, 1980, CRUSTACEANA, V38, P104, DOI 10.1163/156854080X00508; Baeza JA, 2008, MAR BIOL, V153, P387, DOI 10.1007/s00227-007-0815-9; Baeza JA, 2012, BIOL J LINN SOC, V105, P548, DOI 10.1111/j.1095-8312.2011.01803.x; Baeza JA, 2003, MAR BIOL, V142, P93, DOI 10.1007/s00227-002-0927-1; Baeza JA, 2002, MAR FRESHW BEHAV PHY, V35, P189, DOI 10.1080/1023624021000003817; Bolanos J, 2004, SCI MAR, V68, P373, DOI 10.3989/scimar.2004.68n3373; Both C, 2003, AM NAT, V161, P326, DOI 10.1086/346098; Brante A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067050; BROOKS WR, 1989, J EXP MAR BIOL ECOL, V132, P109, DOI 10.1016/0022-0981(89)90218-9; BROOKS WR, 1985, J EXP MAR BIOL ECOL, V87, P111, DOI 10.1016/0022-0981(85)90084-X; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown WD, 2007, ETHOLOGY, V113, P457, DOI 10.1111/j.1439-0310.2007.01357.x; Brown WD, 2006, ANIM BEHAV, V72, P225, DOI 10.1016/j.anbehav.2006.01.012; Calado R, 2007, SCI MAR, V71, P287, DOI 10.3989/scimar.2007.71n2287; CALDWELL RL, 1979, BEHAVIOUR, V69, P254, DOI 10.1163/156853979X00502; Chapman MR, 1996, ANIM BEHAV, V52, P83, DOI 10.1006/anbe.1996.0154; CROWL TA, 1994, J N AM BENTHOL SOC, V13, P291, DOI 10.2307/1467247; CROWLEY PH, 1988, ANIM BEHAV, V36, P1496, DOI 10.1016/S0003-3472(88)80220-3; De Bruyn C, 2009, MAR ECOL PROG SER, V375, P173, DOI 10.3354/meps07733; DIESEL R, 1988, J CRUSTACEAN BIOL, V8, P63, DOI 10.2307/1548431; DUFFY JE, 1992, MAR ECOL PROG SER, V90, P127, DOI 10.3354/meps090127; Duffy JE, 1996, J CRUSTACEAN BIOL, V16, P564, DOI 10.2307/1548748; Elbourne PD, 2010, J EXP MAR BIOL ECOL, V392, P99, DOI 10.1016/j.jembe.2010.04.013; Elliot JM, 1971, SCI PUBLICATIONS, V25; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Figler MH, 2005, MAR FRESHW BEHAV PHY, V38, P237, DOI 10.1080/10236240500376477; Franke HD, 1998, J EXP MAR BIOL ECOL, V227, P1, DOI 10.1016/S0022-0981(97)00253-0; Gandy R, 2015, DIS AQUAT ORGAN, V113, P235, DOI 10.3354/dao02841; Goldstein JS, 2009, LIMNOL OCEANOGR, V54, P1669, DOI 10.4319/lo.2009.54.5.1669; GRAND TC, 1994, ANIM BEHAV, V47, P91, DOI 10.1006/anbe.1994.1010; GRANT JWA, 1993, MAR BEHAV PHYSIOL, V23, P137, DOI 10.1080/10236249309378862; GRANT JWA, 1993, BEHAV ECOL, V4, P293, DOI 10.1093/beheco/4.4.293; GROSBERG RK, 1981, NATURE, V290, P700, DOI 10.1038/290700a0; Hack MA, 1997, BEHAV ECOL, V8, P28, DOI 10.1093/beheco/8.1.28; HARRIGAN P, 1989, B MAR SCI, V44, P65; Henkel TP, 2005, MAR BIOL, V146, P301, DOI 10.1007/s00227-004-1448-x; Hernandez JE, 2012, BIOL BULL-US, V223, P278, DOI 10.1086/BBLv223n3p278; HUBER ME, 1986, MAR ECOL PROG SER, V30, P21, DOI 10.3354/meps030021; HUBER ME, 1987, J CRUSTACEAN BIOL, V7, P238, DOI 10.2307/1548604; JANSSEN A, 1995, BEHAV ECOL SOCIOBIOL, V36, P229, DOI 10.1007/s002650050144; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Kobak J, 2015, J ZOOL, V297, P66, DOI 10.1111/jzo.12252; Langkilde T, 2004, OECOLOGIA, V140, P684, DOI 10.1007/s00442-004-1640-1; Martinez, 1976, AN MUS HIST NAT VALP, V9, P45; McDonald J.H., 2014, HDB BIOL STAT; Ocampo EH, 2012, J EXP MAR BIOL ECOL, V429, P36, DOI 10.1016/j.jembe.2012.06.009; PALOMBIT RA, 1993, AM J PRIMATOL, V31, P311, DOI 10.1002/ajp.1350310407; Payne RJH, 1996, J THEOR BIOL, V183, P185, DOI 10.1006/jtbi.1996.0212; PETERSEN JH, 1984, J EXP MAR BIOL ECOL, V82, P147, DOI 10.1016/0022-0981(84)90100-X; RANTA E, 1992, ETHOLOGY, V92, P217; Rathbun MJ, 1918, B US NATN MUS, V97, p[1, 1], DOI DOI 10.5479/SI.03629236.97.I; SAS Institute Inc, 2015, JMP 12, V12; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; STEBBINS TD, 1989, MAR BIOL, V101, P329, DOI 10.1007/BF00428129; STONER AW, 1984, COPEIA, P174, DOI 10.2307/1445050; SWEATMAN H, 1988, J EXP MAR BIOL ECOL, V124, P163, DOI 10.1016/0022-0981(88)90170-0; TELFORD M, 1982, B MAR SCI, V32, P584; Thiel M, 2003, J ZOOL, V261, P353, DOI 10.1017/S0952836903004333; Thiel M, 2003, B MAR SCI, V72, P89; Thiel M, 2001, SYMBIOSIS, V30, P163; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; Weiss I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3767; WELLS HARRY W., 1961, BULL MAR SCI GULF AND CARIBBEAN, V11, P267; WRIGHT HO, 1968, AM ZOOL, V8, P655; YOUNG CM, 1981, INT J INVER REP DEV, V3, P221; Zamzow JP, 2010, MAR ECOL PROG SER, V400, P155, DOI 10.3354/meps08399; Zar J.H., 2009, BIOSTATISTICAL ANAL	75	21	22	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148285	10.1371/journal.pone.0148285	http://dx.doi.org/10.1371/journal.pone.0148285			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910474	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700007
J	Singh, P; Irwin, DM				Singh, Parmveer; Irwin, David M.			Contrasting Patterns in the Evolution of Vertebrate MLX Interacting Protein (MLXIP) and MLX Interacting Protein-Like (MLXIPL) Genes	PLOS ONE			English	Article							WILLIAMS-BEUREN-SYNDROME; ELEMENT-BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; GLUCOSE-METABOLISM; ENERGY-METABOLISM; WEB SERVER; CHREBP; GLUCOKINASE; ALIGNMENTS; WBSCR14	ChREBP and MondoA are glucose-sensitive transcription factors that regulate aspects of energy metabolism. Here we performed a phylogenomic analysis of Mlxip (encoding MondoA) and Mlxipl (encoding ChREBP) genes across vertebrates. Analysis of extant Mlxip and Mlxipl genes suggests that the most recent common ancestor of these genes was composed of 17 coding exons. Single copy genes encoding both ChREBP and MondoA, along with their interacting partner Mlx, were found in diverse vertebrate genomes, including fish that have experienced a genome duplication. This observation suggests that a single Mlx gene has been retained to maintain coordinate regulation of ChREBP and MondoA. The ChREBP-beta isoform, the more potent and constitutively active isoform, appeared with the evolution of tetrapods and is absent from the Mlxipl genes of fish. Evaluation of the conservation of ChREBP and MondoA sequences demonstrate that MondoA is better conserved and potentially mediates more ancient function in glucose metabolism.	[Singh, Parmveer; Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 1L5, Canada	University of Toronto; University of Toronto	Irwin, DM (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Irwin, DM (corresponding author), Univ Toronto, Banting & Best Diabet Ctr, 100 Coll St, Toronto, ON M5G 1L5, Canada.	david.irwin@utoronto.ca		Irwin, David/0000-0001-6131-4933	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research [CCI - 109605]; Banting and Best Diabetes Summer Studentship	National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research; Banting and Best Diabetes Summer Studentship	This work was funded by a National Science Foundation of China (NSFC) - Canadian Institutes of Health Research (CIHR) China - Canada Joint Health Research Initiative grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html), grant number CCI - 109605 to DMI. Parmveer Singh was supported by a Banting and Best Diabetes Summer Studentship (www.bbdc.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius L, 2008, BIOCHEM J, V414, P1, DOI 10.1042/BJ20080595; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Billin AN, 1999, J BIOL CHEM, V274, P36344, DOI 10.1074/jbc.274.51.36344; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; de Luis O, 2000, EUR J HUM GENET, V8, P215, DOI 10.1038/sj.ejhg.5200435; Eilers AL, 2002, MOL CELL BIOL, V22, P8514, DOI 10.1128/MCB.22.24.8514-8526.2002; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Gertz EM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-41; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harrow J, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-201; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hirota K, 2010, J RECEPT SIG TRANSD, V30, P403, DOI 10.3109/10799893.2010.509730; Iizuka K, 2013, ENDOCR J, V60, P543, DOI 10.1507/endocrj.EJ13-0121; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Kahn A, 1997, BIOCHIMIE, V79, P113, DOI 10.1016/S0300-9084(97)81501-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; McFerrin LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034803; McFerrin LG, 2011, GENOME BIOL EVOL, V3, P915, DOI 10.1093/gbe/evr082; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Oosterveer MH, 2014, CELL MOL LIFE SCI, V71, P1453, DOI 10.1007/s00018-013-1505-z; Panserat S, 2014, NUTR RES REV, V27, P21, DOI 10.1017/S0954422414000018; PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Rojas JM, 2014, DIABETES OBES METAB, V16, P33, DOI 10.1111/dom.12332; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smit A, 1996, REPEATMASKER OPEN 30; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Uyeda K, 2002, BIOCHEM PHARMACOL, V63, P2075, DOI 10.1016/S0006-2952(02)01012-2; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yandell M, 2012, NAT REV GENET, V13, P329, DOI 10.1038/nrg3174	44	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149682	10.1371/journal.pone.0149682	http://dx.doi.org/10.1371/journal.pone.0149682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910886	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700044
J	Erjavec, I; Bordukalo-Niksic, T; Brkljacic, J; Grcevic, D; Mokrovic, G; Kesic, M; Rogic, D; Zavadoski, W; Paralkar, VM; Grgurevic, L; Trkulja, V; Cicin-Sain, L; Vukicevic, S				Erjavec, Igor; Bordukalo-Niksic, Tatjana; Brkljacic, Jelena; Grcevic, Danka; Mokrovic, Gordana; Kesic, Maja; Rogic, Dunja; Zavadoski, William; Paralkar, Vishwas M.; Grgurevic, Lovorka; Trkulja, Vladimir; Cicin-Sain, Lipa; Vukicevic, Slobodan			Constitutively Elevated Blood Serotonin Is Associated with Bone Loss and Type 2 Diabetes in Rats	PLOS ONE			English	Article							TRYPTOPHAN-HYDROXYLASE; PLATELET SEROTONIN; SKELETAL PHENOTYPES; MASS; TRANSPORTER; LRP5; OSTEOPOROSIS; MUTATIONS; DENSITY; GROWTH	Reduced peripheral serotonin (5HT) in mice lacking tryptophan hydroxylase (TPH1), the rate limiting enzyme for 5HT synthesis, was reported to be anabolic to the skeleton. However, in other studies TPH1 deletion either had no bone effect or an age dependent inhibition of osteoclastic bone resorption. The role of 5HT in bone therefore remains poorly understood. To address this issue, we used selective breeding to create rat sublines with constitutively high (high-5HT) and low (low-5HT) platelet 5HT level (PSL) and platelet 5HT uptake (PSU). High-5HT rats had decreased bone volume due to increased bone turnover characterized by increased bone formation and mineral apposition rate, increased osteoclast number and serum C-telopeptide level. Daily oral administration of the TPH1 inhibitor (LX1032) for 6 weeks reduced PSL and increased the trabecular bone volume and trabecular number of the spine and femur in high-5HT rats. High-5HT animals also developed a type 2 diabetes (T2D) phenotype with increased: plasma insulin, glucose, hemoglobin A1c, body weight, visceral fat, beta-cell pancreatic islets size, serum cholesterol, and decreased muscle strength. Serum calcium accretion mediated by parathyroid hormone slightly increased, whereas treatment with 1,25(OH)(2)D-3 decreased PSL. Insulin reduction was paralleled by a drop in PSL in high-5HT rats. In vitro, insulin and 5HT synergistically up-regulated osteoblast differentiation isolated from high-5HT rats, whereas TPH1 inhibition decreased the number of bone marrow-derived osteoclasts. These results suggest that constitutively elevated PSL is associated with bone loss and T2D via a homeostatic interplay between the peripheral 5HT, bone and insulin.	[Erjavec, Igor; Bordukalo-Niksic, Tatjana; Brkljacic, Jelena; Grgurevic, Lovorka; Vukicevic, Slobodan] Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Lab Mineralized Tissues, Zagreb 41001, Croatia; [Grcevic, Danka] Univ Zagreb, Sch Med, Dept Physiol & Immunol, Zagreb 41001, Croatia; [Mokrovic, Gordana; Kesic, Maja; Cicin-Sain, Lipa] Rudjer Boskovic Inst, Dept Mol Biol, Lab Neurochem & Mol Neurobiol, Zagreb, Croatia; [Rogic, Dunja] Clin Hosp Ctr Zagreb, Zagreb, Croatia; [Zavadoski, William; Paralkar, Vishwas M.] Karos Pharmaceut, New Haven, CT USA; [Trkulja, Vladimir] Univ Zagreb, Sch Med, Dept Pharmacol, Zagreb 41001, Croatia	University of Zagreb; University of Zagreb; Rudjer Boskovic Institute; University of Zagreb; University of Zagreb	Vukicevic, S (corresponding author), Univ Zagreb, Sch Med, Ctr Translat & Clin Res, Lab Mineralized Tissues, Zagreb 41001, Croatia.	vukicev@mef.hr	Vukicevic, Slobodan/AEG-2646-2022; Erjavec, Igor/AAU-8987-2020; Grcevic, Danka/AAS-1666-2021	Vukicevic, Slobodan/0000-0003-4076-0285; Erjavec, Igor/0000-0002-3038-9665; Grcevic, Danka/0000-0002-2365-8249; Bordukalo Niksic, Tatjana/0000-0003-2306-6152; Cicin-Sain, Lipa/0000-0002-0222-3174	Croatian National Foundation for Science [08/5]; Karos Pharmaceuticals	Croatian National Foundation for Science; Karos Pharmaceuticals	The study was supported from the Croatian National Foundation for Science to SV (project 08/5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Karos Pharmaceuticals provided support in the form of salaries for authors (WZ and VMP), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Djurdjica Car, Mirjana Marija Renic, Katarina Karlo and Vladimir Vranesa for their technical support in rat experiments and biochemical assays. The study was supported from the Croatian National Foundation for Science to SV (project 08/5).	Amireault P, 2013, ACS CHEM NEUROSCI, V4, P64, DOI 10.1021/cn300154j; Barbosa R, 2008, LIFE SCI, V82, P529, DOI 10.1016/j.lfs.2007.12.011; Battaglino R, 2004, J BONE MINER RES, V19, P1420, DOI 10.1359/JBMR.040606; Brommage R, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.87; Brommage R, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.34; Chabbi-Achengli Y, 2012, P NATL ACAD SCI USA, V109, P2567, DOI 10.1073/pnas.1117792109; Chang MK, 2014, J BONE MINER RES, V29, P29, DOI 10.1002/jbmr.2059; Cicin-Sain L, 2005, LIFE SCI, V77, P452, DOI 10.1016/j.lfs.2005.01.007; Cui YJ, 2014, NAT MED, V20, P1229, DOI 10.1038/nm.3697; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Diaz-Lopez A, 2013, J CLIN ENDOCR METAB, V98, P4524, DOI 10.1210/jc.2013-2472; EHRET M, 1989, J NEUROCHEM, V52, P1886, DOI 10.1111/j.1471-4159.1989.tb07272.x; Farr JN, 2014, J BONE MINER RES, V29, P787, DOI 10.1002/jbmr.2106; Foong JPP, 2010, AM J PHYSIOL-GASTR L, V298, pG384, DOI 10.1152/ajpgi.00438.2009; Frost M, 2011, J BONE MINER RES, V26, P1721, DOI 10.1002/jbmr.376; Frost M, 2010, J BONE MINER RES, V25, P673, DOI 10.1002/jbmr.44; Guo J, 2011, WORLD J GASTROENTERO, V17, P4479, DOI 10.3748/wjg.v17.i40.4479; Gupta PS, 2014, CLIN ENDOCRINOL, V80, P246, DOI 10.1111/cen.12270; Haden ST, 2000, CLIN ENDOCRINOL, V52, P329, DOI 10.1046/j.1365-2265.2000.00912.x; JERNEJ B, 1990, PSYCHIAT RES, V32, P167, DOI 10.1016/0165-1781(90)90083-H; Jernej B, 1998, NEUROCHEM INT, V33, P519, DOI 10.1016/S0197-0186(98)00059-X; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Kode A, 2014, NAT MED, V20, P1228, DOI 10.1038/nm.3698; Kode A, 2012, J CLIN INVEST, V122, P3490, DOI 10.1172/JCI64906; Korvala J, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-26; KREMPIEN B, 1988, J BONE MINER RES, V3, P573; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Lee GS, 2014, J BONE MINER RES, V29, P976, DOI 10.1002/jbmr.2086; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Margolis KG, 2014, GUT, V63, P928, DOI 10.1136/gutjnl-2013-304901; MAZESS RB, 1988, J BONE MINER RES, V3, P13; McKinney J, 2005, J NEUROCHEM, V92, P311, DOI 10.1111/j.1471-4159.2004.02850.x; Milne M, 1998, ENDOCRINOLOGY, V139, P2527, DOI 10.1210/en.139.5.2527; Modder UI, 2010, J BONE MINER RES, V25, P415, DOI 10.1359/jbmr.090721; Niziolek PJ, 2011, BONE, V49, P1010, DOI 10.1016/j.bone.2011.07.034; Patrick RP, 2014, FASEB J, V28, P2398, DOI 10.1096/fj.13-246546; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peric M, 2015, BONE, V70, P73, DOI 10.1016/j.bone.2014.07.010; Rizzoli R, 2012, BONE, V51, P606, DOI 10.1016/j.bone.2012.05.018; Simic P, 2006, J BIOL CHEM, V281, P25509, DOI 10.1074/jbc.M513276200; SMYTHE GA, 1973, NATURE, V244, P230, DOI 10.1038/244230a0; Suwanwalaikorn S, 1996, EUR J ENDOCRINOL, V134, P655, DOI 10.1530/eje.0.1340655; VUKICEVIC S, 1987, J BONE MINER RES, V2, P533; Walsh JS, 2013, J CLIN ENDOCR METAB, V98, P2902, DOI 10.1210/jc.2012-4174; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109028; Warden SJ, 2005, ENDOCRINOLOGY, V146, P685, DOI 10.1210/en.2004-1259; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372	48	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150102	10.1371/journal.pone.0150102	http://dx.doi.org/10.1371/journal.pone.0150102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907598	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371163000031
J	Insam, C; Mean, M; Limacher, A; Angelillo-Scherrer, A; Aschwanden, M; Banyai, M; Beer, JH; Bounameaux, H; Egloff, M; Frauchiger, B; Husmann, M; Kucher, N; Lammle, B; Matter, C; Osterwalder, J; Righini, M; Staub, D; Rodondi, N; Aujesky, D				Insam, Charlene; Mean, Marie; Limacher, Andreas; Angelillo-Scherrer, Anne; Aschwanden, Markus; Banyai, Martin; Beer, Juerg-Hans; Bounameaux, Henri; Egloff, Michael; Frauchiger, Beat; Husmann, Marc; Kucher, Nils; Laemmle, Bernhard; Matter, Christian; Osterwalder, Joseph; Righini, Marc; Staub, Daniel; Rodondi, Nicolas; Aujesky, Drahomir			Anticoagulation Management Practices and Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Clinical Research Study	PLOS ONE			English	Article							INTRAVENOUS UNFRACTIONATED HEPARIN; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; INITIAL TREATMENT; ATRIAL-FIBRILLATION; PULMONARY-EMBOLISM; RISK-FACTORS; THERAPY; WARFARIN; PREDICTORS	Whether anticoagulation management practices are associated with improved outcomes in elderly patients with acute venous thromboembolism (VTE) is uncertain. Thus, we aimed to examine whether practices recommended by the American College of Chest Physicians guidelines are associated with outcomes in elderly patients with VTE. We studied 991 patients aged >= 65 years with acute VTE in a Swiss prospective multicenter cohort study and assessed the adherence to four management practices: parenteral anticoagulation >= 5 days, INR >= 2.0 for >= 24 hours before stopping parenteral anticoagulation, early start with vitamin K antagonists (VKA) >= 24 hours of VTE diagnosis, and the use of low-molecular-weight heparin (LMWH) or fondaparinux. The outcomes were all-cause mortality, VTE recurrence, and major bleeding at 6 months, and the length of hospital stay (LOS). We used Cox regression and lognormal survival models, adjusting for patient characteristics. Overall, 9% of patients died, 3% had VTE recurrence, and 7% major bleeding. Early start with VKA was associated with a lower risk of major bleeding (adjusted hazard ratio 0.37, 95% CI 0.20-0.71). Early start with VKA (adjusted time ratio [TR] 0.77, 95% CI 0.69-0.86) and use of LMWH/fondaparinux (adjusted TR 0.87, 95% CI 0.78-0.97) were associated with a shorter LOS. An INR >= 2.0 for >= 24 hours before stopping parenteral anticoagulants was associated with a longer LOS (adjusted TR 1.2, 95% CI 1.08-1.33). In elderly patients with VTE, the adherence to recommended anticoagulation management practices showed mixed results. In conclusion, only early start with VKA and use of parenteral LMWH/fondaparinux were associated with better outcomes.	[Insam, Charlene; Mean, Marie; Rodondi, Nicolas; Aujesky, Drahomir] Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland; [Limacher, Andreas] Univ Bern, Dept Clin Res, Clin Trial Unit Bern, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Angelillo-Scherrer, Anne; Laemmle, Bernhard] Univ Hosp Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Angelillo-Scherrer, Anne; Laemmle, Bernhard] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Laemmle, Bernhard] Univ Med Ctr, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Aschwanden, Markus; Staub, Daniel] Univ Basel Hosp, Dept Angiol, CH-4031 Basel, Switzerland; [Banyai, Martin] Cantonal Hosp Lucerne, Div Angiol, Luzern, Switzerland; [Beer, Juerg-Hans] Cantonal Hosp Baden, Dept Internal Med, Baden, Switzerland; [Bounameaux, Henri; Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland; [Egloff, Michael] Univ Hosp Geneva, Div Diabetol, Geneva, Switzerland; [Frauchiger, Beat] Cantonal Hosp Frauenfeld, Dept Internal Med, Frauenfeld, Switzerland; [Husmann, Marc] Univ Zurich Hosp, Dept Angiol, CH-8091 Zurich, Switzerland; [Kucher, Nils] Univ Hosp Bern, Div Angiol, CH-3010 Bern, Switzerland; [Matter, Christian] Univ Zurich, Inst Physiol, Cardiovasc Res, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland; [Osterwalder, Joseph] Cantonal Hosp St Gallen, Emergency Dept, St Gallen, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; Johannes Gutenberg University of Mainz; University of Basel; Lucerne Cantonal Hospital; University of Geneva; University of Geneva; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Kantonsspital St. Gallen	Insam, C (corresponding author), Univ Hosp Bern, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	charlene.insam@insel.ch	Laemmle, Bernhard/AAJ-1216-2020; Righini, Marc/AAX-8731-2020	Laemmle, Bernhard/0000-0003-4538-5154; Angelillo-Scherrer, Anne/0000-0003-2872-4863; Mean, Marie/0000-0003-0477-7899; Beer, Jurg Hans/0000-0002-7199-0406; Rodondi, Nicolas/0000-0001-9083-6896	Swiss National Science Foundation [33CSCO-122659/139470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant 33CSCO-122659/139470).	Aujesky D, 2007, J CLIN EPIDEMIOL, V60, P410, DOI 10.1016/j.jclinepi.2006.06.023; Becattini C, 2006, THROMB HAEMOSTASIS, V96, P242, DOI 10.1160/TH06-05-0260; Buller HR, 2003, NEW ENGL J MED, V349, P1695; de Moerloose P, 2006, CAN J ANAESTH, V53, pS80, DOI 10.1007/BF03022255; Erkens PMG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001100.pub3; Flaker GC, 2006, AM HEART J, V152, P967, DOI 10.1016/j.ahj.2006.06.024; Gussoni G, 2013, THROMB RES, V131, P24, DOI 10.1016/j.thromres.2012.10.007; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Kato S, 2012, CORONARY ARTERY DIS, V23, P294, DOI 10.1097/MCA.0b013e328352e510; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Koopman MMW, 1996, NEW ENGL J MED, V334, P682, DOI 10.1056/NEJM199603143341102; Lane DA, 2011, CHEST, V140, P146, DOI 10.1378/chest.10-3270; Mean M, 2009, Rev Med Suisse, V5, P2142; Mean M, 2013, J THROMB THROMBOLYS, V36, P475, DOI 10.1007/s11239-013-0875-2; MOHIUDDIN SM, 1992, AM HEART J, V123, P729, DOI 10.1016/0002-8703(92)90513-U; Naess IA, 2007, J THROMB HAEMOST, V5, P692, DOI 10.1111/j.1538-7836.2007.02450.x; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; Qayyum F, 2012, BLOOD COAGUL FIBRIN, V23, P705, DOI 10.1097/MBC.0b013e328357431f; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Samama MM, 2000, ARCH INTERN MED, V160, P3415, DOI 10.1001/archinte.160.22.3415; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Segal JB, 2007, ANN INTERN MED, V146, P211, DOI 10.7326/0003-4819-146-3-200702060-00150; Spencer FA, 2008, THROMB HAEMOSTASIS, V100, P780, DOI 10.1160/TH08-04-0255; Spirk D, 2012, EUR HEART J, V33, P921, DOI 10.1093/eurheartj/ehr392; tenCate JW, 1997, NEW ENGL J MED, V337, P657; WESSLER S, 1984, NEW ENGL J MED, V311, P645; WESTBLOM TU, 1985, SOUTHERN MED J, V78, P1164, DOI 10.1097/00007611-198510000-00005; ZIVELIN A, 1993, J CLIN INVEST, V92, P2131, DOI 10.1172/JCI116814	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0148348	10.1371/journal.pone.0148348	http://dx.doi.org/10.1371/journal.pone.0148348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906217	Green Published, Green Accepted, gold			2022-12-27	WOS:000371163000004
J	Lyukmanova, EN; Shulepko, MA; Kudryavtsev, D; Bychkov, ML; Kulbatskii, DS; Kasheverov, IE; Astapova, MV; Feofanov, AV; Thomsen, MS; Mikkelsen, JD; Shenkarev, ZO; Tsetlin, VI; Dolgikh, DA; Kirpichnikov, MP				Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Kudryavtsev, Denis; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Kasheverov, Igor E.; Astapova, Maria V.; Feofanov, Alexey V.; Thomsen, Morten S.; Mikkelsen, Jens D.; Shenkarev, Zakhar O.; Tsetlin, Victor I.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.			Human Secreted Ly-6/uPAR Related Protein-1 (SLURP-1) Is a Selective Allosteric Antagonist of alpha 7 Nicotinic Acetylcholine Receptor	PLOS ONE			English	Article							BACTERIAL EXPRESSION; VENOM INTERACTS; NEUROMODULATOR; IDENTIFICATION; LYNX1; TOXIN; SYSTEM; MEMBER	SLURP-1 is a secreted toxin-like Ly-6/uPAR protein found in epithelium, sensory neurons and immune cells. Point mutations in the slurp-1 gene cause the autosomal inflammation skin disease Mal de Meleda. SLURP-1 is considered an autocrine/paracrine hormone that regulates growth and differentiation of keratinocytes and controls inflammation and malignant cell transformation. The majority of previous studies of SLURP-1 have been made using fusion constructs containing, in addition to the native protein, extra polypeptide sequences. Here we describe the activity and pharmacological profile of a recombinant analogue of human SLURP-1 (rSLURP-1) differing from the native protein only by one additional N-terminal Met residue. rSLURP-1 significantly inhibited proliferation (up to similar to 40%, EC50 similar to 4 nM) of human oral keratinocytes (Het-1A cells). Application of mecamylamine and atropine,-non-selective inhibitors of nicotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors, respectively, and anti-alpha 7-nAChRs antibodies revealed alpha 7 type nAChRs as an rSLURP-1 target in keratinocytes. Using affinity purification from human cortical extracts, we confirmed that rSLURP-1 binds selectively to the alpha 7-nAChRs. Exposure of Xenopus oocytes expressing alpha 7-nAChRs to rSLURP-1 caused a significant noncompetitive inhibition of the response to acetylcholine (up to similar to 70%, IC50 similar to 1 mu M). It was shown that rSLURP-1 binds to alpha 7-nAChRs overexpressed in GH(4)C(l) cells, but does not compete with I-125-alpha-bungarotoxin for binding to the receptor. These findings imply an allosteric antagonist-like mode of SLURP-1 interaction with alpha 7-nAChRs outside the classical ligand-binding site. Contrary to rSLURP-1, other inhibitors of alpha 7-nAChRs (mecamylamine, alpha-bungarotoxin and Lynx1) did not suppress the proliferation of keratinocytes. Moreover, the co-application of alpha-bungarotoxin with rSLURP-1 did not influence antiproliferative activity of the latter. This supports the hypothesis that the antiproliferative activity of SLURP-1 is related to 'metabotropic' signaling pathway through alpha 7-nAChR, that activates intracellular signaling cascades without opening the receptor channel.	[Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Feofanov, Alexey V.; Shenkarev, Zakhar O.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; [Lyukmanova, Ekaterina N.; Shulepko, Mikhail A.; Bychkov, Maxim L.; Kulbatskii, Dmitrii S.; Dolgikh, Dmitry A.; Kirpichnikov, Mikhail P.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia; [Kudryavtsev, Denis; Kasheverov, Igor E.; Tsetlin, Victor I.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Mol Basics Neurosignalling, Moscow, Russia; [Astapova, Maria V.; Feofanov, Alexey V.; Shenkarev, Zakhar O.] Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Biol Struct, Moscow, Russia; [Thomsen, Morten S.] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Shenkarev, Zakhar O.] Moscow Inst Phys & Technol, Dolgoprudnyi, Moscow Region, Russia	Lomonosov Moscow State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; University of Copenhagen; Moscow Institute of Physics & Technology	Lyukmanova, EN (corresponding author), Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia.; Lyukmanova, EN (corresponding author), Russian Acad Sci, Shemyakin & Ovchinnikov Inst Bioorgan Chem, Dept Bioengn, Moscow, Russia.	ekaterina-lyukmanova@yandex.ru	Feofanov, Alexey V/K-3082-2012; Shulepko, Mikhail/N-9124-2016; Lyukmanova, Ekaterina/F-2340-2014; Tsetlin, Victor/X-2491-2018; Kudryavtsev, Denis S/O-4811-2015; Dolgikh, Dmitry A/F-2369-2014; Kulbatskiy, Dmitry/S-7845-2016; Shenkarev, Zakhar/P-1808-2015	Feofanov, Alexey V/0000-0002-1596-9506; Lyukmanova, Ekaterina/0000-0002-9728-9407; Kudryavtsev, Denis S/0000-0002-0313-9193; Kulbatskiii, Dmitrii/0000-0001-7212-1360; Shulepko, Mikhail/0000-0002-0436-2127; Dolgikh, Dmitry/0000-0002-9880-7202; Shenkarev, Zakhar/0000-0003-1383-3522; Kirpichnikov, Mikhail/0000-0001-8170-1607	Russian Academy of Sciences; Russian Foundation of Basic Researches [14-04-00885, 16-04-01697]; Russian Science Foundation [14-14-00255]	Russian Academy of Sciences(Russian Academy of Sciences); Russian Foundation of Basic Researches(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	The work was partially supported by the Russian Academy of Sciences (Program of Molecular and Cellular Biology), and Russian Foundation of Basic Researches (project No 14-04-00885 issued to VIT, IEK, and DK, and No 16-04-01697 issued to ENL and MAS). The work on affinity purification from cortical extracts and test of antiproliferative activity of rSLURP-1 was done with the support from the Russian Science Foundation (project 14-14-00255 issued to ENL, MAS, MLB, DSK, ZOS, and DAD).	Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Arredondo J, 2005, J INVEST DERMATOL, V125, P1236, DOI 10.1111/j.0022-202X.2005.23973.x; Arredondo J, 2007, LIFE SCI, V80, P2243, DOI 10.1016/j.lfs.2007.01.003; Arredondo J, 2006, J CELL PHYSIOL, V208, P238, DOI 10.1002/jcp.20661; Chernyavsky A.I., 2008, J STOMATOL INVEST, V2, P5; Chernyavsky AI, 2015, INT IMMUNOPHARMACOL, V29, P36, DOI 10.1016/j.intimp.2015.05.033; Chernyavsky AI, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/609086; Chernyavsky AI, 2010, AM J PHYSIOL-CELL PH, V299, pC903, DOI 10.1152/ajpcell.00216.2010; Chiara DC, 1997, J BIOL CHEM, V272, P32940, DOI 10.1074/jbc.272.52.32940; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; COLQUHOUN D, 1979, J PHYSIOL-LONDON, V293, P247, DOI 10.1113/jphysiol.1979.sp012888; Efremenko AV, 2012, PHOTOCH PHOTOBIO SCI, V11, P645, DOI 10.1039/c2pp05237g; Fujii T, 2014, J NEUROIMMUNOL, V267, P43, DOI 10.1016/j.jneuroim.2013.12.003; Grando SA, 1997, JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, VOL 2, NO 1, AUGUST 1997, P41, DOI 10.1038/jidsymp.1997.10; Jensen MM, 2015, NEUROBIOL AGING, V36, P1629, DOI 10.1016/j.neurobiolaging.2015.01.001; Kabbani N, 2013, BIOESSAYS, V35, P1025, DOI 10.1002/bies.201300082; Kawashima K, 2015, INT IMMUNOPHARMACOL, V29, P127, DOI 10.1016/j.intimp.2015.04.015; Kruse AC, 2014, CURR OPIN PHARMACOL, V16, P24, DOI 10.1016/j.coph.2014.02.006; Lyukmanova EN, 2014, ACTA NATURAE, V6, P60, DOI 10.32607/20758251-2014-6-4-60-66; Lyukmanova EN, 2007, J BIOL CHEM, V282, P24784, DOI 10.1074/jbc.M611263200; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Mordvintsev DY, 2009, FEBS J, V276, P5065, DOI 10.1111/j.1742-4658.2009.07203.x; Moriwaki Y, 2007, LIFE SCI, V80, P2365, DOI 10.1016/j.lfs.2006.12.028; Moriwaki Y, 2009, NEUROSCI RES, V64, P403, DOI 10.1016/j.neures.2009.04.014; Narumoto O, 2013, BIOCHEM BIOPH RES CO, V438, P175, DOI 10.1016/j.bbrc.2013.07.048; Pettersson A, 2009, AUTON NEUROSCI-BASIC, V148, P97, DOI 10.1016/j.autneu.2009.03.002; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; Shulepko MA, 2011, RUSS J BIOORG CHEM+, V37, P543, DOI 10.1134/S1068162011050165; Tekinay AB, 2009, P NATL ACAD SCI USA, V106, P4477, DOI 10.1073/pnas.0813109106; Thomsen MS, 2014, 2014 NEUR M PLANN WA; Tsetlin V, 2009, BIOCHEM PHARMACOL, V78, P720, DOI 10.1016/j.bcp.2009.05.032; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7; Zhao LS, 2014, ACTA DERM-VENEREOL, V94, P707, DOI 10.2340/00015555-1840	38	42	47	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149733	10.1371/journal.pone.0149733	http://dx.doi.org/10.1371/journal.pone.0149733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905431	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000020
J	Mechai, S; Margos, G; Feil, EJ; Barairo, N; Lindsay, LR; Michel, P; Ogden, NH				Mechai, Samir; Margos, Gabriele; Feil, Edward J.; Barairo, Nicole; Lindsay, L. Robbin; Michel, Pascal; Ogden, Nicholas H.			Evidence for Host-Genotype Associations of Borrelia burgdorferi Sensu Stricto	PLOS ONE			English	Article							VECTOR IXODES-SCAPULARIS; CHIPMUNK TAMIAS-STRIATUS; WHITE-FOOTED MICE; LYME-DISEASE; POPULATION-STRUCTURE; EASTERN CHIPMUNK; HEMATOGENOUS DISSEMINATION; RANGE EXPANSION; CLIMATE-CHANGE; NORTH-AMERICA	Different genotypes of the agent of Lyme disease in North America, Borrelia burgdorferi sensu stricto, show varying degrees of pathogenicity in humans. This variation in pathogenicity correlates with phylogeny and we have hypothesized that the different phylogenetic lineages in North America reflect adaptation to different host species. In this study, evidence for host species associations of B. burgdorferi genotypes was investigated using 41 B. burgdorferi-positive samples from five mammal species and 50 samples from host-seeking ticks collected during the course of field studies in four regions of Canada: Manitoba, northwestern Ontario, Quebec, and the Maritimes. The B. burgdorferi genotypes in the samples were characterized using three established molecular markers (multi-locus sequence typing [MLST], 16S-23S rrs-rrlA intergenic spacer, and outer surface protein C sequence [ospC] major groups). Correspondence analysis and generalized linear mixed effect models revealed significant associations between B. burgdorferi genotypes and host species (in particular chipmunks, and white-footed mice and deer mice), supporting the hypotheses that host adaptation contributes to the phylogenetic structure and possibly the observed variation in pathogenicity in humans.	[Mechai, Samir; Michel, Pascal; Ogden, Nicholas H.] Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada; [Margos, Gabriele] Natl Reference Ctr Borrelia, Oberschleissheim, Germany; [Margos, Gabriele] Bavarian Hlth & Food Safety Author, Oberschleissheim, Germany; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Milner Ctr Evolut, Bath BA2 7AY, Avon, England; [Barairo, Nicole; Lindsay, L. Robbin] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Michel, Pascal; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, St Hyacinthe, PQ, Canada	Universite de Montreal; Bavarian Health & Food Safety Authority; University of Bath; Public Health Agency of Canada; Public Health Agency of Canada	Ogden, NH (corresponding author), Univ Montreal, Fac Med Vet, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ J2S 7C6, Canada.	nicholas.ogden@phac-aspc.gc.ca		Mechai, Sam/0000-0001-9979-5525; MARGOS, Gabriele/0000-0001-5304-9615; Lindsay, Robbin/0000-0001-7236-2930	Public Health Agency of Canada	Public Health Agency of Canada	The study was funded by the Public Health Agency of Canada.	ANDERSON JF, 1985, J CLIN MICROBIOL, V22, P36, DOI 10.1128/JCM.22.1.36-38.1985; Barbour AG, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0903-5; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Bush SE, 2006, EVOLUTION, V60, P2158, DOI 10.1111/j.0014-3820.2006.tb01853.x; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Derdakova M, 2004, APPL ENVIRON MICROB, V70, P6783, DOI 10.1128/AEM.70.11.6783-6788.2004; Devevey G, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0381-0; Dragoo JW, 2006, J GEN VIROL, V87, P1997, DOI 10.1099/vir.0.81576-0; Dsouli N, 2006, J MED ENTOMOL, V43, P737, DOI 10.1603/0022-2585(2006)43[737:RROLPA]2.0.CO;2; Dykhuizen DE, 2008, AM J TROP MED HYG, V78, P806, DOI 10.4269/ajtmh.2008.78.806; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Gatewood AG, 2009, APPL ENVIRON MICROB, V75, P2476, DOI 10.1128/AEM.02633-08; Gern Lise, 2002, P149, DOI 10.1079/9780851996325.0149; Ginsberg HS, 2004, ENVIRON ENTOMOL, V33, P1266, DOI 10.1603/0046-225X-33.5.1266; Giorgi MS, 2004, OECOLOGIA, V138, P648, DOI 10.1007/s00442-003-1475-1; Gotelli N. J., 2010, BIOL DIVERSITY FRONT, P39, DOI DOI 10.1016/J.BAAE.2011.07.002; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Halperin JJ, 2015, INFECT DRUG RESIST, V8, DOI 10.2147/IDR.S66739; Hamer SA, 2010, ECOHEALTH, V7, P47, DOI 10.1007/s10393-010-0287-0; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P5008, DOI 10.1128/AEM.00479-08; Hanincova K, 2008, APPL ENVIRON MICROB, V74, P153, DOI 10.1128/AEM.01567-07; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; HARVILLE DA, 1977, J AM STAT ASSOC, V72, P320, DOI 10.2307/2286796; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106; Jungnick S, 2015, INT J MED MICROBIOL, V305, P673, DOI 10.1016/j.ijmm.2015.08.017; Kalkvik HM, 2012, ECOGRAPHY, V35, P54, DOI 10.1111/j.1600-0587.2011.06994.x; Korenberg Edward I., 2002, P175, DOI 10.1079/9780851996325.0175; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; LIVERIS D, 1995, J CLIN MICROBIOL, V33, P589, DOI 10.1128/JCM.33.3.589-595.1995; MANNELLI A, 1993, J MED ENTOMOL, V30, P87, DOI 10.1093/jmedent/30.1.87; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Margos G, 2013, INT J SYST EVOL MICR, V63, P4284, DOI 10.1099/ijs.0.052001-0; Margos G, 2012, PARASITOLOGY, V139, P1952, DOI 10.1017/S0031182012000741; Margos G, 2012, APPL ENVIRON MICROB, V78, P6059, DOI 10.1128/AEM.00231-12; Margos G, 2011, INFECT GENET EVOL, V11, P1545, DOI 10.1016/j.meegid.2011.07.022; Margos G, 2010, TICKS TICK-BORNE DIS, V1, P151, DOI 10.1016/j.ttbdis.2010.09.002; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; MCLEAN RG, 1993, J WILDLIFE DIS, V29, P527, DOI 10.7589/0090-3558-29.4.527; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Mendlova M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-69; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Ogden NH, 2007, PARASITOLOGY, V134, P209, DOI 10.1017/S0031182006001417; Ogden NH, 2015, APPL ENVIRON MICROB, V81, P7350, DOI 10.1128/AEM.01671-15; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00046; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; PRICE PK, 1980, AM MIDL NAT, V103, P73, DOI 10.2307/2425040; Qiu WG, 2002, GENETICS, V160, P833; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Rowe KC, 2006, MOL ECOL, V15, P4003, DOI 10.1111/j.1365-294X.2006.03063.x; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sasal P, 1999, PARASITOLOGY, V119, P635, DOI 10.1017/S0031182099005077; SCHUG MD, 1991, J MAMMAL, V72, P360, DOI 10.2307/1382107; Seinost G, 1999, INFECT IMMUN, V67, P3518, DOI 10.1128/IAI.67.7.3518-3524.1999; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Slajchert T, 1997, J WILDLIFE DIS, V33, P40, DOI 10.7589/0090-3558-33.1.40; Strandh M, 2015, PHILOS T R SOC LON B, V370, P1675; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Teixeira AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119315; TRYON CA, 1973, J MAMMAL, V54, P145, DOI 10.2307/1378877; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Voordouw MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118265; Wang IN, 1999, GENETICS, V151, P15; Wood CL, 2013, TRENDS ECOL EVOL, V28, P239, DOI 10.1016/j.tree.2012.10.011; Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Wormser GP, 1999, J INFECT DIS, V180, P720, DOI 10.1086/314922; Zheng XG, 2003, MOL ECOL, V12, P711, DOI 10.1046/j.1365-294X.2003.01770.x; Zhu M, SAS0262014 INT INC	82	33	34	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149345	10.1371/journal.pone.0149345	http://dx.doi.org/10.1371/journal.pone.0149345			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901761	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100061
J	Hohle, B; Fritzsche, T; Muller, A				Hoehle, Barbara; Fritzsche, Tom; Mueller, Anja			Children's Comprehension of Sentences with Focus Particles and the Role of Cognitive Control: An Eye Tracking Study with German-Learning 4-Year-Olds	PLOS ONE			English	Article							SPOKEN-LANGUAGE COMPREHENSION; YOUNG-CHILDREN; ACQUISITION; INFORMATION; MANDARIN; AUCH	Children's interpretations of sentences containing focus particles do not seem adult-like until school age. This study investigates how German 4-year-old children comprehend sentences with the focus particle 'nur' (only) by using different tasks and controlling for the impact of general cognitive abilities on performance measures. Two sentence types with 'only' in either pre-subject or pre-object position were presented. Eye gaze data and verbal responses were collected via the visual world paradigm combined with a sentence-picture verification task. While the eye tracking data revealed an adult-like pattern of focus particle processing, the sentence-picture verification replicated previous findings of poor comprehension, especially for 'only' in pre-subject position. A second study focused on the impact of general cognitive abilities on the outcomes of the verification task. Working memory was related to children's performance in both sentence types whereas inhibitory control was selectively related to the number of errors for sentences with 'only' in pre-subject position. These results suggest that children at the age of 4 years have the linguistic competence to correctly interpret sentences with focus particles, which-depending on specific task demands-may be masked by immature general cognitive abilities.	[Hoehle, Barbara; Fritzsche, Tom] Univ Potsdam, Dept Linguist, Res Ctr Cognit Sci, Potsdam, Germany; [Mueller, Anja] Goethe Univ Frankfurt, Inst Psycholinguist, D-60054 Frankfurt, Germany	University of Potsdam; Goethe University Frankfurt	Fritzsche, T (corresponding author), Univ Potsdam, Dept Linguist, Res Ctr Cognit Sci, Potsdam, Germany.	tom.fritzsche@uni-potsdam.de		Hohle, Barbara/0000-0002-9240-6117	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 632]; Open Access Publishing Fund of University of Potsdam	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Potsdam	The research presented in this paper was conducted within the Sonderforschungsbereich 632 "Informationsstruktur", Project C3 funded by the Deutsche Forschungsgemeinschaft. We acknowledge the support of the Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Potsdam.	Bates Douglas, 2014, LME4 LINEAR MIXED EF; Berger F, 2012, J CHILD LANG, V39, P383, DOI 10.1017/S0305000911000122; Bergsma W., 2002, PROCESS LANGUAGE ACQ, P263; Boersma P., 2010, PRAAT DOING PHONETIC, DOI DOI 10.1007/s10072-018-3598-5; Brandt-Kobele OC, 2010, LINGUA, V120, P1910, DOI 10.1016/j.lingua.2010.02.008; BROOKS PJ, 2006, LANGUAGE ACQUISITION, V0013; CHEN CS, 1988, J EXP CHILD PSYCHOL, V46, P150, DOI 10.1016/0022-0965(88)90027-6; COOPER RM, 1974, COGNITIVE PSYCHOL, V6, P84, DOI 10.1016/0010-0285(74)90005-X; Costa J, 2006, ACQUISITION SYNTAX R, P319; CRAIN S, 1994, PERSPECTIVES ON SENTENCE PROCESSING, P443; Crain S, 1992, ONLY CHILD LANGUAGE, P26; Drozd KF, 2000, LANG ACQUIS, P341; Endo M, 2004, PROC ANN BUCLD, P141; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; GATHERCOLE SE, 1994, MEM COGNITION, V22, P201, DOI 10.3758/BF03208891; GORDON P, 1996, LANG SPEECH & COMMUN, P211; Gualmini Andrea, 2003, P 25 ANN PENN LING C, P87; Gundel J.K., 1988, STUDIES SYNTACTIC TY, V17, P209, DOI DOI 10.1075/TSL.17.16GUN; Hohle B, 2009, LANG ACQUIS, V16, P36, DOI 10.1080/10489220802584550; Huang YT, 2009, DEV PSYCHOL, V45, P1723, DOI 10.1037/a0016704; Hughes C, 2011, INFANT CHILD DEV, V20, P251, DOI 10.1002/icd.736; Jackendoff Ray S., 1972, SEMANTIC INTERPRETAT; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Kiese-Himmel C, 2007, HNO, V55, P972, DOI 10.1007/s00106-007-1621-x; Kim S., 2011, FOCUS PARTICLES SYNT; Mazuka R, 2009, LANG LINGUIST COMPAS, V3, P59, DOI 10.1111/j.1749-818x.2008.00102.x; Minai U, 2012, J CHILD LANG, V39, P919, DOI 10.1017/S0305000911000316; Muller A., 2011, P GALANA 4, P163; Muller A, 2015, LANG ACQUIS, P330; Muller Anja, 2012, WIE INTERPRETIEREN K; Notley A, 2009, LANG ACQUIS, V16, P240, DOI 10.1080/10489220903266669; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Paterson K, 2006, LANG ACQUIS, V13, P253, DOI DOI 10.1207/S15327817LA1303_4; Paterson KB, 2003, COGNITION, V89, P263, DOI 10.1016/S0010-0277(03)00126-4; Philip W, 2000, PROC ANN BUCLD, P583; R Development Core Team, 2014, R LANG ENV STAT COMP; Reinhart T., 2004, LANG ACQUIS, V12, P109, DOI [DOI 10.1207/s15327817la1202_1, 10.1207/s15327817la1202_1, DOI 10.1207/S15327817LA1202_1]; Rizzi, 1990, RELATIVIZED MINIMALI; Rizzi Luigi., 2001, HDB CONT SYNTACTIC T, P89, DOI [10.1002/9780470756416.ch4, DOI 10.1002/9780470756416.CH4]; Rooth Mats, 1992, NAT LANG SEMANT, V1, P75, DOI [10.1007/BF02342617a, DOI 10.1007/BF02342617A, DOI 10.1007/BF02342617]; Rooth Mats E., 1985, ASS FOCUS; Rothbart M. K., 2005, DEV INDIVIDUALITY HU, P167, DOI DOI 10.1037/11108-009; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Santos AL, 2006, LANG ACQUIS, P487; Tanenhaus MK, 2000, J PSYCHOLINGUIST RES, V29, P557, DOI 10.1023/A:1026464108329; TANENHAUS MK, 1995, SCIENCE, V268, P1632, DOI 10.1126/science.7777863; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Zhou P, 2009, P 3 C GEN APPR LANG, P336; Zhou P, 2012, J CHILD LANG, V39, P687, DOI 10.1017/S0305000911000249	50	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149870	10.1371/journal.pone.0149870	http://dx.doi.org/10.1371/journal.pone.0149870			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930286	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500065
J	Song, L; Xiong, D; Hu, MZ; Kang, XL; Pan, ZM; Jiao, XN				Song, Li; Xiong, Dan; Hu, Maozhi; Kang, Xilong; Pan, Zhiming; Jiao, Xinan			Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice	PLOS ONE			English	Article							DENDRITIC CELLS; BACTERIAL FLAGELLIN; GLYCOPROTEIN ANTIGENS; VIRUS; POLYETHYLENEIMINE; VETERINARY; INFECTION; FERRETS	In spring 2013, human infections with a novel avian influenza A (H7N9) virus were reported in China. The number of cases has increased with over 200 mortalities reported to date. However, there is currently no vaccine available for the H7 subtype of influenza A virus. Virus-specific cellular immune responses play a critical role in virus clearance during influenza infection. In this study, we undertook a side-by-side evaluation of two different adjuvants, Salmonella typhimurium flagellin (fliC) and polyethyleneimine (PEI), through intraperitoneal administration to assess their effects on the immunogenicity of the recombinant HA1-2 subunit vaccine of H7N9 influenza. The fusion protein HA1-2-fliC and HA1-2 combined with PEI could induce significantly higher HA1-2-specific IgG and hemagglutination inhibition titers than HA1-2 alone at 12 days post-boost, with superior HA1-2 specific IgG titers in the HA1-2-fliC group compared with the PEI adjuvanted group. The PEI adjuvanted vaccine induced higher IgG1/IgG2a ratio and significantly increased numbers of IFN-gamma- and IL-4-producing cells than HA1-2 alone, suggesting a mixed Th1/Th2-type cellular immune response with a Th2 bias. Meanwhile, the HA1-2-fliC induced higher IgG2a and IgG1 levels, which is indicative of a mixed Th1/Th2-type profile. Consistent with this, significant levels, and equal numbers, of IFN-gamma- and IL-4-producing cells were detected after HA1-2-fliC vaccination. Moreover, the marked increase in CD69 expression and the proliferative index with the HA1-2-fliC and PEI adjuvanted vaccines indicated that both adjuvanted vaccine candidates effectively induced antigen-specific cellular immune responses. Taken together, our findings indicate that the two adjuvanted vaccine candidates elicit effective and HA1-2-specific humoral and cellular immune responses, offering significant promise for the development of a successful recombinant HA1-2 subunit vaccine for H7N9 influenza.	[Song, Li; Xiong, Dan; Hu, Maozhi; Kang, Xilong; Pan, Zhiming; Jiao, Xinan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Song, Li; Xiong, Dan; Hu, Maozhi; Kang, Xilong; Pan, Zhiming; Jiao, Xinan] Yangzhou Univ, Jiangsu Key Lab Zoonosis, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University	Pan, ZM; Jiao, XN (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.; Pan, ZM; Jiao, XN (corresponding author), Yangzhou Univ, Jiangsu Key Lab Zoonosis, Yangzhou 225009, Jiangsu, Peoples R China.	zmpan@yzu.edu.cn; jiao@yzu.edu.cn			National Natural Science Foundation of China [31372415, 31172299]; Program for New Century Excellent Talents in University [NCET-12-0745]; "Six Talent Peaks Program" of Jiangsu Province [NY-028]; "Qinglan Program" of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); "Six Talent Peaks Program" of Jiangsu Province; "Qinglan Program" of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (31372415, 31172299), the Program for New Century Excellent Talents in University (NCET-12-0745), the "Six Talent Peaks Program" of Jiangsu Province (NY-028), the "Qinglan Program" of Jiangsu Province (2012), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Chang SY, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.16; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Eriksson U, 2003, J EXP MED, V197, P323, DOI 10.1084/jem.20021788; Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hong SH, 2012, VACCINE, V30, P466, DOI 10.1016/j.vaccine.2011.10.058; Jones T, 2004, VACCINE, V22, P3691, DOI 10.1016/j.vaccine.2004.03.035; Kalthoff D, 2014, J VIROL, V88, P9153, DOI 10.1128/JVI.01241-14; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kong HH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11233; Labarthe MC, 2008, CANCER IMMUNOL IMMUN, V57, P453, DOI 10.1007/s00262-007-0384-2; Liu CG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-321; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Liu XY, 2012, VACCINE, V30, P6527, DOI 10.1016/j.vaccine.2012.08.054; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Principi N, 2012, HUM VACC IMMUNOTHER, V8, P59, DOI 10.4161/hv.8.1.18011; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687; Sheppard NC, 2014, INT IMMUNOL, V26, P531, DOI 10.1093/intimm/dxu055; Shi JQ, 2011, PEPTIDES, V32, P1617, DOI 10.1016/j.peptides.2011.06.013; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Song L, 2015, BMC BIOTECHNOL, V15, DOI 10.1186/s12896-015-0195-z; Wang C, 2014, CELL IMMUNOL, V292, P57, DOI 10.1016/j.cellimm.2014.09.003; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037019; Wegmann F, 2012, NAT BIOTECHNOL, V30, P883, DOI 10.1038/nbt.2344; Wesa AK, 2001, INT IMMUNOL, V13, P1053, DOI 10.1093/intimm/13.8.1053; WHO, HUM INF AV INFL A H7; Wild P, 2015, VIRUSES-BASEL, V7, P52, DOI 10.3390/v7010052; Yang JY, 2013, HUM VACC IMMUNOTHER, V9, P1084, DOI 10.4161/hv.23809; Yin YY, 2014, AMINO ACIDS, V46, P1763, DOI 10.1007/s00726-014-1735-x; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510	39	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150678	10.1371/journal.pone.0150678	http://dx.doi.org/10.1371/journal.pone.0150678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930068	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500182
J	Reuter, KE; Randell, H; Wills, AR; Janvier, TE; Belalahy, TR; Sewall, BJ				Reuter, Kim E.; Randell, Haley; Wills, Abigail R.; Janvier, Totozafy Eric; Belalahy, Tertius Rodriguez; Sewall, Brent J.			Capture, Movement, Trade, and Consumption of Mammals in Madagascar	PLOS ONE			English	Article							BUSHMEAT COMMODITY CHAIN; FOOD SECURITY; WILDLIFE CONSUMPTION; WEST-AFRICA; CONGO BASIN; CONSERVATION; LIVELIHOODS; EDUCATION; IMPACTS; ECOLOGY	Wild meat trade constitutes a threat to many animal species. Understanding the commodity chain of wild animals (hunting, transportation, trade, consumption) can help target conservation initiatives. Wild meat commodity chain research has focused on the formal trade and less on informal enterprises, although informal enterprises contribute to a large portion of the wild meat trade in sub-Saharan Africa. We aimed to provide a more comprehensive understanding of the formal and informal components of these commodity chains by focusing on the mammalian wild meat trade in Madagascar. Our objectives were to: (1) identify hunting strategies used to capture different wild mammals; (2) analyze patterns of movement of wild meat from the capture location to the final consumer; (3) examine wild meat prices, volumes, and venues of sale; and (4) estimate the volume of wild meat consumption. Data were collected in May-August 2013 using semi-structured interviews with consumers (n = 1343 households, 21 towns), meat-sellers (n = 520 restaurants, open-air markets stalls, and supermarkets, 9 towns), and drivers of inter-city transit vehicles (n = 61, 5 towns). We found that: (1) a wide range of hunting methods were used, though prevalence of use differed by animal group; (2) wild meat was transported distances of up to 166 km to consumers, though some animal groups were hunted locally (< 10 km) in rural areas; (3) most wild meat was procured from free sources (hunting, gifts), though urban respondents who consumed bats and wild pigs were more likely to purchase those meats; and (4) wild meat was consumed at lower rates than domestic meat, though urban respondents consumed wild meat twice as much per year compared to rural respondents. Apart from the hunting stage, the consumption and trade of wild meat in Madagascar is also likely more formalized than previously thought.	[Reuter, Kim E.; Randell, Haley; Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Wills, Abigail R.] Mpingo Conservat & Dev Initiat, Kilwa Masoko, Tanzania; [Janvier, Totozafy Eric; Belalahy, Tertius Rodriguez] Univ Antsiranana, Dept Sci Nat & Environm, Antsiranana, Madagascar	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Reuter, KE (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	kimeleanorreuter@gmail.com			National Science Foundation [DGE-1144462, DEB-1257916]; Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology [1257916] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. (DGE-1144462) to KER (https://www.nsfgrfp.org), a National Science Foundation grant (DEB-1257916) to BJS (http://www.nsf.gov/funding/), an Explorers Club Grant to KER (https://explorers.org/expeditions/funding/expedition_grants), and a Temple University Faculty Senate grant to BJS (https://www.temple.edu/research/facinitiatives/facini_int_funding.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Benjamin N, 2014, INFORM GROWTH DEV AF; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Berkes F, 2004, CONSERV BIOL, V18, P621, DOI 10.1111/j.1523-1739.2004.00077.x; Bowen-Jones E, 2003, AREA, V35, P390, DOI 10.1111/j.0004-0894.2003.00189.x; Breuer T, 2010, AM J PRIMATOL, V72, P454, DOI 10.1002/ajp.20774; Bulte E, 2007, J ENVIRON ECON MANAG, V54, P311, DOI 10.1016/j.jeem.2007.02.003; Campbell BM, 2010, ECOL SOC, V15; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cowlishaw G, 2005, CONSERV BIOL, V19, P139; Crookes DJ, 2005, ENVIRON CONSERV, V32, P333, DOI 10.1017/S037689290500250X; DUCKWORTH JW, 1995, INT J PRIMATOL, V16, P545, DOI 10.1007/BF02735803; Fa JE, 2003, ENVIRON CONSERV, V30, P71, DOI 10.1017/S0376892903000067; Gardner CJ, 2014, HUM ECOL, V42, P21, DOI 10.1007/s10745-013-9629-1; Golden CD, 2013, ANIM CONSERV, V16, P597, DOI 10.1111/acv.12047; Golden CD, 2014, CONSERV BIOL, V28, P234, DOI 10.1111/cobi.12174; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Goodman Steven M., 2003, Lemur News, V8, P4; Guerbois C, 2013, CONSERV BIOL, V27, P844, DOI 10.1111/cobi.12108; HAWKINS AFA, 1990, BIOL CONSERV, V54, P83, DOI 10.1016/0006-3207(90)90136-D; Irwin Mitchell T., 2000, Lemur News, V5, P20; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Keane A, 2011, CONSERV LETT, V4, P55, DOI 10.1111/j.1755-263X.2010.00144.x; Kumpel NF, 2010, HUM ECOL, V38, P251, DOI 10.1007/s10745-010-9316-4; Lindsey PA, 2013, BIOL CONSERV, V160, P80, DOI 10.1016/j.biocon.2012.12.020; Martinez Barbara, 2008, Lemur News, V13, P11; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Peres C.A., 2001, CONSERVATION EXPLOIT, P203; Rakotoarivelo Andrinajoro R., 2011, Madagascar Conservation & Development, V6, P37; Randrianandrianina FH, 2010, ORYX, V44, P411, DOI 10.1017/S003060531000044X; Razafimanahaka JH, 2012, ORYX, V46, P584, DOI 10.1017/S0030605312000579; Reuter KE, ENV CONSERV IN PRESS; Reuter KE, 2016, ORYX, V50, P344, DOI 10.1017/S003060531400074X; Rietbergen-McCracken J., 1998, PARTICIPATION SOCIAL; Rigamonti MM, 1996, LEMUR NEWS, V2, P9; Rist J, 2010, CONSERV BIOL, V24, P489, DOI 10.1111/j.1523-1739.2010.01470.x; Sarter S, 2010, FOOD CONTROL, V21, P253, DOI 10.1016/j.foodcont.2009.05.015; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Tucker B, 2007, HUM NATURE-INT BIOS, V18, P190, DOI 10.1007/s12110-007-9017-x; United Nations, 2013, OP RAT EXCH; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; Vasey N, 1996, LEMUR NEWS, V2, P7; Westerman Kame, 2013, Conservation Evidence, V10, P4; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871	47	10	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150305	10.1371/journal.pone.0150305	http://dx.doi.org/10.1371/journal.pone.0150305			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926987	Green Published, gold			2022-12-27	WOS:000371424200035
J	Rincon, JA; Poza-Lujan, JL; Julian, V; Posadas-Yague, JL; Carrascosa, C				Rincon, J. A.; Poza-Lujan, Jose-Luis; Julian, V.; Posadas-Yaguee, Juan-Luis; Carrascosa, C.			Extending MAM5 Meta-Model and JaCalIV E Framework to Integrate Smart Devices from Real Environments	PLOS ONE			English	Article							SENSOR NETWORK	This paper presents the extension of a meta-model (MAM5) and a framework based on the model (JaCalIVE) for developing intelligent virtual environments. The goal of this extension is to develop augmented mirror worlds that represent a real and virtual world coupled, so that the virtual world not only reflects the real one, but also complements it. A new component called a smart resource artifact, that enables modelling and developing devices to access the real physical world, and a human in the loop agent to place a human in the system have been included in the meta-model and framework. The proposed extension of MAM5 has been tested by simulating a light control system where agents can access both virtual and real sensor/actuators through the smart resources developed. The results show that the use of real environment interactive elements (smart resource artifacts) in agent-based simulations allows to minimize the error between simulated and real system.	[Rincon, J. A.; Julian, V.; Carrascosa, C.] Univ Politecn Valencia, DSIC, Camino Vera S-N, E-46022 Valencia, Spain; [Poza-Lujan, Jose-Luis; Posadas-Yaguee, Juan-Luis] Univ Politecn Valencia, Inst Control Syst & Ind Comp Ai2, Camino Vera S-N, E-46022 Valencia, Spain	Universitat Politecnica de Valencia; Universitat Politecnica de Valencia	Poza-Lujan, JL (corresponding author), Univ Politecn Valencia, Inst Control Syst & Ind Comp Ai2, Camino Vera S-N, E-46022 Valencia, Spain.	jopolu@disca.upv.es	Poza-Lujan, Jose-Luis/ACY-9738-2022; Corchado Rodríguez, Juan/D-3229-2013; Arango, Jaime Andres Rincon/P-7179-2019; Carrascosa, Carlos/L-5463-2013; Poza-Lujan, Jose-Luis/AAU-8915-2021; Julian, Vicente/K-6029-2013; Posadas-Yague, Juan-Luis/P-2871-2014	Corchado Rodríguez, Juan/0000-0002-2829-1829; Arango, Jaime Andres Rincon/0000-0003-1153-0616; Carrascosa, Carlos/0000-0003-3649-6530; Poza-Lujan, Jose-Luis/0000-0003-2450-9920; Julian, Vicente/0000-0002-2743-6037; Posadas-Yague, Juan-Luis/0000-0002-5017-8689	COST Action [IC0801]; FPI grant [AP2013-01276 548];  [TIN2009-13839-C03-01];  [TIN2011-27652-C03-01];  [547CSD2007-00022];  [FP7-294931]	COST Action(European Cooperation in Science and Technology (COST)); FPI grant; ; ; ; 	This work is partially supported by the TIN2009-13839-C03-01, TIN2011-27652-C03-01, 547CSD2007-00022, COST Action IC0801, FP7-294931 and the FPI grant AP2013-01276 548 awarded to Jaime-Andres Rincon.	Anastassakis G., 2001, KI 2001: Advances in Artificial Intelligence. Joint German/ Austrian Conference on AI. Proceedings (Lecture Notes in Artificial Intelligence Vol.2174), P381; Andreoli R, 2005, Ninth International Conference on Information Visualisation, Proceedings, P515, DOI 10.1109/IV.2005.64; [Anonymous], AGENTS GAMES SIMULAT, DOI DOI 10.1007/978-3-642-18181-8_; Barbero A, 2007, EUROPEAN SIMULATION; Barella A, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON INTELLIGENT AGENT TECHNOLOGY (IAT 2007), P532, DOI 10.1109/IAT.2007.10; Barella A, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P237; Barella A., 2012, 10 EUROPEAN WORKSHOP, P16; Barella A, 2009, IEEE T EDUC, V52, P228, DOI 10.1109/TE.2008.925764; Behrens TM, 2011, ANN MATH ARTIF INTEL, V61, P261, DOI 10.1007/s10472-010-9215-9; Bordini R., 2007, PROGRAMMING MULTIAGE; Castrillon-Santana M, 2014, REV IBEROAM AUTOM IN, V11, P348, DOI 10.1016/j.riai.2014.05.006; Chong CY, 2003, P IEEE, V91, P1247, DOI 10.1109/JPROC.2003.814918; Compton M, 2012, J WEB SEMANT, V17, P25, DOI 10.1016/j.websem.2012.05.003; Cook DJ, 2007, PERVASIVE MOB COMPUT, V3, P53, DOI 10.1016/j.pmcj.2006.12.001; Corchado E, 2014, NEUROCOMPUTING, V126, P1, DOI 10.1016/j.neucom.2013.07.001; Dignum F, 2012, AUTON AGENT MULTI-AG, V24, P217, DOI 10.1007/s10458-011-9169-2; Dimuro GP, 2008, INTERVAL VALUED HIDD; dos Santos C. T., 2004, Proceedings of the 28th Annual International Computer Software and Applications Conference. COMPSAC 2004, P468; Edle MJS, 2011, INT J ENTERPRISE COM, V1, P1; Fenfen Cheng, 2013, Advanced Materials Research, V722, P397, DOI 10.4028/www.scientific.net/AMR.722.397; Garca-Pardo JA, 2011, LECT NOTES ARTIF INT, V6973, P29, DOI 10.1007/978-3-642-24603-6_5; Gelernter D., 1993, MIRROR WORLDS DAY SO; Go CAL, 2007, ADV SOFT COMP, V41, P677, DOI 10.1007/978-3-540-72432-2_68; Gonzalez-Jorge H, 2013, MEASUREMENT, V46, P1800, DOI 10.1016/j.measurement.2013.01.011; Guinard D, 2011, ARCHITECTING THE INTERNET OF THINGS, P97; Jia L., 2007, IEEE INT WORKSH HAPT, P90, DOI [DOI 10.1109/HAVE.2007.4371594, 10.1109/HAVE.2007.4371594]; Kavitha R, INT J SCI RES IJSR, P2319; Kazemi A, 2009, INT J ADV MANUF TECH, V44, P180, DOI 10.1007/s00170-008-1826-5; Kushner D., 2011, IEEE SPECTRUM, V26; Leccese F, 2014, SENSORS-BASEL, V14, P24408, DOI 10.3390/s141224408; Lidoris G, 2006, SPRINGER TRAC ADV RO, V22, P15; Luck M, 2000, APPL ARTIF INTELL, V14, P3, DOI 10.1080/088395100117142; Mago VK, 2007, 20TH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1396; Mateevitsi V., 2013, P 4 AUGMENTED HUMAN, P51, DOI DOI 10.1145/2459236.2459246; Munera Eduardo, 2015, International Journal of Imaging and Robotics, V15, P117; Munera E, 2015, SENSORS-BASEL, V15, P18080, DOI 10.3390/s150818080; Omicini A, 2008, AUTON AGENT MULTI-AG, V17, P432, DOI 10.1007/s10458-008-9053-x; Pan MS, 2008, IEEE SENS J, V8, P1710, DOI 10.1109/JSEN.2008.2004294; Papoutsidakis Michail, 2014, WSEAS Transactions on Systems, V13, P242; Ranathunga S., 2011, AAMAS, P1181; Rehman SU, 2011, COMM COM INF SC, V257, P11; Ricci A., 2007, 5 INT WORKSH PROGR M, P54; Ricci A., 2007, P 6 INT JOINT C AUT, P150; Ricci A, 2008, LECT NOTES ARTIF INT, V4908, P89; Richardson L., 2013, RESTFUL WEB APIS; Rincon JA, 2015, ADV INTELL SYST, V368, P203, DOI 10.1007/978-3-319-19719-7_18; Rincon JA, 2015, COMM COM INF SC, V524, P377, DOI 10.1007/978-3-319-19033-4_33; Roncancio C, 2010, ADV INTELL SOFT COMP, V71, P623; Salzmann C., 2013, 4 IEEE GLOB ENG ED C; Sanchis A, 2014, WIHAS 14 INTELLIGENT, P1; Schmidt A, 2001, IEEE PERS COMMUN, V8, P66, DOI 10.1109/98.944006; Surakul K, 2015, INFORM TECHNOLOGY J, V11; Tian J, 2003, LECT NOTES ARTIF INT, V2831, P85; Upton Eben, 2014, RASPBERRY PI USER GU; Van Oijen J., 2011, AGENTS GAMES SIMULAT, P38; Villarrubia G, 2014, SENSORS-BASEL, V14, P13955, DOI 10.3390/s140813955; Wozniak M, 2014, INFORM FUSION, V16, P3, DOI 10.1016/j.inffus.2013.04.006; Yoder M. A., 2015, BEAGLEBONE COOKBOOK; Yu C.-H., 2008, IROS 2008 WORKSH SEL; Yu CH, 2011, INT J ROBOT RES, V30, P1015, DOI 10.1177/0278364910384753	60	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149665	10.1371/journal.pone.0149665	http://dx.doi.org/10.1371/journal.pone.0149665			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926691	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200014
J	Ball, MS; Shipman, EP; Kim, H; Liby, KT; Pioli, PA				Ball, Michael S.; Shipman, Emilie P.; Kim, Hyunjung; Liby, Karen T.; Pioli, Patricia A.			CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages	PLOS ONE			English	Article							HUMAN MONOCYTES; METHYL ESTER; CANCER; RECEPTOR; POLARIZATION; PROGRESSION; EXPRESSION; PLASTICITY; BLOCKS; CELLS	Tumor-associated macrophages can account for up to 50% of the tumor mass in breast cancer patients and high TAM density is associated with poor clinical prognosis. Because TAMs enhance tumor growth, development, and metastatic potential, redirection of TAM activation may have significant therapeutic benefit. Our studies in primary human macrophages and murine breast TAMs suggest that the synthetic oleanane triterpenoid CDDO-methyl ester (CDDO-Me) reprograms the activation profile of TAMs from tumor-promoting to tumor-inhibiting. We show that CDDO-Me treatment inhibits expression of IL-10 and VEGF in stimulated human M2 macrophages and TAMs but increases expression of TNF-alpha and IL-6. Surface expression of CD206 and CD163, which are characteristic of M2 activation, is significantly attenuated by CDDO-Me. In contrast, CDDO-Me up-regulates surface expression of HLA-DR and CD80, which are markers of M1 activation, and importantly potentiates macrophage activation of autologous T cells but inhibits endothelial cell vascularization. These results show for the first time that CDDO-Me redirects activation of M2 macrophages and TAMs from immune-suppressive to immune-stimulatory, and implicate a role for CDDO-Me as an immunotherapeutic in the treatment of breast and potentially other types of cancer.	[Ball, Michael S.; Shipman, Emilie P.; Kim, Hyunjung; Pioli, Patricia A.] Geisel Sch Med, Dept Obstet & Gynecol, Lebanon, NH USA; [Liby, Karen T.] Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA	Dartmouth College; Dartmouth College	Pioli, PA (corresponding author), Geisel Sch Med, Dept Obstet & Gynecol, Lebanon, NH USA.	Pioli@Dartmouth.edu		Liby, Karen/0000-0003-3317-3437	Centers of Biomedical Research Excellence (COBRE) from the Dartmouth Clinical and Translational Science Institute [P20 RR 016437]; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) [UL1TR001086]; Reata Pharmaceuticals, Inc.; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER	Centers of Biomedical Research Excellence (COBRE) from the Dartmouth Clinical and Translational Science Institute; National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Reata Pharmaceuticals, Inc.; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by the Centers of Biomedical Research Excellence (COBRE) P20 RR 016437 Pilot Project Grant (to KTL and PAP), Pilot Project funding (to KTL and PAP) from the Dartmouth Clinical and Translational Science Institute, under award number UL1TR001086 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH), Reata Pharmaceuticals, Inc. (to KTL) and the Breast Cancer Research Foundation (to KTL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2006, J BIOL CHEM, V281, P35764, DOI 10.1074/jbc.M607160200; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Bynum JA, 2015, PHARMACOLOGY, V95, P181, DOI 10.1159/000381188; Chen JQ, 2011, CANCER CELL, V19, P541, DOI 10.1016/j.ccr.2011.02.006; Chen PW, 2013, INT REV CEL MOL BIO, V301, P1, DOI 10.1016/B978-0-12-407704-1.00001-4; Chen WC, 2013, INTERLEUKIN 17 PRODU, DOI [10.1111/his.12156, DOI 10.1111/HIS.12156]; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Duluc D, 2007, BLOOD; Espey MG, 2006, FREE RADICAL BIO MED, V41, P1621, DOI 10.1016/j.freeradbiomed.2006.08.026; Fujita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110378; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; He ZS, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-86; Holden JA, 2014, INFECT IMMUN, V82, P4190, DOI 10.1128/IAI.02325-14; Hong DS, 2012, CLIN CANCER RES, V18, P3396, DOI 10.1158/1078-0432.CCR-11-2703; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Liby KT, 2012, PHARMACOL REV, V64, P972, DOI 10.1124/pr.111.004846; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Lin EY, 2003, PROGR MALIGNANCY POL; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mantovani A, 2013, ARTERIOSCL THROM VAS, V33, P1478, DOI 10.1161/ATVBAHA.113.300168; Mantovani A, 2009, HUM IMMUNOL, V70, P325, DOI 10.1016/j.humimm.2009.02.008; MENTZER SJ, 1986, CELL IMMUNOL, V101, P312, DOI 10.1016/0008-8749(86)90144-9; Meyer T, 2008, EXPERT OPIN INV DRUG, V17, P1051, DOI [10.1517/13543784.17.7.1051, 10.1517/13543784.17.7.1051 ]; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nagaraj S, 2010, CLIN CANCER RES, V16, P1812, DOI 10.1158/1078-0432.CCR-09-3272; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Prokop S, 2011, AM J PATHOL, V178, P1279, DOI 10.1016/j.ajpath.2010.11.065; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Rego SL, 2014, ANGIOGENESIS, V17, P573, DOI 10.1007/s10456-013-9405-2; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Schmittel A, 1995, SCAND J IMMUNOL, V42, P701, DOI 10.1111/j.1365-3083.1995.tb03714.x; Scotton C, 2001, BRIT J CANCER, V85, P891, DOI 10.1054/bjoc.2001.2020; Shabo I, 2008, INT J CANCER, V123, P780, DOI 10.1002/ijc.23527; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Sica A, 2000, AUTOCRINE PRODUCTION, DOI [10.4049/jimmunol.164.2.762, DOI 10.4049/JIMMUNOL.164.2.762]; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Solinas G, 2009, TUMOR ASS MACROPHAGE; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Tran K, 2012, CANCER PREV RES, V5, P726, DOI 10.1158/1940-6207.CAPR-11-0404; Tripathi C, 2014, ONCOTARGET, V5, P5350, DOI 10.18632/oncotarget.2110; Tsutsui S, 2005, ONCOL REP, V14, P425; Vannini N, 2007, MOL CANCER THER, V6, P3139, DOI 10.1158/1535-7163.MCT-07-0451; Wang YP, 2000, MOL ENDOCRINOL, V14, P1550, DOI 10.1210/me.14.10.1550; Weigert A, 2007, MOL BIOL CELL, V18, P3810, DOI 10.1091/mbc.E06-12-1096; Weiss M, 2013, IRF5 IS SPECIFIC MAR; Yang C, 2010, SPINE, V35, P1668, DOI 10.1097/BRS.0b013e3181c2d2b4; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	66	25	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149600	10.1371/journal.pone.0149600	http://dx.doi.org/10.1371/journal.pone.0149600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918785	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400027
J	de Leng, WWJ; Gadellaa-van Hooijdonk, CG; Barendregt-Smouter, FAS; Koudijs, MJ; Nijman, I; Hinrichs, JWJ; Cuppen, E; van Lieshout, S; Loberg, RD; de Jonge, M; Voest, EE; de Weger, RA; Steeghs, N; Langenberg, MHG; Sleijfer, S; Willems, SM; Lolkema, MP				de Leng, Wendy W. J.; Gadellaa-van Hooijdonk, Christa G.; Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Hinrichs, John W. J.; Cuppen, Edwin; van Lieshout, Stef; Loberg, Robert D.; de Jonge, Maja; Voest, Emile E.; de Weger, Roel A.; Steeghs, Neeltje; Langenberg, Marlies H. G.; Sleijfer, Stefan; Willems, Stefan M.; Lolkema, Martijn P.			Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material	PLOS ONE			English	Article							CLINICALLY RELEVANT MUTATIONS; BURROWS-WHEELER TRANSFORM; CELL LUNG-CANCER; ION TORRENT; COLORECTAL-CANCER; READ ALIGNMENT; VALIDATION; PLATFORMS; ACCURATE; EGFR	Background Targeted Next Generation Sequencing (NGS) offers a way to implement testing of multiple genetic aberrations in diagnostic pathology practice, which is necessary for personalized cancer treatment. However, no standards regarding input material have been defined. This study therefore aimed to determine the effect of the type of input material (e.g. formalin fixed paraffin embedded (FFPE) versus fresh frozen (FF) tissue) on NGS derived results. Moreover, this study aimed to explore a standardized analysis pipeline to support consistent clinical decision-making. Method We used the Ion Torrent PGM sequencing platform in combination with the Ion AmpliSeq Cancer Hotspot Panel v2 to sequence frequently mutated regions in 50 cancer related genes, and validated the NGS detected variants in 250 FFPE samples using standard diagnostic assays. Next, 386 tumour samples were sequenced to explore the effect of input material on variant detection variables. For variant calling, Ion Torrent analysis software was supplemented with additional variant annotation and filtering. Results Both FFPE and FF tissue could be sequenced reliably with a sensitivity of 99.1%. Validation showed a 98.5% concordance between NGS and conventional sequencing techniques, where NGS provided both the advantage of low input DNA concentration and the detection of low-frequency variants. The reliability of mutation analysis could be further improved with manual inspection of sequence data. Conclusion Targeted NGS can be reliably implemented in cancer diagnostics using both FFPE and FF tissue when using appropriate analysis settings, even with low input DNA.	[de Leng, Wendy W. J.; Hinrichs, John W. J.; de Weger, Roel A.; Willems, Stefan M.] Univ Med Ctr Utrecht, Dept Pathol, NL-3584 CX Utrecht, Netherlands; [Gadellaa-van Hooijdonk, Christa G.; Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Cuppen, Edwin; van Lieshout, Stef; de Jonge, Maja; Steeghs, Neeltje; Langenberg, Marlies H. G.; Sleijfer, Stefan; Willems, Stefan M.; Lolkema, Martijn P.] Netherlands Ctr Personalized Canc Treatment, Utrecht, Netherlands; [Gadellaa-van Hooijdonk, Christa G.; Langenberg, Marlies H. G.; Lolkema, Martijn P.] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands; [Barendregt-Smouter, Francoise A. S.; Koudijs, Marco J.; Nijman, Ies; Cuppen, Edwin; van Lieshout, Stef] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Voest, Emile E.; Steeghs, Neeltje] Netherlands Canc Inst, Dept Med Oncol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands; [Loberg, Robert D.] Amgen Inc, Med Sci, Thousand Oaks, CA 91320 USA; [de Jonge, Maja; Sleijfer, Stefan; Lolkema, Martijn P.] Erasmus MC Canc Inst, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands; [de Jonge, Maja; Sleijfer, Stefan; Lolkema, Martijn P.] Canc Genom Netherlands, NL-3075 EA Rotterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Amgen; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute	Lolkema, MP (corresponding author), Netherlands Ctr Personalized Canc Treatment, Utrecht, Netherlands.; Lolkema, MP (corresponding author), Univ Med Ctr Utrecht, Dept Med Oncol, NL-3584 CX Utrecht, Netherlands.; Lolkema, MP (corresponding author), Erasmus MC Canc Inst, Dept Med Oncol, NL-3075 EA Rotterdam, Netherlands.; Lolkema, MP (corresponding author), Canc Genom Netherlands, NL-3075 EA Rotterdam, Netherlands.	m.lolkema@erasmusmc.nl	Steeghs, Neeltje/GQH-3468-2022; Cuppen, Edwin/F-5696-2011; Lolkema, M.P./AAE-2906-2019; Cuppen, Edwin/H-2389-2016	Cuppen, Edwin/0000-0002-0400-9542; Lolkema, M.P./0000-0003-0466-2928; Cuppen, Edwin/0000-0002-0400-9542	Barcode for Life; Stichting NutsOhra; Amgen	Barcode for Life; Stichting NutsOhra; Amgen(Amgen)	Funded by Barcode for Life (www.barcodeforlife.nl) and Stichting NutsOhra (www.fondsnutsohra.nl). These funders only contributed financially for benchfee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Amgen provided support in the form of salaries for RL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belardinilli F, 2015, CLIN BIOCHEM, V48, P908, DOI 10.1016/j.clinbiochem.2015.04.003; Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a; Cottrell CE, 2014, J MOL DIAGN, V16, P89, DOI 10.1016/j.jmoldx.2013.10.002; Diaz LA, 2012, NATURE, V486, P537, DOI 10.1038/nature11219; Dietrich D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077771; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Gleeson FC, 2015, CLIN GASTROENTEROL H, V13, P202, DOI 10.1016/j.cgh.2014.06.024; Hagemann IS, 2015, CANCER-AM CANCER SOC, V121, P631, DOI 10.1002/cncr.29089; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hinrichs JWJ, 2015, AM J CLIN PATHOL, V143, P573, DOI 10.1309/AJCP40XETVYAMJPY; Hoogstraat M, 2015, J MOL DIAGN, V17, P10, DOI 10.1016/j.jmoldx.2014.09.004; Ihle MA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-13; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Johnson DB, 2014, ONCOLOGIST, V19, P616, DOI 10.1634/theoncologist.2014-0011; Latham GJ, 2013, EXPERT REV MOL DIAGN, V13, P769, DOI 10.1586/14737159.2013.845090; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2014, AM J CLIN PATHOL, V141, P856, DOI 10.1309/AJCPMWGWGO34EGOD; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Mafficini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104979; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Malapelle U, 2015, J CLIN PATHOL, V68, P64, DOI 10.1136/jclinpath-2014-202691; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; McCourt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069604; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Pant S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00078; Portier BP, 2014, AM J CLIN PATHOL, V141, P559, DOI 10.1309/AJCP1JUGQMW7ZNTL; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rothe F, 2014, ANN ONCOL, V25, P1959, DOI 10.1093/annonc/mdu288; Sie D, 2014, CELL ONCOL, V37, P353, DOI 10.1007/s13402-014-0196-2; Smits AJJ, 2014, MODERN PATHOL, V27, P168, DOI 10.1038/modpathol.2013.134; Spencer DH, 2013, J MOL DIAGN, V15, P623, DOI 10.1016/j.jmoldx.2013.05.004; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Williams C, 1999, AM J PATHOL, V155, P1467, DOI 10.1016/S0002-9440(10)65461-2; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025	40	66	66	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149405	10.1371/journal.pone.0149405	http://dx.doi.org/10.1371/journal.pone.0149405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919633	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400021
J	Fan, YJ; Li, XS; Zhang, Y; Fan, XF; Zhang, N; Zheng, H; Song, YP; Shen, CF; Shen, JY; Ren, FD; Yang, JL				Fan, Yujuan; Li, Xuesong; Zhang, Yu; Fan, Xiaofang; Zhang, Ning; Zheng, Hui; Song, Yuping; Shen, Chunfang; Shen, Jiayi; Ren, Fengdong; Yang, Jialin			Genetic Variants of TPCN2 Associated with Type 2 Diabetes Risk in the Chinese Population	PLOS ONE			English	Article							DINUCLEOTIDE PHOSPHATE NAADP; PANCREATIC BETA-CELLS; ION CHANNELS; 2-PORE; INVOLVEMENT; CALCIUM; LINKAGE; MICE	Objective The aim of this study was to determine whether TPCN2 genetic variants are associated with type 2 diabetes and to elucidate which variants in TPCN2 confer diabetes susceptibility in the Chinese population. Research Design and Methods The sample population included 384 patients with type 2 diabetes and 1468 controls. Anthropometric parameters, glycemic and lipid profiles and insulin resistance were measured. We selected 6 TPCN2 tag single nucleotide polymorphisms (rs35264875, rs267603153, rs267603154, rs3829241, rs1551305, and rs3750965). Genotypes were determined using a Sequenom MassARRAY SNP genotyping system. Results Ultimately, we genotyped 3 single nucleotide polymorphisms (rs3750965, rs3829241, and rs1551305) in all individuals. There was a 5.1% higher prevalence of the rs1551305 variant allele in type 2 diabetes individuals (A) compared with wild-type homozygous individuals (G). The AA genotype of rs1551305 was associated with a higher diabetes risk (p<0.05). The distributions of rs3829241 and rs3750965 polymorphisms were not significantly different between the two groups. HOMA-%B of subjects harboring the AA genotype of rs1551305 decreased by 14.87% relative to the GG genotype. Conclusions TPCN2 plays a role in metabolic regulation, and the rs1551305 single nucleotide polymorphism is associated with type 2 diabetes risk. Future work will begin to unravel the underlying mechanisms.	[Fan, Yujuan; Li, Xuesong; Zhang, Yu; Fan, Xiaofang; Zhang, Ning; Zheng, Hui; Song, Yuping; Shen, Chunfang; Shen, Jiayi; Ren, Fengdong; Yang, Jialin] Fudan Univ, Dept Endocrinol, Cent Hosp Minhang Dist, Minhang Hosp, Shanghai 200433, Peoples R China	Fudan University	Yang, JL (corresponding author), Fudan Univ, Dept Endocrinol, Cent Hosp Minhang Dist, Minhang Hosp, Shanghai 200433, Peoples R China.	jialinyang2002@163.com			Shanghai Science and Technology Development Fund [114119b0400, 15411970700]; Natural Science Research Project of Minhang District, Shanghai [2015MHZ074]; Shanghai Science and Technology Development [114119b0400, 15411970700]	Shanghai Science and Technology Development Fund; Natural Science Research Project of Minhang District, Shanghai; Shanghai Science and Technology Development	Funded by Shanghai Science and Technology Development Fund (114119b0400,15411970700) (Jialin Yang) and Natural Science Research Project of Minhang District, Shanghai(2015MHZ074)(Yujuan Fan).; This study was funded by the grant from Shanghai Science and Technology Development (114119b0400,15411970700) and Natural Science Research Project of Minhang District, Shanghai(2015MHZ074).	Arredouani A, 2015, J BIOL CHEM, V290, P21376, DOI 10.1074/jbc.M115.671248; Arredouani A, 2010, ISLETS, V2, P323, DOI 10.4161/isl.2.5.12747; Ashcroft FM, 2012, CELL, V148, P1160, DOI 10.1016/j.cell.2012.02.010; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2012, BIOCHEM J, V441, P317, DOI 10.1042/BJ20111617; Henquin JC, 2003, EUR J CLIN INVEST, V33, P742, DOI 10.1046/j.1365-2362.2003.01207.x; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Lear PV, 2015, ENDOCRINOLOGY, V156, P975, DOI 10.1210/en.2014-1766; Park KH, 2013, J BIOL CHEM, V288, P35548, DOI 10.1074/jbc.M113.489278; Patel S, 2011, CELL CALCIUM, V50, P157, DOI 10.1016/j.ceca.2011.03.011; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietdorf K, 2011, J BIOL CHEM, V286, P37058, DOI 10.1074/jbc.C111.289835; Ruas M, 2015, EMBO J, V34, P1743, DOI 10.15252/embj.201490009; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Shawl AI, 2012, ISLETS, V4, P145, DOI 10.4161/isl.19490; Shawl AI, 2009, ISLETS, V1, P216, DOI 10.4161/isl.1.3.9646; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Tsaih SW, 2014, GENETICS, V198, P17, DOI 10.1534/genetics.114.162982; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036	21	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149614	10.1371/journal.pone.0149614	http://dx.doi.org/10.1371/journal.pone.0149614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918892	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400028
J	Fodor, T; Szanto, M; Abdul-Rahman, O; Nagy, L; Der, A; Kiss, B; Bai, P				Fodor, Tamas; Szanto, Magdolna; Abdul-Rahman, Omar; Nagy, Lilla; Der, Adam; Kiss, Borbala; Bai, Peter			Combined Treatment of MCF-7 Cells with AICAR and Methotrexate, Arrests Cell Cycle and Reverses Warburg Metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1	PLOS ONE			English	Article							CANCER; PGC-1-ALPHA; GLUCOSE; SIRT1; PROLIFERATION; COACTIVATORS; MITOCHONDRIA; HOMEOSTASIS; INHIBITION; GLYCOLYSIS	Cancer cells are characterized by metabolic alterations, namely, depressed mitochondrial oxidation, enhanced glycolysis and pentose phosphate shunt flux to support rapid cell growth, which is called the Warburg effect. In our study we assessed the metabolic consequences of a joint treatment of MCF-7 breast cancer cells with AICAR, an inducer of AMP-activated kinase (AMPK) jointly with methotrexate (MTX), a folate-analog antimetabolite that blunts de novo nucleotide synthesis. MCF7 cells, a model of breast cancer cells, were resistant to the individual application of AICAR or MTX, however combined treatment of AICAR and MTX reduced cell proliferation. Prolonged joint application of AICAR and MTX induced AMPK and consequently enhanced mitochondrial oxidation and reduced the rate of glycolysis. These metabolic changes suggest an anti-Warburg rearrangement of metabolism that led to the block of the G1/S and the G2/M transition slowing down cell cycle. The slowdown of cell proliferation was abolished when mitotropic transcription factors, PGC-1 alpha, PGC-1 beta or FOXO1 were silenced. In human breast cancers higher expression of AMPK alpha and FOXO1 extended survival. AICAR and MTX exerts similar additive antiproliferative effect on other breast cancer cell lines, such as SKBR and 4T1 cells, too. Our data not only underline the importance of Warburg metabolism in breast cancer cells but nominate the AICAR+MTX combination as a potential cytostatic regime blunting Warburg metabolism. Furthermore, we suggest the targeting of AMPK and FOXO1 to combat breast cancer.	[Fodor, Tamas; Szanto, Magdolna; Abdul-Rahman, Omar; Nagy, Lilla; Bai, Peter] Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary; [Der, Adam] Univ Debrecen, Sect Radiat Therapy, Dept Oncol, Fac Med, H-4032 Debrecen, Hungary; [Kiss, Borbala] Univ Debrecen, Fac Med, Dept Dermatol, H-4032 Debrecen, Hungary; [Szanto, Magdolna; Abdul-Rahman, Omar; Nagy, Lilla] MTA DE Cell Biol & Signaling Res Grp, H-4032 Debrecen, Hungary; [Bai, Peter] MTA DE Lendulet Lab Cellular Metab, H-4032 Debrecen, Hungary; [Bai, Peter] Univ Debrecen, Res Ctr Mol Med, H-4032 Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen; University of Debrecen	Bai, P (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, H-4032 Debrecen, Hungary.; Bai, P (corresponding author), MTA DE Lendulet Lab Cellular Metab, H-4032 Debrecen, Hungary.; Bai, P (corresponding author), Univ Debrecen, Res Ctr Mol Med, H-4032 Debrecen, Hungary.	baip@med.unideb.hu		Szanto, Magdolna/0000-0002-7714-7065	Bolyai fellowship; Hungarian National, Research, Development and Innovation Office (NKFIH) [K108308, K105872, C120732, C129074]; Momentum fellowship of the Hungarian Academy of Sciences; University of Debrecen;  [TAMOP-4.2.2. A-11/1/KONV-2012-0025]	Bolyai fellowship(Hungarian Academy of Sciences); Hungarian National, Research, Development and Innovation Office (NKFIH); Momentum fellowship of the Hungarian Academy of Sciences; University of Debrecen; 	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author(s) received no specific funding for this work. The authors acknowledge the technical assistance of Erzsebet Herbaly and Laszlo Gelenczei-Finta. This work was supported by a Bolyai fellowship to MS. Furthermore, by grants from The Hungarian National, Research, Development and Innovation Office (NKFIH (K108308, K105872, C120732, C129074)), TAMOP-4.2.2. A-11/1/KONV-2012-0025, the Momentum fellowship of the Hungarian Academy of Sciences and the University of Debrecen.	[Anonymous], 2014, NCCN CLIN GUID ONC; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bai P, 2001, FREE RADICAL BIO MED, V31, P1616, DOI 10.1016/S0891-5849(01)00756-0; Bai P, 2007, J BIOL CHEM, V282, P37738, DOI 10.1074/jbc.M701021200; Bai P, 2015, TRENDS ENDOCRIN MET, V26, P75, DOI 10.1016/j.tem.2014.11.003; Bao Y, 2013, MOL CANCER RES, V11, P973, DOI 10.1158/1541-7786.MCR-12-0669-T; Beckers A, 2006, MOL CANCER THER, V5, P2211, DOI 10.1158/1535-7163.MCT-06-0001; Boratko A, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-99; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Colombo SL, 2011, P NATL ACAD SCI USA, V108, P21069, DOI 10.1073/pnas.1117500108; Ertel A, 2012, CELL CYCLE, V11, P253, DOI 10.4161/cc.11.2.19006; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Feng WG, 2014, STEM CELLS, V32, P1734, DOI 10.1002/stem.1662; Gonzalez-Angulo AM, 2012, CLIN CANCER RES, V18, P1109, DOI 10.1158/1078-0432.CCR-11-2762; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Icard P, 2012, BBA-REV CANCER, V1826, P423, DOI 10.1016/j.bbcan.2012.07.001; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Kim S, 2013, TUMOR BIOL, V34, P1699, DOI 10.1007/s13277-013-0707-1; Kroemer G, 2006, ONCOGENE, V25, P4630, DOI 10.1038/sj.onc.1209589; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Moncada S, 2012, BIOCHEM J, V446, P1, DOI 10.1042/BJ20120427; Mouradian M, 2015, MOL CARCINOGEN, V54, P810, DOI 10.1002/mc.22151; Nagy L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069420; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Suhane S, 2011, BIOCHEM BIOPH RES CO, V414, P73, DOI 10.1016/j.bbrc.2011.09.024; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Szanto M, 2011, CARDIOVASC RES, V92, P430, DOI 10.1093/cvr/cvr246; Tang XH, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0415-9; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wallace DC, 2012, NAT REV CANCER, V12, P685, DOI 10.1038/nrc3365; Wareski P, 2009, J BIOL CHEM, V284, P21379, DOI 10.1074/jbc.M109.018911; Witkiewicz AK, 2012, CELL CYCLE, V11, P1108, DOI 10.4161/cc.11.6.19530; Yadav N, 2013, BBA-REV CANCER, V1836, P336, DOI 10.1016/j.bbcan.2013.10.002; Zhai XM, 2013, ONCOL REP, V30, P2983, DOI 10.3892/or.2013.2735	43	37	43	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150232	10.1371/journal.pone.0150232	http://dx.doi.org/10.1371/journal.pone.0150232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919657	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371274400107
J	Moinfar, Z; Dambach, H; Schoenebeck, B; Forster, E; Prochnow, N; Faustmann, PM				Moinfar, Zahra; Dambach, Hannes; Schoenebeck, Bodo; Foerster, Eckart; Prochnow, Nora; Faustmann, Pedro Michael			Estradiol Receptors Regulate Differential Connexin 43 Expression in F98 and C6 Glioma Cell Lines	PLOS ONE			English	Article							GAP-JUNCTION GENES; REPRODUCTIVE FACTORS; ESTROGEN; GROWTH; TUMORS; BETA; ASTROCYTES; APOPTOSIS; PROTEINS; ROLES	Introduction Glioma is the most common malignant primary brain tumour with male preponderance and poor prognosis. Glioma cells express variable amounts of connexin 43 (Cx43) and estrogen receptors (ERs). Both, Cx43 and ERs, play important roles in cell proliferation and migration. Therefore, we investigated the effects of 17-beta estradiol (E2) on Cx43 expression in two glioma cell lines with variable native expression of Cx43. Materials and Methods F98 and C6 rat glioma cells were cultured for 24 h in the presence of 10 nM or 100 nM E2, and the E2-antagonist, Fulvestrant. An MTT assay was performed to evaluate cell viability. ER alpha, ER beta and Cx43 protein expressions were analysed by western blotting and Cx43 mRNA expression was analysed by real-time polymerase chain reaction. To quantify cell migration, an exclusive zone migration assay was used. Functional coupling of cells via gap junctions was examined using whole-cell patch-clamp technique. Results E2 reduced Cx43 expression in C6 cells, but increased Cx43 expression in F98 cultures. These effects were mediated via ERs. Moreover, E2 promoted C6 cell migration, but it did not affect F98 cell migration. The expression level of ER alpha was found to be high in C6, but low in F98 cells. ER beta was exclusively expressed in C6 cells. In addition, E2 treatment induced a significant decrease of ER beta in C6 cultures, while it decreased ER alpha expression in F98 glioma cells. Discussion These findings show that E2 differentially modulates Cx43 expression in F98 and C6 glioma cells, likely due to the differential expression of ERs in each of these cell lines. Our findings point to the molecular mechanisms that might contribute to the gender-specific differences in the malignancy of glioma and could have implications for therapeutic strategies against glioma.	[Moinfar, Zahra; Dambach, Hannes; Schoenebeck, Bodo; Foerster, Eckart; Prochnow, Nora; Faustmann, Pedro Michael] Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany; [Moinfar, Zahra; Faustmann, Pedro Michael] Ruhr Univ Bochum, IGSN, D-44801 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Faustmann, PM (corresponding author), Ruhr Univ Bochum, Dept Neuroanat & Mol Brain Res, D-44801 Bochum, Germany.; Faustmann, PM (corresponding author), Ruhr Univ Bochum, IGSN, D-44801 Bochum, Germany.	Pedro.m.Faustmann@ruhr-uni-bochum.de	Moinfar, Zahra/AAE-7118-2020		International Graduate School of Neuroscience at Ruhr University Bochum	International Graduate School of Neuroscience at Ruhr University Bochum	This work was performed with funding from International Graduate School of Neuroscience at Ruhr University Bochum.	Anic GM, 2014, J NEURO-ONCOL, V118, P297, DOI 10.1007/s11060-014-1427-0; Barone TA, 2009, J NEURO-ONCOL, V95, P37, DOI 10.1007/s11060-009-9904-6; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruzzone R, 2006, CELL TISSUE RES, V326, P239, DOI 10.1007/s00441-006-0287-0; Chang EC, 2008, MOL ENDOCRINOL, V22, P1032, DOI 10.1210/me.2007-0356; DAHL G, 1981, NATURE, V289, P683, DOI 10.1038/289683a0; Decrock E, 2009, CELL DEATH DIFFER, V16, P151, DOI 10.1038/cdd.2008.138; DERMIETZEL R, 1991, J NEUROSCI, V11, P1421; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Gilmore W, 1997, J IMMUNOL, V158, P446; Gonzalez-Arenas A, 2012, BBA-MOL CELL RES, V1823, P379, DOI 10.1016/j.bbamcr.2011.11.004; Hinkerohe D, 2011, J NEURO-ONCOL, V103, P479, DOI 10.1007/s11060-010-0456-6; Huang K, 2004, CANCER EPIDEM BIOMAR, V13, P1583; Huang RP, 1999, J SURG ONCOL, V70, P21, DOI 10.1002/(SICI)1096-9098(199901)70:1<21::AID-JSO4>3.3.CO;2-S; Kabat GC, 2010, CANCER EPIDEM BIOMAR, V19, P2421, DOI 10.1158/1055-9965.EPI-10-0658; Kim JH, 2011, BMB REP, V44, P452, DOI 10.5483/BMBRep.2011.44.7.452; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Li WJ, 2013, BRAIN RES, V1503, P97, DOI 10.1016/j.brainres.2013.02.004; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Lonn S, 2004, INT J CANCER, V108, P450, DOI 10.1002/ijc.11578; McKinley BP, 2000, J NEUROSURG, V93, P932, DOI 10.3171/jns.2000.93.6.0932; NAUS CCG, 1991, NEUROSCI LETT, V126, P33, DOI 10.1016/0304-3940(91)90364-Y; Nilsson S, 2011, NAT REV DRUG DISCOV, V10, P778, DOI 10.1038/nrd3551; Omori Y, 1998, INT J CANCER, V78, P446, DOI 10.1002/(SICI)1097-0215(19981109)78:4<446::AID-IJC10>3.3.CO;2-4; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Sareddy GR, 2012, MOL CANCER THER, V11, P1174, DOI 10.1158/1535-7163.MCT-11-0960; Sin WC, 2012, BBA-BIOMEMBRANES, V1818, P2058, DOI 10.1016/j.bbamem.2011.10.022; Sur P, 2003, BRAIN RES, V971, P178, DOI 10.1016/S0006-8993(03)02349-7; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Ul-Hussain M, 2014, J BIOL CHEM, V289, P20979, DOI 10.1074/jbc.M113.540187; Yamasaki H, 1999, CR ACAD SCI III-VIE, V322, P151, DOI 10.1016/S0764-4469(99)80038-9; YU W, 1994, P ROY SOC B-BIOL SCI, V255, P125, DOI 10.1098/rspb.1994.0018; Zhang YW, 2003, J BIOL CHEM, V278, P44852, DOI 10.1074/jbc.M305072200	37	7	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150007	10.1371/journal.pone.0150007	http://dx.doi.org/10.1371/journal.pone.0150007			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919293	Green Published, gold			2022-12-27	WOS:000371274400068
J	Sharma, M; Mukhopadhyay, A; Gupta, V; Pental, D; Pradhan, AK				Sharma, Manisha; Mukhopadhyay, Arundhati; Gupta, Vibha; Pental, Deepak; Pradhan, Akshay K.			BjuB.CYP79F1 Regulates Synthesis of Propyl Fraction of Aliphatic Glucosinolates in Oilseed Mustard Brassica juncea: Functional Validation through Genetic and Transgenic Approaches	PLOS ONE			English	Article							SEQ BASED SNPS; CHAIN ELONGATION; BIOSYNTHESIS; EVOLUTION; IDENTIFICATION; OLERACEA; GENOMES; LINES; REVEALS; CYP79F1	Among the different types of methionine-derived aliphatic glucosinolates (GS), sinigrin (2-propenyl), the final product in 3C GS biosynthetic pathway is considered very important as it has many pharmacological and therapeutic properties. In Brassica species, the candidate gene regulating synthesis of 3C GS remains ambiguous. Earlier reports of GSL-PRO, an ortholog of Arabidopsis thaliana gene At1g18500 as a probable candidate gene responsible for 3C GS biosynthesis in B. napus and B. oleracea could not be validated in B. juncea through genetic analysis. In this communication, we report the isolation and characterization of the gene CYP79F1, an ortholog of A. thaliana gene At1g16410 that is involved in the first step of core GS biosynthesis. The gene CYP79F1 in B. juncea showed presence-absence polymorphism between lines Varuna that synthesizes sinigrin and Heera virtually free from sinigrin. Using this presence-absence polymorphism, CYP79F1 was mapped to the previously mapped 3C GS QTL region (J16Gsl4) in the LG B4 of B. juncea. In Heera, the gene was observed to be truncated due to an insertion of a similar to 4.7 kb TE like element leading to the loss of function of the gene. Functional validation of the gene was carried out through both genetic and transgenic approaches. An F-2 population segregating only for the gene CYP79F1 and the sinigrin phenotype showed perfect co-segregation. Finally, genetic transformation of a B. juncea line (QTL-NIL J16Gsl4) having high seed GS but lacking sinigrin with the wild type CYP79F1 showed the synthesis of sinigrin validating the role of CYP79F1 in regulating the synthesis of 3C GS in B. juncea.	[Sharma, Manisha; Pental, Deepak; Pradhan, Akshay K.] Univ Delhi South Campus, Dept Genet, New Delhi, India; [Mukhopadhyay, Arundhati; Gupta, Vibha; Pental, Deepak; Pradhan, Akshay K.] Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India	University of Delhi; University of Delhi	Pradhan, AK (corresponding author), Univ Delhi South Campus, Dept Genet, New Delhi, India.; Pradhan, AK (corresponding author), Univ Delhi South Campus, Ctr Genet Manipulat Crop Plants, New Delhi, India.	pradhancgmcp@gmail.com			National Dairy Development Board (NDDB) [PFA:DU:882]; Department of Biotechnology, Government of India through Centre of Excellence on Brassica breeding [BT/01/COE/08/06-II]; University Grants Commission (UGC), India	National Dairy Development Board (NDDB); Department of Biotechnology, Government of India through Centre of Excellence on Brassica breeding; University Grants Commission (UGC), India(University Grants Commission, India)	The study was funded by the National Dairy Development Board (NDDB) (http://www.nddb.org/) (PF&A:DU:882) and also partly supported by the Department of Biotechnology (http://www.dbtindia.nic.in/), Government of India, through the award of a Centre of Excellence on Brassica breeding (BT/01/COE/08/06-II). MS acknowledges the receipt of research fellowship from the University Grants Commission (UGC) (http://www.ugc.ac.in/), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine R, 2013, PLANT BIOTECHNOL J, V11, P855, DOI 10.1111/pbi.12078; Bhattacharya A, 2010, CARCINOGENESIS, V31, P2105, DOI 10.1093/carcin/bgq202; Bisht NC, 2009, THEOR APPL GENET, V118, P413, DOI 10.1007/s00122-008-0907-z; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chapple C, 1998, ANNU REV PLANT PHYS, V49, P311, DOI 10.1146/annurev.arplant.49.1.311; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; Gao JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088804; Gao MQ, 2007, THEOR APPL GENET, V115, P277, DOI 10.1007/s00122-007-0568-3; Gao MQ, 2006, PLANT CELL REP, V25, P592, DOI 10.1007/s00299-005-0078-1; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gland A, 1981, Z PFLANZENZUECHTUNG, P87; Goldberg T, 2012, BIOINFORMATICS, V28, pI458, DOI 10.1093/bioinformatics/bts390; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen CH, 2001, J BIOL CHEM, V276, P11078, DOI 10.1074/jbc.M010123200; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Ishida M, 2014, BREEDING SCI, V64, P48, DOI 10.1270/jsbbs.64.48; Jagannath A., 2003, PLANT GENETIC ENG, V2, P349; Jie M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110145; Khokon MAR, 2011, PLANT CELL ENVIRON, V34, P1900, DOI 10.1111/j.1365-3040.2011.02385.x; Kroymann J, 2001, PLANT PHYSIOL, V127, P1077, DOI 10.1104/pp.010416; Li G, 2003, THEOR APPL GENET, V107, P168, DOI 10.1007/s00122-003-1236-x; Liu SY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4930; MAGRATH R, 1994, HEREDITY, V72, P290, DOI 10.1038/hdy.1994.39; Okulicz M, 2010, PLANT FOOD HUM NUTR, V65, P217, DOI 10.1007/s11130-010-0183-3; Panjabi P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-113; Paritosh K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-396; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, pS446; Ramchiary N, 2007, THEOR APPL GENET, V116, P77, DOI 10.1007/s00122-007-0648-4; Reintanz B, 2001, PLANT CELL, V13, P351, DOI 10.1105/tpc.13.2.351; Rogers SO, 1994, PLANT MOL BIOL MANUA, P1; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Rout K, 2015, THEOR APPL GENET, V128, P657, DOI 10.1007/s00122-015-2461-9; Sharma S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093260; Sodhi YS, 2002, PLANT BREEDING, V121, P508, DOI 10.1046/j.1439-0523.2002.00747.x; Sonderby IE, 2010, TRENDS PLANT SCI, V15, P283, DOI 10.1016/j.tplants.2010.02.005; Sonderby IE, 2010, PLANT PHYSIOL, V153, P348, DOI 10.1104/pp.109.149286; Sotelo T, 2015, APPL ENVIRON MICROB, V81, P432, DOI 10.1128/AEM.03142-14; Srivastava A, 2001, THEOR APPL GENET, V102, P193, DOI 10.1007/s001220051635; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Van Ooijen JW, 2006, JOINMAP 4 SOFTWARE C, P33; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wang TX, 2012, KOREAN J CHEM ENG, V29, P396, DOI 10.1007/s11814-011-0175-5; Yang JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-107	44	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150060	10.1371/journal.pone.0150060	http://dx.doi.org/10.1371/journal.pone.0150060			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919200	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400080
J	Sherwood, JL; Corcoran, C; Brown, H; Sharpe, AD; Musilova, M; Kohlmann, A				Sherwood, James L.; Corcoran, Claire; Brown, Helen; Sharpe, Alan D.; Musilova, Milena; Kohlmann, Alexander			Optimised Pre-Analytical Methods Improve KRAS Mutation Detection in Circulating Tumour DNA (ctDNA) from Patients with Non-Small Cell Lung Cancer (NSCLC)	PLOS ONE			English	Article							BLOOD-PROCESSING PROTOCOLS; SAMPLE STORAGE; EGFR MUTATIONS; PLASMA; SERUM; QUANTIFICATION; CARCINOMA; TISSUE	Introduction Non-invasive mutation testing using circulating tumour DNA (ctDNA) is an attractive premise. This could enable patients without available tumour sample to access more treatment options. Materials & Methods Peripheral blood and matched tumours were analysed from 45 NSCLC patients. We investigated the impact of pre-analytical variables on DNA yield and/or KRAS mutation detection: sample collection tube type, incubation time, centrifugation steps, plasma input volume and DNA extraction kits. Results 2 hr incubation time and double plasma centrifugation (2000 x g) reduced overall DNA yield resulting in lowered levels of contaminating genomic DNA (gDNA). Reduced "contamination" and increased KRAS mutation detection was observed using cell-free DNA Blood Collection Tubes (cfDNA BCT) (Streck), after 72 hrs following blood draw compared to EDTA tubes. Plasma input volume and use of different DNA extraction kits impacted DNA yield. Conclusion This study demonstrated that successful ctDNA recovery for mutation detection in NSCLC is dependent on pre-analytical steps. Development of standardised methods for the detection of KRAS mutations from ctDNA specimens is recommended to minimise the impact of pre-analytical steps on mutation detection rates. Where rapid sample processing is not possible the use of cfDNA BCT tubes would be advantageous.	[Sherwood, James L.; Corcoran, Claire; Brown, Helen; Sharpe, Alan D.; Musilova, Milena; Kohlmann, Alexander] AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Darwin Bldg,310 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England	AstraZeneca	Sherwood, JL (corresponding author), AstraZeneca, Personalised Healthcare & Biomarkers, Innovat Med & Early Dev Biotech Unit, Darwin Bldg,310 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England.	James.sherwood@astrazeneca.com	Sherwood, James L/C-5559-2016	Sherwood, James L/0000-0002-7429-4369	AstraZeneca	AstraZeneca(AstraZeneca)	This work was funded by AstraZeneca. The funder provided support in the form of salaries for all authors, but did not have any role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Aung KL, 2011, CURRENT STATUS FUTUR, V4, P11; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Das K, EFFECTS NOVEL CELL S, V0203, P55, DOI [10.1016/j.acthis.2013.05.002, DOI 10.1016/J.ACTHIS.2013.05.002]; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Douillard J, 2014, GEFITINIB TREATMENT, V9; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Ellison G, 2010, CLIN CANCER RES, V16, pPR4; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Hirsch FR, 2010, CLIN CANCER RES, V16, P4909, DOI 10.1158/1078-0432.CCR-10-2005; Hung ECW, 2009, J CLIN PATHOL, V62, P308, DOI 10.1136/jcp.2007.048470; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Jahr S, 2001, CANCER RES, V61, P1659; Jiang PY, 2015, P NATL ACAD SCI USA, V112, pE1317, DOI 10.1073/pnas.1500076112; Kerr KM, 2012, HISTOPATHOLOGY, V60, P531, DOI 10.1111/j.1365-2559.2011.03854.x; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; LO YMD, 1999, RAPID CLEARANCE FETA, V64, P218; LUO J, 2014, SCI REP, V4; Morgan SR, 2012, CLIN MED INSIGHTS-PA, V5, P15, DOI 10.4137/CPath.S8798; Mosko MJ, 2016, J MOL DIAGN, V18, P23, DOI 10.1016/j.jmoldx.2015.08.001; Mouliere F, 2015, P NATL ACAD SCI USA, V112, P3178, DOI 10.1073/pnas.1501321112; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Peake Mick, 2014, NATL LUNG CANC AUDIT; Perrone F, 2014, CIRCULATING FREE DNA, P115, DOI [10.1700/1491.16389, DOI 10.1700/1491.16389]; Pirker R, 2014, CURR OPIN ONCOL, V26, P145, DOI 10.1097/CCO.0000000000000056; Qin BM, 2005, CELL RES, V15, P212, DOI 10.1038/sj.cr.7290289; Qiu MT, 2015, CANCER EPIDEM BIOMAR, V24, P206, DOI 10.1158/1055-9965.EPI-14-0895; Sequist LV, 2015, NEW ENGL J MED, V372, P1700, DOI 10.1056/NEJMoa1413654; Sherwood JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100566; Siravegna G, 2015, NAT MED; Su YH, 2008, ANN NY ACAD SCI, V1137, P197, DOI 10.1196/annals.1448.027; Swinkels DW, 2003, CLIN CHEM, V49, P525, DOI 10.1373/49.3.525; Taniguchi K, 2011, CLIN CANCER RES, V17, P7808, DOI 10.1158/1078-0432.CCR-11-1712; Tjensvoll K, 2015, CLIN RELEVANCE CIRCU; Vallee A, 2013, LUNG CANCER, V82, P373, DOI 10.1016/j.lungcan.2013.08.014; Wang SH, 2010, CLIN CANCER RES, V16, P1324, DOI 10.1158/1078-0432.CCR-09-2672; Weber B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-294; Xu JM, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0104-7; Xue XY, 2009, CLIN CHIM ACTA, V404, P100, DOI 10.1016/j.cca.2009.02.018; Yokota M, 1999, J CLIN LAB ANAL, V13, P133, DOI 10.1002/(SICI)1098-2825(1999)13:3<133::AID-JCLA8>3.0.CO;2-0; Zeerleder S, 2006, CRIT CARE, V10, DOI 10.1186/cc4932	45	107	109	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150197	10.1371/journal.pone.0150197	http://dx.doi.org/10.1371/journal.pone.0150197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918901	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400101
J	Zhang, XR; Kluz, T; Gesumaria, L; Matsui, MS; Costa, M; Sun, H				Zhang, Xiaoru; Kluz, Thomas; Gesumaria, Lisa; Matsui, Mary S.; Costa, Max; Sun, Hong			Solar Simulated Ultraviolet Radiation Induces Global Histone Hypoacetylation in Human Keratinocytes	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; DOUBLE-STRAND BREAKS; UV-IRRADIATION; H2AX PHOSPHORYLATION; CHROMATIN-STRUCTURE; HUMAN-CELLS; LYSINE 56; REPAIR; ACETYLATION; PROTEIN	Ultraviolet radiation (UVR) from sunlight is the primary effector of skin DNA damage. Chromatin remodeling and histone post-translational modification (PTM) are critical factors in repairing DNA damage and maintaining genomic integrity, however, the dynamic changes of histone marks in response to solar UVR are not well characterized. Here we report global changes in histone PTMs induced by solar simulated UVR (ssUVR). A decrease in lysine acetylation of histones H3 and H4, particularly at positions of H3 lysine 9, lysine 56, H4 lysine 5, and lysine 16, was found in human keratinocytes exposed to ssUVR. These acetylation changes were highly associated with ssUVR in a dose-dependent and time-specific manner. Interestingly, H4K16ac, a mark that is crucial for higher order chromatin structure, exhibited a persistent reduction by ssUVR that was transmitted through multiple cell divisions. In addition, the enzymatic activities of histone acetyltransferases were significantly reduced in irradiated cells, which may account for decreased global acetylation. Moreover, depletion of histone deacetylase SIRT1 in keratinocytes rescued ssUVR-induced H4K16 hypoacetylation. These results indicate that ssUVR affects both HDAC and HAT activities, leading to reduced histone acetylation.	[Zhang, Xiaoru; Kluz, Thomas; Gesumaria, Lisa; Costa, Max; Sun, Hong] New York Univ, Dept Environm Med, Tuxedo Pk, NY USA; [Matsui, Mary S.] Estee Lauder Co Inc, Melville, NY USA	New York University; Estee Lauder Companies	Costa, M; Sun, H (corresponding author), New York Univ, Dept Environm Med, Tuxedo Pk, NY USA.	Max.Costa@nyumc.org; Hong.Sun@nyumc.org			NIH [R03 ES023028, P30 ES000260]; Estee Lauder Companies, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R03ES023028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Estee Lauder Companies, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grant number R03 ES023028, to HS, XZ; NIH grant number P30 ES000260, to MC. This work was partially funded by Estee Lauder Companies, Inc., which provided the solar simulated UV radiation instrument. Author Mary S. Matsui is employed by Estee Lauder Companies, Inc. Estee Lauder Companies, Inc. provided support in the form of salary for author MSM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Athar M, 2000, BIOCHEM BIOPH RES CO, V277, P107, DOI 10.1006/bbrc.2000.3436; Bartova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027281; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; D'Orazio J, 2013, INT J MOL SCI, V14, P12222, DOI 10.3390/ijms140612222; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Farrell AW, 2011, INT J MOL SCI, V12, P8063, DOI 10.3390/ijms12118063; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Fullgrabe J, 2014, AUTOPHAGY, V10, P556, DOI 10.4161/auto.27280; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gesumaria L, 2015, EXP DERMATOL, V24, P384, DOI 10.1111/exd.12675; Gospodinov A, 2013, MUTAT RES-REV MUTAT, V752, P45, DOI 10.1016/j.mrrev.2012.10.001; Hajji N, 2010, ONCOGENE, V29, P2192, DOI 10.1038/onc.2009.505; Hanasoge S, 2007, CARCINOGENESIS, V28, P2298, DOI 10.1093/carcin/bgm157; Hiraoka N, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.66; Hsiao KY, 2013, J MOL CELL BIOL, V5, P157, DOI 10.1093/jmcb/mjs066; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Khurana S, 2014, CELL REP, V8, P1049, DOI 10.1016/j.celrep.2014.07.024; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Luijsterburg MS, 2011, MOL ONCOL, V5, P349, DOI 10.1016/j.molonc.2011.06.001; Maroschik B, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-15; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Miller KM, 2010, NAT STRUCT MOL BIOL, V17, P1144, DOI 10.1038/nsmb.1899; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Ouyang WM, 2005, CANCER RES, V65, P9287, DOI 10.1158/0008-5472.CAN-05-0469; Pena PV, 2008, J MOL BIOL, V380, P303, DOI 10.1016/j.jmb.2008.04.061; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; RAMANATHAN B, 1986, CARCINOGENESIS, V7, P1087, DOI 10.1093/carcin/7.7.1087; Rastogi RP, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/592980; Rossetto D, 2010, CLIN CANCER RES, V16, P4543, DOI 10.1158/1078-0432.CCR-10-0513; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Sustackova G, 2012, J CELL PHYSIOL, V227, P1838, DOI 10.1002/jcp.22912; Tjeertes JV, 2009, EMBO J, V28, P1878, DOI 10.1038/emboj.2009.119; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vempati RK, 2010, J BIOL CHEM, V285, P28553, DOI 10.1074/jbc.M110.149393; Yang W, 2011, PROTEIN SCI, V20, P1781, DOI 10.1002/pro.723; Young LC, 2013, J BIOL CHEM, V288, P21376, DOI 10.1074/jbc.M113.491514; Yu YC, 2005, P NATL ACAD SCI USA, V102, P8650, DOI 10.1073/pnas.0501458102	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150175	10.1371/journal.pone.0150175	http://dx.doi.org/10.1371/journal.pone.0150175			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918332	Green Published, gold			2022-12-27	WOS:000371274400097
J	Zhao, Y; Zhang, XL; Chen, JZ; Lin, C; Shao, RF; Yan, CX; Chen, C				Zhao, Yan; Zhang, Xinli; Chen, Jiezhong; Lin, Chao; Shao, Renfu; Yan, Chunxia; Chen, Chen			Hexarelin Protects Rodent Pancreatic B-Cells Function from Cytotoxic Effects of Streptozotocin Involving Mitochondrial Signalling Pathways In Vivo and In Vitro	PLOS ONE			English	Article							BETA-CELLS; INSULIN-SECRETION; GLUCOSE-HOMEOSTASIS; GHRELIN RECEPTOR; APOPTOSIS; DYSFUNCTION; RAT; METABOLISM; ABLATION; MODEL	Mitochondrial functions are crucial for pancreatic beta-cell survival and glucose-induced insulin secretion. Hexarelin (Hex) is a synthetic small peptide ghrelin analogue, which has been shown to protect cardiomyocytes from the ischemia-reperfusion process. In this study, we used in vitro and in vivo models of streptozotocin (STZ)-induced beta-cell damage to study the protective effect of Hex and the associated mechanisms. We found that STZ produced a cytotoxic effect in a dose-and time-dependent manner in MIN6 cells (a mouse beta-cell line). Hex (1.0 mu M) decreased the STZ-induced damage in beta-cells. Rhodamine 123 assay and superoxide DHE production assay revealed that Hex ameliorated STZ-induced mitochondrial damage and excessive superoxide activity in beta-cells. In addition, Hex significantly reduced STZ-induced expression of cleaved Caspases-3, Caspases-9 and the ratio of proapoptotic protein Bax to anti-apoptotic protein Bcl-2 in MIN6 cells. We further examined the in vivo effect of Hex in a rat model of type 1 diabetes induced by STZ injection. Hex ameliorated STZ-induced decrease in plasma insulin and protected the structure of islets from STZ-induced disruption. Hex also ameliorated STZ-induced expression of cleaved Caspase-9 and the Bax in beta-cells. In conclusion, our data indicate that Hex is able to protects beta-cell mass from STZ-caused cytotoxic effects involving mitochondrial pathways in vitro and in vivo. Hex may serve as a potential protective agent for the management of diabetes.	[Zhao, Yan] Xian Med Univ, Inst Basic Med Sci, Xian, Peoples R China; [Zhao, Yan; Yan, Chunxia] Xi An Jiao Tong Univ, Dept Forens Sci, Sch Med, Xian 710049, Peoples R China; [Zhao, Yan; Zhang, Xinli; Chen, Jiezhong; Lin, Chao; Chen, Chen] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Shao, Renfu] Univ Sunshine Coast, Gene Cology Res Ctr, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	Xi'an Medical University; Xi'an Jiaotong University; University of Queensland; University of the Sunshine Coast	Chen, C (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	chen.chen@uq.edu.au	CHEN, CHEN/HDM-6657-2022; Chen, Chen/B-4284-2010; chen, chen/GRY-7085-2022	Chen, Chen/0000-0003-2104-534X; Chen, Jiezhong/0000-0003-1977-6143; Shao, Renfu/0000-0002-1686-4968	NHMRC; University of Queensland; National Nature Science Foundation of China (NSFC) [81501175]; Leading Disciplines Development Government Foundation of Shaanxi, China; overseas postgraduate research scholarship from the China Scholarship Council (CSC)	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland); National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Leading Disciplines Development Government Foundation of Shaanxi, China; overseas postgraduate research scholarship from the China Scholarship Council (CSC)	Research work was supported by NHMRC, the University of Queensland, the National Nature Science Foundation of China (NSFC grant no. 81501175) and the Leading Disciplines Development Government Foundation of Shaanxi, China. YZ is a recipient of overseas postgraduate research scholarship from the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arunachalam K, 2013, J ETHNOPHARMACOL, V147, P302, DOI 10.1016/j.jep.2013.03.004; Bando M, 2013, AM J PHYSIOL-ENDOC M, V305, pE140, DOI 10.1152/ajpendo.00112.2013; Chabot F, 2014, WORLD J DIABETES, V5, P328, DOI 10.4239/wjd.v5.i3.328; Chang KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054374; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Ortiz MD, 2013, NEUROCHEM RES, V38, P2570, DOI 10.1007/s11064-013-1172-3; Delhanty PJD, 2012, EUR J ENDOCRINOL, V167, P601, DOI 10.1530/EJE-12-0456; Dezaki K, 2006, DIABETES, V55, P3486, DOI 10.2337/db06-0878; Egro FM, 2013, J MOL ENDOCRINOL, V51, pR1, DOI 10.1530/JME-13-0067; Fink B, 2004, AM J PHYSIOL-CELL PH, V287, pC895, DOI 10.1152/ajpcell.00028.2004; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Gajdosik A, 1999, GEN PHYSIOL BIOPHYS, V18, P54; Ghasemi A, 2014, ACTA PHYSIOL HUNG, V101, P408, DOI 10.1556/APhysiol.101.2014.4.2; Gimenez-Cassina A, 2015, TRENDS ENDOCRIN MET, V26, P165, DOI 10.1016/j.tem.2015.02.004; Ginter E, 2013, ADV EXP MED BIOL, V771, P35; Granata R, 2007, ENDOCRINOLOGY, V148, P512, DOI 10.1210/en.2006-0266; Hosoda H, 2006, J PHARMACOL SCI, V100, P398, DOI 10.1254/jphs.CRJ06002X; Jian L, 2013, HORM METAB RES, V45, P561, DOI 10.1055/s-0033-1341500; Jimenez-Gonzalez M, 2013, DIABETOLOGIA, V56, P838, DOI 10.1007/s00125-012-2822-8; JOHANSSON EB, 1978, ACTA ENDOCRINOL-COP, V89, P339, DOI 10.1530/acta.0.0890339; Kumar S, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-95; Kushner JA, 2013, J CLIN INVEST, V123, P990, DOI 10.1172/JCI64095; Lenzen S, 2008, DIABETOLOGIA, V51, P216, DOI 10.1007/s00125-007-0886-7; Lightfoot YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020617; Lim S, 2011, CELL PHYSIOL BIOCHEM, V28, P873, DOI 10.1159/000335802; Lin CY, 2012, CYTOKINE, V59, P65, DOI 10.1016/j.cyto.2012.04.011; Lin LG, 2011, AGING CELL, V10, P996, DOI 10.1111/j.1474-9726.2011.00740.x; Lin Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.206; Liu L, 2010, GROWTH FACTORS, V28, P370, DOI 10.3109/08977194.2010.504721; Ma XJ, 2012, AM J PHYSIOL-ENDOC M, V303, pE422, DOI 10.1152/ajpendo.00576.2011; Ma Y, 2012, ENDOCRINOLOGY, V153, P5480, DOI 10.1210/en.2012-1404; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035265; Mao YJ, 2014, J GERIATR CARDIOL, V11, P253, DOI 10.11909/j.issn.1671-5411.2014.03.007; Maric G, 2014, ACTA PHYSIOL HUNG, V101, P395, DOI 10.1556/APhysiol.101.2014.4.1; McGill JB, 2012, CURR DIABETES REV, V8, P257, DOI 10.2174/157339912800840541; Mohan V, 2004, J Assoc Physicians India, V52, P468; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Scully Tony, 2012, Nature, V485, pS2; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Stiles L, 2012, BEST PRACT RES CL EN, V26, P725, DOI 10.1016/j.beem.2012.05.004; Sun Y, 2006, CELL METAB, V3, P379, DOI 10.1016/j.cmet.2006.04.004; Supale S, 2012, TRENDS ENDOCRIN MET, V23, P477, DOI 10.1016/j.tem.2012.06.002; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Vestergaard ET, 2008, DIABETES, V57, P3205, DOI 10.2337/db08-0025; Wierup N, 2013, J MOL ENDOCRINOLOGY; Wu JZ, 2015, DIABET METAB SYND OB, V8, P181, DOI 10.2147/DMSO.S82272; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Zhang ZF, 2011, EUR J PHARMACOL, V670, P311, DOI 10.1016/j.ejphar.2011.08.033; Zhao YF, 2010, ENDOCRINE, V37, P76, DOI 10.1007/s12020-009-9275-y	50	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149730	10.1371/journal.pone.0149730	http://dx.doi.org/10.1371/journal.pone.0149730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918825	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400041
J	Guedes, RNC; Yack, JE				Guedes, Raul Narciso C.; Yack, Jayne E.			Shaking Youngsters and Shaken Adults: Female Beetles Eavesdrop on Larval Seed Vibrations to Make Egg-Laying Decisions	PLOS ONE			English	Article							CALLOSOBRUCHUS-MACULATUS COLEOPTERA; AZUKI-BEAN WEEVIL; COWPEA WEEVIL; OVIPOSITION DECISIONS; F COLEOPTERA; BEHAVIOR; COMPETITION; BRUCHIDAE; DISCRIMINATION; CHINENSIS	Egg-laying decisions are critical for insects, and particularly those competing for limited resources. Sensory information used by females to mediate egg-laying decisions has been reported to be primarily chemical, but the role of vibration has received little attention. We tested the hypothesis that vibrational cues produced by feeding larvae occupying a seed influences egg-laying decisions amongst female cowpea beetles. This hypothesis is supported by three lines of evidence using two strains of the cowpea beetle (Callosobruchus maculatus), an Indian strain with choosy females and aggressively competing larvae and a Brazilian strain with less choosy females and larvae exhibiting an "accommodating" type of competition. First, in free-choice bioassays of seed selection, choosy Indian females selected control seeds (free of eggs, larvae, or egg-laying marker) over seeds with live larvae (free of eggs and egg-laying marker), but did not discriminate between control seeds and those with dead larvae. In contrast, less choosy Brazilian females showed no preference for seeds containing live or dead larvae over controls. Second, laser-doppler vibrometer recordings confirmed that larvae feeding inside seeds generate vibrations that are available to the female during egg-laying decisions. Third, during dichotomous choice experiments where artificial vibrations approximating those produced by feeding larvae were played back during seed selection, Indian females preferred immobile control seeds over vibrating seeds, but Brazilian females showed no preference. These results support the hypothesis that females use larval vibrations in their egg-laying decisions; whether these vibrations are passive cues exploited by the female, or active signals that 'steer' the behaviour of the female is unknown. We propose that vibration cues and signals could be important for host selection in insects, particularly those laying on substrates where visual or chemical cues may be unreliable. This seems to be the case with females of the cowpea beetle since visual cues are not important and chemical egg-marking does not last more than two weeks, allowing vibration cues to improve discrimination of egg-laying substrate particularly by choosy females.	[Guedes, Raul Narciso C.] Univ Fed Vicosa, Dept Entomol, BR-36570900 Vicosa, MG, Brazil; [Guedes, Raul Narciso C.; Yack, Jayne E.] Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada	Universidade Federal de Vicosa; Carleton University	Yack, JE (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	jayneyack@cunet.carleton.ca	Guedes, Raul Narciso Carvalho/L-3924-2013	Guedes, Raul Narciso Carvalho/0000-0001-6229-7549	Natural Sciences and Engineering Research Council of Canada (NSERC) [261847-2007]; Canadian Foundation for Innovation (CFI) [9555]; National Council of Scientific and Technological Development (CNPq) [PDE016 301847-2015]; Minas Gerais State Foundation of Research Aid (FAPEMIG) [CAG-201234]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); National Council of Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais State Foundation of Research Aid (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC), grant no: 261847-2007 (URL: http://www.nserc-crsng.gc.ca/index_eng.asp); Canadian Foundation for Innovation (CFI), grant no: 9555 (URL: http://www.innovation.ca/); National Council of Scientific and Technological Development (CNPq), grant no: PDE016 301847-2015 (URL: www.cnpq.br); and Minas Gerais State Foundation of Research Aid (FAPEMIG), grant no: CAG-201234 (URL: www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STUDYING VIBRATIONAL; BELLOWS TS, 1982, J ANIM ECOL, V51, P263, DOI 10.2307/4324; Clotuche G, 2013, BEHAV PROCESS, V92, P24, DOI 10.1016/j.beproc.2012.09.014; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cope JM, 2003, J STORED PROD RES, V39, P355, DOI 10.1016/S0022-474X(02)00028-0; Crediland PF, 1986, J ECON ENTOMOL, V11, P41; CREDLAND PF, 1987, J STORED PROD RES, V23, P31, DOI 10.1016/0022-474X(87)90033-6; CREDLAND PF, 1990, PHYSIOL ENTOMOL, V15, P285, DOI 10.1111/j.1365-3032.1990.tb00517.x; Devereau AD, 2003, J STORED PROD RES, V39, P117, DOI 10.1016/S0022-474X(02)00025-5; Field LH, 1998, ADV INSECT PHYSIOL, V27, P1, DOI 10.1016/S0065-2806(08)60013-2; Fricke C, 2004, J EVOLUTION BIOL, V17, P1345, DOI 10.1111/j.1420-9101.2004.00757.x; Guedes RNC, 2012, J COMP PHYSIOL A, V198, P325, DOI 10.1007/s00359-012-0711-8; Guedes RNC, 2007, AUSTRAL ECOL, V32, P697, DOI 10.1111/j.1442-9993.2007.01769.x; Guedes RNC, 2008, PHYSIOL ENTOMOL, V33, P372, DOI 10.1111/j.1365-3032.2008.00643.x; Guedes RNC, 2003, PHYSIOL ENTOMOL, V28, P298, DOI 10.1111/j.1365-3032.2003.00347.x; Hill P.S., 2008, VIBRATIONAL COMMUNIC, DOI DOI 10.4159/9780674273825; Horng SB, 1999, RES POPUL ECOL, V41, P283, DOI 10.1007/s101440050033; Horng SB, 1997, ANIM BEHAV, V53, P1, DOI 10.1006/anbe.1996.9999; Ignacimuthu S, 2000, ENTOMOL EXP APPL, V96, P213, DOI 10.1023/A:1004016127866; Jeram S, 1996, TISSUE CELL, V28, P227, DOI 10.1016/S0040-8166(96)80011-5; Messina FJ, 2004, ECOL ENTOMOL, V29, P318, DOI 10.1111/j.1365-2311.2004.0599.x; MESSINA FJ, 1991, ECOL ENTOMOL, V16, P509, DOI 10.1111/j.1365-2311.1991.tb00243.x; MESSINA FJ, 1989, J INSECT BEHAV, V2, P727, DOI 10.1007/BF01049397; MESSINA FJ, 1985, ECOL ENTOMOL, V10, P225, DOI 10.1111/j.1365-2311.1985.tb00552.x; MESSINA FJ, 1985, ENTOMOL EXP APPL, V37, P241, DOI 10.1007/BF00191655; MESSINA FJ, 1987, ENTOMOL EXP APPL, V43, P169, DOI 10.1007/BF00301748; MESSINA FJ, 1993, ANN ENTOMOL SOC AM, V86, P207, DOI 10.1093/aesa/86.2.207; MESSINA FJ, 1987, J CHEM ECOL, V13, P219, DOI 10.1007/BF01020364; Messina FJ, 2014, ENTOMOL EXP APPL, V153, P231, DOI 10.1111/eea.12244; Messina FJ, 2013, ANN ENTOMOL SOC AM, V106, P128, DOI 10.1603/AN12103; Messina FJ, 2009, ANN ENTOMOL SOC AM, V102, P181, DOI 10.1603/008.102.0121; Meyhofer R, 1999, J INSECT PHYSIOL, V45, P967, DOI 10.1016/S0022-1910(99)00060-8; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MITCHELL R, 1975, ECOLOGY, V56, P696, DOI 10.2307/1935504; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; OFUYA T, 1989, ECOL ENTOMOL, V14, P243, DOI 10.1111/j.1365-2311.1989.tb00776.x; OSHIMA K, 1973, AGR BIOL CHEM TOKYO, V37, P2679, DOI 10.1080/00021369.1973.10861061; Polajnar J, 2015, PEST MANAG SCI, V71, P15, DOI 10.1002/ps.3848; RYOO MI, 1993, ENVIRON ENTOMOL, V22, P1009, DOI 10.1093/ee/22.5.1009; SAS Institute, 2008, SAS STAT US MAN VER; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; Smith R.H., 1985, P423; SMITH RH, 1991, ADV ECOL RES, V21, P63, DOI 10.1016/S0065-2504(08)60097-5; SMITH RH, 1990, SERIES ENTOM, V46, P351; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; SOUTHGATE BJ, 1979, ANNU REV ENTOMOL, V24, P449, DOI 10.1146/annurev.en.24.010179.002313; Tanaka Y, 2000, ENTOMOL EXP APPL, V96, P239, DOI 10.1023/A:1004059726050; THANTHIANGA C, 1987, ENTOMOL EXP APPL, V44, P15, DOI 10.1007/BF00361303; Tran BMD, 1995, BIOL J LINN SOC, V56, P483, DOI 10.1111/j.1095-8312.1995.tb01106.x; Tuda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106268; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; Wang Xiaoyi, 2008, Acta Ecologica Sinica, V28, P1257; WASSERMAN SS, 1985, J ECON ENTOMOL, V78, P89, DOI 10.1093/jee/78.1.89; WILSON K, 1988, ECOL ENTOMOL, V13, P107, DOI 10.1111/j.1365-2311.1988.tb00338.x; Yack J.E., 2016, SPRINGER HDB AUDITOR, V44; Yang RL, 2006, ECOL ENTOMOL, V31, P285, DOI 10.1111/j.1365-2311.2006.00696.x	56	11	11	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150034	10.1371/journal.pone.0150034	http://dx.doi.org/10.1371/journal.pone.0150034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913508	Green Submitted, gold, Green Published			2022-12-27	WOS:000371175700047
J	Hartung, JC; Wilitzki, S; Thio-Lluch, M; te Pas, AB; Schmalisch, G; Roehr, CC				Hartung, Julia C.; Wilitzki, Silke; Thio-Lluch, Marta; te Pas, Arjan B.; Schmalisch, Gerd; Roehr, Charles C.			Reliability of Single-Use PEEP-Valves Attached to Self-Inflating Bags during Manual Ventilation of Neonates - An In Vitro Study	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; FUNCTIONAL RESIDUAL CAPACITY; PRETERM INFANTS; DELIVERY ROOM; RESUSCITATION; BIRTH; TRANSITION; MINUTES; DEVICES; LAMBS	Introduction International resuscitation guidelines suggest to use positive end-expiratory pressure (PEEP) during manual ventilation of neonates. Aim of our study was to test the reliability of self-inflating bags (SIB) with single-use PEEP valves regarding PEEP delivery and the effect of different peak inflation pressures (PIP) and ventilation rates (VR) on the delivered PEEP. Methods Ten new single-use PEEP valves from 5 manufacturers were tested by ventilating an intubated 1kg neonatal manikin containing a lung model with a SIB that was actuated by an electromechanical plunger device. Standard settings: PIP 20cmH(2)O, VR 60/min, flow 8L/min. PEEP settings of 5 and 10cmH(2)O were studied. A second test was conducted with settings of PIP 40cmH(2)O and VR 40/min. The delivered PEEP was measured by a respiratory function monitor (CO2SMO+). Results Valves from one manufacturer delivered no relevant PEEP and were excluded. The remaining valves showed a continuous decay of the delivered pressure during expiration. The median (25th and 75th percentile) delivered PEEP with standard settings was 3.4(2.7-3.8) cmH(2)O when set to 5cmH(2)O and 6.1(4.9-7.1) cmH(2)O when set to 10cmH(2)O. Increasing the PIP from 20 to 40 cmH2O led to a median (25th and 75th percentile) decrease in PEEP to 2.3 (1.8-2.7) cmH(2)O and 4.3(3.2-4.8) cmH(2)O; changing VR from 60 to 40/min led to a PEEP decrease to 2.8(2.1-3.3) cmH(2)O and 5.0(3.5-6.2) cmH(2)O for both PEEP settings. Conclusion Single-use PEEP valves do not reliably deliver the set PEEP. PIP and VR have an effect on the delivered PEEP. Operators should be aware of these limitations when manually ventilating neonates.	[Hartung, Julia C.; Wilitzki, Silke; Schmalisch, Gerd; Roehr, Charles C.] Charite, Med Ctr, Dept Neonatol, D-13353 Berlin, Germany; [Thio-Lluch, Marta] Royal Womens Hosp, Dept Neonatol, Parkville, Vic, Australia; [te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Neonatol, Leiden, Netherlands; [Roehr, Charles C.] Univ Oxford, John Radcliffe Hosp, Newborn Serv, Oxford OX3 9DU, England; [Roehr, Charles C.] Monash Univ, Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Oxford; Hudson Institute of Medical Research; Monash University	Roehr, CC (corresponding author), Charite, Med Ctr, Dept Neonatol, D-13353 Berlin, Germany.; Roehr, CC (corresponding author), Univ Oxford, John Radcliffe Hosp, Newborn Serv, Oxford OX3 9DU, England.; Roehr, CC (corresponding author), Monash Univ, Hudson Inst Med Res, Ritchie Ctr, Melbourne, Vic 3004, Australia.	charles.roehr@ouh.nhs.uk	pas, arjan te/AAA-9019-2020	pas, arjan te/0000-0001-7831-8797; Roehr, Charles Christoph/0000-0001-7965-4637				Barton SK, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00097; Bennett S, 2005, RESUSCITATION, V67, P113, DOI 10.1016/j.resuscitation.2005.02.016; Dinger J, 2001, J PERINAT MED, V29, P137, DOI 10.1515/JPM.2001.018; Ersdal HL, 2013, SEMIN FETAL NEONAT M, V18, P373, DOI 10.1016/j.siny.2013.07.001; Hartung JC, 2012, NEONATOLOGY, V102, P190, DOI 10.1159/000339325; Hartung JC, 2013, J PAEDIATR CHILD H, V49, P741, DOI 10.1111/jpc.12258; Hooper SB, 2015, PAEDIATR RESPIR REV, V16, P147, DOI 10.1016/j.prrv.2015.03.003; Kelm M, 2009, KLIN PADIATR, V221, P415, DOI 10.1055/s-0029-1233493; Michna J, 1999, AM J RESP CRIT CARE, V160, P634, DOI 10.1164/ajrccm.160.2.9902016; Morley CJ, 2010, J PAEDIATR CHILD H, V46, P51, DOI 10.1111/j.1440-1754.2009.01617.x; O'Donnell CPF, 2004, ACTA PAEDIATR, V93, P583, DOI 10.1111/j.1651-2227.2004.tb02981.x; Perlman JM, 2015, CIRCULATION, V132, pS204, DOI 10.1161/CIR.0000000000000276; Probyn ME, 2004, PEDIATR RES, V56, P198, DOI 10.1203/01.PDR.0000132752.94155.13; Roehr CC, 2010, EUR J MED RES, V15, P493, DOI 10.1186/2047-783X-15-11-493; Schmolzer GM, 2011, KLIN PADIATR, V223, P261, DOI 10.1055/s-0031-1275696; Schmolzer GM, 2008, J PEDIATR-US, V153, P741, DOI 10.1016/j.jpeds.2008.08.016; Siew ML, 2009, J APPL PHYSIOL, V106, P1487, DOI 10.1152/japplphysiol.91591.2008; Szyld E, 2014, J PEDIATR-US, V165, P234, DOI 10.1016/j.jpeds.2014.02.035; te Pas AB, 2009, PEDIATR RES, V65, P537, DOI 10.1203/PDR.0b013e31819da21b; Thallinger M, 2015, ARCH DIS CHILD-FETAL, DOI [10.1136/archdischild-2015-308754, DOI 10.1136/ARCHDISCHILD-2015-308754]; Vento M, 2015, PAEDIATR RESPIR REV, V16, P151, DOI 10.1016/j.prrv.2015.02.004; Vento M, 2010, CHINESE MED J-PEKING, V123, P2924, DOI 10.3760/cma.j.issn.0366-6999.2010.20.032; Vento M, 2009, NEONATOLOGY, V95, P286, DOI 10.1159/000178770; Wyckoff MH, 2014, SEMIN PERINATOL, V38, P12, DOI 10.1053/j.semperi.2013.07.003; Wyllie J, 2015, RESUSCITATION, V95, P249, DOI 10.1016/j.resuscitation.2015.07.029	25	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150224	10.1371/journal.pone.0150224	http://dx.doi.org/10.1371/journal.pone.0150224			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914209	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700064
J	Jee, YH; Sadowski, SM; Celi, FS; Xi, LQ; Raffeld, M; Sacks, DB; Remaley, AT; Wellstein, A; Kebebew, E; Baron, J				Jee, Youn Hee; Sadowski, Samira M.; Celi, Francesco S.; Xi, Liqiang; Raffeld, Mark; Sacks, David B.; Remaley, Alan T.; Wellstein, Anton; Kebebew, Electron; Baron, Jeffrey			Increased Pleiotrophin Concentrations in Papillary Thyroid Cancer	PLOS ONE			English	Article							FOLLICULAR LESIONS; CELL-GROWTH; MIDKINE MK; EXPRESSION; NODULES; MANAGEMENT; DIAGNOSIS; BENIGN; FAMILY; MOUSE	Background Thyroid nodules are common, and approximately 5% of these nodules are malignant. Pleiotrophin (PTN) is a heparin-binding growth factor which is overexpressed in many cancers. The expression of PTN in papillary thyroid cancer (PTC) is unknown. Method and Findings 74 subjects (age 47 +/- 12 y, 15 males) who had thyroidectomy with a histological diagnosis: 79 benign nodules and 23 PTCs (10 classic, 6 tall cell, 6 follicular variant and 1 undetermined). Fine-needle aspiration (FNA) samples were obtained ex vivo from surgically excised tissue and assayed for PTN and thyroglobulin (Tg). Immunohistochemistry (IHC) was performed on tissue sections. In FNA samples, PTN concentration normalized to Tg was significantly higher in PTC than in benign nodules (16 +/- 6 vs 0.3 +/- 0.1 ng/mg, p < 0.001). In follicular variant of PTC (n = 6), the PTN/Tg ratio was also higher than in benign nodules (1.3 +/- 0.6 vs 0.3 +/- 0.1 ng/mg, P < 0.001, respectively). IHC showed cytoplasmic localization of PTN in PTC cells. Conclusion In ex vivo FNA samples, the PTN to thyroglobulin ratio was higher in PTCs, including follicular variant PTC, than in benign thyroid nodules. The findings raise the possibility that measurement of the PTN to Tg ratio may provide useful diagnostic and/or prognostic information in the evaluation of thyroid nodules.	[Jee, Youn Hee; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Sadowski, Samira M.; Kebebew, Electron] NCI, Endocrine Oncol Branch, NIH, Bethesda, MD 20892 USA; [Celi, Francesco S.] Virginia Commonwealth Univ, Div Endocrinol & Metab, Richmond, VA USA; [Xi, Liqiang; Raffeld, Mark] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Sacks, David B.; Remaley, Alan T.] NIH, Dept Lab Med, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Wellstein, Anton] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Wellstein, Anton] Lombardi Comprehens Canc Ctr, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Georgetown University	Baron, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA.	jeffrey.baron@nih.gov		Sacks, David/0000-0003-3100-0735	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Center for Cancer Research, National Cancer Institute (NCI); Clinical Center of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZICBC011079] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Cancer Research, National Cancer Institute (NCI); Clinical Center of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Programs of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the Center for Cancer Research, National Cancer Institute (NCI), and the Clinical Center of the National Institutes of Health.	Adthapanyawanich K, 2013, ARCH ORAL BIOL, V58, P181, DOI 10.1016/j.archoralbio.2012.09.005; Alexander EK, 2012, NEW ENGL J MED, V367, P705, DOI 10.1056/NEJMoa1203208; Ameur N, 2009, ENDOCR-RELAT CANCER, V16, P1261, DOI 10.1677/ERC-08-0289; BELFIORE A, 1989, ACTA ENDOCRINOL-COP, V121, P197, DOI 10.1530/acta.0.1210197; Castro MR, 2005, ANN INTERN MED, V142, P926, DOI 10.7326/0003-4819-142-11-200506070-00011; Chang YC, 2007, P NATL ACAD SCI USA, V104, P10888, DOI 10.1073/pnas.0704366104; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Erlandsen H, 2012, J HISTOCHEM CYTOCHEM, V60, P366, DOI 10.1369/0022155412439316; Fuhrer D, 2005, EUR J ENDOCRINOL, V152, P785, DOI 10.1530/eje.1.01912; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Jee YH, 2014, CLIN ENDOCR IN PRESS; Kitano M, 2012, THYROID, V22, P285, DOI 10.1089/thy.2011.0313; Koyama-Nasu R, 2014, ONCOGENE, V33, P2236, DOI 10.1038/onc.2013.168; Mathur A, 2014, SURG CLIN N AM, V94, P499, DOI 10.1016/j.suc.2014.02.005; NAKAMOTO M, 1992, J BIOCHEM-TOKYO, V112, P346, DOI 10.1093/oxfordjournals.jbchem.a123903; Papadimitriou E, 2009, EUR CYTOKINE NETW, V20, P180, DOI 10.1684/ecn.2009.0172; Rossi M, 2015, THYROID, V25, P221, DOI 10.1089/thy.2014.0338; Sakamoto K, 2012, PATHOL INT, V62, P445, DOI 10.1111/j.1440-1827.2012.02815.x; Sethi G, 2014, MOL CARCINOG IN PRES; Tan GH, 1997, ANN INTERN MED, V126, P226, DOI 10.7326/0003-4819-126-3-199702010-00009; Tsirmoula S, 2012, CANCER SCI, V103, P1826, DOI 10.1111/j.1349-7006.2012.02383.x; TSUTSUI J, 1991, BIOCHEM BIOPH RES CO, V176, P792, DOI 10.1016/S0006-291X(05)80255-4; Weber D, 2000, CANCER RES, V60, P5284; WELLSTEIN A, 1992, J BIOL CHEM, V267, P2582; Wu SJ, 2012, DIAGN CYTOPATHOL, V40, pE8, DOI 10.1002/dc.21477	25	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149383	10.1371/journal.pone.0149383	http://dx.doi.org/10.1371/journal.pone.0149383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914549	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700014
J	Zhu, WY; Hu, FC; Liu, XG; Guo, SC; Tao, Q				Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Guo, Songcan; Tao, Qian			Role of the Accessory Parotid Gland in the Etiology of Parotitis: Statistical Analysis of Sialographic Features	PLOS ONE			English	Article							SALIVARY-GLANDS; RECURRENT PAROTITIS; SIALOLITHIASIS; SIALADENITIS; DIAGNOSIS; FLOW	This retrospective study aimed to identify if the existence of the accessory parotid gland correlated with the etiology of parotitis. This may aid the development of better treatment strategies in the future. Sialographic features of cases with parotitis and healthy subjects were reviewed. The chi-square test was used to compare the incidence of accessory parotid gland between the groups. The Student's t test was used to compare the length of Stensen's duct, the length from the orifice to the confluence of the accessory duct, and the angle between the accessory duct and Stensen's duct between the groups. The incidence of accessory parotid gland in patients with parotitis was 71.8%(28/39), which was significantly higher than that in healthy subjects (P = 0.005). Patients with parotitis had a longer Stensen's duct than healthy subjects (P = 0.003). There was no significant difference in the length from the orifice to the confluence of the accessory duct or the angle between the accessory duct and Stensen's duct (P = 0.136 and 0.511, respectively) between the groups. The accessory parotid gland might play a role in the pathogenesis of parotitis. The existence of an accessory parotid gland is likely to interfere with salivary flow. Computational fluid dynamics analysis of salivary flow in the ductal system would be useful in future etiologic studies on parotitis.	[Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Tao, Qian] Sun Yat Sen Univ, Affiliated Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou 510055, Guangdong, Peoples R China; [Zhu, Wangyong; Hu, Fengchun; Liu, Xingguang; Tao, Qian] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China; [Guo, Songcan] Sun Yat Sen Univ, Sch Engneering, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Tao, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp Stomatol, Dept Oral Maxillofacial Head & Neck Oncol, Guangzhou 510055, Guangdong, Peoples R China.; Tao, Q (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510055, Guangdong, Peoples R China.	taoqian@mail.sysu.edu.cn	刘, 刘兴光/GPW-6396-2022	zhu, wangyong/0000-0002-4422-5258				Bahadir O, 2004, ANN OTO RHINOL LARYN, V113, P52, DOI 10.1177/000348940411300112; Bodner L, 1993, Compendium, V14, P574; Chitre VV, 1997, ARCH DIS CHILD, V77, P359, DOI 10.1136/adc.77.4.359; Debnath SC, 2015, BRIT J ORAL MAX SURG, V53, P658, DOI 10.1016/j.bjoms.2015.04.009; FERGUSON MM, 1978, ORAL SURG ORAL MED O, V45, P696, DOI 10.1016/0030-4220(78)90143-3; FROMMER J, 1977, ORAL SURG ORAL MED O, V43, P671, DOI 10.1016/0030-4220(77)90049-4; HOLTERMAN HJ, 1990, COLLOID POLYM SCI, V268, P1036, DOI 10.1007/BF01410592; Horsburgh A, 2013, INT J ORAL MAX SURG, V42, P124, DOI 10.1016/j.ijom.2012.10.006; KATZ P, 1991, ANN RADIOL, V34, P110; Koch M, 2005, OTOLARYNG HEAD NECK, V133, P863, DOI 10.1016/j.otohns.2005.08.005; McGurk M, 2005, BRIT J SURG, V92, P107, DOI 10.1002/bjs.4789; Nahlieli O, 2000, LARYNGOSCOPE, V110, P988, DOI 10.1097/00005537-200006000-00020; NICHOLS RD, 1977, LARYNGOSCOPE, V87, P2066; Park MS, 2007, ORAL DIS, V13, P181, DOI 10.1111/j.1601-0825.2006.01263.x; SAUNDERS JR, 1986, SURG CLIN N AM, V66, P59; Stenner M, 2008, EUR ARCH OTO-RHINO-L, V265, P1135, DOI 10.1007/s00405-008-0580-5; Sun GW, 2009, J ORAL MAXIL SURG, V67, P1520, DOI 10.1016/j.joms.2008.12.029; TOH H, 1993, ANAT REC, V236, P586, DOI 10.1002/ar.1092360319; WATKIN GT, 1986, BRIT J SURG, V73, P745, DOI 10.1002/bjs.1800730922; Zhu P, 2014, ORAL DIS, V20, P624, DOI 10.1111/odi.12182	20	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150212	10.1371/journal.pone.0150212	http://dx.doi.org/10.1371/journal.pone.0150212			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913509	Green Published, gold			2022-12-27	WOS:000371175700060
J	Hu, J; Yang, ZY; Wang, JB; Yu, J; Guo, J; Liu, SY; Qian, CM; Song, LW; Wu, Y; Cheng, JJ				Hu, Jing; Yang, Zhiyong; Wang, Jinbo; Yu, Jia; Guo, Jing; Liu, Shiying; Qian, Chunmei; Song, Liwen; Wu, Yi; Cheng, Jiajing			Zinc Chloride Transiently Maintains Mouse Embryonic Stem Cell Pluripotency by Activating Stat3 Signaling	PLOS ONE			English	Article							SELF-RENEWAL; DIFFERENTIATION; PHOSPHORYLATION; INVOLVEMENT; EXPRESSION; BIOLOGY; DISEASE; GENOME; MICE; KLF4	An improved understanding of the pluripotency maintenance of embryonic stem (ES) cells is important for investigations of early embryo development and for cell replacement therapy, but the mechanism behind pluripotency is still incompletely understood. Recent findings show that zinc, an essential trace element in humans, is critically involved in regulating various signaling pathways and genes expression. However, its role in ES cell fate determination remains to be further explored. Here we showed that 2 mu M zinc chloride (ZnCl2) transiently maintained mouse ES cell pluripotency in vitro. The cultured mouse ES cells remained undifferentiated under 2 mu M ZnCl2 treatment in leukemia inhibitory factor (LIF) withdrawal, retinoic acid (RA) or embryoid bodies (EBs) differentiation assays. In addition, ZnCl2 increased pluripotency genes expression and inhibited differentiation genes expression. Further mechanistic studies revealed that ZnCl2 transiently activated signal transducers and activators of transcription 3 (Stat3) signaling through promoting Stat3 phosphorylation. Inhibition of Stat3 signaling abrogated the effects of ZnCl2 on mouse ES cell pluripotency. Taken together, this study demonstrated a critical role of zinc in the pluripotency maintenance of mouse ES cells, as well as an important regulator of Stat3 signaling.	[Hu, Jing; Yang, Zhiyong; Wang, Jinbo; Yu, Jia; Guo, Jing; Liu, Shiying; Qian, Chunmei; Song, Liwen; Wu, Yi; Cheng, Jiajing] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China; [Wang, Jinbo; Cheng, Jiajing] Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China	Tongji University; Nanjing Medical University	Wu, Y; Cheng, JJ (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Obstet & Gynecol, Shanghai 200092, Peoples R China.; Cheng, JJ (corresponding author), Nanjing Med Univ, Clin Med Coll 1, Nanjing, Jiangsu, Peoples R China.	wuyi_sh@163.com; chengjiajing0911@163.com			Shanghai Committee of Science and Technology, China [15ZR1432600, 15695841100]; National Natural Science Foundation of China [81202045]	Shanghai Committee of Science and Technology, China(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Shanghai Committee of Science and Technology, China; Grant No. 15ZR1432600; funding recipient: Liwen Song; URL: http://www.stcsm.gov.cn/. Shanghai Committee of Science and Technology, China; Grant No. 15695841100; funding recipient: Jiajing Cheng; URL: http://www.stcsm.gov.cn/. National Natural Science Foundation of China; Grant No. 81202045; URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by two grants from the Shanghai Committee of Science and Technology, China (Grant No. 15ZR1432600 and Grant No. 15695841100), partly by a grant from the National Natural Science Foundation of China (Grant No. 81202045). We are grateful to Bo Zhang for his foundation financial support (the National Natural Science Foundation of China, Grant No. 81202045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Beyersmann D, 2001, BIOMETALS, V14, P331, DOI 10.1023/A:1012905406548; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Boeuf H, 1997, J CELL BIOL, V138, P1207, DOI 10.1083/jcb.138.6.1207; Bonn S, 2012, NAT GENET, V44, P148, DOI 10.1038/ng.1064; Chen HW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8095; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Corradi S, 2015, TOXICOL IN VITRO, V29, P1587, DOI 10.1016/j.tiv.2015.06.015; Freudenberg JM, 2012, NUCLEIC ACIDS RES, V40, P3364, DOI 10.1093/nar/gkr1253; Gorina R, 2005, J NEUROCHEM, V92, P505, DOI 10.1111/j.1471-4159.2004.02878.x; Gruber K, 2013, J BIOL REG HOMEOS AG, V27, P661; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hawkins K, 2012, STEM CELLS, V30, P1842, DOI 10.1002/stem.1148; Ho L, 2011, NAT CELL BIOL, V13, P903, DOI 10.1038/ncb2285; Hogstrand C, 2008, BIOCHEM SOC T, V36, P1252, DOI 10.1042/BST0361252; Hou PP, 2013, SCIENCE, V341, P651, DOI 10.1126/science.1239278; Huang GY, 2014, STEM CELLS, V32, P1149, DOI 10.1002/stem.1609; Jeon Y, 2015, THERIOGENOLOGY, V84, P531, DOI 10.1016/j.theriogenology.2015.04.006; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Laity JH, 2007, ARCH BIOCHEM BIOPHYS, V463, P201, DOI 10.1016/j.abb.2007.03.019; Li WL, 2013, CELL STEM CELL, V13, P270, DOI 10.1016/j.stem.2013.08.002; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Liu MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094934; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mulvey CM, 2015, STEM CELLS IN PRESS; Ryu JM, 2009, J CELL PHYSIOL, V218, P558, DOI 10.1002/jcp.21628; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schnerch A, 2010, STEM CELLS, V28, P419, DOI 10.1002/stem.298; Schugar RC, 2008, GENE THER, V15, P126, DOI 10.1038/sj.gt.3303062; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Webb SE, 2003, NAT REV MOL CELL BIO, V4, P539, DOI 10.1038/nrm1149; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang FX, 2008, BIODRUGS, V22, P361, DOI 10.2165/0063030-200822060-00003; Zhang JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132566; Zhao MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130791	42	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148994	10.1371/journal.pone.0148994	http://dx.doi.org/10.1371/journal.pone.0148994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910359	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700018
J	Chen, HF; Yi, ZF; Schmidt-Vogt, D; Ahrends, A; Beckschafer, P; Kleinn, C; Ranjitkar, S; Xu, JC				Chen, Huafang; Yi, Zhuang-Fang; Schmidt-Vogt, Dietrich; Ahrends, Antje; Beckschaefer, Philip; Kleinn, Christoph; Ranjitkar, Sailesh; Xu, Jianchu			Pushing the Limits: The Pattern and Dynamics of Rubber Monoculture Expansion in Xishuangbanna, SW China	PLOS ONE			English	Article							LAND-COVER CHANGE; SOUTHWEST CHINA; RAIN-FOREST; PLANTATIONS; BIODIVERSITY; DIVERSITY; MENGLUN; TRANSFORMATION; INDICATORS; LANDSCAPE	The rapidly growing car industry in China has led to an equally rapid expansion of monoculture rubber in many regions of South East Asia. Xishuangbanna, the second largest rubber planting area in China, located in the Indo-Burma biodiversity hotspot, supplies about 37% of the domestic natural rubber production. There, high income possibilities from rubber drive a dramatic expansion of monoculture plantations which poses a threat to natural forests. For the first time we mapped rubber plantations in and outside protected areas and their net present value for the years 1988, 2002 (Landsat, 30 m resolution) and 2010 (RapidEye, 5 m resolution). The purpose of our study was to better understand the pattern and dynamics of the expansion of rubber plantations in Xishuangbanna, as well as its economic prospects and conservation impacts. We found that 1) the area of rubber plantations was 4.5% of the total area of Xishuangbanna in 1988, 9.9% in 2002, and 22.2% in 2010; 2) rubber monoculture expanded to higher elevations and onto steeper slopes between 1988 and 2010; 3) the proportion of rubber plantations with medium economic potential dropped from 57% between 1988 and 2002 to 47% in 2010, while the proportion of plantations with lower economic potential had increased from 30% to 40%; and 4) nearly 10% of the total area of nature reserves within Xishuangbanna has been converted to rubber monoculture by 2010. On the basis of our findings, we conclude that the rapid expansion of rubber plantations into higher elevations, steeper terrain, and into nature reserves (where most of the remaining forests of Xishuangbanna are located) poses a serious threat to biodiversity and environmental services while not producing the expected economic returns. Therefore, it is essential that local governments develop long-term land use strategies for balancing economic benefits with environmental sustainability, as well as for assisting farmers with the selection of land suitable for rubber production.	[Chen, Huafang; Yi, Zhuang-Fang; Ranjitkar, Sailesh; Xu, Jianchu] Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Chen, Huafang; Yi, Zhuang-Fang; Schmidt-Vogt, Dietrich; Ranjitkar, Sailesh; Xu, Jianchu] World Agroforestry Ctr ICRAF East & Cent Asia, Kunming, Peoples R China; [Schmidt-Vogt, Dietrich] Univ Cent Asia, Mt Soc Res Inst, Bishkek, Kyrgyzstan; [Ahrends, Antje] Royal Bot Garden Edinburgh, Edinburgh, Midlothian, Scotland; [Beckschaefer, Philip; Kleinn, Christoph] Univ Gottingen, Chair Forest Inventory & Remote Sensing, D-37073 Gottingen, Germany	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; American University of Central Asia; University of Gottingen	Xu, JC (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.; Schmidt-Vogt, D; Xu, JC (corresponding author), World Agroforestry Ctr ICRAF East & Cent Asia, Kunming, Peoples R China.; Schmidt-Vogt, D (corresponding author), Univ Cent Asia, Mt Soc Res Inst, Bishkek, Kyrgyzstan.	dietrich.schmidt-vogt@ucentralasia.org; jxu@mail.kib.ac.cn	Xu, Jianchu/Y-2890-2019; Ranjitkar, Sailesh/I-9307-2014; Kleinn, Christoph/AAG-1768-2020	Ranjitkar, Sailesh/0000-0002-4741-3975; Beckschafer, Philip/0000-0003-1728-724X	Project "Making the Mekong Connected" - Federal Ministry for Economic Cooperation and Development (BMZ) [08.7860.3-001.00]; Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); Project "Green Rubber" - Federal Ministry for Economic Cooperation and Development (BMZ) [13.1432.7-00100]; Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	Project "Making the Mekong Connected" - Federal Ministry for Economic Cooperation and Development (BMZ); Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); Project "Green Rubber" - Federal Ministry for Economic Cooperation and Development (BMZ); Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The work was supported by the following: Project "Making the Mekong Connected" (project No. 08.7860.3-001.00), sponsored by Federal Ministry for Economic Cooperation and Development (BMZ) and Deutsche Gesellschaft fur Technische Zusammenarbeit (GTZ); and Project "Green Rubber" (Project No. 13.1432.7-00100), sponsored by Federal Ministry for Economic Cooperation and Development (BMZ) and Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ). This research is also part of the CGIAR (Consultative Group for International Agricultural Research) Research Program 6: Forests, Trees and Agroforestry. URL: http://www.giz.de/de/html/index.html, http://www.bmz.de/en.	Ahrends A, 2015, GLOBAL ENVIRON CHANG, V34, P48, DOI 10.1016/j.gloenvcha.2015.06.002; [Anonymous], RUBBER BOOM LU UNPUB; Association of Natural Rubber Producing Countries, 2010, NAT RUBB TRENDS STAT; Chen Li, 2013, Shengwu Duoyangxing, V21, P359, DOI 10.3724/SP.J.1003.2013.05162; Dong JW, 2013, REMOTE SENS ENVIRON, V134, P392, DOI 10.1016/j.rse.2013.03.014; Food and Agriculture Organization of the United Nations, FAO STAT YB; Fox, 2011, INT J GEOSCI, V2, P573, DOI [10.4236/ijg.2011.24060, DOI 10.4236/IJG.2011.24060]; Fox J, 2005, ENVIRON MANAGE, V36, P394, DOI 10.1007/s00267-003-0288-7; Fox J, 2014, SOCIAL LIVES FORESTS, P249; Hammond J., 2014, WORKING PAPER; Hu HB, 2008, ENVIRON MONIT ASSESS, V146, P147, DOI 10.1007/s10661-007-0067-7; Hurni K, 2008, DETECTION ACTUAL ASS; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Li HM, 2008, FOREST ECOL MANAG, V255, P16, DOI 10.1016/j.foreco.2007.06.051; Li HM, 2007, BIODIVERS CONSERV, V16, P1731, DOI 10.1007/s10531-006-9052-7; Li HM, 2009, BIODIVERS CONSERV, V18, P3421, DOI 10.1007/s10531-009-9651-1; Li Zeng-Jia, 2008, Zhiwu Shengtai Xuebao, V32, P1091, DOI 10.3773/j.issn.1005-264x.2008.05.014; Li Z, 2012, APPL GEOGR, V32, P420, DOI 10.1016/j.apgeog.2011.06.018; Li Z, 2011, REMOTE SENS LETT, V2, P157, DOI 10.1080/01431161.2010.505589; Liu JJ, 2014, BIOL CONSERV, V171, P99, DOI 10.1016/j.biocon.2014.01.004; Liu WJ, 2006, MT RES DEV, V26, P245, DOI 10.1659/0276-4741(2006)26[245:EASIOI]2.0.CO;2; Liu XN, 2013, J GEOGR SCI, V23, P1019, DOI 10.1007/s11442-013-1060-4; Mann CC, 2009, SCIENCE, V325, P564, DOI 10.1126/science.325_564; Ministry of Environmental Protection of China, 2011 2030 CHIN BIOD; National Bureau of Statistics of China, 2011, CHIN STAT YB; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Priyadarshan P.M., 2005, J CROP IMPROVEMENT, V14, P221, DOI [DOI 10.1300/J411V14N01., DOI 10.1300/J411V14N01_]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rao PS, 1998, AGR FOREST METEOROL, V90, P235, DOI 10.1016/S0168-1923(98)00051-3; Senf C, 2013, REMOTE SENS-BASEL, V5, P2795, DOI 10.3390/rs5062795; Shi, 2008, RUBBER BOOM LUANG NA; Statistics Bureau of Yunnan Province, 2011, YUNN STAT YB 2011; Suratman MN, 2004, INT FOREST REV, V6, P1, DOI 10.1505/ifor.6.1.1.32055; Wang F, 2008, TROP AGR SCI TECHNOL, V31, P15; Wu ZL, 2001, INT J SUST DEV WORLD, V8, P337, DOI 10.1080/13504500109470091; Xiao G, 2007, TROPICAL AGR SCI TEC, V30, P1; Xishuangbanna Bureau of Statistics, 2008, STAT REP SOC DEV XIS; Xu JC, 2005, ENVIRON MANAGE, V36, P404, DOI 10.1007/s00267-003-0289-6; Xu JC, 2006, MT RES DEV, V26, P254, DOI 10.1659/0276-4741(2006)26[254:TPSAET]2.0.CO;2; Xu JC, 2014, ECOL INDIC, V36, P749, DOI 10.1016/j.ecolind.2012.08.023; Yi Z, 2012, NATURAL FORESTS RUBB; Yi ZF, 2014, ECOL INDIC, V36, P788, DOI 10.1016/j.ecolind.2013.03.016; Yu Y, 2006, TROPICAL AGR SCI TEC, V29, P42; Zhai DL, 2012, J ENVIRON MANAGE, V96, P64, DOI 10.1016/j.jenvman.2011.10.011; ZHANG JH, 1995, BIOL CONSERV, V73, P229, DOI 10.1016/0006-3207(94)00118-A; Zhu H, 2004, BIODIVERS CONSERV, V13, P1355, DOI 10.1023/B:BIOC.0000019397.98407.c3; Zhuang J., 2007, THEORY PRACTICE CHOI; Ziegler AD, 2009, SCIENCE, V324, P1024, DOI 10.1126/science.1173833; Zomer RJ, 2014, BIOL CONSERV, V170, P264, DOI 10.1016/j.biocon.2013.11.028; [No title captured]	50	58	59	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0150062	10.1371/journal.pone.0150062	http://dx.doi.org/10.1371/journal.pone.0150062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907479	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000030
J	Bruinvels, G; Burden, R; Brown, N; Richards, T; Pedlar, C				Bruinvels, Georgie; Burden, Richard; Brown, Nicola; Richards, Toby; Pedlar, Charles			The Prevalence and Impact of Heavy Menstrual Bleeding (Menorrhagia) in Elite and Non-Elite Athletes	PLOS ONE			English	Article							IRON-DEFICIENCY; EXERCISE	To identify the prevalence and impact of heavy menstrual bleeding (HMB) in exercising females where anemia may have a significant effect on training and performance a 'Female Health Questionnaire' was designed incorporating a validated diagnostic HMB series, demographics, exercise ability data, training status, anemia, iron supplementation and whether the menstrual cycle had affected training and performance. The survey was conducted in two stages; initially online, advertised via social media, and then repeated via face-to-face interviews with runners registered for the 2015 London Marathon. 789 participants responded to the online survey, and 1073 completed the survey at the marathon. HMB was reported by half of those online (54%), and by more than a third of the marathon runners (36%). Surprisingly, HMB was also prevalent amongst elite athletes (37%). Overall, 32% of exercising females reported a history of anemia, and 50% had previously supplemented with iron. Only a minority (22%) had sought medical advice. HMB is highly prevalent in exercising females, associated with self-reported anemia, increased use of iron supplementation and a perceived negative impact on performance. Further research is needed to investigate the impact of HMB, iron deficiency and anemia in exercising females.	[Bruinvels, Georgie; Richards, Toby] UCL, Div Surg & Intervent Sci, London, England; [Bruinvels, Georgie; Burden, Richard; Brown, Nicola; Pedlar, Charles] St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England; [Bruinvels, Georgie; Burden, Richard; Pedlar, Charles] Orreco Ltd, Inst Technol, Sligo, Ireland; [Burden, Richard] English Inst Sport, Loughborough, Leics, England	University of London; University College London; St Mary's University Twickenham London; Institute of Technology Tralee	Bruinvels, G (corresponding author), UCL, Div Surg & Intervent Sci, London, England.; Bruinvels, G (corresponding author), St Marys Univ, Sch Sport Hlth & Appl Sci, Twickenham, England.; Bruinvels, G (corresponding author), Orreco Ltd, Inst Technol, Sligo, Ireland.	georgie.bruinvels.14@ucl.ac.uk	Richards, Toby/K-6547-2013; Pedlar, Charles/I-4351-2019	Pedlar, Charles/0000-0002-3075-9101; Brown, Nicola/0000-0001-5538-2171	Department of Health [10/104/06] Funding Source: Medline; National Institute for Health Research [10/104/06] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Barrack MT, 2013, CURR REV MUSCULOSKE, V6, P195, DOI 10.1007/s12178-013-9168-9; Beard J, 2000, AM J CLIN NUTR, V72, p594S, DOI 10.1093/ajcn/72.2.594S; Beglinger C, 2010, TREATMENT IRON DEFIC; Bruinvels G, 2016, BRIT J SPORT MED, V50, P566, DOI 10.1136/bjsports-2015-095505; Burden RJ, 2015, MED SCI SPORT EXER, V47, P1399, DOI 10.1249/MSS.0000000000000568; Copher R, 2013, CURR MED RES OPIN, V29, P127, DOI 10.1185/03007995.2012.759096; de Oliveira EP, 2009, CURR OPIN CLIN NUTR, V12, P533, DOI 10.1097/MCO.0b013e32832e6776; Deli C. K., 2013, CURRENT ISSUES SPORT; DeRuisseau KC, 2002, INT J SPORT NUTR EXE, V12, P428, DOI 10.1123/ijsnem.12.4.428; Fraser IS, 2015, INT J GYNECOL OBSTET, V128, P196, DOI 10.1016/j.ijgo.2014.09.027; Garvican LA, 2011, INT J SPORT PHYSIOL, V6, P137, DOI 10.1123/ijspp.6.1.137; HALLBERG L, 1964, SCAND J CLIN LAB INV, V16, P244, DOI 10.3109/00365516409060511; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Kaplowitz MD, 2004, PUBLIC OPIN QUART, V68, P94, DOI 10.1093/poq/nfh006; Karlsson TS, 2014, ACTA OBSTET GYN SCAN, V93, P52, DOI 10.1111/aogs.12292; Liu ZM, 2007, VALUE HEALTH, V10, P183, DOI 10.1111/j.1524-4733.2007.00168.x; Marret H, 2010, EUR J OBSTET GYN R B, V152, P133, DOI 10.1016/j.ejogrb.2010.07.016; MCCORMICK A, 1995, MORBIDITY STAT GEN P; Mountjoy M, 2014, BRIT J SPORT MED, V48, P491, DOI 10.1136/bjsports-2014-093502; National Institute for Health Care and Excellence, 2007, HEAV MENSTR BLEED; Nattiv Aurelia, 2007, Med Sci Sports Exerc, V39, P1867; Nazem TG, 2012, SPORTS HEALTH, V4, P302, DOI 10.1177/1941738112439685; ROWLAND TW, 1989, AM J DIS CHILD, V143, P197, DOI 10.1001/archpedi.1989.02150140087026; Royal College of Obstetricians and Gynaecologists, 2013, 3 ROYAL COLL OBST GY; SIEGEL AJ, 1979, JAMA-J AM MED ASSOC, V241, P391, DOI 10.1001/jama.241.4.391; Taylor S, 2015, POL ARCH MED WEWN, V125, P452, DOI 10.20452/pamw.2888; Telford RD, 2003, J APPL PHYSIOL, V94, P38, DOI 10.1152/japplphysiol.00631.2001	27	75	77	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149881	10.1371/journal.pone.0149881	http://dx.doi.org/10.1371/journal.pone.0149881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901873	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000371276100172
J	Chapman, PA; Owen, H; Flint, M; Traub, RJ; Cribb, TH; Mills, PC				Chapman, Phoebe A.; Owen, Helen; Flint, Mark; Traub, Rebecca J.; Cribb, Thomas H.; Mills, Paul C.			Molecular Characterization of Coccidia Associated with an Epizootic in Green Sea Turtles (Chelonia mydas) in South East Queensland, Australia	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; PHYLOGENETIC TREES; APICOMPLEXA; CARYOSPORA; EIMERIA; MODELS; DIAGNOSIS; INFERENCE; MRBAYES	In the spring of 2014, mass mortalities among wild green sea turtles occurred off the coast of south-east Queensland, Australia. The suspected causative agent was Caryospora cheloniae, an eimeriid coccidian implicated in previous epizootics. Necropsies were undertaken on a subset of 11 dead turtles, with subsequent histopathology and molecular analyses. All turtles returned positive PCR results for coccidial infection in various tissues; these included the brain, gastrointestinal tract, lung, kidney and thyroid. Granulomatous encephalitis was consistently observed, as well as enteritis and, less frequently, thyroiditis and nephritis. Sequencing and phylogenetic analyses indicated the presence of two distinct coccidian genotypes, presumably separate species-one associated with the brain, gastrointestinal tract and lung, and the second with the thyroid and kidney. Maximum likelihood and Bayesian inference analyses placed the first genotype closest to the lankesterellid genus Schellackia, rather than in the Eimeriidae, while the second was paraphyletic to the eimeriids. Presence of coccidial stages in extra-intestinal tissues of the primary host raises questions about the potential presence of intermediate or paratenic hosts within the life cycles, as well as their current placement relative to the genus Caryospora. This study represents the first genetic characterization of this emerging disease agent in green sea turtles, an endangered species, and has relevance for life-cycle elucidation and future development of diagnostics.	[Chapman, Phoebe A.; Owen, Helen; Flint, Mark; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton, Qld, Australia; [Flint, Mark] Univ Florida, Florida Aquariums Ctr Conservat, Sch Forest Resources & Conservat, Apollo Beach, FL USA; [Traub, Rebecca J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic 3052, Australia; [Cribb, Thomas H.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia	University of Queensland; State University System of Florida; University of Florida; University of Melbourne; University of Queensland	Chapman, PA (corresponding author), Univ Queensland, Sch Vet Sci, Vet Marine Anim Res Teaching & Invest Unit, Gatton, Qld, Australia.	p.chapman3@uq.edu.au	Traub, Rebecca/A-4273-2013; Cribb, Thomas/C-4449-2008; Chapman, Phoebe/E-5044-2016	Traub, Rebecca/0000-0002-7484-7592; Cribb, Thomas/0000-0003-1092-9705; Chapman, Phoebe/0000-0002-3303-9134	Australian Research Council [LP110100569]	Australian Research Council(Australian Research Council)	This project was funded by Australian Research Council Linkage Project Grant LP110100569 (URL http://www.arc.gov.au/default.htm) awarded to PCM as first investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AA., 2004, ECOHEALTH, V1, P275, DOI [10.1007/s10393-004-0097-3, DOI 10.1007/S10393-004-0097-3]; [Anonymous], 2009, GEOSP FINCHTV 1 4 0; Austen JM, 2014, EXP PARASITOL, V138, P48, DOI 10.1016/j.exppara.2014.01.007; Ball S, 1989, ADV PARASITOL, V28, P1; Barta JR, 2001, J PARASITOL, V87, P121, DOI 10.1645/0022-3395(2001)087[0121:MPOTOT]2.0.CO;2; Chapman PA, 2015, SYST PARASITOL, V90, P67, DOI 10.1007/s11230-014-9535-y; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Duszynski D.W., 2014, BIOL IDENTIFICATION; Flint M, 2010, ECOHEALTH, V7, P135, DOI 10.1007/s10393-010-0300-7; Flint M, 2009, J VET DIAGN INVEST, V21, P733, DOI 10.1177/104063870902100601; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; GORDON AN, 1993, J WILDLIFE DIS, V29, P490, DOI 10.7589/0090-3558-29.3.490; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T., 2005, BIOEDIT BIOL SEQUENC; Heckeroth AR, 1999, INT J PARASITOL, V29, P1331, DOI 10.1016/S0020-7519(99)00111-3; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; LEIBOVITZ L, 1978, J WILDLIFE DIS, V14, P269, DOI 10.7589/0090-3558-14.2.269; Levine ND, 1988, PROTOZOAN PHYLUM API, V2; LIMPUS C.J., 1994, MEMOIRS QUEENSLAND M, V35, P139; Lindsay D.S., 1989, Journal of Veterinary Parasitology, V3, P1; Liu Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0902-6; Merino S, 2008, J EUKARYOT MICROBIOL, V55, P536, DOI 10.1111/j.1550-7408.2008.00358.x; Merino S, 2010, PARASITOLOGY, V137, P37, DOI 10.1017/S0031182009990710; NOVILLA MN, 1981, J PROTOZOOL, V28, P248, DOI 10.1111/j.1550-7408.1981.tb02844.x; O'Callaghan MG, 2001, T ROY SOC SOUTH AUST, V125, P129; OVERSTREET RM, 1981, J PROTOZOOL, V28, P258, DOI 10.1111/j.1550-7408.1981.tb02846.x; Pellerdy L. P., 1974, COCCIDIA COCCIDIOSIS, V2nd; Perkins F.O., 2000, ILLUSTRATED GUIDE PR, Vsecond; Power ML, 2009, EXP PARASITOL, V122, P165, DOI 10.1016/j.exppara.2009.02.008; Rambaut A., 2014, TRACER V1 6; Rebell G., 1974, Proceedings a Wkshop Wld Maricult Soc, V5, P197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saffo MB, 2010, P NATL ACAD SCI USA, V107, P16190, DOI 10.1073/pnas.1002335107; TELFORD SR, 1993, SYST PARASITOL, V25, P109, DOI 10.1007/BF00009980; Yang RC, 2014, EXP PARASITOL, V145, P68, DOI 10.1016/j.exppara.2014.07.008; Zhu BY, 2009, VET PARASITOL, V159, P105, DOI 10.1016/j.vetpar.2008.10.031	38	17	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149962	10.1371/journal.pone.0149962	http://dx.doi.org/10.1371/journal.pone.0149962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901786	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100194
J	Egan, AM; O'Doherty, JV; Vigors, S; Sweeney, T				Egan, Aine M.; O'Doherty, John V.; Vigors, Stafford; Sweeney, Torres			Prawn Shell Chitosan Exhibits Anti-Obesogenic Potential through Alterations to Appetite, Affecting Feeding Behaviour and Satiety Signals In Vivo	PLOS ONE			English	Article							NEUROPEPTIDE-Y; BODY-WEIGHT; FOOD-INTAKE; MEAL SIZE; BRAIN; LEPTIN; OLIGOSACCHARIDES; EXPRESSION; DIETARY; GAMMA	The crustacean shells-derived polysaccharide chitosan has received much attention for its anti-obesity potential. Dietary supplementation of chitosan has been linked with reductions in feed intake, suggesting a potential link between chitosan and appetite control. Hence the objective of this experiment was to investigate the appetite suppressing potential of prawn shell derived chitosan in a pig model. Pigs (70 +/- 0.90 kg, 125 days of age, SD 2.0) were fed either T1) basal diet or T2) basal diet plus 1000 ppm chitosan (n = 20 gilts per group) for 63 days. The parameter categories which were assessed included performance, feeding behaviour, serum leptin concentrations and expression of genes influencing feeding behaviour in the small intestine, hypothalamus and adipose tissue. Pigs offered chitosan visited the feeder less times per day (P < 0.001), had lower intake per visit (P < 0.001), spent less time eating per day (P < 0.001), had a lower eating rate (P < 0.01) and had reduced feed intake and final body weight (P < 0.001) compared to animals offered the basal diet. There was a treatment (P < 0.05) and time effect (P < 0.05) on serum leptin concentrations in animals offered the chitosan diet compared to animals offered the basal diet. Pigs receiving dietary chitosan had an up-regulation in gene expression of growth hormone receptor (P < 0.05), Peroxisome proliferator activated receptor gamma (P < 0.01), neuromedin B (P < 0.05), neuropeptide Y receptor 5 (P < 0.05) in hypothalamic nuclei and neuropeptide Y (P < 0.05) in the jejunum. Animals consuming chitosan had increased leptin expression in adipose tissue compared to pigs offered the basal diet (P < 0.05). In conclusion, these data support the hypothesis that dietary prawn shell chitosan exhibits anti-obesogenic potential through alterations to appetite, and feeding behaviour affecting satiety signals in vivo.	[Egan, Aine M.; O'Doherty, John V.; Vigors, Stafford] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland; [Sweeney, Torres] Univ Coll Dublin, Sch Vet Med, Dublin 2, Ireland	University College Dublin; University College Dublin	O'Doherty, JV (corresponding author), Univ Coll Dublin, Sch Agr & Food Sci, Dublin 2, Ireland.	john.vodoherty@ucd.ie	O'Doherty, John/AAS-7261-2021	O'Doherty, John/0000-0002-0906-4065; Sweeney, Torres/0000-0003-2639-395X; Vigors, Stafford/0000-0002-9304-2925	Marine Institute [MFFRI/07/01]; Department of Agriculture, Food and the Marine; National Development Plan	Marine Institute; Department of Agriculture, Food and the Marine; National Development Plan	This study was supported financially (Grant-Aid Agreement No. MFFRI/07/01) under the Sea Change Strategy with the support of the Marine Institute and the Department of Agriculture, Food and the Marine, funded under the National Development Plan 2007-2013.	Ahima RS, 2008, ENDOCRIN METAB CLIN, V37, P811, DOI 10.1016/j.ecl.2008.08.005; Baldrick P, 2010, REGUL TOXICOL PHARM, V56, P290, DOI 10.1016/j.yrtph.2009.09.015; BRADY LS, 1990, NEUROENDOCRINOLOGY, V52, P441, DOI 10.1159/000125626; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; CAMPBELL RG, 1988, J ANIM SCI, V66, P676; Chaudhri OB, 2008, DIABETES CARE, V31, pS284, DOI 10.2337/dc08-s269; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Considine RV, 2000, J CLIN ENDOCR METAB, V85, P3551, DOI 10.1210/jc.85.10.3551; Dyer CJ, 1999, DOMEST ANIM ENDOCRIN, V16, P145, DOI 10.1016/S0739-7240(99)00011-9; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Gades MD, 2003, OBES RES, V11, P683, DOI 10.1038/oby.2003.97; Geerling JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055217; Hajji S, 2015, APPL BIOCHEM BIOTECH, V177, P18, DOI 10.1007/s12010-015-1724-x; Heim G, 2014, THE BRITISH JOURNAL, P1; Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089; HIRANO S, 1990, J AGR FOOD CHEM, V38, P1214, DOI 10.1021/jf00095a012; Hopkins DFC, 1997, DIABETIC MED, V14, P1044, DOI 10.1002/(SICI)1096-9136(199712)14:12<1044::AID-DIA508>3.0.CO;2-F; Houseknecht KL, 2003, NUTR RES REV, V16, P83, DOI 10.1079/NRR200256; Huang LL, 2015, MAR DRUGS, V13, P2732, DOI 10.3390/md13052732; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Klok MD, 2007, OBES REV, V8, P21, DOI 10.1111/j.1467-789X.2006.00270.x; Kumar SG, 2009, PROTEOMICS, V9, P2149, DOI 10.1002/pmic.200800571; Lee HW, 2003, BIOL PHARM BULL, V26, P1100; LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; LITTELL RC, 1996, SAS SYSTEM FOR MIXED; Liu SH, 2010, J AGR FOOD CHEM, V58, P5795, DOI 10.1021/jf100662r; McMahon CD, 1999, J ENDOCRINOL, V161, P333, DOI 10.1677/joe.0.1610333; Mhurchu CN, 2005, OBES REV, V6, P35, DOI 10.1111/j.1467-789X.2005.00158.x; Morley JE, 1987, NEUROPEPTIDE Y INCRE; Munro CA, 2001, MED MYCOL, V39, P41, DOI 10.1080/744118878; Muurahainen NE, 1993, INTRAVENOUS INFUSION; MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0; NRC, 2012, NUTRIENT REQUIREMENT; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PENG C, 1993, ENDOCRINOLOGY, V132, P1820, DOI 10.1210/en.132.4.1820; Rehfeld JF, 1998, PHYSIOL REV, V78, P1087, DOI 10.1152/physrev.1998.78.4.1087; Sarruf DA, 2009, ENDOCRINOLOGY, V150, P707, DOI 10.1210/en.2008-0899; SAS, 2004, SAS USERS GUIDE; Sauvant D, 2004, TABLE OF COMPOSITION; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Simpson KA, 2009, ARQ BRAS ENDOCRINOL, V53, P120, DOI 10.1590/S0004-27302009000200002; SKORUPSKI P, 1994, J EXP BIOL, V187, P305; Soumian S, 2005, J CLIN PATHOL, V58, P1255, DOI 10.1136/jcp.2005.026161; STEIN LJ, 1982, PEPTIDES, V3, P833, DOI 10.1016/0196-9781(82)90023-7; Stoving RK, 1999, J PSYCHIATR RES, V33, P139, DOI 10.1016/S0022-3956(98)00049-1; STUCKEY JA, 1985, PEPTIDES, V6, P1249, DOI 10.1016/0196-9781(85)90458-9; Sumiyoshi M, 2006, J PHARM PHARMACOL, V58, P201, DOI 10.1211/jpp.58.2.0007; Suzuki K, 2012, EXP DIABETES RES, DOI 10.1155/2012/824305; Sweeney T, 2012, BRIT J NUTR, V108, P1226, DOI 10.1017/S0007114511006751; Swiatkiewicz S, 2015, J ANIM PHYSIOL AN N, V99, P1, DOI 10.1111/jpn.12222; TATEMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P5485, DOI 10.1073/pnas.79.18.5485; Thanou M, 2001, ADV DRUG DELIVER REV, V52, P117, DOI 10.1016/S0169-409X(01)00231-9; Varley PF, 2011, LIVEST SCI, V135, P282, DOI 10.1016/j.livsci.2010.07.025; Vernarelli JA, 2011, J NUTR, V141, P2204, DOI 10.3945/jn.111.146092; Walsh AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053828; Washington MC, 2014, PEPTIDES, V51, P145, DOI 10.1016/j.peptides.2013.11.016; Yi CX, 2012, DIS MODEL MECH, V5, P583, DOI 10.1242/dmm.009902; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011; Zeng LT, 2008, CARBOHYD POLYM, V71, P435, DOI 10.1016/j.carbpol.2007.06.016; Zhang JL, 2008, NUTR RES, V28, P383, DOI 10.1016/j.nutres.2007.12.013; Zhang W, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-27	63	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149820	10.1371/journal.pone.0149820	http://dx.doi.org/10.1371/journal.pone.0149820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901760	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100159
J	Sakamoto, Y; Kanatsu, J; Toh, M; Naka, A; Kondo, K; Iida, K				Sakamoto, Yuri; Kanatsu, Junko; Toh, Mariko; Naka, Ayano; Kondo, Kazuo; Iida, Kaoruko			The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPAR alpha/gamma and JNK Pathways in Adipocyte and Macrophage Co-Cultures	PLOS ONE			English	Article							OBESITY-RELATED INFLAMMATION; NECROSIS-FACTOR-ALPHA; FREE FATTY-ACIDS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; CIRCULATING INTERLEUKIN-6; KAPPA-B; C-JUN; ACTIVATION; GAMMA	Obesity-induced inflammation caused by adipocyte-macrophage interactions plays a critical role in developing insulin resistance, and peroxisome proliferator-activated receptors (PPARs) regulate inflammatory gene expression in these cells. Recently, the soy isoflavone daidzein was reported to act as a PPAR activator. We examined whether daidzein affected adipocyte-macrophage crosstalk via the regulation of PPARs. Co-cultures of 3T3-L1 adipocytes and RAW264 macrophages, or palmitate-stimulated RAW264 macrophages were treated with daidzein in the presence or absence of specific inhibitors for PPARs: GW6471 (a PPAR alpha antagonist), and GW9662 (a PPAR gamma antagonist). Inflammatory gene expression was then determined. Daidzein significantly decreased chemokine (C-C motif) ligand 2 (Ccl2, known in humans as monocyte chemo-attractant protein 1 (MCP1)) and interleukin 6 (Il6) mRNA levels induced by co-culture. In 3T3-L1 adipocytes, daidzein inversed the attenuation of adiponectin gene expression by co-culture, and these effects were inhibited by the PPAR-gamma specific inhibitor. Daidzein also decreased Ccl2 and Il6 mRNA levels in RAW264 macrophages stimulated with palmitate or conditioned medium (CM) from hypertrophied 3T3-L1 adipocytes. This inhibitory effect on Il6 expression was abrogated by a PPAR-alpha inhibitor. Additionally, we examined the activation of nuclear factor-kappa B (NF-kappa B) and c-Jun N-terminal kinase (JNK) pathways and found that daidzein significantly inhibited palmitate- induced phosphorylation of JNK. Our data suggest that daidzein regulates pro-inflammatory gene expression by activating PPAR-alpha and -gamma and inhibiting the JNK pathway in adipocyte and macrophage co-cultures. These effects might be favorable in improving adipose inflammation, thus, treatment of daidzein may be a therapeutic strategy for chronic inflammation in obese adipose tissue.	[Sakamoto, Yuri; Kanatsu, Junko; Toh, Mariko; Iida, Kaoruko] Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 112, Japan; [Naka, Ayano] Ochanomizu Univ, Fac Human Life & Environm Sci, Lab Appl Nutr, Tokyo 112, Japan; [Kondo, Kazuo] Ochanomizu Univ, Endowed Res Dept Food Hlth, Tokyo 112, Japan	Ochanomizu University; Ochanomizu University; Ochanomizu University	Iida, K (corresponding author), Ochanomizu Univ, Grad Sch Humanities & Sci, Dept Nutr & Food Sci, Bunkyo Ku, Tokyo 112, Japan.	iida.kaoruko@ocha.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [24300254, 26750037, 15J11645, 15H02895]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by grants-in-aid for Scientific Research (grant nos. 24300254, 26750037, 15J11645 and 15H02895) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando C, 2009, FEBS LETT, V583, P3649, DOI 10.1016/j.febslet.2009.10.045; Bai Y, 2015, OBES REV, V16, P127, DOI 10.1111/obr.12242; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bhathena SJ, 2002, AM J CLIN NUTR, V76, P1191, DOI 10.1093/ajcn/76.6.1191; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; Fernandez-Real JM, 2001, J CLIN ENDOCR METAB, V86, P1154, DOI 10.1210/jc.86.3.1154; Friedman M, 2001, J AGR FOOD CHEM, V49, P1069, DOI 10.1021/jf0009246; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Garcia-Lafuente A, 2009, INFLAMM RES, V58, P537, DOI 10.1007/s00011-009-0037-3; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hirai S, 2007, LIFE SCI, V81, P1272, DOI 10.1016/j.lfs.2007.09.001; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2003, INT J OBESITY, V27, pS53, DOI 10.1038/sj.ijo.0802502; Jiao P, 2009, DIABETES, V58, P104, DOI 10.2337/db07-1344; Liu HT, 2000, J IMMUNOL, V164, P4277, DOI 10.4049/jimmunol.164.8.4277; Ma ZQ, 2013, INFLAMMATION, V36, P1560, DOI 10.1007/s10753-013-9700-5; Moller DE, 2003, INT J OBESITY, V27, pS17, DOI 10.1038/sj.ijo.0802494; Murakami K, 2007, EUR J PHARMACOL, V561, P206, DOI 10.1016/j.ejphar.2006.12.037; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Ota T, 2013, DIABETES METAB J, V37, P165, DOI 10.4093/dmj.2013.37.3.165; Park OJ, 2015, IMMUNOBIOLOGY, V220, P1067, DOI 10.1016/j.imbio.2015.05.008; Prasad S, 2010, PLANTA MED, V76, P1044, DOI 10.1055/s-0030-1250111; Qiu LX, 2012, MOL MED REP, V5, P217, DOI 10.3892/mmr.2011.599; Reyes-Farias M, 2015, J MED FOOD, V18, P601, DOI 10.1089/jmf.2014.0031; Rotter V, 2003, J BIOL CHEM, V278, P45777, DOI 10.1074/jbc.M301977200; Sakamoto Y, 2014, MOL NUTR FOOD RES, V58, P718, DOI 10.1002/mnfr.201300482; Sakurai T, 2010, J NUTR BIOCHEM, V21, P47, DOI 10.1016/j.jnutbio.2008.10.003; Setchell KDR, 1998, AM J CLIN NUTR, V68, p1333S, DOI 10.1093/ajcn/68.6.1333S; Setchell KDR, 2003, J NUTR, V133, P1027, DOI 10.1093/jn/133.4.1027; Setchell KDR, 1999, J NUTR, V129, p758S, DOI 10.1093/jn/129.3.758S; Shen P, 2006, J NUTR, V136, P899, DOI 10.1093/jn/136.4.899; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Surmi BK, 2008, FUTURE LIPIDOL, V3, P545, DOI 10.2217/17460875.3.5.545; Toyoda T, 2008, OBESITY, V16, P1199, DOI 10.1038/oby.2008.62; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; van der Velpen V, 2014, AM J CLIN NUTR, V100, P1269, DOI 10.3945/ajcn.114.088484; Vozarova B, 2001, OBES RES, V9, P414, DOI 10.1038/oby.2001.54; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	45	56	59	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149676	10.1371/journal.pone.0149676	http://dx.doi.org/10.1371/journal.pone.0149676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901838	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100127
J	Beisswingert, BM; Zhang, KS; Goetz, T; Fischbacher, U				Beisswingert, Birgit M.; Zhang, Keshun; Goetz, Thomas; Fischbacher, Urs			Spillover Effects of Loss of Control on Risky Decision-Making	PLOS ONE			English	Article							DETERMINANTS; CHOICE; PERCEPTIONS; ATTITUDES; ILLUSION; FEAR; AGE	Decision making in risky situations is frequently required in our everyday lives and has been shown to be influenced by various factors, some of which are independent of the risk context. Based on previous findings and theories about the central role of perceptions of control and their impact on subsequent settings, spillover effects of subjective loss of control on risky decision-making are assumed. After developing an innovative experimental paradigm for inducing loss of control, its hypothesized effects on risky decision-making are investigated. Partially supporting the hypotheses, results demonstrated no increased levels of risk perceptions but decreased risk-taking behavior following experiences of loss of control. Thus, this study makes a methodological contribution by proposing a newly developed experimental paradigm facilitating further research on the effects of subjective loss of control, and additionally provides partial evidence for the spillover effects of loss of control experiences on risky decision-making.	[Beisswingert, Birgit M.; Goetz, Thomas] Univ Konstanz, Dept Empir Educ Res, Constance, Germany; [Zhang, Keshun] Univ Konstanz, Grad Sch Decis Sci, Constance, Germany; [Beisswingert, Birgit M.; Zhang, Keshun; Goetz, Thomas] Thurgau Univ Teacher Educ, Dept Empir Educ Res, Kreuzlingen, Switzerland; [Fischbacher, Urs] Univ Konstanz, Dept Econ, Constance, Germany; [Fischbacher, Urs] Thurgau Inst Econ, Kreuzlingen, Switzerland	University of Konstanz; University of Konstanz; University of Konstanz	Zhang, KS (corresponding author), Univ Konstanz, Grad Sch Decis Sci, Constance, Germany.; Zhang, KS (corresponding author), Thurgau Univ Teacher Educ, Dept Empir Educ Res, Kreuzlingen, Switzerland.	keshun.zhang@uni-konstanz.de			German Research Foundation (DFG) as a part of the Excellence Initiative	German Research Foundation (DFG) as a part of the Excellence Initiative(German Research Foundation (DFG))	This project was conducted within the interdisciplinary Research Initiative "Center for Psychoeconomics" at the University of Konstanz which is funded by the German Research Foundation (DFG) as a part of the Excellence Initiative. The first author received the funding.	ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; [Anonymous], 1998, J RISK RES, DOI DOI 10.1080/136698798377321; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Beauducel A, 2010, IST INTELLIGENCE STR; Bouyer M, 2001, RISK ANAL, V21, P457, DOI 10.1111/0272-4332.213125; Caligiuri PM, 1998, J APPL PSYCHOL, V83, P598, DOI 10.1037/0021-9010.83.4.598; Charness G, 2013, J ECON BEHAV ORGAN, V87, P43, DOI 10.1016/j.jebo.2012.12.023; Charness G, 2010, ECON INQ, V48, P133, DOI 10.1111/j.1465-7295.2009.00219.x; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crosetto P, 2013, J RISK UNCERTAINTY, V47, P31, DOI 10.1007/s11166-013-9170-z; Davis DD, 1992, EXPT EC; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; DUNN DS, 1990, SOC COGNITION, V8, P305, DOI 10.1521/soco.1990.8.3.305; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Filippin A, 2015, WORKING PAPERS GRENO; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Goetz T, 2010, MOTIV EMOTION, V34, P49, DOI 10.1007/s11031-009-9152-2; Greiner B, 2015, J ECON SCI ASSOC-JES, V1, P114, DOI 10.1007/s40881-015-0004-4; Hagen E. P., 2001, COGNITIVE ABILITIES; Hau R, 2008, J BEHAV DECIS MAKING, V21, P493, DOI 10.1002/bdm.598; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; HIROTO DS, 1974, J EXP PSYCHOL, V102, P187, DOI 10.1037/h0035910; Johnson J., 2004, POL PSYCHOL BULL, V35, P153; Kaufman AS, 2004, MANUAL ASSESSMENT BA; Krampen G., 1981, IPC FRAGEBOGEN KONTR; KRUEGER N, 1994, DECISION SCI, V25, P385, DOI 10.1111/j.1540-5915.1994.tb01849.x; LANGER EJ, 1975, J PERS SOC PSYCHOL, V32, P311, DOI 10.1037/0022-3514.32.2.311; Lench HC, 2005, COGNITION EMOTION, V19, P1049, DOI 10.1080/02699930500203112; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Levenson H., 1972, P 80 ANN CONV AM PSY, V7, P261, DOI DOI 10.1037/E465522008-131; Li KK, 2011, J RISK UNCERTAINTY, V43, P39, DOI 10.1007/s11166-011-9122-4; Liepmann D., 2007, INTELLIGENZ STRUKTUR; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; North DW, 1998, J RISK RES, V1, P73, DOI [10.1080/136698798377330, DOI 10.1080/136698798377330]; Perry RP, 2001, J EDUC PSYCHOL, V93, P776, DOI 10.1037/0022-0663.93.4.776; Preacher KJ, 2007, MULTIVAR BEHAV RES, V42, P185, DOI 10.1080/00273170701341316; Presson PK, 1996, J SOCIAL BEHAV PERSO; Rivers L, 2007, J RISK RES, V10, P1085, DOI 10.1080/13669870701615172; Rivers L, 2010, RISK ANAL, V30, P65, DOI 10.1111/j.1539-6924.2009.01313.x; ROTTER JB, 1965, J PERS SOC PSYCHOL, V2, P598, DOI 10.1037/h0022473; Schober B, 2007, Z PSYCHOL, V215, P183, DOI 10.1027/0044-3409.215.3.183; Seligman M. E., 1975, HELPLESSNESS DEPRESS; Simonin BL, 1998, J MARKETING RES, V35, P30, DOI 10.1177/002224379803500105; SITKIN SB, 1992, ACAD MANAGE REV, V17, P9, DOI 10.2307/258646; Sitkin SB, 1995, ACAD MANAGE J, V38, P1573, DOI 10.2307/256844; Skinner EA, 1996, J PERS SOC PSYCHOL, V71, P549, DOI 10.1037/0022-3514.71.3.549; SLOVIC P, 1966, CHILD DEV, V37, P169, DOI 10.1111/j.1467-8624.1966.tb05377.x; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Thompson SC, 1998, PSYCHOL BULL, V123, P143, DOI 10.1037/0033-2909.123.2.143; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; Weiss RH., 2006, GRUNDINTELLIGENZTEST; Whitson JA, 2008, SCIENCE, V322, P115, DOI 10.1126/science.1159845	54	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150470	10.1371/journal.pone.0150470	http://dx.doi.org/10.1371/journal.pone.0150470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930066	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500154
J	Rojas-Rueda, D; de Nazelle, A; Andersen, ZJ; Braun-Fahrlander, C; Bruha, J; Bruhova-Foltynova, H; Desqueyroux, H; Praznoczy, C; Ragettli, MS; Tainio, M; Nieuwenhuijsen, MJ				Rojas-Rueda, David; de Nazelle, Audrey; Andersen, Zorana J.; Braun-Fahrlaender, Charlotte; Bruha, Jan; Bruhova-Foltynova, Hana; Desqueyroux, Helene; Praznoczy, Corinne; Ragettli, Martina S.; Tainio, Marko; Nieuwenhuijsen, Mark J.			Health Impacts of Active Transportation in Europe	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRAVEL; BARCELONA; MORTALITY; BENEFITS; BIKE; CAR	Policies that stimulate active transportation (walking and bicycling) have been related to heath benefits. This study aims to assess the potential health risks and benefits of promoting active transportation for commuting populations (age groups 16-64) in six European cities. We conducted a health impact assessment using two scenarios: increased cycling and increased walking. The primary outcome measure was all-cause mortality related to changes in physical activity level, exposure to fine particulate matter air pollution with a diameter <2.5 mu m, as well as traffic fatalities in the cities of Barcelona, Basel, Copenhagen, Paris, Prague, and Warsaw. All scenarios produced health benefits in the six cities. An increase in bicycle trips to 35% of all trips (as in Copenhagen) produced the highest benefits among the different scenarios analysed in Warsaw 113 (76-163) annual deaths avoided, Prague 61 (29-104), Barcelona 37 (24-56), Paris 37 (18-64) and Basel 5 (3-9). An increase in walking trips to 50% of all trips (as in Paris) resulted in 19 (3-42) deaths avoided annually in Warsaw, 11(3-21) in Prague, 6 (4-9) in Basel, 3 (2-6) in Copenhagen and 3 (24) in Barcelona. The scenarios would also reduce carbon dioxide emissions in the six cities by 1,139 to 26,423 (metric tonnes per year). Policies to promote active transportation may produce health benefits, but these depend of the existing characteristics of the cities. Increased collaboration between health practitioners, transport specialists and urban planners will help to introduce the health perspective in transport policies and promote active transportation.	[Rojas-Rueda, David; Nieuwenhuijsen, Mark J.] Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain; [Rojas-Rueda, David; Nieuwenhuijsen, Mark J.] Hosp del Mar, IMIM, Municipal Inst Med Res, Barcelona, Spain; [Rojas-Rueda, David; Nieuwenhuijsen, Mark J.] UPF, Dept Ciencies Expt & Salut, Barcelona, Spain; [Rojas-Rueda, David; Nieuwenhuijsen, Mark J.] CIBERESP, Madrid, Spain; [de Nazelle, Audrey] Univ London Imperial Coll Sci Technol & Med, London, England; [Andersen, Zorana J.] Univ Copenhagen, Dept Publ Hlth, Ctr Epidemiol & Screening, Copenhagen, Denmark; [Braun-Fahrlaender, Charlotte; Ragettli, Martina S.] Swiss Trop & Publ Hlth Inst SwissTPH, Basel, Switzerland; [Braun-Fahrlaender, Charlotte; Ragettli, Martina S.] Univ Basel, Basel, Switzerland; [Bruha, Jan; Bruhova-Foltynova, Hana] Kolin Inst Technol, Kolin, Czech Republic; [Desqueyroux, Helene] Agcy Environm & Energy Management ADEME, Paris, France; [Praznoczy, Corinne] Univ Versailles St Quentin En Yvelines, Versailles, France; [Tainio, Marko] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland; [Tainio, Marko] Univ Cambridge, MRC Epidemiol Unit, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England	ISGlobal; Pompeu Fabra University; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; University of Copenhagen; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; UDICE-French Research Universities; Universite Paris Saclay; Polish Academy of Sciences; Systems Research Institute of the Polish Academy of Sciences; University of Cambridge	Rojas-Rueda, D (corresponding author), Ctr Res Environm Epidemiol CREAL, ISGlobal, Barcelona, Spain.; Rojas-Rueda, D (corresponding author), Hosp del Mar, IMIM, Municipal Inst Med Res, Barcelona, Spain.; Rojas-Rueda, D (corresponding author), UPF, Dept Ciencies Expt & Salut, Barcelona, Spain.; Rojas-Rueda, D (corresponding author), CIBERESP, Madrid, Spain.	drojas@creal.cat	Rojas-Rueda, David/AAK-2184-2020; Foltynova, Hana Bruhova/J-5759-2015; Brůhová Foltýnová, Hana/M-7624-2019; Nieuwenhuijsen, Mark J/C-3914-2017; Andersen, Zorana Jovanovic/P-4983-2014	Rojas-Rueda, David/0000-0001-5854-2484; Foltynova, Hana Bruhova/0000-0002-2744-5777; Brůhová Foltýnová, Hana/0000-0002-5242-8565; Nieuwenhuijsen, Mark J/0000-0001-9461-7981; Ragettli, Martina/0000-0001-7417-3287; Andersen, Zorana Jovanovic/0000-0003-4138-9828; de Nazelle, Audrey/0000-0002-1092-3971	Coca-Cola Foundation; AGAUR; CREAL; British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under UK Clinical Research Collaboration; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MR/K025147/1, MR/K021796/1, MR/K023187/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K025147/1, MR/K021796/1] Funding Source: researchfish	Coca-Cola Foundation; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); CREAL; British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under UK Clinical Research Collaboration(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work is part of the European-wide project Transportation Air pollution and Physical Activities: an integrated health risk assessment progamme of climate change and urban policies (TAPAS), which has partners in Barcelona, Basel, Copenhagen, Paris, Prague, and Warsaw. TAPAS is a four year project funded by the Coca-Cola Foundation, AGAUR, and CREAL (http://www.tapas-program.org/). The work was also undertaken by the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The sponsors have had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Autoridad del Transporte Metropolitano, 2007, EMQ 2006 REG METR BA; Beelen R, 2014, EPIDEMIOLOGY, V25, P368, DOI 10.1097/EDE.0000000000000076; de Hartog JJ, 2010, ENVIRON HEALTH PERSP, V118, P1109, DOI 10.1289/ehp.0901747; de Nazelle A, 2012, ATMOS ENVIRON, V59, P151, DOI 10.1016/j.atmosenv.2012.05.013; de Nazelle A, 2011, ENVIRON INT, V37, P766, DOI 10.1016/j.envint.2011.02.003; Donaire-Gonzalez D, 2015, AM J PREV M IN PRESS; EPA, 2011, GUID SUST TRANSP PER; European Environmental Agency, 2010, EUR ENV STAT OUTL 20; Grabow ML, 2011, ENV HLTH PERSPECT; Hoek G, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-43; Holm AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001135; Jacobsen PL, 2003, INJURY PREV, V9, P205, DOI 10.1136/ip.9.3.205rep; Joffe M, 2002, J EPIDEMIOL COMMUN H, V56, P132, DOI 10.1136/jech.56.2.132; Kahlmeier S, 2011, HLTH EC ASSESSMENT T; Laden F, 2000, ENVIRON HEALTH PERSP, V108, P941, DOI 10.2307/3435052; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Perez L, 2009, INT J PUBLIC HEALTH, V54, P45, DOI 10.1007/s00038-008-8025-x; Rabl A, 2012, TRANSPORT POLICY, V19, P121, DOI 10.1016/j.tranpol.2011.09.008; Rojas-Rueda D, 2012, ENVIRON INT, V49, P100, DOI 10.1016/j.envint.2012.08.009; Rojas-Rueda D, 2013, PREV MED; Rojas-Rueda D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4521; Sahlqvist S, 2012, PREV MED, V55, P206, DOI 10.1016/j.ypmed.2012.06.028; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Terzano K, 2011, ENVIRON BEHAV, V43, P488, DOI 10.1177/0013916510366644; The World Bank Institute for Health Metrics and Evaluation, 2014, TRANSP HLTH GLOB BUR; UNEP, 2010, SHAR ROAD INV WALK C; Wichmann H E, 2000, Res Rep Health Eff Inst, P5; Woodcock J, 2010, INT J EPIDEMIOL; Woodcock J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g425; Woodcock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051462; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1; World Health Organization, 2008, GLOB BURD DIS 2004	33	97	98	3	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149990	10.1371/journal.pone.0149990	http://dx.doi.org/10.1371/journal.pone.0149990			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930213	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000371434500085
J	Bernal-Ulloa, SM; Heinzmann, J; Herrmann, D; Hadeler, KG; Aldag, P; Winkler, S; Pache, D; Baulain, U; Lucas-Hahn, A; Niemann, H				Bernal-Ulloa, Sandra Milena; Heinzmann, Julia; Herrmann, Doris; Hadeler, Klaus-Gerd; Aldag, Patrick; Winkler, Sylke; Pache, Dorit; Baulain, Ulrich; Lucas-Hahn, Andrea; Niemann, Heiner			Cyclic AMP Affects Oocyte Maturation and Embryo Development in Prepubertal and Adult Cattle	PLOS ONE			English	Article							IN-VITRO MATURATION; DNA METHYLATION; GENE-EXPRESSION; CALF OOCYTES; GONADOTROPIN STIMULATION; PHYSIOLOGICAL FUNCTIONS; PRIMORDIAL FOLLICLES; MEIOTIC PROGRESSION; BOVINE EMBRYOS; MOUSE OVARY	High cAMP levels during in vitro maturation (IVM) have been related to improved blastocyst yields. Here, we employed the cAMP/cGMP modulators, forskolin, IBMX, and cilostamide, during IVM to unravel the role of high cAMP in early embryonic development produced from prepubertal and adult bovine oocytes. Oocytes were collected via transvaginal aspiration and randomly assigned to three experimental groups: TCM24 (24h IVM/control), cAMP30 (2h pre-IVM (forskolin-IBMX), 30h IVM-cilostamide), and DMSO30 (Dimethyl Sulfoxide/vehicle control). After IVM, oocytes were fertilized in vitro and zygotes were cultured in vitro to blastocysts. Meiotic progression, cAMP levels, mRNA abundance of selected genes and DNA methylation were evaluated in oocytes. Blastocysts were used for gene expression or DNA methylation analyses. Blastocysts from the cAMP30 groups were transferred to recipients. The cAMP elevation delayed meiotic progression, but developmental rates were not increased. In immature oocytes, mRNA abundance of PRKACA was higher for cAMP30 protocol and no differences were found for PDE3A, SMAD2, ZAR1, PRDX1 and SLC2A8. EGR1 gene was up-regulated in prepubertal cAMP30 immature oocytes and down-regulated in blastocysts from all in vitro treatments. A similar gene expression profile was observed for DNMT3b, BCL2L1, PRDX1 and SLC2A8 in blastocysts. Satellite DNA methylation profiles were different between prepubertal and adult oocytes and blastocysts derived from the TCM24 and DMSO30 groups. Blastocysts obtained from prepubertal and adult oocytes in the cAMP30 treatment displayed normal methylation profiles and produced offspring. These data indicate that cAMP regulates IVM in prepubertal and adult oocytes in a similar manner, with impact on the establishment of epigenetic marks and acquisition of full developmental competency.	[Bernal-Ulloa, Sandra Milena; Heinzmann, Julia; Herrmann, Doris; Hadeler, Klaus-Gerd; Aldag, Patrick; Baulain, Ulrich; Lucas-Hahn, Andrea; Niemann, Heiner] Friedrich Loeffler Inst, Inst Farm Anim Genet, Biotechnol, Mariensee, Germany; [Bernal-Ulloa, Sandra Milena] Univ Ciencias Aplicadas & Ambientales, Fac Ciencias Agr, Bogota, Colombia; [Winkler, Sylke; Pache, Dorit] Max Planck Inst Mol Cell Biol & Genet, DNA Sequencing Facil, Dresden, Germany	Friedrich Loeffler Institute; Max Planck Society	Niemann, H (corresponding author), Friedrich Loeffler Inst, Inst Farm Anim Genet, Biotechnol, Mariensee, Germany.	heiner.niemann@fli.bund.de			DFG Research Group "Germ Cell potential" [FOR 1041, Ni 256/ 30-2, Ni 256/ 30-3]; German Academic Exchange service (DAAD)	DFG Research Group "Germ Cell potential"; German Academic Exchange service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported in part by the DFG Research Group "Germ Cell potential" (FOR 1041; Ni 256/ 30-2 and 3). Sandra Milena Bernal-Ulloa was supported by the German Academic Exchange service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albarracin JL, 2005, THERIOGENOLOGY, V64, P1740, DOI 10.1016/j.theriogenology.2005.04.018; Albuz FK, 2010, HUM REPROD, V25, P2999, DOI 10.1093/humrep/deq246; ARMSTRONG DT, 1994, THERIOGENOLOGY, V42, P1227, DOI 10.1016/0093-691X(94)90871-0; Avery B, 2000, MOL REPROD DEV, V55, P438, DOI 10.1002/(SICI)1098-2795(200004)55:4&lt;438::AID-MRD12&gt;3.0.CO;2-Y; Bagg MA, 2006, MOL REPROD DEV, V73, P1326, DOI 10.1002/mrd.20555; Bernal SM, 2014, ZYGOTE, P1, DOI [10.1017/S0967199413000658, DOI 10.1017/S0967199413000658]; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019464; BRUOT BC, 1986, J ENDOCRINOL INVEST, V9, P171, DOI 10.1007/BF03348091; BUNGARTZ L, 1994, J REPROD FERTIL, V101, P583, DOI 10.1530/jrf.0.1010583; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Diederich M, 2012, REPRODUCTION, V144, P319, DOI 10.1530/REP-12-0134; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Enukashvily NI, 2013, ADV PROTEIN CHEM STR, V90, P31, DOI 10.1016/B978-0-12-410523-2.00002-X; Estes SJ, 2015, ENDOCRIN METAB CLIN, V44, P799, DOI 10.1016/j.ecl.2015.07.005; Fry RC, 1998, THERIOGENOLOGY, V49, P1077, DOI 10.1016/S0093-691X(98)00057-0; Gilchrist RB, 2015, THERIOGENOLOGY, V84, P656, DOI 10.1016/j.theriogenology.2015.03.032; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Grondahl ML, 2010, HUM REPROD, V25, P957, DOI 10.1093/humrep/deq014; Grupen CG, 2006, REPROD FERT DEVELOP, V18, P309, DOI 10.1071/RD05125; Guimaraes ALS, 2015, THERIOGENOLOGY, V83, P52, DOI 10.1016/j.theriogenology.2014.07.042; Han D, 2010, REPRODUCTION, V139, P959, DOI 10.1530/REP-09-0485; Heinzmann J, 2015, MOL HUM REPROD, V21, P770, DOI 10.1093/molehr/gav040; Kang YK, 2005, MOL REPROD DEV, V71, P29, DOI 10.1002/mrd.20249; Kauffold J, 2005, J REPROD DEVELOP, V51, P325, DOI 10.1262/jrd.17002; Khatir H, 1998, THERIOGENOLOGY, V50, P1201, DOI 10.1016/S0093-691X(98)00220-9; Ledda S, 2001, BIOL REPROD, V65, P247, DOI 10.1095/biolreprod65.1.247; Li BL, 2006, BIOCHEM BIOPH RES CO, V350, P179, DOI 10.1016/j.bbrc.2006.09.016; Mork L, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095208; Niemann H, 2010, CELL REPROGRAM, V12, P33, DOI 10.1089/cell.2009.0063; Oktay K, 2016, J PEDIATR ADOL GYNEC, V29, P409, DOI 10.1016/j.jpag.2015.10.011; Oropeza A, 2004, BIOL REPROD, V70, P1634, DOI 10.1095/biolreprod.103.025494; PARRISH JJ, 1988, BIOL REPROD, V38, P1171, DOI 10.1095/biolreprod38.5.1171; Pincus G, 1935, J EXP MED, V62, P665, DOI 10.1084/jem.62.5.665; R Development Core Team, 2014, R LANG ENV STAT COMP; REVEL F, 1995, J REPROD FERTIL, V103, P115, DOI 10.1530/jrf.0.1030115; Rizos D, 2002, MOL REPROD DEV, V61, P234, DOI 10.1002/mrd.1153; SAS Institute, 2008, SAS SYST WIND REL 9; Shuhaibar LC, 2015, P NATL ACAD SCI USA, V112, P5527, DOI 10.1073/pnas.1423598112; Stinshoff H, 2014, REPROD FERT DEVELOP, V26, P502, DOI 10.1071/RD12372; Suzuki T, 2002, EXP GERONTOL, V37, P1005, DOI 10.1016/S0531-5565(02)00061-X; Taneja M, 2000, BIOL REPROD, V62, P206, DOI 10.1095/biolreprod62.1.206; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; TSAFRIRI A, 1986, CLIN ENDOCRINOL META, V15, P157, DOI 10.1016/S0300-595X(86)80047-0; Urrego R, 2014, EPIGENETICS-US, V9, P803, DOI 10.4161/epi.28711; Wang YJ, 2015, DEVELOPMENT, V142, P343, DOI 10.1242/dev.112755; Wilson AS, 2007, BBA-REV CANCER, V1775, P138, DOI 10.1016/j.bbcan.2006.08.007; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Zaraza J, 2010, THERIOGENOLOGY, V74, P75, DOI 10.1016/j.theriogenology.2009.11.033; Zeng HT, 2013, HUM REPROD, V28, P1536, DOI 10.1093/humrep/det086; Zhang GM, 2013, THERIOGENOLOGY, V80, P328, DOI 10.1016/j.theriogenology.2013.04.019; Zheng WJ, 2014, MOL HUM REPROD, V20, P286, DOI 10.1093/molehr/gau007; Zheng WJ, 2014, HUM MOL GENET, V23, P920, DOI 10.1093/hmg/ddt486	53	25	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150264	10.1371/journal.pone.0150264	http://dx.doi.org/10.1371/journal.pone.0150264			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926596	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200033
J	Treit, S; Zhou, D; Chudley, AE; Andrew, G; Rasmussen, C; Nikkel, SM; Samdup, D; Hanlon-Dearman, A; Loock, C; Beaulieu, C				Treit, Sarah; Zhou, Dongming; Chudley, Albert E.; Andrew, Gail; Rasmussen, Carmen; Nikkel, Sarah M.; Samdup, Dawa; Hanlon-Dearman, Ana; Loock, Christine; Beaulieu, Christian			Relationships between Head Circumference, Brain Volume and Cognition in Children with Prenatal Alcohol Exposure	PLOS ONE			English	Article							ETHANOL EXPOSURE; BIRTH-DEFECTS; GROWTH; PREGNANCY; SIZE; AGE; INTELLIGENCE; CHILDHOOD; OUTCOMES	Head circumference is used together with other measures as a proxy for central nervous system damage in the diagnosis of fetal alcohol spectrum disorders, yet the relationship between head circumference and brain volume has not been investigated in this population. The objective of this study is to characterize the relationship between head circumference, brain volume and cognitive performance in a large sample of children with prenatal alcohol exposure (n = 144) and healthy controls (n = 145), aged 5-19 years. All participants underwent magnetic resonance imaging to yield brain volumes and head circumference, normalized to control for age and sex. Mean head circumference, brain volume, and cognitive scores were significantly reduced in the prenatal alcohol exposure group relative to controls, albeit with considerable overlap between groups. Males with prenatal alcohol exposure had reductions in all three measures, whereas females with prenatal alcohol exposure had reduced brain volumes and cognitive scores, but no difference in head circumference relative to controls. Microcephaly (defined here as head circumference <= 3rd percentile) occurred more often in prenatal alcohol exposed participants than controls, but 90% of the exposed sample had head circumferences above this clinical cutoff indicating that head circumference is not a sensitive marker of prenatal alcohol exposure. Normalized head circumference and brain volume were positively correlated in both groups, and subjects with very low head circumference typically had below-average brain volumes. Conversely, over half of the subjects with very low brain volumes had normal head circumferences, which may stem from differential effects of alcohol on the skeletal and nervous systems. There were no significant correlations between head circumference and any cognitive score. These findings confirm group-level reductions in head circumference and increased rates of microcephaly in children with prenatal alcohol exposure, but raise concerns about the predictive value of this metric at an individual-subject level.	[Treit, Sarah; Beaulieu, Christian] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Zhou, Dongming; Beaulieu, Christian] Univ Alberta, Dept Biomed Engn, Edmonton, AB, Canada; [Chudley, Albert E.; Hanlon-Dearman, Ana] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Chudley, Albert E.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Andrew, Gail; Rasmussen, Carmen] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Andrew, Gail] Glenrose Rehabil Hosp, FASD Diagnost Clin, Edmonton, AB, Canada; [Nikkel, Sarah M.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Samdup, Dawa] Queens Univ, Dept Pediat, Kingston, ON K7L 3N6, Canada; [Loock, Christine] Univ British Columbia, Dept Pediat, Vancouver, BC V6T 1W5, Canada; [Loock, Christine] Sunny Hill Hlth Ctr Children, Vancouver, BC, Canada	University of Alberta; University of Alberta; University of Manitoba; University of Manitoba; University of Alberta; University of Ottawa; Queens University - Canada; University of British Columbia	Treit, S (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	treit@ualberta.ca	Beaulieu, Christian/E-9796-2011	Beaulieu, Christian/0000-0002-2342-3298; Loock, Christine A./0000-0003-4452-0924	Canadian Institutes for Health Research (CIHR); Networks of Centres for Excellence (via NeuroDevNet); Women and Children's Health Research Institute (WCHRI); Alberta Innovates Health Solutions	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Networks of Centres for Excellence (via NeuroDevNet); Women and Children's Health Research Institute (WCHRI); Alberta Innovates Health Solutions	This study was funded by the Canadian Institutes for Health Research (CIHR), the Networks of Centres for Excellence (via NeuroDevNet), and the Women and Children's Health Research Institute (WCHRI). Salary support was provided by Alberta Innovates Health Solutions to co-authors ST & CB. All participants or parents/legal guardians provided written informed consent, and participants were screened for contraindications to MRI.	Aiken CE, 2013, REPRODUCTION, V145, pR1, DOI 10.1530/REP-11-0489; Astley S., 2004, DIAGNOSTIC GUIDE FET; Astley SJ, 2009, ALCOHOL CLIN EXP RES, V33, P1671, DOI 10.1111/j.1530-0277.2009.01004.x; Bagheri MM, 1998, J PERINAT MED, V26, P263, DOI 10.1515/jpme.1998.26.4.263; Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Beauchamp MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024981; Carter RC, 2013, ALCOHOL CLIN EXP RES, V37, P452, DOI 10.1111/j.1530-0277.2012.01940.x; Chen XC, 2012, HUM BRAIN MAPP, V33, P1663, DOI 10.1002/hbm.21313; Chudley AE, 2005, CAN MED ASSOC J, V172, pS1, DOI 10.1503/cmaj.1040302; COLES CD, 1991, NEUROTOXICOL TERATOL, V13, P357, DOI 10.1016/0892-0362(91)90084-A; Day NL, 2002, ALCOHOL CLIN EXP RES, V26, P1584, DOI 10.1097/01.ALC.0000034036.75248.D9; Dunty WC, 2001, ALCOHOL CLIN EXP RES, V25, P1523, DOI 10.1111/j.1530-0277.2001.tb02156.x; Ervalahti N, 2007, AM J MED GENET A, V143A, P2916, DOI 10.1002/ajmg.a.32009; Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629; Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034; Giedd JN, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-19; Giedd JN, ANN NEW YORK ACAD SC, V10212004, P77; Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07; Hernandez-Guerrero JC, 1998, ARCH MED RES, V29, P297; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Ivanovic DM, 2004, NEUROPSYCHOLOGIA, V42, P1118, DOI 10.1016/j.neuropsychologia.2003.11.022; Lebel C, 2008, ALCOHOL CLIN EXP RES, V32, P1732, DOI 10.1111/j.1530-0277.2008.00750.x; Lebel C, 2012, J NEUROSCI, V32, P15243, DOI 10.1523/JNEUROSCI.1161-12.2012; Lebel C, 2011, NEUROPSYCHOL REV, V21, P102, DOI 10.1007/s11065-011-9163-0; LITTLE RE, 1977, AM J PUBLIC HEALTH, V67, P1154, DOI 10.2105/AJPH.67.12.1154; Nardelli A, 2011, ALCOHOL CLIN EXP RES, V35, P1404, DOI 10.1111/j.1530-0277.2011.01476.x; O'Callaghan FV, 2003, EARLY HUM DEV, V71, P137, DOI 10.1016/S0378-3782(03)00003-3; OCONNELL EJ, 1965, PEDIATRICS, V36, P62; Reynolds JN, 2011, SEMIN PEDIATR NEUROL, V18, P49, DOI 10.1016/j.spen.2011.02.006; Rollins JD, 2010, J PEDIATR-US, V156, P907, DOI 10.1016/j.jpeds.2010.01.009; RUSSELL M, 1991, ALCOHOL CLIN EXP RES, V15, P991, DOI 10.1111/j.1530-0277.1991.tb05200.x; SAMPSON PD, 1994, AM J PUBLIC HEALTH, V84, P1421, DOI 10.2105/AJPH.84.9.1421; Shen L, 2013, ALCOHOL, V47, P405, DOI 10.1016/j.alcohol.2013.04.005; Sickmann HM, 2014, HIPPOCAMPUS, V24, P54, DOI 10.1002/hipo.22203; SMITH IE, 1986, NEUROTOXICOL TERATOL, V8, P375; Tate DF, 2007, NEUROPEDIATRICS, V38, P18, DOI 10.1055/s-2007-981450; Uban KA, 2013, PSYCHONEUROENDOCRINO, V38, P1953, DOI 10.1016/j.psyneuen.2013.02.017; Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425; Weinberg J, 2008, J NEUROENDOCRINOL, V20, P470, DOI 10.1111/j.1365-2826.2008.01669.x; Williams CA, 2008, AM J MED GENET A, V146A, P2023, DOI 10.1002/ajmg.a.32434; Wright CM, 2015, PEDIATRICS, V135, pE1393, DOI 10.1542/peds.2014-3172; Zhou DM, 2011, NEUROIMAGE, V58, P16, DOI 10.1016/j.neuroimage.2011.06.026	43	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150370	10.1371/journal.pone.0150370	http://dx.doi.org/10.1371/journal.pone.0150370			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928125	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200040
J	Yang, YL; Qian, MY; Yi, SQ; Liu, SL; Li, B; Yu, R; Guo, Q; Zhang, XP; Yu, CM; Li, JM; Xu, JJ; Chen, W				Yang, Yilong; Qian, Mengying; Yi, Shaoqiong; Liu, Shuling; Li, Bing; Yu, Rui; Guo, Qiang; Zhang, Xiaopeng; Yu, Changming; Li, Jianmin; Xu, Junjie; Chen, Wei			Monoclonal Antibody Targeting Staphylococcus aureus Surface Protein A (SasA) Protect Against Staphylococcus aureus Sepsis and Peritonitis in Mice	PLOS ONE			English	Article							INFECTIONS; DIALYSIS; SEQUENCE; PREVENTION; THERAPY; DISEASE; BINDING; ISAA	Epidemic methicillin-resistant Staphylococcus aureus (MRSA) imposes an increasing impact on public health. Due to multi-antibiotics resistance in MRSA strains, there is an urgent need to develop novel therapeutics such as effective monoclonal antibodies (mAbs) against MRSA infections. Staphylococcus aureus surface protein A (SasA), a large surface-located protein (similar to 240 kDa), is one of MSCRAMMs (microbial surface components recognizing adhesive matrix molecules) and a potential target for immunotherapeutic approaches against S. aureus infections. In the present study, we analyzed the sequence of SasA with bioinformatics tools and generated a protective monoclonal antibody (2H7) targeting the conserved domain of SasA. 2H7 was shown to recognize wild-type S. aureus and promote opsonophagocytic killing of S. aureus. In both sepsis and peritoneal infection models, prophylactic administration of 2H7 improved the survival of BALB/c mice challenged by S. aureus strain USA300 and ST239 (prevalent MRSA clones in North America and Asian countries, respectively) and enhanced bacterial clearance in kidneys. Additionally, 2H7 prophylaxis prevented the formation of intraperitoneal abscess in a murine model of peritoneal infection and therapeutic administration of 2H7 showed protective efficacy in a murine sepsis model. Our results presented here provide supporting evidences that an anti-SasA mAb might be a potential component in an antibody-based immunotherapeutic treatment of MRSA infections.	[Yang, Yilong; Qian, Mengying; Yi, Shaoqiong; Liu, Shuling; Yu, Rui; Guo, Qiang; Zhang, Xiaopeng; Yu, Changming; Li, Jianmin; Xu, Junjie; Chen, Wei] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China; [Li, Bing] Peoples Liberat Army, Hosp 306, Dept Clin Lab, Beijing, Peoples R China		Chen, W (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing, Peoples R China.	cw0226@foxmail.com	li, jian/GSE-0245-2022; LI, JIAN/GRY-2197-2022		National Major Scientific and Technological Special Project for prevention and control of infectious disease [2013ZX1004001]	National Major Scientific and Technological Special Project for prevention and control of infectious disease	This study was supported by grants from the National Major Scientific and Technological Special Project for prevention and control of infectious disease ( grant no. 2013ZX1004001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnoli F, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00016; Broughan J, 2011, EXPERT REV VACCINES, V10, P695, DOI [10.1586/ERV.11.54, 10.1586/erv.11.54]; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Ebert Tim, 2010, Human Antibodies, V19, P113, DOI 10.3233/HAB-2010-0235; Folettit D, 2013, J MOL BIOL, V425, P1641, DOI 10.1016/j.jmb.2013.02.008; Govindarajulu S, 2010, PERITON DIALYSIS INT, V30, P311, DOI 10.3747/pdi.2008.00258; Hall AE, 2003, INFECT IMMUN, V71, P6864, DOI 10.1128/IAI.71.12.6864-6870.2003; Hilliard JJ, 2015, ANTIMICROB AGENTS CH, V59, P299, DOI 10.1128/AAC.03918-14; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim HK, 2012, INFECT IMMUN, V80, P3460, DOI 10.1128/IAI.00230-12; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lizcano A, 2012, MOL ORAL MICROBIOL, V27, P257, DOI 10.1111/j.2041-1014.2012.00653.x; Lorenz U, 2011, ANTIMICROB AGENTS CH, V55, P165, DOI 10.1128/AAC.01144-10; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nguyen DB, 2013, CLIN INFECT DIS, V57, P1393, DOI 10.1093/cid/cit546; Pancari G, 2012, FRONTIERS CELLULAR I; Park J, 2007, CHEM BIOL, V14, P1119, DOI 10.1016/j.chembiol.2007.08.013; Park S, 2014, INFECT IMMUN, V82, P5049, DOI 10.1128/IAI.02373-14; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Provenza G, 2010, FEBS J, V277, P4490, DOI 10.1111/j.1742-4658.2010.07835.x; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rauch S, 2012, INFECT IMMUN, V80, P3721, DOI 10.1128/IAI.00442-12; Roche FM, 2003, MICROBIOL-SGM, V149, P643, DOI 10.1099/mic.0.25996-0; Saylor C, 2009, VACCINE, V27, pG38, DOI 10.1016/j.vaccine.2009.09.105; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Siboo IR, 2005, INFECT IMMUN, V73, P2273, DOI 10.1128/IAI.73.4.2273-2280.2005; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; van den Berg S, 2015, INT J MED MICROBIOL, V305, P55, DOI 10.1016/j.ijmm.2014.11.002; Verkaik NJ, 2011, IMMUNOTHERAPY-UK, V3, P1063, DOI [10.2217/imt.11.84, 10.2217/IMT.11.84]; Weisman LE, 2009, ANTIMICROB AGENTS CH, V53, P2879, DOI 10.1128/AAC.01565-08; Xiao M, 2013, J CLIN MICROBIOL, V51, P3638, DOI 10.1128/JCM.01375-13; Yang Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/145641; Yi SQ, 2012, MICROBIOL IMMUNOL, V56, P406, DOI 10.1111/j.1348-0421.2012.00451.x; Zacharioudakis IM, 2014, J AM SOC NEPHROL, V25, P2131, DOI 10.1681/ASN.2013091028	37	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149460	10.1371/journal.pone.0149460	http://dx.doi.org/10.1371/journal.pone.0149460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926145	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200011
J	Alabi, OJ; Casassa, F; Gutha, LR; Larsen, RC; Henick-Kling, T; Harbertson, JF; Naidu, RA				Alabi, Olufemi J.; Casassa, Federico; Gutha, Linga R.; Larsen, Richard C.; Henick-Kling, Thomas; Harbertson, James F.; Naidu, Rayapati A.			Impacts of Grapevine Leafroll Disease on Fruit Yield and Grape and Wine Chemistry in a Wine Grape (Vitis vinifera L.) Cultivar	PLOS ONE			English	Article							VIRUSES GLRAV-2 AND-3; SUGAR ACCUMULATION; QUALITY; PERFORMANCE; TRANSMISSION; PHYSIOLOGY; INFECTION; FAMILY; GENUS	Grapevine leafroll disease (GLD) is an economically important virus disease affecting wine grapes (Vitis vinifera L.), but little is known about its effect on wine chemistry and sensory composition of wines. In this study, impacts of GLD on fruit yield, berry quality and wine chemistry and sensory features were investigated in a red wine grape cultivar planted in a commercial vineyard. Own-rooted Merlot vines showing GLD symptoms and tested positive for Grapevine leafroll-associated virus 3 and adjacent non-symptomatic vines that tested negative for the virus were compared during three consecutive seasons. Number and total weight of clusters per vine were significantly less in symptomatic relative to non-symptomatic vines. In contrast to previous studies, a time-course analysis of juice from grapes harvested at different stages of berry development from symptomatic and non-symptomatic vines indicated more prominent negative impacts of GLD on total soluble solids (TSS) and berry skin anthocyanins than in juice pH and titratable acidity. Differences in TSS between grapes of symptomatic and non-symptomatic vines were more pronounced after the onset of veraison, with significantly lower concentrations of TSS in grapes from symptomatic vines throughout berry ripening until harvest. Wines made from grapes of GLD-affected vines had significantly lower alcohol, polymeric pigments, and anthocyanins compared to corresponding wines from grapes of non-symptomatic vines. Sensory descriptive analysis of 2010 wines indicated significant differences in color, aroma and astringency between wines made from grapes harvested from GLD-affected and unaffected vines. The impacts of GLD on yield and fruit and wine quality traits were variable between the seasons, with greater impacts observed during a cooler season, suggesting the influence of host plant x environment interactions on overall impacts of the disease.	[Alabi, Olufemi J.; Gutha, Linga R.; Naidu, Rayapati A.] Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA; [Casassa, Federico; Larsen, Richard C.; Henick-Kling, Thomas; Harbertson, James F.] Washington State Univ, Viticulture & Enol Program, Wine Sci Ctr, 2710 Crimson Way, Richland, WA USA; [Alabi, Olufemi J.] Texas A&M AgriLife Res & Extens Ctr, Dept Plant Pathol & Microbiol, Weslaco, TX USA; [Casassa, Federico] Calif Polytech State Univ San Luis Obispo, Wine & Viticulture Dept, San Luis Obispo, CA 93407 USA; [Gutha, Linga R.] EI DuPont India Pvt Ltd, DuPont Knowledge Ctr Hyderabad, Hyderabad, Andhra Pradesh, India	Washington State University; Washington State University; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; California State University System; California Polytechnic State University San Luis Obispo	Naidu, RA (corresponding author), Washington State Univ, Irrigated Agr Res & Extens Ctr, Dept Plant Pathol, Prosser, WA 99350 USA.	naidu.rayapati@wsu.edu	Alabi, Olufemi J./ABD-9930-2020	Alabi, Olufemi J./0000-0002-2471-7052; Rayapati, Naidu/0000-0002-7273-5116	Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences; Wine Advisory Committee; Washington Wine Commission; Washington State Grape & Wine Research Program; USDA-NIFA-Specialty Crop Research Initiative [2009-51181-06027]; USDA Northwest Center for Small Fruits Research; USDA-NIFA -Specialty Crop Research Initiative [2009-51181- 06027]; Hatch Project [WNPO 0616]	Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences; Wine Advisory Committee; Washington Wine Commission; Washington State Grape & Wine Research Program; USDA-NIFA-Specialty Crop Research Initiative; USDA Northwest Center for Small Fruits Research; USDA-NIFA -Specialty Crop Research Initiative; Hatch Project(United States Department of Agriculture (USDA))	This study was funded, in part, by the Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences, the Wine Advisory Committee, the Washington Wine Commission, and Washington State Grape & Wine Research Program, USDA-NIFA-Specialty Crop Research Initiative (Award No. 2009-51181-06027) and USDA Northwest Center for Small Fruits Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded, in part, by the Agriculture Research Center, Washington State University College of Agriculture, Human and Natural Resource Sciences, the Wine Advisory Committee, the Washington Wine Commission, and Washington State Grape & Wine Research Program, USDA-NIFA -Specialty Crop Research Initiative (Award No. 2009-51181- 06027) and USDA Northwest Center for Small Fruits Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Maria Mireles and Christopher W. Beaver for their technical assistance and an anonymous commercial grower for providing the vineyard site for conducting our study. PPNS# 0711, Department of Plant Pathology, College of Agricultural, Human, and Natural Resource Sciences Agricultural Research Center, Hatch Project No. WNPO 0616, Washington State University, Pullman 99164.	Al Rwahnih M, 2012, VIRUS RES, V163, P302, DOI 10.1016/j.virusres.2011.10.018; Alabi OJ, 2012, P 17 C INT COUNC STU, P170; Alabi OJ, 2012, MOL PLANT PATHOL, V13, P1060, DOI 10.1111/j.1364-3703.2012.00815.x; Bacilieri R, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-25; Basso MF, 2010, TROP PLANT PATHOL, V35, P351, DOI 10.1590/S1982-56762010000600003; BOWER JA, 1995, NUTR FOOD SCI, V6, P35, DOI DOI 10.1108/00346659510103647; Casassa LF, 2013, AUST J GRAPE WINE R, V19, P25, DOI 10.1111/ajgw.12009; Castellano M. A., 2000, Journal of Plant Pathology, V82, P9; Castellarin SD, 2011, J EXP BOT, V62, P4345, DOI 10.1093/jxb/err150; Chloupek O, 2004, FIELD CROP RES, V85, P167, DOI 10.1016/S0378-4290(03)00162-X; Cookson SJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-147; Coombe B. G., 2000, Australian Journal of Grape and Wine Research, V6, P131, DOI 10.1111/j.1755-0238.2000.tb00171.x; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Dai ZW, 2011, AM J ENOL VITICULT, V62, P413, DOI 10.5344/ajev.2011.10116; Dal Santo S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-6-r54; Giribaldi M, 2011, J PROTEOMICS, V75, P306, DOI 10.1016/j.jprot.2011.08.006; Golino D. A., 2009, 16 M ICVG DIJ FRANC, P243; Guidoni S, 2008, AM J ENOL VITICULT, V59, P22; Harbertson JF, 2003, AM J ENOL VITICULT, V54, P301; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hayasaka Y, 2003, AUST J GRAPE WINE R, V9, P210, DOI 10.1111/j.1755-0238.2003.tb00272.x; HOLM S, 1979, SCAND J STAT, V6, P65; HUNTER J J, 1988, South African Journal for Enology and Viticulture, V9, P3; Illand P., 2000, TECHNIQUES CHEM ANAL, P111; Jones GV, 2000, AM J ENOL VITICULT, V51, P249; Komar V, 2010, AM J ENOL VITICULT, V61, P68; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Le Maguet J, 2012, PHYTOPATHOLOGY, V102, P717, DOI 10.1094/PHYTO-10-11-0289; Lee JM, 2009, FOOD CHEM, V112, P889, DOI 10.1016/j.foodchem.2008.06.065; Lee J, 2009, FOOD CHEM, V117, P99, DOI 10.1016/j.foodchem.2009.03.082; Legrand H, 1945, J OPT SOC AM, V35, P268; Mannini F, 2012, AM J ENOL VITICULT, V63, P144, DOI 10.5344/ajev.2011.11020; Maree HJ, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00082; Martelli GP, 2012, J PLANT PATHOL, V94, P7; Martelli GP, 2014, J PLANT PATHOL, V96, P1; Meilgaard MC, 2006, SENS EV TECHN 5 ED, V4th, DOI DOI 10.1201/B16452; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; MOTOMURA Y, 1993, AM J ENOL VITICULT, V44, P1; Naidu R. A., 2011, WSU VITICULTURE ENOL, P6; Naidu R, 2014, PLANT DIS, V98, P1172, DOI 10.1094/PDIS-08-13-0880-FE; Naidu RA, 2015, ANNU REV PHYTOPATHOL, V53, P613, DOI 10.1146/annurev-phyto-102313-045946; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Poojari S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-324; Rayapati A. N., 2008, WSU EXTENSION B; SPAYD SE, 2002, AM J ENOL VITICULT, V53, P3; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Vega A, 2011, PLANT MOL BIOL, V77, P261, DOI 10.1007/s11103-011-9807-8; Wallis CM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00502; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207	49	39	39	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149666	10.1371/journal.pone.0149666	http://dx.doi.org/10.1371/journal.pone.0149666			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919614	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400033
J	Holt, LM; Olsen, ML				Holt, Leanne Melissa; Olsen, Michelle Lynne			Novel Applications of Magnetic Cell Sorting to Analyze Cell-Type Specific Gene and Protein Expression in the Central Nervous System	PLOS ONE			English	Article							ADULT-RAT-BRAIN; RETT-SYNDROME; MOUSE-BRAIN; VASCULAR CELLS; IN-VITRO; ASTROCYTES; MICROGLIA; NEURONS; TRANSCRIPTOME; MECP2	The isolation and study of cell-specific populations in the central nervous system (CNS) has gained significant interest in the neuroscience community. The ability to examine cell-specific gene and protein expression patterns in healthy and pathological tissue is critical for our understanding of CNS function. Several techniques currently exist to isolate cell-specific populations, each having their own inherent advantages and shortcomings. Isolation of distinct cell populations using magnetic sorting is a technique which has been available for nearly 3 decades, although rarely used in adult whole CNS tissue homogenate. In the current study we demonstrate that distinct cell populations can be isolated in rodents from early postnatal development through adulthood. We found this technique to be amendable to customization using commercially available membrane-targeted antibodies, allowing for cell-specific isolation across development and animal species. This technique yields RNA which can be utilized for downstream applications-including quantitative PCR and RNA sequencing-at relatively low cost and without the need for specialized equipment or fluorescently labeled cells. Adding to its utility, we demonstrate that cells can be isolated largely intact, retaining their processes, enabling analysis of extrasomatic proteins. We propose that magnetic cell sorting will prove to be a highly useful technique for the examination of cell specific CNS populations.	[Holt, Leanne Melissa; Olsen, Michelle Lynne] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Olsen, Michelle Lynne] Univ Alabama Birmingham, Ctr Glial Biol Med, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Olsen, ML (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA.; Olsen, ML (corresponding author), Univ Alabama Birmingham, Ctr Glial Biol Med, Birmingham, AL USA.	molsen@uab.edu		Olsen, Michelle/0000-0003-1394-664X; Holt, Leanne/0000-0003-0954-2298	National Institutes of Health [R01 NS075062];  [P30AR48311];  [CA13148];  [AI027767]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075062] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01 NS075062. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank E. Keyser from the UAB Flow Cytometry Facility (core supported by P30AR48311) who performed FAC sorting of eGFP+ astrocytes and the Heflin Center for Genomic Science Genomics Core facility (supported by CA13148 and AI027767) who analyzed RNA quality.	Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chadi G, 2009, J MOL HISTOL, V40, P241, DOI 10.1007/s10735-009-9235-0; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Dincman TA, 2012, J NEUROSCI METH, V209, P219, DOI 10.1016/j.jneumeth.2012.06.017; Dong WJ, 2009, J LIPID RES, V50, P2095, DOI 10.1194/jlr.M900236-JLR200; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Emery Ben, 2013, Cold Spring Harb Protoc, V2013, P854, DOI 10.1101/pdb.prot073973; Feldmann M, 2014, J BIOL METHODS, V1; Ferraiuolo L, 2007, J NEUROSCI, V27, P9201, DOI 10.1523/JNEUROSCI.1470-07.2007; Foo Lynette C, 2013, Cold Spring Harb Protoc, V2013, P421, DOI 10.1101/pdb.prot074211; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Gilliam D, 2014, JVETINTERNMED; Guez-Barber D, 2012, J NEUROSCI METH, V203, P10, DOI 10.1016/j.jneumeth.2011.08.045; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Harms Ashley S, 2013, Methods Mol Biol, V1041, P33, DOI 10.1007/978-1-62703-520-0_5; Itakura E, 2007, ENDOCRINOLOGY, V148, P1518, DOI 10.1210/en.2006-1390; Jacob AL, 2015, HIPPOCAMPUS, V25, P798, DOI 10.1002/hipo.22404; Jungblut M, 2012, GLIA, V60, P894, DOI 10.1002/glia.22322; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Losciuto S, 2012, J NEUROSCI METH, V207, P59, DOI 10.1016/j.jneumeth.2012.03.010; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marek R, 2008, J NEUROSCI METH, V175, P108, DOI 10.1016/j.jneumeth.2008.08.016; Matsutani S, 1997, GLIA, V20, P1, DOI 10.1002/(SICI)1098-1136(199705)20:1<1::AID-GLIA1>3.0.CO;2-E; McCullumsmith RE, 2011, BIOL PSYCHIAT, V69, P127, DOI 10.1016/j.biopsych.2010.09.035; MILTENYI S, 1990, CYTOMETRY, V11, P231, DOI 10.1002/cyto.990110203; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nagy JI, 2003, CELL COMMUN ADHES, V10, P401, DOI 10.1080/15419060390263191; Nikodemova M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-147; Nwaobi S, 2013, DNA METHYLATION IS C; Nwaobi SE, 2014, GLIA, V62, P411, DOI 10.1002/glia.22613; Ohtsuki S, 2008, J NEUROCHEM, V104, P147, DOI 10.1111/j.1471-4159.2007.05008.x; Persson M, 2005, GLIA, V51, P111, DOI 10.1002/glia.20191; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Smith SMC, 2014, ASN NEURO, V6, DOI 10.1042/AN20130050; Standaert DG, 2005, ARCH NEUROL-CHICAGO, V62, P203, DOI 10.1001/archneur.62.2.203; Sugino K, 2014, J NEUROSCI, V34, P12877, DOI 10.1523/JNEUROSCI.2674-14.2014; Van Landeghem FKH, 2001, GLIA, V35, P167, DOI 10.1002/glia.1082; Yang YJ, 2011, GLIA, V59, P200, DOI 10.1002/glia.21089; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	44	47	48	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150290	10.1371/journal.pone.0150290	http://dx.doi.org/10.1371/journal.pone.0150290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919701	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400119
J	Liu, X; Wolfe, R; Welch, LR; Domozych, DS; Popper, ZA; Showalter, AM				Liu, Xiao; Wolfe, Richard; Welch, Lonnie R.; Domozych, David S.; Popper, Zoe A.; Showalter, Allan M.			Bioinformatic Identification and Analysis of Extensins in the Plant Kingdom	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; ALGAL PROLYL 4-HYDROXYLASE; CELL-WALL PROTEINS; GENE FAMILY; GENOME SEQUENCE; PROLINE-RICH; ARABIDOPSIS-THALIANA; GREEN-ALGA; MOLECULAR CHARACTERIZATION; TOMATO EXTENSIN	Extensins (EXTs) are a family of plant cell wall hydroxyproline-rich glycoproteins (HRGPs) that are implicated to play important roles in plant growth, development, and defense. Structurally, EXTs are characterized by the repeated occurrence of serine (Ser) followed by three to five prolines (Pro) residues, which are hydroxylated as hydroxyproline (Hyp) and glycosylated. Some EXTs have Tyrosine (Tyr)-X-Tyr (where X can be any amino acid) motifs that are responsible for intramolecular or intermolecular cross-linkings. EXTs can be divided into several classes: classical EXTs, short EXTs, leucine-rich repeat extensins (LRXs), proline-rich extensin-like receptor kinases (PERKs), formin-homolog EXTs (FH EXTs), chimeric EXTs, and long chimeric EXTs. To guide future research on the EXTs and understand evolutionary history of EXTs in the plant kingdom, a bioinformatics study was conducted to identify and classify EXTs from 16 fully sequenced plant genomes, including Ostreococcus lucimarinus, Chlamydomonas reinhardtii, Volvox carteri, Klebsormidium flaccidum, Physcomitrella patens, Selaginella moellendorffii, Pinus taeda, Picea abies, Brachypodium distachyon, Zea mays, Oryza sativa, Glycine max, Medicago truncatula, Brassica rapa, Solanum lycopersicum, and Solanum tuberosum, to supplement data previously obtained from Arabidopsis thaliana and Populus trichocarpa. A total of 758 EXTs were newly identified, including 87 classical EXTs, 97 short EXTs, 61 LRXs, 75 PERKs, 54 FH EXTs, 38 long chimeric EXTs, and 346 other chimeric EXTs. Several notable findings were made: (1) classical EXTs were likely derived after the terrestrialization of plants; (2) LRXs, PERKs, and FHs were derived earlier than classical EXTs; (3) monocots have few classical EXTs; (4) Eudicots have the greatest number of classical EXTs and Tyr-X-Tyr cross-linking motifs are predominantly in classical EXTs; (5) green algae have no classical EXTs but have a number of long chimeric EXTs that are absent in embryophytes. Furthermore, phylogenetic analysis was conducted of LRXs, PERKs and FH EXTs, which shed light on the evolution of three EXT classes.	[Liu, Xiao; Showalter, Allan M.] Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA; [Liu, Xiao; Showalter, Allan M.] Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA; [Wolfe, Richard; Welch, Lonnie R.] Ohio Univ, Russ Coll Engn & Technol, Ctr Intelligent Distributed & Dependable Syst, Athens, OH 45701 USA; [Domozych, David S.] Skidmore Coll, Dept Biol, Saratoga Springs, NY 12866 USA; [Popper, Zoe A.] Natl Univ Ireland, Sch Nat Sci, Bot & Plant Sci, Galway, Ireland; [Popper, Zoe A.] Natl Univ Ireland, Ryan Inst Environm Marine & Energy Res, Sch Nat Sci, Galway, Ireland	University System of Ohio; Ohio University; University System of Ohio; Ohio University; University System of Ohio; Ohio University; Skidmore College; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway	Showalter, AM (corresponding author), Ohio Univ, Dept Environm & Plant Biol, Athens, OH 45701 USA.; Showalter, AM (corresponding author), Ohio Univ, Mol & Cellular Biol Program, Athens, OH 45701 USA.	showalte@ohio.edu		Showalter, Allan/0000-0003-0775-4991; Popper, Zoe/0000-0002-8048-7351	Div Of Molecular and Cellular Bioscience [1517345] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Ahn JH, 1996, PLANT CELL, V8, P1477, DOI 10.1105/tpc.8.9.1477; ArsenijevicMaksimovic I, 1997, MOL PLANT MICROBE IN, V10, P95, DOI 10.1094/MPMI.1997.10.1.95; Bai L, 2009, PLANT J, V60, P314, DOI 10.1111/j.1365-313X.2009.03956.x; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Baumberger N, 2003, PLANT PHYSIOL, V131, P1313, DOI 10.1104/pp.102.014928; Baumberger N, 2001, GENE DEV, V15, P1128, DOI 10.1101/gad.200201; BOWN DP, 1993, GENE, V134, P229, DOI 10.1016/0378-1119(93)90098-N; BROWNLEADER MD, 1993, PLANTA, V191, P457, DOI 10.1007/BF00195747; Bucher M, 1997, PLANT MOL BIOL, V35, P497, DOI 10.1023/A:1005869717158; Cannon MC, 2008, P NATL ACAD SCI USA, V105, P2226, DOI 10.1073/pnas.0711980105; Chalkia D, 2008, MOL BIOL EVOL, V25, P2717, DOI 10.1093/molbev/msn215; Champion A., 2004, Functional & Integrative Genomics, V4, P163, DOI 10.1007/s10142-003-0096-4; CHEN CG, 1992, PLANT CELL, V4, P1053, DOI 10.1105/tpc.4.9.1053; CHEN J, 1985, EMBO J, V4, P2145, DOI 10.1002/j.1460-2075.1985.tb03908.x; CHEN J, 1985, P NATL ACAD SCI USA, V82, P4399, DOI 10.1073/pnas.82.13.4399; Chida H, 2007, PLANT BIOTECHNOL-NAR, V24, P171, DOI 10.5511/plantbiotechnology.24.171; CORBIN DR, 1987, MOL CELL BIOL, V7, P4337, DOI 10.1128/MCB.7.12.4337; Cvrckova F, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/712605; Deeks MJ, 2002, TRENDS PLANT SCI, V7, P492, DOI 10.1016/S1360-1385(02)02341-5; Domozych DS, 2009, ANN BOT-LONDON, V104, P1045, DOI 10.1093/aob/mcp193; Eder M, 2008, J PHYCOL, V44, P1221, DOI 10.1111/j.1529-8817.2008.00576.x; Egelund J, 2007, PLANT MOL BIOL, V64, P439, DOI 10.1007/s11103-007-9162-y; Eisenhaber B, 2003, PLANT PHYSIOL, V133, P1691, DOI 10.1104/pp.103.023580; EPSTEIN L, 1984, PHYTOCHEMISTRY, V23, P1241, DOI 10.1016/S0031-9422(00)80433-1; ERTL H, 1992, EMBO J, V11, P2055, DOI 10.1002/j.1460-2075.1992.tb05263.x; FONG C, 1992, PLANT PHYSIOL, V99, P548, DOI 10.1104/pp.99.2.548; GARCIAMAS J, 1992, PLANT PHYSIOL, V100, P1603, DOI 10.1104/pp.100.3.1603; Gille S, 2009, P NATL ACAD SCI USA, V106, P14699, DOI 10.1073/pnas.0905434106; GOLDMAN MHD, 1992, PLANT CELL, V4, P1041, DOI 10.1105/tpc.4.9.1041; Goodrum LJ, 2000, PHYTOCHEMISTRY, V54, P99, DOI 10.1016/S0031-9422(00)00043-1; Guzzardi P, 2004, BBA-GENE STRUCT EXPR, V1680, P83, DOI 10.1016/j.bbaexp.2004.08.012; Haffani YZ, 2006, PLANT SIGNAL BEHAV, V1, P251, DOI 10.4161/psb.1.5.3324; Held MA, 2004, J BIOL CHEM, V279, P55474, DOI 10.1074/jbc.M408396200; Hieta R, 2002, J BIOL CHEM, V277, P23965, DOI 10.1074/jbc.M201865200; Hirsinger C, 1997, PLANT MOL BIOL, V33, P279, DOI 10.1023/A:1005738815383; HONG JC, 1994, PLANT PHYSIOL, V104, P793, DOI 10.1104/pp.104.2.793; Hori K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4978; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Koski MK, 2007, J BIOL CHEM, V282, P37112, DOI 10.1074/jbc.M706554200; Koski MK, 2009, J BIOL CHEM, V284, P25290, DOI 10.1074/jbc.M109.014050; Lee JH, 2007, PLANT PHYSIOL, V144, P1813, DOI 10.1104/pp.107.100891; LI XB, 1990, PLANT PHYSIOL, V92, P327, DOI 10.1104/pp.92.2.327; Lichtenberg J, 2012, NAT SCI, V4, P1161, DOI DOI 10.4236/NS.2012.412A141; Mao YH, 2011, TRENDS CELL BIOL, V21, P625, DOI 10.1016/j.tcb.2011.08.005; MEMELINK J, 1993, PLANT J, V4, P1011, DOI 10.1046/j.1365-313X.1993.04061011.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Merkouropoulos G, 1999, PLANTA, V208, P212, DOI 10.1007/s004250050552; Mikkelsen MD, 2014, ANN BOT-LONDON, V114, P1217, DOI 10.1093/aob/mcu171; Nakhamchik A, 2004, PLANT CELL PHYSIOL, V45, P1875, DOI 10.1093/pcp/pch206; Nei M., 2000, MOL EVOLUTION PHYLOG; Newman AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023167; Nunez A, 2009, J AGR FOOD CHEM, V57, P10951, DOI 10.1021/jf902162t; Nystedt B, 2013, NATURE, V497, P579, DOI 10.1038/nature12211; Ogawa-Ohnishi M, 2013, NAT CHEM BIOL, V9, P726, DOI [10.1038/nchembio.1351, 10.1038/NCHEMBIO.1351]; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palenik B, 2007, P NATL ACAD SCI USA, V104, P7705, DOI 10.1073/pnas.0611046104; PARMENTIER Y, 1995, PLANT MOL BIOL, V29, P279, DOI 10.1007/BF00043652; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; Rathbun EA, 2002, MOL PLANT MICROBE IN, V15, P350, DOI 10.1094/MPMI.2002.15.4.350; RUBINSTEIN AL, 1995, P NATL ACAD SCI USA, V92, P3086, DOI 10.1073/pnas.92.8.3086; Saito F, 2014, J BIOL CHEM, V289, P20405, DOI 10.1074/jbc.M114.553933; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shimizu T, 2002, GENE, V284, P179, DOI 10.1016/S0378-1119(01)00899-X; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Showalter AM, 2010, PLANT PHYSIOL, V153, P485, DOI 10.1104/pp.110.156554; SHOWALTER AM, 1991, PLANT MOL BIOL, V16, P547, DOI 10.1007/BF00023421; Silva NF, 2002, PLANT MOL BIOL, V50, P667, DOI 10.1023/A:1019951120788; SMITH JJ, 1986, PHYTOCHEMISTRY, V25, P1021, DOI 10.1016/S0031-9422(00)81547-2; Sorensen I, 2011, PLANT J, V68, P201, DOI 10.1111/j.1365-313X.2011.04686.x; STIEFEL V, 1988, PLANT MOL BIOL, V11, P483, DOI 10.1007/BF00039029; Stratford S, 2001, PLANT MOL BIOL, V46, P43, DOI 10.1023/A:1010659425399; Sturaro M, 1998, J EXP BOT, V49, P1935, DOI 10.1093/jexbot/49.329.1935; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00140; Tiainen P, 2005, J BIOL CHEM, V280, P1142, DOI 10.1074/jbc.M411109200; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Vlad F, 2010, PHYSIOL PLANTARUM, V140, P199, DOI 10.1111/j.1399-3054.2010.01390.x; Vlad F, 2007, PLANT SIGNAL BEHAV, V2, P368, DOI 10.4161/psb.2.5.4462; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang XQ, 2000, MOL BIOL EVOL, V17, P773, DOI 10.1093/oxfordjournals.molbev.a026356; WOESSNER JP, 1989, PLANT CELL, V1, P901; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yoshiba Y, 2001, DNA RES, V8, P115, DOI 10.1093/dnares/8.3.115; Young ND, 2011, NATURE, V480, P520, DOI 10.1038/nature10625; Yuasa K, 2005, PLANT J, V41, P81, DOI 10.1111/j.1365-313X.2004.02279.x; ZHOU J, 1992, PLANT MOL BIOL, V20, P5, DOI 10.1007/BF00029144; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	94	36	38	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150177	10.1371/journal.pone.0150177	http://dx.doi.org/10.1371/journal.pone.0150177			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918442	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400098
J	Zeber-Lubecka, N; Kulecka, M; Ambrozkiewicz, F; Paziewska, A; Lechowicz, M; Konopka, E; Majewska, U; Borszewska-Kornacka, M; Mikula, M; Cukrowska, B; Ostrowski, J				Zeber-Lubecka, Natalia; Kulecka, Maria; Ambrozkiewicz, Filip; Paziewska, Agnieszka; Lechowicz, Milosz; Konopka, Ewa; Majewska, Urszula; Borszewska-Kornacka, Maria; Mikula, Michal; Cukrowska, Bozena; Ostrowski, Jerzy			Effect of Saccharomyces boulardii and Mode of Delivery on the Early Development of the Gut Microbial Community in Preterm Infants	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BIRTH-WEIGHT INFANTS; PREVENT NECROTIZING ENTEROCOLITIS; INTESTINAL MICROBIOTA; CONTROLLED-TRIAL; PREMATURE-INFANTS; FECAL MICROBIOTA; AMNIOTIC-FLUID; PROBIOTICS; DIVERSITY	Background Recent advances in culture-independent approaches have enabled insights into the diversity, complexity, and individual variability of gut microbial communities. Objectives To examine the effect of oral administration of Saccharomyces (S.) boulardii and mode of delivery on the intestinal microbial community in preterm infants. Study Design Stool samples were collected from preterm newborns randomly divided into two groups: a probiotic-receiving group (n = 18) or a placebo group (n = 21). Samples were collected before probiotic intake (day 0), and after 2 and 6 weeks of supplementation. The composition of colonizing bacteria was assessed by 16S ribosomal RNA (rRNA) gene sequencing of fecal samples using the Ion 16S Metagenomics Kit and the Ion Torrent Personal Genome Machine platform. Results A total of 11932257 reads were generated, and were clustered into 459, 187, and 176 operational taxonomic units at 0 days, 2 weeks, and 6 weeks, respectively. Of the 17 identified phyla, Firmicutes Actinobacteria, Proteobacteria, and Bacteroidetes were universal. The microbial community differed at day 0 compared with at 2 weeks and 6 weeks. There was a tendency for increased bacterial diversity at 2 weeks and 6 weeks compared with day 0, and infants with a gestational age of 31 weeks or higher presented increased bacterial diversity prior to S. boulardii administration. Firmicutes and Proteobacteria remained stable during the observation period, whereas Actinobacteria and Bacteroidetes increased in abundance, the latter particularly more sharply in vaginally delivered infants. Conclusion While the mode of delivery may influence the development of a microbial community, this study had not enough power to detect statistical differences between cohorts supplemented with probiotics, and in a consequence, to speculate on S. boulardii effect on gut microbiome composition in preterm newborns.	[Zeber-Lubecka, Natalia; Kulecka, Maria; Ambrozkiewicz, Filip; Paziewska, Agnieszka; Ostrowski, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland; [Lechowicz, Milosz; Majewska, Urszula; Borszewska-Kornacka, Maria] Med Univ Warsaw, Neonatal & Intens Care Dept, Warsaw, Poland; [Konopka, Ewa; Cukrowska, Bozena] Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland; [Mikula, Michal; Ostrowski, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, Warsaw, Poland; [Mikula, Michal; Ostrowski, Jerzy] Inst Oncol, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw; Children's Memorial Health Institute; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Ostrowski, J (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol Hepatol & Clin Oncol, Warsaw, Poland.; Cukrowska, B (corresponding author), Childrens Mem Hlth Inst, Dept Pathol, Warsaw, Poland.; Ostrowski, J (corresponding author), Maria Sklodowska Curie Mem Canc Ctr, Dept Genet, Warsaw, Poland.; Ostrowski, J (corresponding author), Inst Oncol, Warsaw, Poland.	b.cukrowska@czd.pl; jostrow@warman.com.pl	Żeber-Lubecka, Natalia/AAL-8834-2020; Mikula, Michal/G-8276-2011; Kulecka, Maria/AAW-8629-2020	Żeber-Lubecka, Natalia/0000-0003-4036-3191; Mikula, Michal/0000-0003-3447-7328; Kulecka, Maria/0000-0002-9830-8892; Ostrowski, Jerzy/0000-0003-1363-3766; Ambrozkiewicz, Filip/0000-0001-6850-780X; Konopka, Ewa/0000-0002-5686-1112; Paziewska, Agnieszka/0000-0002-6644-1509; Cukrowska, Bozena/0000-0001-6887-0094; Borszewska-Kornacka, Maria,Katarzyna/0000-0001-8021-4284	National Science Centre [2011/03/B/NZ5/01511]	National Science Centre(National Science Centre, Poland)	This work was supported by 2011/03/B/NZ5/01511 for JO funded by The National Science Centre (www.ncn.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Abrahamsson TR, 2014, CLIN EXP ALLERGY, V44, P842, DOI 10.1111/cea.12253; Abrahamsson TR, 2012, J ALLERGY CLIN IMMUN, V129, P434, DOI 10.1016/j.jaci.2011.10.025; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Arboleya S, 2012, ANAEROBE, V18, P378, DOI 10.1016/j.anaerobe.2012.04.013; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Arrieta MC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00427; Arvola T, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.5.e64; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berrington JE, 2013, ARCH DIS CHILD-FETAL, V98, pF286, DOI 10.1136/archdischild-2012-302134; Bin-Nun A, 2005, J PEDIATR-US, V147, P192, DOI 10.1016/j.jpeds.2005.03.054; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Buts JP, 2010, SCAND J GASTROENTERO, V45, P175, DOI 10.3109/00365520903453141; Claud EC, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-20; Costalos C, 2003, EARLY HUM DEV, V74, P89, DOI 10.1016/S0378-3782(03)00090-2; Demirel G, 2013, ACTA PAEDIATR, V102, pE560, DOI 10.1111/apa.12416; Demirel G, 2013, EUR J PEDIATR, V172, P1321, DOI 10.1007/s00431-013-2041-4; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fischer A, 2012, J INTEGRATED OMICS, V2, DOI [10.5584/jiomics.v2i1.76, DOI 10.5584/JIOMICS.V2I1.76]; Fouhy F, 2012, ANTIMICROB AGENTS CH, V56, P5811, DOI 10.1128/AAC.00789-12; Guibas GV, 2013, CLIN EXP ALLERGY, V43, P1058, DOI 10.1111/cea.12152; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Jakobsson HE, 2014, GUT, V63, P559, DOI 10.1136/gutjnl-2012-303249; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001; Kuitunen M, 2009, J ALLERGY CLIN IMMUN, V123, P335, DOI 10.1016/j.jaci.2008.11.019; La Rosa PS, 2014, P NATL ACAD SCI USA, V111, P12522, DOI 10.1073/pnas.1409497111; Lab H, FASTX TOOLKIT; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin HC, 2005, PEDIATRICS, V115, P1, DOI 10.1542/peds.2004-1463; Lin HC, 2008, PEDIATRICS, V122, P693, DOI 10.1542/peds.2007-3007; Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14; Martin CR, 2008, SEMIN PERINATOL, V32, P127, DOI 10.1053/j.semperi.2008.01.006; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mizrahi-Man O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053608; Moles L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066986; Nelson MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094249; Neu J, 2014, CLIN PERINATOL, V41, P967, DOI 10.1016/j.clp.2014.08.014; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Roger LC, 2010, MICROBIOL-SGM, V156, P3329, DOI 10.1099/mic.0.043224-0; Rouge C, 2010, ANAEROBE, V16, P362, DOI 10.1016/j.anaerobe.2010.06.002; Sari FN, 2011, EUR J CLIN NUTR, V65, P434, DOI 10.1038/ejcn.2010.278; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Serce O, 2013, EARLY HUM DEV, V89, P1033, DOI 10.1016/j.earlhumdev.2013.08.013; Shen JA, 2011, AM J CLIN NUTR, V93, P261, DOI 10.3945/ajcn.110.001305; Storro O, 2013, CURR OPIN ALLERGY CL, V13, P257, DOI 10.1097/ACI.0b013e328360968b; Turroni F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036957; Voreades N, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00494; Walker AW, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0087-4; Walker WA, 2013, ANN NUTR METAB, V63, P8, DOI 10.1159/000354907; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	64	20	21	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150306	10.1371/journal.pone.0150306	http://dx.doi.org/10.1371/journal.pone.0150306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918330	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400121
J	Zhu, QZ; Zhang, YF; Liu, YL; Cheng, H; Wang, J; Zhang, Y; Rui, YC; Li, TJ				Zhu, Qiuzhen; Zhang, Yuefan; Liu, Yulan; Cheng, Hao; Wang, Jing; Zhang, Yue; Rui, Yaocheng; Li, Tiejun			MLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2	PLOS ONE			English	Article							CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; APOPTOSIS; PROTEIN; EXPRESSION; EEF1A2; CELLS; RAT; FACTOR-1-ALPHA; PROLIFERATION	Monocyte locomotion inhibitory factor (MLIF), a heat-stable pentapeptide, has been shown to exert potent anti-inflammatory effects in ischemic brain injury. In this study, we investigated the neuroprotective action of MLIF against oxygen-glucose deprivation (OGD)-induced injury in human neuroblastoma SH-SY5Y cells. MTT assay was used to assess cell viability, and flow cytometry assay and Hoechst staining were used to evaluate apoptosis. LDH assay was used to exam necrosis. The release of inflammatory cytokines was detected by ELISA. Levels of the apoptosis associated proteins were measured by western blot analysis. To identify the protein target of MLIF, pull-down assay and mass spectrometry were performed. We observed that MLIF enhanced cell survival and inhibited apoptosis and necrosis by inhibiting p-JNK, p53, c-caspase9 and c-caspase3 expression. In the microglia, OGD-induced secretion of inflammatory cytokines was markedly reduced in the presence of MLIF. Furthermore, we found that eukaryotic translation elongation factor 1A2 (eEF1A2) is a downstream target of MLIF. Knockdown eEF1A2 using short interfering RNA (siRNA) almost completely abrogated the anti-apoptotic effect of MLIF in SH-SY5Y cells subjected to OGD, with an associated decrease in cell survival and an increase in expression of pJNK and p53. These results indicate that MLIF ameliorates OGD-induced SH-SY5Y neuroblastoma injury by inhibiting the p-JNK/p53 apoptotic signaling pathway via eEF1A2. Our findings suggest that eEF1A2 may be a new therapeutic target for ischemic brain injury.	[Zhu, Qiuzhen; Zhang, Yuefan; Liu, Yulan; Rui, Yaocheng; Li, Tiejun] Second Mil Med Univ, Dept Pharmacol, Coll Pharm, Shanghai, Peoples R China; [Cheng, Hao; Wang, Jing; Zhang, Yue] Anhui Univ Chinese Med, Coll Pharm, Hefei, Anhui, Peoples R China	Naval Medical University; Anhui University of Chinese Medicine	Rui, YC; Li, TJ (corresponding author), Second Mil Med Univ, Dept Pharmacol, Coll Pharm, Shanghai, Peoples R China.	ruiyc163@163.com; ltj204@163.com	zhang, yuefan/AEE-5392-2022		Shanghai Natural Science Foundation [12ZR1437600]; Shanghai Science and Technology Committee; Shanghai Science and Technology Transformation and Industrialization [15431908500]; National Science and Technology Major Project of the Ministry of Science and Technology of China [2013ZX09103001-005]; Ministry of Science and Technology of China	Shanghai Natural Science Foundation(Natural Science Foundation of Shanghai); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); Shanghai Science and Technology Transformation and Industrialization; National Science and Technology Major Project of the Ministry of Science and Technology of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This project was supported by 3 funds. 1. Shanghai Natural Science Foundation, Grant No. 12ZR1437600, funding institution: Shanghai Science and Technology Committee, website: http://www.stcsm.gov.cn/. 2. The Project of Shanghai Science and Technology Transformation and Industrialization, Grant No. 15431908500, funding institution: Shanghai Science and Technology Committee, website: http://www.stcsm.gov.cn/. 3. National Science and Technology Major Project of the Ministry of Science and Technology of China, Grant No. 2013ZX09103001-005, funding institution: the Ministry of Science and Technology of China, website: http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Amiri A, 2007, ONCOGENE, V26, P3027, DOI 10.1038/sj.onc.1210101; ANN DK, 1992, J BIOL CHEM, V267, P699; Antonelli MC, 2012, NEUROTOX RES, V21, P49, DOI 10.1007/s12640-011-9265-8; Bermeo G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/340727; Blanch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066436; Chambers DM, 1998, P NATL ACAD SCI USA, V95, P4463, DOI 10.1073/pnas.95.8.4463; Chang RY, 2007, J CELL BIOCHEM, V100, P267, DOI 10.1002/jcb.20969; Chen T, 2011, NEUROSCIENCE, V183, P203, DOI 10.1016/j.neuroscience.2011.03.038; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; Chong ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045456; Coffey ET, 2014, NAT REV NEUROSCI, V15, P285, DOI 10.1038/nrn3729; Doig J, 2013, FEBS J, V280, P6528, DOI 10.1111/febs.12554; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Faheem M, 2015, CNS NEUROL DISORD-DR, V14, P468, DOI 10.2174/1871527314666150429111737; Gandin V, 2013, MOL CELL BIOL, V33, P2510, DOI 10.1128/MCB.01362-12; Gehringer M, 2015, EXPERT OPIN THER PAT, V25, P849, DOI 10.1517/13543776.2015.1039984; Gimenez Scherer JA, 1997, ARCH MED RES, V28, P237; Godina-Gonzalez S, 2010, INFLAMM RES, V59, P1041, DOI 10.1007/s00011-010-0224-2; Han QD, 2014, BRAIN RES, V1542, P176, DOI 10.1016/j.brainres.2013.10.026; Henderson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139273; Jeganathan S, 2008, MOL CELL BIOL, V28, P4549, DOI 10.1128/MCB.00150-08; KNUDSEN SM, 1993, EUR J BIOCHEM, V215, P549, DOI 10.1111/j.1432-1033.1993.tb18064.x; Krishna M, 2008, CELL MOL LIFE SCI, V65, P3525, DOI 10.1007/s00018-008-8170-7; Leker RR, 2004, EXP NEUROL, V187, P478, DOI 10.1016/j.expneurol.2004.01.030; LI Y, 1994, STROKE, V25, P849, DOI 10.1161/01.STR.25.4.849; Li Y, 1994, STROKE, V25, P855; Li ZB, 2010, NATIONAL TEACHING SEMINAR ON CRYPTOGRAPHY AND INFORMATION SECURITY (2010NTS-CIS), PROCEEDINGS, P1; Lin LZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136959; Lund A, 1996, GENOMICS, V36, P359, DOI 10.1006/geno.1996.0475; Lv M, 2011, NEUROSCIENCE, V176, P162, DOI 10.1016/j.neuroscience.2010.11.066; Mori T, 2006, BIOORGAN MED CHEM, V14, P5549, DOI 10.1016/j.bmc.2006.04.028; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nakajima J, 2015, CLIN GENET, V87, P356, DOI 10.1111/cge.12394; Newbery HJ, 2005, J NEUROPATH EXP NEUR, V64, P295, DOI 10.1093/jnen/64.4.295; Pan J, 2004, DEV BRAIN RES, V149, P1, DOI 10.1016/j.devbrainres.2003.10.011; Qing Y, 2013, ARCH TOXICOL, V87, P1273, DOI 10.1007/s00204-013-1021-9; Ruest LB, 2002, J BIOL CHEM, V277, P5418, DOI 10.1074/jbc.M110685200; Schulz I, 2014, BBA-MOL CELL RES, V1843, P965, DOI 10.1016/j.bbamcr.2014.01.022; Silva-Garcia R, 2011, INFLAMM RES, V60, P111, DOI 10.1007/s00011-010-0261-x; Sun Y, 2014, BIOCHEM BIOPH RES CO, V450, P1, DOI 10.1016/j.bbrc.2014.05.045; Tendler DS, 2001, CANCER RES, V61, P3682; Tong XX, 2012, PEPTIDES, V38, P217, DOI 10.1016/j.peptides.2012.06.020; Topisirovic I, 2009, P NATL ACAD SCI USA, V106, P12676, DOI 10.1073/pnas.0900596106; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201; Vlasenko DO, 2015, FEBS LETT, V589, P1187, DOI 10.1016/j.febslet.2015.03.030; Wang XL, 2012, PEPTIDES, V33, P298, DOI 10.1016/j.peptides.2011.12.015; Welser JV, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-89; Wen XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062942; Yao J, 2011, PEPTIDES, V32, P1047, DOI 10.1016/j.peptides.2011.03.005; Zang WQ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0315-3; Zhang HT, 2015, BRAIN RES, V1622, P474, DOI 10.1016/j.brainres.2015.07.004; Zhang YF, 2012, STROKE, V43, P2764, DOI 10.1161/STROKEAHA.112.657908; Zhang ZQ, 2015, ARCH VIROL, V160, P1449, DOI 10.1007/s00705-015-2403-5	54	18	22	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149965	10.1371/journal.pone.0149965	http://dx.doi.org/10.1371/journal.pone.0149965			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918757	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400064
J	Turdalieva, A; Solandt, J; Shambetova, N; Xu, H; Blom, H; Brismar, H; Zelenina, M; Fu, Y				Turdalieva, Aizat; Solandt, Johan; Shambetova, Nestan; Xu, Hao; Blom, Hans; Brismar, Hjalmar; Zelenina, Marina; Fu, Ying			Bioelectric and Morphological Response of Liquid-Covered Human Airway Epithelial Calu-3 Cell Monolayer to Periodic Deposition of Colloidal 3-Mercaptopropionic-Acid Coated CdSe-CdS/ZnS Core-Multishell Quantum Dots	PLOS ONE			English	Article							PRIMARY CILIA; IN-VITRO; NANOPARTICLES; JUNCTIONS; TOXICITY; PROMOTES; MUCUS; LINE	Lung epithelial cells are extensively exposed to nanoparticles present in the modern urban environment. Nanoparticles, including colloidal quantum dots (QDs), are also considered to be potentially useful carriers for the delivery of drugs into the body. It is therefore important to understand the ways of distribution and the effects of the various types of nanoparticles in the lung epithelium. We use a model system of liquid-covered human airway epithelial Calu-3 cell cultures to study the immediate and long-term effects of repeated deposition of colloidal 3-mercaptopropionic-acid coated CdSe-CdS/ZnS core-multishell QDs on the lung epithelial cell surface. By live confocal microscope imaging and by QD fluorescence measurements we show that the QD permeation through the mature epithelial monolayers is very limited. At the time of QD deposition, the transepithelial electrical resistance (TEER) of the epithelial monolayers transiently decreased, with the decrement being proportional to the QD dose. Repeated QD deposition, once every six days for two months, lead to accumulation of only small amounts of the QDs in the cell monolayer. However, it did not induce any noticeable changes in the long-term TEER and the molecular morphology of the cells. The colloidal 3-mercaptopropionic-acid coated CdSe-CdS/ZnS core-multishell QDs could therefore be potentially used for the delivery of drugs intended for the surface of the lung epithelia during limited treatment periods.	[Turdalieva, Aizat; Shambetova, Nestan; Xu, Hao; Brismar, Hjalmar; Zelenina, Marina; Fu, Ying] Royal Inst Technol, Dept Appl Phys, Sci Life Lab, SE-10691 Stockholm, Sweden; [Solandt, Johan] AstraZeneca R&D, SE-43183 Molndal, Sweden; [Blom, Hans] Sci Life Lab, Adv Light Microscopy facil, Solna, Sweden	Royal Institute of Technology; AstraZeneca	Fu, Y (corresponding author), Royal Inst Technol, Dept Appl Phys, Sci Life Lab, SE-10691 Stockholm, Sweden.	fu@kth.se	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003	Swedish Research Council [621-2011-4381]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The work was partially supported by Swedish Research Council (621-2011-4381). The funder provided support in the form of salaries for author Y. Fu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Babu Polani B Ramesh, 2005, Pediatr Crit Care Med, V6, P188; Balda MS, 1998, J CELL SCI, V111, P541; Banga A, 2012, CELL PHYSIOL BIOCHEM, V29, P197, DOI 10.1159/000337601; Button B, 2012, SCIENCE, V337, P937, DOI 10.1126/science.1223012; Buzea C, 2007, BIOINTERPHASES, V2, pMR17, DOI 10.1116/1.2815690; Chang YN, 2012, MATERIALS, V5, P2850, DOI 10.3390/ma5122850; Cohen JM, 2014, NANOTOXICOLOGY, V8, P216, DOI 10.3109/17435390.2013.879612; Florea BI, 2003, J CONTROL RELEASE, V87, P131, DOI 10.1016/S0168-3659(02)00356-5; Foster KA, 2000, INT J PHARMACEUT, V208, P1, DOI 10.1016/S0378-5173(00)00452-X; Fu Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/37003; Geys J, 2006, TOXICOL LETT, V160, P218, DOI 10.1016/j.toxlet.2005.07.005; Haghi M, 2010, DRUG DEV IND PHARM, V36, P1207, DOI 10.3109/03639041003695113; Harcourt JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50157; Hoet Peter Hm, 2004, J Nanobiotechnology, V2, P12, DOI 10.1186/1477-3155-2-12; Hu QL, 2014, BIOCHEM CELL BIOL, V92, P547, DOI 10.1139/bcb-2014-0062; Jiang XE, 2010, ACS NANO, V4, P6787, DOI 10.1021/nn101277w; Lanone S, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-14; Li L, 2013, J PHYS CHEM C, V117, P4844, DOI 10.1021/jp311975h; Liu SL, 2011, BIOMATERIALS, V32, P7616, DOI 10.1016/j.biomaterials.2011.06.046; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Mathias NR, 2002, J DRUG TARGET, V10, P31, DOI 10.1080/10611860290007504; McCarthy J, 2011, INT J NANOMED, V6, P1343, DOI 10.2147/IJN.S21145; Molnar M, 2010, CELL MED, V1, P105, DOI 10.3727/215517910X451603; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Morris-Cohen AJ, 2013, CHEM MATER, V25, P1155, DOI 10.1021/cm302108j; Nagy A, 2012, ACS NANO, V6, P4748, DOI 10.1021/nn204886b; Nita-Lazar M, 2010, EXP CELL RES, V316, P1871, DOI 10.1016/j.yexcr.2010.02.008; Popoff MR, 2009, BBA-BIOMEMBRANES, V1788, P797, DOI 10.1016/j.bbamem.2009.01.011; Rajan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066600; Ram S, 2012, BIOPHYS J, V103, P1594, DOI 10.1016/j.bpj.2012.08.054; Resnick A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316378; Rotoli BM, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1069-0; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Starmans LWE, 2011, CONTRAST MEDIA MOL I, V6, P100, DOI 10.1002/cmmi.411; Tan RS, 2015, ACS CHEM BIOL, V10, P2073, DOI 10.1021/acschembio.5b00434; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Zhu Y, 2010, CRIT CARE RES PRACT, V2010, DOI 10.1155/2010/394578	39	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149915	10.1371/journal.pone.0149915	http://dx.doi.org/10.1371/journal.pone.0149915			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913754	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700035
J	Nagata, E; Ogino, M; Iwamoto, K; Kitagawa, Y; Iwasaki, Y; Yoshii, F; Ikeda, JE				Nagata, Eiichiro; Ogino, Mieko; Iwamoto, Kounosuke; Kitagawa, Yasuhisa; Iwasaki, Yasuo; Yoshii, Fumihito; Ikeda, Joh-E.		ALS Consortium Investigators	Bromocriptine Mesylate Attenuates Amyotrophic Lateral Sclerosis: A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Research in Japanese Patients	PLOS ONE			English	Article							OXIDATIVE STRESS; ALS; APOPTOSIS; DEXPRAMIPEXOLE; INDIVIDUALS; MECHANISM; RADICALS; TRIALS; MOUSE	Objective Bromocriptine mesylate (BRC), a dopamine D2 receptor agonist has been shown to confer neuroprotection, sustained motor function and slowed disease progression in mouse models of amyotrophic lateral sclerosis (ALS) Here we report a first in human trial in ALS. Design A multicenter, Riluzole add-on, randomized, double-blind, placebo controlled 102-week extension BRC clinical trial. Methods The trial was conducted between January 2009 and March 2012 on 36 Japanese ALS patients. A 12-week treatment with Riluzole observational period was followed by combined treatment (Riluzole + BRC; n = 29 or Riluzole + placebo; n = 7). The dosing commenced at 1.25 mg/day increasing in steps at two weeks intervals to a maximum of 15 mg/day. The efficacy of BRC was evaluated by comparing BRC and placebo groups upon completion of stepwise dosing at 14 weeks 2 points (1st endpoint) and upon completion or discontinuation of the study (2nd endpoint) of the dosing. Results Statistics analyses revealed a marginal BRC treatment efficacy with P <= 20% to placebo by 1st and 2nd endpoint analysis. In the 1st endpoint analysis, BRC group was significantly effective on the scores of ALSAQ40-communicaton (P = 1.2%), eating and drinking (P = 2.2%), ALSFRS-R total (P = 17.6%), grip strength (P = 19.8%) compared to the placebo group. In the 2nd endpoint analysis, differences between the scores of Limb Norris Scale (P = 18.3%), ALSAQ40-communication (P = 11.9%), eating and drinking (P = 13.6%), and neck forward-bent test (P = 15.4%) of BRC group were detected between the two groups. There was no significant difference between the treatment groups for adverse events or serious drug reactions incidence. Conclusions BRC sustains motoneuronal function at least in part through BRC treatment. Further analysis involving a Phase 2b or 3 clinical trial is required but BRC currently shows promise for ALS treatment.	[Nagata, Eiichiro] Tokai Univ, Sch Med, Dept Neurol, Isehara, Kanagawa 25911, Japan; [Ogino, Mieko] Kitasato Univ, Sch Med, Dept Neurol, Sagamihara, Kanagawa 228, Japan; [Iwamoto, Kounosuke; Iwasaki, Yasuo] Toho Univ, Omori Med Ctr, Dept Neurol, Tokyo, Japan; [Kitagawa, Yasuhisa] Tokai Univ, Hachioji Hosp, Dept Neurol, Tokyo 151, Japan; [Yoshii, Fumihito] Tokai Univ, Oiso Hosp, Dept Neurol, Hiratsuka, Kanagawa 25912, Japan; [Ikeda, Joh-E.] Kitasato Univ, Sch Med, Fac Med, Mol Neurol, Sagamihara, Kanagawa 228, Japan; [Ikeda, Joh-E.] Univ Ottawa, Fac Med, Dept Pediat, ARC Childrens Hosp Eastern Ontario, Ottawa, ON, Canada	Tokai University; Kitasato University; Toho University; Tokai University; Tokai University; Kitasato University; University of Ottawa; Children's Hospital of Eastern Ontario	Ikeda, JE (corresponding author), Kitasato Univ, Sch Med, Fac Med, Mol Neurol, Sagamihara, Kanagawa 228, Japan.; Ikeda, JE (corresponding author), Univ Ottawa, Fac Med, Dept Pediat, ARC Childrens Hosp Eastern Ontario, Ottawa, ON, Canada.	joh-e@mgcheo.med.uottawa.ca			Ministry of Health, Labor and Welfare, Japan [H20-ClinicalResearch-G-014]; Japanese Ministry of Health, Labor and welfare	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Ministry of Health, Labor and welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Ministry of Health, Labor and Welfare, Japan (H20-ClinicalResearch-G-014).; We thank Prof. Alex MacKenzie (Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada) for fruitful discussion and encouragement in the preparation of this manuscript. This work was supported by Grant-of-Aid from Japanese Ministry of Health, Labor and welfare.	Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Barber SC, 2010, FREE RADICAL BIO MED, V48, P629, DOI 10.1016/j.freeradbiomed.2009.11.018; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brooks BR, 2000, AMYOTROPH LATERAL SC, V11, P497; Cudkowicz M, 2011, NAT MED, V17, P1652, DOI 10.1038/nm.2579; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; KONDO T, 1994, ANN NY ACAD SCI, V738, P222; Lim JH, 2008, PHARMACOL RES, V57, P325, DOI 10.1016/j.phrs.2008.03.004; Liston P, 1996, NATURE, V379, P349, DOI 10.1038/379349a0; Liu GT, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/421389; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Ludolph AC, 2010, AMYOTROPH LATERAL SC, V11, P38, DOI 10.3109/17482960903545334; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; OGAWA N, 1994, BRAIN RES, V657, P207, DOI 10.1016/0006-8993(94)90969-5; Okada Y, 2005, J CEREBR BLOOD F MET, V25, P794, DOI 10.1038/sj.jcbfm.9600078; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rao SD, 2003, J NEUROSCI, V23, P2627; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Sreedharan J, 2013, ANN NEUROL, V74, P309, DOI 10.1002/ana.24012; Tanaka K, 2008, EXP NEUROL, V211, P378, DOI 10.1016/j.expneurol.2008.02.004; Tanaka K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087728, 10.1371/journal.pone.0096410]; Tanaka K, 2011, EXP NEUROL, V232, P41, DOI 10.1016/j.expneurol.2011.08.001; Turner BJ, 2008, NAT NEUROSCI, V11, P251; YOSHIKAWA T, 1994, J NEUROCHEM, V62, P1034	28	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149509	10.1371/journal.pone.0149509	http://dx.doi.org/10.1371/journal.pone.0149509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910108	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700037
J	Iyer, AS; Khaskhely, NM; Leggat, DJ; Ohtola, JA; Saul-McBeth, JL; Khuder, SA; Westerink, MAJ				Iyer, Anita S.; Khaskhely, Noor M.; Leggat, David J.; Ohtola, Jennifer A.; Saul-McBeth, Jessica L.; Khuder, Sadik A.; Westerink, M. A. Julie			Inflammatory Markers and Immune Response to Pneumococcal Vaccination in HIV-Positive and -Negative Adults	PLOS ONE			English	Article							MEMORY B-CELLS; ANTIRETROVIRAL THERAPY; BAFF; ACTIVATION; EXPRESSION; RECEPTORS; TACI; INFECTION; BCMA; MECHANISM	Background Members of the Tumor Necrosis Factor (TNF)-superfamily have speculated roles in the response against T-independent type II antigens (TI-II) including pneumococcal polysaccharides (PPS). Dysregulation in their expression is associated with an enhanced risk for pneumococcal disease in neonates but their expression in other high-risk populations including HIV-positive individuals remains to be elucidated. Objective To investigate signals that contribute towards PPS-response and identify potential anomalies that may account for diminished serological response in HIV-positive individuals post Pneumovax (PPV23) immunization. Methods Markers of inflammation, C-reactive protein (CRP), IL-6, sCD27 and sCD30, were assessed in HIV-positive and -negative individuals as potential predictors of PPV23 response. Serum levels of B cell activating factor (BAFF), transmembrane activator and calcium-modulator and cytophilin ligand interactor (TACI), B cell maturation antigen (BCMA) and B cell expression of BAFF-R, TACI, BCMA, CD40 and CD21 were assessed in total (unselected) and PPS23F (antigen)-specific B cells of PPV23 immunized HIV-positive and -negative individuals. Results CRP, sCD27, sCD30 and BAFF were significantly elevated in the serum of HIV-positive individuals but did not adversely affect PPV23 response. Assessment of PPS-specific B cells revealed enhanced TACI and reduced BAFF-R expression compared to unselected B cells in HIV-positive and -negative individuals. Surface TACI was similar but soluble TACI was significantly lower in HIV-positive compared to HIV-negative individuals. Conclusion Current studies highlight a potential role for TACI in PPV23 response based on its enhanced expression on PPS-specific B cells. Although surface levels of TACI were similar, diminished soluble TACI ( sTACI) in HIV-positive compared to HIV-negative individuals could potentially decrease BAFF responsiveness and Ig response. A better understanding of the role of TNF receptors could contribute to the design of improved pneumococcal vaccines.	[Iyer, Anita S.; Khaskhely, Noor M.; Leggat, David J.; Ohtola, Jennifer A.; Saul-McBeth, Jessica L.] Univ Toledo, Dept Med, 3000 Arlington Ave, Toledo, OH 43614 USA; [Khuder, Sadik A.] Univ Toledo, Dept Publ Hlth, 3000 Arlington Ave, Toledo, OH 43614 USA; [Westerink, M. A. Julie] Med Univ S Carolina, Dept Med, 135 Rutledge Ave, Charleston, SC 29425 USA; [Westerink, M. A. Julie] Dept Infect Dis, 135 Rutledge Ave, Charleston, SC 29425 USA; [Westerink, M. A. Julie] Med Univ S Carolina, Dept Microbiol & Immunol, 135 Rutledge Ave, Charleston, SC 29425 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; Medical University of South Carolina; Medical University of South Carolina	Iyer, AS (corresponding author), Univ Toledo, Dept Med, 3000 Arlington Ave, Toledo, OH 43614 USA.; Westerink, MAJ (corresponding author), Med Univ S Carolina, Dept Med, 135 Rutledge Ave, Charleston, SC 29425 USA.; Westerink, MAJ (corresponding author), Dept Infect Dis, 135 Rutledge Ave, Charleston, SC 29425 USA.; Westerink, MAJ (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, 135 Rutledge Ave, Charleston, SC 29425 USA.	Anita.Iyer@rockets.utoledo.edu; westerin@musc.edu		Leggat, David/0000-0003-4019-7170	NIH [R01A081558, R01AG015978]; NATIONAL INSTITUTE ON AGING [R01AG045973, R01AG015978] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by NIH grants R01A081558 and R01AG015978 to M. A. Julie Westerink.	Bennett NM., 2012, MMWR MORB MORTAL WKL, V61, P816; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; De Milito A, 2002, CLIN EXP IMMUNOL, V127, P486, DOI 10.1046/j.1365-2249.2002.01786.x; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Dickinson GS, 2014, INFECT IMMUN, V82, P453, DOI 10.1128/IAI.01147-13; Frasca D, 2014, EXP GERONTOL, V54, P116, DOI 10.1016/j.exger.2014.01.004; Griffin DO, 2011, J EXP MED, V208, P67, DOI 10.1084/jem.20101499; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Heffernan RT, 2005, J INFECT DIS, V191, P2038, DOI 10.1086/430356; Hoffmann FS, 2015, J IMMUNOL, V194, P542, DOI 10.4049/jimmunol.1402070; Hondowicz BD, 2007, INT IMMUNOL, V19, P465, DOI 10.1093/intimm/dxm011; Iyer A. S., 2015, Journal of AIDS and Clinical Research, V6, P421; Jeurissen A, 2004, IMMUNOLOGY, V111, P1, DOI 10.1111/j.1365-2567.2004.01775.x; Katsenelson N, 2007, EUR J IMMUNOL, V37, P1785, DOI 10.1002/eji.200636800; Kaur K, 2007, BLOOD, V110, P2948, DOI 10.1182/blood-2007-01-069245; KEHRL JH, 1983, J CLIN INVEST, V71, P1032, DOI 10.1172/JCI110830; Khaskhely N, 2012, J IMMUNOL, V188, P2455, DOI 10.4049/jimmunol.1102809; Leggat David J, 2015, J AIDS Clin Res, V6; Mackay F, 2008, CYTOKINE GROWTH F R, V19, P263, DOI 10.1016/j.cytogfr.2008.04.006; Moir S, 2004, J EXP MED, V200, P587, DOI 10.1084/jem.20032236; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.iy.13.040195.003255; NAHM M, 2002, TRAINING MANUAL ENZY; Novak AJ, 2004, BLOOD, V103, P689, DOI 10.1182/blood-2003-06-2043; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Pallikkuth S, 2011, J ALLERGY CLIN IMMUN, V128, P1279, DOI 10.1016/j.jaci.2011.05.033; Parmigiani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079816; Pedersen RH, 2011, HIV MED, V12, P323, DOI 10.1111/j.1468-1293.2010.00892.x; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; Pizzolo G, 1997, CLIN EXP IMMUNOL, V108, P251, DOI 10.1046/j.1365-2249.1997.d01-1005.x; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Salzer U, 2005, NAT GENET, V37, P820, DOI 10.1038/ng1600; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Sogaard OS, 2010, CLIN INFECT DIS, V51, P42, DOI 10.1086/653112; Titanji K, 2006, BLOOD, V108, P1580, DOI 10.1182/blood-2005-11-013383; Treml LS, 2006, SEMIN IMMUNOL, V18, P297, DOI 10.1016/j.smim.2006.07.001; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; Vos Q, 2000, IMMUNOL REV, V176, P154; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Westerink MAJ, 2012, AGING DIS, V3, P51	41	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150261	10.1371/journal.pone.0150261	http://dx.doi.org/10.1371/journal.pone.0150261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930208	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500120
J	Kim, JW; Kim, BN; Lee, J; Na, C; Kee, BS; Min, KJ; Han, DH; Kim, JI; Lee, YS				Kim, Jun Won; Kim, Bung-Nyun; Lee, Jaewon; Na, Chul; Kee, Baik Seok; Min, Kyung Joon; Han, Doug Hyun; Kim, Johanna Inhyang; Lee, Young Sik			Desynchronization of Theta-Phase Gamma-Amplitude Coupling during a Mental Arithmetic Task in Children with Attention Deficit/Hyperactivity Disorder	PLOS ONE			English	Article							DEFICIT-HYPERACTIVITY DISORDER; INDEPENDENT COMPONENT ANALYSIS; ANTERIOR CINGULATE CORTEX; RESTING STATE NETWORKS; PREFRONTAL CORTEX; WORKING-MEMORY; NEURONAL OSCILLATIONS; HUMAN BRAIN; EEG; SUBTYPES	Introduction Theta-phase gamma-amplitude coupling (TGC) measurement has recently received attention as a feasible method of assessing brain functions such as neuronal interactions. The purpose of this electroencephalographic (EEG) study is to understand the mechanisms underlying the deficits in attentional control in children with attention deficit/hyperactivity disorder (ADHD) by comparing the power spectra and TGC at rest and during a mental arithmetic task. Methods Nineteen-channel EEGs were recorded from 97 volunteers (including 53 subjects with ADHD) from a camp for hyperactive children under two conditions (rest and task performance). The EEG power spectra and the TGC data were analyzed. Correlation analyses between the Intermediate Visual and Auditory (IVA) continuous performance test (CPT) scores and EEG parameters were performed. Results No significant difference in the power spectra was detected between the groups at rest and during task performance. However, TGC was reduced during the arithmetic task in the ADHD group compared with the normal group (F = 16.70, p < 0.001). The TGC values positively correlated with the IVA CPT scores but negatively correlated with theta power. Conclusions Our findings suggest that desynchronization of TGC occurred during the arithmetic task in ADHD children. TGC in ADHD children is expected to serve as a promising neurophysiological marker of network deactivation during attention-demanding tasks.	[Kim, Jun Won] Catholic Univ Daegu, Dept Psychiat, Sch Med, Daegu, South Korea; [Kim, Bung-Nyun; Kim, Johanna Inhyang] Seoul Natl Univ Hosp, Dept Psychiat, Div Child & Adolescent Psychiat, Seoul 110744, South Korea; [Lee, Jaewon] Korea Inst Neuromodulat, EasyBrain Ctr, Seoul, South Korea; [Na, Chul; Kee, Baik Seok; Min, Kyung Joon; Han, Doug Hyun; Lee, Young Sik] Chung Ang Univ, Coll Med, Dept Psychiat, Seoul 156756, South Korea	Catholic University of Daegu; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital	Lee, YS (corresponding author), Chung Ang Univ, Coll Med, Dept Psychiat, Seoul 156756, South Korea.	hawkeyelys@hanmail.net	Min, Kyung Joon/AAC-3624-2021					Anckarsater H, 2014, IMPACT ADHD AUTISM S; Arns M, 2012, J ATTEN DISORD; Arsalidou M, 2011, NEUROIMAGE, V54, P2382, DOI 10.1016/j.neuroimage.2010.10.009; Asada H, 1999, NEUROSCI LETT, V274, P29, DOI 10.1016/S0304-3940(99)00679-5; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Baeyens D, 2006, CHILD PSYCHIAT HUM D, V36, P403, DOI 10.1007/s10578-006-0011-z; Burke A, 2013, NEURODEVELOPMENTAL P; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chi SE, 2005, PERS INDIV DIFFER, V39, P669, DOI 10.1016/j.paid.2005.02.017; Clarke AR, 2008, INT J PSYCHOPHYSIOL, V67, P35, DOI 10.1016/j.ijpsycho.2007.10.001; Clarke AR, 2011, CLIN NEUROPHYSIOL, V122, P73, DOI 10.1016/j.clinph.2010.05.032; Clarke AR, 2001, PSYCHOPHYSIOLOGY, V38, P212, DOI 10.1017/S0048577201981764; Cohen MX, 2008, J NEUROSCI METH, V168, P494, DOI 10.1016/j.jneumeth.2007.10.012; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Davis KD, 2000, J NEUROPHYSIOL, V83, P3575, DOI 10.1152/jn.2000.83.6.3575; Debener S, 2003, NEUROREPORT, V14, P683, DOI 10.1097/00001756-200304150-00005; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Feldman HM, 2014, NEW ENGL J MED, V370, P838, DOI 10.1056/NEJMcp1307215; Franceschini S, 2012, CURR BIOL, V22, P814, DOI 10.1016/j.cub.2012.03.013; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hartung CM, 1998, PSYCHOL BULL, V123, P260, DOI 10.1037/0033-2909.123.3.260; Hirota T, 2014, J AM ACAD CHILD PSY, V53, P153, DOI 10.1016/j.jaac.2013.11.009; Hunt R D, 1990, J Child Adolesc Psychopharmacol, V1, P87, DOI 10.1089/cap.1990.1.87; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Johnson KA, 2007, NEUROPSYCHOLOGIA, V45, P2234, DOI 10.1016/j.neuropsychologia.2007.02.019; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Knyazev GG, 2011, INT J PSYCHOPHYSIOL, V80, P236, DOI 10.1016/j.ijpsycho.2011.03.013; Konrad K, 2006, BIOL PSYCHIAT, V59, P643, DOI 10.1016/j.biopsych.2005.08.013; Lei X, 2014, HUM BRAIN MAPP, V35, P3517, DOI 10.1002/hbm.22418; Lei X, 2012, J INTEGR NEUROSCI, V11, P313, DOI 10.1142/S0219635212500203; Loo SK, 2013, J ATTEN DISORD, V17, P384, DOI 10.1177/1087054712468050; Loo SK, 2005, APPL NEUROPSYCHOL, V12, P64, DOI 10.1207/s15324826an1202_2; Maltez J, 2004, NEUROPHYSIOL CLIN, V34, P195, DOI 10.1016/j.neucli.2004.09.003; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mizuhara H, 2004, NEUROREPORT, V15, P1233, DOI 10.1097/01.wnr.0000126755.09715.b3; Newcorn JH, 1998, PEDIATR CLIN N AM, V45, P1099, DOI 10.1016/S0031-3955(05)70064-X; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Park JY, 2013, NEUROSCI LETT, V532, P39, DOI 10.1016/j.neulet.2012.10.061; Park JY, 2011, NEUROSCI LETT, V498, P37, DOI 10.1016/j.neulet.2011.04.056; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Ruggiero S, 2014, EUR NEUROPSYCHOPHARM, V24, P1578, DOI 10.1016/j.euroneuro.2014.08.001; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sauseng P, 2009, CURR BIOL, V19, P1846, DOI 10.1016/j.cub.2009.08.062; Shaw P, 2010, HUM BRAIN MAPP, V31, P917, DOI 10.1002/hbm.21028; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; Swanson JM, 2007, NEUROPSYCHOL REV, V17, P39, DOI 10.1007/s11065-007-9019-9; Thibodeau R, 2006, J ABNORM PSYCHOL, V115, P715, DOI 10.1037/0021-843X.115.4.715; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Velikova S, 2010, NEUROIMAGE, V49, P977, DOI 10.1016/j.neuroimage.2009.08.015; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015	55	20	23	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0145288	10.1371/journal.pone.0145288	http://dx.doi.org/10.1371/journal.pone.0145288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930194	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500001
J	Perseguini, JMKC; Oblessuc, PR; Rosa, JRBF; Gomes, KA; Chiorato, AF; Carbonell, SAM; Garcia, AAF; Vianello, RP; Benchimol-Reis, LL				Kuepper Cardoso Perseguini, Juliana Morini; Oblessuc, Paula Rodrigues; Bachega Feijo Rosa, Joao Ricardo; Gomes, Kleber Alves; Chiorato, Alisson Fernando; Morais Carbonell, Sergio Augusto; Franco Garcia, Antonio Augusto; Vianello, Rosana Pereira; Benchimol-Reis, Luciana Lasry			Genome-Wide Association Studies of Anthracnose and Angular Leaf Spot Resistance in Common Bean (Phaseolus vulgaris L.)	PLOS ONE			English	Article							RACE-SPECIFIC RESISTANCE; LINKAGE DISEQUILIBRIUM; COLLETOTRICHUM-LINDEMUTHIANUM; ORYZA-SATIVA; ZINC-FINGER; GENES; QTL; IDENTIFICATION; RECOMBINATION; DOMESTICATION	The common bean (Phaseolus vulgaris L.) is the world's most important legume for human consumption. Anthracnose (ANT; Colletotrichum lindemuthianum) and angular leaf spot (ALS; Pseudocercospora griseola) are complex diseases that cause major yield losses in common bean. Depending on the cultivar and environmental conditions, anthracnose and angular leaf spot infections can reduce crop yield drastically. This study aimed to estimate linkage disequilibrium levels and identify quantitative resistance loci (QRL) controlling resistance to both ANT and ALS diseases of 180 accessions of common bean using genome-wide association analysis. A randomized complete block design with four replicates was performed for the ANT and ALS experiments, with four plants per genotype in each replicate. Association mapping analyses were performed for ANT and ALS using a mixed linear model approach implemented in TASSEL. A total of 17 and 11 significant statistically associations involving SSRs were detected for ANT and ALS resistance loci, respectively. Using SNPs, 21 and 17 significant statistically associations were obtained for ANT and angular ALS, respectively, providing more associations with this marker. The SSR-IAC167 and PvM95 markers, both located on chromosome Pv03, and the SNP scaffold00021_89379, were associated with both diseases. The other markers were distributed across the entire common bean genome, with chromosomes Pv03 and Pv08 showing the greatest number of loci associated with ANT resistance. The chromosome Pv04 was the most saturated one, with six markers associated with ALS resistance. The telomeric region of this chromosome showed four markers located between approximately 2.5 Mb and 4.4 Mb. Our results demonstrate the great potential of genome-wide association studies to identify QRLs related to ANT and ALS in common bean. The results indicate a quantitative and complex inheritance pattern for both diseases in common bean. Our findings will contribute to more effective screening of elite germplasm to find resistance alleles for marker-assisted selection in breeding programs.	[Kuepper Cardoso Perseguini, Juliana Morini] Univ Tecnol Fed Parana UTFPR, Dois Vizinhos, Parana, Brazil; [Kuepper Cardoso Perseguini, Juliana Morini; Gomes, Kleber Alves; Benchimol-Reis, Luciana Lasry] IAC, Ctr Recursos Genet Vegetais, Campinas, SP, Brazil; [Oblessuc, Paula Rodrigues] Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Bachega Feijo Rosa, Joao Ricardo; Franco Garcia, Antonio Augusto] Univ Sao Paulo, ESALQ, Dept Genet, Piracicaba, SP, Brazil; [Chiorato, Alisson Fernando; Morais Carbonell, Sergio Augusto] IAC, Ctr Graos & Fibras, Campinas, SP, Brazil; [Vianello, Rosana Pereira] Empresa Brasileira Pesquisa Agr, Ctr Nacl Pesquisa Arroz & Feijao, Goiania, Go, Brazil	Universidade Tecnologica Federal do Parana; Instituto Agronomico de Campinas (IAC); Universidade de Sao Paulo; Instituto Agronomico de Campinas (IAC); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Perseguini, JMKC (corresponding author), Univ Tecnol Fed Parana UTFPR, Dois Vizinhos, Parana, Brazil.; Perseguini, JMKC (corresponding author), IAC, Ctr Recursos Genet Vegetais, Campinas, SP, Brazil.	julianamorini@hotmail.com	Rosa, João R Bachega F/H-3822-2011; Oblessuc, Paula R/M-1184-2016; Benchimol-Reis, Luciana Lasry/B-9371-2012; Garcia, Antonio A F/A-4538-2010; Oblessuc, Paula Rodrigues/AAJ-7755-2020; Chiorato, Alisson Fernando/C-6434-2012	Rosa, João R Bachega F/0000-0002-9584-1691; Oblessuc, Paula R/0000-0002-4977-3317; Benchimol-Reis, Luciana Lasry/0000-0003-1008-5936; Garcia, Antonio A F/0000-0003-0634-3277; Oblessuc, Paula Rodrigues/0000-0002-4977-3317; Chiorato, Alisson Fernando/0000-0002-7004-4717	Sao Paulo Research Foundation (FAPESP) [2009/05284-1, 2009/02502-8]; CNPq [477239/2010-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by grants from Sao Paulo Research Foundation (FAPESP) (process numbers 2009/05284-1 LLB-R and 2009/02502-8-JMKCP) and CNPq (process number 477239/2010-2-LLB-R).	Abdurakhmonov Ibrokhim Y, 2008, Int J Plant Genomics, V2008, P574927, DOI 10.1155/2008/574927; ADAMBLONDON AF, 1994, GENOME, V37, P915, DOI 10.1139/g94-131; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allorent D, 2005, EUR J PLANT PATHOL, V113, P329, DOI 10.1007/s10658-005-4038-y; Altermann E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-60; Alzate-Marin AL, 2003, EUPHYTICA, V133, P165, DOI 10.1023/A:1025551006444; Azarpazhooh E, 2012, COMMON BEANS PULSES; Barnaud A, 2010, HEREDITY, V104, P431, DOI 10.1038/hdy.2009.143; Belkhadir Y, 2004, CURR OPIN PLANT BIOL, V7, P391, DOI 10.1016/j.pbi.2004.05.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair MW, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-79; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Broughton WJ, 2003, PLANT SOIL, V252, P55, DOI 10.1023/A:1024146710611; Campa A, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-115; Campa A, 2009, THEOR APPL GENET, V119, P1, DOI 10.1007/s00122-009-1011-8; Chiorato AF, 2006, GENET MOL BIOL, V29, P105, DOI 10.1590/S1415-47572006000100020; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crous PW, 2006, STUD MYCOL, P163, DOI 10.3114/sim.55.1.163; de Campos T, 2011, MOL BREEDING, V27, P549, DOI 10.1007/s11032-010-9453-x; Ferreira J.J., 2013, TRANSLATIONAL GENOMI, VI, P151, DOI DOI 10.1002/9781118728475.CH9; Feurtado JA, 2011, PLANT CELL, V23, P1772, DOI 10.1105/tpc.111.085134; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Galeano CH, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-48; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Geffroy V, 1999, MOL PLANT MICROBE IN, V12, P774, DOI 10.1094/MPMI.1999.12.9.774; Geffroy V, 1998, THEOR APPL GENET, V96, P494, DOI 10.1007/s001220050766; Geffroy V, 2000, MOL PLANT MICROBE IN, V13, P287, DOI 10.1094/MPMI.2000.13.3.287; Geffroy V, 2008, THEOR APPL GENET, V116, P407, DOI 10.1007/s00122-007-0678-y; Gepts P, 2008, MOL BREEDING, V28, P57; Giri J, 2011, NEW PHYTOL, V191, P721, DOI 10.1111/j.1469-8137.2011.03740.x; Goncalves-Vidigal MC, 2013, THEOR APPL GENET, V126, P2245, DOI 10.1007/s00122-013-2131-8; Gonzalez AM, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00141; Hanai LR, 2007, GENOME, V50, P266, DOI 10.1139/G07-007; Hanai LR, 2010, MOL BREEDING, V25, P25, DOI 10.1007/s11032-009-9306-7; Hao CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017279; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; HILL WG, 1966, GENET RES, V8, P269, DOI 10.1017/S0016672300010156; Huang XH, 2014, ANNU REV PLANT BIOL, V65, P531, DOI 10.1146/annurev-arplant-050213-035715; JOHNSON R, 1981, PHYTOPATHOLOGY, V71, P567, DOI 10.1094/Phyto-71-567; Keller B, 2015, THEOR APPL GENET, V128, P813, DOI 10.1007/s00122-015-2472-6; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Perseguini JMKC, 2015, GENET MOL BIOL, V38, P67, DOI 10.1590/S1415-475738120140126; Kwak M, 2009, THEOR APPL GENET, V118, P979, DOI 10.1007/s00122-008-0955-4; Lacanallo GF, 2010, ANN RPT BEAN IMPROV, V53, P95; Mather KA, 2007, GENETICS, V177, P2223, DOI 10.1534/genetics.107.079616; Melotto M, 2000, COLLETOTRICHUM, P346; Mendez-Vigo B, 2005, EUPHYTICA, V141, P237, DOI 10.1007/s10681-005-7075-x; Miklas PN, 2006, EUPHYTICA, V147, P105, DOI 10.1007/s10681-006-4600-5; Monda EO, 2001, PLANT PATHOL, V50, P103, DOI 10.1046/j.1365-3059.2001.00537.x; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nair RB, 2004, PLANT CELL, V16, P544, DOI 10.1105/tpc.017509; Nemli S, 2014, J SCI FOOD AGR, V94, P3141, DOI 10.1002/jsfa.6664; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2000, GENETICS, V154, P923; Oblessuc PR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00152; Oblessuc PR, 2014, MOL BREEDING, V34, P1313, DOI 10.1007/s11032-014-0118-z; Oblessuc PR, 2013, THEOR APPL GENET, V126, P2451, DOI 10.1007/s00122-013-2146-1; Oblessuc PR, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-50; Oliveira MF, 2010, FIELD CROP RES, V119, P277, DOI 10.1016/j.fcr.2010.07.021; Pastor Corrales Marcial A., 1995, Fitopatologia Colombiana, V19, P15; Pastor-Corrales M.A., 1989, BEAN PRODUCTION PROB, P77; Pritchard JK, 2000, GENETICS, V155, P945; Richard MMS, 2014, THEOR APPL GENET, V127, P1653, DOI 10.1007/s00122-014-2328-5; Rodriguez-Suarez C, 2008, THEOR APPL GENET, V116, P807, DOI 10.1007/s00122-008-0714-6; Rodriguez-Suarez C, 2007, THEOR APPL GENET, V114, P713, DOI 10.1007/s00122-006-0471-3; Rossi M, 2009, EVOL APPL, P1; Schmutz J, 2014, NAT GENET, V46, P707, DOI 10.1038/ng.3008; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shi C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-52; Stenglein S, 2003, ADV APPL MICROBIOL, V52, P209, DOI 10.1016/S0065-2164(03)01009-8; Vanderplank JE., 1968, DIS RESISTANCE PLANT; Vianello RP, QTL DROUGHT TOLERANC; Weir B. S., 1996, GENETIC DATA ANAL; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Xu P, 2012, HEREDITY, V109, P34, DOI 10.1038/hdy.2012.8; Zhu HY, 2002, MOL PLANT MICROBE IN, V15, P529, DOI 10.1094/MPMI.2002.15.6.529; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	79	54	55	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150506	10.1371/journal.pone.0150506	http://dx.doi.org/10.1371/journal.pone.0150506			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930078	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500161
J	Baskoy, K; Ay, SA; Altundag, A; Kurt, O; Salihoglu, M; Deniz, F; Tekeli, H; Yonem, A; Hummel, T				Baskoy, Kamil; Ay, Seyid Ahmet; Altundag, Aytug; Kurt, Onuralp; Salihoglu, Murat; Deniz, Ferhat; Tekeli, Hakan; Yonem, Arif; Hummel, Thomas			Is There Any Effect on Smell and Taste Functions with Levothyroxine Treatment in Subclinical Hypothyroidism?	PLOS ONE			English	Article							TURKISH POPULATION; OLFACTORY FUNCTION; THYROID-DISEASE; PERFORMANCE; RATS	Subclinical hypothyroidism has been accused for coronary heart disease, lipid metabolism disorders, neuropsychiatric disorders, infertility or pregnancy related problems with various strength of evidence. Currently there is insufficient knowledge about olfaction and taste functions in subclinical hypothyroidism. Aim of the present study is to investigate the degree of smell and taste dysfunction in patients with subclinical hypothyroidism. 28 subclinical hypothyroid patients, and 31 controls enrolled in the prospective study in Istanbul, Turkey. Subclinical hypothyroid patients were treated with L-thyroxine for 3 months. Psychophysiological olfactory testing was performed using odor dispensers similar to felt-tip pens ("Sniffin' Sticks", Burghart, Wedel, Germany). Taste function tests were made using " Taste Strips" (Burghart, Wedel, Germany) which are basically tastant adsorbed filter paper strip. Patients scored lower on psychophysical olfactory tests than controls (odor thresholds: 8.1 +/- 1.0 vs 8.9 +/- 1.1, p = 0.007; odor discrimination: 12.4 +/- 1.3 vs 13.1 +/- 0.9, p = 0.016; odor identification: 13.1 +/- 0.9 vs 14.0 +/- 1.1, p = 0.001; TDI score: 33.8 +/- 2.4 vs 36.9 +/- 2.1, p = 0.001). In contrast, results from psychophysical gustatory tests showed only a decreased score for "bitter" in patients, but not for other tastes (5.9 +/- 1.8 vs 6.6 +/- 1.0, p = 0.045). Three month after onset of treatment olfactory test scores already indicated improvement (odor thresholds: 8.1 +/- 1.0 vs 8.6 +/- 0.6, p< 0.001; odor discrimination: 12.4 +/- 1.31 vs 12.9 +/- 0.8, p = 0.011; odor identification: 13.1 +/- 0.9 vs 13.9 +/- 0.8, p< 0.001; TDI scores: 33.8 +/- 2.4 vs 35.5 +/- 1.7, p< 0.001) respectively. Taste functions did not differ between groups for sweet, salty and, sour tastes but bitter taste was improved after 3 months of thyroxin substitution (patients: 5.9 +/- 1.8 vs 6.6 +/- 1.2, p = 0.045). Correlation of changes in smell and taste, with thyroid function test were also evaluated. TSH, fT4 were found have no correlation with smell and taste changes with treatment. However bitter taste found positively correlated with T3 with treatment(r: 0.445, p: 0.018). Subclinical hypothyroid patients exhibited a significantly decreased olfactory sensitivity; in addition, bitter taste was significantly affected. Most importantly, these deficits can be remedied on average within 3 months with adequate treatment.	[Baskoy, Kamil; Ay, Seyid Ahmet; Deniz, Ferhat; Yonem, Arif] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Endocrinol & Metab, Istanbul, Turkey; [Altundag, Aytug] Istanbul Surg Hosp, Dept Otorhinolaryngol, Istanbul, Turkey; [Kurt, Onuralp] Erzincan Mil Hosp, Dept Otorhinolaryngol, Erzincan, Turkey; [Salihoglu, Murat] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Otorhinolaryngol, Istanbul, Turkey; [Tekeli, Hakan] Haydarpasa Training Hosp, Gulhane Mil Med Sch, Dept Neurol, Istanbul, Turkey; [Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell Taste, Dresden, Germany	Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Istanbul Cerrahi Hospital; Erzincan Military Hospital; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Gulhane Military Medical Academy; Istanbul Haydarpasa Numune Training & Research Hospital; Istanbul Haydarpasa Sultan Abdulhamid Training & Research Hospital; Technische Universitat Dresden	Altundag, A (corresponding author), Istanbul Surg Hosp, Dept Otorhinolaryngol, Istanbul, Turkey.	aaltundagkbb@yahoo.com	Altundag, Aytug/AAP-5557-2020; TEKELİ, HAKAN/B-6117-2016	Yonem, Arif/0000-0003-1517-9376				Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P811, DOI 10.4103/2230-8210.141355; Baumgartner C, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.14058; Brosvic Gary M., 1996, Physiology and Behavior, V59, P117, DOI 10.1016/0031-9384(95)00145-X; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Clark AA, 2015, FASEB J, V29, P164, DOI 10.1096/fj.14-262246; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Dhong HJ, 2003, OTOLARYNG HEAD NECK, V129, P24, DOI 10.1016/S0194-5998(03)00530-8; Gunbey E, 2015, INT FORUM ALLERGY RH, V5, P919, DOI 10.1002/alr.21565; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Landis BN, 2009, J NEUROL, V256, P242, DOI 10.1007/s00415-009-0088-y; MCCONNELL RJ, 1975, AM J MED, V59, P354, DOI 10.1016/0002-9343(75)90394-0; Mueller C, 2003, RHINOLOGY, V41, P2; PATERNOSTRO MA, 1991, INT J DEV NEUROSCI, V9, P439, DOI 10.1016/0736-5748(91)90030-P; Salihoglu M, 2014, MED SCI MONITOR, V20, P569, DOI 10.12659/MSM.890071; Smith CD, 2015, THYROID, V25, P28, DOI 10.1089/thy.2014.0371; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Tekeli H, 2013, MED SCI MONITOR, V19, P1221, DOI 10.12659/MSM.889838; Zhang LQ, 2009, NEUROBIOL DIS, V34, P366, DOI 10.1016/j.nbd.2009.02.006	19	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149979	10.1371/journal.pone.0149979	http://dx.doi.org/10.1371/journal.pone.0149979			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927632	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200018
J	Sendlhofer, G; Lumenta, DB; Leitgeb, K; Kober, B; Jantscher, L; Schanbacher, M; Berghold, A; Pregartner, G; Brunner, G; Tax, C; Kamolz, LP				Sendlhofer, Gerald; Lumenta, David Benjamin; Leitgeb, Karina; Kober, Brigitte; Jantscher, Lydia; Schanbacher, Monika; Berghold, Andrea; Pregartner, Gudrun; Brunner, Gernot; Tax, Christa; Kamolz, Lars Peter			The Gap between Individual Perception and Compliance: A Qualitative Follow-Up Study of the Surgical Safety Checklist Application	PLOS ONE			English	Article							IMPLEMENTATION	Background "The Surgical Safety Checklist (SSC) is important, but we don't use it adequately" is a well-suited statement that reflects the SSC's application in hospitals. Our aim was to follow up on our initial study on compliance (2014) by analysing differences between individual perception and compliance with the SSC. Methods We conducted a follow-up online survey to assess healthcare professionals' individual perception of, as well as satisfaction and compliance with the SSC three years following its thorough implementation. Results 171 (19.5%) of 875 operating team members completed the online survey. 99.4% confirmed using the SSC. Self-estimated subjective knowledge about the intention of the checklist was high, whereas objective knowledge was moderate, but improved as compared to 2014. According to an independent audit the SSC was used in 93.1% of all operations and among the SSCs used the completion rate was 57.2%. The use of the SSC was rated as rather easy [median (IQR): 7 (6-7)], familiar [7 (6-7)], generally important [7 (7-7)], and good for patients [7 (6-7)] as well as for employees [7 (7-7)]. Only comfort of use was rated lower [6 (5-7)]. Conclusion There is a gap between individual perception and actual application of the SSC. Despite healthcare professionals confirming the importance of the SSC, compliance was moderate. The introduction of SSCs in the health care sector remains a constant challenge and requires continuous re-evaluation as well as a sensible integration into existing workflows in hospitals.	[Sendlhofer, Gerald; Leitgeb, Karina; Kober, Brigitte; Jantscher, Lydia] Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria; [Sendlhofer, Gerald; Lumenta, David Benjamin; Kamolz, Lars Peter] Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, Graz, Austria; [Sendlhofer, Gerald; Leitgeb, Karina; Kober, Brigitte; Kamolz, Lars Peter] Med Univ Graz, Res Unit Safety Hlth, Graz, Austria; [Schanbacher, Monika] Med Univ Graz, Dept Dent & Maxillofacial Surg, Div Oral & Craniomaxillofacial Surg, Graz, Austria; [Berghold, Andrea; Pregartner, Gudrun] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Brunner, Gernot; Tax, Christa] Univ Hosp Graz, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz; Medical University of Graz	Sendlhofer, G (corresponding author), Univ Hosp Graz, Execut Dept Qual & Risk Management, Graz, Austria.; Sendlhofer, G (corresponding author), Med Univ Graz, Div Plast Aesthet & Reconstruct Surg, Dept Surg, Graz, Austria.; Sendlhofer, G (corresponding author), Med Univ Graz, Res Unit Safety Hlth, Graz, Austria.	gerald.sendlhofer@klinikum-graz.at	Lumenta, David Benjamin/AAD-5935-2019	Lumenta, David Benjamin/0000-0003-0903-252X; Kamolz, Lars-Peter/0000-0002-5975-876X; Sendlhofer, Gerald/0000-0002-6538-3116	Austrian Society for Quality and Safety (ASQS)	Austrian Society for Quality and Safety (ASQS)	The Austrian Society for Quality and Safety (ASQS) supported the study as GS, GB, LPK, BK and KL are ASQS-members, however, there was no financial support. The funder ( ASQS) had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthes E, 2015, NATURE, V523, P516, DOI 10.1038/523516a; Bergs J, 2014, BRIT J SURG, V101, P150, DOI 10.1002/bjs.9381; Biffl WL, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-014-0056-z; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; Cullati S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101915; Dixon-Woods M, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-70; Fudickar A, 2012, DTSCH ARZTEBL INT, V109, P695, DOI 10.3238/arztebl.2012.0695; Haugen AS, 2015, ANN SURG, V261, P821, DOI 10.1097/SLA.0000000000000716; Haynes AB, 2015, ANN SURG, V261; Hill MR, 2015, BRIT J ANAESTH, V114, P958, DOI 10.1093/bja/aev063; Kamolz LP, 2015, SAFETY HLTH, V1, P1, DOI [10.1186/2056-5917-1-1, DOI 10.1186/2056-5917-1-1]; Klei WA, 2011, ANN SURG, P1, DOI DOI 10.1097/SLA.0B013E3181FCD991; Mayer EK, 2015, ANN SURG; Pugel AE, 2015, J INFECT PUBLIC HEAL, V8, P219, DOI 10.1016/j.jiph.2015.01.001; Rakoff D, 2015, J PATIENT SAFETY; Russ S, 2014, ANN SURG, V58, P859; Russ SJ, 2015, ANN SURG, V261, P81, DOI 10.1097/SLA.0000000000000793; Russ SJ, 2014, BMJ QUAL SAF, V23, P939, DOI 10.1136/bmjqs-2013-002772; Rydenfalt C, 2013, INT J QUAL HEALTH C, V25, P182, DOI 10.1093/intqhc/mzt004; Sendlhofer G, 2015, THE SSC; Sendlhofer G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116926; Tang R, 2014, ANZ J SURG, V84, P148, DOI 10.1111/ans.12168; Urbach DR, 2014, NEW ENGL J MED, V370, P1029, DOI 10.1056/NEJMsa1308261	25	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149212	10.1371/journal.pone.0149212	http://dx.doi.org/10.1371/journal.pone.0149212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26925579	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200007
J	Stason, WB; Ritter, GA; Martin, T; Prottas, J; Tompkins, C; Shepard, DS				Stason, William B.; Ritter, Grant A.; Martin, Timothy; Prottas, Jeffrey; Tompkins, Christopher; Shepard, Donald S.			Effects of Expanded Coverage for Chiropractic Services on Medicare Costs in a CMS Demonstration	PLOS ONE			English	Article							MANIPULATIVE THERAPY; PUBLIC-HEALTH; CARE; UPDATE; PAIN	Background Moderately convincing evidence supports the benefits of chiropractic manipulations for low back pain. Its effectiveness in other applications is less well documented, and its cost-effectiveness is not known. These questions led the Centers for Medicaid and Medicare Services (CMS) to conduct a two-year demonstration of expanded Medicare coverage for chiropractic services in the treatment of beneficiaries with neuromusculoskeletal (NMS) conditions affecting the back, limbs, neck, or head. Methods The demonstration was conducted in 2005-2007 in selected counties of Illinois, Iowa, and Virginia and the entire states of Maine and New Mexico. Medicare claims were compiled for the preceding year and two demonstration years for the demonstration areas and matched comparison areas. The impact of the demonstration was analyzed through multivariate regression analysis with a difference-in-difference framework. Results Expanded coverage increased Medicare expenditures by $ 50 million or 28.5% in users of chiropractic services and by $ 114 million or 10.4% in all patients treated for NMS conditions in demonstration areas during the two-year period. Results varied widely among demonstration areas ranging from increased costs per user of $ 485 in Northern Illinois and Chicago counties to decreases in costs per user of $ 59 in New Mexico and $ 178 in Scott County, Iowa. Conclusion The demonstration did not assess possible decreases in costs to other insurers, out-of-pocket payments by patients, the need for and costs of pain medications, or longer term clinical benefits such as avoidance of orthopedic surgical procedures beyond the two-year period of the demonstration. It is possible that other payers or beneficiaries saved money during the demonstration while costs to Medicare were increased.	[Stason, William B.; Ritter, Grant A.; Martin, Timothy; Prottas, Jeffrey; Tompkins, Christopher; Shepard, Donald S.] Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, MS 035, Waltham, MA 02254 USA	Brandeis University	Shepard, DS (corresponding author), Brandeis Univ, Heller Sch, Schneider Inst Hlth Policy, MS 035, Waltham, MA 02254 USA.	shepard@brandeis.edu			Centers for Medicare & Medicaid Services [500-00-0031/TO 007]	Centers for Medicare & Medicaid Services	This work was supported by the Centers for Medicare & Medicaid Services to Brandeis University (www.cms.gov) contract number 500-00-0031/TO 007. The funders approved the study design and analysis in the underlying report (Stason et al., 2010, reference 2) but had no role in the decision to publish or preparation of this manuscript.	Biondi DM, 2005, HEADACHE, V45, P738, DOI 10.1111/j.1526-4610.2005.05141.x; Bronfort G, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001878.PUB2; Cooper RA, 2003, MILBANK Q, V81, P107, DOI 10.1111/1468-0009.00040; DeVocht JW, 2006, CLIN ORTHOP RELAT R, P243, DOI 10.1097/01.blo.0000203460.89887.8d; Ernst E, 2006, J ROY SOC MED, V99, P192, DOI 10.1258/jrsm.99.4.192; Ernst E, 2008, J PAIN SYMPTOM MANAG, V35, P544, DOI 10.1016/j.jpainsymman.2007.07.004; French HP, 2011, MANUAL THER, V16, P109, DOI 10.1016/j.math.2010.10.011; Gaumer G, 2006, J MANIP PHYSIOL THER, V29, P455, DOI 10.1016/j.jmpt.2006.06.013; Hahne AJ, 2010, SPINE, V35, pE488, DOI 10.1097/BRS.0b013e3181cc3f56; Haynes MJ, 2012, INT J CLIN PRACT, V66, P940, DOI 10.1111/j.1742-1241.2012.03004.x; Herd CR, 2008, J MAN MANIP THER, V16, P225, DOI 10.1179/106698108790818288; Jansen MJ, 2011, J PHYSIOTHER, V57, P11, DOI 10.1016/S1836-9553(11)70002-9; Johnson C, 2008, J MANIP PHYSIOL THER, V31, P397, DOI 10.1016/j.jmpt.2008.07.001; Johnson C, 2012, J MANIP PHYSIOL THER, V35, P493, DOI 10.1016/j.jmpt.2012.09.001; Keating Jr JC, 2004, CHIROPRACTIC HSTORY; Leboeuf-Yde Charlotte, 2008, Chiropr Osteopat, V16, P3, DOI 10.1186/1746-1340-16-3; Leininger B, 2011, PHYS MED REH CLIN N, V22, P105, DOI 10.1016/j.pmr.2010.11.002; Lin CWC, 2011, EUR SPINE J, V20, P1024, DOI 10.1007/s00586-010-1676-3; Meeker WC, 2002, ANN INTERN MED, V136, P216, DOI 10.7326/0003-4819-136-3-200202050-00010; Mootz RD, 1997, CHIROPRACTIC IN THE; National Board of Chiropractic Examiners (NBCE), 2014, ABOUT CHIROPRACTIC 2; Nelson Craig F, 2005, Chiropr Osteopat, V13, P9, DOI 10.1186/1746-1340-13-9; Posadzki P, 2011, NEW ZEAL MED J, V124, P55; Pribicevic M, 2010, J MANIP PHYSIOL THER, V33, P679, DOI 10.1016/j.jmpt.2010.08.019; Rubinstein SM, 2013, SPINE, V38, pE158, DOI 10.1097/BRS.0b013e31827dd89d; Short R., 2010, THE CHIROPRACTIC DEM; Stapleton DC, 2005, MEDICARE CHIROPRACTI; Stason WB, 2010, FINAL REPORT; Weeks WB, 2013, J MANIP PHYSIOL THER, V36, P468, DOI 10.1016/j.jmpt.2013.07.003; Whedon James M, 2013, J Chiropr Humanit, V20, P9, DOI 10.1016/j.echu.2013.07.001; Whedon JM, 2012, J MANIP PHYSIOL THER, V35, P101, DOI 10.1016/j.jmpt.2011.12.004; Whedon JM, 2010, TOPICS IN INTEGRATIV, V1	32	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0147959	10.1371/journal.pone.0147959	http://dx.doi.org/10.1371/journal.pone.0147959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928221	gold, Green Submitted, Green Published			2022-12-27	WOS:000371424200001
J	De Cicco, V; Barresi, M; Fantozzi, MPT; Cataldo, E; Parisi, V; Manzoni, D				De Cicco, Vincenzo; Barresi, Massimo; Fantozzi, Maria Paola Tramonti; Cataldo, Enrico; Parisi, Vincenzo; Manzoni, Diego			Oral Implant-Prostheses: New Teeth for a Brighter Brain	PLOS ONE			English	Article							TRIGEMINAL NERVE-STIMULATION; AGED SAMP8 MICE; LOCUS-COERULEUS; CHEWING GUM; RETICULAR-FORMATION; SPATIAL MEMORY; PUPIL SIZE; PERIODONTAL MECHANORECEPTORS; ASTROGLIAL RESPONSIVENESS; MOLARLESS CONDITION	Several studies have demonstrated that chewing can be regarded as a preventive measure for cognitive impairment, whereas masticatory deficiency, associated with soft-diet feeding, is a risk factor for the development of dementia. At present the link between orofacial sensorimotor activity and cognitive functions is unknown. In subjects with unilateral molar loss we have shown asymmetries in both pupil size and masticatory muscles electromyographic (EMG) activity during clenching: the molar less side was characterized by a lower EMG activity and a smaller pupil. Since implant-prostheses, greatly reduced both the asymmetry in EMG activity and in pupil's size, trigeminal unbalance, leading to unbalance in the activity of the Locus Coeruleus (LC), may be responsible for the pupil's asymmetry. According to the findings obtained in animal models, we propose that the different activity of the right and left LC may induce an asymmetry in brain activity, thus leading to cognitive impairment. According to this hypothesis, prostheses improved the performance in a complex sensorimotor task and increased the mydriasis associated with haptic tasks. In conclusion, the present study indicates that the implant-prosthesis therapy, which reduces the unbalance of trigeminal proprioceptive afferents and the asymmetry in pupil's size, may improve arousal, boosting performance in a complex sensorimotor task.	[De Cicco, Vincenzo; Fantozzi, Maria Paola Tramonti; Manzoni, Diego] Univ Pisa, Dept Translat Res, Pisa, Italy; [Barresi, Massimo] Univ Catania, Dept Drug Sci, Catania, Italy; [Cataldo, Enrico] Univ Pisa, Dept Phys, I-56100 Pisa, Italy; [Parisi, Vincenzo] GB Bietti Fdn, IRCCS, Rome, Italy	University of Pisa; University of Catania; University of Pisa; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia	Barresi, M (corresponding author), Univ Catania, Dept Drug Sci, Catania, Italy.	mbarresi@unict.it	Parisi, Vincenzo/J-6137-2018; Tramonti Fantozzi, Maria Paola/AAB-5912-2022	Tramonti Fantozzi, Maria Paola/0000-0001-5146-4997; barresi, massimo/0000-0001-9610-1890; De Cicco, Vincenzo/0000-0003-3048-1194	University of Pisa; Iacer Company; Implafavourite Company; Italian Ministry of Health; Fondazione Roma	University of Pisa; Iacer Company; Implafavourite Company; Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission)	The research was supported by grants of the University of Pisa, Iacer Company and Implafavourite Company. The contribution of the GB Bietti Foundation, IRCCS, was supported by Italian Ministry of Health and by Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2012, NUTR NEUROSCI, V15, P176, DOI 10.1179/1476830512Y.0000000009; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Aoki H, 2010, NEUROSCI LETT, V469, P44, DOI 10.1016/j.neulet.2009.11.041; Areso MP, 1999, J DENT RES, V78, P1204, DOI 10.1177/00220345990780060301; Bartsch T, 2000, AUTON NEUROSCI-BASIC, V83, P66, DOI 10.1016/S0165-1838(00)00158-2; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bourque MJ, 2001, J NEUROPHYSIOL, V86, P2583, DOI 10.1152/jn.2001.86.5.2583; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; BREEN LA, 1983, BRAIN RES, V261, P303, DOI 10.1016/0006-8993(83)90633-9; BRODIN P, 1993, J PHYSIOL-LONDON, V464, P711, DOI 10.1113/jphysiol.1993.sp019659; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; CEDARBAUM JM, 1978, J COMP NEUROL, V178, P1, DOI 10.1002/cne.901780102; Cook IA, 2013, EPILEPSY BEHAV, V28, P221, DOI 10.1016/j.yebeh.2013.05.008; de Cicco V, 2014, ARCH ITAL BIOL, V152, P1; DeGiorgio Christopher M, 2013, Continuum (Minneap Minn), V19, P743, DOI 10.1212/01.CON.0000431397.61970.2b; DeGiorgio CM, 2013, NEUROLOGY, V80, P786, DOI 10.1212/WNL.0b013e318285c11a; Diagne M, 2006, J COMP NEUROL, V496, P759, DOI 10.1002/cne.20964; Edelmann E, 2015, NEURON, V86, P1041, DOI 10.1016/j.neuron.2015.04.007; Esser MJ, 1998, J COMP NEUROL, V391, P526, DOI 10.1002/(SICI)1096-9861(19980222)391:4<526::AID-CNE8>3.0.CO;2-2; Fan GP, 2000, DEV DYNAM, V218, P359, DOI 10.1002/(SICI)1097-0177(200006)218:2<359::AID-DVDY9>3.3.CO;2-C; Figley CR, 2011, EUR J NEUROSCI, V33, P577, DOI 10.1111/j.1460-9568.2010.07584.x; Fujita K, 2012, J PLAST SURG HAND SU, V46, P383, DOI 10.3109/2000656X.2012.722094; Gabay S, 2011, ATTEN PERCEPT PSYCHO, V73, P123, DOI 10.3758/s13414-010-0015-4; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hirano Yoshiyuki, 2014, Brain Nerve, V66, P25; Hirano Y, 2013, BRAIN COGNITION, V81, P376, DOI 10.1016/j.bandc.2012.12.002; Hoffing RC, 2015, J COGNITIVE NEUROSCI, V27, P765, DOI 10.1162/jocn_a_00749; Howells FM, 2012, METAB BRAIN DIS, V27, P267, DOI 10.1007/s11011-012-9287-9; Johnson AJ, 2012, PHYSIOL BEHAV, V105, P815, DOI 10.1016/j.physbeh.2011.10.020; Juric DM, 2006, BRAIN RES, V1108, P54, DOI 10.1016/j.brainres.2006.06.008; Kato T, 1997, BEHAV BRAIN RES, V83, P239, DOI 10.1016/S0166-4328(97)86078-0; Kihara K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00827; Kim JJ, 2002, NAT REV NEUROSCI, V3, P453, DOI 10.1038/nrn849; Kubo K, 2005, BRAIN RES, V1057, P191, DOI 10.1016/j.brainres.2005.07.038; Lomber SG, 1996, VISUAL NEUROSCI, V13, P1143, DOI 10.1017/S0952523800007781; LUND JP, 1983, TRENDS NEUROSCI, V6, P458, DOI 10.1016/0166-2236(83)90219-9; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90066-8; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Notsu K, 2008, BRAIN RES, V1244, P71, DOI 10.1016/j.brainres.2008.09.076; Ohkubo C, 2013, J ORAL REHABIL, V40, P119, DOI 10.1111/j.1365-2842.2012.02316.x; Okamoto N, 2011, J PROSTHODONT RES, V55, P206, DOI 10.1016/j.jpor.2011.01.003; Okamoto N, 2015, J ALZHEIMERS DIS, V44, P777, DOI 10.3233/JAD-141665; Ono Y, 2010, J ORAL REHABIL, V37, P624, DOI 10.1111/j.1365-2842.2010.02079.x; Onozuka M, 2002, BEHAV BRAIN RES, V131, P125, DOI 10.1016/S0166-4328(01)00378-3; Onozuka M, 2000, BEHAV BRAIN RES, V108, P145, DOI 10.1016/S0166-4328(99)00145-X; Oue H, 2013, BEHAV BRAIN RES, V252, P318, DOI 10.1016/j.bbr.2013.06.015; Ozawa T, 2014, BEHAV BRAIN RES, V263, P210, DOI 10.1016/j.bbr.2014.01.034; Panneton WM, 2000, BRAIN RES, V874, P48, DOI 10.1016/S0006-8993(00)02549-X; Paukert M, 2014, NEURON, V82, P1263, DOI 10.1016/j.neuron.2014.04.038; RAJKOWSKI J, 1994, BRAIN RES BULL, V35, P607, DOI 10.1016/0361-9230(94)90175-9; Rajkowski J., 1993, Society for Neuroscience Abstracts, V19, P974; Sakamoto K, 2009, CLIN NEUROPHYSIOL, V120, P41, DOI 10.1016/j.clinph.2008.10.001; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schrader LM, 2011, EPILEPSY BEHAV, V22, P475, DOI 10.1016/j.yebeh.2011.06.026; SHAMMAHLAGNADO SJ, 1992, NEUROSCIENCE, V50, P403, DOI 10.1016/0306-4522(92)90433-3; Silvetti M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00160; Smith A, 2009, NUTR NEUROSCI, V12, P81, DOI 10.1179/147683009X423247; SORG O, 1991, BRAIN RES, V563, P227, DOI 10.1016/0006-8993(91)91538-C; Spinnler H., 1987, ITAL J NEUROL SCI, V6, P1; Szabadi E, 1996, J PSYCHOPHARMACOL, V10, P6; TENTUSSCHER MPM, 1989, BRAIN RES, V494, P95, DOI 10.1016/0006-8993(89)90147-9; Trulsson M, 2006, J ORAL REHABIL, V33, P262, DOI 10.1111/j.1365-2842.2006.01629.x; Tsutsui K, 2007, BIOMED RES-TOKYO, V28, P1, DOI 10.2220/biomedres.28.1; Tucha O, 2004, APPETITE, V42, P327, DOI 10.1016/j.appet.2004.01.003; Turker KS, 2007, ARCH ORAL BIOL, V52, P361, DOI 10.1016/j.archoralbio.2006.11.014; Watanabe K, 2002, BEHAV BRAIN RES, V128, P19, DOI 10.1016/S0166-4328(01)00268-6; Watanabe K, 2001, EXP GERONTOL, V36, P283, DOI 10.1016/S0531-5565(00)00216-3; Weijenberg RAF, 2011, NEUROSCI BIOBEHAV R, V35, P483, DOI 10.1016/j.neubiorev.2010.06.002; Wilhelm B, 2001, J SLEEP RES, V10, P1, DOI 10.1046/j.1365-2869.2001.00239.x; Yamamoto Tetsu, 2009, Bull Tokyo Dent Coll, V50, P117; Yamamoto Tetsu, 2008, Bull Tokyo Dent Coll, V49, P185; Yoshihara T, 2011, NEUROSCI LETT, V503, P43, DOI 10.1016/j.neulet.2011.08.004; Zare Mohammad, 2014, Adv Biomed Res, V3, P81, DOI 10.4103/2277-9175.127994; Zhang JS, 2007, BRAIN RES, V1184, P121, DOI 10.1016/j.brainres.2007.09.061	77	28	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148715	10.1371/journal.pone.0148715	http://dx.doi.org/10.1371/journal.pone.0148715			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919258	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400008
J	Vonasek, BJ; Bajunirwe, F; Jacobson, LE; Twesigye, L; Dahm, J; Grant, MJ; Sethi, AK; Conway, JH				Vonasek, Bryan J.; Bajunirwe, Francis; Jacobson, Laura E.; Twesigye, Leonidas; Dahm, James; Grant, Monica J.; Sethi, Ajay K.; Conway, James H.			Do Maternal Knowledge and Attitudes towards Childhood Immunizations in Rural Uganda Correlate with Complete Childhood Vaccination?	PLOS ONE			English	Article							INFLUENZA VACCINATION; PARENTS KNOWLEDGE; CHILDREN; COVERAGE; DETERMINANTS; TIMELINESS; URBAN; PERCEPTIONS; COUNTRIES; SURVIVAL	Improving childhood vaccination coverage and timeliness is a key health policy objective in many developing countries such as Uganda. Of the many factors known to influence uptake of childhood immunizations in under resourced settings, parents' understanding and perception of childhood immunizations has largely been overlooked. The aims of this study were to survey mothers' knowledge and attitudes towards childhood immunizations and then determine if these variables correlate with the timely vaccination coverage of their children. From September to December 2013, we conducted a cross-sectional survey of 1,000 parous women in rural Sheema district in southwest Uganda. The survey collected socio-demographic data and knowledge and attitudes towards childhood immunizations. For the women with at least one child between the age of one month and five years who also had a vaccination card available for the child (N = 302), the vaccination status of this child was assessed. 88% of these children received age-appropriate, on-time immunizations. 93.5% of the women were able to state that childhood immunizations protect children from diseases. The women not able to point this out were significantly more likely to have an under-vaccinated child (PR 1.354: 95% CI 1.018-1.802). When asked why vaccination rates may be low in their community, the two most common responses were "fearful of side effects" and "ignorance/disinterest/laziness" (44% each). The factors influencing caregivers' demand for childhood immunizations vary widely between, and also within, developing countries. Research that elucidates local knowledge and attitudes, like this study, allows for decisions and policy pertaining to vaccination programs to be more effective at improving child vaccination rates.	[Vonasek, Bryan J.; Dahm, James; Conway, James H.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA; [Bajunirwe, Francis; Twesigye, Leonidas] Mbarara Univ Sci & Technol, Dept Community Hlth, Mbarara, Uganda; [Jacobson, Laura E.; Sethi, Ajay K.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA; [Grant, Monica J.] Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; Mbarara University of Science & Technology; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vonasek, BJ (corresponding author), Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI USA.; Sethi, AK (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA.	vonasek@wisc.edu; ajay.sethi@wisc.edu		Vonasek, Bryan/0000-0002-5657-0980	Global Health Institute, University of Wisconsin-Madison	Global Health Institute, University of Wisconsin-Madison	The work was supported by Global Health Institute, http://ghi.wisc.edu, University of Wisconsin-Madison. Authors who received funding: MG AS JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmatov MK, 2012, J EPIDEMIOL COMMUN H, V66, DOI 10.1136/jech.2010.124651; Antai D, 2009, J BIOSOC SCI, V41, P57, DOI 10.1017/S0021932008002861; Babirye JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035432; Braka F, 2012, MATERN CHILD HLTH J, V16, P1045, DOI 10.1007/s10995-011-0826-5; BRUGHA R, 1995, HEALTH POLICY PLANN, V10, P312, DOI 10.1093/heapol/10.3.312; Callreus T, 2010, ACTA PAEDIATR, V99, P166, DOI 10.1111/j.1651-2227.2009.01583.x; Canavan ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095709; Cassell JA, 2006, HEALTH POLICY PLANN, V21, P373, DOI 10.1093/heapol/czl020; Fadnes LT, 2011, VACCINE, V29, P3564, DOI 10.1016/j.vaccine.2011.02.093; Favin M, 2012, INT HEALTH, V4, P229, DOI 10.1016/j.inhe.2012.07.004; Gram L, 2014, TROP MED INT HEALTH, V19, P802, DOI 10.1111/tmi.12324; Gyimah SO, 2007, J BIOSOC SCI, V39, P923, DOI 10.1017/S0021932007001927; Helman CG, 2004, SAMJ S AFR MED J, V94, P835; Hofstetter AM, 2013, PREV MED, V56, P165, DOI 10.1016/j.ypmed.2012.11.018; Howe LD, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-3; Jheeta M, 2008, B WORLD HEALTH ORGAN, V86, P419, DOI 10.2471/BLT.07.047159; Kahn JA, 2003, INT J STD AIDS, V14, P300, DOI 10.1258/095646203321605486; Kharbanda EO, 2011, VACCINE, V29, P2537, DOI 10.1016/j.vaccine.2011.01.065; Mohamud AN, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-865; Muhwezi WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106686; Mutua MK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-6; Nankabirwa V, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-92; Ndirangu J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-372; Oria PA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-391; Rademacher NJ, 2010, RURAL REMOTE HEALTH, V10; Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096; Rwashana AS, 2009, HEALTH INFORM J, V15, P95, DOI 10.1177/1460458209102971; Schoeps A, 2013, VACCINE, V32, P96, DOI 10.1016/j.vaccine.2013.10.063; Semali IA, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-299; Stockwell MS, 2015, PEDIATRICS, V135, pE83, DOI 10.1542/peds.2014-2475; Sturm LA, 2005, J DEV BEHAV PEDIATR, V26, P441, DOI 10.1097/00004703-200512000-00009; Uganda Bureau of Statistics, 2014, PROF HIGH LOC GOV; UNICEF: Level & Trends in Child Mortality, 2014, UNICEF LEV TRENDS CH; Waisbord S.L., 2005, WHY INVEST COMMUNICA; Wakadha H, 2013, VACCINE, V31, P987, DOI 10.1016/j.vaccine.2012.11.093; WHO, 2008, WEEKLY EPIDEMIOL REC, V83, P1; WHO, 2014, IMM SUMM STAT REF CO; World Health Organization, 2009, STAT WORLDS VACC IMM	38	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150131	10.1371/journal.pone.0150131	http://dx.doi.org/10.1371/journal.pone.0150131			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918890	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400089
J	Wallis, LA; Fleming, J; Hasselberg, M; Laflamme, L; Lundin, J				Wallis, Lee A.; Fleming, Julian; Hasselberg, Marie; Laflamme, Lucie; Lundin, Johan			A Smartphone App and Cloud-Based Consultation System for Burn Injury Emergency Care	PLOS ONE			English	Article							TELEMEDICINE; DIAGNOSIS	Background Each year more than 10 million people worldwide are burned severely enough to require medical attention, with clinical outcomes noticeably worse in resource poor settings. Expert clinical advice on acute injuries can play a determinant role and there is a need for novel approaches that allow for timely access to advice. We developed an interactive mobile phone application that enables transfer of both patient data and pictures of a wound from the point-of-care to a remote burns expert who, in turn, provides advice back. Methods and Results The application is an integrated clinical decision support system that includes a mobile phone application and server software running in a cloud environment. The client application is installed on a smartphone and structured patient data and photographs can be captured in a protocol driven manner. The user can indicate the specific injured body surface(s) through a touchscreen interface and an integrated calculator estimates the total body surface area that the burn injury affects. Predefined standardised care advice including total fluid requirement is provided immediately by the software and the case data are relayed to a cloud server. A text message is automatically sent to a burn expert on call who then can access the cloud server with the smartphone app or a web browser, review the case and pictures, and respond with both structured and personalized advice to the health care professional at the point-of-care. Conclusions In this article, we present the design of the smartphone and the server application alongside the type of structured patient data collected together with the pictures taken at point-of-care. We report on how the application will be introduced at point-of-care and how its clinical impact will be evaluated prior to roll out. Challenges, strengths and limitations of the system are identified that may help materialising or hinder the expected outcome to provide a solution for remote consultation on burns that can be integrated into routine acute clinical care and thereby promote equity in injury emergency care, a growing public health burden.	[Wallis, Lee A.; Fleming, Julian] Univ Stellenbosch, Div Emergency Med, ZA-7600 Stellenbosch, South Africa; [Hasselberg, Marie; Laflamme, Lucie; Lundin, Johan] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Hasselberg, Marie; Laflamme, Lucie] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Marais St, ZA-7600 Stellenbosch, South Africa; [Laflamme, Lucie] Univ S Africa, Preller St, ZA-0002 Pretoria, South Africa; [Lundin, Johan] Univ Helsinki, Inst Mol Med Finland FIMM, Tukholmankatu 8, FI-00290 Helsinki, Finland	Stellenbosch University; Karolinska Institutet; Stellenbosch University; University of South Africa; University of Helsinki	Lundin, J (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Lundin, J (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Tukholmankatu 8, FI-00290 Helsinki, Finland.	johan.lundin@ki.se	Lundin, Johan/I-1843-2018; Laflamme, Lucie/T-2953-2019; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Laflamme, Lucie/0000-0002-6443-1307; Lundin, Johan/0000-0002-2681-4139; Wallis, Lee/0000-0003-2711-3139	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA)	Swedish International Development Cooperation Agency (SIDA) http://www.sida.se/English/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acha B, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1921227; Barnes J, 2015, EMERG MED J, V32, P637, DOI 10.1136/emermed-2013-203416; BAXTER CR, 1968, ANN NY ACAD SCI, V150, P874, DOI 10.1111/j.1749-6632.1968.tb14738.x; Boccara D, 2011, BURNS, V37, P69, DOI 10.1016/j.burns.2010.05.017; Boissin C, 2015, BURNS, V41, P1253, DOI 10.1016/j.burns.2014.12.014; Boissin C, 2015, TELEMED E-HEALTH, V21, P887, DOI 10.1089/tmj.2014.0221; Boulanger B, 2001, J AM COLL SURGEONS, V192, P447, DOI 10.1016/S1072-7515(01)00796-7; Giretzlehner M, 2013, RAP BURN ASS 15 EPA; Godwin ZR, 2013, BURNS, V39, P1395, DOI 10.1016/j.burns.2013.03.021; Hasselberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098539; Karpelowsky JS, 2007, SAMJ S AFR MED J, V97, P574; Keane MG, 2009, J TELEMED TELECARE, V15, P132, DOI 10.1258/jtt.2009.003008; Kiser M, 2013, BURNS, V39, P155, DOI 10.1016/j.burns.2012.04.003; Morris R, 2014, BURNS, V40, P826, DOI 10.1016/j.burns.2013.10.015; Parvizi D, 2014, Ann Burns Fire Disasters, V27, P94; Rao B, 2009, J DRUGS DERMATOL, V8, P371; Saffle JR, 2009, J TRAUMA, V67, P358, DOI 10.1097/TA.0b013e3181ae9b02; Serrano C, 2005, BURNS, V31, P275, DOI 10.1016/j.burns.2004.11.019; Shokrollahi K, 2007, EMERG MED J, V24, P753, DOI 10.1136/emj.2007.046730; Wallace DL, 2012, BURNS, V38, P465, DOI 10.1016/j.burns.2011.09.024; Wantanajittikul K, 2011, BIOMEDICAL ENG INT C, V2011; WHO, 2015, WHO PLAN BURN PREV C; Wurzer P, 2015, BURNS, V41, P977, DOI 10.1016/j.burns.2014.11.010	23	40	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0147253	10.1371/journal.pone.0147253	http://dx.doi.org/10.1371/journal.pone.0147253			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918631	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400003
J	Schildknecht, K; Tabelow, K; Dickhaus, T				Schildknecht, Konstantin; Tabelow, Karsten; Dickhaus, Thorsten			More Specific Signal Detection in Functional Magnetic Resonance Imaging by False Discovery Rate Control for Hierarchically Structured Systems of Hypotheses	PLOS ONE			English	Article							OPTIMAL REJECTION CURVE; FMRI DATA; TESTING PROCEDURES; DEPENDENCY; ACTIVATION	Signal detection in functional magnetic resonance imaging (fMRI) inherently involves the problem of testing a large number of hypotheses. A popular strategy to address this multiplicity is the control of the false discovery rate (FDR). In this work we consider the case where prior knowledge is available to partition the set of all hypotheses into disjoint subsets or families, e.g., by a-priori knowledge on the functionality of certain regions of interest. If the proportion of true null hypotheses differs between families, this structural information can be used to increase statistical power. We propose a two-stage multiple test procedure which first excludes those families from the analysis for which there is no strong evidence for containing true alternatives. We show control of the family-wise error rate at this first stage of testing. Then, at the second stage, we proceed to test the hypotheses within each non-excluded family and obtain asymptotic control of the FDR within each family at this second stage. Our main mathematical result is that this two-stage strategy implies asymptotic control of the FDR with respect to all hypotheses. In simulations we demonstrate the increased power of this new procedure in comparison with established procedures in situations with highly unbalanced families. Finally, we apply the proposed method to simulated and to real fMRI data.	[Schildknecht, Konstantin; Tabelow, Karsten] Weierstrass Inst Appl Anal & Stochast, Berlin, Germany; [Dickhaus, Thorsten] Univ Bremen, Inst Stat, D-28359 Bremen, Germany	Weierstrass Institute for Applied Analysis & Stochastics; Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen	Schildknecht, K (corresponding author), Weierstrass Inst Appl Anal & Stochast, Berlin, Germany.	Konstantin.Schildknecht@wias-berlin.de	Dickhaus, Thorsten/O-9120-2019; Tabelow, Karsten/AAI-4490-2021	Dickhaus, Thorsten/0000-0003-3084-3036; Tabelow, Karsten/0000-0003-1274-9951	Federal Ministry of Education and Research of Germany (BMBF) [031A191]; Weierstrass Institute for Applied Analysis and Stochastics; University of Bremen	Federal Ministry of Education and Research of Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); Weierstrass Institute for Applied Analysis and Stochastics; University of Bremen	This research is partly supported by the Federal Ministry of Education and Research of Germany (BMBF, http://www.bmbf.de) via grant No. 031A191 (EPILYZE project). Institutional funding by Weierstrass Institute for Applied Analysis and Stochastics and the University of Bremen is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler R., 2007, RANDOM FIELDS GEOMET; Auguie B, 2017, GRIDEXTRA MISCELLANE; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2007, J AM STAT ASSOC, V102, P1272, DOI 10.1198/016214507000000941; Benjamini Y, 2014, J R STAT SOC B, V76, P297, DOI 10.1111/rssb.12028; Benjamini Y, 2008, BIOMETRICS, V64, P1215, DOI 10.1111/j.1541-0420.2007.00984.x; Bogomolov M., 2011, THESIS TEL AVIV U; Brodmann K, 1909, VERGLEICHENDE LOKALI; Chen SN, 2009, HUM BRAIN MAPP, V30, P2304, DOI 10.1002/hbm.20669; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dickhaus T, 2014, SIMULTANEOUS STAT IN; Finner H, 2012, SCAND J STAT, V39, P382, DOI 10.1111/j.1467-9469.2012.00791.x; Finner H, 2009, ANN STAT, V37, P596, DOI 10.1214/07-AOS569; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Gontscharuk V, 2010, THESIS HEINRICH HEIN; Guo WG, 2008, J STAT PLAN INFER, V138, P3176, DOI 10.1016/j.jspi.2008.01.003; Heller R, 2006, NEUROIMAGE, V33, P599, DOI 10.1016/j.neuroimage.2006.04.233; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Huettel SA, 2014, FUNCTIONAL MAGNETIC RESONANCE IMAGING, THIRD EDITION, P1; Lazar NA, 2008, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-78191-4_1; Li YH, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-108; Logan BR, 2008, HUM BRAIN MAPP, V29, P1379, DOI 10.1002/hbm.20471; MARCUS R, 1976, BIOMETRIKA, V63, P655, DOI 10.1093/biomet/63.3.655; Peterson C, 2015, ARXIV150400701V1; Sarkar SK, 2002, ANN STAT, V30, P239, DOI 10.1214/aos/1015362192; Singh AK, 2010, NEUROIMAGE, V50, P40, DOI 10.1016/j.neuroimage.2009.12.030; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; TABELOW K, 2011, J STAT SOFTW, V44, P1, DOI DOI 10.18637/JSS.V044.I11; Tabelow K, 2015, FMRI ANAL FMRI EXPT; Tamhane AC, 1998, CAN J STAT, V26, P353, DOI 10.2307/3315516; Welvaert M, 2012, NEUROSIM FUNCTIONS G; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127; Worsley KJ, 2003, STAT METHODS MED RES, V12, P401, DOI 10.1191/0962280203sm340ra; Yekutieli D, 2008, J AM STAT ASSOC, V103, P309, DOI 10.1198/016214507000001373; Yekutieli D, 2006, STAT NEERL, V60, P414, DOI 10.1111/j.1467-9574.2006.00343.x; Zhao HB, 2014, J STAT PLAN INFER, V151, P90, DOI 10.1016/j.jspi.2014.04.004	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149016	10.1371/journal.pone.0149016	http://dx.doi.org/10.1371/journal.pone.0149016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914144	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700011
J	Haddow, JE; Craig, WY; Neveux, LM; Palomaki, GE; Lambert-Messerlian, G; Malone, FD; D'Alton, ME				Haddow, James E.; Craig, Wendy Y.; Neveux, Louis M.; Palomaki, Glenn E.; Lambert-Messerlian, Geralyn; Malone, Fergal D.; D'Alton, Mary E.		First Second Trimester Risk	Free Thyroxine During Early Pregnancy and Risk for Gestational Diabetes	PLOS ONE			English	Article							THYROID-HORMONE; CARBOHYDRATE-METABOLISM; WOMEN; MELLITUS; WEIGHT; HYPOTHYROIDISM; FREQUENCY; OBESITY; FAT	Several studies have now reported associations between gestational diabetes mellitus (GDM) and low free thyroxine (fT4) during the second and third trimesters, but not in the first trimester. The present study further examines relationships between low fT4, maternal weight, and GDM among women in the FaSTER (First and Second Trimester Evaluation of Risk) trial, in an effort to determine the extent to which thyroid hormones might contribute to causality. The FaSTER cohort includes 9351 singleton, euthyroid women; 272 of these women were subsequently classified as having GDM. Thyrotropin (TSH), fT4, and thyroid antibodies were measured at 11-14 weeks' gestation (first trimester) and 15-18.9 weeks' gestation (second trimester). An earlier report of this cohort documented an inverse relationship between fT4 in the second trimester and maternal weight. In the current analysis, women with GDM were significantly older (32 vs. 28 years) and weighed more (75 vs. 64.5 kg). Maternal weight and age (but not TSH) were significantly associated univariately with fT4 (dependent variable), in the order listed. Second trimester fT4 odds ratios (OR) for GDM were 2.06 [95% CI 1.37-3.09] (unadjusted); and 1.89 [95% CI 1.26-2.84] (adjusted). First trimester odds ratios were not significant: OR 1.45 [95% CI 0.97-2.16] (unadjusted) and 1.11 [95% CI 0.74-1.62] (adjusted). The second trimester fT4/GDM relationship thus appeared to strengthen as gestation progressed. In FaSTER, high maternal weight was associated with both low fT4 and a higher GDM rate in the second trimester. Peripheral deiodinase activity is known to increase with high caloric intake (represented by high weight). We speculate that weight-related low fT4 (the metabolically inactive prohormone) is a marker for deiodinase activity, serving as a substrate for conversion of fT4 to free triiodothyronine (fT3), the active hormone responsible for glucose-related metabolic activity.	[Haddow, James E.; Neveux, Louis M.; Palomaki, Glenn E.; Lambert-Messerlian, Geralyn] Brown Univ, Women & Infants Hosp, Div Med Screening & Special Testing, Dept Pathol & Lab Med, Providence, RI USA; [Haddow, James E.; Neveux, Louis M.; Palomaki, Glenn E.; Lambert-Messerlian, Geralyn] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Haddow, James E.; Neveux, Louis M.; Palomaki, Glenn E.] Savjani Inst Hlth Res, Windham, ME USA; [Craig, Wendy Y.] Maine Med Ctr, Res Inst, Scarborough, ME USA; [Malone, Fergal D.; D'Alton, Mary E.] Univ Coll Phys & Surg, Div Maternal Fetal Med, Dept Obstet & Gynecol, New York, NY USA; [Malone, Fergal D.] Royal Coll Surgeons Ireland, Dept Obstet & Gynecol, Dublin 2, Ireland	Brown University; Women & Infants Hospital Rhode Island; Brown University; Maine Medical Center; Royal College of Surgeons - Ireland	Haddow, JE (corresponding author), Brown Univ, Women & Infants Hosp, Div Med Screening & Special Testing, Dept Pathol & Lab Med, Providence, RI USA.; Haddow, JE (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.; Haddow, JE (corresponding author), Savjani Inst Hlth Res, Windham, ME USA.	jhaddow@ipmms.org		Messerlian, Geralyn/0000-0002-9440-3411	National Institute of Child Health and Human Development [RO1 HD 38652]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038652] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The FaSTER dataset was funded by Grant Number RO1 HD 38652 from the National Institute of Child Health and Human Development (https://www.nichd.nih.gov/Pages/index.aspx) MED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The present analysis of the FaSTER dataset was carried out by investigators in the Department of Pathology and Laboratory Medicine at Women & Infants Hospital and the Alpert Medical School at Brown University.	Agarwal MM, 2006, GYNECOL ENDOCRINOL, V22, P261, DOI 10.1080/09513590600630470; Agnihothri RV, 2014, THYROID, V24, P19, DOI 10.1089/thy.2013.0055; Ashoor G, 2010, FETAL DIAGN THER, V27, P156, DOI 10.1159/000313301; Bassols J, 2011, J CLIN ENDOCR METAB, V96, P3717, DOI 10.1210/jc.2011-1784; Bestwick JP, 2014, CLIN CHIM ACTA, V430, P33, DOI 10.1016/j.cca.2013.12.030; BRAY GA, 1976, LANCET, V1, P1206; Buchanan TA, 2007, DIABETES CARE, V30, pS105, DOI 10.2337/dc07-s201; CARLSON HE, 1977, J CLIN ENDOCR METAB, V45, P707, DOI 10.1210/jcem-45-4-707; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cleary-Goldman J, 2008, OBSTET GYNECOL, V112, P85, DOI 10.1097/AOG.0b013e3181788dd7; DANFORTH E, 1979, J CLIN INVEST, V64, P1336, DOI 10.1172/JCI109590; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Guzman-Gutierrez E, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00136; Haddow JE, 2015, THYROID, V25, P949, DOI 10.1089/thy.2015.0085; Haddow JE, 2014, J CLIN ENDOCR METAB, V99, P2038, DOI 10.1210/jc.2014-1053; Haddow JE, 2013, THYROID, V23, P225, DOI 10.1089/thy.2012.0440; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Knight B, 2012, EUR THYROID J S1, V1, P89; Lambert-Messerlian G, 2008, AM J OBSTET GYNECOL, V199, pe1; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Mannisto T, 2011, THYROID, V21, P291, DOI 10.1089/thy.2010.0337; Metzger BE, 2007, DIABETES CARE, V30, pS251, DOI 10.2337/dc07-s225; Oguz A, 2015, GYNECOL ENDOCRINOL, V31, P792, DOI 10.3109/09513590.2015.1054801; Olivieri A, 2000, EUR J ENDOCRINOL, V143, P741, DOI 10.1530/eje.0.1430741; Pelletier P, 2008, ENDOCRINOLOGY, V149, P6471, DOI 10.1210/en.2008-0718; Pisarev MA, 2010, CURR OPIN ENDOCRINOL, V17, P437, DOI 10.1097/MED.0b013e32833e0750; Potenza M, 2009, ENDOCR PRACT, V15, P254, DOI 10.4158/EP.15.3.254; Rauh-Hain JA, 2009, J MATERN-FETAL NEO M, V22, P293, DOI 10.1080/14767050802663194; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; SPAULDING SW, 1976, J CLIN ENDOCR METAB, V42, P197, DOI 10.1210/jcem-42-1-197; SUDA AK, 1978, J CLIN ENDOCR METAB, V47, P1311, DOI 10.1210/jcem-47-6-1311; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; VAGENAKIS AG, 1975, J CLIN ENDOCR METAB, V41, P191, DOI 10.1210/jcem-41-1-191; Velkoska NV, 2010, SEC BIOL SCI MASA, V31, P51	35	25	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149065	10.1371/journal.pone.0149065	http://dx.doi.org/10.1371/journal.pone.0149065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910563	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700020
J	Luef, EM; Breuer, T; Pika, S				Luef, Eva Maria; Breuer, Thomas; Pika, Simone			Food-Associated Calling in Gorillas (Gorilla g. gorilla) in the Wild	PLOS ONE			English	Article							WHITE-FACED CAPUCHINS; WESTERN GORILLAS; CLOSE CALLS; COMMUNICATION; VOCALIZATIONS; BEHAVIOR; MOUNTAIN; MONKEYS; DIET	Many nonhuman primates produce food-associated vocalizations upon encountering or ingesting particular food. Concerning the great apes, only food-associated vocalizations of chimpanzees (Pan troglodytes) and bonobos (Pan paniscus) have been studied in detail, providing evidence that these vocalizations can be produced flexibly in relation to a variety of factors, such as the quantity and quality of food and/or the type of audience. Only anecdotal evidence exists of eastern (Gorilla beringei) and western gorillas (Gorilla gorilla) producing food-associated vocalizations, termed SINGING or HUMMING. To enable a better understanding of the context in which these calls are produced, we investigated and compared the vocal behavior of two free-ranging groups of western lowland gorillas (Gorilla g. gorilla) at Mondika, Republic of Congo. Our results show that (a) food-associated call production occurs only during feeding and not in other contexts; (b) calling is not uniformly distributed across age and sex classes; (c) calls are only produced during feeding on specific foods; and (d) normally just one individual gives calls during group feeding sessions, however, certain food types elicit simultaneous calling of two or more individuals. Our findings provide new insight into the vocal abilities of gorillas but also carry larger implications for questions concerning vocal variability among the great apes. Food-associated calls of nonhuman primates have been shown to be flexible in terms of when they are used and who they are directed at, making them interesting vocalizations from the viewpoint of language evolution. Food-associated vocalizations in great apes can offer new opportunities to investigate the phylogenetic development of vocal communication within the primate lineage and can possibly contribute novel insights into the origins of human language.	[Luef, Eva Maria; Pika, Simone] Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Eberhard Gwinner Str, D-82319 Seewiesen, Germany; [Breuer, Thomas] Wildlife Conservat Soc, Global Conservat Program, 2300 Southern Blvd, Bronx, NY 10460 USA	Max Planck Society; Wildlife Conservation Society	Pika, S (corresponding author), Max Planck Inst Ornithol, Humboldt Res Grp Comparat Gestural Signalling, Eberhard Gwinner Str, D-82319 Seewiesen, Germany.	spika@orn.mpg.de	Luef, Eva/AAN-6158-2020	Pika, Simone/0000-0002-4398-2337	Alexander von Humboldt Stiftung (Germany) [Sofja-Kovalevskaja]; Fritz-Thyssen Stiftung (Germany); Fritz-Thyssen Foundation (Germany); Alexander-von-Humboldt-Foundation (Germany)	Alexander von Humboldt Stiftung (Germany)(Alexander von Humboldt Foundation); Fritz-Thyssen Stiftung (Germany); Fritz-Thyssen Foundation (Germany); Alexander-von-Humboldt-Foundation (Germany)(Alexander von Humboldt Foundation)	This work was supported by Alexander von Humboldt Stiftung (Germany), Simone Pika, Grant Number: Sofja-Kovalevskaja-Award 2010-2015, https://www.humboldt-foundation.de/web/start.html; and Fritz-Thyssen Stiftung (Germany), Eva Maria Luef, 2012, http://www.fritz-thyssen-stiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by a Fellowship of the Fritz-Thyssen Foundation (Germany) awarded to EML and a Sofja-Kovalevskaja-Award of the Alexander-von-Humboldt-Foundation (Germany) awarded to SP. We are grateful to the Ministere de la Recherche Scientifique of the Republic of Congo for authorizing us to work at Mondika. We thank the Wildlife Conservation Society and the Ministere de l'Economie Forestiere et Developpement Durable for logistic support of our work in Mondika. We are grateful to R. Mundry and R. Schmitz for their statistical advice and P. Kuchenbuch for reliability coding and stimulating discussions about gorilla vocalizations. We furthermore thank Katie Slocombe for helpful comments on our manuscript and J. Ahern-Seronde for her help with editing. We are particularly indebted to L. Hall for her help in the field and our Congolese assistant S. Pebou as well as the Ba'aka trackers of Central Africa who were of great help with daily tracking of the gorilla groups. The data underlying the findings of this study are available from the institutional server of the Max-Planck Institute for Ornithology, Seewiesen (Germany) following the link: http://edmond.mpdl.mpg.de/imeji/collection/s1PVeZMnznMV2m0.	Altmann D, 1991, PRACTICAL STAT MED R; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D, 2012, LME4 LINEAR MIXED EF; BENZ JJ, 1992, J COMP PSYCHOL, V106, P142, DOI 10.1037/0735-7036.106.2.142; Boinski S, 1996, ETHOLOGY, V102, P826; Breuer T, 2009, AM J PRIMATOL, V71, P106, DOI 10.1002/ajp.20628; Brosnan SF, 2002, EVOL COMMUN, V4, P211; Bugnyar T, 2001, ANIM BEHAV, V61, P949, DOI 10.1006/anbe.2000.1668; CAINE NG, 1995, ANIM BEHAV, V50, P53, DOI 10.1006/anbe.1995.0220; Clay Z, 2009, PLOS ONE, V6; Clay Z, 2012, ANIM BEHAV, V83, P323, DOI 10.1016/j.anbehav.2011.12.008; Clay Z, 2009, ANIM BEHAV, V77, P1387, DOI 10.1016/j.anbehav.2009.02.016; Doran DM, 2002, AM J PRIMATOL, V58, P91, DOI 10.1002/ajp.10053; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheehy DM, 2007, AM J PRIMATOL, V69, P1354, DOI 10.1002/ajp.20442; ELOWSON AM, 1991, ANIM BEHAV, V42, P931, DOI 10.1016/S0003-3472(05)80145-9; Evans CS, 1999, ANIM BEHAV, V58, P307, DOI 10.1006/anbe.1999.1143; Ey E, 2009, ETHOLOGY, V115, P493, DOI 10.1111/j.1439-0310.2009.01638.x; Fedurek P, 2013, AM J PRIMATOL, V75, P726, DOI 10.1002/ajp.22122; Fedurek P, 2011, HUM BIOL, V83, P153, DOI 10.3378/027.083.0202; FOSSEY D, 1972, ANIM BEHAV, V20, P36, DOI 10.1016/S0003-3472(72)80171-4; Fossey Diane, 1983, GORILLAS IN THE MIST; Gros-Louis J, 2006, INT J PRIMATOL, V27, P273, DOI 10.1007/s10764-005-9012-1; Gros-Louis J, 2004, J COMP PSYCHOL, V118, P396, DOI 10.1037/0735-7036.118.4.396; GROSLOUIS J, 2003, ANIM BEHAV, V140, P565; HARCOURT AH, 1993, BEHAVIOUR, V124, P89, DOI 10.1163/156853993X00524; HAUSER MD, 1987, FOLIA PRIMATOL, V48, P207, DOI 10.1159/000156298; HAUSER MD, 1993, BEHAV ECOL, V4, P194, DOI 10.1093/beheco/4.3.194; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; Kalan AK, 2015, ANIM BEHAV, V101, P1, DOI 10.1016/j.anbehav.2014.12.011; Manser MB, 2013, ANIM BEHAV, V86, P491, DOI 10.1016/j.anbehav.2013.07.006; Marshall AJ, 2009, AM J PHYS ANTHROPOL, V140, P603, DOI 10.1002/ajpa.21082; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; MORTON ES, 1977, AM NAT, V111, P855, DOI 10.1086/283219; NISHIHARA T, 1991, FOLIA PRIMATOL, V57, P48, DOI 10.1159/000156564; R Development Core Team, 2012, R LANG ENV STAT COMP; Rendall D, 2009, ANIM BEHAV, V78, P233, DOI 10.1016/j.anbehav.2009.06.007; Roush RS, 1999, ANIM BEHAV, V58, P1299, DOI 10.1006/anbe.1999.1262; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Schaefer SA., 2011, PERSONALITY SUBJECTI; Schaller G.E., 1963, MOUNTAIN GORILLA ECO; Schel AM, 2013, ANIM BEHAV, V86, P955, DOI 10.1016/j.anbehav.2013.08.013; Slocombe KE, 2005, CURR BIOL, V15, P1779, DOI 10.1016/j.cub.2005.08.068; WASER PM, 1986, AM J PRIMATOL, V10, P135, DOI 10.1002/ajp.1350100205; Watson SK, 2015, CURR BIOL, V25, P495, DOI 10.1016/j.cub.2014.12.032	46	10	10	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0144197	10.1371/journal.pone.0144197	http://dx.doi.org/10.1371/journal.pone.0144197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909518	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700001
J	Garea-Rodriguez, E; Eesmaa, A; Lindholm, P; Schlumbohm, C; Konig, J; Meller, B; Krieglstein, K; Helms, G; Saarma, M; Fuchs, E				Garea-Rodriguez, Enrique; Eesmaa, Ave; Lindholm, Paeivi; Schlumbohm, Christina; Koenig, Jessica; Meller, Birgit; Krieglstein, Kerstin; Helms, Gunther; Saarma, Mart; Fuchs, Eberhard			Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's Disease	PLOS ONE			English	Article							CONVECTION-ENHANCED DELIVERY; COMMON MARMOSET MONKEY; MIDBRAIN DOPAMINE NEURONS; HUMAN ALPHA-SYNUCLEIN; IN-VIVO; RAT MODEL; FUNCTIONAL RECOVERY; SUBSTANTIA-NIGRA; RHESUS-MONKEYS; KDEL RECEPTORS	Cerebral dopamine neurotrophic factor (CDNF) belongs to a newly discovered family of evolutionarily conserved neurotrophic factors. We demonstrate for the first time a therapeutic effect of CDNF in a unilateral 6-hydroxydopamine (6-OHDA) lesion model of Parkinson's disease in marmoset monkeys. Furthermore, we tested the impact of high chronic doses of human recombinant CDNF on unlesionedmonkeys and analyzed the amino acid sequence ofmarmoset CDNF. The severity of 6-OHDA lesions and treatment effects weremonitored in vivo using 123I-FP-CIT (DaTSCAN) SPECT. Quantitative analysis of 123I-FP-CIT SPECT showed a significant increase of dopamine transporter binding activity in lesioned animals treated with CDNF. Glial cell line-derived neurotrophic factor (GDNF), a well-characterized and potent neurotrophic factor for dopamine neurons, served as a control in a parallel comparison with CDNF. By contrast with CDNF, only single animals responded to the treatment with GDNF, but no statistical difference was observed in the GDNF group. However, increased numbers of tyrosine hydroxylase immunoreactive neurons, observed within the lesioned caudate nucleus of GDNF-treated animals, indicate a strong bioactive potential of GDNF.	[Garea-Rodriguez, Enrique; Schlumbohm, Christina; Koenig, Jessica; Fuchs, Eberhard] German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany; [Garea-Rodriguez, Enrique] Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Garea-Rodriguez, Enrique; Fuchs, Eberhard] Univ Gottingen, CMPB, D-37073 Gottingen, Germany; [Eesmaa, Ave; Lindholm, Paeivi; Saarma, Mart] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Schlumbohm, Christina; Koenig, Jessica] Encepharm, Gottingen, Germany; [Meller, Birgit] Univ Gottingen, Dept Nucl Med, Univ Med Ctr, Gottingen, Germany; [Krieglstein, Kerstin] Univ Freiburg, Dept Mol Embryol, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany; [Helms, Gunther] Univ Gottingen, Dept Cognit Neurol, Univ Med Ctr, D-37073 Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Freiburg; University of Gottingen; University of Helsinki; University of Gottingen; University of Freiburg; University of Gottingen	Garea-Rodriguez, E (corresponding author), German Primate Ctr, Clin Neurobiol Lab, Gottingen, Germany.; Garea-Rodriguez, E (corresponding author), Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, Hugstetter Str 55, D-79106 Freiburg, Germany.; Garea-Rodriguez, E (corresponding author), Univ Gottingen, CMPB, D-37073 Gottingen, Germany.	enrique.garea.rodriguez@anat.uni-freiburg.de	Helms, Gunther/A-9114-2010	Helms, Gunther/0000-0002-1371-5123; Eesmaa, Ave/0000-0002-3397-3330; Pulkkila, Paivi/0000-0003-3022-5035	EU ERA-Net NEURON (PARKCDNF); DFG Research Center Molecular Physiology of the Brain (CMPB); S. Juselius Foundation	EU ERA-Net NEURON (PARKCDNF); DFG Research Center Molecular Physiology of the Brain (CMPB)(German Research Foundation (DFG)); S. Juselius Foundation	EGR was funded by EU ERA-Net NEURON (PARKCDNF) (http://www.neuron-eranet.eu/). The study was partially supported by the DFG Research Center Molecular Physiology of the Brain (CMPB) (http://www.cmpb.uni-goettingen.de/) and by a S. Juselius Foundation (http://www.sigridjuselius.fi/foundation) grant to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airavaara M, 2012, CELL TRANSPLANT, V21, P1213, DOI 10.3727/096368911X600948; Alvarez-Fischer D, 2007, NEUROIMAGE, V38, P5, DOI 10.1016/j.neuroimage.2007.05.056; Andringa G, 2005, NEUROIMAGE, V26, P1150, DOI 10.1016/j.neuroimage.2005.03.034; Apostolou A, 2008, EXP CELL RES, V314, P2454, DOI 10.1016/j.yexcr.2008.05.001; Back S, 2013, BRAIN BEHAV, V3, P75, DOI 10.1002/brb3.117; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Blanchard V, 1996, BRAIN RES, V709, P319, DOI 10.1016/0006-8993(95)01391-1; Booij J, 2002, EUR J NUCL MED MOL I, V29, P1221, DOI 10.1007/s00259-002-0845-y; DayLollini PA, 1997, EXP NEUROL, V145, P24, DOI 10.1006/exnr.1997.6448; de la Fuente-Fernandez R, 2012, NEUROLOGY, V78, P696, DOI 10.1212/WNL.0b013e318248e520; Decressac M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004676; Decressac M, 2011, BRAIN, V134, P2302, DOI 10.1093/brain/awr149; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Eberling JL, 2009, HUM GENE THER, V20, P511, DOI 10.1089/hum.2008.201; Eslamboli A, 2003, EXP NEUROL, V184, P536, DOI 10.1016/j.expneurol.2003.08.007; Eslamboli A, 2005, REV NEUROSCIENCE, V16, P303; Eslamboli A, 2005, J NEUROSCI, V25, P769, DOI 10.1523/JNEUROSCI.4421-04.2005; Eslamboli A, 2007, BRAIN, V130, P799, DOI 10.1093/brain/awl382; Franke SK, 2016, NEUROSCIENCE, V312, P247, DOI 10.1016/j.neuroscience.2015.09.065; Garea-Rodriguez E, 2012, J NEUROSCI METH, V210, P195, DOI 10.1016/j.jneumeth.2012.07.009; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Gill SS, 2003, NAT MED, V9, P589, DOI 10.1038/nm850; Gimenez F, 2011, NEUROIMAGE, V54, pS189, DOI 10.1016/j.neuroimage.2010.01.023; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; Hamilton JF, 2001, EXP NEUROL, V168, P155, DOI 10.1006/exnr.2000.7571; Hellman M, 2011, J BIOL CHEM, V286, P2675, DOI 10.1074/jbc.M110.146738; Helms G, 2013, J NEUROSCI METH, V215, P121, DOI 10.1016/j.jneumeth.2013.02.011; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Henderson MJ, 2013, J BIOL CHEM, V288, P4209, DOI 10.1074/jbc.M112.400648; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; Hovland DN, 2007, TOXICOL PATHOL, V35, P1013, DOI 10.1177/01926230701481899; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; KEARNS CM, 1995, BRAIN RES, V672, P104, DOI 10.1016/0006-8993(94)01366-P; Kells AP, 2010, J NEUROSCI, V30, P9567, DOI 10.1523/JNEUROSCI.0942-10.2010; Kirik D, 2004, NAT NEUROSCI, V7, P105, DOI 10.1038/nn1175; Kirik D, 2000, J NEUROSCI, V20, P4686, DOI 10.1523/JNEUROSCI.20-12-04686.2000; Kirik D, 2003, P NATL ACAD SCI USA, V100, P2884, DOI 10.1073/pnas.0536383100; Kordower JH, 1999, ANN NEUROL, V46, P419, DOI 10.1002/1531-8249(199909)46:3<419::AID-ANA21>3.0.CO;2-Q; Kordower JH, 2000, SCIENCE, V290, P767, DOI 10.1126/science.290.5492.767; Lang AE, 2006, ANN NEUROL, V59, P459, DOI 10.1002/ana.20737; Latge C, 2015, J BIOL CHEM, V290, P20527, DOI 10.1074/jbc.M115.662254; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Lindahl M, 2014, CELL REP, V7, P366, DOI 10.1016/j.celrep.2014.03.023; Lindholm P, 2010, DEV NEUROBIOL, V70, P360, DOI 10.1002/dneu.20760; Lindholm P, 2007, NATURE, V448, P73, DOI 10.1038/nature05957; Lindstrom R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073928; Lo Bianco C, 2004, NEUROBIOL DIS, V17, P283, DOI 10.1016/j.nbd.2004.06.008; Mizobuchi N, 2007, CELL STRUCT FUNCT, V32, P41, DOI 10.1247/csf.07001; Nutt JG, 2003, NEUROLOGY, V60, P69, DOI 10.1212/WNL.60.1.69; Olanow CW, 2014, NAT REV NEUROL, V10, P186, DOI 10.1038/nrneurol.2014.45; ONN SP, 1986, BRAIN RES, V376, P8, DOI 10.1016/0006-8993(86)90894-2; Palfi S, 2002, J NEUROSCI, V22, P4942, DOI 10.1523/JNEUROSCI.22-12-04942.2002; Palgi M, 2009, P NATL ACAD SCI USA, V106, P2429, DOI 10.1073/pnas.0810996106; Parkash V, 2009, PROTEIN ENG DES SEL, V22, P233, DOI 10.1093/protein/gzn080; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Porritt MJ, 2000, LANCET, V356, P44, DOI 10.1016/S0140-6736(00)02437-5; Ramaswamy S, 2009, PROG BRAIN RES, V175, P201, DOI 10.1016/S0079-6123(09)17514-3; Raykhel I, 2007, J CELL BIOL, V179, P1193, DOI 10.1083/jcb.200705180; Ren XM, 2013, EXP NEUROL, V248, P148, DOI 10.1016/j.expneurol.2013.06.002; Richardson RM, 2011, MOL THER, V19, P1048, DOI 10.1038/mt.2011.11; Saji H, 2003, ANAL SCI, V19, P67, DOI 10.2116/analsci.19.67; Schober A, 2004, CELL TISSUE RES, V318, P215, DOI 10.1007/s00441-004-0938-y; Seibyl JP, 1998, J NUCL MED, V39, P1500; Sherer TB, 2006, MOVEMENT DISORD, V21, P136, DOI 10.1002/mds.20861; Slevin JT, 2005, J NEUROSURG, V102, P216, DOI 10.3171/jns.2005.102.2.0216; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Stephan H, 1980, THE BRAIN OF THE COM; Sun ZP, 2011, J NEUROCHEM, V117, P121, DOI 10.1111/j.1471-4159.2011.07179.x; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Voutilainen MH, 2011, EXP NEUROL, V228, P99, DOI 10.1016/j.expneurol.2010.12.013; Voutilainen MH, 2009, J NEUROSCI, V29, P9651, DOI 10.1523/JNEUROSCI.0833-09.2009; Yin D, 2010, J NEUROSCI METH, V187, P46, DOI 10.1016/j.jneumeth.2009.12.008; Yuasa S, 2009, STEREOTAXIC ATLAS MA; Zhang ZM, 1997, J PHARMACOL EXP THER, V282, P1396	76	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149776	10.1371/journal.pone.0149776	http://dx.doi.org/10.1371/journal.pone.0149776			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901822	Green Published, gold			2022-12-27	WOS:000371276100150
J	Albert, J				Albert, Jaroslav			A Hybrid of the Chemical Master Equation and the Gillespie Algorithm for Efficient Stochastic Simulations of Sub-Networks	PLOS ONE			English	Article							TAU	Modeling stochastic behavior of chemical reaction networks is an important endeavor in many aspects of chemistry and systems biology. The chemical master equation (CME) and the Gillespie algorithm (GA) are the two most fundamental approaches to such modeling; however, each of them has its own limitations: the GA may require long computing times, while the CME may demand unrealistic memory storage capacity. We propose a method that combines the CME and the GA that allows one to simulate stochastically a part of a reaction network. First, a reaction network is divided into two parts. The first part is simulated via the GA, while the solution of the CME for the second part is fed into the GA in order to update its propensities. The advantage of this method is that it avoids the need to solve the CME or stochastically simulate the entire network, which makes it highly efficient. One of its drawbacks, however, is that most of the information about the second part of the network is lost in the process. Therefore, this method is most useful when only partial information about a reaction network is needed. We tested this method against the GA on two systems of interest in biology - the gene switch and the Griffith model of a genetic oscillator -and have shown it to be highly accurate. Comparing this method to four different stochastic algorithms revealed it to be at least an order of magnitude faster than the fastest among them.	[Albert, Jaroslav] Vrije Univ Brussel, Appl Phys Res Grp, Brussels, Belgium	Vrije Universiteit Brussel	Albert, J (corresponding author), Vrije Univ Brussel, Appl Phys Res Grp, Brussels, Belgium.	jalbert@ulb.ac.be			Interuniversity Attraction Poles program of the Belgian Science Policy Office [IAP P7-35]; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research program "Applied Physics and Systems Biology"	Interuniversity Attraction Poles program of the Belgian Science Policy Office; Onderzoeksraad of the Vrije Universiteit Brussel through the strategic research program "Applied Physics and Systems Biology"	This work was supported by The Interuniversity Attraction Poles program of the Belgian Science Policy Office, under grant IAP P7-35 (www.belspo.be) and The Onderzoeksraad of the Vrije Universiteit Brussel (www.vub.ac.be) through the strategic research program "Applied Physics and Systems Biology".	Albert J, 2016, J MATH BIOL, V72, P157, DOI 10.1007/s00285-015-0877-0; Albert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047256; Barzel B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031117; Burrage K, 2004, PROG BIOPHYS MOL BIO, V85, P217, DOI 10.1016/j.pbiomolbio.2004.01.014; Cance E., 2005, ESAIM P, V14, P1, DOI DOI 10.1051/PROC:2005001; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; Cao Y, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1992473; Cao Y, 2004, J CHEM PHYS, V121, P4059, DOI 10.1063/1.1778376; DOI M, 1976, J PHYS A-MATH GEN, V9, P1479, DOI 10.1088/0305-4470/9/9/009; DOOB JL, 1945, T AM MATH SOC, V58, P455, DOI 10.2307/1990339; Gibson MA, 2000, J PHYS CHEM A, V104, P1876, DOI 10.1021/jp993732q; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GRIFFITH JS, 1968, J THEOR BIOL, V20, P202, DOI 10.1016/0022-5193(68)90189-6; Grima R, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3702848; Hellander A, 2007, J COMPUT PHYS, V227, P100, DOI 10.1016/j.jcp.2007.07.020; Jahnke T, 2011, MULTISCALE MODEL SIM, V9, P1646, DOI 10.1137/110821500; Jahnke T, 2010, BIT, V50, P797, DOI 10.1007/s10543-010-0286-0; Lee CH, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3103264; Macnamara S, 2008, MULTISCALE MODEL SIM, V6, P1146, DOI 10.1137/060678154; Mugler A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041921; Munsky B, 2008, IET SYST BIOL, V2, P323, DOI 10.1049/iet-syb:20070082; Munsky B, 2007, J COMPUT PHYS, V226, P818, DOI 10.1016/j.jcp.2007.05.016; PELITI L, 1986, J PHYS A-MATH GEN, V19, pL365, DOI 10.1088/0305-4470/19/6/012; Ramsey Stephen, 2005, Journal of Bioinformatics and Computational Biology, V3, P415, DOI 10.1142/S0219720005001132; Rathinam M, 2007, J COMPUT PHYS, V224, P897, DOI 10.1016/j.jcp.2006.10.034; Salis H, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1835951; Smith S, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4936394; Walczak Aleksandra M, 2012, Methods Mol Biol, V880, P273, DOI 10.1007/978-1-61779-833-7_13; Wolf V, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-42; Zeldovich Ya B, 1978, SOV PHYS JETP, V47, P829	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149909	10.1371/journal.pone.0149909	http://dx.doi.org/10.1371/journal.pone.0149909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930199	Green Published, gold			2022-12-27	WOS:000371434500071
J	Davis, SW; Keisler, JL				Davis, Shannon W.; Keisler, Jessica L.			Embryonic Development of the Deer Mouse, Peromyscus maniculatus	PLOS ONE			English	Article							COLOR PATTERN; EVOLUTION; MICE; MUTATION; GENETICS; GENES	Deer mice, or Peromyscus maniculatus, are an emerging model system for use in biomedicine. P. maniculatus are similar in appearance to laboratory mice, Mus musculus, but are more closely related to hamsters than to Mus. The laboratory strains of Peromyscus have captured a high degree of the genetic variability observed in wild populations, and are more similar to the genetic variability observed in humans than are laboratory strains of Mus. The Peromyscus Genetic Stock Center at the University of South Carolina maintains several lines of Peromyscus harboring mutations that result in developmental defects. We present here a description of P. maniculatus development from gastrulation to late gestation to serve as a guide for researchers interested in pursuing developmental questions in Peromyscus.	[Davis, Shannon W.; Keisler, Jessica L.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Davis, SW (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	swdavis@mailbox.sc.edu			University of South Carolina	University of South Carolina	This work was supported by University of South Carolina startup to SWD.	ANDERSON RS, 1979, J HERED, V70, P27, DOI 10.1093/oxfordjournals.jhered.a109183; Bedford NL, 2015, ELIFE, V4, DOI 10.7554/eLife.06813; COWLING K, 1994, J HERED, V85, P48; Feldman HW, 1936, J HERED, V27, P301, DOI 10.1093/oxfordjournals.jhered.a104232; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Joyner Charlotte P., 1998, ILAR J, V39, P322; Kenney-Hunt J, 2014, MAMM GENOME, V25, P160, DOI 10.1007/s00335-014-9500-8; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Manceau M, 2011, SCIENCE, V331, P1062, DOI 10.1126/science.1200684; Ramsdell CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-65; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Theiler Karl, 1989, pi; Vrana PB, 2014, WIRES DEV BIOL, V3, P211, DOI 10.1002/wdev.132; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847	16	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150598	10.1371/journal.pone.0150598	http://dx.doi.org/10.1371/journal.pone.0150598			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930071	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500175
J	Cortes, KC; Zagordi, O; Jablonska, J; Pawelczyk, A; Kubisa, N; Perlejewski, K; Bukowska-Osko, I; Ploski, R; Radkowski, M; Laskus, T				Cortes, Kamila Caraballo; Zagordi, Osvaldo; Jablonska, Joanna; Pawelczyk, Agnieszka; Kubisa, Natalia; Perlejewski, Karol; Bukowska-Osko, Iwona; Ploski, Rafal; Radkowski, Marek; Laskus, Tomasz			Spouse-to-Spouse Transmission and Evolution of Hypervariable Region 1 and 5 ' Untranslated Region of Hepatitis C Virus Analyzed by Next-Generation Sequencing	PLOS ONE			English	Article							INTRAFAMILIAL TRANSMISSION; SEXUAL TRANSMISSION; NONSEXUAL TRANSMISSION; RISK-FACTORS; HCV; INFECTION; PROTEIN; PROGRESSION; ANTIBODIES; DIVERSITY	Hepatitis C virus (HCV) transmission between spouses remains poorly characterized, largely due to the limited availability of samples from the early stage of infection, as well as methodological constraints. A fifty-eight year-old male developed acute hepatitis C infection and his 53-year old spouse has been HCV-positive for over 10 years. Serum samples were collected from both at the time of acute hepatitis C diagnosis in male (baseline) and then at 9 and 13 months. Hypervariable region 1 (HVR1) and 5' untranslated region (5' UTR) sequences were amplified and subjected to next generation sequencing (NGS) using a pyrosequencing platform. Genetic variants were inferred by Shorah reconstruction method and compared by phylogenetic and sequence diversity analysis. As the sequencing error of the procedure was previously determined to be <= 1.5%, the analysis was conducted with and without the 1.5% cut-off with regard to the frequency of variants. No identical HVR1 variants were identified in spouses at baseline and follow-up samples regardless whether the cut-off was applied or not. However, there was high similarity (98.3%) between a minor baseline donor variant (1.7% frequency) and the most abundant baseline recipient variant (62.5% frequency). Furthermore, donor and recipient strains clustered together when compared to 10 control subjects from the same area and infected with the same HCV subtype. There was an increase in HVR1 complexity (number of genetic variants) over time in both spouses. In contrast, the 5' UTR region was stable and of low complexity throughout the study. In conclusion, intrafamilial HCV transmission may be established by a very minor variant and investigation of this phenomenon requires high-sensitivity assays, such as NGS.	[Cortes, Kamila Caraballo; Pawelczyk, Agnieszka; Kubisa, Natalia; Perlejewski, Karol; Bukowska-Osko, Iwona; Radkowski, Marek; Laskus, Tomasz] Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland; [Zagordi, Osvaldo] Univ Zurich, Inst Med Virol, Zurich, Switzerland; [Jablonska, Joanna] Med Univ Warsaw, Clin Infect Trop Dis & Hepatol, Warsaw, Poland; [Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland	Medical University of Warsaw; University of Zurich; Medical University of Warsaw; Medical University of Warsaw	Cortes, KC (corresponding author), Med Univ Warsaw, Dept Immunopathol Infect & Parasit Dis, Warsaw, Poland.	kcaraballo@wum.edu.pl	Pawełczyk, Agnieszka/M-4934-2018; Jabłońska, Joanna/V-5997-2018; Zagordi, Osvaldo/H-2879-2019; Bukowska-Ośko, Iwona/V-3859-2018; Cortés, Kamila Caraballo/ABB-9291-2020; Perlejewski, Karol/V-3854-2018; Caraballo Cortes, Kamila/W-2011-2018; Radkowski, Marek/V-3860-2018	Pawełczyk, Agnieszka/0000-0001-9336-8258; Jabłońska, Joanna/0000-0003-0210-0091; Zagordi, Osvaldo/0000-0002-9082-8607; Bukowska-Ośko, Iwona/0000-0002-0216-7184; Cortés, Kamila Caraballo/0000-0002-7924-7852; Perlejewski, Karol/0000-0002-3782-6442; Caraballo Cortes, Kamila/0000-0002-7924-7852; Radkowski, Marek/0000-0003-1808-679X; Ploski, Rafal/0000-0001-6286-5526	Medical University of Warsaw [1M24/PM11/14]	Medical University of Warsaw	This work was supported by grant 1M24/PM11/14 from the Medical University of Warsaw.	Akhtar S, 2002, J VIRAL HEPATITIS, V9, P309, DOI 10.1046/j.1365-2893.2002.00350.x; Barzon L, 2013, J CLIN VIROL, V58, P346, DOI 10.1016/j.jcv.2013.03.003; Barzona L, 2011, J CLIN VIROL, V52, P93, DOI 10.1016/j.jcv.2011.07.006; Bhat P, 2015, NUCLEIC ACIDS RES, V43, P2888, DOI 10.1093/nar/gkv110; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Burke KP, 2010, IMMUNOL RES, V47, P216, DOI 10.1007/s12026-009-8152-3; Callens N, 2005, J VIROL, V79, P15331, DOI 10.1128/JVI.79.24.15331-15341.2005; Cavalheiro ND, 2010, BRAZ J INFECT DIS, V14, P427, DOI 10.1590/S1413-86702010000500001; CHANG TT, 1994, J MED VIROL, V42, P91, DOI 10.1002/jmv.1890420117; Cochrane A, 2002, J INFECT DIS, V186, P1212, DOI 10.1086/344314; Cortes KC, 2012, ADV MED SCI-POLAND, V57, P370, DOI 10.2478/v10039-012-0024-8; Cortes KC, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-389; Cortes KC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/626083; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cruz-Rivera M, 2013, J CLIN MICROBIOL, V51, P629, DOI 10.1128/JCM.03042-12; D'Arienzo V, 2013, J VIROL, V87, P13609, DOI 10.1128/JVI.02119-13; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Gotz HM, 2005, AIDS, V19, P969, DOI 10.1097/01.aids.0000171412.61360.f8; Hajiani E, 2006, WORLD J GASTROENTERO, V12, P7025, DOI 10.3748/wjg.v12.i43.7025; Hashem Y, 2013, NATURE, V503, P539, DOI 10.1038/nature12658; Herring BL, 2005, J VIROL, V79, P4340, DOI 10.1128/JVI.79.7.4340-4346.2005; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Indolfi G, 2008, J MED VIROL, V80, P1907, DOI 10.1002/jmv.21316; Indolfi G, 2013, J MED VIROL, V85, P608, DOI 10.1002/jmv.23522; Jimenez AP, 2010, GUT, V59, P1554, DOI 10.1136/gut.2009.194266; Kamal SM, 2004, J VIROL, V78, P12252, DOI 10.1128/JVI.78.22.12252-12258.2004; KATO N, 1994, JPN J CANCER RES, V85, P987, DOI 10.1111/j.1349-7006.1994.tb02894.x; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kim YS, 1998, INT J EPIDEMIOL, V27, P525, DOI 10.1093/ije/27.3.525; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kouyos RD, 2014, INT J EPIDEMIOL, V43, P887, DOI 10.1093/ije/dyt276; La Torre G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-237; Laskus T, 2000, J VIROL, V74, P1014, DOI 10.1128/JVI.74.2.1014-1017.2000; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Minola E, 2006, EUR J EPIDEMIOL, V21, P293, DOI 10.1007/s10654-006-0016-8; Mohamed MK, 2005, HEPATOLOGY, V42, P683, DOI 10.1002/hep.20811; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakamura I, 2011, HEPATOL RES, V41, P838, DOI 10.1111/j.1872-034X.2011.00843.x; NAKASHIMA K, 1995, JAMA-J AM MED ASSOC, V274, P1459, DOI 10.1001/jama.274.18.1459; Nguyen O, 2010, J CLIN VIROL, V49, P65, DOI 10.1016/j.jcv.2010.06.008; Noguchi S, 1997, SCAND J INFECT DIS, V29, P23, DOI 10.3109/00365549709008659; Nowicki MJ, 2005, J INFECT DIS, V192, P1557, DOI 10.1086/491742; Orlando R, 2007, INFECTION, V35, P465, DOI 10.1007/s15010-007-6188-7; Pawlotsky JM, 1999, J VIROL, V73, P6490, DOI 10.1128/JVI.73.8.6490-6499.1999; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Plancoulaine S, 2008, GUT, V57, P1268, DOI 10.1136/gut.2007.140681; Polyak SJ, 1998, J VIROL, V72, P4288, DOI 10.1128/JVI.72.5.4288-4296.1998; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; Prosperi MCF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013619; RICE PS, 1993, LANCET, V342, P1052, DOI 10.1016/0140-6736(93)92908-C; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sheridan I, 2004, J VIROL, V78, P3447, DOI 10.1128/JVI.78.7.3447-3454.2004; SKIDMORE SJ, 1994, J MED VIROL, V42, P247, DOI 10.1002/jmv.1890420308; Solmone M, 2009, J VIROL, V83, P1718, DOI 10.1128/JVI.02011-08; Tahan V, 2005, AM J GASTROENTEROL, V100, P821, DOI 10.1111/j.1572-0241.2005.40879.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797; Tohme RA, 2010, HEPATOLOGY, V52, P1497, DOI 10.1002/hep.23808; Vandelli C, 2004, AM J GASTROENTEROL, V99, P855, DOI 10.1111/j.1572-0241.2004.04150.x; Verbinnen T, 2010, J VIROL, V84, P11124, DOI 10.1128/JVI.01217-10; de Carvalho-Mello IMVG, 2010, J GEN VIROL, V91, P691, DOI 10.1099/vir.0.015594-0; von Wagner M, 2003, J VIRAL HEPATITIS, V10, P413; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Wang GP, 2010, J VIROL, V84, P6218, DOI 10.1128/JVI.02271-09; Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119	70	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150311	10.1371/journal.pone.0150311	http://dx.doi.org/10.1371/journal.pone.0150311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918636	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400123
J	Ferrando, PM; Balmativola, D; Cambieri, I; Scalzo, MS; Bergallo, M; Annaratone, L; Casarin, S; Fumagalli, M; Stella, M; Sapino, A; Castagnoli, C				Ferrando, Pietro Maria; Balmativola, Davide; Cambieri, Irene; Scalzo, Maria Stella; Bergallo, Massimiliano; Annaratone, Laura; Casarin, Stefania; Fumagalli, Mara; Stella, Maurizio; Sapino, Anna; Castagnoli, Carlotta			Glycerolized Reticular Dermis as a New Human Acellular Dermal Matrix: An Exploratory Study	PLOS ONE			English	Article							COLLAGEN/ELASTIN-MEMBRANE; EXTRACELLULAR-MATRIX; RECONSTRUCTION; SKIN; EXPERIENCE; SCAFFOLDS; ALLODERM; TISSUES	Human Acellular Dermal Matrices (HADM) are employed in various reconstructive surgery procedures as scaffolds for autologous tissue regeneration. The aim of this project was to develop a new type of HADM for clinical use, composed of glycerolized reticular dermis decellularized through incubation and tilting in Dulbecco's Modified Eagle's Medium (DMEM). This manufacturing method was compared with a decellularization procedure already described in the literature, based on the use of sodium hydroxide (NaOH), on samples from 28 donors. Cell viability was assessed using an MTT assay and microbiological monitoring was performed on all samples processed after each step. Two surgeons evaluated the biomechanical characteristics of grafts of increasing thickness. The effects of the different decellularization protocols were assessed by means of histological examination and immunohistochemistry, and residual DNA after decellularization was quantified using a real-time TaqMan MGB probe. Finally, we compared the results of DMEM based decellularization protocol on reticular dermis derived samples with the results of the same protocol applied on papillary dermis derived grafts. Our experimental results indicated that the use of glycerolized reticular dermis after 5 weeks of treatment with DMEM results in an HADM with good handling and biocompatibility properties.	[Ferrando, Pietro Maria] Citta Salute & Sci, Dept Gen & Specialized Surg, Div Breast Surg, Turin, Italy; [Balmativola, Davide; Scalzo, Maria Stella; Annaratone, Laura; Sapino, Anna] Univ Turin, Dept Med Sci, Div Pathol, Turin, Italy; [Cambieri, Irene; Casarin, Stefania; Fumagalli, Mara; Stella, Maurizio; Castagnoli, Carlotta] Citta Salute & Sci, Dept Gen & Specialized Surg, Skin Bank, Turin, Italy; [Bergallo, Massimiliano] Univ Turin, Dept Publ Hlth & Pediat, Cytoimmunodiagnost Lab, Turin, Italy; [Sapino, Anna] Fdn Piemonte Oncol FPO, Candiolo Canc Inst IRCCs, Candiolo, Italy	A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; IRCCS Fondazione del Piemonte per l'Oncologia	Ferrando, PM (corresponding author), Citta Salute & Sci, Dept Gen & Specialized Surg, Div Breast Surg, Turin, Italy.	pmferrando@hotmail.it	Sapino, Anna/AGY-9901-2022; Annaratone, Laura/J-9261-2016; Sapino, Anna/J-4113-2018; Balmativola, Davide/AAB-7662-2019; Bergallo, Massimiliano/AHD-2214-2022	Sapino, Anna/0000-0003-3542-9571; Annaratone, Laura/0000-0001-5750-1445; Sapino, Anna/0000-0003-3542-9571; Balmativola, Davide/0000-0002-3583-1846; Bergallo, Massimiliano/0000-0002-9291-1332	Compagnia di San Paolo, Turin, Italy; Fondazione CRT, Turin, Italy; Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia; Ministry of Health, Ricerca Sanitaria Finalizzata [RF-2010-2310674]; LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch)	Compagnia di San Paolo, Turin, Italy(Compagnia di San Paolo); Fondazione CRT, Turin, Italy; Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia; Ministry of Health, Ricerca Sanitaria Finalizzata; LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch)	CC was supported by funds from the Compagnia di San Paolo, Turin, Italy, from Fondazione CRT, Turin, Italy, and from Piedmont Foundation of Studies and Research on Burns Simone TeichAlasia. AS was supported by the Ministry of Health, Ricerca Sanitaria Finalizzata (RF-2010-2310674) and by LILT - Lega Italiana per Lotta contro iTumori, local section of Turin (HealthResearch2014). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Bernabei P, 1999, BURNS, V25, P43, DOI 10.1016/S0305-4179(98)00128-4; Bondioli E, 2014, J TISSUE ENG REGEN M, V8, P325, DOI 10.1002/term.1530; Brown B, 2006, TISSUE ENG, V12, P519, DOI 10.1089/ten.2006.12.519; CASTAGNOLI C, 1990, CLIN EXP IMMUNOL, V82, P350; Castagnoli C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/840363; Derwin KA, 2006, J BONE JOINT SURG AM, V88A, P2665, DOI 10.2106/JBJS.E.01307; Gilbert TW, 2009, J SURG RES, V152, P135, DOI 10.1016/j.jss.2008.02.013; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972; Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4; KREUZ FP, 1951, J BONE JOINT SURG AM, V33-A, P863, DOI 10.2106/00004623-195133040-00005; LAMKE L-O, 1971, Scandinavian Journal of Plastic and Reconstructive Surgery, V5, P82; Lin HJ, 2009, AM J SURG, V197, P599, DOI 10.1016/j.amjsurg.2008.12.022; LIVESEY SA, 1995, TRANSPLANTATION, V60, P1, DOI 10.1097/00007890-199507150-00001; Livesey SA., 2006, Pub, Patent No. [US 2006/0210960, 20060210960]; Mackie David, 2002, Burns, V28 Suppl 1, pS40; MELLONIG J T, 1991, Dental Clinics of North America, V35, P505; Moore MA, 2015, CELL TISSUE BANK, V16, P249, DOI 10.1007/s10561-014-9467-4; Nicklas JA, 2003, ANAL BIOANAL CHEM, V376, P1160, DOI 10.1007/s00216-003-1924-z; Richters CD, 2008, CELL TISSUE BANK, V9, P309, DOI 10.1007/s10561-008-9073-4; Richters CD, 1996, BURNS, V22, P113, DOI 10.1016/0305-4179(95)00103-4; Salzberg CA, 2011, PLAST RECONSTR SURG, V127, P514, DOI 10.1097/PRS.0b013e318200a961; SEDMAK DD, 1991, ARCH PATHOL LAB MED, V115, P260; Sun WQ, 2013, J TISSUE ENG, V4, DOI 10.1177/2041731413505305; Trabuco EC, 2007, INT UROGYNECOL J, V18, P555, DOI 10.1007/s00192-006-0288-2; vanBaare J, 1944, BURNS, V20, pS77; WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I; YUKNA RA, 1977, J PERIODONTAL RES, V12, P197, DOI 10.1111/j.1600-0765.1977.tb00122.x	28	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149124	10.1371/journal.pone.0149124	http://dx.doi.org/10.1371/journal.pone.0149124			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918526	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400013
J	Liu, JH; Liu, M; Zheng, B; Yao, ZP; Xia, J				Liu, Jiahui; Liu, Miao; Zheng, Bo; Yao, Zhongping; Xia, Jiang			Affinity Enhancement by Ligand Clustering Effect Inspired by Peptide Dendrimers-Shank PDZ Proteins Interactions	PLOS ONE			English	Article							MASS-SPECTROMETRY; POSTSYNAPTIC DENSITY; STRUCTURAL BASIS; COMPLEXES; DOMAINS; ORGANIZATION; BINDING	High-affinity binders are desirable tools to probe the function that specific protein-protein interactions play in cell. In the process of seeking a general strategy to design high-affinity binders, we found a clue from the beta PIX (p21-activated kinase interacting exchange factor)-Shank PDZ interaction in synaptic assembly:three PDZ-binding sites are clustered by a parallel coiled-coil trimer but bind to Shank PDZ protein with 1:1 stoichiometry (1 trimer/1 PDZ). Inspired by this architecture, we proposed that peptide dendrimer, mimicking the ligand clustering in beta PIX, will also show enhanced binding affinity, yet with 1:1 stoichiometry. This postulation has been proven here, as we synthesized a set of monomeric, dimeric and trimeric peptides and measured their binding affinity and stoichiometry with Shank PDZ domains by isothermal titration calorimetry, native mass spectrometry and surface plasmon resonance. This affinity enhancement, best explained by proximity effect, will be useful to guide the design of high-affinity blockers for protein-protein interactions.	[Liu, Jiahui; Liu, Miao; Xia, Jiang] Chinese Univ Hong Kong, Dept Chem, Ctr Novel Biomat, Shatin, Hong Kong, Peoples R China; [Zheng, Bo; Yao, Zhongping] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China	Chinese University of Hong Kong; Hong Kong Polytechnic University	Xia, J (corresponding author), Chinese Univ Hong Kong, Dept Chem, Ctr Novel Biomat, Shatin, Hong Kong, Peoples R China.	jiangxia@cuhk.edu.hk	Yao, Zhongping/K-2117-2014; CHEN, Huanwen/B-1794-2008; Xia, Jiang/AAT-2366-2020	Yao, Zhongping/0000-0003-3555-9632; Xia, Jiang/0000-0001-8112-7625	Research Grants Council [CUHK 404812, 403711, 404413, AoE/M-09/12]	Research Grants Council(Hong Kong Research Grants Council)	This work was supported by the Research Grants Council, Early Career Scheme grant CUHK 404812 (website: http://www.ugc.edu.hk/eng/rgc/fund/grants.htm#a), the Research Grants Council, General Research Fund grants 403711 and 404413 (website: http://www.ugc.edu.hk/eng/rgc/fund/grants.htm#b), and the Research Grants Council, Areas of Excellence Scheme, AoE/M-09/12 (website: http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm). Prof. Xia received all the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dev KK, 2004, NAT REV DRUG DISCOV, V3, P1047, DOI 10.1038/nrd1578; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Gopalakrishnan M, 2005, BIOPHYS J, V89, P3686, DOI 10.1529/biophysj.105.065300; Grassme H, 2002, J BIOL CHEM, V277, P30289, DOI 10.1074/jbc.M200494200; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; HERMANOWSKIVOSATKA A, 1988, J BIOL CHEM, V263, P17822; Im YJ, 2010, J MOL BIOL, V397, P457, DOI 10.1016/j.jmb.2010.01.048; Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016; Kitov PI, 2003, J AM CHEM SOC, V125, P16271, DOI 10.1021/ja038223n; Kreienkamp HJ, 2002, CURR OPIN PHARMACOL, V2, P581, DOI 10.1016/S1471-4892(02)00203-5; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Lorenzen Kristina, 2010, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1712s62; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Pieters RJ, 2009, ORG BIOMOL CHEM, V7, P2013, DOI 10.1039/b901828j; RAO C, 1994, J AM CHEM SOC, V116, P6975, DOI 10.1021/ja00094a078; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Saupe J, 2011, CHEMMEDCHEM, V6, P1411, DOI 10.1002/cmdc.201100094; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Tomas S, 2010, NAT CHEM, V2, P1077, DOI 10.1038/NCHEM.892; van Baal I, 2005, ANGEW CHEM INT EDIT, V44, P5052, DOI 10.1002/anie.200500635; van den Heuvel RH, 2004, CURR OPIN CHEM BIOL, V8, P519, DOI 10.1016/j.cbpa.2004.08.006; Wang CK, 2010, PROTEIN CELL, V1, P737, DOI 10.1007/s13238-010-0099-6; Xia J, 2005, BIOCHEMISTRY-US, V44, P4442, DOI 10.1021/bi047747c; Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783	25	6	8	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149580	10.1371/journal.pone.0149580	http://dx.doi.org/10.1371/journal.pone.0149580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918521	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400025
J	Werth, AJ; Potvin, J				Werth, Alexander J.; Potvin, Jean			Baleen Hydrodynamics and Morphology of Cross-Flow Filtration in Balaenid Whale Suspension Feeding	PLOS ONE			English	Article							BOWHEAD WHALE; MECHANISMS; BEHAVIOR; PERFORMANCE; KINEMATICS	The traditional view of mysticete feeding involves static baleen directly sieving particles from seawater using a simple, dead-end flow-through filtration mechanism. Flow tank experiments on bowhead (Balaena mysticetus) baleen indicate the long-standing model of dead-end filtration, at least in balaenid (bowhead and right) whales, is not merely simplistic but wrong. To recreate continuous intraoral flow, sections of baleen were tested in a flume through which water and buoyant particles circulated with variable flow velocity. Kinematic sequences were analyzed to investigate movement and capture of particles by baleen plates and fringes. Results indicate that very few particles flow directly through the baleen rack; instead much water flows anteroposteriorly along the interior (lingual) side of the rack, allowing items to be carried posteriorly and accumulate at the posterior of the mouth where they might readily be swallowed. Since water flows mainly parallel to rather than directly through the filter, the cross-flow mechanism significantly reduces entrapment and tangling of minute items in baleen fringes, obviating the need to clean the filter. The absence of copepods or other prey found trapped in the baleen of necropsied right and bowhead whales supports this hypothesis. Reduced through-baleen flow was observed with and without boundaries modeling the tongue and lips, indicating that baleen itself is the main if not sole agent of crossflow. Preliminary investigation of baleen from balaenopterid whales that use intermittent filter feeding suggests that although the biomechanics and hydrodynamics of oral flow differ, cross-flow filtration may occur to some degree in all mysticetes.	[Werth, Alexander J.] Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA; [Potvin, Jean] St Louis Univ, Dept Phys, St Louis, MO 63103 USA	Saint Louis University	Werth, AJ (corresponding author), Hampden Sydney Coll, Dept Biol, Hampden Sydney, VA 23943 USA.	awerth@hsc.edu		Werth, Alexander/0000-0002-7777-478X	Hampden-Sydney College; Virginia Foundation for Independent Colleges; University of British Columbia	Hampden-Sydney College; Virginia Foundation for Independent Colleges; University of British Columbia	Funding for AJW was provided by faculty grants from Hampden-Sydney College, and Mednick and Harris Awards from the Virginia Foundation for Independent Colleges.; Samples of baleen are from animals harvested by Inupiat hunters of the Alaska Eskimo Whaling Commission in accordance with their exemption to the U.S. Marine Mammal Protection Act and other national and international restrictions. We are grateful to hunters for allowing examination and sampling of their whales. Tissues were collected under Permit #519 issued by the National Marine Fisheries Service to T.F. Albert of the North Slope Borough (Alaska) Department of Wildlife Management. We are indebted to I. Robertson for flow tank construction and S. Vogel for design advice, and to numerous students for assistance with data collection and logistics. D.E. Lowry provided valuable assistance with statistical analysis. Our dataset is available at http://dx.doi.org/10.6084/m9.figshare.2056602. We thank R.E. Shadwick for his hospitality and financial support during our stay at the University of British Columbia. For ideas and discussion of whale feeding and experimental methods we thank J. Goldbogen, R. Shadwick, S. Pinto, M. Lillie, M. Piscitelli, N. Pyenson, F. Fish, H. Ito, J. Reidenberg, J.C. George, T. Sformo, R. Suydam, B. Kot, C. Marshall, P. van de Graaf, M. Simon, P. Madsen, T. Ford, R. Payne, A. Friedlaender, M. Baumgartner, D. Wiley, C. Mayo, S. Kraus, and S.L. Sanderson.	Aristotle, 2009, PARTIBUS ANIMALIUM; Aristotle, 2002, HIST ANIMALIUM; BAKER RJ, 1985, DESALINATION, V53, P81, DOI 10.1016/0011-9164(85)85053-0; Bannister J.L., 2008, ENCY MARINE MAMMALS, V2nd, P80; Baumgartner Mark F., 2007, P138; BELFORT G, 1994, J MEMBRANE SCI, V96, P1, DOI 10.1016/0376-7388(94)00119-7; Blatt W.F., 1970, MEMBRANE SCI TECHNOL; Brainerd EL, 2001, NATURE, V412, P387, DOI 10.1038/35086666; CARROLL GM, 1987, ARCTIC, V40, P105; Cheer AY, 2001, J THEOR BIOL, V210, P463, DOI 10.1006/jtbi.2001.2325; Croll DA, 2008, ENCY MARINE MAMMALS, P429; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Geraci J.R., 1990, P167; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2006, J EXP BIOL, V209, P1231, DOI 10.1242/jeb.02135; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2013, BIOSCIENCE, V63, P90, DOI 10.1525/bio.2013.63.2.5; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Humphries S, 2009, P NATL ACAD SCI USA, V106, P7882, DOI 10.1073/pnas.0809063106; Kot BW, 2009, THESIS U CALIFORNIA; Kundu P.K, 2011, VORTICITY DYNAMICS F; Lambertsen RH, 2005, J MAMMAL, V86, P342, DOI 10.1644/BER-123.1; Lowry Lloyd F., 1993, Society for Marine Mammalogy Special Publication, V2, P201; LU WM, 1993, CHEM ENG SCI, V48, P863, DOI 10.1016/0009-2509(93)80325-K; LU WM, 1989, SEPAR SCI TECHNOL, V24, P517, DOI 10.1080/01496398908049789; Marshall CM, 2008, ENCY MARINE MAMMALS, V2e, P406; Mayo C. A., 2001, Journal of Cetacean Research and Management Special Issue, P225; Moore Michael J., 2012, Journal of Marine Biology, P1; Murkes J, 1988, CROSSFLOW FILTRATION; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Nowacek DP, 2001, P ROY SOC B-BIOL SCI, V268, P1811, DOI 10.1098/rspb.2001.1730; Paig-Tran EWM, 2013, J MORPHOL, V274, P1026, DOI 10.1002/jmor.20160; Paig-Tran EWM, 2013, ANAT REC, P701; Pinto SJD, 2011, THESIS U BRIT COLUMB; PIVORUNAS A, 1979, AM SCI, V67, P432; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Potvin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044854; Ripperger S, 2002, SEP PURIF TECHNOL, V26, P19, DOI 10.1016/S1383-5866(01)00113-7; RUBENSTEIN DI, 1977, AM NAT, V111, P981, DOI 10.1086/283227; Ryerson WG, 2012, J EXP ZOOL PART A, V317A, P127, DOI 10.1002/jez.725; Sanderson S. Laurie, 1993, P37; Sanderson SL, 2001, NATURE, V412, P439, DOI 10.1038/35086574; SANDERSON SL, 1990, SCI AM, V262, P96, DOI 10.1038/scientificamerican0390-96; Sears R, 2008, ENCY MARINE MAMMALS, P120; Simon M, 2009, P ROY SOC B-BIOL SCI, V276, P3819, DOI 10.1098/rspb.2009.1135; SONG LF, 1995, J CHEM SOC FARADAY T, V91, P3389, DOI 10.1039/ft9959103389; STAUBIN DJ, 1984, CAN J ZOOL, V62, P193, DOI 10.1139/z84-032; Vogel S, 2013, COMP BIOMECHANICS E; Vogel S, 1996, LIFE MOVING FLUIDS; Ware C, 2011, MAR MAMMAL SCI, V27, P587, DOI 10.1111/j.1748-7692.2010.00427.x; Werth AJ, 2004, J EXP BIOL, V207, P3569, DOI 10.1242/jeb.01202; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]; Werth Alexander J., 2001, Bulletin of the Museum of Comparative Zoology, V156, P189; Werth Alexander J., 2012, International Journal of Ecology, P1; Werth AJ, 2013, J EXP BIOL, V216, P1152, DOI 10.1242/jeb.078931; Williamson G.R., 1973, Scientific Rep Whales Res Inst Tokyo, VNo. 25, P279; Yochem P.K., 1985, HDB MARINE MAMMALS, V3, P305; Zeman L. J., 1996, MICROFILTRATION ULTR	59	41	43	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150106	10.1371/journal.pone.0150106	http://dx.doi.org/10.1371/journal.pone.0150106			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918630	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400087
J	Wong, JD; Bobbert, MF; van Soest, AJ; Gribble, PL; Kistemaker, DA				Wong, Jeremy D.; Bobbert, Maarten F.; van Soest, Arthur J.; Gribble, Paul L.; Kistemaker, Dinant A.			Optimizing the Distribution of Leg Muscles for Vertical Jumping	PLOS ONE			English	Article							EXPLOSIVE MOVEMENTS	A goal of biomechanics and motor control is to understand the design of the human musculoskeletal system. Here we investigated human functional morphology by making predictions about the muscle volume distribution that is optimal for a specific motor task. We examined a well-studied and relatively simple human movement, vertical jumping. We investigated how high a human could jump if muscle volume were optimized for jumping, and determined how the optimal parameters improve performance. We used a four-link inverted pendulum model of human vertical jumping actuated by Hill-type muscles, that well-approximates skilled human performance. We optimized muscle volume by allowing the cross-sectional area and muscle fiber optimum length to be changed for each muscle, while maintaining constant total muscle volume. We observed, perhaps surprisingly, that the reference model, based on human anthropometric data, is relatively good for vertical jumping; it achieves 90% of the jump height predicted by a model with muscles designed specifically for jumping. Alteration of cross-sectional areas-which determine the maximum force deliverable by the muscles-constitutes the majority of improvement to jump height. The optimal distribution results in large vastus, gastrocnemius and hamstrings muscles that deliver more work, while producing a kinematic pattern essentially identical to the reference model. Work output is increased by removing muscle from rectus femoris, which cannot do work on the skeleton given its moment arm at the hip and the joint excursions during push-off. The gluteus composes a disproportionate amount of muscle volume and jump height is improved by moving it to other muscles. This approach represents a way to test hypotheses about optimal human functional morphology. Future studies may extend this approach to address other morphological questions in ethological tasks such as locomotion, and feature other sets of parameters such as properties of the skeletal segments.	[Wong, Jeremy D.; Gribble, Paul L.; Kistemaker, Dinant A.] Univ Western Ontario, Brain & Mind Inst, London, ON N6A 3K7, Canada; [Wong, Jeremy D.; Bobbert, Maarten F.; van Soest, Arthur J.; Kistemaker, Dinant A.] Vrije Univ Amsterdam, MOVE Res Inst, Nord Holland, Netherlands; [Wong, Jeremy D.] Simon Fraser Univ, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada	Western University (University of Western Ontario); Vrije Universiteit Amsterdam; Simon Fraser University	Wong, JD (corresponding author), Univ Western Ontario, Brain & Mind Inst, London, ON N6A 3K7, Canada.; Wong, JD (corresponding author), Vrije Univ Amsterdam, MOVE Res Inst, Nord Holland, Netherlands.; Wong, JD (corresponding author), Simon Fraser Univ, Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada.	jeremy_wong_4@sfu.ca		Wong, Jeremy/0000-0001-5564-1794	Michael Smith Foundation for Health Research [5552]; European Union [CORDIS FP7-PEOPLE-2011-CIG-303849]; Natural Sciences and Engineering Research Council of Canada [RGPIN-238338]; Canadian Institutes of Health Research [MOP-53296]	Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); European Union(European Commission); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Michael Smith Foundation for Health Research #5552 (JDW), European Union Seventh Framework Programme for Research #CORDIS FP7-PEOPLE-2011-CIG-303849(DAK), Natural Sciences and Engineering Research Council of Canada #RGPIN-238338 (PLG), and Canadian Institutes of Health Research #MOP-53296 (PLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobbert MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071209; Bobbert MF, 2013, NEUROSCIENCE, V237, P232, DOI 10.1016/j.neuroscience.2013.01.055; Bobbert MF, 2001, J EXP BIOL, V204, P533; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Johnson S. G., 2015, NLOPT NONLINEAR OPTI; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; KRAFT D, 1994, ACM T MATH SOFTWARE, V20, P262, DOI 10.1145/192115.192124; MENDEZ J, 1960, METABOLISM, V9, P184; Pai DK, 2010, J BIOMECH, V43, P2093, DOI 10.1016/j.jbiomech.2010.04.004; Powell M.J.D., 2009, BOBYQA ALGORITHM BOU; POWELL M. J. D., 1994, MATH APPL, V275, P51, DOI DOI 10.1007/978-94-015-8330-5_; Roach NT, 2013, NATURE, V498, P483, DOI 10.1038/nature12267; Seth A, 2007, J BIOMECH, V40, P356, DOI 10.1016/j.jbiomech.2005.12.017; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; van Soest AJK, 2003, J BIOMECH ENG-T ASME, V125, P141, DOI 10.1115/1.1537735; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VANSOEST AJ, 1993, J BIOMECH, V26, P1, DOI 10.1016/0021-9290(93)90608-H; VANSOEST AJ, 1994, J NEUROPHYSIOL, V71, P1390, DOI 10.1152/jn.1994.71.4.1390	18	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150019	10.1371/journal.pone.0150019	http://dx.doi.org/10.1371/journal.pone.0150019			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919645	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400071
J	Zhou, JM; Lu, QY; Liu, F; Li, YQ				Zhou, Jianming; Lu, Qiuyuan; Liu, Fan; Li, Yinqiao			A Novel Picosecond Pulse Generation Circuit Based on SRD and NLTL	PLOS ONE			English	Article								Because of the importance of ultra-wideband (UWB) radar in various applications, short pulse generation in UWB systems has attracted a lot of attention in recent years. In order to shorten the pulse, nonlinear transmission line (NLTL) is imported, which expands the application of step recovery diode (SRD) for pulse generation. Detailed analysis and equations for this SRD and NLTL-based pulse generation are provided and verified by simulation and experimental results. Factors that could cause pulse waveform distortions are also analyzed. The generator circuit presented in this paper generates 130ps and 3.3V pulse, which can be used in UWB radar systems that require sub-nanosecond pulses.	[Zhou, Jianming; Lu, Qiuyuan; Liu, Fan] Beijing Inst Technol, Sch Informat & Elect, Beijing 100081, Peoples R China; [Li, Yinqiao] CAST, Inst Telecommun Satellite, Beijing 100094, Peoples R China	Beijing Institute of Technology	Zhou, JM (corresponding author), Beijing Inst Technol, Sch Informat & Elect, Beijing 100081, Peoples R China.	zhoujm@bit.edu.cn	Liu, Fan/U-1728-2019	Liu, Fan/0000-0002-5299-9317	Chinese Defense Advance Research Program of Science and Technology, China [40404110203]	Chinese Defense Advance Research Program of Science and Technology, China	This project is supported by the Chinese Defense Advance Research Program of Science and Technology, China (Grant No. 40404110203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetto A, 2005, IEEE SENS J, V5, P471, DOI 10.1109/JSEN.2005.846176; Chan KKM, 2010, IET MICROW ANTENNA P, V4, P2196, DOI 10.1049/iet-map.2010.0030; Choi GW, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3523342; Chow WH, 2003, APACE: 2003 ASIA-PACIFIC CONFERENCE ON APPLIED ELECTROMAGNETICS, PROCEEDINGS, P21, DOI 10.1109/APACE.2003.1234459; De Angelis A, 2009, IEEE T INSTRUM MEAS, V58, P3935, DOI 10.1109/TIM.2009.2020834; Gerding M., 2004, ADV RADIO SCI, V2, P7, DOI DOI 10.5194/ARS-2-7-2004; Han J, 2005, IEEE T MICROW THEORY, V53, P1875, DOI 10.1109/TMTT.2005.848091; Han JW, 2002, IEEE MICROW WIREL CO, V12, P206, DOI 10.1109/LMWC.2002.1009996; Hirsch O, 2010, IEEE T INSTRUM MEAS, V59, P2949, DOI 10.1109/TIM.2010.2046359; Holzman JF, 2000, APPL PHYS LETT, V76, P134, DOI 10.1063/1.125679; Immoreev IY, 2006, ULTRAWIDEBAND AND ULTRASHORT IMPULSE SIGNALS, PROCEEDINGS, P44, DOI 10.1109/UWBUS.2006.307156; Immoreev IY, 2004, ULTRAWIDEBAND AND ULTRASHORT IMPULSE SIGNALS, PROCEEDINGS, P214, DOI 10.1109/UWBUS.2004.1388105; Kamal A, 2014, MICROW OPT TECHN LET, V56, P2289, DOI 10.1002/mop.28581; Lee JS, 2001, IEEE T MICROW THEORY, V49, P1126, DOI 10.1109/22.925501; Lee JS, 2001, IEEE MICROW WIREL CO, V11, P208, DOI 10.1109/7260.923030; Lemaire O, 2009, 2009 JOINT IEEE NORTH-EAST WORKSHOP ON CIRCUITS AND SYSTEMS AND TAISA CONFERENCE, P1; OUSLIMANI A, 1990, ELECTRON LETT, V26, P1563, DOI 10.1049/el:19901003; Ruai Y Y, 1994, MICROWAVE THEORY TEC, V47, P1118, DOI [10.1109/22.775445, DOI 10.1109/22.775445]; Salameh D, 1999, IEEE T MICROW THEORY, V47, P1118, DOI 10.1109/22.775445; Salvador S, 2007, IEEE ANTENNAS PROP, P253, DOI 10.1109/APS.2007.4395478; Wang Q, 2008, I C WIREL COMM NETW, P1101; Xia T, 2012, IEEE T INSTRUM MEAS, V61, P261, DOI 10.1109/TIM.2011.2161022; Zhang CM, 2006, IEEE MTT S INT MICR, P407, DOI 10.1109/MWSYM.2006.249557; Zhou JM, 2006, IEICE ELECTRON EXPR, V3, P534, DOI 10.1587/elex.3.534; Zito F, 2010, IEEE T CIRCUITS-I, V57, P2654, DOI 10.1109/TCSI.2010.2047751	25	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149645	10.1371/journal.pone.0149645	http://dx.doi.org/10.1371/journal.pone.0149645			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919290	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400031
J	Choi, BH; Ro, H; Jung, ES; Kim, AJ; Chang, JH; Lee, HH; Chung, W; Jung, JY				Choi, Byoung Ho; Ro, Han; Jung, Eul Sik; Kim, Ae Jin; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong			Circulating S100A12 Levels Are Associated with Progression of Abdominal Aortic Calcification in Hemodialysis Patients	PLOS ONE			English	Article							GLYCATION END-PRODUCT; SOLUBLE RECEPTOR; VASCULAR CALCIFICATION; PLASMA S100A12; SERUM S100A12; ALL-CAUSE; RAGE; MORTALITY; DISEASE; SRAGE	Vascular calcification is an important factor associated with mortality in dialysis patients. Recently, soluble receptor for advanced glycation end product (sRAGE) and extracellular RAGE binding protein S100A12 (EN-RAGE) have been reported to be involved in the process of vascular calcification. Therefore, we investigated whether sRAGE and S100A12 are useful indicators of progression of abdominal aortic calcification in hemodialysis (HD) patients. We analyzed annual changes in vascular calcification score (VCS) for up to 4 years, compared to clinical and biological parameters in 149 HD patients. VCS was assessed annually using plain X-ray images of the lateral lumbar spine. The progression group was defined as patients with an increase in VCS more than 1 point each year on average during the observation period. Time-averaged concentrations were also evaluated to examine the association between biological parameters and changes in VCS. The patients had a mean age of 58.59 +/- 12.93 years; 53.7% were male, and 45% were diabetic. The VCS increased in 55 patients; the mean increase was 1.60 +/- 2.91 points. In a stepwise multivariate logistic analysis, we found that higher levels of S100A12 were significantly associated with progression of VCS (odds ratio [OR], 2.622; 95% confidence interval [CI], 1.371-5.016; P = 0.004). The relationship between sRAGE and VCS was not statistically significant (OR, 0.644; 95% CI, 0.302-1.374; P = 0.255). Our findings suggest that serum levels of S100A12 are associated with progression of abdominal aortic calcification in HD patients, independent of sRAGE level.	[Choi, Byoung Ho; Ro, Han; Jung, Eul Sik; Kim, Ae Jin; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Incheon, South Korea; [Ro, Han; Chang, Jae Hyun; Lee, Hyun Hee; Chung, Wookyung; Jung, Ji Yong] Gachon Univ, Sch Med, Incheon, South Korea	Gachon University; Gachon University	Jung, JY (corresponding author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Nephrol, Incheon, South Korea.; Jung, JY (corresponding author), Gachon Univ, Sch Med, Incheon, South Korea.	jyjung@gachon.ac.kr		Jung, Eul Sik/0000-0003-3898-4693				Bowman MAH, 2011, ARTERIOSCL THROM VAS, V31, P337, DOI 10.1161/ATVBAHA.110.217745; Foley RN, 1998, J NEPHROL, V11, P239; Gawdzik J, 2011, AM J NEPHROL, V33, P250, DOI 10.1159/000324693; Hanford LE, 2004, J BIOL CHEM, V279, P50019, DOI 10.1074/jbc.M409782200; Heller F, 2011, CLIN J AM SOC NEPHRO, V6, P2347, DOI 10.2215/CJN.02490311; Humpert PM, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-9; Isoyama N, 2015, NEPHROL DIAL TRANSPL, V30, P84, DOI 10.1093/ndt/gfu259; Kauppila LI, 1997, ATHEROSCLEROSIS, V132, P245, DOI 10.1016/S0021-9150(97)00106-8; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147255; Kim HS, 2013, NEPHROLOGY, V18, P777, DOI 10.1111/nep.12166; Kim JK, 2012, ATHEROSCLEROSIS, V220, P208, DOI 10.1016/j.atherosclerosis.2011.07.115; Kimura K, 1999, KIDNEY INT, V56, pS238, DOI 10.1046/j.1523-1755.1999.07163.x; Lindholm B, 2015, AM J NEPHROL, V42, P1, DOI 10.1159/000438873; Lindsey JB, 2009, DIABETES VASC DIS RE, V6, P7, DOI 10.3132/dvdr.2009.002; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Morrow DA, 2008, AM HEART J, V155, P49, DOI 10.1016/j.ahj.2007.08.018; Nakashima A, 2010, CLIN J AM SOC NEPHRO, V5, P2213, DOI 10.2215/CJN.03360410; NasrAllah MM, 2012, INT UROL NEPHROL, V44, P1201, DOI 10.1007/s11255-011-0067-y; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Oesterle A, 2015, ARTERIOSCL THROM VAS, V35, P2496, DOI 10.1161/ATVBAHA.115.302072; Okuno S, 2007, AM J KIDNEY DIS, V49, P417, DOI 10.1053/j.ajkd.2006.12.017; Saran R, 2015, AM J KIDNEY DIS, V66, pS1, DOI 10.1053/j.ajkd.2015.05.001; Schlieper G, 2016, NEPHROL DIAL TRANSPL, V31, P31, DOI 10.1093/ndt/gfv111; Shiotsu Y, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-16; Shiotsu Y, 2011, NEPHRON EXTRA, V1, P242, DOI 10.1159/000335198; Shiotsu Y, 2011, CLIN J AM SOC NEPHRO, V6, P718, DOI 10.2215/CJN.08310910; Towler DA, 2011, ARTERIOSCL THROM VAS, V31, P237, DOI 10.1161/ATVBAHA.110.220038; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang YN, 2015, AM J NEPHROL, V42, P4, DOI 10.1159/000438869; Wilson PWF, 2001, CIRCULATION, V103, P1529, DOI 10.1161/01.cir.103.11.1529; Yan L, 2013, ATHEROSCLEROSIS, V228, P69, DOI 10.1016/j.atherosclerosis.2013.02.023	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150145	10.1371/journal.pone.0150145	http://dx.doi.org/10.1371/journal.pone.0150145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914918	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700056
J	Lind, AL; Wu, D; Freyhult, E; Bodolea, C; Ekegren, T; Larsson, A; Gustafsson, MG; Katila, L; Bergquist, J; Gordh, T; Landegren, U; Kamali-Moghaddam, M				Lind, Anne-Li; Wu, Di; Freyhult, Eva; Bodolea, Constantin; Ekegren, Titti; Larsson, Anders; Gustafsson, Mats G.; Katila, Lenka; Bergquist, Jonas; Gordh, Torsten; Landegren, Ulf; Kamali-Moghaddam, Masood			A Multiplex Protein Panel Applied to Cerebrospinal Fluid Reveals Three New Biomarker Candidates in ALS but None in Neuropathic Pain Patients	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD STIMULATION; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; INTERLEUKIN-1 RECEPTOR; PROXIMITY LIGATION; PLASMA BIOMARKERS; GLIAL ACTIVATION; BINDING-PROTEIN	The objective of this study was to develop and apply a novel multiplex panel of solid-phase proximity ligation assays (SP-PLA) requiring only 20 mu L of samples, as a tool for discovering protein biomarkers for neurological disease and treatment thereof in cerebrospinal fluid (CSF). We applied the SP-PLA to samples from two sets of patients with poorly understood nervous system pathologies amyotrophic lateral sclerosis (ALS) and neuropathic pain, where patients were treated with spinal cord stimulation (SCS). Forty-seven inflammatory and neurotrophic proteins were measured in samples from 20 ALS patients and 15 neuropathic pain patients, and compared to normal concentrations in CSF from control individuals. Nineteen of the 47 proteins were detectable in more than 95% of the 72 controls. None of the 21 proteins detectable in CSF from neuropathic pain patients were significantly altered by SCS. The levels of the three proteins, follistatin, interleukin-1 alpha, and kallikrein-5 were all significantly reduced in the ALS group compared to age-matched controls. These results demonstrate the utility of purpose designed multiplex SP-PLA panels in CSF biomarker research for understanding neuropathological and neurotherapeutic mechanisms. The protein changes found in the CSF of ALS patients may be of diagnostic interest.	[Lind, Anne-Li; Katila, Lenka; Gordh, Torsten] Uppsala Univ, Dept Surg Sci Anaesthesiol & Intens Care, Uppsala, Sweden; [Lind, Anne-Li; Katila, Lenka; Gordh, Torsten] Uppsala Univ, Uppsala Berzelii Technol Ctr Neurodiagnost, Uppsala, Sweden; [Wu, Di; Landegren, Ulf; Kamali-Moghaddam, Masood] Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Freyhult, Eva] Uppsala Univ, Bioinformat Infrastruct Life Sci, Sci Life Lab, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden; [Bodolea, Constantin] Univ Med & Pharm, Dept Anaesthesia & Intens Care, Cluj Napoca, Napoca, Romania; [Ekegren, Titti] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden; [Larsson, Anders] Uppsala Univ, Dept Med Sci Biochem Struct & Funct, Uppsala, Sweden; [Gustafsson, Mats G.] Uppsala Univ, Dept Med Sci Canc Pharmacol & Computat Med, Uppsala, Sweden; [Bergquist, Jonas] Uppsala Univ, Dept Chem BMC, Analyt Chem & Sci Life Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University; Uppsala University; Iuliu Hatieganu University of Medicine & Pharmacy; Uppsala University; Uppsala University; Uppsala University; Uppsala University	Kamali-Moghaddam, M (corresponding author), Uppsala Univ, Sci Life Lab, Dept Immunol Genet & Pathol, Uppsala, Sweden.	masood.kamali@igp.uu.se	Bodolea, Constantin/AAB-4279-2020; Landegren, Ulf D/A-8197-2019	Katila, Lenka/0000-0001-7621-963X; Freyhult, Eva/0000-0003-0226-1047; Bergquist, Jonas/0000-0002-4597-041X	Swedish Governmental Agency for Innovation Systems; Swedish Research Council (Vetenskapsradet); Uppsala University; Inga-Britt och Arne Lundbergs Forskningsstiftelse; Knut and Alice Wallenberg Foundation; European Research Council under the European Union [316929]; ERC [294409]; SRC [621-2011-4423]	Swedish Governmental Agency for Innovation Systems(Vinnova); Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Uppsala University; Inga-Britt och Arne Lundbergs Forskningsstiftelse; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); SRC	This work was performed at Uppsala Berzelii Technology Centre for Neurodiagnostics, financed by the Swedish Governmental Agency for Innovation Systems, the Swedish Research Council (Vetenskapsradet), and Uppsala University. Additional funding was provided by Inga-Britt och Arne Lundbergs Forskningsstiftelse, Knut and Alice Wallenberg Foundation, the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/GastricGlycoExplorer grant agreement No. 316929, ERC grant agreement No. 294409 and SRC (621-2011-4423).	Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; BAN E, 1991, NEUROSCIENCE, V43, P21, DOI 10.1016/0306-4522(91)90412-H; BAN EM, 1993, NEUROSCIENCE, V52, P725, DOI 10.1016/0306-4522(93)90421-B; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Berjaoui S, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/573784; Blasi F, 1999, BIOL CHEM, V380, P259, DOI 10.1515/BC.1999.034; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Cunha TM, 2005, P NATL ACAD SCI USA, V102, P1755, DOI 10.1073/pnas.0409225102; CUNNINGHAM ET, 1993, IMMUNOL TODAY, V14, P171; Darmanis S, 2009, MOL CELL PROTEOMICS; Darmanis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025583; Darmanis S, 2010, MOL CELL PROTEOMICS, V9, P327, DOI 10.1074/mcp.M900248-MCP200; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Devon HA, 2014, NURS RES, V63, P51, DOI 10.1097/NNR.0000000000000013; Elf K, 2014, J PROTEOMICS, V108, P55, DOI 10.1016/j.jprot.2014.05.004; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Fredriksson S, 2008, CLIN CHEM, V54, P582, DOI 10.1373/clinchem.2007.093195; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; French RA, 1999, J NEUROIMMUNOL, V93, P194, DOI 10.1016/S0165-5728(98)00224-0; Friedman WJ, 2001, EXP NEUROL, V168, P23, DOI 10.1006/exnr.2000.7595; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; Gordon PH, 2007, LANCET NEUROL, V6, P1045, DOI 10.1016/S1474-4422(07)70270-3; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hammond EA, 1999, BRAIN, V122, P1697, DOI 10.1093/brain/122.9.1697; He Y, 2015, GLIA, V63, P1568, DOI 10.1002/glia.22828; Henkel JS, 2009, J NEUROIMMUNE PHARM, V4, P389, DOI 10.1007/s11481-009-9171-5; HETIER E, 1988, J NEUROSCI RES, V21, P391, DOI 10.1002/jnr.490210230; Hewett Sandra J, 2012, Eur J Neurodegener Dis, V1, P195; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Iwahori Y, 1997, BRAIN RES, V760, P52, DOI 10.1016/S0006-8993(97)00275-8; Jing Z, 2005, NEUROBIOL AGING, V26, P207, DOI 10.1016/j.neurobiolaging.2004.03.012; Kawasaki Y, 2008, NAT MED, V14, P331, DOI 10.1038/nm1723; Kiguchi N, 2014, J NEUROCHEM, V129, P169, DOI 10.1111/jnc.12614; Kim SJ, 2011, SPINE, V36, P2139, DOI 10.1097/BRS.0b013e31821945a3; Knerlich F, 1999, MOL BRAIN RES, V68, P73, DOI 10.1016/S0169-328X(99)00064-9; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; Lewin GR, 2014, EUR J NEUROSCI, V39, P363, DOI 10.1111/ejn.12466; LIEBERMAN AP, 1989, P NATL ACAD SCI USA, V86, P6348, DOI 10.1073/pnas.86.16.6348; Liou JT, 2013, PAIN, V154, P2150, DOI 10.1016/j.pain.2013.06.042; Lundberg M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004978; Mann CLA, 2002, J NEUROIMMUNOL, V129, P197, DOI 10.1016/S0165-5728(02)00181-9; McCarthy KF, 2013, NEUROMODULATION, V16, P519, DOI 10.1111/j.1525-1403.2012.00527.x; McCombe PA, 2011, CURR MOL MED, V11, P246; McMahon SB, 2004, J NEUROBIOL, V61, P72, DOI 10.1002/neu.20093; McMahon SB, 2009, NEURON, V64, P46, DOI 10.1016/j.neuron.2009.09.033; Michel W, 2000, EUR J ENDOCRINOL, V143, P809, DOI 10.1530/eje.0.1430809; Mika J, 2013, EUR J PHARMACOL, V716, P106, DOI 10.1016/j.ejphar.2013.01.072; Miller TM, 2006, P NATL ACAD SCI USA, V103, P19546, DOI 10.1073/pnas.0609411103; Mirowska-Guzel D, 2011, J NEUROIMMUNOL, V236, P87, DOI 10.1016/j.jneuroim.2011.04.014; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Nie FC, 2013, INT J MOL MED, V31, P1333, DOI 10.3892/ijmm.2013.1344; Nijs J, 2015, EXPERT OPIN THER TAR, V19, P565, DOI 10.1517/14728222.2014.994506; Nikodemova M, 2014, NEUROBIOL DIS, V69, P43, DOI 10.1016/j.nbd.2013.11.009; Noh MY, 2014, NEUROSCI LETT, V574, P53, DOI 10.1016/j.neulet.2014.05.001; Ohnmeiss DD, 1996, SPINE, V21, P1344, DOI 10.1097/00007632-199606010-00013; Pan S, 2007, PROTEOMICS, V7, P469, DOI 10.1002/pmic.200600756; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Phillips DJ, 1998, FRONT NEUROENDOCRIN, V19, P287, DOI 10.1006/frne.1998.0169; Pinteaux E, 2002, J NEUROCHEM, V83, P754, DOI 10.1046/j.1471-4159.2002.01184.x; Pluijms WA, 2012, BRIT J ANAESTH, V109, P623, DOI 10.1093/bja/aes251; Prassas I, 2015, NAT REV DRUG DISCOV, V14, P183, DOI 10.1038/nrd4534; Ramstrom M, 2004, PROTEOMICS, V4, P4010, DOI 10.1002/pmic.200400871; Richner M, 2014, MOL NEUROBIOL, V50, P945, DOI 10.1007/s12035-014-8706-9; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROBERTSON DM, 1987, BIOCHEM BIOPH RES CO, V149, P744, DOI 10.1016/0006-291X(87)90430-X; Rose FF, 2009, HUM MOL GENET, V18, P997, DOI 10.1093/hmg/ddn426; Saika F, 2012, EUR J PAIN, V16, P1271, DOI 10.1002/j.1532-2149.2012.00146.x; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; SCHUBERT D, 1990, NATURE, V344, P868, DOI 10.1038/344868a0; Schutzer SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010980; Sekizawa T, 1998, J NEUROL SCI, V154, P194, DOI 10.1016/S0022-510X(97)00228-1; Shtilbans A, 2011, AMYOTROPH LATERAL SC, V12, P250, DOI 10.3109/17482968.2011.560946; SPIEGELMANN R, 1991, NEUROSURGERY, V28, P65, DOI 10.1227/00006123-199101000-00011; Staniland AA, 2010, J NEUROCHEM, V114, P1143, DOI 10.1111/j.1471-4159.2010.06837.x; Sussmuth SD, 2010, NEUROLOGY, V74, P982, DOI 10.1212/WNL.0b013e3181d5dc3b; Sweitzer SM, 2002, J NEUROIMMUNOL, V125, P82, DOI 10.1016/S0165-5728(02)00036-X; TAKAO T, 1990, ENDOCRINOLOGY, V127, P3070, DOI 10.1210/endo-127-6-3070; Tavoosidana G, 2011, P NATL ACAD SCI USA, V108, P8809, DOI 10.1073/pnas.1019330108; TOMOZAWA Y, 1995, NEUROSCI LETT, V195, P57, DOI 10.1016/0304-3940(95)11781-Q; Truin M, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2011.04.004; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Tsuda M, 2016, NEUROPHARMACOLOGY, V104, P76, DOI 10.1016/j.neuropharm.2015.08.042; Tsuda M, 2013, GLIA, V61, P55, DOI 10.1002/glia.22379; Tufan K, 2012, J SPINAL DISORD TECH, V25, P443, DOI 10.1097/BSD.0b013e318238e2db; Urshansky N, 2011, J NEUROIMMUNOL, V238, P96, DOI 10.1016/j.jneuroim.2011.08.003; van Hecke O, 2014, PAIN, V155, P654, DOI 10.1016/j.pain.2013.11.013; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Wang LJ, 2009, NEUROBIOL DIS, V35, P234, DOI 10.1016/j.nbd.2009.05.002; Wang XF, 2006, J MOL NEUROSCI, V29, P45, DOI 10.1385/JMN:29:1:45; Watt JA, 2000, J NEUROSCI RES, V60, P478, DOI 10.1002/(SICI)1097-4547(20000515)60:4<478::AID-JNR6>3.0.CO;2-R; WERDELIN L, 1990, ACTA NEUROL SCAND, V82, P132; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Wong Ma-Li, 1994, Neuroimmunomodulation, V1, P110, DOI 10.1159/000097143; Wu DD, 1999, BRAIN RES, V835, P369, DOI 10.1016/S0006-8993(99)01638-8; Xu J, 2006, INT REV NEUROBIOL, V73, P29, DOI 10.1016/S0074-7742(06)73002-1; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; YAO JB, 1992, BRAIN RES, V591, P88, DOI 10.1016/0006-8993(92)90981-E; Yousef GM, 2003, CLIN CHIM ACTA, V329, P1, DOI 10.1016/S0009-8981(03)00004-4; Zhang WD, 2000, J CEREBR BLOOD F MET, V20, P967, DOI 10.1097/00004647-200006000-00009; Zhu X, 2014, J PAIN, V15, P516, DOI 10.1016/j.jpain.2014.01.492	109	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149821	10.1371/journal.pone.0149821	http://dx.doi.org/10.1371/journal.pone.0149821			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914813	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700030
J	Rodriguez-Jorquera, IA; Silva-Sanchez, C; Strynar, M; Denslow, ND; Toor, GS				Rodriguez-Jorquera, Ignacio A.; Silva-Sanchez, Cecilia; Strynar, Mark; Denslow, Nancy D.; Toor, Gurpal S.			Footprints of Urban Micro-Pollution in Protected Areas: Investigating the Longitudinal Distribution of Perfluoroalkyl Acids in Wildlife Preserves	PLOS ONE			English	Article							WASTE-WATER TREATMENT; PERFLUOROOCTANE SULFONATE PFOS; PERFLUORINATED COMPOUNDS; TREATMENT PLANTS; QUANTITATIVE-DETERMINATION; RIVER-BASIN; TOKYO BAY; SURFACTANTS; SEDIMENTS; FATE	Current approaches to protect biodiversity by establishing protected areas usually gloss over water pollution as a threat. Our objective was to determine the longitudinal and seasonal distribution of perfluoroalkyl acids (PFAAs) in water column and sediments from a wastewater dominated stream that enters preservation areas. Water samples were collected along the longitudinal section (six sites, 1000 m away from each other) of the stream during the dry and wet seasons. Sediments were collected from three sites along the stream from three depths. Water and sediments were analyzed for PFAAs using high performance liquid chromatography-tandem mass spectrometry. Eleven PFAAs with 5 to 14 carbon atoms were detected in the water column at all sampling points, with a minor reduction at the last point suggesting a dilution effect. The most detected PFAAs was PFOS, followed by perfluorooctanoic acid (PFOA), and perfluorohexanoic acid (PFHxA). Seasonal differences in PFAAs concentrations suggested contribution of stormwater runoff during the wet season. All analyzed PFAAs in sediments were under the limit of quantification, likely due to the high proportion of sand and low organic matter. However, high concentrations of PFAAs were detected in the water column inside the protected areas, which includes PFOS in concentrations considered not safe for avian wildlife. Water samples appear to be more relevant than sediments to determine PFAAs micro-pollution in water bodies with sandy sediments. Inclusion of a management plans on micro-pollution research, monitoring, and mitigation is recommended for protected areas.	[Rodriguez-Jorquera, Ignacio A.] Univ Florida, Sch Nat Resources & Environm, Soil & Water Sci Dept, Interdisciplinary Ecol Program, Gainesville, FL USA; [Rodriguez-Jorquera, Ignacio A.; Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Rodriguez-Jorquera, Ignacio A.; Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA; [Silva-Sanchez, Cecilia] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Prote & Mass Spectrometry, Gainesville, FL USA; [Strynar, Mark] US EPA, Natl Exposure Res Lab, Durham, NC USA; [Toor, Gurpal S.] Univ Florida, Inst Food & Agr Sci, Gulf Coast Res & Educ Ctr, Soil & Water Qual Lab, Wimauma, FL USA; [Rodriguez-Jorquera, Ignacio A.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; United States Environmental Protection Agency; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Sch Nat Resources & Environm, Soil & Water Sci Dept, Interdisciplinary Ecol Program, Gainesville, FL USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA.; Toor, GS (corresponding author), Univ Florida, Inst Food & Agr Sci, Gulf Coast Res & Educ Ctr, Soil & Water Qual Lab, Wimauma, FL USA.; Rodriguez-Jorquera, IA (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL USA.	irodriguezj@ufl.edu; gstoor@ufl.edu		Strynar, Mark/0000-0003-3472-7921	Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida; BecasChile Conicyt; CONCIYT-Chile; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER	Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida; BecasChile Conicyt; CONCIYT-Chile; Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding for this research was provided by the Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center, University of Florida. BecasChile Conicyt provided a graduate research fellowship to IARJ.; We acknowledge the help of Kevin Kroll, Viet Dang, Cristina Colli-Dulla, Sixue Chen, Todd Osborne, and Claudio Verdugo during various phases of this research. The first author thank CONCIYT-Chile for providing a graduate student fellowship for PhD study at University of Florida. Funding for this research was provided by Soil and Water Quality Laboratory located at the Gulf Coast Research and Education Center of the University of Florida-Institute of Food and Agricultural Sciences.	Abell R, 2002, CONSERV BIOL, V16, P1435, DOI 10.1046/j.1523-1739.2002.01532.x; ACEPD. Alachua County Environmental Protection Department, 2010, RES SCREEN AN ORG WA, V15; Ahrens L, 2010, DETERMINATION PERFLU; Ahrens L, 2011, CHEMOSPHERE, V85, P731, DOI 10.1016/j.chemosphere.2011.06.046; Ahrens L, 2011, J ENVIRON MONITOR, V13, P20, DOI 10.1039/c0em00373e; Ahrens L, 2010, CHEMOSPHERE, V79, P266, DOI 10.1016/j.chemosphere.2010.01.045; Ahrens L, 2009, ENVIRON SCI TECHNOL, V43, P6969, DOI 10.1021/es901213s; Ahrens L, 2009, MAR POLLUT BULL, V58, P1326, DOI 10.1016/j.marpolbul.2009.04.028; [Anonymous], 2014, AGRICOLAE STAT PROCE; [Anonymous], 2019, STATE WORLDS PARKS I; [Anonymous], 2015, R LANG ENV STAT COMP; Becker AM, 2008, ENVIRON POLLUT, V156, P818, DOI 10.1016/j.envpol.2008.05.024; Bossi R, 2008, ENVIRON INT, V34, P443, DOI 10.1016/j.envint.2007.10.002; Boulanger B, 2005, ENVIRON SCI TECHNOL, V39, P5524, DOI 10.1021/es050213u; Clara M, 2004, WATER RES, V38, P947, DOI 10.1016/j.watres.2003.10.058; Deguignet M, 2014, UN LIST PROTECTED AR, P44; Department ACEP, 2007, STAT REP BAS WAT QUA, P185; Froese KL, 1998, ENVIRON TOXICOL CHEM, V17, P484, DOI 10.1002/etc.5620170320; Giesy J P, 2001, ScientificWorldJournal, V1, P627; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Gremillion P, 2000, HYDROL PROCESS, V14, P1465, DOI [10.1002/1099-1085(20000615)14:8<1465::AID-HYP987>3.0.CO;2-6, 10.1002/1099-1085(20000615)14:8&lt;1465::AID-HYP987&gt;3.0.CO;2-6]; Guo R, 2010, WATER RES, V44, P3476, DOI 10.1016/j.watres.2010.03.028; Heidler J, 2008, ENVIRON SCI TECHNOL, V42, P6324, DOI 10.1021/es703008y; Herbert J, 2013, DROPLET, V5; Higgins CP, 2006, ENVIRON SCI TECHNOL, V40, P7251, DOI 10.1021/es061000n; Higgins CP, 2005, ENVIRON SCI TECHNOL, V39, P3946, DOI 10.1021/es048245p; Houde M, 2011, ENVIRON SCI TECHNOL, V45, P7962, DOI 10.1021/es104326w; Jacobs JM, 2002, WETLANDS, V22, P374, DOI 10.1672/0277-5212(2002)022[0374:EFAWPW]2.0.CO;2; Kannan K, 2004, ENVIRON SCI TECHNOL, V38, P4489, DOI 10.1021/es0493446; Kim SK, 2007, ENVIRON SCI TECHNOL, V41, P8328, DOI 10.1021/es072107t; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Lin AYC, 2010, CHEMOSPHERE, V80, P1167, DOI 10.1016/j.chemosphere.2010.06.018; Liu CH, 2013, ENVIRON TOXICOL CHEM, V32, P2226, DOI 10.1002/etc.2306; Loganathan BG, 2007, WATER RES, V41, P4611, DOI 10.1016/j.watres.2007.06.045; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P5379, DOI 10.1021/es049331s; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, p248A, DOI 10.1021/es0405528; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; Murakami M, 2009, CHEMOSPHERE, V74, P487, DOI 10.1016/j.chemosphere.2008.10.018; Nakayama SF, 2010, ENVIRON SCI TECHNOL, V44, P4103, DOI 10.1021/es100382z; Newsted JL, 2005, ENVIRON SCI TECHNOL, V39, P9357, DOI 10.1021/es050989v; Nishikoori H, 2011, CHEMOSPHERE, V84, P1125, DOI 10.1016/j.chemosphere.2011.04.036; Pan YY, 2011, SCI CHINA CHEM, V54, P552, DOI 10.1007/s11426-010-4093-x; Pistocchi A, 2009, ENVIRON SCI TECHNOL, V43, P9237, DOI 10.1021/es901246d; Prevedouros K, 2006, ENVIRON SCI TECHNOL, V40, P32, DOI 10.1021/es0512475; Radeloff VC, 2010, P NATL ACAD SCI USA, V107, P940, DOI 10.1073/pnas.0911131107; Ratola N, 2012, J HAZARD MATER, V15, P1; Rodriguez-Jorquera IA, 2015, ENVIRON POLLUT, V199, P155, DOI 10.1016/j.envpol.2015.01.021; Sakurai T, 2010, ENVIRON SCI TECHNOL, V44, P4110, DOI 10.1021/es1007609; Schultz MM, 2006, ENVIRON SCI TECHNOL, V40, P289, DOI 10.1021/es051381p; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Shoemaker J.A. GPE, 2009, DETERMINATION SELECT, V1, P5; Simcik MF, 2005, ENVIRON SCI TECHNOL, V39, P8678, DOI 10.1021/es0511218; Sinclair E, 2006, ENVIRON SCI TECHNOL, V40, P1408, DOI 10.1021/es051798v; So MK, 2004, ENVIRON SCI TECHNOL, V38, P4056, DOI 10.1021/es049441z; Strynar MJ, 2012, CHEMOSPHERE, V86, P252, DOI 10.1016/j.chemosphere.2011.09.036; Sumpter JP, 2009, PHILOS T R SOC A, V367, P3877, DOI 10.1098/rsta.2009.0106; Theobald N, 2012, ENVIRON SCI POLLUT R, V19, P313, DOI 10.1007/s11356-011-0559-4; Tsuda T, 2010, B ENVIRON CONTAM TOX, V85, P593, DOI 10.1007/s00128-010-0116-8; Usenko S, 2010, ENVIRON SCI TECHNOL, V44, P4512, DOI 10.1021/es903844n; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Xiao F, 2012, WATER RES, V46, P6601, DOI 10.1016/j.watres.2011.11.029; Yang Y., 2015, J SOIL SEDIMENT, P1; Yu J, 2009, WATER RES, V43, P2399, DOI 10.1016/j.watres.2009.03.009; Zareitalabad P, 2013, PERFLUOROOCTANOIC AC; Zushi Y, 2009, CHEMOSPHERE, V76, P833, DOI 10.1016/j.chemosphere.2009.04.004	65	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148654	10.1371/journal.pone.0148654	http://dx.doi.org/10.1371/journal.pone.0148654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909512	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700012
J	Tapper, EB; Hunink, MGM; Afdhal, NH; Lai, M; Sengupta, N				Tapper, Elliot B.; Hunink, M. G. Myriam; Afdhal, Nezam H.; Lai, Michelle; Sengupta, Neil			Cost-Effectiveness Analysis: Risk Stratification of Nonalcoholic Fatty Liver Disease (NAFLD) by the Primary Care Physician Using the NAFLD Fibrosis Score	PLOS ONE			English	Article							CONTROLLED TRANSIENT ELASTOGRAPHY; STIFFNESS MEASUREMENT; UNITED-STATES; NONINVASIVE ASSESSMENT; XL PROBE; DIAGNOSIS; METAANALYSIS; MANAGEMENT; STEATOSIS; ACCURACY	Background The complications of Nonalcoholic Fatty Liver Disease (NAFLD) are dependent on the presence of advanced fibrosis. Given the high prevalence of NAFLD in the US, the optimal evaluation of NAFLD likely involves triage by a primary care physician (PCP) with advanced disease managed by gastroenterologists. Methods We compared the cost-effectiveness of fibrosis risk-assessment strategies in a cohort of 10,000 simulated American patients with NAFLD performed in either PCP or referral clinics using a decision analytical microsimulation state-transition model. The strategies included use of vibration-controlled transient elastography (VCTE), the NAFLD fibrosis score (NFS), combination testing with NFS and VCTE, and liver biopsy (usual care by a specialist only). NFS and VCTE performance was obtained from a prospective cohort of 164 patients with NAFLD. Outcomes included cost per quality adjusted life year (QALY) and correct classification of fibrosis. Results Risk-stratification by the PCP using the NFS alone costs $5,985 per QALY while usual care costs $7,229/QALY. In the microsimulation, at a willingness-to-pay threshold of $100,000, the NFS alone in PCP clinic was the most cost-effective strategy in 94.2% of samples, followed by combination NFS/VCTE in the PCP clinic (5.6%) and usual care in 0.2%. The NFS based strategies yield the best biopsy-correct classification ratios (3.5) while the NFS/VCTE and usual care strategies yield more correct-classifications of advanced fibrosis at the cost of 3 and 37 additional biopsies per classification. Conclusion Risk-stratification of patients with NAFLD primary care clinic is a cost-effective strategy that should be formally explored in clinical practice.	[Tapper, Elliot B.; Afdhal, Nezam H.; Lai, Michelle] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol Hepatol,Dept Med, Boston, MA 02215 USA; [Hunink, M. G. Myriam] Erasmus Univ, Med Ctr, Dept Epidemiol, Dept Radiol, Rotterdam, Netherlands; [Hunink, M. G. Myriam] Harvard Univ, TH Chan Sch Publ Hlth, Ctr Hlth Decis Sci, Boston, MA 02115 USA; [Sengupta, Neil] Univ Chicago, Dept Med, Div Gastroenterol Hepatol Nutr, 5841 S Maryland Ave, Chicago, IL 60637 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard T.H. Chan School of Public Health; University of Chicago	Tapper, EB (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol Hepatol,Dept Med, Boston, MA 02215 USA.	etapper@bidmc.harvard.edu		Afdhal, Nezam/0000-0002-7342-6593	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR000430] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Afdhal NH, 2012, JAMA-J AM MED ASSOC, V308, P608, DOI 10.1001/jama.2012.8402; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; de Ledinghen V, 2014, J HEPATOL, V60, P1026, DOI 10.1016/j.jhep.2013.12.018; de Ledinghen V, 2012, J HEPATOL, V56, P833, DOI 10.1016/j.jhep.2011.10.017; Dixon JB, 2004, HEPATOLOGY, V39, P1647, DOI 10.1002/hep.20251; Dowman JK, 2011, ALIMENT PHARM THER, V33, P525, DOI 10.1111/j.1365-2036.2010.04556.x; Doycheva I, 2015, ALIMENTARY PHARM THE; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Festi D, 2013, ALIMENT PHARM THER, V37, P392, DOI 10.1111/apt.12186; Forrest CB, 2007, ANN FAM MED, V5, P361, DOI 10.1370/afm.703; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Kwok R, 2014, ALIMENT PHARM THER, V39, P254, DOI 10.1111/apt.12569; Kwok R, 2015, GUT; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Mehrotra A, 2011, MILBANK Q, V89, P39, DOI 10.1111/j.1468-0009.2011.00619.x; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Petrou S, 2011, BMJ, V342; Petta S, 2015, HEPATOLOGY, V62, P1101, DOI 10.1002/hep.27844; Petta S, 2015, LIVER INT, V35, P1566, DOI 10.1111/liv.12584; Promrat K, 2010, HEPATOLOGY, V51, P121, DOI 10.1002/hep.23276; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Singal AG, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001624; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Tapper EB, 2014, DIGEST DIS SCI, P1; Tapper EB, 2014, GASTROENTEROL REP OX; Tapper EB, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2015.07.019; Tapper EB, 2015, AM J GASTROENTEROL, V110, P1298, DOI 10.1038/ajg.2015.241; Tapper EB, 2015, CURR OPIN GASTROEN, V31, P192, DOI 10.1097/MOG.0000000000000169; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P27, DOI 10.1016/j.cgh.2014.04.039; Tapper EB, 2013, AM J MED, V126, P926, DOI 10.1016/j.amjmed.2013.01.039; Tapper EB, 2012, CLIN GASTROENTEROL H, V10, P932, DOI 10.1016/j.cgh.2012.01.015; Wong VWS, 2012, AM J GASTROENTEROL, V107, P1862, DOI 10.1038/ajg.2012.331; World Health Organisation, 2003, ADHERENCE LONG TERM; Younossi ZM, 2015, J CLIN GASTROENTEROL, V49, P222, DOI 10.1097/MCG.0000000000000071	41	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0147237	10.1371/journal.pone.0147237	http://dx.doi.org/10.1371/journal.pone.0147237			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905872	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000002
J	Wang, CH; Shi, CX; Rou, KM; Zhao, Y; Cao, XB; Luo, W; Liu, EW; Wu, ZY				Wang, Changhe; Shi, Cynthia X.; Rou, Keming; Zhao, Yan; Cao, Xiaobin; Luo, Wei; Liu, Enwu; Wu, Zunyou			Baseline HCV Antibody Prevalence and Risk Factors among Drug Users in China's National Methadone Maintenance Treatment Program	PLOS ONE			English	Article							HEPATITIS-C VIRUS; GLOBAL EPIDEMIOLOGY; TREATMENT CLINICS; INJECT DRUGS; INFECTION; HIV; PEOPLE; IMPACT; KNOWLEDGE; SHANGHAI	Background Hepatitis C virus (HCV) is the most common viral infection among injecting drug users worldwide. We aimed to assess HCV antibody prevalence and associated risk factors among clients in the Chinese national methadone maintenance treatment (MMT) program. Methods Data from 296,209 clients who enrolled in the national MMT program between March 2004 and December 2012 were analyzed to assess HCV antibody prevalence, associated risk factors, and geographical distribution. Results Anti-HCV screening was positive for 54.6% of clients upon MMT entry between 2004 and 2012. HCV antibody prevalence at entry declined from 66.8% in 2005 to 45.9% in 2012. The most significant predictors of HCV seropositivity were injecting drug use (adjusted odds ratio [AOR]: 8.34, 95% confidence interval [CI]: 8.17-8.52, p<0.0001) and a history of drug use >= 9 years (AOR: 2.01, 95% CI: 1.96-2.06, p<0.0001). Being female, of Uyghur or Zhuang ethnicity, and unmarried were identified as demographic risk factors (all p-values<0.0001). Of the 28 provincial-level divisions included in the study, we found that 5 divisions had HCV antibody prevalence above 70% and 20 divisions above 50%. The HCV screening rate within 6 months after MMT entry greatly increased from 30.4% in 2004 to 93.1% in 2012. Conclusions The current HCV antibody prevalence remains alarmingly high among MMT clients throughout most provincial-level divisions in China, particularly among injecting drug users and females. A comprehensive prevention strategy is needed to control the HCV epidemic among MMT clients in China.	[Wang, Changhe; Shi, Cynthia X.; Rou, Keming; Zhao, Yan; Cao, Xiaobin; Luo, Wei; Liu, Enwu; Wu, Zunyou] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Wu, ZY (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wuzy@263.net	Liu, Enwu/AGC-4748-2022	Liu, Enwu/0000-0003-2580-3523	China National Health and Family Planning Commission [131-14-000-105-01]; US NIH Fogarty International Center and National Institute on Drug Abuse [U2RTW06918]	China National Health and Family Planning Commission; US NIH Fogarty International Center and National Institute on Drug Abuse	This work was supported by funding from China National Health and Family Planning Commission (Grant # 131-14-000-105-01), and by US NIH Fogarty International Center and National Institute on Drug Abuse (Grant# U2RTW06918). Funding organizations had no role in the design of this study, in the collection, analysis, or interpretation of data, or in the final decision to submit the manuscript for publication.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Bao YP, 2009, INT J STD AIDS, V20, P399, DOI 10.1258/ijsa.2008.008362; Bao YP, 2012, AM J DRUG ALCOHOL AB, V38, P140, DOI 10.3109/00952990.2011.643984; Broers B, 1998, AIDS, V12, P2059, DOI 10.1097/00002030-199815000-00018; Chen Ang, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P1230; Chen Yuan-sheng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P888; Crofts N, 1997, ADDICTION, V92, P999, DOI 10.1111/j.1360-0443.1997.tb02979.x; Crofts N, 2001, AUSTR PERSPECTIVE; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Du J, 2012, AM J DRUG ALCOHOL AB, V38, P228, DOI 10.3109/00952990.2011.643974; Fuller CM, 2001, PUBLIC HEALTH REP, V116, P136, DOI 10.1093/phr/116.S1.136; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; Hser Y, 2012, J PUBLIC HEALTH-UK, V34, P24, DOI 10.1093/pubmed/fdr098; Kulsudjarit K, 2004, ANN NY ACAD SCI, V1025, P446, DOI 10.1196/annals.1316.055; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lee KCK, 2008, J CLIN VIROL, V41, P297, DOI 10.1016/j.jcv.2007.09.013; Li L, 2012, ADDICT BEHAV, V37, P264, DOI 10.1016/j.addbeh.2011.11.004; Lu J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008467; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Mao YR, 2010, INT J EPIDEMIOL, V39, pII79, DOI 10.1093/ije/dyq213; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Maxwell S, 2002, HEROIN ADDICT REL CL, V4, P5; McCarthy JJ, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n01_03; Metzger David S, 2010, Curr HIV/AIDS Rep, V7, P220, DOI 10.1007/s11904-010-0059-z; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Murray JM, 2003, INT J EPIDEMIOL, V32, P708, DOI 10.1093/ije/dyg102; National Center for AIDS/STD Control and Prevention/China CDC, 2013, ANN REP IMPL NAT HIV; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Novick DM, 2000, MT SINAI J MED, V67, P437; Rao HY, 2012, J VIRAL HEPATITIS, V19, P173, DOI 10.1111/j.1365-2893.2011.01497.x; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruan YH, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000304695.54884.4f; Scheinmann R, 2007, DRUG ALCOHOL DEPEN, V89, P1, DOI 10.1016/j.drugalcdep.2006.11.014; Shah DP, 2012, J MED VIROL, V84, P235, DOI 10.1002/jmv.22271; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sun Y, 2007, OCCUPATION HLTH, V23, P881; Treloar C, 2012, DRUG ALCOHOL REV, V31, P918, DOI 10.1111/j.1465-3362.2012.00468.x; Turner KME, 2011, ADDICTION, V106, P1978, DOI 10.1111/j.1360-0443.2011.03515.x; Vlahov D, 2004, J URBAN HEALTH, V81, P14, DOI 10.1093/jurban/jth083; Wiessing L, 2011, EURO SURVEILL, V16; Xia X, 2008, PUBLIC HEALTH, V122, P990, DOI 10.1016/j.puhe.2008.01.014; Xia YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066787; Yin WY, 2010, INT J EPIDEMIOL, V39, pII29, DOI 10.1093/ije/dyq210; Zhuang X, 2012, DRUG ALCOHOL DEPEN, V126, P286, DOI 10.1016/j.drugalcdep.2012.05.028; Zhuang X, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-130	46	9	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0147922	10.1371/journal.pone.0147922	http://dx.doi.org/10.1371/journal.pone.0147922			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2HK	26906025	Green Published, Green Submitted, gold			2022-12-27	WOS:000371163000003
J	Koenig, SP; Bernard, D; Devieux, JG; Atwood, S; McNairy, ML; Severe, P; Marcelin, A; Julma, P; Apollon, A; Pape, JW				Koenig, Serena P.; Bernard, Daphne; Devieux, Jessy G.; Atwood, Sidney; McNairy, Margaret L.; Severe, Patrice; Marcelin, Adias; Julma, Pierrot; Apollon, Alexandra; Pape, Jean W.			Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; SOUTH-AFRICA; FOLLOW-UP; SCALE-UP; TREATMENT PROGRAM; INFECTED ADULTS; RISK-FACTORS; MORTALITY; OUTCOMES	Background High attrition during the period from HIV testing to antiretroviral therapy (ART) initiation is widely reported. Though treatment guidelines have changed to broaden ART eligibility and services have been widely expanded over the past decade, data on the temporal trends in pre-ART outcomes are limited; such data would be useful to guide future policy decisions. Methods We evaluated temporal trends and predictors of retention for each step from HIV testing to ART initiation over the past decade at the GHESKIO clinic in Port-au-Prince Haiti. The 24,925 patients >17 years of age who received a positive HIV test at GHESKIO from March 1, 2003 to February 28, 2013 were included. Patients were followed until they remained in pre-ART care for one year or initiated ART. Results 24,925 patients (61% female, median age 35 years) were included, and 15,008 (60%) had blood drawn for CD4 count within 12 months of HIV testing; the trend increased over time from 36% in Year 1 to 78% in Year 10 (p<0.0001). Excluding transfers, the proportion of patients who were retained in pre-ART care or initiated ART within the first year after HIV testing was 84%, 82%, 64%, and 64%, for CD4 count strata <= 200, 201 to 350, 351 to 500, and >500 cells/mm(3), respectively. The trend increased over time for each CD4 strata, and in Year 10, 94%, 95%, 79%, and 74% were retained in pre-ART care or initiated ART for each CD4 strata. Predictors of pre-ART attrition included male gender, low income, and low educational status. Older age and tuberculosis (TB) at HIV testing were associated with retention in care. Conclusions The proportion of patients completing assessments for ART eligibility, remaining in pre-ART care, and initiating ART have increased over the last decade across all CD4 count strata, particularly among patients with CD4 count <= 350 cells/mm(3). However, additional retention efforts are needed for patients with higher CD4 counts.	[Koenig, Serena P.; Bernard, Daphne; Severe, Patrice; Marcelin, Adias; Julma, Pierrot; Apollon, Alexandra; Pape, Jean W.] Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti; [Koenig, Serena P.; Atwood, Sidney] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Global Hlth Equ, Boston, MA 02115 USA; [Devieux, Jessy G.] Florida Int Univ, AIDS Prevent Program, Miami, FL 33199 USA; [McNairy, Margaret L.; Pape, Jean W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; State University System of Florida; Florida International University; Cornell University	Koenig, SP (corresponding author), Haitian Study Grp Kaposis Sarcoma & Opportunist I, Port Au Prince, Haiti.; Koenig, SP (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Global Hlth Equ, Boston, MA 02115 USA.	skoenig@partners.org			National Institute of Allergy and Infectious Diseases (NIAID) [R01AI104344]; Haiti Research Training Program in the Prevention of AIDS Cervical Cancer [1D43TW009606]; Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor) [5R25TW009337]; United States President's Emergency Plan for AIDS Relief (PEPFAR); Global Fund to Fight AIDS, Tuberculosis and Malaria; FOGARTY INTERNATIONAL CENTER [D43TW009606, R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104344] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Haiti Research Training Program in the Prevention of AIDS Cervical Cancer; Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor); United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Global Fund to Fight AIDS, Tuberculosis and Malaria; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported in part by the National Institute of Allergy and Infectious Diseases (NIAID) Grant Number R01AI104344, Haiti Research Training Program in the Prevention of AIDS Cervical Cancer 1D43TW009606, and the Vanderbilt-Emory-Cornell-Duke Consortium for Global Health Fellows (VECDor) 5R25TW009337. The United States President's Emergency Plan for AIDS Relief (PEPFAR) and the Global Fund to Fight AIDS, Tuberculosis and Malaria provided funding for medications and patient care. No funder was involved in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyu MH, 2014, JAIDS-J ACQ IMM DEF, V65, pE41, DOI 10.1097/QAI.0b013e31829ceaec; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; [Anonymous], 2014, UNAIDS COUNTRY REPOR; April MD, 2009, JAIDS-J ACQ IMM DEF, V51, P310, DOI 10.1097/QAI.0b013e3181a248e6; Assefa Y, 2010, AIDS PATIENT CARE ST, V24, P521, DOI 10.1089/apc.2009.0286; Auld AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018453; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cornell M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001304; Fox MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110252; Fox MP, 2012, TROP MED INT HEALTH, V17, P1235, DOI 10.1111/j.1365-3156.2012.03055.x; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Govindasamy D, 2014, T ROY SOC TROP MED H, V108, P1, DOI 10.1093/trstmh/trt105; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Hawkins C, 2011, AIDS, V25, P1189, DOI 10.1097/QAD.0b013e3283471deb; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Kohler PK, 2011, AIDS, V25, P1657, DOI 10.1097/QAD.0b013e32834957fd; Kranzer K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013801; Kumarasamy N, 2008, J WOMENS HEALTH, V17, P1471, DOI 10.1089/jwh.2007.0670; Larson BA, 2010, B WORLD HEALTH ORGAN, V88, P675, DOI 10.2471/BLT.09.068981; Larson BA, 2010, TROP MED INT HEALTH, V15, P43, DOI 10.1111/j.1365-3156.2010.02511.x; Lessells RJ, 2011, JAIDS-J ACQ IMM DEF, V56, pE79, DOI 10.1097/QAI.0b013e3182075ae2; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Madec Y, 2007, AIDS, V21, P351, DOI 10.1097/QAD.0b013e328012c54f; Marks G, 2010, AIDS, V24, P2665, DOI 10.1097/QAD.0b013e32833f4b1b; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Micek MA, 2009, JAIDS-J ACQ IMM DEF, V52, P397, DOI 10.1097/QAI.0b013e3181ab73e2; Mills EJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-52; Moon TD, 2011, INT J STD AIDS, V22, P621, DOI 10.1258/ijsa.2011.010442; MSPP, 2013, MAN NORM PRIS CHARG; MSPP, 2008, MAN NORM PRIS CHARG; Mugglin C, 2012, TROP MED INT HEALTH, V17, P1509, DOI 10.1111/j.1365-3156.2012.03089.x; Mulissa Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013268; Mutevedzi PC, 2010, B WORLD HEALTH ORGAN, V88, P593, DOI 10.2471/BLT.09.069419; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Nglazi MD, 2011, JAIDS-J ACQ IMM DEF, V56, pE1, DOI 10.1097/QAI.0b013e3181ff0bdc; Noel E, 2012, J ACQUIR IMMUNE DEFI; Palombi L, 2009, CLIN INFECT DIS, V48, P115, DOI 10.1086/593312; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Severe P, 2010, NEW ENGL J MED, V363, P257, DOI 10.1056/NEJMoa0910370; Tayler-Smith K, 2010, T ROY SOC TROP MED H, V104, P313, DOI 10.1016/j.trstmh.2010.01.007; van Griensven J, 2010, T ROY SOC TROP MED H, V104, P690, DOI 10.1016/j.trstmh.2010.07.006; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD; World Health Organization (WHO), 2006, GUID COTR PROPH HIV; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P421, DOI 10.1016/j.trstmh.2011.04.014	51	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0146903	10.1371/journal.pone.0146903	http://dx.doi.org/10.1371/journal.pone.0146903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901795	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100007
J	Wu, ML; Lu, L; Zhang, Q; Guo, Q; Zhao, FX; Li, TW; Zhang, XN				Wu, Menglin; Lu, Li; Zhang, Qi; Guo, Qi; Zhao, Feixiang; Li, Tongwei; Zhang, Xuening			Relating Doses of Contrast Agent Administered to TIC and Semi-Quantitative Parameters on DCE-MRI: Based on a Murine Breast Tumor Model	PLOS ONE			English	Article							ENHANCED MRI; NEOADJUVANT CHEMOTHERAPY; PATHOLOGICAL RESPONSE; EARLY PREDICTION; CANCER; CELLULARITY; MULTICENTER; CARCINOMA; ACCURACY; SURVIVAL	Objective To explore the changes in the time-signal intensity curve(TIC) type and semi-quantitative parameters of dynamic contrast-enhanced(DCE)imaging in relation to variations in the contrast agent(CA) dosage in the Walker 256 murine breast tumor model, and to determine the appropriate parameters for the evaluation of neoadjuvantchemotherapy(NAC) response. Materials and Methods Walker 256 breast tumor models were established in 21 rats, which were randomly divided into three groups of7rats each. Routine scanning and DCE-magnetic resonance imaging (MRI) of the rats were performed using a 7T MR scanner. The three groups of rats were administered different dosages of the CA0.2mmol/kg, 0.3mmol/kg, and 0.5mmol/kg, respectively; and the corresponding TICs the semi-quantitative parameters were calculated and compared among the three groups. Results The TICs were not influenced by the CA dosage and presented a washout pattern in all of the tumors evaluated and weren't influenced by the CA dose. The values of the initial enhancement percentage(E-first), initial enhancement velocity(V-first), maximum signal(S-max), maximum enhancement percentage(E-max), washout percentage(E-wash), and signal enhancement ratio(SER) showed statistically significant differences among the three groups (F = 16.952, p = 0.001; F = 69.483, p<0.001; F = 54.838, p<0.001; F = 12.510, p = 0.003; F = 5.248, p = 0.031; F = 9.733, p = 0.006, respectively). However, the values of the time to peak(T-peak), maximum enhancement velocity(V-max), and washout velocity(V-wash) did not differ significantly among the three dosage groups (F = 0.065, p = 0.937; F = 1.505, p = 0.273; chi(2) = 1.423, p = 0.319, respectively); the washout slope(Slope(wash)), too, was uninfluenced by the dosage(F = 1.654, p = 0.244). Conclusion The CA dosage didn't affect the TIC type, T-peak, V-max, V-wash or Slopewash. These dose-independent parameters as well as the TIC type might be more useful for monitoring the NAC response because they allow the comparisons of the DCE data obtained using different CA dosages.	[Wu, Menglin; Zhang, Qi; Guo, Qi; Zhao, Feixiang; Li, Tongwei; Zhang, Xuening] Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China; [Lu, Li] Tianjin Med Univ, Gen Hosp, Dept Gen Surg, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhang, XN (corresponding author), Tianjin Med Univ, Hosp 2, Dept Radiol, Tianjin, Peoples R China.	luckyxn_tianjin@163.com						Abramson RG, 2013, MAGN RESON IMAGING, V31, P1457, DOI 10.1016/j.mri.2013.07.002; Aryal MP, 2014, MAGN RESON MED, V71, P2206, DOI 10.1002/mrm.24873; Ashraf AB, 2014, RADIOLOGY, V272, P374, DOI 10.1148/radiol.14131375; Atuegwu NC, 2013, TRANSL ONCOL, V6, P256, DOI 10.1593/tlo.13130; Bernardin L, 2012, EUR RADIOL, V22, P880, DOI 10.1007/s00330-011-2331-z; Bottcher J, 2014, ACTA ONCOL, V53, P759, DOI 10.3109/0284186X.2013.852688; Cho N, 2014, RADIOLOGY, V272, P385, DOI 10.1148/radiol.14131332; Choi JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051712; DeSantis C, 2014, CA-CANCER J CLIN, V64, P52, DOI 10.3322/caac.21203; El Khouli RH, 2014, RADIOLOGY, V272, P79, DOI 10.1148/radiol.14131384; El Khouli RH, 2011, AM J ROENTGENOL, V197, P1498, DOI 10.2214/AJR.10.4665; Fedorov A, 2015, ACAD RADIOL, V22, P548, DOI 10.1016/j.acra.2014.12.022; Galie M, 2009, MICROVASC RES, V78, P370, DOI 10.1016/j.mvr.2009.09.004; Gutierrez RL, 2012, AM J ROENTGENOL, V199, P703, DOI 10.2214/AJR.11.7836; He DF, 2012, CLIN BREAST CANCER, V12, P94, DOI 10.1016/j.clbc.2011.11.002; Heywang-Korunner SH, 2001, EUR RADIOL, V11, P531, DOI 10.1007/s003300000745; HEYWANGKOBRUNNER SH, 1994, RADIOLOGY, V191, P639, DOI 10.1148/radiology.191.3.8184040; Jansen SA, 2010, ACAD RADIOL, V17, P24, DOI 10.1016/j.acra.2009.06.015; Jansen SA, 2009, AM J ROENTGENOL, V193, P832, DOI 10.2214/AJR.08.2025; Jones EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061969; Kanal E, 2007, AM J ROENTGENOL, V188, P1447, DOI 10.2214/AJR.06.1616; Khalifa F, 2014, MED PHYS, V41, DOI 10.1118/1.4898202; Knopp MV, 2003, AM J ROENTGENOL, V181, P663, DOI 10.2214/ajr.181.3.1810663; Leach MO, 2005, LANCET, V365, P1769, DOI 10.1016/S0140-6736(05)66481-1; Levman J, 2014, J DIGIT IMAGING, V27, P670, DOI 10.1007/s10278-014-9723-y; Li X, 2014, MAGN RESON MED, V71, P1592, DOI 10.1002/mrm.24782; Lim I, 2014, EUR J NUCL MED MOL I, V41, P1852, DOI 10.1007/s00259-014-2797-4; Marinovich ML, 2012, BREAST, V21, P669, DOI 10.1016/j.breast.2012.07.006; Murakami Koichiro, 2008, Magn Reson Med Sci, V7, P105, DOI 10.2463/mrms.7.105; Nadrljanski MM, 2013, DIAGN INTERV RADIOL, V19, P463, DOI 10.5152/dir.2013.13201; Padhani AR, 2010, TARGET ONCOL, V5, P39, DOI 10.1007/s11523-010-0135-8; Partridge SC, 2014, ACAD RADIOL, V21, P1195, DOI 10.1016/j.acra.2014.04.013; Pickles MD, 2015, EUR RADIOL, V25, P1097, DOI 10.1007/s00330-014-3502-5; Popiel M, 2012, POL J RADIOL, V77, P35, DOI 10.12659/PJR.883627; Rahbar H, 2015, EUR J RADIOL, V84, P611, DOI 10.1016/j.ejrad.2014.12.029; Schmitz AMT, 2014, BREAST CANCER RES TR, V148, P541, DOI 10.1007/s10549-014-3170-9; Tateishi U, 2012, RADIOLOGY, V263, P53, DOI 10.1148/radiol.12111177; Woolf DK, 2014, BREAST CANCER RES TR, V147, P335, DOI 10.1007/s10549-014-3072-x; Yankeelov TE, 2006, J MAGN RESON IMAGING, V24, P1140, DOI 10.1002/jmri.20729; Yi B, 2014, EUR RADIOL, V24, P1089, DOI 10.1007/s00330-014-3100-6	40	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149279	10.1371/journal.pone.0149279	http://dx.doi.org/10.1371/journal.pone.0149279			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901876	gold, Green Published			2022-12-27	WOS:000371276100051
J	Zhu, BC; Wang, JC; Zhao, LH; Sun, ZX; Brauth, SE; Tang, YZ; Cui, JG				Zhu, Bicheng; Wang, Jichao; Zhao, Longhui; Sun, Zhixin; Brauth, Steven E.; Tang, Yezhong; Cui, Jianguo			Bigger Is Not Always Better: Females Prefer Males of Mean Body Size in Philautus odontotarsus	PLOS ONE			English	Article							MALE-MATING ADVANTAGE; SEXUAL SELECTION; WATER STRIDER; EVOLUTION; DIMORPHISM; TREEFROG; COMPETITION; MECHANISMS; SUCCESS; QUALITY	Most species are believed to evolve larger body sizes over evolutionary time. Previous studies have suggested that sexual selection, through male-male competition and female choice, favors larger males. However, there is little evidence of selection against large size. The female serrate-legged small treefrogs (Philautus odontotarsus) must carry passive males from leks to breeding grounds over relatively long distances after amplexus to find a suitable place to lay eggs. The costs of large male size may therefore decrease mating success due to reduced agility and/or higher energy requirements. Thus, we hypothesized that selection would not favor larger males in P. odontotarsus. Females can assess male body size on the basis of the dominant frequency of male calls in frogs. To assess female P. odontotarsus preferences for a potential mate's body size, male calls of high, average and low dominant frequency were played back to the females in phonotaxis experiments. Results showed that most females prefer the advertisement call with average dominant frequency. In addition, we compared the body mass distribution of amplectant males with that of single males in nature. The body masses of amplectant males are more narrowly distributed in the intermediate range than that of single males. The phonotaxis results and the data of actual female preferences in the field show that females strongly prefer potential mates of mean body sizes, consistent with the view that, in this species at least, larger males are not always perceived as better by females. In the present study, P. odontotarsus provides an example of an amphibian species in which large size does not have an advantage in mating success for males. Instead, our results provide evidences that stabilizing selection favors the optimal intermediate size of males.	[Zhu, Bicheng; Zhao, Longhui; Tang, Yezhong; Cui, Jianguo] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China; [Wang, Jichao; Sun, Zhixin] Hainan Normal Univ, Dept Biol, Haikou, Hainan, Peoples R China; [Brauth, Steven E.] Univ Maryland, Dept Psychol, College Pk, MD 20742 USA	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Hainan Normal University; University System of Maryland; University of Maryland College Park	Cui, JG (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Sichuan, Peoples R China.	cuijgcn@gmail.com	Zhu, Bicheng/AAU-3425-2020		National Natural Science Foundation of China [31270042, 31260518, 31372217]; Youth Professor Project of CIB; Guangdong Province [2012B091100260]; Chinese Academy of Sciences [2012B091100260]; Youth Innovation Promotion Association of CAS; Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Professor Project of CIB; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); Youth Innovation Promotion Association of CAS; Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University)	This work was supported by the National Natural Science Foundation of China grant 31270042 (JC), 31260518 (JW), 31372217 (GF), Youth Professor Project of CIB (JC), the Project of Comprehensive Strategic Cooperation between Guangdong Province and Chinese Academy of Sciences grant 2012B091100260 (JC), Youth Innovation Promotion Association of CAS and Open Fund of the Hainan Province Key Laboratory of Tropical Plant and Animal Ecology (Hainan Normal University) (JC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akre KL, 2011, SCIENCE, V333, P751, DOI 10.1126/science.1205623; Andersson Malte, 1994; ARAK A, 1983, NATURE, V306, P261, DOI 10.1038/306261a0; ARNQVIST G, 1989, ANIM BEHAV, V38, P749, DOI 10.1016/S0003-3472(89)80107-1; Bee MA, 1999, BEHAV ECOL SOCIOBIOL, V45, P177, DOI 10.1007/s002650050551; Blanckenhorn WU, 2005, ETHOLOGY, V111, P977, DOI 10.1111/j.1439-0310.2005.01147.x; Blanckenhorn WU, 2000, Q REV BIOL, V75, P385, DOI 10.1086/393620; Blanckenhorn WU, 1998, J EVOLUTION BIOL, V11, P735, DOI 10.1007/s000360050116; Bonner JT., 1988, EVOLUTION COMPLEXITY; Dziminski MA, 2010, REPROD FERT DEVELOP, V22, P516, DOI 10.1071/RD09124; Endler J.A., 1986, Monographs in Population Biology, pviii; FAIRBAIRN DJ, 1994, AM NAT, V144, P101, DOI 10.1086/285663; FOX CW, 1995, ANIM BEHAV, V50, P281, DOI 10.1006/anbe.1995.0242; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; GIVEN MF, 1987, HERPETOLOGICA, V43, P467; Gress BE, 2014, P ROY SOC B, V281, P2013; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; LaBarbera M., 1986, Life Sciences Research Report, P69; Liao WB, 2011, BEHAVIOUR, V148, P1087, DOI 10.1163/000579511X589848; Maynard Smith J., 1982, pi; MCLAIN DK, 1993, OIKOS, V68, P490, DOI 10.2307/3544917; MORRIS MR, 1989, BEHAV ECOL SOCIOBIOL, V25, P65, DOI 10.1007/BF00299712; Nali RC, 2014, AM NAT, V184, P727, DOI 10.1086/678455; Narins P.M., 2006, HEARING SOUND COMMUN, DOI DOI 10.1007/978-0-387-47796-1; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rausch AM, 2014, BEHAVIOUR, V151, P1869, DOI 10.1163/1568539X-00003220; Reichert MS, 2011, ANIM BEHAV, V82, P1357, DOI 10.1016/j.anbehav.2011.09.019; Richardson C, 2008, ANIM BEHAV, V76, P1487, DOI 10.1016/j.anbehav.2008.06.019; Richardson C, 2010, BEHAVIOUR, V147, P1737, DOI 10.1163/000579510X530221; ROBERTSON JGM, 1986, ANIM BEHAV, V34, P763, DOI 10.1016/S0003-3472(86)80060-4; Rowe C, 2011, SCIENCE, V333, P708, DOI 10.1126/science.1210723; RYAN MJ, 1980, SCIENCE, V209, P523, DOI 10.1126/science.209.4455.523; RYAN MJ, 1992, AM NAT, V139, pS4, DOI 10.1086/285303; SCHLUTER D, 1991, P ROY SOC B-BIOL SCI, V246, P11, DOI 10.1098/rspb.1991.0118; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Tammaru T, 2002, OECOLOGIA, V133, P430, DOI 10.1007/s00442-002-1057-7; Taylor BW, 1998, OECOLOGIA, V114, P494, DOI 10.1007/s004420050473; TEJEDO M, 1992, ANIM BEHAV, V44, P557, DOI 10.1016/0003-3472(92)90065-H; TRAVIS J, 1989, ANNU REV ECOL SYST, V20, P279, DOI 10.1146/annurev.es.20.110189.001431; Wang JC, 2012, ASIAN HERPETOL RES, V3, P205, DOI 10.3724/SP.J.1245.2012.00205; WARNER RR, 1984, AM SCI, V72, P128; William E, 1989, BEHAV ECOL SOCIOBIOL, V25, P429; WOOLBRIGHT LL, 1983, AM NAT, V121, P110, DOI 10.1086/284042	44	17	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149879	10.1371/journal.pone.0149879	http://dx.doi.org/10.1371/journal.pone.0149879			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901766	gold, Green Published			2022-12-27	WOS:000371276100171
J	Reito, A; Lainiala, O; Elo, P; Eskelinen, A				Reito, Aleksi; Lainiala, Olli; Elo, Petra; Eskelinen, Antti			Prevalence of Failure due to Adverse Reaction to Metal Debris in Modern, Medium and Large Diameter Metal-on-Metal Hip Replacements - The Effect of Novel Screening Methods: Systematic Review and Metaregression Analysis	PLOS ONE			English	Review							ARTICULAR SURFACE REPLACEMENT; 5-YEAR FOLLOW-UP; SINGLE SURGEON SERIES; RESURFACING ARTHROPLASTY; ION LEVELS; FAILED METAL; FEMORAL-HEAD; PSEUDOTUMOR FORMATION; CONSECUTIVE HIPS; ACETABULAR CUP	Metal-on-metal (MoM) hip replacements were used for almost a decade before adverse reactions to metal debris (ARMD) were found to be a true clinical problem. Currently, there is a paucity of evidence regarding the usefulness of systematic screening for ARMD. We implemented a systematic review and meta-analysis to establish the prevalence of revision confirmed ARMD stratified by the use of different screening protocols in patients with MoM hip replacements. Five levels of screening were identified: no screening (level 0), targeted blood metal ion measurement and/or cross-sectional imaging (level 1), metal ion measurement without imaging (level 2), metal ion measurement with targeted imaging (level 3) and comprehensive screening (both metal ions and imaging for all; level 4). 122 studies meeting our eligibility criteria were included in analysis. These studies included 144 study arms: 100 study arms with hip resurfacings, 33 study arms with large-diameter MoM total hip replacements (THR), and 11 study arms with medium-diameter MoM THRs. For hip resurfacing, the lowest prevalence of ARMD was seen with level 0 screening (pooled prevalence 0.13%) and the highest with level 4 screening (pooled prevalace 9.49%). Pooled prevalence of ARMD with level 0 screening was 0.29% and with level 4 screening 21.3% in the large-diameter MoM THR group. In metaregression analysis of hip resurfacings, level 4 screening was superior with regard to prevalence of ARMD when compared with other levels. In the large diameter THR group level 4 screening was superior to screening 0,2 and 3. These outcomes were irrespective of follow-up time or study publication year. With hip resurfacings, routine cross-sectional imaging regardless of clinical findings is advisable. It is clear, however, that targeted metal ion measurement and/or imaging is not sufficient in the screening for ARMD in any implant concepts. However, economic aspects should be weighed when choosing the preferred screening level.	[Reito, Aleksi; Lainiala, Olli; Elo, Petra; Eskelinen, Antti] Coxa Hosp Joint Replacement, Biokatu 6b, Tampere 33900, Finland	Coxa Hospital for Joint Replacement	Reito, A (corresponding author), Coxa Hosp Joint Replacement, Biokatu 6b, Tampere 33900, Finland.	aleksi.reito@fimnet.fi	Eskelinen, Antti/AAW-9209-2021; Eskelinen, Antti/AAW-9223-2021; Reito, Aleksi/AAC-3832-2020	Eskelinen, Antti/0000-0003-0302-0253; Reito, Aleksi/0000-0002-6903-6461				Amstutz HC, 2011, J ARTHROPLASTY, V26, P198, DOI 10.1016/j.arth.2010.03.033; Arndt Justin Michael, 2013, HSS J, V9, P145, DOI 10.1007/s11420-013-9333-0; Aulakh TS, 2010, ARCH ORTHOP TRAUM SU, V130, P841, DOI 10.1007/s00402-009-0963-0; Australian Orthopaedic Association National Joint Replacement Registry, 2014 ANN REP; Azam MQ, 2015, INT ORTHOP; Baker RP, 2011, J BONE JOINT SURG BR, V93B, P158, DOI 10.1302/0301-620X.93B2.25625; Barnes LA, 2014, INT ORTHOP, V38, P2435, DOI 10.1007/s00264-014-2506-8; Barrett WP, 2012, J ARTHROPLASTY, V27, P976, DOI 10.1016/j.arth.2012.01.019; Bayley N, 2015, CLIN ORTHOP RELAT R, V473, P477, DOI 10.1007/s11999-014-3824-2; Bergeron SG, 2009, BULL HOSP JT DIS, V67, P132; Bernasek TL, 2013, J ARTHROPLASTY, V28, P1231, DOI 10.1016/j.arth.2013.03.012; Berton C, 2010, J BONE JOINT SURG BR, V92B, P202, DOI 10.1302/0301-620X.92B2.22653; Bisschop R, 2013, J BONE JOINT SURG AM, V95A, P1554, DOI 10.2106/JBJS.L.00716; Bisseling P, 2015, J ARTHROPLASTY, V30, P61, DOI 10.1016/j.arth.2014.07.036; Bolland BJRF, 2011, J BONE JOINT SURG BR, V93B, P608, DOI 10.1302/0301-620X.93B5.26309; Bose VC, 2010, J BONE JOINT SURG BR, V92B, P922, DOI 10.1302/0301-620X.92B7.23639; Bosker BH, 2012, J BONE JOINT SURG BR, V94B, P755, DOI 10.1302/0301-620X.94B6.28373; Bozic KJ, 2009, J BONE JOINT SURG AM, V91A, P1614, DOI 10.2106/JBJS.H.01220; Browne JA, 2010, CLIN ORTHOP RELAT R, V468, P2313, DOI 10.1007/s11999-010-1419-0; Chatrath V, 2013, AM SOC TEST MATER, V1560, P73, DOI 10.1520/STP156020120045; Cip J, 2014, J ARTHROPLASTY, V29, P2127, DOI 10.1016/j.arth.2014.06.025; Coulter G, 2012, J BONE JOINT SURG BR, V94B, P315, DOI 10.1302/0301-620X.94B3.28185; Daniel J, 2014, BONE JOINT J, V96B, P1298, DOI 10.1302/0301-620X.96B10.33695; Daniel J, 2010, J BONE JOINT SURG BR, V92B, P20, DOI 10.1302/0301-620X.92B1.21530; De Smet KA, 2005, ORTHOP CLIN N AM, V36, P203, DOI 10.1016/j.ocl.2005.01.004; Della Valle CJ, 2009, CLIN ORTHOP RELAT R, V467, P72, DOI 10.1007/s11999-008-0563-2; Delport HP, 2011, ACTA ORTHOP BELG, V77, P609; Dramis A, 2014, HIP INT, V24, P442, DOI 10.5301/hipint.5000150; El Hachmi M, 2014, J ARTHROPLASTY, V29, P808, DOI 10.1016/j.arth.2013.09.014; Engh CA, 2010, CLIN ORTHOP RELAT R, V468, P406, DOI 10.1007/s11999-009-1063-8; Fernandez-Valencia J, 2014, ADV ORTHOP, V2014, DOI 10.1155/2014/982523; Fowble VA, 2009, BULL HOSP JT DIS, V67, P108; Giannini S, 2011, HIP INT, V21, P52, DOI 10.5301/HIP.2011.6281; Glyn-Jones S, 2009, J BONE JOINT SURG BR, V91B, P1566, DOI 10.1302/0301-620X.91B12.22287; Griffin WL, 2010, CLIN ORTHOP RELAT R, V468, P2328, DOI 10.1007/s11999-010-1383-8; Grigoris P, 2006, P I MECH ENG H, V220, P95, DOI 10.1243/095441105X69042; Gross TP, 2008, J BONE JOINT SURG AM, V90A, P32, DOI 10.2106/JBJS.H.00614; Gross TP, 2013, HIP INT, V23, P250, DOI 10.5301/hipint.5000030; Gross TP, 2012, J ARTHROPLASTY, V27, P533, DOI 10.1016/j.arth.2011.06.019; Haddad FS, 2015, BONE JOINT J, V97B, P617, DOI 10.1302/0301-620X.97B5.34537; Hart AJ, 2009, J BONE JOINT SURG BR, V91B, P738, DOI 10.1302/0301-620X.91B6.21682; Hartmann A, 2012, CLIN ORTHOP RELAT R, V470, P3118, DOI 10.1007/s11999-012-2329-0; Hasegawa M, 2013, ORTHOPEDICS, V36, pE606, DOI 10.3928/01477447-20130426-23; Hayter CL, 2012, AM J ROENTGENOL, V199, P884, DOI 10.2214/AJR.11.8203; Heilpern GNA, 2008, J BONE JOINT SURG BR, V90B, P1137, DOI 10.1302/0301-620X.90B9.20524; Holland JP, 2012, J BONE JOINT SURG BR, V94B, P471, DOI 10.1302/0301-620X.94B4.27895; Hosny HAH, 2013, ACTA ORTHOP BELG, V79, P386; Hug KT, 2013, CLIN ORTHOP RELAT R, V471, P430, DOI 10.1007/s11999-012-2547-5; Hull P, 2011, HIP INT, V21, P475, DOI 10.5301/HIP.2011.8513; Isaac GH, 2009, J BONE JOINT SURG BR, V91B, P1134, DOI 10.1302/0301-620X.91B9.22306; Isaac GH, 2009, HIP INT, V19, P330, DOI 10.1177/112070000901900406; Issa K, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-161; Jack CM, 2013, J ARTHROPLASTY, V28, P650, DOI 10.1016/j.arth.2012.07.032; Jameson SS, 2010, J BONE JOINT SURG BR, V92B, P28, DOI 10.1302/0301-620X.92B1.22769; Jeffers JRT, 2009, BULL HOSP JT DIS, V67, P189; Junnila M, 2015, ACTA ORTHOP, V86, P345, DOI 10.3109/17453674.2014.1004015; Kadar A, 2013, ISR MED ASSOC J, V15, P505; Khan M, 2009, J ARTHROPLASTY, V24, P1044, DOI 10.1016/j.arth.2008.07.016; Kim PR, 2008, J ARTHROPLASTY, V23, P44, DOI 10.1016/j.arth.2008.05.022; Kim PR, 2011, J BONE JOINT SURG AM, V93A, P107, DOI 10.2106/JBJS.J.01721; Kindsfater KA, 2012, J ARTHROPLASTY, V27, P545, DOI 10.1016/j.arth.2011.07.002; Kordas G, 2012, HIP INT, V22, P189, DOI 10.5301/HIP.2012.9209; Kostensalo I, 2012, SCAND J SURG, V101, P62, DOI 10.1177/145749691210100112; Kostensalo I, 2014, ACTA ORTHOP BELG, V80, P222; Lainiala O, 2014, BONE JOINT J, V96B, P1610, DOI 10.1302/0301-620X.96B12.33742; Lainiala O, 2015, ACTA ORTHOP, P1; Lainiala O, 2014, ACTA ORTHOP, V85, P474, DOI 10.3109/17453674.2014.934189; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P1011, DOI 10.1302/0301-620X.93B8.26040; Langton DJ, 2011, J BONE JOINT SURG BR, V93B, P164, DOI 10.1302/0301-620X.93B2.25099; Langton DJ, 2010, J BONE JOINT SURG BR, V92B, P38, DOI 10.1302/0301-620X.92B1.22770; Lardanchet JF, 2012, ORTHOP TRAUMATOL-SUR, V98, P265, DOI 10.1016/j.otsr.2011.11.009; Latteier MJ, 2011, J ARTHROPLASTY, V26, P19, DOI 10.1016/j.arth.2011.04.012; Lavigne M, 2011, J BONE JOINT SURG AM, V93A, P93, DOI 10.2106/JBJS.J.01711; Leclercq S, 2013, ORTHOP TRAUMATOL-SUR, V99, P273, DOI 10.1016/j.otsr.2012.10.018; Levy YD, 2013, J ARTHROPLASTY, V28, P1212, DOI 10.1016/j.arth.2012.10.005; Madadi F, 2011, MED SCI MONITOR, V17, pCR78, DOI 10.12659/MSM.881391; Madhu TS, 2011, J ARTHROPLASTY, V26, P1, DOI 10.1016/j.arth.2009.10.010; Malhotra R, 2012, J ARTHROPLASTY, V27, P15, DOI 10.1016/j.arth.2011.02.016; Marker DR, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-227; Marulanda GA, 2008, ORTHOPEDICS, V31, P113; Matharu GS, 2014, ANN ROY COLL SURG, V96, P530, DOI 10.1308/003588414X14055925058030; Matharu GS, 2015, J ARTHROPLASTY, V30, P1317, DOI 10.1016/j.arth.2015.03.009; Matharu GS, 2015, INT ORTHOP, V39, P609, DOI 10.1007/s00264-015-2667-0; Matthies AK, 2013, J ORTHOP RES, V31, P1677, DOI 10.1002/jor.22431; McAndrew AR, 2007, HIP INT, V17, P1; McBryde CW, 2010, J BONE JOINT SURG AM, V92A, P105, DOI 10.2106/JBJS.I.00197; McGrath MS, 2008, J BONE JOINT SURG AM, V90A, P27, DOI 10.2106/JBJS.H.00464; McMinn DJW, 2011, INT ORTHOP, V35, P231, DOI 10.1007/s00264-010-1148-8; McMinn DJW, 2011, CLIN ORTHOP RELAT R, V469, P1589, DOI 10.1007/s11999-010-1739-0; Medicines & Healthcare products Regulatory Agency, 2012, MDA2012036 MED HEALT; Mertl P, 2010, ORTHOP TRAUMATOL-SUR, V96, P13, DOI [10.1016/j.otsr.2009.09.013, 10.1016/j.rcot.2009.12.006]; Mokka J, 2013, ACTA ORTHOP, V84, P549, DOI 10.3109/17453674.2013.859419; Murray DW, 2012, J BONE JOINT SURG BR, V94B, P1180, DOI 10.1302/0301-620X.94B9.29462; Naal FD, 2011, CLIN ORTHOP RELAT RE; Naal FD, 2009, CLIN ORTHOP RELAT R, V467, P1516, DOI 10.1007/s11999-008-0456-4; Naal FD, 2009, CLIN ORTHOP RELAT R, V467, P923, DOI 10.1007/s11999-008-0689-2; Nam D, 2012, HIP INT, V22, P566, DOI 10.5301/HIP.2012.9749; Natu S, 2012, J CLIN PATHOL, V65, P409, DOI 10.1136/jclinpath-2011-200398; Newman MA, 2008, ARCH PHYS MED REHAB, V89, P660, DOI 10.1016/j.apmr.2007.09.045; Ollivere B, 2009, J BONE JOINT SURG BR, V91B, P1025, DOI 10.1302/0301-620X.91B8.21701; Pailhe R, 2014, INT ORTHOP, V38, P1139, DOI 10.1007/s00264-013-2240-7; Pailhe R, 2013, ORTHOP REV, V5, P93, DOI 10.4081/or.2013.e20; Patel NK, 2014, ANN ROY COLL SURG, V96, P67, DOI 10.1308/003588414X13824511649850; Radtke K, 2014, TECHNOL HEALTH CARE, V22, P263, DOI 10.3233/THC-140820; Rahman L, 2011, HIP INT, V21, P356, DOI 10.5301/HIP.2011.8407; Rahman L, 2010, CLIN ORTHOP RELAT R, V468, P3221, DOI 10.1007/s11999-010-1438-x; Reito A, 2015, BMC MUSCULOSKEL DIS, V16; Reito A, 2015, INT ORTHOP, V39, P611, DOI 10.1007/s00264-015-2666-1; Reito A, 2014, INT ORTHOP, V38, P2251, DOI 10.1007/s00264-014-2429-4; Reito A, 2013, CLIN ORTHOP RELAT R, V471, P2954, DOI 10.1007/s11999-013-3023-6; Reito A, 2011, INT ORTHOP, V35, P1119, DOI 10.1007/s00264-010-1066-9; Ribas M, 2014, HIP INT, V24, pS19, DOI 10.5301/hipint.5000172; Robinson PG, 2014, HIP INT, V24, P123, DOI 10.5301/hipint.5000113; Sabah SA, 2011, J ARTHROPLASTY, V26, P71, DOI 10.1016/j.arth.2009.11.008; Sandiford NA, 2014, HIP INT, V24, P249, DOI 10.5301/hipint.5000126; Saragaglia D, 2015, ORTHOP TRAUMATOL-SUR, V101, P437, DOI 10.1016/j.otsr.2015.02.008; Schouten R, 2012, J BONE JOINT SURG BR, V94B, P1462, DOI 10.1302/0301-620X.94B11.29343; Shemesh S, 2014, Eur J Orthop Surg Traumatol, V24, P925, DOI 10.1007/s00590-013-1272-4; Siddiqui IA, 2013, CLIN RADIOL, V68, pE472, DOI 10.1016/j.crad.2013.02.003; Siebel T, 2006, P I MECH ENG H, V220, P345, DOI 10.1243/095441105X69079; Smeekes C, 2015, INT ORTHOP, V39, P631, DOI 10.1007/s00264-014-2605-6; Steele GD, 2011, J ARTHROPLASTY, V26, P14, DOI 10.1016/j.arth.2011.03.027; Stulberg BN, 2008, J BONE JOINT SURG AM, V90A, P21, DOI 10.2106/JBJS.H.00718; Sturup Jens, 2012, Open Orthop J, V6, P366, DOI 10.2174/1874325001206010366; Su EP, 2014, J ARTHROPLASTY, V29, P1571, DOI 10.1016/j.arth.2014.03.021; Swank ML, 2009, BULL HOSP JT DIS, V67, P113; Takamura KM, 2014, BONE JOINT RES, V3, P150, DOI 10.1302/2046-3758.35.2000282; The NJR Editorial Board, 2014, NAT JOINT REG ENGL W; Toms AP, 2008, CLIN RADIOL, V63, P49, DOI 10.1016/j.crad.2007.07.012; Van der Straeten C, 2013, BONE JOINT J, V95B, P1332, DOI 10.1302/0301-620X.95B10.32022; van der Weegen W, 2014, J ARTHROPLASTY, V29, P416, DOI 10.1016/j.arth.2013.06.021; van der Weegen W, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-247; Vendittoli PA, 2013, BONE JOINT J, V95B, P1464, DOI 10.1302/0301-620X.95B11.31604; Wang Qi, 2008, Zhonghua Wai Ke Za Zhi, V46, P1293; Whitehouse MR, 2013, J ARTHROPLASTY, V28, P842, DOI 10.1016/j.arth.2013.01.007; Whitwell GS, 2012, HIP INT, V22, P362, DOI 10.5301/HIP.2012.9351; Witzleb WC, 2008, EUR J MED RES, V13, P39; Woon RP, 2013, J ARTHROPLASTY, V28, P1010, DOI 10.1016/j.arth.2012.07.043; Wynn-Jones H, 2011, ACTA ORTHOP, V82, P301, DOI 10.3109/17453674.2011.579518; Yang J, 2011, J ARTHROPLASTY, V26, P65, DOI 10.1016/j.arth.2009.11.019; Zylberberg AD, 2015, J ARTHROPLASTY, V30, P68, DOI 10.1016/j.arth.2014.08.005	141	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0147872	10.1371/journal.pone.0147872	http://dx.doi.org/10.1371/journal.pone.0147872			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930057	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500007
J	Lasek, AL; McPherson, BM; Trueman, NG; Burkard, ME				Lasek, Amber L.; McPherson, Brittany M.; Trueman, Natalie G.; Burkard, Mark E.			The Functional Significance of Posttranslational Modifications on Polo-Like Kinase 1 Revealed by Chemical Genetic Complementation	PLOS ONE			English	Article							SPINDLE ASSEMBLY CHECKPOINT; PLK1 PHOSPHORYLATION; CANCER-CELLS; ACTIVATION; AURORA; CYTOKINESIS; PROTEIN; MITOSIS; ENTRY; BORA	Mitosis is coordinated by carefully controlled phosphorylation and ubiquitin-mediated proteolysis. Polo-like kinase 1 (Plk1) plays a central role in regulating mitosis and cytokinesis by phosphorylating target proteins. Yet, Plk1 is itself a target for posttranslational modification by phosphorylation and ubiquitination. We developed a chemical-genetic complementation assay to evaluate the functional significance of 34 posttranslational modifications (PTMs) on human Plk1. To do this, we used human cells that solely express a modified analog-sensitive Plk1 (Plk1(AS)) and complemented with wildtype Plk1. The wildtype Plk1 provides cells with a functional Plk1 allele in the presence of 3-MB-PP1, a bulky ATP-analog inhibitor that specifically inhibits Plk1(AS). Using this approach, we evaluated the ability of 34 singly non-modifiable Plk1 mutants to complement Plk1(AS) in the presence of 3-MB-PP1. Mutation of the T-loop activating residue T210 and adjacent T214 are lethal, but surprisingly individual mutation of the remaining 32 posttranslational modification sites did not disrupt the essential functions of Plk1. To evaluate redundancy, we simultaneously mutated all phosphorylation sites in the kinase domain except for T210 and T214 or all sites in the C-terminal polo-box domain (PBD). We discovered that redundant phosphorylation events within the kinase domain are required for accurate chromosome segregation in anaphase but those in the PBD are dispensable. We conclude that PTMs within the T-loop of Plk1 are essential and nonredundant, additional modifications in the kinase domain provide redundant control of Plk1 function, and those in the PBD are dispensable for essential mitotic functions of Plk1. This comprehensive evaluation of Plk1 modifications demonstrates that although phosphorylation and ubiquitination are important for mitotic progression, many individual PTMs detected in human tissue may have redundant, subtle, or dispensable roles in gene function.	[Lasek, Amber L.; McPherson, Brittany M.; Trueman, Natalie G.; Burkard, Mark E.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA; [Lasek, Amber L.; McPherson, Brittany M.; Trueman, Natalie G.; Burkard, Mark E.] Univ Wisconsin, Dept Med, Hematol Oncol Div, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA.; Burkard, ME (corresponding author), Univ Wisconsin, Dept Med, Hematol Oncol Div, Madison, WI 53705 USA.	mburkard@wisc.edu			NIH [R01 GM097245]; NIH CTSA program of the NCATS [9U54TR000021];  [P30 CA014520];  [T32 CA009135]; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097245] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSA program of the NCATS; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by NIH grant R01 GM097245 to MEB. Additional support was obtained from the NIH CTSA program of the NCATS 9U54TR000021 (K award to MEB) and from P30 CA014520 and T32 CA009135 (salary support for AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bayliss R, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120136; Beck J, 2013, NAT CELL BIOL, V15, P430, DOI 10.1038/ncb2695; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bruinsma W, 2014, J CELL SCI, V127, P801, DOI 10.1242/jcs.137216; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chow JPH, 2011, MOL CELL BIOL, V31, P1478, DOI 10.1128/MCB.00891-10; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gnad F, 2011, NUCLEIC ACIDS RES, V39, pD253, DOI 10.1093/nar/gkq1159; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Lera RF, 2012, J BIOL CHEM, V287, P42812, DOI 10.1074/jbc.M112.412544; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lindqvist A, 2009, J CELL BIOL, V185, P193, DOI 10.1083/jcb.200812045; Liu D, 2012, J CELL BIOL, V198, P491, DOI 10.1083/jcb.201205090; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Matsumoto T, 2009, P NATL ACAD SCI USA, V106, P14542, DOI 10.1073/pnas.0904229106; Mortensen EM, 2005, CURR BIOL, V15, P2033, DOI 10.1016/j.cub.2005.10.046; Neef R, 2003, J CELL BIOL, V162, P863, DOI 10.1083/jcb.200306009; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; Potapova TA, 2009, MOL BIOL CELL, V20, P1737, DOI 10.1091/mbc.E08-07-0771; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Simeonov A, 2013, EXPERT OPIN DRUG DIS, V8, P1071, DOI 10.1517/17460441.2013.806479; Song B, 2011, MOL CELL BIOL, V31, P4844, DOI 10.1128/MCB.06110-11; Sumara I, 2004, CURR BIOL, V14, P1712, DOI 10.1016/j.cub.2004.09.049; Sur S, 2009, P NATL ACAD SCI USA, V106, P3964, DOI 10.1073/pnas.0813333106; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Tsvetkov L, 2005, CELL CYCLE, V4, P166, DOI 10.4161/cc.4.1.1348; van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005; Van Horn RD, 2010, J BIOL CHEM, V285, P21849, DOI 10.1074/jbc.M110.141010; van Vugt MATM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000287; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; von Schubert C, 2015, CELL REP, V12, P66, DOI 10.1016/j.celrep.2015.06.007; Walter AO, 2000, MITOTIC SERINE THREO, P4906; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110	50	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150225	10.1371/journal.pone.0150225	http://dx.doi.org/10.1371/journal.pone.0150225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919439	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400105
J	Robertson, DJ; Noyes, E; Dowsett, AJ; Jenkins, R; Burton, AM				Robertson, David J.; Noyes, Eilidh; Dowsett, Andrew J.; Jenkins, Rob; Burton, A. Mike			Face Recognition by Metropolitan Police Super-Recognisers	PLOS ONE			English	Article							UNFAMILIAR FACES; QUALITY; PHOTOGRAPHS; IDENTITIES; IMAGES; MEMORY; VIDEO; CCTV	Face recognition is used to prove identity across a wide variety of settings. Despite this, research consistently shows that people are typically rather poor at matching faces to photos. Some professional groups, such as police and passport officers, have been shown to perform just as poorly as the general public on standard tests of face recognition. However, face recognition skills are subject to wide individual variation, with some people showing exceptional ability-a group that has come to be known as 'super-recognisers'. The Metropolitan Police Force (London) recruits 'super-recognisers' from within its ranks, for deployment on various identification tasks. Here we test four working super-recognisers from within this police force, and ask whether they are really able to perform at levels above control groups. We consistently find that the police 'super-recognisers' perform at well above normal levels on tests of unfamiliar and familiar face matching, with degraded as well as high quality images. Recruiting employees with high levels of skill in these areas, and allocating them to relevant tasks, is an efficient way to overcome some of the known difficulties associated with unfamiliar face recognition.	[Robertson, David J.; Noyes, Eilidh; Dowsett, Andrew J.; Jenkins, Rob; Burton, A. Mike] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England	University of York - UK	Burton, AM (corresponding author), Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England.	mike.burton@york.ac.uk	Burton, Mike/A-9491-2008; Jenkins, Rob/C-5289-2008; Robertson, David/H-6515-2017	Burton, Mike/0000-0002-2035-2084; Robertson, David/0000-0002-8393-951X; Noyes, Eilidh/0000-0001-8709-879X	European Research Council under European Union / ERC [323262]; Economic and Social Research Council, UK [ES/J022950/1]; Economic and Social Research Council [ES/J022950/1, ES/J022950/2, 1215797] Funding Source: researchfish; ESRC [ES/J022950/1, ES/J022950/2] Funding Source: UKRI	European Research Council under European Union / ERC(European Research Council (ERC)); Economic and Social Research Council, UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC Grant Agreement n.323262, and from the Economic and Social Research Council, UK (ES/J022950/1). http://erc.europa.eu/; http://www.esrc.ac.uk/. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenezi HM, 2013, APPL COGNITIVE PSYCH, V27, P735, DOI 10.1002/acp.2968; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Bobak AK, 2016, APPL COGNITIVE PSYCH, V30, P81, DOI 10.1002/acp.3170; Bruce V, 1999, J EXP PSYCHOL-APPL, V5, P339, DOI 10.1037/1076-898X.5.4.339; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Burton A.M., 2011, OXFORD HDB FACE PERC, P287; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; Burton AM, 1999, PSYCHOL SCI, V10, P243, DOI 10.1111/1467-9280.00144; Clutterbuck R, 2004, VIS COGN, V11, P857, DOI 10.1080/13506280444000021; Clutterbuck R, 2002, PERCEPTION, V31, P985, DOI 10.1068/p3335; Davis JP, 2009, APPL COGNITIVE PSYCH, V23, P482, DOI 10.1002/acp.1490; Dowsett AJ, 2015, BRIT J PSYCHOL, V106, P433, DOI 10.1111/bjop.12103; Duchaine B, 2005, J COGNITIVE NEUROSCI, V17, P249, DOI 10.1162/0898929053124857; Edmond G, 2010, INT J EVID PROOF, V14, P146, DOI 10.1350/ijep.2010.14.2.349; Hussain Z, 2009, VISION RES, V49, P2624, DOI 10.1016/j.visres.2009.08.022; Keane, 2011, HDB FACE PERCEPTION, P307; Kemp R, 1997, APPL COGNITIVE PSYCH, V11, P211; Kleinberg KF, 2007, J FORENSIC SCI, V52, P779, DOI 10.1111/j.1556-4029.2007.00458.x; Megreya AM, 2006, MEM COGNITION, V34, P865, DOI 10.3758/BF03193433; Megreya AM, 2008, J EXP PSYCHOL-APPL, V14, P364, DOI 10.1037/a0013464; Norell K, 2015, J FORENSIC SCI, V60, P331, DOI 10.1111/1556-4029.12660; Potts L., BBC NEWS; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; White D, 2015, P R SOC B, V282; White D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139827; White D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103510; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; Yovel G, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00562	28	93	93	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150036	10.1371/journal.pone.0150036	http://dx.doi.org/10.1371/journal.pone.0150036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918457	Green Accepted, Green Published, gold			2022-12-27	WOS:000371274400074
J	Simon, UK; Gesslbauer, L; Fink, A				Simon, Uwe K.; Gesslbauer, Lisa; Fink, Andreas			A Three-Lesson Teaching Unit Significantly Increases High School Students' Knowledge about Epilepsy and Positively Influences Their Attitude towards This Disease	PLOS ONE			English	Article							PUBLIC-ATTITUDES; CHILDREN; PERCEPTION; TEACHERS; GERMANY; STIGMA	Epilepsy is not a regular topic in many countries' schools. Thus many people harbor misconceptions about people suffering from this disease. It was our aim to a) examine what grade ten students know and believe about epilepsy, and b) to develop and test a teaching unit to improve their knowledge and attitude. The test group comprised eight grade ten classes from six different Austrian high schools (54 girls and 51 boys aged 14-17), the control group (no intervention) five grade ten classes from the same schools (26 girls and 37 boys aged 14-17). The teaching unit consisted of three 45-min lessons using different methods and material. Changes in knowledge about and attitude towards epilepsy as a result of the intervention were psychometrically assessed in a pre-test intervention post-test design (along with a follow-up assessment two months after the intervention) by means of a questionnaire capturing different facets of epilepsy-related knowledge and attitude. Across all knowledge/attitude domains, students of the test group had a significantly improved knowledge about and a more positive attitude towards epilepsy and people suffering from it after the teaching unit. However, starting levels were different between the five knowledge/attitude domains tested. Medical background knowledge was lowest and consequently associated with the highest increase after the intervention. This study shows that epilepsy-related knowledge of many grade ten high school students is fragmentary and that some harbor beliefs and attitudes which require improvement. Our comprehensive but concise teaching unit significantly increased knowledge about epilepsy and positively influenced attitude towards individuals with epilepsy. Thus we recommend implementing this unit into regular school curricula.	[Simon, Uwe K.; Gesslbauer, Lisa] Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr 51, A-8010 Graz, Austria; [Fink, Andreas] Karl Franzens Univ Graz, Inst Psychol, Univ Pl 2-DG, A-8010 Graz, Austria	University of Graz; University of Graz	Simon, UK (corresponding author), Karl Franzens Univ Graz, Ctr Didact Biol, Schubertstr 51, A-8010 Graz, Austria.	uwe.simon@uni-graz.at	Simon, Uwe K./D-4555-2015	Simon, Uwe K./0000-0003-4164-8287; Fink, Andreas/0000-0001-7316-3140				Aldenkamp AP, 1999, EPILEPSIA, V40, P94; [Anonymous], 2009, EP SCHUL UNT; Baumgartner C, 2012, LEBEN EPILEPSIE INFO; Bautista RED, 2014, EPILEPSY BEHAV, V35, P42, DOI 10.1016/j.yebeh.2014.04.006; Bhalla D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046296; Bishop M, 2006, EPILEPSY BEHAV, V8, P397, DOI 10.1016/j.yebeh.2005.11.008; Bishop M, 2004, EPILEPSY BEHAV, V5, P308, DOI 10.1016/j.yebeh.2004.01.011; BMUKK, 2008, LEHRPL BIOL UMW; Bozkaya IO, 2010, EPILEPSY BEHAV, V17, P56, DOI 10.1016/j.yebeh.2009.10.011; Brabcova D, 2013, SEIZURE-EUR J EPILEP, V22, P179, DOI 10.1016/j.seizure.2012.11.017; Diamantopoulos N, 2006, EPILEPSIA, V47, P2154, DOI 10.1111/j.1528-1167.2006.00891.x; DIEHL LW, 1975, NERVENARZT, V46, P519; Etschenberg K, 2001, CHRONISCHE ERKRANKUN; Feger JM, 2012, PSYCHIAT PSYCHOTHERA; Feucht M, 2005, MITTEILUNGEN OSTERRE, V5, P1; FINKE M, 1981, NERVENARZT, V52, P581; Gesslbauer L, MNU IN PRESS; Goel D, 2011, ANN INDIAN ACAD NEUR, V14, P116, DOI 10.4103/0972-2327.82799; GUTTELING JM, 1986, EPILEPSIA, V27, P739, DOI 10.1111/j.1528-1157.1986.tb03604.x; Jacoby A, 2008, CURR NEUROL NEUROSCI, V8, P339, DOI 10.1007/s11910-008-0052-8; Jacoby A, 2007, EPILEPSIA, V48, P6, DOI 10.1111/j.1528-1167.2007.01391.x; Joshi HS, 2012, ANN INDIAN ACAD NEUR, V15, P125, DOI 10.4103/0972-2327.94996; Kosters W, 2001, CHRONISCHE ERKRANKUN, P17; Kramer G, 2012, EPILEPTOLOGIE, V29, P1; Lee RA, 2011, NEUROL ASIA, V16, P143; Lerche H, 2011, LEHRBUCH NEUROLOGIE, P75; May TW, 2004, Z EPILEPTOL, V17, P287, DOI [10.1007/s10309, DOI 10.1007/S10309]; Mecarelli O, 2011, EPILEPSY BEHAV, V22, P285, DOI 10.1016/j.yebeh.2011.06.019; Prpic I, 2003, EPILEPSY BEHAV, V4, P142, DOI 10.1016/S1525-5050(03)00025-8; Schneble H, 2009, GRUNDSCHULE WEITERFU; Spatt J, 2005, EPILEPSIA, V46, P736, DOI 10.1111/j.1528-1167.2005.52404.x; Thorbecke R, 2010, Z EPILEPTOL, V23, P82, DOI 10.1007/s10309-009-0088-z; VASEY MW, 1987, PSYCHOPHYSIOLOGY, V24, P479, DOI 10.1111/j.1469-8986.1987.tb00324.x; Windisch R, 2009, EPILEPSIEN PADAGOGIS	34	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150014	10.1371/journal.pone.0150014	http://dx.doi.org/10.1371/journal.pone.0150014			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919557	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400070
J	Tajkarimi, M; Harrison, SH; Hung, AM; Graves, JL				Tajkarimi, Mehrdad; Harrison, Scott H.; Hung, Albert M.; Graves, Joseph L., Jr.			Mechanobiology of Antimicrobial Resistant Escherichia coli and Listeria innocua	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; BACTERIAL ADHESION; BIOFILM FORMATION; IN-VITRO; CELLS; ACID; QUANTIFICATION; PREVENTION; SURFACE; SILVER	A majority of antibiotic-resistant bacterial infections in the United States are associated with biofilms. Nanoscale biophysical measures are increasingly revealing that adhesive and viscoelastic properties of bacteria play essential roles across multiple stages of biofilm development. Atomic Force Microscopy (AFM) applied to strains with variation in antimicrobial resistance enables new opportunities for investigating the function of adhesive forces (stickiness) in biofilm formation. AFM force spectroscopy analysis of a field strain of Listeria innocua and the strain Escherichia coli K-12 MG1655 revealed differing adhesive forces between antimicrobial resistant and nonresistant strains. Significant increases in stickiness were found at the nanonewton level for strains of Listeria innocua and Escherichia coli in association with benzalkonium chloride and silver nanoparticle resistance respectively. This advancement in the usage of AFM provides for a fast and reliable avenue for analyzing antimicrobial resistant cells and the molecular dynamics of biofilm formation as a protective mechanism.	[Tajkarimi, Mehrdad] Joint Sch Nanosci & Nanoengn, Dept Nanosci, Greensboro, NC USA; [Harrison, Scott H.; Graves, Joseph L., Jr.] N Carolina Agr & Tech State Univ, Dept Biol, Greensboro, NC 27411 USA; [Hung, Albert M.] N Carolina Agr & Tech State Univ, Joint Sch Nanosci & Nanoengn, Dept Nanoengn, Greensboro, NC 27411 USA; [Hung, Albert M.] UNC Greensboro, Greensboro, NC USA	University of North Carolina; North Carolina A&T State University; University of North Carolina; North Carolina A&T State University; University of North Carolina; University of North Carolina Greensboro	Tajkarimi, M (corresponding author), Joint Sch Nanosci & Nanoengn, Dept Nanosci, Greensboro, NC USA.	m_tajkar@uncg.edu			Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro	Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro	The work was sponsored by Joint School Of Nanoscience and Nanoengineering, University of North Carolina at Greensboro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu AC, 2014, INT BIODETER BIODEGR, V86, P34, DOI 10.1016/j.ibiod.2013.03.024; Allison DP, 2011, JOVE-J VIS EXP, DOI 10.3791/2880; Alsteens D, 2012, METHOD ENZYMOL, V506, P3, DOI 10.1016/B978-0-12-391856-7.00025-1; An RS, 2011, MICROBIOL-SGM, V157, P2595, DOI 10.1099/mic.0.048959-0; [Anonymous], 2015, R PROJECT STAT COMPU; Brooks JD, 2008, INT J FOOD SCI TECH, V43, P2163, DOI 10.1111/j.1365-2621.2008.01839.x; Chao YQ, 2011, APPL MICROBIOL BIOT, V92, P381, DOI 10.1007/s00253-011-3551-5; Chen M, 2013, INT J MOL SCI, V14, P18488, DOI 10.3390/ijms140918488; Chmielewski R A N, 2003, Compr Rev Food Sci Food Saf, V2, P22, DOI 10.1111/j.1541-4337.2003.tb00012.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Doktycz MJ, 2003, ULTRAMICROSCOPY, V97, P209, DOI 10.1016/S0304-3991(03)00045-7; Dorobantu LS, 2012, MICRON, V43, P1312, DOI 10.1016/j.micron.2012.05.005; Dubrovin EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047348; Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002; Dufrene YF, 2014, MBIO, V5, DOI 10.1128/mBio.01363-14; Dufrene YF, 2013, NANOSCALE, V5, P4094, DOI 10.1039/c3nr00340j; Dutta V, 2014, APPL ENVIRON MICROB, V80, P5379, DOI 10.1128/AEM.01398-14; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; Fang HHP, 2000, J MICROBIOL METH, V40, P89, DOI 10.1016/S0167-7012(99)00137-2; Fazlara A., 2012, AM EURASIAN J AGR EN, V12, P23, DOI DOI 10.1186/1471-2334-14-292; Ferguson BJ, 2005, AM J RHINOL, V19, P452, DOI 10.1177/194589240501900506; Garrett TR, 2008, PROG NAT SCI-MATER, V18, P1049, DOI 10.1016/j.pnsc.2008.04.001; Graves JL, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00042; Hamadi F, 2008, COLLOID SURFACE B, V65, P134, DOI 10.1016/j.colsurfb.2008.03.010; Hanna A, 2003, APPL ENVIRON MICROB, V69, P4474, DOI 10.1128/AEM.69.8.4474-4481.2003; Katharios-Lanwermeyer S, 2012, APPL ENVIRON MICROB, V78, P7549, DOI 10.1128/AEM.02245-12; Kawamura-Sato K, 2008, J ANTIMICROB CHEMOTH, V61, P568, DOI 10.1093/jac/dkm498; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lau PCY, 2009, BIOPHYS J, V96, P2935, DOI 10.1016/j.bpj.2008.12.3943; Longo G, 2013, J MICROBIOL METH, V93, P80, DOI 10.1016/j.mimet.2013.01.022; Ma Q, 2009, ENVIRON MICROBIOL, V11, P2735, DOI 10.1111/j.1462-2920.2009.02000.x; Marks LR, 2012, INFECT IMMUN, V80, P2744, DOI 10.1128/IAI.00488-12; Poortinga AT, 1999, J MICROBIOL METH, V38, P183, DOI 10.1016/S0167-7012(99)00100-1; Rizzello L, 2013, NANOMEDICINE-UK, V8, P807, DOI [10.2217/NNM.13.63, 10.2217/nnm.13.63]; Roos WH, 2010, BIOPHYS J, V99, P1175, DOI 10.1016/j.bpj.2010.05.033; Silagyi K. S., 2007, BIOFILM FORMATION ES; Simoes LC, 2010, APPL ENVIRON MICROB, V76, P6673, DOI 10.1128/AEM.00872-10; Simoes M, 2010, LWT-FOOD SCI TECHNOL, V43, P573, DOI 10.1016/j.lwt.2009.12.008; Simojoki H, 2012, VET MICROBIOL, V158, P344, DOI 10.1016/j.vetmic.2012.02.031; Soumet C, 2012, VET MICROBIOL, V158, P147, DOI 10.1016/j.vetmic.2012.01.030; Srey S, 2013, FOOD CONTROL, V31, P572, DOI 10.1016/j.foodcont.2012.12.001; Tajkarimi M, 2015, BIOPHYSICAL J BIOPHY, P402; Tajkarimi M, 2015, BIOPHYS J, V108, P402; Thio BJR, 2008, COLLOID SURFACE B, V65, P308, DOI 10.1016/j.colsurfb.2008.05.005; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004; Vadillo-Rodriguez V, 2011, SOFT MATTER, V7, P4101, DOI 10.1039/c0sm01054e; Vesterlund S, 2005, J MICROBIOL METH, V60, P225, DOI 10.1016/j.mimet.2004.09.013; Weimer PJ, 2006, APPL ENVIRON MICROB, V72, P7559, DOI 10.1128/AEM.01632-06; Wen M, 2008, MOL VIS, V14, P114; Wijnhoven SWP, 2009, NANOTOXICOLOGY, V3, P109, DOI 10.1080/17435390902725914; Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1; Zhao C, 2013, LANGMUIR, V29, P1517, DOI 10.1021/la304511s	55	7	7	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149769	10.1371/journal.pone.0149769	http://dx.doi.org/10.1371/journal.pone.0149769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914334	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700026
J	Blanco-Kelly, F; Hoyos, MG; Martinez, MAL; Lopez-Molina, I; Riveiro-Alvarez, R; Fernandez-San Jose, P; Avila-Fernandez, A; Corton, M; Millan, JM; Sandoval, BG; Ayuso, C				Blanco-Kelly, Fiona; Garcia Hoyos, Maria; Lopez Martinez, Miguel Angel; Lopez-Molina, Isabel; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Millan, Jose M.; Garcia Sandoval, Blanca; Ayuso, Carmen			Dominant Retinitis Pigmentosa, p.Gly56Arg Mutation in NR2E3: Phenotype in a Large Cohort of 24 Cases	PLOS ONE			English	Article							S-CONE SYNDROME; RETINAL DEGENERATION; MACULOPATHY	Importance This research is the single largest NR2E3 genotype-phenotype correlation study performed to date in autosomal dominant Retinitis Pigmentosa. Objective The aim of this study is to analyse the frequency of the p.Gly56Arg mutation in NR2E3 for the largest cohort of autosomal dominant Retinitis Pigmentosa patients to date and its associated phenotype. Patients and Methods A cohort of 201 unrelated Spanish families affected by autosomal dominant Retinitis Pigmentosa. The p.Gly56Arg mutation in the NR2E3 (NM_014249.2) gene was analysed in 201 families. In the 24 cases where the mutation had been detected, a haplotype analysis linked to the p.Gly56Arg families was performed, using four extragenic polymorphic markers D15S967, D15S1050, D15S204 and D15S188. Phenotype study included presence and age of onset of night blindness, visual field loss and cataracts; and an ophthalmoscopic examination after pupillary dilation and electroretinogram for the 24 cases. Results Seven of the 201 analyzed families were positive for the p.Gly56Arg, leading to a prevalence of 3.5%. Clinical data were available for 24 subjects. Night blindness was the first noticeable symptom (mean 15.9 years). Visual field loss onset was variable (23.3 +/- 11.9 years). Loss of visual acuity appeared late in the disease's evolution. Most of the patients with cataracts (50%) presented it from the third decade of life. Fundus changes showed inter and intrafamiliar variability, but most of the patients showed typical RP changes and it was common to find macular affectation (47.4%). Electroretinogram was impaired from the beginning of the disease. Two families shared a common haplotype. Additionally, all patients shared a 104Kb region between D15S1050 and the NR2E3 gene. Conclusions This study highlights the importance of p.Gly56Arg in the NR2E3 gene as a common mutation associated with adRP, and provides new clues to its phenotype, which can allow for a better clinical management and genetic counselling of patients and their families.	[Blanco-Kelly, Fiona; Lopez Martinez, Miguel Angel; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Ayuso, Carmen] UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Genet, Madrid, Spain; [Blanco-Kelly, Fiona; Riveiro-Alvarez, Rosa; Fernandez-San Jose, Patricia; Avila-Fernandez, Almudena; Corton, Marta; Millan, Jose M.; Ayuso, Carmen] ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain; [Garcia Hoyos, Maria] Inst Med Genom IMEGEN, Valencia, Spain; [Lopez-Molina, Isabel; Garcia Sandoval, Blanca] UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Ophthalmol, Madrid, Spain; [Millan, Jose M.] IIS La Fe, Grp Invest Biomed Mol Celular & Genom, Valencia, Spain; [Millan, Jose M.] Hosp Univ & Politecn La Fe, Unidad Genet Diagnost Prenatal, Valencia, Spain	Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Autonomous University of Madrid; Hospital Universitari i Politecnic La Fe	Ayuso, C (corresponding author), UAM, Inst Invest Sanitaria Fdn Jimenez Diaz Univ Hosp, Dept Genet, Madrid, Spain.; Ayuso, C (corresponding author), ISCIII, Ctr Biomed Network Res Rare Dis CIBERER, Madrid, Spain.	cayuso@fjd.es		Blanco-Kelly, Fiona/0000-0003-0052-5651; Ayuso, Carmen/0000-0002-9242-7065; Corton, Marta/0000-0003-0087-1626	FIS [PI: 13/00226]; Centre for Biomedical Network Research on Rare Diseases-CIBERER [06/07/0036]; Biobank of Fundacion Jimenez Diaz University Hospital [RD09/0076/00101]; ONCE; Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce [4019-002]; Rio Hortega grant [CM12/00013]; Marta Corton by a Miguel Servet grant [CP/03256]	FIS(Instituto de Salud Carlos III); Centre for Biomedical Network Research on Rare Diseases-CIBERER; Biobank of Fundacion Jimenez Diaz University Hospital; ONCE; Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce; Rio Hortega grant; Marta Corton by a Miguel Servet grant	Support was provided by FIS (PI: 13/00226), the Centre for Biomedical Network Research on Rare Diseases-CIBERER (06/07/0036), the Biobank of Fundacion Jimenez Diaz University Hospital (RD09/0076/00101), ONCE 2014, Feder (Fondos Europeo de Desarrollo Regional) and Fundaluce (4019-002). Patricia Fernandez-San Jose's work is supported by a Rio Hortega grant (CM12/00013), Marta Corton by a Miguel Servet grant (CP/03256) all from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audo I, 2008, INVEST OPHTH VIS SCI, V49, P2082, DOI 10.1167/iovs.05-1629; AYUSO C, 1995, CLIN GENET, V48, P120; Ayuso C, 2001, ESTUDIO RETINOSIS PI; Blanco-Kelly F, 2012, MOL VIS, V18, P1478; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; Drake JW, 1998, GENETICS, V148, P1667; Escher P, 2012, INVEST OPHTH VIS SCI, V53, P4754, DOI 10.1167/iovs.11-8693; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Jose PFS, 2015, ACTA OPHTHALMOL, V93, pE38, DOI 10.1111/aos.12486; Ganesh A, 2011, CURR OPIN OPHTHALMOL, V22, P332, DOI 10.1097/ICU.0b013e328349229e; GAWANDE AA, 1989, BRIT J OPHTHALMOL, V73, P115, DOI 10.1136/bjo.73.2.115; Gire AI, 2007, MOL VIS, V13, P1970; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; HAIM M, 1993, CLIN GENET, V44, P62; Hamel C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-40; Ikeda Y, 2013, BRIT J OPHTHALMOL, V97, P1187, DOI 10.1136/bjophthalmol-2012-303005; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; MARMOR MF, 1991, ARCH OPHTHALMOL-CHIC, V109, P13, DOI 10.1001/archopht.1991.01080010015006; MARMOR MF, 1990, AM J OPHTHALMOL, V110, P124, DOI 10.1016/S0002-9394(14)76980-6; MARMOR MF, 1980, AM J OPHTHALMOL, V89, P692, DOI 10.1016/0002-9394(80)90289-5; MARMOR MF, 1979, ARCH OPHTHALMOL-CHIC, V97, P1300; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NASR YG, 1990, RETINA-J RET VIT DIS, V10, P178, DOI 10.1097/00006982-199001030-00004; Roduit R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007379; Schorderet DF, 2009, HUM MUTAT, V30, P1475, DOI 10.1002/humu.21096; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Sullivan LS, 2013, INVEST OPHTH VIS SCI, V54, P6255, DOI 10.1167/iovs.13-12605; Tonisson N, 2000, MICROARRAY BIOCHIP TECHNOLOGY, P247; Yang YP, 2010, INVEST OPHTH VIS SCI, V51, P2229, DOI 10.1167/iovs.09-4299; Yzer S, 2013, JAMA OPHTHALMOL, V131, P1324, DOI 10.1001/jamaophthalmol.2013.4349	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149473	10.1371/journal.pone.0149473	http://dx.doi.org/10.1371/journal.pone.0149473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910043	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700036
J	Cain, SM; Ashton-Miller, JA; Perkins, NC				Cain, Stephen M.; Ashton-Miller, James A.; Perkins, Noel C.			On the Skill of Balancing While Riding a Bicycle	PLOS ONE			English	Article							CENTER-OF-MASS; RIDER MOTION; BODY CENTER; GRAVITY; STABILITY; DYNAMICS	Humans have ridden bicycles for over 200 years, yet there are no continuous measures of how skill differs between novice and expert. To address this knowledge gap, we measured the dynamics of human bicycle riding in 14 subjects, half of whom were skilled and half were novice. Each subject rode an instrumented bicycle on training rollers at speeds ranging from 1 to 7 m/s. Steer angle and rate, steer torque, bicycle speed, and bicycle roll angle and rate were measured and steering power calculated. A force platform beneath the roller assembly measured the net force and moment that the bicycle, rider and rollers exerted on the floor, enabling calculations of the lateral positions of the system centers of mass and pressure. Balance performance was quantified by cross-correlating the lateral positions of the centers of mass and pressure. The results show that all riders exhibited similar balance performance at the slowest speed. However at higher speeds, the skilled riders achieved superior balance performance by employing more rider lean control (quantified by crosscorrelating rider lean angle and bicycle roll angle) and less steer control (quantified by cross-correlating steer rate and bicycle roll rate) than did novice riders. Skilled riders also used smaller steering control input with less variation (measured by average positive steering power and standard deviations of steer angle and rate) and less rider lean angle variation (measured by the standard deviation of the rider lean angle) independent of speed. We conclude that the reduction in balance control input by skilled riders is not due to reduced balance demands but rather to more effective use of lean control to guide the center of mass via center of pressure movements.	[Cain, Stephen M.; Ashton-Miller, James A.; Perkins, Noel C.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cain, SM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	smcain@umich.edu			NIA NIH HHS [P30 AG024824] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cain S.M., 2012, ASME 2012 5 ANN DYN; Cain SM, 2011, 35 ANN M AM SOC BIOM; Cain SM, 2012, VEHICLE SYST DYN, V50, P1341, DOI 10.1080/00423114.2011.650181; Dempster WT, 1955, REPORT NO WADC TECHN; Doyle AJR, 1987, THESIS U SHEFFIELD; Dressel A, 2012, EUR J PHYS, V33, pL21, DOI 10.1088/0143-0807/33/4/L21; DRURY CG, 1980, J SAFETY RES, V12, P86; Hasan S. S., 1996, GAIT POSTURE, V4, P1; Hof AL, 2005, J BIOMECH, V38, P2134, DOI 10.1016/j.jbiomech.2005.03.029; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lenzi D, 2003, J BIOMECH, V36, P1335, DOI 10.1016/S0021-9290(03)00151-9; Lunteren Av, 1969, S ERG MACH DES OCT 2, P349; Meijaard JP, 2007, P ROY SOC A-MATH PHY, V463, P1955, DOI 10.1098/rspa.2007.1857; Moore J, 2008, ENGINEERING OF SPORT 7, VOL 2, P311, DOI 10.1007/978-2-287-09413-2_39; Moore JK, 2011, MULTIBODY SYST DYN, V25, P225, DOI 10.1007/s11044-010-9225-8; Moore JK, 2010, PROCEDIA ENGINEER, V2, P2937, DOI 10.1016/j.proeng.2010.04.091; Morasso PG, 1999, HUM MOVEMENT SCI, V18, P759, DOI 10.1016/S0167-9457(99)00039-1; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Prem H, 1983, THESIS U MELBOURNE; Rice RS, 1978, SAE, P79; Schewe G, 1984, Blutalkohol, V21, P97; Schwab AL, 2013, VEHICLE SYST DYN, V51, P1059, DOI 10.1080/00423114.2013.793365; Schwab AL, 2012, ASME 2012 5 ANN DYN; Sheridan T. B., 1974, MAN MACHINE SYSTEMS; SHIMBA T, 1984, J BIOMECH, V17, P53, DOI 10.1016/0021-9290(84)90080-0; Visser JE, 2008, CLIN NEUROPHYSIOL, V119, P2424, DOI 10.1016/j.clinph.2008.07.220; Whipple F., 1899, Q J PURE APPL MATH, V30, P312; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079; Zatsiorsky VM, 1998, J BIOMECH, V31, P161, DOI 10.1016/S0021-9290(97)00116-4; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185; Zok M, 2004, MED ENG PHYS, V26, P791, DOI 10.1016/j.medengphy.2004.07.005	34	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149340	10.1371/journal.pone.0149340	http://dx.doi.org/10.1371/journal.pone.0149340			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910774	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700031
J	Liu, F; Heiner, M; Yang, M				Liu, Fei; Heiner, Monika; Yang, Ming			Fuzzy Stochastic Petri Nets for Modeling Biological Systems with Uncertain Kinetic Parameters	PLOS ONE			English	Article							SIMULATION	Stochastic Petri nets (SPNs) have been widely used to model randomness which is an inherent feature of biological systems. However, for many biological systems, some kinetic parameters may be uncertain due to incomplete, vague or missing kinetic data (often called fuzzy uncertainty), or naturally vary, e.g., between different individuals, experimental conditions, etc. (often called variability), which has prevented a wider application of SPNs that require accurate parameters. Considering the strength of fuzzy sets to deal with uncertain information, we apply a specific type of stochastic Petri nets, fuzzy stochastic Petri nets (FSPNs), to model and analyze biological systems with uncertain kinetic parameters. FSPNs combine SPNs and fuzzy sets, thereby taking into account both randomness and fuzziness of biological systems. For a biological system, SPNs model the randomness, while fuzzy sets model kinetic parameters with fuzzy uncertainty or variability by associating each parameter with a fuzzy number instead of a crisp real value. We introduce a simulation-based analysis method for FSPNs to explore the uncertainties of outputs resulting from the uncertainties associated with input parameters, which works equally well for bounded and unbounded models. We illustrate our approach using a yeast polarization model having an infinite state space, which shows the appropriateness of FSPNs in combination with simulation-based analysis for modeling and analyzing biological systems with uncertain information.	[Liu, Fei; Yang, Ming] Harbin Inst Technol, Control & Simulat Ctr, Harbin 150080, Peoples R China; [Heiner, Monika] Brandenburg Univ Technol Cottbus Senftenberg, Dept Comp Sci, D-03013 Cottbus, Germany	Harbin Institute of Technology; Brandenburg University of Technology Cottbus	Liu, F; Yang, M (corresponding author), Harbin Inst Technol, Control & Simulat Ctr, Harbin 150080, Peoples R China.	liufei@hit.edu.cn; myang@hit.edu.cn	liu, fei/AAI-2944-2020; Heiner, Monika/AAG-1022-2019	Heiner, Monika/0000-0003-1815-1205	National Natural Science Foundation of China [61273226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is funded by National Natural Science Foundation of China (61273226). FL received the funding. The website is http://www.nsfc.gov.cn/. This funding supports the design, data collection and analysis of this study.	Alexopoulos C, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P138; [Anonymous], 2013, MATLAB LANG TECHN CO; Blatke MA, 2013, MOL BIOSYST, V9, P1290, DOI 10.1039/c3mb25593j; Blatke M, 2015, BIOMODEL ENG PETRI N, P141; Blatke M, 2011, TUTORIAL PETRI NETS; Blatke Mary Ann, 2012, Computational Methods in Systems Biology. Proceedings of the 10th International Conference, CMSB 2012, P87, DOI 10.1007/978-3-642-33636-2_7; Bordon J, 2013, BIOPPN 2013 SATELLIT, V988; Castaldi D, 2013, LECT NOTES COMPUT SC, V7640, P248, DOI 10.1007/978-3-642-36949-0_28; Daigle BJ, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3522769; David R, 2010, DISCRETE, CONTINUOUS, AND HYBRID PETRI NETS, SECOND EDITION, P1, DOI 10.1007/978-3-642-10669-9; Ding ZH, 2005, MATH COMPUT MODEL, V41, P345, DOI 10.1016/j.mcm.2003.02.015; Donaldson R, 2008, LECT N BIOINFORMAT, V5307, P269, DOI 10.1007/978-3-540-88562-7_20; Donatelli S, 1994, WILEY SERIES PARALLE; Drawert B, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3310809; Dubois D., 1988, POSSIBILITY THEORY A; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gintrowski A, 2010, 6 DOCT WORKSH MATH E, P32; Goss PJE, 1998, P NATL ACAD SCI USA, V95, P6750, DOI 10.1073/pnas.95.12.6750; Hamed RI, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-113; Heiner M., 2012, LNCS, P398, DOI [DOI 10.1007/978-3-642-31131-4_22, DOI 10.1007/978-3-642-31131-422]; Heiner M, 2010, P 8 INT C COMP METH, P96; Heiner M, 2015, LECT NOTES COMPUT SC, V9115, P200, DOI 10.1007/978-3-319-19488-2_10; Heiner M, 2008, LECT NOTES COMPUT SC, V5016, P215; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Koh G, 2006, BIOINFORMATICS, V22, pE271, DOI 10.1093/bioinformatics/btl264; Lamprecht R, 2011, NAT COMPUT, V10, P1045, DOI 10.1007/s11047-009-9143-y; Law A., 2007, J AM STATAL ASS, V4th; Li C, 2011, MOL BIOSYST, V7, P1576, DOI 10.1039/c0mb00253d; Liu BD., 2002, THEORY PRACTICE UNCE; Liu F, 2013, NAT COMPUT, V12, P617, DOI 10.1007/s11047-013-9367-8; Liu F, 2013, IET SYST BIOL, V7, P106, DOI 10.1049/iet-syb.2012.0017; Marsan MA, 1995, MODELLING GEN STOCHA; Marwan W, 2005, J THEOR BIOL, V236, P349, DOI 10.1016/j.jtbi.2005.03.018; Marwan W, 2012, METHODS MOL BIOL, V804, P409, DOI 10.1007/978-1-61779-361-5_21; Meister Arwen, 2014, Quant Biol, V2, P1; Meng Tan Chee, 2004, In Silico Biol, V4, P293; Mura I, 2008, J THEOR BIOL, V254, P850, DOI 10.1016/j.jtbi.2008.07.019; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; Parvu O, 2015, ACM TRANSACTIONS ON, V25; Petri CA, 1962, SCHRIFTEN IIM; Phillips A, 2007, LECT NOTES COMPUT SC, V4695, P184; Sandmann W, 2008, P 5 INT WORKSH COMP, P153; Shaw O, 2006, ELECTRON NOTES THEOR, V151, P111, DOI 10.1016/j.entcs.2006.03.015; Srivastava R, 2001, BIOTECHNOL BIOENG, V75, P120, DOI 10.1002/bit.1171; Tareen SHK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117519; Tuysuz F, 2010, EXPERT SYST APPL, V37, P3910, DOI 10.1016/j.eswa.2009.11.026; Valette R., 1989, Proceedings. IEEE International Symposium on Intelligent Control 1989 (Cat. No.89TH0282-4), P233, DOI 10.1109/ISIC.1989.238688; Wang S, 2012, FUZZY STOCHASTIC OPTIMIZATION: THEORY, MODELS AND APPLICATIONS, P1, DOI 10.1007/978-1-4419-9560-5; Yang RT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-12; Yang X, 2011, J STAT COMPUT SIM, V81, P1879, DOI 10.1080/00949655.2010.507764; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	51	30	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149674	10.1371/journal.pone.0149674	http://dx.doi.org/10.1371/journal.pone.0149674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910830	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700043
J	Ma, YF; Hu, J; Zhang, N; Dong, XR; Li, Y; Yang, B; Tian, WD; Wang, XQ				Ma, Yanfen; Hu, Jian; Zhang, Ning; Dong, Xinran; Li, Ying; Yang, Bo; Tian, Weidong; Wang, Xiaoqin			Prediction of Candidate Drugs for Treating Pancreatic Cancer by Using a Combined Approach	PLOS ONE			English	Article							EXPRESSION SIGNATURES; CONNECTIVITY MAP; CELL-LINES; DISCOVERY; GENE; INHIBITOR; CHEMOTHERAPY; DATABASE; TARGETS; BIOLOGY	Pancreatic cancer is the leading cause of death from solid malignancies worldwide. Currently, gemcitabine is the only drug approved for treating pancreatic cancer. Developing new therapeutic drugs for this disease is, therefore, an urgent need. The C-Map project has provided a wealth of gene expression data that can be mined for repositioning drugs, a promising approach to new drug discovery. Typically, a drug is considered potentially useful for treating a disease if the drug-induced differential gene expression profile is negatively correlated with the differentially expressed genes in the target disease. However, many of the potentially useful drugs (PUDs) identified by gene expression profile correlation are likely false positives because, in C-Map, the cultured cell lines to which the drug is applied are not derived from diseased tissues. To solve this problem, we developed a combined approach for predicting candidate drugs for treating pancreatic cancer. We first identified PUDs for pancreatic cancer by using C-Map-based gene expression correlation analyses. We then applied an algorithm (Met-express) to predict key pancreatic cancer (KPC) enzymes involved in pancreatic cancer metabolism. Finally, we selected candidates from the PUDs by requiring that their targets be KPC enzymes or the substrates/products of KPC enzymes. Using this combined approach, we predicted seven candidate drugs for treating pancreatic cancer, three of which are supported by literature evidence, and three were experimentally validated to be inhibitory to pancreatic cancer celllines.	[Ma, Yanfen; Hu, Jian; Zhang, Ning; Yang, Bo; Wang, Xiaoqin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian 710049, Shaanxi, Peoples R China; [Ma, Yanfen; Zhang, Ning; Li, Ying] Xi An Jiao Tong Univ, Hlth Sci Ctr, Xian 710049, Shaanxi, Peoples R China; [Dong, Xinran; Tian, Weidong] Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200433, Peoples R China; [Li, Ying] SHAANXI Kang Fu Hosp, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Fudan University	Wang, XQ (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Clin Lab, Xian 710049, Shaanxi, Peoples R China.; Tian, WD (corresponding author), Fudan Univ, Sch Life Sci, Dept Biostat & Computat Biol, Shanghai 200433, Peoples R China.	weidong.tian@fudan.edu.cn; 1493722680@qq.com	Dong, Xinran/AAF-7799-2019		International Science and Technology Cooperation and Exchange Program of Shaanxi Province [2015KW-045]; Science and Technology Research Program of Shaanxi Province [2013K-12-20-10]; National Natural Science Foundation of China [91231116, 31471245, 31071113]	International Science and Technology Cooperation and Exchange Program of Shaanxi Province; Science and Technology Research Program of Shaanxi Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the International Science and Technology Cooperation and Exchange Program of Shaanxi Province (Grant No. 2015KW-045, XW), the Science and Technology Research Program of Shaanxi Province (2013K-12-20-10, JH), and the National Natural Science Foundation of China [91231116, 31471245, 31071113, WT]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Brockhausen I, 1999, BBA-GEN SUBJECTS, V1473, P67, DOI 10.1016/S0304-4165(99)00170-1; Butcher EC, 2004, NAT BIOTECHNOL, V22, P1253, DOI 10.1038/nbt1017; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Chaika NV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032996; Chen B, 2015, CPT-PHARMACOMET SYST, V4, P576, DOI 10.1002/psp4.12009; Chen JQ, 2013, J PROTEOME RES, V12, P2354, DOI 10.1021/pr400162t; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Fiorino S, 2013, PANCREATOLOGY, V13, P147, DOI 10.1016/j.pan.2013.01.005; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gansauge S, 1998, CELL GROWTH DIFFER, V9, P611; Greeshma N, 2015, CHEM-BIOL INTERACT, V238, P118, DOI 10.1016/j.cbi.2015.06.025; Gungor C, 2014, BRIT J PHARMACOL, V171, P849, DOI 10.1111/bph.12401; Guo JM, 2006, J GASTROEN HEPATOL, V21, P443, DOI 10.1111/j.1440-1746.2006.04180.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hempen PM, 2003, HUM MUTAT, V21, DOI 10.1002/humu.9120; Henderson MC, 2009, MOL CANCER THER, V8, P36, DOI 10.1158/1535-7163.MCT-08-0789; Herreros-Villanueva M, 2013, WORLD J GASTROENTERO, V19, P638, DOI 10.3748/wjg.v19.i5.638; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hollander M., 2013, NONPARAMETRIC STAT M, VVolume 751; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kempen EC, 2001, ANAL BIOCHEM, V297, P183, DOI 10.1006/abio.2001.5325; Kim JJ, 2013, ENDOCR REV, V34, P130, DOI 10.1210/er.2012-1043; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Qu XYA, 2012, DRUG DISCOV TODAY, V17, P1289, DOI 10.1016/j.drudis.2012.07.017; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; ROSS J, 1987, GUT, V28, P197, DOI 10.1136/gut.28.Suppl.197; Ruan JH, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016104; Sakai R, 2014, TOXICOLOGY, V315, P8, DOI 10.1016/j.tox.2013.10.009; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Shore S, 2003, ALIMENT PHARM THER, V18, P1049, DOI 10.1111/j.1365-2036.2003.01781.x; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Skinner HG, 2006, CANCER EPIDEM BIOMAR, V15, P1688, DOI 10.1158/1055-9965.EPI-06-0206; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tanimoto K, 2010, NUCL MED COMMUN, V31, P604, DOI 10.1097/MNM.0b013e328339350c; Verovski VN, 1996, BRIT J CANCER, V73, P596, DOI 10.1038/bjc.1996.103; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zhang G, 2012, J CONTROL SCI ENG, V2012, P7, DOI DOI 10.1371/J0URNAL.P0NE.0044568; ZIEVE GW, 1980, EXP CELL RES, V126, P397, DOI 10.1016/0014-4827(80)90279-7	46	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149896	10.1371/journal.pone.0149896	http://dx.doi.org/10.1371/journal.pone.0149896			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910401	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700052
J	Verhofstadt, L; Devoldre, I; Buysse, A; Stevens, M; Hinnekens, C; Ickes, W; Davis, M				Verhofstadt, Lesley; Devoldre, Inge; Buysse, Ann; Stevens, Michael; Hinnekens, Celine; Ickes, William; Davis, Mark			The Role of Cognitive and Affective Empathy in Spouses' Support Interactions: An Observational Study	PLOS ONE			English	Article							GENDER-DIFFERENCES; SOCIAL SUPPORT; PROSOCIAL BEHAVIOR; PROVISION; ACCURACY; COUPLES; ADOLESCENTS; MARRIAGE; SEX; ADJUSTMENT	The present study examined how support providers' empathic dispositions (dispositional perspective taking, empathic concern, and personal distress) as well as their situational empathic reactions (interaction-based perspective taking, empathic concern, and personal distress) relate to the provision of spousal support during observed support interactions. Forty-five committed couples provided questionnaire data and participated in two ten-minute social support interactions designed to assess behaviors when partners are offering and soliciting social support. A video-review task was used to assess situational forms of perspective taking (e.g., empathic accuracy), empathic concern and personal distress. Data were analyzed by means of the multi-level Actor-Partner Interdependence Model. Results revealed that providers scoring higher on affective empathy (i.e., dispositional empathic concern), provided lower levels of negative support. In addition, for male partners, scoring higher on cognitive empathy (i.e., situational perspective taking) was related to lower levels of negative support provision. For both partners, higher scores on cognitive empathy (i.e., situational perspective taking) correlated with more instrumental support provision. Male providers scoring higher on affective empathy (i.e., situational personal distress) provided higher levels of instrumental support. Dispositional perspective taking was related to higher scores on emotional support provision for male providers. The current study furthers our insight into the empathy-support link, by revealing differential effects (a) for men and women, (b) of both cognitive and affective empathy, and (c) of dispositional as well as situational empathy, on different types of support provision.	[Verhofstadt, Lesley; Devoldre, Inge; Buysse, Ann; Hinnekens, Celine] Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium; [Stevens, Michael] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Ickes, William] Univ Texas, Dept Psychol, Arlington, TX USA; [Davis, Mark] Eckerd Coll, Dept Psychol, St Petersburg, FL 33733 USA	Ghent University; Ghent University; University of Texas System; University of Texas Arlington	Verhofstadt, L (corresponding author), Univ Ghent, Dept Expt Clin & Hlth Psychol, B-9000 Ghent, Belgium.	lesley.verhofstadt@ugent.be		Buysse, Ann/0000-0001-5047-3293; verhofstadt, lesley/0000-0003-2767-5422; Hinnekens, Celine/0000-0001-8728-3258	Ghent University-Department of Experimental-Clinical & Health Psychology	Ghent University-Department of Experimental-Clinical & Health Psychology	This research was funded by Ghent University-Department of Experimental-Clinical & Health Psychology.	[Anonymous], 1996, SOCIAL SUPPORT COUPL; Barbee A.P., 1998, HDB COMMUNICATION EM, P281, DOI [10.1016/B978-012057770-5/50012-6, DOI 10.1016/B978-012057770-5/50012-6]; BATSON CD, 1987, ADV EXP SOC PSYCHOL, V20, P65, DOI 10.1016/S0065-2601(08)60412-8; Batson CD., 1991, ALTRUISM QUESTION SO; Bradbury T. N., 1991, COGNITION CLOSE RELA, P127, DOI [10.4324/9780203772027, DOI 10.4324/9780203772027]; Carlo G, 2003, J EARLY ADOLESCENCE, V23, P107, DOI 10.1177/0272431602239132; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Cutrona C. E., 1990, PERS RELATIONSHIP, P30; Davila J., 2010, SUPPORT PROCESSES IN, P3, DOI DOI 10.1093/ACPR0F:0S0/9780195380170.003.0001; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Davis M.H., OXFORD HDB COMPASSIO; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Davis MH., 2015, OXFORD HDB PROSOCIAL, P282; De Corte K, 2007, PSYCHOL BELG, V47, P235, DOI 10.5334/pb-47-4-235; Devoldre I, 2010, J PSYCHOL, V144, P259, DOI 10.1080/00223981003648294; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; Eisenberg N, 1987, EMPATHY ITS DEV, P195; Eisenberg N, 2010, SOC ISS POLICY REV, V4, P143, DOI 10.1111/j.1751-2409.2010.01020.x; Eisenberg Nancy, 1987, CRITICAL ISSUES STUD; Feeney BC, 2004, J PERS SOC PSYCHOL, V87, P631, DOI 10.1037/0022-3514.87.5.631; Gleason KA, 2009, PERS SOC PSYCHOL B, V35, P997, DOI 10.1177/0146167209336605; Gleason MEJ, 2008, J PERS SOC PSYCHOL, V94, P824, DOI 10.1037/0022-3514.94.5.824; Gottman JM, 1998, J MARRIAGE FAM, V60, P5, DOI 10.2307/353438; Hall J. A., 1984, NONVERBAL SEX DIFFER; Hatfield E., 1994, REV PERSONALITY SOCI; Hoffman Martin L., 1982, DEV PROSOCIAL BEHAV, V281, P281; HOGAN R, 1969, J CONSULT CLIN PSYCH, V33, P307, DOI 10.1037/h0027580; Ickes, 2010, EVERYDAY MIND READIN; ICKES W, 1990, J PERS SOC PSYCHOL, V59, P730, DOI 10.1037/0022-3514.59.4.730; Ickes W, 2000, PERS RELATIONSHIP, V7, P95, DOI 10.1111/j.1475-6811.2000.tb00006.x; Ickes W, 2001, LEA SER PER CLIN PSY, P219; Kenny D. A., 2006, DYADIC DATA ANAL; Knafo A, 2008, EMOTION, V8, P737, DOI 10.1037/a0014179; Lawrence E, 2008, PERS RELATIONSHIP, V15, P445, DOI 10.1111/j.1475-6811.2008.00209.x; McMahon SD, 2006, J ADOLESCENT HEALTH, V39, P135, DOI 10.1016/j.jadohealth.2005.10.008; Neff LA, 2005, J PERS SOC PSYCHOL, V88, P79, DOI 10.1037/0022-3514.88.1.79; Pasch LA, 1998, J CONSULT CLIN PSYCH, V66, P219, DOI 10.1037/0022-006X.66.2.219; Pasch LA., 2004, COUPLE OBSERVATIONAL, P319; Pearlin L. I., 1990, STRESS WORK FAMILY, P39, DOI DOI 10.1007/978-1-4899-2097-3_3; PIERCE GR, 1997, PL S SOC CL, P3; Rafaeli E., 2009, J FAM THEOR REV, V1, P20, DOI [10.1111/j.1756-2589.2009.00003.x, DOI 10.1111/J.1756-2589.2009.00003.X]; Roberts W, 1996, CHILD DEV, V67, P449, DOI 10.2307/1131826; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; Stotland E, 1969, ADV EXP SOC PSYCHOL, V4, P271, DOI DOI 10.1016/S0065-2601(08)60080-5; Sullivan K. T., 2010, SUPPORT PROCESSES IN; Toussaint L, 2005, J SOC PSYCHOL, V145, P673, DOI 10.3200/SOCP.145.6.673-686; Verhofstadt L. L., 2010, SUPPORT PROCESSES IN, P71, DOI DOI 10.1093/ACPROF:OSO/9780195380170.003.0003; Verhofstadt LL, 2007, SEX ROLES, V57, P267, DOI 10.1007/s11199-007-9257-6; Verhofstadt LL, 2012, SOC BEHAV PERSONAL, V40, P175, DOI 10.2224/sbp.2012.40.1.175; Verhofstadt LL, 2007, PSYCHOL BELG, V47, P195, DOI 10.5334/pb-47-3-195; Verhofstadt LL, 2008, EMOTION, V8, P792, DOI 10.1037/a0013976; Verhofstadt LL, 2005, PERS RELATIONSHIP, V12, P23, DOI 10.1111/j.1350-4126.2005.00100.x; Verhofstadt LL., 2011, MANAGING INTERPERSON, P169; WISPE L, 1986, J PERS SOC PSYCHOL, V50, P314, DOI 10.1037/0022-3514.50.2.314	54	33	33	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149944	10.1371/journal.pone.0149944	http://dx.doi.org/10.1371/journal.pone.0149944			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910769	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700055
J	Shearrer, GE; House, BT; Gallas, MC; Luci, JJ; Davis, JN				Shearrer, Grace E.; House, Benjamin T.; Gallas, Michelle C.; Luci, Jeffrey J.; Davis, Jaimie N.			Fat Imaging via Magnetic Resonance Imaging (MRI) in Young Children (Ages 1-4 Years) without Sedation	PLOS ONE			English	Article							ABDOMINAL FAT; WHITE-MATTER; ADIPOSE-TISSUE; VISCERAL FAT; ADOLESCENTS; RISK; INFANTS; DISEASE	Introduction This pilot study developed techniques to perform Magnetic Resonance Imaging (MRI) of specific fat deposition in 18 children (age 18 months to 4 years). Methods The children engaged in a series of practice tests to become acclimated to the scanner noises, reduce claustrophobia, and rehearse holding still for a set time. The practice tests assessed if the child could remain still for two minutes while watching a video, first while lying on a blanket, second, on the blanket with headphones, and third, in the mock scanner. The children who passed the three practice tests were then scanned with a 3T Siemens Skyra magnet. Abdominal fat distribution (region of interest (ROI) from the top of the ileac crest to the bottom of the ribcage) volume was measured using 2-point DIXON technique. This region was chosen to give an indication of the body composition around the liver. Results Twelve out of eighteen participants successfully completed the actual MRI scan. Chisquared test showed no significant difference between male and female pass-fail rates. The median age of completed scans was 36 months, whereas the median age for children unable to complete a scan was 28 months. The average total trunk fat was 240.9 +/- 85.2mL and the average total VAT was 37.7 +/- 25.9mLand liver fat was not quantifiable due to physiological motion. Several strategies (modeling, videos, and incentives) were identified to improve pediatric imaging in different age ranges. Conclusion Using an age-specific and tailored protocol, we were able to successfully use MRI for fat imaging in a majority of young children. Development of such protocols enables researchers to better understand the etiology of fat deposition in young children, which can be used to aid in the prevention and treatment of adiposity.	[Shearrer, Grace E.; House, Benjamin T.; Davis, Jaimie N.] Univ Texas Austin, Nutr Sci, Austin, TX 78712 USA; [Gallas, Michelle C.] Univ Texas Southwestern, Dept Pediat, Austin, TX USA; [Luci, Jeffrey J.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Austin	Shearrer, GE (corresponding author), Univ Texas Austin, Nutr Sci, Austin, TX 78712 USA.	grace.shearrer@gmail.com	Davis, Jaimie/AAU-7800-2021	Davis, Jaimie/0000-0002-9103-696X	University of Texas	University of Texas	This study was funded through the University of Texas' start up funding for Dr. Davis. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2007, NEUROIMAGE, V35, P308, DOI 10.1016/j.neuroimage.2006.08.058; Armpilia CI, 2002, BRIT J RADIOL, V75, P590, DOI 10.1259/bjr.75.895.750590; Brambilla P, 1999, INT J OBESITY, V23, P299, DOI 10.1038/sj.ijo.0800815; Brody AS, 2007, PEDIATRICS, V120, P677, DOI 10.1542/peds.2007-1910; Dabelea D, 2014, JAMA-J AM MED ASSOC, V311, P1778, DOI 10.1001/jama.2014.3201; de Amorim e Silva C J T, 2006, Australas Radiol, V50, P319; Dean DC, 2014, PEDIATR RADIOL, V44, P64, DOI 10.1007/s00247-013-2752-8; Dean DC, 2014, NEUROIMAGE, V84, P742, DOI 10.1016/j.neuroimage.2013.09.058; Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090; Fox KR, 2000, INT J OBESITY, V24, P1653, DOI 10.1038/sj.ijo.0801464; Gastaldelli A, 2008, AM J CLIN NUTR, V87, P1118, DOI 10.1093/ajcn/87.5.1118; Goran MI, 1999, AM J CLIN NUTR, V70, p149S; Gower BA, 1999, DIABETES, V48, P1515, DOI 10.2337/diabetes.48.8.1515; Hallowell LM, 2008, PEDIATR RADIOL, V38, P271, DOI 10.1007/s00247-007-0704-x; Hu HH, 2011, OBES REV, V12, pe504, DOI 10.1111/j.1467-789X.2010.00824.x; Hu HH, 2010, OBESITY, V18, P841, DOI 10.1038/oby.2009.352; Kim SH, 2006, RADIOLOGY, V240, P116, DOI 10.1148/radiol.2393042218; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Owens S, 2000, OBES RES, V8, P287, DOI 10.1038/oby.2000.34; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Schwimmer JB, 2009, GASTROENTEROLOGY, V136, P1585, DOI 10.1053/j.gastro.2009.01.050; Serafini G, 2008, CURR OPIN ANESTHESIO, V21, P499, DOI 10.1097/ACO.0b013e328304115b; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Valentiner DP, 1996, COGNITIVE THER RES, V20, P593, DOI 10.1007/BF02227963; Wolff JJ, 2012, AM J PSYCHIAT, V169, P589, DOI 10.1176/appi.ajp.2011.11091447	27	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149744	10.1371/journal.pone.0149744	http://dx.doi.org/10.1371/journal.pone.0149744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901881	gold, Green Published			2022-12-27	WOS:000371276100139
J	He, GX; Tan, W; Wang, BJ; Chen, JZ; Li, GN; Zhu, SH; Xie, J; Xu, B				He, Guixin; Tan, Wei; Wang, Bingjian; Chen, Jianzhou; Li, Guannan; Zhu, Suhui; Xie, Jun; Xu, Biao			Increased M1 Macrophages Infiltration Is Associated with Thrombogenesis in Rheumatic Mitral Stenosis Patients with Atrial Fibrillation	PLOS ONE			English	Article							INFLAMMATION; ACTIVATION; INFLAMMASOMES	Atrial fibrillation (AF) is the most common arrhythmia. In patients with AF, the role of macrophage subsets in thrombogenesis is unclear. In the present study, we analyzed the role of M1 and M2 macrophages and related cytokines in thrombogenesis of AF. Immunohistochemistry, Western blot, and TUNEL assay were used to detect M1/M2 macrophage infiltration, the expression pattern of IL-1 beta and inflammasome components, and apoptosis of cardiomyocytes in 71 specimens obtained from the left atrial appendage of patients with rheumatic mitral stenosis (MS) with or without thrombosis. We demonstrated that proinflammatory M1 macrophages were predominant in the atrium of MS patients with AF and thrombus. NLRP3 inflammasomes and IL-1 beta, which are primarily functional in macrophages, were activated in those patients. We also showed that increased cell death was associated with thrombogenesis in MS patients. These data indicate that infiltration of M1 macrophages and over-activation of NLRP3 inflammasomes may play a role in progressive atrial inflammation and thrombogenesis in rheumatic mitral stenosis patients with AF.	[He, Guixin; Chen, Jianzhou; Li, Guannan; Zhu, Suhui; Xie, Jun; Xu, Biao] Nanjing Univ, Dept Cardiol, Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [He, Guixin; Tan, Wei] Guangxi Univ Chinese Med, Dept Cardiol, Affiliated Hosp 1, Nanning, Peoples R China; [Wang, Bingjian] Huaian First Peoples Hosp, Dept Cardiol, Huaian, Peoples R China	Nanjing University; Guangxi University of Chinese Medicine	Xie, J; Xu, B (corresponding author), Nanjing Univ, Dept Cardiol, Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.	darcy_pann@hotmail.com; xubiao@medmail.com.cn	xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242	Natural Science Foundation of China [81200148, 81270281, 81000055]; Jiangsu Provincial Special Program of Medical Science [BL2012014]; State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901]; Peak of Six Personnel in Jiangsu Province [2013-WSN-008]; Funds for Distinguished Young Scientists in Nanjing [JQX13006]; Key Program of Science Foundation in Nanjing [ZKX13023]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science; State Key Laboratory of Pharmaceutical Biotechnology; Peak of Six Personnel in Jiangsu Province; Funds for Distinguished Young Scientists in Nanjing; Key Program of Science Foundation in Nanjing	This work was supported by grants from the Natural Science Foundation of China (81200148, 81270281 and 81000055), Jiangsu Provincial Special Program of Medical Science (BL2012014), State Key Laboratory of Pharmaceutical Biotechnology (KF-GN-200901), Peak of Six Personnel in Jiangsu Province (2013-WSN-008), Funds for Distinguished Young Scientists in Nanjing (JQX13006), and the Key Program of Science Foundation in Nanjing (ZKX13023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cianfrocca C, 2010, INT J CARDIOL, V142, P22, DOI 10.1016/j.ijcard.2008.12.052; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; Harada M, 2015, CIRC J, V79, P495, DOI 10.1253/circj.CJ-15-0138; Kaski JC, 2011, REV ESP CARDIOL, V64, P551, DOI [10.1016/j.recesp.2011.03.015, 10.1016/j.rec.2011.03.014]; Katoh S, 2014, HEART VESSELS, V29, P263, DOI 10.1007/s00380-013-0369-3; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Parthenakis FI, 2007, INT J CARDIOL, V118, P206, DOI 10.1016/j.ijcard.2006.03.090; Patel P, 2010, J CARDIOVASC ELECTR, V21, P1064, DOI 10.1111/j.1540-8167.2010.01774.x; Saint Lindsey L, 2012, Mo Med, V109, P281; Shen Y, 2014, TEX HEART I J, V42, P109, DOI 10.14503/THIJ-14-4254; Wang H, 2010, CLIN CHIM ACTA, V411, P1700, DOI 10.1016/j.cca.2010.07.005	18	23	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149910	10.1371/journal.pone.0149910	http://dx.doi.org/10.1371/journal.pone.0149910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930272	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500072
J	Perrone, D; Jeurissen, B; Aelterman, J; Roine, T; Sijbers, J; Pizurica, A; Leemans, A; Philips, W				Perrone, Daniele; Jeurissen, Ben; Aelterman, Jan; Roine, Timo; Sijbers, Jan; Pizurica, Aleksandra; Leemans, Alexander; Philips, Wilfried			D-BRAIN: Anatomically Accurate Simulated Diffusion MRI Brain Data	PLOS ONE			English	Article							CONSTRAINED SPHERICAL DECONVOLUTION; STRUCTURAL CORTICAL NETWORKS; WHITE-MATTER; TENSOR TRACTOGRAPHY; FIBER-TRACKING; TOPOLOGICAL ORGANIZATION; VALIDATION; DENSITY; RESOLUTION; PHANTOM	Diffusion Weighted (DW) MRI allows for the non-invasive study of water diffusion inside living tissues. As such, it is useful for the investigation of human brain white matter (WM) connectivity in vivo through fiber tractography (FT) algorithms. Many DW-MRI tailored restoration techniques and FT algorithms have been developed. However, it is not clear how accurately these methods reproduce the WM bundle characteristics in real-world conditions, such as in the presence of noise, partial volume effect, and a limited spatial and angular resolution. The difficulty lies in the lack of a realistic brain phantom on the one hand, and a sufficiently accurate way of modeling the acquisition-related degradation on the other. This paper proposes a software phantom that approximates a human brain to a high degree of realism and that can incorporate complex brain-like structural features. We refer to it as a Diffusion BRAIN (D-BRAIN) phantom. Also, we propose an accurate model of a (DW) MRI acquisition protocol to allow for validation of methods in realistic conditions with data imperfections. The phantom model simulates anatomical and diffusion properties for multiple brain tissue components, and can serve as a ground-truth to evaluate FT algorithms, among others. The simulation of the acquisition process allows one to include noise, partial volume effects, and limited spatial and angular resolution in the images. In this way, the effect of image artifacts on, for instance, fiber tractography can be investigated with great detail. The proposed framework enables reliable and quantitative evaluation of DW-MR image processing and FT algorithms at the level of large-scale WM structures. The effect of noise levels and other data characteristics on cortico-cortical connectivity and tractographybased grey matter parcellation can be investigated as well.	[Perrone, Daniele; Aelterman, Jan; Pizurica, Aleksandra; Philips, Wilfried] Univ Ghent, IMinds IPI TELIN, B-9000 Ghent, Belgium; [Jeurissen, Ben; Roine, Timo; Sijbers, Jan] Univ Antwerp, Dept Phys, IMinds Vis Lab, B-2020 Antwerp, Belgium; [Sijbers, Jan] Univ Med Ctr Utrecht, Image Sci Inst, Utrecht, Netherlands	Ghent University; IMEC; IMEC; University of Antwerp; Utrecht University; Utrecht University Medical Center	Perrone, D (corresponding author), Univ Ghent, IMinds IPI TELIN, B-9000 Ghent, Belgium.	daniele.perrone@ugent.be	Roine, Timo/M-5865-2013; Pizurica, Aleksandra/K-6866-2015; Leemans, Alexander/A-1784-2011; Pizurica, Aleksandra/AAG-4687-2021; Jeurissen, Ben/C-3246-2011; Sijbers, Jan/C-4214-2011; Sijbers, Jan/H-4324-2015	Roine, Timo/0000-0002-3104-9734; Pizurica, Aleksandra/0000-0002-9322-4999; Leemans, Alexander/0000-0002-9306-6126; Jeurissen, Ben/0000-0002-3488-9819; Sijbers, Jan/0000-0003-4225-2487; Sijbers, Jan/0000-0003-4225-2487; Aelterman, Jan/0000-0002-5543-2631	Fund for Scientific Research-Flanders (FWO); Interuniversity Attraction Poles Program [P7/11]; Netherlands Organisation for Scientific Research (NWO) [639.072.411]; NIH [1U54MH091657]; NATIONAL INSTITUTE OF MENTAL HEALTH [U54MH091657] Funding Source: NIH RePORTER	Fund for Scientific Research-Flanders (FWO)(FWO); Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Fund for Scientific Research-Flanders (FWO). The authors thank the Interuniversity Attraction Poles Program (P7/11) initiated by the Belgian Science Policy Office. Ben Jeurissen is a postdoctoral fellow of the Research Fund Flanders (FWO). The research of A. L. is supported by VIDI Grant 639.072.411 from the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University for providing part of the data.	Alexander DC, 2005, ANN NY ACAD SCI, V1064, P113, DOI 10.1196/annals.1340.018; Alfano B, 2011, MED IMAGE ANAL, V15, P329, DOI 10.1016/j.media.2011.01.004; Bach M, 2014, MAGN RESON MED, V71, P1108, DOI 10.1002/mrm.24774; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2014, HUM BRAIN MAPP, V35, P4944, DOI 10.1002/hbm.22524; Caeyenberghs K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00726; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Campbell JSW, 2005, NEUROIMAGE, V27, P725, DOI 10.1016/j.neuroimage.2005.05.014; Caparelli EC, 2008, BIOMED SIGNAL PROCES, V3, P107, DOI 10.1016/j.bspc.2007.11.003; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Close TG, 2009, NEUROIMAGE, V47, P1288, DOI 10.1016/j.neuroimage.2009.03.077; Cocosco C. A., 1997, NEUROIMAGE, V5, pS425, DOI DOI 10.1016/S1053-8119(97)80018-3; Cote MA, 2013, MED IMAGE ANAL, V17, P844, DOI 10.1016/j.media.2013.03.009; den Dekker AJ, 2014, PHYS MEDICA, V30, P725, DOI 10.1016/j.ejmp.2014.05.002; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Drobnjak I, 2010, MAGN RESON IMAGING, V28, P1014, DOI 10.1016/j.mri.2010.03.029; Dyrby TB, 2013, MAGN RESON MED, V70, P711, DOI 10.1002/mrm.24501; Ferizi U, 2014, MAGN RESON MED, V72, P1785, DOI 10.1002/mrm.25080; Ferizi U, 2013, LECT NOTES COMPUT SC, V8149, P74, DOI 10.1007/978-3-642-40811-3_10; Fieremans E, 2008, J MAGN RESON, V190, P189, DOI 10.1016/j.jmr.2007.10.014; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Gallichan D, 2010, HUM BRAIN MAPP, V31, P193, DOI 10.1002/hbm.20856; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Heringa SM, 2014, J ALZHEIMERS DIS, V38, P211, DOI 10.3233/JAD-130542; Huang SY, 2015, NEUROIMAGE, V106, P464, DOI 10.1016/j.neuroimage.2014.12.008; Hubbard P, 2014, MAGN RESON IN PRESS; Jansons KM, 2003, LECT NOTES COMPUT SC, V2732, P672; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jeurissen B, 2013, HUM BRAIN MAPP, V34, P2747, DOI 10.1002/hbm.22099; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kamali A, 2009, EUR RADIOL, V19, P1480, DOI 10.1007/s00330-009-1305-x; Latt J, 2007, MAGN RESON MATER PHY, V20, P213, DOI 10.1007/s10334-007-0085-z; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; LEBIHAN D, 1985, CR ACAD SCI II, V301, P1109; Leemans A, 2005, MAGN RESON MED, V53, P944, DOI 10.1002/mrm.20418; Leemans A., 2009, P INT SOC MAG RESON, P3537, DOI DOI 10.1093/OCCMED/KQR069; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Lin CP, 2003, NEUROIMAGE, V19, P482, DOI 10.1016/S1053-8119(03)00154-X; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Neher PF, 2013, MAGN RESON IN PRESS; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Perrone D, 2014, P INT SOC MAGN RES M, P4427; Perrone D, 2015, NEUROIMAGE, V120, P441, DOI 10.1016/j.neuroimage.2015.06.068; Poupon C., 2010, PROC INT SOC MAGNETI, V18, P581; Pullens P, 2010, J MAGN RESON IMAGING, V32, P482, DOI 10.1002/jmri.22243; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reijmer YD, 2015, BRAIN, V138, P179, DOI 10.1093/brain/awu316; Reijmer YD, 2013, DIABETES, V62, P2112, DOI 10.2337/db12-1644; Reijmer YD, 2013, NEUROLOGY, V80, P1370, DOI 10.1212/WNL.0b013e31828c2ee5; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Saygin ZM, 2011, NEUROIMAGE, V56, P1353, DOI 10.1016/j.neuroimage.2011.03.006; Schultz T, 2014, COMPUTATIONAL DIFFUS; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stuart G, 2007, DENDRITES; Tax CMW, 2014, MAGN RESON MED, P1; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier J-D., 2010, P INT SOC MAGNETIC R, V1670; Tournier JD, 2013, NMR BIOMED, V26, P1775, DOI 10.1002/nbm.3017; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tournier JD, 2002, MAGN RESON MED, V47, P701, DOI 10.1002/mrm.10116; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Van Hecke W, 2009, NEUROIMAGE, V46, P692, DOI 10.1016/j.neuroimage.2009.02.032; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Weeden VJ, 2000, PROC 8TH ANNUAL MEET, P82; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yanasak N, 2006, MAGN RESON IMAGING, V24, P1349, DOI 10.1016/j.mri.2006.08.001; Yeh CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076626; Yo TS, 2009, LECT NOTES COMPUT SC, V5761, P886; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	95	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149778	10.1371/journal.pone.0149778	http://dx.doi.org/10.1371/journal.pone.0149778			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930054	Green Submitted, gold, Green Published			2022-12-27	WOS:000371434500056
J	Fogelmark, K; Peterson, C; Troein, C				Fogelmark, Karl; Peterson, Carsten; Troein, Carl			Selection Shapes Transcriptional Logic and Regulatory Specialization in Genetic Networks	PLOS ONE			English	Article							EVOLUTION; DUPLICATION; EXPRESSION; DESIGN	Background Living organisms need to regulate their gene expression in response to environmental signals and internal cues. This is a computational task where genes act as logic gates that connect to form transcriptional networks, which are shaped at all scales by evolution. Large-scale mutations such as gene duplications and deletions add and remove network components, whereas smaller mutations alter the connections between them. Selection determines what mutations are accepted, but its importance for shaping the resulting networks has been debated. Methodology To investigate the effects of selection in the shaping of transcriptional networks, we derive transcriptional logic from a combinatorially powerful yet tractable model of the binding between DNA and transcription factors. By evolving the resulting networks based on their ability to function as either a simple decision system or a circadian clock, we obtain information on the regulation and logic rules encoded in functional transcriptional networks. Comparisons are made between networks evolved for different functions, as well as with structurally equivalent but non-functional (neutrally evolved) networks, and predictions are validated against the transcriptional network of E. coli. Principal Findings We find that the logic rules governing gene expression depend on the function performed by the network. Unlike the decision systems, the circadian clocks show strong cooperative binding and negative regulation, which achieves tight temporal control of gene expression. Furthermore, we find that transcription factors act preferentially as either activators or repressors, both when binding multiple sites for a single target gene and globally in the transcriptional networks. This separation into positive and negative regulators requires gene duplications, which highlights the interplay between mutation and selection in shaping the transcriptional networks.	[Fogelmark, Karl; Peterson, Carsten; Troein, Carl] Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, S-22362 Lund, Sweden	Lund University	Troein, C (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Computat Biol & Biol Phys, S-22362 Lund, Sweden.	carl@thep.lu.se			Swedish Research Council [621-2010-5219, 621-2013-4547]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	CT and KF were supported by grant 621-2010-5219 and CP by grant 621-2013-4547 from the Swedish Research Council (http://vr.se/).	Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Banzhaf W, 2003, LECT NOTES ARTIF INT, V2801, P217; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Carre I, 2013, SEMIN CELL DEV BIOL, V24, P393, DOI 10.1016/j.semcdb.2013.03.011; De Smet R, 2012, CURR OPIN PLANT BIOL, V15, P168, DOI 10.1016/j.pbi.2012.01.003; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Fogelmark K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003705; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Gerland U, 2002, P NATL ACAD SCI USA, V99, P12015, DOI 10.1073/pnas.192693599; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Kuo PD, 2006, BIOSYSTEMS, V85, P177, DOI 10.1016/j.biosystems.2006.01.004; Layne L, 2012, B MATH BIOL, V74, P422, DOI 10.1007/s11538-011-9692-y; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Matsushika A, 2000, PLANT CELL PHYSIOL, V41, P1002, DOI 10.1093/pcp/pcd043; McWatters HG, 2011, FEBS LETT, V585, P1474, DOI 10.1016/j.febslet.2011.03.051; Paladugu SR, 2006, IEE P SYST BIOL, V153, P223, DOI 10.1049/ip-syb:20050096; Pokhilko A, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-23; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Salgado H, 2013, NUCLEIC ACIDS RES, V41, pD203, DOI 10.1093/nar/gks1201; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sorrells TR, 2015, CELL, V161, P714, DOI 10.1016/j.cell.2015.04.014; Traven A, 2006, EMBO REP, V7, P496, DOI 10.1038/sj.embor.7400679; Troein C, 2009, CURR BIOL, V19, P1961, DOI 10.1016/j.cub.2009.09.024	26	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150340	10.1371/journal.pone.0150340	http://dx.doi.org/10.1371/journal.pone.0150340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927540	gold, Green Published, Green Submitted			2022-12-27	WOS:000371424200037
J	Tosoni, K; Cassidy, D; Kerr, B; Land, SC; Mehta, A				Tosoni, Kendra; Cassidy, Diane; Kerr, Barry; Land, Stephen C.; Mehta, Anil			Using Drugs to Probe the Variability of Trans-Epithelial Airway Resistance	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CILIARY BEAT FREQUENCY; CYSTIC-FIBROSIS; IN-VITRO; PERSONALIZED THERAPY; CELL MONOLAYERS; LUNG-DISEASE; CULTURES; SODIUM; CFTR	Background Precision medicine aims to combat the variability of the therapeutic response to a given medicine by delivering the right medicine to the right patient. However, the application of precision medicine is predicated on a prior quantitation of the variance of the reference range of normality. Airway pathophysiology provides a good example due to a very variable first line of defence against airborne assault. Humans differ in their susceptibility to inhaled pollutants and pathogens in part due to the magnitude of trans-epithelial resistance that determines the degree of epithelial penetration to the submucosal space. This initial 'set-point' may drive a sentinel event in airway disease pathogenesis. Epithelia differentiated in vitro from airway biopsies are commonly used to model trans-epithelial resistance but the 'reference range of normality' remains problematic. We investigated the range of electrophysiological characteristics of human airway epithelia grown at air-liquid interface in vitro from healthy volunteers focusing on the inter-and intra-subject variability both at baseline and after sequential exposure to drugs modulating ion transport. Methodology/Principal Findings Brushed nasal airway epithelial cells were differentiated at air-liquid interface generating 137 pseudostratified ciliated epithelia from 18 donors. A positively-skewed baseline range exists for trans-epithelial resistance (Min/Max: 309/2963 Omega. cm(2)), trans-epithelial voltage (-62.3/-1.8 mV) and calculated equivalent current (-125.0/-3.2 mu A/cm(2); all non-normal, P< 0.001). A minority of healthy humans manifest a dramatic amiloride sensitivity to voltage and trans-epithelial resistance that is further discriminated by prior modulation of cAMP-stimulated chloride transport. Conclusions/Significance Healthy epithelia show log-order differences in their ion transport characteristics, likely reflective of their initial set-points of basal trans-epithelial resistance and sodium transport. Our data may guide the choice of the background set point in subjects with airway diseases and frame the reference range for the future delivery of precision airway medicine.	[Tosoni, Kendra; Cassidy, Diane; Land, Stephen C.; Mehta, Anil] Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland; [Kerr, Barry] Univ Dundee, Sch Med, Dundee, Scotland	University of Dundee; University of Dundee	Tosoni, K; Mehta, A (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee DD1 9SY, Scotland.	k.tosoni@dundee.ac.uk; a.mehta@dundee.ac.uk			Myrovlytis Trust [804824]; Russell Trust	Myrovlytis Trust; Russell Trust	This work was funded by the Myrovlytis Trust (#804824) awarded to AM and SCL (www.myrovlytistrust.org) and the early work was funded by the Russell Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annesi-Maesano I, 2012, EUR RESPIR J, V40, P12, DOI 10.1183/09031936.00072712; Awatade NT, 2015, EBIOMEDICINE, V2, P147, DOI 10.1016/j.ebiom.2014.12.005; Bachhuber T, 2008, J BIOL CHEM, V283, P13225, DOI 10.1074/jbc.M704532200; Beekman JM, 2014, J CYST FIBROS, V13, P363, DOI 10.1016/j.jcf.2014.05.007; Borthwick LA, 2016, PLOS ONE IN PRESS; Bukowy Z, 2011, J APPL GENET, V52, P39, DOI 10.1007/s13353-010-0005-1; Chen ZX, 2014, AM J PHYSIOL-LUNG C, V307, pL609, DOI 10.1152/ajplung.00126.2014; Chow CY, 2016, NAT REV GENET, V17, P63, DOI 10.1038/nrg.2015.9; Collaco JM, 2010, J PEDIATR-US, V157, P802, DOI 10.1016/j.jpeds.2010.05.018; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Crespin S, 2014, INT J BIOCHEM CELL B, V52, P152, DOI 10.1016/j.biocel.2014.02.010; de Courcey F, 2012, AM J PHYSIOL-CELL PH, V303, pC1173, DOI 10.1152/ajpcell.00384.2011; Deng XF, 2014, J VIROL METHODS, V195, P112, DOI 10.1016/j.jviromet.2013.10.012; Dimova S, 2005, TOXICOL IN VITRO, V19, P107, DOI 10.1016/j.tiv.2004.07.003; Hilfinger A, 2015, NATURE, V519, P422, DOI 10.1038/nature14210; Holgate ST, 2011, IMMUNOL REV, V242, P205, DOI 10.1111/j.1600-065X.2011.01030.x; Jepsen M, 2000, AM J RHINOL, V14, P405, DOI 10.2500/105065800779954365; Keenan K, 2015, J CYST FIBROS, V14, P310, DOI 10.1016/j.jcf.2014.09.006; Kunzelmann K, 2000, PFLUG ARCH EUR J PHY, V440, P193, DOI 10.1007/s004240000255; Kunzelmann K, 2013, FEBS J, V280, P4417, DOI 10.1111/febs.12457; LeSimple P, 2010, J PHYSIOL-LONDON, V588, P1195, DOI 10.1113/jphysiol.2009.182246; Luijten MNH, 2013, HUM MOL GENET, V22, P4383, DOI 10.1093/hmg/ddt288; Maiuri L, 2016, CELL DEATH IN PRESS; Mansley MK, 2010, BRIT J PHARMACOL, V161, P571, DOI 10.1111/j.1476-5381.2010.00898.x; Martel G, 2014, INT J BIOCHEM CELL B, V52, P146, DOI 10.1016/j.biocel.2014.02.002; McDougall CM, 2008, AM J RESP CELL MOL, V39, P560, DOI 10.1165/rcmb.2007-0325OC; Molenda N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100621; Mwimbi XKMS, 2003, CELL SIGNAL, V15, P395, DOI 10.1016/S0898-6568(02)00143-2; Mwimbi XKMS, 2000, J AEROSOL MED, V13, P273, DOI 10.1089/jam.2000.13.273; Nasreen N, 2014, AM J PHYSIOL-CELL PH, V306, pC1154, DOI 10.1152/ajpcell.00415.2012; Parker JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061023; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Pier GB, 2006, INFECT IMMUN, V74, P7043, DOI 10.1128/IAI.01233-06; Portelli M, 2012, EXPERT REV RESP MED, V6, P223, DOI [10.1586/ERS.12.9, 10.1586/ers.12.9]; Prytherch Z, 2011, MACROMOL BIOSCI, V11, P1467, DOI 10.1002/mabi.201100181; Sartori C, 2004, EUR RESPIR J, V23, P916, DOI 10.1183/09031936.04.00115304; Smith RP, 1996, J PHYSIOL-LONDON, V496, P883, DOI 10.1113/jphysiol.1996.sp021735; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Stewart Ceri E, 2012, J Allergy (Cairo), V2012, P943982, DOI 10.1155/2012/943982; Taouil K, 2003, J BIOL CHEM, V278, P17320, DOI 10.1074/jbc.M212227200; Thavagnanam S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085802; Vermeulen F, 2015, J CYST FIBROS, V14, P317, DOI 10.1016/j.jcf.2014.08.006; Weiser N, 2011, CELL PHYSIOL BIOCHEM, V28, P289, DOI 10.1159/000331742; Xu R, 2013, BIOSCIENCE REP, V33, P847, DOI 10.1042/BSR20130087	44	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0149550	10.1371/journal.pone.0149550	http://dx.doi.org/10.1371/journal.pone.0149550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26926476	gold, Green Published, Green Submitted			2022-12-27	WOS:000371424200013
J	Gomes, CS; Matozinhos, FP; Mendes, LL; Pessoa, MC; Velasquez-Melendez, G				Gomes, Crizian Saar; Matozinhos, Fernanda Penido; Mendes, Larissa Loures; Pessoa, Milene Cristine; Velasquez-Melendez, Gustavo			Physical and Social Environment Are Associated to Leisure Time Physical Activity in Adults of a Brazilian City: A Cross-Sectional Study	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; BUILT ENVIRONMENT; PERCEIVED ENVIRONMENT; NEIGHBORHOOD ENVIRONMENTS; MULTILEVEL ANALYSIS; CURITIBA; EPIDEMIOLOGY; INDICATORS; TELEPHONE; VALIDITY	The physical activity practice is highlighted as a strategy to health promotion and to avoid chronic diseases. In addition to individual factors, environmental characteristics in which people live, may offer opportunities or barriers in adopting healthy habits and this is related to the physical activity (PA) practice among individuals. The aim of this study is to investigate the associations between neighborhood environment and leisure-time physical activity in adults. This is a cross-sectional study, developed using the database of Surveillance System for Risk and Protective Factors for Chronic Diseases by Telephone Survey (VIGITEL 2008/2010) of Belo Horizonte, Brazil. Individuals with the habit of practicing PA for at least 150 minutes of moderate-intensity PA or at least 75 minutes of vigorous-intensity PA throughout the week in leisure time were classified as active in leisure time. To characterize the built and social environment we used georeferenced data of public and private places for physical activity, population density, residential density, homicide rate and total income of the coverage area of the basic health units. The covered area of the basic health units was used as context unit. For data analysis, we used multilevel logistic regression. The study included 5779 adults, 58.77% female. There was variability of physical activity in leisure time between area covered by the basic health units (Median Odds ratio = 1.30). After adjusting for individual characteristics, the increase of density of private places for physical activity (Odds ratios-OR = 1.31; 95% confidence interval-95% CI: 1.15 to 1.48) and the smaller homicide rate (OR = 0.82; IC95%: 0.70 to 0.96) in the neighborhood increased physical activity in leisure time. The evidence of this study shows that neighborhood environment may influence the physical activity practice in leisure time and should be considered in future interventions and health promotion strategies.	[Gomes, Crizian Saar; Matozinhos, Fernanda Penido; Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; [Mendes, Larissa Loures] Univ Fed Minas Gerais, Dept Nutr, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil; [Pessoa, Milene Cristine] Univ Fed Ouro Preto, Dept Clin & Social Nutr, R Diogo de Vasconcelos 122, BR-35400000 Ouro Preto, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Ouro Preto	Velasquez-Melendez, G (corresponding author), Univ Fed Minas Gerais, Dept Maternal & Child Nursing & Publ Hlth, Av Alfredo Balena 190, BR-30130100 Belo Horizonte, MG, Brazil.	jguveme@gmail.com	Mendes, Larissa/Q-4817-2017; Mendes, Larissa/AAL-6662-2020; Matozinhos, Fernanda/AAW-5799-2020	Mendes, Larissa/0000-0003-0776-6845; Matozinhos, Fernanda/0000-0003-1368-4248	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CSG and FPM received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). MCP received grant from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ). GVM is researcher from the Fundacao de Amparo a Pesquisa do estado de Minas Gerais- PPM 00114 -13 (FAPEMIG).	Amesty SC, 2003, J PUBLIC HEALTH POL, V24, P41, DOI 10.2307/3343176; Amorim TC, 2010, J PHYS ACT HEALTH, V7, pS204, DOI 10.1123/jpah.7.s2.s204; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; [Anonymous], 2013, GLOB BURD DIS GEN EV; Arango CM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-122; Bennett GG, 2007, PLOS MED, V4, P1599, DOI 10.1371/journal.pmed.0040306; Bernal Regina, 2009, Rev. Saúde Pública, V43, P421, DOI 10.1590/S0034-89102009005000024; Cerin E, 2006, MED SCI SPORT EXER, V38, P1682, DOI 10.1249/01.mss.0000227639.83607.4d; Cerin E, 2013, PREV MED, V56, P86, DOI 10.1016/j.ypmed.2012.10.024; Corseuil MW, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/641010; Del Duca GF, 2013, CAD SAUDE PUBLICA, V29, P2119, DOI 10.1590/0102-311X00130412; Evenson KR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-146; Florindo Alex Antonio, 2013, Rev. bras. cineantropom. desempenho hum., V15, P243, DOI 10.5007/1980-0037.2013v15n2p243; Florindo AA, 2013, J PHYS ACT HEALTH, V10, P563, DOI 10.1123/jpah.10.4.563; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Gebel K, 2007, AM J PREV MED, V32, P361, DOI 10.1016/j.amepre.2007.01.020; Gomes GAO, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-111; Gomez LF, 2010, J PHYS ACT HEALTH, V7, pS196, DOI 10.1123/jpah.7.s2.s196; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2010, J PHYS ACT HEALTH, V7, pS213, DOI 10.1123/jpah.7.s2.s213; Hanibuchi T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-657; Hino AAF, 2011, PREV MED, V52, P419, DOI 10.1016/j.ypmed.2011.03.019; Instituto Brasileiro de Geografia e Estatistica, 2012, CENS 2010; Jesus Gilmar Mercês de, 2012, Rev. Bras. Ciênc. Esporte, V34, P433; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Malta DC, 2012, LANCET, V380, P195, DOI 10.1016/S0140-6736(12)61041-1; McCormack GR, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-125; Mendes MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108136; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Monteiro CA, 2008, REV SAUDE PUBL, V42, P575, DOI 10.1590/S0034-89102008000400002; Moura Erly Catarina, 2008, Rev. bras. epidemiol., V11, P20; Nakamura PM, 2013, REV BRAS ATIV FIS SA, V18, P424; Parra DC, 2011, PREV MED, V52, P234, DOI 10.1016/j.ypmed.2010.12.008; Parra DC, 2010, AM J PUBLIC HEALTH, V100, P1420, DOI 10.2105/AJPH.2009.181230; Rech CR, 2014, PREV MED, V58, P53, DOI 10.1016/j.ypmed.2013.10.023; Rech CR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-72; Reis RS, 2013, AM J PREV MED, V45, P269, DOI 10.1016/j.amepre.2013.04.020; Saelens BE, 2012, MED SCI SPORT EXER, V44, P637, DOI 10.1249/MSS.0b013e318237fe18; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; SALLIS JF, 1990, PUBLIC HEALTH REP, V105, P179; Salvador EP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-67; Salvador Emanuel Péricles, 2009, Rev. Saúde Pública, V43, P972, DOI 10.1590/S0034-89102009005000082; Boclin KDS, 2014, REV SAUDE PUBL, V48, P249, DOI 10.1590/S0034-8910.2014048004935; Van Dyck D, 2013, HEALTH PLACE, V19, P59, DOI 10.1016/j.healthplace.2012.09.017; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; Wong F, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.5276	49	21	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150017	10.1371/journal.pone.0150017	http://dx.doi.org/10.1371/journal.pone.0150017			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26915091	gold, Green Published			2022-12-27	WOS:000371175700046
J	Overdyk, FJ; Dowling, O; Marino, J; Qiu, JJ; Chien, HL; Erslon, M; Morrison, N; Harrison, B; Dahan, A; Gan, TJ				Overdyk, Frank J.; Dowling, Oonagh; Marino, Joseph; Qiu, Jiejing; Chien, Hung-Lun; Erslon, Mary; Morrison, Neil; Harrison, Brooke; Dahan, Albert; Gan, Tong J.			Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database	PLOS ONE			English	Article							CARDIAC-ARREST; ADVERSE EVENTS; RESUSCITATION; SURVIVAL; SYSTEM; TRENDS; IMPACT; GUIDELINES; HYPOXEMIA; MORTALITY	Background While opioid use confers a known risk for respiratory depression, the incremental risk of in-hospital cardiopulmonary arrest, respiratory arrest, or cardiopulmonary resuscitation (CPRA) has not been studied. Our aim was to investigate the prevalence, outcomes, and risk profile of in-hospital CPRA for patients receiving opioids and medications with central nervous system sedating side effects (sedatives). Methods A retrospective analysis of adult inpatient discharges from 2008-2012 reported in the Premier Database. Patients were grouped into four mutually exclusive categories: (1) opioids and sedatives, (2) opioids only, (3) sedatives only, and (4) neither opioids nor sedatives. Results Among 21,276,691 inpatient discharges, 53% received opioids with or without sedatives. A total of 96,554 patients suffered CPRA (0.92 per 1000 hospital bed-days). Patients who received opioids and sedatives had an adjusted odds ratio for CPRA of 3.47 (95% CI: 3.40-3.54; p<0.0001) compared with patients not receiving opioids or sedatives. Opioids alone and sedatives alone were associated with a 1.81-fold and a 1.82-fold (p<0.0001 for both) increase in the odds of CPRA, respectively. In opioid patients, locations of CPRA were intensive care (54%), general care floor (25%), and stepdown units (15%). Only 42% of patients survived CPRA and only 22% were discharged home. Opioid patients with CPRA had mean increased hospital lengths of stay of 7.57 days and mean increased total hospital costs of $27,569. Conclusions Opioids and sedatives are independent and additive risk factors for in-hospital CPRA. The impact of opioid sparing analgesia, reduced sedative use, and better monitoring on CPRA incidence deserves further study.	[Overdyk, Frank J.; Marino, Joseph] Hofstra North Shore LIJ Sch Med, Dept Anesthesiol, New Hyde Pk, NY USA; [Overdyk, Frank J.; Marino, Joseph] North Amer Partners Anesthesia, Melville, NY USA; [Dowling, Oonagh] Hofstra North Shore LIJ Sch Med, Dept Med, Hempstead, NY USA; [Qiu, Jiejing; Chien, Hung-Lun] Covidien Healthcare Econ & Outcomes Res, Mansfield, MA USA; [Erslon, Mary] Covidien Resp & Monitoring Solut, Boulder, CO USA; [Morrison, Neil] Harrier Consultancy, Lancaster, England; [Harrison, Brooke] Boulder Med Writing, Boulder, CO USA; [Dahan, Albert] Leiden Univ, Med Ctr, Dept Anesthesiol, Leiden, Netherlands; [Gan, Tong J.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA	Hofstra University; Northwell Health; Hofstra University; Northwell Health; Covidien; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Overdyk, FJ (corresponding author), Hofstra North Shore LIJ Sch Med, Dept Anesthesiol, New Hyde Pk, NY USA.; Overdyk, FJ (corresponding author), North Amer Partners Anesthesia, Melville, NY USA.	overdykf@icloud.com	Dahan, Albert/B-8845-2008	Dahan, Albert/0000-0003-3161-3945	Covidien Healthcare Economics and Outcome Research; Covidien; Boulder Medical Writing	Covidien Healthcare Economics and Outcome Research; Covidien; Boulder Medical Writing	This analysis was supported by Covidien Healthcare Economics and Outcome Research. JQ, HLC, and ME are Covidien employees. The funder, Covidien, provided support in the form of salaries for authors JQ, HLC, and ME, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. FJO and JM are employed by North American Partners in Anesthesia. NM is employed by Harrier Consultancy. BH is employed by Boulder Medical Writing. North American Partners in Anesthesia, Harrier Consultancy, and Boulder Medical Writing provided support in the form of salaries for authors FJO, JM, NM, and BH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	BAILEY PL, 1990, ANESTHESIOLOGY, V73, P826, DOI 10.1097/00000542-199011000-00005; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Chen J, 2009, RESUSCITATION, V80, P35, DOI 10.1016/j.resuscitation.2008.10.009; Dahan A, 2010, ANESTHESIOLOGY, V112, P226, DOI 10.1097/ALN.0b013e3181c38c25; Davies EC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004439; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Ebell MH, 2013, JAMA INTERN MED, V173, P1872, DOI 10.1001/jamainternmed.2013.10037; Ehlenbach WJ, 2009, NEW ENGL J MED, V361, P22, DOI 10.1056/NEJMoa0810245; Galhotra S, 2007, QUAL SAF HEALTH CARE, V16, P260, DOI 10.1136/qshc.2007.022210; Girotra S, 2012, NEW ENGL J MED, V367, P1912, DOI 10.1056/NEJMoa1109148; Giummarra MJ, 2014, PAIN MED; Herzig SJ, 2014, J HOSP MED, V9, P73, DOI 10.1002/jhm.2102; Hillman K, 2005, LANCET, V365, P2091; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Howington JA, 2012, CHEST, V141, P429, DOI 10.1378/chest.10-3013; Jarzyna D, 2011, PAIN MANAG NURS, V12, P118, DOI 10.1016/j.pmn.2011.06.008; Kelly JP, 2008, PAIN, V138, P507, DOI 10.1016/j.pain.2008.01.027; KOHN LT, 1999, TO ERR IS HUMAN BUIL; Larkin GL, 2010, RESUSCITATION, V81, P302, DOI 10.1016/j.resuscitation.2009.11.021; Lee LA, 2015, ANESTHESIOLOGY, V122, P659, DOI 10.1097/ALN.0000000000000564; Lindenauer PK, 2014, JAMA INTERN MED, V174, P1982, DOI 10.1001/jamainternmed.2014.5430; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Morrison LJ, 2013, CIRCULATION, V127, P1538, DOI 10.1161/CIR.0b013e31828b2770; Oderda GM, 2007, ANN PHARMACOTHER, V41, P400, DOI 10.1345/aph.1H386; Oderda Gary M, 2013, J Pain Palliat Care Pharmacother, V27, P62, DOI 10.3109/15360288.2012.751956; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Reed K, 2011, HEALTHGRADES PATIENT; Sandroni C, 2007, INTENS CARE MED, V33, P237, DOI 10.1007/s00134-006-0326-z; Sullivan MD, 2008, PAIN, V138, P440, DOI 10.1016/j.pain.2008.04.027; Sun Z, 2015, ANESTH ANALG, V121, P709, DOI 10.1213/ANE.0000000000000836; Taenzer AH, 2010, ANESTHESIOLOGY, V112, P282, DOI 10.1097/ALN.0b013e3181ca7a9b; The Joint Commission, 2012, SENTINEL EVENT ALERT; Zerzan JT, 2006, MED CARE, V44, P1005, DOI 10.1097/01.mlr.0000228025.04535.25	37	52	52	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150214	10.1371/journal.pone.0150214	http://dx.doi.org/10.1371/journal.pone.0150214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26913753	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700061
J	Sholzberg, M; Gomes, T; Juurlink, DN; Yao, Z; Mamdani, MM; Laupacis, A				Sholzberg, Michelle; Gomes, Tara; Juurlink, David N.; Yao, Zhan; Mamdani, Muhammad M.; Laupacis, Andreas			The Influence of Socioeconomic Status on Selection of Anticoagulation for Atrial Fibrillation	PLOS ONE			English	Article							COST-EFFECTIVENESS; STROKE PREVENTION; WARFARIN; DABIGATRAN; CANADA; IMPACT; DRUGS; CARE; PHARMACARE; PHYSICIANS	Importance Without third-party insurance, access to marketed drugs is limited to those who can afford to pay. We examined this phenomenon in the context of anticoagulation for patients with nonvalvular atrial fibrillation (NVAF). Objective To determine whether, among older Ontarians receiving anticoagulation for NVAF, patients of higher socioeconomic status (SES) were more likely to switch from warfarin to dabigatran prior to its addition to the provincial formulary. Design, Setting and Participants Population-based retrospective cohort study of Ontarians aged 66 years and older, between 2008 and 2012. Exposure Socioeconomic status, as approximated by median neighborhood income. Main Outcomes and Measure We identified two groups of older adults with nonvalvular atrial fibrillation: those who appeared to switch from warfarin to dabigatran after its market approval but prior to its inclusion on the provincial formulary ("switchers"), and those with ongoing warfarin use during the same interval ("non-switchers"). Results We studied 34,797 patients, including 3183 "switchers" and 31,614 "non-switchers". We found that higher SES was associated with switching to dabigatran prior to its coverage on the provincial formulary (p<0.0001). In multivariable analysis, subjects in the highest quintile were 50% more likely to switch to dabigatran than those in the lowest income quintile (11.3% vs. 7.3%; adjusted odds ratio 1.50; 95% CI 1.32 to 1.68). Following dabigatran's addition to the formulary, the income gradient disappeared. Conclusions and Relevance We documented socioeconomic inequality in access to dabigatran among patients receiving warfarin for NVAF. This disparity was eliminated following the drug's addition to the provincial formulary, highlighting the importance of timely reimbursement decisions.	[Sholzberg, Michelle; Laupacis, Andreas] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Sholzberg, Michelle; Juurlink, David N.; Laupacis, Andreas] Univ Toronto, Fac Med, Toronto, ON, Canada; [Sholzberg, Michelle] St Michaels Hosp, Dept Lab Med & Pathobiol, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Mamdani, Muhammad M.; Laupacis, Andreas] St Michaels Hosp, Li Ka Shing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada; [Gomes, Tara; Juurlink, David N.; Yao, Zhan; Mamdani, Muhammad M.; Laupacis, Andreas] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Gomes, Tara; Juurlink, David N.; Mamdani, Muhammad M.; Laupacis, Andreas] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Juurlink, David N.] Sunnybrook Res Inst, Clin Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sholzberg, M (corresponding author), St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada.; Sholzberg, M (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.; Sholzberg, M (corresponding author), St Michaels Hosp, Dept Lab Med & Pathobiol, 30 Bond St, Toronto, ON M5B 1W8, Canada.	sholzbergm@smh.ca		Sholzberg, Michelle/0000-0003-1220-0301; Gomes, Tara/0000-0002-1468-1965	Ontario Drug Policy Research Network (ODPRN) - Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC); Canada Research Chair; Boehringer-Ingelheim	Ontario Drug Policy Research Network (ODPRN) - Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Boehringer-Ingelheim(Boehringer Ingelheim)	This study was supported by the Ontario Drug Policy Research Network (ODPRN) which is funded by grants from the Ontario Ministry of Health and Long-term Care (MOHLTC) Health System Research Fund. This study was also supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Dr. Laupacis is partially funded through a Canada Research Chair. Dr. Sholzberg has previously taken part in a paid advisory board for Boehringer-Ingelheim. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	AbuDagga A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-310; Anis AH, 2001, MED CARE, V39, P315, DOI 10.1097/00005650-200104000-00003; Antoniou Tony, 2012, Open Med, V6, pe146; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Canary LA, 2015, ANN INTERN MED, V163, P226, DOI 10.7326/M15-0320; Choudhry NK, 2006, AM J MED, V119, P607, DOI 10.1016/j.amjmed.2005.09.052; Davidson T, 2013, EUR HEART J, V34, P177, DOI 10.1093/eurheartj/ehs157; Daw JR, 2012, HEALTH POLICY, V104, P19, DOI 10.1016/j.healthpol.2011.08.015; Dunlop S, 2000, SOC SCI MED, V51, P123, DOI 10.1016/S0277-9536(99)00424-4; Evans William K, 2002, Chronic Dis Can, V23, P152; Ezekowitz MD, 2011, J INTERV CARD ELECTR, V32, P173, DOI 10.1007/s10840-011-9593-x; Fletcher RH, 2012, CLIN EPIDEMIOLOGY ES, P187; Florentinus SR, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-6; Fugh-Berman A, 2007, PLOS MED, V4, P621, DOI 10.1371/journal.pmed.0040150; Gage BF, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6980; Gemmill MC, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-12; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Gomes T, 2013, CAN MED ASSOC J, V185, pE121, DOI 10.1503/cmaj.121218; Gonzalez-Juanatey JR, 2012, REV ESP CARDIOL, V65, P901, DOI [10.1016/j.recesp.2012.06.006, 10.1016/j.rec.2012.06.003]; Harrington AR, 2013, STROKE, V44, P1676, DOI 10.1161/STROKEAHA.111.000402; Huskamp HA, 2005, ARCH GEN PSYCHIAT, V62, P435, DOI 10.1001/archpsyc.62.4.435; Garjon FJ, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-56; Jensen PN, 2012, PHARMACOEPIDEM DR S, V21, P141, DOI 10.1002/pds.2317; Krieger C, 2015, ANN CARDIOLOGIE ANGE; KRIEGER N, 1992, AM J PUBLIC HEALTH, V82, P703, DOI 10.2105/AJPH.82.5.703; Laupacis A, 2006, PHARMACOECONOMICS, V24, P1157, DOI 10.2165/00019053-200624110-00011; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Morgan SG, 2003, HEALTH AFFAIR, V22, P49, DOI 10.1377/hlthaff.22.3.49; Naylor CD, 1999, HEALTH AFFAIR, V18, P9, DOI 10.1377/hlthaff.18.3.9; Pink J, 2011, BMJ-BRIT MED J, P343; Pletscher M, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13732; Rawson NSB, 2002, PHARMACOEPIDEM DR S, V11, P335, DOI 10.1002/pds.740; Roblin DW, 2005, MED CARE, V43, P951, DOI 10.1097/01.mlr.0000178216.23514.b7; Shapiro S, 2008, J FAM PLAN REPROD H, V34, P83, DOI 10.1783/147118908783972113; Steinberg BA, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000535; Tamblyn R, 2001, Can J Clin Pharmacol, V8 Suppl A, p39A; Wilkins R, 2010, PCCF VERSION 5F USER; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741	39	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149142	10.1371/journal.pone.0149142	http://dx.doi.org/10.1371/journal.pone.0149142			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2LW	26914450	Green Submitted, gold, Green Published			2022-12-27	WOS:000371175700013
J	MacKellar, DA; Williams, D; Storer, N; Okello, V; Azih, C; Drummond, J; Nuwagaba-Biribonwoha, H; Preko, P; Morgan, RL; Dlamini, M; Byrd, J; Agolory, S; Baughman, AL; McNairy, ML; Sahabo, R; Ehrenkranz, P				MacKellar, Duncan A.; Williams, Daniel; Storer, Nosipho; Okello, Velephi; Azih, Charles; Drummond, Jennifer; Nuwagaba-Biribonwoha, Harriet; Preko, Peter; Morgan, Rebecca L.; Dlamini, Makhosazana; Byrd, Johnita; Agolory, Simon; Baughman, Andrew L.; McNairy, Margaret L.; Sahabo, Ruben; Ehrenkranz, Peter			Enrollment in HIV Care Two Years after HIV Diagnosis in the Kingdom of Swaziland: An Evaluation of a National Program of New Linkage Procedures	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; RETENTION; INITIATION; INFECTION; PERCEPTIONS; ADHERENCE; COMMUNITY; BARRIERS	To improve early enrollment in HIV care, the Swaziland Ministry of Health implemented new linkage procedures for persons HIV diagnosed during the Soka Uncobe male circumcision campaign (SOKA, 2011-2012) and the Swaziland HIV Incidence Measurement Survey (SHIMS, 2011). Abstraction of clinical records and telephone interviews of a retrospective cohort of HIV-diagnosed SOKA and SHIMS clients were conducted in 2013-2014 to evaluate compliance with new linkage procedures and enrollment in HIV care at 92 facilities throughout Swaziland. Of 1,105 clients evaluated, within 3, 12, and 24 months of diagnosis, an estimated 14.0%, 24.3%, and 37.0% enrolled in HIV care, respectively, after adjusting for lost to follow-up and non-response. Kaplan-Meier functions indicated lower enrollment probability among clients 14-24 (P = 0.0001) and 25-29 (P = 0.001) years of age compared with clients > 35 years of age. At 69 facilities to which clients were referred for HIV care, compliance with new linkage procedures was low: referral forms were located for less than half (46.8%) of the clients, and few (9.6%) were recorded in the appointment register or called either before (0.3%) or after (4.9%) their appointment. Of over one thousand clients newly HIV diagnosed in Swaziland in 2011 and 2012, few received linkage services in accordance with national procedures and most had not enrolled in HIV care two years after their diagnosis. Our findings are a call to action to improve linkage services and early enrollment in HIV care in Swaziland.	[MacKellar, Duncan A.; Williams, Daniel; Drummond, Jennifer; Agolory, Simon; Baughman, Andrew L.] Ctr Dis Control & Prevent, Div Global HIV AIDS, Natl Ctr Global Hlth, Atlanta, GA USA; [Storer, Nosipho; Nuwagaba-Biribonwoha, Harriet; Sahabo, Ruben] Columbia Univ, ICAP, Columbia, Swaziland; [Okello, Velephi; Azih, Charles] Swaziland Minist Hlth, Swaziland Natl AIDS Programme, Mbabane, Swaziland; [Nuwagaba-Biribonwoha, Harriet; McNairy, Margaret L.] Columbia Univ, ICAP, New York, NY USA; [Preko, Peter] Ctr Dis Control & Prevent Country Off, CTS Global assigned, Mbabane, Swaziland; [Morgan, Rebecca L.] McMaster Univ, Hamilton, ON, Canada; [Dlamini, Makhosazana] Populat Serv Int Country Program, Mbabane, Swaziland; [Byrd, Johnita] ICF Int, Atlanta, GA USA; [Byrd, Johnita] Bill & Melinda Gates Fdn, Seattle, WA USA	Centers for Disease Control & Prevention - USA; Columbia University; McMaster University; Bill & Melinda Gates Foundation	MacKellar, DA (corresponding author), Ctr Dis Control & Prevent, Div Global HIV AIDS, Natl Ctr Global Hlth, Atlanta, GA USA.	dym4@cdc.gov	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754; Morgan, Rebecca/0000-0002-1012-4897	ICF International; Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention [U2GPS002005]	ICF International; Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention	This work was funded through the President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (cooperative agreement U2GPS002005). ICF International was contracted by the U.S. Centers for Disease Control and Prevention to provide data-management services only. Author Johnita Byrd is employed by ICF International. ICF International provided support in the form of salary for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bassett IV, 2014, HIV MED, V15, P367, DOI 10.1111/hiv.12115; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Bigogo G, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-376; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Clouse K, 2013, JAIDS-J ACQ IMM DEF, V62, pE39, DOI 10.1097/QAI.0b013e318273ac48; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Fagan JL, 2012, AIDS CARE, V24, P737, DOI 10.1080/09540121.2011.630360; Fox MP, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-8; Genberg BL, 2015, LANCET HIV, V2, pE20, DOI 10.1016/S2352-3018(14)00034-4; Govindasamy D, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19032; Govindasamy D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080017; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hatcher AM, 2012, AIDS BEHAV, V16, P1295, DOI 10.1007/s10461-011-0065-1; John Snow Inc, 2012, PROC EV SOK UNC SWAZ; Kayigamba FR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036792; Kranzer K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17383; Labhardt ND, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001768; Liau A, 2013, AIDS BEHAV, V17, P1941, DOI 10.1007/s10461-013-0435-y; McNairy ML, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0291-4; Medley A, 2013, AIDS BEHAV, V17, P224, DOI 10.1007/s10461-012-0344-5; Nakigozi G, 2011, AIDS CARE, V23, P764, DOI 10.1080/09540121.2010.525614; Parker LA, 2015, TROP MED INT HEALTH, V20, P893, DOI 10.1111/tmi.12501; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Scanlon ML, 2013, HIV AIDS-RES PALLIAT, V5, P1, DOI 10.2147/HIV.S28912; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Swaziland National AIDS Programme, 2004, SWAZ NAT ART PROGR E; Swaziland National AIDS Programme, 2010, NAT COMPR HIV PACK C; Swaziland National AIDS Programme, 2012, PAT LINK RET FOLL UP; Thompson MA, 2012, ANN INTERN MED, V156, P817, DOI 10.7326/0003-4819-156-11-201206050-00419; Tumwesigye E, 2010, AIDS PATIENT CARE ST, V24, P735, DOI 10.1089/apc.2010.0096; van Rooyen H, 2013, JAIDS-J ACQ IMM DEF, V64, pE1, DOI 10.1097/QAI.0b013e31829b567d; World Health Organization (WHO), 2013, CONSOLIDATED GUIDELI	35	24	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150086	10.1371/journal.pone.0150086	http://dx.doi.org/10.1371/journal.pone.0150086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910847	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700065
J	Merola, I; Mills, DS				Merola, Isabella; Mills, Daniel S.			Behavioural Signs of Pain in Cats: An Expert Consensus	PLOS ONE			English	Article							POSTOPERATIVE PAIN	Objectives To identify where a consensus can be reached between veterinary experts in feline medicine on the core signs sufficient for pain (sufficient to indicate pain when they occur, but not necessarily present in all painful conditions) and necessary for pain (necessary in the presence of pain, but not always indicative of pain). Methods A modified Delphi technique was used, consisting of four rounds of questions and evaluation using nineteen participants during the period December 2014 and May 2015. Agreement was considered to be established when 80% of the experts concurred with the same opinion. Results Twenty-five signs were considered sufficient to indicate pain, but no single sign was considered necessary for it. Discussion Further studies are needed to evaluate the validity of these 25 behavioural signs if a specific pain assessment tool is to be developed that is capable of assessing pain in cats based on observational methods alone. The signs reported here may nonetheless help both vets and owners form an initial evaluation of the pain status of cats in their care.	[Merola, Isabella; Mills, Daniel S.] Lincoln Univ, Sch Life Sci, Joseph Banks Labs Green Lane, Lincoln LN6 7DL, England	University of Lincoln	Mills, DS (corresponding author), Lincoln Univ, Sch Life Sci, Joseph Banks Labs Green Lane, Lincoln LN6 7DL, England.	dmills@lincoln.ac.uk			Feline Friends Derbyshire	Feline Friends Derbyshire	This work was supported by Feline Friends Derbyshire (http://www.feline-friends.org.uk).	[Anonymous], 2014, J SMALL ANIM PRACT, V55; Benito J, 2013, VET J, V196, P368, DOI 10.1016/j.tvjl.2012.12.015; Brondani JT, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-143; Calvo G, 2014, J SMALL ANIM PRACT, V55, P622, DOI 10.1111/jsap.12280; Cambridge AJ, 2000, J AM VET MED ASSOC, V217, P685, DOI 10.2460/javma.2000.217.685; Cloutier S, 2005, APPL ANIM BEHAV SCI, V92, P325, DOI 10.1016/j.applanim.2004.11.009; Diamond IR, 2014, J CLIN EPIDEMIOL, V67, P401, DOI 10.1016/j.jclinepi.2013.12.002; Egger Christine M., 2013, PAIN MANAGEMENT VET; Foster D, PRIV SEC RISK TRUST, P712; Gruen ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131839; Hansen GR, 2005, EMERG MED CLIN N AM, V23, P339, DOI 10.1016/j.emc.2004.12.005; Holden E, 2014, J SMALL ANIM PRACT, V55, P615, DOI 10.1111/jsap.12283; Hsu CC, 2007, PARE, V12, P1; Klinck MP, 2012, CAN VET J, V53, P1181; Kranenburg HC, 2012, VET COMP ORTHOPAED, V25, P217, DOI 10.3415/VCOT-11-06-0092; Lascelles BDX, 1999, VET REC, V145, P601, DOI 10.1136/vr.145.21.601; Merola I, 2015, J FELINE MED SURG, P1; Mills DS., 2010, ENCY APPL ANIMAL BEH, P685; Prunier A, 2013, ANIMAL, V7, P998, DOI 10.1017/S1751731112002406; Robertson SA, 2008, VET CLIN N AM-SMALL, V38, P1267, DOI 10.1016/j.cvsm.2008.06.008; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Steagall PVM, 2007, VET ANAESTH ANALG, V34, P344, DOI 10.1111/j.1467-2995.2006.00331.x; Vaisanen MAM, 2007, JAVMA-J AM VET MED A, V231, P236, DOI 10.2460/javma.231.2.236; Waran N, 2007, ANIM WELFARE, V16, P105; Yousuf M.I., 2007, PRACT ASSESS RES EVA, V12, P8, DOI [10.7275/rrph-t210, DOI 10.7275/RRPH-T210]; Zamprogno H, 2010, AM J VET RES, V71, P1417, DOI 10.2460/ajvr.71.12.1417	26	34	34	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150040	10.1371/journal.pone.0150040	http://dx.doi.org/10.1371/journal.pone.0150040			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909809	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371164700058
J	Smieszek, T; White, PJ				Smieszek, Timo; White, Peter J.			Apparently-Different Clearance Rates from Cohort Studies of Mycoplasma genitalium Are Consistent after Accounting for Incidence of Infection, Recurrent Infection, and Study Design	PLOS ONE			English	Article							FEMALE SEX WORKERS; NONGONOCOCCAL URETHRITIS; CHLAMYDIA-TRACHOMATIS; TREATMENT FAILURE; NATURAL-HISTORY; HIGH PREVALENCE; WOMEN; PCR; SUSCEPTIBILITY; AZITHROMYCIN	Mycoplasma genitalium is a potentially major cause of urethritis, cervicitis, pelvic inflammatory disease, infertility, and increased HIV risk. A better understanding of its natural history is crucial to informing control policy. Two extensive cohort studies (students in London, UK; Ugandan sex workers) suggest very different clearance rates; we aimed to understand the reasons and obtain improved estimates by making maximal use of the data from the studies. As M. genitalium is a sexually-transmitted infectious disease, we developed a model for time-to-event analysis that incorporates the processes of (re) infection and clearance, and fitted to data from the two cohort studies to estimate incidence and clearance rates under different scenarios of sexual partnership dynamics and study design (including sample handling and associated test sensitivity). In the London students, the estimated clearance rate is 0.80p.a. (mean duration 15 months), with incidence 1.31%-3.93%p.a. Without adjusting for study design, corresponding estimates from the Ugandan data are 3.44p.a. (mean duration 3.5 months) and 58%p.a. Apparent differences in clearance rates are probably mostly due to lower testing sensitivity in the Uganda study due to differences in sample handling, with 'true' clearance rates being similar, and adjusted incidence in Uganda being 28%p.a. Some differences are perhaps due to the sex workers having more-frequent antibiotic treatment, whilst reinfection within ongoing sexual partnerships might have caused some of the apparently-persistent infection in the London students. More information on partnership dynamics would inform more accurate estimates of natural-history parameters. Detailed studies in men are also required.	[Smieszek, Timo; White, Peter J.] Univ London Imperial Coll Sci Technol & Med, NIHR Hlth Protect Res Unit Modelling Methodol, London W2 1PG, England; [Smieszek, Timo; White, Peter J.] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Smieszek, Timo; White, Peter J.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London NW9 5EQ, England	Imperial College London; Imperial College London; Public Health England	Smieszek, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, NIHR Hlth Protect Res Unit Modelling Methodol, London W2 1PG, England.; Smieszek, T (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Outbreak Anal & Modelling, London W2 1PG, England.; Smieszek, T (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Modelling & Econ Unit, London NW9 5EQ, England.	timo.smieszek@phe.gov.uk			UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE) [HPRU-2012-10080]; UK Medical Research Council for Centre [MR/K010174/1]; MRC [MR/K010174/1] Funding Source: UKRI; Medical Research Council [MR/K010174/1B, MR/K010174/1] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish	UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London; Public Health England (PHE); UK Medical Research Council for Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the UK National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Modelling Methodology at Imperial College London in partnership with Public Health England (PHE) [grant number HPRU-2012-10080; http://www.nihr.ac.uk] and by the UK Medical Research Council for Centre funding [grant number MR/K010174/1; http://www.mrc.ac.uk]. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the authors and not necessarily those of the MRC, NHS, the NIHR, the Department of Health, or Public Health England.	Anagrius C, 2005, SEX TRANSM INFECT, V81, P458, DOI 10.1136/sti.2004.012062; Burroughs VJ, 2002, J NATL MED ASSOC, V94, P1; Carlsen KH, 2010, J CLIN MICROBIOL, V48, P3624, DOI 10.1128/JCM.00232-10; Daley GM, 2014, INT J STD AIDS, V25, P475, DOI 10.1177/0956462413515196; Davies B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-8; Duffy LB, 2000, J ANTIMICROB CHEMOTH, V45, P29, DOI 10.1093/jac/45.suppl_3.29; Golden MR, 2005, NEW ENGL J MED, V352, P676, DOI 10.1056/NEJMoa041681; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; Hamasuna R, 2005, ANTIMICROB AGENTS CH, V49, P4993, DOI 10.1128/AAC.49.12.4993-4998.2005; Horner P, 2001, CLIN INFECT DIS, V32, P995, DOI 10.1086/319594; Horner P, 2014, CURR OPIN INFECT DIS, V27, P68, DOI 10.1097/QCO.0000000000000030; Hosenfeld CB, 2009, SEX TRANSM DIS, V36, P478, DOI 10.1097/OLQ.0b013e3181a2a933; Jensen JS, 2008, CLIN INFECT DIS, V47, P1546, DOI 10.1086/593188; Johnston LG, 2012, INT J STD AIDS, V23, P5, DOI 10.1258/ijsa.2009.009446; Le Roy C, 2014, J CLIN MICROBIOL, V52, P971, DOI 10.1128/JCM.02567-13; Lillis RA, 2011, J CLIN MICROBIOL, V49, P1990, DOI 10.1128/JCM.00129-11; Manhart LE, 2003, J INFECT DIS, V187, P650, DOI 10.1086/367992; Manhart Lisa E, 2010, Curr Infect Dis Rep, V12, P306, DOI 10.1007/s11908-010-0114-3; Manhart LE, 2014, CLIN INFECT DIS, V59, P31, DOI 10.1093/cid/ciu224; Manhart LE, 2011, CLIN INFECT DIS, V53, pS129, DOI 10.1093/cid/cir702; Manhart LE, 2013, SEX TRANSM DIS, V40, P428, DOI 10.1097/OLQ.0b013e3182924b3b; Manhart LE, 2013, CLIN INFECT DIS, V56, P934, DOI 10.1093/cid/cis1022; McGowin CL, 2012, INFECT IMMUN, V80, P3842, DOI 10.1128/IAI.00819-12; Mena LA, 2009, CLIN INFECT DIS, V48, P1649, DOI 10.1086/599033; Oakeshott P, 2010, CLIN INFECT DIS, V51, P1160, DOI 10.1086/656739; Pepin J, 2005, SEX TRANSM INFECT, V81, P67, DOI 10.1136/sti.2003.009100; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Salado-Rasmussen K, 2014, CLIN INFECT DIS, V59, P24, DOI 10.1093/cid/ciu217; Smieszek T, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-35; Sonnenberg P, 2013, LANCET, V382, P1795, DOI 10.1016/S0140-6736(13)61947-9; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Svenstrup HF, 2008, FERTIL STERIL, V90, P513, DOI 10.1016/j.fertnstert.2006.12.056; Taylor BD, 2013, J INFECT DIS, V207, P940, DOI 10.1093/infdis/jis922; Taylor BD, 2012, J INFECT DIS, V205, P603, DOI 10.1093/infdis/jir822; Taylor-Robinson D, 2014, EXPERT REV ANTI-INFE, V12, P715, DOI 10.1586/14787210.2014.919220; Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11; Tosh AK, 2007, J ADOLESCENT HEALTH, V40, P412, DOI 10.1016/j.jadohealth.2006.12.005; Vandepitte J, 2014, SEX TRANSM INFECT, V90, P545, DOI 10.1136/sextrans-2013-051467; Vandepitte J, 2013, SEX TRANSM DIS, V40, P422, DOI 10.1097/OLQ.0b013e31828bfccf; Vandepitte J, 2012, J INFECT DIS, V205, P289, DOI 10.1093/infdis/jir733; Vandepitte J, 2011, SEX TRANSM DIS, V38, P316, DOI 10.1097/OLQ.0b013e3182099545; Walker J, 2013, CLIN INFECT DIS, V56, P1094, DOI 10.1093/cid/cis1210; Workowski KA, 2011, CLIN INFECT DIS, V53, pS59, DOI 10.1093/cid/cir694; Wroblewski JKH, 2006, J CLIN MICROBIOL, V44, P3306, DOI 10.1128/JCM.00553-06	44	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149087	10.1371/journal.pone.0149087	http://dx.doi.org/10.1371/journal.pone.0149087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910762	Green Published, gold, Green Submitted			2022-12-27	WOS:000371164700021
J	Amin, MN; Zaheer, S; Alazba, AA; Saleem, MU; Niazi, MUK; Khurram, N; Amin, MT				Amin, Muhammad Nasir; Zaheer, Selman; Alazba, Abdulrahman Ali; Saleem, Muhammad Umair; Niazi, Muhammad Umar Khan; Khurram, Nauman; Amin, Muhammad Tahir			A Component-Based Study of the Effect of Diameter on Bond and Anchorage Characteristics of Blind-Bolted Connections	PLOS ONE			English	Article							BEHAVIOR; JOINTS	Structural hollow sections are gaining worldwide importance due to their structural and architectural advantages over open steel sections. The only obstacle to their use is their connection with other structural members. To overcome the obstacle of tightening the bolt from one side has given birth to the concept of blind bolts. Blind bolts, being the practical solution to the connection hindrance for the use of hollow and concrete filled hollow sections play a vital role. Flowdrill, the Huck High Strength Blind Bolt and the Lindapter Hollobolt are the well-known commercially available blind bolts. Although the development of blind bolts has largely resolved this issue, the use of structural hollow sections remains limited to shear resistance. Therefore, a new modified version of the blind bolt, known as the "Extended Hollo-Bolt" (EHB) due to its enhanced capacity for bonding with concrete, can overcome the issue of low moment resistance capacity associated with blind-bolted connections. The load transfer mechanism of this recently developed blind bolt remains unclear, however. This study uses a parametric approach to characterising the EHB, using diameter as the variable parameter. Stiffness and load-carrying capacity were evaluated at two different bolt sizes. To investigate the load transfer mechanism, a component-based study of the bond and anchorage characteristics was performed by breaking down the EHB into its components. The results of the study provide insight into the load transfer mechanism of the blind bolt in question. The proposed component-based model was validated by a spring model, through which the stiffness of the EHB was compared to that of its components combined. The combined stiffness of the components was found to be roughly equivalent to that of the EHB as a whole, validating the use of this component-based approach.	[Amin, Muhammad Nasir; Saleem, Muhammad Umair; Niazi, Muhammad Umar Khan; Khurram, Nauman] King Faisal Univ, Coll Engn, Dept Civil & Environm Engn, POB 380, Al Hufuf 31982, Al Ahsa, Saudi Arabia; [Zaheer, Selman] Univ Nottingham, Dept Civil Engn, Nottingham NG7 2RD, England; [Alazba, Abdulrahman Ali; Amin, Muhammad Tahir] King Saud Univ, Alamoudi Water Res Chair, POB 2460, Riyadh 11451, Saudi Arabia; [Amin, Muhammad Tahir] COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad 22060, Pakistan	King Faisal University; University of Nottingham; King Saud University; COMSATS University Islamabad (CUI)	Amin, MT (corresponding author), King Saud Univ, Alamoudi Water Res Chair, POB 2460, Riyadh 11451, Saudi Arabia.; Amin, MT (corresponding author), COMSATS Inst Informat Technol, Dept Environm Sci, Abbottabad 22060, Pakistan.	mtamin@ksu.edu.sa	Amin, Muhammad Nasir/D-2089-2014; Saleem, Muhammad Umair UMR/K-6245-2018; Niazi, M. Umar B./ABA-6117-2021; Amin, Muhammad Tahir/G-1525-2011	Amin, Muhammad Nasir/0000-0001-6524-4389; Saleem, Muhammad Umair UMR/0000-0002-0617-9975; Amin, Muhammad Tahir/0000-0001-8283-9958; Khurram, Nauman/0000-0002-0694-9554	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [11-WAT1875-02]	National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, Award Number (11-WAT1875-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataei A, 2015, ENG STRUCT, V99, P616, DOI 10.1016/j.engstruct.2015.05.012; Barnett T., 2000, P CONN STEEL STRUCT, P340; Ellison S., 2004, STRUCT ENG, V82, P16; Lindapter Type HB, 2009, TYP HB HOLL BOLT CAV, P41; MacGregor JG., 1997, REINFORCED CONCRETE; MAYER KH, 1973, WIRE, V23, P1; Mesquita AM, 2008, NORD STEEL CONSTR C, P230; Mirza O, 2011, ENG STRUCT, V33, P647, DOI 10.1016/j.engstruct.2010.11.024; Pitrakkos T, 2011, 6 EUR C STEEL COMP S, P513; Pitrakkos T., 2012, TENSILE STIFFNESS NO; Swanson JA, 2001, J STRUCT ENG-ASCE, V127, P498, DOI 10.1061/(ASCE)0733-9445(2001)127:5(498); Wang JF, 2009, J CONSTR STEEL RES, V65, P925, DOI 10.1016/j.jcsr.2008.10.010; Wang JF, 2013, J CONSTR STEEL RES, V82, P33, DOI 10.1016/j.jcsr.2012.12.002; Wang JF, 2012, J CONSTR STEEL RES, V79, P56, DOI 10.1016/j.jcsr.2012.07.016	14	0	0	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149490	10.1371/journal.pone.0149490	http://dx.doi.org/10.1371/journal.pone.0149490			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901866	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100084
J	Kanthack, TFD; Guillot, A; Altimari, LR; Nagy, SN; Collet, C; Di Rienzo, F				Dias Kanthack, Thiago Ferreira; Guillot, Aymeric; Altimari, Leandro Ricardo; Nunez Nagy, Susana; Collet, Christian; Di Rienzo, Franck			Selective Efficacy of Static and Dynamic Imagery in Different States of Physical Fatigue	PLOS ONE			English	Article							MOTOR IMAGERY; MENTAL PRACTICE; EXERCISE; PERFORMANCE; CHALLENGE; ACCURACY; EXERTION; STROKE; SPEED	There is compelling evidence that motor imagery contributes to improved motor performance, and recent work showed that dynamic motor imagery (dMI) might provide additional benefits by comparison with traditional MI practice. However, the efficacy of motor imagery in different states of physical fatigue remains largely unknown, especially as imagery accuracy may be hampered by the physical fatigue states elicited by training. We investigated the effect of static motor imagery (sMI) and dMI on free-throw accuracy in 10 high-level basketball athletes, both in a non -fatigued state (Experiment 1) and immediately after an incremental running test completed until exhaustion (20m shuttle run-test Experiment 2). We collected perceived exhaustion and heart rate to quantify the subjective experience of fatigue and energy expenditure. We found that dMI brought better shooting performance than sMI, except when athletes were physically exhausted. These findings shed light on the conditions eliciting optimal use of sMI and dMI. In particular, considering that the current physical state affects body representation, performing dMI under fatigue may result in mismatches between actual and predicted body states.	[Dias Kanthack, Thiago Ferreira; Guillot, Aymeric; Collet, Christian; Di Rienzo, Franck] Univ Lyon 1, LIBM, F-69622 Villeurbanne, France; [Dias Kanthack, Thiago Ferreira; Altimari, Leandro Ricardo] Univ Estadual Londrina, Grp Pesquisa Sistema Neuromuscular & Exercicio, Londrina, Parana, Brazil; [Dias Kanthack, Thiago Ferreira] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Guillot, Aymeric] Inst Univ France, Paris, France; [Nunez Nagy, Susana] Univ Alcala de Henares, Unidad Fisioterapia, Madrid, Spain	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universidade Estadual de Londrina; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Institut Universitaire de France; Universidad de Alcala	Di Rienzo, F (corresponding author), Univ Lyon 1, LIBM, F-69622 Villeurbanne, France.	franck.di-rienzo@univ-lyon1.fr	Ferreira Dias Kanthack, Thiago/N-8419-2017	Ferreira Dias Kanthack, Thiago/0000-0002-8725-9044	CAPES Foundation, Ministry of Education of Brazil; CAPES foundation	CAPES Foundation, Ministry of Education of Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CAPES Foundation, Ministry of Education of Brazil, http://capes.academia.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank CAPES foundation for the financial support on this project.	Baguley T, 2012, SERIOUS STATS GUIDE; Bates D., 2020, LME4 LINEAR MIXED EF; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Callow N., 2006, Journal of Imagery Research in Sport and Physical Activity, V1, P2, DOI 10.2202/1932-0191.1001; Coelho CJ, 2012, J EXP PSYCHOL LEARN, V38, P1759, DOI 10.1037/a0028065; Collet C, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00415; Collet C, 2011, EXERC SPORT SCI REV, V39, P85, DOI 10.1097/JES.0b013e31820ac5e0; Csataljay Gabor, 2009, INT J PERFORM ANAL S, V9, P60, DOI DOI 10.1080/24748668.2009.11868464; Cumming J., 2013, MOVEMENT SPORT SCI, V82, P69, DOI [10.1051/sm/2013098, DOI 10.1051/SM/2013098, 10.3917/sm.082.0069, DOI 10.3917/SM.082.0069]; Debarnot U, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00280; Demougeot L, 2011, J NEUROSCI, V31, P10712, DOI 10.1523/JNEUROSCI.6032-10.2011; Di Rienzo F, 2014, NEUROPSYCHOL REV, V24, P116, DOI 10.1007/s11065-014-9257-6; Di Rienzo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047207; Dijkerman HC, 2004, CLIN REHABIL, V18, P538, DOI 10.1191/0269215504cr769oa; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Driediger M, 2006, J SPORT SCI, V24, P261, DOI 10.1080/02640410500128221; DRISKELL JE, 1994, J APPL PSYCHOL, V79, P481, DOI 10.1037/0021-9010.79.4.481; Edelman BJ, 2016, IEEE T BIO-MED ENG, V63, P4, DOI 10.1109/TBME.2015.2467312; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Fusco A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00760; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Guillot A, 2005, EUR J APPL PHYSIOL, V95, P186, DOI 10.1007/s00421-005-1400-x; Guillot A, 2005, BIOL SPORT, V22, P215; Guillot A., 2008, INT REV SPORT EXER P, V1, P31, DOI [10.1080/17509840701823139, DOI 10.1080/17509840701823139]; Guillot A, 2013, J SPORT SCI MED, V12, P332; Guillot A, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-8; Guillot A, 2012, INT REV SPORT EXER P, V5, P3, DOI 10.1080/1750984X.2011.623787; Guillot A, 2012, PSYCHOL SPORT EXERC, V13, P533, DOI 10.1016/j.psychsport.2012.03.002; He B, 2015, P IEEE, V103, P907, DOI [10.1109/JPROC.2015.2407272, 10.1109/jproc.2015.2407272]; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Kanekar N, 2008, CLIN NEUROPHYSIOL, V119, P2304, DOI 10.1016/j.clinph.2008.06.015; Kanthack Thiago Ferreira Dias, 2014, Rev. bras. cineantropom. desempenho hum., V16, P47, DOI 10.5007/1980-0037.2014v16n1p47; Lacey J, 1980, SPECIFIC ROLE HEART, P495; LaFleur K, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046003; LAMIRAND M, 1994, PERCEPT MOTOR SKILL, V78, P1229, DOI 10.2466/pms.1994.78.3c.1229; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Louis M, 2008, J MOTOR BEHAV, V40, P117, DOI 10.3200/JMBR.40.2.117-132; MacIntyre TE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00104; Martin K, 2015, EUR J APPL PHYSIOL, V115, P715, DOI 10.1007/s00421-014-3052-1; Maruff P, 2000, NEUROPSYCHOLOGIA, V38, P1251, DOI 10.1016/S0028-3932(00)00031-2; Olsson CJ, 2010, SCAND J MED SCI SPOR, V20, P711, DOI 10.1111/j.1600-0838.2010.01101.x; Peynircioglu ZF, 2000, J GEN PSYCHOL, V127, P145, DOI 10.1080/00221300009598574; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Post P. G., 2010, J IMAGERY RES SPORT, V5; R Core Team, 2021, R LANGUAGE ENV STAT; Rozand V, 2015, NEUROSCIENCE, V297, P219, DOI 10.1016/j.neuroscience.2015.03.066; Rozand V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00755; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Utter AC, 2004, MED SCI SPORT EXER, V36, P1776, DOI 10.1249/01.MSS.0000142310.97274.94; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Williams SE, 2012, EUR J SPORT SCI, V12, P499, DOI 10.1080/17461391.2011.630102; Williams SE, 2010, J SPORT EXERCISE PSY, V32, P339, DOI 10.1123/jsep.32.3.339; Winter B., 2013, ARXIV13085499; Wrisberg C. A., 1989, SPORT PSYCHOL, V2, P95, DOI DOI 10.1123/TSP.3.2.95; Yuan H, 2010, NEUROIMAGE, V49, P2596, DOI 10.1016/j.neuroimage.2009.10.028	59	13	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149654	10.1371/journal.pone.0149654	http://dx.doi.org/10.1371/journal.pone.0149654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930279	gold, Green Published, Green Submitted			2022-12-27	WOS:000371434500037
J	Gotia, HT; Munro, JB; Knowles, DP; Daubenberger, CA; Bishop, RP; Silva, JC				Gotia, Hanzel T.; Munro, James B.; Knowles, Donald P.; Daubenberger, Claudia A.; Bishop, Richard P.; Silva, Joana C.			Absolute Quantification of the Host-To-Parasite DNA Ratio in Theileria parva-Infected Lymphocyte Cell Lines	PLOS ONE			English	Article							APICAL MEMBRANE ANTIGEN-1; POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; PLASMODIUM-FALCIPARUM; BABESIA-BIGEMINA; GENOME SEQUENCE; CARRIER STATE; CATTLE; BUFFALOS; INVASION	Theileria parva is a tick-transmitted intracellular apicomplexan pathogen of cattle in sub-Saharan Africa that causes East Coast fever (ECF). ECF is an acute fatal disease that kills over one million cattle annually, imposing a tremendous burden on African small-holder cattle farmers. The pathology and level of T. parva infections in its wildlife host, African buffalo (Syncerus caffer), and in cattle are distinct. We have developed an absolute quantification method based on quantitative PCR (qPCR) in which recombinant plasmids containing single copy genes specific to the parasite (apical membrane antigen 1 gene, ama1) or the host (hypoxanthine phosphoribosyltransferase 1, hprt1) are used as the quantification reference standards. Our study shows that T. parva and bovine cells are present in similar numbers in T. parva-infected lymphocyte cell lines and that consequently, due to its much smaller genome size, T. parva DNA comprises between 0.9% and 3% of the total DNA samples extracted from these lines. This absolute quantification assay of parasite and host genome copy number in a sample provides a simple and reliable method of assessing T. parva load in infected bovine lymphocytes, and is accurate over a wide range of host-to-parasite DNA ratios. Knowledge of the proportion of target DNA in a sample, as enabled by this method, is essential for efficient high-throughput genome sequencing applications for a variety of intracellular pathogens. This assay will also be very useful in future studies of interactions of distinct host-T. parva stocks and to fully characterize the dynamics of ECF infection in the field.	[Gotia, Hanzel T.; Munro, James B.; Silva, Joana C.] Univ Maryland, Sch Med, Inst Genome Sci, 801 West Baltimore St, Baltimore, MD USA; [Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Daubenberger, Claudia A.] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4002 Basel, Switzerland; [Daubenberger, Claudia A.] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Bishop, Richard P.] Int Livestock Res Inst, POB 30709, Nairobi 00100, Kenya; [Silva, Joana C.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; United States Department of Agriculture (USDA); Washington State University; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; CGIAR; International Livestock Research Institute (ILRI); University System of Maryland; University of Maryland Baltimore	Silva, JC (corresponding author), Univ Maryland, Sch Med, Inst Genome Sci, 801 West Baltimore St, Baltimore, MD USA.; Silva, JC (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.	jcsilva@som.umaryland.edu	Silva, Joana/GYQ-9526-2022; Munro, James B./C-5489-2009; Silva, Joana/GVT-6441-2022	Munro, James B./0000-0003-3067-6434; Daubenberger, Claudia/0000-0001-7136-0642	CGIAR Consortium [CRP3.7]; United States Department of Agriculture, Agricultural Research Service [58-5348-4-013]; USAID [PASA - AID-BFS-P-13-00002, PASA-AID-BFS-P-13-00002]	CGIAR Consortium(CGIAR); United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USAID(United States Agency for International Development (USAID))	RPB was partly funded by CGIAR Consortium Research Project More Meat, Fish and Livestock by and for the poor (CRP3.7). This work was partly supported by the United States Department of Agriculture, Agricultural Research Service (Scientific Cooperative Agreement #58-5348-4-013 to JCS), and by USAID (PASA - AID-BFS-P-13-00002, Collaboration to Advance Vaccine Control of East Coast Fever, to DPK). The contents of this study are the sole responsibility of authors and do not necessarily reflect the views of the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Matthew Adams, from the University of Maryland Institute for Global Health, for his methodological guidance, Roger Pelle and Elias Awino, from ILRI, for providing DNA from T. parva-infected bovine lymphocyte cell lines, and Curt Van Tassell and Tad Sonstegard, from the USDA, Agricultural Research Service, in Beltsville, Maryland, for providing Bos taurus gDNA. RPB was partly funded by CGIAR Consortium Research Project More Meat, Fish and Livestock by and for the poor (CRP3.7). This work was partly supported by the United States Department of Agriculture, Agricultural Research Service (Scientific Cooperative Agreement #58-5348-4-013 to JCS), and by USAID (PASA-AID-BFS-P-13-00002, Collaboration to Advance Vaccine Control of East Coast Fever, to DPK). The contents of this study are the sole responsibility of authors and do not necessarily reflect the views of the United States Government.	Auburn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022213; Besteiro S, 2011, CELL MICROBIOL, V13, P797, DOI 10.1111/j.1462-5822.2011.01597.x; BISHOP R, 1992, PARASITOLOGY, V104, P215, DOI 10.1017/S0031182000061655; Bishop Richard P., 2009, P191, DOI 10.1007/978-3-540-74042-1_6; Brown C. G. D., 1979, Practical tissue culture applications. (Proc. Conf. Internat. Lab. Res. Anim. Dis., Nairobi, Kenya, August 24-29 1978)., P223; Burgos JS, 2002, MOL CELL PROBE, V16, P257, DOI 10.1006/mcpr.2002.0419; Chaisi ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075827; CONRAD PA, 1987, MOL BIOCHEM PARASIT, V25, P213, DOI 10.1016/0166-6851(87)90085-5; Elsify A, 2015, PARASITOL INT, V64, P79, DOI 10.1016/j.parint.2014.10.002; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Ferre F, 1992, PCR Methods Appl, V2, P1; Gardner MJ, 2005, SCIENCE, V309, P134, DOI 10.1126/science.1110439; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Harvey KL, 2014, INT J PARASITOL, V44, P853, DOI 10.1016/j.ijpara.2014.08.001; HULLIGER L, 1964, NATURE, V203, P728, DOI 10.1038/203728a0; IRVIN AD, 1982, RES VET SCI, V33, P298, DOI 10.1016/S0034-5288(18)32305-1; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; MEDLEY GF, 1993, PARASITOLOGY, V106, P251, DOI 10.1017/S0031182000075077; Moreau E, 2015, EXP PARASITOL, V155, P40, DOI 10.1016/j.exppara.2015.04.024; MORZARIA SP, 1995, PARASITOLOGY, V111, P39, DOI 10.1017/S0031182000064581; Norval RAI., 1992, EPIDEMIOLOGY THEILER; Odongo DO, 2010, PARASITOL RES, V106, P357, DOI 10.1007/s00436-009-1670-z; Odongo DO, 2009, J MED ENTOMOL, V46, P888, DOI 10.1603/033.046.0422; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sibeko KP, 2008, VET PARASITOL, V155, P37, DOI 10.1016/j.vetpar.2008.03.033; Sivakumar T, 2014, VET PARASITOL, V200, P24, DOI 10.1016/j.vetpar.2013.11.029; Sivakumar T, 2012, VET PARASITOL, V187, P17, DOI 10.1016/j.vetpar.2012.01.008; Skilton RA, 2002, PARASITOLOGY, V124, P265, DOI 10.1017/S0031182001001196; Sudarshan M, 2011, J ANTIMICROBIAL CHEM; Takala SL, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000257; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torina A, 2010, TRANSBOUND EMERG DIS, V57, P52, DOI 10.1111/j.1865-1682.2010.01118.x; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Yamada S, 2009, VET J, V182, P352, DOI 10.1016/j.tvjl.2008.06.007; Yoshinari T, 2013, J VET MED SCI, V75, P211, DOI 10.1292/jvms.12-0329	39	11	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150401	10.1371/journal.pone.0150401	http://dx.doi.org/10.1371/journal.pone.0150401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930209	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000371434500141
J	de Gauna, SR; Gonzalez-Otero, DM; Ruiz, J; Russell, JK				Ruiz de Gauna, Sofia; Gonzalez-Otero, Digna M.; Ruiz, Jesus; Russell, James K.			Feedback on the Rate and Depth of Chest Compressions during Cardiopulmonary Resuscitation Using Only Accelerometers	PLOS ONE			English	Article							QUALITY; PERFORMANCE; BYSTANDER; DEVICES; HEART	Background Quality of cardiopulmonary resuscitation (CPR) is key to increase survival from cardiac arrest. Providing chest compressions with adequate rate and depth is difficult even for well-trained rescuers. The use of real-time feedback devices is intended to contribute to enhance chest compression quality. These devices are typically based on the double integration of the acceleration to obtain the chest displacement during compressions. The integration process is inherently unstable and leads to important errors unless boundary conditions are applied for each compression cycle. Commercial solutions use additional reference signals to establish these conditions, requiring additional sensors. Our aim was to study the accuracy of three methods based solely on the acceleration signal to provide feedback on the compression rate and depth. Materials and Methods We simulated a CPR scenario with several volunteers grouped in couples providing chest compressions on a resuscitation manikin. Different target rates (80, 100, 120, and 140 compressions per minute) and a target depth of at least 50 mm were indicated. The manikin was equipped with a displacement sensor. The accelerometer was placed between the rescuer's hands and the manikin's chest. We designed three alternatives to direct integration based on different principles (linear filtering, analysis of velocity, and spectral analysis of acceleration). We evaluated their accuracy by comparing the estimated depth and rate with the values obtained from the reference displacement sensor. Results The median (IQR) percent error was 5.9% (2.8-10.3), 6.3% (2.9-11.3), and 2.5% (1.2-4.4) for depth and 1.7% (0.0-2.3), 0.0% (0.0-2.0), and 0.9% (0.4-1.6) for rate, respectively. Depth accuracy depended on the target rate (p < 0.001) and on the rescuer couple (p < 0.001) within each method. Conclusions Accurate feedback on chest compression depth and rate during CPR is possible using exclusively the chest acceleration signal. The algorithm based on spectral analysis showed the best performance. Despite these encouraging results, further research should be conducted to asses the performance of these algorithms with clinical data.	[Ruiz de Gauna, Sofia; Gonzalez-Otero, Digna M.; Ruiz, Jesus] Univ Basque Country, Fac Engn, Dept Commun Engn, Bilbao, Bizkaia, Spain; [Russell, James K.] Oregon Hlth & Sci Univ, Dept Emergency Med, Portland, OR 97201 USA	University of Basque Country; Oregon Health & Science University	de Gauna, SR (corresponding author), Univ Basque Country, Fac Engn, Dept Commun Engn, Bilbao, Bizkaia, Spain.	sofia.ruizdegauna@ehu.es	Russell, James/AAW-8820-2021	Russell, James/0000-0002-5133-9720; Ruiz de Gauna, Sofia/0000-0002-0414-0946; Gonzalez-Otero, Digna Maria/0000-0002-6594-5748	Ministerio de Economia y Competitividad [TEC2012-31144]; Basque Government (Gobierno Vasco) [BFI-2011-166]	Ministerio de Economia y Competitividad(Spanish Government); Basque Government (Gobierno Vasco)(Basque Government)	This work was supported by Ministerio de Economia y Competitividad: TEC2012-31144 (http://www.mineco.gob.es, SRDG JR DMGO) and Basque Government (Gobierno Vasco): BFI-2011-166 (https://www.euskadi.eus, DMGO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase SO, 2002, IEEE T BIO-MED ENG, V49, P263, DOI 10.1109/10.983461; Abella BS, 2005, JAMA-J AM MED ASSOC, V293, P305, DOI 10.1001/jama.293.3.305; Alonso E, 2015, RESUSCITATION, V88, P28, DOI 10.1016/j.resuscitation.2014.11.027; Alonso E, 2014, RESUSCITATION, V85, P637, DOI 10.1016/j.resuscitation.2013.12.035; Ayala U, 2014, RESUSCITATION, V85, P957, DOI 10.1016/j.resuscitation.2014.04.007; Babbs CF, 2008, RESUSCITATION, V77, P306, DOI 10.1016/j.resuscitation.2007.12.018; Beesems SG, 2014, RESUSCITATION, V85, P1439, DOI 10.1016/j.resuscitation.2014.08.005; Dellimore GKH, 2014, RESUSCITATION, V85, P820, DOI 10.1016/j.resuscitation.2014.03.003; Fishman GI, 2010, CIRCULATION, V122, P2335, DOI 10.1161/CIRCULATIONAHA.110.976092; Gonzalez-Otero DM, 2015, RESUSCITATION, V93, P82, DOI 10.1016/j.resuscitation.2015.05.027; Gonzalez-Otero DM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/865967; Gruber J, 2012, TRENDS ANAESTH CRIT, V2, P287, DOI 10.1016/j.tacc.2012.09.004; Holmberg M, 2000, RESUSCITATION, V47, P59, DOI 10.1016/S0300-9572(00)00199-4; Meaney PA, 2013, CIRCULATION, V128, P417, DOI 10.1161/CIR.0b013e31829d8654; Myklebust H, 2009, EP Patent, Patent No. [1,057,451, 1057451]; Nolan J, 2006, RESUSCITATION, V71, P270, DOI 10.1016/j.resuscitation.2006.09.001; Nysaether J, 2008, EP Patent App, Patent No. [EP20,080,250,519, 20080250519]; Oh J, 2013, RESUSCITATION, V84, P987, DOI 10.1016/j.resuscitation.2012.12.027; Palazzolo JA, 2004, US Patent, Patent No. [6,827,695, 6827695]; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Perkins GD, 2009, RESUSCITATION, V80, P79, DOI 10.1016/j.resuscitation.2008.08.011; Ristagno G, 2014, RESUSCITATION, V85, P579, DOI 10.1016/j.resuscitation.2014.03.002; Stecher FS, 2008, RESUSCITATION, V79, P432, DOI 10.1016/j.resuscitation.2008.08.007; Tomlinson AE, 2007, RESUSCITATION, V72, P364, DOI 10.1016/j.resuscitation.2006.07.017; Waalewijn RA, 2001, RESUSCITATION, V51, P113, DOI 10.1016/S0300-9572(01)00407-5; Wik L, 2005, JAMA-J AM MED ASSOC, V293, P299, DOI 10.1001/jama.293.3.299; Yeung J, 2009, RESUSCITATION, V80, P743, DOI 10.1016/j.resuscitation.2009.04.012	27	21	22	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150139	10.1371/journal.pone.0150139	http://dx.doi.org/10.1371/journal.pone.0150139			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930061	Green Submitted, Green Published, gold			2022-12-27	WOS:000371434500105
J	Skardal, K; Espe, EKS; Zhang, LL; Aronsen, JM; Sjaastad, I				Skardal, Kristine; Espe, Emil K. S.; Zhang, Lili; Aronsen, Jan Magnus; Sjaastad, Ivar			Three-Directional Evaluation of Mitral Flow in the Rat Heart by Phase-Contrast Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC FUNCTION; AORTIC FLOW; ECHOCARDIOGRAPHY; VALVE; MICE; FAILURE; MRI; HYPERTROPHY; ASSOCIATION; DOPPLER	Purpose Determination of mitral flow is an important aspect in assessment of cardiac function. Traditionally, mitral flow is measured by Doppler echocardiography which suffers from several challenges, particularly related to the direction and the spatial inhomogeneity of flow. These challenges are especially prominent in rodents. The purpose of this study was to establish a cardiovascular magnetic resonance (CMR) protocol for evaluation of three-directional mitral flow in a rodent model of cardiac disease. Materials and Methods Three-directional mitral flow were evaluated by phase contrast CMR (PC-CMR) in rats with aortic banding (AB) (N = 7) and sham-operated controls (N = 7). Peak mitral flow and deceleration rate from PC-CMR was compared to conventional Doppler echocardiography. The accuracy of PC-CMR was investigated by comparison of spatiotemporally integrated mitral flow with left ventricular stroke volume assessed by cine CMR. Results PC-CMR portrayed the spatial distribution of mitral flow and flow direction in the atrioventricular plane throughout diastole. Both PC-CMR and echocardiography demonstrated increased peak mitral flow velocity and higher deceleration rate in AB compared to sham. Comparison with cine CMR revealed that PC-CMR measured mitral flow with excellent accuracy. Echocardiography presented significantly lower values of flow compared to PC-CMR. Conclusions For the first time, we show that PC-CMR offers accurate evaluation of three-directional mitral blood flow in rodents. The method successfully detects alterations in the mitral flow pattern in response to cardiac disease and provides novel insight into the characteristics of mitral flow.	[Skardal, Kristine; Espe, Emil K. S.; Zhang, Lili; Aronsen, Jan Magnus; Sjaastad, Ivar] Oslo Univ Hosp, Expt Med Res Inst, N-0450 Oslo, Norway; [Skardal, Kristine; Espe, Emil K. S.; Zhang, Lili; Aronsen, Jan Magnus; Sjaastad, Ivar] Univ Oslo, Oslo, Norway; [Skardal, Kristine; Espe, Emil K. S.; Zhang, Lili; Sjaastad, Ivar] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Skardal, Kristine; Espe, Emil K. S.; Zhang, Lili; Sjaastad, Ivar] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Skardal, K (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, N-0450 Oslo, Norway.; Skardal, K (corresponding author), Univ Oslo, Oslo, Norway.; Skardal, K (corresponding author), Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway.; Skardal, K (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	kristine.skardal@medisin.uio.no	Espe, Emil/AAF-6293-2020	Espe, Emil/0000-0001-8500-4921; Young-Halvorsen, Kristine/0000-0001-6980-0880	South-Eastern Norway Regional Health Authority; Anders Jahre's fund for the Promotion of Science; Research Council of Norway; Familien Blix' Fond Til Fremme Av Medisinsk Forskning; Stiftelsen KG Jebsen	South-Eastern Norway Regional Health Authority; Anders Jahre's fund for the Promotion of Science; Research Council of Norway(Research Council of Norway); Familien Blix' Fond Til Fremme Av Medisinsk Forskning; Stiftelsen KG Jebsen	This work was supported by the South-Eastern Norway Regional Health Authority, Anders Jahre's fund for the Promotion of Science, the Research Council of Norway, Familien Blix' Fond Til Fremme Av Medisinsk Forskning and Stiftelsen KG Jebsen.	Bollache E, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-63; Bovenkamp PR, 2015, MAGN RESON MATER PHY, V28, P315, DOI 10.1007/s10334-014-0466-z; Brattelid T, 2007, J MOL CELL CARDIOL, V43, P767, DOI 10.1016/j.yjmcc.2007.08.019; Cawley PJ, 2013, CIRC-CARDIOVASC IMAG, V6, P48, DOI 10.1161/CIRCIMAGING.112.975623; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Espe EKS, 2014, MAGN RESON MED, V72, P1096, DOI 10.1002/mrm.25023; Espe EKS, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-82; Espe EKS, 2013, MAGN RESON MED, V69, P48, DOI 10.1002/mrm.24226; Frydrychowicz A, 2011, EUR J RADIOL, V80, P24, DOI 10.1016/j.ejrad.2011.01.094; Hamdani N, 2014, CARDIOVASC RES, V104, P423, DOI 10.1093/cvr/cvu223; HARTIALA JJ, 1993, AM HEART J, V125, P1054, DOI 10.1016/0002-8703(93)90114-O; Haugen B O, 2000, Eur J Echocardiogr, V1, P252, DOI 10.1053/euje.2000.0041; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; Markl M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-7; Martin-Fernandez B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111104; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Muzzarelli S, 2014, EUR HEART J-CARD IMG, V15, P77, DOI 10.1093/ehjci/jet129; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; SAMSTAD SO, 1992, CIRCULATION, V86, P748, DOI 10.1161/01.CIR.86.3.748; Schneider JE, 2006, J CARDIOVASC MAGN R, V8, P693, DOI 10.1080/10976640600723664; Schubert T, 2014, INVEST RADIOL, V49, P189, DOI 10.1097/RLI.0000000000000013; Thavendiranathan P, 2012, J AM SOC ECHOCARDIOG, V25, P56, DOI 10.1016/j.echo.2011.10.004	24	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150536	10.1371/journal.pone.0150536	http://dx.doi.org/10.1371/journal.pone.0150536			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930073	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500168
J	Song, T; Li, N; Zarepisheh, M; Li, YB; Gautier, Q; Zhou, LH; Mell, L; Jiang, S; Cervino, L				Song, Ting; Li, Nan; Zarepisheh, Masoud; Li, Yongbao; Gautier, Quentin; Zhou, Linghong; Mell, Loren; Jiang, Steve; Cervino, Laura			An Automated Treatment Plan Quality Control Tool for Intensity-Modulated Radiation Therapy Using a Voxel-Weighting Factor-Based Re-Optimization Algorithm	PLOS ONE			English	Article							CONFORMAL RADIOTHERAPY; IMRT; PROSTATE; REGISTRATION	Intensity-modulated radiation therapy (IMRT) currently plays an important role in radiotherapy, but its treatment plan quality can vary significantly among institutions and planners. Treatment plan quality control (QC) is a necessary component for individual clinics to ensure that patients receive treatments with high therapeutic gain ratios. The voxel-weighting factor-based plan re-optimization mechanism has been proved able to explore a larger Pareto surface (solution domain) and therefore increase the possibility of finding an optimal treatment plan. In this study, we incorporated additional modules into an in-house developed voxel weighting factor-based re-optimization algorithm, which was enhanced as a highly automated and accurate IMRT plan QC tool (TPS-QC tool). After importing an underassessment plan, the TPS-QC tool was able to generate a QC report within 2 minutes. This QC report contains the plan quality determination as well as information supporting the determination. Finally, the IMRT plan quality can be controlled by approving quality-passed plans and replacing quality-failed plans using the TPS-QC tool. The feasibility and accuracy of the proposed TPS-QC tool were evaluated using 25 clinically approved cervical cancer patient IMRT plans and 5 manually created poor-quality IMRT plans. The results showed high consistency between the QC report quality determinations and the actual plan quality. In the 25 clinically approved cases that the TPS-QC tool identified as passed, a greater difference could be observed for dosimetric endpoints for organs at risk (OAR) than for planning target volume (PTV), implying that better dose sparing could be achieved in OAR than in PTV. In addition, the dose-volume histogram (DVH) curves of the TPS-QC tool re-optimized plans satisfied the dosimetric criteria more frequently than did the under-assessment plans. In addition, the criteria for unsatisfied dosimetric endpoints in the 5 poor-quality plans could typically be satisfied when the TPS-QC tool generated re-optimized plans without sacrificing other dosimetric endpoints. In addition to its feasibility and accuracy, the proposed TPS-QC tool is also user-friendly and easy to operate, both of which are necessary characteristics for clinical use.	[Song, Ting; Zhou, Linghong] Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China; [Li, Nan; Zarepisheh, Masoud; Gautier, Quentin; Mell, Loren; Cervino, Laura] Univ Calif San Diego, Ctr Adv Radiotherapy Technol, La Jolla, CA 92093 USA; [Li, Nan; Zarepisheh, Masoud; Gautier, Quentin; Mell, Loren; Cervino, Laura] Univ Calif San Diego, Dept Radiat Oncol, La Jolla, CA 92093 USA; [Song, Ting; Li, Yongbao; Jiang, Steve] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA	Southern Medical University - China; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhou, LH (corresponding author), Southern Med Univ, Dept Biomed Engn, Guangzhou, Guangdong, Peoples R China.; Cervino, L (corresponding author), Univ Calif San Diego, Ctr Adv Radiotherapy Technol, La Jolla, CA 92093 USA.; Cervino, L (corresponding author), Univ Calif San Diego, Dept Radiat Oncol, La Jolla, CA 92093 USA.; Jiang, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	smart@smu.edu.au; Steve.Jiang@UTSouthwestern.edu; lcervino@ucsd.edu	Jiang, Steve/GRO-3951-2022	Cervino, Laura/0000-0001-6479-6990	National Natural Science Foundation of China [30970866]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/), No. 30970866 (receiver: LZ).	Alber M, 2001, PHYS MED BIOL, V46, P3229, DOI 10.1088/0031-9155/46/12/311; Bohsung J, 2005, RADIOTHER ONCOL, V76, P354, DOI 10.1016/j.radonc.2005.08.003; Chung HT, 2008, INT J RADIAT ONCOL, V71, P1167, DOI 10.1016/j.ijrobp.2007.11.040; Cotrutz C, 2003, MED PHYS, V30, P544, DOI 10.1118/1.1556610; Cotrutz C, 2002, PHYS MED BIOL, V47, P1659, DOI 10.1088/0031-9155/47/10/304; Fredriksson A, 2012, PHYS MED BIOL, V57, P7799, DOI 10.1088/0031-9155/57/23/7799; Gu X, 2011, INT J RADIAT ONCOL, V81, pS803, DOI 10.1016/j.ijrobp.2011.06.1409; Gu XJ, 2011, PHYS MED BIOL, V56, P3337, DOI 10.1088/0031-9155/56/11/010; Gu XJ, 2010, PHYS MED BIOL, V55, P207, DOI 10.1088/0031-9155/55/1/012; Halabi T, 2006, PHYS MED BIOL, V51, P3809, DOI 10.1088/0031-9155/51/15/014; Hall EJ, 2003, INT J RADIAT ONCOL, V56, P83, DOI 10.1016/S0360-3016(03)00073-7; Hunt MA, 2006, INT J RADIAT ONCOL, V66, P296, DOI 10.1016/j.ijrobp.2006.05.028; Jia X, 2011, PHYS MED BIOL, V56, P6205, DOI 10.1088/0031-9155/56/19/004; Li N, 2013, PHYS MED BIOL, V58, P8725, DOI 10.1088/0031-9155/58/24/8725; Lu RZ, 2007, PHYS MED BIOL, V52, P849, DOI 10.1088/0031-9155/52/3/022; Men CH, 2010, MED PHYS, V37, P5787, DOI 10.1118/1.3491675; Men CH, 2010, PHYS MED BIOL, V55, P4309, DOI 10.1088/0031-9155/55/15/008; Moore KL, 2012, SEMIN RADIAT ONCOL, V22, P62, DOI 10.1016/j.semradonc.2011.09.005; Mutic S, 2003, MED PHYS, V30, P2762, DOI 10.1118/1.1609271; Petit SF, 2012, RADIOTHER ONCOL, V102, P38, DOI 10.1016/j.radonc.2011.05.025; Sveistrup J, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-44; Teh B S, 1999, Oncologist, V4, P433; Teh BS, 2001, INT J RADIAT ONCOL, V49, P465, DOI 10.1016/S0360-3016(00)01474-7; Vlachaki MT, 2005, MED DOSIM, V30, P69, DOI 10.1016/j.meddos.2005.01.002; Williams MJ, 2007, AUSTRALAS RADIOL, V51, P472, DOI 10.1111/j.1440-1673.2007.01873.x; Wu BB, 2009, MED PHYS, V36, P5497, DOI 10.1118/1.3253464; Wu C, 2003, PHYS MED BIOL, V48, P2479, DOI 10.1088/0031-9155/48/15/315; Wu QW, 2000, MED PHYS, V27, P701, DOI 10.1118/1.598932; Young R, 2000, RADIOLOGY MANAGEMENT, V23, P3; Young R, 2000, RADIOL MANAG, V23, P20; Young R, 2000, RADIOLOGY MANAGEMENT, V23, P8; Young R, 2000, RADIOLOGY MANAGEMENT, V23, P30; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zarepisheh M, 2012, ARXIV12107006; Zarepisheh M, 2014, MED PHYS, V41, DOI 10.1118/1.4875700; Zelefsky MJ, 2001, J UROLOGY, V166, P876, DOI 10.1016/S0022-5347(05)65855-7; Zhen X, 2012, PHYS MED BIOL, V57, P6807, DOI 10.1088/0031-9155/57/21/6807	37	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149273	10.1371/journal.pone.0149273	http://dx.doi.org/10.1371/journal.pone.0149273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930204	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500022
J	Skvortsov, T; de Leeuwe, C; Quinn, JP; McGrath, JW; Allen, CCR; McElarney, Y; Watson, C; Arkhipova, K; Lavigne, R; Kulakov, LA				Skvortsov, Timofey; de Leeuwe, Colin; Quinn, John P.; McGrath, John W.; Allen, Christopher C. R.; McElarney, Yvonne; Watson, Catherine; Arkhipova, Ksenia; Lavigne, Rob; Kulakov, Leonid A.			Metagenomic Characterisation of the Viral Community of Lough Neagh, the Largest Freshwater Lake in Ireland	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MARINE VIRUSES; PCR PRIMERS; BACTERIAL COMMUNITY; BARCODED PRIMERS; SEQUENCING DATA; VIROME ANALYSIS; AMPLIFICATION; DIVERSITY; DYNAMICS	Lough Neagh is the largest and the most economically important lake in Ireland. It is also one of the most nutrient rich amongst the world's major lakes. In this study, 16S rRNA analysis of total metagenomic DNA from the water column of Lough Neagh has revealed a high proportion of Cyanobacteria and low levels of Actinobacteria, Acidobacteria, Chloroflexi, and Firmicutes. The planktonic virome of Lough Neagh has been sequenced and 2,298,791 2x300 bp Illumina reads analysed. Comparison with previously characterised lakes demonstrates that the Lough Neagh viral community has the highest level of sequence diversity. Only about 15% of reads had homologs in the RefSeq database and tailed bacteriophages (Caudovirales) were identified as a major grouping. Within the Caudovirales, the Podoviridae and Siphoviridae were the two most dominant families (34.3% and 32.8% of the reads with sequence homology to the RefSeq database), while ssDNA bacteriophages constituted less than 1% of the virome. Putative cyanophages were found to be abundant. 66,450 viral contigs were assembled with the largest one being 58,805 bp; its existence, and that of another 34,467 bp contig, in the water column was confirmed. Analysis of the contigs confirmed the high abundance of cyanophages in the water column.	[Skvortsov, Timofey; de Leeuwe, Colin; Quinn, John P.; McGrath, John W.; Allen, Christopher C. R.; Arkhipova, Ksenia; Kulakov, Leonid A.] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland; [McElarney, Yvonne; Watson, Catherine] Agri Food & Biosci Inst, Belfast, Antrim, North Ireland; [Lavigne, Rob] Katholieke Univ Leuven, Lab Gene Technol, Leuven, Belgium	Queens University Belfast; Agri-Food & Biosciences Institute; KU Leuven	Kulakov, LA (corresponding author), Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland.	l.kulakov@qub.ac.uk		Lavigne, Rob/0000-0001-7377-1314; Skvortsov, Timofey/0000-0002-4048-6725; Allen, Christopher/0000-0002-2435-4327	Leverhulme Trust [RPG-2013-040]	Leverhulme Trust(Leverhulme Trust)	The work was supported by Leverhulme Trust (https://www.leverhulme.ac.uk/); Grant RPG-2013-040, received by LAK, JPQ, JWM, and CCRA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaenssens EM, 2015, ENVIRON MICROBIOL, V17, P480, DOI 10.1111/1462-2920.12528; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11; Boucher D, 2006, FEMS MICROBIOL ECOL, V55, P79, DOI 10.1111/j.1574-6941.2005.00011.x; Breitbart M, 2012, ANNU REV MAR SCI, V4, P425, DOI 10.1146/annurev-marine-120709-142805; Bunting L, 2007, LIMNOL OCEANOGR, V52, P354, DOI 10.4319/lo.2007.52.1.0354; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Chen F, 2001, APPL ENVIRON MICROB, V67, P539, DOI 10.1128/AEM.67.2.539-545.2001; Debroas D, 2009, ENVIRON MICROBIOL, V11, P2412, DOI 10.1111/j.1462-2920.2009.01969.x; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Fancello L, 2013, ISME J, V7, P359, DOI 10.1038/ismej.2012.101; Ge Xingyi, 2013, Virologica Sinica, V28, P280, DOI 10.1007/s12250-013-3365-y; Ghai R, 2014, MOL ECOL, V23, P6073, DOI 10.1111/mec.12985; Ghai R, 2012, ENV MICROBIOL REP, V4, P29, DOI 10.1111/j.1758-2229.2011.00274.x; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Haukka K, 2006, MICROB ECOL, V51, P137, DOI 10.1007/s00248-005-0049-7; Havens KE, 2008, ADV EXP MED BIOL, V619, P733, DOI 10.1007/978-0-387-75865-7_33; Huys G, 2008, CURR MICROBIOL, V56, P553, DOI 10.1007/s00284-008-9122-z; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lopez-Bueno A, 2009, SCIENCE, V326, P858, DOI 10.1126/science.1179287; Mao XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022556; Marchesi JR, 1998, APPL ENVIRON MICROB, V64, P795; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Paerl HW, 2012, WATER RES, V46, P1349, DOI 10.1016/j.watres.2011.08.002; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Paul JH, 2008, ISME J, V2, P579, DOI 10.1038/ismej.2008.35; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quinn JP., 1993, LOUGH NEAGH ECOLOGY, P369; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Roh SW, 2010, ISME J, V4, P1, DOI 10.1038/ismej.2009.83; Roux S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-76; Roux S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033641; Roux S, 2011, BIOINFORMATICS, V27, P3074, DOI 10.1093/bioinformatics/btr519; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Thurber RV., 2011, HDB MOL MICROBIAL EC; Tseng CH, 2013, ISME J, V7, P2374, DOI 10.1038/ismej.2013.118; Weitz Joshua S, 2012, F1000 Biol Rep, V4, P17; Wilke A., 2014, MG RAST MANUAL VERSI; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Willner D, 2009, ENVIRON MICROBIOL, V11, P1752, DOI 10.1111/j.1462-2920.2009.01901.x; Wilson WH, 1998, ESTUAR COAST SHELF S, V46, P49, DOI 10.1006/ecss.1998.0333; Wilson WH, 1996, J PHYCOL, V32, P506, DOI 10.1111/j.0022-3646.1996.00506.x; Wood RB, 1993, LOUGH NEAGH ECOLOGY; Zeidner G, 2005, ENVIRON MICROBIOL, V7, P1505, DOI 10.1111/j.1462-2920.2005.00833.x; Zhao YL, 2013, NATURE, V494, P357, DOI 10.1038/nature11921; Zwart G, 1998, SYST APPL MICROBIOL, V21, P546, DOI 10.1016/S0723-2020(98)80067-2	65	51	52	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150361	10.1371/journal.pone.0150361	http://dx.doi.org/10.1371/journal.pone.0150361			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927795	Green Published, gold, Green Submitted			2022-12-27	WOS:000371424200038
J	de Graav, GN; Hesselink, DA; Dieterich, M; Kraaijeveld, R; Weimar, W; Baan, CC				de Graav, Gretchen N.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.			Down-Regulation of Surface CD28 under Belatacept Treatment: An Escape Mechanism for Antigen-Reactive T-Cells	PLOS ONE			English	Article							ALLOGRAFT SURVIVAL; MEMORY; TACROLIMUS; PHENOTYPE; BLOCKADE	Background The co-stimulatory inhibitor of the CD28-CD80/86-pathway, belatacept, allows calcineurin-inhibitor-free immunosuppression in kidney transplantation. However, aggressive T-cell mediated allogeneic responses have been observed in belatacept-treated patients, which could be explained by effector-memory T-cells that lack membrane expression of CD28, i.e. CD28-negative (CD28(NULL)) T-cells. CD28-positive (CD28(POS)) T-cells that down regulate their surface CD28 after allogeneic stimulation could also pose a threat against the renal graft. The aim of this study was to investigate this potential escape mechanism for CD28(POS) T-cells under belatacept treatment. Materials & Methods PBMCs, isolated T-cell memory subsets and isolated CD28(POS) T-cells were obtained from end-stage renal disease (ESRD) patients and co-cultured with allo-antigen in the presence of belatacept to mimic allogeneic reactions in kidney-transplant patients under belatacept treatment. As a control, IgG was used in the absence of belatacept. Results Despite high in vitro belatacept concentrations, a residual T-cell growth of +/- 30% was observed compared to the IgG control after allogeneic stimulation. Of the alloreactive T-cells, the majority expressed an effector-memory phenotype. This predominance for effector-memory T-cells within the proliferated cells was even larger when a higher dose of belatacept was added. Contrary to isolated naive and central-memory T cells, isolated effector-memory T cells could not be inhibited by belatacept in differentiation or allogeneic IFN gamma production. The proportion of CD28-positive T cells was lower within the proliferated T cell population, but was still substantial. A fair number of the isolated initially CD28(POS) T-cells differentiated into CD28(NULL) T-cells, which made them not targetable by belatacept. These induced CD28(NULL) T-cells were not anergic as they produced high amounts of IFN gamma upon allogeneic stimulation. The majority of the proliferated isolated originally CD28(POS) T-cells, however, still expressed CD28 and also expressed IFN gamma. Conclusion This study provides evidence that, apart from CD28(NULL) T-cells, also CD28(POS), mostly effector-memory T-cells can mediate allogeneic responses despite belatacept treatment.	[de Graav, Gretchen N.; Hesselink, Dennis A.; Dieterich, Marjolein; Kraaijeveld, Rens; Weimar, Willem; Baan, Carla C.] Univ Med Ctr, Erasmus MC, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	de Graav, GN (corresponding author), Univ Med Ctr, Erasmus MC, Dept Internal Med, Sect Transplantat & Nephrol, Rotterdam, Netherlands.	g.degraav@erasmusmc.nl		Baan, Carla/0000-0003-2274-2788	Bristol-Myers Squibb; Astellas Pharma; Chiesi Pharmaceuticals	Bristol-Myers Squibb(Bristol-Myers Squibb); Astellas Pharma(Astellas Pharmaceuticals); Chiesi Pharmaceuticals(Chiesi Pharmaceuticals Inc)	D.A. Hesselink has received grant support from Bristol-Myers Squibb and Astellas Pharma. D.A. Hesselink has received lecture and consulting fees from Astellas Pharma and Chiesi Pharmaceuticals. W. Weimar and C.C. Baan received a research grant from Bristol-Myers Squibb. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Orsogna LJA, 2011, TRANSPLANTATION, V91, P494, DOI 10.1097/TP.0b013e318207944c; de Graav GN, 2016, TRANSPLANTATION, V100, P1111, DOI 10.1097/TP.0000000000001004; de Graav GN, 2015, THER DRUG MONIT, V37, P560, DOI 10.1097/FTD.0000000000000179; Demmers MWHJ, 2014, TRANSPLANTATION, V97, P47, DOI 10.1097/01.TP.0000435697.31148.b2; Espinosa J, 2016, AM J TRANSPLANT, V16, P1102, DOI 10.1111/ajt.13613; Grimbert P, 2011, NEPHROL DIAL TRANSPL, V26, P1087, DOI 10.1093/ndt/gfq453; Larsen CP, 2005, AM J TRANSPLANT, V5, P443, DOI 10.1111/j.1600-6143.2005.00749.x; Liu Z, 1998, INT IMMUNOL, V10, P775, DOI 10.1093/intimm/10.6.775; Lo DJ, 2011, AM J TRANSPLANT, V11, P22, DOI 10.1111/j.1600-6143.2010.03317.x; Mou D, 2014, AM J TRANSPLANT, V14, P2460, DOI 10.1111/ajt.12937; Pearl JP, 2005, AM J TRANSPLANT, V5, P465, DOI 10.1111/j.1600-6143.2005.00759.x; Riella LV, 2012, AM J TRANSPLANT, V12, P846, DOI 10.1111/j.1600-6143.2011.03929.x; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shen JS, 2014, CLIN DRUG INVEST, V34, P117, DOI 10.1007/s40261-013-0153-2; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Trzonkowski P, 2006, TRANSPLANTATION, V82, P1342, DOI 10.1097/01.tp.0000239268.64408.84; Vallejo AN, 1998, J BIOL CHEM, V273, P8119, DOI 10.1074/jbc.273.14.8119; Valujskikh A, 2002, AM J TRANSPLANT, V2, P501, DOI 10.1034/j.1600-6143.2002.20603.x; Vincenti F, 2012, AM J TRANSPLANT, V12, P210, DOI 10.1111/j.1600-6143.2011.03785.x; Vincenti F, 2010, AM J TRANSPLANT, V10, P535, DOI 10.1111/j.1600-6143.2009.03005.x; Vincenti F, 2010, J AM SOC NEPHROL, V21, P1587, DOI 10.1681/ASN.2009111109; Vu MD, 2006, J IMMUNOL, V176, P1394, DOI 10.4049/jimmunol.176.3.1394; Weaver TA, 2009, NAT MED, V15, P746, DOI 10.1038/nm.1993; Xu H, 2014, AM J TRANSPLANT, V14, P319, DOI 10.1111/ajt.12574	24	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148604	10.1371/journal.pone.0148604	http://dx.doi.org/10.1371/journal.pone.0148604			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919152	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400007
J	Etz, A; Vandekerckhove, J				Etz, Alexander; Vandekerckhove, Joachim			A Bayesian Perspective on the Reproducibility Project: Psychology	PLOS ONE			English	Article							FAILURE; CRISIS; TESTS	We revisit the results of the recent Reproducibility Project: Psychology by the Open Science Collaboration. We compute Bayes factors-a quantity that can be used to express comparative evidence for an hypothesis but also for the null hypothesis-for a large subset (N = 72) of the original papers and their corresponding replication attempts. In our computation, we take into account the likely scenario that publication bias had distorted the originally published results. Overall, 75% of studies gave qualitatively similar results in terms of the amount of evidence provided. However, the evidence was often weak (i.e., Bayes factor < 10). The majority of the studies (64%) did not provide strong evidence for either the null or the alternative hypothesis in either the original or the replication, and no replication attempts provided strong evidence in favor of the null. In all cases where the original paper provided strong evidence but the replication did not (15%), the sample size in the replication was smaller than the original. Where the replication provided strong evidence but the original did not (10%), the replication sample size was larger. We conclude that the apparent failure of the Reproducibility Project to replicate many target effects can be adequately explained by overestimation of effect sizes (or overestimation of evidence against the null hypothesis) due to small sample sizes and publication bias in the psychological literature. We further conclude that traditional sample sizes are insufficient and that a more widespread adoption of Bayesian methods is desirable.	[Etz, Alexander] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Vandekerckhove, Joachim] Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA; [Vandekerckhove, Joachim] Univ Calif Irvine, Dept Stat, Irvine, CA USA	University of Amsterdam; University of California System; University of California Irvine; University of California System; University of California Irvine	Vandekerckhove, J (corresponding author), Univ Calif Irvine, Dept Cognit Sci, Irvine, CA 92717 USA.; Vandekerckhove, J (corresponding author), Univ Calif Irvine, Dept Stat, Irvine, CA USA.	joachim+pone@uci.edu		Vandekerckhove, Joachim/0000-0003-2600-5937	National Science Foundation from Methods, 335 Measurements, and Statistics panel [1230118, 1534472]; John Templeton Foundation [48192]; Direct For Social, Behav & Economic Scie [1534472] Funding Source: National Science Foundation	National Science Foundation from Methods, 335 Measurements, and Statistics panel; John Templeton Foundation; Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This work was partly funded by the National Science Foundation grants #1230118 and #1534472 from the Methods, 335 Measurements, and Statistics panel (www.nsf.gov) and the John Templeton Foundation grant #48192 (www.templeton.org). This publication was made possible through the support of a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; American Psychological Association, 2015, SCI PAP SHOWS LOW RE; BAKAN D, 1966, PSYCHOL BULL, V66, P423, DOI 10.1037/h0020412; Barrett L. F., 2015, PSYCHOL IS NOT CRISI; BERGER JO, 1987, J AM STAT ASSOC, V82, P112, DOI 10.2307/2289131; Berger JO, 1987, STAT SCI, V2, P317, DOI [10.1214/ss/1177013238distributionsininvariantsituations, DOI 10.1214/SS/1177013238DISTRIBUTIONSININVARIANTSITUATIONS, DOI 10.1214/SS/1177013238, 10.2307/2245772]; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Connor S, 2015, STUDY REVEALS LOT PS; Davis P.J., 1972, HDB MATH FUNCTIONS F, V10; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; Etz A, 2015, PREPRINT; Etz A., 2015, BAYESIAN REPROD PROJ; Fraley RC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109019; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Guan M, 2016, PSYCHON B REV, V23, P74, DOI 10.3758/s13423-015-0868-6; Handwerk B, 2015, SCI REPLICATED 100 P; Ioannidis JPA, 2008, EPIDEMIOLOGY, V19, P640, DOI 10.1097/EDE.0b013e31818131e7; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Johnson VE, 2013, P NATL ACAD SCI USA, V110, P19313, DOI 10.1073/pnas.1313476110; Jump P, 2015, MORE HALF PSYCHOL PA; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Love J, 2015, JASP COMPUTER SOFTWA; Marsman M, 2015, UNPUB; Matzke D, 2015, J EXP PSYCHOL GEN, V144, pE1, DOI 10.1037/xge0000038; Maxwell SE, 2015, AM PSYCHOL, V70, P487, DOI 10.1037/a0039400; Pashler H, 2012, PERSPECT PSYCHOL SCI, V7, P528, DOI 10.1177/1745691612465253; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rouder JN, 2014, PSYCHON B REV, V21, P301, DOI 10.3758/s13423-014-0595-4; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Schonbrodt FD, PSYCHOL MET IN PRESS; Stanley TD, 2014, RES SYNTH METHODS, V5, P60, DOI 10.1002/jrsm.1095; STERLING TD, 1959, J AM STAT ASSOC, V54, P30, DOI 10.2307/2282137; Verhagen J, 2014, J EXP PSYCHOL GEN, V143, P1457, DOI 10.1037/a0036731; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; WALSTER GW, 1970, AM STAT, V24, P16, DOI 10.2307/2681924; Wetzels R, 2011, PERSPECT PSYCHOL SCI, V6, P291, DOI 10.1177/1745691611406923; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	38	141	142	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149794	10.1371/journal.pone.0149794	http://dx.doi.org/10.1371/journal.pone.0149794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919473	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400046
J	Gurusamy, KS; Vaughan, J; Fraser, IS; Best, LMJ; Richards, T				Gurusamy, Kurinchi S.; Vaughan, Jessica; Fraser, Ian S.; Best, Lawrence M. J.; Richards, Toby			Medical Therapies for Uterine Fibroids - A Systematic Review and Network Meta-Analysis of Randomised Controlled Trials	PLOS ONE			English	Review							PROGESTERONE-RECEPTOR MODULATOR; HORMONE AGONIST TREATMENT; LEUPROLIDE ACETATE DEPOT; ARTERY BLOOD-FLOW; QUALITY-OF-LIFE; DOUBLE-BLIND; PREMENOPAUSAL WOMEN; GNRH AGONIST; ULIPRISTAL ACETATE; PREOPERATIVE TREATMENT	Background Uterine fibroids are common, often symptomatic and a third of women need repeated time off work. Consequently 25% to 50% of women with fibroids receive surgical treatment, namely myomectomy or hysterectomy. Hysterectomy is the definitive treatment as fibroids are hormone dependent and frequently recurrent. Medical treatment aims to control symptoms in order to replace or delay surgery. This may improve the outcome of surgery and prevent recurrence. Purpose To determine whether any medical treatment can be recommended in the treatment of women with fibroids about to undergo surgery and in those for whom surgery is not planned based on currently available evidence. Study Selection Two authors independently identified randomised controlled trials (RCT) of all pharmacological treatments aimed at the treatment of fibroids from a list of references obtained by formal search of MEDLINE, EMBASE, Cochrane library, Science Citation Index, and ClinicalTrials.gov until December 2013. Data Extraction Two authors independently extracted data from identified studies. Data Synthesis A Bayesian network meta-analysis was performed following the National Institute for Health and Care Excellence-Decision Support Unit guidelines. Odds ratios, rate ratios, or mean differences with 95% credible intervals (CrI) were calculated. Results and Limitations A total of 75 RCT met the inclusion criteria, 47 of which were included in the network meta-analysis. The overall quality of evidence was very low. The network meta-analysis showed differing results for different outcomes. Conclusions There is currently insufficient evidence to recommend any medical treatment in the management of fibroids. Certain treatments have future promise however further, well designed RCTs are needed.	[Gurusamy, Kurinchi S.; Vaughan, Jessica; Best, Lawrence M. J.; Richards, Toby] Royal Free Hosp, Univ Coll London, Div Surg & Intervent Sci, 9th Floor,Pond St, London NW3 2QG, England; [Fraser, Ian S.] Family Planning New South Wales, Sydney Ctr Reprod Hlth Res, Sydney, NSW 2131, Australia; [Fraser, Ian S.] Univ Sydney, Sydney, NSW 2006, Australia	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Sydney	Richards, T (corresponding author), Royal Free Hosp, Univ Coll London, Div Surg & Intervent Sci, 9th Floor,Pond St, London NW3 2QG, England.	toby.richards@ucl.ac.uk	Richards, Toby/K-6547-2013	Gurusamy, Kurinchi/0000-0002-0313-9134				Arleo Elizabeth Kagan, 2007, Int J Fertil Womens Med, V52, P111; Armstrong A, 2010, HUM REPROD, V25, pI90, DOI 10.1093/humrep/de.25.s1.58; AUDEBERT AJM, 1994, BRIT J OBSTET GYNAEC, V101, P29, DOI 10.1111/j.1471-0528.1994.tb13683.x; Bagaria M, 2009, AUST NZ J OBSTET GYN, V49, P77, DOI 10.1111/j.1479-828X.2008.00931.x; Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99; Baird DD, 2013, EPIDEMIOLOGY, V24, P447, DOI 10.1097/EDE.0b013e31828acca0; BALASCH J, 1995, ACTA OBSTET GYN SCAN, V74, P562, DOI 10.3109/00016349509024390; BARBIERI RL, 1993, FERTIL STERIL, V60, P569; Baytur YB, 2007, EUR J OBSTET GYN R B, V135, P94, DOI 10.1016/j.ejogrb.2006.07.042; Biglia N, 2014, DRUG DES DEV THER, V8, P285, DOI 10.2147/DDDT.S54565; Borah BJ, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.017; Bulun SE, 2013, NEW ENGL J MED, V369, P1344, DOI 10.1056/NEJMra1209993; Campo S, 1999, HUM REPROD, V14, P44, DOI 10.1093/humrep/14.1.44; Esteve JLC, 2013, INT J WOMENS HEALTH, V5, P361, DOI 10.2147/IJWH.S42770; Cardozo ER, 2012, AM J OBSTET GYNECOL, V206, DOI [10.1016/j.ajog.2011.12.002, 10.1016/j.ajog.2012.08.020]; Carls GS, 2008, J WOMENS HEALTH, V17, P1119, DOI 10.1089/jwh.2008.0456; Chwalisz K, 2007, FERTIL STERIL, V87, P1399, DOI 10.1016/j.fertnstert.2006.11.094; Coddington CC, 2009, FERTIL STERIL, V91, P1909, DOI 10.1016/j.fertnstert.2008.02.128; COSTANTINI S, 1990, EUR J OBSTET GYN R B, V37, P63, DOI 10.1016/0028-2243(90)90096-J; D'Anna R, 1994, Minerva Ginecol, V46, P343; Daniels A, 2002, FERTIL STERIL, V78, pS65, DOI 10.1016/S0015-0282(02)03551-3; de Aloysio D, 1998, MATURITAS, V29, P261, DOI 10.1016/S0378-5122(98)00014-0; De Falco M, 2009, EUR J OBSTET GYN R B, V144, P44, DOI 10.1016/j.ejogrb.2009.02.006; Deng LY, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005287.pub4; Di Lieto A, 2005, STEROIDS, V70, P95, DOI 10.1016/j.steroids.2004.10.008; Dias S., 2012, 1 NICE DSU; Donnez J, 2003, FERTIL STERIL, V79, P1380, DOI 10.1016/S0015-0282(03)00261-9; Donnez J, 2012, NEW ENGL J MED, V366, P421, DOI 10.1056/NEJMoa1103180; Donnez J, 2012, NEW ENGL J MED, V366, P409, DOI 10.1056/NEJMoa1103182; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Engel JB, 2007, EUR J OBSTET GYN R B, V134, P225, DOI 10.1016/j.ejogrb.2006.07.018; Engman M, 2009, HUM REPROD, V24, P1870, DOI 10.1093/humrep/dep100; FEDELE L, 1990, BRIT J OBSTET GYNAEC, V97, P393, DOI 10.1111/j.1471-0528.1990.tb01824.x; FEDELE L, 1991, EUR J OBSTET GYN R B, V38, P53, DOI 10.1016/0028-2243(91)90207-2; Fedele L, 2000, EUR J OBSTET GYN R B, V88, P91, DOI 10.1016/S0301-2115(99)00115-3; FERNANDEZMONTOLI ME, 1995, FERTIL STERIL, V63, P522, DOI 10.1016/S0015-0282(16)57420-2; Fiscella K, 2006, OBSTET GYNECOL, V108, P1381, DOI 10.1097/01.AOG.0000243776.23391.7b; FRIEDMAN AJ, 1991, OBSTET GYNECOL, V77, P720; FRIEDMAN AJ, 1989, FERTIL STERIL, V52, P728; FRIEDMAN AJ, 1990, FERTIL STERIL, V53, P250; FRIEDMAN AJ, 1988, FERTIL STERIL, V49, P404; Gerris J, 1996, HORM RES, V45, P279, DOI 10.1159/000184806; GOLAN A, 1993, HUM REPROD, V8, P450, DOI 10.1093/oxfordjournals.humrep.a138070; Green LJ, 2012, FERTIL STERIL, V98, pS96, DOI 10.1016/j.fertnstert.2012.07.351; Gregoriou O, 1997, MATURITAS, V27, P187, DOI 10.1016/S0378-5122(97)00036-4; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P380, DOI 10.1016/j.jclinepi.2010.09.011; Higgins J.P.T., 2019, COCHRANE HDB SYSTEMA, V2nd, DOI [DOI 10.1002/9781119536604, 10.1002/9780470712184.ch1, DOI 10.1002/9780470712184.CH1]; Hodges KR, 2014, CLIN OBSTET GYNECOL, V57, P43, DOI 10.1097/GRF.0000000000000004; Hudecek R, 2012, Ceska Gynekol, V77, P109; Jirecek S, 2004, FERTIL STERIL, V81, P132, DOI 10.1016/j.fertnstert.2003.06.009; Johnson N, 2005, BMJ-BRIT MED J, V330, P1478, DOI 10.1136/bmj.330.7506.1478; Kroon B, 2011, AUST NZ J OBSTET GYN, V51, P289, DOI 10.1111/j.1479-828X.2011.01300.x; Kumar A, 2013, FERTIL STERIL, V100, pS78, DOI 10.1016/j.fertnstert.2013.07.1924; Lethaby A, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000547; Levens ED, 2008, OBSTET GYNECOL, V111, P1129, DOI 10.1097/AOG.0b013e3181705d0e; Levy G, 2011, REPROD SCI, V18, p95A; Lim SS, 2008, INT J GYNECOL OBSTET, V101, P178, DOI 10.1016/j.ijgo.2007.10.020; Lopez HH Bustos, 1995, GINECOL OBSTET MEX, V63, P356; LUMSDEN MA, 1994, BRIT J OBSTET GYNAEC, V101, P438, DOI 10.1111/j.1471-0528.1994.tb11919.x; Marsh EE, 2013, FERTIL STERIL, V99, P1951, DOI 10.1016/j.fertnstert.2013.02.017; Mavrelos D, 2010, HUM REPROD, V25, P2264, DOI 10.1093/humrep/deq188; Melli MS, 2007, SAUDI MED J, V28, P445; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moorman PG, 2013, FERTIL STERIL, V99, P768, DOI 10.1016/j.fertnstert.2012.10.039; Morris EP, 2008, FERTIL STERIL, V89, P421, DOI 10.1016/j.fertnstert.2007.02.064; Moshesh M, 2014, J SEX MED, V11, P800, DOI 10.1111/jsm.12425; Muneyyirci-Delale O, 2007, CLIN THER, V29, P1682, DOI 10.1016/j.clinthera.2007.08.024; Munro MG, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.01.046; Muzii L, 2010, FERTIL STERIL, V94, P1496, DOI 10.1016/j.fertnstert.2009.05.070; Myers SL, 2012, J WOMENS HEALTH, V21, P285, DOI 10.1089/jwh.2011.3008; Nieman LK, 2011, FERTIL STERIL, V95, P767, DOI 10.1016/j.fertnstert.2010.09.059; Orsini G, 1999, Minerva Ginecol, V51, P421; Palomba S, 2005, FERTIL STERIL, V84, P154, DOI 10.1016/j.fertnstert.2004.12.058; Palomba S, 1998, FERTIL STERIL, V70, P111, DOI 10.1016/S0015-0282(98)00128-9; Palomba S, 2004, HUM REPROD, V19, P415, DOI 10.1093/humrep/deh053; Palomba S, 2002, HUM REPROD, V17, P3213, DOI 10.1093/humrep/17.12.3213; Palomba S, 2002, J AM ASSOC GYN LAP, V9, P170, DOI 10.1016/S1074-3804(05)60126-0; Palomba S, 2002, J CLIN ENDOCR METAB, V87, P4476, DOI 10.1210/jc.2002-020780; Palomba S, 2002, J CLIN ENDOCR METAB, V87, P3603, DOI 10.1210/jc.87.8.3603; Palomba S, 2001, FERTIL STERIL, V75, P429, DOI 10.1016/S0015-0282(00)01676-9; Palomba S, 2008, FERTIL STERIL, V90, P165, DOI 10.1016/j.fertnstert.2007.05.061; Parazzini F, 1999, EUR J OBSTET GYN R B, V87, P31, DOI 10.1016/S0301-2115(99)00089-5; Parsanezhad ME, 2010, FERTIL STERIL, V93, P192, DOI 10.1016/j.fertnstert.2008.09.064; Polatti F, 2000, MATURITAS, V37, P27, DOI 10.1016/S0378-5122(00)00159-6; Puri K, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.09.038; Rees M, 2001, GYNAECOL ENDOSC, V10, P33, DOI 10.1046/j.1365-2508.2001.00396.x; REINSCH RC, 1994, AM J OBSTET GYNECOL, V170, P1623; Roshdy E, 2013, INT J WOMENS HEALTH, V5, P477, DOI 10.2147/IJWH.S41021; RUTGERS JL, 1995, OBSTET GYNECOL, V86, P386, DOI 10.1016/0029-7844(95)00191-S; Sadan O, 2001, EUR J OBSTET GYN R B, V96, P183, DOI 10.1016/S0301-2115(00)00468-1; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sayed GH, 2011, INT J GYNECOL OBSTET, V112, P126, DOI 10.1016/j.ijgo.2010.08.009; Sayyah-Melli M, 2009, SAUDI MED J, V30, P1024; SCHLAFF WD, 1989, OBSTET GYNECOL, V74, P856; Segars JH, 2014, HUM REPROD UPDATE, V20, P309, DOI 10.1093/humupd/dmt058; Seracchioli R, 2003, J AM ASSOC GYN LAP, V10, P316, DOI 10.1016/S1074-3804(05)60254-X; Shaw RW, 1997, GYNAECOLOGICAL EN S1, V6, P1; Simsek T, 2002, MATURITAS, V42, P243, DOI 10.1016/S0378-5122(02)00081-6; Song H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009505.pub2; STOVALL TG, 1995, OBSTET GYNECOL, V86, P65, DOI 10.1016/0029-7844(95)00102-W; STOVALL TG, 1994, AM J OBSTET GYNECOL, V170, P1744; STOVALL TG, 1991, AM J OBSTET GYNECOL, V164, P1420, DOI 10.1016/0002-9378(91)91419-W; Tristan M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007687.pub2; van de Ven J, 2001, Gynecol Endocrinol, V15 Suppl 6, P61, DOI 10.1080/713602771; van de Ven  J, 2002, FERTIL STERIL, V77, P1227, DOI 10.1016/S0015-0282(02)03093-5; Varghese SJ, 2011, HUM REPROD, V26, pI70; Vercellini P, 2003, FERTIL STERIL, V79, P1390, DOI 10.1016/S0015-0282(03)00362-5; Verspyck E, 2000, EUR J OBSTET GYN R B, V89, P7, DOI 10.1016/S0301-2115(99)00168-2; Wilkens J, 2008, J CLIN ENDOCR METAB, V93, P4664, DOI 10.1210/jc.2008-1104; Williams ARW, 2007, HUM REPROD, V22, P1696, DOI 10.1093/humrep/dem026; Williams ARW, 2012, INT J GYNECOL PATHOL, V31, P556, DOI 10.1097/PGP.0b013e318251035b; Zimmermann A, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-6; Zullo E, 1997, ITALIAN J GYNAECOLOG, V9, P63; Zullo F, 1998, AM J OBSTET GYNECOL, V178, P108, DOI 10.1016/S0002-9378(98)70635-0; Zullo F, 1998, J AM ASSOC GYN LAP, V5, P361, DOI 10.1016/S1074-3804(98)80048-0	115	38	43	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149631	10.1371/journal.pone.0149631	http://dx.doi.org/10.1371/journal.pone.0149631			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919185	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400030
J	Hettne, KM; Thompson, M; van Haagen, HHHBM; van der Horst, E; Kaliyaperumal, R; Mina, E; Tatum, Z; Laros, JFJ; van Mulligen, EM; Schuemie, M; Aten, E; Li, TS; Bruskiewich, R; Good, BM; Su, AI; Kors, JA; den Dunnen, J; van Ommen, GJB; Roos, M; 't Hoen, PA; Mons, B; Schultes, EA				Hettne, Kristina M.; Thompson, Mark; van Haagen, Herman H. H. B. M.; van der Horst, Eelke; Kaliyaperumal, Rajaram; Mina, Eleni; Tatum, Zuotian; Laros, Jeroen F. J.; van Mulligen, Erik M.; Schuemie, Martijn; Aten, Emmelien; Li, Tong Shu; Bruskiewich, Richard; Good, Benjamin M.; Su, Andrew I.; Kors, Jan A.; den Dunnen, Johan; van Ommen, Gert-Jan B.; Roos, Marco; 't Hoen, Peter A. C.; Mons, Barend; Schultes, Erik A.			The Implicitome: A Resource for Rationalizing Gene-Disease Associations	PLOS ONE			English	Article							CONCEPT PROFILES; BIOMEDICAL TEXT; MICROARRAY DATA; MUTATIONS; PROTEIN; EXPRESSION; KNOWLEDGE; UMLS; RECOGNITION; DICTIONARY	High-throughput experimental methods such as medical sequencing and genome-wide association studies (GWAS) identify increasingly large numbers of potential relations between genetic variants and diseases. Both biological complexity (millions of potential gene-disease associations) and the accelerating rate of data production necessitate computational approaches to prioritize and rationalize potential gene-disease relations. Here, we use concept profile technology to expose from the biomedical literature both explicitly stated gene-disease relations (the explicitome) and a much larger set of implied gene-disease associations (the implicitome). Implicit relations are largely unknown to, or are even unintended by the original authors, but they vastly extend the reach of existing biomedical knowledge for identification and interpretation of gene-disease associations. The implicitome can be used in conjunction with experimental data resources to rationalize both known and novel associations. We demonstrate the usefulness of the implicitome by rationalizing known and novel gene-disease associations, including those from GWAS. To facilitate the re-use of implicit gene-disease associations, we publish our data in compliance with FAIR Data Publishing recommendations [https://www.force11.org/group/fairgroup] using nanopublications. An online tool (http://knowledge.bio) is available to explore established and potential gene-disease associations in the context of other biomedical relations.	[Hettne, Kristina M.; Thompson, Mark; van Haagen, Herman H. H. B. M.; van der Horst, Eelke; Kaliyaperumal, Rajaram; Mina, Eleni; Tatum, Zuotian; Laros, Jeroen F. J.; van Mulligen, Erik M.; Aten, Emmelien; den Dunnen, Johan; van Ommen, Gert-Jan B.; Roos, Marco; 't Hoen, Peter A. C.; Mons, Barend; Schultes, Erik A.] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands; [van Mulligen, Erik M.; Schuemie, Martijn; Kors, Jan A.] Erasmus Univ, Dept Med Informat, Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands; [Mons, Barend] Dutch Techctr Life Sci, Utrecht, Netherlands; [Schultes, Erik A.] Leiden Inst Adv Comp Sci, Leiden, Netherlands; [Li, Tong Shu; Good, Benjamin M.; Su, Andrew I.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Bruskiewich, Richard] STAR Informat Delphinai Corp, Port Moody, BC, Canada	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Scripps Research Institute	Hettne, KM (corresponding author), Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands.	k.m.hettne@lumc.nl	Schultes, Erik/B-6035-2012; Hoen, Peter A 't/D-3950-2018; dunnen, johan den/ABH-4228-2020; Hettne, Kristina/J-6252-2014; Mina, Eleni/J-7846-2013	Schultes, Erik/0000-0001-8888-635X; Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; Laros, Jeroen F.J./0000-0002-8715-7371; Mons, Barend/0000-0003-3934-0072; Su, Andrew I./0000-0002-9859-4104; Roos, Marco/0000-0002-8691-772X; Hettne, Kristina/0000-0002-4182-7560; Mina, Eleni/0000-0002-8972-9206; van Mulligen, Erik/0000-0003-1377-9386	Dutch Center of Medical Systems Biology (CMSB); ODEX4all [NWO 650.002.002]; Melton Foundation; John Templeton Foundation; European Commission [305444]; Innovative Medicines Initiative Joint Undertaking [115191]; European Union; National Institutes of Health [U54GM114833, GM089820]; Scripps Institute; Delphinai Corporation; SURF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM114833, R01GM089820] Funding Source: NIH RePORTER	Dutch Center of Medical Systems Biology (CMSB); ODEX4all; Melton Foundation; John Templeton Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scripps Institute; Delphinai Corporation; SURF Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was sponsored by the Dutch Center of Medical Systems Biology (CMSB), ODEX4all (NWO 650.002.002), Melton Foundation, and a grant from the John Templeton Foundation. Funding from the European Commission (FP-7 project RD-Connect, grant agreement No. 305444), and the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115191 (Open PHACTS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and in-kind contribution of EFPIA companies are gratefully acknowledged. This work was also supported by the National Institutes of Health (U54GM114833 and GM089820). Delphinai Corporation has an open ended "payasyougo" subcontract with the Scripps Institute to develop the Knowledge.bio system, which is MIT opensourced, with joint copyright attribution. Scripps Institute has USA NIH approval to fund the collaboration with Delphinai Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was sponsored by the Dutch Center of Medical Systems Biology (CMSB), ODEX4all (NWO 650.002.002), Melton Foundation, and a grant from the John Templeton Foundation. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. Funding from the European Commission (FP-7 project RD-Connect, grant agreement No. 305444), and the Innovative Medicines Initiative Joint Undertaking under grant agreement No. 115191 (Open PHACTS), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and in-kind contribution of EFPIA companies are gratefully acknowledged. This work was also supported by the National Institutes of Health (U54GM114833 and GM089820). This work was carried out on the Dutch national e-infrastructure with the support of SURF Foundation. We would like to thank Tobias Messemaker and Yu Sun for their expert advice on the Seckel Syndrome case study, and Jaap van den Herik of the Leiden Center for Data Science for carefully reading the manuscript.	Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Ayvaz S, 2015, J BIOMED INFORM, V55, P206, DOI 10.1016/j.jbi.2015.04.006; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bravo A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0472-9; Bruford EA, 2008, NUCLEIC ACIDS RES, V36, pD445, DOI 10.1093/nar/gkm881; Cheng JB, 2004, P NATL ACAD SCI USA, V101, P7711, DOI 10.1073/pnas.0402490101; Coulet Adrien, 2011, J Biomed Semantics, V2 Suppl 2, pS10, DOI 10.1186/2041-1480-2-S2-S10; Deans AR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002033; Dogan RI, 2014, J BIOMED INFORM, V47, P1, DOI 10.1016/j.jbi.2013.12.006; Fitzky BU, 1998, P NATL ACAD SCI USA, V95, P8181, DOI 10.1073/pnas.95.14.8181; Funk C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-59; Ganapathiraju MK, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-11; Good BM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0438-7; Goodman LA, 1979, MEASURES ASS CROSS C, DOI [10.1007/978-1-4612-9995-0, DOI 10.1007/978-1-4612-9995-0]; Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80; Groth Paul, 2010, Information Services & Use, V30, P51, DOI 10.3233/ISU-2010-0613; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hettne KM, 2014, F1000RESEARCH, V3, DOI 10.12688/f1000research.4830; Hettne KM, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-2; Hettne KM, 2010, J BIOMED SEMANT, V1, DOI 10.1186/2041-1480-1-5; Hettne KM, 2009, BIOINFORMATICS, V25, P2983, DOI 10.1093/bioinformatics/btp535; Houlden H, 2007, NAT GENET, V39, P1434, DOI 10.1038/ng.2007.43; Hussain MS, 2013, CLIN GENET, V83, P446, DOI 10.1111/j.1399-0004.2012.01932.x; Jelier R, 2008, INT J MED INFORM, V77, P354, DOI 10.1016/j.ijmedinf.2007.07.004; Jelier R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-14; Jelier R, 2011, BRIEF BIOINFORM, V12, P518, DOI 10.1093/bib/bbq082; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Jelier R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-291; Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725; Kilicoglu H, 2012, BIOINFORMATICS, V28, P3158, DOI 10.1093/bioinformatics/bts591; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Machado CM, 2015, BRIEF BIOINFORM, V16, P89, DOI 10.1093/bib/bbt079; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; MCCRAY AT, 1994, J AM MED INFORM ASSN, P235; McInnes BT, 2014, J BIOMED INFORM, V47, P83, DOI 10.1016/j.jbi.2013.09.009; Mons B, 2011, NAT GENET, V43, P281, DOI 10.1038/ng0411-281; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002945; Qvist P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002310; Rindflesch TC, 2003, J BIOMED INFORM, V36, P462, DOI 10.1016/j.jbi.2003.11.003; Schuemie M, 2007, PROTEOMICS, V7, P921, DOI 10.1002/pmic.200600693; Schuemie MJ, 2007, J BIOMED INFORM, V40, P316, DOI 10.1016/j.jbi.2006.09.002; Schuemie MJ, P 2 BIOCREACTIVE CHA, P131; Shaheen R, 2014, GENOME RES, V24, P291, DOI 10.1101/gr.160572.113; Swanson D. R., 1991, SIGIR Forum, P280; TINT GS, 1994, NEW ENGL J MED, V330, P107, DOI 10.1056/NEJM199401133300205; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; van Haagen HHHBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078665; van Haagen HHHBM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007894; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Williams AJ, 2012, DRUG DISCOV TODAY, V17, P1188, DOI 10.1016/j.drudis.2012.05.016; Yepes AJ, 2015, J BIOMED INFORM, V53, P300, DOI 10.1016/j.jbi.2014.11.015; Yu TW, 2010, NAT GENET, V42, P1015, DOI 10.1038/ng.683	58	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149621	10.1371/journal.pone.0149621	http://dx.doi.org/10.1371/journal.pone.0149621			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919047	Green Published, gold			2022-12-27	WOS:000371274400029
J	Mastitskaya, S; Basalay, M; Hosford, PS; Ramage, AG; Gourine, A; Gourine, AV				Mastitskaya, Svetlana; Basalay, Marina; Hosford, Patrick S.; Ramage, Andrew G.; Gourine, Andrey; Gourine, Alexander V.			Identifying the Source of a Humoral Factor of Remote (Pre)Conditioning Cardioprotection	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; BYPASS-SURGERY; NERVOUS-SYSTEM; LIMB ISCHEMIA; MECHANISMS; PROTECTION; INFARCTION; HEART; PATHWAYS	Signalling pathways underlying the phenomenon of remote ischaemic preconditioning (RPc) cardioprotection are not completely understood. The existing evidence agrees that intact sensory innervation of the remote tissue/organ is required for the release into the systemic circulation of preconditioning factor(s) capable of protecting a transplanted or isolated heart. However, the source and molecular identities of these factors remain unknown. Since the efficacy of RPc cardioprotection is critically dependent upon vagal activity and muscarinic mechanisms, we hypothesized that the humoral RPc factor is produced by the internal organ(s), which receive rich parasympathetic innervation. In a rat model of myocardial ischaemia/reperfusion injury we determined the efficacy of limb RPc in establishing cardioprotection after denervation of various visceral organs by sectioning celiac, hepatic, anterior and posterior gastric branches of the vagus nerve. Electrical stimulation was applied to individually sectioned branches to determine whether enhanced vagal input to a particular target area is sufficient to establish cardioprotection. It was found that RPc cardioprotection is abolished in conditions of either total subdiaphragmatic vagotomy, gastric vagotomy or sectioning of the posterior gastric branch. The efficacy of RPc cardioprotection was preserved when hepatic, celiac or anterior gastric vagal branches were cut. In the absence of remote ischaemia/reperfusion, electrical stimulation of the posterior gastric branch reduced infarct size, mimicking the effect of RPc. These data suggest that the circulating factor (or factors) of RPc are produced and released into the systemic circulation by the visceral organ(s) innervated by the posterior gastric branch of the vagus nerve.	[Mastitskaya, Svetlana; Basalay, Marina; Hosford, Patrick S.; Ramage, Andrew G.; Gourine, Alexander V.] UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England; [Gourine, Andrey] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	University of London; University College London; Karolinska Institutet; Karolinska University Hospital	Gourine, AV (corresponding author), UCL, Ctr Cardiovasc & Metab Neurosci, Neurosci Physiol & Pharmacol, London, England.; Gourine, A (corresponding author), Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden.	agourine@hotmail.com; a.gourine@ucl.ac.uk	Basalay, Maryna/AAQ-8824-2020; Hosford, Patrick/GWQ-4408-2022; Ramage, Andrew G/A-4458-2009; Mastitskaya, Svetlana/ABF-4358-2021	Basalay, Maryna/0000-0001-5608-3878; Mastitskaya, Svetlana/0000-0002-4819-2908; Hosford, Patrick/0000-0002-3252-4832	British Heart Foundation [RG/14/4/30736, PG/13/79/30429]; Wellcome Trust [095064]; Marie Sklodowska-Curie Individual Fellowship [654691]	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Marie Sklodowska-Curie Individual Fellowship	Experimental work described in this paper was funded by the British Heart Foundation (project grants RG/14/4/30736 and PG/13/79/30429, https://www.bhf.org.uk/) and The Wellcome Trust (http://www.wellcome.ac.uk/). SM is supported by Marie Sklodowska-Curie Individual Fellowship (ref. 654691, http://ec.europa.eu/). AVG is a Wellcome Trust Senior Research Fellow (ref. 095064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basalay M, 2012, EXP PHYSIOL, V97, P908, DOI 10.1113/expphysiol.2012.064923; BERTHOUD HR, 1991, AM J PHYSIOL, V260, pR200, DOI 10.1152/ajpregu.1991.260.1.R200; Botker HE, 2010, LANCET, V375, P727, DOI 10.1016/S0140-6736(09)62001-8; Candilio L, 2015, HEART, V101, P185, DOI 10.1136/heartjnl-2014-306178; Coote JH, 2013, J PHYSIOL-LONDON, V591, P4073, DOI 10.1113/jphysiol.2013.257758; Davidson SM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0377-6; Donato M, 2013, EXP PHYSIOL, V98, P425, DOI 10.1113/expphysiol.2012.066217; Dong Jing-Hui, 2004, Shengli Xuebao, V56, P41; Gho BCG, 1996, CIRCULATION, V94, P2193, DOI 10.1161/01.CIR.94.9.2193; Gourine A, 2010, EUR HEART J, V31, P319; Gourine A, 2014, PHYSIOLOGY, V29, P133, DOI 10.1152/physiol.00037.2013; Hausenloy DJ, 2015, NEW ENGL J MED, V373, P1408, DOI 10.1056/NEJMoa1413534; Hausenloy DJ, 2008, CARDIOVASC RES, V79, P377, DOI 10.1093/cvr/cvn114; Hepponstall M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048284; Heusch G, 2015, CIRC RES, V116, P674, DOI 10.1161/CIRCRESAHA.116.305348; Jensen RV, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0285-1; Jones WK, 2009, CIRCULATION, V120, pS1, DOI 10.1161/CIRCULATIONAHA.108.843938; Kingma JG, 2011, CARDIOVASC RES, V89, P384, DOI 10.1093/cvr/cvq306; Konstantinov IE, 2005, TRANSPLANTATION, V79, P1691, DOI 10.1097/01.TP.0000159137.76400.5D; Lang SC, 2006, BASIC RES CARDIOL, V101, P149, DOI 10.1007/s00395-005-0565-0; Li J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0423-z; Liem DA, 2002, AM J PHYSIOL-HEART C, V283, pH29, DOI 10.1152/ajpheart.01031.2001; Lim SY, 2010, BASIC RES CARDIOL, V105, P651, DOI 10.1007/s00395-010-0099-y; Loukogeorgakis SP, 2005, J AM COLL CARDIOL, V46, P450, DOI 10.1016/j.jacc.2005.04.044; Mastitskaya S, 2013, EUR HEART J, V34, P929; Mastitskaya S, 2012, CARDIOVASC RES, V95, P487, DOI 10.1093/cvr/cvs212; McDougall SJ, 2008, NEUROPHARMACOLOGY, V54, P552, DOI 10.1016/j.neuropharm.2007.11.001; Merlocco AC, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0406-0; Meybohm P, 2015, NEW ENGL J MED, V373, P1397, DOI 10.1056/NEJMoa1413579; Pauza DH, 2013, AUTON NEUROSCI-BASIC, V176, P32, DOI 10.1016/j.autneu.2013.01.006; Pickard JMJ, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-014-0453-6; Prasad A, 2013, CATHETER CARDIO INTE, V81, P930, DOI 10.1002/ccd.24443; PRECHTL JC, 1985, J COMP NEUROL, V235, P182, DOI 10.1002/cne.902350204; PRZYKLENK K, 1993, CIRCULATION, V87, P893, DOI 10.1161/01.CIR.87.3.893; Rahman IA, 2010, CIRCULATION, V122, pS53, DOI 10.1161/CIRCULATIONAHA.109.926667; Rassaf T, 2014, CIRC RES, V114, P1601, DOI 10.1161/CIRCRESAHA.114.303822; Redington KL, 2013, J PHYSIOL SCI, V63, P219, DOI 10.1007/s12576-013-0259-6; Redington KL, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0241-5; Rysevaite K, 2011, HEART RHYTHM, V8, P731, DOI 10.1016/j.hrthm.2011.01.013; Shahid M, 2008, EXP PHYSIOL, V93, P954, DOI 10.1113/expphysiol.2007.041442; Shimizu M, 2009, CLIN SCI, V117, P191, DOI 10.1042/CS20080523; Siddiqi N, 2014, EUR HEART J, V35, P1255, DOI 10.1093/eurheartj/ehu096; Steensrud T, 2010, AM J PHYSIOL-HEART C, V299, pH1598, DOI 10.1152/ajpheart.00396.2010; Thielmann M, 2013, LANCET, V382, P597, DOI 10.1016/S0140-6736(13)61450-6; Wang X, 2004, ANESTHESIOLOGY, V100, P1198, DOI 10.1097/00000542-200405000-00023; Weinbrenner C, 2002, CARDIOVASC RES, V55, P590, DOI 10.1016/S0008-6363(02)00446-7; Yasuhara O, 2007, J HISTOCHEM CYTOCHEM, V55, P287, DOI 10.1369/jhc.6A7092.2006	47	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150108	10.1371/journal.pone.0150108	http://dx.doi.org/10.1371/journal.pone.0150108			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918777	gold, Green Submitted, Green Published			2022-12-27	WOS:000371274400088
J	Tanaka, H; Mori, Y; Noro, A; Kogure, A; Kamimura, M; Yamada, N; Hanada, S; Masahashi, N; Itoi, E				Tanaka, Hidetatsu; Mori, Yu; Noro, Atsushi; Kogure, Atsushi; Kamimura, Masayuki; Yamada, Norikazu; Hanada, Shuji; Masahashi, Naoya; Itoi, Eiji			Apatite Formation and Biocompatibility of a Low Young's Modulus Ti-Nb-Sn Alloy Treated with Anodic Oxidation and Hot Water	PLOS ONE			English	Article							BETA TINBSN ALLOYS; MO-ZR-FE; MECHANICAL-PROPERTIES; TITANIUM-ALLOYS; HEAT-TREATMENT; FORMING ABILITY; THIN-FILMS; METAL; SURFACE; BEHAVIOR	Ti-6Al-4V alloy is widely prevalent as a material for orthopaedic implants because of its good corrosion resistance and biocompatibility. However, the discrepancy in Young's modulus between metal prosthesis and human cortical bone sometimes induces clinical problems, thigh pain and bone atrophy due to stress shielding. We designed a Ti-Nb-Sn alloy with a low Young's modulus to address problems of stress disproportion. In this study, we assessed effects of anodic oxidation with or without hot water treatment on the bone-bonding characteristics of a Ti-Nb-Sn alloy. We examined surface analyses and apatite formation by SEM micrographs, XPS and XRD analyses. We also evaluated biocompatibility in experimental animal models by measuring failure loads with a pull-out test and by quantitative histomorphometric analyses. By SEM, abundant apatite formation was observed on the surface of Ti-Nb-Sn alloy discs treated with anodic oxidation and hot water after incubation in Hank's solution. A strong peak of apatite formation was detected on the surface using XRD analyses. XPS analysis revealed an increase of the H2O fraction in O 1s XPS. Results of the pull-out test showed that the failure loads of Ti-Nb-Sn alloy rods treated with anodic oxidation and hot water was greater than those of untreated rods. Quantitative histomorphometric analyses indicated that anodic oxidation and hot water treatment induced higher new bone formation around the rods. Our findings indicate that Ti-Nb-Sn alloy treated with anodic oxidation and hot water showed greater capacity for apatite formation, stronger bone bonding and higher biocompatibility for osteosynthesis. Ti-Nb-Sn alloy treated with anodic oxidation and hot water treatment is a promising material for orthopaedic implants enabling higher osteosynthesis and lower stress disproportion.	[Tanaka, Hidetatsu; Mori, Yu; Noro, Atsushi; Kogure, Atsushi; Kamimura, Masayuki; Yamada, Norikazu; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan; [Hanada, Shuji; Masahashi, Naoya] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Mori, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Sendai, Miyagi 980, Japan.	yu-mori@med.tohoku.ac.jp	Hanada, Shuji/AAU-1523-2021; Tanaka, Hidetatsu/ABB-9533-2021; Masahashi, Naoya/A-8131-2011; Mori, Yu/AAX-5874-2021	Hanada, Shuji/0000-0001-6005-0163; Masahashi, Naoya/0000-0001-6373-5926; Tanaka, Hidetatsu/0000-0001-8679-9121; Mori, Yu/0000-0002-8225-4690	Japan Society for the Promotion of Science [15K10428, 15H04138]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (No. 15K10428 to Yu Mori; No. 15H04138 to Naoya Masahashi). URL of Japan Society for the Promotion of Science is as follows: https://www.jsps.go.jp/english./index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1995, BIOCOMPATIBLE TITANI, P1760; Banerjee R, 2004, BIOMATERIALS, V25, P3413, DOI 10.1016/j.biomaterials.2003.10.041; Cai KY, 2006, COLLOID SURFACE B, V50, P1, DOI 10.1016/j.colsurfb.2006.03.016; CHOI WY, 1994, J PHYS CHEM-US, V98, P13669, DOI 10.1021/j100102a038; Cui X, 2009, DENT MATER, V25, P80, DOI 10.1016/j.dental.2008.04.012; Cui XY, 2008, J MATER SCI-MATER M, V19, P1767, DOI 10.1007/s10856-007-3314-0; DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; FROST HM, 1958, STAIN TECHNOL, V33, P273, DOI 10.3109/10520295809111862; Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077; Glassman AH, 2006, CLIN ORTHOP RELAT R, P64, DOI 10.1097/01.blo.0000246541.41951.20; Hanada S, 2003, MATER SCI FORUM, P426; Hao YL, 2006, MAT SCI ENG A-STRUCT, V441, P112, DOI 10.1016/j.msea.2006.09.051; HEAD WC, 1995, CLIN ORTHOP RELAT R, P85; Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083; Jinno T, 1998, J BIOMED MATER RES, V42, P20, DOI 10.1002/(SICI)1097-4636(199810)42:1<20::AID-JBM4>3.0.CO;2-Q; Jung TK, 2010, MATER SCI FORUM, V631-632, P205, DOI 10.4028/www.scientific.net/MSF.631-632.205; Jung TK, 2013, MAT SCI ENG C-MATER, V33, P1629, DOI 10.1016/j.msec.2012.12.072; Jung TK, 2009, MATER SCI FORUM, V620-622, P591, DOI 10.4028/www.scientific.net/MSF.620-622.591; Karthega M, 2007, ACTA BIOMATER, V3, P1019, DOI 10.1016/j.actbio.2007.02.009; Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443; King R.C., 1992, PERKIN ELMER CORPORA, V40, P221; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3; LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103; Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4; Matsumoto H, 2005, MATER TRANS, V46, P1070, DOI 10.2320/matertrans.46.1070; Matsumoto H, 2007, J ALLOY COMPD, V439, P146, DOI 10.1016/j.jallcom.2006.08.267; McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H; Miura K, 2011, ACTA BIOMATER, V7, P2320, DOI 10.1016/j.actbio.2011.02.008; Nag S, 2005, J MATER SCI-MATER M, V16, P679, DOI 10.1007/s10856-005-2540-6; Nishiguchi S, 2003, J BIOMED MATER RES A, V67A, P26, DOI 10.1002/jbm.a.10540; Nishiguchi S, 2001, BIOMATERIALS, V22, P2525, DOI 10.1016/S0142-9612(00)00443-9; Nishiguchi S, 1999, BIOMATERIALS, V20, P491, DOI 10.1016/S0142-9612(98)90203-4; Nourbash PS, 1998, CLIN ORTHOP RELAT R, P189; Nozoe F, 2007, MATER TRANS, V48, P3007, DOI 10.2320/matertrans.MER2007182; Ozaki T, 2004, MATER TRANS, V45, P2776, DOI 10.2320/matertrans.45.2776; Seo DS, 2001, J CRYST GROWTH, V233, P298, DOI 10.1016/S0022-0248(01)01494-4; Shimizu K, 1999, THIN SOLID FILMS, V351, P220, DOI 10.1016/S0040-6090(99)00084-X; Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978; Uchida M, 2002, J BIOMED MATER RES, V63, P522, DOI 10.1002/jbm.10304; Wu JM, 2004, J AM CERAM SOC, V87, P1635, DOI 10.1111/j.1551-2916.2004.01635.x; Xie L, 2011, J BIOMED MATER RES A, V98A, P312, DOI 10.1002/jbm.a.33120; Yang BC, 2004, BIOMATERIALS, V25, P1003, DOI 10.1016/S0142-9612(03)00626-4; Yoneyama Y, 2013, DENT MATER J, V32, P115, DOI 10.4012/dmj.2012-087	45	15	15	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150081	10.1371/journal.pone.0150081	http://dx.doi.org/10.1371/journal.pone.0150081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914329	Green Published, gold			2022-12-27	WOS:000371175700051
J	van Hoek, AJ; Miller, E				van Hoek, Albert Jan; Miller, Elizabeth			Cost-Effectiveness of Vaccinating Immunocompetent >= 65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England	PLOS ONE			English	Article							PNEUMONIA; DISEASE; ADULTS	Background Recently a large clinical trial showed that the use of 13-valent pneumococcal conjugate vaccine (PCV13) among immunocompetent individuals aged 65 years and over was safe and efficacious. The aim of this study was to assess the cost-effectiveness of vaccinating immunocompetent 65 year olds with PCV13 vaccine in England. England is a country with universal childhood pneumococcal conjugate vaccination programme in place (7-valent (PCV7) since 2006 and PCV13 since 2010), as well as a 23-valent pneumococcal polysaccharide (PPV23) vaccination programme targeting clinical risk-groups and those >= 65 years. Method A static cohort cost-effectiveness model was developed to follow a cohort of 65 year olds until death, which will be vaccinated in the autumn of 2016 with PCV13. Sensitivity analysis was performed to test the robustness of the results. Results The childhood vaccination programme with PCV7 has induced herd protection among older unvaccinated age groups, with a resultant low residual disease burden caused by PCV7 vaccine types. We show similar herd protection effects for the 6 additional serotypes included in PCV13, and project a new low post-introduction equilibrium of vaccine-type disease in 2018/19. Applying these incidence projections for both invasive disease and community-acquired pneumonia (CAP), and using recent measures of vaccine efficacy against these endpoints for >= 65 year olds, we estimate that vaccination of a cohort of immunocompetent 65 year olds with PCV13 would directly prevent 26 cases of IPD, 69 cases of CAP and 15 deaths. The associated cost-effectiveness ratio is 257,771 pound per QALY gained (using list price of 49.10 pound per dose and 7.51 pound administration costs) and is therefore considered not cost-effective. To obtain a cost-effective programme the price per dose would need to be negative. The results were sensitive to disease incidence, waning vaccine protection and case fatality rate; despite this, the overall conclusion was robust. Conclusions Vaccinating immunocompetent individuals aged >= 65 years with PCV13 is efficacious. However the absolute incidence of vaccine-type disease will likely become very low due to wider benefits of the childhood PCV13 vaccination programme, such that a specific PCV13 vaccination programme targeting the immunocompetent elderly would not be cost-effective.	[van Hoek, Albert Jan] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England; [van Hoek, Albert Jan; Miller, Elizabeth] Publ Hlth England, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 5EQ, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	van Hoek, AJ (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Keppel St, London WC1E 7HT, England.	albert.vanhoek@lshtm.ac.uk			National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England	National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine; Public Health England	AJVH was part funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Immunisation at the London School of Hygiene and Tropical Medicine in partnership with Public Health England. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, the Department of Health or Public Health England. The NIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; BMJ Publishing Group, 2015, BRIT NATL FORMULARY; Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544; Dirmesropian S, 2015, HUM VACC IMMUNOTHER, V11, P818, DOI 10.1080/21645515.2015.1011954; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; Gutierrez Rodriguez M A, 2014, Euro Surveill, V19, P20922, DOI 10.2807/1560-7917.ES2014.19.40.20922; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Leventer-Roberts M, 2015, CLIN INFECT DIS, V60, P1472, DOI 10.1093/cid/civ096; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; National Institute for Health and Clinical Excellence, 2013, GUID METH TECHN APPR; Office for National Statistics, 2014, MID 2013 POP EST ENG; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Petrou S, 2005, HEALTH ECON, V14, P1169, DOI 10.1002/hec.1006; Public Health England, 2014, PNEUM POL VACC PPV C; Rodrigo C, 2015, EUR RESPIR J, V45, P1632, DOI 10.1183/09031936.00183614; Roysted W, 2016, CLIN RESPIR J, V10, P756, DOI 10.1111/crj.12283; Rozenbaum Mark H, 2012, BMJ, V345, pe6879, DOI 10.1136/bmj.e6879; Tomczyk S, 2014, MMWR-MORBID MORTAL W, V63; Torres A, 2015, EUR RESPIR J, V45, P1353, DOI 10.1183/09031936.00152514; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van Hoek AJ, 2014, VACCINE, V32, P4349, DOI 10.1016/j.vaccine.2014.03.017; van Hoek AJ, 2012, J INFECTION, V65, P17, DOI 10.1016/j.jinf.2012.02.017; Waight PA, 2015, LANCET INFECT DIS, V15, P535, DOI 10.1016/S1473-3099(15)70044-7	23	43	46	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149540	10.1371/journal.pone.0149540	http://dx.doi.org/10.1371/journal.pone.0149540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914907	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000371175700017
J	Lohse, T; Rohrmann, S; Bopp, M; Faeh, D				Lohse, Tina; Rohrmann, Sabine; Bopp, Matthias; Faeh, David			Heavy Smoking Is More Strongly Associated with General Unhealthy Lifestyle than Obesity and Underweight	PLOS ONE			English	Article							SWISS HEALTH SURVEY; RISK-FACTORS; PROSPECTIVE COHORT; TOBACCO USE; FOLLOW-UP; MORTALITY; POPULATION; BEHAVIORS; WEIGHT; ADULTS	Background Smoking and obesity are major causes of non-communicable diseases. We investigated the associations of heavy smoking, obesity, and underweight with general lifestyle to infer which of these risk groups has the most unfavourable lifestyle. Methods We used data from the population-based cross-sectional Swiss Health Survey (5 rounds 1992-2012), comprising 85,575 individuals aged >= 18 years. Height, weight, smoking, diet, alcohol intake and physical activity were self-reported. Multinomial logistic regression was performed to analyse differences in lifestyle between the combinations of body mass index (BMI) category and smoking status. Results Compared to normal-weight never smokers (reference), individuals who were normal-weight, obese, or underweight and smoked heavily at the same time had a poorer general lifestyle. The lifestyle of obese and underweight never smokers differed less from reference. Regardless of BMI category, in heavy smoking men and women the fruit and vegetable consumption was lower (e.g. obese heavy smoking men: relative risk ratio (RRR) 1.69 [95% confidence interval 1.30;2.21]) and high alcohol intake was more common (e.g. normal-weight heavy smoking women 5.51 [3.71;8.20]). In both sexes, physical inactivity was observed more often in heavy smokers and obese or underweight (e.g. underweight never smoking 1.29 [1.08;1.54] and heavy smoking women 2.02 [1.33;3.08]). A decrease of smoking prevalence was observed over time in normal-weight, but not in obese individuals. Conclusions Unhealthy general lifestyle was associated with both heavy smoking and BMI extremes, but we observed a stronger association for heavy smoking. Future smoking prevention measures should pay attention to improvement of general lifestyle and co-occurrence with obesity and underweight.	[Lohse, Tina; Rohrmann, Sabine; Bopp, Matthias; Faeh, David] Univ Zurich, EBPI, Div Chron Dis Epidemiol, Zurich, Switzerland	University of Zurich	Lohse, T (corresponding author), Univ Zurich, EBPI, Div Chron Dis Epidemiol, Zurich, Switzerland.	tina.lohse@uzh.ch	Rohrmann, Sabine/D-2113-2012	Rohrmann, Sabine/0000-0002-2215-1200; Bopp, Matthias/0000-0003-0766-3723	Swiss Cancer Research foundation (SCR) [KFS-3048-08-2012]; Swiss Federal Statistical Office	Swiss Cancer Research foundation (SCR); Swiss Federal Statistical Office	This work was supported by the Swiss Cancer Research foundation (SCR), grant no. KFS-3048-08-2012, http://www.krebsliga.ch, and the Swiss Federal Statistical Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Swiss Cancer Research foundation (SCR) for supporting our study (grant no. KFS-3048-08-2012) and the Swiss Federal Statistical Office for providing data.	Bopp M, 2014, AM J EPIDEMIOL, V180, P1028, DOI 10.1093/aje/kwu226; Bottorff JL, 2012, NURS CLIN N AM, V47, P55, DOI 10.1016/j.cnur.2011.10.010; Buck D, 2012, CLUSTERING OF UNHEAL; Bundesamt fuar Statistik, 2013, SCHWEIZ GES 2012 KUR; Bundesamt fur Statistik, 2012, STAT BEV HAUSH STATP; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Chiolero A, 2006, PREV MED, V42, P348, DOI 10.1016/j.ypmed.2006.01.011; Choi OJE, 2013, KOREAN J FAM MED, V34, P393, DOI 10.4082/kjfm.2013.34.6.393; Dallongeville J, 1998, J NUTR, V128, P1450; Danaei G, 2005, LANCET, V366, P1784, DOI 10.1016/S0140-6736(05)67725-2; De Leon J, 2007, ALCOHOL ALCOHOLISM, V42, P252, DOI 10.1093/alcalc/agm029; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Eichholzer M, 2000, EUR J CLIN NUTR, V54, P136, DOI 10.1038/sj.ejcn.1600907; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Faeh D, 2011, OBES REV, V12, P151, DOI 10.1111/j.1467-789X.2010.00793.x; Faeh D, 2011, EUR J EPIDEMIOL, V26, P647, DOI 10.1007/s10654-011-9593-2; Faeh D, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13090; Fan JY, 2013, INT J CARDIOL, V168, P4761, DOI 10.1016/j.ijcard.2013.07.230; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2011, AM J EPIDEMIOL, V173, P1, DOI 10.1093/aje/kwq341; Gallus S, 2014, EUR J CANCER PREV, V23, P177, DOI 10.1097/CEJ.0000000000000009; Higgins ST, 2015, PREV MED, V80, P89, DOI 10.1016/j.ypmed.2015.06.009; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Li KR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-59; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Loprinzi PD, 2014, AM J PREV MED, P1, DOI [10.1016/j.amepre,2014.08.019, DOI 10.1016/J.AMEPRE,2014.08.019]; Ma JM, 2013, PREV MED, V56, P178, DOI 10.1016/j.ypmed.2012.12.012; Maag J, 2013, NICOTINE TOB RES, V15, P1588, DOI 10.1093/ntr/ntt023; Malvezzi M., 2015, ANN ONCOL, V2015, P1, DOI DOI 10.1093/ANN0NC/MDV001; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; Martin-Diener E, 2014, PREV MED, V65, P148, DOI 10.1016/j.ypmed.2014.05.023; National Institutes of Health, 1998, OBES RES; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; REHM J, 1993, EUR J CLIN NUTR, V47, pS25; Renehan AG, 2007, LANCET, P569; Roh L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-371; Schneider H., 2014, COST OBESITY SWITZER; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Siddarth D, 2013, J INVEST MED, V61, P1039, DOI 10.2310/JIM.0b013e31829c39d0; Stommel M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-421; Tobias M, 2007, AUST NZ J PUBL HEAL, V31, P155, DOI 10.1111/j.1753-6405.2007.00034.x; UNESCO Institute for Statistics, 2012, COMP SOCIAL RES; Wanner M, 2014, PREV MED, V62, P89, DOI 10.1016/j.ypmed.2014.01.025; Wardle J, 2001, J EPIDEMIOL COMMUN H, V55, P185, DOI 10.1136/jech.55.3.185; WHO, FRUIT VEG PROM IN RE; Wieser S, 2010, SYNTHESEBERICHT OKON; Willett WC, 1999, NEW ENGL J MED, V341, P427, DOI 10.1056/NEJM199908053410607	49	45	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148563	10.1371/journal.pone.0148563	http://dx.doi.org/10.1371/journal.pone.0148563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910775	gold, Green Published			2022-12-27	WOS:000371164700009
J	Koch, C; Neumann, P; Valerius, O; Feussner, I; Ficner, R				Koch, Christian; Neumann, Piotr; Valerius, Oliver; Feussner, Ivo; Ficner, Ralf			Crystal Structure of Alcohol Oxidase from Pichia pastoris	PLOS ONE			English	Article							FLAVIN ADENINE-DINUCLEOTIDE; HANSENULA-POLYMORPHA; CATALYTIC MECHANISM; ELECTRON-MICROSCOPY; METHANOL OXIDASE; YEAST; REPRESSION; CRYSTALLOGRAPHY; CRYSTALLIZATION; IDENTIFICATION	FAD-dependent alcohol oxidases (AOX) are key enzymes of methylotrophic organisms that can utilize lower primary alcohols as sole source of carbon and energy. Here we report the crystal structure analysis of the methanol oxidase AOX1 from Pichia pastoris. The crystallographic phase problem was solved by means of Molecular Replacement in combination with initial structure rebuilding using Rosetta model completion and relaxation against an averaged electron density map. The subunit arrangement of the homo-octameric AOX1 differs from that of octameric vanillyl alcohol oxidase and other dimeric or tetrameric alcohol oxidases, due to the insertion of two large protruding loop regions and an additional C-terminal extension in AOX1. In comparison to other alcohol oxidases, the active site cavity of AOX1 is significantly reduced in size, which could explain the observed preference for methanol as substrate. All AOX1 subunits of the structure reported here harbor a modified flavin adenine dinucleotide, which contains an arabityl chain instead of a ribityl chain attached to the isoalloxazine ring.	[Koch, Christian; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Neumann, Piotr; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Valerius, Oliver] Univ Gottingen, Dept Mol Microbiol & Genet, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany; [Koch, Christian; Neumann, Piotr; Valerius, Oliver; Feussner, Ivo; Ficner, Ralf] Univ Gottingen, Goettingen Ctr Mol Biosciences GZMB, Justus von Liebig Weg 11, D-37077 Gottingen, Germany	University of Gottingen; University of Gottingen; University of Gottingen; University of Gottingen	Neumann, P (corresponding author), Univ Gottingen, Dept Mol Struct Biol, Inst Microbiol & Genet, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.; Neumann, P (corresponding author), Univ Gottingen, Goettingen Ctr Mol Biosciences GZMB, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	pneuman2@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	Open Access Publication Funds of the Goettingen University; DFG [IRTG 1422]; Biomolecules PhD program of the DFG; Kathrin Schroder-Tittmann	Open Access Publication Funds of the Goettingen University; DFG(German Research Foundation (DFG)); Biomolecules PhD program of the DFG; Kathrin Schroder-Tittmann	Synchrotron data collection was supported by the Helmholtz-Zentrum Berlin. The authors acknowledge support by the Open Access Publication Funds of the Goettingen University. The authors are grateful for financial support from the DFG (IRTG 1422) to C.K. and I.F., and C.K. was additionally supported by the Biomolecules PhD program of the DFG-funded Goettingen Graduate School of Neurosciences and Molecular Biology (GGNB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Pichia pastoris fermentation was greatly supported by Kathrin Schroder-Tittmann. We thank the Helmholtz Zentrum Berlin (HZB, Germany) for the allocation of synchrotron radiation beamtime.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashin VV, 1998, BIOCHEMISTRY-MOSCOW+, V63, P1407; BOYS CWG, 1989, J MOL BIOL, V208, P211, DOI 10.1016/0022-2836(89)90099-5; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; BYSTRYKH LV, 1991, J GEN MICROBIOL, V137, P2381, DOI 10.1099/00221287-137-10-2381; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; DIXON DA, 1979, BIOCHEMISTRY-US, V18, P5770, DOI 10.1021/bi00593a004; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan F, 2005, J AM CHEM SOC, V127, P2067, DOI 10.1021/ja044541q; Finnegan S, 2010, ARCH BIOCHEM BIOPHYS, V501, P207, DOI 10.1016/j.abb.2010.06.014; Finnegan S, 2010, BIOCHEMISTRY-US, V49, P2952, DOI 10.1021/bi902048c; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; GEISSLER J, 1986, EUR J BIOCHEM, V160, P93, DOI 10.1111/j.1432-1033.1986.tb09944.x; Ghanem M, 2006, BIOCHEMISTRY-US, V45, P3437, DOI 10.1021/bi052514m; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIUSEPPIN MLF, 1988, BIOTECHNOL BIOENG, V32, P577, DOI 10.1002/bit.260320502; Gvozdev AR, 2010, BIOCHEMISTRY-MOSCOW+, V75, P242, DOI 10.1134/S000629791002015X; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KATO N, 1976, EUR J BIOCHEM, V64, P341, DOI 10.1111/j.1432-1033.1976.tb10307.x; KELLOGG RM, 1992, TETRAHEDRON, V48, P4147, DOI 10.1016/S0040-4020(01)92193-3; Kiess M, 1998, EUR J BIOCHEM, V252, P90, DOI 10.1046/j.1432-1327.1998.2520090.x; KOUTZ P, 1989, YEAST, V5, P167, DOI 10.1002/yea.320050306; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mattevi A, 1997, STRUCTURE, V5, P907, DOI 10.1016/S0969-2126(97)00245-1; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McCoy AJ, 2007, J APPL CRYSTALLOGR 4, V40, P658, DOI 10.1107/S0021889807021206; MENON V, 1995, BIOORG CHEM, V23, P42, DOI 10.1006/bioo.1995.1004; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Ozimek P, 2005, FEMS YEAST RES, V5, P975, DOI 10.1016/j.femsyr.2005.06.005; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; ROGGENKAMP R, 1984, MOL GEN GENET, V194, P489, DOI 10.1007/BF00425563; Salvi F, 2014, ACTA CRYSTALLOGR D, V70, P405, DOI 10.1107/S1399004713029283; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shleev SV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P245, DOI 10.1134/S0006297906030035; SIBIRNY AA, 1987, YEAST, V3, P233, DOI 10.1002/yea.320030404; Smitherman C, 2015, BIOCHEMISTRY-US, V54, P413, DOI 10.1021/bi500982y; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stasyk OV, 2004, J BIOL CHEM, V279, P8116, DOI 10.1074/jbc.M310960200; TYKARSKA E, 1990, J PROTEIN CHEM, V9, P83, DOI 10.1007/BF01024988; VANDERKLEI IJ, 1989, FEBS LETT, V244, P213, DOI 10.1016/0014-5793(89)81195-0; VONCK J, 1992, J STRUCT BIOL, V109, P78, DOI 10.1016/1047-8477(92)90070-Q; Waterham HR, 1997, J CELL BIOL, V139, P1419, DOI 10.1083/jcb.139.6.1419; Yurimoto Hiroya, 2011, Int J Microbiol, V2011, P101298, DOI 10.1155/2011/101298; Zhang H, 2009, MOL MICROBIOL, V71, P702, DOI 10.1111/j.1365-2958.2008.06557.x	53	25	26	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149846	10.1371/journal.pone.0149846	http://dx.doi.org/10.1371/journal.pone.0149846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905908	Green Published, Green Submitted, gold			2022-12-27	WOS:000371163000023
J	Eikrem, O; Beisland, C; Hjeiie, K; Flatberg, A; Scherer, A; Landolt, L; Skogstrand, T; Leh, S; Beisvag, V; Marti, HP				Eikrem, Oystein; Beisland, Christian; Hjeiie, Karin; Flatberg, Arnar; Scherer, Andreas; Landolt, Lea; Skogstrand, Trude; Leh, Sabine; Beisvag, Vidar; Marti, Hans-Peter			Transcriptome Sequencing (RNAseq) Enables Utilization of Formalin-Fixed, Paraffin-Embedded Biopsies with Clear Cell Renal Cell Carcinoma for Exploration of Disease Biology and Biomarker Development	PLOS ONE			English	Article							CARBONIC-ANHYDRASE IX; TARGETED THERAPY; GENE FUSION; TISSUE; CANCER; EPIGENOMICS; PROGNOSIS; DIAGNOSIS; GENOMICS; CAPTURE	Formalin-fixed, paraffin-embedded (FFPE) tissues are an underused resource for molecular analyses. This proof of concept study aimed to compare RNAseq results from FFPE biopsies with the corresponding RNAlater (R) (Qiagen, Germany) stored samples from clear cell renal cell carcinoma (ccRCC) patients to investigate feasibility of RNAseq in archival tissue. From each of 16 patients undergoing partial or full nephrectomy, four core biopsies, such as two specimens with ccRCC and two specimens of adjacent normal tissue, were obtained with a 16g needle. One normal and one ccRCC tissue specimen per patient was stored either in FFPE or RNAlater (R). RNA sequencing libraries were generated applying the new Illumina TruSeq (R) Access library preparation protocol. Comparative analysis was done using voom/Limma R-package. The analysis of the FFPE and RNAlater (R) datasets yielded similar numbers of detected genes, differentially expressed transcripts and affected pathways. The FFPE and RNAlater datasets shared 80% (n = 1106) differentially expressed genes. The average expression and the log2 fold changes of these transcripts correlated with R-2 = 0.97, and R-2 = 0.96, respectively. Among transcripts with the highest fold changes in both datasets were carbonic anhydrase 9 (CA9), neuronal pentraxin-2 (NPTX2) and uromodulin (UMOD) that were confirmed by immunohistochemistry. IPA revealed the presence of gene signatures of cancer and nephrotoxicity, renal damage and immune response. To simulate the feasibility of clinical biomarker studies with FFPE samples, a classifier model was developed for the FFPE dataset: expression data for CA9 alone had an accuracy, specificity and sensitivity of 94%, respectively, and achieved similar performance in the RNAlater dataset. Transforming growth factor-beta 1 (TGFB1)-regulated genes, epithelial to mesenchymal transition (EMT) and NOTCH signaling cascade may support novel therapeutic strategies. In conclusion, in this proof of concept study, RNAseq data obtained from FFPE kidney biopsies are comparable to data obtained from fresh stored material, thereby expanding the utility of archival tissue specimens.	[Eikrem, Oystein; Landolt, Lea; Skogstrand, Trude; Leh, Sabine; Marti, Hans-Peter] Univ Bergen, Dept Clin Med, Nephrol, Bergen, Norway; [Beisland, Christian; Hjeiie, Karin] Univ Bergen, Dept Clin Med, Urol, Bergen, Norway; [Flatberg, Arnar; Beisvag, Vidar] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Scherer, Andreas] Spheromics, Kontiolahti, Finland; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Marti, Hans-Peter] Haukeland Hosp, Dept Med, Nephrol, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Marti, HP (corresponding author), Univ Bergen, Dept Clin Med, Nephrol, Bergen, Norway.; Marti, HP (corresponding author), Haukeland Hosp, Dept Med, Nephrol, N-5021 Bergen, Norway.	hans-peter.marti@uib.no	Leh, Sabine/E-6053-2011; Scherer, Andreas/ABD-8660-2020; Beisland, Christian/R-6046-2019	Leh, Sabine/0000-0002-0764-2941; Beisland, Christian/0000-0002-3216-4937; Scherer, Andreas/0000-0002-4254-7122; Landolt, Lea/0000-0002-9176-8933; Marti, Hans-Peter/0000-0002-6331-5902	University of Bergen; Faculty of Medicine at NTNU; Central Norway Regional Health Authority	University of Bergen; Faculty of Medicine at NTNU; Central Norway Regional Health Authority	The funder, namely the University of Bergen, provided support in the form of the salary for author Oystein Eikrem (O.E.) as PhD student scholarship but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The library preparation, sequencing and partly the bioinformatics analysis were provided by the Genomics Core Facility (GCF), which is funded by the Faculty of Medicine at NTNU and Central Norway Regional Health Authority. The specific roles of this author is articulated in the 'author contributions' section." Note, O.E. was an essential part in performing experiments and manuscript writing. Andreas Scherer (A.S.) is the sole owner/employee of Spheromics (http://spheromics.com/) and provided help in RNA sequencing data analysis and preparation of respective manuscript parts. Illumina Inc. was not involved in the present study at all; accordingly, no funding was obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bostrom AK, 2013, BIOCHEM BIOPH RES CO, V435, P126, DOI 10.1016/j.bbrc.2013.04.054; Cieply B, 2013, CANCER RES, V73, P6299, DOI 10.1158/0008-5472.CAN-12-4082; Cieslik M, 2015, GENOME RES, V25, P1372, DOI 10.1101/gr.189621.115; Eisengart LJ, 2012, ARCH PATHOL LAB MED, V136, P490, DOI 10.5858/arpa.2010-0308-RA; Erdmann R, 2015, J PATHOL, V236, P403, DOI 10.1002/path.4544; Feng JY, 2013, EUR REV MED PHARMACO, V17, P2994; Funakoshi T, 2014, CANCER TREAT REV, V40, P533, DOI 10.1016/j.ctrv.2013.11.008; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gimenez-Bachs JM, 2012, SCAND J UROL NEPHROL, V46, P358, DOI 10.3109/00365599.2012.685493; Halvardson J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks816; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Huang QB, 2014, ONCOTARGET, V5, P3066, DOI 10.18632/oncotarget.1827; Huang WH, 2015, GENE CHROMOSOME CANC, V54, P500, DOI 10.1002/gcc.22261; Iacovelli R, 2015, CURR DRUG TARGETS, V16, P164, DOI 10.2174/1389450115666141120120145; Idzenga T, 2008, NEUROUROL URODYNAM, V27, P802, DOI 10.1002/nau.20594; Li P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1087; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Maher ER, 2013, SEMIN CANCER BIOL, V23, P10, DOI 10.1016/j.semcancer.2012.06.003; Medeiros F, 2007, ARCH PATHOL LAB MED, V131, P1805; Mutter GL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-88; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Oosterwijk E, 2014, SUBCELL BIOCHEM, V75, P181, DOI 10.1007/978-94-007-7359-2_10; Puls F, 2016, J PATHOL, V238, P502, DOI 10.1002/path.4683; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; Rydzanicz M, 2013, CANCER LETT, V341, P111, DOI 10.1016/j.canlet.2013.08.006; Stewart GD, 2014, EUR UROL, V66, P956, DOI 10.1016/j.eururo.2014.04.007; Stillebroer AB, 2010, EUR UROL, V58, P75, DOI 10.1016/j.eururo.2010.03.015; Takacova M, 2013, ONCOL LETT, V5, P191, DOI 10.3892/ol.2012.1001; Tostain J, 2010, EUR J CANCER, V46, P3141, DOI 10.1016/j.ejca.2010.07.020; Tun HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010696; von Roemeling CA, 2014, CANCER RES, V74, P4796, DOI 10.1158/0008-5472.CAN-14-0210; Walther C, 2015, LAB INVEST, V95, P1071, DOI 10.1038/labinvest.2015.83; Wang W, 2014, ONCOL LETT, V8, P2627, DOI 10.3892/ol.2014.2554; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Webster AF, 2015, TOXICOL SCI, V148, P460, DOI 10.1093/toxsci/kfv195; Wu CX, 2012, J PATHOL, V227, P53, DOI 10.1002/path.3987; Xiao YL, 2013, J PATHOL, V229, P535, DOI 10.1002/path.4145; Zaravinos Apostolos, 2014, Oncoscience, V1, P117; Zhang X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118659; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhao W, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-419; Zwiener I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085150	44	40	40	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149743	10.1371/journal.pone.0149743	http://dx.doi.org/10.1371/journal.pone.0149743			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901863	Green Published, Green Submitted, gold			2022-12-27	WOS:000371276100138
J	Hung, IFN; Wong, DKH; Poon, RTP; Fong, DYT; Chui, AHW; Seto, WK; Fung, JYY; Chan, ACY; Yuen, JCH; Tiu, R; Choi, O; Lai, CL; Yuen, MF				Hung, Ivan Fan-Ngai; Wong, Danny Ka-Ho; Poon, Ronnie Tung-Ping; Fong, Daniel Yee-Tak; Chui, Ada Hang-Wai; Seto, Wai-Kay; Fung, James Yan-Yue; Chan, Albert Chi-Yan; Yuen, John Chi-Hang; Tiu, Randal; Choi, Olivia; Lai, Ching-Lung; Yuen, Man-Fung			Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							HIGH VIRAL LOAD; LIVER RESECTION; RADIOFREQUENCY ABLATION; TUMOR RECURRENCE; VIRUS; SURVIVAL; MUTATIONS; IMPACT; ASSOCIATION; PROGNOSIS	Background Independent risk factors associated with hepatitis B (HBV)-related hepatocellular carcinoma (HCC) after resection remains unknown. An accurate risk score for HCC recurrence is lacking. Methods We prospectively followed up 200 patients who underwent liver resection for HBV-related HCC for at least 2 years. Demographic, biochemical, tumor, virological and anti-viral treatment factors were analyzed to identify independent risk factors associated with recurrence after resection and a risk score for HCC recurrence formulated. Results Two hundred patients (80% male) who underwent liver resection for HBV-related HCC were recruited. The median time of recurrence was 184 weeks (IQR 52-207 weeks) for the entire cohort and 100 patients (50%) developed HCC recurrence. Stepwise Cox regression analysis identified that one-month post resection HBV DNA >20,000 IU/mL (p = 0.019; relative risk (RR) 1.67; 95% confidence interval (C.I.): 1.09-2.57), the presence of lymphovascular permeation (p<0.001; RR 2.69; 95% C.I.: 1.75-4.12), microsatellite lesions (p<0.001; RR 2.86; 95% C.I.: 1.82-4.51), and AFP >100ng/mL before resection (p = 0.021; RR 1.63; 95% C.I.: 1.08-2.47) were independently associated with HCC recurrence. Antiviral treatment before resection (p = 0.024; RR 0.1; 95% C.I.: 0.01-0.74) was independently associated with reduced risk of HCC recurrence. A post-resection independent predictive score (PRIPS) was derived and validated with sensitivity of 75.3% and 60.6% and specificity of 55.7% and 79.2%, to predict the 1- and 3-year risks for the HCC recurrence respectively with the hazard ratio of 2.71 (95% C.I.: 2.12-3.48; p<0.001). The AUC for the 1-and 3-year prediction were 0.675 (95% C.I.: 0.6-0.78) and 0.746 (95% C.I.: 0.69-0.82) respectively. Conclusion Several tumor, virological and biochemical factors were associated with a higher cumulative risk of HCC recurrence after resection. PRIPS was derived for more accurate risk assessment. Regardless of the HBV DNA level, antiviral treatment should be given to patients before resection to reduce the risk of recurrence.	[Hung, Ivan Fan-Ngai; Wong, Danny Ka-Ho; Seto, Wai-Kay; Fung, James Yan-Yue; Yuen, John Chi-Hang; Choi, Olivia; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Wong, Danny Ka-Ho; Yuen, John Chi-Hang; Lai, Ching-Lung; Yuen, Man-Fung] Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Poon, Ronnie Tung-Ping; Chan, Albert Chi-Yan] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Fong, Daniel Yee-Tak] Univ Hong Kong, Queen Mary Hosp, Sch Nursing Studies, Hong Kong, Hong Kong, Peoples R China; [Chui, Ada Hang-Wai] Hosp Author, New Territories West Cluster, Qual & Safety Div, Hong Kong, Hong Kong, Peoples R China; [Tiu, Randal] Univ Hong Kong, Queen Mary Hosp, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.; Yuen, MF (corresponding author), Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China.	mfyuen@hkucc.hku.hk	Wong, Danny/H-6819-2016; Chan, Albert/AAC-1642-2022; Fung, James/AAG-4832-2020; Hung, Ivan FN/ABD-5916-2021; Fong, Daniel YT/C-4269-2009; SETO, Wai-Kay/H-4452-2012; Wong, Danny/S-6230-2019	Chan, Albert/0000-0002-1383-2952; Hung, Ivan FN/0000-0002-1556-2538; Fong, Daniel YT/0000-0001-7365-9146; SETO, Wai-Kay/0000-0002-9012-313X; Fung, James/0000-0002-1286-8902; /0000-0001-9078-5005; Lai, Ching-Lung/0000-0002-5927-2436	Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong [09080862]	Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong	The study was fully supported by the Health and Medical Research Fund, Food and Health Bureau, The Government of Hong Kong Special Administrative Region, Hong Kong (reference number: 09080862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LANG ENV STAT COMP; Beard RE, 2013, SURGERY, V154, P545, DOI 10.1016/j.surg.2013.02.019; Befeler AS, 2002, GASTROENTEROLOGY, V122, P1609, DOI 10.1053/gast.2002.33411; Cha C, 2003, J AM COLL SURGEONS, V197, P753, DOI 10.1016/j.jamcollsurg.2003.07.003; Chan ACY, 2011, ARCH SURG-CHICAGO, V146, P675, DOI 10.1001/archsurg.2011.125; Cheung TK, 2006, ALIMENT PHARM THERAP, V24, P573, DOI 10.1111/j.1365-2036.2006.03029.x; EFRON B, 1983, J AM STAT ASSOC, V78, P316, DOI 10.2307/2288636; ElAssal ON, 1997, SURGERY, V122, P571, DOI 10.1016/S0039-6060(97)90130-6; Grazi GL, 2003, ALIMENT PHARM THER, V17, P119, DOI 10.1046/j.1365-2036.17.s2.9.x; Hasegawa K, 2005, ANN SURG, V242, P252, DOI 10.1097/01.sla.0000171307.37401.db; Hastie T, 2003, NEURAL COMPUT, V15, P1477, DOI 10.1162/089976603321891765; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hung IFN, 2008, AM J GASTROENTEROL, V103, P1663, DOI 10.1111/j.1572-0241.2008.01872.x; Jang JW, 2007, CANCER, V110, P1760, DOI 10.1002/cncr.22984; Jeng KS, 2004, AM J GASTROENTEROL, V99, P1503, DOI 10.1111/j.1572-0241.2004.30227.x; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Kubo S, 2000, CANCER-AM CANCER SOC, V88, P1016, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1016::AID-CNCR10>3.0.CO;2-V; Kubo S, 2007, HEPATOL RES, V37, P94, DOI 10.1111/j.1872-034X.2007.00013.x; Kumar AMS, 2015, HEPATOB PANCREAT DIS, V14, P269, DOI 10.1016/S1499-3872(15)60382-4; LAI ECS, 1995, ANN SURG, V221, P291, DOI 10.1097/00000658-199503000-00012; Lee SY, 2014, HPB, V16, P943, DOI 10.1111/hpb.12311; Leung C. M., 2010, Hong Kong Medical Journal, V16, P463; Li N, 2010, ANN SURG ONCOL, V17, P179, DOI 10.1245/s10434-009-0694-z; Lin CL, 2007, J GASTROEN HEPATOL, V22, P1098, DOI 10.1111/j.1440-1746.2006.04515.x; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lyu H, 2013, J VIRAL HEPATITIS, V20, P219, DOI 10.1111/j.1365-2893.2012.01654.x; Mathews P, 2013, ANN SURG ONCOL, V20, P1216, DOI 10.1245/s10434-012-2706-7; Ohata K, 2004, J GASTROEN HEPATOL, V19, P670, DOI 10.1111/j.1440-1746.2004.03360.x; Pan JB, 2004, J GEN VIROL, V85, P275, DOI 10.1099/vir.0.19650-0; Pan QX, 2014, ONCOL RES TREAT, V37, P192, DOI 10.1159/000361082; Parkin DM, 2005, CA CANC J CLIN, V55, P74; Pompili M, 2013, J HEPATOL, V59, P89, DOI 10.1016/j.jhep.2013.03.009; Poon RTP, 2000, J CLIN ONCOL, V18, P1094, DOI 10.1200/JCO.2000.18.5.1094; Roayaie S, 2009, GASTROENTEROLOGY, V137, P850, DOI 10.1053/j.gastro.2009.06.003; Schaffer C., 1994, MACHINE LEARNING P, P259, DOI DOI 10.1016/B978-1-55860-335-6.50039-8; Shah SA, 2007, SURGERY, V141, P330, DOI 10.1016/j.surg.2006.06.028; Shim JH, 2012, ANN SURG ONCOL, V19, P3687, DOI 10.1245/s10434-012-2416-1; Sinn DH, 2015, HEPATOLOGY, V62, P694, DOI 10.1002/hep.27889; Tanaka Y, 2006, J HEPATOL, V45, P646, DOI 10.1016/j.jhep.2006.06.018; Taura K, 2007, SURGERY, V142, P685, DOI 10.1016/j.surg.2007.05.009; Wang Q, 2013, BRIT J CANCER, V109, P573, DOI 10.1038/bjc.2013.352; Wolpert DH, 1994, TECHNICAL REPORT; World Health Organization, GLOB STAT REP NONC D; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu JC, 2009, J HEPATOL, V51, P890, DOI 10.1016/j.jhep.2009.07.009; Xia F, 2012, ANN SURG ONCOL, V19, P1284, DOI 10.1245/s10434-011-2042-3; Yamamura K, 2014, J HEPATO-BIL-PAN SCI, V21, P682, DOI 10.1002/jhbp.114; Yeung P, 2011, J INFECT DIS, V203, P646, DOI 10.1093/infdis/jiq096; Yuen MF, 2008, GUT, V57, P98, DOI 10.1136/gut.2007.119859; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Yuen MF, 2009, J HEPATOL, V50, P80, DOI 10.1016/j.jhep.2008.07.023; Zhao WH, 2002, WORLD J GASTROENTERO, V8, P237	53	18	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0148493	10.1371/journal.pone.0148493	http://dx.doi.org/10.1371/journal.pone.0148493			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901762	gold, Green Published, Green Submitted			2022-12-27	WOS:000371276100017
J	Sardinha, LB; Santos, DA; Silva, AM; Grontved, A; Andersen, LB; Ekelund, U				Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.; Grontved, Anders; Andersen, Lars B.; Ekelund, Ulf			A Comparison between BMI, Waist Circumference, and Waist-To-Height Ratio for Identifying Cardio-Metabolic Risk in Children and Adolescents	PLOS ONE			English	Article							BODY-MASS INDEX; TYPE-2 DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; CARDIOVASCULAR RISK; BOGALUSA HEART; PHYSICAL-ACTIVITY; OVERWEIGHT; ADIPOSITY; HEALTH; DEFINITION	Background There is controversial evidence on the associations between anthropometric measures with clustering of cardiovascular disease risk factors in pediatric ages. We aimed to examine the associations between body mass index (BMI), waist circumference (WC), and waist-to-height ratio (WHtR) with clustered cardiometabolic risk factors and to determine whether these anthropometric variables can be used to discriminate individuals with increased cardiometabolic risk (increased clustered triglycerides, HDL-cholesterol, systolic and diastolic blood pressure, and HOMA-IR). Methods The study sample of 4255 (2191 girls and 2064 boys) participants (8-17 years) was derived from pooled cross-sectional data comprising five studies. Outcomes included a continuous cardiometabolic risk factor z-score [corresponding to the sum of z-scores for triglycerides, HDL-cholesterol, systolic and diastolic blood pressure (mean arterial pressure), and HOMA-IR] and children with >= 1.0 SD in this score were defined as being at risk for clustering cardiometabolic risk factors.. Exposure variables were BMI, WC, WHtR. Statistics included mixed-effect regression and ROC analysis. Results All anthropometric variables were associated with clustered risk and the magnitudes of associations were similar for BMI, WC, and WHtR. Models including anthropometric variables were similar in discriminating children and adolescents at increased risk with areas under the ROC curve between 0.70 and 0.74. The sensitivity (boys: 80.5-86.4%; girls: 76.6-82.3%) was markedly higher than specificity (boys: 51.85-59.4%; girls: 60.8%). Conclusions The magnitude of associations for BMI, WC, and WHtR are similar in relation to clustered cardiometabolic risk factors, and perform better at higher levels of BMI. However, the precision of these anthropometric variables to classify increased risk is low.	[Sardinha, Luis B.; Santos, Diana A.; Silva, Analiza M.] Univ Lisbon, Fac Motricidade Humana, Exercise & Hlth Lab, CIPER, Cruz Quebrada, Portugal; [Grontved, Anders; Andersen, Lars B.] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Ctr Res Childhood Hlth, Odense, Denmark; [Ekelund, Ulf] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, MRC,Epidemiol Unit, Hills Rd, Cambridge CB2 2QQ, England; [Andersen, Lars B.; Ekelund, Ulf] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway	Universidade de Lisboa; University of Southern Denmark; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Norwegian School of Sport Sciences	Sardinha, LB (corresponding author), Univ Lisbon, Fac Motricidade Humana, Exercise & Hlth Lab, CIPER, Cruz Quebrada, Portugal.	lsardinha@fmh.ulisboa.pt	Ekelund, Ulf/AAE-8471-2019; Sardinha, Luís B./ABG-5389-2020; Silva, Analiza M/C-9858-2010; Santos, Vanessa/AAP-4130-2020; Sardinha, Luís Bettencourt/F-2641-2013; Grøntved, Anders/AAA-8025-2022; Santos, Diana A/H-9086-2013	Ekelund, Ulf/0000-0003-2115-9267; Sardinha, Luís B./0000-0002-6230-6027; Silva, Analiza M/0000-0002-8984-8600; Sardinha, Luís Bettencourt/0000-0002-6230-6027; Santos, Diana A/0000-0003-0429-3093; Grontved, Anders/0000-0003-1584-679X	Portuguese Foundation for Science and Technology [SFRH/BPD/92462/2013]; Medical Research Council [MC_U106179473, MC_UU_12015/3] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U106179473] Funding Source: UKRI	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	DAS is supported by a scholarship from the Portuguese Foundation for Science and Technology (SFRH/BPD/92462/2013). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegboye ARA, 2010, INT J PEDIATR OBES, V5, P130, DOI 10.3109/17477160903111730; Anderssen SA, 2007, EUR J CARDIOV PREV R, V14, P526, DOI 10.1097/HJR.0b013e328011efc1; [Anonymous], 2007, GROWTH REF DAT 5 19; [Anonymous], 2009, NAT HLTH NUTR EX SUR; Bell L, 2013, J PAEDIATR CHILD H, V49, P955, DOI 10.1111/jpc.12298; Bugge A, 2012, MED SCI SPORT EXER, V44, P1310, DOI 10.1249/MSS.0b013e31824bd579; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; de Giorgis T, 2014, EUR J ENDOCRINOL, V170, P173, DOI 10.1530/EJE-13-0452; de Onis M, 2013, PUBLIC HEALTH NUTR, V16, P625, DOI 10.1017/S1368980012004776; Freedman DS, 2007, AM J CLIN NUTR, V86, P33, DOI 10.1093/ajcn/86.1.33; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Freedman DS, 2010, AM J CLIN NUTR, V92, P1298, DOI 10.3945/ajcn.2010.29758; Friend A, 2013, METAB SYNDR RELAT D, V11, P71, DOI 10.1089/met.2012.0122; Garnett SP, 2008, INT J OBESITY, V32, P1028, DOI 10.1038/ijo.2008.51; Hara Mitsuhiko, 2002, J Atheroscler Thromb, V9, P127; IDF, 2007, IDF CONS DEF MET SYN; Juonala M, 2011, NEW ENGL J MED, V365, P1876, DOI 10.1056/NEJMoa1010112; Kahn HS, 2014, J OBES, V2014, DOI 10.1155/2014/421658; Kahn HS, 2005, J PEDIATR-US, V146, P482, DOI 10.1016/j.jpeds.2004.12.028; Katzmarzyk PT, 2013, INT J OBES LOND; Kuczmarski RJ., 2002, VITAL HLTH STAT, V11, P1, DOI DOI 10.1016/J.BBRC.2015.06.114; Magnussen CG, 2012, J AM COLL CARDIOL, V60, P1631, DOI 10.1016/j.jacc.2012.05.056; Magnussen CG, 2010, CIRCULATION, V122, P1604, DOI 10.1161/CIRCULATIONAHA.110.940809; Mark AE, 2008, MED SCI SPORT EXER, V40, P1007, DOI 10.1249/MSS.0b013e318169032d; Mark AE, 2009, AM J PREV MED, V36, P416, DOI 10.1016/j.amepre.2009.01.027; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; National Institutes of Health, 2000, PRACT GUID ID EV TRE; Patry-Parisien J, 2012, HEALTH REP, V23, P53; Radziuk J, 2000, J CLIN ENDOCR METAB, V85, P4426, DOI 10.1210/jc.85.12.4426; Reinehr T, 2013, J PEDIATR-US, V163, P327, DOI 10.1016/j.jpeds.2013.01.032; Riddoch C, 2005, J PHYS ACT HEALTH, V2, P115, DOI DOI 10.1123/JPAH.2.1.115; Savva SC, 2000, INT J OBESITY, V24, P1453, DOI 10.1038/sj.ijo.0801401; Taksali SE, 2008, DIABETES, V57, P367, DOI 10.2337/db07-0932; World Health Organization, 2005, WHO STEPS SURV MAN W; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	35	96	99	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149351	10.1371/journal.pone.0149351	http://dx.doi.org/10.1371/journal.pone.0149351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901828	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100062
J	Nagayama, H; Tomori, K; Ohno, K; Takahashi, K; Ogahara, K; Sawada, T; Uezu, S; Nagatani, R; Yamauchi, K				Nagayama, Hirofumi; Tomori, Kounosuke; Ohno, Kanta; Takahashi, Kayoko; Ogahara, Kakuya; Sawada, Tatsunori; Uezu, Sei; Nagatani, Ryutaro; Yamauchi, Keita			Effectiveness and Cost-Effectiveness of Occupation-Based Occupational Therapy Using the Aid for Decision Making in Occupation Choice (ADOC) for Older Residents: Pilot Cluster Randomized Controlled Trial	PLOS ONE			English	Article							NONPARAMETRIC BAYESIAN METHOD; SF-36 HEALTH SURVEY; PREFERENCE DATA; LIFE; VALIDITY; PURPOSE; RISK	Background Care-home residents are mostly inactive, have little interaction with staff, and are dependent on staff to engage in daily occupations. We recently developed an iPad application called the Aid for Decision-making in Occupation Choice (ADOC) to promote shared decision-making in activities and occupation-based goal setting by choosing from illustrations describing daily activities. This study aimed to evaluate if interventions based on occupation-based goal setting using the ADOC could focus on meaningful activities to improve quality of life and independent activities of daily living, with greater cost-effectiveness than an impairment-based approach as well as to evaluate the feasibility of conducting a large cluster, randomized controlled trial. Method In this single (assessor)-blind pilot cluster randomized controlled trial, the intervention group (ADOC group) received occupational therapy based on occupation-based goal setting using the ADOC, and the interventions were focused on meaningful occupations. The control group underwent an impairment-based approach focused on restoring capacities, without goal setting tools. In both groups, the 20-minute individualized intervention sessions were conducted twice a week for 4 months. Main Outcome Measures Short Form-36 (SF-36) score, SF-6D utility score, quality adjusted life years (QALY), Barthel Index, and total care cost. Results We randomized and analyzed 12 facilities (44 participants, 18.5% drop-out rate), with 6 facilities each allocated to the ADOC (n = 23) and control (n = 21) groups. After the 4-month intervention, the ADOC group had a significantly greater change in the BI score, with improved scores (P = 0.027, 95% CI 0.41 to 6.87, intracluster correlation coefficient = 0.14). No other outcome was significantly different. The incremental cost-effectiveness ratio, calculated using the change in BI score, was $63.1. Conclusion The results suggest that occupational therapy using the ADOC for older residents might be effective and cost-effective. We also found that conducting an RCT in the occupational therapy setting is feasible.	[Nagayama, Hirofumi; Tomori, Kounosuke; Ogahara, Kakuya; Nagatani, Ryutaro] Kanagawa Univ Human Serv, Dept Occupat Therapy, Yokosuka, Kanagawa, Japan; [Ohno, Kanta] Kanagawa Univ Human Serv, Grad Course Hlth & Social, Yokosuka, Kanagawa, Japan; [Takahashi, Kayoko] Kitasato Univ, Dept Occupat Therapy, Sch Allied Hlth, Sagamihara, Kanagawa, Japan; [Sawada, Tatsunori] IMS Itabashi Rehabil Hosp, Tokyo, Japan; [Uezu, Sei] Naha City Ajya Complex Welf Facil, Naha City, Okinawa, Japan; [Nagayama, Hirofumi; Yamauchi, Keita] Keio Univ, Grad Sch Hlth Management, Yokohama, Kanagawa, Japan	Kitasato University; Keio University	Nagayama, H (corresponding author), Kanagawa Univ Human Serv, Dept Occupat Therapy, Yokosuka, Kanagawa, Japan.; Nagayama, H (corresponding author), Keio Univ, Grad Sch Hlth Management, Yokohama, Kanagawa, Japan.	hirofuminagayama@gmail.com	Nagayama, Hirofumi/AAF-1364-2020; Tomori, Kounosuke/AAN-3565-2020	Nagayama, Hirofumi/0000-0002-1763-1330; Tomori, Kounosuke/0000-0003-0695-4385	Japanese Association of Occupational Therapists [2012-03]; Japanese Association of Occupational Therapists;  [24790510]	Japanese Association of Occupational Therapists; Japanese Association of Occupational Therapists; 	This research was supported by the challenge research subsidy program from the Japanese Association of Occupational Therapists (No. 2012-03) and a Grant-in-Aid for Young Scientists (B; Grant Number 24790510).; The authors thank all of the occupational therapists (Kida Y, Oniki N, Nomura J, Ikejiri N, Kinjyo A, Iida S, Hosaka K, Muguruma R, Nakamura M, Hatsushika M, Uechi Y, Takenishi I, Sugawara A) that participated in this study. We would like to thank Editage (www.editage.jp) for English language editing. Finally, we would like to thank the Japanese Association of Occupational Therapists and Grant-in-Aid for Young Scientists (B; Grant Number 24790510) for the grants that made it possible to complete this study.	Boyle PA, 2010, AM J GERIAT PSYCHIAT, V18, P1093, DOI 10.1097/JGP.0b013e3181d6c259; Boyle PA, 2009, PSYCHOSOM MED, V71, P574, DOI 10.1097/PSY.0b013e3181a5a7c0; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Fisher AG, 2009, OCCUPATIONAL THERAPY; Fisher AG, 2013, SCAND J OCCUP THER, V20, P162, DOI 10.3109/11038128.2012.754492; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Holthe Torhild, 2007, Scand J Occup Ther, V14, P96, DOI 10.1080/11038120600963796; Hooker S.A., 2014, J HLTH PSYCHOL; Kharroubi SA, 2005, J R STAT SOC C-APPL, V54, P879, DOI 10.1111/j.1467-9876.2005.00511.x; Kharroubi SA, 2007, J HEALTH ECON, V26, P597, DOI 10.1016/j.jhealeco.2006.09.002; KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Law M., 2014, CANADIAN OCCUPATIONA, VAnniversary; Law M.C., 2005, MEASURING OCCUPATION; Levack WMM, 2006, CLIN REHABIL, V20, P739, DOI 10.1177/0269215506070791; MAHONEY F I, 1965, Md State Med J, V14, P61; Ministry of Health Labour and Welfare, 2014, GEN COND CAR SERV FA; Murray DM, 1998, DESIGN ANAL GROUP RA; Nagayama H, 2015, OCCUP THER INT; Polatajko HJ, 2012, CAN J OCCUP THER, V79, P259, DOI 10.2182/cjot.2012.79.5.1; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Sackley C, 2006, INT J THER REHABIL, V13, P370, DOI 10.12968/ijtr.2006.13.8.370; Sackley CM, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-52; Sackley CM, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3123; Saito Y, 2013, JPN J OCCUP THER, V32, P55; Saito Y, 2012, JPN J OCCUP THER, V31, P22; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Toba K, 2014, GERIATR GERONTOL INT, V14, P206, DOI 10.1111/ggi.12080; Tomori K, 2013, DISABIL REHABIL ASSI; Tomori K, 2013, DISABIL REHABIL, V35, P113, DOI 10.3109/09638288.2012.689919; Tomori K, 2012, OCCUP THER INT, V19, P88, DOI 10.1002/oti.325; Weinstein MC, 1996, COST EFFECTIVENESS H, V55; WHO, 2001, WHO INT CLASS FUNCT; World Federation of Occupational Therapists, 2010, WORLD FED OCC THER S; ZIKA S, 1992, BRIT J PSYCHOL, V83, P133, DOI 10.1111/j.2044-8295.1992.tb02429.x	36	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150374	10.1371/journal.pone.0150374	http://dx.doi.org/10.1371/journal.pone.0150374			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5ZW	26930191	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500134
J	Hu, C; Tian, HZ; Li, HQ; Hu, AQ; Xing, FW; Bhattacharjee, A; Hsu, TC; Kumar, P; Chung, SW				Hu, Chao; Tian, Huaizhen; Li, Hongqing; Hu, Aiqun; Xing, Fuwu; Bhattacharjee, Avishek; Hsu, Tianchuan; Kumar, Pankaj; Chung, Shihwen			Phylogenetic Analysis of a 'Jewel Orchid' Genus Goodyera (Orchidaceae) Based on DNA Sequence Data from Nuclear and Plastid Regions	PLOS ONE			English	Article							SPIRANTHINAE ORCHIDACEAE; MOLECULAR PHYLOGENETICS; RIBOSOMAL DNA; CRANICHIDEAE; PRESCOTTIINAE; SYSTEMATICS; UTILITY	A molecular phylogeny of Asiatic species of Goodyera (Orchidaceae, Cranichideae, Goodyerinae) based on the nuclear ribosomal internal transcribed spacer (ITS) region and two chloroplast loci (matK and trnL-F) was presented. Thirty-five species represented by 132 samples of Goodyera were analyzed, along with other 27 genera/48 species, using Pterostylis longifolia and Chloraea gaudichaudii as outgroups. Bayesian inference, maximum parsimony and maximum likelihood methods were used to reveal the intrageneric relationships of Goodyera and its intergeneric relationships to related genera. The results indicate that: 1) Goodyera is not monophyletic; 2) Goodyera could be divided into four sections, viz., Goodyera, Otosepalum, Reticulum and a new section; 3) sect. Reticulum can be further divided into two subsections, viz., Reticulum and Foliosum, whereas sect. Goodyera can in turn be divided into subsections Goodyera and a new subsection.	[Hu, Chao; Tian, Huaizhen; Li, Hongqing] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Hu, Chao] Shanghai Chenshan Bot Garden, Shanghai Key Lab Plant Funct Genom & Resources, Shanghai, Peoples R China; [Hu, Chao] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai, Peoples R China; [Hu, Aiqun] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Hong Kong, Peoples R China; [Xing, Fuwu] Chinese Acad Sci, South China Bot Garden, Guangzhou, Guangdong, Peoples R China; [Bhattacharjee, Avishek] Bot Survey India, Cent Natl Herbarium, Bot Garden, Howrah, India; [Hsu, Tianchuan] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Kumar, Pankaj] Kadoorie Farm & Bot Garden, Flora Conservat Dept, Orchid Conservat Sect, Lam Kam Rd, Tai Po, Hong Kong, Peoples R China; [Chung, Shihwen] Taiwan Forestry Res Inst, Div Forest Biol, Taipei, Taiwan	East China Normal University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Hong Kong; Chinese Academy of Sciences; South China Botanical Garden, CAS; Botanical Survey of India (BSI); National Tsing Hua University	Tian, HZ (corresponding author), E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China.; Chung, SW (corresponding author), Taiwan Forestry Res Inst, Div Forest Biol, Taipei, Taiwan.	hztian@bio.ecnu.edu.cn; biflora@gmail.com	Kumar, Pankaj/B-6261-2015; Bhattacharjee, Avishek/R-3104-2019	Kumar, Pankaj/0000-0002-3469-5731; Bhattacharjee, Avishek/0000-0003-4574-3804; Hu, Ai-Qun/0000-0001-9564-878X	Natural Science Foundation of China [30900077]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China no. 30900077 to HZT.	Alvarez-Molina A, 2009, AM J BOT, V96, P1020, DOI 10.3732/ajb.0800219; Chemisquy MA, 2012, MOL PHYLOGENET EVOL, V62, P889, DOI 10.1016/j.ympev.2011.11.026; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bhattacharjee Avishek, 2012, Kew Bulletin, V67, P503, DOI 10.1007/s12225-012-9388-y; Burland T G, 2000, Methods Mol Biol, V132, P71; Cameron KM, 2004, MOL PHYLOGENET EVOL, V31, P1157, DOI 10.1016/j.ympev.2003.10.010; Cameron KM, 1999, AM J BOT, V86, P208, DOI 10.2307/2656938; Chen SC., 2009, FLORA CHINA, V25; Chung SW, 2008, THESIS NATL CHUNG HS; Doyle J. J., 1987, PHYTOCHEM B, P11; Dressler RL, 1993, PHYLOGENY CLASSIFICA; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; Figueroa C, 2008, ANN BOT-LONDON, V101, P509, DOI 10.1093/aob/mcm328; Freudenstein JV, 2001, SYST BOT, V26, P643; Goldman DH, 2001, SYST BOT, V26, P670; Guan QX, 2014, PHYTOTAXA, V186, P51; Juswara L.S, 2010, THESIS OHIO STATE U; Kallunki JA, 2002, FLORA N AM MEXICO, V26; Kee-SunShin, 2002, [Journal of Plant Biology, Journal of Plant Biology(한국식물학회지)], V45, P182; Lang KY, 1999, FLORA REIPUBLICAE PO, V17; McNeill J., 2012, INT COD NOM ALG FUNG; Nuin P, 2005, MRMTGUI 10 VERSION 1; Nylander JAA., 2004, BIOINFORMATICS; Ormerod Paul, 2013, Taiwania, V58, P20; Pearce NR, 2002, ORCHIDS OF BHUTAN; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Pridgeon A.M., 2003, GENERA ORCHIDENDAC 2, V3; Ramirez SR, 2007, NATURE, V448, P1042, DOI 10.1038/nature06039; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Salazar GA, 2003, AM J BOT, V90, P777, DOI 10.3732/ajb.90.5.777; Salazar GA, 2011, BOT J LINN SOC, V167, P1, DOI 10.1111/j.1095-8339.2011.01161.x; Salazar GA, 2009, ANN BOT-LONDON, V104, P403, DOI 10.1093/aob/mcn257; Schlechter R, 1911, REPERORIUM SPECIERUM, V1, P47; SEIDENFADEN G, 1978, DAN BOT ARK, V32, P7; Seidenfaden G, 1992, ORCHIDS PENINULAR MA; Shui YM, 2006, SEED PLANTS KARST RE, V1; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian HZ, 2008, THESIS CHINESE ACAD; Tsiftsis S, 2012, PLANT BIOSYST, V146, P857, DOI 10.1080/11263504.2011.642416; Xu Z. H., 2010, WILD ORCHIDS YUNNAN; Zwickl D.J., 2006, THESIS	43	24	24	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150366	10.1371/journal.pone.0150366	http://dx.doi.org/10.1371/journal.pone.0150366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26927946	Green Published, Green Submitted, gold			2022-12-27	WOS:000371424200039
J	Chang, TS; Chen, CL; Wu, YC; Liu, JJ; Kuo, YC; Lee, KF; Lin, SY; Lin, SE; Tung, SY; Kuo, LM; Tsai, YH; Huang, YH				Chang, Te-Sheng; Chen, Chi-Long; Wu, Yu-Chih; Liu, Jun-Jen; Kuo, Yung Che; Lee, Kam-Fai; Lin, Sin-Yi; Lin, Sey-En; Tung, Shui-Yi; Kuo, Liang-Mou; Tsai, Ying-Huang; Huang, Yen-Hua			Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							FACTOR-I RECEPTOR; LIVER INFLAMMATION; HEPATITIS-C; CANCER; CELLS; INFECTION; PATHWAY; HCC; RECURRENCE; ACTIVATION	The expression of cancer stemness is believed to reduce the efficacy of current therapies against hepatocellular carcinoma (HCC). Understanding of the stemness-regulating signaling pathways incurred by a specific etiology can facilitate the development of novel targets for individualized therapy against HCC. Niche environments, such as virus-induced inflammation, may play a crucial role. However, the mechanisms linking inflammation and stemness expression in HCC remain unclear. Here we demonstrated the distinct role of inflammatory mediators in expressions of stemness-related properties involving the pluripotent octamer-binding transcription factor 4 (OCT4) in cell migration and drug resistance of hepatitis B virus-related HCC (HBV-HCC). We observed positive immunorecognition for macrophage chemoattractant protein 1 (MCP-1)/CD68 and OCT4/NANOG in HBV-HCC tissues. The inflammation-conditioned medium (inflamed-CM) generated by lipopolysaccharide-stimulated U937 human leukemia cells significantly increased the mRNA and protein levels of OCT4/NANOG preferentially in HBV-active (HBV(+)HBsAg(+)) HCC cells. The inflamed-CM also increased the side population (SP) cell percentage, green fluorescent protein (GFP)-positive cell population, and luciferase activity of OCT4 promoter-GFP/luciferase in HBV-active HCC cells. Furthermore, the inflamed-CM upregulated the expressions of insulin-like growth factor-I (IGF-I)/IGF-I receptor (IGF-IR) and activated IGF-IR/Akt signaling in HBV-HCC. The IGF-IR phosphorylation inhibitor picropodophyllin (PPP) suppressed inflamed-CM-induced OCT4 and NANOG levels in HBV(+)HBsAg(+) Hep3B cells. Forced expression of OCT4 significantly increased the secondary sphere formation and cell migration, and reduced susceptibility of HBV-HCC cells to cisplatin, bleomycin, and doxorubicin. Taking together, our results show that niche inflammatory mediators play critical roles in inducing the expression of stemness-related properties involving IGF-IR activation, and the upregulation of OCT4 contributes to cancer migration and drug resistance of HBV-HCC cells. Findings in this paper would provide potential targets for a therapeutic strategy targeting on inflammatory environment for HBV-HCC.	[Chang, Te-Sheng; Wu, Yu-Chih; Kuo, Yung Che; Lin, Sin-Yi; Huang, Yen-Hua] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan; [Chang, Te-Sheng; Tung, Shui-Yi] Chang Gung Mem Hosp, Div Gastroenterol & Hepatol, Dept Internal Med, Chiayi, Taiwan; [Chen, Chi-Long; Lin, Sey-En] Taipei Med Univ, Wan Fang Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long] Taipei Med Univ, Taipei Med Univ Hosp, Dept Pathol, Taipei, Taiwan; [Chen, Chi-Long; Lin, Sey-En] Taipei Med Univ, Sch Med, Dept Pathol, Coll Med, Taipei, Taiwan; [Wu, Yu-Chih; Kuo, Yung Che; Huang, Yen-Hua] Taipei Med Univ, TMU Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Liu, Jun-Jen] Taipei Med Univ, Sch Med, Lab Sci & Biotechnol, Taipei, Taiwan; [Lee, Kam-Fai] Chang Gung Mem Hosp, Dept Pathol, Chiayi, Taiwan; [Kuo, Liang-Mou] Chang Gung Mem Hosp, Dept Gen Surg, Chiayi, Taiwan; [Tsai, Ying-Huang] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Chiayi, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Huang, YH (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, TMU Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan.; Huang, YH (corresponding author), Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan.	rita1204@tmu.edu.tw	Liu, Jun-Jen/AAP-1788-2021	Lin, Sey-En/0000-0002-8994-9452; Huang, Yen-Hua/0000-0001-6020-9998; Kuo, Yung-Che/0000-0002-9425-7389; Wu, Yu-Chih/0000-0001-5781-2665	National Science Council, Taiwan [NSC(100-102)-2321-B-038-003, NSC101-2314-B-182A-028, NSC102-2628-B-038-008-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2321-B-038-011, MOST104-2321-B-038-003, MOST 104-2314-B-182A-020-MY2]; Health and Welfare Surcharge of Tobacco Products [MOHW104-TDU-B-212-124-001, MOHW105-TDU-B-212-134001]; Taipei Medical University [TMUTOP103002-9, TMU-T104-06]; Wan-Fang Hospital [103TMU-WFH-01-2]; Chang Gung Memorial Hospital [CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382, CMRPG6F0161]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Health and Welfare Surcharge of Tobacco Products; Taipei Medical University; Wan-Fang Hospital; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC(100-102)-2321-B-038-003, NSC101-2314-B-182A-028, and NSC102-2628-B-038-008-MY3) (http://www.most.gov.tw/), Ministry of Science and Technology, Taiwan (MOST 103-2321-B-038-011, MOST104-2321-B-038-003, MOST 104-2314-B-182A-020-MY2) (http://www.most.gov.tw/), Health and Welfare Surcharge of Tobacco Products (MOHW104-TDU-B-212-124-001) and (MOHW105-TDU-B-212-134001) (http://www.mohw.gov.tw/EN/Ministry/Index.aspx), Taipei Medical University (TMUTOP103002-9) and (TMU-T104-06) (http://www.tmu.edu.tw/english/main.php), Wan-Fang Hospital (103TMU-WFH-01-2) (http://www.taiwanhealthcare.com/english/index.aspx), and Chang Gung Memorial Hospital (CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382 and CMRPG6F0161) (https://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2015, SEMIN ONCOL, V42, pS3, DOI 10.1053/j.seminoncol.2015.01.001; Arndt W, 2014, J CLIN GASTROENTEROL, V48, P279, DOI [10.1097/MCG.0b013e3182a8a793, DOI 10.1097/MCG.0B013E3182A8A793]; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Berasain G, 2009, ANN NY ACAD SCI, V1155, P206, DOI [10.1111/j.1749-6632.2009.03704.x, DOI 10.1111/J.1749-6632.2009.03704.X]; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cescon M, 2009, ARCH SURG-CHICAGO, V144, P906, DOI 10.1001/archsurg.2009.99; Chang TS, 2015, CLIN CANCER RES, V21, P201, DOI 10.1158/1078-0432.CCR-13-3274; Chiao H, 1996, J CLIN INVEST, V97, P2038, DOI 10.1172/JCI118639; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Csermely P, 2015, SEMIN CANCER BIOL, V30, P42, DOI 10.1016/j.semcancer.2013.12.004; Desbois-Mouthon C, 2009, CLIN CANCER RES, V15, P5445, DOI 10.1158/1078-0432.CCR-08-2980; Fransvea E, 2009, CELL ONCOL, V31, P227, DOI 10.3233/CLO-2009-0473; He GB, 2013, CELL, V155, P384, DOI 10.1016/j.cell.2013.09.031; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Knight B, 2005, IMMUNOL CELL BIOL, V83, P364, DOI 10.1111/j.1440-1711.2005.01346.x; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Ma N, 2011, BIOCHEM BIOPH RES CO, V414, P344, DOI 10.1016/j.bbrc.2011.09.073; Matsumoto K, 2002, HEPATOL RES, V23, P196, DOI 10.1016/S1386-6346(01)00180-2; Ramanan V, 2014, ANNU REV VIROL, V1, P475, DOI 10.1146/annurev-virology-031413-085437; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Shan JJ, 2012, HEPATOLOGY, V56, P1004, DOI 10.1002/hep.25745; Shigdar S, 2014, CANCER LETT, V345, P271, DOI 10.1016/j.canlet.2013.07.031; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanno T, 2011, J NIPPON MED SCH, V78, P138, DOI 10.1272/jnms.78.138; Tarao K, 1997, CANCER, V79, P688, DOI 10.1002/(SICI)1097-0142(19970215)79:4<688::AID-CNCR5>3.0.CO;2-A; Tovar V, 2010, J HEPATOL, V52, P550, DOI 10.1016/j.jhep.2010.01.015; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wang XQ, 2010, HEPATOLOGY, V52, P528, DOI 10.1002/hep.23692; Wu HC, 2014, HUM PATHOL, V45, P1294, DOI 10.1016/j.humpath.2013.10.039; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007	33	29	29	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149897	10.1371/journal.pone.0149897	http://dx.doi.org/10.1371/journal.pone.0149897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919045	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400055
J	Duncan, DT; Kapadia, F; Regan, SD; Goedel, WC; Levy, MD; Barton, SC; Friedman, SR; Halkitis, PN				Duncan, Dustin T.; Kapadia, Farzana; Regan, Seann D.; Goedel, William C.; Levy, Michael D.; Barton, Staci C.; Friedman, Samuel R.; Halkitis, Perry N.			Feasibility and Acceptability of Global Positioning System (GPS) Methods to Study the Spatial Contexts of Substance Use and Sexual Risk Behaviors among Young Men Who Have Sex with Men in New York City: A P18 Cohort Sub-Study	PLOS ONE			English	Article							UNPROTECTED ANAL INTERCOURSE; PHYSICAL-ACTIVITY BEHAVIORS; LGBT HATE CRIMES; HIV-INFECTION; DRUG-USERS; NEIGHBORHOOD; GAY; ADOLESCENTS; MOBILITY; HEALTH	Background No global positioning system (GPS) technology study has been conducted among a sample of young gay, bisexual, and other men who have sex with men (YMSM). As such, the purpose of this study was to evaluate the feasibility and acceptability of using GPS methods to understand the spatial context of substance use and sexual risk behaviors among a sample of YMSM in New York City, a high-risk population. Methods Data came from a subsample of the ongoing P18 Cohort Study (n = 75). GPS feasibility and acceptability among participants was measured with: 1) a pre- and post-survey and 2) adherence to the GPS protocol which included returning the GPS device, self-report of charging and carrying the GPS device as well as objective data analyzed from the GPS devices. Analyses of the feasibility surveys were treated as repeated measures as each participant had a pre-and post-feasibility survey. When comparing the similar GPS survey items asked at baseline and at follow-up, we present percentages and associated p-values based on chi-square statistics. Results Participants reported high ratings of pre-GPS acceptability, ease of use, and low levels of wear-related concerns in addition to few concerns related to safety, loss, or appearance, which were maintained after baseline GPS feasibility data collection. The GPS return rate was 100%. Most participants charged and carried the GPS device on most days. Of the total of 75 participants with GPS data, 75 (100%) have at least one hour of GPS data for one day and 63 (84%) had at least one hour on all 7 days. Conclusions Results from this pilot study demonstrate that utilizing GPS methods among YMSM is feasible and acceptable. GPS devices may be used in spatial epidemiology research in YMSM populations to understand place-based determinants of health such as substance use and sexual risk behaviors.	[Duncan, Dustin T.; Kapadia, Farzana; Regan, Seann D.; Goedel, William C.; Halkitis, Perry N.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Goedel, William C.; Halkitis, Perry N.] NYU, Coll Global Publ Hlth, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Halkitis, Perry N.] NYU, Populat Ctr, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Levy, Michael D.; Barton, Staci C.; Halkitis, Perry N.] NYU, Ctr Hlth Ident Behav & Prevent Studies, New York, NY USA; [Duncan, Dustin T.; Kapadia, Farzana; Friedman, Samuel R.; Halkitis, Perry N.] NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA; [Duncan, Dustin T.] NYU, Ctr Data Sci, New York, NY USA; [Friedman, Samuel R.] Natl Dev & Res Inst Inc, Inst Infect Dis Res, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University; National Development & Research Institutes, Inc	Duncan, DT (corresponding author), NYU, Sch Med, Dept Populat Hlth, New York, NY USA.; Duncan, DT (corresponding author), NYU, Coll Global Publ Hlth, New York, NY USA.; Duncan, DT (corresponding author), NYU, Populat Ctr, New York, NY USA.; Duncan, DT (corresponding author), NYU, Ctr Hlth Ident Behav & Prevent Studies, New York, NY USA.; Duncan, DT (corresponding author), NYU, Coll Nursing, Ctr Drug Use & HIV Res, New York, NY USA.; Duncan, DT (corresponding author), NYU, Ctr Data Sci, New York, NY USA.	Dustin.Duncan@nyumc.org	Kapadia, farzana/AAI-8304-2020; Regan, Seann/AAL-3863-2021	Regan, Seann/0000-0002-1034-0282; Goedel, William/0000-0002-2869-1048; Kapadia, Farzana/0000-0003-3459-767X; Friedman, Sam/0000-0003-2083-1226	NYU Center for Drug Use and HIV Research Pilot Project Awards Program; National Institute on Drug Abuse [5P30DA011041-17, 18, 1R01DA025537, 2R01DA025537-06A1]; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA011041, R01DA025537] Funding Source: NIH RePORTER	NYU Center for Drug Use and HIV Research Pilot Project Awards Program; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the NYU Center for Drug Use and HIV Research Pilot Project Awards Program (Drs. Dustin Duncan and Farzana Kapadia, co-Principal Investigators). The NYU Center for Drug Use and HIV Research is funded by the National Institute on Drug Abuse (Grant# 5P30DA011041-17). The parent study, Project 18, was also funded by the National Institute on Drug Abuse (Grant # 1R01DA025537; 2R01DA025537-06A1, Dr. Perry Halkitis, Principal Investigator).	[Anonymous], HIV SURVEILLANCE SUP; Brewster KL, 2012, AM J PUBLIC HEALTH, V102, P1168, DOI 10.2105/AJPH.2011.300261; Brouwer KC, 2008, INTEGRATING GIS STUD, P27; Buttram ME, 2013, AM J MENS HEALTH, V7, P110, DOI 10.1177/1557988312458793; Byrnes HF, 2015, J ADOLESCENT HEALTH, V57, P245, DOI 10.1016/j.jadohealth.2015.04.013; Carpiano RM, 2011, J HEALTH SOC BEHAV, V52, P74, DOI 10.1177/0022146510395026; CDC, 2015, HIV SURV REP, V25, P1; Chaix B, 2013, HEALTH PLACE, V21, P46, DOI 10.1016/j.healthplace.2013.01.003; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Chum A, 2013, HEALTH PLACE, V24, P73, DOI 10.1016/j.healthplace.2013.07.007; Clark RA, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-37; Cummins S, 2007, INT J EPIDEMIOL, V36, P355, DOI 10.1093/ije/dym033; Dasgupta S, 2014, JMIR RES PROTOC, V3, DOI 10.2196/resprot.2946; Dessing D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-227; Duncan DT, 2015, J MAPS IN PRESS; Duncan DT, 2014, GEOSPATIAL HEALTH, V9, P57, DOI 10.4081/gh.2014.6; Duncan DT, 2014, INT J ENV RES PUB HE, V11, P8962, DOI 10.3390/ijerph110908962; Duncan DT, 2014, AM J PUBLIC HEALTH, V104, P272, DOI 10.2105/AJPH.2013.301424; Duncan DT, 2014, DRUG ALCOHOL DEPEN, V135, P65, DOI 10.1016/j.drugalcdep.2013.11.001; Duncan DT, 2014, AM J EPIDEMIOL, V179, P373, DOI 10.1093/aje/kwt251; Duncan JS, 2009, J SCI MED SPORT, V12, P583, DOI 10.1016/j.jsams.2008.09.010; Eaton LA, 2015, AM J PUBLIC HEALTH, V105, pE75, DOI 10.2105/AJPH.2014.302322; Epstein DH, 2014, DRUG ALCOHOL DEPEN, V134, P22, DOI [10.1016/j.drugalcdep.2013.09.007, 10.1016/j.d]; Evenson KR, 2013, MED SCI SPORT EXER, V45, P1981, DOI 10.1249/MSS.0b013e318293330e; Frye V, 2010, AIDS BEHAV, V14, P974, DOI 10.1007/s10461-008-9438-5; Georgiadou Y., 1988, Manuscripta Geodaetica, V13, P172; Goedel William C, 2015, JMIR Public Health Surveill, V1, pe4, DOI 10.2196/publichealth.4353; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Halkitis P, 2015, J ACQUIR IMMUNE DEFI; Halkitis PN, 2015, AIDS BEHAV, V19, P970, DOI 10.1007/s10461-014-0892-y; Halkitis PN, 2013, AM J PUBLIC HEALTH, V103, P889, DOI 10.2105/AJPH.2012.300963; Halkitis PN, 2013, AIDS PATIENT CARE ST, V27, P181, DOI 10.1089/apc.2012.0415; Harrison F, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-5; Hatzenbuehler ML, 2015, VIOLENCE VICTIMS, V30, P663, DOI 10.1891/0886-6708.VV-D-13-00166; Hoyt MA, 2012, HEALTH PSYCHOL, V31, P269, DOI 10.1037/a0025953; Hurvitz PM, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00002; Hurvitz PM, 2012, AM J PREV MED, V42, P411, DOI 10.1016/j.amepre.2011.11.015; Kawachi I., 2003, NEIGHBORHOODS HLTH; Kelly BC, 2012, SOCIOL HEALTH ILL, V34, P1085, DOI 10.1111/j.1467-9566.2011.01446.x; Kirchner TR, 2014, 3 INT WORKSH URB COM; Klinker Charlotte D, 2014, Int J Behav Nutr Phys Act, V11, P8, DOI 10.1186/1479-5868-11-8; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075878; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kwan MP, 2012, ANN ASSOC AM GEOGR, V102, P958, DOI 10.1080/00045608.2012.687349; Landovitz RJ, 2013, J URBAN HEALTH, V90, P729, DOI 10.1007/s11524-012-9766-7; Martinez AN, 2014, INT J DRUG POLICY, V25, P516, DOI 10.1016/j.drugpo.2013.11.008; Matthews SA, 2011, SOC DISPAR H H CARE, P35, DOI 10.1007/978-1-4419-7482-2_3; McCluskey A, 2012, ISRN REHAB, V2012; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Mirzazadeh A, 2014, TECHNOL HEALTH CARE, V22, P689, DOI 10.3233/THC-140838; Mustanski B, 2015, AIDS BEHAV, V19, P1037, DOI 10.1007/s10461-014-0955-0; Neaigus A, 2012, AIDS BEHAV, V16, P516, DOI 10.1007/s10461-011-0050-8; O'Connor TM, 2013, GEOSPATIAL HEALTH, V7, P375, DOI 10.4081/gh.2013.94; Oliver M, 2010, J PHYS ACT HEALTH, V7, P102, DOI 10.1123/jpah.7.1.102; Paz-Soldan VA, 2010, AM J TROP MED HYG, V82, P723, DOI 10.4269/ajtmh.2010.09-0496; Perchoux C, 2015, PREV MED, V81, P142, DOI 10.1016/j.ypmed.2015.08.010; Phillips G, 2015, ARCH SEX BEHAV, V44, P1773, DOI 10.1007/s10508-014-0459-z; Raymond HF, 2014, AIDS BEHAV, V18, P346, DOI 10.1007/s10461-013-0508-y; Reif S, 2006, AM J PUBLIC HEALTH, V96, P970, DOI 10.2105/AJPH.2005.063149; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Rendina HJ, 2014, AIDS BEHAV, V18, P41, DOI 10.1007/s10461-013-0573-2; Rice E, 2012, J AIDS CLIN RES S, VS4, DOI DOI 10.4172/2155-6113.S4-005; Robinson AI, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-57; Sobell L.C., 1996, TIMELINE FOLLOW BACK; Spielman SE, 2013, ENVIRON PLANN B, V40, P489, DOI 10.1068/b38007; Spielman SE, 2009, SOC SCI MED, V68, P1098, DOI 10.1016/j.socscimed.2008.12.048; Stewart T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0176-6; Tiggemann M., 2007, PSYCHOL MEN MASCULIN, V8, P15, DOI [10.1037/1524-9220.8.1.15, DOI 10.1037/1524-9220.8.1.15]; Vaughan AS, 2014, AIDS RES HUM RETROV, V30, P740, DOI [10.1089/aid.2014.0144, 10.1089/AID.2014.0144]; Webber SC, 2009, J AGING PHYS ACTIV, V17, P455, DOI 10.1123/japa.17.4.455; Wiehe SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077667; Winetrobe H, 2014, AIDS CARE, V26, P1303, DOI 10.1080/09540121.2014.911811; Yan K, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/328076; Yen IH, 2015, J APPL GERONTOL, V34, pNP190, DOI 10.1177/0733464813479024; Zenk SN, 2012, J PHYS ACT HEALTH, V9, P924, DOI 10.1123/jpah.9.7.924; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	77	44	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0147520	10.1371/journal.pone.0147520	http://dx.doi.org/10.1371/journal.pone.0147520			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918766	Green Submitted, Green Published, gold			2022-12-27	WOS:000371274400004
J	Gebrezgabiher, G; Romha, G; Ejeta, E; Asebe, G; Zemene, E; Ameni, G				Gebrezgabiher, Gebremedhin; Romha, Gebremedhin; Ejeta, Eyasu; Asebe, Getahun; Zemene, Endalew; Ameni, Gobena			Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study	PLOS ONE			English	Article							POSITIVE PULMONARY TUBERCULOSIS; CONTROL PROGRAM; DOTS; REGION; CHINA	Tuberculosis (TB) is one of the major public health and socio-economic issues in the 21st century globally. Assessment of TB treatment outcomes, and monitoring and evaluation of its risk factors in Directly Observed Treatment Short Course (DOTS) are among the major indicators of the performance of a national TB control program. Hence, this institution-based retrospective study was conducted to determine the treatment outcome of TB patients and investigate factors associated with unsuccessful outcome at Dilla University Referral Hospital, southern Ethiopia. Five years (2008 to 2013) TB record of TB clinic of the hospital was reviewed. A total 1537 registered TB patients with complete information were included. Of these, 942 (61.3%) were male, 1015 (66%) were from rural areas, 544 (35.4%) were smear positive pulmonary TB (PTB+), 816 (53.1%) were smear negative pulmonary TB (PTB-) and 177(11.5%) were extra pulmonary TB (EPTB) patients. Records of the 1537 TB patients showed that 181 (11.8%) were cured, 1129(73.5%) completed treatment, 171 (11.1%) defaulted, 52 (3.4%) died and 4 (0.3%) had treatment failure. The overall mean treatment success rate of the TB patients was 85.2%. The treatment success rate of the TB patients increased from 80.5% in September 2008-August 2009 to 84.8% in September 2012-May 2013. Tuberculosis type, age, residence and year of treatment were significantly associated with unsuccessful treatment outcome. The risk of unsuccessful outcome was significantly higher among TB patients from rural areas (AOR = 1.63, 95% CI: 1.21-2.20) compared to their urban counterparts. Unsuccessful treatment outcome was also observed in PTB-patients (AOR = 1.77, 95% CI: 1.26-2.50) and EPTB (AOR = 2.07, 95% CI: 1.28-3.37) compared to the PTB+ patients. In conclusion, it appears that DOTS have improved treatment success in the hospital during five years. Regular follow-up of patients with poor treatment outcome and provision of health information on TB treatment to patients from rural area is recommended.	[Gebrezgabiher, Gebremedhin; Zemene, Endalew] Jimma Univ, Coll Hlth Sci, POB 378, Jimma, Ethiopia; [Romha, Gebremedhin] Dilla Univ, Coll Agr & Nat Resource, POB 419, Dilla, Ethiopia; [Gebrezgabiher, Gebremedhin] Samara Univ, Coll Vet Med, POB 132, Samara, Ethiopia; [Ejeta, Eyasu] Wollega Univ, Coll Hlth Sci, POB 395, Nekemte, Ethiopia; [Asebe, Getahun] Gambella Univ, Coll Agr & Nat Resource, POB 126, Gambella, Ethiopia; [Ameni, Gobena] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, POB 1176, Addis Ababa, Ethiopia	Jimma University; Dilla University; Samara University; Addis Ababa University	Gebrezgabiher, G (corresponding author), Jimma Univ, Coll Hlth Sci, POB 378, Jimma, Ethiopia.; Gebrezgabiher, G (corresponding author), Samara Univ, Coll Vet Med, POB 132, Samara, Ethiopia.	gebruska2012@yahoo.com	Ameni, Gobena/AAR-4201-2020; Zemene, Endalew/HHS-0999-2022; Asebe, Getahun/AAV-7235-2021; Gebrezgabiher, Gebremedhin/GLV-3693-2022	Ameni, Gobena/0000-0003-3987-0671; Zemene, Endalew/0000-0001-6810-5800; Asebe, Getahun/0000-0002-1123-4545	Dilla University [CAN/09/2012]; Graduate Study of Addis Ababa University; graduate school of Addis Ababa University	Dilla University; Graduate Study of Addis Ababa University; graduate school of Addis Ababa University	The research was funded by Dilla University (Grant No. CAN/09/2012) and Graduate Study of Addis Ababa University. The funding agents had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been part of the research project of Epidemiology and Public Health Importance of Bovine TB in Gedeo Zone, Southern Ethiopia. It has partly received financial support from both graduate school of Addis Ababa University and Dilla University (Grant No. CAN/09/2012). We are grateful to the TB Unit experts in the hospital who facilitated the data collection.	Ahlburg DA, 2000, EC IMPACTS TUBERCULO; Ayeno HD, 2014, IJPBS, V2, P2347; Bao QS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-344; Begum V, 2001, INT J TUBERC LUNG D, V5, P604; Berhe G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-537; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Dangisso MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114225; Diel R, 2003, INT J TUBERC LUNG D, V7, P124; Esmael A, 2014, INT J PHARM SCI RES, V5, P1500, DOI 10.13040/IJPSR.0975-8232.5(4).1500-05; Farah MG, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-14; Federal Democratic Republic of Ethiopia Ministry of Health (FMoH), 2014, Q HLTH B, V6; Fielder JF, 2002, INT J TUBERC LUNG D, V6, P1114; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Harries AD, 1999, T ROY SOC TROP MED H, V93, P443, DOI 10.1016/S0035-9203(99)90153-0; Liu JJ, 2005, INT J TUBERC LUNG D, V9, P450; MOH, 2019, TUB LEPR CAS MAN DES; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Parry E, 2004, PRINCIPLES MED AFRIC, V3rd; Ramos Jose Manuel, 2008, Ethiop Med J, V46, P173; Rodger AJ, 2002, B WORLD HEALTH ORGAN, V80, P451; Romanus V, 2000, Lakartidningen, V97, P5613; Santos L. C., 2012, OPEN J MED MICROBIOL, V2, P24, DOI DOI 10.4236/ojmm.2012.21004; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Sisay Solomon, 2014, BMC Res Notes, V7, P44, DOI 10.1186/1756-0500-7-44; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tadesse S., 2014, Health, V6, P306, DOI 10.4236/health.2014.65044; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; TRAC/FMOH TRAC, 2013, ROADM TUB OP RES ETH; Woldeyohannes Desalegn, 2011, Ethiop Med J, V49, P221; World Health Organization, 2008, GLOB TUB CONTR SURV; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2009, WHOHTMTB200940; Zellweger JP, 1998, INT J TUBERC LUNG D, V2, P372	33	70	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150560	10.1371/journal.pone.0150560	http://dx.doi.org/10.1371/journal.pone.0150560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918458	gold, Green Submitted, Green Published			2022-12-27	WOS:000371274400134
J	Hamaie, Y; Ohmuro, N; Katsura, M; Obara, C; Kikuchi, T; Ito, F; Miyakoshi, T; Matsuoka, H; Matsumoto, K				Hamaie, Yumiko; Ohmuro, Noriyuki; Katsura, Masahiro; Obara, Chika; Kikuchi, Tatsuo; Ito, Fumiaki; Miyakoshi, Tetsuo; Matsuoka, Hiroo; Matsumoto, Kazunori			Criticism and Depression among the Caregivers of At-Risk Mental State and First-Episode Psychosis Patients	PLOS ONE			English	Article							FAMILY ATTITUDE SCALE; EXPRESSED EMOTION; COMPREHENSIVE ASSESSMENT; YOUNG-PEOPLE; INVENTORY-II; FOLLOW-UP; SCHIZOPHRENIA; RELATIVES; BURDEN; ATTRIBUTIONS	Expressed emotion (EE), especially criticism, is an important predictor of outcomes for the patient for a wide range of mental health problems. To understand complex links between EE and various relevant variables in early phase psychosis, this study examined criticism, distress of caregivers, other patients', and caregivers' variables, and links between criticism and these variables in those with at-risk mental state (ARMS) for psychosis and first-episode psychosis (FEP). The participants were 56 patients (mean age 18.8 +/- 4.2 years) with ARMS and their caregivers (49.4 +/- 5.8 years) and 43 patients (21.7 +/- 5.2 years) with FEP and their caregivers (49.3 +/- 7.4 years). We investigated criticisms made by caregivers using the Japanese version of the Family Attitude Scale and caregiver depressive symptoms via the self-report Beck Depression Inventory. We also assessed psychiatric symptoms and functioning of the patients. Approximately one-third of caregivers of patients with ARMS or FEP had depressive symptoms, predominately with mild-to-moderate symptom levels, whereas only a small portion exhibited high criticism. The level of criticism and depression were comparable between ARMS and FEP caregivers. The link between criticism, caregivers' depression, and patients' symptoms were observed in FEP but not in ARMS caregivers. These findings imply that the interaction between criticism and caregivers' and patients' mental states may develop during or after the onset of established psychosis and interventions for the caregivers should be tailored to the patient's specific stage of illness. Interventions for FEP caregivers should target their emotional distress and include education about patient's general symptoms.	[Hamaie, Yumiko; Ohmuro, Noriyuki; Katsura, Masahiro; Ito, Fumiaki; Matsuoka, Hiroo] Tohoku Univ Hosp, Dept Psychiat, Sendai, Miyagi, Japan; [Hamaie, Yumiko; Obara, Chika; Kikuchi, Tatsuo; Matsuoka, Hiroo; Matsumoto, Kazunori] Tohoku Univ, Dept Psychiat, Grad Sch Med, Sendai, Miyagi 980, Japan; [Miyakoshi, Tetsuo] Chiba Prison, Chiba, Chiba, Japan; [Matsumoto, Kazunori] Tohoku Univ, Dept Prevent Psychiat, Grad Sch Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University; Tohoku University	Hamaie, Y (corresponding author), Tohoku Univ Hosp, Dept Psychiat, Sendai, Miyagi, Japan.; Hamaie, Y (corresponding author), Tohoku Univ, Dept Psychiat, Grad Sch Med, Sendai, Miyagi 980, Japan.	hama-ie72@umin.ac.jp		matsumoto, kazunori/0000-0002-5753-0104; Ohmuro, Noriyuki/0000-0001-6257-2715	Japan Society for the Promotion of Science [2578044, 22390219, 25461747]; Health and Labor Sciences Research Grants (Comprehensive Research on Disability, Health and Welfare) [H25-Seishin- Ippan-009]; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP [24-1, 25-1]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health and Labor Sciences Research Grants (Comprehensive Research on Disability, Health and Welfare); Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP(National Center for Neurology & Psychiatry - Japan)	This work was supported by Grant-in-Aid for Young Scientists (B) 2578044 and Grant-in-Aid for Scientific Research (B) 22390219 and (C) 25461747 from the Japan Society for the Promotion of Science, http://www.jsps.go.jp/j-grantsinaid/01_seido/04_seika/; Health and Labor Sciences Research Grants (Comprehensive Research on Disability, Health and Welfare, H25-Seishin- Ippan-009), http://mhlw-grants.niph.go.jp/; and Intramural Research Grant (24-1, 25-1) for Neurological and Psychiatric Disorders of NCNP, http://www.ncnp.go.jp/guide/cost.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addington J, 2003, ACTA PSYCHIAT SCAND, V108, P285, DOI 10.1034/j.1600-0447.2003.00153.x; Alvarez-Jimenez M, 2010, PSYCHOL MED, V40, P63, DOI 10.1017/S0033291708004765; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrowclough C, 1996, SCHIZOPHRENIA BULL, V22, P691, DOI 10.1093/schbul/22.4.691; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Beck AT, 1996, PSYCHOL ASSESS; BREWIN CR, 1991, J ABNORM PSYCHOL, V100, P546, DOI 10.1037/0021-843X.100.4.546; Butzlaff RL, 1998, ARCH GEN PSYCHIAT, V55, P547, DOI 10.1001/archpsyc.55.6.547; Cechnicki A, 2013, J PSYCHIATR RES, V47, P208, DOI 10.1016/j.jpsychires.2012.10.004; Clarke K, 2012, EARLY INTERV PSYCHIA, V6, P309, DOI 10.1111/j.1751-7893.2011.00335.x; Dominguez-Martinez T, 2014, PSYCHIAT RES, V218, P48, DOI 10.1016/j.psychres.2014.04.012; Dyck DG, 1999, PSYCHOSOM MED, V61, P411, DOI 10.1097/00006842-199907000-00001; Fujita H, 2002, PSYCHIAT RES, V110, P273, DOI 10.1016/S0165-1781(02)00108-7; Gleeson J, 1999, RECOGNITION MANAGEME, P376; Hooley JM, 2007, ANNU REV CLIN PSYCHO, V3, P329, DOI 10.1146/annurev.clinpsy.2.022305.095236; Hooley JM, 1998, J NERV MENT DIS, V186, P374, DOI 10.1097/00005053-199806000-00009; Hooley JM, 2002, PSYCHOL MED, V32, P1091, DOI 10.1017/S0033291702005779; Jansen JE, 2014, CLIN PSYCHOL PSYCHOT; Katsura M, 2014, SCHIZOPHR RES, V158, P32, DOI 10.1016/j.schres.2014.06.013; Kavanagh DJ, 1997, PSYCHIAT RES, V70, P185, DOI 10.1016/S0165-1781(97)00033-4; Kay S.R., 1991, POSITIVE NEGATIVE SY; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; King S, 2000, SCHIZOPHR RES, V45, P65, DOI 10.1016/S0920-9964(99)00174-7; Kojima M, 2002, PSYCHIAT RES, V110, P291, DOI 10.1016/S0165-1781(02)00106-3; Kuipers E, 2006, BRIT J PSYCHIAT, V188, P173, DOI 10.1192/bjp.bp.104.007294; Kuipers E, 2000, WIL CL PSY, P128; Linszen D, 1996, PSYCHOL MED, V26, P333, DOI 10.1017/S0033291700034723; Lowyck B, 2004, EUR PSYCHIAT, V19, P395, DOI 10.1016/j.eurpsy.2004.04.006; Magliano L, 2005, SOC SCI MED, V61, P313, DOI 10.1016/j.socscimed.2004.11.064; Martens L, 2001, SOC PSYCH PSYCH EPID, V36, P128, DOI 10.1007/s001270050301; McFarlane WR, 2007, FAM PROCESS, V46, P185, DOI 10.1111/j.1545-5300.2007.00203.x; McNab C, 2007, PSYCHIAT RES, V151, P97, DOI 10.1016/j.psychres.2006.08.004; Meneghelli A, 2011, PSYCHIAT RES, V189, P331, DOI 10.1016/j.psychres.2011.03.021; Miyakoshi T, 2009, EARLY INTERV PSYCHIA, V3, P123, DOI 10.1111/j.1751-7893.2009.00118.x; Mizuno M, 2012, ASIAN J PSYCHIATR, V5, P93, DOI 10.1016/j.ajp.2012.02.004; Mo F.M.Y., 2007, HONG KONG J PSYCHIAT, V17, P38; National Institute for Health and Clinical Excellanece, 2014, PSYCH SCHIZ AD PREV, pCG178; O'Brien MP, 2006, SCHIZOPHR RES, V81, P269, DOI 10.1016/j.schres.2005.10.005; Patterson P, 2005, BRIT J PSYCHIAT, V187, pS59, DOI 10.1192/bjp.187.48.s59; Pilling S, 2002, PSYCHOL MED, V32, P763, DOI 10.1017/S0033291702005895; Raune D, 2004, BRIT J PSYCHIAT, V184, P321, DOI 10.1192/bjp.184.4.321; Scazufca M, 1996, BRIT J PSYCHIAT, V168, P580, DOI 10.1192/bjp.168.5.580; Schlosser DA, 2010, SCHIZOPHR RES, V118, P69, DOI 10.1016/j.schres.2010.01.017; Shimodera S, 2000, COMPR PSYCHIAT, V41, P392, DOI 10.1053/comp.2000.9019; SMITH J, 1993, SOC PSYCH PSYCH EPID, V28, P11, DOI 10.1007/BF00797827; Steele A, 2010, J AFFECT DISORDERS, V121, P10, DOI 10.1016/j.jad.2009.04.020; Tienari P, 2003, AM J PSYCHIAT, V160, P1587, DOI 10.1176/appi.ajp.160.9.1587; Tomlinson E, 2014, EARLY INTERV PSYCHIA, V8, P253, DOI 10.1111/eip.12040; Vasconcelos ESD, 2013, SOC PSYCHIAT PSYCHIA; Vaughn C, 1999, J PSYCHOSOM RES, V47, P461, DOI 10.1016/S0022-3999(99)00047-1; Wearden AJ, 2000, CLIN PSYCHOL REV, V20, P633, DOI 10.1016/S0272-7358(99)00008-2; Yamada H, 1991, POSITIVE NEGATIVE SY; Yung AR, 2005, AUST NZ J PSYCHIAT, V39, P964, DOI 10.1080/j.1440-1614.2005.01714.x; Yung AR, 2003, SCHIZOPHR RES, V60, P21, DOI 10.1016/S0920-9964(02)00167-6; Yung AR, 1998, BRIT J PSYCHIAT, V172, P14, DOI 10.1192/S0007125000297602; Yung AR, 1996, SCHIZOPHRENIA BULL, V22, P283, DOI 10.1093/schbul/22.2.283	56	15	15	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149875	10.1371/journal.pone.0149875	http://dx.doi.org/10.1371/journal.pone.0149875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26918629	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400052
J	Isasi, CR; Jung, M; Parrinello, CM; Kaplan, RC; Kim, R; Crespo, NC; Gonzalez, P; Gouskova, NA; Penedo, FJ; Perreira, KM; Perrino, T; Sotres-Alvarez, D; Van Horn, L; Gallo, LC				Isasi, Carmen R.; Jung, Molly; Parrinello, Christina M.; Kaplan, Robert C.; Kim, Ryung; Crespo, Noe C.; Gonzalez, Patricia; Gouskova, Natalia A.; Penedo, Frank J.; Perreira, Krista M.; Perrino, Tatiana; Sotres-Alvarez, Daniela; Van Horn, Linda; Gallo, Linda C.			Association of Childhood Economic Hardship with Adult Height and Adult Adiposity among Hispanics/Latinos. The HCHS/SOL Socio-Cultural Ancillary Study	PLOS ONE			English	Article							BODY-MASS INDEX; ANTHROPOMETRIC INDICATORS; SOCIOECONOMIC POSITION; PSYCHOSOCIAL STRESS; BIRTH COHORT; DIET QUALITY; LATER LIFE; OBESITY; HEALTH; OVERWEIGHT	The study examined the association of childhood and current economic hardship with anthropometric indices in Hispanic/Latino adults, using data from the HCHS/SOL Socio-cultural ancillary study (N = 5,084), a community-based study of Hispanic/Latinos living in four urban areas (Bronx, NY, Chicago, IL, Miami, FL, and San Diego, CA). Childhood economic hardship was defined as having experienced a period of time when one's family had trouble paying for basic needs (e.g., food, housing), and when this economic hardship occurred: between 0-12, 13-18 years old, or throughout both of those times. Current economic hardship was defined as experiencing trouble paying for basic needs during the past 12 months. Anthropometry included height, body mass index (BMI), waist circumference (WC), and percentage body fat (%BF). Complex survey linear regression models were used to test the associations of childhood economic hardship with adult anthropometric indices, adjusting for potential confounders (e.g., age, sex, Hispanic background). Childhood economic hardship varied by Hispanic background, place of birth, and adult socio-economic status. Childhood economic hardship during both periods, childhood and adolescence, was associated with shorter height. Childhood economic hardship was associated with greater adiposity among US born individuals only. Current economic hardship was significantly associated with all three measures of adiposity (BMI, WC, %BF). These findings suggest that previous periods of childhood economic hardship appear to influence adult height more than adiposity, whereas current economic hardship may be a better determinant of adult adiposity in Hispanics.	[Isasi, Carmen R.; Jung, Molly; Parrinello, Christina M.; Kaplan, Robert C.; Kim, Ryung] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Crespo, Noe C.] Arizona State Univ, Sch Nutr & Hlth Promot, Phoenix, AZ USA; [Gonzalez, Patricia] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Gouskova, Natalia A.; Sotres-Alvarez, Daniela] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Penedo, Frank J.] Northwestern Univ, Dept Med Social Sci, Feinberg Sch Med, Chicago, IL 60611 USA; [Perreira, Krista M.] Univ N Carolina, Dept Publ Policy, Chapel Hill, NC USA; [Perrino, Tatiana] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Van Horn, Linda] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Gallo, Linda C.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA	Yeshiva University; Albert Einstein College of Medicine; Arizona State University; Arizona State University-Downtown Phoenix; California State University System; San Diego State University; University of North Carolina; University of North Carolina Chapel Hill; Northwestern University; Feinberg School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of Miami; Northwestern University; Feinberg School of Medicine; California State University System; San Diego State University	Isasi, CR (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	carmen.isasi@einstein.yu.edu	DeMarcus, Forrest/O-9190-2016; Sotres-Alvarez, Daniela/O-9085-2016	Sotres-Alvarez, Daniela/0000-0002-3226-6140; Gallo, Linda C./0000-0002-3678-5888	NHLBI [RC2HL101649]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL101649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The HCHS/SOL Socio-Cultural Ancillary Study was supported by grant number RC2HL101649 from NHLBI (http://www.nhlbi.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Calkins K, 2011, CURR PROB PEDIATR AD, V41, P158, DOI 10.1016/j.cppeds.2011.01.001; Casey PH, 2012, J PERINATOL, V32, P91, DOI 10.1038/jp.2011.75; Coly AN, 2006, J NUTR, V136, P2412, DOI 10.1093/jn/136.9.2412; Crimmins EM, 2005, SOC BIOL, V52, P164; Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Gallo LC, 2014, ETHNIC DIS, V24, P77; Gigante DP, 2009, EUR J CLIN NUTR, V63, P375, DOI 10.1038/sj.ejcn.1602949; Gonzalez D, 2009, CAD SAUDE PUBLICA, V25, pS427, DOI 10.1590/S0102-311X2009001500008; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Hernandez DC, 2014, J EPIDEMIOL COMMUN H, V68, P478, DOI 10.1136/jech-2013-203062; Howel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079027; Isasi CR, 2015, ANN EPIDEMIOL, V25, P84, DOI 10.1016/j.annepidem.2014.11.002; Kauhanen L, 2006, INT J EPIDEMIOL, V35, P962, DOI 10.1093/ije/dyl046; Kestila L, 2009, SCAND J PUBLIC HEALT, V37, P206, DOI 10.1177/1403494808100827; Khlat M, 2009, SOC SCI MED, V68, P1692, DOI 10.1016/j.socscimed.2009.02.024; Kivimaki M, 2006, HEART, V92, P474, DOI 10.1136/hrt.2005.067108; Klohe-Lehman DM, 2006, J AM DIET ASSOC, V106, P65, DOI 10.1016/j.jada.2005.09.047; Lavange LM, 2010, ANN EPIDEMIOL, V20, P642, DOI 10.1016/j.annepidem.2010.05.006; Leung CW, 2014, J ACAD NUTR DIET, V114, P1943, DOI 10.1016/j.jand.2014.06.353; Levine ME, 2015, SOC SCI MED, V130, P16, DOI 10.1016/j.socscimed.2015.01.030; Li HJ, 2003, AM J CLIN NUTR, V77, P1498, DOI 10.1093/ajcn/77.6.1498; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Nelson CP, 2015, N ENGL J MED; Nguyen BT, 2014, MAYO CLIN PROC, V89, P1211, DOI 10.1016/j.mayocp.2014.05.010; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Sachdev HS, 2005, AM J CLIN NUTR, V82, P456, DOI 10.1093/ajcn/82.2.456; Sarlio-Lahteenkorva S, 2007, ACTA PAEDIATR, V96, P26, DOI 10.1111/j.1651-2227.2007.00166.x; Senese LC, 2009, EPIDEMIOL REV, V31, P21, DOI 10.1093/epirev/mxp006; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; van der Horst K, 2007, HEALTH EDUC RES, V22, P203, DOI 10.1093/her/cyl069; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wormser D, 2012, INT J EPIDEMIOL, V41, P1419, DOI 10.1093/ije/dys086	33	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149923	10.1371/journal.pone.0149923	http://dx.doi.org/10.1371/journal.pone.0149923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919283	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400057
J	Kim, SY; Sim, S; Park, B; Kim, JH; Choi, HG				Kim, So Young; Sim, Songyong; Park, Bumjung; Kim, Jin-Hwan; Choi, Hyo Geun			High-Fat and Low-Carbohydrate Diets Are Associated with Allergic Rhinitis But Not Asthma or Atopic Dermatitis in Children	PLOS ONE			English	Article							NONDIGESTIBLE OLIGOSACCHARIDES; CHILDHOOD ASTHMA; PREVALENCE; ACIDS; RISK; SENSITIZATION; LACTATION; HABITS; HEALTH; MICE	Background Numerous studies have suggested that nutritional intake is related to allergic diseases. Although conflicting results exist, fat intake is often associated with allergic diseases. We investigated the relationship between allergic diseases and nutritional intake after adjusting for various demographic and socioeconomic factors in a large, representative sample of Korean children. Methods A total of 3,040 participants, aged 4 to 13 years old, were enrolled in the present study from the Korean National Health and Nutrition Examination Survey (KNHANES), 2010-2012. Nutritional intake data, including total calories, protein, fat, carbohydrate, vitamin A, vitamin C, thiamine, riboflavin, and niacin, were retrieved from the survey using the complete 24-hour recall method. The associations between each nutritional factor and allergic rhinitis/asthma/atopic dermatitis were analyzed using simple and multiple logistic regression analyses with complex sampling. Age, sex, body mass index (BMI), number of household members, income level, and region of residence were adjusted for as covariates. Results Of the participants, 22.1%, 6.0%, and 15.5% suffered from allergic rhinitis, asthma, and atopic dermatitis, respectively. Allergic rhinitis was significantly correlated with high-fat and low-carbohydrate diets. The adjusted odds ratio (AOR) was 1.25 (95% CIs = 1.06-1.46, P = 0.007) for fat intake, denoting a 10% increase. Carbohydrate intake (10% increase) was negatively related to allergic rhinitis with an AOR of 0.84 (95% CIs = 0.74-0.95, P = 0.004). No other significant relationships were found between the retrieved nutritional factors and either asthma or atopic dermatitis. Conclusion Allergic rhinitis was related to high-fat and low-carbohydrate diets. Although the underlying mechanisms and causal relationships remain elusive, the present study provides reliable evidence regarding the associations between nutritional factors and allergic rhinitis by considering numerous factors within a large and representative population.	[Kim, So Young] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul 110744, South Korea; [Kim, So Young] CHA Univ, Dept Otorhinolaryngol Head & Neck Surg, CHA Bundang Med Ctr, Seoul, South Korea; [Sim, Songyong; Choi, Hyo Geun] Hallym Univ, Dept Stat, Chunchon, South Korea; [Park, Bumjung] Hallym Univ, Sacred Heart Hosp, Dept Otorhinolaryngol Head & Neck Surg, Anyang, South Korea; [Kim, Jin-Hwan] Hallym Univ, Sacred Heart Hosp, Dept Otolaryngol Head & Neck Surg, Anyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; Pochon Cha University; Hallym University; Hallym University; Hallym University	Choi, HG (corresponding author), Hallym Univ, Dept Stat, Chunchon, South Korea.	pupen@naver.com	Choi, Hyo Geun/K-4461-2019	Choi, Hyo Geun/0000-0003-1655-9549	Hallym University Sacred Heart Hospital [HURF-2014-58]; National Research Foundation (NRF) of Korea [NRF-2015R1D1A1A01060860]	Hallym University Sacred Heart Hospital; National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by a Research Grant funded by Hallym University Sacred Heart Hospital (HURF-2014-58). This work was supported, in part, by a research grant (NRF-2015R1D1A1A01060860) funded by the National Research Foundation (NRF) of Korea.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; [Anonymous], 2014, GLOB ATL ALL; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Black PN, 1997, EUR RESPIR J, V10, P6, DOI 10.1183/09031936.97.10010006; Branum AM, 2009, PEDIATRICS, V124, P1549, DOI 10.1542/peds.2009-1210; Centers for Disease Control and Prevention, 2015, AB CHILD TEEN BMI, V5, P15; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Garn H, 2007, IMMUNOBIOLOGY, V212, P441, DOI 10.1016/j.imbio.2007.03.006; Hogenkamp A, 2015, J NUTR, V145, P996, DOI 10.3945/jn.115.210401; Hogenkamp A, 2015, J NUTR, V145, P640, DOI 10.3945/jn.114.197707; Huang SL, 2001, CLIN EXP ALLERGY, V31, P259, DOI 10.1046/j.1365-2222.2001.00938.x; Institute RRD, 2006, FOOD COMP TABL; Kim BK, 2016, ALLERGOL INT, V65, P186, DOI 10.1016/j.alit.2015.11.002; KOLETZKO B, 1992, ACTA PAEDIATR, V81, P302, DOI 10.1111/j.1651-2227.1992.tb12230.x; Lumia M, 2012, ACTA PAEDIATR, V101, pe337, DOI 10.1111/j.1651-2227.2012.02718.x; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; MANKU MS, 1984, BRIT J DERMATOL, V110, P643, DOI 10.1111/j.1365-2133.1984.tb04698.x; Mortz CG, 2015, ALLERGY, V70, P836, DOI 10.1111/all.12619; Nurmatov U, 2011, J ALLERGY CLIN IMMUN, V127, P724, DOI 10.1016/j.jaci.2010.11.001; Nwaru BI, 2014, J ALLERGY CLIN IMMUN, V133, P1084, DOI 10.1016/j.jaci.2013.12.1069; Okada Y, 2016, ALLERGOL INT, V65, P37, DOI 10.1016/j.alit.2015.06.010; Precht D, 1995, NAHRUNG, V39, P343, DOI 10.1002/food.19950390503; Raj D, 2014, IMMUNOL ALLERGY CLIN, V34, P753, DOI 10.1016/j.iac.2014.07.001; Schwarze J, 2002, EUR RESPIR J, V19, P341, DOI 10.1183/09031936.02.00254302; Seo JH, 2013, ALLERGY ASTHMA IMMUN, V5, P81, DOI 10.4168/aair.2013.5.2.81; Soh JY, 2015, ASIA PAC ALLERGY, V5, P17, DOI 10.5415/apallergy.2015.5.1.17; Tamay Z, 2014, ALLERGOL INT, V63, P553, DOI 10.2332/allergolint.13-OA-0661; Tamay Z, 2013, INT J PEDIATR OTORHI, V77, P1416, DOI 10.1016/j.ijporl.2013.05.014; The Korean Nutrition Society, 2010, DIET REF INT KOR 201; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Weiland SK, 1999, LANCET, V353, P2040, DOI 10.1016/S0140-6736(99)01609-8; Wollenberg A, 2013, ALLERGY, V68, P1509, DOI 10.1111/all.12324; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105	33	11	13	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150202	10.1371/journal.pone.0150202	http://dx.doi.org/10.1371/journal.pone.0150202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919190	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400103
J	Low, SK; Fukunaga, K; Takahashi, A; Matsuda, K; Hongo, F; Nakanishi, H; Kitamura, H; Inoue, T; Kato, Y; Tomita, Y; Fukasawa, S; Tanaka, T; Nishimura, K; Uemura, H; Hara, I; Fujisawa, M; Matsuyama, H; Hashine, K; Tatsugami, K; Enokida, H; Kubo, M; Miki, T; Mushiroda, T				Low, Siew-Kee; Fukunaga, Koya; Takahashi, Atsushi; Matsuda, Koichi; Hongo, Fumiya; Nakanishi, Hiroyuki; Kitamura, Hiroshi; Inoue, Takamitsu; Kato, Yoichiro; Tomita, Yoshihiko; Fukasawa, Satoshi; Tanaka, Tomoaki; Nishimura, Kazuo; Uemura, Hirotsugu; Hara, Isao; Fujisawa, Masato; Matsuyama, Hideyasu; Hashine, Katsuyoshi; Tatsugami, Katsunori; Enokida, Hideki; Kubo, Michiaki; Miki, Tsuneharu; Mushiroda, Taisei			Association Study of a Functional Variant on ABCG2 Gene with Sunitinib-Induced Severe Adverse Drug Reaction	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; SINGLE-NUCLEOTIDE POLYMORPHISMS; TYROSINE KINASE INHIBITORS; ENDOTHELIAL GROWTH-FACTOR; ANTITUMOR-ACTIVITY; INTERFERON-ALPHA; LUNG-CANCER; MUTATIONS; GEFITINIB; EFFICACY	Sunitinib is a tyrosine kinase inhibitor and used as the first-line treatment for advanced renal cell carcinoma (RCC). Nevertheless, inter-individual variability of drug's toxicity was often observed among patients who received sunitinib treatment. This study is to investigate the association of a functional germline variant on ABCG2 that affects the pharmacokinetics of sunitinib with sunitinib-induced toxicity of RCC patients in the Japanese population. A total of 219 RCC patients were recruited to this pharmacogenetic study. ABCG2 421C> A (Q141K) was genotyped by using PCR-Invader assay. The associations of both clinical and genetic variables were evaluated with logistic regression analysis and subsequently receiver operating characteristic (ROC) curve was plotted. About 43% (92/216) of RCC patients that received sunitinib treatment developed severe grade 3 or grade 4 thrombocytopenia according to the National Cancer Institute-Common Terminology Criteria for Adverse Events version 3.0, the most common sunitinib-induced adverse reaction in this study. In the univariate analysis, both age (P = 7.77x10(-3), odds ratio (OR) = 1.04, 95% CI = 1.01-1.07) and ABCG2 421C> A (P = 1.87x10(-2), OR = 1.71, 95% CI = 1.09-2.68) showed association with sunitinib-induced severe thrombocytopenia. Multivariate analysis indicated that the variant ABCG2 421C> A is suggestively associated with severe thrombocytopenia (P = 8.41x10(-3), OR = 1.86, 95% CI = 1.17-2.94) after adjustment of age as a confounding factor. The area under curve (AUC) of the risk prediction model that utilized age and ABCG2 421C>A was 0.648 with sensitivity of 0.859 and specificity of 0.415. Severe thrombocytopenia is the most common adverse reaction of sunitinib treatment in Japanese RCC patients. ABCG2 421C>A could explain part of the inter-individual variability of sunitinib-induced severe thrombocytopenia.	[Low, Siew-Kee; Fukunaga, Koya; Takahashi, Atsushi; Kubo, Michiaki; Mushiroda, Taisei] RIKEN Ctr Integrat Med Sci, Core Genom Med, Yokohama, Kanagawa, Japan; [Low, Siew-Kee] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Matsuda, Koichi] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Hongo, Fumiya; Nakanishi, Hiroyuki; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Kyoto, Japan; [Kitamura, Hiroshi] Sapporo Med Univ, Sapporo, Hokkaido, Japan; [Inoue, Takamitsu] Akita Univ, Sch Med, Akita 010, Japan; [Kato, Yoichiro] Iwate Med Univ, Morioka, Iwate 020, Japan; [Tomita, Yoshihiko] Yamagata Univ, Fac Med, Yamagata 990, Japan; [Fukasawa, Satoshi] Chiba Canc Ctr, 666-2 Nitonacho, Chiba 2608717, Japan; [Tanaka, Tomoaki] Osaka City Univ, Grad Sch Med, Osaka 558, Japan; [Nishimura, Kazuo] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan; [Uemura, Hirotsugu] Kinki Univ, Fac Med, Osakasayama, Japan; [Hara, Isao] Wakayama Med Univ, Wakayama, Japan; [Fujisawa, Masato] Kobe Univ, Grad Sch Med, Kobe, Hyogo 657, Japan; [Matsuyama, Hideyasu] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Hashine, Katsuyoshi] Shikoku Canc Ctr, Matsuyama, Ehime, Japan; [Tatsugami, Katsunori] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Enokida, Hideki] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	RIKEN; University of Sydney; University of Tokyo; Kyoto Prefectural University of Medicine; Sapporo Medical University; Akita University; Iwate Medical University; Yamagata University; Chiba Cancer Center; Osaka Metropolitan University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kindai University (Kinki University); Wakayama Medical University; Kobe University; Yamaguchi University; Kyushu University; Kagoshima University	Mushiroda, T (corresponding author), RIKEN Ctr Integrat Med Sci, Core Genom Med, Yokohama, Kanagawa, Japan.	mushiroda@riken.jp	Tanaka, Tomoaki/H-7837-2019; Kato, Yoichiro/H-8342-2019; Fukunaga, Koya/C-4180-2017; Matsuyama, Hideyasu/AAC-7487-2020; Nakanishi, Hiroyuki/AAD-9324-2020	Kato, Yoichiro/0000-0003-3778-9300; Fukunaga, Koya/0000-0002-5241-6062; Matsuyama, Hideyasu/0000-0001-5607-7769; Nakanishi, Hiroyuki/0000-0003-3982-3314; Inoue, Takamitsu/0000-0002-1362-4344; Low, Siew-Kee/0000-0003-2386-0698	Ministry of Education, Culture, Sports, Science and Technology of Japan; Pfizer, Inc.; Center for Integrative Medical Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pfizer, Inc.(Pfizer); Center for Integrative Medical Sciences	Supported in part by a Grant-in-Aid for Leading Project of Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. Kubo) and Pfizer, Inc. (to T. Miki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to express our heartfelt gratitude to all the patients who participate to this study. We would like to extend our gratitude to the members of the laboratory for statistical analysis, Center for Integrative Medical Sciences for their kind support and fruitful discussions.	Adams VR, 2007, CLIN THER, V29, P1338, DOI 10.1016/j.clinthera.2007.07.022; Arora A, 2005, J PHARMACOL EXP THER, V315, P971, DOI 10.1124/jpet.105.084145; Beuselinck B, 2013, BRIT J CANCER, V108, P887, DOI 10.1038/bjc.2012.548; Beuselinck B, 2014, ACTA ONCOL, V53, P103, DOI 10.3109/0284186X.2013.770600; Chow LQM, 2007, J CLIN ONCOL, V25, P884, DOI 10.1200/JCO.2006.06.3602; Cusatis G, 2008, PHARMACOGENOMICS, V9, P1005, DOI 10.2217/14622416.9.8.1005; Diekstra MHM, 2015, EUR UROL, V68, P621, DOI 10.1016/j.eururo.2015.04.018; Eechoute K, 2012, CLIN PHARMACOL THER, V92, P503, DOI 10.1038/clpt.2012.136; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Hegedus T, 2002, BBA-MOL BASIS DIS, V1587, P318, DOI 10.1016/S0925-4439(02)00095-9; Hong MH, 2009, CANCER RES TREAT, V41, P67, DOI 10.4143/crt.2009.41.2.67; Imai Y, 2002, MOL CANCER THER, V1, P611; Kim HR, 2013, CANCER CHEMOTH PHARM, V72, P825, DOI 10.1007/s00280-013-2258-y; Kim JJ, 2012, CANCER-AM CANCER SOC, V118, P1946, DOI 10.1002/cncr.26491; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Miyake H, 2013, INT J CLIN ONCOL, V18, P81, DOI 10.1007/s10147-011-0347-7; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Mizuno T, 2012, DRUG METAB PHARMACOK, V27, P631, DOI 10.2133/dmpk.DMPK-12-RG-026; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Motzer RJ, 2006, JAMA-J AM MED ASSOC, V295, P2516, DOI 10.1001/jama.295.21.2516; Noguchi K, 2009, ADV DRUG DELIVER REV, V61, P26, DOI 10.1016/j.addr.2008.07.003; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Scartozzi M, 2013, BRIT J CANCER, V108, P1126, DOI 10.1038/bjc.2012.501; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Uemura H, 2010, JPN J CLIN ONCOL, V40, P194, DOI 10.1093/jjco/hyp146; Vlaming MLH, 2009, ADV DRUG DELIVER REV, V61, P14, DOI 10.1016/j.addr.2008.08.007; Yoo C, 2010, JPN J CLIN ONCOL, V40, P980, DOI 10.1093/jjco/hyq073	29	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148177	10.1371/journal.pone.0148177	http://dx.doi.org/10.1371/journal.pone.0148177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914831	gold, Green Published			2022-12-27	WOS:000371175700004
J	Newman, JA; Cooper, CDO; Roos, AK; Aitkenhead, H; Oppermann, UCT; Cho, HJ; Osman, R; Gileadi, O				Newman, Joseph A.; Cooper, Christopher D. O.; Roos, Anette K.; Aitkenhead, Hazel; Oppermann, Udo C. T.; Cho, Hearn J.; Osman, Roman; Gileadi, Opher			Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MAGE PROTEINS; EXPRESSION; APOPTOSIS; GENES; MACROMOLECULES; SCATTERING; COMPLEXES; SYSTEM; FAMILY	The MAGE (melanoma associated antigen) protein family are tumour-associated proteins normally present only in reproductive tissues such as germ cells of the testis. The human genome encodes over 60 MAGE genes of which one class (containing MAGE-A3 and MAGE-A4) are exclusively expressed in tumours, making them an attractive target for the development of targeted and immunotherapeutic cancer treatments. Some MAGE proteins are thought to play an active role in driving cancer, modulating the activity of E3 ubiquitin ligases on targets related to apoptosis. Here we determined the crystal structures of MAGE-A3 and MAGE-A4. Both proteins crystallized with a terminal peptide bound in a deep cleft between two tandem-arranged winged helix domains. MAGE-A3 (but not MAGE-A4), is predominantly dimeric in solution. Comparison of MAGE-A3 and MAGE-A3 with a structure of an effector-bound MAGE-G1 suggests that a major conformational rearrangement is required for binding, and that this conformational plasticitymay be targeted by allosteric binders.	[Newman, Joseph A.; Cooper, Christopher D. O.; Roos, Anette K.; Aitkenhead, Hazel; Gileadi, Opher] Univ Oxford, ORCRB, Struct Genom Consortium, Roosevelt Dr, Oxford OX3 7DQ, England; [Oppermann, Udo C. T.] Univ Oxford, Botnar Res Ctr, NDORMS, Oxford OX3 7LD, England; [Cho, Hearn J.] Mt Sinai Sch Med, Tisch Canc Inst, Icahn 15-20B 1425 Madison Ave, New York, NY 10029 USA; [Osman, Roman] Mt Sinai Sch Med, Dept Struct & Chem Biol, Box 1677, New York, NY 10029 USA; [Cooper, Christopher D. O.] Univ Huddersfield, Sch Appl Sci, Dept Biol Sci, Huddersfield HD1 3DH, W Yorkshire, England; [Roos, Anette K.] Uppsala Univ, BMC, Sci Life Lab, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden	University of Oxford; University of Oxford; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Huddersfield; Uppsala University	Gileadi, O (corresponding author), Univ Oxford, ORCRB, Struct Genom Consortium, Roosevelt Dr, Oxford OX3 7DQ, England.	opher.gileadi@sgc.ox.ac.uk	Cooper, Chris/G-9982-2014; Gileadi, Opher/F-1105-2013	Cooper, Chris/0000-0002-9197-8041; newman, Joseph/0000-0003-4488-0516; Gileadi, Opher/0000-0001-6886-898X	AbbVie [1097737]; Bayer Pharma AG; Boehringer Ingelheim; Canada Foundation for Innovation; GlaxoSmithKline; Genome Canada; Janssen; Lilly Canada; Merck Co.; Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer; Sao Paulo Research Foundation-FAPESP; Takeda; Wellcome Trust [092809/Z/10/Z]; NIH [1 R21 CA191898-01]; NATIONAL CANCER INSTITUTE [R21CA191898] Funding Source: NIH RePORTER	AbbVie(AbbVie); Bayer Pharma AG; Boehringer Ingelheim(Boehringer Ingelheim); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); GlaxoSmithKline(GlaxoSmithKline); Genome Canada(Genome Canada); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Lilly Canada(Eli Lilly); Merck Co.(Merck & Company); Novartis Research Foundation; Ontario Ministry of Economic Development and Innovation; Pfizer(Pfizer); Sao Paulo Research Foundation-FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Takeda(Takeda Pharmaceutical Company Ltd); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Janssen, Lilly Canada, Merck & Co., the Novartis Research Foundation, the Ontario Ministry of Economic Development and Innovation, Pfizer, Sao Paulo Research Foundation-FAPESP, Takeda, and the Wellcome Trust [092809/Z/10/Z]. This work was partially funded by NIH grant 1 R21 CA191898-01 to HJC, RO and OG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; Bergeron A, 2009, INT J CANCER, V125, P1365, DOI 10.1002/ijc.24503; BRASSEUR F, 1995, INT J CANCER, V63, P375, DOI 10.1002/ijc.2910630313; Chng WJ, 2007, CANCER RES, V67, P2982, DOI 10.1158/0008-5472.CAN-06-4046; Chomez P, 2001, CANCER RES, V61, P5544; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; De Smet C, 1999, MOL CELL BIOL, V19, P7327; DESMET C, 1995, IMMUNOGENETICS, V42, P282, DOI 10.1007/BF00176446; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gure AO, 2005, CLIN CANCER RES, V11, P8055, DOI 10.1158/1078-0432.CCR-05-1203; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jungbluth AA, 2005, BLOOD, V106, P167, DOI 10.1182/blood-2004-12-4931; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Marcar L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127713; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagao T, 2003, J BIOL CHEM, V278, P10668, DOI 10.1074/jbc.M206104200; Nardiello T, 2011, CLIN CANCER RES, V17, P4309, DOI 10.1158/1078-0432.CCR-10-1820; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Picard V, 2007, INT J CANCER, V120, P2170, DOI 10.1002/ijc.22282; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Sakurai T, 2004, J BIOL CHEM, V279, P15505, DOI 10.1074/jbc.M310437200; Savitsky P, 2010, J STRUCT BIOL, V172, P3, DOI 10.1016/j.jsb.2010.06.008; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tyagi P, 2009, CLIN LUNG CANCER, V10, P371, DOI 10.3816/CLC.2009.n.052; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Xiao TZ, 2014, ARCH BIOCHEM BIOPHYS, V563, P136, DOI 10.1016/j.abb.2014.07.026; Yang B, 2007, CANCER RES, V67, P9954, DOI 10.1158/0008-5472.CAN-07-1478; Zhao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048240	38	21	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148762	10.1371/journal.pone.0148762	http://dx.doi.org/10.1371/journal.pone.0148762			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910052	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000371164700015
J	Sandoz, KM; Popham, DL; Beare, PA; Sturdevant, DE; Hansen, B; Nair, V; Heinzen, RA				Sandoz, Kelsi M.; Popham, David L.; Beare, Paul A.; Sturdevant, Daniel E.; Hansen, Bryan; Nair, Vinod; Heinzen, Robert A.			Transcriptional Profiling of Coxiella burnetii Reveals Extensive Cell Wall Remodeling in the Small Cell Variant Developmental Form	PLOS ONE			English	Article							LEGIONELLA-PNEUMOPHILA ENHC; Q-FEVER; STATIONARY-PHASE; ESCHERICHIA-COLI; PEPTIDOGLYCAN DEACETYLASE; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; CROSS-LINKING; PROTEIN; VIRULENCE	A hallmark of Coxiella burnetii, the bacterial cause of human Q fever, is a biphasic developmental cycle that generates biologically, ultrastructurally, and compositionally distinct large cell variant (LCV) and small cell variant (SCV) forms. LCVs are replicating, exponential phase forms while SCVs are non-replicating, stationary phase forms. The SCV has several properties, such as a condensed nucleoid and an unusual cell envelope, suspected of conferring enhanced environmental stability. To identify genetic determinants of the LCV to SCV transition, we profiled the C. burnetii transcriptome at 3 (early LCV), 5 (late LCV), 7 (intermediate forms), 14 (early SCV), and 21 days (late SCV) post-infection of Vero epithelial cells. Relative to early LCV, genes downregulated in the SCV were primarily involved in intermediary metabolism. Upregulated SCV genes included those involved in oxidative stress responses, arginine acquisition, and cell wall remodeling. A striking transcriptional signature of the SCV was induction (>7-fold) of five genes encoding predicted L, D transpeptidases that catalyze nonclassical 3-3 peptide cross-links in peptidoglycan (PG), a modification that can influence several biological traits in bacteria. Accordingly, of cross-links identified, muropeptide analysis showed PG of SCV with 46% 3-3 cross-links as opposed to 16% 3-3 cross-links for LCV. Moreover, electron microscopy revealed SCV with an unusually dense cell wall/ outer membrane complex as compared to LCV with its clearly distinguishable periplasm and inner and outer membranes. Collectively, these results indicate the SCV produces a unique transcriptome with a major component directed towards remodeling a PG layer that likely contributes to Coxiella's environmental resistance.	[Sandoz, Kelsi M.; Beare, Paul A.; Heinzen, Robert A.] NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA; [Popham, David L.] Virginia Tech, Dept Biol Sci, Blacksburg, VA USA; [Sturdevant, Daniel E.] NIAID, Genom Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA; [Hansen, Bryan; Nair, Vinod] NIAID, Electron Microscopy Unit, Res Technol Branch, Rocky Mt Labs,NIH, Hamilton, MT USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Virginia Polytechnic Institute & State University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Heinzen, RA (corresponding author), NIAID, Coxiella Pathogenesis Sect, Bacteriol Lab, Rocky Mt Labs,NIH, Hamilton, MT USA.	rheinzen@niaid.nih.gov	Popham, David L/F-8066-2015	Popham, David L/0000-0002-2614-143X	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000931, ZICAI001052] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute of Allergy and Infectious Diseases (RAH).	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Abraham RT, 2015, SCIENCE, V347, P128, DOI 10.1126/science.aaa4570; Agafonov DE, 2004, BIOCHEM BIOPH RES CO, V320, P354, DOI 10.1016/j.bbrc.2004.05.171; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; AMANO KI, 1984, J BACTERIOL, V160, P982, DOI 10.1128/JB.160.3.982-988.1984; AMANO KI, 1984, J BACTERIOL, V160, P989, DOI 10.1128/JB.160.3.989-993.1984; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Beare PA, 2014, J BACTERIOL, V196, P1925, DOI 10.1128/JB.01532-14; Beare PA, 2011, MBIO, V2, DOI 10.1128/mBio.00175-11; Beare PA, 2009, J BACTERIOL, V191, P1369, DOI 10.1128/JB.01580-08; Beare PA, 2009, INFECT IMMUN, V77, P642, DOI 10.1128/IAI.01141-08; Biarrotte-Sorin S, 2006, J MOL BIOL, V359, P533, DOI 10.1016/j.jmb.2006.03.014; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Blair DE, 2005, P NATL ACAD SCI USA, V102, P15429, DOI 10.1073/pnas.0504339102; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; BURTON PR, 1975, J BACTERIOL, V122, P316, DOI 10.1128/JB.122.1.316-324.1975; Caufrier F, 2003, CARBOHYD RES, V338, P687, DOI 10.1016/S0008-6215(03)00002-8; Chen DE, 2008, MICROBIOL-SGM, V154, P42, DOI 10.1099/mic.0.2007/010611-0; Cho BK, 2012, NAT CHEM BIOL, V8, P65, DOI 10.1038/nchembio.710; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; Coleman SA, 2004, J BACTERIOL, V186, P7344, DOI 10.1128/JB.186.21.7344-7352.2004; Cordillot M, 2013, ANTIMICROB AGENTS CH, V57, P5940, DOI 10.1128/AAC.01663-13; Davis KM, 2011, INFECT IMMUN, V79, P562, DOI 10.1128/IAI.00651-10; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Dowd MM, 2008, J BACTERIOL, V190, P4541, DOI 10.1128/JB.00249-08; ENRIGHT JB, 1957, AM J PUBLIC HEALTH N, V47, P695, DOI 10.2105/AJPH.47.6.695; French CE, 2008, FEMS MICROBIOL LETT, V279, P131, DOI 10.1111/j.1574-6968.2007.01011.x; GonzalezCastro MJ, 1997, J CHROMATOGR SCI, V35, P181, DOI 10.1093/chromsci/35.4.181; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hackert VH, 2012, CLIN INFECT DIS, V55, P1591, DOI 10.1093/cid/cis734; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Heinzen RA, 1999, TRENDS MICROBIOL, V7, P149, DOI 10.1016/S0966-842X(99)01475-4; Hovel-Miner G, 2010, J BACTERIOL, V192, P4504, DOI 10.1128/JB.00465-10; Hovel-Miner G, 2009, J BACTERIOL, V191, P2461, DOI 10.1128/JB.01578-08; Howe D, 2010, INFECT IMMUN, V78, P3465, DOI 10.1128/IAI.00406-10; Jin LH, 2005, J MOL BIOL, V346, P43, DOI 10.1016/j.jmb.2004.11.031; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Kaoukab-Raji A, 2012, MICROBES INFECT, V14, P619, DOI 10.1016/j.micinf.2012.01.009; Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10; KHAVKIN T, 1988, INFECT IMMUN, V56, P1792, DOI 10.1128/IAI.56.7.1792-1799.1988; Kloosterman TG, 2011, J BIOL CHEM, V286, P44594, DOI 10.1074/jbc.M111.295832; Kojima S, 2011, J BACTERIOL, V193, P2347, DOI 10.1128/JB.00106-11; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kroos L, 2003, J BACTERIOL, V185, P1128, DOI 10.1128/JB.184.4.1128-1146.2003; Kulkarni PR, 2006, NUCLEIC ACIDS RES, V34, P3361, DOI 10.1093/nar/gkl439; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; LENNETTE EH, 1951, AM J HYG, V54, P44, DOI 10.1093/oxfordjournals.aje.a119469; Li M, 2007, P NATL ACAD SCI USA, V104, P9469, DOI 10.1073/pnas.0702159104; Li WJ, 2013, CELL RES, V23, P728, DOI 10.1038/cr.2013.53; Liu MY, 2008, CELL MICROBIOL, V10, P1906, DOI 10.1111/j.1462-5822.2008.01180.x; Liu MY, 2012, CELL HOST MICROBE, V12, P166, DOI 10.1016/j.chom.2012.06.004; Lovering AL, 2012, ANNU REV BIOCHEM, V81, P451, DOI 10.1146/annurev-biochem-061809-112742; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; McCaul T. F., 1991, Q FEVER BIOL COXIELL, P223; MCCAUL TF, 1981, J BACTERIOL, V147, P1063, DOI 10.1128/JB.147.3.1063-1076.1981; MCCAUL TF, 1991, INFECT IMMUN, V59, P3243, DOI 10.1128/IAI.59.9.3243-3253.1991; McCaul TF, 1981, RICKETTSIAE RICKETTS, P267; Mertens K, 2012, ADV EXP MED BIOL, V984, P39, DOI 10.1007/978-94-007-4315-1_3; Million M, 2014, CLIN INFECT DIS, V59, P256, DOI 10.1093/cid/ciu259; Minnick MF, 2012, ADV EXP MED BIOL, V984, P231, DOI 10.1007/978-94-007-4315-1_12; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Narberhaus F, 2002, MICROBIOL MOL BIOL R, V66, P64, DOI 10.1128/MMBR.66.1.64-93.2002; Llorens JMN, 2010, FEMS MICROBIOL REV, V34, P476, DOI 10.1111/j.1574-6976.2010.00213.x; Newton HJ, 2011, MBIO, V2, DOI 10.1128/mBio.00226-11; Nystrom T, 2004, ANNU REV MICROBIOL, V58, P161, DOI 10.1146/annurev.micro.58.030603.123818; Omsland A, 2011, ANNU REV MICROBIOL, V65, P111, DOI 10.1146/annurev-micro-090110-102927; Omsland A, 2011, APPL ENVIRON MICROB, V77, P3720, DOI 10.1128/AEM.02826-10; Omsland A, 2009, P NATL ACAD SCI USA, V106, P4430, DOI 10.1073/pnas.0812074106; PISABARRO AG, 1985, J BACTERIOL, V161, P238, DOI 10.1128/JB.161.1.238-242.1985; Popham DL, 1996, J BACTERIOL, V178, P6451, DOI 10.1128/jb.178.22.6451-6458.1996; Porten K, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-147; Porter Sarah Rebecca, 2011, Int J Microbiol, V2011, P248418, DOI 10.1155/2011/248418; Puertollano Rosa, 2014, F1000Prime Rep, V6, P52, DOI 10.12703/P6-52; Quintela JC, 1997, MOL MICROBIOL, V23, P693, DOI 10.1046/j.1365-2958.1997.2561621.x; Ramond E, 2015, MOL CELL PROTEOMICS, V14, P870, DOI 10.1074/mcp.M114.044552; REEVE CA, 1984, J BACTERIOL, V157, P758, DOI 10.1128/JB.157.3.758-763.1984; Reguera RM, 2009, MOL BIOCHEM PARASIT, V165, P48, DOI 10.1016/j.molbiopara.2009.01.001; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sacco E, 2014, MBIO, V5, DOI 10.1128/mBio.01446-14; Sakoh M, 2005, J BIOL CHEM, V280, P33305, DOI 10.1074/jbc.M506180200; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Sanders AN, 2014, MICROBIOL-SGM, V160, P1795, DOI 10.1099/mic.0.078980-0; Sandoz KM, 2014, J MICROBIOL METH, V96, P104, DOI 10.1016/j.mimet.2013.11.010; Scheurwater EM, 2011, FEMS MICROBIOL LETT, V318, P1, DOI 10.1111/j.1574-6968.2011.02228.x; Schoonmaker MK, 2014, J BACTERIOL, V196, P1394, DOI 10.1128/JB.01396-13; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Shannon Jeffrey G., 2008, V431, P189; Stead CM, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-222; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; Stein A, 2005, INFECT IMMUN, V73, P2469, DOI 10.1128/IAI.73.4.2469-2477.2005; StJohn G, 1996, J BACTERIOL, V178, P1578, DOI 10.1128/jb.178.6.1578-1584.1996; Thomas AC, 2014, FRONT IMMUNOL, V5, DOI [10.3389/fimmu.2014.00479, 10.3389/fimmu.2014.00478]; TIGERTT WD, 1961, BACTERIOL REV, V25, P285, DOI 10.1128/MMBR.25.3.285-293.1961; Tissot-Dupont H, 2004, EMERG INFECT DIS, V10, P1264, DOI 10.3201/eid1007.030724; Tocheva EI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003442; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Virtaneva K, 2005, P NATL ACAD SCI USA, V102, P9014, DOI 10.1073/pnas.0503671102; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2004, J BACTERIOL, V186, P5978, DOI 10.1128/jb.186.18.5978-5987.2004; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wang G, 2009, J BIOL CHEM, V284, P6790, DOI 10.1074/jbc.M808071200; Warrier I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100147; Weichart D, 2003, J BACTERIOL, V185, P115, DOI 10.1128/JB.185.1.115-125.2003; WELSH HH, 1951, PUBLIC HEALTH REP, V66, P1473, DOI 10.2307/4587909; WILLIAMS JC, 1991, Q FEVER BIOL COXIELL, P21; Wong FH, 2012, J MOL MICROB BIOTECH, V22, P105, DOI 10.1159/000338542; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Zheng WH, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-98	121	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149957	10.1371/journal.pone.0149957	http://dx.doi.org/10.1371/journal.pone.0149957			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909555	Green Submitted, gold, Green Published			2022-12-27	WOS:000371164700056
J	VanderBeek, BL; Shah, N; Parikh, PC; Ma, LY				VanderBeek, Brian L.; Shah, Neepa; Parikh, Purak C.; Ma, Liyuan			Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort	PLOS ONE			English	Article							DEFERRED LASER; RANIBIZUMAB; DEGENERATION; TRIAL; MANAGEMENT; PROMPT	Purpose To evaluate how the monitoring and treatment for diabetic macular edema (DME) has changed in a national sample. Design Retrospective cohort study. Methods Setting: Administrative medical claims data from a large, national U.S. insurer. Study population: Beneficiaries of a U.S. insurance company. Observation procedures: All incident cases of DME were found. Those in years 2002/3, 2006 and 2010 were followed for a 2-year observation period and those from 2009, 2010 and 2011 for a 1-year observation period. Main Outcome Measures: Types and frequencies of treatment were tallied and compared over each of the cohorts. Results Two-year cohorts had 233, 251 and 756 patients in 2002/3, 2006 and 2010 respectively. One-year cohorts had 1002, 1119 and 1382 patients in 2009, 2010 and 2011, respectively. Both percentage of patients receiving therapy and number of treatments given increased across the 2-year cohorts for both focal laser and anti-vascular endothelial growth factor (anti-VEGF) (p<0.001). The highest use of anti-VEGF agents in any of the cohorts was in the 2011 1-year group that only averaged 3.78 injections. Focal laser was used 2.5x as frequently as anti-VEGF injections in the most recent cohorts with only a high of 14.0% of DME patients receiving anti-VEGF therapy in any of the cohorts. Conclusion Regardless of treatment modality (laser or injection) DME patients received vastly fewer treatments than patients in randomized control trials. Despite the proven superior visual outcomes of anti-VEGF agents over focal laser in DME, focal laser was still used more frequently.	[VanderBeek, Brian L.; Shah, Neepa; Parikh, Purak C.] Univ Penn, Perelman Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA; [VanderBeek, Brian L.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [VanderBeek, Brian L.; Ma, Liyuan] Univ Penn, Perelman Sch Med, Leonard Davis Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Dept Ophthalmol, Scheie Eye Inst, Philadelphia, PA 19104 USA.; VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.; VanderBeek, BL (corresponding author), Univ Penn, Perelman Sch Med, Leonard Davis Inst, Philadelphia, PA 19104 USA.	brian.vanderbeek@uphs.upenn.edu		VanderBeek, Brian L./0000-0003-4953-118X	National Institutes of Health K12 Award [K12-EY015398]; Scheie Eye Institute; Paul and Evanina Mackall Foundation; NATIONAL EYE INSTITUTE [K23EY025729, K12EY015398] Funding Source: NIH RePORTER	National Institutes of Health K12 Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scheie Eye Institute; Paul and Evanina Mackall Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Financial Support: National Institutes of Health K12 Award (Dr. Brian VanderBeek, K12-EY015398). Additional funding was provided in the form of block grants for general research purposes to the Scheie Eye Institute by Research to Prevent Blindness (no grant #; website:https://www.rpbusa.org/rpb/?) and the Paul and Evanina Mackall Foundation (no website or grant #). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bearelly S, 2008, ARCH OPHTHALMOL-CHIC, V126, P986, DOI 10.1001/archopht.126.7.986; Curtis LH, 2012, AM J OPHTHALMOL, V153, P1116, DOI 10.1016/j.ajo.2011.11.032; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Do DV, 2012, ARCH OPHTHALMOL-CHIC, P1; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Holekamp NM, 2014, AM J OPHTHALMOL, V157, P825, DOI 10.1016/j.ajo.2013.12.018; Jusufbegovic D, 2015, RETINA; Kiss S, 2014, CLIN OPHTHALMOL, V8, P1611, DOI 10.2147/OPTH.S60893; Lad EM, 2014, AM J OPHTHALMOL; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Mitchell P, 2012, BRIT J OPHTHALMOL, V96, P688, DOI 10.1136/bjophthalmol-2011-300726; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Rajendram R, 2012, ARCH OPHTHALMOL-CHIC, V130, P972, DOI 10.1001/archophthalmol.2012.393; Schneider EW, 2014, INVEST OPHTH VIS SCI, V55, P542, DOI 10.1167/iovs.13-13034; The Diabetic Retinopathy Clinical Research Network, 2015, NEW ENGLAND J MED; Varma R, 2014, JAMA OPHTHALMOL	17	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149450	10.1371/journal.pone.0149450	http://dx.doi.org/10.1371/journal.pone.0149450			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909797	gold, Green Published			2022-12-27	WOS:000371164700035
J	O'Brien, CC; Kolandaivelu, K; Brown, J; Lopes, AC; Kunio, M; Kolachalama, VB; Edelman, ER				O'Brien, Caroline C.; Kolandaivelu, Kumaran; Brown, Jonathan; Lopes, Augusto C.; Kunio, Mie; Kolachalama, Vijaya B.; Edelman, Elazer R.			Constraining OCT with Knowledge of Device Design Enables High Accuracy Hemodynamic Assessment of Endovascular Implants	PLOS ONE			English	Article							ENDOTHELIAL SHEAR-STRESS; OPTICAL COHERENCE TOMOGRAPHY; CORONARY-ARTERIES; IN-VIVO; INTRAVASCULAR ULTRASOUND; SCAFFOLD IMPLANTATION; ANGIOGRAPHIC DATA; DRUG DEPOSITION; FLOW; RECONSTRUCTION	Background Stacking cross-sectional intravascular images permits three-dimensional rendering of endovascular implants, yet introduces between-frame uncertainties that limit characterization of device placement and the hemodynamic microenvironment. In a porcine coronary stent model, we demonstrate enhanced OCT reconstruction with preservation of betweenframe features through fusion with angiography and a priori knowledge of stent design. Methods and Results Strut positions were extracted from sequential OCT frames. Reconstruction with standard interpolation generated discontinuous stent structures. By computationally constraining interpolation to known stent skeletons fitted to 3D 'clouds' of OCT-Angio-derived struts, implant anatomy was resolved, accurately rendering features from implant diameter and curvature (n = 1 vessels, r(2) = 0.91, 0.90, respectively) to individual strut-wall configurations (average displacement error similar to 15 mu m). This framework facilitated hemodynamic simulation (n = 1 vessel), showing the critical importance of accurate anatomic rendering in characterizing both quantitative and basic qualitative flow patterns. Discontinuities with standard approaches systematically introduced noise and bias, poorly capturing regional flow effects. In contrast, the enhanced method preserved multi-scale (local strut to regional stent) flow interactions, demonstrating the impact of regional contexts in defining the hemodynamic consequence of local deployment errors. Conclusion Fusion of planar angiography and knowledge of device design permits enhanced OCT image analysis of in situ tissue-device interactions. Given emerging interests in simulation-derived hemodynamic assessment as surrogate measures of biological risk, such fused modalities offer a new window into patient-specific implant environments.	[O'Brien, Caroline C.; Kolandaivelu, Kumaran; Brown, Jonathan; Lopes, Augusto C.; Kunio, Mie; Kolachalama, Vijaya B.; Edelman, Elazer R.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kolandaivelu, Kumaran; Lopes, Augusto C.; Kolachalama, Vijaya B.; Edelman, Elazer R.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Cardiovasc Div, Boston, MA 02115 USA; [Kolachalama, Vijaya B.] Charles Stark Draper Lab Inc, 555 Technol Sq, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; The Charles Stark Draper Laboratory, Inc.	O'Brien, CC (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ccob@mit.edu	Kolachalama, Vijaya B./AAH-3528-2020	Kolachalama, Vijaya B./0000-0002-5312-8644; Brown, Jonathan/0000-0002-4821-832X; Edelman, Elazer/0000-0002-7832-7156	NIH [R01 GM-49039]; AHA FTF Award [12FTF12080241]; Arie Research Fellowship from the Brazilian Society of Interventional Cardiology; NSF [OCI-1053575]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA FTF Award; Arie Research Fellowship from the Brazilian Society of Interventional Cardiology; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work was supported by a grant from the NIH (R01 GM-49039) to ERE. KK is supported in part by an AHA FTF Award (12FTF12080241). ACL is supported in part by an Arie Research Fellowship from the Brazilian Society of Interventional Cardiology. Computational work used the Extreme Science and Engineering Discovery Environment (XSEDE) supported by NSF (OCI-1053575).	Bezerra HG, 2009, JACC-CARDIOVASC INTE, V2, P1035, DOI 10.1016/j.jcin.2009.06.019; Bourantas CV, 2014, JACC-CARDIOVASC INTE, V7, P315, DOI 10.1016/j.jcin.2013.05.034; Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Bourantas CV, 2013, EUROINTERVENTION, V9, P582, DOI 10.4244/EIJV9I5A94; Bourantas CV, 2012, INT J CARDIOL, V155, pE24, DOI 10.1016/j.ijcard.2011.07.005; Capodanno D, 2014, EUROINTERVENTION; Coskun AU, 2003, CATHETER CARDIO INTE, V60, P67, DOI 10.1002/ccd.10594; Council NR., 2011, GUIDE CARE USE LAB A; Duraiswamy N, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118764; Ellwein LM., 2011, CARDIOVASC ENG TECHN, V2, P212, DOI [10.1007/s13239-011-0047-5, DOI 10.1007/S13239-011-0047-5]; Euthanasia APo, 2013, EUTH APO AVMA GUID E; Farooq V, 2013, EUR HEART J, V34, P875, DOI 10.1093/eurheartj/ehr409; Feldman CL, 2002, AM HEART J, V143, P931, DOI 10.1067/mhj.2002.123118; Foin N, 2014, CIRC-CARDIOVASC INTE, V7, P180, DOI 10.1161/CIRCINTERVENTIONS.113.000931; Gonzalo N, 2009, EUROINTERVENTION, V5, P224, DOI 10.4244/EIJV5I2A35; Grauer D, 2010, ANGLE ORTHOD, V80, P286, DOI 10.2319/030909-135.1; Haralick R.M., 1992, COMPUTER ROBOT VISIO, VVolume 1; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; Kolachalama VB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008105; Kolachalama VB, 2009, J CONTROL RELEASE, V133, P24, DOI 10.1016/j.jconrel.2008.09.075; Kolandaivelu K, 2014, J BIOMECH, V47, P908, DOI 10.1016/j.jbiomech.2014.01.006; Kolandaivelu K, 2011, CIRCULATION, V123, P1400, DOI 10.1161/CIRCULATIONAHA.110.003210; Koo BK, 2011, J AM COLL CARDIOL, V58, P1989, DOI 10.1016/j.jacc.2011.06.066; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; Maresca D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097215; Moller T., 1997, J GRAPH TOOL, V2, P21, DOI [DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Moore JE, 2002, ANN BIOMED ENG, V30, P498, DOI 10.1114/1.1458594; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; O'Brien CC, 2013, J CONTROL RELEASE, V168, P115, DOI 10.1016/j.jconrel.2013.03.014; Piegl L., 1997, MONOGRAPHS VISUAL CO; Prause GPM, 1997, INT J CARDIAC IMAG, V13, P451, DOI 10.1023/A:1005843222820; Slager CJ, 2000, CIRCULATION, V102, P511; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Tsantis S, 2012, MED PHYS, V39, P503, DOI 10.1118/1.3673067; Tu SX, 2011, INT J CARDIOVAS IMAG, V27, P197, DOI 10.1007/s10554-011-9809-2; Ughi GJ, 2012, INT J CARDIOVAS IMAG, V28, P229, DOI 10.1007/s10554-011-9824-3; Williams AR, 2010, J APPL PHYSIOL, V109, P532, DOI 10.1152/japplphysiol.00086.2010; Zhang L, 2002, PATTERN RECOGN LETT, V23, P1771, DOI 10.1016/S0167-8655(02)00151-4	38	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149178	10.1371/journal.pone.0149178	http://dx.doi.org/10.1371/journal.pone.0149178			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906566	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000006
J	Rooney, C; Geh, C; Williams, V; Heuckmann, JM; Menon, R; Schneider, P; Al-Kadhimi, K; Dymond, M; Smith, NR; Baker, D; French, T; Smith, PD; Harrington, EA; Barrett, JC; Kilgour, E				Rooney, Claire; Geh, Catherine; Williams, Victoria; Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra; Al-Kadhimi, Katherine; Dymond, Michael; Smith, Neil R.; Baker, Dawn; French, Tim; Smith, Paul D.; Harrington, Elizabeth A.; Barrett, J. Carl; Kilgour, Elaine			Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon	PLOS ONE			English	Article							CELL LUNG-CANCER; HUMAN BREAST-CANCER; MESSENGER-RNA; EXPRESSION; SENSITIVITY; SURVIVAL	FGFR1 amplification occurs in similar to 20% of sqNSCLC and trials with FGFR inhibitors have selected FGFR1 amplified patients by FISH. Lung cancer cell lines were profiled for sensitivity to AZD4547, a potent, selective inhibitor of FGFRs 1-3. Sensitivity to FGFR inhibition was associated with but not wholly predicted by increased FGFR1 gene copy number. Additional biomarker assays evaluating expression of FGFRs and correlation between amplification and expression in clinical tissues are therefore warranted. We validated nanoString for mRNA expression analysis of 194 genes, including FGFRs, from clinical tumour tissue. In a panel of sqNSCLC tumours 14.4% (13/90) were FGFR1 amplified by FISH. Although mean FGFR1 expression was significantly higher in amplified samples, there was significant overlap in the range of expression levels between the amplified and non-amplified cohorts with several non-amplified samples expressing FGFR1 to levels equivalent to amplified samples. Statistical analysis revealed increased expression of FGFR1 neighboring genes on the 8p12 amplicon (BAG4, LSM1 and WHSC1L1) in FGFR1 amplified tumours, suggesting a broad rather than focal amplicon and raises the potential for codependencies. High resolution aCGH analysis of pre-clinical and clinical samples supported the presence of a broad and heterogeneous amplicon around the FGFR1 locus. In conclusion, the range of FGFR1 expression levels in both FGFR1 amplified and non-amplified NSCLC tissues, together with the breadth and intra-patient heterogeneity of the 8p amplicon highlights the need for gene expression analysis of clinical samples to inform the understanding of determinants of response to FGFR inhibitors. In this respect the nanoString platform provides an attractive option for RNA analysis of FFPE clinical samples.	[Rooney, Claire; Geh, Catherine; Al-Kadhimi, Katherine; Smith, Neil R.; Baker, Dawn; Smith, Paul D.; Harrington, Elizabeth A.; Kilgour, Elaine] AstraZeneca, Oncol Innovat Med, Alderley Pk, Macclesfield, Cheshire, England; [Williams, Victoria; French, Tim] AstraZeneca, Personalised Healthcare & Biomarkers Innovat Med, Alderley Pk, Cambridge, England; [Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra] Blackfield AG, Cologne, Germany; [Dymond, Michael] AstraZeneca, Discovery Sci Innovat Med, Alderley Pk, Macclesfield, Cheshire, England; [Barrett, J. Carl] AstraZeneca Oncol Innovat Med, Gatehouse Pk, Waltham, MA USA; [Heuckmann, Johannes M.; Menon, Roopika; Schneider, Petra] NEO New Oncol AG, Cologne, Germany	AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca	Rooney, C (corresponding author), AstraZeneca, Oncol Innovat Med, Alderley Pk, Macclesfield, Cheshire, England.	claire.rooney@astrazeneca.com						Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dutt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020351; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Gelsi-Boyer W, 2005, MOL CANCER RES, V3, P655, DOI 10.1158/1541-7786.MCR-05-0128; Goke F, 2015, CLIN CANCER RES, V21, P4356, DOI 10.1158/1078-0432.CCR-14-3357; Kilgour E, 2014, J CLIN ONCOL S; Kim HR, 2013, J CLIN ONCOL, V31, P731, DOI 10.1200/JCO.2012.43.8622; Kohler LH, 2012, VIRCHOWS ARCH, V461, P49, DOI 10.1007/s00428-012-1250-y; Kotani H, 2016, ONCOGENE, V35, P3587, DOI 10.1038/onc.2015.426; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Malchers F, 2014, CANCER DISCOV, V4, P246, DOI 10.1158/2159-8290.CD-13-0323; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Ornitz DM, 2015, WIRES DEV BIOL, V4, P215, DOI 10.1002/wdev.176; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Wolf J, P 103 M AM ASS CANC; Wynes MW, 2014, CLIN CANCER RES, V20, P3299, DOI 10.1158/1078-0432.CCR-13-3060; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Yang ZQ, 2010, CANCER RES, V70, P8487, DOI 10.1158/0008-5472.CAN-10-1013; Zhang JC, 2012, CLIN CANCER RES, V18, P6658, DOI 10.1158/1078-0432.CCR-12-2694	26	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149628	10.1371/journal.pone.0149628	http://dx.doi.org/10.1371/journal.pone.0149628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905262	Green Published, gold, Green Submitted			2022-12-27	WOS:000371163000018
J	Hendrick, VJ; Hutchison, ZL; Last, KS				Hendrick, Vicki J.; Hutchison, Zoe L.; Last, Kim S.			Sediment Burial Intolerance of Marine Macroinvertebrates	PLOS ONE			English	Article							DREDGED MATERIAL; IMPACT; DYNAMICS; RECOVERY; COMMUNITIES; CESSATION; PATTERNS; SCALLOPS; BENTHOS; COAST	The marine environment contains suspended particulate matter which originates from natural and anthropogenic sources. Settlement of this material can leave benthic organisms susceptible to smothering, especially if burial is sudden i.e. following storms or activities such as dredging. Their survival will depend on their tolerance to, and their ability to escape from burial. Here we present data from a multi-factorial experiment measuring burial responses incorporating duration, sediment fraction and depth. Six macroinvertebrates commonly found in sediment rich environments were selected for their commercial and/or conservation importance. Assessments revealed that the brittle star (Ophiura ophiura), the queen scallop (Aequipecten opercularis) and the sea squirt (Ciona intestinalis) were all highly intolerant to burial whilst the green urchin (Psammichinus miliaris) and the anemone (Sagartiogeton laceratus), showed intermediate and low intolerance respectively, to burial. The least intolerant, with very high survival was the Ross worm (Sabellaria spinulosa). With the exception of C. intestinalis, increasing duration and depth of burial with finer sediment fractions resulted in increased mortality for all species assessed. For C. intestinalis depth of burial and sediment fraction were found to be inconsequential since there was complete mortality of all specimens buried for more than one day. When burial emergence was assessed O. ophiura emerged most frequently, followed by P. miliaris. The former emerged most frequently from the medium and fine sediments whereas P. miliaris emerged more frequently from coarse sediment. Both A. opercularis and S. laceratus showed similar emergence responses over time, with A. opercularis emerging more frequently under coarse sediments. The frequency of emergence of S. laceratus increased with progressively finer sediment and C. intestinalis did not emerge from burial irrespective of sediment fraction or depth. Finally, and perhaps unsurprisingly, the greatest ability to emerge from burial in all other species was from shallow (2 cm) burial. Although survival was consistently highly dependent on duration and depth of burial as expected, emergence behaviour was not as easily predictable thereby confounding predictions. We conclude that responses to burial are highly species specific and therefore tolerance generalisations are likely to be oversimplifications. These data may be used to inform environmental impact models that allow forecasting of the cumulative impacts of seabed disturbance and may provide mitigation measures for the sustainable use of the seabed.	[Hendrick, Vicki J.; Hutchison, Zoe L.; Last, Kim S.] Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland	UHI Millennium Institute	Last, KS (corresponding author), Scottish Assoc Marine Sci, Oban PA37 1QA, Argyll, Scotland.	kim.last@sams.ac.uk		Hutchison, Zoe/0000-0003-1866-7877	Marine Aggregate Levy Sustainability Fund (MALSF) [08/P76]; research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund [RE011]; FP7 Tidal Demonstration for Energy Scheme (TIDES) [322428]	Marine Aggregate Levy Sustainability Fund (MALSF); research consortium Marine Renewable Energy and the Environment (MaREE) - European Regional Development Fund; FP7 Tidal Demonstration for Energy Scheme (TIDES)	Funding was secured from the Marine Aggregate Levy Sustainability Fund (MALSF; grant number 08/P76) and the research consortium Marine Renewable Energy and the Environment (MaREE; grant number RE011) which was supported by the European Regional Development Fund. The work was also supported by the FP7 Tidal Demonstration for Energy Scheme (TIDES; grant number 322428). All funding was secured by KSL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besio G, 2008, OCEAN ENG, V35, P653, DOI 10.1016/j.oceaneng.2008.01.002; Boyd SE, 2005, ICES J MAR SCI, V62, P145, DOI 10.1016/j.icesjms.2004.11.014; Boyd SE, 2003, ESTUAR COAST SHELF S, V57, P209, DOI 10.1016/S0272-7714(02)00346-3; Bromirski PD, 2003, J CLIMATE, V16, P982, DOI 10.1175/1520-0442(2003)016<0982:SVATCC>2.0.CO;2; Cottrell RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147534; Dale AC, 2011, MAR POLLUT BULL, V62, P2433, DOI 10.1016/j.marpolbul.2011.08.024; Davies AJ, 2009, J EXP MAR BIOL ECOL, V370, P35, DOI 10.1016/j.jembe.2008.11.015; Foden J, 2009, MAR ECOL PROG SER, V390, P15, DOI 10.3354/meps08169; GLADFELTER WB, 1978, MAR BIOL, V47, P149, DOI 10.1007/BF00395636; Gooding S, 2012, ENV IMPACT SUBSEA TR; Green MO, 1997, MAR GEOL, V144, P97, DOI 10.1016/S0025-3227(97)00065-0; Guderley H, 2010, CAN J ZOOL, V88, P753, DOI 10.1139/Z10-039; Hall-Spencer JM, 2000, ICES J MAR SCI, V57, P1407, DOI 10.1006/jmsc.2000.0918; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hinchey EK, 2006, HYDROBIOLOGIA, V556, P85, DOI 10.1007/s10750-005-1029-0; Holt TJ, 1998, BIOGENIC REEFS OVERV, P170; Hutchison ZL, 2015, PLOSONE IN PRESS; Jackson A, 2008, ROSS WORM SABELLARIA; James E, 2007, UK SEA FISHERIES STA; Kenny AJ, 1991E27 ICES CM; KIRTLEY DW, 1968, J SEDIMENT PETROL, V38, P73; Kotta Jonne, 2009, Estonian Journal of Ecology, V58, P286, DOI 10.3176/eco.2009.4.04; KRANZ PM, 1974, J GEOL, V82, P237, DOI 10.1086/627961; MAURER D, 1981, MAR ENVIRON RES, V4, P299, DOI 10.1016/0141-1136(81)90043-X; MBA UK, MAR LIF INF NETW BIO; Mikkelsen OA, 2000, MAR GEOL, V170, P443, DOI 10.1016/S0025-3227(00)00105-5; Miles JR, 2001, J COASTAL RES, V17, P195; Miller DC, 2002, ECOL ENG, V19, P211, DOI 10.1016/S0925-8574(02)00081-2; Miller RG, 2013, FRONT ECOL ENVIRON, V11, P433, DOI 10.1890/120089; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Neill SP, 2012, RENEW ENERG, V37, P387, DOI 10.1016/j.renene.2011.07.003; Neill SP, 2009, RENEW ENERG, V34, P2803, DOI 10.1016/j.renene.2009.06.015; Newell RC, 1998, OCEANOGR MAR BIOL<D>, V36, P127; Newell RC, 2004, J COASTAL RES, P115; Nicolaidou A, 2003, J MAR BIOL ASSOC UK, V83, P1223, DOI 10.1017/S0025315403008531; PICKENS PE, 1988, J EXP BIOL, V135, P133; Precht E, 2004, LIMNOL OCEANOGR, V49, P693, DOI 10.4319/lo.2004.49.3.0693; Rees I., 2009, ASSESSMENT MODIOLUS; Roberts DA, 2012, ENVIRON INT, V40, P230, DOI 10.1016/j.envint.2011.11.013; Seiderer LJ, 1999, ICES J MAR SCI, V56, P757, DOI 10.1006/jmsc.1999.0495; SHICK JM, 1979, PHYSIOL ZOOL, V52, P50, DOI 10.1086/physzool.52.1.30159931; SHUMWAY SE, 1978, MAR BIOL, V48, P235, DOI 10.1007/BF00397150; Smith R, 2006, ESTUAR COAST SHELF S, V70, P207, DOI 10.1016/j.ecss.2006.04.026; Stronkhorst J, 2003, ENVIRON POLLUT, V124, P17, DOI 10.1016/S0269-7491(02)00430-X; Szostek CL, 2013, MAR ECOL PROG SER, V474, P155, DOI 10.3354/meps10088; Van Rijn L.C., 1993, PRINCIPLES SEDIMENT; Wilber DH, 2001, N AM J FISH MANAGE, V21, P855, DOI 10.1577/1548-8675(2001)021<0855:BEOSSA>2.0.CO;2; WILSON DOUGLAS P., 1929, JOUR MARINE BIOL ASSOC, V16, P221; WILSON DP, 1970, J MAR BIOL ASSOC UK, V50, P1, DOI 10.1017/S0025315400000576; Zuur Alain F., 2009, P1	51	12	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149114	10.1371/journal.pone.0149114	http://dx.doi.org/10.1371/journal.pone.0149114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901775	gold, Green Submitted, Green Published			2022-12-27	WOS:000371276100039
J	Ho, CMK; Donovan-Banfield, IZ; Tan, L; Zhang, TH; Gray, NS; Strang, BL				Ho, Catherine M. K.; Donovan-Banfield, I'ah Z.; Tan, Li; Zhang, Tinghu; Gray, Nathanael S.; Strang, Blair L.			Inhibition of IKK alpha by BAY61-3606 Reveals IKK alpha-Dependent Histone H3 Phosphorylation in Human Cytomegalovirus Infected Cells	PLOS ONE			English	Article							NF-KAPPA-B; PROTEIN-KINASE UL97; EPSTEIN-BARR-VIRUS; GENE-EXPRESSION; BINDING-SITES; UL84 PROTEIN; IE2 86; REPLICATION; TRANSCRIPTION; ACTIVATION	Protein kinase inhibitors can be used as tools to identify proteins and pathways required for virus replication. Using virus replication assays and western blotting we found that the widely used protein kinase inhibitor BAY61-3606 inhibits replication of human cytomegalovirus (HCMV) strain AD169 and the accumulation of HCMV immediate-early proteins in AD169 infected cells, but has no effect on replication of HCMV strain Merlin. Using in vitro kinase assays we found that BAY61-3606 is a potent inhibitor of the cellular kinase IKK alpha. Infection of cells treated with siRNA targeting IKK alpha indicated IKK alpha was required for efficient AD169 replication and immediate-early protein production. We hypothesized that IKK alpha was required for AD169 immediate-early protein production as part of the canonical NF-kappa B signaling pathway. However, although BAY61-3606 inhibited phosphorylation of the IKK alpha substrate I kappa B alpha, we found no canonical or non-canonical NF-kappa B signaling in AD169 infected cells. Rather, we observed that treatment of cells with BAY61-3606 or siRNA targeting IKK alpha decreased phosphorylation of histone H3 at serine 10 (H3S10p) in western blotting assays. Furthermore, we found treatment of cells with BAY61-3606, but not siRNA targeting IKK alpha, inhibited the accumulation of histone H3 acetylation (H3K9ac, H3K18ac and H3K27ac) and tri-methylation (H3K27me3 and H3K36me3) modifications. Therefore, the requirement for IKK alpha in HCMV replication was strain-dependent and during replication of an HCMV strain requiring IKK alpha, IKK alpha-dependent H3S10 phosphorylation was associated with efficient HCMV replication and immediate-early protein production. Plus, inhibition of HCMV replication by BAY61-3606 is associated with acetylation and tri-methylation modifications of histone H3 that do not involve IKK alpha.	[Ho, Catherine M. K.; Donovan-Banfield, I'ah Z.; Strang, Blair L.] Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England; [Tan, Li; Zhang, Tinghu; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Tan, Li; Zhang, Tinghu; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Longwood Ave, Boston, MA 02115 USA	St Georges University London; University of London; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Strang, BL (corresponding author), Univ London, Inst Infect & Immun, Cranmer Terrace, London SW17 0RE, England.	bstrang@sgul.ac.uk		Donovan-Banfield, I'ah/0000-0002-5124-2427; Strang, Blair/0000-0001-9407-1974; Tan, Li/0000-0002-1199-9046	St George's, University of London; St George's Impact & Innovation Award; PARK/WestFocus Award	St George's, University of London; St George's Impact & Innovation Award; PARK/WestFocus Award	New Investigator funds from St George's, University of London, a St George's Impact & Innovation Award and a PARK/WestFocus Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Benedict CA, 2004, J VIROL, V78, P741, DOI 10.1128/JVI.78.2.741-750.2004; BROWN K, 1993, P NATL ACAD SCI USA, V90, P2532, DOI 10.1073/pnas.90.6.2532; Caposio P, 2004, J VIROL, V78, P3190, DOI 10.1128/JVI.78.6.3190-3195.2004; Caposio P, 2007, ANTIVIR RES, V73, P175, DOI 10.1016/j.antiviral.2006.10.001; Cuevas-Bennett C, 2008, J VIROL, V82, P9525, DOI 10.1128/JVI.00946-08; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; DeMeritt IB, 2004, J VIROL, V78, P4498, DOI 10.1128/JVI.78.9.4498-4507.2004; Dong W, 2012, NUCLEIC ACIDS RES, V40, P2940, DOI 10.1093/nar/gkr1216; Ersing I, 2013, VIRUSES-BASEL, V5, P1587, DOI 10.3390/v5061587; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Gu SY, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-124; Gustems M, 2006, J VIROL, V80, P9899, DOI 10.1128/JVI.00640-06; He ZW, 1997, J VIROL, V71, P405, DOI 10.1128/JVI.71.1.405-411.1997; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Kew VG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004195; LAU KS, 2012, PLOS BIOL, V10, P24451, DOI DOI 10.1371/JOURNAL.PONE.0041343; Li G, 2014, J VIROL, V88, P6047, DOI 10.1128/JVI.00447-14; Loregian A, 2006, CHEM BIOL, V13, P191, DOI 10.1016/j.chembiol.2005.12.002; Lubin FD, 2007, NEURON, V55, P942, DOI 10.1016/j.neuron.2007.07.039; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; MARKHAM A, 1994, DRUGS, V48, P455, DOI 10.2165/00003495-199448030-00009; Mathers C, 2014, J VIROL, V88, P14289, DOI 10.1128/JVI.02552-14; Migawa MT, 1998, J MED CHEM, V41, P1242, DOI 10.1021/jm970545c; Mocarski E. S., 2015, FIELDS VIROLOGY, P1960; Monier K, 2000, NAT CELL BIOL, V2, P661, DOI 10.1038/35023615; Nevels M, 2004, P NATL ACAD SCI USA, V101, P17234, DOI 10.1073/pnas.0407933101; Penfold MET, 1997, VIROLOGY, V239, P46, DOI 10.1006/viro.1997.8848; Reeves MB, 2010, J GEN VIROL, V91, P599, DOI 10.1099/vir.0.015602-0; Rodems SM, 1998, J VIROL, V72, P2697, DOI 10.1128/JVI.72.4.2697-2707.1998; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Sanders RL, 2008, J VIROL, V82, P11383, DOI 10.1128/JVI.01293-08; Sanders RL, 2010, J VIROL, V84, P5158, DOI 10.1128/JVI.00090-10; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Stevenson EV, 2014, VIRUSES-BASEL, V6, P782, DOI 10.3390/v6020782; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; Strang BL, 2012, J VIROL, V86, P2089, DOI 10.1128/JVI.06720-11; Tan L, 2015, J MED CHEM, V58, P183, DOI 10.1021/jm500480k; Thorne JL, 2012, NUCLEIC ACIDS RES, V40, P7676, DOI 10.1093/nar/gks509; Wang SK, 2009, J GEN VIROL, V90, P2840, DOI 10.1099/vir.0.013037-0; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; White EA, 2007, J VIROL, V81, P2573, DOI 10.1128/JVI.02454-06; Whitmer T, 2015, J VIROL, V89, P8687, DOI 10.1128/JVI.01149-15; Wilkinson GWG, 2015, MED MICROBIOL IMMUN, V204, P273, DOI 10.1007/s00430-015-0411-4; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yurochko AD, 1997, J VIROL, V71, P5051, DOI 10.1128/JVI.71.7.5051-5059.1997; YUROCHKO AD, 1995, J VIROL, V69, P5391, DOI 10.1128/JVI.69.9.5391-5400.1995; Yurochko AD, 1997, J VIROL, V71, P4638, DOI 10.1128/JVI.71.6.4638-4648.1997; Zhu H, 2002, P NATL ACAD SCI USA, V99, P3932, DOI 10.1073/pnas.052713799	52	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150339	10.1371/journal.pone.0150339	http://dx.doi.org/10.1371/journal.pone.0150339			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930276	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500128
J	Kazmi, N; Gaunt, TR				Kazmi, Nabila; Gaunt, Tom R.			Diagnosis of Coronary Heart Diseases Using Gene Expression Profiling; Stable Coronary Artery Disease, Cardiac Ischemia with and without Myocardial Necrosis	PLOS ONE			English	Article							IDENTIFICATION; PREDICTION; EVENTS; TRANSCRIPTOME; BIOMARKERS; FAMILY	Cardiovascular disease (including coronary artery disease and myocardial infarction) is one of the leading causes of death in Europe, and is influenced by both environmental and genetic factors. With the recent advances in genomic tools and technologies there is potential to predict and diagnose heart disease using molecular data from analysis of blood cells. We analyzed gene expression data from blood samples taken from normal people (n = 21), non-significant coronary artery disease (n = 93), patients with unstable angina (n = 16), stable coronary artery disease (n = 14) and myocardial infarction (MI; n = 207). We used a feature selection approach to identify a set of gene expression variables which successfully differentiate different cardiovascular diseases. The initial features were discovered by fitting a linear model for each probe set across all arrays of normal individuals and patients with myocardial infarction. Three different feature optimisation algorithms were devised which identified two discriminating sets of genes, one using MI and normal controls (total genes = 6) and another one using MI and unstable angina patients (total genes = 7). In all our classification approaches we used a non-parametric k-nearest neighbour (KNN) classification method (k = 3). The results proved the diagnostic robustness of the final feature sets in discriminating patients with myocardial infarction from healthy controls. Interestingly it also showed efficacy in discriminating myocardial infarction patients from patients with clinical symptoms of cardiac ischemia but no myocardial necrosis or stable coronary artery disease, despite the influence of batch effects and different microarray gene chips and platforms.	[Kazmi, Nabila; Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England	University of Bristol	Kazmi, N (corresponding author), Univ Bristol, Sch Social & Community Med, MRC Integrat Epidemiol Unit, Bristol BS8 2BN, Avon, England.	nabila.kazmi@bristol.ac.uk	Gaunt, Tom R/O-3918-2014	Gaunt, Tom R/0000-0003-0924-3247	MRC [MC_UU_12013/8] Funding Source: UKRI; Medical Research Council [MC_UU_12013/8] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Archacki SR, 2003, PHYSIOL GENOMICS, V15, P65, DOI 10.1152/physiolgenomics.00181.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; de Planell-Saguer M, 2013, CLIN BIOCHEM, V46, P869, DOI 10.1016/j.clinbiochem.2013.02.017; DIXON KH, 1994, J BIOL CHEM, V269, P17; Doliana R, 2001, J BIOL CHEM, V276, P12003, DOI 10.1074/jbc.M011591200; Eggers KM, 2009, AM J CARDIOL, V103, P588, DOI 10.1016/j.amjcard.2008.11.007; Elashoff MR, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-26; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fushimi K, 2008, P NATL ACAD SCI USA, V105, P15708, DOI 10.1073/pnas.0805569105; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hossain MM, 2005, J BIOL CHEM, V280, P42442, DOI 10.1074/jbc.M509952200; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kiliszek M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050054; Kim J, 2014, GENOME MED, V6, DOI 10.1186/gm560; Kittleson MM, 2005, PHYSIOL GENOMICS, V21, P299, DOI 10.1152/physiolgenomics.00255.2004; Kittleson MM, 2004, CIRCULATION, V110, P3444, DOI 10.1161/01.CIR.0000148178.19465.11; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Masuda H, 1996, J BIOCHEM-TOKYO, V120, P415; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Min KD, 2010, BIOCHEM BIOPH RES CO, V393, P55, DOI 10.1016/j.bbrc.2010.01.076; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Pedrotty DM, 2012, PROG CARDIOVASC DIS, V55, P64, DOI 10.1016/j.pcad.2012.06.003; Raijmakers R, 2002, J MOL BIOL, V315, P809, DOI 10.1006/jmbi.2001.5265; Randi AM, 2003, J THROMB HAEMOST, V1, P829, DOI 10.1046/j.1538-7836.2003.00113.x; Ripley B. D., 1996, PATTERN RECOGNITION; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Suresh R, 2014, J MOL CELL CARDIOL, V74, P13, DOI 10.1016/j.yjmcc.2014.04.017; Tang Dong-ling, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P636; Thirumuruganathan S, 2010, DETAILED INTRO K NEA; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Timmer T, 1999, EUR J HUM GENET, V7, P478, DOI 10.1038/sj.ejhg.5200334; Tuncel H, 2012, INT J ONCOL, V41, P2079, DOI 10.3892/ijo.2012.1652; Venables W.N., 2002, MODERN APPL STAT S, Vfourth, DOI [DOI 10.1007/978-0-387-21706-2, 10.1007/978-0-387-21706-2]; Wang ZG, 2008, J MOL MED, V86, P771, DOI 10.1007/s00109-008-0341-3; Willenbrock H, 2004, LEUKEMIA, V18, P1270, DOI 10.1038/sj.leu.2403392; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Yang YH, 2003, INST MATH S, V40, P403	41	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149475	10.1371/journal.pone.0149475	http://dx.doi.org/10.1371/journal.pone.0149475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930047	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500028
J	Dietsch, GN; Lu, HL; Yang, Y; Morishima, C; Chow, LQ; Disis, ML; Hershberg, RM				Dietsch, Gregory N.; Lu, Hailing; Yang, Yi; Morishima, Chihiro; Chow, Laura Q.; Disis, Mary L.; Hershberg, Robert M.			Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity	PLOS ONE			English	Article							CD8(+) T-CELLS; NK CELLS; NALP3 INFLAMMASOME; IMMUNE-RESPONSES; CANCER CELLS; GENERATION; CRYSTALS; ENHANCE; TUMORS; HEAD	VTX-2337 (USAN: motolimod) is a selective toll-like receptor 8 (TLR8) agonist, which is in clinical development as an immunotherapy for multiple oncology indications, including squamous cell carcinoma of the head and neck (SCCHN). Activation of TLR8 enhances natural killer cell activation, increases antibody-dependent cell-mediated cytotoxicity, and induces Th1 polarizing cytokines. Here, we show that VTX-2337 stimulates the release of mature IL-1 beta and IL-18 from monocytic cells through coordinated actions on both TLR8 and the NOD-like receptor pyrin domain containing 3 (NLRP3) inflammasome complex. In vitro, VTX-2337 primed monocytic cells to produce pro-IL-1 beta, pro-IL-18, and caspase-1, and also activated the NLRP3 inflammasome, thereby mediating the release of mature IL-1 beta family cytokines. Inhibition of caspase-1 blocked VTX-2337-mediated NLRP3 inflammasome activation, but had little impact on production of other TLR8-induced mediators such as TNF alpha. IL-18 activated natural killer cells and complemented other stimulatory pathways, including Fc gamma RIII and NKG2D, resulting in IFN gamma production and expression of CD107a. NLRP3 activation in vivo was confirmed by a dose-related increase in plasma IL-1 beta and IL-18 levels in cynomolgus monkeys administered VTX-2337. These results are highly relevant to clinical studies of combination VTX-2337/cetuximab treatment. Cetuximab, a clinically approved, epidermal growth factor receptor-specific monoclonal antibody, activates NK cells through interactions with Fc gamma RIII and facilitates ADCC of tumor cells. Our preliminary findings from a Phase I open-label, dose-escalation, trial that enrolled 13 patients with recurrent or metastatic SCCHN show that patient NK cells become more responsive to stimulation by NKG2D or Fc gamma RIII following VTX-2337 treatment. Together, these results indicate that TLR8 stimulation and inflammasome activation by VTX-2337 can complement Fc gamma RIII engagement and may augment clinical responses in SCCHN patients treated with cetuximab.	[Dietsch, Gregory N.; Hershberg, Robert M.] VentiRx Pharmaceut, Seattle, WA USA; [Lu, Hailing; Yang, Yi; Morishima, Chihiro; Disis, Mary L.] Univ Washington, Ctr Translat Med Womens Hlth, Tumor Vaccine Grp, Seattle, WA 98195 USA; [Morishima, Chihiro] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Chow, Laura Q.] Univ Washington, Dept Med, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dietsch, GN (corresponding author), VentiRx Pharmaceut, Seattle, WA USA.	gdietsch@ventirx.com		Morishima, Chihiro/0000-0001-5330-9464	VentiRx Pharmaceuticals	VentiRx Pharmaceuticals	Funding for both basic research and the Phase 1b Clinical trial of VTX-2337 in squamous cell carcinoma of the head and neck (SCCHN) described in this manuscript was provided by VentiRx Pharmaceuticals. The company website is www.ventirx.com. The funder provided support in the form of salaries for multiple authors (HL, YY, MD). LC and CM are employed by the University of Washington, which conducted the clinical study sponsored by VentiRx Pharmaceuticals. Role of funders: VentiRx Pharmaceuticals employees Gregory N. Dietsch and Robert M. Hershberg played an active role in the study designs described in this manuscript, were involved in data collection and analysis of study data, the decision to publish, and the preparation of this manuscript. The specific roles of these authors (GD, RH) are articulated in the "author contributions" section.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Chen X, 2007, P NATL ACAD SCI USA, V104, P6329, DOI 10.1073/pnas.0611655104; Diefenbach A, 2002, IMMUNOL REV, V188, P9, DOI 10.1034/j.1600-065X.2002.18802.x; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Hart OM, 2005, J IMMUNOL, V175, P1636, DOI 10.4049/jimmunol.175.3.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Imai C, 2005, BLOOD, V106, P376, DOI 10.1182/blood-2004-12-4797; Kaifu T, 2011, CELL MOL LIFE SCI, V68, P3531, DOI 10.1007/s00018-011-0802-7; Liu J, 2010, MOL IMMUNOL, V47, P1083, DOI 10.1016/j.molimm.2009.11.003; Lopez-Albaitero A, 2009, CANCER IMMUNOL IMMUN, V58, P1855, DOI 10.1007/s00262-009-0697-4; Lu HL, 2006, CANCER RES, V66, P9754, DOI 10.1158/0008-5472.CAN-06-1083; Lu HL, 2012, CLIN CANCER RES, V18, P499, DOI 10.1158/1078-0432.CCR-11-1625; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mueller SC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-112; Pufnock JS, 2011, BLOOD, V117, P6542, DOI 10.1182/blood-2010-11-317966; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Roda JM, 2005, J IMMUNOL, V175, P1619, DOI 10.4049/jimmunol.175.3.1619; Schilling B, 2012, CANCER IMMUNOL IMMUN, V61, P1395, DOI 10.1007/s00262-011-1197-x; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Srivastava RM, 2013, CLIN CANCER RES, V19, P1858, DOI 10.1158/1078-0432.CCR-12-2426; Srivastava S, 2013, CANCER IMMUNOL IMMUN, V62, P1073, DOI 10.1007/s00262-013-1403-0; Stephenson RM, 2013, CANCER IMMUNOL IMMUN, V62, P1347, DOI 10.1007/s00262-013-1437-3; Stoll S, 1998, EUR J IMMUNOL, V28, P3231, DOI 10.1002/(SICI)1521-4141(199810)28:10<3231::AID-IMMU3231>3.0.CO;2-Q; Wysocka M, 2011, LEUKEMIA LYMPHOMA, V52, P1970, DOI 10.3109/10428194.2011.582202; Zhou ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036928	30	40	41	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0148764	10.1371/journal.pone.0148764	http://dx.doi.org/10.1371/journal.pone.0148764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928328	Green Submitted, Green Published, gold			2022-12-27	WOS:000371424200002
J	Dal Grande, E; Chittleborough, CR; Campostrini, S; Dollard, M; Taylor, AW				Dal Grande, Eleonora; Chittleborough, Catherine Ruth; Campostrini, Stefano; Dollard, Maureen; Taylor, Anne Winifred			Pre-Survey Text Messages (SMS) Improve Participation Rate in an Australian Mobile Telephone Survey: An Experimental Study	PLOS ONE			English	Article							CELL PHONE SURVEY; LANDLINE; US; NUMBERS	Mobile telephone numbers are increasingly being included in household surveys samples. As approach letters cannot be sent because many do not have address details, alternatives approaches have been considered. This study assesses the effectiveness of sending a short message service (SMS) to a random sample of mobile telephone numbers to increase response rates. A simple random sample of 9000 Australian mobile telephone numbers: 4500 were randomly assigned to be sent a pre-notification SMS, and the remaining 4500 did not have a SMS sent. Adults aged 18 years and over, and currently in paid employment, were eligible to participate. American Association for Public Opinion Research formulas were used to calculated response cooperation and refusal rates. Response and cooperation rate were higher for the SMS groups (12.4% and 28.6% respectively) than the group with no SMS (7.7% and 16.0%). Refusal rates were lower for the SMS group (27.3%) than the group with no SMS (35.9%). When asked, 85.8% of the pre-notification group indicated they remembered receiving a SMS about the study. Sending a pre-notification SMS is effective in improving participation in population-based surveys. Response rates were increased by 60% and cooperation rates by 79%.	[Dal Grande, Eleonora; Campostrini, Stefano; Taylor, Anne Winifred] Univ Adelaide, Sch Med, Populat Res & Outcome Studies, Adelaide, SA, Australia; [Chittleborough, Catherine Ruth] Univ Adelaide, Sch Populat Hlth, Adelaide, SA, Australia; [Campostrini, Stefano] Univ Ca Foscari, Venice, Italy; [Dollard, Maureen] Univ S Australia, Asia Pacific Ctr Work Hlth & Safety, Sch Psychol Social Work & Social Policy, Adelaide, SA 5001, Australia	University of Adelaide; University of Adelaide; Universita Ca Foscari Venezia; University of South Australia	Dal Grande, E (corresponding author), Univ Adelaide, Sch Med, Populat Res & Outcome Studies, Adelaide, SA, Australia.	eleonora.dalgrande@adelaide.edu.au	Dollard, Maureen/E-7040-2011; Taylor, Anne w/F-5708-2010; Chittleborough, Catherine/A-7436-2011	Dollard, Maureen/0000-0002-3128-8727; Taylor, Anne w/0000-0002-4422-7974; Chittleborough, Catherine/0000-0003-3196-7137; Campostrini, Stefano/0000-0002-7113-4458; Dal Grande, Eleonora/0000-0002-5919-3893	ARC; Safe Work Australia; SafeWork SA	ARC(Australian Research Council); Safe Work Australia; SafeWork SA	The project is supported by an ARC Discovery grant, an ARC Linkage grant, funding from Safe Work Australia and SafeWork SA, and involves the collaboration of industry experts and academics from across Australia and international institutions. The opinions expressed in this work are those of the authors and may not represent the position or policy of Safe work Australia or SafeWork SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2011 Census, 2011, TABLEBUILDER PRO INT; AAPOR, 2016, STAND DEF FIN DISP C; AAPOR Cell Phone Task Force, 2008, GUID CONS SURV RES P; Australian Bureau of Statistics, 2013, PROGR INT ASS AD COM; Australian Communication and Media Authority, 2014, COMM REP 2013 14; Australian Communications and Media Authority, 2014, 6 EM TRENDS MED COMM; Barr ML, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-177; Blumberg S. J., 2012, WIRELESS SUBSTITUTIO; Bosnjak M, 2010, SOC SCI COMPUT REV, V28, P350, DOI 10.1177/0894439309353395; Brick JM, 2007, PUBLIC OPIN QUART, V71, P23, DOI 10.1093/poq/nfl040; Brick JM, 2011, PUBLIC OPIN QUART, V75, P872, DOI 10.1093/poq/nfr045; Brick JM, 2007, ADV TELEPHONE SURVEY, P149; Buskirk TD, 2008, MY CELL PHONES RINGI; Dal Grande E, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-77; De Leeuw E, 2007, PUBLIC OPIN QUART, V71, P413, DOI 10.1093/poq/nfm014; Dollard M.F., AUSTR WORKPLACE BARO; DuBray P, 2013, FEDERAL COMMITTEE ST; Guterbock TM, 2011, SOC SCI RES, V40, P860, DOI 10.1016/j.ssresearch.2011.01.001; Hader M, 2012, TELEPHONE SURVEYS EU; Hu SS, 2011, AM J EPIDEMIOL, V173, P703, DOI 10.1093/aje/kwq442; Kannisto KA, 2014, J MED INTERNET RES, V16, P100, DOI 10.2196/jmir.3442; Kempf AM, 2007, ANNU REV PUBL HEALTH, V28, P113, DOI 10.1146/annurev.publhealth.28.021406.144059; Kuusela V., 2007, ADV TELEPHONE SURVEY, P87; Lepkowski J.M., 2008, ADV TELEPHONE SURVEY; Link MW, 2007, PUBLIC OPIN QUART, V71, P814, DOI 10.1093/poq/nfm051; Livingston M, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-41; Mohorko A, 2013, SURV METHODS INSIGHT, P0; Pierannunzi Carol, 2012, Morbidity and Mortality Weekly Report, V61, P410; Sampleworxs Pty Ltd, 2014, MOB RAND DIG DIALL R; Steeh C, 2007, FIELD METHOD, V19, P59, DOI 10.1177/1525822X06292852; Tesfaye, 2014, MOBILE TECHNOLOGIES; Ward C, 2013, HOME IS COOPERATION; Zhu S, 2014, P SOC INF TECHN TEAC, P1724	33	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150231	10.1371/journal.pone.0150231	http://dx.doi.org/10.1371/journal.pone.0150231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919558	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000371274400106
J	Welzenbach, J; Neuhoff, C; Looft, C; Schellander, K; Tholen, E; Grosse-Brinkhaus, C				Welzenbach, Julia; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tholen, Ernst; Grosse-Brinkhaus, Christine			Different Statistical Approaches to Investigate Porcine Muscle Metabolome Profiles to Highlight New Biomarkers for Pork Quality Assessment	PLOS ONE			English	Article							MEAT QUALITY; DRIP LOSS; POSTMORTEM; MECHANISMS; REGRESSION; INDUCTION; GENES; PIGS	The aim of this study was to elucidate the underlying biochemical processes to identify potential key molecules of meat quality traits drip loss, pH of meat 1 h post-mortem (pH1), pH in meat 24 h post-mortem (pH24) and meat color. An untargeted metabolomics approach detected the profiles of 393 annotated and 1,600 unknown metabolites in 97 Duroc x Pietrain pigs. Despite obvious differences regarding the statistical approaches, the four applied methods, namely correlation analysis, principal component analysis, weighted network analysis (WNA) and random forest regression (RFR), revealed mainly concordant results. Our findings lead to the conclusion that meat quality traits pH1, pH24 and color are strongly influenced by processes of post-mortem energy metabolism like glycolysis and pentose phosphate pathway, whereas drip loss is significantly associated with metabolites of lipid metabolism. In case of drip loss, RFR was the most suitable method to identify reliable biomarkers and to predict the phenotype based on metabolites. On the other hand, WNA provides the best parameters to investigate the metabolite interactions and to clarify the complex molecular background of meat quality traits. In summary, it was possible to attain findings on the interaction of meat quality traits and their underlying biochemical processes. The detected key metabolites might be better indicators of meat quality especially of drip loss than the measured phenotype itself and potentially might be used as bio indicators.	[Welzenbach, Julia; Neuhoff, Christiane; Looft, Christian; Schellander, Karl; Tholen, Ernst; Grosse-Brinkhaus, Christine] Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany	University of Bonn	Grosse-Brinkhaus, C (corresponding author), Univ Bonn, Inst Anim Sci, Endenicher Allee 15, D-53115 Bonn, Germany.	cgro@itw.uni-bonn.de	Welzenbach, Julia/K-1794-2019; Große-Brinkhaus, Christine/AAF-6712-2020	Große-Brinkhaus, Christine/0000-0002-6190-4463	Federal Ministry of Education and Research (BMBF) Germany [0315536E]	Federal Ministry of Education and Research (BMBF) Germany(Federal Ministry of Education & Research (BMBF))	Authors are grateful to Dierk-Christoph Pother from Metabolomic Discoveries GmbH who performed the metabolite profiling. This work was a part of the Phanomics (Network of competence agricultural and nutritional research) project and supported by the Federal Ministry of Education and Research (BMBF) Germany (grant nr. 0315536E).; The work is part of the project Phanomics (Network of competence agricultural and nutritional research) project and was supported by the Federal Ministry of Education and Research (BMBF) Germany (grant nr.: 0315536E).	Acharjee A, 2011, ANAL CHIM ACTA, V705, P56, DOI 10.1016/j.aca.2011.03.050; Batagelj V, 2002, LECT NOTES COMPUT SC, V2265, P477; Bertram HC, 2010, MEAT SCI, V84, P108, DOI 10.1016/j.meatsci.2009.08.031; Binke R, 2004, FLEISCHWIRTSCHAFT, V84, P224; Boulesteix AL, 2012, WIRES DATA MIN KNOWL, V2, P493, DOI 10.1002/widm.1072; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chagoyen M, 2013, BRIEF BIOINFORM, V14, P737, DOI 10.1093/bib/bbs055; Ciobanu DC, 2011, GENETICS OF THE PIG, 2ND EDITION, P355, DOI 10.1079/9781845937560.0355; D'Alessandro A, 2011, J PROTEOMICS, V75, P610, DOI 10.1016/j.jprot.2011.08.024; DiLeo MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026683; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Guyon I., 2006, FEATURE EXTRACTION F, V207; Hidalgo FJ, 2013, FOOD CHEM, V140, P183, DOI 10.1016/j.foodchem.2013.02.052; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; HONIKEL KO, 1986, FLEISCHWIRTSCHAFT, V66, P349; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; Jolliffe IT, 2003, J COMPUT GRAPH STAT, V12, P531, DOI 10.1198/1061860032148; Lambert IH, 2001, J AGR FOOD CHEM, V49, P4876, DOI 10.1021/jf010121y; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu G, 2007, ANIM GENET, V38, P241, DOI 10.1111/j.1365-2052.2007.01592.x; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; MacLennan NK, 2009, MOL GENET METAB, V98, P203, DOI 10.1016/j.ymgme.2009.05.004; Muroya S, 2014, MEAT SCI, V98, P726, DOI 10.1016/j.meatsci.2014.07.018; Nicodemus KK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-110; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Pas M. F. W. te, 2011, Journal on Chain and Network Science, V11, P155, DOI 10.3920/JCNS2011.Qpork6; Ponsuksili S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-367; Poulsen KA, 2007, J AGR FOOD CHEM, V55, P1970, DOI 10.1021/jf062341n; Rohart F, 2012, J ANIM SCI, V90, P4729, DOI 10.2527/jas.2012-5338; Schafer A, 2002, MEAT SCI, V61, P355, DOI 10.1016/S0309-1740(01)00205-4; Scheffler TL, 2007, MEAT SCI, V77, P7, DOI 10.1016/j.meatsci.2007.04.024; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Strobl C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-307; Terenina E, 2013, DOMEST ANIM ENDOCRIN, V44, P81, DOI 10.1016/j.domaniend.2012.09.004; Toldra F, 2000, FOOD CHEM, V69, P387, DOI 10.1016/S0308-8146(00)00052-2; Verbeke W, 2010, MEAT SCI, V84, P284, DOI 10.1016/j.meatsci.2009.05.001; Wishart DS, 2011, BIOANALYSIS, V3, P1769, DOI [10.4155/bio.11.155, 10.4155/BIO.11.155]; Zentralverband der Deutschen Schweineproduktion ZDS, 2003, RICHTL STAT MASTL SC	44	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149758	10.1371/journal.pone.0149758	http://dx.doi.org/10.1371/journal.pone.0149758			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919205	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400044
J	Chmura, GL; Kellman, L; van Ardenne, L; Guntenspergen, GR				Chmura, Gail L.; Kellman, Lisa; van Ardenne, Lee; Guntenspergen, Glenn R.			Greenhouse Gas Fluxes from Salt Marshes Exposed to Chronic Nutrient Enrichment	PLOS ONE			English	Article							NITROUS-OXIDE FLUXES; CARBON; BAY; METHANE; FUNDY; WETLANDS; SOILS	We assessed the impact of nutrient additions on greenhouse gas fluxes using dark static chambers in a microtidal and a macrotidal marsh along the coast of New Brunswick, Canada approximately monthly over a year. Both were experimentally fertilized for six years with varying levels of N and P. For unfertilized, N and NPK treatments, average yearly CO2 emissions (which represent only respiration) at the microtidal marsh (13, 19, and 28 mmoles CO2 m(-2) hr(-1), respectively) were higher than at the macrotidal marsh (12, 15, and 19 mmoles m(-2) hr(-1), respectively, with a flux under the additional high N/low P treatment of 21 mmoles m(-2) hr(-1)). Response of CH4 to fertilization was more variable. At the macrotidal marsh average yearly fluxes were 1.29, 1.26, and 0.77 mu mol CH4 m(-2) hr(-1) with control, N, and NPK treatments, respectively and 1.21 mu mol m(-2) hr(-1) under high N/low P treatment. At the microtidal marsh CH4 fluxes were 0.23, 0.16, and -0.24 mu mol CH4 m(-2) hr(-1) in control, N, and NPK and treatments, respectively. Fertilization changed soils from sinks to sources of N2O. Average yearly N2O fluxes at the macrotidal marsh were -0.07, 0.08, and 1.70, mu mol N(2)Om(-2) hr(-1) in control, N, NPK and treatments, respectively and 0.35 mu mol m(-2) hr(-1) under high N/low P treatment. For the control, N, and NPK treatments at the microtidal marsh N2O fluxes were -0.05, 0.30, and 0.52 mu mol N(2)Om(-2) hr(-1), respectively. Our results indicate that N2O fluxes are likely to vary with the source of pollutant nutrients but emissions will be lower if N is not accompanied by an adequate supply of P (e.g., atmospheric deposition vs sewage or agricultural runoff). With chronic fertilization the global warming potential of the increased N2O emissions may be enough to offset the global cooling potential of the C sequestered by salt marshes.	[Chmura, Gail L.; van Ardenne, Lee] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Kellman, Lisa] St Francis Xavier Univ, Environm Sci Res Ctr, Antigonish, NS B2G 1C0, Canada; [Guntenspergen, Glenn R.] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA	McGill University; Saint Francis Xavier University - Canada; United States Department of the Interior; United States Geological Survey	Chmura, GL (corresponding author), McGill Univ, Dept Geog, Montreal, PQ, Canada.	gail.chmura@mcgill.ca		van Ardenne, Lee/0000-0002-2759-7869; Chmura, Gail/0000-0001-7163-3903	Natural Sciences and Engineering Research Council of Canada; US Geological Survey Climate and Land Use Research and Development program; St. Francis Xavier University	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); US Geological Survey Climate and Land Use Research and Development program; St. Francis Xavier University	Natural Sciences and Engineering Research Council of Canada Discovery Grant Program GLC, LK. US Geological Survey Climate and Land Use Research and Development program GRG. St. Francis Xavier University James Chair Fellowship GLC. Natural Sciences and Engineering Research Council of Canada Graduate Fellowship LvA.	[Anonymous], 2003, GLOBAL BIOGEOCHEM CY, DOI DOI 10.1029/2002GB001917; [Anonymous], 2000, CAN TID CURR TABL, V2; Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Byers SE, 2007, ESTUAR COAST, V30, P869; Canadian Hydrographic Survey, 2000, CAN TID CURR TABL, V1; Childers DL, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P391; Chmura GL, 2001, A312 NAT RES CAN; Connor RF, 2001, GLOBAL BIOGEOCHEM CY, V15, P943, DOI 10.1029/2000GB001346; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Daoust RJ, 1996, J COASTAL RES, V12, P520; Darby FA, 2008, MAR ECOL PROG SER, V363, P63, DOI 10.3354/meps07423; Davies J.L., 1964, Z GEOMORPHOL, V8, P27; Grunfeld S, 1999, AQUAT BOT, V64, P63, DOI 10.1016/S0304-3770(99)00010-8; Irvine IC, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00090; Kronvang B, 2005, J ENVIRON QUAL, V34, P2129, DOI 10.2134/jeq2004.0439; Liikanen A, 2009, BOREAL ENVIRON RES, V14, P351; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Magenheimer JF, 1996, ESTUARIES, V19, P139, DOI 10.2307/1352658; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; McVicar K, 2014, BIOGEOCHEMISTRY, V120, P225, DOI 10.1007/s10533-014-9992-z; Morris J. T., 2014, PERSPECTIVES RESTORA, P111; Moseman-Valtierra S, 2011, ATMOS ENVIRON, V45, P4390, DOI 10.1016/j.atmosenv.2011.05.046; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Neubauer SC, 2015, ECOSYSTEMS, V18, P1000, DOI 10.1007/s10021-015-9879-4; Neubauer SC, 2014, LANDSCAPE ECOL, V29, P571, DOI 10.1007/s10980-014-9986-1; Poffenbarger HJ, 2011, WETLANDS, V31, P831, DOI 10.1007/s13157-011-0197-0; Seitzinger SP, 1998, GLOBAL BIOGEOCHEM CY, V12, P93, DOI 10.1029/97GB03657; Sundareshwar PV, 2003, SCIENCE, V299, P563, DOI 10.1126/science.1079100; Tobias CR, 2001, LIMNOL OCEANOGR, V46, P1977, DOI 10.4319/lo.2001.46.8.1977; Tobias C, 2019, COASTAL WETLANDS: AN INTEGRATED ECOSYSTEM APPROACH, 2ND EDITION, P539, DOI 10.1016/B978-0-444-63893-9.00016-2; Van Drecht G, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003458; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Yu O, 2010, ENVIRON CONSERV, V36, P312, DOI DOI 10.1017/S0376892910000184; [No title captured]	34	30	30	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149937	10.1371/journal.pone.0149937	http://dx.doi.org/10.1371/journal.pone.0149937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914333	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700039
J	Li, QL; Xie, J; Wang, BJ; Li, R; Bai, J; Ding, L; Gu, R; Wang, L; Xu, BA				Li, Qiaoling; Xie, Jun; Wang, Bingjian; Li, Ran; Bai, Jian; Ding, Liang; Gu, Rong; Wang, Lian; Xu, Biao			Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy	PLOS ONE			English	Article							FAILING HEART; GROWTH; INHIBITION; MECHANISMS; PREVENTS	Pathological cardiomyocyte hypertrophy is associated with significantly increased risk of heart failure, one of the leading medical causes of mortality worldwide. MicroRNAs are known to be involved in pathological cardiac remodeling. However, whether miR-99a participates in the signaling cascade leading to cardiac hypertrophy is unknown. To evaluate the role of miR-99a in cardiac hypertrophy, we assessed the expression of miR-99a in hypertrophic cardiomyocytes induced by isoprenaline (ISO)/angiotensin-II (Ang II) and in mice model of cardiac hypertrophy induced by transverse aortic constriction (TAC). Expression of miR-99a was evaluated in these hypertrophic cells and hearts. We also found that miR99a expression was highly correlated with cardiac function of mice with heart failure (8 weeks after TAC surgery). Overexpression of miR-99a attenuated cardiac hypertrophy in TAC mice and cellular hypertrophy in stimuli treated cardiomyocytes through down-regulation of expression of mammalian target of rapamycin (mTOR). These results indicate that miR-99a negatively regulates physiological hypertrophy through mTOR signaling pathway, which may provide a new therapeutic approach for pressure-overload heart failure.	[Li, Qiaoling; Xie, Jun; Li, Ran; Bai, Jian; Ding, Liang; Gu, Rong; Wang, Lian; Xu, Biao] Nanjing Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Bingjian] Nanjing Med Univ, Drum Tower Clin Hosp, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Xu, BA (corresponding author), Nanjing Univ, Affiliated Hosp, Nanjing Drum Tower Hosp, Dept Cardiol, Nanjing 210008, Jiangsu, Peoples R China.	xubiao@medmail.com.cn	li, ran/GPW-6786-2022; xie, jun/C-2193-2017	xie, jun/0000-0002-9385-3242; Ding, Liang/0000-0002-1043-0923	Natural Science Foundations of China [81071859, 81000055, 81200148, 81270281, 81200092]; Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Jiangsu Provincial Special Program of Medical Science [BL2012014]; State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901]; Peak of Six Personnel in Jiangsu Province [2013-WSN-008]; Funds for Distinguished Young Scientists in Nanjing; Natural Science Foundation of Jiangsu Province Youth Fund Project [BK20150106]	Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Jiangsu Key Laboratory for Molecular Medicine of Nanjing University; Jiangsu Provincial Special Program of Medical Science; State Key Laboratory of Pharmaceutical Biotechnology; Peak of Six Personnel in Jiangsu Province; Funds for Distinguished Young Scientists in Nanjing; Natural Science Foundation of Jiangsu Province Youth Fund Project	This work was supported by grants from the Natural Science Foundations of China [Research Grants 81071859, 81000055, 81200148, 81270281 and 81200092], and Jiangsu Key Laboratory for Molecular Medicine of Nanjing University [Research Grant 2008], Jiangsu Provincial Special Program of Medical Science (BL2012014), and the State Key Laboratory of Pharmaceutical Biotechnology [KF-GN-200901], and the Peak of Six Personnel in Jiangsu Province (2013-WSN-008), and Funds for Distinguished Young Scientists in Nanjing (Xie Jun), Natural Science Foundation of Jiangsu Province Youth Fund Project, Qiaoling Li, BK20150106.	Aurora AB, 2012, J CLIN INVEST, V122, P1222, DOI 10.1172/JCI59327; Barry SP, 2010, INT REV CEL MOL BIO, V284, P113, DOI 10.1016/S1937-6448(10)84003-1; BONNIN CM, 1983, J MOL CELL CARDIOL, V15, P245, DOI 10.1016/0022-2828(83)90279-1; Buss SJ, 2009, J AM COLL CARDIOL, V54, P2435, DOI 10.1016/j.jacc.2009.08.031; Buss SJ, 2006, ENDOCRINOLOGY, V147, P2526, DOI 10.1210/en.2005-1167; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Du XN, 2012, CANCER RES, V72, P5843, DOI 10.1158/0008-5472.CAN-12-1329; Eulalio A, 2012, NATURE, V492, P376, DOI 10.1038/nature11739; Fiedler J, 2013, ARTERIOSCL THROM VAS, V33, P201, DOI 10.1161/ATVBAHA.112.300137; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hu SJ, 2010, CIRCULATION, V122, pS124, DOI 10.1161/CIRCULATIONAHA.109.928424; Iekushi K, 2012, CIRCULATION, V125, P1765, DOI 10.1161/CIRCULATIONAHA.111.079699; Katz AM, 2002, CARDIOVASC DRUG THER, V16, P245, DOI 10.1023/A:1020604623427; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Lee A, 2014, ANTIOXID REDOX SIGNA; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Lerman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020916; Li RC, 2013, CIRC RES, V112, P601, DOI 10.1161/CIRCRESAHA.112.300806; Liao YL, 2002, AM J PHYSIOL-HEART C, V282, pH1703, DOI 10.1152/ajpheart.00238.2001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2003, P NATL ACAD SCI USA, V100, P12355, DOI 10.1073/pnas.1934654100; MORGAN HE, 1987, ANNU REV PHYSIOL, V49, P533; Nanka O, 2012, CARDIOVASC RES, V93, pS92, DOI 10.1093/cvr/cvr336; Oneyama C, 2011, ONCOGENE, V30, P3489, DOI 10.1038/onc.2011.63; Qin FZ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00084.2014; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Sen S, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.004796; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Sun DD, 2011, CANCER RES, V71, P1313, DOI 10.1158/0008-5472.CAN-10-1031; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Walker N, 2013, J HEART LUNG TRANSPL, V32, pS28, DOI 10.1016/j.healun.2013.01.054	35	27	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0148480	10.1371/journal.pone.0148480	http://dx.doi.org/10.1371/journal.pone.0148480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914935	gold, Green Submitted, Green Published			2022-12-27	WOS:000371175700005
J	MacDonald, ME; Forkert, ND; Pike, GB; Frayne, R				MacDonald, M. Ethan; Forkert, Nils D.; Pike, G. Bruce; Frayne, Richard			Phase Error Correction in Time-Averaged 3D Phase Contrast Magnetic Resonance Imaging of the Cerebral Vasculature	PLOS ONE			English	Article							BASE-LINE CORRECTION; FLOW MEASUREMENT; BLOOD-FLOW; OFFSET ERRORS; MR; QUANTIFICATION; ACCURACY; IMAGES	Purpose Volume flow rate (VFR) measurements based on phase contrast (PC)-magnetic resonance (MR) imaging datasets have spatially varying bias due to eddy current induced phase errors. The purpose of this study was to assess the impact of phase errors in time averaged PC-MR imaging of the cerebral vasculature and explore the effects of three common correction schemes (local bias correction (LBC), local polynomial correction (LPC), and whole brain polynomial correction (WBPC)). Methods Measurements of the eddy current induced phase error from a static phantom were first obtained. In thirty healthy human subjects, the methods were then assessed in background tissue to determine if local phase offsets could be removed. Finally, the techniques were used to correct VFR measurements in cerebral vessels and compared statistically. Results In the phantom, phase error was measured to be <2.1 ml/s per pixel and the bias was reduced with the correction schemes. In background tissue, the bias was significantly reduced, by 65.6% (LBC), 58.4%(LPC) and 47.7%(WBPC) (p < 0.001 across all schemes). Correction did not lead to significantly different VFR measurements in the vessels (p = 0.997). In the vessel measurements, the three correction schemes led to flow measurement differences of -0.04 +/- 0.05 ml/s, 0.09 +/- 0.16 ml/s, and -0.02 +/- 0.06 ml/s. Although there was an improvement in background measurements with correction, there was no statistical difference between the three correction schemes (p = 0.242 in background and p = 0.738 in vessels). Conclusions While eddy current induced phase errors can vary between hardware and sequence configurations, our results showed that the impact is small in a typical brain PC-MR protocol and does not have a significant effect on VFR measurements in cerebral vessels.	[MacDonald, M. Ethan; Forkert, Nils D.; Pike, G. Bruce; Frayne, Richard] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [MacDonald, M. Ethan; Forkert, Nils D.; Pike, G. Bruce; Frayne, Richard] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [MacDonald, M. Ethan; Forkert, Nils D.; Pike, G. Bruce; Frayne, Richard] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [MacDonald, M. Ethan; Pike, G. Bruce; Frayne, Richard] Alberta Hlth Serv, Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Alberta Health Services (AHS); University of Calgary	MacDonald, ME (corresponding author), Univ Calgary, Dept Radiol, Calgary, AB, Canada.; MacDonald, ME (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada.; MacDonald, ME (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.; MacDonald, ME (corresponding author), Alberta Hlth Serv, Foothills Med Ctr, Seaman Family MR Res Ctr, Calgary, AB, Canada.	memacdon@ucalgary.ca	Forkert, Nils Daniel/K-6273-2012; Frayne, Richard/AAA-9217-2021; Pike, Bruce/K-5562-2014	Forkert, Nils Daniel/0000-0003-2556-3224; Frayne, Richard/0000-0003-0358-1210; Pike, Bruce/0000-0001-8924-683X; MacDonald, M Ethan/0000-0001-5421-3536	Natural Science and Engineering Research Council (NSERC); Canadian Institutes for Health Research (CHIR); NSERC CREATE I3T program	Natural Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CHIR)(Canadian Institutes of Health Research (CIHR)); NSERC CREATE I3T program	Operational funding for this project was provided through the Natural Science and Engineering Research Council (NSERC) and the Canadian Institutes for Health Research (CHIR). Alberta Health Services and the University of Calgary also contributed resources. MEM holds a postdoctoral fellowship award through the NSERC CREATE I3T program. GBP is the Campus Alberta Innovation Program (CAIP) Chair of healthy brain aging. RF is the Hopewell Professor of Brain Imaging.	Bernstein MA, 1998, MAGN RESON MED, V39, P300, DOI 10.1002/mrm.1910390218; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Busch J, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0097-6; Cebral JR, 2009, J ENG MATH, V64, P367, DOI 10.1007/s10665-009-9266-2; Chernobelsky A, 2007, J CARDIOVASC MAGN R, V9, P681, DOI 10.1080/10976640601187588; Dyverfeldt P, 2008, J MAGN RESON IMAGING, V28, P655, DOI 10.1002/jmri.21475; FRAYNE R, 1992, JMRI-J MAGN RESON IM, V2, P605, DOI 10.1002/jmri.1880020522; Gach HM, 1998, MAGNET RESON MED, V40, P427, DOI 10.1002/mrm.1910400313; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Gatehouse PD, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-72; Gatehouse PD, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-5; Giese D, 2012, MAGN RESON MED, V67, P1294, DOI 10.1002/mrm.23111; Holland BJ, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-11; Jiang J, 2015, MAGN RESON IMAGING, V33, P185, DOI 10.1016/j.mri.2014.10.009; Johnson KM, 2008, MAGN RESON MED, V60, P1329, DOI 10.1002/mrm.21763; Lankhaar JW, 2005, J MAGN RESON IMAGING, V22, P73, DOI 10.1002/jmri.20361; Lotz J, 2002, RADIOGRAPHICS, V22, P651, DOI 10.1148/radiographics.22.3.g02ma11651; MacDonald Matthew Ethan, 2015, Radiol Case Rep, V10, P1109, DOI 10.2484/rcr.v10i2.1109; MacDonald ME, 2015, NMR BIOMED, V28, P767, DOI 10.1002/nbm.3322; MacDonald ME, 2015, PHYSIOL MEAS, V36, P1517, DOI 10.1088/0967-3334/36/7/1517; Markl M, 2003, MAGN RESON MED, V50, P791, DOI 10.1002/mrm.10582; Middione MJ, 2013, MAGN RESON MED, V69, P391, DOI 10.1002/mrm.24262; Rolf MP, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-18; Spees WM, 2011, J MAGN RESON, V212, P116, DOI 10.1016/j.jmr.2011.06.016; Swailes NE, 2011, J MAGN RESON IMAGING, V34, P941, DOI 10.1002/jmri.22688; TANG C, 1993, JMRI-J MAGN RESON IM, V3, P377, DOI 10.1002/jmri.1880030213; WALKER PG, 1993, JMRI-J MAGN RESON IM, V3, P521, DOI 10.1002/jmri.1880030315	27	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149930	10.1371/journal.pone.0149930	http://dx.doi.org/10.1371/journal.pone.0149930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910600	gold, Green Submitted, Green Published			2022-12-27	WOS:000371164700054
J	Saunders, A; Huang, KW; Sabatini, BL				Saunders, Arpiar; Huang, Kee Wui; Sabatini, Bernardo Luis			Globus Pallidus Externus Neurons Expressing parvalbumin Interconnect the Subthalamic Nucleus and Striatal Interneurons	PLOS ONE			English	Article							BASAL GANGLIA; RAT; OUTPUT; LIGHT; ELECTROPHYSIOLOGY; ORGANIZATION; OSCILLATIONS; CONNECTIONS; ANTEROGRADE; PROJECTIONS	The globus pallidus externus (GP) is a nucleus of the basal ganglia (BG), containing GABAergic projection neurons that arborize widely throughout the BG, thalamus and cortex. Ongoing work seeks to map axonal projection patterns from GP cell types, as defined by their electrophysiological and molecular properties. Here we use transgenic mice and recombinant viruses to characterize parvalbumin expressing (PV+) GP neurons within the BG circuit. We confirm that PV+ neurons 1) make up similar to 40% of the GP neurons 2) exhibit fast-firing spontaneous activity and 3) provide the major axonal arborization to the STN and substantia nigra reticulata/compacta (SNr/c). PV+ neurons also innervate the striatum. Retrograde labeling identifies similar to 17% of pallidostriatal neurons as PV+, at least a subset of which also innervate the STN and SNr. Optogenetic experiments in acute brain slices demonstrate that the PV+ pallidostriatal axons make potent inhibitory synapses on low threshold spiking (LTS) and fast-spiking interneurons (FS) in the striatum, but rarely on spiny projection neurons (SPNs). Thus PV+ GP neurons are synaptically positioned to directly coordinate activity between BG input nuclei, the striatum and STN, and thalamic-output from the SNr.	[Saunders, Arpiar; Huang, Kee Wui; Sabatini, Bernardo Luis] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bernardo_sabatini@hms.harvard.edu			Howard Hughes Medical Institute; NIH [R01 (NS046579)]; NIH F31 grant [MH093026-01A1]; Harvard Medical School/Boston Children's Hospital Cellular Imaging Core [NIH P30NS072030]; Boston Children's Hospital Viral Core [NIH P30EY012196]; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH093026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579, P30NS072030] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH F31 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School/Boston Children's Hospital Cellular Imaging Core; Boston Children's Hospital Viral Core; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for this work was provided by Howard Hughes Medical Institute and an R01 (NS046579) from the NIH to BLS and an NIH F31 grant (MH093026-01A1) to AS. Funding for this work was also provided to the Boston Children's Hospital Viral Core (NIH P30EY012196) and the Harvard Medical School/Boston Children's Hospital Cellular Imaging Core (NIH P30NS072030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi A, 2015, J NEUROSCI, V35, P6667, DOI 10.1523/JNEUROSCI.4662-14.2015; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Alexi T, 2000, PROG NEUROBIOL, V60, P409, DOI 10.1016/S0301-0082(99)00032-5; BENNETT BD, 1994, J COMP NEUROL, V347, P340, DOI 10.1002/cne.903470303; Bevan MD, 2002, TRENDS NEUROSCI, V25, P525, DOI 10.1016/S0166-2236(02)02235-X; Bevan MD, 1998, J NEUROSCI, V18, P9438; Castle MJ, 2014, HUM GENE THER, V25, P705, DOI 10.1089/hum.2013.189; Cazorla M, 2014, NEURON, V81, P153, DOI 10.1016/j.neuron.2013.10.041; Chan CS, 2004, J NEUROSCI, V24, P9921, DOI 10.1523/JNEUROSCI.2162-04.2004; CHANG HT, 1981, SCIENCE, V213, P915, DOI 10.1126/science.7256286; Chen MC, 2015, EUR J NEUROSCI, V41, P748, DOI 10.1111/ejn.12822; Cooper AJ, 2000, J PHYSIOL-LONDON, V527, P291, DOI 10.1111/j.1469-7793.2000.t01-1-00291.x; CORNWALL J, 1990, EXP BRAIN RES, V80, P157; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dejean C, 2011, J NEUROSCI, V31, P6098, DOI 10.1523/JNEUROSCI.3311-09.2011; DELONG MR, 1971, J NEUROPHYSIOL, V34, P414, DOI 10.1152/jn.1971.34.3.414; Dodson PD, 2015, NEURON, V86, P501, DOI 10.1016/j.neuron.2015.03.007; FALLS WM, 1983, J COMP NEUROL, V221, P229, DOI 10.1002/cne.902210210; Fujiyama F, 2016, BRAIN STRUCT FUNCT, V221, P4733, DOI 10.1007/s00429-015-1152-2; Gage GJ, 2010, NEURON, V67, P466, DOI 10.1016/j.neuron.2010.06.034; Gasca-Martinez D, 2010, NEUROSCIENCE, V169, P1672, DOI 10.1016/j.neuroscience.2010.05.048; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Gertler TS, 2008, J NEUROSCI, V28, P10814, DOI 10.1523/JNEUROSCI.2660-08.2008; Gittis AH, 2010, J NEUROSCI, V30, P2223, DOI 10.1523/JNEUROSCI.4870-09.2010; GROVE EA, 1986, BRAIN RES, V367, P379, DOI 10.1016/0006-8993(86)91623-9; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Henderson Z, 1997, NEUROSCIENCE, V78, P943, DOI 10.1016/S0306-4522(96)00636-7; Hernandez VM, 2015, J NEUROSCI, V35, P11830, DOI 10.1523/JNEUROSCI.4672-14.2015; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hoover BR, 2002, NEUROSCIENCE, V111, P111, DOI 10.1016/S0306-4522(01)00565-6; Ibanez-Sandoval O, 2011, J NEUROSCI, V31, P16757, DOI 10.1523/JNEUROSCI.2628-11.2011; Jin X, 2014, NAT NEUROSCI, V17, P423, DOI 10.1038/nn.3632; KITA H, 1994, BRAIN RES, V657, P31, DOI 10.1016/0006-8993(94)90950-4; Kita H, 2001, J COMP NEUROL, V437, P438, DOI 10.1002/cne.1294; Kita H, 2007, PROG BRAIN RES, V160, P111, DOI 10.1016/S0079-6123(06)60007-1; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mallet N, 2012, NEURON, V74, P1075, DOI 10.1016/j.neuron.2012.04.027; Mastro KJ, 2014, J NEUROSCI, V34, P2087, DOI 10.1523/JNEUROSCI.4646-13.2014; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Nambu A, 1997, J COMP NEUROL, V377, P85; NAMBU A, 1994, J NEUROPHYSIOL, V72, P1127, DOI 10.1152/jn.1994.72.3.1127; Oldenburg IA, 2015, NEURON, V86, P1174, DOI 10.1016/j.neuron.2015.05.008; Person AL, 2012, NATURE, V481, P502, DOI 10.1038/nature10732; Sadek AR, 2007, J NEUROSCI, V27, P6352, DOI 10.1523/JNEUROSCI.0953-07.2007; Sato F, 2000, J COMP NEUROL, V417, P17; Saunders A, 2015, NATURE, V521, P85, DOI 10.1038/nature14179; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schmidt R, 2013, NAT NEUROSCI, V16, P1118, DOI 10.1038/nn.3456; SMITH Y, 1990, J COMP NEUROL, V296, P47, DOI 10.1002/cne.902960105; Smith Y, 1998, NEUROSCIENCE, V86, P353; SMITH Y, 1987, J COMP NEUROL, V259, P50, DOI 10.1002/cne.902590105; STAINES WA, 1984, EXP BRAIN RES, V56, P217; Taverna S, 2008, J NEUROSCI, V28, P5504, DOI 10.1523/JNEUROSCI.5493-07.2008; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tkatch T, 1998, NEUROREPORT, V9, P1935, DOI 10.1097/00001756-199806220-00004; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	58	48	48	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149798	10.1371/journal.pone.0149798	http://dx.doi.org/10.1371/journal.pone.0149798			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26905595	Green Submitted, Green Published, gold			2022-12-27	WOS:000371163000021
J	Bornhorst, C; Siani, A; Russo, P; Kourides, Y; Sion, I; Molnar, D; Moreno, LA; Rodriguez, G; Ben-Shlomo, Y; Howe, L; Lissner, L; Mehlig, K; Regber, S; Bammann, K; Foraita, R; Ahrens, W; Tilling, K				Boernhorst, Claudia; Siani, Alfonso; Russo, Paola; Kourides, Yannis; Sion, Isabelle; Molnar, Denes; Moreno, Luis A.; Rodriguez, Gerardo; Ben-Shlomo, Yoav; Howe, Laura; Lissner, Lauren; Mehlig, Kirsten; Regber, Susann; Bammann, Karin; Foraita, Ronja; Ahrens, Wolfgang; Tilling, Kate			Early Life Factors and Inter-Country Heterogeneity in BMI Growth Trajectories of European Children: The IDEFICS Study	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANCY-RELATED EVENTS; GESTATIONAL WEIGHT-GAIN; CHILDHOOD GROWTH; RISK-FACTORS; SOCIOECONOMIC DIFFERENCES; MEDITERRANEAN DIET; PHYSICAL-ACTIVITY; POSTNATAL FACTORS; YOUNG ADULTHOOD	Background Starting from birth, this explorative study aimed to investigate between-country differences in body mass index (BMI) trajectories and whether early life factors explain these differences. Methods The sample included 7,644 children from seven European countries (Belgium, Cyprus, Germany, Hungary, Italy, Spain, Sweden) participating in the multi-centre IDEFICS study. Information on early life factors and in total 53,409 repeated measurements of height and weight from 0 to <12 years of age were collected during the baseline (2007/2008) and follow-up examination (2009/2010) supplemented by records of routine child health visits. Country-specific BMI growth curves were estimated using fractional polynomial mixed effects models. Several covariates focussing on early life factors were added to the models to investigate their role in the between-countries differences. Results Large between-country differences were observed with Italian children showing significantly higher mean BMI values at all ages >= 3 years compared to the other countries. For instance, at age 11 years mean BMI values in Italian boys and girls were 22.3 [21.9; 22.8; 99% confidence interval] and 22.0 [21.5; 22.4], respectively, compared to a range of 18.4 [18.1; 18.8] to 20.3 [19.8; 20.7] in boys and 18.2 [17.8; 18.6] to 20.3 [19.8; 20.7] in girls in the other countries. After adjustment for early life factors, differences between country-specific BMI curves became smaller. Maternal BMI was the factor being most strongly associated with BMI growth (p<0.01 in all countries) with associations increasing during childhood. Gestational weight gain (GWG) was weakly associated with BMI at birth in all countries. In some countries, positive associations between BMI growth and children not being breastfed, mothers' smoking during pregnancy and low educational level of parents were found. Conclusion Early life factors seem to explain only some of the inter-country variation in growth. Maternal BMI showed the strongest association with children's BMI growth.	[Boernhorst, Claudia; Foraita, Ronja; Ahrens, Wolfgang] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Siani, Alfonso; Russo, Paola] CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy; [Kourides, Yannis] Res & Educ Inst Child Hlth, Strovolos, Cyprus; [Sion, Isabelle] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium; [Molnar, Denes] Univ Pecs, Dept Pediat, Pecs, Hungary; [Moreno, Luis A.; Rodriguez, Gerardo] Univ Zaragoza, Fac Hlth Sci, GENUD Growth Exercise Nutr & Dev Res Grp, Zaragoza, Spain; [Rodriguez, Gerardo] IIS Aragon Aragon Hlth Res Inst, Zaragoza, Spain; [Ben-Shlomo, Yoav; Howe, Laura; Tilling, Kate] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Howe, Laura] Univ Bristol, MRC, Integrat Epidemiol Unit, Bristol, Avon, England; [Lissner, Lauren; Mehlig, Kirsten; Regber, Susann] Univ Gothenburg, Sahlgrenska Acad, Dept Publ Hlth & Community Med, Sect Epidemiol & Social Med,Inst Med, Gothenburg, Sweden; [Regber, Susann] Halmstad Univ, Sch Hlth & Welf, Halmstad, Sweden; [Bammann, Karin] Univ Bremen, Fac Human & Hlth Sci, Inst Publ Hlth & Nursing Res IPP, D-28359 Bremen, Germany; [Ahrens, Wolfgang] Univ Bremen, Fac Math & Comp Sci, D-28359 Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Ghent University; University of Pecs; University of Zaragoza; University of Bristol; University of Bristol; University of Gothenburg; Halmstad University; University of Bremen; University of Bremen	Bornhorst, C (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	boern@bips.uni-bremen.de	Mehlig, Kirsten/AAT-3468-2020; Tilling, Kate/AAY-1578-2021; Russo, Paola/AAW-8308-2020; Ben-Shlomo, Yoav/ABD-2004-2021; Molnár, Dénes/AAB-6820-2022; Siani, Alfonso/B-7925-2015; Moreno, Luis/S-1780-2019; Rodriguez, Gerardo/AAG-9855-2020; Ahrens, Wolfgang/A-2740-2012	Ben-Shlomo, Yoav/0000-0001-6648-3007; Moreno, Luis/0000-0003-0454-653X; Rodriguez, Gerardo/0000-0002-7985-9912; Howe, Laura/0000-0003-3357-2796; Ahrens, Wolfgang/0000-0003-3777-570X; Tilling, Kate/0000-0002-1010-8926; Bammann, Karin/0000-0002-5623-8160; Bornhorst, Claudia/0000-0001-9004-1540	European Community; Sixth RTD Framework Programme [016181]; Research Foundation - Flanders [1.2.683.14.N.00]; German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany) [FKZ: 01GI1121A]; Open Access fund of the Leibniz Association; MRC [MC_UU_12013/5, MR/M020894/1] Funding Source: UKRI; Medical Research Council [MC_UU_12013/5, MR/M020894/1] Funding Source: researchfish	European Community(European Commission); Sixth RTD Framework Programme; Research Foundation - Flanders(FWO); German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany); Open Access fund of the Leibniz Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the European Community and was funded within the Sixth RTD Framework Programme [Contract No. 016181 (FOOD)]. Isabelle Sioen is financially supported by the Research Foundation - Flanders (Grant no: 1.2.683.14.N.00). This analysis was supported by the German Federal Ministry of Education and Research (Competence Network Obesity, EPI Germany, FKZ: 01GI1121A). The publication of this article was funded by the Open Access fund of the Leibniz Association.	Ahrens W, 2006, NUTR METAB CARDIOVAS, V16, P302, DOI 10.1016/j.numecd.2006.01.011; Ahrens W, 2014, INT J OBESITY, V38, pS99, DOI 10.1038/ijo.2014.140; Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Alavi N, 2013, OBES REV, V14, P68, DOI 10.1111/j.1467-789X.2012.01059.x; Bammann K, 2013, PEDIATR OBES, V8, P1, DOI 10.1111/j.2047-6310.2012.00075.x; Bammann K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086914; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Belahsen R, 2006, PUBLIC HEALTH NUTR, V9, P1130, DOI 10.1017/S1368980007668517; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Cnattingius S, 2002, SEMIN PERINATOL, V26, P286, DOI 10.1053/sper.2002.34771; Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dello Russo M, 2013, INT J OBESITY, V37, P914, DOI 10.1038/ijo.2013.35; Gaillard R, 2013, OBESITY, V21, P1046, DOI 10.1002/oby.20088; Giles LC, 2015, INT J OBESITY, V39, P1049, DOI 10.1038/ijo.2015.42; Gracia-Marco L, 2013, J SPORT SCI, V31, P1831, DOI 10.1080/02640414.2013.803595; Hense S, 2013, EPIDEMIOLOGY RES INT, DOI [10. 1155/2013/936365, 10.1155/2013/936365, DOI 10.1155/2013/936365]; Herrmann D, 2011, INT J OBESITY, V35, pS52, DOI 10.1038/ijo.2011.35; Howe LD, 2009, ARCH DIS CHILD, V94, P950, DOI 10.1136/adc.2009.162552; Howe LD, 2012, J EPIDEMIOL COMMUN H, V66, P143, DOI 10.1136/jech.2010.113068; Howe LD, 2011, INT J PEDIATR OBES, V6, pE144, DOI 10.3109/17477166.2010.500387; Macdonald-Wallis C, 2014, HYPERTENSION, V64, P36, DOI 10.1161/HYPERTENSIONAHA.113.02766; McCarthy A, 2007, AM J CLIN NUTR, V86, P907, DOI 10.1093/ajcn/86.4.907; Mendez Robert, 2013, FP Essent, V410, P20; Fernandez-Alvira JM, 2015, BRIT J NUTR, V113, P517, DOI 10.1017/S0007114514003663; Miyake Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-79; Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Owen CG, 2005, AM J CLIN NUTR, V82, P1298, DOI 10.1093/ajcn/82.6.1298; Patel R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-932; Regber S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-418; Ridgers ND, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0245-x; Robinson SM, 2015, AM J CLIN NUTR, V101, P368, DOI [10.3945/ajcn.114.094268, 10.3945/ajcn.1]; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Schneider S, 2008, EUR J CONTRACEP REPR, V13, P138, DOI 10.1080/13625180802027993; Scott C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-167; Shawe J, 2015, EUR J CONTRACEP REPR, V20, P77, DOI 10.3109/13625187.2014.990088; Silventoinen K, 2008, GENET EPIDEMIOL, V32, P341, DOI 10.1002/gepi.20308; Smedberg J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-213; Tilling K, 2014, ANN NUTR METAB, V65, P129, DOI 10.1159/000362695; Tilling K, 2011, AM J CLIN NUTR, V94, p1808S, DOI 10.3945/ajcn.110.001644; Tognon G, 2014, INT J OBESITY, V38, pS108, DOI 10.1038/ijo.2014.141; Tognon G, 2014, NUTR METAB CARDIOVAS, V24, P205, DOI 10.1016/j.numecd.2013.04.013; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Turchin MC, 2012, NAT GENET, V44, P1015, DOI 10.1038/ng.2368; Uauy R, 2008, ANN MED, V40, P11, DOI 10.1080/07853890701704683; van der Klaauw AA, 2015, CELL, V161, P119, DOI 10.1016/j.cell.2015.03.008; Van Rossem L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-722; Weber M, 2014, AM J CLIN NUTR, V99, P1041, DOI 10.3945/ajcn.113.064071; Weng SF, 2012, ARCH DIS CHILD, V97, P1019, DOI 10.1136/archdischild-2012-302263; Wijnhoven TMA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-806; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1306, DOI 10.1079/PHN2001147; Yngve A, 2001, PUBLIC HEALTH NUTR, V4, P1353, DOI 10.1079/PHN2001217; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x	54	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149268	10.1371/journal.pone.0149268	http://dx.doi.org/10.1371/journal.pone.0149268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901773	Green Published, gold, Green Submitted			2022-12-27	WOS:000371276100050
J	Mueller, AS; Timney, B				Mueller, Alexandra S.; Timney, Brian			Visual Acceleration Perception for Simple and Complex Motion Patterns	PLOS ONE			English	Article							OPTIC FLOW STIMULI; SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; MST NEURONS; IN-DEPTH; SPATIOTEMPORAL FREQUENCY; PSYCHOPHYSICAL EVIDENCE; EXPANSION CONTRACTION; RESPONSE SELECTIVITY; HEADING PERCEPTION	Humans are able to judge whether a target is accelerating in many viewing contexts, but it is an open question how the motion pattern per se affects visual acceleration perception. We measured acceleration and deceleration detection using patterns of random dots with horizontal (simpler) or radial motion (more visually complex). The results suggest that we detect acceleration better when viewing radial optic flow than horizontal translation. However, the direction within each type of pattern has no effect on performance and observers detect acceleration and deceleration similarly within each condition. We conclude that sensitivity to the presence of acceleration is generally higher for more complex patterns, regardless of the direction within each type of pattern or the sign of acceleration.	[Mueller, Alexandra S.; Timney, Brian] Univ Western Ontario, Dept Psychol, London, ON, Canada	Western University (University of Western Ontario)	Mueller, AS (corresponding author), Univ Western Ontario, Dept Psychol, London, ON, Canada.	amuelle4@alumni.uwo.ca			Ontario Graduate Scholarship; Provost's Research Grant	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Provost's Research Grant	This research was financially supported by an Ontario Graduate Scholarship to ASM and by a Provost's Research Grant to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen-Stockdale C, 2007, VISION RES, V47, P1798, DOI 10.1016/j.visres.2007.02.022; ANDERSEN RA, 1990, COLD SH Q B, V55, P741; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; [Anonymous], VPIXX PROGR VERS 3 1; BABLER TG, 1993, J EXP PSYCHOL HUMAN, V19, P15, DOI 10.1037/0096-1523.19.1.15; Beardsley SA, 2005, VISION RES, V45, P1569, DOI 10.1016/j.visres.2004.11.025; Bertone A, 2003, VISION RES, V43, P2591, DOI 10.1016/S0042-6989(03)00465-6; Bex PJ, 1998, J OPT SOC AM A, V15, P769, DOI 10.1364/JOSAA.15.000769; Bex PJ, 1997, VISION RES, V37, P3399, DOI 10.1016/S0042-6989(97)00088-6; Blake R, 1998, JPN PSYCHOL RES, V40, P19, DOI 10.1111/1468-5884.00071; Braun DI, 2010, VISION RES, V50, P2740, DOI 10.1016/j.visres.2010.07.028; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Britten KH, 2002, CEREB CORTEX, V12, P692, DOI 10.1093/cercor/12.7.692; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; CALDERONE JB, 1989, PERCEPT PSYCHOPHYS, V45, P391, DOI 10.3758/BF03210711; Clifford CWG, 1999, VISION RES, V39, P2213, DOI 10.1016/S0042-6989(98)00314-9; DEBRUYN B, 1988, VISION RES, V28, P1323, DOI 10.1016/0042-6989(88)90064-8; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; DUFFY CJ, 1995, J NEUROSCI, V15, P5192; Eagleson Roy, 1992, Spatial Vision, V6, P183, DOI 10.1163/156856892X00073; Edwards M, 1998, VISION RES, V38, P1573, DOI 10.1016/S0042-6989(97)00353-2; EDWARDS M, 1993, PERCEPTION, V22, P1013, DOI 10.1068/p221013; Edwards M, 2007, PERCEPTION, V36, P113, DOI 10.1068/p5626; FREEMAN TCA, 1992, VISION RES, V32, P81, DOI 10.1016/0042-6989(92)90115-Y; Geesaman BJ, 1998, VISION RES, V38, P1223, DOI 10.1016/S0042-6989(97)00279-4; Giaschi D, 2007, VISION RES, V47, P887, DOI 10.1016/j.visres.2006.12.017; Gibson J.J., 1986, ECOLOGICAL APPROACH; GOTTSDANKER R, 1961, BRIT J PSYCHOL, V52, P31, DOI 10.1111/j.2044-8295.1961.tb00765.x; Gray R, 1999, PERCEPT PSYCHOPHYS, V61, P236, DOI 10.3758/BF03206885; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Habak C, 2002, VISION RES, V42, P2843, DOI 10.1016/S0042-6989(02)00355-3; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; Khuu SK, 2002, VISION RES, V42, P3031, DOI 10.1016/S0042-6989(02)00384-X; Lee ALF, 2010, J VISION, V10, DOI 10.1167/10.4.9; Lisberger SG, 1999, J NEUROSCI, V19, P2224; Maloney RT, 2013, J NEUROPHYSIOL, V110, P2545, DOI 10.1152/jn.00445.2013; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCKEE SP, 1984, VISION RES, V24, P25, DOI 10.1016/0042-6989(84)90140-8; MCKEE SP, 1981, VISION RES, V21, P491, DOI 10.1016/0042-6989(81)90095-X; MONEN J, 1994, PERCEPTION, V23, P681, DOI 10.1068/p230681; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; ORBAN GA, 1985, J OPT SOC AM A, V2, P1836, DOI 10.1364/JOSAA.2.001836; ORBAN GA, 1984, VISION RES, V24, P33, DOI 10.1016/0042-6989(84)90141-X; Palmisano S, 2008, PERCEPTION, V37, P22, DOI 10.1068/p5806; Pas SFT, 1996, VISION RES, V36, P259, DOI 10.1016/0042-6989(95)00084-D; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; Priebe NJ, 2006, J NEUROSCI, V26, P2941, DOI 10.1523/JNEUROSCI.3936-05.2006; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Schlack A, 2007, J NEUROSCI, V27, P11009, DOI 10.1523/JNEUROSCI.3165-07.2007; Shirai N, 2006, INFANT BEHAV DEV, V29, P204, DOI 10.1016/j.infbeh.2005.10.003; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Smith AT, 2006, EUR J NEUROSCI, V23, P561, DOI 10.1111/j.1460-9568.2005.04526.x; SNOWDEN RJ, 1991, VISION RES, V31, P907, DOI 10.1016/0042-6989(91)90156-Y; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Trewhella J, 2003, CLIN EXP OPHTHALMOL, V31, P258, DOI 10.1046/j.1442-9071.2003.00641.x; VANESSEN DC, 1994, NEURON, V13, P1, DOI 10.1016/0896-6273(94)90455-3; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; Whitaker D, 1999, VISION RES, V39, P2999, DOI 10.1016/S0042-6989(99)00010-3; Zhang T, 2011, J NEUROSCI, V31, P2569, DOI 10.1523/JNEUROSCI.5520-10.2011	63	9	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149413	10.1371/journal.pone.0149413	http://dx.doi.org/10.1371/journal.pone.0149413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901879	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100073
J	Egunsola, O; Choonara, I; Sammons, HM				Egunsola, Oluwaseun; Choonara, Imti; Sammons, Helen Mary			Safety of Levetiracetam in Paediatrics: A Systematic Review	PLOS ONE			English	Review							PARTIAL-ONSET SEIZURES; PLACEBO-CONTROLLED TRIAL; ADD-ON LEVETIRACETAM; ADJUNCTIVE LEVETIRACETAM; OPEN-LABEL; ANTIEPILEPTIC DRUGS; INTRAVENOUS LEVETIRACETAM; CENTROTEMPORAL SPIKES; REFRACTORY EPILEPSY; CHILDHOOD EPILEPSY	Objective To identify adverse events (AEs) associated with Levetiracetam (LEV) in children. Methods Databases EMBASE (1974-February 2015) and Medline (1946-February 2015) were searched for articles in which paediatric patients (<= 18 years) received LEV treatment for epilepsy. All studies with reports on safety were included. Studies involving adults, mixed age population (i.e. children and adults) in which the paediatric subpopulation was not sufficiently described, were excluded. A meta-analysis of the RCTs was carried out and association between the commonly reported AEs or treatment discontinuation and the type of regimen (polytherapy or monotherapy) was determined using Chi(2) analysis. Results Sixty seven articles involving 3,174 paediatric patients were identified. A total of 1,913 AEs were reported across studies. The most common AEs were behavioural problems and somnolence, which accounted for 10.9% and 8.4% of all AEs in prospective studies. 21 prospective studies involving 1120 children stated the number of children experiencing AEs. 47% of these children experienced AEs. Significantly more children experienced AEs with polytherapy (64%) than monotherapy (22%) (p<0.001). Levetiracetam was discontinued in 4.5% of all children on polytherapy and 0.9% on monotherapy (p<0.001), the majority were due to behavioural problems. Conclusion Behavioural problems and somnolence were the most prevalent adverse events to LEV and the most common causes of treatment discontinuation. Children on polytherapy have a greater risk of adverse events than those receiving monotherapy.	[Egunsola, Oluwaseun; Choonara, Imti; Sammons, Helen Mary] Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Royal Derby Hosp, Derby DE22 3DT, England	University of Nottingham	Egunsola, O (corresponding author), Univ Nottingham, Sch Med, Div Med Sci & Grad Entry Med, Royal Derby Hosp, Derby DE22 3DT, England.	mzxoe@nottingham.ac.uk	Choonara, Imti/I-3559-2019	Choonara, Imti/0000-0002-3069-6323; Sammons, Helen/0000-0002-4472-433X	commonwealth Scholarship Commission	commonwealth Scholarship Commission	OE received PhD funding from the commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil Bassel, 2008, Neuropsychiatr Dis Treat, V4, P507; Anderson M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008298; Anderson M, 2010, ARCH DIS CHILD, V95, P731, DOI 10.1136/adc.2009.165902; Borggraefe I, 2013, EUR J PAEDIATR NEURO, V17, P507, DOI 10.1016/j.ejpn.2013.03.014; BRODIE MJ, 1987, EUR J CLIN PHARMACOL, V31, P655, DOI 10.1007/BF00541291; Brodtkorb E, 2004, EPILEPSY BEHAV, V5, P231, DOI 10.1016/j.yebeh.2003.12.005; Callenbach PMC, 2008, EUR J PAEDIATR NEURO, V12, P321, DOI 10.1016/j.ejpn.2007.09.004; Chhun S, 2011, SEIZURE-EUR J EPILEP, V20, P320, DOI 10.1016/j.seizure.2010.12.017; Coppola G, 2007, BRAIN DEV-JPN, V29, P281, DOI 10.1016/j.braindev.2006.09.008; Cramer JA, 2003, EPILEPSY BEHAV, V4, P124, DOI 10.1016/S1525-5050(03)00005-2; Dinkelacker V, 2003, EPILEPSY BEHAV, V4, P537, DOI 10.1016/j.yebeh.2003.07.008; Dureau-Pournin C, 2014, EUR J PAEDIATR NEURO, V18, P19, DOI 10.1016/j.ejpn.2013.07.003; Egunsola O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007711; Fattore C, 2011, EPILEPSIA, V52, P802, DOI 10.1111/j.1528-1167.2010.02976.x; [冯雪菲 Feng Xuefei], 2014, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V39, P324; Furwentsches A, 2010, SEIZURE-EUR J EPILEP, V19, P185, DOI 10.1016/j.seizure.2010.01.003; Gao Zhi-Jie, 2008, Zhongguo Dang Dai Er Ke Za Zhi, V10, P711; Glauser TA, 2006, NEUROLOGY, V66, P1654, DOI 10.1212/01.wnl.0000217916.00225.3a; Glauser TA, 2002, EPILEPSIA, V43, P518, DOI 10.1046/j.1528-1157.2002.13101.x; Halma E, 2014, SEIZURE-EUR J EPILEP, V23, P685, DOI 10.1016/j.seizure.2014.06.004; Hamer HM, 2012, J NEUROL, V259, P2376, DOI 10.1007/s00415-012-6509-3; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Institute JB, 2004, SYST UN MAN REV ASS; Kanemura H, 2013, BRAIN DEV-JPN, V35, P386, DOI 10.1016/j.braindev.2012.07.005; Kastner M, 2006, J MED INTERNET RES, V8, DOI 10.2196/jmir.8.4.e25; Kim HJ, 2014, PEDIATR NEUROL, V51, P527, DOI 10.1016/j.pediatrneurol.2014.06.004; Kwong KL, 2012, PEDIATR NEUROL, V46, P281, DOI 10.1016/j.pediatrneurol.2012.02.019; Lagae L, 2006, SEIZURE-EUR J EPILEP, V15, P235, DOI 10.1016/j.seizure.2006.02.013; Lee YJ, 2010, PEDIATR NEUROL, V42, P86, DOI 10.1016/j.pediatrneurol.2009.08.002; Levisohn PM, 2009, EPILEPSIA, V50, P2377, DOI 10.1111/j.1528-1167.2009.02197.x; Li JH, 2011, BRAIN DEV-JPN, V33, P145, DOI 10.1016/j.braindev.2010.03.002; McTague A, 2012, SEIZURE-EUR J EPILEP, V21, P529, DOI 10.1016/j.seizure.2012.05.010; Nakken KO, 2003, SEIZURE-EUR J EPILEP, V12, P42, DOI 10.1016/S1059131102001723; National Institute for Health and Clinical Excellence: Guidance, 2012, EP DIAGN MAN EP AD C; Ng YT, 2010, J CHILD NEUROL, V25, P551, DOI 10.1177/0883073809348795; Parentelli AS, 2013, PEDIATR BLOOD CANCER, V60, P340, DOI 10.1002/pbc.24371; Pellock JM, 2001, EPILEPSIA, V42, P1574, DOI 10.1046/j.1528-1157.2001.41300.x; Pickrell WO, 2014, SEIZURE-EUR J EPILEP, V23, P77, DOI 10.1016/j.seizure.2013.09.007; Pina-Garza JE, 2009, EPILEPSIA, V50, P1141, DOI 10.1111/j.1528-1167.2008.01981.x; Ramantani G, 2011, EUR J PAEDIATR NEURO, V15, P1, DOI 10.1016/j.ejpn.2010.10.003; Schiemann-Delgado J, 2012, J CHILD NEUROL, V27, P80, DOI 10.1177/0883073811417183; UCB Pharma limited, KEPPR 250 500 750 10; Verrotti A, 2007, SEIZURE-EUR J EPILEP, V16, P271, DOI 10.1016/j.seizure.2006.12.006; Verrotti A, 2009, ACTA NEUROL SCAND, V120, P342, DOI 10.1111/j.1600-0404.2009.01264.x; Weinstock A, 2013, J CHILD NEUROL, V28, P1423, DOI 10.1177/0883073813480241; White JR, 2003, NEUROLOGY, V61, P1218, DOI 10.1212/01.WNL.0000091865.46063.67; Zhang Yuxin, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P364	47	40	41	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149686	10.1371/journal.pone.0149686	http://dx.doi.org/10.1371/journal.pone.0149686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930201	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500043
J	Neerathilingam, M; Bairy, SG; Mysore, S				Neerathilingam, Muniasamy; Bairy, Sneha G.; Mysore, Sumukh			Deciphering Mode of Action of Functionally Important Regions in the Intrinsically Disordered Paxillin (Residues 1-313) Using Its Interaction with FAT (Focal Adhesion Targeting Domain of Focal Adhesion Kinase)	PLOS ONE			English	Article							CELL-FREE SYSTEM; MOLECULAR RECOGNITION; LUNG-CANCER; LD MOTIFS; PROTEIN; EXPRESSION; LOCALIZATION; MUTATIONS; PEPTIDE; BINDING	Intrinsically disordered proteins (IDPs) play a major role in various cellular functions ranging from transcription to cell migration. Mutations/modifications in such IDPs are shown to be associated with various diseases. Current strategies to study the mode of action and regulatory mechanisms of disordered proteins at the structural level are time consuming and challenging. Therefore, using simple and swift strategies for identifying functionally important regions in unstructured segments and understanding their underlying mechanisms is critical for many applications. Here we propose a simple strategy that employs dissection of human paxillin (residues 1-313) that comprises intrinsically disordered regions, followed by its interaction study using FAT (Focal adhesion targeting domain of focal adhesion kinase) as its binding partner to retrace structural behavior. Our findings show that the paxillin interaction with FAT exhibits a masking and unmasking effect by a putative intra-molecular regulatory region. This phenomenon suggests how cancer associated mutations in paxillin affect its interactions with Focal Adhesion Kinase (FAK). The strategy could be used to decipher the mode of regulations and identify functionally relevant constructs for other studies.	[Neerathilingam, Muniasamy; Bairy, Sneha G.; Mysore, Sumukh] NCBS TIFR, Ctr Cellular & Mol Platforms C CAMP, Prot Technol Core, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India; [Neerathilingam, Muniasamy] Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Oxford	Neerathilingam, M (corresponding author), NCBS TIFR, Ctr Cellular & Mol Platforms C CAMP, Prot Technol Core, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.; Neerathilingam, M (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	munish@ccamp.res.in	/AAO-4852-2020		Department of Biotechnology, India [BT/IN/FINLAND/29/MN/2013]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by the Department of Biotechnology, India [ Award Number: BT/IN/FINLAND/29/MN/2013 Recipient: Muniasamy Neerathilingam, D. Phil ( Oxford)]. The funding body does not have any role in the design of the research study and publication decision.	Adessi C, 2002, CURR MED CHEM, V9, P963, DOI 10.2174/0929867024606731; Arold ST, 2002, STRUCTURE, V10, P319, DOI 10.1016/S0969-2126(02)00717-7; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Caltagarone J, 2010, J NEUROPATH EXP NEUR, V69, P356, DOI 10.1097/NEN.0b013e3181d53d98; Chouard T, 2011, NATURE, V471, P151, DOI 10.1038/471151a; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; Deakin Nicholas O, 2012, Genes Cancer, V3, P362, DOI 10.1177/1947601912458582; Deakin NO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037990; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Gao GH, 2004, J BIOL CHEM, V279, P8441, DOI 10.1074/jbc.M309808200; Goodson Michael L, 2007, Nucl Recept Signal, V5, pe002; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Karplus K, 2009, NUCLEIC ACIDS RES, V37, pW492, DOI 10.1093/nar/gkp403; Kawada I, 2013, CANCER BIOL THER, V14, P679, DOI 10.4161/cbt.25091; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kwak TK, 2012, J BIOL CHEM, V287, P27499, DOI 10.1074/jbc.M111.323360; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li XF, 2011, J BIOL CHEM, V286, P26138, DOI 10.1074/jbc.M110.211250; Neerathilingam M, 2005, J BIOMOL NMR, V31, P11, DOI 10.1007/s10858-004-5357-6; Sitararnan Kalavathy, 2009, V498, P229, DOI 10.1007/978-1-59745-196-3_15; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150153	10.1371/journal.pone.0150153	http://dx.doi.org/10.1371/journal.pone.0150153			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928467	Green Published, gold			2022-12-27	WOS:000371424200023
J	Farcet, A; de Decker, L; Pauly, V; Rousseau, F; Bergman, H; Molines, C; Retornaz, F				Farcet, Anais; de Decker, Laure; Pauly, Vanessa; Rousseau, Frederique; Bergman, Howard; Molines, Catherine; Retornaz, Frederique			Frailty Markers and Treatment Decisions in Patients Seen in Oncogeriatric Clinics: Results from the ASRO Pilot Study	PLOS ONE			English	Article							COMPREHENSIVE GERIATRIC ASSESSMENT; OLDER CANCER-PATIENTS; MINI-MENTAL-STATE; ELDERLY-PATIENTS; COGNITIVE IMPAIRMENT; FUNCTIONAL STATUS; ONCOLOGY; HEALTH; IMPACT; CHEMOTHERAPY	Background Comprehensive Geriatric Assessment (CGA) is the gold standard to help oncologists select the best cancer treatment for their older patients. Some authors have suggested that the concept of frailty could be a more useful approach in this population. We investigated whether frailty markers are associated with treatment recommendations in an oncogeriatric clinic. Methods This prospective study included 70 years and older patients with solid tumors and referred for an oncogeriatric assessment. The CGA included nine domains: autonomy, comorbidities, medication, cognition, nutrition, mood, neurosensory deficits, falls, and social status. Five frailty markers were assessed (nutrition, physical activity, energy, mobility, and strength). Patients were categorized as Frail (three or more frailty markers), pre-frail (one or two frailty markers), or not-frail (no frailty marker). Treatment recommendations were classified into two categories: standard treatment with and without any changes and supportive/palliative care. Multiple logistic regression models were used to analyze factors associated with treatment recommendations. Results 217 patients, mean age 83 years (+/- Standard deviation (SD) 5.3), were included. In the univariate analysis, number of frailty markers, grip strength, physical activity, mobility, nutrition, energy, autonomy, depression, Eastern Cooperative Oncology Group Scale of Performance Status (ECOG-PS), and falls were significantly associated with final treatment recommendations. In the multivariate analysis, the number of frailty markers and basic Activities of Daily Living (ADL) were significantly associated with final treatment recommendations (p<0.001 and p = 0.010, respectively). Conclusion Frailty markers are associated with final treatment recommendations in older cancer patients. Longitudinal studies are warranted to better determine their use in a geriatric oncology setting.	[Farcet, Anais; Molines, Catherine; Retornaz, Frederique] Ctr Gerontol Dept, Unite Coordinat Oncol Geriatr, Marseille, France; [de Decker, Laure] Ctr Hosp Univ, Dept Geriatrie, Nantes, France; [Pauly, Vanessa; Retornaz, Frederique] Aix Marseille Univ, Lab Sante Publ EA 3279, Ctr Evaluat Pharmacodependance Addictovigilance C, Fac Med, Marseille, France; [Rousseau, Frederique] Inst J Paoli I Calmettes, Unite Coordinat Oncol Geriatr, F-13009 Marseille, France; [Bergman, Howard] McGill Univ, Dept Family Med, Montreal, PQ H3T 1E2, Canada; [Retornaz, Frederique] Hop Europeen, Unite Soins & Rech Med Interne & Malad Infect, Marseille, France	Nantes Universite; CHU de Nantes; UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); McGill University	Farcet, A (corresponding author), Ctr Gerontol Dept, Unite Coordinat Oncol Geriatr, Marseille, France.	afarcet.cgd13@e-santepaca.fr			Association Sud de Recherche en Oncogeriatrie (ASRO); Unite de Coordination en Oncogeriatrie PACA Quest	Association Sud de Recherche en Oncogeriatrie (ASRO); Unite de Coordination en Oncogeriatrie PACA Quest	Dr Farcet was supported in part by the Association Sud de Recherche en Oncogeriatrie (ASRO). Dr Retornaz was supported in part by the Unite de Coordination en Oncogeriatrie PACA Quest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aparicio T, 2011, CRIT REV ONCOL HEMAT, V77, P64, DOI 10.1016/j.critrevonc.2010.01.003; Balducci Lodovico, 2007, Cancer Control, V14, P7; Balducci L, 2013, INTERD T GERONT GERI, V38, P61, DOI 10.1159/000343586; Bandeen-Roche K, 2006, J GERONTOL A-BIOL, V61, P262, DOI 10.1093/gerona/61.3.262; Barthelemy P, 2011, CRIT REV ONCOL HEMAT, V79, P196, DOI 10.1016/j.critrevonc.2010.06.005; Bernabei R, 2000, CRIT REV ONCOL HEMAT, V33, P45, DOI 10.1016/S1040-8428(99)00048-7; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Borson S, 2005, J AM GERIATR SOC, V53, P871, DOI 10.1111/j.1532-5415.2005.53269.x; Boulahssass R, 2014, J CLIN ONCOL, V32, p5s; Cahn DA, 1996, ARCH CLIN NEUROPSYCH, V11, P529, DOI 10.1016/0887-6177(95)00041-0; Caillet P, 2011, J CLIN ONCOL, V29, P3636, DOI 10.1200/JCO.2010.31.0664; Chaibi P, 2011, CRIT REV ONCOL HEMAT, V79, P302, DOI 10.1016/j.critrevonc.2010.08.004; Chen CCH, 2004, CRIT REV ONCOL HEMAT, V49, P53, DOI 10.1016/S1040-8428(03)00098-2; Cook Z, 2005, P NUTR SOC, V64, P313, DOI 10.1079/PNS2005437; Cornali C, 2005, J AM GERIATR SOC, V53, P354, DOI 10.1111/j.1532-5415.2005.53126_4.x; Davis HS, 2001, INT PSYCHOGERIATR, V13, P177, DOI 10.1017/S1041610202008128; Extermann M, 2005, CRIT REV ONCOL HEMAT, V55, P241, DOI 10.1016/j.critrevonc.2005.06.003; Falandry C, 2013, ANN ONCOL, V24, P2808, DOI 10.1093/annonc/mdt360; Ferrucci L, 2003, CRIT REV ONCOL HEMAT, V46, P127, DOI 10.1016/S1040-8428(02)00177-4; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Girre V, 2008, J GERONTOL A-BIOL, V63, P724, DOI 10.1093/gerona/63.7.724; Guo CB, 1996, BRIT J ORAL MAX SURG, V34, P325, DOI 10.1016/S0266-4356(96)90012-1; KALFARENTZOS F, 1989, JPEN-PARENTER ENTER, V13, P34, DOI 10.1177/014860718901300134; KATZ S, 1983, J AM GERIATR SOC, V31, P721, DOI 10.1111/j.1532-5415.1983.tb03391.x; Kristjansson SR, 2012, J GERIATR ONCOL, V3, P1, DOI 10.1016/j.jgo.2011.09.002; Liu JJ, 2012, CLIN GERIATR MED, V28, P19, DOI 10.1016/j.cger.2011.10.001; Maas HAAM, 2007, EUR J CANCER, V43, P2161, DOI 10.1016/j.ejca.2007.08.002; Makary MA, 2010, J AM COLL SURGEONS, V210, P901, DOI 10.1016/j.jamcollsurg.2010.01.028; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Pal SK, 2010, CA-CANCER J CLIN, V60, P120, DOI 10.3322/caac.20059; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Puts MTE, 2012, JNCI-J NATL CANCER I, V104, P1133, DOI 10.1093/jnci/djs285; Puts MTE, 2011, CRIT REV ONCOL HEMAT, V78, P138, DOI 10.1016/j.critrevonc.2010.04.003; Repetto L, 1998, CANCER, V82, P760, DOI 10.1002/(SICI)1097-0142(19980215)82:4<760::AID-CNCR20>3.0.CO;2-V; Repetto L, 2003, EUR J CANCER, V39, P870, DOI 10.1016/S0959-8049(03)00062-5; Retornaz F, 2014, J CLIN ONCOL S, V32, p5s; Retornaz F, 2008, J GERONTOL A-BIOL, V63, P518, DOI 10.1093/gerona/63.5.518; Retornaz F, 2007, J GERONTOL A-BIOL, V62, P917, DOI 10.1093/gerona/62.8.917; Rouge-Bugat ME, 2013, J NUTR HEALTH AGING, V17, P473, DOI 10.1007/s12603-012-0435-z; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Soubeyran P, 2012, J CLIN ONCOL, V30, P1829, DOI 10.1200/JCO.2011.35.7442; Sourial N, 2013, J GERONTOL A-BIOL, V68, P1505, DOI 10.1093/gerona/glt053; Tan KY, 2012, AM J SURG, V204, P139, DOI 10.1016/j.amjsurg.2011.08.012; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735, DOI 10.1111/j.1532-5415.1997.tb01479.x	47	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149732	10.1371/journal.pone.0149732	http://dx.doi.org/10.1371/journal.pone.0149732			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918947	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400042
J	Lee, JH; Om, JY; Kim, YH; Kim, KM; Choi, EH; Kim, KN				Lee, Jung-Hwan; Om, Ji-Yeon; Kim, Yong-Hee; Kim, Kwang-Mahn; Choi, Eun-Ha; Kim, Kyoung-Nam			Selective Killing Effects of Cold Atmospheric Pressure Plasma with NO Induced Dysfunction of Epidermal Growth Factor Receptor in Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							TYROSINE KINASE INHIBITOR; OXIDATIVE STRESS; DOWN-REGULATION; CANCER CELLS; ACQUIRED-RESISTANCE; COLORECTAL-CANCER; CYTOTOXIC DRUGS; LUNG-CANCER; NECK-CANCER; GLUTATHIONE	The aim of this study is to investigate the effects of cold atmospheric pressure plasma (CAP)-induced radicals on the epidermal growth factor receptor (EGFR), which is overexpressed by oral squamous cell carcinoma, to determine the underlying mechanism of selective killing. CAP-induced highly reactive radicals were observed in both plasma plume and cell culture media. The selective killing effect was observed in oral squamous cell carcinoma compared with normal human gingival fibroblast. Degradation and dysfunction of EGFRs were observed only in the EGFR-overexpressing oral squamous cell carcinoma and not in the normal cell. Nitric oxide scavenger pretreatment in cell culture media before CAP treatment rescued above degradation and dysfunction of the EGFR as well as the killing effect in oral squamous cell carcinoma. CAP may be a promising cancer treatment method by inducing EGFR dysfunction in EGFR-overexpressing oral squamous cell carcinoma via nitric oxide radicals.	[Lee, Jung-Hwan; Om, Ji-Yeon; Kim, Kwang-Mahn; Kim, Kyoung-Nam] Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Dept & Res Inst Dent Biomat & Bioengn, 50-1 Yonsei Ro, Seoul 120752, South Korea; [Lee, Jung-Hwan] Dankook Univ, Inst Tissue Regenerat Engn ITREN, Cheonan, South Korea; [Kim, Yong-Hee; Choi, Eun-Ha] Kwangwoon Univ, Plasma Biosci Res Ctr, 20 Kwangwoon Gil, Seoul 139701, South Korea	Yonsei University; Yonsei University Health System; Dankook University; Kwangwoon University	Kim, KN (corresponding author), Yonsei Univ, Coll Dent, Brain Korea PLUS Project 21, Dept & Res Inst Dent Biomat & Bioengn, 50-1 Yonsei Ro, Seoul 120752, South Korea.; Choi, EH (corresponding author), Kwangwoon Univ, Plasma Biosci Res Ctr, 20 Kwangwoon Gil, Seoul 139701, South Korea.	ehchoi@kw.ac.kr; kimkn@yuhs.ac	Choi, Eun Ha/AFN-9488-2022; Lee, Jung-Hwan/AFK-0831-2022	Choi, Eun Ha/0000-0001-5385-1878; Lee, Jung-Hwan/0000-0001-8678-5459; KIM, KWANG-MAHN/0000-0002-5235-0294	National Research Foundation of Korea (NRF) - Korea government (MSIP; Ministry of Science, ICT & Future Planning) [NRF-2010-0027963]; National Research Foundation of Korea(NRF) - Ministry of Education [2009-0093829]	National Research Foundation of Korea (NRF) - Korea government (MSIP; Ministry of Science, ICT & Future Planning); National Research Foundation of Korea(NRF) - Ministry of Education	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP; Ministry of Science, ICT & Future Planning) (NRF-2010-0027963) and by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education(grant number: 2009-0093829).	Abe Y, 1998, J BIOL CHEM, V273, P11150, DOI 10.1074/jbc.273.18.11150; Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; BERTHOIS Y, 1986, P NATL ACAD SCI USA, V83, P2496, DOI 10.1073/pnas.83.8.2496; Bruno M, 2009, J PROTEOME RES, V8, P2070, DOI 10.1021/pr801061r; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Choi YJ, 2013, MOL CELL BIOCHEM, V375, P59, DOI 10.1007/s11010-012-1528-z; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Chrapko W, 2006, NEUROPSYCHOPHARMACOL, V31, P1286, DOI 10.1038/sj.npp.1300961; CHRISTENSEN ME, 1992, EUR ARCH OTO-RHINO-L, V249, P243, DOI 10.1007/BF00714485; COOK JA, 1991, CANCER RES, V51, P4287; Correale P, 2010, EUR J CANCER, V46, P1703, DOI 10.1016/j.ejca.2010.03.005; Deneke SM, 2000, CURR TOP CELL REGUL, V36, P151; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; Florian J, 2015, IEEE T PLASMA SCI, V43, P3332, DOI 10.1109/TPS.2015.2404879; Foltin V, 2006, CZECH J PHYS, V56, pB712, DOI 10.1007/s10582-006-0276-2; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Gweon B, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3352316; He YY, 2003, J BIOL CHEM, V278, P42457, DOI 10.1074/jbc.M303376200; Hong YC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3272089; Hybertson BM, 2011, MOL ASPECTS MED, V32, P234, DOI 10.1016/j.mam.2011.10.006; Iseki S, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3694928; Jackman D, 2010, J CLIN ONCOL, V28, P357, DOI 10.1200/JCO.2009.24.7049; Jin DJ, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4819246; Jung-Hwan L, 2014, JPN J APPL PHYS, V53; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalyankrishna S, 2006, J CLIN ONCOL, V24, P2666, DOI 10.1200/JCO.2005.04.8306; Kaushik NK, 2013, CURR APPL PHYS, V13, P176, DOI 10.1016/j.cap.2012.07.002; Keidar M, 2011, BRIT J CANCER, V105, P1295, DOI 10.1038/bjc.2011.386; Kim GJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292206; Kwon J, 2014, ONCOL REP, V32, P1188, DOI 10.3892/or.2014.3302; Lee EJ, 2007, ANN NY ACAD SCI, V1095, P113, DOI 10.1196/annals.1397.015; Lee JH, 2013, THIN SOLID FILMS, V547, P99, DOI 10.1016/j.tsf.2013.04.105; Lee JH, 2013, ACTA ODONTOL SCAND, V71, P168, DOI 10.3109/00016357.2011.654256; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lunov O, 2014, SCI REP-UK, V4, DOI 10.1038/srep07129; Ma YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091947; MCALLISTER BS, 1993, ARCH BIOCHEM BIOPHYS, V304, P294, DOI 10.1006/abbi.1993.1352; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MILLER WM, 1988, BIOTECHNOL BIOENG, V32, P947, DOI 10.1002/bit.260320803; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Morelli MP, 2005, ANN ONCOL, V16, P61, DOI 10.1093/annonc/mdi910; Nims Raymond W., 1995, Methods (Orlando), V7, P48, DOI 10.1006/meth.1995.1007; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Panngom K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.168; Park SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129931; PETTENGELL R, 1994, BONE MARROW TRANSPL, V14, P703; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Schlegel J, 2013, CLIN PLASMA MED, V1, P2, DOI 10.1016/j.cpme.2013.08.001; Shackelford RE, 2000, FREE RADICAL BIO MED, V28, P1387, DOI 10.1016/S0891-5849(00)00224-0; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; Truong TH, 2012, BIOCHEMISTRY-US, V51, P9954, DOI 10.1021/bi301441e; Vacaresse N, 2001, BRIT J PHARMACOL, V132, P1777, DOI 10.1038/sj.bjp.0703981; Verhaar R, 2008, BLOOD, V112, P4935, DOI 10.1182/blood-2008-04-151043; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; Wartenberg M, 2003, INT J CANCER, V104, P274, DOI 10.1002/ijc.10928; Yi YW, 2015, INT J ONCOL, V47, P122, DOI 10.3892/ijo.2015.2982; Zhang S, 2004, CANCER LETT, V208, P143, DOI 10.1016/j.canlet.2003.11.028; Zhuang SG, 2003, ONCOGENE, V22, P4413, DOI 10.1038/sj.onc.1206604	62	32	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150279	10.1371/journal.pone.0150279	http://dx.doi.org/10.1371/journal.pone.0150279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919318	Green Published, Green Submitted, gold			2022-12-27	WOS:000371274400116
J	Shen, ZJ; Hu, J; Shiizaki, K; Kuro-o, M; Malter, JS				Shen, Zhong-Jian; Hu, Jie; Shiizaki, Kazuhiro; Kuro-o, Makoto; Malter, James S.			Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1	PLOS ONE			English	Article							DIETARY PHOSPHORUS; TGF-BETA; PROTEIN; PROGRESSION; KIDNEY; CALCIFICATION; EXPRESSION; RESTRICTION; ACTIVATION; INDUCTION	Tubulo-interstitial fibrosis is a common, destructive endpoint for a variety of kidney diseases. Fibrosis is well correlated with the loss of kidney function in both humans and rodents. The identification of modulators of fibrosis could provide novel therapeutic approaches to reducing disease progression or severity. Here, we show that the peptidylprolyl isomerase Pin1 is an important molecular contributor that facilitates renal fibrosis in a well-characterized animal model. While wild-type mice fed a high phosphate diet (HPD) for 8-12 weeks developed calcium deposition, macrophage infiltration and extracellular matrix (ECM) accumulation in the kidney interstitium, Pin1 null mice showed significantly less pathology. The serum Pi in both WT and KO mice were significantly increased by the HPD, but the serum Ca was slightly decreased in KO compared to WT. In addition, both WT and KO HPD mice had less weight gain but exhibited normal organ mass (kidney, lung, spleen, liver and heart). Unexpectedly, renal function was not initially impaired in either genotype irrespective of the HPD. Our results suggest that diet containing high Pi induces rapid renal fibrosis before a significant impact on renal function and that Pin1 plays an important role in the fibrotic process.	[Shen, Zhong-Jian; Hu, Jie; Shiizaki, Kazuhiro; Kuro-o, Makoto; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shen, ZJ; Malter, JS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	Zhong.Shen@UTsouthwestern.edu; James.Malter@UTsouthwestern.edu			National Institutes of Health [P01HL088594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15K09269] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by National Institutes of Health Grant P01HL088594 (to J.S.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRASS CK, 1995, AM J PATHOL, V146, P742; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Camalier CE, 2013, J CELL PHYSIOL, V228, P1536, DOI 10.1002/jcp.24312; Cao Q, 2014, KIDNEY INT SUPPL, V4, P16, DOI 10.1038/kisup.2014.4; Chakrabarti S, 2013, VET PATHOL, V50, P147, DOI 10.1177/0300985812453176; Chen ZH, 2012, CELL PHYSIOL BIOCHEM, V30, P151, DOI 10.1159/000339054; Cozzolino M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025782.24383.0D; CRAIG JM, 1959, ARCH PATHOL, V68, P306; Di Marco GS, 2008, AM J PHYSIOL-RENAL, V294, pF1381, DOI 10.1152/ajprenal.00003.2008; Earl GL, 2012, J AM PHARM ASSOC, V52, P637, DOI 10.1331/JAPhA.2012.10241; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Eraranta A, 2012, AM J NEPHROL, V35, P401, DOI 10.1159/000337942; Finch JL, 2013, KIDNEY INT, V84, P1145, DOI 10.1038/ki.2013.213; FINCO DR, 1992, AM J VET RES, V53, P2264; GIMENEZ LF, 1987, KIDNEY INT, V31, P93, DOI 10.1038/ki.1987.14; HAUT LL, 1980, KIDNEY INT, V17, P722, DOI 10.1038/ki.1980.85; He JH, 2013, CLIN EXP NEPHROL, V17, P488, DOI 10.1007/s10157-013-0781-0; Huen SC, 2013, AM J PHYSIOL-RENAL, V305, pF477, DOI 10.1152/ajprenal.00624.2012; Kang DH, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133806; Kendrick J, 2011, AM J KIDNEY DIS, V58, P826, DOI 10.1053/j.ajkd.2011.07.020; Koizumi T, 2002, BIOCHEM BIOPH RES CO, V295, P917, DOI 10.1016/S0006-291X(02)00793-3; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; LAU K, 1989, KIDNEY INT, V36, P918, DOI 10.1038/ki.1989.281; Liao Y, 2010, AM J TRANSL RES, V2, P19; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; LOGHMANADHAM M, 1993, J LAB CLIN MED, V122, P16; Lu KP, 2007, NAT REV MOL CELL BIO, V8, P904, DOI 10.1038/nrm2261; LUMLERTGUL D, 1986, KIDNEY INT, V29, P658, DOI 10.1038/ki.1986.49; MacKay EM, 1935, J EXP MED, V61, P319, DOI 10.1084/jem.61.3.319; Maschio G, 1983, Kidney Int Suppl, V16, pS273; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Ohnishi M, 2010, FASEB J, V24, P3562, DOI 10.1096/fj.09-152488; Qi WE, 2006, INT J BIOCHEM CELL B, V38, P1, DOI 10.1016/j.biocel.2005.09.005; Rohatgi R, 2010, CURR OPIN NEPHROL HY, V19, P65, DOI 10.1097/MNH.0b013e32833327f3; ROSS LA, 1982, AM J VET RES, V43, P1023; Shen ZY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079443, 10.1371/journal.pone.0054520]; Shen ZJ, 2008, J CLIN INVEST, V118, P479, DOI [10.1172/JC132789, 10.1172/JCI32789]; Shen ZJ, 2012, J BIOL CHEM, V287, P23294, DOI 10.1074/jbc.M111.313684; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Shuto E, 2009, J AM SOC NEPHROL, V20, P1504, DOI 10.1681/ASN.2008101106; Sorkness RL, 2007, AM J PHYSIOL-LUNG C, V292, pL85, DOI 10.1152/ajplung.00234.2006; Sun Y., 2014, ADV ENERGY MATER, V4, P1, DOI [DOI 10.1038/SREP06563, DOI 10.1002/aenm.201300611]; Takemura A, 2011, ARTERIOSCL THROM VAS, V31, P2054, DOI 10.1161/ATVBAHA.110.216739; Tan RJ, 2013, AM J PHYSIOL-RENAL, V305, pF821, DOI 10.1152/ajprenal.00356.2013; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Wolf G, 2006, KIDNEY INT, V70, P1914, DOI 10.1038/sj.ki.5001846; Yang JW, 2014, J HEPATOL, V60, P1235, DOI 10.1016/j.jhep.2014.02.004; Yung S, 2003, PERITON DIALYSIS INT, V23, pS37; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175	49	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150093	10.1371/journal.pone.0150093	http://dx.doi.org/10.1371/journal.pone.0150093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914452	Green Submitted, Green Published, gold			2022-12-27	WOS:000371175700052
J	Dennis, B; Kemp, WP				Dennis, Brian; Kemp, William P.			How Hives Collapse: Allee Effects, Ecological Resilience, and the Honey Bee	PLOS ONE			English	Article							POPULATION-DYNAMICS; COLONY; DISORDER; POLLINATION; STATES; SCALE; MODEL	We construct a mathematical model to quantify the loss of resilience in collapsing honey bee colonies due to the presence of a strong Allee effect. In the model, recruitment and mortality of adult bees have substantial social components, with recruitment enhanced and mortality reduced by additional adult bee numbers. The result is an Allee effect, a net per-individual rate of hive increase that increases as a function of adult bee numbers. The Allee effect creates a critical minimum size in adult bee numbers, below which mortality is greater than recruitment, with ensuing loss of viability of the hive. Under ordinary and favorable environmental circumstances, the critical size is low, and hives remain large, sending off viably-sized swarms (naturally or through beekeeping management) when hive numbers approach an upper stable equilibrium size (carrying capacity). However, both the lower critical size and the upper stable size depend on many parameters related to demographic rates and their enhancement by bee sociality. Any environmental factors that increase mortality, decrease recruitment, or interfere with the social moderation of these rates has the effect of exacerbating the Allee effect by increasing the lower critical size and substantially decreasing the upper stable size. As well, the basin of attraction to the upper stable size, defined by the model potential function, becomes narrower and shallower, indicating the loss of resilience as the hive becomes subjected to increased risk of falling below the critical size. Environmental effects of greater severity can cause the two equilibria to merge and the basin of attraction to the upper stable size to disappear, resulting in collapse of the hive from any initial size. The model suggests that multiple proximate causes, among them pesticides, mites, pathogens, and climate change, working singly or in combinations, could trigger hive collapse.	[Dennis, Brian] Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA; [Dennis, Brian] Univ Idaho, Dept Stat Sci, Moscow, ID 83844 USA; [Kemp, William P.] ARS, USDA, Red River Valley Agr Res Ctr, 1605 Albrecht Blvd North, Fargo, ND 58102 USA	Idaho; University of Idaho; Idaho; University of Idaho; United States Department of Agriculture (USDA)	Dennis, B (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Moscow, ID 83844 USA.; Dennis, B (corresponding author), Univ Idaho, Dept Stat Sci, Moscow, ID 83844 USA.	brian@uidaho.edu			US Department of Agriculture	US Department of Agriculture(United States Department of Agriculture (USDA))	This work was supported by US Department of Agriculture (http://www.ars.usda.gov/main/site_main.htm?modecode=30-00-00-00 58-5442-2-327) to BD.	Allee W., 1938, SOCIAL LIFE ANIMALS; Allee W., 1949, PRINCIPLES ANIMAL EC; Allee W.C, 1931, ANIMAL AGGREGATION S; Becher MA, 2013, J APPL ECOL, V50, P868, DOI 10.1111/1365-2664.12112; Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Bryden J, 2013, ECOL LETT, V16, P1463, DOI 10.1111/ele.12188; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Case T. J, 2000, ILLUSTRATED GUIDE TH; Clark C.W., 2010, MATH BIOECONOMICS, V3rd; Courchamp F, 1999, P ROY SOC B-BIOL SCI, V266, P557, DOI 10.1098/rspb.1999.0672; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; DEGRANDIHOFFMAN G, 1989, ECOL MODEL, V45, P133, DOI 10.1016/0304-3800(89)90088-4; Deguines N, 2014, FRONT ECOL ENVIRON, V12, P212, DOI 10.1890/130054; Dennis B., 1989, Natural Resource Modeling, V3, P481; Dennis B, 2002, OIKOS, V96, P389, DOI 10.1034/j.1600-0706.2002.960301.x; Dively GP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118748; Eberl HJ, 2010, ELECTRON J DIFFER EQ, P85; Gallant AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099268; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; HARBO JR, 1986, J APICULT RES, V25, P22, DOI 10.1080/00218839.1986.11100687; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Kapheim KM, 2015, SCIENCE, V348, P1139, DOI 10.1126/science.aaa4788; Khoury DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059084; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Kramer AM, 2009, POPUL ECOL, V51, P341, DOI 10.1007/s10144-009-0152-6; Kribs-Zaleta CM, 2014, MATH BIOSCI ENG, V11, P1275, DOI 10.3934/mbe.2014.11.1275; Kritsky Gene, 2010, QUEST PERFECT HIVE H; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Lidicker William Z. Jr, 2010, Open Ecology Journal, V3, P71; Lu CS, 2014, B INSECTOL, V67, P125; Ludwig D., 1997, CONSERV ECOL, V1, P1; Luque GM, 2013, J ANIM ECOL, V82, P956, DOI 10.1111/1365-2656.12091; MAKELA ME, 1993, ECOL MODEL, V67, P259, DOI 10.1016/0304-3800(93)90009-H; Mikheyev AS, 2008, DIVERS DISTRIB, V14, P301, DOI 10.1111/j.1472-4642.2007.00463.x; ODUM HT, 1954, ECOLOGY, V35, P95, DOI 10.2307/1931412; Pettis JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070182; PHILIP JR, 1957, ECOLOGY, V38, P107, DOI 10.2307/1932132; Russell S, 2013, ECOL MODEL, V265, P158, DOI 10.1016/j.ecolmodel.2013.06.005; Sanford MT, 2010, STOREYS GUIDE KEEPIN; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stankus T, 2008, J AGRIC FOOD INF, V9, P115, DOI 10.1080/10496500802173939; Stankus Tony, 2014, Science & Technology Libraries, V33, P228, DOI 10.1080/0194262X.2014.912573; Steinhauer NA, 2014, J APICULT RES, V53, P1, DOI 10.3896/IBRA.1.53.1.01; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Volterra V., 1938, HUM BIOL, V3, P1; Watanabe ME, 2008, BIOSCIENCE, V58, P384, DOI 10.1641/B580503	54	24	24	4	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150055	10.1371/journal.pone.0150055	http://dx.doi.org/10.1371/journal.pone.0150055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910061	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700059
J	Adeniyi, OV; Yogeswaran, P; Longo-Mbenza, B; Ter Goon, D				Adeniyi, Oladele Vincent; Yogeswaran, Parimalaranie; Longo-Mbenza, Benjamin; Ter Goon, Daniel			Uncontrolled Hypertension and Its Determinants in Patients with Concomitant Type 2 Diabetes Mellitus (T2DM) in Rural South Africa	PLOS ONE			English	Article							BLOOD-PRESSURE; HEALTH; PREVALENCE; AWARENESS; OBESITY; MORTALITY; DISTRICT; TRIAL	Background Paucity of data on the prevalence, treatment and control of hypertension in individuals living with type 2 diabetes mellitus (T2DM) in the rural communities of South Africa may undermine efforts to reduce the morbidity and mortality associated with cardiovascular diseases. This study examines the socio-demographic and clinical determinants of uncontrolled hypertension among individuals living with T2DM in the rural communities of Mthatha, South Africa. Methods This cross-sectional study involved a serially selected sample of 265 individuals living with T2DM and hypertension at Mthatha General Hospital, Mthatha. Uncontrolled hypertension was defined as systolic blood pressure greater than or equal to 140mmHg and diastolic blood pressure greater than or equal to 90mmHg in accordance with the Eight Joint National Committee Report (JNC 8) (2014). We performed univariate and multivariate logistic regression analyses to identify the significant determinants of uncontrolled hypertension. Results Of the total participants (n = 265), the prevalence of uncontrolled hypertension was 75.5% (n = 200). In univariate analysis of all participants, male gender (p = 0.029), age >= 65 years (p = 0.016), unemployed status (p<0.0001), excessive alcohol intake (p = 0.005) and consumption of western-type diet (p<0.0001) were positively associated with uncontrolled hypertension. In multivariate logistic regression (LR method) analysis, unemployed status (p<0.0001), excessive alcohol intake (p = 0.007) and consumption of western-type diet (p<0.0001) were independently and significantly associated with uncontrolled hypertension. There is significant association between increasing number and classes of anti-hypertensive drugs and uncontrolled hypertension (p = 0.05 and 0.02, respectively). Conclusion Prevalence of uncontrolled hypertension was high in individuals with concomitant hypertension and T2DM in the study population. Male sex, aging, clinic inertia, unemployed status and nutritional transitions are the most important determinants of uncontrolled hypertension in T2DM in Mthatha, South Africa. Treatment to blood pressure targets, though feasible in our setting, would require concerted efforts by addressing these determinants and clinic inertia.	[Adeniyi, Oladele Vincent] Walter Sisulu Univ, Dept Family Med, East London, South Africa; [Yogeswaran, Parimalaranie; Longo-Mbenza, Benjamin] Walter Sisulu Univ, Dept Family Med, Mthatha, South Africa; [Ter Goon, Daniel] Univ Ft Hare, East London, South Africa	Walter Sisulu University; Walter Sisulu University; University of Fort Hare	Adeniyi, OV (corresponding author), Walter Sisulu Univ, Dept Family Med, East London, South Africa.	vincoladele@gmail.com	Goon, Daniel Ter/C-2912-2019	Goon, Daniel Ter/0000-0001-9070-7875				Abubakari AR, 2009, PUBLIC HEALTH, V123, P602, DOI 10.1016/j.puhe.2009.07.009; Adeniyi OV, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1622-8; Agyemang C, 2006, J HUM HYPERTENS, V20, P874, DOI 10.1038/sj.jhh.1002073; Alaba O, 2014, INT J ENV RES PUB HE, V11, P3387, DOI 10.3390/ijerph110303387; Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; [Anonymous], 2012, JEMDSA, V17, pS1, DOI 10.1080/22201009.2012.10872277; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Berraho M, 2012, PAN AFR MED J, V11; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Cheung BMY, 2012, CURR ATHEROSCLER REP, V14, P160, DOI 10.1007/s11883-012-0227-2; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Goverwa Tafadzwa Priscilla, 2014, BMC Res Notes, V7, P703, DOI 10.1186/1756-0500-7-703; Guessous I, 2012, 1999 2000 TRENDS PRE; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jenson A, 2011, GLOB PUBLIC HEALTH, V6, P293, DOI 10.1080/17441692.2010.510478; Kandala N-B, 2014, GEOGRAPHIC VARIATION; Kayima J, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-54; Kibirige D, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-40; Kruger HS, 2005, PUBLIC HEALTH NUTR, V8, P491, DOI 10.1079/PHN2005785; Lopez-Jaramillo P, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-31; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; MENOTTI A, 1991, J HUM HYPERTENS, V5, P137; Nejjari C, 2013, J HYPERTENS, V31, P49, DOI 10.1097/HJH.0b013e32835a6611; Nteta TP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013909; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534; Rodgers A, 2004, PLOS MED, V1, P44, DOI 10.1371/journal.pmed.0010027; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steyn K, 2008, SAMJ S AFR MED J, V98, P376; Vaccaro O, 1998, INT J EPIDEMIOL, V27, P636, DOI 10.1093/ije/27.4.636; Wang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062469; Williams EA, 2013, DIABETES METAB SYND, V7, P123, DOI 10.1016/j.dsx.2013.06.015; World Health Organization, 1995, PHYS STAT US INT ANT; Yang L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-903	41	43	45	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150033	10.1371/journal.pone.0150033	http://dx.doi.org/10.1371/journal.pone.0150033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930050	Green Published, gold, Green Submitted			2022-12-27	WOS:000371434500091
J	Armstrong, GAB; Liao, MJ; You, ZP; Lissouba, A; Chen, BE; Drapeau, P				Armstrong, Gary Alan Barclay; Liao, Meijiang; You, Zhipeng; Lissouba, Alexandra; Chen, Brian Edwin; Drapeau, Pierre			Homology Directed Knockin of Point Mutations in the Zebrafish tardbp and fus Genes in ALS Using the CRISPR/Cas9 System	PLOS ONE			English	Article							MOTOR-NEURON; TDP-43; FUS/TLS	The methodology for site-directed editing of single nucleotides in the vertebrate genome is of considerable interest for research in biology and medicine. The clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 type II (Cas9) system has emerged as a simple and inexpensive tool for editing genomic loci of interest in a variety of animal models. In zebrafish, error-prone non-homologous end joining (NHEJ) has been used as a simple method to disrupt gene function. We sought to develop a method to easily create site-specific SNPs in the zebrafish genome. Here, we report simple methodologies for using CRISPR/Cas9-mediated homology directed repair using single-stranded oligodeoxynucleotide donor templates (ssODN) for site-directed single nucleotide editing, for the first time in two disease-related genes, tardbp and fus.	[Armstrong, Gary Alan Barclay; Liao, Meijiang; You, Zhipeng; Lissouba, Alexandra; Drapeau, Pierre] Univ Montreal, Ctr Hosp, Res Ctr, Dept Neurosci, Montreal, PQ, Canada; [Chen, Brian Edwin] McGill Univ, Dept Neurol & Neurosurg, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Chen, Brian Edwin] McGill Univ, Ctr Res Neurosci, Montreal, PQ H3A 2T5, Canada	Universite de Montreal; McGill University; McGill University	Armstrong, GAB (corresponding author), Univ Montreal, Ctr Hosp, Res Ctr, Dept Neurosci, Montreal, PQ, Canada.	gary.ab.armstrong@gmail.com		Armstrong, Gary/0000-0003-4613-8817	Weston Brain Institute [RR130306]; Canadian Institutes of Health Research [119610, MOP-285438]; Brain Canada; OCE-CQDM Life Sciences R&R Challenge grant; ALSA TREAT ALS Drug Development grant; ALS Canada [316877]	Weston Brain Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Brain Canada; OCE-CQDM Life Sciences R&R Challenge grant; ALSA TREAT ALS Drug Development grant; ALS Canada	This work was supported by Weston Brain Institute, http://westonbraininstitute.ca/, RR130306, awarded to GA; Funding Agency: Canadian Institutes of Health Research, Grant number: 119610, awarded to BC, http://www.cihr-irsc.gc.ca/; Funding Agency: Canadian Institutes of Health Research, Grant number: MOP-285438, awarded to PD, http://www.cihr-irsc.gc.ca/; Funding Agency: Brain Canada Platform grant, Grant number: no grant number, awarded to PD, http://braincanada.ca/; Funding Agency: OCE-CQDM Life Sciences R&R Challenge grant, Grant number: no grant number, awarded to PD, http://www.cqdm.org/; Funding Agency: ALSA TREAT ALS Drug Development grant, Grant number: no grant number, awarded to PD, http://www.alsa.org/; Funding Agency: ALS Canada Ph.D. fellowship, Grant number: 316877, https://www.als.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer TO, 2013, GENOME RES; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; Hewamadduma CAA, 2013, HUM MOL GENET, V22, P2376, DOI 10.1093/hmg/ddt082; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002214; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Schmid B, 2013, P NATL ACAD SCI USA, V110, P4986, DOI 10.1073/pnas.1218311110; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Zhao P, 2014, CELL RES, V24, P247, DOI 10.1038/cr.2014.9	16	77	83	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150188	10.1371/journal.pone.0150188	http://dx.doi.org/10.1371/journal.pone.0150188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930076	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500112
J	Yin, J; Yuan, JQ; Hu, YH; We, XL				Yin, Jia; Yuan, Jinqiu; Hu, Yanhong; We, Xiaolin			Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; MDR-TB PATIENTS; INDIVIDUALIZED TREATMENT; PULMONARY TUBERCULOSIS; TREATMENT INTERRUPTION; HEALTH-WORKERS; FOLLOW-UP; DOTS; FEASIBILITY; EXPERIENCE	Background Multidrug-resistant tuberculosis (MDR-TB) represents a major obstacle towards successful TB control. Directly observed therapy (DOT) was recommended by WHO to improve adherence and treatment outcomes of MDR-TB patients, however, the effectiveness of DOT on treatment outcomes of MDR-TB patients was mixed in previous studies. We conducted this systematic review and meta-analysis to assess the association between DOT and treatment outcomes and to examine the impact of different DOT providers and DOT locations on successful treatment outcomes in MDR-TB patients. Methods We searched studies published in English between January 1970 and December 2015 in major electronic databases. Two reviewers independently screened articles and extracted information of DOT, treatment success rate and other characteristics of studies. Random effects model was used to calculate the pooled treatment success rate and 95% confidence interval (CI). Sub-group analyses were conducted to access factors associated with successful treatment outcomes. Results A total of 31 articles 7,466 participants were included. Studies reporting full DOT (67.4%, 95% CI: 61.4-72.8%) had significantly higher pooled treatment success rates than those reporting self-administration therapy (46.9%, 95% CI: 41.4-52.4%). No statistically difference was found among DOT provided by healthcare providers (65.8%, 95% CI: 55.7-74.7%), family members (72.0%, 95% CI: 31.5-93.5%) and private DOT providers (69.5%, 95% CI: 57.0-79.7%); and neither did we find significantly difference on pooled treatment success rates between patients having health facility based DOT (70.5%, 95% CI: 61.5-78.1%) and home-based DOT (68.4%, 95% CI: 51.5-81.5%). Conclusion Providing DOT for a full course of treatment associated with a higher treatment success rate in MDR-TB patients.	[Yin, Jia; Yuan, Jinqiu; Hu, Yanhong; We, Xiaolin] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China; [We, Xiaolin] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Chinese University of Hong Kong; University of Toronto	We, XL (corresponding author), Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Shatin, Hong Kong, Peoples R China.; We, XL (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	Xiaolin.wei@utoronto.ca	hu, jessika/T-7106-2018; Yuan, Jinqiu/A-4867-2018	hu, jessika/0000-0002-0923-7923; 	Hong Kong Research Grants Council [CUHK 14411614]; UKAID of the UK Department for International Development; Department for International Development (DFID) [201025] Funding Source: researchfish	Hong Kong Research Grants Council(Hong Kong Research Grants Council); UKAID of the UK Department for International Development; Department for International Development (DFID)	This study was supported by the General Research Fund grant through the Hong Kong Research Grants Council (ref CUHK 14411614), and also partly supported by the UKAID of the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Bastard M, 2015, J INFECT DIS, V211, P1607, DOI 10.1093/infdis/jiu551; Bendayan D, 2011, EUR J CLIN MICROBIOL, V30, P375, DOI 10.1007/s10096-010-1096-7; Borenstein M., 2009, INTRO METAANALYSIS; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chaulk CP, 1998, JAMA-J AM MED ASSOC, V279, P943, DOI 10.1001/jama.279.12.943; CHAULK CP, 1995, JAMA-J AM MED ASSOC, V274, P945, DOI 10.1001/jama.274.12.945; Chiang CY, 2006, EUR RESPIR J, V28, P980, DOI 10.1183/09031936.06.00125705; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Escudero E, 2006, INT J TUBERC LUNG D, V10, P409; Ferrara G, 2005, INT J TUBERC LUNG D, V9, P507; Ferrer G, 2010, AM J TROP MED HYG, V83, P1056, DOI 10.4269/ajtmh.2010.10-0145; Frieden T R, 2007, WORLD HOSP HLTH SERV, V43, P30; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hoa NB, 2014, TROP MED INT HEALTH, V19, P1076, DOI 10.1111/tmi.12347; Impellizzeri FM, 2012, INT J SPORTS PHYS TH, V7, P493; International Monetary Fund, 2014, WORLD EC OUTL REC ST; Jain K, 2014, J PHARMACOL PHARMACO, V5, P145, DOI 10.4103/0976-500X.130062; Jeon DS, 2011, J KOREAN MED SCI, V26, P33, DOI 10.3346/jkms.2011.26.1.33; Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914; Joseph P, 2011, INDIAN J MED RES, V133, P529; Keshavjee S, 2008, LANCET, V372, P1403, DOI 10.1016/S0140-6736(08)61204-0; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Kunawararak P, 2011, SE ASIAN J TROP MED, V42, P1444; Kwon YS, 2008, CLIN INFECT DIS, V47, P496, DOI 10.1086/590005; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Leimane V, 2005, LANCET, V365, P318, DOI 10.1016/S0140-6736(05)17786-1; Lemos EF, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-237; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088330; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Malla P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008313; Manders AJE, 2001, INT J TUBERC LUNG D, V5, P838; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Ngamvithayapong J, 2001, INT J TUBERC LUNG D, V5, P741; Olle-Goig JE, 2005, INT J TUBERC LUNG D, V9, P765; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palacios E, 2009, CLIN INFECT DIS, V48, P1413, DOI 10.1086/598191; Palmero DJ, 2004, INT J TUBERC LUNG D, V8, P778; Park SK, 2004, INT J TUBERC LUNG D, V8, P361; Rodriguez M, 2013, INT J TUBERC LUNG D, V17, P520, DOI 10.5588/ijtld.12.0481; Sagbakken M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-25; Selgelid M J, 2011, Int J Tuberc Lung Dis, V15 Suppl 2, P9, DOI 10.5588/ijtld.10.0434; Shin S, 2004, SOC SCI MED, V59, P1529, DOI 10.1016/j.socscimed.2004.01.027; Shin S, 2011, HEALTH SOC CARE COMM, V19, P261, DOI 10.1111/j.1365-2524.2010.00968.x; Singla R, 2009, INT J TUBERC LUNG D, V13, P976; Sun Q, 2008, INT J TUBERC LUNG D, V12, P625; Tang SJ, 2011, SCAND J INFECT DIS, V43, P280, DOI 10.3109/00365548.2010.548080; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Tupasi TE, 2006, PLOS MED, V3, P1587, DOI 10.1371/journal.pmed.0030352; van Altena R, 2015, INT J TUBERC LUNG D, V19, P406, DOI 10.5588/ijtld.14.0838; Verma Geetika, 2004, BMC Med Ethics, V5, pE2, DOI 10.1186/1472-6939-5-2; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; Walley JD, 2001, LANCET, V357, P664, DOI 10.1016/S0140-6736(00)04129-5; Ward HA, 2005, INT J TUBERC LUNG D, V9, P164; Wei XL, 2015, INT J TUBERC LUNG D, V19, P413, DOI 10.5588/ijtld.14.0485; Wei XL, 2013, TROP MED INT HEALTH, V18, P1392, DOI 10.1111/tmi.12197; Wei XL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-260; WEIS SE, 1994, NEW ENGL J MED, V330, P1179, DOI 10.1056/NEJM199404283301702; WHO, 2014, GLOB TUB REP 2014; WHO, 2000, GEN EST DOTS PLUS PI; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zwarenstein M, 2000, INT J TUBERC LUNG D, V4, P550	68	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150511	10.1371/journal.pone.0150511	http://dx.doi.org/10.1371/journal.pone.0150511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930287	gold, Green Submitted, Green Published			2022-12-27	WOS:000371434500163
J	Restani, P; Di Lorenzo, C; Garcia-Alvarez, A; Badea, M; Ceschi, A; Egan, B; Dima, L; Lude, S; Maggi, FM; Marculescu, A; Mila-Villarroel, R; Raats, MM; Ribas-Barba, L; Uusitalo, L; Serra-Majem, L				Restani, Patrizia; Di Lorenzo, Chiara; Garcia-Alvarez, Alicia; Badea, Mihaela; Ceschi, Alessandro; Egan, Bernadette; Dima, Lorena; Luede, Saskia; Maggi, Franco M.; Marculescu, Angela; Mila-Villarroel, Raimon; Raats, Monique M.; Ribas-Barba, Lourdes; Uusitalo, Liisa; Serra-Majem, Lluis			Adverse Effects of Plant Food Supplements Self-Reported by Consumers in the PlantLIBRA Survey Involving Six European Countries	PLOS ONE			English	Article							BODY-WEIGHT REDUCTION; DIETARY-SUPPLEMENTS; MONASCUS-PURPUREUS; CONTROLLED-TRIAL; DOUBLE-BLIND; EFFICACY; GINSENG; HYPERLIPIDEMIA; ALOPECIA; THERAPY	Background The use of food supplements containing botanicals is increasing in European markets. Although intended to maintain the health status, several cases of adverse effects to Plant Food Supplements (PFS) have been described. Objectives To describe the self-reported adverse effects collected during the European PlantLIBRA PFS Consumer Survey 2011-2012, with a critical evaluation of the plausibility of the symptomatology reported using data from the literature and from the PlantLIBRA Poisons Centers' survey. Subjects/Setting From the total sample of 2359 consumers involved in the consumers' survey, 82 subjects reported adverse effects due to a total of 87 PFS. Results Cases were self-reported, therefore causality was not classified on the basis of clinical evidence, but by using the frequency/strength of adverse effects described in scientific papers: 52 out of 87 cases were defined as possible (59.8%) and 4 as probable (4.6%). Considering the most frequently cited botanicals, eight cases were due to Valeriana officinalis (garden valerian); seven to Camellia sinensis (tea); six to Ginkgo biloba (Maidenhair tree) and Paullinia cupana (guarana). Most adverse events related to the gastrointestinal tract, nervous and cardiovascular systems. Conclusions Comparing the data from this study with those published in scientific papers and obtained by the PlantLIBRA Poisons Centers' survey, some important conclusions can be drawn: severe adverse effects to PFS are quite rare, although mild or moderate adverse symptoms can be present. Data reported in this paper can help health professionals (and in particular family doctors) to become aware of possible new problems associated with the increasing use of food supplements containing botanicals.	[Restani, Patrizia; Di Lorenzo, Chiara; Maggi, Franco M.] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Garcia-Alvarez, Alicia; Mila-Villarroel, Raimon; Ribas-Barba, Lourdes; Serra-Majem, Lluis] Univ Barcelona, Fdn Invest Nutr, Barcelona Sci Pk, Barcelona, Spain; [Badea, Mihaela; Dima, Lorena; Marculescu, Angela] Transilvania Univ Brasov, Brasov, Romania; [Ceschi, Alessandro; Luede, Saskia] Univ Zurich, Associated Inst, Tox Info Suisse, Natl Poisons Ctr, Zurich, Switzerland; [Ceschi, Alessandro] Ente Osped Cantonale, Dept Internal Med, Div Clin Pharmacol & Toxicol, Lugano, Switzerland; [Ceschi, Alessandro] Univ Zurich Hosp, Dept Clin Pharmacol & Toxicol, CH-8091 Zurich, Switzerland; [Egan, Bernadette; Raats, Monique M.] Univ Surrey, Food Consumer Behav & Hlth Res Ctr, Guildford GU2 5XH, Surrey, England; [Uusitalo, Liisa] Finnish Food Safety Author Evira, Helsinki, Finland; [Ribas-Barba, Lourdes; Serra-Majem, Lluis] Inst Salud Carlos III, Ciber Obn Fisiopatol Obesidad & Nutr, Madrid, Spain; [Serra-Majem, Lluis] Univ Las Palmas Gran Canaria, Inst Biomed & Hlth Res Las Palmas, Las Palmas Gran Canaria, Spain	University of Milan; University of Barcelona; Transylvania University of Brasov; University of Zurich; University of Zurich; University Zurich Hospital; University of Surrey; Finnish Food Authority; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; Universidad de Las Palmas de Gran Canaria	Restani, P (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	patrizia.restani@unimi.it	Raats, Monique/G-5348-2012; Badea, Mihaela/Z-1490-2018; Dima, Lorena/ABV-9548-2022; Garcia-Alvarez, Alicia/AAV-9762-2020; Serra-Majem, Lluis/I-6708-2019; Milà Villarroel, Raimon/AGR-2823-2022	Raats, Monique/0000-0002-8057-2783; Badea, Mihaela/0000-0003-4824-2175; Dima, Lorena/0000-0002-4406-9304; Serra-Majem, Lluis/0000-0002-9658-9061; Ceschi, Alessandro/0000-0002-4308-0405	European Community [245199]	European Community(European Commission)	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n. 245199. It has been carried out within the PlantLIBRA project (www.plantlibra.eu).	Akbay P, 2003, PHYTOTHER RES, V17, P34, DOI 10.1002/ptr.1068; Ali BH, 2008, FOOD CHEM TOXICOL, V46, P409, DOI 10.1016/j.fct.2007.09.085; [Anonymous], 2012, NUTR BUSINESS J; [Anonymous], REV COULD GINKG BIL; Arun N, 2012, INT J PHARM SCI RES, V3, P1240, DOI 10.13040/IJPSR.0975-8232.3(5).1240-45; Bailey RL, 2014, NUTR REV, V72, P9, DOI 10.1111/nure.12138; Barrett B, 2003, PHYTOMEDICINE, V10, P66, DOI 10.1078/094471103321648692; Bauer BA, 2016, I READ HERBAL SUPPLE; Borsuk OS, 2011, B EXP BIOL MED+, V151, P194, DOI 10.1007/s10517-011-1287-y; Burnham TH, 1997, REV NATURAL PRODUCTS; Chaabane M, 2010, ARCH PEDIATRIE, V17, P502, DOI 10.1016/j.arcped.2010.02.011; Chacko Sabu M, 2010, Chin Med, V5, P13, DOI 10.1186/1749-8546-5-13; Cheetham PJ, 2013, CURR UROL REP, V14, P606, DOI 10.1007/s11934-013-0372-3; Cunningham AB, 1993, SUSTAINIBILITY HARVE; DAVIS RH, 1992, J AM PODIAT MED ASSN, V82, P140, DOI 10.7547/87507315-82-3-140; DFG-Permanent Senate Commission on Food Safety SKLM, 2013, TOX EV RED MOULD RIC; Di Lorenzo C, 2015, BRIT J CLIN PHARMACO, V79, P578, DOI 10.1111/bcp.12519; Drozd Janina, 2003, Acta Pol Pharm, V60, P467; EMA, 2013, COMM HERB MON CAM SI; EMA (European Medicines Agency), 2014, COMM HERB MON GINKG; EMA (European Medicines Agency), 2012, ASS REP PAULL CUP KU; EMA (European Medicines Agency), 2010, COMM HERB MON VAL OF; EMA (European Medicines Agency), 2006, COMM HERB MON CASS S; EMA (European Medicines Agency), 2010, COMM HERB MON ARCT L; EMA (European Medicines Agency), 2011, ASS REP CYN SCOL FOL; EMA (European Medicines Agency), 2014, EUR UN HERB MON BET; EMA (European Medicines Agency), 2012, COMM HERB MON ZING O; EMA (European Medicines Agency), 2015, EUR UN HERB MON EQ A; EMA (European Medicines Agency), 2013, COMM HERB MON PAN GI; EMA (European Medicines Agency), 2011, ASS REP OEN BIENN L; EMA (European Medicines Agency), 2007, COMM HERB MON RHAMN; Erdogrul O, 2004, TURK ELECT J BIOTECH, V2, P37; European Advisory Services (EAS), 2007, NRSANCO2006E4018 EAS; European Medicines Agency (EMA), 2008, COMM HERB MON HARP P; European Medicines Agency-EMA, HERB MED HUM US; Fleming T., 2000, PDR HERBAL MED, V2nd ed.; Garcia-Alvarez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092265; Ghanbari R, 2012, INT J MOL SCI, V13, P3291, DOI 10.3390/ijms13033291; Harris JC, 2001, APPL MICROBIOL BIOT, V57, P282, DOI 10.1007/s002530100722; HENDERSON JA, 1952, J AM VET MED ASSOC, V120, P375; Kaatabi H, 2012, J FAM COMMUNITY MED, V19, P155, DOI 10.4103/2230-8229.102311; Kabalak AA, 2004, J WOMENS HEALTH, V13, P830, DOI 10.1089/jwh.2004.13.830; Karkos PD, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen058; Kim SH, 2003, PHARMACOL RES, V48, P511, DOI 10.1016/S1043-6618(03)00189-0; Klimek Matthew, 2009, P T, V34, P313; Lin CC, 2005, EUR J ENDOCRINOL, V153, P679, DOI 10.1530/eje.1.02012; Liu Jianping, 2006, Chin Med, V1, P4, DOI 10.1186/1749-8546-1-4; Lonsdale D., 1998, J ADV MED, V11, P209; Lude S, 2013, CLIN TOXICOL, V51, P267; Mayo Clinic, 2013, GINKG GINKG BIL; Mayo Clinic, 2010, VAL SAF EFF HERB SLE; McIntyre A., 2005, HERBAL TREATMENT CHI, P59; Minami T, 2015, J ALLER CL IMM-PRACT, V3, P441, DOI 10.1016/j.jaip.2014.11.024; NCCIH-National Center for Complementary and Integrative Health-NIH, 2012, GREEN TEA; NIAMS-National Institute of Arthritis and Musculoskeletal and Skin Diseases, 2011, RES FINDS LINK STATI; Oh GN, 2012, J GINSENG RES, V36, P391, DOI 10.5142/jgr.2012.36.4.391; Parnham MJ, 1996, PHYTOMEDICINE, V3, P95, DOI 10.1016/S0944-7113(96)80020-1; Paur I, 2011, HERBAL MED BIOMOLECU; PennState Hershey Milton S. Hershey Medical Center, POMEGRANATE; Pittler MH, 2005, OBES REV, V6, P93, DOI 10.1111/j.1467-789X.2005.00169.x; Pittler MH, 2001, AM J MED, V110, P724, DOI 10.1016/S0002-9343(01)00702-1; Prager N, 2002, J ALTERN COMPLEM MED, V8, P143; Reuter J, 2010, AM J CLIN DERMATOL, V11, P247, DOI 10.2165/11533220-000000000-00000; Salehi B, 2010, PROG NEURO-PSYCHOPH, V34, P76, DOI 10.1016/j.pnpbp.2009.09.026; Salem ML, 2005, INT IMMUNOPHARMACOL, V5, P1749, DOI 10.1016/j.intimp.2005.06.008; Shenefelt PD, 2011, HERBAL MED BIOMOLECU; Silano V, 2011, FOOD FUNCT, V2, P710, DOI 10.1039/c1fo10105f; Skeie G, 2009, EUR J CLIN NUTR, V63, pS226, DOI 10.1038/ejcn.2009.83; Smith N, 2010, EVID-BASED COMPL ALT, V7, P279, DOI 10.1093/ecam/nem162; UMM-University of Maryland Medical Center, 2013, RED YEAST RIC; UMM-University of Maryland Medical Center, 2013, GARLIC; UMM-University of Maryland Medical Center, 2014, ECHINACEA; UMM-University of Maryland Medical Center, 2013, SPIR; Unsel M, 2009, J INVEST ALLERG CLIN, V19, P497; Valli G, 2002, J AM COLL CARDIOL, V39, P1083, DOI 10.1016/S0735-1097(02)01749-7; Vargas-Murga L, 2011, FOOD FUNCT, V2, P731, DOI 10.1039/c1fo10075k; World Health Organization, 2004, WHO GUID SAF MON HER; Wright CI, 2007, J ETHNOPHARMACOL, V114, P1, DOI 10.1016/j.jep.2007.07.023	78	21	24	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150089	10.1371/journal.pone.0150089	http://dx.doi.org/10.1371/journal.pone.0150089			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5WU	26928206	Green Published, Green Accepted, gold			2022-12-27	WOS:000371424200021
J	Fernandez-Costa, JM; Llamusi, B; Bargiela, A; Zulaica, M; Alvarez-Abril, MC; Perez-Alonso, M; de Munain, AL; Lopez-Castel, A; Artero, R				Fernandez-Costa, Juan M.; Llamusi, Beatriz; Bargiela, Ariadna; Zulaica, Miren; Carmen Alvarez-Abril, M.; Perez-Alonso, Manuel; Lopez de Munain, Adolfo; Lopez-Castel, Arturo; Artero, Ruben			Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers	PLOS ONE			English	Article							REAL-TIME PCR; IN-VIVO; SKELETAL-MUSCLE; MESSENGER-RNA; TRANSCRIPTION; EXPRESSION; REPEAT; MBNL; EXPANSION; REGION	Myotonic dystrophy type 1 (DM1) is an autosomal dominant genetic disease caused by expansion of a CTG microsatellite in the 3' untranslated region of the DMPK gene. Despite characteristic muscular, cardiac, and neuropsychological symptoms, CTG trinucleotide repeats are unstable both in the somatic and germinal lines, making the age of onset, clinical presentation, and disease severity very variable. A molecular biomarker to stratify patients and to follow disease progression is, thus, an unmet medical need. Looking for a novel biomarker, and given that specific miRNAs have been found to be misregulated in DM1 heart and muscle tissues, we profiled the expression of 175 known serum miRNAs in DM1 samples. The differences detected between patients and controls were less than 2.6 fold for all of them and a selection of six candidate miRNAs, miR-103, miR-107, miR-21, miR-29a, miR-30c, and miR-652 all failed to show consistent differences in serum expression in subsequent validation experiments.	[Fernandez-Costa, Juan M.; Llamusi, Beatriz; Bargiela, Ariadna; Perez-Alonso, Manuel; Artero, Ruben] Incliva Hlth Res Inst, Translat Genom Grp, Valencia, Spain; [Fernandez-Costa, Juan M.; Llamusi, Beatriz; Bargiela, Ariadna; Perez-Alonso, Manuel; Artero, Ruben] Univ Valencia, Dept Genet & Estruct Recerca Interdisciplinar Bio, Valencia, Spain; [Fernandez-Costa, Juan M.; Carmen Alvarez-Abril, M.; Lopez-Castel, Arturo] Univ Valencia, Valentia BioPharma, Sci Pk, Valencia, Spain; [Zulaica, Miren; Lopez de Munain, Adolfo] Biodonostia Inst, Neurosci Area, Donostia San Sebastian, Spain; [Lopez de Munain, Adolfo] Donostia Univ Hosp, Donostia San Sebastian, Spain	University of Valencia; University of Valencia; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia	Artero, R (corresponding author), Incliva Hlth Res Inst, Translat Genom Grp, Valencia, Spain.; Artero, R (corresponding author), Univ Valencia, Dept Genet & Estruct Recerca Interdisciplinar Bio, Valencia, Spain.	ruben.artero@uv.es	Artero, Ruben/K-6815-2014; Pérez-Alonso, Manuel/M-3333-2014; Castel, Arturo López/AAL-9778-2020; DE MUNAIN, ADOLFO LOPEZ/AAB-1824-2020; Bargiela, Ariadna/ABF-9125-2020; Fernandez-Costa, Juan M/Q-1670-2015	Artero, Ruben/0000-0003-1596-047X; Pérez-Alonso, Manuel/0000-0002-3266-0340; Fernandez-Costa, Juan M/0000-0002-1854-6082; Bargiela, Ariadna/0000-0003-4336-2522; /0000-0002-9509-4032	Ministerio de Economia y Competitividad [SAF2012-36854]; FEDER; Marie Curie grant [276930]; Fondo de Investigacion Sanitaria from the Instituto de Salud Carlos III [PI14/00436]; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED)	Ministerio de Economia y Competitividad(Spanish Government); FEDER(European Commission); Marie Curie grant(European Commission); Fondo de Investigacion Sanitaria from the Instituto de Salud Carlos III; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED)	This study was funded by a grant from the Ministerio de Economia y Competitividad (SAF2012-36854, including funds from FEDER) to R.A.; A.L.C. was supported by a Marie Curie grant (Call FP7-PEOPLE-2010-RG Proposal No 276930). Additional funding came from the Fondo de Investigacion Sanitaria from the Instituto de Salud Carlos III (PI14/00436) and the Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED) awarded to A.L.M.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Ashizawa Tetsuo, 2011, Handb Clin Neurol, V101, P193, DOI 10.1016/B978-0-08-045031-5.00015-3; ASLANIDIS C, 1992, NATURE, V355, P548, DOI 10.1038/355548a0; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Blondal T, 2013, METHODS, V59, pS1, DOI 10.1016/j.ymeth.2012.09.015; BROOK, 1992, CELL, V69, P385; BUXTON J, 1992, NATURE, V355, P547, DOI 10.1038/355547a0; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Castel AL, 2011, HUM MOL GENET, V20, P1, DOI 10.1093/hmg/ddq427; Chen YY, 2012, MED MICROBIOL IMMUN, V201, P389, DOI 10.1007/s00430-011-0223-0; Cizeron-Clairac G, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1505-5; Cleary JD, 2013, HUM MOL GENET, V22, pR45, DOI 10.1093/hmg/ddt371; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Ebralidze A, 2004, SCIENCE, V303, P383, DOI 10.1126/science.1088679; Ercolin B, 2013, DYSPHAGIA, V28, P446, DOI 10.1007/s00455-013-9458-9; Erginel-Unaltuna N, 2004, J CLIN LAB ANAL, V18, P50, DOI 10.1002/jcla.20004; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fernandez-Costa JM, 2013, HUM MOL GENET, V22, P704, DOI 10.1093/hmg/dds478; Gagnon C, 2007, J NEUROL NEUROSUR PS, V78, P800, DOI 10.1136/jnnp.2006.107185; Gambardella S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-48; Garcia-Lopez A, 2011, P NATL ACAD SCI USA, V108, P11866, DOI 10.1073/pnas.1018213108; Geekiyanage H, 2012, EXP NEUROL, V235, P491, DOI 10.1016/j.expneurol.2011.11.026; Gonzalez-Barriga A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121556; Guan YL, 2015, INT J CLIN EXP PATHO, V8, P6576; Harper PS, 2001, MYOTONIC DYSTROPHY; Hennessey PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032307; Hermans MCE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139944; Iwakawa HO, 2015, TRENDS CELL BIOL; Kalsotra A, 2014, CELL REP, V6, P336, DOI 10.1016/j.celrep.2013.12.025; Kang K, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-4; Kim YK, 2014, HUM MOL GENET, V23, P293, DOI 10.1093/hmg/ddt419; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024145; Koscianska E, 2015, NUCLEIC ACIDS RES, V43, P9500, DOI 10.1093/nar/gkv849; Koutsoulidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125341; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kuyumcu-Martinez NM, 2007, MOL CELL, V28, P68, DOI 10.1016/j.molcel.2007.07.027; Lopez de Munain A, 1994, Neurologia, V9, P342; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Nakamori M, 2013, ANN NEUROL, V74, P862, DOI 10.1002/ana.23992; Nakamori M, 2011, HUM MOL GENET, V20, P580, DOI 10.1093/hmg/ddq501; Orang AV, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/970607; Pandey SK, 2015, J PHARMACOL EXP THER, V355, P329, DOI 10.1124/jpet.115.226969; Parkesh R, 2012, J AM CHEM SOC, V134, P4731, DOI 10.1021/ja210088v; Perbellini R, 2011, NEUROMUSCULAR DISORD, V21, P81, DOI 10.1016/j.nmd.2010.11.012; Perfetti A, 2014, NEUROMUSCUL DISORD; Petri H, 2012, INT J CARDIOL, V160, P82, DOI 10.1016/j.ijcard.2011.08.037; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Qing S, 2014, CELL PHYSIOL BIOCHEM, V34, P1733, DOI 10.1159/000366374; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Suenaga K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033218; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang ET, 2015, GENOME RES, V25, P858, DOI 10.1101/gr.184390.114; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041561; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Witwer KW, 2015, CLIN CHEM, V61, P56, DOI 10.1373/clinchem.2014.221341; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263; Zhao C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023925	62	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150501	10.1371/journal.pone.0150501	http://dx.doi.org/10.1371/journal.pone.0150501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919350	Green Submitted, gold, Green Published			2022-12-27	WOS:000371274400129
J	Green, JE; Dalikova, M; Sahara, K; Marec, F; Akam, M				Green, Jack E.; Dalikova, Martina; Sahara, Ken; Marec, Frantisek; Akam, Michael			XX/XY System of Sex Determination in the Geophilomorph Centipede Strigamia maritima	PLOS ONE			English	Article							SEGMENT NUMBER; CHROMOSOMES; MYRIAPODA; DIPLOPODA	We show that the geophilomorph centipede Strigamia maritima possesses an XX/XY system of sex chromosomes, with males being the heterogametic sex. This is, to our knowledge, the first report of sex chromosomes in any geophilomorph centipede. Using the recently assembled Strigamia genome sequence, we identified a set of scaffolds differentially represented in male and female DNA sequence. Using quantitative real-time PCR, we confirmed that three candidate X chromosome-derived scaffolds are present at approximately twice the copy number in females as in males. Furthermore, we confirmed that six candidate Y chromosome-derived scaffolds contain male-specific sequences. Finally, using this molecular information, we designed an X chromosome-specific DNA probe and performed fluorescent in situ hybridization against mitotic and meiotic chromosome spreads to identify the Strigamia XY sex-chromosome pair cytologically. We found that the X and Y chromosomes are recognizably different in size during the early pachytene stage of meiosis, and exhibit incomplete and delayed pairing.	[Green, Jack E.; Akam, Michael] Dept Zool, Lab Dev & Evolut, Downing St, Cambridge CB2 3EJ, England; [Dalikova, Martina; Marec, Frantisek] CAS, Ctr Biol, Lab Mol Cytogenet, Inst Entomol, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Sahara, Ken] Iwate Univ, Fac Agr, Appl Entomol Lab, Morioka, Iwate 0208550, Japan; [Green, Jack E.] Aix Marseille Univ, IBDM, Marseille, France	University of Cambridge; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Iwate University; UDICE-French Research Universities; Aix-Marseille Universite	Green, JE (corresponding author), Dept Zool, Lab Dev & Evolut, Downing St, Cambridge CB2 3EJ, England.; Green, JE (corresponding author), Aix Marseille Univ, IBDM, Marseille, France.	jack.green@univ-amu.fr	Marec, Frantisek/G-7943-2014; Dalikova, Martina/J-5722-2015	Marec, Frantisek/0000-0002-6745-5603; Dalikova, Martina/0000-0002-0266-8894	Wellcome Trust [WT089615MA]; Grant Agency of The Czech Academy of Sciences [IAA600960925]; Czech Science Foundation [14-22765S]; JSPS [21-7147]	Wellcome Trust(Wellcome TrustEuropean Commission); Grant Agency of The Czech Academy of Sciences(Grant Agency of the Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was in part funded by Wellcome Trust (wellcome.ac.uk) Ph.D. studentship WT089615MA to JEG. Cytological experiments by MD and FM were funded by Grant IAA600960925 of the Grant Agency of The Czech Academy of Sciences (until 2013; gaav.cz) and by Grant 14-22765S of the Czech Science Foundation (since 2014; gacr.cz). KS was supported by JSPS Excellent Young Researchers Overseas Visit Program (21-7147; jsps.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHAR KP, 1986, CARYOLOGIA, V39, P89, DOI 10.1080/00087114.1986.10797770; ACHAR KP, 1987, CARYOLOGIA, V40, P145, DOI 10.1080/00087114.1987.10797818; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambarish CN, 2013, NUCLEUS CALCUTTA, V56, P205, DOI 10.1007/s13237-013-0096-2; Arthur W, 1999, EVOL DEV, V1, P62; Brena C, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-112; Brena C, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-22; Brena C, 2012, DEV BIOL, V363, P290, DOI 10.1016/j.ydbio.2011.11.006; Carabajal Paladino LZ, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S2-S15; Chipman AD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002005; COLMAGRO R, 1986, CARYOLOGIA, V39, P309, DOI 10.1080/00087114.1986.10797793; Eason E. H., 1964, CENTIPEDES BRIT ISLE; Fratello B., 1990, P109; Hall AB, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-273; Kettle C, 2000, P ROY SOC B-BIOL SCI, V267, P1393, DOI 10.1098/rspb.2000.1155; Kirov IV, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0233-9; MAREC F, 1994, GENOME, V37, P426, DOI 10.1139/g94-060; MINELLI A, 1988, BIOL J LINN SOC, V33, P323, DOI 10.1111/j.1095-8312.1988.tb00448.x; Minelli Alessandro, 2011, P279; Nguyen P, 2013, P NATL ACAD SCI USA, V110, P6931, DOI 10.1073/pnas.1220372110; OGAWA K, 1961, JPN J GENET, V36, P122, DOI 10.1266/jjg.36.122; OGAWA K, 1954, CYTOLOGIA, V19, P265, DOI 10.1508/cytologia.19.265; Ogawa K., 1961, Zoological Magazine Tokyo, V70, P203; Ogawa K, 1950, JAP J GENET, V25, P106; OGAWA KAZUO, 1961, JAPANESE JOUR ZOOL, V13, P63; OGAWA KAZUO, 1955, ANNOT ZOOL JAPAN, V28, P244; OGAWA KAZUO, 1953, JAPANESE JOUR GENETICS, V28, P12, DOI 10.1266/jjg.28.12; PUTTANNA CR, 1959, CHROMOSOMA, V10, P179, DOI 10.1007/BF00396570; Rehm P, 2014, MOL PHYLOGENET EVOL, V77, P25, DOI 10.1016/j.ympev.2014.04.007; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Sahara K, 1999, CHROMOSOME RES, V7, P449, DOI 10.1023/A:1009297729547; SOLARI AJ, 1992, CYTOGENET CELL GENET, V59, P52, DOI 10.1159/000133199; Traut W, 1999, CHROMOSOMA, V108, P173, DOI 10.1007/s004120050366; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; White M.J.D., 1979, P3	35	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150292	10.1371/journal.pone.0150292	http://dx.doi.org/10.1371/journal.pone.0150292			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919730	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400120
J	Kothur, K; Wienholt, L; Tantsis, EM; Earl, J; Bandodkar, S; Prelog, K; Tea, F; Ramanathan, S; Brilot, F; Dale, RC				Kothur, Kavitha; Wienholt, Louise; Tantsis, Esther M.; Earl, John; Bandodkar, Sushil; Prelog, Kristina; Tea, Fiona; Ramanathan, Sudarshini; Brilot, Fabienne; Dale, Russell C.			B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination	PLOS ONE			English	Article							MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; NEUROMYELITIS-OPTICA; MULTIPLE-SCLEROSIS; T-CELLS; CXCL13; CHEMOKINES; INTERLEUKIN-17; INFLAMMATION; MECHANISMS; FOLLICLES	Background Myelin oligodendrocyte glycoprotein antibody (MOG Ab) associated demyelination represents a subgroup of autoimmune demyelination that is separate from multiple sclerosis and aquaporin 4 IgG-positive NMO, and can have a relapsing course. Unlike NMO and MS, there is a paucity of literature on immunopathology and CSF cytokine/chemokines in MOG Ab associated demyelination. Aim To study the differences in immunopathogenesis based on cytokine/chemokine profile in MOG Ab-positive (POS) and -negative (NEG) groups. Methods We measured 34 cytokines/chemokines using multiplex immunoassay in CSF collected from paediatric patients with serum MOG Ab POS [ acute disseminated encephalomyelitis (ADEM = 8), transverse myelitis (TM = 2) n = 10] and serum MOG Ab NEG (ADEM = 5, TM = 4, n = 9) demyelination. We generated normative data using CSF from 20 non-inflammatory neurological controls. Results The CSF cytokine and chemokine levels were higher in both MOG Ab POS and MOG Ab NEG demyelination groups compared to controls. The CSF in MOG Ab POS patients showed predominant elevation of B cell related cytokines/chemokines (CXCL13, APRIL, BAFF and CCL19) as well as some of Th17 related cytokines (IL-6 AND G-CSF) compared to MOG Ab NEG group (all p<0.01). In addition, patients with elevated CSF MOG antibodies had higher CSF CXCL13, CXCL12, CCL19, IL-17A and G-CSF than patients without CSF MOG antibodies. Conclusion Our findings suggest that MOG Ab POS patients have a more pronounced CNS inflammatory response with elevation of predominant humoral associated cytokines/chemokines, as well as some Th 17 and neutrophil related cytokines/chemokines suggesting a differential inflammatory pathogenesis associated with MOG antibody seropositivity. This cytokine/chemokine profiling provides new insight into disease pathogenesis, and improves our ability to monitor inflammation and response to treatment. In addition, some of these molecules may represent potential immunomodulatory targets.	[Kothur, Kavitha; Tantsis, Esther M.; Tea, Fiona; Ramanathan, Sudarshini; Brilot, Fabienne; Dale, Russell C.] Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Neuroimmunol Grp, Sydney, NSW 2006, Australia; [Wienholt, Louise] Royal Prince Alfred Hosp, Dept Clin Immunol, Sydney, NSW, Australia; [Earl, John; Bandodkar, Sushil] Childrens Hosp Westmead, Dept Biochem, Sydney, NSW, Australia; [Prelog, Kristina] Childrens Hosp Westmead, Dept Med Imaging, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Dale, RC (corresponding author), Univ Sydney, Childrens Hosp Westmead, Inst Neurosci & Muscle Res, Neuroimmunol Grp, Sydney, NSW 2006, Australia.	russell.dale@health.nsw.gov.au	kothur, kavitha/M-3330-2018; Ramanathan, Sudarshini/D-4303-2013; Brilot, Fabienne/AAT-3138-2020	kothur, kavitha/0000-0002-0109-8877; Ramanathan, Sudarshini/0000-0002-0294-9768; Brilot, Fabienne/0000-0002-7025-2276; Tea, Fiona/0000-0002-0451-6296; Wienholt, Louise/0000-0002-5618-4772; Bandodkar, Sushil/0000-0001-5000-4518	Petre Foundation; Australian Postgraduate award; Multiple Sclerosis Research Australia	Petre Foundation; Australian Postgraduate award(Australian Government); Multiple Sclerosis Research Australia	This work was supported by a scholarship from the Petre Foundation, an Australian Postgraduate award, and Multiple Sclerosis Research Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud H, 2015, MULTIPLE SCLEROSIS H; Akdis M, 2011, J ALLERGY CLIN IMMUN, V127, P701, DOI 10.1016/j.jaci.2010.11.050; Aloisi F, 2008, J NEUROIMMUNOL, V198, P106, DOI 10.1016/j.jneuroim.2008.04.025; Araki M, 2013, MOD RHEUMATOL, V23, P827, DOI 10.1007/s10165-012-0715-9; Baumann M, 2015, J NEUROL NEUROSUR PS, V86, P265, DOI 10.1136/jnnp-2014-308346; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Brandes M, 2000, INT IMMUNOL, V12, P1285, DOI 10.1093/intimm/12.9.1285; Brilot F, 2009, ANN NEUROL, V66, P833, DOI 10.1002/ana.21916; Carotenuto A, 2001, J MED CHEM, V44, P2378, DOI 10.1021/jm010811t; Chevalier N, 2011, J IMMUNOL, V186, P5556, DOI 10.4049/jimmunol.1002828; Dale RC, 2003, NEUROPEDIATRICS, V34, P141; Dale RC, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000012; Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Fossiez F, 1996, J EXP MED, V183, P2593, DOI 10.1084/jem.183.6.2593; Gunn MD, 1998, NATURE, V391, P799, DOI 10.1038/35876; Hacohen Y, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000081; Hoftberger R, 2015, MULT SCLER J, V21, P866, DOI 10.1177/1352458514555785; Horellou P, 2015, J NEUROIMMUNOL, V289, P1, DOI 10.1016/j.jneuroim.2015.10.002; Jarius S, 2014, CLIN EXP IMMUNOL, V176, P149, DOI 10.1111/cei.12271; Ketelslegers IA, 2015, MULTIPLE SCLEROSIS H; Khademi M, 2011, MULT SCLER J, V17, P335, DOI 10.1177/1352458510389102; Kim SH, 2013, JAMA NEUROL, V70, P1110, DOI 10.1001/jamaneurol.2013.3071; Kitley J, 2012, NEUROLOGY, V79, P1273, DOI 10.1212/WNL.0b013e31826aac4e; Kowarik MC, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-93; Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Leypoldt F., 2014, JAMA NEUROL; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184; MALEFYT RD, 1991, J EXP MED, V174, P1209; Marta CB, 2003, J NEUROSCI, V23, P5461; Mayer MC, 2012, THER ADV NEUROL DISO, V5, P147, DOI 10.1177/1756285611433772; Michael BD, 2013, CYTOKINE, V64, P90, DOI 10.1016/j.cyto.2013.07.019; Mitsdoerffer M, 2013, ANN NY ACAD SCI, V1283, P57, DOI 10.1111/nyas.12118; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Pashenkov M, 2003, J NEUROIMMUNOL, V135, P154, DOI 10.1016/S0165-5728(02)00441-1; Patakas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049715; Peter Delves J, 2011, ROITTS ESSENTIAL IMM; PIDDLESDEN SJ, 1993, AM J PATHOL, V143, P555; Pranzatelli MR, 2013, J NEUROL SCI, V326, P53, DOI 10.1016/j.jns.2013.01.011; Probstel AK, 2011, NEUROLOGY, V77, P580, DOI 10.1212/WNL.0b013e318228c0b1; Ramanathan S, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000040; Reindl M, 2013, NAT REV NEUROL, V9, P455, DOI 10.1038/nrneurol.2013.118; Rostasy K, 2012, ARCH NEUROL-CHICAGO, V69, P752, DOI 10.1001/archneurol.2011.2956; Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Uzawa A, 2014, BRAIN PATHOL, V24, P67, DOI 10.1111/bpa.12097; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Zhong XN, 2011, J NEUROIMMUNOL, V240, P104, DOI 10.1016/j.jneuroim.2011.10.001; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	53	45	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149411	10.1371/journal.pone.0149411	http://dx.doi.org/10.1371/journal.pone.0149411			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919719	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400022
J	Lee, HB; Kim, J; Oh, SH; Kim, SH; Kim, HS; Kim, WC; Kim, S; Kim, OJ				Lee, Han-Bin; Kim, Jinkwon; Oh, Seung-Hun; Kim, Sang-Heum; Kim, Hyun-Sook; Kim, Won-Chan; Kim, Soonhag; Kim, Ok-Joon			Red Blood Cell Distribution Width Is Associated with Severity of Leukoaraiosis	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; ISCHEMIC-STROKE; DISEASE; RDW; INFLAMMATION; MARKERS	Red blood cell distribution width (RDW) is one of the routine hematologic parameters reported in the complete blood count test, which has been recognized as strong prognostic marker for various medical conditions, especially cardiovascular disease. We evaluated that RDW was also associated with the leukoaraiosis; common radiological finding of brain and that has been strongly associated with risk of stroke and dementia. In the present study, we included 1006 non-stroke individuals who underwent brain MRI and routine complete blood count test including RDW. Fazekas scale was used to measure the severity of leukoaraiosis based on fluid-attenuated inversion recovery image, and the severity was dichotomized to mild-degree (Fazekas scale: 0-1) and severe-degree leukoaraiosis (Fazekas scale: 2-3). Univariate and multivariate logistic regression models were constructed to evaluate independent risk factor for severe-degree of leukoaraiosis. Mean age of 1006 subjects was 64.34 +/- 9.11 year, and mean of RDW was 12.97 +/- 0.86%. The severe-degree of leukoaraiosis (Fazekas scale >= 2) was found in 28.83%. In the multivariate logistic regression, 4th quartile of RDW(> 13.3%) were significantly associated with the presence of severe-degree of leukoaraiosis (adjusted odds ratio, 1.87; 95% confidence interval, 1.20-2.92) compared to the 1st quartile of RDW (< 12.5%). The significance was not changed after adjustments for hemoglobin and other hematologic indices. These findings suggest that RDW is independently associated with severity of leukoaraiosis.	[Lee, Han-Bin; Kim, Jinkwon; Oh, Seung-Hun; Kim, Hyun-Sook; Kim, Won-Chan; Kim, Ok-Joon] CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea; [Kim, Sang-Heum] CHA Univ, CHA Bundang Med Ctr, Dept Radiol, Songnam, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Coll Med, Inst Biomed Convergence, Gangneung Si, South Korea; [Kim, Soonhag] Catholic Kwandong Univ, Int St Marys Hosp, Inchon, South Korea	Pochon Cha University; Pochon Cha University; Catholic Kwandong University; Catholic Kwandong University	Oh, SH (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Neurol, Songnam, South Korea.	ohsh72@chamc.co.kr	KIM, WON CHAN/AAJ-4506-2020		National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2014R1A1A1002067]; National Research Foundation of Korea (NRF) - Ministry of Science and Technology [2011-0021344]; Ministry for Health, Welfare & Family Affairs, Republic of Korea [HC14C3297]	National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); National Research Foundation of Korea (NRF) - Ministry of Science and Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2014R1A1A1002067), and by a grant of Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and Technology (2011-0021344), and a grant of the Korea Healthcare technology R&D project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (HC14C3297).	Arsava EM, 2009, NEUROLOGY, V72, P1403, DOI 10.1212/WNL.0b013e3181a18823; Aslan D, 2002, AM J HEMATOL, V69, P31, DOI 10.1002/ajh.10011; Cavalieri M, 2012, STROKE, V43, P3266, DOI 10.1161/STROKEAHA.112.665703; Chimowitz MI, 2005, NEW ENGL J MED, V352, P1305, DOI 10.1056/NEJMoa043033; Cines DB, 2014, BLOOD, V123, P1596, DOI 10.1182/blood-2013-08-523860; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; Fornal M, 2014, CLIN HEMORHEOL MICRO, V56, P325, DOI 10.3233/CH-131745; Grueter BE, 2012, POSTGRAD MED J, V88, P79, DOI 10.1136/postgradmedj-2011-130307; Hammarsten O, 2010, EUR J HEART FAIL, V12, P213, DOI 10.1093/eurjhf/hfp208; Henninger N, 2014, STROKE, V45, P689, DOI 10.1161/STROKEAHA.113.002855; Hernandez MDV, 2013, NEUROEPIDEMIOLOGY, V40, P13, DOI 10.1159/000341859; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kim J, 2012, THROMB HAEMOSTASIS, V108, P349, DOI 10.1160/TH12-03-0165; Kim OJ, 2011, STROKE, V42, P2393, DOI 10.1161/STROKEAHA.110.607739; Leonards CO, 2012, STROKE, V43, P3046, DOI 10.1161/STROKEAHA.111.646554; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Ozturk ZA, 2013, ARCH GERONTOL GERIAT, V56, P50, DOI 10.1016/j.archger.2012.10.002; Pantoni L, 1997, STROKE, V28, P652, DOI 10.1161/01.STR.28.3.652; Park SY, 2013, THROMB RES, V131, pE12, DOI 10.1016/j.thromres.2012.11.011; Patel KV, 2013, ADV EXP MED BIOL, V765, P211, DOI 10.1007/978-1-4614-4989-8_29; Poludasu S, 2009, THROMB HAEMOSTASIS, V102, P581, DOI 10.1160/TH09-02-0127; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; SIMCHON S, 1987, AM J PHYSIOL, V253, pH898, DOI 10.1152/ajpheart.1987.253.4.H898; Solak Y, 2014, AM J MED SCI, V347, P118, DOI 10.1097/MAJ.0b013e3182996a96; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tonelli M, 2008, CIRCULATION, V117, P163, DOI 10.1161/CIRCULATIONAHA.107.727545; Umemura T, 2011, J NEUROL NEUROSUR PS, V82, P1186, DOI 10.1136/jnnp.2010.217380; Wright CB, 2009, STROKE, V40, P3466, DOI 10.1161/STROKEAHA.109.559567; Zalawadiya SK, 2012, VASC MED, V17, P155, DOI 10.1177/1358863X12442443	33	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150308	10.1371/journal.pone.0150308	http://dx.doi.org/10.1371/journal.pone.0150308			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918441	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400122
J	Mohanta, TK; Mohanta, N; Parida, P; Panda, SK; Ponpandian, LN; Bae, H				Mohanta, Tapan Kumar; Mohanta, Nibedita; Parida, Pratap; Panda, Sujogya Kumar; Ponpandian, Lakshmi Narayanan; Bae, Hanhong			Genome-Wide Identification of Mitogen-Activated Protein Kinase Gene Family across Fungal Lineage Shows Presence of Novel and Diverse Activation Loop Motifs	PLOS ONE			English	Article							CELL-WALL INTEGRITY; SACCHAROMYCES-CEREVISIAE; STATISTICAL TESTS; SIGNALING PATHWAY; MAPK CASCADE; PHOSPHORYLATION; PLANTS; GROWTH; YEAST; SENSITIVITY	The mitogen-activated protein kinase (MAPK) is characterized by the presence of the T-E-Y, T-D-Y, and T-G-Y motifs in its activation loop region and plays a significant role in regulating diverse cellular responses in eukaryotic organisms. Availability of large-scale genome data in the fungal kingdom encouraged us to identify and analyse the fungal MAPK gene family consisting of 173 fungal species. The analysis of the MAPK gene family resulted in the discovery of several novel activation loop motifs (T-T-Y, T-I-Y, T-N-Y, T-H-Y, T-S-Y, K-G-Y, T-Q-Y, S-E-Y and S-D-Y) in fungal MAPKs. The phylogenetic analysis suggests that fungal MAPKs are non-polymorphic, had evolved from their common ancestors around 1500 million years ago, and are distantly related to plant MAPKs. We are the first to report the presence of nine novel activation loop motifs in fungal MAPKs. The specificity of the activation loop motif plays a significant role in controlling different growth and stress related pathways in fungi. Hence, the presences of these nine novel activation loop motifs in fungi are of special interest.	[Mohanta, Tapan Kumar] Yeungnam Univ, Free Major Nat Sci, Coll Basic Studies, Gyongsan 712749, Gyeongsangbuk D, South Korea; [Mohanta, Nibedita] North Orissa Univ, Dept Biotechnol, Takatpur 757003, Baripada, India; [Parida, Pratap] Indian Council Med Res, Reg Med Res Ctr, NE Reg, Dibrugarh 786001, Assam, India; [Panda, Sujogya Kumar] North Orissa Univ, Dept Zool, Baripada 757003, Odisha, India; [Ponpandian, Lakshmi Narayanan; Bae, Hanhong] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongsangbuk D, South Korea	Yeungnam University; Indian Council of Medical Research (ICMR); Yeungnam University	Mohanta, TK (corresponding author), Yeungnam Univ, Free Major Nat Sci, Coll Basic Studies, Gyongsan 712749, Gyeongsangbuk D, South Korea.; Bae, H (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, Gyeongsangbuk D, South Korea.	nostoc.tapan@gmail.com; hanhongbae@ynu.ac.kr	Mohanta, Tapan Kumar/F-9907-2018; PANDA, SUJOGYA KUMAR/AAA-8392-2021; PANDA, SUJOGYA KUMAR/V-7750-2018; Parida, Pratap/J-6727-2015	Mohanta, Tapan Kumar/0000-0002-3196-7746; PANDA, SUJOGYA KUMAR/0000-0003-3123-1218; PANDA, SUJOGYA KUMAR/0000-0003-3123-1218; Parida, Pratap/0000-0002-8193-335X	"Forest Science and Technology" project by Korea forest service [S121414L030110]	"Forest Science and Technology" project by Korea forest service	This study was carried out with the support of the "Forest Science and Technology" project (Project No. S121414L030110) provided by Korea forest service. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Brundrett MC, 2002, NEW PHYTOL, V154, P275, DOI 10.1046/j.1469-8137.2002.00397.x; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cheetham J, 2007, MOL BIOL CELL, V18, P4603, DOI 10.1091/mbc.E07-06-0581; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Cherkasova V, 1999, GENETICS, V151, P989; Ciesla J, 2011, ACTA BIOCHIM POL, V58, P137; Colcombet J, 2008, BIOCHEM J, V413, P217, DOI 10.1042/BJ20080625; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Deutscher J, 2005, J MOL MICROB BIOTECH, V9, P125, DOI 10.1159/000089641; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FU YX, 1993, GENETICS, V133, P693; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Hamel LP, 2006, TRENDS PLANT SCI, V11, P192, DOI 10.1016/j.tplants.2006.02.007; Humphreys CP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1105; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kojima K, 2006, MICROBIOL-SGM, V152, P591, DOI 10.1099/mic.0.28571-0; Kontopoulos DG, 2013, COMPUT METH PROG BIO, V111, P711, DOI 10.1016/j.cmpb.2013.05.021; Kumar K, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28502; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leberer E, 1996, P NATL ACAD SCI USA, V93, P13217, DOI 10.1073/pnas.93.23.13217; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Levin DE, 2011, GENETICS, V189, P1145, DOI 10.1534/genetics.111.128264; Lin CH, 2010, FUNGAL GENET BIOL, V47, P381, DOI 10.1016/j.fgb.2009.12.009; Mohanta TK, 2015, J PLANT INTERACT, V10, P21, DOI 10.1080/17429145.2015.1005180; Mohanta TK, 2015, BIOL PROCED ONLINE, V17, DOI 10.1186/s12575-015-0020-z; Mohanta TK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1244-7; Moriwaki A, 2006, FEMS MICROBIOL LETT, V257, P253, DOI 10.1111/j.1574-6968.2006.00178.x; Morrison Deborah K, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a011254; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Palecek SP, 2002, MICROBIOL-SGM, V148, P893, DOI 10.1099/00221287-148-4-893; Popescu SC, 2009, GENE DEV, V23, P80, DOI 10.1101/gad.1740009; RAY LB, 1988, P NATL ACAD SCI USA, V85, P3753, DOI 10.1073/pnas.85.11.3753; Ren DT, 2008, P NATL ACAD SCI USA, V105, P5638, DOI 10.1073/pnas.0711301105; Roman E, 2013, MAP KINASE, V2, pe5; Roman E, 2007, TRENDS MICROBIOL, V15, P181, DOI 10.1016/j.tim.2007.02.001; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Shen Y, 2001, P NATL ACAD SCI USA, V98, P13613, DOI 10.1073/pnas.231499098; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SIMONSEN KL, 1995, GENETICS, V141, P413; Singh P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123620; Sinha AK, 2011, PLANT SIGNAL BEHAV, V6, P196, DOI 10.4161/psb.6.2.14701; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor TN, 1996, REV PALAEOBOT PALYNO, V90, P249, DOI 10.1016/0034-6667(95)00086-0; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wang DYC, 1999, P ROY SOC B-BIOL SCI, V266, P163, DOI 10.1098/rspb.1999.0617; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984; Xu JR, 1996, GENE DEV, V10, P2696, DOI 10.1101/gad.10.21.2696; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	59	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149861	10.1371/journal.pone.0149861	http://dx.doi.org/10.1371/journal.pone.0149861			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918378	Green Published, gold			2022-12-27	WOS:000371274400050
J	Schierenberg, A; Minnaard, MC; Hopstaken, RM; van de Pol, AC; Broekhuizen, BDL; de Wit, NJ; Reitsma, JB; van Vugt, SF; Graffelman, AW; Melbye, H; Rainer, TH; Steurer, J; Holm, A; Gonzales, R; Dinant, GJ; de Groot, JAH; Verheij, TJM				Schierenberg, Alwin; Minnaard, Margaretha C.; Hopstaken, Rogier M.; van de Pol, Alma C.; Broekhuizen, Berna D. L.; de Wit, Niek J.; Reitsma, Johannes B.; van Vugt, Saskia F.; Graffelman, Aleida W.; Melbye, Hasse; Rainer, Timothy H.; Steurer, Johann; Holm, Anette; Gonzales, Ralph; Dinant, Geert-Jan; de Groot, Joris A. H.; Verheij, Theo J. M.			External Validation of Prediction Models for Pneumonia in Primary Care Patients with Lower Respiratory Tract Infection: An Individual Patient Data Meta-Analysis	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; C-REACTIVE PROTEIN; CLINICAL-PREDICTION; SEARCH STRATEGIES; ACUTE COUGH; DIAGNOSIS; GUIDELINES; MANAGEMENT; PERFORMANCE; PROGNOSIS	Background Pneumonia remains difficult to diagnose in primary care. Prediction models based on signs and symptoms (S&S) serve to minimize the diagnostic uncertainty. External validation of these models is essential before implementation into routine practice. In this study all published S&S models for prediction of pneumonia in primary care were externally validated in the individual patient data (IPD) of previously performed diagnostic studies. Methods and Findings S&S models for diagnosing pneumonia in adults presenting to primary care with lower respiratory tract infection and IPD for validation were identified through a systematical search. Six prediction models and IPD of eight diagnostic studies (N total = 5308, prevalence pneumonia 12%) were included. Models were assessed on discrimination and calibration. Discrimination was measured using the pooled Area Under the Curve (AUC) and delta AUC, representing the performance of an individual model relative to the average dataset performance. Prediction models by van Vugt et al. and Heckerling et al. demonstrated the highest pooled AUC of 0.79 (95% CI 0.74-0.85) and 0.72 (0.68-0.76), respectively. Other models by Diehr et al., Singal et al., Melbye et al., and Hopstaken et al. demonstrated pooled AUCs of 0.65 (0.61-0.68), 0.64 (0.61-0.67), 0.56 (0.49-0.63) and 0.53 (0.5-0.56), respectively. A similar ranking was present based on the delta AUCs of the models. Calibration demonstrated close agreement of observed and predicted probabilities in the models by van Vugt et al. and Singal et al., other models lacked such correspondence. The absence of predictors in the IPD on dataset level hampered a systematical comparison of model performance and could be a limitation to the study. Conclusions The model by van Vugt et al. demonstrated the highest discriminative accuracy coupled with reasonable to good calibration across the IPD of different study populations. This model is therefore the main candidate for primary care use.	[Schierenberg, Alwin; Minnaard, Margaretha C.; van de Pol, Alma C.; Broekhuizen, Berna D. L.; de Wit, Niek J.; Reitsma, Johannes B.; van Vugt, Saskia F.; de Groot, Joris A. H.; Verheij, Theo J. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Hopstaken, Rogier M.] Saltro Diagnost Ctr Primary Care, Utrecht, Netherlands; [Graffelman, Aleida W.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Melbye, Hasse] Univ Tromso, Dept Community Med, Tromso, Norway; [Rainer, Timothy H.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Steurer, Johann] Univ Zurich, Horten Ctr Patient Oriented Res & Knowledge Trans, Zurich, Switzerland; [Holm, Anette] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Gonzales, Ralph] Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; [Dinant, Geert-Jan] Maastricht Univ, Med Ctr, Dept Family Med, CAPHRI Sch Publ Hlth & Primary Care, NL-6200 MD Maastricht, Netherlands; [Rainer, Timothy H.] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; UiT The Arctic University of Tromso; Chinese University of Hong Kong; University of Zurich; University of Southern Denmark; Odense University Hospital; University of California System; University of California San Francisco; Maastricht University; Cardiff University	Schierenberg, A (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	A.Schierenberg@umcutrecht.nl	Rainer, Timothy/I-2591-2013	Rainer, Timothy/0000-0003-3355-3237; de Groot, Joris/0000-0002-4846-5697; Hopstaken, Rogier/0000-0002-8357-5197; Melbye, Hasse/0000-0002-9773-3141; Reitsma, Johannes/0000-0003-4026-4345				Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Bleeker SE, 2003, J CLIN EPIDEMIOL, V56, P826, DOI 10.1016/S0895-4356(03)00207-5; Bradley JS, 2007, LANCET INFECT DIS, V7, P68, DOI 10.1016/S1473-3099(06)70689-2; Cals JWL, 2013, ANN FAM MED, V11, P157, DOI 10.1370/afm.1477; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Collins GS, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-40; de Groot JAH, 2011, EPIDEMIOLOGY, V22, P234, DOI 10.1097/EDE.0b013e318207fc5c; DIEHR P, 1984, J CHRON DIS, V37, P215, DOI 10.1016/0021-9681(84)90149-8; Flanders SA, 2004, AM J MED, V116, P529, DOI 10.1016/j.amjmed.2003.11.023; Graffelman AW, 2007, J FAM PRACTICE, V56, P465; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell FE, 2001, REGRESSION MODELING; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040, DOI 10.1136/bmj.38068.557998.EE; HECKERLING PS, 1990, ANN INTERN MED, V113, P664, DOI 10.7326/0003-4819-113-9-664; HEDGES LV, 1983, PSYCHOL BULL, V93, P388, DOI 10.1037/0033-2909.93.2.388; Holm A, 2007, BRIT J GEN PRACT, V57, P547; Hopstaken RM, 2003, BRIT J GEN PRACT, V53, P358; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; KAPLAN EL, 1979, PEDIATRICS, V64, P904; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mathew T, 2010, BIOMETRICAL J, V52, P271, DOI 10.1002/bimj.200900143; MELBYE H, 1992, Scandinavian Journal of Primary Health Care, V10, P226, DOI 10.3109/02813439209014066; Melbye Hasse, 1993, Scandinavian Journal of Primary Health Care, V11, P241, DOI 10.3109/02813439308994838; Mortensen EM, 2002, ARCH INTERN MED, V162, P1059, DOI 10.1001/archinte.162.9.1059; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; Rainer TH, 2009, J INFECTION, V58, P123, DOI 10.1016/j.jinf.2008.11.007; Rubin DB, 2009, MULTIPLE IMPUTATION, V307; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; Smith SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000245.pub2, 10.1002/14651858.CD000245, DOI 10.1002/14651858.CD000245.PUB2]; Steurer J, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-56; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Tacconelli Evelina, 2010, Expert Rev Anti Infect Ther, V8, P761, DOI 10.1586/eri.10.57; van Vugt SF, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2450; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilczynski NL, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-7; Woodhead M, 2011, CLIN MICROBIOL INFEC, V17, pE1, DOI 10.1111/j.1469-0691.2011.03672.x	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149895	10.1371/journal.pone.0149895	http://dx.doi.org/10.1371/journal.pone.0149895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918859	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000371274400054
J	Yu, ZL; Lee, VYW; Kang, AWC; Chan, S; Foo, M; Chan, CM; Griva, K				Yu, Zhen Li; Lee, Vanessa Yin Woan; Kang, Augustine Wee Cheng; Chan, Sally; Foo, Marjorie; Chan, Choong Meng; Griva, Konstadina			Rates of Intentional and Unintentional Nonadherence to Peritoneal Dialysis Regimes and Associated Factors	PLOS ONE			English	Article							QUALITY-OF-LIFE; SELF-EFFICACY; HEMODIALYSIS-PATIENTS; HOSPITAL ANXIETY; HEALTH-STATUS; DEPRESSION SCALE; ADHERENCE; NONCOMPLIANCE; MEDICINES; BELIEFS	With increasing emphasis on expanding home-based dialysis, there is a need to understand adherence outcomes. This study set out to examine the prevalence and predictors of non-adherence among patients undergoing peritoneal dialysis. A cross sectional sample of 201 peritoneal dialysis patients recruited between 2010-2011 from Singapore General Hospital completed measures of quality of life, medication beliefs, self-efficacy and emotional distress. Nonadherence rates were high; 18% for dialysis, 46% for medication and 78% for diet. Intentional nonadherence was more common for dialysis (p = .03), whereas unintentional nonadherence was more common for medication (p = .002). Multivariate models indicated significant associations for higher education (intermediate vs low OR = 3.18, high vs low OR = 4.70), lower environment quality of life (OR = 0.79), dialysis self-efficacy (OR = 0.80) with dialysis nonadherence; higher education (OR = 2.22), self-care peritoneal dialysis (OR = 3.10), perceived necessity vs concerns over medication (OR = 0.90), self-efficacy (OR = 0.76) with nonadherence to medication. The odds for nonadherence to diet were higher among patients who were younger (OR = 0.96), of Chinese ethnicity (OR = 2.99) and those reporting better physical health (OR = 1.30) and lower self-efficacy (OR = 0.49). Nonadherence is common in peritoneal dialysis. Self-efficacy and beliefs about medication are promising targets for interventions designed to improve adherence.	[Yu, Zhen Li; Lee, Vanessa Yin Woan; Kang, Augustine Wee Cheng; Griva, Konstadina] Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore; [Chan, Sally] Natl Univ Singapore Hosp, Alice Lee Ctr Nursing Studies, Singapore, Singapore; [Foo, Marjorie; Chan, Choong Meng] Singapore Gen Hosp, Dept Renal Med, Singapore, Singapore; [Griva, Konstadina] City Univ London, Hlth Serv Res Grp, London EC1V 0HB, England	National University of Singapore; National University of Singapore; Singapore General Hospital; City University London	Griva, K (corresponding author), Natl Univ Singapore, Dept Psychol, Singapore 117548, Singapore.; Griva, K (corresponding author), City Univ London, Hlth Serv Res Grp, London EC1V 0HB, England.	psygk@nus.edu.sg	Barretti, Pasqual/K-4156-2012; Chan, Sally Wai Chi/ABB-8520-2020; Griva, Konstadina/A-6549-2018; Barretti, Pasqual/AAK-7934-2021	Barretti, Pasqual/0000-0003-4979-4836; Chan, Sally Wai Chi/0000-0001-5484-4645; Barretti, Pasqual/0000-0003-4979-4836; GRIVA, KONSTADINA/0000-0001-8173-5663; Kang, Augustine/0000-0002-4268-993X	National University of Singapore (NUS-Cross Faculty Research Grant) [CFG11P3]	National University of Singapore (NUS-Cross Faculty Research Grant)	This research was supported by a grant from the National University of Singapore (NUS-Cross Faculty Research Grant - CFG11P3) awarded to Associate Professor KG and Professor SC, which is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen D, 2011, SOC SCI MED, V73, P129, DOI 10.1016/j.socscimed.2011.05.018; [Anonymous], 2013, US REN DAT SYST USRD; Arramreddy R, 2014, AM J KIDNEY DIS, V63, P390, DOI 10.1053/j.ajkd.2013.09.018; Bandura Albert, 1977, SOCIAL LEARNING THEO; Beddhu S, 2002, AM J MED, V112, P696, DOI 10.1016/S0002-9343(02)01097-5; Bernardini J, 2000, AM J KIDNEY DIS, V35, P1104, DOI 10.1016/S0272-6386(00)70047-3; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Browne T, 2010, AM J KIDNEY DIS, V56, P547, DOI 10.1053/j.ajkd.2010.03.002; Choong HL, 2013, 8 MIN HLTH SING NAT; Chow SKY, 2010, J ADV NURS, V66, P1780, DOI 10.1111/j.1365-2648.2010.05324.x; Clifford S, 2008, J PSYCHOSOM RES, V64, P41, DOI 10.1016/j.jpsychores.2007.05.004; Clifford S, 2006, PHARM WORLD SCI, V28, P165, DOI 10.1007/s11096-006-9026-6; DENOUR AK, 1972, PSYCHOSOM MED, V34, P333; Arenas MD, 2010, J NEPHROL, V23, P525; DONOVAN JL, 1992, SOC SCI MED, V34, P507, DOI 10.1016/0277-9536(92)90206-6; Fernandes GV, 2010, J SEX MED, V7, P4003, DOI 10.1111/j.1743-6109.2010.01993.x; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; Garcia-Llana H, 2013, PSICOTHEMA, V25, P79, DOI 10.7334/psicothema2012.96; Ghaffari A, 2012, AM J KIDNEY DIS, V59, P400, DOI 10.1053/j.ajkd.2011.08.034; Griva K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089001; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Hays RD, 1997, KIDNEY DIS QUALITY L; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Jain AK, 2012, J AM SOC NEPHROL, V23, P533, DOI 10.1681/ASN.2011060607; Jiwakanon S, 2010, CURR OPIN NEPHROL HY, V19, P573, DOI 10.1097/MNH.0b013e32833d67a3; Karamanidou C, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-2; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Kutner NG, 2001, SEMIN DIALYSIS, V14, P324, DOI 10.1046/j.1525-139X.2001.00080.x; Lam LW, 2010, J ADV NURS, V66, P763, DOI 10.1111/j.1365-2648.2009.05235.x; Leung C M, 1993, Int J Psychosom, V40, P29; Leventhal H., 2003, SELF REGULATION HLTH, P138; Lindberg M, 2010, J REN CARE, V36, P133, DOI 10.1111/j.1755-6686.2010.00182.x; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Mawar S, 2012, INT UROL NEPHROL, V44, P1243, DOI 10.1007/s11255-011-0079-7; McCarthy A, 2009, INT J NURS PRACT, V15, P219, DOI 10.1111/j.1440-172X.2009.01747.x; Mo PKH, 2009, AIDS CARE, V21, P785, DOI 10.1080/09540120802511968; Moe SM, 2005, KIDNEY INT, V67, P760, DOI 10.1111/j.1523-1755.2005.67139.x; NOLPH KD, 1995, PERITON DIALYSIS INT, V15, P22; Plantinga LC, 2004, J AM SOC NEPHROL, V15, P3144, DOI 10.1097/01.ASN.0000146424.91128.2A; Polaschek N, 2007, J CLIN NURS, V16, P51, DOI 10.1111/j.1365-2702.2006.01622.x; Rees G, 2010, OPHTHALMOLOGY, V117, P903, DOI 10.1016/j.ophtha.2009.10.038; RUSSELL D, 1980, J PERS SOC PSYCHOL, V39, P472, DOI 10.1037/0022-3514.39.3.472; Sayin A, 2007, TRANSPL P, V39, P3047, DOI 10.1016/j.transproceed.2007.09.030; Schuz B, 2011, J PSYCHOSOM RES, V70, P179, DOI 10.1016/j.jpsychores.2010.07.014; Smarr KL, 2011, ARTHRIT CARE RES, V63, pS454, DOI 10.1002/acr.20556; Su CY, 2009, J ADV NURS, V65, P1381, DOI 10.1111/j.1365-2648.2009.04993.x; Szeto CC, 2005, AM J KIDNEY DIS, V46, P128, DOI 10.1053/j.ajkd.2005.03.015; TAAL E, 1993, PATIENT EDUC COUNS, V20, P63, DOI 10.1016/0738-3991(93)90122-D; Tsay SL, 2003, J ADV NURS, V43, P370, DOI 10.1046/j.1365-2648.2003.02725.x; Unni EJ, 2011, PATIENT EDUC COUNS, V83, P265, DOI 10.1016/j.pec.2010.05.006; *USRDS, 1997, AM J KIDNEY DIS S, V30, pS67; Warde A., 2000, EATING OUT SOCIAL DI; Yu ZL, 2012, SINGAP MED J, V53, P474; Yusoff N, 2011, ASIAN PAC J CANCER P, V12, P915; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zrinyi M, 2003, NEPHROL DIAL TRANSPL, V18, P1869, DOI 10.1093/ndt/gfg307	57	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149784	10.1371/journal.pone.0149784	http://dx.doi.org/10.1371/journal.pone.0149784			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919323	Green Submitted, gold, Green Published			2022-12-27	WOS:000371274400045
J	Cooke, GE; Wetter, NC; Banducci, SE; Mackenzie, MJ; Zuniga, KE; Awick, EA; Roberts, SA; Sutton, BP; McAuley, E; Kramer, AF				Cooke, Gillian E.; Wetter, Nathan C.; Banducci, Sarah E.; Mackenzie, Michael J.; Zuniga, Krystle E.; Awick, Elizabeth A.; Roberts, Sarah A.; Sutton, Brad P.; McAuley, Edward; Kramer, Arthur F.			Moderate Physical Activity Mediates the Association between White Matter Lesion Volume and Memory Recall in Breast Cancer Survivors	PLOS ONE			English	Article							COGNITIVE FEATURES 10; 30-YEAR FOLLOW-UP; DALLAS BED REST; ADJUVANT CHEMOTHERAPY; CARDIORESPIRATORY FITNESS; HIPPOCAMPAL VOLUME; CONTROLLED-TRIAL; AEROBIC FITNESS; EXERCISE; LIFE	Increased survival rates among breast cancer patients have drawn significant attention to consequences of both the presence of cancer, and the subsequent treatment-related impact on the brain. The incidence of breast cancer and the effects of treatment often result in alterations in the microstructure of white matter and impaired cognitive functioning. However, physical activity is proving to be a successful modifiable lifestyle factor in many studies that could prove beneficial to breast cancer survivors. This study investigates the link between white matter lesion volume, moderate physical activity, and cognition in breast cancer survivors following treatment compared to non-cancer age-matched controls. Results revealed that brain structure significantly predicted cognitive function via mediation of physical activity in breast cancer survivors. Overall, the study provided preliminary evidence suggesting moderate physical activity may help reduce the treatment related risks associated with breast cancer, including changes to WM integrity and cognitive impairment.	[Cooke, Gillian E.; Wetter, Nathan C.; Banducci, Sarah E.; Sutton, Brad P.; McAuley, Edward; Kramer, Arthur F.] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA; [Mackenzie, Michael J.] Univ Delaware, Coll Hlth Sci, Dept Behav Hlth & Nutr, Newark, DE USA; [Zuniga, Krystle E.] Texas State Univ, Sch Family & Consumer Sci, San Marcos, TX USA; [Awick, Elizabeth A.; Roberts, Sarah A.; McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Urbana, IL USA; [Banducci, Sarah E.; Kramer, Arthur F.] Univ Illinois, Dept Psychol, Urbana, IL USA; [Wetter, Nathan C.; Sutton, Brad P.] Univ Illinois, Dept Bioengn, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Delaware; Texas State University System; Texas State University San Marcos; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cooke, GE (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL USA.	gcooke@illinois.edu	Sutton, Bradley P./A-4801-2008; Kramer, Arthur/AAB-2937-2019; Salerno, Elizabeth/N-1317-2019	Sutton, Bradley P./0000-0002-8443-0408; Salerno, Elizabeth/0000-0001-5152-3168; Kramer, Arthur/0000-0001-5870-2724; Zuniga, Krystle/0000-0002-3857-155X	National Institute on Aging at the National Institutes of Health [R01AG020118, R37AG025667]; NATIONAL INSTITUTE ON AGING [R37AG025667, R01AG020118] Funding Source: NIH RePORTER	National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The investigators are supported by the National Institute on Aging at the National Institutes of Health - grant numbers R01AG020118 (EMA) and R37AG025667 (AFK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2008, CLIN BREAST CANCER, V8, P88, DOI 10.3816/CBC.2008.n.007; Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Andersson J.L.R., 2007, TR07JA2 FMRIB; Burzynska AZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107413; Chandwani KD, 2014, J CLIN ONCOL, V32, P1058, DOI 10.1200/JCO.2012.48.2752; Colcombe SJ, 2004, J MOL NEUROSCI, V24, P9, DOI 10.1385/JMN:24:1:009; Colcombe SJ, 2003, J GERONTOL A-BIOL, V58, P176; Courneya KS, 2007, CANCER EPIDEM BIOMAR, V16, P2572, DOI 10.1158/1055-9965.EPI-07-0413; Courneya KS, 2007, J CLIN ONCOL, V25, P4396, DOI 10.1200/JCO.2006.08.2024; Crowgey T, 2014, APPL PHYSIOL NUTR ME, V39, P724, DOI 10.1139/apnm-2013-0380; de Ruiter MB, 2012, HUM BRAIN MAPP, V33, P2971, DOI 10.1002/hbm.21422; Deprez S, DIFFUSION TENSOR MRI; Deprez S, 2012, J CLIN ONCOL, V30, P274, DOI 10.1200/JCO.2011.36.8571; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Erickson KI, 2010, J NEUROSCI, V30, P5368, DOI 10.1523/JNEUROSCI.6251-09.2010; Erickson KI, 2009, HIPPOCAMPUS, V19, P1030, DOI 10.1002/hipo.20547; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Folstein MF, 2010, MINIMENTAL STATE EXA; Galantino ML, 2012, EXPLORE-NY, V8, P127, DOI 10.1016/j.explore.2011.12.001; Gow AJ, 2012, NEUROLOGY, V79, P1802, DOI 10.1212/WNL.0b013e3182703fd2; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Henderson Tara O, 2014, Am Soc Clin Oncol Educ Book, pe423, DOI 10.14694/EdBook_AM.2014.34.e423; Irwin ML, 2003, CANCER-AM CANCER SOC, V97, P1746, DOI 10.1002/cncr.11227; Jones LW, 2009, LANCET ONCOL, V10, P598, DOI 10.1016/S1470-2045(09)70031-2; Kaiser J, 2014, CORTEX, V54, P33, DOI 10.1016/j.cortex.2014.01.010; Kempermann Gerd, 2010, Front Neurosci, V4, P189, DOI 10.3389/fnins.2010.00189; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Koppelmans V, 2015, J CLIN ONCOL, V33, P588, DOI 10.1200/JCO.2014.56.8345; Koppelmans V, 2014, HUM BRAIN MAPP, V35, P889, DOI 10.1002/hbm.22221; Koppelmans V, 2012, BREAST CANCER RES TR, V132, P1099, DOI 10.1007/s10549-011-1888-1; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Mackenzie MJ, J WOMENS HL IN PRESS; Mandelblatt JS, 2014, J CLIN ONCOL, V32, P1909, DOI 10.1200/JCO.2013.54.2050; Mandelblatt JS, 2013, SEMIN ONCOL, V40, P709, DOI 10.1053/j.seminoncol.2013.09.006; McDonald BC, 2013, BRAIN IMAGING BEHAV, V7, P374, DOI 10.1007/s11682-013-9256-x; McGuire DK, 2001, CIRCULATION, V104, P1350, DOI 10.1161/circ.104.12.1350; McGuire DK, 2001, CIRCULATION, V104, P1358, DOI 10.1161/hc3701.096099; Mustian Karen M, 2012, Oncol Hematol Rev, V8, P81; Nguyen CM, 2013, PSYCHO-ONCOLOGY, V22, P862, DOI 10.1002/pon.3086; Oh B, 2012, SUPPORT CARE CANCER, V20, P1235, DOI 10.1007/s00520-011-1209-6; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Sabiston CM, 2014, CANCER EPIDEM BIOMAR, V23, P1324, DOI 10.1158/1055-9965.EPI-13-1179; Sanoff HK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju057; Saykin AJ, 2013, BRAIN IMAGING BEHAV, V7, P363, DOI 10.1007/s11682-013-9283-7; Scherling C, 2012, J CLIN EXP NEUROPSYC, V34, P543, DOI 10.1080/13803395.2012.666227; Scherling C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00122; Schmitz KH, 2007, CANCER EPIDEM BIOMAR, V16, P866, DOI 10.1158/1055-9965.EPI-06-0980; Schmitz KH, 2010, MED SCI SPORT EXER, V42, P1409, DOI 10.1249/MSS.0b013e3181e0c112; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Simo M, 2013, NEUROSCI BIOBEHAV R, V37, P1311, DOI 10.1016/j.neubiorev.2013.04.015; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Society AC, 2015, WHAT ARE THE KEY STA; Spence RR, 2010, CANCER TREAT REV, V36, P185, DOI 10.1016/j.ctrv.2009.11.003; Stouten-Kemperman MM, 2014, BRAIN IMAGING BEHAV; Stouten-Kemperman MM, 2014, J INT NEUROPSYCH SOC, P1; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Wefel JS, 2015, CA-CANCER J CLIN, V65, P123, DOI 10.3322/caac.21258; Wefel JS, 2004, CANCER-AM CANCER SOC, V101, P466, DOI 10.1002/cncr.20393; Wetter NC, 2015, T2 WM HYPERINTENSITY, P1408; Wirth M, 2014, NEUROBIOL AGING, V35, P1873, DOI 10.1016/j.neurobiolaging.2014.02.015; Yamada TH, 2010, J NEUROPSYCH CLIN N, V22, P48, DOI 10.1176/appi.neuropsych.22.1.48; Yoshikawa E, 2005, BREAST CANCER RES TR, V92, P81, DOI 10.1007/s10549-005-1412-6; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	71	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149552	10.1371/journal.pone.0149552	http://dx.doi.org/10.1371/journal.pone.0149552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915025	gold, Green Published, Green Submitted			2022-12-27	WOS:000371175700018
J	Eng, CLP; Tong, JC; Tan, TW				Eng, Christine L. P.; Tong, Joo Chuan; Tan, Tin Wee			Distinct Host Tropism Protein Signatures to Identify Possible Zoonotic Influenza A Viruses	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; HUMAN INFECTION; NS1 PROTEIN; H7N9 VIRUS; H5N1 VIRUS; POULTRY; ORIGIN; DETERMINANTS; TRANSMISSION; VIRULENCE	Zoonotic influenza A viruses constantly pose a health threat to humans as novel strains occasionally emerge from the avian population to cause human infections. Many past epidemic as well as pandemic strains have originated from avian species. While most viruses are restricted to their primary hosts, zoonotic strains can sometimes arise from mutations or reassortment, leading them to acquire the capability to escape host species barrier and successfully infect a new host. Phylogenetic analyses and genetic markers are useful in tracing the origins of zoonotic infections, but there are still no effective means to identify high risk strains prior to an outbreak. Here we show that distinct host tropism protein signatures can be used to identify possible zoonotic strains in avian species which have the potential to cause human infections. We have discovered that influenza A viruses can now be classified into avian, human, or zoonotic strains based on their host tropism protein signatures. Analysis of all influenza A viruses with complete proteome using the host tropism prediction system, based on machine learning classifications of avian and human viral proteins has uncovered distinct signatures of zoonotic strains as mosaics of avian and human viral proteins. This is in contrast with typical avian or human strains where they show mostly avian or human viral proteins in their signatures respectively. Moreover, we have found that zoonotic strains from the same influenza outbreaks carry similar host tropism protein signatures characteristic of a common ancestry. Our results demonstrate that the distinct host tropism protein signature in zoonotic strains may prove useful in influenza surveillance to rapidly identify potential high risk strains circulating in avian species, which may grant us the foresight in anticipating an impending influenza outbreak.	[Eng, Christine L. P.; Tong, Joo Chuan; Tan, Tin Wee] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore; [Tong, Joo Chuan] Inst High Performance Comp, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC)	Eng, CLP (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore.	christine@bic.nus.edu.sg						[Anonymous], 2007, EURO SURVEILL, V12; [Anonymous], 2006, EURO SURVEILL, V11; [Anonymous], 2006, EURO SURVEILL, V11; Antonovics J, 2006, NATURE, V440, pE9, DOI 10.1038/nature04824; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400; Barrera-Badillo Gisela, 2012, Morbidity and Mortality Weekly Report, V61, P726; Butt AM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-319; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Cauldwell AV, 2014, J GEN VIROL, V95, P1193, DOI 10.1099/vir.0.062836-0; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P516; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P1204; Ceyhan M, 2010, EPIDEMIOL INFECT, V138, P1274, DOI 10.1017/S095026880999166X; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Eng CLP, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-S3-S1; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gibbs MJ, 2006, NATURE, V440, pE8, DOI 10.1038/nature04823; Gilsdorf A, 2006, Euro Surveill, V11, P3, DOI 10.2807/esm.11.05.00620-en; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Harder TC, 2006, AVIAN INFLUENZA; Heymann DL, 2013, CURR TOP MICROBIOL, V366, P207, DOI 10.1007/82_2012_285; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Jhung M., 2010, Morbidity and Mortality Weekly Report, V59, P1270; Kalthoff D, 2010, VET MICROBIOL, V140, P237, DOI 10.1016/j.vetmic.2009.08.022; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Kobasa D, 2005, CURR MOL MED, V5, P791, DOI 10.2174/156652405774962281; Koopmans M, 2004, LANCET, V363, P587, DOI 10.1016/S0140-6736(04)15589-X; Krug RM, 2013, TEXTBOOK OF INFLUENZA, 2ND EDITION, P57; Krumbholz A, 2011, MED MICROBIOL IMMUN, V200, P69, DOI 10.1007/s00430-010-0176-8; Kurtz J, 1996, LANCET, V348, P901, DOI 10.1016/S0140-6736(05)64783-6; Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1257, DOI 10.1038/aps.2013.121; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Nayak DP, 2009, VIRUS RES, V143, P147, DOI 10.1016/j.virusres.2009.05.010; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Oner AF, 2006, NEW ENGL J MED, V355, P2179, DOI 10.1056/NEJMoa060601; Pantin-Jackwood MJ, 2014, J VIROL, V88, P5381, DOI 10.1128/JVI.03689-13; Paterson D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003019; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris M, 1999, LANCET, V354, P916, DOI 10.1016/S0140-6736(99)03311-5; Reid AH, 2003, J GEN VIROL, V84, P2285, DOI 10.1099/vir.0.19302-0; Reperant LA, 2012, VACCINE, V30, P4419, DOI 10.1016/j.vaccine.2012.04.049; Richard M, 2014, FUTURE VIROL, V9, P513, DOI 10.2217/fvl.14.30; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shortridge KF, 1998, VIROLOGY, V252, P331, DOI 10.1006/viro.1998.9488; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tang RB, 2013, J CHIN MED ASSOC, V76, P245, DOI 10.1016/j.jcma.2013.04.003; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tiensin T, 2005, EMERG INFECT DIS, V11, P1664, DOI 10.3201/eid1111.050608; To KK, 2014, J INFECT, V69; Tweed SA, 2004, EMERG INFECT DIS, V10, P2196, DOI 10.3201/eid1012.040961; Vana G, 2008, MOL PHYLOGENET EVOL, V47, P1100, DOI 10.1016/j.ympev.2008.02.003; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHO, 2010, ANT GEN CHAR INFL A; World Health Organization, 2014, CONF HUM CAS AV INFL; World Health Organization, 2014, AV INFL A H10N8; World Health Organization, 2011, WEEKL EP REP; World Health Organization, 2014, ANT GEN CHAR ZOON IN; World Health Organization, 2015, H5N1 RES ISS; World Health Organization, 2013, OV EM CHAR AV INFL A; World Health Organization, 2014, CUM NUMB CONF HUM CA; World Health Organization, 2013, CHIN WHO JOINT MISS; World Health Organization, 2005, AV INFL ASS PAND THR; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Yang JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119792	70	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150173	10.1371/journal.pone.0150173	http://dx.doi.org/10.1371/journal.pone.0150173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915079	Green Submitted, gold, Green Published			2022-12-27	WOS:000371175700058
J	Kaczmarczyk, L; Labrie-Dion, E; Sehgal, K; Sylvester, M; Skubal, M; Josten, M; Steinhauser, C; De Koninck, P; Theis, M				Kaczmarczyk, Lech; Labrie-Dion, Etienne; Sehgal, Kapil; Sylvester, Marc; Skubal, Magdalena; Josten, Michele; Steinhaeuser, Christian; De Koninck, Paul; Theis, Martin			New Phosphospecific Antibody Reveals Isoform-Specific Phosphorylation of CPEB3 Protein	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; XENOPUS OOCYTE MATURATION; LONG-TERM FACILITATION; CYTOPLASMIC POLYADENYLATION; SYNAPTIC PLASTICITY; KINASE-II; CELLULAR SENESCENCE; MEIOTIC PROGRESSION; ELEMENT; EXPRESSION	Cytoplasmic Polyadenylation Element Binding proteins (CPEBs) are a family of polyadenylation factors interacting with 3'UTRs of mRNA and thereby regulating gene expression. Various functions of CPEBs in development, synaptic plasticity, and cellular senescence have been reported. Four CPEB family members of partially overlapping functions have been described to date, each containing a distinct alternatively spliced region. This region is highly conserved between CPEBs-2-4 and contains a putative phosphorylation consensus, overlapping with the exon seven of CPEB3. We previously found CPEBs-2-4 splice isoforms containing exon seven to be predominantly present in neurons, and the isoform expression pattern to be cell type-specific. Here, focusing on the alternatively spliced region of CPEB3, we determined that putative neuronal isoforms of CPEB3 are phosphorylated. Using a new phosphospecific antibody directed to the phosphorylation consensus we found Protein Kinase A and Calcium/Calmodulin-dependent Protein Kinase II to robustly phosphorylate CPEB3 in vitro and in primary hippocampal neurons. Interestingly, status epilepticus induced by systemic kainate injection in mice led to specific upregulation of the CPEB3 isoforms containing exon seven. Extensive analysis of CPEB3 phosphorylation in vitro revealed two other phosphorylation sites. In addition, we found plethora of potential kinases that might be targeting the alternatively spliced kinase consensus site of CPEB3. As this site is highly conserved between the CPEB family members, we suggest the existence of a splicing-based regulatory mechanism of CPEB function, and describe a robust phosphospecific antibody to study it in future.	[Kaczmarczyk, Lech; Skubal, Magdalena; Steinhaeuser, Christian; Theis, Martin] Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany; [De Koninck, Paul] Univ Laval, Dept Biochim Microbiol & Bioinformat, Quebec City, PQ, Canada; [Labrie-Dion, Etienne; Sehgal, Kapil; De Koninck, Paul] Inst Univ Sante Mentale Quebec, Quebec City, PQ, Canada; [Sylvester, Marc] Univ Bonn, Inst Biochem & Mol Biol, Bonn, Germany; [Josten, Michele] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Kaczmarczyk, Lech] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany	University of Bonn; Laval University; Laval University; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Kaczmarczyk, L (corresponding author), Univ Bonn, Fac Med, Inst Cellular Neurosci, Bonn, Germany.	lech@dzne.de	Kaczmarczyk, Lech/AAK-2892-2020	Kaczmarczyk, Lech/0000-0003-2747-3134; Sylvester, Marc/0000-0002-4275-0200	German Research Foundation [SFB/TR3, STE 552/3, N01]; Else-Kroner-Fresenius-Stiftung; Canadian Institute of Health Research; European Community [FP7-202167]	German Research Foundation(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); European Community(European Commission)	This work was supported by grants of the German Research Foundation SFB/TR3, N01, C9 (to MT), SFB/TR3, C1, C9 (to CS); STE 552/3 (to CS); the Else-Kroner-Fresenius-Stiftung (to MT); Canadian Institute of Health Research (to PDK) and of the European Community FP7-202167 (to CS and MT).	Alarcon JM, 2004, LEARN MEMORY, V11, P318, DOI 10.1101/lm.72704; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Atkins CM, 2004, J NEUROSCI, V24, P5193, DOI 10.1523/JNEUROSCI.0854-04.2004; Belloc E, 2008, BIOCHEM SOC T, V36, P665, DOI 10.1042/BST0360665; Burns DM, 2011, NATURE, V473, P105, DOI 10.1038/nature09908; Burns DM, 2008, GENE DEV, V22, P3449, DOI 10.1101/gad.1697808; Chao HW, 2013, J NEUROSCI, V 33, P17008, DOI 10.1523/JNEUROSCI.3043-13.2013; Drisaldi B, 2015, CELL REP, V11, P1694, DOI 10.1016/j.celrep.2015.04.061; Fernandez-Miranda G, 2012, AGEING RES REV, V11, P460, DOI 10.1016/j.arr.2012.03.004; Fioriti L, 2015, NEURON, V86, P1433, DOI 10.1016/j.neuron.2015.05.021; Flynn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041185; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; Groisman I, 2006, GENE DEV, V20, P2701, DOI 10.1101/gad.1438906; Hagele S, 2009, BIOCHEM J, V417, P235, DOI 10.1042/BJ20081353; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hansen CN, 2009, APMIS, V117, P53, DOI 10.1111/j.1600-0463.2008.00015.x; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hodgman R, 2001, DEVELOPMENT, V128, P2815; Huang WH, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00367; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Huang YS, 2002, EMBO J, V21, P2139, DOI 10.1093/emboj/21.9.2139; Hudmon A, 2005, J NEUROSCI, V25, P6971, DOI 10.1523/JNEUROSCI.4698-04.2005; Igea A, 2010, EMBO J, V29, P2182, DOI 10.1038/emboj.2010.111; JENO P, 1995, ANAL BIOCHEM, V224, P75, DOI 10.1006/abio.1995.1010; Jones KJ, 2008, GLIA, V56, P1401, DOI 10.1002/glia.20707; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lemieux M, 2012, J CELL BIOL, V198, P1055, DOI 10.1083/jcb.201202058; Lin CL, 2010, RNA, V16, P338, DOI 10.1261/rna.1779810; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Makhinson M, 1999, J NEUROSCI, V19, P2500; McEvoy M, 2007, J NEUROSCI, V27, P6400, DOI 10.1523/JNEUROSCI.5211-06.2007; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; Mendez R, 2000, MOL CELL, V6, P1253, DOI 10.1016/S1097-2765(00)00121-0; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126; Morgan M, 2010, NUCLEIC ACIDS RES, V38, P7698, DOI 10.1093/nar/gkq635; Nault F, 2010, SPRINGER PROTOC HAND, P137, DOI 10.1007/978-1-60761-292-6_8; Novoa I, 2010, NAT CELL BIOL, V12, P447, DOI 10.1038/ncb2046; Pavlopoulos E, 2011, CELL, V147, P1369, DOI 10.1016/j.cell.2011.09.056; Peng SC, 2010, NUCLEIC ACIDS RES, V38, P7446, DOI 10.1093/nar/gkq634; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Richter JD, 2010, BIOCHEM SOC T, V38, P1527, DOI 10.1042/BST0381527; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Sajikumar S, 2007, J NEUROSCI, V27, P5068, DOI 10.1523/JNEUROSCI.4940-06.2007; Sarkissian M, 2004, GENE DEV, V18, P48, DOI 10.1101/gad.1136004; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Souaze F, 1996, BIOTECHNIQUES, V21, P280; Stephan JS, 2015, CELL REP, V11, P1772, DOI 10.1016/j.celrep.2015.04.060; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tay J, 2003, GENE DEV, V17, P1457, DOI 10.1101/gad.1071403; Tay J, 2001, DEV CELL, V1, P201, DOI 10.1016/S1534-5807(01)00025-9; Theis M, 2003, P NATL ACAD SCI USA, V100, P9602, DOI 10.1073/pnas.1133424100; Turimella SL, 2015, HIPPOCAMPUS, V25, P630, DOI 10.1002/hipo.22399; Wang XP, 2010, BIOINFORM BIOL INSIG, V4, P61, DOI 10.4137/BBI.S5087; Wang XP, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-109; Whalley K, 2012, NAT REV NEUROSCI, V13, P73, DOI 10.1038/nrn3175; Zearfoss NR, 2008, J NEUROSCI, V28, P8502, DOI 10.1523/JNEUROSCI.1756-08.2008	61	3	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150000	10.1371/journal.pone.0150000	http://dx.doi.org/10.1371/journal.pone.0150000			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26915047	Green Published, gold, Green Submitted			2022-12-27	WOS:000371175700045
J	Lane, J; Verani, A; Hijazi, M; Hurley, E; Hagopian, A; Judice, N; MacInnis, R; Sanford, S; Zelek, S; Katz, A				Lane, Jeffrey; Verani, Andre; Hijazi, Mai; Hurley, Erin; Hagopian, Amy; Judice, Nicole; MacInnis, Ron; Sanford, Sallie; Zelek, Sarah; Katz, Aaron			Monitoring HIV and AIDS Related Policy Reforms: A Road Map to Strengthen Policy Monitoring and Implementation in PEPFAR Partner Countries	PLOS ONE			English	Article							SOUTH-AFRICA; PROGRAMS; HIV/AIDS; IMPACT	Achieving an AIDS-free generation will require the adoption and implementation of critical health policy reforms. However, countries with high HIV burden often have low policy development, advocacy, and monitoring capacity. This lack of capacity may be a significant barrier to achieving the AIDS-free generation goals. This manuscript describes the increased focus on policy development and implementation by the United States President's Emergency Plan for AIDS Relief (PEPFAR). It evaluates the curriculum and learning modalities used for two regional policy capacity building workshops organized around the PEPFAR Partnership Framework agreements and the Road Map for Monitoring and Implementing Policy Reforms. A total of 64 participants representing the U.S. Government, partner country governments, and civil society organizations attended the workshops. On average, participants responded that their policy monitoring skills improved and that they felt they were better prepared to monitor policy reforms three months after the workshop. When followed-up regarding utilization of the Road Map action plan, responses were mixed. Reasons cited for not making progress included an inability to meet or a lack of time, personnel, or governmental support. This lack of progress may point to a need for building policy monitoring systems in high HIV burden countries. Because the success of policy reforms cannot be measured by the mere adoption of written policy documents, monitoring the implementation of policy reforms and evaluating their public health impact is essential. In many high HIV burden countries, policy development and monitoring capacity remains weak. This lack of capacity could hinder efforts to achieve the ambitious AIDS-free generation treatment, care and prevention goals. The Road Map appears to be a useful tool for strengthening these critical capacities.	[Lane, Jeffrey; Hagopian, Amy; Zelek, Sarah; Katz, Aaron] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Lane, Jeffrey; Sanford, Sallie] Univ Washington, Sch Law, Seattle, WA 98195 USA; [Lane, Jeffrey] Foster Pepper PLLC, Seattle, WA USA; [Verani, Andre; Hurley, Erin] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Hijazi, Mai] US Agcy Int Dev, Washington, DC 20523 USA; [Judice, Nicole; MacInnis, Ron] Hlth Policy Project, Futures Grp, Washington, DC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID)	Lane, J (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lanej3@u.washington.edu			Centers for Disease Control and Prevention (CDC.) [U48-DP001911]; Health Policy Project - U.S. Agency for International Development; U.S. President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-10-00067]; United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention; United States Agency for International Development; Foster Pepper, PLLC; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP001911] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention (CDC.)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Health Policy Project - U.S. Agency for International Development; U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention; United States Agency for International Development(United States Agency for International Development (USAID)); Foster Pepper, PLLC; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research is a product of the University of Washington Health Promotion Research Center and was supported by Cooperative Agreement Number U48-DP001911 from the Centers for Disease Control and Prevention (CDC.) Support for the study was also provided through the Health Policy Project, which is funded by the U.S. Agency for International Development and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) under Agreement No. AID-OAA-A-10-00067, beginning 30th September 2010. This work was supported by the United States President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention and the United States Agency for International Development. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the U.S. Centers for Disease Control and Prevention or of the U.S. Agency for International Development. Foster Pepper, PLLC, provided support in the form of salary for author Jeffrey Lane, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of Jeffrey Lane are articulated in the 'author contributions' section.	[Anonymous], 2005, SUMM COUNTR PROF HIV; [Anonymous], [No title captured]; Attaran A, 2001, WASHINGTON POST; *BILL MEL GAT FDN, 2005, GLOB HLTH PARTN ASS; Brewer G. D., 1983, FDN POLICY ANAL; Brugha R., 2005, GLOBAL FUND TRACKING; Butler A, 2005, AFR AFFAIRS, V104, P591, DOI 10.1093/afraf/adi036; Chigwedere P, 2008, JAIDS-J ACQ IMM DEF, V49, P410, DOI 10.1097/QAI.0b013e31818a6cd5; Chimbwandira F, 2013, MMWR-MORBID MORTAL W, V62, P148; Gostin LO, 2008, JAMA-J AM MED ASSOC, V300, P2046, DOI 10.1001/jama.2008.588; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; Holmes CB, 2012, HEALTH AFFAIR, V31, P1553, DOI 10.1377/hlthaff.2012.0562; Kaiser Family Foundation, 2013, US GLOB HLTH POL FAC; KENDALL ALEXANDRA, 2012, US RESPONSE GLOBAL T; Kober K, 2004, LANCET, V364, P103, DOI 10.1016/S0140-6736(04)16597-5; Kruk ME, 2012, HEALTH AFFAIR, V31, P1478, DOI 10.1377/hlthaff.2012.0197; Lasswell H. D, 1956, DECISION PROCESS 7 C; Leite G., 2012, MOZAMBIQUE NATL COMM; Nunn A, 2012, GLOB PUBLIC HEALTH, V7, P1031, DOI 10.1080/17441692.2012.736681; Office of the President National AIDS Control Council Kenya (NACC Kenya), 2011, KEN AIDS EP UPD 2011; OGAC, 2012, PEPFAR BLUEPR CREAT; PEPFAR, 2008, POW PARTN PRES EM PL; PEPFAR, 2012, SUPP COUNTR OWN KEY; PEPFAR, 2013, NEXT GEN IND REF GUI; PEPFAR (The U.S. President's Emergency Plan for AIDS Relief), 2009, GUID PEPFAR PARTN FR; Pisani E, 1999, ACTING EARLY PREVENT; Renaud-Thery F, 2010, AIDS RES TREATMENT, V2011, P1; Renaud-Thery F., 2011, ANN 2010 SURVEY ARV; South Africa and U.S.A, 2012, PARTN FRAM IMPL PLAN; UNAIDS, 2012, SEN SUCC STOR AIDS I; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2012, 2012 UNAIDS WORLD AI; UNICEF, 2001, HIV AIDS	32	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0146720	10.1371/journal.pone.0146720	http://dx.doi.org/10.1371/journal.pone.0146720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914708	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700003
J	Carballo, I; Alvela, L; Perez, LF; Gude, F; Vidal, C; Alonso, M; Sopena, B; Gonzalez-Quintela, A				Carballo, Iago; Alvela, Lucia; Perez, Luis-Fernando; Gude, Francisco; Vidal, Carmen; Alonso, Manuela; Sopena, Bernardo; Gonzalez-Quintela, Arturo			Serum Concentrations of IgG4 in the Spanish Adult Population: Relationship with Age, Gender, and Atopy	PLOS ONE			English	Article							IGG4-RELATED DISEASE; ALCOHOL-CONSUMPTION; ALLERGIC SENSITIZATION; IMMUNOGLOBULIN G4; PANCREATITIS; PREVALENCE; SUBCLASSES; DIAGNOSIS; TH2	Background and Aim Serum IgG4 concentrations are commonly measured in clinical practice. The aim of this study was to investigate serum IgG4 concentrations in adults and their potential relationship with demographic, lifestyle, metabolic, and allergy-related factors. Methods Serum IgG4 concentrations were measured with a commercial assay in 413 individuals (median age 55 years, 45% males) who were randomly selected from a general adult population. Results Median IgG4 concentration was 26.8 mg/dL. Five out of the 413 individuals (1.2%) exhibited IgG4 concentrations >135 mg/dL, and 17 out of 411 (4.1%) exhibited an IgG4/total IgG ratio >8%. Serum IgG4 concentrations were significantly higher in males than in females and decreased with age. After adjusting for age and sex, serum IgG4 concentrations were not significantly influenced by alcohol consumption, smoking or common metabolic abnormalities (obesity and the related metabolic syndrome). Serum IgG4 concentrations were not significantly correlated with serum concentrations of proinflammatory cytokines and inflammation markers. Serum IgG4 concentrations were significantly correlated with IgE concentrations. Serum IgG4 concentrations tended to be higher in atopics (individuals with IgE-mediated sensitization to aeroallergens) than in non-atopics, particularly among atopics without respiratory symptoms. Serum IgG4 concentrations were not significantly correlated with total eosinophil blood count. Cases of IgG4-related disease were neither present at baseline nor detected after a median of 11 years of follow-up. Conclusions Studies aimed at defining reference IgG4 values should consider partitioning by age and sex. Further studies are needed to confirm the potential influence of atopy status on serum IgG4 concentrations.	[Carballo, Iago; Alvela, Lucia; Alonso, Manuela; Sopena, Bernardo; Gonzalez-Quintela, Arturo] Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain; [Perez, Luis-Fernando] Complejo Hosp Univ, Dept Clin Biochem, Santiago De Compostela, Spain; [Gude, Francisco; Alonso, Manuela] Complejo Hosp Univ, Dept Clin Epidemiol, Santiago De Compostela, Spain; [Vidal, Carmen] Complejo Hosp Univ, Dept Allergy, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Gonzalez-Quintela, A (corresponding author), Complejo Hosp Univ, Dept Internal Med, Santiago De Compostela, Spain.	arturo.gonzalez.quintela@usc.es	Alonso, Manuela/F-7682-2016	Gonzalez-Quintela, Arturo/0000-0002-6909-1807	Instituto de Salud Carlos III, Spanish Ministry of Health (Red de Investigacion en Actividades Preventivas y Promocion de la Salud) [PI13/02594, RD12/0005/0007]; Fondo Europeo de Desarrollo Regional (FEDER); Conselleria de Innovacion e Industria; Xunta de Galicia [PGIDIT06PXIB918313]	Instituto de Salud Carlos III, Spanish Ministry of Health (Red de Investigacion en Actividades Preventivas y Promocion de la Salud); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Conselleria de Innovacion e Industria; Xunta de Galicia(Xunta de GaliciaEuropean Commission)	The study was supported by grants from the Instituto de Salud Carlos III, Spanish Ministry of Health (PI13/02594 and Red de Investigacion en Actividades Preventivas y Promocion de la Salud, redIAPP RD12/0005/0007), Fondo Europeo de Desarrollo Regional (FEDER), and the Conselleria de Innovacion e Industria, Xunta de Galicia (PGIDIT06PXIB918313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Alvarado MI, 2014, ALLERGY, V69, P1610, DOI 10.1111/all.12509; AUCOUTURIER P, 1984, J IMMUNOL METHODS, V74, P151, DOI 10.1016/0022-1759(84)90376-4; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; BURTON DR, 1986, MONOGR ALLERGY, V19, P7; Carruthers MN, 2015, ANN RHEUM DIS, V74, P14, DOI 10.1136/annrheumdis-2013-204907; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Della Torre E, 2014, ALLERGY, V69, P269, DOI 10.1111/all.12320; Della-Torre E, 2015, CLIN EXP IMMUNOL, V181, P191, DOI 10.1111/cei.12641; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; Fragoulis GE, 2010, J RHEUMATOL, V37, P1369, DOI 10.3899/jrheum.100383; FRENCH M, 1986, MONOGR ALLERGY, V19, P100; FRENCH MAH, 1984, CLIN EXP IMMUNOL, V56, P473; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Gonzalez-Quintela A, 2008, CLIN EXP IMMUNOL, V151, P42, DOI 10.1111/j.1365-2249.2007.03545.x; Gonzalez-Quintela A, 2003, CLIN EXP ALLERGY, V33, P199, DOI 10.1046/j.1365-2222.2003.01582.x; Gonzalez-Quintela A, 2008, ALCOHOL, V42, P513, DOI 10.1016/j.alcohol.2008.04.008; Gonzalez-Quintela A, 2007, CYTOKINE, V38, P54, DOI 10.1016/j.cyto.2007.05.006; Gonzalez-Quintela A, 2010, CLIN CHEM LAB MED, V48, P701, DOI 10.1515/CCLM.2010.124; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; Gual A, 1999, ALCOHOL ALCOHOLISM, V34, P153, DOI 10.1093/alcalc/34.2.153; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Inoue D, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000680; Islam AD, 2015, AUTOIMMUN REV, V14, P914, DOI 10.1016/j.autrev.2015.06.003; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; Kanda N, 1999, J ALLERGY CLIN IMMUN, V103, P282, DOI 10.1016/S0091-6749(99)70503-8; Khosroshahi A, 2015, ARTHRITIS RHEUMATOL, V67, P1688, DOI 10.1002/art.39132; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Masaki Y, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/580814; Mattoo H, 2014, ALLERGY, V69, P399, DOI 10.1111/all.12342; MORELL A, 1970, J CLIN INVEST, V49, P673, DOI 10.1172/JCI106279; Rigby RA, 2006, STAT MODEL, V6, P209, DOI 10.1191/1471082X06st122oa; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Stone JH, 2015, MAYO CLIN PROC, V90, P927, DOI 10.1016/j.mayocp.2015.03.020; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Uchida K, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/358371; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Vidal C, 2005, J INVEST ALLERG CLIN, V15, P124; Vidal C, 2004, ALLERGY, V59, P401, DOI 10.1111/j.1398-9995.2003.00430.x; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697	43	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149330	10.1371/journal.pone.0149330	http://dx.doi.org/10.1371/journal.pone.0149330			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910567	gold, Green Submitted, Green Published			2022-12-27	WOS:000371164700030
J	Chandler, HC; Rypel, AL; Jiao, Y; Haas, CA; Gorman, TA				Chandler, Houston C.; Rypel, Andrew L.; Jiao, Yan; Haas, Carola A.; Gorman, Thomas A.			Hindcasting Historical Breeding Conditions for an Endangered Salamander in Ephemeral Wetlands of the Southeastern USA: Implications of Climate Change	PLOS ONE			English	Article							FLATWOODS SALAMANDER; AMBYSTOMA-CINGULATUM; COASTAL-PLAIN; AMPHIBIAN DECLINES; FLORIDA POPULATION; HYDROLOGY; HYDROPERIOD; HABITAT; SIZE; ECOSYSTEMS	The hydroperiod of ephemeral wetlands is often the most important characteristic determining amphibian breeding success, especially for species with long development times. In mesic and wet pine flatwoods of the southeastern United States, ephemeral wetlands were a common landscape feature. Reticulated flatwoods salamanders (Ambystoma bishopi), a federally endangered species, depend exclusively on ephemeral wetlands and require at least 11 weeks to successfully metamorphose into terrestrial adults. We empirically modeled hydroperiod of 17 A. bishopi breeding wetlands by combining downscaled historical climate- model data with a recent 9-year record (2006-2014) of observed water levels. Empirical models were subsequently used to reconstruct wetland hydrologic conditions from 1896-2014 using the downscaled historical climate datasets. Reconstructed hydroperiods for the 17 wetlands were highly variable through time but were frequently unfavorable for A. bishopi reproduction (e.g., only 61% of years, using a conservative estimate of development time [12 weeks], were conducive to larval development and metamorphosis). Using change-point analysis, we identified significant shifts in average hydroperiod over the last century in all 17 wetlands. Mean hydroperiods were shorter in recent years than at any other point since 1896, and thus less suitable for A. bishopi reproduction. We suggest that climate change will continue to impact the reproductive success of flatwoods salamanders and other ephemeral wetland breeders by reducing the number of years these wetlands have suitable hydroperiods. Consequently, we emphasize the importance of conservation and management for mitigating other forms of habitat degradation, especially maintenance of high quality breeding sites where reproduction can occur during appropriate environmental conditions.	[Chandler, Houston C.; Rypel, Andrew L.; Jiao, Yan; Haas, Carola A.; Gorman, Thomas A.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA	Virginia Polytechnic Institute & State University	Chandler, HC (corresponding author), Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA USA.	houstonc@vt.edu	Haas, Carola A./B-5056-2009	Haas, Carola A./0000-0002-5490-6882; Jiao, Yan/0000-0002-8804-5005	Eglin Air Force Base [F14AC00068]; DoD Legacy Resource Management Program [W9132T-11-2-0028]; Hurlburt Field [W9126G-12-2-0004]; Virginia Tech Open Access Subvention Fund	Eglin Air Force Base; DoD Legacy Resource Management Program; Hurlburt Field; Virginia Tech Open Access Subvention Fund	The authors received funding from three sources for this study: 1) Government Award, Issued by U.S. Fish and Wildlife Service (http://www.fws.gov/), through Cooperative Agreement #F14AC00068 to CAH and TAG. Sponsored by Eglin Air Force Base. 2) Government Award, Issued by Army Corps of Engineers (http://www.usace.army.mil/), through Cooperative agreement #W9132T-11-2-0028 to TAG and CAH. Sponsored by DoD Legacy Resource Management Program (https://www.dodlegacy.org/legacy/). 3) Government Award, Issued by Army Corps of Engineers (http://www.usace.army.mil/), through Cooperative agreement #W9126G-12-2-0004 to TAG and CAH. Sponsored by Hurlburt Field. 4) Open access publishing costs were funded by the Virginia Tech Open Access Subvention Fund (http://www.lib.vt.edu/oafund/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J D, 1976, Herpetologica, V32, P214; Ashton Jr R.E., 1992, RARE ENDANGERED BIOT, V3, P39; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bishop DC, 2005, NAT AREA J, V25, P290; Bishop DC, 2005, THESIS VIRGINIA POLY; Brooks RT, 2009, CLIMATIC CHANGE, V95, P469, DOI 10.1007/s10584-008-9531-9; Brooks RT, 2004, WETLANDS, V24, P104, DOI 10.1672/0277-5212(2004)024[0104:WEOWVP]2.0.CO;2; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carey C, 2003, DIVERS DISTRIB, V9, P111, DOI 10.1046/j.1472-4642.2003.00011.x; Chandler HC, 2015, WETLANDS, V35, P1201, DOI 10.1007/s13157-015-0707-6; Church DR, 2007, ECOLOGY, V88, P891, DOI 10.1890/06-0896; CROWNOVER SH, 1995, SOIL SCI SOC AM J, V59, P1199, DOI 10.2136/sssaj1995.03615995005900040036x; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; Dodd CK, 1998, CONSERV BIOL, V12, P331, DOI 10.1046/j.1523-1739.1998.97183.x; Finlayson CM, 1999, WETLANDS INT PUBLICA, V53; Gorman TA, 2014, HERPETOL CONSERV BIO, V9, P543; Gorman TA, 2013, FIRE ECOL, V9, P96, DOI 10.4996/fireecology.0901096; Gorman TA, 2009, WETLANDS, V29, P323, DOI 10.1672/08-155.1; Greenberg CH, 2015, WETLANDS, V35, P899, DOI 10.1007/s13157-015-0680-0; Hill E. Pierson, 2013, Herpetological Review, V44, P112; Ingram K. T., 2013, CLIMATE SE US VARIAB; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; Karl T. R., 2009, Global climate change impacts in the United States; Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745; Killick R, 2014, R PACKAGE CHANGEPOIN; Kinkead KE, 2007, HERPETOLOGICA, V63, P151, DOI 10.1655/0018-0831(2007)63[151:ESSAAP]2.0.CO;2; Kirkman LK, 1995, FIRE WETLANDS MANAGE, V19, P10; Leibowitz Scott G., 2007, P31, DOI 10.1201/9781420005394.ch3; LIDE RF, 1995, WETLANDS, V15, P47, DOI 10.1007/BF03160679; Lu JB, 2003, J AM WATER RESOUR AS, V39, P887, DOI 10.1111/j.1752-1688.2003.tb04413.x; Lu JB, 2009, WETLANDS, V29, P826, DOI 10.1672/07-162.1; Mansell RS, 2000, SOIL SCI, V165, P384, DOI 10.1097/00010694-200005000-00002; Martin MD, 2011, AM MIDL NAT, V166, P404, DOI 10.1674/0003-0031-166.2.404; Mazerolle MJ, 2015, AICCMODAVG MODEL SEL; McMenamin SK, 2008, P NATL ACAD SCI USA, V105, P16988, DOI 10.1073/pnas.0809090105; Means D. Bruce, 1996, P210; Means DB, 1996, CONSERV BIOL, V10, P426, DOI 10.1046/j.1523-1739.1996.10020426.x; Means DB, 2004, CONSERV BIOL, V18, P1149, DOI 10.1111/j.1523-1739.2004.00017.x; Miller RC, 2003, PLANT ECOL, V167, P57, DOI 10.1023/A:1023918619073; Mulholland PJ, 1997, HYDROL PROCESS, V11, P949; Palis JG, 2006, SOUTHEAST NAT, V5, P1, DOI 10.1656/1528-7092(2006)5[1:BBOAFP]2.0.CO;2; Palis JG, 1996, NAT AREA J, V16, P49; Palis JG, 1997, J HERPETOL, V31, P71, DOI 10.2307/1565331; Palis JG, 2005, AMPHIBIAN DECLINES C, P608; Palis JG, 1995, FINAL REPORT; Palis John G., 1995, Florida Scientist, V58, P352; Pechmann J.H.K., 1989, Wetlands Ecology and Management, V1, P3; Petranka J.W, 1998, SALAMANDERS US CANAD; R Core Team, 2021, R LANGUAGE ENV STAT; Riekerk H, 2000, WETLANDS, V20, P448, DOI 10.1672/0277-5212(2000)020[0448:THOCWI]2.0.CO;2; Rohr JR, 2013, CONSERV BIOL, V27, P741, DOI 10.1111/cobi.12086; Romero-Lankao P, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1439; Russell KR, 2002, FOREST ECOL MANAG, V163, P43, DOI 10.1016/S0378-1127(01)00526-6; Rypel AL, 2012, ECOSYSTEMS, V15, P555, DOI 10.1007/s10021-012-9528-0; Schmitz OJ, 2015, NAT AREA J, V35, P190, DOI 10.3375/043.035.0120; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Semlitsch RD, 1998, CONSERV BIOL, V12, P1129, DOI 10.1046/j.1523-1739.1998.98166.x; SEMLITSCH RD, 1988, COPEIA, P978; Sim LL, 2013, FRESHW SCI, V32, P327, DOI 10.1899/12-024.1; Skelly DK, 2014, ECOL APPL, V24, P340, DOI 10.1890/13-1042.1; Skelly DK, 1997, AM SCI, V85, P36; Skelly DK, 1996, COPEIA, P599; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; Southard LF, 2011, FOREST HIST TODA SPR, P17; Strzepek K, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044012; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sun G, 2002, J HYDROL, V263, P92, DOI 10.1016/S0022-1694(02)00064-1; Taylor BE, 2006, CONSERV BIOL, V20, P792, DOI 10.1111/j.1523-1739.2005.00321.x; Trenham PC, 2000, COPEIA, P365, DOI 10.1643/0045-8511(2000)000[0365:LHADVI]2.0.CO;2; Turner AM, 2009, FRESHWATER BIOL, V54, P1189, DOI 10.1111/j.1365-2427.2009.02168.x; United States Department of the Interior Fish and Wildlife Service, 2009, FED REGISTER, V74, P6700; Walls Susan C., 2013, Biology - Basel, V2, P399, DOI 10.3390/biology2010399; Walls SC, 2013, WETLANDS, V33, P345, DOI 10.1007/s13157-013-0391-3; Westervelt JD, 2013, ECOL MODEL, V268, P18, DOI 10.1016/j.ecolmodel.2013.07.026	75	23	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150169	10.1371/journal.pone.0150169	http://dx.doi.org/10.1371/journal.pone.0150169			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910245	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700072
J	Kuypers, KPC; Theunissen, EL; van Wel, JHP; de Sousa, EB; Perna, F; Linssen, A; Sambeth, A; Schultz, BG; Ramaekers, JG				Kuypers, Kim P. C.; Theunissen, Eef L.; van Wel, Janelle H. P.; de Sousa, Elizabeth B.; Perna, Fernandes; Linssen, Anke; Sambeth, Anke; Schultz, Benjamin G.; Ramaekers, Johannes G.			Verbal Memory Impairment in Polydrug Ecstasy Users: A Clinical Perspective	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; MDMA ECSTASY; BRAIN; PERFORMANCE; DEFICITS; ADULTS	Background cstasy use has been associated with short-term and long-term memory deficits on a standard Word Learning Task (WLT). The clinical relevance of this has been debated and is currently unknown. The present study aimed at evaluating the clinical relevance of verbal memory impairment in Ecstasy users. To that end, clinical memory impairment was defined as decrement in memory performance that exceeded the cut-off value of 1.5 times the standard deviation of the average score in the healthy control sample. The primary question was whether being an Ecstasy user (E-user) was predictive of having clinically deficient memory performance compared to a healthy control group. Methods WLT data were pooled from four experimental MDMA studies that compared memory performance during placebo and MDMA intoxication. Control data were taken from healthy volunteers with no drug use history who completed the WLT as part of a placebo-controlled clinical trial. This resulted in a sample size of 65 E-users and 65 age-and gender-matched healthy drug-naive controls. All participants were recruited by similar means and were tested at the same testing facilities using identical standard operating procedures. Data were analyzed using linear mixed-effects models, Bayes factor, and logistic regressions. Results Findings were that verbal memory performance of placebo-treated E-users did not differ from that of controls, and there was substantial evidence in favor of the null hypothesis. History of use was not predictive of memory impairment. During MDMA intoxication of E-users, verbal memory was impaired. Conclusion The combination of the acute and long-term findings demonstrates that, while clinically relevant memory impairment is present during intoxication, it is absent during abstinence. This suggests that use of Ecstasy/MDMA does not lead to clinically deficient memory performance in the long term. Additionally, it has to be investigated whether the current findings apply to more complex cognitive measures in diverse 'user categories' using a combination of genetics, imaging techniques and neuropsychological assessments.	[Kuypers, Kim P. C.; Theunissen, Eef L.; van Wel, Janelle H. P.; de Sousa, Elizabeth B.; Perna, Fernandes; Linssen, Anke; Sambeth, Anke; Schultz, Benjamin G.; Ramaekers, Johannes G.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands	Maastricht University	Kuypers, KPC (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands.	k.kuypers@maastrichtuniversity.nl	Kuypers, Kim/L-1206-2019; Sambeth, Anke/ABH-7800-2020; Schultz, Ben/AAD-9976-2019	Kuypers, Kim/0000-0001-7634-3809; Schultz, Ben/0000-0002-8306-0206; Sambeth, Anke/0000-0002-3654-9383				Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Becker B, 2013, PSYCHOPHARMACOLOGY, V225, P923, DOI 10.1007/s00213-012-2873-z; Bedi G, 2008, PSYCHOL MED, V38, P1319, DOI 10.1017/S0033291708002730; Biezonski DK, 2011, CURR NEUROPHARMACOL, V9, P84, DOI 10.2174/157015911795017146; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Bolla KI, 1998, NEUROLOGY, V51, P1532, DOI 10.1212/WNL.51.6.1532; Brown J, 2010, PSYCHOPHARMACOLOGY, V209, P51, DOI 10.1007/s00213-009-1766-2; Brunt TM, 2012, INT J DRUG POLICY, V23, P134, DOI 10.1016/j.drugpo.2011.05.016; Busse A, 2006, BRIT J PSYCHIAT, V189, P399, DOI 10.1192/bjp.bp.105.014779; Cowan RL, 2007, PSYCHOPHARMACOLOGY, V189, P539, DOI 10.1007/s00213-006-0467-3; Curran HV, 2000, NEUROPSYCHOBIOLOGY, V42, P34, DOI 10.1159/000026668; Cuyas E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027206; de la Torre Rafael, 2012, Frontiers in Genetics, V3, P235, DOI 10.3389/fgene.2012.00235; de Win MML, 2005, INT J METH PSYCH RES, V14, P167, DOI 10.1002/mpr.6; den Hollander B, 2012, J NEUROL NEUROSUR PS, V83, P83, DOI 10.1136/jnnp.2010.228387; DIMS, 2014, JAARB 2014; DIMS, 2009, DIMS JAARB 2009; EMCDDA, 2015, EUR DRUG REP 2015; EMCDDA, 2014, EUR DRUG REP; Gallagher DT, 2014, NEUROPSYCHOLOGY, V28, P43, DOI 10.1037/neu0000004; Gamma A, 2001, MAPS B, V10; Goldberg TE, 2010, AM J PSYCHIAT, V167, P845, DOI 10.1176/appi.ajp.2010.09050692; Green AR, 2012, BRIT J PHARMACOL, V166, P1523, DOI 10.1111/j.1476-5381.2011.01819.x; Karch S. B., 2011, OPEN FORENSIC SCI J, V4, P20, DOI DOI 10.2174/1874402801104010020; Kelly BC, 2009, J PSYCHOACTIVE DRUGS, V41, P19, DOI 10.1080/02791072.2009.10400671; Kovacs GG, 2007, NEUROPATH APPL NEURO, V33, P193, DOI 10.1111/j.1365-2990.2006.00790.x; Krebs TS, 2008, ARCH GEN PSYCHIAT, V65, P236, DOI 10.1001/archgenpsychiatry.2007.36; Kuypers KPC, 2013, BRIT J PHARMACOL, V168, P607, DOI 10.1111/j.1476-5381.2012.02196.x; Kuypers KPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100719; Kuypers KPC, 2005, J PSYCHOPHARMACOL, V19, P633, DOI 10.1177/0269881105056670; Laws KR, 2007, HUM PSYCHOPHARM CLIN, V22, P381, DOI 10.1002/hup.857; Linssen AMW, 2014, EUR NEUROPSYCHOPHARM, V24, P200, DOI 10.1016/j.euroneuro.2013.09.009; Linssen AMW, 2012, PSYCHOPHARMACOLOGY, V221, P611, DOI 10.1007/s00213-011-2605-9; Linssen AMW, 2011, J PSYCHOPHARMACOL, V25, P230, DOI 10.1177/0269881109348160; McGuire P, 2000, TOXICOL LETT, V112, P153, DOI 10.1016/S0378-4274(99)00219-2; Mograbi DC, 2014, ANN INDIAN ACAD NEUR, V17, P71, DOI 10.4103/0972-2327.128558; Mohamed WMY, 2011, PHARMACOL BIOCHEM BE, V99, P759, DOI 10.1016/j.pbb.2011.06.032; Morey R. D., 2009, BAYESFACTOR R PACKAG, P10; Nulsen CE, 2010, NEUROPSYCHOL REV, V20, P21, DOI 10.1007/s11065-009-9124-z; Parrott AC, 1998, J PSYCHOPHARMACOL, V12, P79, DOI 10.1177/026988119801200110; Parrott AC, 2013, NEUROSCI BIOBEHAV R, V37, P1466, DOI 10.1016/j.neubiorev.2013.04.016; Perna EBDF, 2014, NEUROPHARMACOLOGY, V87, P198, DOI 10.1016/j.neuropharm.2014.03.008; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pinheiro J., 2007, R PACKAGE VERSION, V3, P57; RCore Team, 2020, R LANG ENV STAT COMP; Reneman L, 2001, LANCET, V358, P1864, DOI 10.1016/S0140-6736(01)06888-X; Rey A., 1958, CLIN EXAMINATION PSY; ROGERS G, 2009, HLTH TECHNOLOGY ASSE, V13, P354; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Roxburgh A., 2013, TRENDS DRUG USE RELA; Schilt T, 2007, ARCH GEN PSYCHIAT, V64, P728, DOI 10.1001/archpsyc.64.6.728; Shariati MBH, 2014, BASIC CLIN NEUROSCI, V5, P225; Smirnov A, 2013, ADDICT BEHAV, V38, P2667, DOI 10.1016/j.addbeh.2013.06.018; Team RC, 2015, R LANG ENV STAT COMP; van Wel JHP, 2011, NEUROPSYCHOPHARMACOL, V36, P1932, DOI 10.1038/npp.2011.80; Wagner D, 2013, ADDICTION, V108, P136, DOI 10.1111/j.1360-0443.2012.03977.x; Watkins TJ, 2013, PSYCHOPHARMACOLOGY, V227, P41, DOI 10.1007/s00213-012-2936-1	57	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149438	10.1371/journal.pone.0149438	http://dx.doi.org/10.1371/journal.pone.0149438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26907605	gold, Green Published			2022-12-27	WOS:000371163000010
J	Hatakeyama, S; Koie, T; Narita, T; Hosogoe, S; Yamamoto, H; Tobisawa, Y; Yoneyama, T; Yoneyama, T; Hashimoto, Y; Ohyama, C				Hatakeyama, Shingo; Koie, Takuya; Narita, Takuma; Hosogoe, Shogo; Yamamoto, Hayato; Tobisawa, Yuki; Yoneyama, Tohru; Yoneyama, Takahiro; Hashimoto, Yasuhiro; Ohyama, Chikara			Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer	PLOS ONE			English	Article							SHORT ILEAL SEGMENT; RADICAL CYSTECTOMY; ORTHOTOPIC NEOBLADDER; CONDUIT; HYDRONEPHROSIS; EXPERIENCE; CONTINENT; GRADE	Objectives To assess the effects of urinary diversion on renal function, we retrospectively investigated renal function over 5 years after urinary diversion using a propensity score matching strategy. Methods Between May 1996 and November 2013, 345 consecutive adult patients underwent radical cystectomy and urinary diversion in our hospital; one hundred and fifteen patients with more than a 5-year follow-up were enrolled. Propensity scores were calculated using logistic analysis, and the data used in the analyses included age, gender, Eastern Cooperative Oncology Group Performance Status (ECOG-PS), clinical tumor stage, presence of cardiovascular disease; hypertension; and type 2 diabetes and preoperative eGFR at the initial visit. Multivariate logistic regression analysis was used to assess the risk factors for stage 3B chronic kidney disease (CKD) after the different types of urinary diversion. Results Continent and incontinent diversion were performed in 68 and 47 patients, respectively. The mean preoperative eGFR was significantly lower in the incontinent than in the continent group (P < 0.001). In propensity score-matched patients (n = 34 each), no significant differences were observed in pre- and postoperative eGFR and 5-year eGFR decrease rates between the groups. In the incontinent group, the number of postoperative stage 3B CKD patients was significantly increased than the continent group. Using multivariate analysis, independent risk factors significantly associated with stage 3B CKD at 5 years after surgery were older age, eGFR before surgery, incontinent diversion (cutaneous ureterostomy), and postoperative hydronephrosis. Conclusions The types of urinary diversion had no significant impact on renal function decline, whereas older age, preexisting impaired renal function, postoperative hydronephrosis, and cutaneous ureterostomy were independent risk factors for stage 3B CKD at 5 years after radical cystectomy.	[Hatakeyama, Shingo; Koie, Takuya; Narita, Takuma; Hosogoe, Shogo; Yamamoto, Hayato; Tobisawa, Yuki; Yoneyama, Takahiro; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan; [Yoneyama, Tohru; Hashimoto, Yasuhiro; Ohyama, Chikara] Hirosaki Univ, Grad Sch Med, Dept Adv Transplant & Regenerat Med, Hirosaki, Aomori, Japan	Hirosaki University; Hirosaki University	Hatakeyama, S (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan.	shingorilla2@gmail.com	Hatakeyama, Shingo/AAQ-2583-2020; Yoneyama, Tohru/P-7820-2016; Yoneyama, Tohru/ABG-2670-2020; Hatakeyama, Shingo/E-9234-2013; Narita, Takuma/AAV-1693-2021; Tobisawa, Yuki/G-3802-2014	Hatakeyama, Shingo/0000-0002-0026-4079; Yoneyama, Tohru/0000-0002-1098-407X; Narita, Takuma/0000-0003-2572-3590; Tobisawa, Yuki/0000-0001-8026-9541; Hashimoto, Yasuhiro/0000-0003-0967-6835	Japan Society for the Promotion of Science [23791737]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for Scientific Research No. 23791737 from the Japan Society for the Promotion of Science. URL: https://www.jsps.go.jp/english/index.html.	Aleksic P, 2010, INT J UROL, V17, P768, DOI 10.1111/j.1442-2042.2010.02599.x; BRICKER EM, 1950, SURG CLIN N AM, V30, P1511; Canter D, 2011, UROLOGY, V77, P160, DOI 10.1016/j.urology.2010.03.091; Cho KS, 2007, UROLOGY, V70, P662, DOI 10.1016/j.urology.2007.06.1106; COLOGNE JB, 1995, EPIDEMIOLOGY, V6, P271, DOI 10.1097/00001648-199505000-00014; Eisenberg MS, 2014, J UROLOGY, V191, P619, DOI 10.1016/j.juro.2013.09.011; Gershman B, 2015, INT J UROL, V22, P651, DOI 10.1111/iju.12770; Hautmann RE, 2003, J UROLOGY, V169, P834, DOI 10.1097/01.ju.0000029010.97686.eb; Hautmann RE, 2007, UROLOGY, V69, P17, DOI 10.1016/j.urology.2006.05.058; Hautmann RE, 2011, J UROLOGY, V185, P2207, DOI 10.1016/j.juro.2011.02.006; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ito Y, 2011, J UROLOGY, V185, P1621, DOI 10.1016/j.juro.2010.12.035; Jin XD, 2012, EUR UROL, V61, P491, DOI 10.1016/j.eururo.2011.09.004; Jonsson O, 2001, EUR UROL, V40, P632, DOI 10.1159/000049849; Koie T, 2012, EJSO-EUR J SURG ONC, V38, P1101, DOI 10.1016/j.ejso.2012.07.115; Koie T, 2006, INT J UROL, V13, P1175, DOI 10.1111/j.1442-2042.2006.01525.x; Koie T, 2013, INT J CLIN ONCOL, V18, P724, DOI 10.1007/s10147-012-0447-z; Koie T, 2010, INT J UROL, V17, P774, DOI [10.1111/j.1442-2042.2010.02600.x, 10.1111/j.1442-2042.2010.02601.x]; Koie T, 2010, UROLOGY, V75, P1499, DOI 10.1016/j.urology.2009.08.083; Kristjansson A, 1999, BJU INT, V84, P905; Lawrentschuk N, 2010, EUR UROL, V57, P983, DOI 10.1016/j.eururo.2010.02.024; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Osawa T, 2013, UROL J, V10, P784; Samuel JD, 2006, J UROLOGY, V176, P2518, DOI 10.1016/j.juro.2006.07.146; Shabsigh A, 2009, EUR UROL, V55, P164, DOI 10.1016/j.eururo.2008.07.031; Shimko MS, 2011, J UROLOGY, V185, P562, DOI 10.1016/j.juro.2010.09.096; Sobin L, 2009, TNM CLASSIFICATION M; TOYODA Y, 1977, J UROLOGY, V117, P276, DOI 10.1016/S0022-5347(17)58431-1; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	30	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149544	10.1371/journal.pone.0149544	http://dx.doi.org/10.1371/journal.pone.0149544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901860	gold, Green Published			2022-12-27	WOS:000371276100095
J	Herland, A; van der Meer, AD; FitzGerald, EA; Park, TE; Sleeboom, JJF; Ingber, DE				Herland, Anna; van der Meer, Andries D.; FitzGerald, Edward A.; Park, Tae-Eun; Sleeboom, Jelle J. F.; Ingber, Donald E.			Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip	PLOS ONE			English	Article							IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; G-CSF; CEREBRAL-ISCHEMIA; SHEAR-STRESS; TNF-ALPHA; PERMEABILITY; INTERLEUKIN-6; INFLAMMATION; PHYSIOLOGY	Neurovascular inflammation is a major contributor to many neurological disorders, but modeling these processes in vitro has proven to be difficult. Here, we microengineered a three-dimensional (3D) model of the human blood-brain barrier (BBB) within a microfluidic chip by creating a cylindrical collagen gel containing a central hollow lumen inside a micro-channel, culturing primary human brain microvascular endothelial cells on the gel's inner surface, and flowing medium through the lumen. Studies were carried out with the engineered microvessel containing endothelium in the presence or absence of either primary human brain pericytes beneath the endothelium or primary human brain astrocytes within the surrounding collagen gel to explore the ability of this simplified model to identify distinct contributions of these supporting cells to the neuroinflammatory response. This human 3D BBB-on-a-chip exhibited barrier permeability similar to that observed in other in vitro BBB models created with non-human cells, and when stimulated with the inflammatory trigger, tumor necrosis factor-alpha (TNF-alpha), different secretion profiles for granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6) were observed depending on the presence of astrocytes or pericytes. Importantly, the levels of these responses detected in the 3D BBB chip were significantly greater than when the same cells were co-cultured in static Transwell plates. Thus, as G-CSF and IL-6 have been reported to play important roles in neuroprotection and neuroactivation in vivo, this 3D BBB chip potentially offers a new method to study human neurovascular function and inflammation in vitro, and to identify physiological contributions of individual cell types.	[Herland, Anna; van der Meer, Andries D.; FitzGerald, Edward A.; Park, Tae-Eun; Sleeboom, Jelle J. F.; Ingber, Donald E.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ingber, Donald E.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Ingber, Donald E.] Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA USA	Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Harvard Univ, John A Paulson Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Ingber, DE (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.; Ingber, DE (corresponding author), Boston Childrens Hosp, Dept Surg, Vasc Biol Program, Boston, MA USA.	don.ingber@wyss.harvard.edu	van der Meer, Andries/A-6131-2011; van der Meer, Andries/L-2449-2019; Ingber, Donald E/AAC-5894-2019	van der Meer, Andries/0000-0002-8761-4077; van der Meer, Andries/0000-0002-8761-4077; FitzGerald, Edward A./0000-0002-0603-1241; Park, Tae-Eun/0000-0003-3979-5405; Herland, Anna/0000-0002-5002-2537	Defense Advanced Research Projects Agency [W911NF-12-2-0036]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Sverige-Amerika Stiftelsen; Carl Trygger Stiftelse; Erik och Edith Fernstrom's stiftelse; KTH opportunities fund	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Wyss Institute for Biologically Inspired Engineering at Harvard University; Sverige-Amerika Stiftelsen; Carl Trygger Stiftelse; Erik och Edith Fernstrom's stiftelse; KTH opportunities fund	This work was supported by the Defense Advanced Research Projects Agency under Cooperative Agreement Number W911NF-12-2-0036 and the Wyss Institute for Biologically Inspired Engineering at Harvard University. The content of the information does not necessarily reflect the position or the policy of the Defense Advanced Research Projects Agency or the U.S. Government and no official endorsement should be inferred. Additional funding was provided by Sverige-Amerika Stiftelsen [http://sweamfo.se], Carl Trygger Stiftelse [http://www.carltryggersstiftelse.se], Erik och Edith Fernstrom's stiftelse [https://internwebben.ki.se/en/erik-and-edith-fernstrom-foundation-medical-research] (AH) and KTH opportunities fund [https://www.kth.se/en/opportunities] (EAF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Achyuta AKH, 2013, LAB CHIP, V13, P542, DOI 10.1039/c2lc41033h; Alcendor DJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-95; ALOISI F, 1992, J IMMUNOL, V149, P2358; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bell RD, 2009, ACTA NEUROPATHOL, V118, P103, DOI 10.1007/s00401-009-0522-3; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Bischel LL, 2012, JALA-J LAB AUTOM, V17, P96, DOI 10.1177/2211068211426694; Booth R, 2014, ANN BIOMED ENG, V42, P2379, DOI 10.1007/s10439-014-1086-5; Booth R, 2012, LAB CHIP, V12, P1784, DOI 10.1039/c2lc40094d; Brown JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4934713; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chaudhuri A, 2008, J CEREBR BLOOD F MET, V28, P697, DOI 10.1038/sj.jcbfm.9600567; Cho H., 2015, SCI REPORTS, V5; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Cucullo L, 2002, BRAIN RES, V951, P243, DOI 10.1016/S0006-8993(02)03167-0; Cucullo L, 2008, J CEREBR BLOOD F MET, V28, P312, DOI 10.1038/sj.jcbfm.9600525; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Cucullo L, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-40; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DELI MA, 1995, J NEUROSCI RES, V41, P717, DOI 10.1002/jnr.490410602; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Deosarkar SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142725; Dong B, 2010, COMPUT FLUIDS, V39, P768, DOI 10.1016/j.compfluid.2009.12.005; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Fee D, 2000, CYTOKINE, V12, P655, DOI 10.1006/cyto.1999.0599; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Gaillard PJ, 2001, EUR J PHARM SCI, V12, P215, DOI 10.1016/S0928-0987(00)00123-8; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Griep LM, 2013, BIOMED MICRODEVICES, V15, P145, DOI 10.1007/s10544-012-9699-7; Hasan A, 2015, BIOMED MICRODEVICES, V17, DOI 10.1007/s10544-015-9993-2; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Hofman FM, 1999, J NEUROIMMUNOL, V94, P28, DOI 10.1016/S0165-5728(98)00198-2; HUXLEY VH, 1987, AM J PHYSIOL, V252, pH188, DOI 10.1152/ajpheart.1987.252.1.H188; Jansson D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-104; Jones SA, 2005, J IMMUNOL, V175, P3463, DOI 10.4049/jimmunol.175.6.3463; Kang QJ, 2004, ADV WATER RESOUR, V27, P13, DOI 10.1016/j.advwatres.2003.10.002; Kim D, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4816934; Kim JA, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4917508; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Kossmann T, 1997, J CEREBR BLOOD F MET, V17, P280, DOI 10.1097/00004647-199703000-00005; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Kuo YC, 2011, COLLOID SURFACE B, V86, P225, DOI 10.1016/j.colsurfb.2011.04.005; Mabondzo A, 2010, MOL PHARMACEUT, V7, P1805, DOI 10.1021/mp1002366; Minagar A, 2003, MULT SCLER J, V9, P540, DOI 10.1191/1352458503ms965oa; Moya ML, 2013, TISSUE ENG PART C-ME, V19, P730, DOI [10.1089/ten.tec.2012.0430, 10.1089/ten.TEC.2012.0430]; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Nehme A, 2008, INVEST OPHTH VIS SCI, V49, P2030, DOI 10.1167/iovs.07-0273; Penkowa M, 2000, GLIA, V32, P271, DOI 10.1002/1098-1136(200012)32:3<271::AID-GLIA70>3.0.CO;2-5; Prabhakarpandian B, 2013, LAB CHIP, V13, P1093, DOI 10.1039/c2lc41208j; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Santaguida S, 2006, BRAIN RES, V1109, P1, DOI 10.1016/j.brainres.2006.06.027; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sellgren KL, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4935594; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Shibata K, 2008, JPN J APPL PHYS, V47, P5208, DOI 10.1143/JJAP.47.5208; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Swartz KR, 2001, BRAIN RES, V896, P86, DOI 10.1016/S0006-8993(01)02013-3; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; Thomsen LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134765; Trickler WJ, 2014, DRUG METAB REV, V46, P224, DOI 10.3109/03602532.2013.873450; Urich E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01500; van der Helm MW, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1142493; van der Meer AD, 2013, LAB CHIP, V13, P3562, DOI 10.1039/c3lc50435b; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Veszelka S, 2007, NEUROCHEM INT, V50, P219, DOI 10.1016/j.neuint.2006.08.006; Villa P, 2007, MOL MED, V13, P125, DOI 10.2119/2007-00008.Villa; Walter FR, 2016, SENSOR ACTUAT B-CHEM, V222, P1209, DOI 10.1016/j.snb.2015.07.110; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolburg H, 2003, ACTA NEUROPATHOL, V105, P586, DOI 10.1007/s00401-003-0688-z; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Xiao BG, 2007, J CELL MOL MED, V11, P1272, DOI 10.1111/j.1582-4934.2007.00101.x; Yeon JH, 2012, BIOMED MICRODEVICES, V14, P1141, DOI 10.1007/s10544-012-9680-5; Yeon JH, 2012, LAB CHIP, V12, P2815, DOI [10.1039/c2lc40131b, 10.1039/C2LC40131B]; Yousefzadeh-Chabok S, 2015, ARCH TRAUMA RES, V4, DOI 10.5812/atr.18357; Yuan W, 2009, MICROVASC RES, V77, P166, DOI 10.1016/j.mvr.2008.08.004; ZSEBO KM, 1988, BLOOD, V71, P99	84	236	241	15	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0150360	10.1371/journal.pone.0150360	http://dx.doi.org/10.1371/journal.pone.0150360			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930059	gold, Green Published			2022-12-27	WOS:000371434500133
J	Mavaddat, N; van der Linde, R; Parker, R; Savva, G; Kinmonth, AL; Brayne, C; Mant, J				Mavaddat, Nahal; van der Linde, Rianne; Parker, Richard; Savva, George; Kinmonth, Ann Louise; Brayne, Carol; Mant, Jonathan			Relationship of Self-Rated Health to Stroke Incidence and Mortality in Older Individuals with and without a History of Stroke: A Longitudinal Study of the MRC Cognitive Function and Ageing (CFAS) Population	PLOS ONE			English	Article							RISK-FACTORS; COHORT; RATINGS; DETERMINES; COMMUNITY; ABILITY; ONSET; MEN	Introduction Poor self-rated health (SRH) has been associated with increased risk of death and poor health outcomes even after adjusting for confounders. However its' relationship with disease-specific mortality and morbidity has been less studied. SRH may also be particularly predictive of health outcomes in those with pre-existing conditions. We studied whether SRH predicts new stroke in older people who have never had a stroke, or a recurrence in those with a prior history of stroke. Methods MRC CFAS I is a multicentre cohort study of a population representative sample of people in their 65th year and older. A comprehensive interview at baseline included questions about presence of stroke, self-rated health and functional disability. Follow-up at 2 years included self-report of stroke and stroke death obtained from death certificates. Multiple logistical regression determined odds of stroke at 2 years adjusting for confounders including disability and health behaviours. Survival analysis was performed until June 2014 with follow-up for up to 13 years. Results 11,957 participants were included, of whom 11,181 (93.8%) had no history of stroke and 776 (6.2%) one or more previous strokes. Fewer with no history of stroke reported poor SRH than those with stroke (5 versus 21%). In those with no history of stroke, poor self-rated health predicted stroke incidence (OR 1.5 (1.1-1.9)), but not stroke mortality (OR 1.2 (0.8-1.9)) at 2 years nor for up to 13 years (OR 1.2(0.9-1.7)). In those with a history of stroke, self-rated health did not predict stroke incidence (OR 0.9(0.6-1.4)), stroke mortality (OR 1.1(0.5-2.5)), or survival (OR 1.1(0.6-2.1)). Conclusions Poor self-rated health predicts risk of stroke at 2 years but not stroke mortality among the older population without a previous history of stroke. SRH may be helpful in predicting who may be at risk of developing a stroke in the near future.	[Mavaddat, Nahal; Kinmonth, Ann Louise; Mant, Jonathan] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Worts Causeway, Cambridge CB1 8RN, England; [van der Linde, Rianne; Brayne, Carol] Univ Cambridge, Dept Publ Hlth & Primary Care, Inst Publ Hlth, Univ Forvie Site,Robinson Way, Cambridge CB2 0SR, England; [Parker, Richard] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Hlth Serv Res Unit, Edinburgh, Midlothian, Scotland; [Savva, George] Univ E Anglia, Sch Hlth Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	University of Cambridge; University of Edinburgh; University of East Anglia	Mavaddat, N (corresponding author), Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Worts Causeway, Cambridge CB1 8RN, England.	nm212@medschl.cam.ac.uk	Savva, George M/E-9670-2011; Brayne, Carol/AAA-4285-2020	Savva, George M/0000-0001-9190-124X; Brayne, Carol/0000-0001-5307-663X	Medical Research Council [MRC/G9901400]; Department of Health; National Institute for Health Research (NIHR) Walport Clinical Lectureship in Primary Care Research; Medical Research Council [G9901400, G0601022] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10121, CL-2008-14-006, NF-SI-0611-10084] Funding Source: researchfish; MRC [G0601022, G9901400] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; National Institute for Health Research (NIHR) Walport Clinical Lectureship in Primary Care Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The MRC CFAS I Study has had funding by major awards from the Medical Research Council (MRC/G9901400) and Department of Health. NM was funded by a National Institute for Health Research (NIHR) Walport Clinical Lectureship in Primary Care Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Boden-Albala B, 2000, Curr Atheroscler Rep, V2, P160, DOI 10.1007/s11883-000-0111-3; Brayne C, 2006, INT J EPIDEMIOL, V35, P1140, DOI 10.1093/ije/dyl199; Elias P, 1993, CASOC COMPUTER ASSIS; Emmelin M, 2003, J HYPERTENS, V21, P887, DOI 10.1097/00004872-200305000-00012; Fang Xiang-hua, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P184; Fernandez-Ruiz M, 2013, GERONTOLOGY, V59, P368, DOI 10.1159/000348781; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hillen T, 2003, J EPIDEMIOLOGY COMMU, V57, P960; Hoeymans N, 1999, J GERONTOL A-BIOL, V54, pM501, DOI 10.1093/gerona/54.10.M501; Idler E, 2004, J HEALTH SOC BEHAV, V45, P336, DOI 10.1177/002214650404500307; IDLER EL, 1995, J GERONTOL B-PSYCHOL, V50, pS344, DOI 10.1093/geronb/50B.6.S344; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kaplan G, 2003, SOC SCI MED, V56, P1669, DOI 10.1016/S0277-9536(02)00179-X; Latham K, 2013, J GERONTOL B-PSYCHOL, V68, P107, DOI 10.1093/geronb/gbs104; MANSON JE, 1991, ARCH INTERN MED, V151, P1141, DOI 10.1001/archinte.151.6.1141; Mavaddat N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103509; Mavaddat N, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-85; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Simons LA, 1998, STROKE, V29, P1341, DOI 10.1161/01.STR.29.7.1341; Singh-Manoux A, 2006, J EPIDEMIOL COMMUN H, V60, P364, DOI 10.1136/jech.2005.039883; TSUJI I, 1994, J AM GERIATR SOC, V42, P153, DOI 10.1111/j.1532-5415.1994.tb04944.x; World Health Organization, 2006, WHO STEPS STROK MAN	23	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 29	2016	11	2							e0150178	10.1371/journal.pone.0150178	http://dx.doi.org/10.1371/journal.pone.0150178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF5WU	26928666	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000371424200024
J	Dore, S; Fry, DL; Collins, BM; Vargas, R; York, RA; Stephens, SL				Dore, Sabina; Fry, Danny L.; Collins, Brandon M.; Vargas, Rodrigo; York, Robert A.; Stephens, Scott L.			Management Impacts on Carbon Dynamics in a Sierra Nevada Mixed Conifer Forest	PLOS ONE			English	Article							PONDEROSA PINE PLANTATION; SOIL CO2 EFFLUX; FUEL REDUCTION TREATMENTS; PRESCRIBED FIRE; THINNING TREATMENT; TREE MORTALITY; NATIONAL FIRE; DRY FORESTS; CLEAR-CUT; RESPIRATION	Forest ecosystems can act as sinks of carbon and thus mitigate anthropogenic carbon emissions. When forests are actively managed, treatments can alter forests carbon dynamics, reducing their sink strength and switching them from sinks to sources of carbon. These effects are generally characterized by fast temporal dynamics. Hence this study monitored for over a decade the impacts of management practices commonly used to reduce fire hazards on the carbon dynamics of mixed-conifer forests in the Sierra Nevada, California, USA. Soil CO2 efflux, carbon pools (i.e. soil carbon, litter, fine roots, tree biomass), and radial tree growth were compared among un-manipulated controls, prescribed fire, thinning, thinning followed by fire, and two clear-cut harvested sites. Soil CO2 efflux was reduced by both fire and harvesting (ca. 15%). Soil carbon content (upper 15 cm) was not significantly changed by harvest or fire treatments. Fine root biomass was reduced by clear-cut harvest (60-70%) but not by fire, and the litter layer was reduced 80% by clear-cut harvest and 40% by fire. Thinning effects on tree growth and biomass were concentrated in the first year after treatments, whereas fire effects persisted over the seven-year post-treatment period. Over this period, tree radial growth was increased (25%) by thinning and reduced (12%) by fire. After seven years, tree biomass returned to pre-treatment levels in both fire and thinning treatments; however, biomass and productivity decreased 30%-40% compared to controls when thinning was combined with fire. The clear-cut treatment had the strongest impact, reducing ecosystem carbon stocks and delaying the capacity for carbon uptake. We conclude that post-treatment carbon dynamics and ecosystem recovery time varied with intensity and type of treatments. Consequently, management practices can be selected to minimize ecosystem carbon losses while increasing future carbon uptake, resilience to high severity fire, and climate related stresses.	[Dore, Sabina; Fry, Danny L.; York, Robert A.; Stephens, Scott L.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Collins, Brandon M.] US Forest Serv, USDA, Pacific Southwest Res Stn, Davis, CA USA; [Collins, Brandon M.] Univ Calif Berkeley, Ctr Fire Res & Outreach, Coll Nat Resources, Berkeley, CA 94720 USA; [Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA; [York, Robert A.] Univ Calif Berkeley, Ctr Forestry, Georgetown, CA USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA); United States Forest Service; University of California System; University of California Berkeley; University of Delaware; University of California System; University of California Berkeley	Dore, S (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	sabina.dore@gmail.com	Vargas, Rodrigo/C-4720-2008	Vargas, Rodrigo/0000-0001-6829-5333; York, Robert/0000-0002-1277-8704	Joint Fire Sciences Program Project [10-1-10-21]; USDA [2014-67003-22070]	Joint Fire Sciences Program Project; USDA(United States Department of Agriculture (USDA))	This work was supported by the Joint Fire Sciences Program Project #10-1-10-21, received by SS. RV acknowledges partial support from USDA (2014-67003-22070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Campbell JL, 2011, FRONTIERS ECOLOGY EN; Campbell J, 2009, FOREST ECOL MANAG, V257, P453, DOI 10.1016/j.foreco.2008.09.021; Collins BM, 2014, ECOL APPL, V24, P1879, DOI 10.1890/14-0971.1; Concilio A, 2006, FOREST ECOL MANAG, V228, P82, DOI 10.1016/j.foreco.2006.02.029; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; Dore S, 2014, FOREST ECOL MANAG, V319, P150, DOI 10.1016/j.foreco.2014.02.012; Dore S, 2012, GLOBAL CHANGE BIOL, V18, P3171, DOI 10.1111/j.1365-2486.2012.02775.x; Finkral AJ, 2008, FOREST ECOL MANAG, V255, P2743, DOI 10.1016/j.foreco.2008.01.041; Grady KC, 2006, FOREST ECOL MANAG, V234, P123, DOI 10.1016/j.foreco.2006.06.031; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Hartsough BR, 2008, FOREST POLICY ECON, V10, P344, DOI 10.1016/j.forpol.2008.02.001; Hessburg PF, 2005, FOREST ECOL MANAG, V211, P117, DOI 10.1016/j.foreco.2005.02.016; Hirano T, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003766; Houghton J.T., 1990, CLIMATE CHANGE IPCC; Humphreys ER, 2006, AGR FOREST METEOROL, V140, P6, DOI 10.1016/j.agrformet.2006.03.018; Hurteau MD, 2011, BIOSCIENCE, V61, P139, DOI 10.1525/bio.2011.61.2.9; Irvine J, 2007, GLOBAL CHANGE BIOL, V13, P1748, DOI 10.1111/j.1365-2486.2007.01368.x; Jassal R, 2005, AGR FOREST METEOROL, V130, P176, DOI 10.1016/j.agrformet.2005.03.005; Jenkins JC, 2003, FOREST SCI, V49, P12; Kobziar LN, 2006, AGR FOREST METEOROL, V141, P161, DOI 10.1016/j.agrformet.2006.09.008; Laudenslayer W.F., 1990, T W SECTION WILDLIFE, V26, P12; Ma SY, 2004, ENVIRON MANAGE, V33, pS148, DOI 10.1007/s00267-003-9125-2; McIver J, 2009, ECOL APPL, V19, P283, DOI 10.1890/07-1785.1; Metlen KL, 2004, NORTHWEST SCI, V78, P175; Miesel JR, 2012, FOREST ECOL MANAG, V284, P163, DOI 10.1016/j.foreco.2012.07.054; Misson L, 2005, AGR FOREST METEOROL, V130, P207, DOI 10.1016/j.agrformet.2005.04.001; Moghaddas JJ, 2007, INT J WILDLAND FIRE, V16, P673, DOI 10.1071/WF06066; Ngao J, 2012, AGR FOREST METEOROL, V154, P136, DOI 10.1016/j.agrformet.2011.11.003; North M, 2009, ECOL APPL, V19, P1385, DOI 10.1890/08-1173.1; Olson CM, 1996, FOREST GROWTH STAND, VIII, P681; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Peng YY, 2008, ENVIRON REV, V16, P93, DOI 10.1139/A08-003; Reichstein M, 2002, FUNCT ECOL, V16, P27, DOI 10.1046/j.0269-8463.2001.00597.x; Restaino JC, 2013, FOREST ECOL MANAG, V303, P46, DOI 10.1016/j.foreco.2013.03.043; Savage KE, 2003, J EXP BOT, V54, P891, DOI 10.1093/jxb/erg121; Smith TF, 2005, FOREST SCI, V51, P266; Stark DT, 2013, FOREST ECOL MANAG, V306, P61, DOI 10.1016/j.foreco.2013.06.018; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Stephens SL, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00289.1; Stephens SL, 2009, CAN J FOREST RES, V39, P1538, DOI 10.1139/X09-081; Stephens SL, 2005, FOREST ECOL MANAG, V215, P21, DOI 10.1016/j.foreco.2005.03.070; Stephens SL, 2004, NORTHWEST SCI, V78, P12; Stewart-Oaten A, 2001, ECOL MONOGR, V71, P305, DOI 10.1890/0012-9615(2001)071[0305:TASVIE]2.0.CO;2; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Sullivan B, 2008, FOREST ECOL MANAG, V255, P4047, DOI 10.1016/j.foreco.2008.03.051; Tang JW, 2005, AGR FOREST METEOROL, V132, P212, DOI 10.1016/j.agrformet.2005.07.011; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Vargas R, 2010, ECOL APPL, V20, P1569, DOI 10.1890/09-0693.1; Wagner F., 2003, IPCC GOOD PRACTICE G; Williams CA, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003947; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x	55	8	8	8	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150256	10.1371/journal.pone.0150256	http://dx.doi.org/10.1371/journal.pone.0150256			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918460	Green Published, gold			2022-12-27	WOS:000371274400110
J	Karch, CM; Ezerskiy, LA; Bertelsen, S; Goate, AM				Karch, Celeste M.; Ezerskiy, Lubov A.; Bertelsen, Sarah; Goate, Alison M.		ADGC	Alzheimer's Disease Risk Polymorphisms Regulate Gene Expression in the ZCWPW1 and the CELF1 Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; COMMON VARIANTS; PILR-ALPHA; PROTEIN; CD33; PICALM; CELLS; CD2AP; EPHA1	Late onset Alzheimer's disease (LOAD) is a genetically complex and clinically heterogeneous disease. Recent large-scale genome wide association studies (GWAS) have identified more than twenty loci that modify risk for AD. Despite the identification of these loci, little progress has been made in identifying the functional variants that explain the association with AD risk. Thus, we sought to determine whether the novel LOAD GWAS single nucleotide polymorphisms (SNPs) alter expression of LOAD GWAS genes and whether expression of these genes is altered in AD brains. The majority of LOAD GWAS SNPs occur in gene dense regions under large linkage disequilibrium (LD) blocks, making it unclear which gene(s) are modified by the SNP. Thus, we tested for brain expression quantitative trait loci (eQTLs) between LOAD GWAS SNPs and SNPs in high LD with the LOAD GWAS SNPs in all of the genes within the GWAS loci. We found a significant eQTL between rs1476679 and PILRB and GATS, which occurs within the ZCWPW1 locus. PILRB and GATS expression levels, within the ZCWPW1 locus, were also associated with AD status. Rs7120548 was associated with MTCH2 expression, which occurs within the CELF1 locus. Additionally, expression of several genes within the CELF1 locus, including MTCH2, were highly correlated with one another and were associated with AD status. We further demonstrate that PILRB, as well as other genes within the GWAS loci, are most highly expressed in microglia. These findings together with the function of PILRB as a DAP12 receptor supports the critical role of microglia and neuroinflammation in AD risk.	[Karch, Celeste M.; Ezerskiy, Lubov A.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Karch, Celeste M.] Washington Univ, Sch Med, Hope Ctr, Program Prot Aggregat & Neurodegenerat, St Louis, MO 63110 USA; [Bertelsen, Sarah; Goate, Alison M.] Icahn Sch Med Mt Sinai, Dept Neurosci, 1425 Madison Ave, New York, NY 10029 USA	Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai	Karch, CM (corresponding author), Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA.; Karch, CM (corresponding author), Washington Univ, Sch Med, Hope Ctr, Program Prot Aggregat & Neurodegenerat, St Louis, MO 63110 USA.; Goate, AM (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, 1425 Madison Ave, New York, NY 10029 USA.	karchc@psychiatry.wustl.edu; alison.goate@mssm.edu	Tsuang, Debby/L-7234-2016; Hardy, John/C-2451-2009; Saykin, Andrew/A-1318-2007	Tsuang, Debby/0000-0002-4716-1894; Hardy, John/0000-0002-3122-0423; Lin, Chiao-Feng/0000-0002-6177-8807; Saykin, Andrew/0000-0002-1376-8532; Lunetta, Kathryn/0000-0002-9268-810X; DeKosky, Steven/0000-0003-3743-2758; Goate, Alison/0000-0002-0576-2472; Ezerskiy, Lubov/0000-0002-1869-0658; Demirci, F. Yesim/0000-0001-6907-9843; Barmada, M Michael/0000-0002-3604-6460; Cao, Chuanhai/0000-0002-5765-6401; Kamboh, M. Ilyas/0000-0002-3453-1438; Buxbaum, Joseph/0000-0001-8898-8313; Poon, Wayne/0000-0003-0625-3968; Karch, Celeste/0000-0002-6854-5547; Leverenz, James/0000-0002-0896-0749	Barnes Jewish Foundation; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm; Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council [503480]; Alzheimer's Research UK [503176]; Wellcome Trust [082604/2/07/Z]; German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) [01GI0102, 01GI0711, 01GI0420]; NIH/NIA [R01 AG033193, U01 AG032984, U24 AG021886, U01 AG016976]; NIA [AG081220, AG041232]; AGES [N01-AG-12100]; NHLBI [R01 HL105756]; Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association [ADGC-10-196728, IIRG-08-89720, IIRG-05-14147]; National Institutes of Health, National Institute on Aging (NIH-NIA) [U01 AG032984, ADGC, RC2 AG036528]; National Institute on Aging (NIA) [U24 AG21886]; NINDS [NS39764]; NIMH [MH60451]; Glaxo Smith Kline; Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council; state of Arizona; NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; National Institutes of Health [U01 AG024904]; Department of Defense [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health Research;  [NIH-AG035083];  [NIH-AG049508];  [NIH-AG046374]; NATIONAL CANCER INSTITUTE [R01CA129769] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451, R01MH080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764, R01NS059873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010124, P30AG012300, P30AG008051, P01AG010491, P30AG010133, P50AG005146, P50AG005144, P50AG005142, U01AG016976, P50AG008671, P50AG023501, P50AG005134, R01AG041797, P50AG008702, P30AG019610, U24AG041689, P01AG003991, P50AG005128, P50AG016570, P30AG010161, U01AG010483, R01AG026916, P30AG010129, R01AG020688, P50AG005138, P50AG005133, R01AG041232, P50AG005131, P01AG019724, P50AG025688, P50AG005136, P50AG016574, R01AG013616, R01AG035137, K01AG046374, R01AG030146, R01AG041718, R01AG022374, R01AG025259, U24AG021886, R01AG035083, U01AG032984, R01AG012101, R37AG015473, R01AG021547, P50AG016573, P01AG002219, P30AG013846, R01AG017173, R01AG027944, P30AG008017, U01AG024904, R01AG019757, U24AG026395, R01AG019085, R01AG031581, RC2AG036528, U01AG049508, P30AG013854, R01AG030653, P50AG033514, N01AG012100, P50AG016582, P30AG028377, R01AG007562, U01AG006781, RC2AG036502, P50AG005681, P30AG028383, R01AG033193, R01AG015819, R01AG017917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006849] Funding Source: NIH RePORTER	Barnes Jewish Foundation; French National Foundation on Alzheimer's disease and related disorders; LABEX (laboratory of excellence program investment for the future) DISTALZ grant; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut Pasteur de Lille, Universite de Lille 2; Lille University Hospital; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Wellcome Trust(Wellcome Trust); German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND)(Federal Ministry of Education & Research (BMBF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGES; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's Association(Alzheimer's Association); National Institutes of Health, National Institute on Aging (NIH-NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Glaxo Smith Kline(GlaxoSmithKline); Banner Alzheimer's Foundation; Johnnie B. Byrd Sr. Alzheimer's Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); state of Arizona; NHS trusts; Newcastle University; Higher Education Funding Council for England (HEFCE)(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Alzheimer's Research Trust (ART); BRACE; North Bristol NHS Trust Research and Innovation Department; DeNDRoN; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds; Internationale Stiching Alzheimer Onderzoek; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by NIH-AG035083 (AMG), NIH-AG049508 (AMG) NIH-AG046374 (CMK), and the Barnes Jewish Foundation (AMG). This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by NIH-AG035083 (AMG), NIH-AG049508 (AMG) NIH-AG046374 (CMK), and the Barnes Jewish Foundation (AMG). This work was supported by access to equipment made possible by the Hope Center for Neurological Disorders, and the Departments of Neurology and Psychiatry at Washington University School of Medicine.; We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for these analyses. The investigators within IGAP contributed to the design and implementation of IGAP and/or provided data but did not participate in analysis or writing of this report. IGAP was made possible by the generous participation of the control subjects, the patients, and their families. The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. EADI was supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant, Inserm, Institut Pasteur de Lille, Universite de Lille 2 and the Lille University Hospital. GERAD was supported by the Medical Research Council (Grant no 503480), Alzheimer's Research UK (Grant no 503176), the Wellcome Trust (Grant no 082604/2/07/Z) and German Federal Ministry of Education and Research (BMBF): Competence Network Dementia (CND) grant no 01GI0102, 01GI0711, 01GI0420. CHARGE was partly supported by the NIH/NIA grant R01 AG033193 and the NIA AG081220 and AGES contract N01-AG-12100, the NHLBI grant R01 HL105756, the Icelandic Heart Association, and the Erasmus Medical Center and Erasmus University. ADGC was supported by the NIH/NIA grants: U01 AG032984, U24 AG021886, U01 AG016976, and the Alzheimer's Association grant ADGC-10-196728.; The National Institutes of Health, National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; Samples from the National Cell Repository for Alzheimer's Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible; Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer's Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689-01); NACC, U01 AG016976; NIA LOAD, U24 AG026395, R01AG041797; Banner Sun Health Research Institute P30 AG019610; Boston University, P30 AG013846, U01 AG10483, R01 CA129769, R01 MH080295, R01 AG017173, R01 AG025259, R01AG33193; Columbia University, P50 AG008702, R37 AG015473; Duke University, P30 AG028377, AG05128; Emory University, AG025688; Group Health Research Institute, UO1 AG006781, UO1 HG004610, UO1 HG006375; Indiana University, P30 AG10133; Johns Hopkins University, P50 AG005146, R01 AG020688; Massachusetts General Hospital, P50 AG005134; Mayo Clinic, P50 AG016574; Mount Sinai School of Medicine, P50 AG005138, P01 AG002219; New York University, P30 AG08051, UL1 RR029893, 5R01AG012101, 5R01AG022374, 5R01AG013616, 1RC2AG036502, 1R01AG035137; Northwestern University, P30 AG013854; Oregon Health & Science University, P30 AG008017, R01 AG026916; Rush University, P30 AG010161, R01 AG019085, R01 AG15819, R01 AG17917, R01 AG30146; TGen, R01 NS059873; University of Alabama at Birmingham, P50 AG016582; University of Arizona, R01 AG031581; University of California, Davis, P30 AG010129; University of California, Irvine, P50 AG016573; University of California, Los Angeles, P50 AG016570; University of California, San Diego, P50 AG005131; University of California, San Francisco, P50 AG023501, P01 AG019724; University of Kentucky, P30 AG028383, AG05144; University of Michigan, P50 AG008671; University of Pennsylvania, P30 AG010124; University of Pittsburgh, P50 AG005133, AG030653, AG041718, AG07562, AG02365; University of Southern California, P50 AG005142; University of Texas Southwestern, P30 AG012300; University of Miami, R01 AG027944, AG010491, AG027944, AG021547, AG019757; University of Washington, P50 AG005136; University of Wisconsin, P50 AG033514; Vanderbilt University, R01 AG019085; and Washington University, P50 AG005681, P01 AG03991. The Kathleen Price Bryan Brain Bank at Duke University Medical Center is funded by NINDS grant # NS39764, NIMH MH60451 and by Glaxo Smith Kline. Genotyping of the TGEN2 cohort was supported by Kronos Science. The TGen series was also funded by NIA grant AG041232 to AJM and MJH, The Banner Alzheimer's Foundation, The Johnnie B. Byrd Sr.; Alzheimer's Institute, the Medical Research Council, and the state of Arizona and also includes samples from the following sites: Newcastle Brain Tissue Resource (funding via the Medical Research Council, local NHS trusts and Newcastle University), MRC London Brain Bank for Neurodegenerative Diseases (funding via the Medical Research Council), South West Dementia Brain Bank (funding via numerous sources including the Higher Education Funding Council for England (HEFCE), Alzheimer's Research Trust (ART), BRACE as well as North Bristol NHS Trust Research and Innovation Department and DeNDRoN), The Netherlands Brain Bank (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. ADNI data collection and sharing was funded by the National Institutes of Health Grant U01 AG024904 and Department of Defense award number W81XWH-12-2-0012. ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. We thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-officio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the US Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. P.S.G.-H. is supported by Wellcome Trust, Howard Hughes Medical Institute, and the Canadian Institute of Health Research.	Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; Escott-Price V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094661; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guerreiro RJ, 2012, NEUROBIOL AGING, V33, P437, DOI 10.1016/j.neurobiolaging.2010.03.025; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Karch CM, 2014, NEURON, V83, P11, DOI 10.1016/j.neuron.2014.05.041; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lu Q, 2014, P NATL ACAD SCI USA, V111, P8221, DOI 10.1073/pnas.1320716111; Malik M, 2013, J NEUROSCI, V33, P13320, DOI 10.1523/JNEUROSCI.1224-13.2013; Mousseau DD, 2000, J BIOL CHEM, V275, P4467, DOI 10.1074/jbc.275.6.4467; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rosenthal SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095152; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shiratori I, 2004, J EXP MED, V199, P525, DOI 10.1084/jem.20031885; Woulfe JM, 2002, BRAIN PATHOL, V12, P300; Wunderlich P, 2013, J BIOL CHEM, V288, P33027, DOI 10.1074/jbc.M113.517540; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Xu XM, 2002, J BIOL CHEM, V277, P48913, DOI 10.1074/jbc.M209613200; Zeller T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010693; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	37	62	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0148717	10.1371/journal.pone.0148717	http://dx.doi.org/10.1371/journal.pone.0148717			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919393	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400009
J	Potter, EE; Thornber, CS; Swanson, JD; McFarland, M				Potter, Elaine E.; Thornber, Carol S.; Swanson, John-David; McFarland, Malcolm			Ploidy Distribution of the Harmful Bloom Forming Macroalgae Ulva spp. in Narragansett Bay, Rhode Island, USA, Using Flow Cytometry Methods	PLOS ONE			English	Article							GRAZING FACILITATES GROWTH; NUCLEAR-DNA CONTENT; LIFE-HISTORY; TEMPORAL VARIATION; MARINE MACROALGAE; CHLOROPHYTA; NITROGEN; POPULATION; ESTUARIES; EVOLUTION	Macroalgal blooms occur worldwide and have the potential to cause severe ecological and economic damage. Narragansett Bay, RI is a eutrophic system that experiences summer macroalgal blooms composed mostly of Ulva compressa and Ulva rigida, which have biphasic life cycles with separate haploid and diploid phases. In this study, we used flow cytometry to assess ploidy levels of U. compressa and U. rigida populations from five sites in Narragansett Bay, RI, USA, to assess the relative contribution of both phases to bloom formation. Both haploid gametophytes and diploid sporophytes were present for both species. Sites ranged from a relative overabundance of gametophytes to a relative overabundance of sporophytes, compared to the null model prediction of root 2 gametophytes: 1 sporophyte. We found significant differences in cell area between ploidy levels for each species, with sporophyte cells significantly larger than gametophyte cells in U. compressa and U. rigida. We found no differences in relative growth rate between ploidy levels for each species. Our results indicate the presence of both phases of each of the two dominant bloom forming species throughout the bloom season, and represent one of the first studies of in situ Ulva life cycle dynamics.	[Potter, Elaine E.; Thornber, Carol S.] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; [Swanson, John-David] Salve Regina Univ, Dept Biol & Biomed Sci, Newport, RI USA; [McFarland, Malcolm] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; [McFarland, Malcolm] Florida Atlantic Univ, Harbor Branch, Oceanog Inst, Ft Pierce, FL USA	University of Rhode Island; University of Rhode Island; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University	Thornber, CS (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	thornber@uri.edu	Thornber, Carol/B-5786-2014	Thornber, Carol/0000-0003-0034-1035	Rhode Island Science and Technology Advisory Committee; Quebec-Labrador Foundation Sounds Conservancy; University of Rhode Island; National Science Foundation [EPS-1004057]	Rhode Island Science and Technology Advisory Committee; Quebec-Labrador Foundation Sounds Conservancy; University of Rhode Island; National Science Foundation(National Science Foundation (NSF))	Funding for this research was provided by a 2012 Rhode Island Science and Technology Advisory Committee award to CST and JDS (http://stac.ri.gov/), the Quebec-Labrador Foundation Sounds Conservancy to EEP (http://www.qlf.org/), and the University of Rhode Island to EEP (http://ww2.uri.edu/). This material is based upon work conducted at the Rhode Island NSF EPSCoR Marine Life Science Center, supported in part by the National Science Foundation Experimental Program to Stimulate Competitive Research, Cooperative Agreement #EPS-1004057 (http://www.nsf.gov/od/iia/programs/epscor/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELFATTAH AF, 1972, QUAL PLANT MATER VEG, V22, P15, DOI 10.1007/BF01099733; ADAMS J, 1974, GENETICS, V76, P327; Alstrom-Rapaport C, 2010, AQUAT BOT, V93, P244, DOI 10.1016/j.aquabot.2010.08.003; BLIDING C., 1963, CRITICAL SURVEY EURO; CLAYTON MN, 1992, BRIT PHYCOL J, V27, P219, DOI 10.1080/00071619200650231; CROW JAMES F., 1965, AMER NATUR, V99, P439, DOI 10.1086/282389; Deacutis CF, 2008, SPRINGER SER ENV MAN, P349, DOI 10.1007/978-0-387-35299-2_12; Deacutis CF, 2006, NORTHEAST NAT, V13, P173, DOI 10.1656/1092-6194(2006)13[173:HITUHO]2.0.CO;2; DESTOMBE C, 1993, HYDROBIOLOGIA, V261, P131; Doleel J., 2007, FLOW CYTOMETRY PLANT; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; DYCK LJ, 1995, PHYCOLOGIA, V34, P390, DOI 10.2216/i0031-8884-34-5-390.1; Fulton John P, 2003, Med Health R I, V86, P365; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Gao S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008571; Guidone M., 2012, THESIS U RHODE ISLAN; Guidone M, 2013, J PHYCOL, V49, P979, DOI 10.1111/jpy.12108; Guidone M, 2013, HARMFUL ALGAE, V24, P1, DOI 10.1016/j.hal.2012.12.007; Guidone M, 2012, J ECOL, V100, P1105, DOI 10.1111/j.1365-2745.2012.02002.x; Guidone M, 2010, MAR ECOL PROG SER, V420, P83, DOI 10.3354/meps08894; Guillemin ML, 2013, J APPL PHYCOL, V25, P215, DOI 10.1007/s10811-012-9855-8; HANNACH G, 1985, MAR ECOL PROG SER, V22, P291, DOI 10.3354/meps022291; Hauxwell J, 2003, MAR ECOL PROG SER, V247, P59, DOI 10.3354/meps247059; Hauxwell J, 1998, ESTUARIES, V21, P347, DOI 10.2307/1352481; Hiraoka M, 2010, J PHYCOL, V46, P882, DOI 10.1111/j.1529-8817.2010.00873.x; Hughes JS, 1999, AM NAT, P154; Jahns H. M., 1995, ALGAE INTRO PHYCOLOG; Kagami Y, 2005, PHYCOL RES, V53, P77, DOI 10.1111/j.1440-183.2005.00375.x; Kim JH, 2011, J APPL PHYCOL, V23, P421, DOI 10.1007/s10811-010-9590-y; LEGALL Y, 1993, PROTOPLASMA, V173, P123; Leletkin V. A., 2004, Biologiya Morya (Vladivostok), V30, P393; LEWIS J, 1979, J THEOR BIOL, V78, P425, DOI 10.1016/0022-5193(79)90341-2; LEWIS WM, 1985, AM NAT, V125, P692, DOI 10.1086/284372; Liu DY, 2013, ESTUAR COAST SHELF S, V129, P2, DOI 10.1016/j.ecss.2013.05.021; Lyons P, 2009, NORTHEAST NAT, V16, P53, DOI 10.1656/045.016.0105; Management RIDoE, 2003, GREENW BAY FISH KILL; Mao YX, 2014, J OCEAN U CHINA, V13, P865, DOI 10.1007/s11802-014-2419-6; Merceron M, 2007, SCI TOTAL ENVIRON, V384, P293, DOI 10.1016/j.scitotenv.2007.05.007; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morand P, 2004, RECENT RES DEV ENV B, V1, P395; Morgan JA, 2003, BIOL BULL-US, V205, P252, DOI 10.2307/1543280; Nakanishi K, 1996, J PHYCOL, V32, P479, DOI 10.1111/j.0022-3646.1996.00479.x; Nixon SW, 2008, SPRINGER SER ENV MAN, P101, DOI 10.1007/978-0-387-35299-2_5; Nixon SW, 1995, BIOGEOCHEMISTRY, V31, P15; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Oviatt C, 2002, ESTUAR COAST SHELF S, V54, P1013, DOI 10.1006/ecss.2001.0872; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; PECKOL P, 1994, MAR BIOL, V121, P175, DOI 10.1007/BF00349487; PHILLIPS JA, 1990, BOT MAR, V33, P79, DOI 10.1515/botm.1990.33.1.79; PRINGLE JD, 1986, OCEAN MANAGE, V10, P11, DOI 10.1016/0302-184X(86)90003-X; R Core Team, 2021, R LANGUAGE ENV STAT; Reddy CRK, 2006, AQUACULTURE, V260, P290, DOI 10.1016/j.aquaculture.2006.06.034; RIVERS JS, 1995, J PHYCOL, V31, P223, DOI 10.1111/j.0022-3646.1995.00223.x; ROSENBERG R, 1985, MAR POLLUT BULL, V16, P227, DOI 10.1016/0025-326X(85)90505-3; Sankaranarayanan S, 2006, CONT SHELF RES, V26, P1571, DOI 10.1016/j.csr.2006.04.004; Smith JE, 2005, MAR ECOL PROG SER, V302, P77, DOI 10.3354/meps302077; Thomsen MS, 2006, J EXP MAR BIOL ECOL, V328, P22, DOI 10.1016/j.jembe.2005.06.016; Thornber C, 2006, ECOLOGY, V87, P2255, DOI 10.1890/0012-9658(2006)87[2255:TTMSHO]2.0.CO;2; Thornber CS, 2006, INTEGR COMP BIOL, V46, P605, DOI 10.1093/icb/icl018; Thornber CS, 2004, ECOLOGY, V85, P1661, DOI 10.1890/02-4101; Thornber CS, 2003, MAR ECOL PROG SER, V258, P65, DOI 10.3354/meps258065; ULRICH I, 1991, PROTOPLASMA, V165, P212, DOI 10.1007/BF01322292; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Worm B, 2006, LIMNOL OCEANOGR, V51, P569, DOI 10.4319/lo.2006.51.1_part_2.0569; Ye NH, 2011, ECOL RES, V26, P477, DOI 10.1007/s11284-011-0821-8	68	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149182	10.1371/journal.pone.0149182	http://dx.doi.org/10.1371/journal.pone.0149182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26918869	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400015
J	Song, FJ; Zeng, KW; Liao, LX; Yu, Q; Tu, PF; Wang, XM				Song, Fangjiao; Zeng, Kewu; Liao, Lixi; Yu, Qian; Tu, Pengfei; Wang, Xuemei			Schizandrin A Inhibits Microglia-Mediated Neuroninflammation through Inhibiting TRAF6-NF-kappa B and Jak2-Stat3 Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; PARKINSONS-DISEASE; IMMUNE-SYSTEM; CELLS; INFLAMMATION; ACTIVATION; KINASE	Microglial-mediated neuroinflammation has been established as playing a vital role in pathogenesis of neurodegenerative disorders. Thus, rational regulation of microglia functions to inhibit inflammation injury may be a logical and promising approach to neurodegenerative disease therapy. The purposes of the present study were to explore the neuroprotective effects and potential molecular mechanism of Schizandrin A (Sch A), a lignin compound isolated from Schisandra chinesnesis. Our observations showed that Sch A could significantly down-regulate the increased production of nitric oxide (NO), tumor necrosis factor (TNF)-alpha and interleukin (IL)-6 induced by lipopolysaccharide (LPS) both in BV-2 cells and primary microglia cells. Moreover, Sch A exerted obvious neuroprotective effects against inflammatory injury in neurons when exposed to microglia-conditioned medium. Investigations of the mechanism showed the anti-inflammatory effect of Sch A involved the inhibition of inducible nitric oxide synthase (iNOS) and cyclooxygenase 2 (COX-2) expression levels and inhibition of the LPS-induced TRAF6-IKK beta-NF-kappa B pathway. Furthermore, inhibition of Jak2-Stat3 pathway activation and Stat3 nuclear translocation also was observed. In conclusion, SchA can exert anti-inflammatory and neuroprotective effects by alleviating microglia-mediated neuroinflammation injury through inhibiting the TRAF6-IKK beta-NF-kappa B and Jak2-Stat3 signaling pathways.	[Song, Fangjiao; Yu, Qian; Wang, Xuemei] Peking Univ, Hosp 1, Res Studio Integrat Tradit & Western Med, Beijing 100034, Peoples R China; [Zeng, Kewu; Liao, Lixi; Tu, Pengfei] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China	Peking University; Peking University	Wang, XM (corresponding author), Peking Univ, Hosp 1, Res Studio Integrat Tradit & Western Med, Beijing 100034, Peoples R China.	wangxuemeibjmu@163.com	Tu, Peng Fei/E-2089-2018; Wang, Xuemei/GXF-3702-2022; Ke-wu, Zeng/U-6930-2019		National Natural Science Foundation of China [81173369, 81303253]; Natural Science Foundation of Beijing [7132210]; Doctoral Scientific Fund Project of the Ministry of Education of China [20120001110105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Doctoral Scientific Fund Project of the Ministry of Education of China	This work was funded by the National Natural Science Foundation of China (81173369) to WXM, the National Natural Science Foundation of China (81303253) to ZKW, the Natural Science Foundation of Beijing (7132210) to WXM, and the Doctoral Scientific Fund Project of the Ministry of Education of China (20120001110105) to WXM.	Androsova LV, 2013, ZH NEVROL PSIKHIATR, V113, P49; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Datla P, 2010, BRIT J PHARMACOL, V160, P1158, DOI 10.1111/j.1476-5381.2010.00780.x; Dilshara MG, 2014, INT IMMUNOPHARMACOL, V18, P203, DOI 10.1016/j.intimp.2013.11.020; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Kim SR, 2004, J NEUROSCI RES, V76, P397, DOI 10.1002/jnr.20089; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Kovarik P, 2001, EMBO J, V20, P91, DOI 10.1093/emboj/20.1.91; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lin XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067633; Liu PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050363; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; McBerry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038384; Panaro MA, 2012, CURR PHARM DESIGN, V18, P200; Park HY, 2013, INT J MOL MED, V32, P1171, DOI 10.3892/ijmm.2013.1478; Picchianti-Diamanti A, 2014, INT J MOL SCI, V15, P4965, DOI 10.3390/ijms15034965; Ren DY, 2013, AM J CHINESE MED, V41, P601, DOI 10.1142/S0192415X13500420; Sanchez-Guajardo V, 2013, ASN NEURO, V5, P113, DOI 10.1042/AN20120066; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wang CP, 2014, J PHYSIOL BIOCHEM, V70, P735, DOI 10.1007/s13105-014-0342-3; Wang SX, 2012, CHINESE J PHYSIOL, V55, P428, DOI [10.4077/CJP.2012.BAA045, 10.4077/CJP.2011.AMM045]; Yao LL, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-23; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	26	71	81	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0149991	10.1371/journal.pone.0149991	http://dx.doi.org/10.1371/journal.pone.0149991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919063	gold, Green Published, Green Submitted			2022-12-27	WOS:000371274400066
J	Valero-Pacheco, N; Perez-Toledo, M; Villasis-Keever, MA; Nunez-Valencia, A; Bosco-Garate, I; Lozano-Dubernard, B; Lara-Puente, H; Espitia, C; Alpuche-Aranda, C; Bonifaz, LC; Arriaga-Pizano, L; Pastelin-Palacios, R; Isibasi, A; Lopez-Macias, C				Valero-Pacheco, Nuriban; Perez-Toledo, Marisol; Villasis-Keever, Miguel Angel; Nunez-Valencia, Adriana; Bosco-Garate, Ilka; Lozano-Dubernard, Bernardo; Lara-Puente, Horacio; Espitia, Clara; Alpuche-Aranda, Celia; Bonifaz, Laura C.; Arriaga-Pizano, Lourdes; Pastelin-Palacios, Rodolfo; Isibasi, Armando; Lopez-Macias, Constantino			Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine	PLOS ONE			English	Article							LONG-TERM IMMUNOGENICITY; CELLULAR IMMUNE-RESPONSES; INACTIVATED INFLUENZA; A/H1N1 INFLUENZA; CLINICAL-TRIAL; OPEN-LABEL; CHILDREN; SAFETY; MEMORY; YOUNG	The influenza virus is a human pathogen that causes epidemics every year, as well as potential pandemic outbreaks, as occurred in 2009. Vaccination has proven to be sufficient in the prevention and containment of viral spreading. In addition to the current egg-based vaccines, new and promising vaccine platforms, such as cell culture-derived vaccines that include virus-like particles (VLPs), have been developed. VLPs have been shown to be both safe and immunogenic against influenza infections. Although antibody persistence has been studied in traditional egg-based influenza vaccines, studies on antibody response durations induced by VLP influenza vaccines in humans are scarce. Here, we show that subjects vaccinated with an insect cell-derived VLP vaccine, in the midst of the 2009 H1N1 influenza pandemic outbreak in Mexico City, showed antibody persistence up to 24 months post-vaccination. Additionally, we found that subjects that reported being revaccinated with a subsequent inactivated influenza virus vaccine showed higher antibody titres to the pandemic influenza virus than those who were not revaccinated. These findings provide insights into the duration of the antibody responses elicited by an insect cell-derived pandemic influenza VLP vaccine and the possible effects of subsequent influenza vaccination on antibody persistence induced by this VLP vaccine in humans.	[Valero-Pacheco, Nuriban; Perez-Toledo, Marisol; Nunez-Valencia, Adriana; Bosco-Garate, Ilka; Bonifaz, Laura C.; Arriaga-Pizano, Lourdes; Isibasi, Armando; Lopez-Macias, Constantino] Specialties Hosp, Mexican Social Secur Inst, Med Res Unit Immunochem, Natl Med Ctr Siglo 21, Mexico City, DF, Mexico; [Valero-Pacheco, Nuriban; Perez-Toledo, Marisol] Inst Politecn Nacl, Dept Inmunol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Villasis-Keever, Miguel Angel] Hosp Pediat Mexico City, Ctr Med Nacl Siglo 21, Unidad Invest Epidemiol Clin, Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Lozano-Dubernard, Bernardo; Lara-Puente, Horacio] Lab Avi Mex SA CV, Dept Invest & Desarrollo, Mexico City, DF, Mexico; [Espitia, Clara] Univ Nacl Autonoma Mexico, Dept Inmunol, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Alpuche-Aranda, Celia] Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico; [Pastelin-Palacios, Rodolfo] Univ Nacl Autonoma Mexico, Fac Quim, Mexico City 04510, DF, Mexico; [Lopez-Macias, Constantino] Univ Oxford, Nuffield Dept Med, Oxford, England	Instituto Mexicano del Seguro Social; Instituto Politecnico Nacional - Mexico; Instituto Mexicano del Seguro Social; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; University of Oxford	Lopez-Macias, C (corresponding author), Specialties Hosp, Mexican Social Secur Inst, Med Res Unit Immunochem, Natl Med Ctr Siglo 21, Mexico City, DF, Mexico.; Lopez-Macias, C (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.	constantino@sminmunologia.org	López Macías, Constatino III Roberto/ABG-3414-2021; Valero-Pacheco, Nuriban/GPS-5781-2022; Arriaga-Pizano, Lourdes/AAI-9628-2021; Villasís-Keever, Miguel Angel/ABB-7807-2020	López Macías, Constatino III Roberto/0000-0003-0530-492X; Valero-Pacheco, Nuriban/0000-0001-6091-6043; Arriaga-Pizano, Lourdes/0000-0003-4433-2106; Villasís-Keever, Miguel Angel/0000-0002-8566-0811; Lopez-Macias, Constantino III Roberto/0000-0002-7756-8468; Pastelin-Palacios, Rodolfo/0000-0001-9242-8589	Mexican Social Security Institute (IMSS) through IMSS Fondo de Investigacion en Salud [FIS/IMSS/PROT/G12/1152, FIS/IMSS/PROT/PRIO/11/013]; Mexican National Science and Technology Council (CONACYT) [CB166946-2011]	Mexican Social Security Institute (IMSS) through IMSS Fondo de Investigacion en Salud; Mexican National Science and Technology Council (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by grants from the Mexican Social Security Institute (IMSS) through the IMSS Fondo de Investigacion en Salud projects as follows: FIS/IMSS/PROT/G12/1152 and FIS/IMSS/PROT/PRIO/11/013 awarded to CLM. Funding was also provided by the Mexican National Science and Technology Council (CONACYT), project number CB166946-2011, awarded to RPP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YH, 2015, HUM VACC IMMUNOTHER, V11, P1648, DOI 10.1080/21645515.2015.1037998; Beyer WEP, 1996, VACCINE, V14, P1331, DOI 10.1016/S0264-410X(96)00058-8; Borja-Aburto VH, 2012, ARCH MED RES, V43, P563, DOI 10.1016/j.arcmed.2012.09.005; CLARK A, 1983, J HYG-CAMBRIDGE, V90, P361, DOI 10.1017/S0022172400028990; CLEMENTS ML, 1986, J CLIN MICROBIOL, V23, P66, DOI 10.1128/JCM.23.1.66-72.1986; David MP, 2009, GYNECOL ONCOL, V115, pS1, DOI 10.1016/j.ygyno.2009.01.011; Eidem S, 2015, VACCINE, V33, P4146, DOI 10.1016/j.vaccine.2015.05.081; Faenzi E, 2012, VACCINE, V30, P4086, DOI 10.1016/j.vaccine.2012.04.020; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Garcia-Sicilia J, 2015, HUM VACC IMMUNOTHER, V11, P2359, DOI 10.1080/21645515.2015.1063754; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gillard P, 2013, INFLUENZA OTHER RESP, V7, P55, DOI 10.1111/j.1750-2659.2012.00349.x; Gross S, 2009, VACCINE, V27, P3398, DOI 10.1016/j.vaccine.2009.01.070; Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4; Hatz C, 2012, VACCINE, V30, P4820, DOI 10.1016/j.vaccine.2012.05.013; Hatz C, 2012, VACCINE, V30, P3470, DOI 10.1016/j.vaccine.2012.03.017; Hervada Vidal Xurxo, 2004, Rev. Esp. Salud Publica, V78, P277, DOI 10.1590/s1135-57272004000200013; Huijskens E, 2011, CLIN VACCINE IMMUNOL, V18, P1401, DOI 10.1128/CVI.05046-11; Ikematsu H, 2012, HUM VACC IMMUNOTHER, V8, P1119, DOI 10.4161/hv.21081; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; JOHNSON PR, 1985, J MED VIROL, V17, P325, DOI 10.1002/jmv.1890170405; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kundig TM, 2006, J ALLERGY CLIN IMMUN, V117, P1470, DOI 10.1016/j.jaci.2006.01.040; Landry N, 2014, CLIN IMMUNOL, V154, P164, DOI 10.1016/j.clim.2014.08.003; Landry N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015559; Langley JM, 2012, PEDIATR INFECT DIS J, V31, P848, DOI 10.1097/INF.0b013e31825e6cd6; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Lopez P, 2013, CLIN VACCINE IMMUNOL, V20, P753, DOI 10.1128/CVI.00626-12; Lopez-Macias Constantino, 2012, Hum Vaccin Immunother, V8, P411, DOI 10.4161/hv.18757; Lopez-Macias C, 2011, VACCINE, V29, P7826, DOI 10.1016/j.vaccine.2011.07.099; Low JGH, 2014, VACCINE, V32, P5041, DOI 10.1016/j.vaccine.2014.07.011; Madalinski K, 2001, VACCINE, V20, P92, DOI 10.1016/S0264-410X(01)00312-7; Moris P, 2011, J CLIN IMMUNOL, V31, P443, DOI 10.1007/s10875-010-9490-6; Nardin EH, 2004, INFECT IMMUN, V72, P6519, DOI 10.1128/IAI.72.11.6519-6527.2004; Nicholson KG, 2003, LANCET, V362, P1733, DOI 10.1016/S0140-6736(03)14854-4; Organization. WH, 2013, GLOB EP SURV STAND I; Petrie JG, 2015, J INFECT DIS, V212, P1914, DOI 10.1093/infdis/jiv313; Plummer EM, 2011, WIRES NANOMED NANOBI, V3, P174, DOI 10.1002/wnan.119; Reisinger KS, 2014, HUM VACC IMMUNOTHER, V10, P2395, DOI 10.4161/hv.29393; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Saitoh A, 2012, HUM VACC IMMUNOTHER, V8, P749, DOI 10.4161/hv.19684; Perez MIS, 2010, REV PANAM SALUD PUBL, V27, P80, DOI 10.1590/S1020-49892010000100012; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Song JY, 2013, CLIN EXP VACCINE RES, V2, P115, DOI 10.7774/cevr.2013.2.2.115; Song JY, 2013, CLIN VACCINE IMMUNOL, V20, P513, DOI 10.1128/CVI.00725-12; Song JY, 2012, CLIN VACCINE IMMUNOL, V19, P638, DOI 10.1128/CVI.00026-12; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Tacket CO, 2003, CLIN IMMUNOL, V108, P241, DOI 10.1016/S1521-6616(03)00120-7; Talaat KR, 2014, J INFECT DIS, V209, P1860, DOI 10.1093/infdis/jiu123; Tandale BV, 2013, HUM VACC IMMUNOTHER, V9, P125, DOI 10.4161/hv.22421; Van Damme P, 2013, HUM VACC IMMUNOTHER, V9, P1512, DOI 10.4161/hv.24504; van der Velden MVW, 2012, VACCINE, V30, P6127, DOI 10.1016/j.vaccine.2012.07.077; Ward BJ, 2014, VACCINE, V32, P6098, DOI [10.1016/j.vaccine.2014.08.079, 10.10]; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; World Health Organization, 2011, MAN LAB DIAGN VIR SU; Yang Zhongdong, 2012, Results Immunol, V2, P184, DOI 10.1016/j.rinim.2012.10.001; Zuccotti GV, 2009, VACCINE, V27, P5357, DOI 10.1016/j.vaccine.2009.06.082; Zuccotti G, 2007, VACCINE, V25, P6692, DOI 10.1016/j.vaccine.2007.07.013	60	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150146	10.1371/journal.pone.0150146	http://dx.doi.org/10.1371/journal.pone.0150146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919288	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400092
J	Zahm, CD; Szulczewski, JM; Leystra, AA; Olson, TJP; Clipson, L; Albrecht, DM; Middlebrooks, M; Thliveris, AT; Matkowskyj, KA; Washington, MK; Newton, MA; Eliceiri, KW; Halberg, RB				Zahm, Christopher D.; Szulczewski, Joseph M.; Leystra, Alyssa A.; Olson, Terrah J. Paul; Clipson, Linda; Albrecht, Dawn M.; Middlebrooks, Malisa; Thliveris, Andrew T.; Matkowskyj, Kristina A.; Washington, Mary Kay; Newton, Michael A.; Eliceiri, Kevin W.; Halberg, Richard B.			Advanced Intestinal Cancers often Maintain a Multi-Ancestral Architecture	PLOS ONE			English	Article							MOUSE INTESTINE; MIN MICE; TUMOR; ADENOMAS; NEOPLASIA; ORIGIN; GENE; MUTATION; APC(+); CELLS	A widely accepted paradigm in the field of cancer biology is that solid tumors are uni-ancestral being derived from a single founder and its descendants. However, data have been steadily accruing that indicate early tumors in mice and humans can have a multi-ancestral origin in which an initiated primogenitor facilitates the transformation of neighboring co-genitors. We developed a new mouse model that permits the determination of clonal architecture of intestinal tumors in vivo and ex vivo, have validated this model, and then used it to assess the clonal architecture of adenomas, intramucosal carcinomas, and invasive adenocarcinomas of the intestine. The percentage of multi-ancestral tumors did not significantly change as tumors progressed from adenomas with low-grade dysplasia [40/65 (62%)], to adenomas with high-grade dysplasia [21/37 (57%)], to intramucosal carcinomas [10/23 (43%]), to invasive adenocarcinomas [13/19 (68%)], indicating that the clone arising from the primogenitor continues to coexist with clones arising from co-genitors. Moreover, neoplastic cells from distinct clones within a multi-ancestral adenocarcinoma have even been observed to simultaneously invade into the underlying musculature [2/15 (13%)]. Thus, intratumoral heterogeneity arising early in tumor formation persists throughout tumorigenesis.	[Zahm, Christopher D.; Leystra, Alyssa A.; Clipson, Linda] Univ Wisconsin, Dept Oncol, Madison, WI USA; [Szulczewski, Joseph M.; Eliceiri, Kevin W.] Univ Wisconsin, LOCI, Madison, WI USA; [Szulczewski, Joseph M.; Eliceiri, Kevin W.] Univ Wisconsin, Lab Cell & Mol Biol, Madison, WI USA; [Olson, Terrah J. Paul] Univ Wisconsin, Dept Surg, Madison, WI USA; [Albrecht, Dawn M.; Middlebrooks, Malisa; Halberg, Richard B.] Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI USA; [Thliveris, Andrew T.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Matkowskyj, Kristina A.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Matkowskyj, Kristina A.; Newton, Michael A.; Eliceiri, Kevin W.; Halberg, Richard B.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Washington, Mary Kay] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37212 USA; [Newton, Michael A.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Newton, Michael A.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Halberg, RB (corresponding author), Univ Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Madison, WI USA.; Halberg, RB (corresponding author), Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA.	rbhalberg@medicine.wisc.edu	Eliceiri, Kevin/ABD-4516-2020; Zahm, Christopher/AAX-1237-2021	Eliceiri, Kevin/0000-0001-8678-670X; Zahm, Christopher/0000-0002-2117-7003; Szulczewski, Joseph/0000-0002-9269-2344	National Cancer Institute of the National Institutes of Health [R01 CA123438, P30 CA014520, P30 DK058404, P50 CA095013, K08 CA84146, T32 CA009135, T32 CA090217]; University of Wisconsin-Madison Division of Gastroenterology and Hepatology, Department of Medicine, and School of Medicine and Public Health; NATIONAL CANCER INSTITUTE [T32CA009135, P30CA014520, K08CA084146, R01CA123438, T32CA090217] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Wisconsin-Madison Division of Gastroenterology and Hepatology, Department of Medicine, and School of Medicine and Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute (http://www.cancer.gov/) of the National Institutes of Health (R01 CA123438 to RBH; P30 CA014520 to University of Wisconsin Carbone Cancer Center; P30 DK058404, Preclinical Models of Digestive Diseases Core, Vanderbilt Digestive Diseases Research Center; P50 CA095013, Translational Pathology and Imaging Core, Vanderbilt GI SPORE; K08 CA84146 to ATT; T32 CA009135 to CDZ and AAL; and T32 CA090217 to TJPO) and start-up funds from the University of Wisconsin-Madison Division of Gastroenterology and Hepatology, Department of Medicine, and School of Medicine and Public Health to RBH.	Amos-Landgraf JM, 2012, P NATL ACAD SCI USA, V109, P2060, DOI 10.1073/pnas.1120753109; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; BEUTLER E, 1967, NEW ENGL J MED, V276, P389, DOI 10.1056/NEJM196702162760706; Elahi SF, 2011, BIOMED OPT EXPRESS, V2, P981, DOI 10.1364/BOE.2.000981; Fischer JM, 2014, CARCINOGENESIS, V35, P237, DOI 10.1093/carcin/bgt296; Haigis KM, 2004, P NATL ACAD SCI USA, V101, P9769, DOI 10.1073/pnas.0403338101; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Halberg RB, 2009, CANCER RES, V69, P5768, DOI 10.1158/0008-5472.CAN-09-0446; Kang H, 2015, J PATHOL; Linkert M, 2010, J CELL BIOL, V189, P777, DOI 10.1083/jcb.201004104; Luongo C, 1996, GENE CHROMOSOME CANC, V17, P194, DOI 10.1002/1098-2264(199611)17:3<194::AID-GCC2870170302>3.0.CO;2-E; LUONGO C, 1994, CANCER RES, V54, P5947; Merritt AJ, 1997, P NATL ACAD SCI USA, V94, P13927, DOI 10.1073/pnas.94.25.13927; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; NAGASE H, 1993, HUM MUTAT, V2, P425, DOI 10.1002/humu.1380020602; Newton MA, 2006, BIOMETRICS, V62, P721, DOI 10.1111/j.1541-0420.2006.00522.x; Novelli MR, 1996, SCIENCE, V272, P1187, DOI 10.1126/science.272.5265.1187; Parsons BL, 2008, MUTAT RES-REV MUTAT, V659, P232, DOI 10.1016/j.mrrev.2008.05.004; Parsons BL, 2010, CANCER INVEST, V28, P364, DOI 10.3109/07357901003630975; Paul Olson TJ, 2011, COLONOSCOPY; Pietras A, 2011, ADV CANCER RES, V112, P255, DOI 10.1016/B978-0-12-387688-1.00009-0; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sklyar O, 2012, EBIMAGE IMAGE PROCES; Sottoriva A, 2015, NAT GENET, V47, P209, DOI 10.1038/ng.3214; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Thirlwell C, 2010, GASTROENTEROLOGY, V138, P1441, DOI 10.1053/j.gastro.2010.01.033; Thliveris AT, 2013, P NATL ACAD SCI USA, V110, P11523, DOI 10.1073/pnas.1303064110; Thliveris AT, 2011, CANCER PREV RES, V4, P916, DOI 10.1158/1940-6207.CAPR-11-0022; Thliveris AT, 2005, P NATL ACAD SCI USA, V102, P6960, DOI 10.1073/pnas.0502662102; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997	34	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150170	10.1371/journal.pone.0150170	http://dx.doi.org/10.1371/journal.pone.0150170			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3UU	26919712	Green Published, gold			2022-12-27	WOS:000371274400095
J	Zhang, N; Andrighetto, G; Ottone, S; Ponzano, F; Steinmo, S				Zhang, Nan; Andrighetto, Giulia; Ottone, Stefania; Ponzano, Ferruccio; Steinmo, Sven			"Willing to Pay?" Tax Compliance in Britain and Italy: An Experimental Analysis	PLOS ONE			English	Article							UNITED-STATES; EVASION; MORALE; ATTITUDES; GENDER; REDISTRIBUTION; INSTITUTIONS; ECONOMICS; CULTURE; WELFARE	As shown by the recent crisis, tax evasion poses a significant problem for countries such as Greece, Spain and Italy. While these societies certainly possess weaker fiscal institutions as compared to other EU members, might broader cultural differences between northern and southern Europe also help to explain citizens' (un)willingness to pay their taxes? To address this question, we conduct laboratory experiments in the UK and Italy, two countries which straddle this North-South divide. Our design allows us to examine citizens' willingness to contribute to public goods via taxes while holding institutions constant. We report a surprising result: when faced with identical tax institutions, redistribution rules and audit probabilities, Italian participants are significantly more likely to comply than Britons. Overall, our findings cast doubt upon "culturalist" arguments that would attribute cross-country differences in tax compliance to the lack of morality amongst southern European taxpayers.	[Zhang, Nan; Andrighetto, Giulia] European Univ Inst, Dept Social & Polit Sci, Fiesole, FI, Italy; [Andrighetto, Giulia] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Ottone, Stefania] Univ Milano Bicocca, Dept Econ Management & Stat, Milan, Italy; [Ponzano, Ferruccio] Univ Piemonte Orientale, Dept Law Polit Econ & Social Sci, Alessandria, Italy; [Steinmo, Sven] European Univ Inst, Robert Schumann Ctr Adv Studies, Fiesole, FI, Italy; [Steinmo, Sven] Univ Colorado, Dept Polit Sci, Boulder, CO 80309 USA	European University Institute; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); University of Milano-Bicocca; University of Eastern Piedmont Amedeo Avogadro; European University Institute; University of Colorado System; University of Colorado Boulder	Zhang, N (corresponding author), European Univ Inst, Dept Social & Polit Sci, Fiesole, FI, Italy.	nan.zhang@eui.eu		PONZANO, Ferruccio/0000-0003-1485-1386; STEINMO, SVEN/0000-0003-3162-8741	European Research Council under the European Union [295675]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement n. [295675]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm J, 2006, J ECON PSYCHOL, V27, P224, DOI 10.1016/j.joep.2005.09.002; Alm J, 2004, CONTRIB ECON ANAL, V268, P11; ALM J, 1992, NATL TAX J, V45, P107; ALM J, 1992, J PUBLIC ECON, V48, P21, DOI 10.1016/0047-2727(92)90040-M; Alm J, 1999, KYKLOS, V52, P141, DOI 10.1111/j.1467-6435.1999.tb01440.x; ALM J, 1995, KYKLOS, V48, P3; ALM J, 1992, AM ECON REV, V82, P1018; Alm J, 2015, ECON INQ, V53, P1170, DOI 10.1111/ecin.12196; Andreoni J, 1998, J ECON LIT, V36, P818; Banfield E.C., 1967, MORAL BASIS BACKWARD; BECKER W, 1987, J PUBLIC ECON, V34, P243, DOI 10.1016/0047-2727(87)90022-3; Bergman M., 2009, TAX EVASION RULE LAW; Bernasconi M, 2014, J ECON PSYCHOL, V40, P103, DOI 10.1016/j.joep.2013.01.005; Bosco L, 1997, KYKLOS, V50, P297, DOI 10.1111/1467-6435.00018; Charron N, 2014, SOCIAL INDICATORS RE, P1; Charron N, 2014, REG STUD, V48, P68, DOI 10.1080/00343404.2013.770141; Christian RC, 2014, J ECON PSYCHOL, V40, P62, DOI 10.1016/j.joep.2012.10.001; Chung J, 2003, J BUS ETHICS, V47, P133, DOI 10.1023/A:1026004716676; Cullis J, 2006, J ECON PSYCHOL, V27, P304, DOI 10.1016/j.joep.2005.07.003; Cummings RG, 2009, J ECON BEHAV ORGAN, V70, P447, DOI 10.1016/j.jebo.2008.02.010; Edlund J, 1999, EUR J POLIT RES, V35, P341; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; Frey B., 2002, 760 CESIFO; Frey BS, 2007, J COMP ECON, V35, P136, DOI 10.1016/j.jce.2006.10.006; FRIEDLAND N, 1978, J PUBLIC ECON, V10, P107, DOI 10.1016/0047-2727(78)90008-7; Gerxhani K, 2007, FEM ECON, V13, P119, DOI 10.1080/13545700601184856; GRAETZ MJ, 1985, NATL TAX J, V38, P355; Greiner B, 2004, ONLINE RECRUITMENT S, V10, P63; Hofstede G., 2001, CULTURES CONSEQUENCE; Inglehart R, 2010, PERSPECT POLIT, V8, P551, DOI 10.1017/S1537592710001258; Kastlunger B, 2010, J ECON PSYCHOL, V31, P542, DOI 10.1016/j.joep.2010.03.015; Levi M., 1989, RULE REVENUE; Levi M, 2009, AM BEHAV SCI, V53, P354, DOI 10.1177/0002764209338797; Lewis A, 2009, J ECON PSYCHOL, V30, P431, DOI 10.1016/j.joep.2008.11.002; Platteau J.P., 2000, I SOCIAL NORMS EC DE; POMMEREHNE WW, 1994, PUBLIC FINANC, V49, P52; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rothstein B., 2011, QUALITY GOVT CORRUPT; Santoro A., 2010, LEVASIONE FISCALE QU; Schneider Friedrich, 2013, SHADOW EC INT SURVEY; Scholz JT, 1998, AM J POLIT SCI, V42, P398, DOI 10.2307/2991764; Slemrod J, 1998, NATL TAX J, V51, P485; Slemrod J., 1992, WHY PEOPLE PAY TAXES, P311; Slemrod J, 2007, J ECON PERSPECT, V21, P25, DOI 10.1257/jep.21.1.25; Smith K.W., 1992, WHY PEOPLE PAY TAXES, P223; Smith Kent W., 1991, LAW POLICY, V13, P35, DOI DOI 10.1111/J.1467-9930.1991.TB00056.X; STEINMO S, 1989, WORLD POLIT, V41, P500, DOI 10.2307/2010528; Svallfors S, 1997, EUR SOCIOL REV, V13, P283, DOI 10.1093/oxfordjournals.esr.a018219; Tabellini G, 2010, J EUR ECON ASSOC, V8, P677; Taylor-Gooby P, 1995, EYE BEHOLDER OPINION, P11; Torgler B, 2002, J ECON SURV, V16, P657, DOI 10.1111/1467-6419.00185; Torgler B, 2005, PUBLIC FINANC REV, V33, P403, DOI 10.1177/1091142105275438; Torgler B, 2007, SOC SCI QUART, V88, P443, DOI 10.1111/j.1540-6237.2007.00466.x; Torgler B, 2010, CONTEMP ECON POLICY, V28, P554, DOI 10.1111/j.1465-7287.2009.00188.x; Wartick M., 1999, J AM TAXATION ASS, V21, P20, DOI DOI 10.2308/JATA.1999.21.1.20	55	27	29	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2016	11	2							e0150277	10.1371/journal.pone.0150277	http://dx.doi.org/10.1371/journal.pone.0150277			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF3UU	26919201	Green Published, gold, Green Submitted			2022-12-27	WOS:000371274400115
J	Ferreira, VM; Passos, CS; Maquigussa, E; Pontes, RB; Bergamaschi, CT; Campos, RR; Boim, MA				Ferreira, Vanessa Meira; Passos, Clevia Santos; Maquigussa, Edgar; Pontes, Roberto Braz; Bergamaschi, Cassia Toledo; Campos, Ruy Ribeiro; Boim, Mirian Aparecida			Chronic Nicotine Exposure Abolishes Maternal Systemic and Renal Adaptations to Pregnancy in Rats	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SYMPATHETIC-NERVE ACTIVITY; CIGARETTE-SMOKING; BLOOD-PRESSURE; NITRIC-OXIDE; GLOMERULAR-FILTRATION; BARORECEPTOR REFLEX; REPLACEMENT THERAPY; KIDNEY-DISEASE; CONSCIOUS RATS	Pregnancy is characterized by maternal systemic and intrarenal vasodilation, leading to increases in the renal plasma flow (RPF) and glomerular filtration rate (GFR). These responses are mainly mediated by nitric oxide (NO) and relaxin. The impact of cigarette smoking on the maternal adaptations to pregnancy is unclear. Here we evaluated the effects of chronic exposure to nicotine on systemic and intrarenal parameters in virgin (V) and 14-day pregnant (P) Wistar rats. V and P groups received saline or nicotine (6 mg.kg(-1).day(-1)) respectively, via osmotic minipumps for 28 days, starting 14 days before pregnancy induction. Nicotine induced a 10% increase in blood pressure in the V group and minimized the characteristic pregnancy-induced hypotension. Renal sympathetic nerve activity (rSNA) and baroreflex sensitivity were impaired by nicotine mainly in the P group, indicating that the effect of nicotine on blood pressure was not mediated by nervous system stimulation. Nicotine had no effect on GFR in the V rats but reduced GFR of the P group by 30%. Renal expression of sodium and water transporters was downregulated by nicotine, resulting in increased fractional sodium excretion mainly in the P group, suggesting that nicotine compromised the sodium and water retention required for normal gestation. There was a reduction in the expression of inducible NO synthase (iNOS) in both the kidney tissue and renal artery, as well as in the expression of the relaxin receptor (LGR7). These results clearly show that nicotine induced deleterious effects in both virgin and pregnant animals, and abolished the maternal capacity to adapt to pregnancy.	[Ferreira, Vanessa Meira; Passos, Clevia Santos; Maquigussa, Edgar; Boim, Mirian Aparecida] Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil; [Pontes, Roberto Braz; Bergamaschi, Cassia Toledo; Campos, Ruy Ribeiro] Univ Fed Sao Paulo, Dept Physiol, Cardiovasc Div, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	Boim, MA (corresponding author), Univ Fed Sao Paulo, Dept Med, Div Renal, Sao Paulo, Brazil.	maboim@unifesp.br	Campos, Ruy R/H-8339-2017; Boim, Mirian A/L-6574-2013; Maquigussa, Edgar/G-7685-2016; Pontes, Roberto B/D-1211-2014; Campos, Ruy R R/I-3691-2015; Bergamaschi, Cassia/AAZ-9441-2020; Passos, Clevia/B-8463-2014	Campos, Ruy R/0000-0002-9404-0817; Pontes, Roberto B/0000-0002-2937-575X; Campos, Ruy R R/0000-0002-9404-0817; Passos, Clevia/0000-0001-6954-2535; Maquigussa, Edgar/0000-0003-1756-1579; Bergamaschi, Cassia/0000-0002-5741-6993	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/11953-0, 2010/098490]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) - Grant no. 2010/11953-0 and 2010/098490. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NP, 2008, HYPERTENS PREGNANCY, V27, P49, DOI 10.1080/10641950701825887; Agbor LN, 2014, J PHARMACOL EXP THER, V351, P688, DOI 10.1124/jpet.114.219535; Agbor LN, 2012, TOXICOL APPL PHARM, V264, P351, DOI 10.1016/j.taap.2012.09.007; Alexander BT, 1999, HYPERTENSION, V33, P435, DOI 10.1161/01.HYP.33.1.435; ARMITAGE AK, 1965, BRIT J PHARM CHEMOTH, V25, P515, DOI 10.1111/j.1476-5381.1965.tb02069.x; BARON JA, 1990, AM J OBSTET GYNECOL, V162, P502, DOI 10.1016/0002-9378(90)90420-C; BAYLIS C, 1994, BAILLIERE CLIN OB GY, V8, P235, DOI 10.1016/S0950-3552(05)80320-7; BAYLIS C, 1987, AM J KIDNEY DIS, V9, P260, DOI 10.1016/S0272-6386(87)80119-1; BAYLIS C, 1980, J PHYSIOL-LONDON, V305, P405, DOI 10.1113/jphysiol.1980.sp013372; BERTA L, 1992, HORM RES, V37, P45, DOI 10.1159/000182280; Bobadilla RA, 2003, CAN J PHYSIOL PHARM, V81, P1, DOI 10.1139/Y02-168; BOIM MA, 1994, BRAZ J MED BIOL RES, V27, P1431; Brooks VL, 2010, AM J PHYSIOL-REG I, V299, pR439, DOI 10.1152/ajpregu.00059.2010; Cadnapaphornchai MA, 2001, AM J PHYSIOL-RENAL, V280, pF592, DOI 10.1152/ajprenal.2001.280.4.F592; Conrad KP, 1999, AM J PHYSIOL-RENAL, V276, pF767, DOI 10.1152/ajprenal.1999.276.5.F767; Conrad KP, 2005, ANN NY ACAD SCI, V1041, P147, DOI 10.1196/annals.1282.022; Cooper RG, 2006, INDIAN J MED RES, V124, P261; Cornelis T, 2011, SEMIN NEPHROL, V31, P4, DOI 10.1016/j.semnephrol.2010.10.002; Danielson LA, 1996, CIRC RES, V79, P1161, DOI 10.1161/01.RES.79.6.1161; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; EASTERLING TR, 1988, OBSTET GYNECOL, V72, P550; Ekpu VU, 2015, TOB USE INSIGHTS, V8, P1, DOI 10.4137/TUI.S15628; El-Mas MM, 2011, TOXICOL APPL PHARM, V254, P229, DOI 10.1016/j.taap.2011.04.014; El-Sherbeni AA, 2014, DRUG METAB DISPOS, V42, P1498, DOI 10.1124/dmd.114.057836; Ferreira VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004845; Franken R A, 1996, Arq Bras Cardiol, V66, P371; Gabrielsson Johan, 2012, Methods Mol Biol, V929, P377; Go RE, 2015, J STEROID BIOCHEM, V147, P24, DOI 10.1016/j.jsbmb.2014.11.003; HAMMOND DK, 1991, DRUG METAB DISPOS, V19, P804; Hua P, 2010, AM J PHYSIOL-RENAL, V299, pF732, DOI 10.1152/ajprenal.00293.2010; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; Hukkanen J, 2011, BRIT J CLIN PHARMACO, V72, P836, DOI 10.1111/j.1365-2125.2011.04023.x; Jaimes EA, 2007, AM J PHYSIOL-HEART C, V292, pH76, DOI 10.1152/ajpheart.00693.2006; Jain G, 2013, BIOCHEM PHARMACOL, V86, P1215, DOI 10.1016/j.bcp.2013.07.014; JENSEN J, 1985, NEW ENGL J MED, V313, P973, DOI 10.1056/NEJM198510173131602; Kubo T, 1987, CENTRAL NICOTINIC RE; Lauritzen L, 2011, MATERN CHILD NUTR, V7, P41, DOI 10.1111/j.1740-8709.2011.00303.x; Malpas SC, 2004, AM J PHYSIOL-REG I, V286, pR1, DOI 10.1152/ajpregu.00496.2003; MASSICOTTE G, 1987, CAN J PHYSIOL PHARM, V65, P2466, DOI 10.1139/y87-391; Murphy JG, 2001, AM J PHYSIOL-REG I, V280, pR87, DOI 10.1152/ajpregu.2001.280.1.R87; Najem B, 2006, HYPERTENSION, V47, P1162, DOI 10.1161/01.HYP.0000219284.47970.34; Nasr SH, 2007, J AM SOC NEPHROL, V18, P2032, DOI 10.1681/ASN.2006121328; Nishi EE, 2010, AM J HYPERTENS, V23, P473, DOI 10.1038/ajh.2010.11; Novak J, 2001, J CLIN INVEST, V107, P1469, DOI 10.1172/JCI11975; Ohara M, 1998, J CLIN INVEST, V101, P1076, DOI 10.1172/JCI649; Orth SR, 2004, J AM SOC NEPHROL, V15, pS58, DOI 10.1097/01.ASN.0000093461.36097.D5; Paller MS CJ, 2004, KIDNEY, V2, P1659; Pontes RB, 2015, AM J PHYSIOL-RENAL, V308, pF848, DOI 10.1152/ajprenal.00515.2014; Rieg T, 2013, JOVE-J VIS EXP, DOI 10.3791/50330; Ritz E, 1998, J AM SOC NEPHROL, V9, P1798; Rosembert J RA, 2003, NICOTINA; Shimokawa A, 1998, J AUTONOM NERV SYST, V72, P46, DOI 10.1016/S0165-1838(98)00084-8; Smith CA, 2010, AM J PHYSIOL-RENAL, V299, pF830, DOI 10.1152/ajprenal.00300.2010; Tamaoki L, 2009, AM J NEPHROL, V30, P377, DOI 10.1159/000235622; WHITESCARVER SA, 1991, HYPERTENSION, V17, P179, DOI 10.1161/01.HYP.17.2.179; Xiao DL, 2008, HYPERTENSION, V51, P1239, DOI 10.1161/HYPERTENSIONAHA.107.106203; Xiao DL, 2007, J PHARMACOL EXP THER, V320, P654, DOI 10.1124/jpet.106.113332; Yang Z, 2007, EXP PHYSIOL, V92, P109, DOI 10.1113/expphysiol.2006.034884; ZACNY JP, 1990, BRIT J ADDICT, V85, P555	59	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0150096	10.1371/journal.pone.0150096	http://dx.doi.org/10.1371/journal.pone.0150096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914675	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700054
J	Fonseca, MI; Chu, SH; Pierce, AL; Brubaker, WD; Hauhart, RE; Mastroeni, D; Clarke, EV; Rogers, J; Atkinson, JP; Tenner, AJ				Fonseca, Maria I.; Chu, Shuhui; Pierce, Aimee L.; Brubaker, William D.; Hauhart, Richard E.; Mastroeni, Diego; Clarke, Elizabeth V.; Rogers, Joseph; Atkinson, John P.; Tenner, Andrea J.			Analysis of the Putative Role of CR1 in Alzheimer's Disease: Genetic Association, Expression and Function	PLOS ONE			English	Article							AMYLOID-BETA PEPTIDE; COMPLEMENT ACTIVATION; PERIPHERAL CLEARANCE; PRION DISEASE; MOUSE MODELS; A-BETA; RECEPTOR; C1Q; BRAIN; MICE	Chronic activation of the complement system and induced inflammation are associated with neuropathology in Alzheimer's disease (AD). Recent large genome wide association studies (GWAS) have identified single nucleotide polymorphisms (SNPs) in the C3b/C4b receptor (CR1 or CD35) that are associated with late onset AD. Here, anti-CR1 antibodies (Abs) directed against different epitopes of the receptor, were used to localize CR1 in brain, and relative binding affinities of the CR1 ligands, C1q and C3b, were assessed by ELISA. Most Abs tested stained red blood cells in blood vessels but showed no staining in brain parenchyma. However, two monoclonal anti-CR1 Abs labeled astrocytes in all of the cases tested, and this reactivity was preabsorbed by purified recombinant human CR1. Human brain-derived astrocyte cultures were also reactive with both mAbs. The amount of astrocyte staining varied among the samples, but no consistent difference was conferred by diagnosis or the GWAS-identified SNPs rs4844609 or rs6656401. Plasma levels of soluble CR1 did not correlate with diagnosis but a slight increase was observed with rs4844609 and rs6656401 SNP. There was also a modest but statistically significant increase in relative binding activity of C1q to CR1 with the rs4844609 SNP compared to CR1 without the SNP, and of C3b to CR1 in the CR1 genotypes containing the rs6656401 SNP (also associated with the larger isoform of CR1) regardless of clinical diagnosis. These results suggest that it is unlikely that astrocyte CR1 expression levels or C1q or C3b binding activity are the cause of the GWAS identified association of CR1 variants with AD. Further careful functional studies are needed to determine if the variant-dictated number of CR1 expressed on red blood cells contributes to the role of this receptor in the progression of AD, or if another mechanism is involved.	[Fonseca, Maria I.; Chu, Shuhui; Clarke, Elizabeth V.; Tenner, Andrea J.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; [Pierce, Aimee L.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Pierce, Aimee L.; Tenner, Andrea J.] Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA; [Brubaker, William D.; Rogers, Joseph] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Hauhart, Richard E.; Atkinson, John P.] Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; [Mastroeni, Diego] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Mastroeni, Diego] Maastricht Univ, Med Ctr, European Grad Sch Neurosci EURON,Sch Mental Hlth, Dept Psychiat & Neuropsychol,Fac Hlth Med & Life, NL-6200 MD Maastricht, Netherlands; [Tenner, Andrea J.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Tenner, Andrea J.] Univ Calif Irvine, Dept Pathol & Lab Sci, Irvine, CA 92697 USA; [Mastroeni, Diego] Arizona State Univ, NDRC, Biodesign Inst, Tempe, AZ 85287 USA; [Clarke, Elizabeth V.] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97239 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; SRI International; Washington University (WUSTL); Banner Research; Banner Health; Banner Sun Health Research Institute; Maastricht University; University of California System; University of California Irvine; University of California System; University of California Irvine; Arizona State University; Arizona State University-Tempe; Oregon Health & Science University	Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Inst Memory Impairment & Neurol Disorders, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.; Tenner, AJ (corresponding author), Univ Calif Irvine, Dept Pathol & Lab Sci, Irvine, CA 92697 USA.	atenner@uci.edu		Clarke, Elizabeth/0000-0002-4447-0077; Atkinson, John/0000-0002-2514-3441	National Institutes of Health [AG 00538, NS35144, P50 AG16573, R01 AI041592, P30 AR048335, AG039750, AG007367]; NIH/NIA [P50 AG16573, R01 AI041592, P30 AR048335, AG039750, AG007367]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035144] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG000538, R01AG039750, R01AG007367, R56AG007367, P50AG016573] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants AG 00538 and NS35144 (AT), National Institutes of Health Grant P50 AG16573 (AIP), R01 AI041592 and P30 AR048335 (JPA), and AG039750 and AG007367 (JR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH grants AG 00538 and NS35144 (AT), NIH/NIA Grant P50 AG16573 (UCI-ADRC), R01 AI041592 and P30 AR048335 (JPA), and AG039750 and AG007367 (JR). The authors thank Drs. Ronald Kim, Wayne Poon and Edwin Monuki and the Tissue Repository of the UCI Institute for Memory Impairments and Neurological Disorders for preparing and providing brain tissue samples with pathological diagnosis, and Marwan Sabbagh, M.D. (Banner Sun Health Research Institute) who provided RBC samples. The authors thank Dr Jonathan Hannan University of Colorado, Denver for kindly providing K562 cells expressing CR2 and mAb (M171) against CR2, and Drs. Changiz Geula and Aras Rezvanian of Northwestern University Alzheimer's Disease Center for a generous gift of human brain derived microglia. The authors also thank Pooja Selvan (UCI) and Eric Nguyen (UCI) for excellent technical assistance.	Afagh A, 1996, EXP NEUROL, V138, P22, DOI 10.1006/exnr.1996.0043; Aiyaz M, 2012, IMMUNOBIOLOGY, V217, P204, DOI 10.1016/j.imbio.2011.07.023; Alexander JJ, 2008, J NEUROCHEM, V107, P1169, DOI 10.1111/j.1471-4159.2008.05668.x; Benoit ME, 2013, J BIOL CHEM, V288, P654, DOI 10.1074/jbc.M112.400168; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; BERGER M, 1984, J CLIN INVEST, V74, P1566, DOI 10.1172/JCI111572; Bradt BM, 1998, J EXP MED, V188, P431, DOI 10.1084/jem.188.3.431; Brouwers N, 2012, MOL PSYCHIATR, V17, P223, DOI 10.1038/mp.2011.24; Canova C, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-22; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Chen CH, 2007, CLIN EXP IMMUNOL, V148, P546, DOI 10.1111/j.1365-2249.2007.03355.x; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Corneveaux JJ, 2010, HUM MOL GENET, V19, P3295, DOI 10.1093/hmg/ddq221; Daborg J, 2012, J NEURAL TRANSM, V119, P789, DOI 10.1007/s00702-012-0797-8; Deane R, 2009, CNS NEUROL DISORD-DR, V8, P16, DOI 10.2174/187152709787601867; DYKMAN TR, 1983, P NATL ACAD SCI-BIOL, V80, P1698, DOI 10.1073/pnas.80.6.1698; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Fonseca MI, 2004, J NEUROSCI, V24, P6457, DOI 10.1523/JNEUROSCI.0901-04.2004; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Gasque P, 1996, J IMMUNOL, V156, P2247; Hazrati LN, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.001; Jacquet M, 2013, J IMMUNOL, V190, P3721, DOI 10.4049/jimmunol.1202451; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Karthikeyan G, 2007, J THROMB THROMBOLYS, V23, P115, DOI 10.1007/s11239-006-9040-5; Keenan BT, 2012, HUM MOL GENET, V21, P2377, DOI 10.1093/hmg/dds054; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Klickstein LB, 1997, IMMUNITY, V7, P345, DOI 10.1016/S1074-7613(00)80356-8; Kovacs GG, 2004, NEUROBIOL DIS, V15, P21, DOI 10.1016/j.nbd.2003.09.010; Krych-Goldberg M, 2001, IMMUNOL REV, V180, P112, DOI 10.1034/j.1600-065X.2001.1800110.x; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Larvie M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/929803; Lemere CA, 2003, NEUROBIOL DIS, V14, P10, DOI 10.1016/S0969-9961(03)00044-5; Leonard BW, 2009, J COMP NEUROL, V515, P269, DOI 10.1002/cne.22040; Liu D, 2009, IMMUNOPHARM IMMUNOT, V31, P524, DOI 10.3109/08923970902845768; Lue LF, 1996, NEUROBIOL AGING, V17, P421, DOI 10.1016/0197-4580(96)00006-1; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mahmoudi R, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.01.006; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; MAKRIDES SC, 1992, J BIOL CHEM, V267, P24754; Michel B, 2012, J IMMUNOL, V189, P4520, DOI 10.4049/jimmunol.1201579; MOLDENHAUER F, 1988, CLIN EXP IMMUNOL, V72, P74; Moulds JM, 1998, EXP CLIN IMMUNOGENET, V15, P291, DOI 10.1159/000019084; Nickells M, 1998, CLIN EXP IMMUNOL, V112, P27; PASCUAL M, 1993, J IMMUNOL, V151, P1702; Pisalyaput K, 2008, J NEUROCHEM, V104, P696, DOI 10.1111/j.1471-4159.2007.05012.x; RAFF MC, 1983, J NEUROSCI, V3, P1289; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; Rogers J, 2006, NEUROBIOL AGING, V27, P1733, DOI 10.1016/j.neurobiolaging.2005.09.043; Sadallah S, 1999, EUR J IMMUNOL, V29, P3754, DOI 10.1002/(SICI)1521-4141(199911)29:11<3754::AID-IMMU3754>3.3.CO;2-X; Shi QQ, 2015, J NEUROSCI, V35, P13029, DOI 10.1523/JNEUROSCI.1698-15.2015; Singhrao SK, 1999, LAB INVEST, V79, P1247; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Tetteh-Quarcoo PB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034820; Valazquez P, 1997, NAT MED, V3, P77, DOI 10.1038/nm0197-77; Van Cauwenberghe C, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.008; van den Berge SA, 2010, AGING CELL, V9, P313, DOI 10.1111/j.1474-9726.2010.00556.x; Villiers MB, 1996, IMMUNOLOGY, V89, P348, DOI 10.1046/j.1365-2567.1996.d01-747.x; Walker JR, 2013, J NEUROSCI, V33, P2457, DOI 10.1523/JNEUROSCI.3407-12.2013; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Zanjani H, 2005, ALZ DIS ASSOC DIS, V19, P55, DOI 10.1097/01.wad.0000165506.60370.94; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030	65	59	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149792	10.1371/journal.pone.0149792	http://dx.doi.org/10.1371/journal.pone.0149792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914463	Green Published, Green Submitted, gold			2022-12-27	WOS:000371175700027
J	Maltman, C; Walter, G; Yurkov, V				Maltman, Chris; Walter, Graham; Yurkov, Vladimir			A Diverse Community of Metal(loid) Oxide Respiring Bacteria Is Associated with Tube Worms in the Vicinity of the Juan de Fuca Ridge Black Smoker Field	PLOS ONE			English	Article							HYDROTHERMAL VENT; SP NOV.; GEN. NOV.; ANAEROBIC RESPIRATION; MICROBIAL COMMUNITIES; THAUERA-SELENATIS; WELL WATER; GOLD MINE; MONO LAKE; REDUCTION	Epibiotic bacteria associated with tube worms living in the vicinity of deep sea hydrothermal vents of the Juan de Fuca Ridge in the Pacific Ocean were investigated for the ability to respire anaerobically on tellurite, tellurate, selenite, selenate, metavanadate and orthovanadate as terminal electron acceptors. Out of 107 isolates tested, 106 were capable of respiration on one or more of these oxides, indicating that metal(loid) oxide based respiration is not only much more prevalent in nature than is generally believed, but also is an important mode of energy generation in the habitat. Partial 16S rRNA gene sequencing revealed the bacterial community to be rich and highly diverse, containing many potentially new species. Furthermore, it appears that the worms not only possess a close symbiotic relationship with chemolithotrophic sulfide-oxidizing bacteria, but also with the metal(loid) oxide transformers. Possibly they protect the worms through reduction of the toxic compounds that would otherwise be harmful to the host.	[Maltman, Chris; Walter, Graham; Yurkov, Vladimir] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Yurkov, V (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	vyurkov@umanitoba.ca			NSERC; University of Manitoba GETS grant	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); University of Manitoba GETS grant	This work was supported by a NSERC Discovery grant and a University of Manitoba GETS grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar SE, 2002, J BACTERIOL, V184, P1349, DOI 10.1128/JB.184.5.1349-1358.2002; Baesman SM, 2009, EXTREMOPHILES, V13, P695, DOI 10.1007/s00792-009-0257-z; Baesman SA, 2007, APPL ENVIRON MICROB, V73, P2135, DOI 10.1128/AEM.02558-06; Blum JS, 1998, ARCH MICROBIOL, V171, P19, DOI 10.1007/s002030050673; Blum JS, 2001, ARCH MICROBIOL, V175, P208; Bouroushian M, 2010, MONOGR ELECTROCHEM, P1, DOI 10.1007/978-3-642-03967-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Csotonyi JT, 2006, APPL ENVIRON MICROB, V72, P4950, DOI 10.1128/AEM.00223-06; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Ding LX, 2010, J GEN APPL MICROBIOL, V56, P267, DOI 10.2323/jgam.56.267; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Duperron S, 2014, DEEP-SEA RES PT 1, V2, P225; Duperron S, 2009, FEMS MICROBIOL ECOL, V69, P395, DOI 10.1111/j.1574-6941.2009.00724.x; Etezad SM, 2009, ENZYME MICROB TECH, V45, P1, DOI 10.1016/j.enzmictec.2009.04.004; Evtushenko LI, 2002, INT J SYST EVOL MICR, V52, P987, DOI 10.1099/00207713-52-3-987; Fontaine Kyle M., 2012, Plants-Basel, V1, P39, DOI 10.3390/plants1020039; Guzzo J, 2000, APPL ENVIRON MICROB, V66, P4972, DOI 10.1128/AEM.66.11.4972-4978.2000; HESSLER RR, 1988, DEEP-SEA RES, V35, P1681, DOI 10.1016/0198-0149(88)90044-1; Holden JF, 2003, CURR OPIN CHEM BIOL, V7, P160, DOI 10.1016/S1367-5931(03)00026-7; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huber JA, 2010, FEMS MICROBIOL ECOL, V73, P538, DOI 10.1111/j.1574-6941.2010.00910.x; James G, 2010, PCR FOR CLINICAL MICROBIOLOGY: AN AUSTRALIAN AND INTERNATIONAL PERSPECTIVE, P209, DOI 10.1007/978-90-481-9039-3_28; JEANTHON C, 1990, APPL ENVIRON MICROB, V56, P3308, DOI 10.1128/AEM.56.11.3308-3314.1990; Jeanthon C, 2000, ANTON LEEUW INT J G, V77, P117, DOI 10.1023/A:1002463825025; Jewett MC, 2009, J BACTERIOL, V191, P1083, DOI 10.1128/JB.00852-08; Kalmbach S, 1999, INT J SYST BACTERIOL, V49, P769, DOI 10.1099/00207713-49-2-769; Knott R, 1995, MINERALOGY SULFUR IS, P207; Lopez-Garcia P, 2002, ENVIRON MICROBIOL, V4, P204, DOI 10.1046/j.1462-2920.2002.00286.x; LOVLEY DR, 1993, ANNU REV MICROBIOL, V47, P263, DOI 10.1146/annurev.mi.47.100193.001403; MACY JM, 1993, INT J SYST BACTERIOL, V43, P135, DOI 10.1099/00207713-43-1-135; Maltman C, 2015, EXTREMOPHILES, V19, P1013, DOI 10.1007/s00792-015-0776-8; Michibata H, 2003, COORDIN CHEM REV, V237, P41, DOI 10.1016/S0010-8545(02)00278-3; MOYER CL, 1995, APPL ENVIRON MICROB, V61, P1555, DOI 10.1128/AEM.61.4.1555-1562.1995; Myers JM, 2004, APPL ENVIRON MICROB, V70, P1405, DOI 10.1128/AEM.70.3.1405-1412.2004; Narasingarao P, 2007, INT J SYST EVOL MICR, V57, P1937, DOI 10.1099/ijs.0.64980-0; Narasingarao P, 2007, APPL ENVIRON MICROB, V73, P3519, DOI 10.1128/AEM.02737-06; Narasingarao P, 2006, SYST APPL MICROBIOL, V29, P382, DOI 10.1016/j.syapm.2005.12.011; Ortiz-Bernad I, 2004, APPL ENVIRON MICROB, V70, P3091, DOI 10.1128/AEM.70.5.3091-3095.2004; Page A, 2004, GEOBIOLOGY, V2, P225, DOI 10.1111/j.1472-4677.2004.00034.x; Rauschenbach I, 2011, INT J SYST EVOL MICR, V61, P654, DOI 10.1099/ijs.0.022392-0; Schroder I, 1997, J BIOL CHEM, V272, P23765, DOI 10.1074/jbc.272.38.23765; Stolz JF, 1999, FEMS MICROBIOL REV, V23, P615, DOI 10.1016/S0168-6445(99)00024-8; Takai K, 2002, APPL ENVIRON MICROB, V68, P3046, DOI 10.1128/AEM.68.6.3046-3054.2002; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; TUNNICLIFFE V, 1990, PROG OCEANOGR, V24, P1, DOI 10.1016/0079-6611(90)90015-T; Van Dover C.L., 2000, ECOLOGY DEEP SEA HYD; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Xie W, 2011, ISME J, V5, P414, DOI 10.1038/ismej.2010.144; YURKOV V, 1994, INT J SYST BACTERIOL, V44, P427, DOI 10.1099/00207713-44-3-427; Yurkov VV, 2003, RECENT RES DEV BACTE, V1, P247; YURKOVA N A, 1990, Mikrobiologiya, V59, P968	54	11	11	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2016	11	2							e0149812	10.1371/journal.pone.0149812	http://dx.doi.org/10.1371/journal.pone.0149812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2LW	26914590	gold, Green Published			2022-12-27	WOS:000371175700028
J	Liu, HQ; Dong, CL; Zhao, TC; Han, JC; Wang, TL; Wen, XZ; Huang, Q				Liu, Huiqin; Dong, Chunling; Zhao, Tingchang; Han, Jucai; Wang, Tieling; Wen, Xiangzhen; Huang, Qi			Functional Analysis of the Ferric Uptake Regulator Gene fur in Xanthomonas vesicatoria	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; ORYZAE PV. ORYZAE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; MOLECULAR ANALYSIS; VIRULENCE FACTORS; SMALL RNAS; IRON; MOTILITY; POLYSACCHARIDES	Iron is essential for the growth and survival of many organisms. Intracellular iron homeostasis must be maintained for cell survival and protection against iron toxicity. The ferric uptake regulator protein (Fur) regulates the high-affinity ferric uptake system in many bacteria. To investigate the function of the fur gene in Xanthomonas vesicatoria (Xv), we generated a fur mutant strain, fur-m, by site-directed mutagenesis. Whereas siderophore production increased in the Xv fur mutant, extracellular polysaccharide production, biofilm formation, swimming ability and quorum sensing signals were all significantly decreased. The fur mutant also had significantly reduced virulence in tomato leaves. The above-mentioned phenotypes significantly recovered when the Xv fur mutation allele was complemented with a wild-type fur gene. Thus, Fur either negatively or positively regulates multiple important physiological functions in Xv.	[Liu, Huiqin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Liu, Huiqin; Dong, Chunling; Zhao, Tingchang; Wang, Tieling] Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China; [Liu, Huiqin; Han, Jucai] Shanxi Agr Univ, Agron Coll, Taigu, Shanxi, Peoples R China; [Wen, Xiangzhen] Shanxi Agr Univ, Hort Coll, Taigu, Shanxi, Peoples R China; [Huang, Qi] ARS, Floral & Nursery Plants Res Unit, USDA, Beltsville, MD USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Tianjin Agricultural University; Shanxi Agricultural University; Shanxi Agricultural University; United States Department of Agriculture (USDA)	Zhao, TC (corresponding author), Tianjin Agr Univ, Coll Hort & Landscape, Tianjin, Peoples R China.	tzhaotgcg@163.com		Dong, Chunling/0000-0003-3968-5556	earmarked fund for Modern Agro-industry Technology Research System [CARS-26]; Special Fund for Agro-scientific Research in the Public Interest [201003066]; ARS [ARS-0423161] Funding Source: Federal RePORTER	earmarked fund for Modern Agro-industry Technology Research System; Special Fund for Agro-scientific Research in the Public Interest; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the earmarked fund for Modern Agro-industry Technology Research System (CARS-26) and Special Fund for Agro-scientific Research in the Public Interest (201003066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Bahar O, 2009, MOL PLANT MICROBE IN, V22, P909, DOI 10.1094/MPMI-22-8-0909; Bender KS, 2007, APPL ENVIRON MICROB, V73, P5389, DOI 10.1128/AEM.00276-07; Brown I, 1995, MOL PLANT MICROBE IN, V8, P825, DOI 10.1094/MPMI-8-0825; Buttner D, 2003, J BIOTECHNOL, V106, P203, DOI 10.1016/j.jbiotec.2003.07.012; Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536; Cha C, 1998, MOL PLANT MICROBE IN, V11, P1119, DOI 10.1094/MPMI.1998.11.11.1119; Cha JY, 2008, BIOCHEM BIOPH RES CO, V366, P281, DOI 10.1016/j.bbrc.2007.11.021; Chen X, 2010, SPECIES PHYSL RACES; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Chugani SA, 2001, P NATL ACAD SCI USA, V98, P2752, DOI 10.1073/pnas.051624298; COHEN MS, 1987, ANTIMICROB AGENTS CH, V31, P1507, DOI 10.1128/AAC.31.10.1507; DENNY TP, 1995, ANNU REV PHYTOPATHOL, V33, P173, DOI 10.1146/annurev.py.33.090195.001133; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Harvie DR, 2005, MICROBIOL-SGM, V151, P569, DOI 10.1099/mic.0.27744-0; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; Ichinose Y, 2013, J GEN PLANT PATHOL, V79, P285, DOI 10.1007/s10327-013-0452-8; Inoue T, 2007, J BACTERIOL, V189, P950, DOI 10.1128/JB.01294-06; Jittawuttipoka T, 2010, ARCH MICROBIOL, V192, P331, DOI 10.1007/s00203-010-0558-8; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; Kaplan JB, 2004, ANTIMICROB AGENTS CH, V48, P2633, DOI 10.1128/AAC.48.7.2633-2636.2004; KAY E, 2006, MICROBE, V1, P63; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kazy SK, 2002, WORLD J MICROB BIOT, V18, P583, DOI 10.1023/A:1016354713289; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LABES M, 1990, GENE, V89, P37, DOI 10.1016/0378-1119(90)90203-4; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LATIFI A, 1995, MOL MICROBIOL, V17, P333, DOI 10.1111/j.1365-2958.1995.mmi_17020333.x; LINDOW SE, 1993, APPL ENVIRON MICROB, V59, P1593, DOI 10.1128/AEM.59.5.1593-1601.1993; Liu HQ, 2004, FUNCTION ANAL FUR GE; MacLean AA, 2006, APPL ENVIRON MICROB, V72, P5403, DOI 10.1128/AEM.00580-06; Marcotte L, 2007, ANAL BIOCHEM, V361, P7, DOI 10.1016/j.ab.2006.11.009; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; OCHSNER UA, 1995, J BACTERIOL, V177, P7194, DOI 10.1128/jb.177.24.7194-7201.1995; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; PARK SJ, 1995, J BACTERIOL, V177, P6255, DOI 10.1128/jb.177.21.6255-6262.1995; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Quinones B, 2005, MOL PLANT MICROBE IN, V18, P682, DOI 10.1094/MPMI-18-0682; Rui HP, 2008, FEMS MICROBIOL LETT, V285, P155, DOI 10.1111/j.1574-6968.2008.01185.x; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Subramoni S, 2005, MOL PLANT MICROBE IN, V18, P644, DOI 10.1094/MPMI-18-0644; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; Thieme F, 2005, J BACTERIOL, V187, P7254, DOI 10.1128/JB.187.21.7254-7266.2005; Torres VJ, 2010, INFECT IMMUN, V78, P1618, DOI 10.1128/IAI.01423-09; Venisse JS, 2001, PLANT PHYSIOL, V125, P2164, DOI 10.1104/pp.125.4.2164; Wang F, 2008, J MICROBIOL, V46, P350, DOI 10.1007/s12275-008-0038-x; Windgassen M, 2000, FEMS MICROBIOL LETT, V193, P201, DOI 10.1016/S0378-1097(00)00476-6; Yang WF, 2007, CURR MICROBIOL, V54, P307, DOI 10.1007/s00284-006-0485-8; Young GM, 1999, J BACTERIOL, V181, P2823, DOI 10.1128/JB.181.9.2823-2833.1999	55	8	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149280	10.1371/journal.pone.0149280	http://dx.doi.org/10.1371/journal.pone.0149280			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910324	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700028
J	Piersma, D; Fuermaier, ABM; de Waard, D; Davidse, RJ; de Groot, J; Doumen, MJA; Bredewoud, RA; Claesen, R; Lemstra, AW; Vermeeren, A; Ponds, R; Verhey, F; Brouwer, WH; Tucha, O				Piersma, Dafne; Fuermaier, Anselm B. M.; de Waard, Dick; Davidse, Ragnhild J.; de Groot, Jolieke; Doumen, Michelle J. A.; Bredewoud, Ruud A.; Claesen, Rene; Lemstra, Afina W.; Vermeeren, Annemiek; Ponds, Rudolf; Verhey, Frans; Brouwer, Wiebo H.; Tucha, Oliver			Prediction of Fitness to Drive in Patients with Alzheimer's Dementia	PLOS ONE			English	Article							QUALITY STANDARDS SUBCOMMITTEE; MINI-MENTAL-STATE; SIMULATOR SICKNESS; OLDER-ADULTS; PRACTICE PARAMETER; AMERICAN ACADEMY; PERFORMANCE; DISEASE; SAFETY; RISK	The number of patients with Alzheimer's disease (AD) is increasing and so is the number of patients driving a car. To enable patients to retain their mobility while at the same time not endangering public safety, each patient should be assessed for fitness to drive. The aim of this study is to develop a method to assess fitness to drive in a clinical setting, using three types of assessments, i.e. clinical interviews, neuropsychological assessment and driving simulator rides. The goals are (1) to determine for each type of assessment which combination of measures is most predictive for on-road driving performance, (2) to compare the predictive value of clinical interviews, neuropsychological assessment and driving simulator evaluation and (3) to determine which combination of these assessments provides the best prediction of fitness to drive. Eighty-one patients with AD and 45 healthy individuals participated. All participated in a clinical interview, and were administered a neuropsychological test battery and a driving simulator ride (predictors). The criterion fitness to drive was determined in an on-road driving assessment by experts of the CBR Dutch driving test organisation according to their official protocol. The validity of the predictors to determine fitness to drive was explored by means of logistic regression analyses, discriminant function analyses, as well as receiver operating curve analyses. We found that all three types of assessments are predictive of on-road driving performance. Neuropsychological assessment had the highest classification accuracy followed by driving simulator rides and clinical interviews. However, combining all three types of assessments yielded the best prediction for fitness to drive in patients with AD with an overall accuracy of 92.7%, which makes this method highly valid for assessing fitness to drive in AD. This method may be used to advise patients with AD and their family members about fitness to drive.	[Piersma, Dafne; Fuermaier, Anselm B. M.; de Waard, Dick; Doumen, Michelle J. A.; Brouwer, Wiebo H.; Tucha, Oliver] Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands; [Davidse, Ragnhild J.; de Groot, Jolieke] SWOV Inst Rd Safety Res, The Hague, Netherlands; [Bredewoud, Ruud A.; Claesen, Rene] CBR Dutch Driving Test Org, Rijswijk, Netherlands; [Lemstra, Afina W.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Alzheimer Ctr, Amsterdam, Netherlands; [Vermeeren, Annemiek] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, NL-6200 MD Maastricht, Netherlands; [Ponds, Rudolf; Verhey, Frans] Maastricht Univ, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Neuropsychol, NL-6200 MD Maastricht, Netherlands; [Brouwer, Wiebo H.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Maastricht University; Maastricht University; University of Groningen	Piersma, D (corresponding author), Univ Groningen, Dept Clin & Dev Neuropsychol, Groningen, Netherlands.	d.piersma@rug.nl	Tucha, Oliver/AAD-1403-2019; de Waard, Dick/G-8458-2016	de Waard, Dick/0000-0003-0262-4573; ponds, rudolf/0000-0002-9748-4659; Fuermaier, Anselm/0000-0002-2331-0840; Davidse, Ragnhild J./0000-0003-1808-8541	Ministerie van Infrastructuur en Milieu (NL) [5000001470, 31052108]	Ministerie van Infrastructuur en Milieu (NL)	This work was funded by Beschikkingsnummer: 5000001470, Zaaknummer: 31052108, https://www.rijksoverheid.nl/ministeries/ministerie-van-infrastructuur-en-milieu, Ministerie van Infrastructuur en Milieu (NL), WHB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alosco ML, 2011, DEMENT GER COGN D EX, V1, P358, DOI 10.1159/000333366; Anderson SW, 2012, J CLIN EXP NEUROPSYC, V34, P895, DOI 10.1080/13803395.2011.630654; Association A.P., 2000, DIAGN STAT MAN MENT, VFourth; Ball K, 2003, J AM GERIATR SOC, V51, P1499, DOI 10.1046/j.1532-5415.2003.51487.x; Bowers AR, 2013, ACCIDENT ANAL PREV, V59, P537, DOI 10.1016/j.aap.2013.06.037; Bridgeman B, 2014, HUM FACTORS, V56, P1472, DOI 10.1177/0018720814533992; Brouwer W, 2010, HDB OUDERENPSYCHIATR, P183; Brouwer W, 2011, HDB DRIVING SIMULATI, V50-1-50-11; Brown LB, 2004, J GERIATR PSYCH NEUR, V17, P232, DOI 10.1177/0891988704269825; Carr DB, 2015, INT PSYCHOGERIATR, V27, P1613, DOI 10.1017/S104161021500085X; Chaparro A, 2004, P HUM FACT ERG SOC A, V48, P2319, DOI [10.1177/154193120404801924, DOI 10.1177/154193120404801924]; Classen S, 2013, AM J OCCUP THER, V67, P108, DOI 10.5014/ajot.2013.005116; Classen S, 2011, AM J OCCUP THER, V65, P179, DOI 10.5014/ajot.2011.000802; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cornutiu Gavril, 2015, J Clin Med Res, V7, P657, DOI 10.14740/jocmr2106w; Dawson JD, 2009, NEUROLOGY, V72, P521, DOI 10.1212/01.wnl.0000341931.35870.49; Dobbs BM, 2002, NEUROLOGIST, V8, P61, DOI 10.1097/00127893-200203000-00001; Dobbs BM, 2013, AGE AGEING, V42, P577, DOI 10.1093/ageing/aft073; Domeyer JE, 2013, ACCIDENT ANAL PREV, V53, P127, DOI 10.1016/j.aap.2012.12.039; Drane DL, 2002, NEUROPSY NEUROPSY BE, V15, P39; Dubinsky RM, 2000, NEUROLOGY, V54, P2205, DOI 10.1212/WNL.54.12.2205; Duchek JM, 2003, J AM GERIATR SOC, V51, P1342, DOI 10.1046/j.1532-5415.2003.51481.x; Edwards CJ, 2003, P 2 INT DRIV S HUM F; Ernst J, 2010, NERVENARZT, V81, P79, DOI 10.1007/s00115-009-2847-5; Etienne V, 2013, IATSS RES, V37, P16, DOI 10.1016/j.iatssr.2013.06.005; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freund B, 2002, J AM GERIATR SOC, V50, P1309, DOI 10.1046/j.1532-5415.2002.50325.x; HUNT L, 1993, J AM GERIATR SOC, V41, P747, DOI 10.1111/j.1532-5415.1993.tb07465.x; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Kay LG, 2012, AUST OCCUP THER J, V59, P89, DOI 10.1111/j.1440-1630.2011.00989.x; Keshavarz B, 2015, EXP BRAIN RES, V233, P1353, DOI 10.1007/s00221-015-4209-9; Kok RM., 2002, MINIMENTAL STATE EXA; Lacy M, 2015, AM J ALZHEIMERS DIS, V30, P145, DOI 10.1177/1533317514539378; Levy J, 2008, APPL COGNITIVE PSYCH, V22, P507, DOI 10.1002/acp.1378; Lincoln NB, 2006, INT J GERIATR PSYCH, V21, P1044, DOI 10.1002/gps.1604; Louwerens JW., 1987, ALCOHOL DRUGS TRAFFI, P183, DOI DOI 10.1080/15389588.2014.935356; Lundberg C, 1997, ALZ DIS ASSOC DIS, V11, P28, DOI 10.1097/00002093-199703000-00006; MACCALLUM RC, 1992, PSYCHOL BULL, V111, P490, DOI 10.1037/0033-2909.111.3.490; Manning KJ, 2014, ARCH CLIN NEUROPSYCH, V29, P1, DOI 10.1093/arclin/act088; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Molnar F, 2009, GERIATR AGING, V12, P83; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mullen NW, 2010, AM J OCCUP THER, V64, P288, DOI 10.5014/ajot.64.2.288; Mullen R, 1996, INT J GERIATR PSYCH, V11, P645; O'Connor ML, 2013, ACCIDENT ANAL PREV, V61, P197, DOI 10.1016/j.aap.2013.05.010; Ott BR, 2005, J AM GERIATR SOC, V53, P829, DOI 10.1111/j.1532-5415.2005.53265.x; Piersma D, 2016, TRAFFIC INJ PREV, V17, P9, DOI 10.1080/15389588.2015.1038786; Prieler J, 2008, MANUAL RT REACTION T; REBOK GW, 1994, ALZ DIS ASSOC DIS, V8, P228, DOI 10.1097/00002093-199408040-00002; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Rizzo M, 2001, ALZ DIS ASSOC DIS, V15, P10, DOI 10.1097/00002093-200101000-00002; Schuhfried G, 2009, MANUAL ATAVT 22, V22; Schuhfried G, 2012, VIENNA TEST SYSTEM T; Silverstein N, 2015, DEMENTIA CARE EVIDEN, P123; Smits LL, 2015, EUR NEUROPSYCHOPHARM, V25, P1010, DOI 10.1016/j.euroneuro.2015.03.014; Snyder Charlene Hoffman, 2005, J Am Acad Nurse Pract, V17, P393, DOI 10.1111/j.1745-7599.2005.00070.x; Staplin L, 2013, ACCIDENT ANAL PREV, V50, P483, DOI 10.1016/j.aap.2012.05.025; Tant MLM, 2002, NEUROPSYCHOL REHABIL, V12, P419, DOI 10.1080/09602010244000183; Taylor BD, 2001, ACCIDENT ANAL PREV, V33, P519, DOI 10.1016/S0001-4575(00)00065-8; Uc EY, 2004, NEUROLOGY, V63, P832, DOI 10.1212/01.WNL.0000139301.01177.35; van Wolffelaar P. C, 1993, GENERIC INTELLIGENT, P175; Vaucher P, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-123; Veldstra JL, 2015, PSYCHOPHARMACOLOGY, V232, P2911, DOI 10.1007/s00213-015-3927-9; Vlakveld W, 2011, THESIS U GRONINGEN G; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Withaar FK, 2000, DIVIDED ATTENTION DR; Wood JM, 2008, J AM GERIATR SOC, V56, P986, DOI 10.1111/j.1532-5415.2008.01709.x; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	70	48	50	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149566	10.1371/journal.pone.0149566	http://dx.doi.org/10.1371/journal.pone.0149566			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DF2IA	26910535	Green Submitted, gold, Green Published			2022-12-27	WOS:000371164700041
J	Ribacke, KJB; van Duinen, AJ; Nordenstedt, H; Hoijer, J; Molnes, R; Froseth, TW; Koroma, AP; Darj, E; Bolkan, HA; Ekstrom, A				Ribacke, Kim J. Brolin; van Duinen, Alex J.; Nordenstedt, Helena; Hoijer, Jonas; Molnes, Ragnhild; Froseth, Torunn Wigum; Koroma, A. P.; Darj, Elisabeth; Bolkan, Hakon Angel; Ekstrom, AnnaMia			The Impact of the West Africa Ebola Outbreak on Obstetric Health Care in Sierra Leone	PLOS ONE			English	Article								Background As Sierra Leone celebrates the end of the Ebola Virus Disease (EVD) outbreak, we can begin to fully grasp its impact on already weak health systems. The EVD outbreak in West Africa forced many hospitals to close down or reduce their activity, either to prevent nosocomial transmission or because of staff shortages. The aim of this study is to assess the potential impact of EVD on nationwide access to obstetric care in Sierra Leone. Methods and Findings Community health officers collected weekly data between January 2014-May 2015 on inhospital deliveries and caesarean sections (C-sections) from all open facilities (public, private for-profit and private non-profit sectors) offering emergency obstetrics in Sierra Leone. This was compared to official data of EVD cases per district. Logistic and Poisson regression analyses were used to compute risk and rate estimates. Nationwide, the number of inhospital deliveries and C-sections decreased by over 20% during the EVD outbreak. The decline occurred early on in the EVD outbreak and was mainly attributable to the closing of private not-for-profit hospitals rather than government facilities. Due to difficulties in collecting data in the midst of an epidemic, limitations of this study include some missing data points. Conclusions Both the number of in-hospital deliveries and C-sections substantially declined shortly after the onset of the EVD outbreak. Since access to emergency obstetric care, like C-sections, is associated with decreased maternal mortality, many women are likely to have died due to the reduced access to appropriate care during childbirth. Future research on indirect health effects of health system breakdown should ideally be nationwide and continue also into the recovery phase. It is also important to understand the mechanisms behind the deterioration so that important health services can be reestablished.	[Ribacke, Kim J. Brolin; Nordenstedt, Helena; Ekstrom, AnnaMia] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [van Duinen, Alex J.; Bolkan, Hakon Angel] St Olav Hosp, Dept Surg, Trondheim, Norway; [van Duinen, Alex J.; Bolkan, Hakon Angel] CapaCare, Trondheim, Norway; [Hoijer, Jonas] Karolinska Inst, Inst Environm Med, Unit Biostat, Stockholm, Sweden; [Molnes, Ragnhild; Froseth, Torunn Wigum; Darj, Elisabeth] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Koroma, A. P.] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Darj, Elisabeth] St Olav Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Bolkan, Hakon Angel] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway; [Ekstrom, AnnaMia] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden	Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Norwegian University of Science & Technology (NTNU); Ministry of Health & Sanitation Sierra Leone; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Karolinska Institutet; Karolinska University Hospital	Ribacke, KJB (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	kim.brolin@ki.se	van Duinen, Alex/Q-2504-2019	van Duinen, Alex/0000-0002-6943-0100; Bolkan, Hakon Angell/0000-0002-9609-4093	Swedish National Board of Health and Welfare; Wallenberg Foundation; CapaCare; Norwegian University of Science and Technology	Swedish National Board of Health and Welfare; Wallenberg Foundation(European Commission); CapaCare; Norwegian University of Science and Technology	This study was funded by the Swedish National Board of Health and Welfare, The Wallenberg Foundation, CapaCare and the Norwegian University of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barden-O'Fallon J, 2015, PLOS CURRENTS, V7; Bolkan HA, 2014, PLOS CURRENTS, V6; Bolkan HA, 2015, SURGERY, V157, P992, DOI 10.1016/j.surg.2014.12.028; Donnelly J, 2011, LANCET, V377, P1393, DOI 10.1016/S0140-6736(11)60559-X; Dorwie FM, 2014, J TRANSCULT NURS, V25, P33, DOI 10.1177/1043659613503874; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Hayden EC, 2015, NATURE, V519, P24, DOI 10.1038/519024a; Hayden EC, 2014, NATURE, V516, P294, DOI 10.1038/516295a; Iyengar P, 2015, PLOS CURRENTS, V7; Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540; Lori JR, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0694-x; Ministry of Health and Sanitation SL, EB VIR DIS UPD 2015; *UNICEF, STAT WORLDS CHILDR 2; UNICEF, 2015, SIERR LEON HLTH FAC; WHO, 2015, EB SIT REP; WHO, 2015, EB VIR DIS SIERR LEO; WHO UNICEF UNFPA Bank W & UNDP, 2014, TRENDS MAT MORT 1990; World Health Organization Human Reproduction Programme 10 April 2015, 2015, Reprod Health Matters, V23, P149, DOI 10.1016/j.rhm.2015.07.007; Ye J, 2015, BJOG INT J OBSTET GY	19	61	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150080	10.1371/journal.pone.0150080	http://dx.doi.org/10.1371/journal.pone.0150080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910462	Green Published, Green Submitted, gold			2022-12-27	WOS:000371164700062
J	Shao, YX; Wei, JB; Wu, FL; Zhang, HH; Yang, DF; Liang, ZS; Jin, WB				Shao, Yuxuan; Wei, Jiabo; Wu, Fangli; Zhang, Haihua; Yang, Dongfeng; Liang, Zongsuo; Jin, Weibo			DsTRD: Danshen Transcriptional Resource Database	PLOS ONE			English	Article							ANNOTATION	Salvia miltiorrhiza has been comprehensively studied as a medicinal model plant. However, research progress on this species is significantly hindered by its unavailable genome sequences and limited number of expressed sequence tags in the National Center for Biotechnology Information database. Thus, a transcript database must be developed to assist researchers to browse, search, and align sequences for gene cloning and functional analysis in S. miltiorrhiza. In this study, the Danshen Transcriptional Resource Database (DsTRD) was built using 76,531 transcribed sequences assembled from 12 RNA-Seq transcriptomes. Among these 12 RNA-seq data, ten were downloaded from NCBI database. The remaining two were enced on the Hiseq2000 platform using the stem and hairy-root of S. miltiorrhiza. The transcripts were annotated as protein-coding RNAs, long non-coding RNAs, microRNA precursors, and phased secondary small-interfering RNA genes through several bioinformatics methods. The tissue expression levels for each transcript were also calculated and presented in terms of RNA-Seq data. Overall, DsTRD facilitates browsing and searching for sequences and functional annotations of S. miltiorrhiza. DsTRD is freely available at http://bi.sky.zstu.edu.cn/DsTRD/home.php.	[Shao, Yuxuan; Wei, Jiabo; Wu, Fangli; Zhang, Haihua; Yang, Dongfeng; Liang, Zongsuo; Jin, Weibo] Zhejiang Sci Tech Univ, Inst Bioengn, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China	Zhejiang Sci-Tech University	Liang, ZS; Jin, WB (corresponding author), Zhejiang Sci Tech Univ, Inst Bioengn, Coll Life Sci, Hangzhou 310018, Zhejiang, Peoples R China.	liangzs@ms.iswc.ac.cn; weibojin@gmail.com			521 Talent Foundation of Zhejiang Sci-Tech University; Doctoral Scientific Research Foundation of Zhejiang Sci-Tech University; grants of the Natural Science Foundation of China [81373908, 81403033]	521 Talent Foundation of Zhejiang Sci-Tech University; Doctoral Scientific Research Foundation of Zhejiang Sci-Tech University; grants of the Natural Science Foundation of China	This work was supported by the 521 Talent Foundation of Zhejiang Sci-Tech University, the website is http://www.zstu.edu.cn/. This work was supported by the Doctoral Scientific Research Foundation of Zhejiang Sci-Tech University, the website is http://www.zstu.edu.cn/. This work was supported by the grants of the Natural Science Foundation of China (grant No. 81373908 and 81403033), and the website is http://isisn.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell MJ, 2013, RNA, V19, P740, DOI 10.1261/rna.035279.112; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Guo QL, 2015, BIOINFORMATICS, V31, P284, DOI 10.1093/bioinformatics/btu628; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Thakur V, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-108	9	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0149747	10.1371/journal.pone.0149747	http://dx.doi.org/10.1371/journal.pone.0149747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26909679	Green Submitted, Green Published, gold			2022-12-27	WOS:000371164700046
J	Teixeira, ND				Teixeira, Nuno De Sa			How Fast Do Objects Fall in Visual Memory? Uncovering the Temporal and Spatial Features of Representational Gravity	PLOS ONE			English	Article							INTERNAL-MODELS; CENTRIPETAL FORCE; FINAL POSITION; EYE-MOVEMENTS; ICONIC MEMORY; MOMENTUM; DISPLACEMENT; MOTION; MISLOCALIZATION; PSYCHOPHYSICS	Visual memory for the spatial location where a moving target vanishes has been found to be systematically displaced downward in the direction of gravity. Moreover, it was recently reported that the magnitude of the downward error increases steadily with increasing retention intervals imposed after object's offset and before observers are allowed to perform the spatial localization task, in a pattern where the remembered vanishing location drifts downward as if following a falling trajectory. This outcome was taken to reflect the dynamics of a representational model of earth's gravity. The present study aims to establish the spatial and temporal features of this downward drift by taking into account the dynamics of the motor response. The obtained results show that the memory for the last location of the target drifts downward with time, thus replicating previous results. Moreover, the time taken for completion of the behavioural localization movements seems to add to the imposed retention intervals in determining the temporal frame during which the visual memory is updated. Overall, it is reported that the representation of spatial location drifts downward by about 3 pixels for each two-fold increase of time until response. The outcomes are discussed in relation to a predictive internal model of gravity which outputs an on-line spatial update of remembered objects' location.	[Teixeira, Nuno De Sa] Univ Coimbra, Inst Cognit Psychol, Coimbra, Portugal	Universidade de Coimbra	Teixeira, ND (corresponding author), Univ Coimbra, Inst Cognit Psychol, Coimbra, Portugal.	nuno_desateixeira@fpce.uc.pt	De Sá Teixeira, N. A./H-6014-2019	De Sá Teixeira, N. A./0000-0003-4915-7802	Fundacao para a Ciencia e Tecnologia (PT) [SFRH/BPD/84118/2012]	Fundacao para a Ciencia e Tecnologia (PT)	This work was supported by Fundacao para a Ciencia e Tecnologia (PT): grant SFRH/BPD/84118/2012.	Angelaki DE, 2004, NATURE, V430, P560, DOI 10.1038/nature02754; Bradley C, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00355; COLTHEART M, 1980, PERCEPT PSYCHOPHYS, V27, P183, DOI 10.3758/BF03204258; Teixeira NAD, 2014, J VESTIBUL RES-EQUIL, V24, P267, DOI 10.3233/VES-140511; Teixeira NAD, 2013, J EXP PSYCHOL HUMAN, V39, P1690, DOI 10.1037/a0031777; FREYD JJ, 1987, J EXP PSYCHOL LEARN, V13, P259, DOI 10.1037/0278-7393.13.2.259; FREYD JJ, 1985, B PSYCHONOMIC SOC, V23, P443; FREYD JJ, 1984, J EXP PSYCHOL LEARN, V10, P126, DOI 10.1037/0278-7393.10.1.126; Hubbard TL, 2014, PSYCHON B REV, V21, P1371, DOI 10.3758/s13423-014-0624-3; Hubbard TL, 1997, J EXP PSYCHOL LEARN, V23, P1484, DOI 10.1037/0278-7393.23.6.1484; Hubbard TL, 2005, PSYCHON B REV, V12, P822, DOI 10.3758/BF03196775; Hubbard TL, 2006, PSYCHON B REV, V13, P174, DOI 10.3758/BF03193830; HUBBARD TL, 1988, PERCEPT PSYCHOPHYS, V44, P211, DOI 10.3758/BF03206290; Hubbard TL, 2001, J EXP PSYCHOL LEARN, V27, P294, DOI 10.1037/0278-7393.27.1.294; Hubbard TL, 1996, J EXP PSYCHOL LEARN, V22, P1049, DOI 10.1037/0278-7393.22.4.1049; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; IRWIN DE, 1986, J EXP PSYCHOL HUMAN, V12, P343, DOI 10.1037/0096-1523.12.3.343; Kerzel D, 2006, PSYCHON B REV, V13, P166, DOI 10.3758/BF03193829; Kerzel D, 2003, J EXP PSYCHOL LEARN, V29, P458, DOI 10.1037/0278-7393.29.3.458; Kerzel D, 2002, PERCEPT PSYCHOPHYS, V64, P680, DOI 10.3758/BF03194735; Kerzel D, 2001, J EXP PSYCHOL HUMAN, V27, P829, DOI 10.1037//0096-1523.27.4.829; Kerzel D, 2000, VISION RES, V40, P3703, DOI 10.1016/S0042-6989(00)00226-1; Lacquaniti F, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00101; Ludwig CJH, 2002, BEHAV RES METH INS C, V34, P618, DOI 10.3758/BF03195490; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nijhawan R, 2008, BEHAV BRAIN SCI, V31, P179, DOI 10.1017/S0140525X08003804; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Sheth BR, 2001, VISION RES, V41, P329, DOI 10.1016/S0042-6989(00)00230-3; Smithson H, 2006, Q J EXP PSYCHOL, V59, P150, DOI 10.1080/17470210500269345; SPERLING G, 1960, PSYCHOL MONOGRAPHS, V74; Teixeira ND, 2014, J EXP PSYCHOL LEARN, V40, P1664, DOI 10.1037/xlm0000011; Teixeira ND, 2014, ATTEN PERCEPT PSYCHO, V76, P1106, DOI 10.3758/s13414-014-0626-2; Teixeira ND, 2010, PSICOLOGICA, V31, P659; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0148953	10.1371/journal.pone.0148953	http://dx.doi.org/10.1371/journal.pone.0148953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910260	Green Published, gold			2022-12-27	WOS:000371164700017
J	Yang, YH; Buhamrah, A; Schneider, A; Lin, YL; Zhou, H; Bugshan, A; Basile, JR				Yang, Ying-Hua; Buhamrah, Asma; Schneider, Abraham; Lin, Yi-Ling; Zhou, Hua; Bugshan, Amr; Basile, John R.			Semaphorin 4D Promotes Skeletal Metastasis in Breast Cancer	PLOS ONE			English	Article							TUMOR-INDUCED ANGIOGENESIS; BONE HISTOMORPHOMETRY; PROSTATE-CANCER; OSTEOCLASTOGENESIS; PLEXIN-B1; EXPRESSION; CELLS; MICE; IL-8; NOMENCLATURE	Bone density is controlled by interactions between osteoclasts, which resorb bone, and osteoblasts, which deposit it. The semaphorins and their receptors, the plexins, originally shown to function in the immune system and to provide chemotactic cues for axon guidance, are now known to play a role in this process as well. Emerging data have identified Semaphorin 4D (Sema4D) as a product of osteoclasts acting through its receptor Plexin-B1 on osteoblasts to inhibit their function, tipping the balance of bone homeostasis in favor of resorption. Breast cancers and other epithelial malignancies overexpress Sema4D, so we theorized that tumor cells could be exploiting this pathway to establish lytic skeletal metastases. Here, we use measurements of osteoblast and osteoclast differentiation and function in vitro and a mouse model of skeletal metastasis to demonstrate that both soluble Sema4D and protein produced by the breast cancer cell line MDA-MB-231 inhibits differentiation of MC3T3 cells, an osteoblast cell line, and their ability to form mineralized tissues, while Sema4D-mediated induction of IL-8 and LIX/CXCL5, the murine homologue of IL-8, increases osteoclast numbers and activity. We also observe a decrease in the number of bone metastases in mice injected with MDA-MB-231 cells when Sema4D is silenced by RNA interference. These results are significant because treatments directed at suppression of skeletal metastases in bone-homing malignancies usually work by arresting bone remodeling, potentially leading to skeletal fragility, a significant problem in patient management. Targeting Sema4D in these cancers would not affect bone remodeling and therefore could elicit an improved therapeutic result without the debilitating side effects.	[Yang, Ying-Hua; Buhamrah, Asma; Schneider, Abraham; Zhou, Hua; Bugshan, Amr; Basile, John R.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Schneider, Abraham; Basile, John R.] Greenebaum Canc Ctr, Baltimore, MD USA; [Lin, Yi-Ling] Univ Calif Los Angeles, Sch Dent, Div Diagnost & Surg Sci, Los Angeles, CA 90024 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of California System; University of California Los Angeles	Basile, JR (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.; Basile, JR (corresponding author), Greenebaum Canc Ctr, Baltimore, MD USA.	jbasile@umaryland.edu	Schneider, Abraham/AAR-5941-2021; Bugshan, Amr/AAH-8565-2019		National Cancer Institute [R01-CA133162]; NATIONAL CANCER INSTITUTE [R01CA133162] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.R.B was supported by a National Cancer Institute grant R01-CA133162 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Meenakshi A. Chellaiah of the University of Maryland Dental School for the luciferase-expressing breast cancer cell lines and Ernest Smith and Maurice Zauderer of Vaccinex, Inc., for providing the anti-SEMA4D antibody and offering technical support. J.R.B was supported by a National Cancer Institute grant R01-CA133162.	Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bender RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061788; Ch'ng E, 2007, CANCER-AM CANCER SOC, V110, P164, DOI 10.1002/cncr.22764; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Clezardin P, 2007, CLIN EXP METASTAS, V24, P599, DOI 10.1007/s10585-007-9112-8; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Dacquin R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026627; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Deng SH, 2007, J NEUROSCI, V27, P6333, DOI 10.1523/JNEUROSCI.5381-06.2007; Evans EE, 2015, CANCER IMMUNOL RES, V3, P689, DOI 10.1158/2326-6066.CIR-14-0171; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; Hernandez M, 2011, J PERIODONTAL RES, V46, P58, DOI 10.1111/j.1600-0765.2010.01310.x; Hol J, 2010, J LEUKOCYTE BIOL, V87, P501, DOI 10.1189/jlb.0809532; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Hsu YL, 2010, CARCINOGENESIS, V31, P587, DOI 10.1093/carcin/bgq030; Hwang YS, 2012, ORAL ONCOL, V48, P40, DOI 10.1016/j.oraloncology.2011.08.022; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Matsumoto T, 2011, BONE, V48, P129, DOI 10.1016/j.bone.2010.05.036; Moriarity BS, 2015, NAT GENET; Nanjundaiah SM, 2012, J BIOL CHEM, V287, P22216, DOI 10.1074/jbc.M112.356816; Negishi-Koga Takako, 2012, Bonekey Rep, V1, P183, DOI 10.1038/bonekey.2012.183; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Paddison Patrick J, 2004, Methods Mol Biol, V265, P85; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; SABOKBAR A, 1994, BONE MINER, V27, P57, DOI 10.1016/S0169-6009(08)80187-0; Schneider A, 2005, ENDOCRINOLOGY, V146, P1727, DOI 10.1210/en.2004-1211; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Smith ES, 2015, NEUROBIOL DIS, V73, P254, DOI 10.1016/j.nbd.2014.10.008; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Sutton ALM, 2008, MOL ENDOCRINOL, V22, P1370, DOI 10.1210/me.2007-0363; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Verlinden L, 2013, BONE, V55, P465, DOI 10.1016/j.bone.2013.03.023; Wang JS, 2015, WORLD J GASTROENTERO, V21, P2191, DOI 10.3748/wjg.v21.i7.2191; Wang S, 2015, INNATE IMMUN-LONDON, V21, P726, DOI 10.1177/1753425915593162; Wong OGW, 2007, P NATL ACAD SCI USA, V104, P19040, DOI 10.1073/pnas.0702544104; Worzfeld T, 2012, J CLIN INVEST, V122, P1296, DOI 10.1172/JCI60568; Yamauchi M, 2005, AM J PHYSIOL-ENDOC M, V288, pE608, DOI 10.1152/ajpendo.00229.2004; Yang YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025826; Yazdani U, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-211; Yoshida Y, 2015, ARTHRITIS RHEUMATOL; Zhou H, 2012, ANGIOGENESIS	50	26	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 24	2016	11	2							e0150151	10.1371/journal.pone.0150151	http://dx.doi.org/10.1371/journal.pone.0150151			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2IA	26910109	gold, Green Published, Green Submitted			2022-12-27	WOS:000371164700071
J	Agallou, M; Athanasiou, E; Samiotaki, M; Panayotou, G; Karagouni, E				Agallou, Maria; Athanasiou, Evita; Samiotaki, Martina; Panayotou, George; Karagouni, Evdokia			Identification of Immunoreactive Leishmania infantum Protein Antigens to Asymptomatic Dog Sera through Combined Immunoproteomics and Bioinformatics Analysis	PLOS ONE			English	Article							CANINE VISCERAL LEISHMANIASIS; POTENTIAL VACCINE CANDIDATES; LONG-LASTING PROTECTION; FACTOR-ALPHA PRODUCTION; PROTEOMIC ANALYSIS; CUTANEOUS LEISHMANIASIS; DONOVANI PROMASTIGOTES; INTRANASAL VACCINATION; SYSTEMIC CANDIDIASIS; VIANNIA BRAZILIENSIS	Leishmania infantum is the etiologic agent of zoonotic visceral leishmaniasis (VL) in countries in the Mediterranean basin, where dogs are the domestic reservoirs and represent important elements in the transmission of the disease. Since the major focal areas of human VL exhibit a high prevalence of seropositive dogs, the control of canine VL could reduce the infection rate in humans. Efforts toward this have focused on the improvement of diagnostic tools, as well as on vaccine development. The identification of parasite antigens including suitable major histocompatibility complex (MHC) class I-and/or II-restricted epitopes is very important since disease protection is characterized by strong and long-lasting CD8(+) T and CD4(+) Th1 cell-dominated immunity. In the present study, total protein extract from late-log phase L. infantum promastigotes was analyzed by two-dimensional western blots and probed with sera from asymptomatic and symptomatic dogs. A total of 42 protein spots were found to differentially react with IgG from asymptomatic dogs, while 17 of these identified by Coommasie stain were extracted and analyzed. Of these, 21 proteins were identified by mass spectrometry; they were mainly involved in metabolism and stress responses. An in silico analysis predicted that the chaperonin HSP60, dihydrolipoamide dehydrogenase, enolase, cyclophilin 2, cyclophilin 40, and one hypothetical protein contain promiscuous MHCI and/or MHCII epitopes. Our results suggest that the combination of immunoproteomics and bioinformatics analyses is a promising method for the identification of novel candidate antigens for vaccine development or with potential use in the development of sensitive diagnostic tests.	[Agallou, Maria; Athanasiou, Evita; Karagouni, Evdokia] Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece; [Athanasiou, Evita] Aristotle Univ Thessaloniki, Dept Chem Engn, Chem Engn Lab, Dept Anal Design & Control Chem Proc, GR-54006 Thessaloniki, Greece; [Samiotaki, Martina; Panayotou, George] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece	Aristotle University of Thessaloniki; Alexander Fleming Biomedical Sciences Research Center	Karagouni, E (corresponding author), Hellenic Pasteur Inst, Dept Microbiol, Cellular Immunol Lab, Athens, Greece.	ekaragouni@pasteur.gr	Samiotaki, Martina/B-3851-2018; Agallou, Maria/AAC-6502-2020	Samiotaki, Martina/0000-0001-9952-0636; Agallou, Maria/0000-0003-0241-1340; Karagouni, Evdokia/0000-0002-0987-4877	Actions "KRIPIS" [MIS 450598, MIS448143]; European Union; National Ministry of Education and Religion Affairs; General Secretariat of Research and Technology (GSRT)	Actions "KRIPIS"; European Union(European Commission); National Ministry of Education and Religion Affairs; General Secretariat of Research and Technology (GSRT)(Greek Ministry of Development-GSRT)	This work was supported by grants from the Actions "KRIPIS" (MIS 450598 and MIS448143) awarded to EK and GP, respectively. These two Actions were co-financed by European Union and the National Ministry of Education and Religion Affairs under the Operational Strategic Reference Framework (NSFR 2007-2013) and the General Secretariat of Research and Technology (GSRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanades DR, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001687; Alexandre-Pires G, 2010, VET IMMUNOL IMMUNOP, V137, P275, DOI 10.1016/j.vetimm.2010.06.007; ALVAR J, 1994, ANN TROP MED PARASIT, V88, P371, DOI 10.1080/00034983.1994.11812879; Ashford RW, 1996, CLIN DERMATOL, V14, P523, DOI 10.1016/0738-081X(96)00041-7; Athanasiou LV, 2012, ACTA TROP, V122, P291, DOI 10.1016/j.actatropica.2012.02.003; Barhoumi M, 2013, PARASITE IMMUNOL, V35, P194, DOI 10.1111/pim.12026; Barhoumi M, 2011, PARASITE IMMUNOL, V33, P583, DOI 10.1111/j.1365-3024.2011.01320.x; Bente M, 2003, PROTEOMICS, V3, P1811, DOI 10.1002/pmic.200300462; Braga MS, 2014, MOL BIOCHEM PARASIT, V195, P43, DOI 10.1016/j.molbiopara.2014.07.001; Bras-Goncalves R, 2014, INFECT GENET EVOL, V24, P1, DOI 10.1016/j.meegid.2014.02.017; Brotherton MC, 2014, INT J PARASITOL-DRUG, V4, P126, DOI 10.1016/j.ijpddr.2014.05.002; Brotherton MC, 2010, J PROTEOME RES, V9, P3842, DOI 10.1021/pr100048m; Bull PC, 2005, J INFECT DIS, V192, P1119, DOI 10.1086/432761; Cardoso L, 2007, VET IMMUNOL IMMUNOP, V117, P35, DOI 10.1016/j.vetimm.2007.01.014; Carnielli JBT, 2014, J PROTEOMICS, V108, P198, DOI 10.1016/j.jprot.2014.05.010; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Cuervo P, 2009, J PROTEOMICS, V73, P79, DOI 10.1016/j.jprot.2009.08.006; Cunningham DA, 2005, MOL MICROBIOL, V58, P636, DOI 10.1111/j.1365-2958.2005.04840.x; Dantas-Torres F, 2016, TRENDS PARASITOL, V32, P43, DOI 10.1016/j.pt.2015.09.004; Gomes DCD, 2012, PARASITOLOGY, V139, P1562, DOI 10.1017/S0031182012000868; Dea-Ayuela MA, 2006, PROTEOMICS, V6, P4187, DOI 10.1002/pmic.200600101; do Monte-Neto RL, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001167; Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4; Duarte MC, 2015, CLIN VACCINE IMMUNOL, V22, P1187, DOI 10.1128/CVI.00465-15; Dubois ME, 2005, INFECT IMMUN, V73, P2690, DOI 10.1128/IAI.73.5.2690-2697.2005; Dunston CR, 2015, J PHARM PHARMACOL, V67, P290, DOI 10.1111/jphp.12383; Esgleas M, 2009, FEMS MICROBIOL LETT, V294, P82, DOI 10.1111/j.1574-6968.2009.01551.x; Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095; Fernandes AP, 2012, CURR OPIN MICROBIOL, V15, P476, DOI 10.1016/j.mib.2012.05.002; Fernandez-Perez FJ, 2003, ACTA TROP, V86, P83, DOI 10.1016/S0001-706X(03)00004-4; Finco O, 2005, VACCINE, V23, P1178, DOI 10.1016/j.vaccine.2004.07.045; Forgber M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000040; Frank SA, 2006, INFECT GENET EVOL, V6, P141, DOI 10.1016/j.meegid.2004.10.005; Fujiwara RT, 2005, VET RES, V36, P827, DOI 10.1051/vetres:2005033; Gradoni L, 2015, VET PARASITOL, V208, P94, DOI 10.1016/j.vetpar.2015.01.003; Gupta R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086073; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Kamoun-Essghaier S, 2005, CLIN DIAGN LAB IMMUN, V12, P310, DOI 10.1128/CDLI.12.2.310-320.2005; Kaur H, 2015, PARASITE IMMUNOL, V37, P192, DOI 10.1111/pim.12176; Koutsoni O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097319; KRAUTHSIEGEL RL, 1995, FASEB J, V9, P1138, DOI 10.1096/fasebj.9.12.7672506; Kumar A, 2015, PARASITE IMMUNOL, V37, P368, DOI 10.1111/pim.12189; Kumar A, 2010, BRIT J CLIN PHARMACO, V70, P609, DOI 10.1111/j.1365-2125.2010.03716.x; Kumari S, 2008, VACCINE, V26, P5700, DOI 10.1016/j.vaccine.2008.08.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAWRENCE F, 1985, P NATL ACAD SCI USA, V82, P4414, DOI 10.1073/pnas.82.13.4414; Lemesre JL, 2007, VACCINE, V25, P4223, DOI 10.1016/j.vaccine.2007.02.083; Maalej IA, 2003, AM J TROP MED HYG, V68, P312, DOI 10.4269/ajtmh.2003.68.312; Magnan CN, 2010, BIOINFORMATICS, V26, P2936, DOI 10.1093/bioinformatics/btq551; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Matrangolo FSV, 2013, MOL BIOCHEM PARASIT, V190, P63, DOI 10.1016/j.molbiopara.2013.06.006; Melby PC, 2001, INFECT IMMUN, V69, P4719, DOI 10.1128/IAI.69.8.4719-4725.2001; Montagnoli C, 2004, MED MYCOL, V42, P319, DOI 10.1080/13693780310001644653; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Ntais P, 2013, AM J TROP MED HYG, V89, P906, DOI 10.4269/ajtmh.13-0070; Oliveira C D, 2001, Cad Saude Publica, V17, P1231, DOI 10.1590/S0102-311X2001000500023; Pal-Bhowmick I, 2007, INFECT IMMUN, V75, P5500, DOI 10.1128/IAI.00551-07; Palatnik-de-Sousa CB, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00069; Pinto EF, 2004, INFECT IMMUN, V72, P4521, DOI 10.1128/IAI.72.8.4521-4527.2004; Pitarch A, 2006, MOL CELL PROTEOMICS, V5, P79, DOI 10.1074/mcp.M500243-MCP200; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reis AB, 2010, TRENDS PARASITOL, V26, P341, DOI 10.1016/j.pt.2010.04.005; Requena JM, 2000, PARASITOL TODAY, V16, P246, DOI 10.1016/S0169-4758(00)01651-3; Requena JM, 2001, TRENDS PARASITOL, V17, P64, DOI 10.1016/S1471-4922(00)01769-4; ReyLadino JA, 1997, EXP PARASITOL, V85, P249, DOI 10.1006/expr.1996.4137; Sacks D. L., 1998, CURR PROTOC IMMUNOL, V29; Salay G, 2007, CLIN VACCINE IMMUNOL, V14, P1173, DOI 10.1128/CVI.00060-07; Santos-Gomes GM, 2014, VACCINE, V32, P1247, DOI 10.1016/j.vaccine.2014.01.024; Schluter A, 2000, BBA-GENE STRUCT EXPR, V1491, P65, DOI 10.1016/S0167-4781(00)00028-2; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sideris V, 1999, EUR J EPIDEMIOL, V15, P271, DOI 10.1023/A:1007526401175; Singh AK, 2014, J PROTEOMICS, V102, P44, DOI 10.1016/j.jprot.2014.02.030; SKEIKY YAW, 1995, J EXP MED, V181, P1527, DOI 10.1084/jem.181.4.1527; Skeiky YAW, 1998, J IMMUNOL, V161, P6171; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-86; Tarcha EJ, 2006, INFECT IMMUN, V74, P516, DOI 10.1128/IAI.74.1.516-527.2006; Tarcha EJ, 2006, INFECT IMMUN, V74, P5802, DOI 10.1128/IAI.00961-06; Thakur CP, 2001, T ROY SOC TROP MED H, V95, P187, DOI 10.1016/S0035-9203(01)90160-9; Todoli F, 2009, VET PARASITOL, V164, P154, DOI 10.1016/j.vetpar.2009.05.032; TZAMOURANIS N, 1984, ANN TROP MED PARASIT, V78, P363, DOI 10.1080/00034983.1984.11811833; Veiga-Malta I, 2004, CELL MICROBIOL, V6, P79, DOI 10.1046/j.1462-5822.2003.00344.x; Wagner JL, 2003, J HERED, V94, P23, DOI 10.1093/jhered/esg002; World Health Organization, 2010, TECH REP SER, V949, P186; Yau WL, 2014, MOL MICROBIOL, V93, P80, DOI 10.1111/mmi.12639	88	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 23	2016	11	2							e0149894	10.1371/journal.pone.0149894	http://dx.doi.org/10.1371/journal.pone.0149894			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF2HK	26906226	Green Published, Green Submitted, gold			2022-12-27	WOS:000371163000025
J	Ordonez-Gomez, JD; Cristobal-Azkarate, J; Arroyo-Rodriguez, V; Santillan-Doherty, AM; Valdez, RA; Romano, MC				Ordonez-Gomez, Jose D.; Cristobal-Azkarate, Jurgi; Arroyo-Rodriguez, Victor; Santillan-Doherty, Ana M.; Valdez, Ricardo A.; Romano, Marta C.			Proximal and Distal Predictors of the Spider Monkey's Stress Levels in Fragmented Landscapes	PLOS ONE			English	Article							FECAL CORTISOL-LEVELS; ALOUATTA-PALLIATA-MEXICANA; LACANDONA RAIN-FOREST; ATELES-GEOFFROYI; HOWLER MONKEYS; LOS-TUXTLAS; HABITAT FRAGMENTATION; ACTIVITY PATTERNS; TROPICAL FOREST; IMPACT	The rapid loss, fragmentation and degradation of tropical forests threaten the survival of many animal species. However, the way in which these phenomena affect animal health has been poorly explored, thus limiting the design of appropriate conservation strategies. To address this, here we identified using linear mixed models the effect of proximal (diet, activity pattern, hunting and logging) and distal (sum of the basal areas of fruiting-tree species [SBAFS], landscape forest cover and degree of forest fragmentation) variables over fecal glucocorticoid metabolite (fGCM) levels-hormones associated with animal health and fitness-of six groups of spider monkeys (Ateles geoffroyi) inhabiting six landscapes with different spatial structures in Mexico. Proximal variables showed a stronger predictive power over fGCMs than distal. In this sense, increases in travel time, the occurrence of hunting, and reductions in rest time and fruit consumption resulted in higher fGCM levels. Regarding distal variables, increases in SBAFS were negatively related to fGCM levels, thus suggesting that food scarcity increases stress hormone levels. Nevertheless, contrary to theoretical expectations, spider monkeys living in smaller tracts of forest spent less time travelling, but the same time feeding on fruit as those in more forested areas. The lower net energy return associated with this combination of factors would explain why, contrary to theoretical expectations, increased forest cover was associated with increased levels of fGCMs in these groups. Our study shows that, at least in the short term, spider monkeys in fragmented landscapes do not always present higher levels of stress hormones compared to those inhabiting continuous forest, and the importance of preserving fruit sources and controlling hunting for reducing the levels of stress hormones in free ranging spider monkeys.	[Ordonez-Gomez, Jose D.] Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Mexico City 04510, DF, Mexico; [Cristobal-Azkarate, Jurgi] Univ Cambridge, Div Biol Anthropol, Cambridge, England; [Arroyo-Rodriguez, Victor] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Santillan-Doherty, Ana M.] Inst Nacl Psiquiatria Ramon de la Fuente Muniz, Neurociencias, Mexico City, DF, Mexico; [Valdez, Ricardo A.; Romano, Marta C.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Fisiol Biofis & Neurociencias, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Cambridge; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Ordonez-Gomez, JD (corresponding author), Univ Nacl Autonoma Mexico, Posgrad Ciencias Biol, Mexico City 04510, DF, Mexico.	josed_ordonez@hotmail.com	Arroyo-Rodríguez, Víctor/C-9255-2009	Arroyo-Rodríguez, Víctor/0000-0002-0858-0324; Ordonez Gomez, Jose Domingo/0000-0002-6929-1470; Cristobal-Azkarate, Jurgi/0000-0002-2799-8638; VALDEZ, RICARDO/0000-0002-0278-4940; Romano Pardo, Marta Catalina/0000-0003-2932-0801	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [VER-2008-C02-109147]; CONACyT, Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACyT Project VER-2008-C02-109147). JDOG obtained a scholarship from the CONACyT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Arroyo-Rodriguez V, 2010, AM J PRIMATOL, V72, P1, DOI 10.1002/ajp.20753; Arroyo-Rodriguez V, 2007, BIOTROPICA, V39, P760, DOI 10.1111/j.1744-7429.2007.00330.x; Arroyo-Rodriguez V, 2007, BIOL CONSERV, V138, P198, DOI 10.1016/j.biocon.2007.04.016; Arroyo-Rodriguez V, 2006, INT J PRIMATOL, V27, P1079, DOI 10.1007/s10764-006-9061-0; Arroyo-Rodriguez V, 2014, AM J PRIMATOL, V76, P901, DOI 10.1002/ajp.22282; Arroyo-Rodriguez V, 2013, LANDSCAPE ECOL, V28, P1717, DOI 10.1007/s10980-013-9929-2; Arroyo-Rodriguez V, 2009, CONSERV BIOL, V23, P729, DOI 10.1111/j.1523-1739.2008.01120.x; Aureli F, 2008, CAM S BIO EVOL ANTHR, V55, P236; Balestri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107698; Barton K, 2015, PACKAGE MUMIN VERSIO; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Boyle SA, 2010, BIOL CONSERV, V143, P1134, DOI 10.1016/j.biocon.2010.02.008; Brousset DM, 2003, THESIS U NACL AUTONO; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Bryan HM, 2015, FUNCT ECOL, V29, P347, DOI 10.1111/1365-2435.12354; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Carrara E, 2015, BIOL CONSERV, V184, P117, DOI 10.1016/j.biocon.2015.01.014; Cavigelli SA, 1999, ANIM BEHAV, V57, P935, DOI 10.1006/anbe.1998.1054; CHAPMAN CA, 1992, BIOTROPICA, V24, P527, DOI 10.2307/2389015; Chapman CA, 2006, AM J PHYS ANTHROPOL, V131, P525, DOI 10.1002/ajpa.20477; Chatterjee S., 2012, REGRESSION ANAL EXAM; Chaves OM, 2012, BIOTROPICA, V44, P105, DOI 10.1111/j.1744-7429.2011.00766.x; Chaves OM, 2011, INT J PRIMATOL, V32, P960, DOI 10.1007/s10764-011-9515-x; Couturier S, 2012, TROPICAL FORESTS, P269; Cristobal-Azkarate J, 2005, AM J PRIMATOL, V67, P209, DOI 10.1002/ajp.20178; Cristobal-Azkarate J, 2007, AM J PRIMATOL, V69, P1013, DOI 10.1002/ajp.20420; Cuaron A. D., 2008, ATELES GEOFFROYI IUC, V2008; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; Didham RK, 2012, OIKOS, V121, P161, DOI 10.1111/j.1600-0706.2011.20273.x; Duarte-Quiroga A, 2003, AM J PRIMATOL, V61, P53, DOI 10.1002/ajp.10108; Dunn JC, 2013, INT J PRIMATOL, V34, P246, DOI 10.1007/s10764-013-9657-0; Dunn JC, 2009, AM J PRIMATOL, V71, P654, DOI 10.1002/ajp.20700; Ellis EC, 2013, CURR OPIN ENV SUST, V5, P368, DOI 10.1016/j.cosust.2013.07.002; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fahrig L, 2013, J BIOGEOGR, V40, P1649, DOI 10.1111/jbi.12130; Foerster S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050108; Foerster S, 2010, HORM BEHAV, V58, P685, DOI 10.1016/j.yhbeh.2010.06.002; Fox J., 2019, R COMPANION APPL REG, V.; Garber PA, 2006, DEV PRIMATOL-PROG PR, P563, DOI 10.1007/0-387-25872-8_27; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Garmendia A, 2013, J TROP ECOL, V29, P331, DOI 10.1017/S0266467413000370; GENUTH SM, 1993, PHYSIOLOGY, P813; Gesquiere LR, 2008, HORM BEHAV, V54, P410, DOI 10.1016/j.yhbeh.2008.04.007; Gomez-Espinosa E, 2014, AM J PRIMATOL, V76, P362, DOI 10.1002/ajp.22240; Gonzalez-Zamora A, 2015, J TROP ECOL, V31, P305, DOI 10.1017/S026646741500022X; Gonzalez-Zamora A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089346; Gonzalez-Zamora A, 2011, AM J PRIMATOL, V73, P1189, DOI 10.1002/ajp.20989; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hernandez-Ruedas MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098931; Hothorn T, 2015, SIMULTANEOUS INFEREN; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Lenth RV, 2013, USING ISMEANS PACKAG; Martinez E, 2003, DEFORESTACION 24 REG, P124; Martinez-Mota R, 2007, ANIM CONSERV, V10, P374, DOI 10.1111/j.1469-1795.2007.00122.x; Michalski F, 2005, BIOL CONSERV, V124, P383, DOI 10.1016/j.biocon.2005.01.045; MILTON K, 1981, AM NAT, V117, P496, DOI 10.1086/283730; Muller MN, 2004, BEHAV ECOL SOCIOBIOL, V55, P332, DOI 10.1007/s00265-003-0713-1; Ordonez-Gomez JD, 2015, AM J PRIMATOL, V77, P56, DOI 10.1002/ajp.22310; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; Rimbach R, 2014, AM J PRIMATOL, V76, P1049, DOI 10.1002/ajp.22292; Rimbach R, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot031; Romano MC, 2010, NEUROIMMUNOMODULAT, V17, P209, DOI 10.1159/000258726; Russildi G, 2016, BIODIVERS CONSERV, V25, P375, DOI 10.1007/s10531-016-1056-3; SAGARPA, PROYECT ESTR TROP HU; Sanchez-de-Jesus HA, 2016, LANDSCAPE ECOL, V31, P843, DOI 10.1007/s10980-015-0293-2; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Stevenson PR, 1998, BIOTROPICA, V30, P129, DOI 10.1111/j.1744-7429.1998.tb00376.x; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Thornton DH, 2011, ECOL APPL, V21, P2324, DOI 10.1890/10-2124.1; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; Wieczkowski J, 2004, AM J PRIMATOL, V63, P125, DOI 10.1002/ajp.20046; Wingfield J.C., 2001, HANDBK PHYSL, P211, DOI [10.1002/cphy.cp070411, DOI 10.1002/CPHY.CP070411]; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; Rodas-Martinez AZ, 2013, ZOO BIOL, V32, P641, DOI 10.1002/zoo.21101	80	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2016	11	2							e0149671	10.1371/journal.pone.0149671	http://dx.doi.org/10.1371/journal.pone.0149671			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF3VL	26901767	Green Submitted, Green Published, gold			2022-12-27	WOS:000371276100126
J	Wu, HY; Li, P; Pan, DQ; Yin, ZX; Fang, QH; Wu, WS				Wu, Hanyu; Li, Ping; Pan, Duoqiang; Yin, Zhuoxin; Fang, Qiaohui; Wu, Wangsuo			Interactions between Silicon Oxide Nanoparticles (SONPs) and U(VI) Contaminations: Effects of pH, Temperature and Natural Organic Matters	PLOS ONE			English	Article							HUMIC-ACID; AQUEOUS-SOLUTIONS; IONIC-STRENGTH; SURFACE COMPLEXATION; SORPTION-DESORPTION; URANYL SORPTION; FULVIC-ACID; URANIUM(VI); ADSORPTION; REMOVAL	The interactions between contaminations of U(VI) and silicon oxide nanoparticles (SONPs), both of which have been widely used in modern industry and induced serious environmental challenge due to their high mobility, bioavailability, and toxicity, were studied under different environmental conditions such as pH, temperature, and natural organic matters (NOMs) by using both batch and spectroscopic approaches. The results showed that the accumulation process, i.e., sorption, of U(VI) on SONPs was strongly dependent on pH and ionic strength, demonstrating that possible outer- and/or inner-sphere complexes were controlling the sorption process of U(VI) on SONPs in the observed pH range. Humic acid (HA), one dominated component of NOMs, bounded SONPs can enhance U(VI) sorption below pH -4.5, whereas restrain at high pH range. The reversible sorption of U(VI) on SONPs possibly indicated that the outer-sphere complexes were prevalent at pH 5. However, an irreversible interaction of U(VI) was observed in the presence of HA (Fig 1). It was mainly due to the ternary SONPs-HA-U(VI) complexes (Type A Complexes). After SONPs adsorbed U(VI), the particle size in suspension was apparently increased from similar to 240 nm to similar to 350 nm. These results showed that toxicity of both SONPs and U(VI) will decrease to some extent after the interaction in the environment. These findings are key for providing useful information on the possible mutual interactions among different contaminants in the environment.	[Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China; [Fang, Qiaohui] Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China; [Li, Ping] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang 621000, Sichuan, Peoples R China; [Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Engineering Physics	Wu, WS (corresponding author), Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China.; Fang, QH (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China.; Wu, WS (corresponding author), Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China.	fanqh@lzb.ac.cn; wuws@lzu.edu.cn			Special Foundation for High Level Waste Disposal, China [[2012] 494]; National Natural Science Foundation of China [21327801, J1210001, 41573128]; Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University [Izujbky-2015-70]; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University [Izummm2015011]	Special Foundation for High Level Waste Disposal, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University	The funding or sources of support received during this specific study (whether external or internal to the organization): 1) Special Foundation for High Level Waste Disposal, China ([2012] 494) http://www.sastind.gov.cn; 2) National Natural Science Foundation of China (21327801) http://www.nsfc.gov.cn/publish/portal1/; 3) National Natural Science Foundation of China (J1210001) http://www.nsfc.gov.cn/publish/portal1/; 4) National Natural Science Foundation of China (41573128) http://www.nsfc.gov.cn/publish/portal1/; 5) "100-Talent" Program from Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS http://english.cas.cn; 6) The Basic Scientific Research Business Expenses of the Central University (Izujbky-2015-70) http://en.lzu.edu.cn; 7) Open Project of Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University (Izummm2015011) (http://en.lzu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW NJ, 1986, J SOIL SCI, V37, P295, DOI 10.1111/j.1365-2389.1986.tb00031.x; Batuk DN, 2011, ACTINIDE NANOPARTICL, P315, DOI [10.1007/978-3-642-11432-8_11, DOI 10.1007/978-3-642-11432-8_11]; Bhalara PD, 2014, J ENVIRON CHEM ENG, V2, P1621, DOI 10.1016/j.jece.2014.06.007; Campos B, 2013, APPL CLAY SCI, V85, P53, DOI 10.1016/j.clay.2013.08.046; Chisholm-Brause CJ, 2001, J COLLOID INTERF SCI, V233, P38, DOI 10.1006/jcis.2000.7227; Das D, 2010, J RADIOANAL NUCL CH, V285, P447, DOI 10.1007/s10967-010-0627-0; Dinesh R, 2012, GEODERMA, V173, P19, DOI 10.1016/j.geoderma.2011.12.018; Fan QH, 2014, ENVIRON SCI-PROC IMP, V16, P534, DOI 10.1039/c3em00324h; Fan QH, 2012, APPL RADIAT ISOTOPES, V70, P13, DOI 10.1016/j.apradiso.2011.07.004; Fan QH, 2009, ENVIRON SCI TECHNOL, V43, P5776, DOI 10.1021/es901241f; Fan QH, 2011, J HAZARD MATER, V192, P1851, DOI 10.1016/j.jhazmat.2011.07.022; Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001; Guo ZJ, 2009, RADIOCHIM ACTA, V97, P133, DOI 10.1524/ract.2009.1589; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ivanov P, 2012, J ENVIRON MONITOR, V14, P2968, DOI 10.1039/c2em30512g; Katsoyiannis IA, 2013, DESALIN WATER TREAT, V51, P2915, DOI 10.1080/19443994.2012.748300; Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Krepelova A, 2008, J COLLOID INTERF SCI, V319, P40, DOI 10.1016/j.jcis.2007.11.010; Krepelova A, 2007, ENVIRON SCI TECHNOL, V41, P6142, DOI 10.1021/es070419q; Kushwaha S, 2013, J ENVIRON RADIOACTIV, V126, P115, DOI 10.1016/j.jenvrad.2013.07.021; Li P, 2014, ENVIRON SCI-PROC IMP, V16, P2278, DOI 10.1039/c4em00301b; Massey MS, 2014, ENVIRON SCI TECHNOL, V48, P8636, DOI 10.1021/es501064m; McCarthy J, 2012, CHEM RES TOXICOL, V25, P2227, DOI 10.1021/tx3002884; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nilchi A, 2013, DESALINATION, V321, P67, DOI 10.1016/j.desal.2012.06.022; Niu ZW, 2009, APPL RADIAT ISOTOPES, V67, P1582, DOI 10.1016/j.apradiso.2009.03.113; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Olu-Owolabi BI, 2014, J ENVIRON MANAGE, V137, P1, DOI 10.1016/j.jenvman.2014.01.048; Ozer A, 2005, CHEM ENG J, V112, P181, DOI 10.1016/j.cej.2005.07.007; Payne TE, 2004, APPL CLAY SCI, V26, P151, DOI 10.1016/j.clay.2003.08.013; Rengaraj S, 2004, J COLLOID INTERF SCI, V273, P14, DOI 10.1016/j.jcis.2004.01.007; Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j; Sachs S, 2008, CHEMOSPHERE, V72, P1441, DOI 10.1016/j.chemosphere.2008.05.027; Sachs S, 2011, J RADIOANAL NUCL CH, V290, P17, DOI 10.1007/s10967-011-1084-0; Schafer T, 2012, APPL GEOCHEM, V27, P390, DOI 10.1016/j.apgeochem.2011.09.009; Schmeide K, 2003, INORG CHIM ACTA, V351, P133, DOI 10.1016/S0020-1693(03)00184-1; Sun YB, 2012, J ENVIRON RADIOACTIV, V105, P40, DOI 10.1016/j.jenvrad.2011.10.009; Tan XL, 2008, ENVIRON SCI TECHNOL, V42, P6532, DOI 10.1021/es8007062; Tan XL, 2010, MOLECULES, V15, P8431, DOI 10.3390/molecules15118431; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Tian G, 2011, J HAZARD MATER, V190, P442, DOI 10.1016/j.jhazmat.2011.03.066; Tipping Edward, 1993, Analytical Proceedings, V30, P186, DOI 10.1039/ap9933000186; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Weng LP, 2006, ENVIRON SCI TECHNOL, V40, P7494, DOI 10.1021/es060777d; Wu WS, 2007, APPL RADIAT ISOTOPES, V65, P1108, DOI 10.1016/j.apradiso.2007.05.009; Xu D, 2008, APPL CLAY SCI, V39, P133, DOI 10.1016/j.clay.2007.05.006; Yang SP, 2013, ENVIRON SCI TECHNOL, V47, P4718, DOI 10.1021/es3047334	48	32	37	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149632	10.1371/journal.pone.0149632	http://dx.doi.org/10.1371/journal.pone.0149632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930197	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500036
